PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Goldman, JA; Garlick, JD; Kingston, RE				Goldman, Joseph A.; Garlick, Joseph D.; Kingston, Robert E.			Chromatin Remodeling by Imitation Switch (ISWI) Class ATP-dependent Remodelers Is Stimulated by Histone Variant H2A.Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME SURFACE; PROMOTERS; COMPLEXES; TRANSCRIPTION; SWI/SNF; GENES; RECEPTOR; REGIONS; GENOME; ALTERS	ATP-dependent chromatin remodeling complexes rearrange nucleosomes by altering the position of DNA around the histone octamer. Although chromatin remodelers and the histone variant H2A.Z colocalize on transcriptional control regions, whether H2A.Z directly affects remodeler association or activity is unclear. We determined the relative association of remodelers with H2A.Z chromatin and tested whether replacement of H2A.Z in a nucleosome altered the activity of remodeling enzymes. Many families of remodelers showed increased association with H2A.Z chromatin, but only the ISWI family of chromatin remodelers showed stimulated activity in vitro. An acidic patch on the nucleosome surface, extended by inclusion of H2A.Z in nucleosomes and essential for viability, is required for ISWI stimulation. We conclude that H2A.Z incorporation increases nucleosome remodeling activity of the largest class of mammalian remodelers (ISWI) and that it correlates with increased association of other remodelers to chromatin. This reveals two possible modes for regulation of a remodeler by a histone variant.	[Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	Kingston@molbio.mgh.harvard.edu		Goldman, Joseph/0000-0002-0800-6189				Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Chang EY, 2008, BIOCHEMISTRY-US, V47, P13726, DOI 10.1021/bi8016944; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hanai K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000011; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Luger K, 1999, METH MOL B, V119, P1; Narlikar GJ, 2001, MOL CELL, V8, P1219, DOI 10.1016/S1097-2765(01)00412-9; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	39	49	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4645	4651		10.1074/jbc.M109.072348	http://dx.doi.org/10.1074/jbc.M109.072348			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19940112	Green Published, hybrid			2022-12-27	WOS:000275274800043
J	Ohira, T; Arita, M; Omori, K; Recchiuti, A; Van Dyke, TE; Serhan, CN				Ohira, Taisuke; Arita, Makoto; Omori, Kazuhiro; Recchiuti, Antonio; Van Dyke, Thomas E.; Serhan, Charles N.			Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESOLUTION; AIRWAY INFLAMMATION; LIPID MEDIATORS; CELLS; KINASE; GRANULOCYTES; SPECIFICITY; NEUTROPHILS; PROGRAMS; CHEMR23	Resolvins are endogenous lipid mediators that actively regulate the resolution of acute inflammation. Resolvin E1 (RvE1; (5S, 12R, 18R)-trihydroxy-6Z, 8E, 10E, 14Z, 16E-eicosapentaenoic acid) is an endogenous anti-inflammatory and pro-resolving mediator derived from eicosapentaenoic acid that regulates leukocyte migration and enhances macrophage phagocytosis of apoptotic neutrophils to resolve inflammation. In the inflammatory milieu, RvE1 mediates counter-regulatory actions initiated via specific G protein-coupled receptors. Here, we have identified RvE1-specific signaling pathways initiated by the RvE1 receptor ChemR23. RvE1 stimulated phosphorylation of Akt that was both ligand-and receptor-dependent. RvE1 regulated Akt phosphorylation in a time (0-15 min)- and dose-dependent (0.01-100 nM) manner in human ChemR23-transfected Chinese hamster ovary cells. RvE1 stimulated phosphorylation of both Akt and a 30-kDa protein, a downstream target of Akt, identified using a phospho-Akt substrate antibody. The 30-kDa protein was identified as ribosomal protein S6, a translational regulator, and its phosphorylation was inhibited by a phosphatidylinositol 3-kinase (PI3K) inhibitor (wortmannin) and an ERK inhibitor (PD98059) but not by a p38-MAPK inhibitor (SB203580). Ribosomal protein S6 is a downstream target of the PI3K/Akt signaling pathway as well as the Raf/ERK pathway. In ChemR23-expressing differentiated HL60 cells, RvE1 also stimulated the phosphorylation of ribosomal protein S6. In addition, RvE1 enhanced phagocytosis of zymosanAby human macrophages, which are inhibited by PD98059 and rapamycin (mTOR inhibitor). These results indicate that RvE1 initiates direct activation of ChemR23 and signals receptor-dependent phosphorylation. These phosphorylation-signaling pathways identified for RvE1 receptor-ligand interactions underscore the importance of endogenous pro-resolving agonists in resolving acute inflammation.	[Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus, Boston, MA 02115 USA; [Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ohira, Taisuke; Omori, Kazuhiro; Van Dyke, Thomas E.] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University	Serhan, CN (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus, HIM 829,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Omori, Kazuhiro/AAX-5268-2020; Recchiuti, Antonio/K-7670-2016	Recchiuti, Antonio/0000-0002-1409-5261; Arita, Makoto/0000-0001-9902-0463	National Institutes of Health [DE-016191, DE-015566, GM38765]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R37GM038765, R29GM038765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE-016191 (to C. N. S. and T. E. V. D.), DE-015566 (to T. E. V. D.), and GM38765 (to C. N. S.). Brigham and Women's Hospital and Boston University are assigned patents on resolvins that are licensed for clinical development and are subject to consultant agreements for Drs. Charles N. Serhan and Thomas E. Van Dyke.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gronert K, 2008, MOL INTERV, V8, P28, DOI 10.1124/mi.8.1.7; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Hong S, 2008, J IMMUNOL, V180, P3512, DOI 10.4049/jimmunol.180.5.3512; Ly C, 2003, CANCER RES, V63, P5716; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Ohira T, 2003, J IMMUNOL METHODS, V281, P79, DOI 10.1016/S0022-1759(03)00278-3; SAVINAINEN A, 2007, 10 INT C BIOACT LIP; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Starosta V, 2008, J IMMUNOL, V181, P8688, DOI 10.4049/jimmunol.181.12.8688; Vassiliou EK, 2008, J IMMUNOL, V181, P4534, DOI 10.4049/jimmunol.181.7.4534; Yoshimura T, 2008, J EXP MED, V205, P2187, DOI 10.1084/jem.20081736; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003	31	189	200	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3451	3461		10.1074/jbc.M109.044131	http://dx.doi.org/10.1074/jbc.M109.044131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19906641	hybrid, Green Published			2022-12-27	WOS:000273829000059
J	Cartier, EA; Parra, LA; Baust, TB; Quiroz, M; Salazar, G; Faundez, V; Egana, L; Torres, GE				Cartier, Etienne A.; Parra, Leonardo A.; Baust, Tracy B.; Quiroz, Marisol; Salazar, Gloria; Faundez, Victor; Egana, Loreto; Torres, Gonzalo E.			A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR MONOAMINE TRANSPORTER-2; BOVINE CAUDATE NUCLEUS; DENSE CORE VESICLES; TYROSINE-HYDROXYLASE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; QUANTAL SIZE; REGULATORY PROPERTIES; GTP CYCLOHYDROLASE; CYTOSOLIC DOPAMINE	Synaptic transmission depends on neurotransmitter pools stored within vesicles that undergo regulated exocytosis. In the brain, the vesicular monoamine transporter-2 (VMAT(2)) is responsible for the loading of dopamine (DA) and other mono-amines into synaptic vesicles. Prior to storage within vesicles, DA synthesis occurs at the synaptic terminal in a two-step enzymatic process. First, the rate-limiting enzyme tyrosine hydroxylase (TH) converts tyrosine to di-OH-phenylalanine. Aromatic aminoacid decarboxylase(AADC) then converts di-OH-phenylalanine into DA. Here, we provide evidence that VMAT(2) physically and functionally interacts with the enzymes responsible for DA synthesis. In rat striata, TH and AADC co-immunoprecipitate with VMAT(2), whereas in PC 12 cells, TH co-immunoprecipitates with the closely related VMAT(1) and with overexpressed VMAT(2). GST pull-down assays further identified three cytosolic domains of VMAT(2) involved in the interaction with TH and AADC. Furthermore, in vitro binding assays demonstrated that TH directly interacts with VMAT(2). Additionally, using fractionation and immunoisolation approaches, we demonstrate that TH and AADC associate with VMAT(2)-containing synaptic vesicles from rat brain. These vesicles exhibited specific TH activity. Finally, the coupling between synthesis and transport of DA into vesicles was impaired in the presence of fragments involved in the VMAT(2)/TH/AADC interaction. Taken together, our results indicate that DA synthesis can occur at the synaptic vesicle membrane, where it is physically and functionally coupled to VMAT(2)-mediated transport into vesicles.	[Egana, Loreto; Torres, Gonzalo E.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Torres, Gonzalo E.] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Salazar, Gloria] Emory Univ, Div Cardiol, Dept Med, Atlanta, GA 30322 USA; [Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Emory University	Torres, GE (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Rm 6061,BST3,3501 5th Ave, Pittsburgh, PA 15261 USA.	gtorres@pitt.edu		Parra Rivas, Leonardo/0000-0002-6707-1255; Faundez, Victor/0000-0002-2114-5271				Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BERRY MD, 1994, PROG NEUROBIOL, V42, P375, DOI 10.1016/0301-0082(94)90081-7; Bowling KM, 2008, J BIOL CHEM, V283, P31449, DOI 10.1074/jbc.M802552200; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Caudle WM, 2008, TRENDS NEUROSCI, V31, P303, DOI 10.1016/j.tins.2008.02.010; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; CHRISTENSON JG, 1972, P NATL ACAD SCI USA, V69, P343, DOI 10.1073/pnas.69.2.343; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; FAHN S, 1969, J NEUROCHEM, V16, P1293, DOI 10.1111/j.1471-4159.1969.tb05979.x; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; Guo JT, 2008, CELL MOL NEUROBIOL, V28, P35, DOI 10.1007/s10571-007-9227-0; Hastings TG, 1996, ADV EXP MED BIOL, V387, P97; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; HAYCOCK JW, 1991, J BIOL CHEM, V266, P5650; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; KELNER KL, 1986, P NATL ACAD SCI USA, V83, P2998, DOI 10.1073/pnas.83.9.2998; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; KUCZENSKI RT, 1972, J BIOL CHEM, V247, P3114; KUHN DM, 1990, J BIOL CHEM, V265, P5780; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Makinae K, 2000, J NEUROCHEM, V75, P1429, DOI 10.1046/j.1471-4159.2000.0751429.x; MANDELL AJ, 1972, BIOCHEM PHARMACOL, V21, P2737, DOI 10.1016/0006-2952(72)90022-6; Michelsen KA, 2008, PROG BRAIN RES, V172, P233, DOI 10.1016/S0079-6123(08)00912-6; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; MORITA K, 1987, J BIOL CHEM, V262, P5654; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Mosharov EV, 2006, J NEUROSCI, V26, P9304, DOI 10.1523/JNEUROSCI.0519-06.2006; NAGATSU T, 1970, EXPERIENTIA, V26, P722, DOI 10.1007/BF02232504; NAGATSU T, 1971, J NEUROCHEM, V18, P2179, DOI 10.1111/j.1471-4159.1971.tb05076.x; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Nirenberg MJ, 1997, SYNAPSE, V26, P194; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; PETER D, 1995, J NEUROSCI, V15, P6179; PICKEL VM, 1975, J HISTOCHEM CYTOCHEM, V23, P1, DOI 10.1177/23.1.234988; PICKEL VM, 1976, J HISTOCHEM CYTOCHEM, V24, P792, DOI 10.1177/24.7.8567; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pothos EN, 2000, J NEUROSCI, V20, P7297; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; Requena DF, 2009, J NEUROCHEM, V110, P581, DOI 10.1111/j.1471-4159.2009.06135.x; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; SCHERMAN D, 1988, NEUROSCIENCE, V27, P1029, DOI 10.1016/0306-4522(88)90207-2; SCHERMAN D, 1986, J NEUROCHEM, V47, P331; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Tsudzuki T, 2004, J BIOCHEM, V136, P239, DOI 10.1093/jb/mvh113; Vermetten E, 2002, DEPRESS ANXIETY, V15, P126, DOI 10.1002/da.10016; Wang J, 2009, J BIOL CHEM, V284, P14011, DOI 10.1074/jbc.M901310200; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	61	83	86	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1957	1966		10.1074/jbc.M109.054510	http://dx.doi.org/10.1074/jbc.M109.054510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19903816	hybrid, Green Published			2022-12-27	WOS:000273429100042
J	Kii, I; Nishiyama, T; Li, MQ; Matsumoto, K; Saito, M; Amizuka, N; Kudo, A				Kii, Isao; Nishiyama, Takashi; Li, Minqi; Matsumoto, Ken-ichi; Saito, Mitsuru; Amizuka, Norio; Kudo, Akira			Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL OXIDASE; MATRICELLULAR PROTEINS; PERIODONTAL-LIGAMENT; BINDING-SITE; CROSS-LINKS; EXPRESSION; FIBRONECTIN; COLLAGEN; MICE; CELL	Extracellular matrix (ECM) underlies a complicated multicellular architecture that is subjected to significant forces from mechanical environment. Although various components of the ECM have been enumerated, mechanisms that evolve the sophisticated ECM architecture remain to be addressed. Here we show that periostin, a matricellular protein, promotes incorporation of tenascin-C into the ECM and organizes a meshwork architecture of the ECM. We found that both periostin null mice and tenascin-C null mice exhibited a similar phenotype, confined tibial periostitis, which possibly corresponds to medial tibial stress syndrome in human sports injuries. Periostin possessed adjacent domains that bind to tenascin-C and the other ECM protein: fibronectin and type I collagen, respectively. These adjacent domains functioned as a bridge between tenascin-C and the ECM, which increased deposition of tenascin-C on the ECM. The deposition of hexabrachions of tenascin-C may stabilize bifurcations of the ECM fibrils, which is integrated into the extracellular meshwork architecture. This study suggests a role for periostin in adaptation of the ECM architecture in the mechanical environment.	[Kii, Isao; Nishiyama, Takashi; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; [Li, Minqi; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Div Oral Hlth Sci,Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Matsumoto, Ken-ichi] Shimane Univ, Dept Biosignaling & Radioisotope Expt, Ctr Integrated Res Sci, Izumo, Shimane 6938501, Japan; [Saito, Mitsuru] Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, Tokyo 1058461, Japan	Tokyo Institute of Technology; Hokkaido University; Shimane University; Jikei University		akudo@bio.titech.ac.jp	Kudo, Akira/C-7340-2015; KII, Isao/C-4117-2017; Nishiyama, Takashi/ABC-8965-2021	Kudo, Akira/0000-0001-6289-3391; KII, Isao/0000-0002-6153-6250; Nishiyama, Takashi/0000-0002-4496-240X	Ministry of Education, Science, Culture, and Sports of Japan; Japan Space Forum	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan (to I. K. and A. K.) and by grants from the Ground-based Research Program for Space Utilization promoted by Japan Space Forum (to A. K.).	Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; AUKHIL I, 1993, J BIOL CHEM, V268, P2542; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bornstein P, 2000, MATRIX BIOL, V19, P555, DOI 10.1016/S0945-053X(00)00103-7; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Chung CY, 1997, J CELL SCI, V110, P1413; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; FISCHER D, 1995, J BIOL CHEM, V270, P3378, DOI 10.1074/jbc.270.7.3378; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Gaeta M, 2005, RADIOLOGY, V235, P553, DOI 10.1148/radiol.2352040406; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Imanaka-Yoshida K, 2004, HISTOL HISTOPATHOL, V19, P517, DOI 10.14670/HH-19.517; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; Jang JH, 2004, J BIOL CHEM, V279, P25562, DOI 10.1074/jbc.M403170200; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Koyama E, 1996, J ORTHOPAED RES, V14, P403, DOI 10.1002/jor.1100140310; Kudo H, 2004, DEV BIOL, V267, P473, DOI 10.1016/j.ydbio.2003.12.007; Litvin J, 2007, AM J PHYSIOL-CELL PH, V292, pC1672, DOI 10.1152/ajpcell.00153.2006; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pischon N, 2005, J CELL PHYSIOL, V203, P111, DOI 10.1002/jcp.20206; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; SAGA Y, 1991, GENE, V104, P177, DOI 10.1016/0378-1119(91)90248-A; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; SUGIURA T, 1995, PROTEIN EXPRES PURIF, V6, P305, DOI 10.1006/prep.1995.1040; Suzuki H, 2004, ANAT REC PART A, V281A, P1264, DOI 10.1002/ar.a.20080; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Takayama I, 2009, J BIOCHEM, V146, P713, DOI 10.1093/jb/mvp117; Tamaoki M, 2005, AM J PATHOL, V167, P71, DOI 10.1016/S0002-9440(10)62954-9; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tweed JL, 2008, J AM PODIAT MED ASSN, V98, P107; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; WEBER P, 1995, J BIOL CHEM, V270, P4619, DOI 10.1074/jbc.270.9.4619; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Yoshioka N, 2002, EXP CELL RES, V279, P91, DOI 10.1006/excr.2002.5590; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	59	207	214	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2028	2039		10.1074/jbc.M109.051961	http://dx.doi.org/10.1074/jbc.M109.051961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19887451	Green Published, hybrid			2022-12-27	WOS:000273429100048
J	Matsuura, I; Chiang, KN; Lai, CY; He, DM; Wang, GN; Ramkumar, R; Uchida, T; Ryo, A; Lu, KP; Liu, F				Matsuura, Isao; Chiang, Keng-Nan; Lai, Chen-Yu; He, Dongming; Wang, Guannan; Ramkumar, Romila; Uchida, Takafumi; Ryo, Akihide; Lu, Kunping; Liu, Fang			Pin1 Promotes Transforming Growth Factor-beta-induced Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL-ISOMERASE PIN1; BREAST-CANCER CELLS; TGF-BETA; SMAD3 PHOSPHORYLATION; N-CADHERIN; ANTIPROLIFERATIVE FUNCTION; MAP KINASE; KAPPA-B; C-JUN; PATHWAYS	Transforming growth factor-beta (TGF-beta) regulates a wide variety of biological activities. It induces potent growth-inhibitory responses in normal cells but promotes migration and invasion of cancer cells. Smads mediate the TGF-beta responses. TGF-beta binding to the cell surface receptors leads to the phosphorylation of Smad2/3 in their C terminus as well as in the proline-rich linker region. The serine/threonine phosphorylation sites in the linker region are followed by the proline residue. Pin1, a peptidyl-prolyl cis/trans isomerase, recognizes phosphorylated serine/threonine-proline motifs. Here we show that Smad2/3 interacts with Pin1 in a TGF-beta-dependent manner. We further show that the phosphorylated threonine 179-proline motif in the Smad3 linker region is the major binding site for Pin1. Although epidermal growth factor also induces phosphorylation of threonine 179 and other residues in the Smad3 linker region the same as TGF-beta, Pin1 is unable to bind to the epidermal growth factor-stimulated Smad3. Further analysis suggests that phosphorylation of Smad3 in the C terminus is necessary for the interaction with Pin1. Depletion of Pin1 by small hairpin RNA does not significantly affect TGF-beta-induced growth-inhibitory responses and a number of TGF-beta/Smad target genes analyzed. In contrast, knockdown of Pin1 in human PC3 prostate cancer cells strongly inhibited TGF-beta-mediated migration and invasion. Accordingly, TGF-beta induction of N-cadherin, which plays an important role in migration and invasion, is markedly reduced when Pin1 is depleted in PC3 cells. Because Pin1 is overexpressed in many cancers, our findings highlight the importance of Pin1 in TGF-beta-induced migration and invasion of cancer cells.	[Matsuura, Isao; Chiang, Keng-Nan; Lai, Chen-Yu] Natl Hlth Res Inst, Div Mol Genom & Med, Zhunan Town 350, Miaoli County, Taiwan; [Liu, Fang] Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Matsuura, Isao; He, Dongming; Wang, Guannan; Ramkumar, Romila; Liu, Fang] Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Piscataway, NJ 08854 USA; [Matsuura, Isao; He, Dongming; Wang, Guannan; Ramkumar, Romila; Liu, Fang] Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Ryo, Akihide] Yokohama City Univ, Dept Microbiol, Sch Med, Yokohama, Kanagawa 2360004, Japan; [Lu, Kunping] Harvard Univ, Canc Biol Program, Div Hematol Oncol, Beth Israel Deaconess Med Ctr,Med Sch,Dept Med, Boston, MA 02105 USA	National Health Research Institutes - Taiwan; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Tohoku University; Yokohama City University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Matsuura, I (corresponding author), Natl Hlth Res Inst, Div Mol Genom & Med, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan.	imatsuura@nhri.org.tw; fangliu@cabm.rutgers.edu	Matsuura, Isao/E-3979-2010	Uchida, Takafumi/0000-0003-3665-4906	National Institutes of Health [CA93771]; National Health Research Institutes; NATIONAL CANCER INSTITUTE [R01CA093771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes(National Health Research Institutes, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA93771 (to F. L.). This work was also supported by the National Health Research Institutes (to I. M.).	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; BEHRENS J, 1993, BREAST CANCER RES TR, V24, P175, DOI 10.1007/BF01833258; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Fan G, 2009, CANCER RES, V69, P4589, DOI 10.1158/0008-5472.CAN-08-4117; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; He J, 2007, LUNG CANCER, V56, P51, DOI 10.1016/j.lungcan.2006.11.024; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kim CJ, 2005, WORLD J GASTROENTERO, V11, P5006, DOI 10.3748/wjg.v11.i32.5006; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lam PB, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-91; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Liu F, 2005, CELL CYCLE, V4, P63, DOI 10.4161/cc.4.1.1366; Liu F, 2003, FRONT BIOSCI-LANDMRK, V8, pS1280, DOI 10.2741/1149; Lopez-Rovira T, 2000, J BIOL CHEM, V275, P28937, DOI 10.1074/jbc.M909923199; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Pang R, 2004, ONCOGENE, V23, P4182, DOI 10.1038/sj.onc.1207493; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Price JT, 1997, CRIT REV BIOCHEM MOL, V32, P175, DOI 10.3109/10409239709082573; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sachdev P, 2002, J BIOL CHEM, V277, P17638, DOI 10.1074/jbc.M111575200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamagata H, 2005, CANCER RES, V65, P157; Yang YA, 2006, CANCER CELL, V9, P445, DOI 10.1016/j.ccr.2006.04.025; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200	86	81	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1754	1764		10.1074/jbc.M109.063826	http://dx.doi.org/10.1074/jbc.M109.063826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920136	Green Published, hybrid			2022-12-27	WOS:000273429100021
J	Nakamura, K; Kimple, AJ; Siderovski, DP; Johnson, GL				Nakamura, Kazuhiro; Kimple, Adam J.; Siderovski, David P.; Johnson, Gary L.			PB1 Domain Interaction of p62/Sequestosome 1 and MEKK3 Regulates NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNALING ADAPTER P62; NERVE-GROWTH-FACTOR; IMPORTANT MEDIATOR; AUTOPHAGY; PATHWAYS; RECEPTOR; SCAFFOLD; CANCER; TUMORIGENESIS	p62/Sequestosome 1 is a scaffold protein involved in the regulation of autophagy, trafficking of proteins to the proteasome, and activation of NF-kappa B. p62 encodes an N-terminal PB1 domain in addition to the ZZ domain, TRAF6-binding domain, LC3 interaction region, and ubiquitin-associated domain, each critical for the physiological function of p62. PB1 domains have a beta-grasp topology where the front end of one PB1 domain binds the back end of a second PB1 domain. The p62 PB1 domain homodimerizes as well as heterodimerizes with other PB1 domains. The front end of the PB1 domain in p62 binds the PB1 domain of atypical protein kinases C, the MAPK kinase, MEK5, and the NBR1 protein. Other than its role in homodimerization, the rear end acidic cluster region of the p62 PB1 domain had no previous defined binding partners. Herein, we demonstrate that the rear end acidic cluster region of the p62 PB1 domain binds the front end basic region of the MAPK kinase kinase, MEKK3. p62 and MEKK3 co-localize in speckles or aggregates that are centers for organizing TRAF6-regulated NF-kappa B signaling and the assembly of polyubiquinated proteins sorting to sequestosomes and proteasomes. The p62-MEKK3 complex binds TRAF6, which regulates the ubiquitination of the IKK complex and NF-kappa B activation. p62 is required for the association of MEKK3 with TRAF6 and short hairpin RNA knockdown of p62 inhibits IL-1 and MEKK3 activation of NF-kappa B. The rear end acidic cluster of the p62 PB1 domain is used to organize cytosolic aggregates or speckles-associated TRAF6-p62-MEKK3 complex for control of NF-kappa B activation.	[Johnson, Gary L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 4016 Genet Med Bldg,120 Mason Farm Rd,CB 7365, Chapel Hill, NC 27599 USA.	gary_johnson@med.unc.edu	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Kimple, Adam/0000-0003-1670-8401	National Institutes of Health [GM30324, DK37871, T32 GM008719, F30 MH074266]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030324, R37GM030324, R01GM068820, T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH074266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM30324 and DK37871.; Supported by National Institutes of Health Grant T32 GM008719 and Fellowship F30 MH074266.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blonska M, 2004, MOL CELL BIOL, V24, P10757, DOI 10.1128/MCB.24.24.10757-10765.2004; Di YW, 2008, CELL SIGNAL, V20, P705, DOI 10.1016/j.cellsig.2007.12.007; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Martin P, 2006, EMBO J, V25, P3524, DOI 10.1038/sj.emboj.7601250; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Nakamura K, 2007, MOL CELL BIOL, V27, P4566, DOI 10.1128/MCB.00125-07; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Roccato E, 2003, ONCOGENE, V22, P807, DOI 10.1038/sj.onc.1206189; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200	35	90	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2077	2089		10.1074/jbc.M109.065102	http://dx.doi.org/10.1074/jbc.M109.065102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19903815	Green Published, hybrid			2022-12-27	WOS:000273429100052
J	Sakaue, T; Takeuchi, K; Maeda, T; Yamamoto, Y; Nishi, K; Ohkubo, I				Sakaue, Tomohisa; Takeuchi, Keisuke; Maeda, Toshinaga; Yamamoto, Yoshio; Nishi, Katsuji; Ohkubo, Iwao			Factor H in Porcine Seminal Plasma Protects Sperm against Complement Attack in Genital Tracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE COFACTOR PROTEIN; HEMOLYTIC-UREMIC SYNDROME; FUNCTIONALLY ACTIVE COMPLEMENT; DECAY-ACCELERATING FACTOR; INHIBITING ACTIVITY; REGULATORY PROTEIN; MOLECULAR-CLONING; PROSTASOMAL CD59; CD46; SYSTEM	We found that factor H (FH) exists in porcine seminal plasma. Purified FH strongly inhibited serum alternative pathway complement activation against lipopolysaccharide. The molecular weight, pI, and heparin-binding activity of the purified protein were different from those of purified FH from porcine serum. The complement regulatory activity of seminal plasma FH was similar to 2-fold stronger than that of serum FH. Treatment of purified serum FH with sialidase and N-glycosidase F gave almost the same results as those of seminal plasma FH. The deletion of sialic acid from the carbohydrate chains of both FHs contributed to heparin-binding and complement regulatory activities. Results of reverse transcriptase-PCR, Western blot analysis, and immunohistochemistry showed that seminal plasma FH is mainly secreted from epithelial cells of the seminal vesicle in male genital tracts. FH was also detected in the outer acrosomal region of ejaculated sperm by immunofluorescence staining, and found that the purified FH from the sperm membrane has the same complement regulatory activity as that of seminal plasma FH. The ejaculated sperm possessing FH in the outer acrosomal region considerably evaded complement attack. We also found that there is strong complement activity in fluids from female genital tract ducts. These findings indicate that FH bound to the outer acrosomal region and soluble FH play important roles in protecting sperm against complement attack in male and female genital tracts.	[Sakaue, Tomohisa; Takeuchi, Keisuke; Maeda, Toshinaga; Ohkubo, Iwao] Shiga Univ Med Sci, Dept Med Biochem, Otsu, Shiga 5202192, Japan; [Nishi, Katsuji] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan; [Yamamoto, Yoshio] Mie Univ, Cooperat Res Ctr, Iga Res Inst, Iga, Mie 5180131, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Mie University	Ohkubo, I (corresponding author), Shiga Univ Med Sci, Dept Med Biochem, Otsu, Shiga 5202192, Japan.	ionfox@belle.shiga-med.ac.jp			Ministry of Education, Science and Culture of Japan [19590304]; President's Discretionary Fund of Shiga University of Medical Science	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); President's Discretionary Fund of Shiga University of Medical Science	This work was supported in part by Grant-in-Aid for Scientific Research 19590304 (to I.O.) from the Ministry of Education, Science and Culture of Japan and by the President's Discretionary Fund of Shiga University of Medical Science (to K. T.).	Amirlak I, 2006, NEPHROLOGY, V11, P213, DOI 10.1111/j.1440-1797.2006.00556.x; Babiker AA, 2005, PROSTATE, V62, P105, DOI 10.1002/pros.20102; Babiker AA, 2002, AM J REPROD IMMUNOL, V47, P183, DOI 10.1034/j.1600-0897.2002.1o023.x; BLENK H, 1991, INFECTION, V19, pS138, DOI 10.1007/BF01643683; Boit R, 2003, ANDROLOGIA, V35, P93, DOI 10.1046/j.1439-0272.2003.00545.x; Chabottaux V, 2006, CANCER RES, V66, P5165, DOI 10.1158/0008-5472.CAN-05-3012; Chowdhury NA, 1996, ARCH ANDROLOGY, V36, P109, DOI 10.3109/01485019608987086; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; DUTOIT D, 1994, ARCH ANDROLOGY, V32, P21, DOI 10.3109/01485019408987762; FUJITA T, 1988, IMMUNOLOGY, V64, P369; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Harris CL, 2006, MOL IMMUNOL, V43, P57, DOI 10.1016/j.molimm.2005.06.026; Hegasy GA, 2003, IMMUNOGENETICS, V55, P462, DOI 10.1007/s00251-003-0605-6; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; JIN MS, 1991, AM J REPROD IMMUNOL, V26, P53, DOI 10.1111/j.1600-0897.1991.tb00970.x; KITAMURA M, 1995, IMMUNOLOGY, V84, P626; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; McLaughlin PJ, 1996, J REPROD IMMUNOL, V31, P209, DOI 10.1016/0165-0378(96)00967-9; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184; NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277; NISHI K, 1992, INT J LEGAL MED, V105, P75, DOI 10.1007/BF02340827; OGLESBY TJ, 1998, HUMAN COMPLEMENT SYS, P355; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PERRICONE R, 1992, CLIN EXP IMMUNOL, V89, P154, DOI 10.1111/j.1365-2249.1992.tb06895.x; PETERSEN BH, 1980, J LAB CLIN MED, V96, P582; PRICE RJ, 1984, AM J REPROD IMMUNOL, V6, P92, DOI 10.1111/j.1600-0897.1984.tb00121.x; Rahimi A, 1999, AM J REPROD IMMUNOL, V41, P330; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SEYA T, 1993, EUR J IMMUNOL, V23, P1322, DOI 10.1002/eji.1830230620; Sienel W, 2007, CLIN CANCER RES, V13, P3840, DOI 10.1158/1078-0432.CCR-06-2507; SIM RB, 1982, BIOCHEM J, V205, P285, DOI 10.1042/bj2050285; SIMPSON KL, 1994, J REPROD FERTIL, V102, P419; Takeuchi K, 2007, COMP BIOCHEM PHYS B, V146, P215, DOI 10.1016/j.cbpb.2006.10.108; TARTER TH, 1984, AM J REPROD IMMUNOL, V6, P28, DOI 10.1111/j.1600-0897.1984.tb00105.x; TAYLOR CT, 1994, HUM REPROD, V9, P907, DOI 10.1093/oxfordjournals.humrep.a138615; TURNER TT, 1979, INVEST UROL, V16, P311; VANDERPUYE OA, 1993, INT ARCH ALLERGY IMM, V101, P376, DOI 10.1159/000236480; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Zipfel PF, 2006, CURR OPIN RHEUMATOL, V18, P548, DOI 10.1097/01.bor.0000240370.47336.ae	47	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2184	2192		10.1074/jbc.M109.063495	http://dx.doi.org/10.1074/jbc.M109.063495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920146	Green Published, hybrid			2022-12-27	WOS:000273429100062
J	Schroeder, AC; Zhu, CM; Yanamadala, SR; Cahoon, RE; Arkus, KAJ; Wachsstock, L; Bleeke, J; Krishnan, HB; Jez, JM				Schroeder, Amy C.; Zhu, Chuanmei; Yanamadala, Srinivasa Rao; Cahoon, Rebecca E.; Arkus, Kiani A. J.; Wachsstock, Leia; Bleeke, Jeremy; Krishnan, Hari B.; Jez, Joseph M.			Threonine-insensitive Homoserine Dehydrogenase from Soybean GENOMIC ORGANIZATION, KINETIC MECHANISM, AND IN VIVO ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOFUNCTIONAL ASPARTATE KINASE; ISOTOPE-EXCHANGE KINETICS; AMINO-ACID CONTENT; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; EVOLUTIONARY RELATIONSHIPS; BIFUNCTIONAL PROTEIN; SULFUR ASSIMILATION; GENE; ASPARTOKINASE	Aspartate kinase (AK) and homoserine dehydrogenase (HSD) function as key regulatory enzymes at branch points in the aspartate amino acid pathway and are feedback-inhibited by threonine. In plants the biochemical features of AK and bifunctional AK-HSD enzymes have been characterized, but the molecular properties of the monofunctional HSD remain unexamined. To investigate the role of HSD, we have cloned the cDNA and gene encoding the monofunctional HSD (GmHSD) from soybean. Using heterologously expressed and purified GmHSD, initial velocity and product inhibition studies support an ordered bi bi kinetic mechanism in which nicotinamide cofactor binds first and leaves last in the reaction sequence. Threonine inhibition of GmHSD occurs at concentrations (K-i = 160-240 mM) more than 1000-fold above physiological levels. This is in contrast to the two AK-HSD isoforms in soybean that are sensitive to threonine inhibition (K-i similar to 150 mu M). In addition, GmHSD is not inhibited by other aspartate-derived amino acids. The ratio of threonine-resistant to threonine-sensitive HSD activity in soybean tissues varies and likely reflects different demands for amino acid biosynthesis. This is the first cloning and detailed biochemical characterization of a monofunctional feedback-insensitive HSD from any plant. Threonine-resistant HSD offers a useful biotechnology tool for manipulating the aspartate amino acid pathway to increase threonine and methionine production in plants for improved nutritional content.	[Schroeder, Amy C.; Zhu, Chuanmei; Arkus, Kiani A. J.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Schroeder, Amy C.; Cahoon, Rebecca E.; Arkus, Kiani A. J.; Wachsstock, Leia; Bleeke, Jeremy; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Yanamadala, Srinivasa Rao; Krishnan, Hari B.] Univ Missouri, Plant Genet Res Unit, USDA ARS, Dept Agron, Columbia, MO 65211 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Jez, JM (corresponding author), WA Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			United States Department of Agriculture [NRI-2005-02518]; Illinois-Missouri Biotechnology Alliance [2006-4]; American Society of Plant; University of Missouri Interdisciplinary Plant Group; Pfizer-Solutia Students and Teachers as Research Scientists Internships	United States Department of Agriculture(United States Department of Agriculture (USDA)); Illinois-Missouri Biotechnology Alliance; American Society of Plant; University of Missouri Interdisciplinary Plant Group; Pfizer-Solutia Students and Teachers as Research Scientists Internships	This work was supported by United States Department of Agriculture Grant NRI-2005-02518 (to J.M.J.) and Illinois-Missouri Biotechnology Alliance Grant 2006-4 (to H.B.K. and J.M.J.).; Supported in part by an American Society of Plant Biologists Summer Research Fellowship.; Present address: Biochemistry and Molecular Biology Program, University of California, Davis, CA 95616.; Supported in part by a University of Missouri Interdisciplinary Plant Group graduate research fellowship.; Supported by Pfizer-Solutia Students and Teachers as Research Scientists Internships.	ANGELES TS, 1990, ARCH BIOCHEM BIOPHYS, V283, P96, DOI 10.1016/0003-9861(90)90617-8; ANGELES TS, 1989, BIOCHEMISTRY-US, V28, P8771, DOI 10.1021/bi00448a014; ARCHER JAC, 1991, GENE, V107, P53, DOI 10.1016/0378-1119(91)90296-N; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Bareich DC, 2003, CHEM BIOL, V10, P967, DOI 10.1016/j.chembiol.2003.09.016; BLACK S, 1955, J BIOL CHEM, V213, P39; BRYAN JK, 1990, PLANT PHYSIOL, V92, P785, DOI 10.1104/pp.92.3.785; Cook P. F., 2007, ENZYME KINETICS MECH; Curien G, 2005, J BIOL CHEM, V280, P41178, DOI 10.1074/jbc.M509324200; DICAMELLI CA, 1980, PLANT PHYSIOL, V65, P176, DOI 10.1104/pp.65.2.176; FAZEL A, 1983, BIOCHEMISTRY-US, V22, P158, DOI 10.1021/bi00270a023; Frankard V, 1997, PLANT MOL BIOL, V34, P233, DOI 10.1023/A:1005863128558; Galili G, 2002, METAB ENG, V4, P3, DOI 10.1006/mben.2001.0203; Gebhardt J. S., 1999, Plant Physiology, V120, P634; GHISLAIN M, 1994, PLANT MOL BIOL, V24, P835, DOI 10.1007/BF00014439; Hacham Y, 2008, PLANT J, V54, P260, DOI 10.1111/j.1365-313X.2008.03415.x; Jacques SL, 2001, BBA-PROTEIN STRUCT M, V1544, P42, DOI 10.1016/S0167-4838(00)00202-8; Krishnan HB, 2005, CROP SCI, V45, P454, DOI 10.2135/cropsci2005.0454; LIZARDI PM, 1983, METHOD ENZYMOL, V96, P24; MUEHLBAUER GJ, 1994, PLANT PHYSIOL, V106, P1303, DOI 10.1104/pp.106.4.1303; Paris S, 2003, J BIOL CHEM, V278, P5361, DOI 10.1074/jbc.M207379200; Paris S, 2002, PROTEIN EXPRES PURIF, V24, P105, DOI 10.1006/prep.2001.1539; PARSOT C, 1988, J BIOL CHEM, V263, P14654; Phartiyal P, 2008, PHYTOCHEMISTRY, V69, P356, DOI 10.1016/j.phytochem.2007.07.013; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Purich D L, 1980, Methods Enzymol, V64, P1; REINSCHEID DJ, 1991, J BACTERIOL, V173, P3228, DOI 10.1128/JB.173.10.3228-3230.1991; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sambrook J., 2002, MOL CLONING LAB MANU; SHAUL O, 1993, PLANT MOL BIOL, V23, P759, DOI 10.1007/BF00021531; SIBILLI L, 1981, J BIOL CHEM, V256, P228; Tang GL, 1997, PLANT MOL BIOL, V34, P287, DOI 10.1023/A:1005849228945; THOMAS D, 1993, FEBS LETT, V323, P289, DOI 10.1016/0014-5793(93)81359-8; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; WALTER TJ, 1979, J BIOL CHEM, V254, P1349; Wang XL, 2001, PLANT PHYSIOL, V125, P1778, DOI 10.1104/pp.125.4.1778; WEDLER FC, 1992, BIOCHIM BIOPHYS ACTA, V1119, P247, DOI 10.1016/0167-4838(92)90209-V; WEDLER FC, 1993, J BIOL CHEM, V268, P4880; WILSON BJ, 1991, PLANT PHYSIOL, V97, P1323, DOI 10.1104/pp.97.4.1323; ZhuShimoni JX, 1997, PLANT PHYSIOL, V113, P695, DOI 10.1104/pp.113.3.695	40	15	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					827	834		10.1074/jbc.M109.068882	http://dx.doi.org/10.1074/jbc.M109.068882			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897476	hybrid, Green Published			2022-12-27	WOS:000273258200003
J	Henriksson, N; Nilsson, P; Wu, MS; Song, HW; Virtanen, A				Henriksson, Niklas; Nilsson, Per; Wu, Mousheng; Song, Haiwei; Virtanen, Anders			Recognition of Adenosine Residues by the Active Site of Poly(A)-specific Ribonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MESSENGER-RNA; CRYSTAL-STRUCTURE; POLY(A) BINDING; 3' EXONUCLEASE; RRM DOMAIN; CAP; DEADENYLATION; DEGRADATION; OLIGOURIDYLATION; POLYMERASES	Poly(A)-specific ribonuclease (PARN) is a mammalian 3'-exoribonuclease that degrades poly(A) with high specificity. To reveal mechanisms by which poly(A) is recognized by the active site of PARN, we have performed a kinetic analysis using a large repertoire of trinucleotide substrates. Our analysis demonstrated that PARN harbors specificity for adenosine recognition in its active site and that the nucleotides surrounding the scissile bond are critical for adenosine recognition. We propose that two binding pockets, which interact with the nucleotides surrounding the scissile bond, play a pivotal role in providing specificity for the recognition of adenosine residues by the active site of PARN. In addition, we show that PARN, besides poly(A), also quite efficiently degrades poly(U), similar to 10-fold less efficiently than poly(A). The poly(U)-degrading property of PARN could be of biological significance as oligo(U) tails recently have been proposed to play a role in RNA stabilization and destabilization.	[Henriksson, Niklas; Nilsson, Per; Virtanen, Anders] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Wu, Mousheng; Song, Haiwei] Inst Mol & Cell Biol, Singapore 138673, Singapore	Uppsala University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Virtanen, A (corresponding author), Box 596, SE-75124 Uppsala, Sweden.	Virtanen@icm.uu.se	Henriksson, Niklas/A-5898-2013		Swedish Research Council; Swedish Research Council to the Uppsala RNA Research Centre; Lennanders Foundation at Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council to the Uppsala RNA Research Centre; Lennanders Foundation at Uppsala University	This work was supported in part by the Swedish Research Council, the Linneus Support from the Swedish Research Council to the Uppsala RNA Research Centre, and the Lennanders Foundation at Uppsala University.	Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Andersen KR, 2009, RNA, V15, P850, DOI 10.1261/rna.1489409; ASTROM J, 1991, EMBO J, V10, P3067, DOI 10.1002/j.1460-2075.1991.tb07858.x; ASTROM J, 1992, J BIOL CHEM, V267, P18154; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Jonstrup AT, 2007, NUCLEIC ACIDS RES, V35, P3153, DOI 10.1093/nar/gkm178; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Monecke T, 2008, J MOL BIOL, V382, P827, DOI 10.1016/j.jmb.2008.07.073; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nagata T, 2008, NUCLEIC ACIDS RES, V36, P4754, DOI 10.1093/nar/gkn458; Nilsson P, 2007, J BIOL CHEM, V282, P32902, DOI 10.1074/jbc.M702375200; Nilsson P, 2006, INT J BIOL MACROMOL, V39, P95, DOI 10.1016/j.ijbiomac.2006.02.025; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Ren YG, 2004, J BIOL CHEM, V279, P48702, DOI 10.1074/jbc.M403858200; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; Rissland OS, 2008, BBA-GENE REGUL MECH, V1779, P286, DOI 10.1016/j.bbagrm.2008.03.003; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; Wilusz CJ, 2008, GENE DEV, V22, P1, DOI 10.1101/gad.1634508; Wu MS, 2009, STRUCTURE, V17, P276, DOI 10.1016/j.str.2008.11.012; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	35	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					163	170		10.1074/jbc.M109.043893	http://dx.doi.org/10.1074/jbc.M109.043893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19901024	Green Published, hybrid			2022-12-27	WOS:000273070100017
J	Mangialavori, I; Ferreira-Gomes, M; Pignataro, MF; Strehler, EE; Rossi, JPFC				Mangialavori, Irene; Ferreira-Gomes, Mariela; Pignataro, Maria F.; Strehler, Emanuel E.; Rossi, Juan Pablo F. C.			Determination of the Dissociation Constants for Ca2+ and Calmodulin from the Plasma Membrane Ca2+ Pump by a Lipid Probe That Senses Membrane Domain Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; ENERGY-TRANSFER; CA-2+ PUMP; ACTIVATION; BINDING; CA2+-ATPASE; INTERACTS; CONFORMATION; PROTEINS; ATPASES	The purpose of this work was to obtain information about conformational changes of the plasma membrane Ca2+-pump (PMCA) in the membrane region upon interaction with Ca2+, calmodulin (CaM) and acidic phospholipids. To this end, we have quantified labeling of PMCA with the photoactivatable phosphatidylcholine analog [I-125]TID-PC/16, measuring the shift of conformation E-2 to the auto-inhibited conformation E1I and to the activated E(1)A state, titrating the effect of Ca2+ under different conditions. Using a similar approach, we also determined the CaM-PMCA dissociation constant. The results indicate that the PMCA possesses a high affinity site for Ca2+ regardless of the presence or absence of activators. Modulation of pump activity is exerted through the C-terminal domain, which induces an apparent auto-inhibited conformation for Ca2+ transport but does not modify the affinity for Ca2+ at the transmembrane domain. The C-terminal domain is affected by CaM and CaM-like treatments driving the auto-inhibited conformation E1I to the activated E(1)A conformation and thus modulating the transport of Ca2+. This is reflected in the different apparent constants for Ca2+ in the absence of CaM (calculated by Ca2+-ATPase activity) that sharply contrast with the lack of variation of the affinity for the Ca2+ site at equilibrium. This is the first time that equilibrium constants for the dissociation of Ca2+ and CaM ligands from PMCA complexes are measured through the change of transmembrane conformations of the pump. The data further suggest that the transmembrane domain of the PMCA undergoes major rearrangements resulting in altered lipid accessibility upon Ca2+ binding and activation.	[Mangialavori, Irene; Ferreira-Gomes, Mariela; Pignataro, Maria F.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Rossi, JPFC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fis Quim Biol, Junin 956 1113, RA-1113 Buenos Aires, DF, Argentina.	jprossi@mail.retina.ar	Mangialavori, Irene/GLU-8182-2022	Rossi, Juan Pablo/0000-0001-7087-844X; Mangialavori, Irene/0000-0003-3187-3130	National Institutes of Health, Fogarty International Center [R03TW006837]; Agencia Nacional de Promocio n Cientifica y Tecnologica, CONICET; Universidad de Buenos Aires Ciencia y Tecnica from Argentina; FOGARTY INTERNATIONAL CENTER [R03TW006837] Funding Source: NIH RePORTER	National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agencia Nacional de Promocio n Cientifica y Tecnologica, CONICET(ANPCyTConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica from Argentina(University of Buenos Aires); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by the National Institutes of Health, Fogarty International Center Grant R03TW006837 and by Agencia Nacional de Promocio n Cientifica y Tecnologica, CONICET, and Universidad de Buenos Aires Ciencia y Tecnica from Argentina.	BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BRUNNER J, 1981, BIOCHEMISTRY-US, V20, P7174, DOI 10.1021/bi00528a019; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Giraldo AMM, 2006, CELL BIOCHEM BIOPHYS, V44, P431, DOI 10.1385/CBB:44:3:431; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; Liyanage MR, 2009, ANAL BIOCHEM, V385, P1, DOI 10.1016/j.ab.2008.10.022; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; PENNISTON JT, 1998, ADV MOL CEL A&B, V23, P249; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; SARKADI B, 1986, J BIOL CHEM, V261, P9552; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013	31	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					123	130		10.1074/jbc.M109.076679	http://dx.doi.org/10.1074/jbc.M109.076679			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19892708	hybrid, Green Published			2022-12-27	WOS:000273070100013
J	Renko, M; Sabotic, J; Mihelic, M; Brzin, J; Kos, J; Turk, D				Renko, Miha; Sabotic, Jerica; Mihelic, Marko; Brzin, Joze; Kos, Janko; Turk, Dusan			Versatile Loops in Mycocypins Inhibit Three Protease Families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CYSTEINE PROTEASE; PROTEINASE-INHIBITOR; MACROMOLECULAR STRUCTURES; ANGSTROM RESOLUTION; MAMMALIAN LEGUMAIN; TRYPSIN-INHIBITOR; TRANSGENIC PLANTS; ERYTHRINA-CAFFRA; STRUCTURAL BASIS	Mycocypins, clitocypins and macrocypins, are cysteine protease inhibitors isolated from the mushrooms Clitocybe nebularis and Macrolepiota procera. Lack of sequence homology to other families of protease inhibitors suggested that mycocypins inhibit their target cysteine protease by a unique mechanism and that a novel fold may be found. The crystal structures of the complex of clitocypin with the papain-like cysteine protease cathepsin V and of macrocypin and clitocypin alone have revealed yet another motif of binding to papain like-cysteine proteases, which in a yet unrevealed way occludes the catalytic residue. The binding is associated with a peptide-bond flip of glycine that occurs before or concurrently with the inhibitor docking. Mycocypins possess a beta-trefoil fold, the hallmark of Kunitz-type inhibitors. It is a tree-like structure with two loops in the root region, a stem comprising a six-stranded beta-barrel, and two layers of loops (6 + 3) in the crown region. The two loops that bind to cysteine cathepsins belong to the lower layer of the crown loops, whereas a single loop from the crown region can inhibit trypsin or asparaginyl endopeptidase, as demonstrated by site-directed mutagenesis. These loops present a versatile surface with the potential to bind to additional classes of proteases. When appropriately engineered, they could provide the basis for possible exploitation in crop protection.	[Renko, Miha; Mihelic, Marko; Turk, Dusan] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana 1000, Slovenia; [Sabotic, Jerica; Brzin, Joze; Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana 1000, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Turk, D (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova 39, Ljubljana 1000, Slovenia.	dusan.turk@ijs.si	Sabotič, Jerica/AAJ-5050-2021	Sabotič, Jerica/0000-0002-2404-0192; Turk, Dusan/0000-0003-0205-6609	Slovenian Research Agency [P1-0048, P4-0127]; Young Researcher fellowship; European Commission [LSHG-2006-018830]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Young Researcher fellowship; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Slovenian Research Agency Grants P1-0048 (to D.T.) and P4-0127 (to J.K.), by a Young Researcher fellowship (to M.R.), and by the European Commission Framework VI Program (CAMP project, LSHG-2006-018830).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; Araujo APU, 2005, BIOL CHEM, V386, P561, DOI 10.1515/BC.2005.066; Benchabane M, 2008, PLANT PHYSIOL BIOCH, V46, P701, DOI 10.1016/j.plaphy.2008.04.005; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brzin J, 2000, J BIOL CHEM, V275, P20104, DOI 10.1074/jbc.M001392200; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Galesa K, 2006, ACTA CRYSTALLOGR F, V62, P10, DOI 10.1107/S1744309105038534; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Guncar G, 1999, EMBO J, V18, P793, DOI 10.1093/emboj/18.4.793; Hansen D, 2007, BIOCHEM BIOPH RES CO, V360, P735, DOI 10.1016/j.bbrc.2007.06.144; Jenko S, 2003, J MOL BIOL, V326, P875, DOI 10.1016/S0022-2836(02)01432-8; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; Ljunggren A, 2007, J MOL BIOL, V371, P137, DOI 10.1016/j.jmb.2007.05.005; Micheelsen PO, 2008, J MOL BIOL, V380, P681, DOI 10.1016/j.jmb.2008.05.034; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; Mihelic M, 2006, FEBS LETT, V580, P4195, DOI 10.1016/j.febslet.2006.06.076; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ONESTI S, 1991, J MOL BIOL, V217, P153, DOI 10.1016/0022-2836(91)90618-G; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ravichandran S, 1999, ACTA CRYSTALLOGR D, V55, P1814, DOI 10.1107/S0907444999009877; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sabotic J, 2007, PROTEIN EXPRES PURIF, V53, P104, DOI 10.1016/j.pep.2006.11.015; Sabotic J, 2006, BIOL CHEM, V387, P1559, DOI 10.1515/BC.2006.194; Sabotic J, 2009, FEBS J, V276, P4334, DOI 10.1111/j.1742-4658.2009.07138.x; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Turk B, 1997, BIOL CHEM, V378, P141; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; TURK D, 1992, THESIS TU MUENCHEN G; Ussuf KK, 2001, CURR SCI INDIA, V80, P847; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; WEINER MP, 1994, PCR METH APPL, V4, pS131	49	49	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					308	316		10.1074/jbc.M109.043331	http://dx.doi.org/10.1074/jbc.M109.043331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19846555	Green Published, hybrid			2022-12-27	WOS:000273070100032
J	Demory, ML; Boerner, JL; Davidson, R; Faust, W; Miyake, T; Lee, I; Huttemann, M; Douglas, R; Haddad, G; Parsons, SJ				Demory, Michelle L.; Boerner, Julie L.; Davidson, Robert; Faust, William; Miyake, Tsuyoshi; Lee, Icksoo; Huettemann, Maik; Douglas, Robert; Haddad, Gabriel; Parsons, Sarah J.			Epidermal Growth Factor Receptor Translocation to the Mitochondria REGULATION AND EFFECT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CLATHRIN-MEDIATED ENDOCYTOSIS; EGF RECEPTOR; OXIDATIVE-PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; OUTER-MEMBRANE; BREAST-CANCER; CELLULAR SRC; SUBUNIT-II; KINASE	Co-overexpression of the epidermal growth factor (EGF) receptor (EGFR) and c-Src frequently occurs in human tumors and is linked to enhanced tumor growth. In experimental systems this synergistic growth requires EGF-dependent association of c-Src with the EGFR and phosphorylation of Tyr-845 of the receptor by c-Src. A search for signaling mediators of Tyr(P)-845 revealed that mitochondrial cytochrome c oxidase subunit II (CoxII) binds EGFR in a Tyr(P)-845- and EGF-dependent manner. In cells this association involves translocation of EGFR to the mitochondria, but regulation of this process is ill-defined. The current study demonstrates that c-Src translocates to the mitochondria with similar kinetics as EGFR and that the catalytic activity of EGFR and c-Src as well as endocytosis and a mitochondrial localization signal are required for these events. CoxII can be phosphorylated by EGFR and c-Src, and EGF stimulation reduces Cox activity and cellular ATP, an event that is dependent in large part on EGFR localized to the mitochondria. These findings suggest EGFR plays a novel role in modulating mitochondrial function via its association with, and modification of CoxII.	[Demory, Michelle L.; Boerner, Julie L.; Davidson, Robert; Faust, William; Miyake, Tsuyoshi; Parsons, Sarah J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Demory, Michelle L.; Boerner, Julie L.; Davidson, Robert; Faust, William; Miyake, Tsuyoshi; Parsons, Sarah J.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA; [Boerner, Julie L.; Lee, Icksoo; Huettemann, Maik] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Boerner, Julie L.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; [Lee, Icksoo; Huettemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Douglas, Robert; Haddad, Gabriel] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Haddad, Gabriel] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Virginia; University of Virginia; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; University of California System; University of California San Diego; University of California System; University of California San Diego	Parsons, SJ (corresponding author), Univ Virginia, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.	sap@virginia.edu		Huttemann, Maik/0000-0001-6310-7081	National Institutes of Health [PO1 HD 32473, CA71449, CA123037]; Susan G. Komen Breast Cancer Foundation [DISS 0402970]; The Sharp Foundation of the University of Virginia Cancer Center [119867]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032473] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA123037, R01CA071449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); The Sharp Foundation of the University of Virginia Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HD 32473 (to R. D. and G. H.), CA71449 (to S. J. P.), and CA123037 ( to S. J. P.). This study was also supported by Susan G. Komen Breast Cancer Foundation Grant DISS 0402970 (to M. L. D.) and The Sharp Foundation of the University of Virginia Cancer Center Project 119867 (to S. J. P.).	Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CABRAL F, 1978, J BIOL CHEM, V253, P297; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Douglas RM, 2006, NEUROSCIENCE, V139, P1249, DOI 10.1016/j.neuroscience.2006.01.061; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; HERTEL C, 1985, J BIOL CHEM, V260, P2547; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Itoh S, 2005, J BIOL CHEM, V280, P26383, DOI 10.1074/jbc.M410262200; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; LARKIN JM, 1986, J CELL BIOL, V103, P2619, DOI 10.1083/jcb.103.6.2619; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Lunn JA, 2000, AM J PHYSIOL-CELL PH, V279, pC2019, DOI 10.1152/ajpcell.2000.279.6.C2019; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; SAINSBURY JRC, 1987, LANCET, V1, P1398; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Yang WL, 1998, BIOCHEMISTRY-US, V37, P14175, DOI 10.1021/bi981402a	41	118	120	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36592	36604		10.1074/jbc.M109.000760	http://dx.doi.org/10.1074/jbc.M109.000760			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19840943	hybrid, Green Published			2022-12-27	WOS:000272970500060
J	Feng, Q; He, B; Jung, SY; Song, YC; Qin, J; Tsai, SY; Tsai, MJ; O'Malley, BW				Feng, Qin; He, Bin; Jung, Sung-Yun; Song, Yongcheng; Qin, Jun; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.			Biochemical Control of CARM1 Enzymatic Activity by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLTRANSFERASE CARM1; HORMONE RECEPTOR SUPERFAMILY; COACTIVATOR COMPLEX; HISTONE H3; METHYLATION; PROTEIN; GENE; COACTIVATOR-ASSOCIATED-ARGININE-METHYLTRANSFERASE-1; TRANSCRIPTION; ACTIVATION	Coactivator-associated arginine methyltransferase 1 (CARM1) is a dual functional coregulator that facilitates transcription initiation by methylation of Arg(17) and Arg(26) of histone H3 and also dictates the subsequent coactivator complex disassembly by methylation of the steroid receptor coactivator family coactivators and p300/cAMP-response element-binding protein-binding protein. However, the regulation of CARM1 enzymatic activity and substrate specificity remains largely unknown. In this study, we report that CARM1 function is regulated by phosphorylation at Ser(217), a residue completely conserved in the type I protein arginine methyltransferase (PRMT) family of enzymes. Comparative analysis of the published CARM1 crystal structures reveals that the hydroxyl group of Ser(217) forms a strong hydrogen bond with the carbonyl oxygen atom of Tyr(154) to lock the cofactor S-adenosylmethionine inside the binding cavity. Phosphorylation of Ser(217) disrupts this hydrogen bond and subsequently abolishes S-adenosylmethionine binding and its methyltransferase activity. Importantly, Tyr(154) is also conserved in the type I PRMT family of enzymes, suggesting a general role of this hydrogen bond in maintaining the holo structure of the type I PRMT catalytic domain. Moreover, we found that phosphorylation at Ser(217) also promoted CARM1 cytoplasmic localization and that this translocation occurred mainly during mitosis. We propose that phosphorylation at Ser(217) serves as a molecular switch for controlling CARM1 enzymatic activity during the cell cycle.	[Feng, Qin; He, Bin; Jung, Sung-Yun; Qin, Jun; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jung, Sung-Yun; Qin, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Song, Yongcheng] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu		Jung, Sung Yun/0000-0003-1521-7977	National Institutes of Health [5F32DK078473]; NIDDK [1K01DK081446, 5P01 DK059820]; NCI Baylor College of Medicine Cancer Center [P30CA125123]; NIDDK-NURSA (Nuclear Receptor Signaling Atlas) [U19 DK062434]; Baylor College of Medicine; Welch Foundation [Q-1521]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK078473, P01DK059820, K01DK081446, U19DK062434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI Baylor College of Medicine Cancer Center; NIDDK-NURSA (Nuclear Receptor Signaling Atlas); Baylor College of Medicine; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK National Research Service Award Individual Postdoctoral Fellowship 5F32DK078473 (to Q. F.), NIDDK Mentored Research Scientist Development Award 1K01DK081446 (to B. H.), NIDDK Grant 5P01 DK059820 and NCI Baylor College of Medicine Cancer Center Cores Grant P30CA125123 (to B. W. O.), and NIDDK-NURSA (Nuclear Receptor Signaling Atlas) Grant U19 DK062434 (to B. W. O., M.-J. T., and S. Y. T.). This work was also supported by a Baylor College of Medicine start-up fund (to Y. S.) and Welch Foundation Grant Q-1521 (to B. W. O.).	Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Chevillard-Briet M, 2002, EMBO J, V21, P5457, DOI 10.1093/emboj/cdf548; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Jung SY, 2008, ANAL CHEM, V80, P1721, DOI 10.1021/ac7021025; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; ONATE SA, 1995, SCIENCE, V270, P1354; Stallcup MR, 2000, BIOCHEM SOC T, V28, P415, DOI 10.1042/0300-5127:0280415; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Urwyler O, 2007, DIFFERENTIATION, V75, P757, DOI 10.1111/j.1432-0436.2007.00175.x; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; ZENG ZM, 1994, ENDOCRINOLOGY, V135, P248, DOI 10.1210/en.135.1.248; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	39	50	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36167	36174		10.1074/jbc.M109.065524	http://dx.doi.org/10.1074/jbc.M109.065524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843527	Green Published, hybrid			2022-12-27	WOS:000272970500018
J	Ge, X; Qiu, Y; Loh, HH; Law, PY				Ge, Xin; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee			GRIN1 Regulates mu-Opioid Receptor Activities by Tethering the Receptor and G Protein in the Lipid Raft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; CELL-ADHESION MOLECULE; RICH MEMBRANE DOMAINS; NEURITE OUTGROWTH; SIGNAL-TRANSDUCTION; SPINAL-CORD; ADENYLATE-CYCLASE; COUPLED RECEPTOR; BINDING-SITE; PC12 CELLS	The lipid raft location of mu-opioid receptor (MOR) determines the receptor activities. However, the manner in which MOR is anchored within the lipid rafts is undetermined. Using the targeted proteomic approach and mass spectrometry analyses, we have identified GRIN1 (G protein-regulated inducer of neurite outgrowth 1) can tether MOR with the G protein alpha-subunit and subsequently regulate the receptor distribution within the lipid rafts. Glutathione S-transferase fusion pulldown and receptor mutational analyses indicate that GRIN1-MOR interaction involves a receptor sequence (267)GSKEK(271) within the MOR third intracellular loop that is not involved in G alpha interaction. The GRIN1 domains involved in MOR interaction are also distinct from those involved in G alpha interaction. Pertussis toxin pretreatment reduced the amount of GRIN1 co-immunoprecipitated with MOR but not the amount with G alpha. Furthermore, overexpression of GRIN1 significantly enhanced the amount of MOR in lipid raft and the receptor signaling magnitude as measured by Src kinase activation. Such increase in MOR signaling was demonstrated further by determining the GRIN1-dependent pertussis toxin-sensitive neurite outgrowth. In contrast to minimal neurite outgrowth induced by etorphine in control neuroblastoma N2A cells, overexpression of GRIN1 resulted in the increase in etorphine- and non-morphine-induced neurite outgrowth in these cells. Knocking down endogenous GRIN1 by small interfering RNA attenuated the agonist-induced neurite outgrowth. Disrupting lipid raft by methyl-beta-cyclodextrin also blocked neurite outgrowth. Hence, by tethering G alpha with MOR, GRIN1 stabilizes the receptor within the lipid rafts and potentiates the receptor signaling in the neurite outgrowth processes.	[Ge, Xin; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ge, X (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	gexx0019@umn.edu		Law, Ping-Yee/0000-0002-5364-1093	National Institutes of Health [DA007339, DA016674, DA000564, DA011806]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA000564, R01DA007339, R56DA000564, P50DA011806, K05DA000513, R01DA016674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, and DA011806.	Anafi M, 1996, J BIOL CHEM, V271, P21365, DOI 10.1074/jbc.271.35.21365; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; Balbis A, 2007, ENDOCRINOLOGY, V148, P2944, DOI 10.1210/en.2006-1674; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; Besson JM, 1999, LANCET, V353, P1610, DOI 10.1016/S0140-6736(99)01313-6; Brailoiu E, 2004, NEUROSCI LETT, V365, P10, DOI 10.1016/j.neulet.2004.03.092; CARTER BD, 1992, J NEUROCHEM, V58, P1611, DOI 10.1111/j.1471-4159.1992.tb10032.x; Chaipatikul V, 2003, J PHARMACOL EXP THER, V305, P909, DOI 10.1124/jpet.102.046219; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; CONNAUGHTON JF, 1975, ADDICT DIS, V2, P21; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Evan BJ, 2008, BIOCHEM BIOPH RES CO, V377, P1067, DOI 10.1016/j.bbrc.2008.10.108; Ge X, 2009, MOL PHARMACOL, V75, P1307, DOI 10.1124/mol.108.054064; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kahn L, 2005, EUR J NEUROSCI, V21, P493, DOI 10.1111/j.1460-9568.2005.03883.x; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; Miller JH, 1999, DEV BRAIN RES, V114, P69, DOI 10.1016/S0165-3806(99)00021-8; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; Nassogne MC, 1998, DEV BRAIN RES, V110, P61, DOI 10.1016/S0165-3806(98)00094-7; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Oh DY, 2007, J CELL BIOCHEM, V101, P221, DOI 10.1002/jcb.21166; Ohkubo S, 2007, YAKUGAKU ZASSHI, V127, P27, DOI 10.1248/yakushi.127.27; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Philip F, 2004, BIOCHEMISTRY-US, V43, P11691, DOI 10.1021/bi049381+; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; RAMOSMORALES F, 1995, ONCOGENE, V11, P1665; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Reversi A, 2006, AM J PHYSIOL-REG I, V291, pR861, DOI 10.1152/ajpregu.00333.2006; ROERIG SC, 1992, MOL PHARMACOL, V41, P822; ROSS EM, 1995, CURR BIOL, V5, P107, DOI 10.1016/S0960-9822(95)00026-1; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schmid RS, 2000, J NEUROSCI, V20, P4177; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Trujillo KA, 2002, NEUROTOX RES, V4, P373, DOI 10.1080/10298420290023954; VANOOYEN A, 1995, J THEOR BIOL, V172, P63, DOI 10.1006/jtbi.1995.0005; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Yeh GC, 1998, NEUROSCI LETT, V252, P25, DOI 10.1016/S0304-3940(98)00528-X; Yin DL, 1997, NEUROSCI RES, V29, P121, DOI 10.1016/S0168-0102(97)00080-1; Zhang L, 2006, MOL PHARMACOL, V69, P1810, DOI 10.1124/mol.105.021352; Zhang L, 2009, J BIOL CHEM, V284, P1990, DOI 10.1074/jbc.M807971200; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhang WS, 2007, J NEUROCHEM, V103, P1157, DOI 10.1111/j.1471-4159.2007.04813.x; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105	64	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36521	36534		10.1074/jbc.M109.024109	http://dx.doi.org/10.1074/jbc.M109.024109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861419	Green Published, hybrid			2022-12-27	WOS:000272970500054
J	Wu, ZZ; Li, DP; Chen, SR; Pan, HL				Wu, Zi-Zhen; Li, De-Pei; Chen, Shao-Rui; Pan, Hui-Lin			Aminopyridines Potentiate Synaptic and Neuromuscular Transmission by Targeting the Voltage-activated Calcium Channel beta Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EATON MYASTHENIC SYNDROME; GATED POTASSIUM CHANNELS; PRIMARY SENSORY NEURONS; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; K+ CURRENTS; N-TYPE; GANGLION NEURONS; 4-AMINOPYRIDINE; EXPRESSION	Aminopyridines such as 4-aminopyridine (4-AP) are widely used as voltage-activated K+ (Kv) channel blockers and can improve neuromuscular function in patients with spinal cord injury, myasthenia gravis, or multiple sclerosis. Here, we present novel evidence that 4-AP and several of its analogs directly stimulate high voltage-activated Ca2+ channels (HVACCs) in acutely dissociated neurons. 4-AP, 4-(aminomethyl) pyridine, 4-(methylamino) pyridine, and 4-di(methylamino) pyridine profoundly increased HVACC, but not T-type, currents in dissociated neurons from the rat dorsal root ganglion, superior cervical ganglion, and hippocampus. The widely used Kv channel blockers, including tetraethylammonium, alpha-dendrotoxin, phrixotoxin-2, and BDS-I, did not mimic or alter the effect of 4-AP on HVACCs. In HEK293 cells expressing various combinations of N-type (Cav2.2) channel subunits, 4-AP potentiated Ca2+ currents primarily through the intracellular beta(3) subunit. In contrast, 4-AP had no effect on Cav3.2 channels expressed in HEK293 cells. Furthermore, blocking Kv channels did not mimic or change the potentiating effects of 4-AP on neurotransmitter release from sensory and motor nerve terminals. Thus, our findings challenge the conventional view that 4-AP facilitates synaptic and neuromuscular transmission by blocking Kv channels. Aminopyridines can directly target presynaptic HVACCs to potentiate neurotransmitter release independent of Kv channels.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Div Anesthesiol & Crit Care, Unit 110, Houston, TX 77030 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Sch Biomed Sci, Program Neurosci, Houston, TX 77225 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Anesthesiol & Crit Care, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM64830, NS45602]; American Heart Association; Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM64830 and NS45602 and by the American Heart Association. This work was also supported by the Hawkins Endowment (to H.-L. P.).	BALDWIN TJ, 1992, COLD SPRING HARB SYM, V57, P491, DOI 10.1101/SQB.1992.057.01.054; BEVER CT, 1994, NEUROLOGY, V44, P1054, DOI 10.1212/WNL.44.6.1054; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Catacuzzeno L, 2008, J PHYSIOL-LONDON, V586, P5101, DOI 10.1113/jphysiol.2008.159384; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DAVIS FA, 1990, ANN NEUROL, V27, P186, DOI 10.1002/ana.410270215; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; FICKER E, 1992, J PHYSIOL-LONDON, V445, P431, DOI 10.1113/jphysiol.1992.sp018932; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; HANSEBOUT RR, 1993, J NEUROTRAUM, V10, P1, DOI 10.1089/neu.1993.10.1; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; HAYDON PG, 1994, NEURON, V13, P1275, DOI 10.1016/0896-6273(94)90414-6; HOFER CA, 1993, AM J MED, V95, P431, DOI 10.1016/0002-9343(93)90314-F; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; KIM YI, 1988, SCIENCE, V239, P405, DOI 10.1126/science.2447652; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Ludwig A, 1997, J NEUROSCI, V17, P1339; LUNDH H, 1979, J NEUROL NEUROSUR PS, V42, P171, DOI 10.1136/jnnp.42.2.171; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Moyer M, 1999, J NEUROPHYSIOL, V82, P3030, DOI 10.1152/jn.1999.82.6.3030; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; POLMAN CH, 1994, ARCH NEUROL-CHICAGO, V51, P1136, DOI 10.1001/archneur.1994.00540230074016; POLMAN CH, 1994, ARCH NEUROL-CHICAGO, V51, P292, DOI 10.1001/archneur.1994.00540150090022; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; ROBERTSON BE, 1994, AM J PHYSIOL-CELL PH, V267, pC1589, DOI 10.1152/ajpcell.1994.267.6.C1589; Sanders DB, 2000, NEUROLOGY, V54, P603, DOI 10.1212/WNL.54.3.603; SHERRATT RM, 1980, NATURE, V283, P570, DOI 10.1038/283570a0; Strupp M, 2004, NEUROLOGY, V62, P1623, DOI 10.1212/01.WNL.0000125691.74109.53; THOMSEN RH, 1983, J PHARMACOL EXP THER, V227, P260; Vydyanathan A, 2005, J NEUROPHYSIOL, V93, P3401, DOI 10.1152/jn.01267.2004; Wang YG, 2006, J CARDIOVASC ELECTR, V17, P298, DOI 10.1111/j.1540-8167.2006.00362.x; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; Wirtz PW, 2009, CLIN PHARMACOL THER, V86, P44, DOI 10.1038/clpt.2009.35; Wu ZZ, 2005, J BIOL CHEM, V280, P18142, DOI 10.1074/jbc.M501229200; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Zhou HY, 2009, J NEUROCHEM, V108, P305, DOI 10.1111/j.1471-4159.2008.05772.x	44	83	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36453	36461		10.1074/jbc.M109.075523	http://dx.doi.org/10.1074/jbc.M109.075523			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850918	hybrid, Green Published			2022-12-27	WOS:000272970500047
J	Ikonomov, OC; Sbrissa, D; Fenner, H; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Fenner, Homer; Shisheva, Assia			PIKfyve-ArPIKfyve-Sac3 Core Complex CONTACT SITES AND THEIR CONSEQUENCE FOR Sac3 PHOSPHATASE ACTIVITY AND ENDOCYTIC MEMBRANE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; LIPID KINASE; ENDOCYTOSED RECEPTORS; MULTIVESICULAR BODY; MAMMALIAN ORTHOLOG; PROTEIN-KINASE; PIKFYVE; VAC14; INSULIN; PHOSPHATASE	The phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) metabolizing enzymes, the kinase PIKfyve and the phosphatase Sac3, constitute a single multiprotein complex organized by the PIKfyve regulator ArPIKfyve and its ability to homodimerize. We previously established that PIKfyve is activated within the triple PIKfyve-ArPIKfyve-Sac3 (PAS) core. These data assign an atypical function for the phosphatase in PtdIns(3,5)P-2 biosynthesis, thus raising the question of whether Sac3 retains its PtdIns(3,5)P-2 hydrolyzing activity within the PAS complex. Herein, we address the issue of Sac3 functionality by a combination of biochemical and morphological assays in triple-transfected COS cells using a battery of truncated or point mutants of the three proteins. We identified the Cpn60_TCP1 domain of PIKfyve as a major determinant for associating the ArPIKfyve-Sac3 subcomplex. Neither Sac3 nor PIKfyve enzymatic activities affected the PAS complex formation or stability. Using the well established formation of aberrant cell vacuoles as a sensitive functional measure of localized PtdIns(3,5)P-2 reduction, we observed a mitigated vacuolar phenotype by kinase-deficient PIKfyve(K1831E) if its ArPIKfyve- Sac3 binding region was deleted, suggesting reduced Sac3 access to, and turnover of PtdIns(3,5)P-2. In contrast, PIKfyve(K1831E), which displays intact ArPIKfyve-Sac3 binding, triggered a more severe vacuolar phenotype if coexpressed with ArPIKfyve(WT)-Sac3(WT) but minimal defects when coexpressed with ArPIKfyve(WT) and phosphatase-deficient Sac3(D488A). These data indicate that Sac3 assembled in the PAS regulatory core complex is an active PtdIns(3,5)P-2 phosphatase. Based on these and other data, presented herein, we propose a model of domain interactions within the PAS core and their role in regulating the enzymatic activities.	[Ikonomov, Ognian C.; Sbrissa, Diego; Fenner, Homer; Shisheva, Assia] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu			National Institutes of Health [DK58058]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058 (to A.S.). This work was also supported by American Diabetes Association Research grants (to A.S.).	Balla T, 2006, J ENDOCRINOL, V188, P135, DOI 10.1677/joe.1.06595; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2009, J BIOL CHEM, V284, P23961, DOI 10.1074/jbc.M109.025361; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Poccia D, 2009, BIOCHEM J, V418, P233, DOI 10.1042/BJ20082105; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2002, J BIOL CHEM, V277, P6073, DOI 10.1074/jbc.M110194200; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shisheva A, 2001, METHOD ENZYMOL, V329, P39; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shisheva A, 2008, AM J PHYSIOL-ENDOC M, V295, pE536, DOI 10.1152/ajpendo.90353.2008; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	37	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35794	35806		10.1074/jbc.M109.037515	http://dx.doi.org/10.1074/jbc.M109.037515			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840946	Green Published, hybrid			2022-12-27	WOS:000272645600056
J	Tong, YF; Hota, PK; Penachioni, JY; Hamaneh, MB; Kim, S; Alviani, RS; Shen, LM; He, H; Tempel, W; Tamagnone, L; Park, HW; Buck, M				Tong, Yufeng; Hota, Prasanta K.; Penachioni, Junia Y.; Hamaneh, Mehdi B.; Kim, SoonJeung; Alviani, Rebecca S.; Shen, Limin; He, Hao; Tempel, Wolfram; Tamagnone, Luca; Park, Hee-Won; Buck, Matthias			Structure and Function of the Intracellular Region of the Plexin-B1 Transmembrane Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; R-RAS; CRYSTAL-STRUCTURE; BINDING; DOMAIN; GAP; SEMAPHORINS; AUTOINHIBITION; REFINEMENT; MODEL	Members of the plexin family are unique transmembrane receptors in that they interact directly with Rho family small GTPases; moreover, they contain a GTPase-activating protein (GAP) domain for R-Ras, which is crucial for plexin-mediated regulation of cell motility. However, the functional role and structural basis of the interactions between the different intracellular domains of plexins remained unclear. Here we present the 2.4 angstrom crystal structure of the complete intracellular region of human plexin-B1. The structure is monomeric and reveals that the GAP domain is folded into one structure from two segments, separated by the Rho GTPase binding domain (RBD). The RBD is not dimerized, as observed previously. Instead, binding of a conserved loop region appears to compete with dimerization and anchors the RBD to the GAP domain. Cell-based assays on mutant proteins confirm the functional importance of this coupling loop. Molecular modeling based on structural homology to p120(GAP).H-Ras suggests that Ras GTPases can bind to the plexin GAP region. Experimentally, we show that the monomeric intracellular plexin-B1 binds R-Ras but not H-Ras. These findings suggest that the monomeric form of the intracellular region is primed for GAP activity and extend a model for plexin activation.	[Hota, Prasanta K.; Hamaneh, Mehdi B.; Kim, SoonJeung; Alviani, Rebecca S.; Buck, Matthias] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Shen, Limin; He, Hao; Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L7, Canada; [Penachioni, Junia Y.; Tamagnone, Luca] Univ Turin, Inst Canc Res & Treatment, I-10060 Turin, Italy	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Turin	Tamagnone, L (corresponding author), Univ Turin, IRCC, Str Prov 142, I-10060 Candiolo, Italy.	luca.tamagnone@ircc.it; heewon.park@utoronto.ca; matthias.buck@case.edu	Tong, Yufeng/D-2785-2011; Buck, Matthias/B-2106-2017; Hota, Prasanta Kumar/J-4319-2019; Tamagnone, Luca/J-8948-2018	Tong, Yufeng/0000-0001-7740-1812; Buck, Matthias/0000-0002-2958-0403; Hota, Prasanta Kumar/0000-0002-4057-1831; Tamagnone, Luca/0000-0002-2884-7946	National Institutes of Health [R01GM73071, K02HL084384, Y1-GM-1104]; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Italian Association for Cancer Research and Regione Piemonte; NCI [Y1-CO-1020]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Italian Association for Cancer Research and Regione Piemonte(Fondazione AIRC per la ricerca sul cancro); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM73071 and K02HL084384 (to M. B.) and in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. Supported by grants from the Italian Association for Cancer Research and Regione Piemonte. Drs. Christina Kiel and Luis Serrano (EMBLCRG, Barcelona) helped us early in this project with a homology model of plexin-B1 based on p120<SUP>GAP</SUP>. Crystallographic data shown in this report were derived from work performed at Argonne National Laboratory, Structural Biology Center, beam line 19ID, at the Advanced Photon Source. Data collection at GM/CA CAT, beam line 23ID-B, has been funded by NCI Grant Y1-CO-1020 and NIGM Grant Y1-GM-1104 from the National Institutes of Health. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Calculations were carried out at the Case Western Reserve University High Performance Cluster, at the Ohio Supercomputer Center (Columbus, OH), and at LoneStar (Austin, TX) via a TeraGrid Award (to M. B.).	Ahmadian MR, 2003, J MOL BIOL, V329, P699, DOI 10.1016/S0022-2836(03)00514-X; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Drugan JK, 2000, J BIOL CHEM, V275, P35021, DOI 10.1074/jbc.M004386200; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasterkamp RJ, 2005, TRENDS CELL BIOL, V15, P61, DOI 10.1016/j.tcb.2004.12.005; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Puschel AW, 2007, ADV EXP MED BIOL, V600, P12; Radley TL, 2003, J MOL BIOL, V332, P529, DOI 10.1016/S0022-2836(03)00925-2; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tong YF, 2005, STRUCTURE, V13, P7, DOI 10.1016/j.str.2004.10.018; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020	48	63	66	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35962	35972		10.1074/jbc.M109.056275	http://dx.doi.org/10.1074/jbc.M109.056275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843518	hybrid, Green Published			2022-12-27	WOS:000272645600071
J	Rha, GB; Wu, G; Shoelson, SE; Chi, YI				Rha, Geun Bae; Wu, Guangteng; Shoelson, Steven E.; Chi, Young-In			Multiple Binding Modes between HNF4 alpha and the LXXLL Motifs of PGC-1 alpha Lead to Full Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; NUCLEAR FACTOR 4-ALPHA; ALPHA ERR-ALPHA; TRANSCRIPTIONAL COACTIVATOR; ESTROGEN-RECEPTOR; GENE-EXPRESSION; LIGAND-BINDING; STRUCTURAL BASIS; INSULIN-SECRETION; ANDROGEN RECEPTOR	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a novel nuclear receptor that participates in a hierarchical network of transcription factors regulating the development and physiology of such vital organs as the liver, pancreas, and kidney. Among the various transcriptional coregulators with which HNF4 alpha interacts, peroxisome proliferation-activated receptor gamma(PPAR gamma) coactivator 1 alpha(PGC-1 alpha) represents a novel coactivator whose activation is unusually robust and whose binding mode appears to be distinct from that of canonical coactivators such as NCoA/SRC/p160 family members. To elucidate the potentially unique molecular mechanism of PGC-1 alpha recruitment, we have determined the crystal structure of HNF4 alpha in complex with a fragment of PGC-1 alpha containing all three of its LXXLL motifs. Despite the presence of all three LXXLL motifs available for interactions, only one is bound at the canonical binding site, with no additional contacts observed between the two proteins. However, a close inspection of the electron density map indicates that the bound LXXLL motif is not a selected one but an averaged structure of more than one LXXLL motif. Further biochemical and functional studies show that the individual LXXLL motifs can bind but drive only minimal transactivation. Only when more than one LXXLL motif is involved can significant transcriptional activity be measured, and full activation requires all three LXXLL motifs. These findings led us to propose a model wherein each LXXLL motif has an additive effect, and the multiple binding modes by HNF4 alpha toward the LXXLL motifs of PGC-1 alpha could account for the apparent robust activation by providing a flexible mechanism for combinatorial recruitment of additional coactivators and mediators.	[Rha, Geun Bae; Wu, Guangteng; Chi, Young-In] Univ Kentucky, Dept Mol & Cellular Biochem, Struct Biol Ctr, Lexington, KY 40536 USA; [Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Shoelson, Steven E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University of Kentucky; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Chi, YI (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Struct Biol Ctr, 741 S Limestone Ave, Lexington, KY 40536 USA.	ychi@uky.edu			National Institutes of Health [P20RR20171]; American Diabetes Association [7-08-CD-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR20171 from the COBRE Program of the NCRR. This work was also supported by American Diabetes Association Grant 7-08-CD-03 (to Y.I.C.).	Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Bourdoncle A, 2005, J MOL BIOL, V347, P921, DOI 10.1016/j.jmb.2005.01.048; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Dubbink HJ, 2006, MOL ENDOCRINOL, V20, P1742, DOI 10.1210/me.2005-0348; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; Greschik H, 2008, J BIOL CHEM, V283, P20220, DOI 10.1074/jbc.M801920200; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Iordanidou P, 2005, J BIOL CHEM, V280, P21810, DOI 10.1074/jbc.M501221200; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Needham M, 2000, J STEROID BIOCHEM, V72, P35, DOI 10.1016/S0960-0760(00)00027-3; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Ruse MD, 2002, MOL CELL BIOL, V22, P1626, DOI 10.1128/MCB.22.6.1626-1638.2002; Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.; Savkur RS, 2005, J PHARMACOL EXP THER, V312, P170, DOI 10.1124/jpet.104.072124; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shiraki T, 2005, PROTEINS, V58, P418, DOI 10.1002/prot.20266; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Sladek FM, 2001, NUCL RECEPTORS GENET; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Stallcup MR, 2000, BIOCHEM SOC T, V28, P415, DOI 10.1042/0300-5127:0280415; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; VAGIN A, 1997, J APPL CRYSTALLOGR, V30, P1002; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	75	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35165	35176		10.1074/jbc.M109.052506	http://dx.doi.org/10.1074/jbc.M109.052506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846556	hybrid, Green Published			2022-12-27	WOS:000272439600070
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			DNA Transcription and tRNA Ligase: the Work of John Abelson	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item														Kresge, Nicole/0000-0003-1551-6627				ABELSON J, PUBLICATION LIST	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45							e20					2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19891053				2022-12-27	WOS:000271378400075
J	Basi, GS; Feinberg, H; Oshidari, F; Anderson, J; Barbour, R; Baker, J; Comery, TA; Diep, L; Gill, D; Johnson-Wood, K; Goel, A; Grantcharova, K; Lee, M; Li, JZ; Partridge, A; Griswold-Prenner, I; Piot, N; Walker, D; Widom, A; Pangalos, MN; Seubert, P; Jacobsen, JS; Schenk, D; Weis, WI				Basi, Guriqbal S.; Feinberg, Hadar; Oshidari, Farshid; Anderson, John; Barbour, Robin; Baker, Jeanne; Comery, Thomas A.; Diep, Linnea; Gill, Davinder; Johnson-Wood, Kelly; Goel, Amita; Grantcharova, Katerina; Lee, Mike; Li, Jingzhi; Partridge, Anthony; Griswold-Prenner, Irene; Piot, Nicolas; Walker, Don; Widom, Angela; Pangalos, Menelas N.; Seubert, Peter; Jacobsen, J. Steven; Schenk, Dale; Weis, William I.			Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid beta-related Behavioral Deficits in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; MOLECULAR-BASIS; PASSIVE IMMUNOTHERAPY; LEARNING-DEFICITS; COGNITIVE DECLINE; KINETIC-ANALYSIS; MEMORY DEFICITS; TRANSGENIC MICE; PEPTIDE; IMMUNIZATION	Immunotherapy targeting of amyloid beta (A beta) peptide in transgenic mouse models of Alzheimer disease (AD) has been widely demonstrated to resolve amyloid deposition as well as associated neuronal, glial, and inflammatory pathologies. These successes have provided the basis for ongoing clinical trials of immunotherapy for treatment of AD in humans. Acute as well as chronic A beta-targeted immunotherapy has also been demonstrated to reverse A beta-related behavioral deficits assessing memory in AD transgenic mouse models. We observe that three antibodies targeting the same linear epitope of A beta, A beta(3-7), differ in their ability to reverse contextual fear deficits in Tg2576 mice in an acute testing paradigm. Reversal of contextual fear deficit by the antibodies does not correlate with in vitro recognition of A beta in a consistent or correlative manner. To better define differences in antigen recognition at the atomic level, we determined crystal structures of Fab fragments in complex with A beta. The conformation of the A beta peptide recognized by all three antibodies was highly related and is also remarkably similar to that observed in independently reported A beta: antibody crystal structures. Sequence and structural differences between the antibodies, particularly in CDR3 of the heavy chain variable region, are proposed to account for differing in vivo properties of the antibodies under study. These findings provide a structural basis for immunotherapeutic strategies targeting A beta species postulated to underlie cognitive deficits in AD.	[Basi, Guriqbal S.; Oshidari, Farshid; Anderson, John; Barbour, Robin; Baker, Jeanne; Diep, Linnea; Johnson-Wood, Kelly; Goel, Amita; Grantcharova, Katerina; Lee, Mike; Partridge, Anthony; Griswold-Prenner, Irene; Piot, Nicolas; Walker, Don; Seubert, Peter; Schenk, Dale] Elan Pharmaceut Inc, San Francisco, CA 94080 USA; [Barbour, Robin; Baker, Jeanne; Seubert, Peter; Schenk, Dale] Janssen Alzheimers Immunotherapy Res & Dev, San Francisco, CA 94080 USA; [Feinberg, Hadar; Li, Jingzhi; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Feinberg, Hadar; Li, Jingzhi; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Comery, Thomas A.; Pangalos, Menelas N.; Jacobsen, J. Steven] Wyeth Res, Discovery Neurosci, Princeton, NJ 08543 USA; [Gill, Davinder; Widom, Angela] Wyeth Res, Biol Technol, Cambridge, MA 02140 USA	Johnson & Johnson; Johnson & Johnson USA; Stanford University; Stanford University; Pfizer; Pfizer	Basi, GS (corresponding author), Elan Pharmaceut Inc, 700 Gateway Blvd, San Francisco, CA 94080 USA.	guriq.basi@elan.com	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Bombois S, 2007, ARCH NEUROL-CHICAGO, V64, P583, DOI 10.1001/archneur.64.4.583; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen GQ, 2007, J NEUROSCI, V27, P2654, DOI 10.1523/JNEUROSCI.3710-06.2007; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES ST, 1991, BIO-TECHNOL, V9, P88, DOI 10.1038/nbt0191-88; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lee M, 2005, ANN NEUROL, V58, P430, DOI 10.1002/ana.20592; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Miles LA, 2008, J MOL BIOL, V377, P181, DOI 10.1016/j.jmb.2007.12.036; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200	60	37	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3417	3427		10.1074/jbc.M109.045187	http://dx.doi.org/10.1074/jbc.M109.045187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19923222	Green Published, hybrid			2022-12-27	WOS:000273829000056
J	Britt, RL; Haruta, N; Lusetti, SL; Chitteni-Pattu, S; Inman, RB; Cox, MM				Britt, Rachel L.; Haruta, Nami; Lusetti, Shelley L.; Chitteni-Pattu, Sindhu; Inman, Ross B.; Cox, Michael M.			Disassembly of Escherichia coli RecA E38K/Delta C17 Nucleoprotein Filaments Is Required to Complete DNA Strand Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTED ATP HYDROLYSIS; BINDING-PROTEIN; STABLE COMPLEXES; NTP HYDROLYSIS; NUCLEOSIDE TRIPHOSPHATE; HELICAL FILAMENTS; BRANCH MIGRATION; SSB PROTEIN; C-TERMINUS; IN-VIVO	Disassembly of RecA protein subunits from a RecA filament has long been known to occur during DNA strand exchange, although its importance to this process has been controversial. An Escherichia coli RecA E38K/Delta C17 double mutant protein displays a unique and pH-dependent mutational separation of DNA pairing and extended DNA strand exchange. Single strand DNA-dependent ATP hydrolysis is catalyzed by this mutant protein nearly normally from pH 6 to 8.5. It will also form filaments on DNA and promote DNA pairing. However, below pH 7.3, ATP hydrolysis is completely uncoupled from extended DNA strand exchange. The products of extended DNA strand exchange do not form. At the lower pH values, disassembly of RecA E38K/Delta C17 filaments is strongly suppressed, even when homologous DNAs are paired and available for extended DNA strand exchange. Disassembly of RecA E38K/Delta C17 filaments improves at pH 8.5, whereas complete DNA strand exchange is also restored. Under these sets of conditions, a tight correlation between filament disassembly and completion of DNA strand exchange is observed. This correlation provides evidence that RecA filament disassembly plays a major role in, and may be required for, DNA strand exchange. A requirement for RecA filament disassembly in DNA strand exchange has a variety of ramifications for the current models linking ATP hydrolysis to DNA strand exchange.	[Britt, Rachel L.; Chitteni-Pattu, Sindhu; Inman, Ross B.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Haruta, Nami] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Lusetti, Shelley L.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	University of Wisconsin System; University of Wisconsin Madison; Osaka University; New Mexico State University	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu		Haruta, Nami/0000-0002-4232-9635	National Institutes of Health [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335 (to M.M.C.).	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; BENEDICT RC, 1988, J BIOL CHEM, V263, P15513; Bianco P R, 1998, Front Biosci, V3, pD570; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Campbell MJ, 1999, J MOL BIOL, V286, P437, DOI 10.1006/jmbi.1998.2457; Campbell MJ, 1999, J MOL BIOL, V286, P417, DOI 10.1006/jmbi.1998.2456; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Churchill JJ, 2000, J MOL BIOL, V297, P537, DOI 10.1006/jmbi.2000.3590; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2008, J BIOL CHEM, V283, P24909, DOI 10.1074/jbc.M803934200; Cox Michael M., 2005, P369; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; COX MM, 1995, J BIOL CHEM, V270, P26021, DOI 10.1074/jbc.270.44.26021; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1982, J BIOL CHEM, V257, P8523; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; COX MM, 1983, J BIOL CHEM, V258, P2586; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Datta S, 2003, PROTEINS, V50, P474, DOI 10.1002/prot.10315; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; ENNIS DG, 1995, MUTAT RES-DNA REPAIR, V336, P39, DOI 10.1016/0921-8777(94)00045-8; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Holmes VF, 2002, J BIOL CHEM, V277, P38945, DOI 10.1074/jbc.M206962200; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LEE JW, 1990, BIOCHEMISTRY-US, V29, P7677, DOI 10.1021/bi00485a017; LINDSLEY JE, 1989, J MOL BIOL, V205, P695, DOI 10.1016/0022-2836(89)90315-X; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MacFarland KJ, 1997, J BIOL CHEM, V272, P17675, DOI 10.1074/jbc.272.28.17675; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MORRICAL SW, 1990, BIOCHEMISTRY-US, V29, P837, DOI 10.1021/bi00455a034; Nayak S, 1999, J BIOL CHEM, V274, P25979, DOI 10.1074/jbc.274.37.25979; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; Sandler SJ, 1996, NUCLEIC ACIDS RES, V24, P2125, DOI 10.1093/nar/24.11.2125; Schnos M, 2000, MOL BIOTECHNOL, V16, P77, DOI 10.1385/MB:16:1:77; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1998, MOL CELL, V1, P309, DOI 10.1016/S1097-2765(00)80031-3; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shan Q, 1996, J MOL BIOL, V257, P756, DOI 10.1006/jmbi.1996.0200; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Stole E, 1997, BIOCHEMISTRY-US, V36, P3483, DOI 10.1021/bi962881l; STOLE E, 1994, J BIOL CHEM, V269, P7919; STOLE E, 1995, J BIOL CHEM, V270, P20322, DOI 10.1074/jbc.270.35.20322; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; TATEISHI S, 1992, J MOL BIOL, V223, P115, DOI 10.1016/0022-2836(92)90720-5; UMEZU K, 1994, J BIOL CHEM, V269, P30005; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8829; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	82	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3211	3226		10.1074/jbc.M109.028951	http://dx.doi.org/10.1074/jbc.M109.028951			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19910465	Green Published, hybrid			2022-12-27	WOS:000273829000036
J	Kariya, Y; Kawamura, C; Tabei, T; Gu, JG				Kariya, Yoshinobu; Kawamura, Chihiro; Tabei, Toshiki; Gu, Jianguo			Bisecting GlcNAc Residues on Laminin-332 Down-regulate Galectin-3-dependent Keratinocyte Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; JUNCTIONAL EPIDERMOLYSIS-BULLOSA; BASEMENT-MEMBRANE ADHESION; EPIDERMAL-GROWTH-FACTOR; MEDIATED CELL-ADHESION; BREAST-CARCINOMA CELLS; BETA-PROPELLER DOMAIN; ALPHA-3-BETA-1 INTEGRIN; LIPID RAFTS; EXTRACELLULAR-MATRIX	Laminin-332 (Lm332; formerly laminin-5) is a basement membrane protein in the skin, which promotes cell motility in wound healing and cancer invasion. In a previous study, we reported that the introduction of bisecting GlcNAc into Lm332 (GnT-III-Lm332), catalyzed by N-acetylglucosaminyltransferase III (GnT-III), reduced cell migration (Kariya, Y., Kato, R., Itoh, S., Fukuda, T., Shibukawa, Y., Sanzen, N., Sekiguchi, K., Wada, Y., Kawasaki, N., and Gu, J. (2008) J. Biol. Chem. 283, 3303633045). However, the underlying molecular mechanism by which GnT-III-Lm332 suppresses the normal biological functions of Lm332 remains to be elucidated. In this study, we show that galectin-3, which is a beta-galactoside-binding protein, strongly bound to unmodified Lm332 but not to GnT-III-Lm332 and that binding of galectin-3 was completely blocked by lactose. Exogenous galectin-3 significantly enhanced keratinocyte cell motility on control Lm332 but not on GnT-III-Lm332. A functional blocking antibody against galectin-3 inhibited Lm332-induced alpha 3 beta 1 and alpha 6 beta 4 integrin clustering and focal contact formation. Co-immunoprecipitation revealed that galectin-3 associated with both beta 4 integrin and epidermal growth factor receptor, thereby cross-linking the two molecules. The associations were inhibited by either the presence of lactose or expression of GnT-III. Moreover, galectin-3 consistently enhanced ERK activation. Taken together, the results of this study are the first to clearly identify the molecular mechanism responsible for the inhibitory effects of GnT-III on extracellular matrix-integrin-meditated cell adhesion, migration, and signal transduction. The findings presented herein shed light on the importance of N-glycosylation-mediated supramolecular complex formation on the cell surface.	[Kariya, Yoshinobu; Kawamura, Chihiro; Tabei, Toshiki; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [21370059]	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Core Research for Evolutional Science and Technology, the Japan Science and Technology Agency, the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Grant-in-aid for Scientific Research 21370059 from Japan Society for the Promotion of Science.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Akama R, 2008, PROTEOMICS, V8, P3221, DOI 10.1002/pmic.200800038; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; CARTER BZ, 1991, LAB INVEST, V65, P610; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DENNIS JW, 1989, CANCER RES, V49, P945; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Gagnoux-Palacios L, 2003, J CELL BIOL, V162, P1189, DOI 10.1083/jcb.200305006; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Granovsky M, 2000, NAT MED, V6, P306; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2002, CANCER RES, V62, P6837; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hittelet A, 2003, INT J CANCER, V103, P370, DOI 10.1002/ijc.10843; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Hsu DK, 2009, J INVEST DERMATOL, V129, P573, DOI 10.1038/jid.2008.276; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Kapucuoglu N, 2009, PATHOL RES PRACT, V205, P97, DOI 10.1016/j.prp.2008.09.001; Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Kariya Y, 2008, J BIOL CHEM, V283, P33036, DOI 10.1074/jbc.M804526200; LeMarer N, 1996, J CELL PHYSIOL, V168, P51, DOI 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.3.CO;2-E; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Paret C, 2005, INT J CANCER, V115, P724, DOI 10.1002/ijc.20977; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; RYAN MC, 1994, J BIOL CHEM, V269, P22779; SATO S, 1992, J BIOL CHEM, V267, P6983; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	64	53	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3330	3340		10.1074/jbc.M109.038836	http://dx.doi.org/10.1074/jbc.M109.038836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940114	Green Published, hybrid			2022-12-27	WOS:000273829000048
J	Kozela, E; Pietr, M; Juknat, A; Rimmerman, N; Levy, R; Vogel, Z				Kozela, Ewa; Pietr, Maciej; Juknat, Ana; Rimmerman, Neta; Levy, Rivka; Vogel, Zvi			Cannabinoids Delta(9)-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-kappa B and Interferon-beta/STAT Proinflammatory Pathways in BV-2 Microglial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; MEDIATED INHIBITION; CB2 RECEPTOR; SIGNALING PATHWAY; BINDING PROTEIN; CUTTING EDGE; TNF-ALPHA; IN-VIVO; STAT3; MACROPHAGES	Cannabinoids have been shown to exert anti-inflammatory activities in various in vivo and in vitro experimental models as well as ameliorate various inflammatory degenerative diseases. However, the mechanisms of these effects are not completely understood. Using the BV-2 mouse microglial cell line and lipopolysaccharide (LPS) to induce an inflammatory response, we studied the signaling pathways engaged in the anti-inflammatory effects of cannabinoids as well as their influence on the expression of several genes known to be involved in inflammation. We found that the two major cannabinoids present in marijuana, Delta(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD), decrease the production and release of proinflammatory cytokines, including interleukin-1 beta, interleukin-6, and interferon (IFN)beta, from LPS-activated microglial cells. The cannabinoid anti-inflammatory action does not seem to involve the CB1 and CB2 cannabinoid receptors or the abn-CBD-sensitive receptors. In addition, we found that THC and CBD act through different, although partially overlapping, mechanisms. CBD, but not THC, reduces the activity of the NF-kappa B pathway, a primary pathway regulating the expression of proinflammatory genes. Moreover, CBD, but not THC, up-regulates the activation of the STAT3 transcription factor, an element of homeostatic mechanism(s) inducing anti-inflammatory events. Following CBD treatment, but less so with THC, we observed a decreased level of mRNA for the Socs3 gene, a main negative regulator of STATs and particularly of STAT3. However, both CBD and THC decreased the activation of the LPS-induced STAT1 transcription factor, a key player in IFN beta-dependent proinflammatory processes. In summary, our observations show that CBD and THC vary in their effects on the anti-inflammatory pathways, including the NF-kappa B and IFN beta-dependent pathways.	[Kozela, Ewa; Pietr, Maciej; Rimmerman, Neta; Levy, Rivka; Vogel, Zvi] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Juknat, Ana; Vogel, Zvi] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Ctr Biol Addict Dis, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Vogel, Z (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	zvi.vogel@weizmann.ac.il	Rimmerman, Neta/F-1331-2010		Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases; Adelsons' Program for Nerve Regeneration and Repair; Nella and Leon Benoziyo Center for Neurosciences; Israeli Ministry of Health	Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases; Adelsons' Program for Nerve Regeneration and Repair; Nella and Leon Benoziyo Center for Neurosciences; Israeli Ministry of Health	This work was supported in part by the Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, by the Adelsons' Program for Nerve Regeneration and Repair, by the Nella and Leon Benoziyo Center for Neurosciences, and by the Israeli Ministry of Health (to Z. V.).	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Baker D, 2007, BRIT J PHARMACOL, V152, P649, DOI 10.1038/sj.bjp.0707458; Barton BE, 2006, EXPERT OPIN THER TAR, V10, P459, DOI 10.1517/14728222.10.3.459; Bayewitch M, 1996, J BIOL CHEM, V271, P9902, DOI 10.1074/jbc.271.17.9902; Ben-Shabat S, 2006, J MED CHEM, V49, P1113, DOI 10.1021/jm050709m; Berdyshev EV, 2001, BIOCHEM J, V360, P67, DOI 10.1042/0264-6021:3600067; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Borrelli F, 2009, J MOL MED, V87, P1111, DOI 10.1007/s00109-009-0512-x; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Butovsky E, 2006, MOL CELL NEUROSCI, V31, P795, DOI 10.1016/j.mcn.2006.01.008; Cabral GA, 2001, ADV EXP MED BIOL, V493, P207; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; De Filippis D, 2008, NEUROGASTROENT MOTIL, V20, P919, DOI 10.1111/j.1365-2982.2008.01114.x; De Filippis D, 2007, J MOL MED, V85, P635, DOI 10.1007/s00109-007-0188-z; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Esposito G, 2006, NEUROSCI LETT, V399, P91, DOI 10.1016/j.neulet.2006.01.047; FELDER CC, 1992, MOL PHARMACOL, V42, P838; Franklin A, 2003, EUR J PHARMACOL, V474, P195, DOI 10.1016/S0014-2999(03)02074-0; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Herring AC, 1999, J PHARMACOL EXP THER, V291, P1156; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Jeon YJ, 1996, MOL PHARMACOL, V50, P334; Jin HJ, 2008, MOL IMMUNOL, V45, P1258, DOI 10.1016/j.molimm.2007.09.015; Kaplan BLF, 2003, J PHARMACOL EXP THER, V306, P1077, DOI 10.1124/jpet.103.051961; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim SH, 2004, NEUROBIOL AGING, V25, P431, DOI 10.1016/S0197-4580(03)00126-X; Klein TW, 2006, J NEUROIMMUNE PHARM, V1, P50, DOI 10.1007/s11481-005-9007-x; Lacaze P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-372; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; MAKRIYANNIS A, 1990, BIOCHIM BIOPHYS ACTA, V1028, P31, DOI 10.1016/0005-2736(90)90262-M; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Ock J, 2007, J NEUROSCI RES, V85, P1989, DOI 10.1002/jnr.21322; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Price TJ, 2004, BRIT J PHARMACOL, V142, P257, DOI 10.1038/sj.bjp.0705778; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rajesh M, 2008, BRIT J PHARMACOL, V153, P347, DOI 10.1038/sj.bjp.0707569; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Roche M, 2006, J NEUROIMMUNOL, V181, P57, DOI 10.1016/j.jneuroim.2006.08.001; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Sacerdote P, 2005, J NEUROIMMUNOL, V159, P97, DOI 10.1016/j.jneuroim.2004.10.003; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Srivastava MD, 1998, IMMUNOPHARMACOLOGY, V40, P179, DOI 10.1016/S0162-3109(98)00041-1; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Thomas BF, 1998, J PHARMACOL EXP THER, V285, P285; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; WATZL B, 1991, INT J IMMUNOPHARMACO, V13, P1091, DOI 10.1016/0192-0561(91)90160-9; Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27, DOI 10.18388/abp.2007_3266; Wormald S, 2007, CURR OPIN HEMATOL, V14, P9, DOI 10.1097/00062752-200701000-00004; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zuardi AW, 2008, REV BRAS PSIQUIATR, V30, P271, DOI 10.1590/S1516-44462008000300015	74	154	158	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1616	1626		10.1074/jbc.M109.069294	http://dx.doi.org/10.1074/jbc.M109.069294			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19910459	Green Published, hybrid			2022-12-27	WOS:000273429100007
J	Olson, ML; Chalmers, S; McCarron, JG				Olson, Marnie L.; Chalmers, Susan; McCarron, John G.			Mitochondrial Ca2+ Uptake Increases Ca2+ Release from Inositol 1,4,5-Trisphosphate Receptor Clusters in Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTES; SARCOPLASMIC-RETICULUM; CALCIUM PUFFS; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR; GATED CHANNELS; CYTOSOLIC CA2+; IP3 RECEPTORS; INTACT-CELLS; TRISPHOSPHATE	Smooth muscle activities are regulated by inositol 1,4,5-trisphosphate (InsP(3))-mediated increases in cytosolic Ca2+ concentration ([Ca2+](c)). Local Ca2+ release from an InsP(3) receptor (InsP(3)R) cluster present on the sarcoplasmic reticulum is termed a Ca2+ puff. Ca2+ released via InsP(3)R may diffuse to adjacent clusters to trigger further release and generate a cell-wide (global) Ca2+ rise. In smooth muscle, mitochondrial Ca2+ uptake maintains global InsP(3)-mediated Ca2+ release by preventing a negative feedback effect of high [Ca2+] on InsP(3)R. Mitochondria may regulate InsP(3)-mediated Ca2+ signals by operating between or within InsP(3)R clusters. In the former mitochondria could regulate only global Ca2+ signals, whereas in the latter both local and global signals would be affected. Here whether mitochondria maintain InsP(3)-mediated Ca2+ release by operating within (local) or between (global) InsP(3)R clusters has been addressed. Ca2+ puffs evoked by localized photolysis of InsP(3) in single voltage-clamped colonic smooth muscle cells had amplitudes of 0.5-4.0 F/F-0, durations of similar to 112 ms at half-maximum amplitude, and were abolished by the InsP(3)R inhibitor 2-aminoethoxydiphenyl borate. The protonophore carbonyl cyanide 3-chloropheylhydrazone and complex I inhibitor rotenone each depolarized Delta Psi(M) to prevent mitochondrial Ca2+ uptake and attenuated Ca2+ puffs by similar to 66 or similar to 60%, respectively. The mitochondrial uniporter inhibitor, RU360, attenuated Ca2+ puffs by similar to 62%. The "fast" Ca2+ chelator 1,2-bis(o-aminophenoxy) ethane-N,N,N', N'-tetraacetic acid acted like mitochondria to prolong InsP(3)-mediated Ca2+ release suggesting that mitochondrial influence is via their Ca2+ uptake facility. These results indicate Ca2+ uptake occurs quickly enough to influence InsP(3)R communication at the intra-cluster level and that mitochondria regulate both local and global InsP(3)-mediated Ca2+ signals.	[Olson, Marnie L.; Chalmers, Susan; McCarron, John G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	University of Strathclyde	McCarron, JG (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, John Arbuthnott Bldg, Glasgow G4 0NR, Lanark, Scotland.	john.mccarron@strath.ac.uk	Chalmers, Susan/C-1392-2009	Chalmers, Susan/0000-0002-8073-7576	Wellcome Trust [078054/Z/05/Z]; British Heart Foundation [PG/08/066]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by Wellcome Trust Grant 078054/Z/05/Z and British Heart Foundation Grant PG/08/066.	BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Boittin FX, 2000, BIOCHEM J, V349, P323, DOI 10.1042/0264-6021:3490323; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; Bradley KN, 2002, J PHYSIOL-LONDON, V538, P465, DOI 10.1113/jphysiol.2001.013039; Callamaras N, 2000, EMBO J, V19, P3608, DOI 10.1093/emboj/19.14.3608; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Collins TJ, 2000, BIOCHEM J, V347, P593, DOI 10.1042/0264-6021:3470593; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dai JZ, 2005, CELL CALCIUM, V37, P333, DOI 10.1016/j.ceca.2004.12.002; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Drummond RM, 1999, J PHYSIOL-LONDON, V516, P139, DOI 10.1111/j.1469-7793.1999.139aa.x; Haak LL, 2002, J NEUROCHEM, V80, P405, DOI 10.1046/j.0022-3042.2001.00727.x; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Horne JH, 1997, SCIENCE, V276, P1690, DOI 10.1126/science.276.5319.1690; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; Marchant JS, 2002, AM J PHYSIOL-CELL PH, V282, pC1374, DOI 10.1152/ajpcell.00446.2001; Marchant JS, 1998, BIOCHEM J, V334, P505, DOI 10.1042/bj3340505; McCarron JG, 2004, J BIOL CHEM, V279, P8417, DOI 10.1074/jbc.M311797200; McCarron JG, 2002, J CELL SCI, V115, P2207; McCarron JG, 1999, J PHYSIOL-LONDON, V516, P149, DOI 10.1111/j.1469-7793.1999.149aa.x; McCarron JG, 2008, J BIOL CHEM, V283, P7206, DOI 10.1074/jbc.M708923200; McCarron JG, 2008, J CELL SCI, V121, P86, DOI 10.1242/jcs.017541; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; NIXON GF, 1994, J MUSCLE RES CELL M, V15, P682, DOI 10.1007/BF00121075; Oancea E, 1996, J BIOL CHEM, V271, P17253, DOI 10.1074/jbc.271.29.17253; Parker I, 1996, J PHYSIOL-LONDON, V491, P663, DOI 10.1113/jphysiol.1996.sp021247; PARKER I, 1995, CIBA F SYMP, V188, P50; PARKER I, 1991, P ROY SOC B-BIOL SCI, V246, P269, DOI 10.1098/rspb.1991.0154; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rose HJ, 2006, BIOPHYS J, V91, P4024, DOI 10.1529/biophysj.106.088872; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; Shuai JW, 2006, BIOPHYS J, V91, P4033, DOI 10.1529/biophysj.106.088880; Simpson PB, 1996, J BIOL CHEM, V271, P33493, DOI 10.1074/jbc.271.52.33493; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Sward K, 2002, CIRC RES, V90, P792, DOI 10.1161/01.RES.0000015214.40360.84; Swillens S, 1999, P NATL ACAD SCI USA, V96, P13750, DOI 10.1073/pnas.96.24.13750; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Thomas D, 1998, J BIOL CHEM, V273, P27130, DOI 10.1074/jbc.273.42.27130; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538	49	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2040	2050		10.1074/jbc.M109.027094	http://dx.doi.org/10.1074/jbc.M109.027094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19889626	Green Published, hybrid			2022-12-27	WOS:000273429100049
J	Quoyer, J; Longuet, C; Broca, C; Linck, N; Costes, S; Varin, E; Bockaert, J; Bertrand, G; Dalle, S				Quoyer, Julie; Longuet, Christine; Broca, Christophe; Linck, Nathalie; Costes, Safia; Varin, Elodie; Bockaert, Joel; Bertrand, Gyslaine; Dalle, Stephane			GLP-1 Mediates Antiapoptotic Effect by Phosphorylating Bad through a beta-Arrestin 1-mediated ERK1/2 Activation in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; SIGNAL-REGULATED KINASES; ELEMENT-BINDING PROTEIN; INSULIN-SECRETION; DIFFERENTIAL REGULATION; RECEPTOR; GLUCOSE; SURVIVAL; CAMP; APOPTOSIS	Strategies based on activating GLP-1 receptor (GLP-1R) are intensively developed for the treatment of type 2 diabetes. The exhaustive knowledge of the signaling pathways linked to activated GLP-1R within the beta-cells is of major importance. In beta-cells, GLP-1 activates the ERK1/2 cascade by diverse pathways dependent on either G alpha(s)/cAMP/cAMP-dependent protein kinase (PKA) or beta-arrestin 1, a scaffold protein. Using pharmacological inhibitors, beta-arrestin 1 small interfering RNA, and islets isolated from beta-arrestin 1 knock-out mice, we demonstrate that GLP-1 stimulates ERK1/2 by two temporally distinct pathways. The PKA-dependent pathway mediates rapid and transient ERK1/2 phosphorylation that leads to nuclear translocation of the activated kinases. In contrast, the beta-arrestin 1-dependent pathway produces a late ERK1/2 activity that is restricted to the beta-cell cytoplasm. We further observe that GLP-1 phosphorylates the cytoplasmic proapoptotic protein Bad at Ser-112 but not at Ser-155. We find that the beta-arrestin 1-dependent ERK1/2 activation engaged by GLP-1 mediates the Ser-112 phosphorylation of Bad, through p90RSK activation, allowing the association of Bad with the scaffold protein 14-3-3, leading to its inactivation. beta-Arrestin 1 is further found to mediate the antiapoptotic effect of GLP-1 in beta-cells through the ERK1/2-p90RSK-phosphorylation of Bad. This new regulatory mechanism engaged by activated GLP-1R involving a beta-arrestin 1-dependent spatiotemporal regulation of the ERK1/2-p90RSK activity is now suspected to participate in the protection of beta-cells against apoptosis. Such signaling mechanism may serve as a prototype to generate new therapeutic GLP-1R ligands.	[Quoyer, Julie; Broca, Christophe; Linck, Nathalie; Costes, Safia; Varin, Elodie; Bockaert, Joel; Bertrand, Gyslaine; Dalle, Stephane] Univ Montpellier I, Inst Genom Fonct, INSERM, CNRS,U661,Equipe Avenir,UMR5203, F-34094 Montpellier 5, France; [Quoyer, Julie; Broca, Christophe; Linck, Nathalie; Costes, Safia; Varin, Elodie; Bockaert, Joel; Bertrand, Gyslaine; Dalle, Stephane] Univ Montpellier 2, F-34094 Montpellier 5, France; [Longuet, Christine; Bockaert, Joel; Bertrand, Gyslaine; Dalle, Stephane] Mt Sinai Hosp, Dept Med, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Longuet, Christine; Bockaert, Joel; Bertrand, Gyslaine; Dalle, Stephane] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5T 3L9, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dalle, S (corresponding author), Univ Montpellier I, Inst Genom Fonct, INSERM, CNRS,U661,Equipe Avenir,UMR5203, 141 Rue Cardonille, F-34094 Montpellier 5, France.	stephane.dalle@igf.cnrs.fr	Longuet, Christine/ABC-2556-2020; Dalle, Stephane/E-4552-2018; bertrand, gyslaine/AAC-6716-2020; , Costes/AAC-2820-2020	Dalle, Stephane/0000-0002-3423-4548; , Costes/0000-0001-8323-1207; Broca, Christophe/0000-0002-7715-8231; Linck, Nathalie/0000-0002-2218-239X	INSERM; Region Languedoc-Roussillon; Fondation pour la Recherche Medicale	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Supported by INSERM, the "Region Languedoc-Roussillon," and the "Fondation pour la Recherche Medicale."	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Broca C, 2009, J BIOL CHEM, V284, P4332, DOI 10.1074/jbc.M807595200; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Conner DA, 1997, CIRC RES, V81, P1021; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Dalle S, 2004, J BIOL CHEM, V279, P20345, DOI 10.1074/jbc.M312483200; Dalle S, 1999, J BIOL CHEM, V274, P10869, DOI 10.1074/jbc.274.16.10869; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DELAAGE MA, 1978, MOL BIOL PHARM CYCLI, P151; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HOLST JJ, 2007, J PHYSL REV, V87, P1409; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Jorgensen R, 2007, J PHARMACOL EXP THER, V322, P148, DOI 10.1124/jpet.107.120006; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; SVENSSON C, 1993, J ENDOCRINOL, V136, P289, DOI 10.1677/joe.0.1360289; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Volmat V, 2001, J CELL SCI, V114, P3433; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XP, 2005, CANCER RES, V65, P7338, DOI 10.1158/0008-5472.CAN-04-2263; Zraika S, 2006, DIABETOLOGIA, V49, P1254, DOI 10.1007/s00125-006-0212-9	68	122	129	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1989	2002		10.1074/jbc.M109.067207	http://dx.doi.org/10.1074/jbc.M109.067207			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915011	Green Published, hybrid			2022-12-27	WOS:000273429100045
J	Redmond, TM; Poliakov, E; Kuo, S; Chander, P; Gentleman, S				Redmond, T. Michael; Poliakov, Eugenia; Kuo, Stephanie; Chander, Preethi; Gentleman, Susan			RPE65, Visual Cycle Retinol Isomerase, Is Not Inherently 11-cis-specific SUPPORT FOR A CARBOCATION MECHANISM OF RETINOL ISOMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBERS CONGENITAL AMAUROSIS; PIGMENT EPITHELIAL-CELLS; CATION-PI INTERACTIONS; ALL-TRANS-RETINOL; BETA-CAROTENE; VITAMIN-A; BINDING PROTEIN; ENERGY-SOURCE; GENE-THERAPY; CIS-RETINOLS	The mechanism of retinol isomerization in the vertebrate retina visual cycle remains controversial. Does the isomerase enzyme RPE65 operate via nucleophilic addition at C-11 of the all-trans substrate, or via a carbocation mechanism? To determine this, we modeled the RPE65 substrate cleft to identify residues interacting with substrate and/or intermediate. We find that wild-type RPE65 in vitro produces 13-cis and 11-cis isomers equally robustly. All Tyr-239 mutations abolish activity. Trp-331 mutations reduce activity (W331Y to similar to 75% of wild type, W331F to similar to 50%, and W331L and W331Q to 0%) establishing a requirement for aromaticity, consistent with cation-pi carbocation stabilization. Two cleft residues modulate isomerization specificity: Thr-147 is important, because replacement by Ser increases 11-cis relative to 13-cis by 40% compared with wild type. Phe-103 mutations are opposite in action: F103L and F103I dramatically reduce 11-cis synthesis relative to 13-cis synthesis compared with wild type. Thr-147 and Phe-103 thus may be pivotal in controlling RPE65 specificity. Also, mutations affecting RPE65 activity coordinately depress 11-cis and 13-cis isomer production but diverge as 11-cis decreases to zero, whereas 13-cis reaches a plateau consistent with thermal isomerization. Lastly, experiments using labeled retinol showed exchange at 13-cis-retinol C-15 oxygen, thus confirming enzymatic isomerization for both isomers. Thus, RPE65 is not inherently 11-cis-specific and can produce both 11- and 13-cis isomers, supporting a carbocation (or radical cation) mechanism for isomerization. Specific visual cycle selectivity for 11-cis isomers instead resides downstream, attributable to mass action by CRALBP, retinol dehydrogenase 5, and high affinity of opsin apoproteins for 11-cis-retinal.	[Redmond, T. Michael; Poliakov, Eugenia; Kuo, Stephanie; Chander, Preethi; Gentleman, Susan] NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Redmond, TM (corresponding author), NEI, Retinal Cell & Mol Biol Lab, NIH, Bldg 6,Room 117A, Bethesda, MD 20892 USA.	redmond@helix.nih.gov		Redmond, T. Michael/0000-0002-1813-5291	National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of NEI.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Bouvier F, 1997, ARCH BIOCHEM BIOPHYS, V346, P53, DOI 10.1006/abbi.1997.0278; CANADA FJ, 1990, BIOCHEMISTRY-US, V29, P9690, DOI 10.1021/bi00493a026; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; Grutter C, 2006, ANGEW CHEM INT EDIT, V45, P1126, DOI 10.1002/anie.200503123; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Gurzadyan GG, 2007, PHYS CHEM CHEM PHYS, V9, P288, DOI 10.1039/b609165m; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; HUBBARD R, 1952, J GEN PHYSIOL, V36, P269, DOI 10.1085/jgp.36.2.269; Jenson C, 1997, J AM CHEM SOC, V119, P10846, DOI 10.1021/ja9714245; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; Lesburg CA, 1998, CURR OPIN STRUC BIOL, V8, P695, DOI 10.1016/S0959-440X(98)80088-2; Lorenz B, 2008, INVEST OPHTH VIS SCI, V49, P5235, DOI 10.1167/iovs.07-1671; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; PIENTA NJ, 1992, J AM CHEM SOC, V114, P2419, DOI 10.1021/ja00033a017; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Prigge ST, 2004, SCIENCE, V304, P864, DOI 10.1126/science.1094583; RANDO RR, 1991, BIOCHEMISTRY-US, V30, P595, DOI 10.1021/bi00217a001; RANDO RR, 1983, J AM CHEM SOC, V105, P2879, DOI 10.1021/ja00347a058; Redmond TM, 2007, MOL VIS, V13, P1813; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; REUTER T, 1964, NATURE, V204, P784, DOI 10.1038/204784a0; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wingerath T, 1999, ANAL BIOCHEM, V272, P232, DOI 10.1006/abio.1999.4194; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d	55	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1919	1927		10.1074/jbc.M109.027458	http://dx.doi.org/10.1074/jbc.M109.027458			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920137	Green Published, hybrid			2022-12-27	WOS:000273429100038
J	Kuhn, DE; Nuovo, GJ; Terry, AV; Martin, MM; Malana, GE; Sansom, SE; Pleister, AP; Beck, WD; Head, E; Feldman, DS; Elton, TS				Kuhn, Donald E.; Nuovo, Gerard J.; Terry, Alvin V., Jr.; Martin, Mickey M.; Malana, Geraldine E.; Sansom, Sarah E.; Pleister, Adam P.; Beck, Wayne D.; Head, Elizabeth; Feldman, David S.; Elton, Terry S.			Chromosome 21-derived MicroRNAs Provide an Etiological Basis for Aberrant Protein Expression in Human Down Syndrome Brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME; GENE-EXPRESSION; TRANSCRIPTION FACTOR; MECP2 EXPRESSION; TS65DN MICE; MOUSE MODEL; IN-VIVO; TARGETS; BINDING; TRANSLATION	Down syndrome (DS), or Trisomy 21, is the most common genetic cause of cognitive impairment and congenital heart defects in the human population. Bioinformatic annotation has established that human chromosome 21 (Hsa21) harbors five microRNA (miRNAs) genes: miR-99a, let-7c, miR-125b-2, miR-155, and miR-802. Our laboratory recently demonstrated that Hsa21-derived miRNAs are overexpressed in DS brain and heart specimens. The aim of this study was to identify important Hsa21-derived miRNA/mRNA target pairs that may play a role, in part, in mediating the DS phenotype. We demonstrate by luciferase/target mRNA 3'-untranslated region reporter assays, and gain- and lossof-function experiments that miR- 155 and -802 can regulate the expression of the predicted mRNA target, the methyl-CpG-binding protein (MeCP2). We also demonstrate that MeCP2 is underexpressed in DS brain specimens isolated from either humans or mice. We further demonstrate that, as a consequence of attenuated MeCP2 expression, transcriptionally activated and silenced MeCP2 target genes, CREB1/Creb1 and MEF2C/Mef2c, are also aberrantly expressed in these DS brain specimens. Finally, in vivo silencing of endogenous miR-155 or -802, by antagomir intraventricular injection, resulted in the normalization of MeCP2 and MeCP2 target gene expression. Taken together, these results suggest that improper repression of MeCP2, secondary to trisomic overexpression of Hsa21-derived miRNAs, may contribute, in part, to the abnormalities in the neurochemistry observed in the brains of DS individuals. Finally these results suggest that selective inactivation of Hsa21-derived miRNAs may provide a novel therapeutic tool in the treatment of DS.	[Elton, Terry S.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA; [Nuovo, Gerard J.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Feldman, David S.; Elton, Terry S.] Ohio State Univ, Dept Med, Div Cardiol, Columbus, OH 43210 USA; [Kuhn, Donald E.; Nuovo, Gerard J.; Martin, Mickey M.; Malana, Geraldine E.; Sansom, Sarah E.; Pleister, Adam P.; Feldman, David S.; Elton, Terry S.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Terry, Alvin V., Jr.; Beck, Wayne D.] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Head, Elizabeth] Univ Calif Irvine, Dept Neurol, Inst Brain Aging & Dementia, Irvine, CA 92697 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Georgia; Augusta University; University of California System; University of California Irvine	Elton, TS (corresponding author), DHLRI 515,473 W 12th Ave, Columbus, OH 43210 USA.	terry.elton@osumc.edu	Huang, H/E-9490-2010	Sansom, Sarah/0000-0002-1924-8941; Terry, Alvin/0000-0003-2071-4767	National Institutes of Health [HL48848, HD058997, HL084498, ES012241, AG21912]; Fondation Jerome Lejeune; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048848, R01HL084498, R01HL048848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Jerome Lejeune; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL48848, HD058997 (to T.S.E.), HL084498 (to D.S.F.), ES012241 (to A.V.T.), and AG21912 (to E.H.), and a grant from the Fondation Jerome Lejeune (to T.S.E.).	Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Enright AJ, 2004, GENOME BIOL, V5; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gardiner K, 2006, AM J MED GENET C, V142C, P196, DOI 10.1002/ajmg.c.30098; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hon LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r166; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; HOOK EG, 1982, EPIDEMIOLOGY DOWN SY, P11; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kahlem P, 2006, BEHAV GENET, V36, P416, DOI 10.1007/s10519-006-9053-z; Kaufmann WE, 2005, BRAIN DEV-JPN, V27, pS77, DOI 10.1016/j.braindev.2004.10.008; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Moore CS, 2006, MAMM GENOME, V17, P1005, DOI 10.1007/s00335-006-0032-8; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Pidoux G, 2004, PLACENTA, V25, P469, DOI 10.1016/j.placenta.2003.10.016; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Standart N, 2007, GENE DEV, V21, P1975, DOI 10.1101/gad.1591507; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; VANDERWOLF CH, 2001, STEREOTAXIC SURG RAT; Wang Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2316, DOI 10.2741/2234; Williams AD, 2008, DEV DYNAM, V237, P426, DOI 10.1002/dvdy.21416	58	91	96	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1529	1543		10.1074/jbc.M109.033407	http://dx.doi.org/10.1074/jbc.M109.033407			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897480	Green Published, hybrid			2022-12-27	WOS:000273258200072
J	Moreno-Manzano, V; Rodriguez-Jimenez, FJ; Acena-Bonilla, JL; Fustero-Lardies, S; Erceg, S; Dopazo, J; Montaner, D; Stojkovic, M; Sanchez-Puelles, JM				Moreno-Manzano, Victoria; Rodriguez-Jimenez, Francisco J.; Acena-Bonilla, Jose L.; Fustero-Lardies, Santos; Erceg, Slaven; Dopazo, Joaquin; Montaner, David; Stojkovic, Miodrag; Sanchez-Puelles, Jose M.			FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT SPINAL-CORD; EMBRYONIC-DEVELOPMENT; PROLYL HYDROXYLASES; LOWERED OXYGEN; TUMOR-GROWTH; IN-VITRO; EXPRESSION; CANCER; FACTOR-1-ALPHA; IDENTIFICATION	The biology of the alpha subunits of hypoxia-inducible factors (HIF alpha) has expanded from their role in angiogenesis to their current position in the self-renewal and differentiation of stem cells. The results reported in this article show the discovery of FM19G11, a novel chemical entity that inhibits HIF alpha proteins that repress target genes of the two alpha subunits, in various tumor cell lines as well as in adult and embryonic stem cell models from rodents and humans, respectively. FM19G11 inhibits at nanomolar range the transcriptional and protein expression of Oct4, Sox2, Nanog, and Tgf-alpha undifferentiating factors, in adult rat and human embryonic stem cells, FM19G11 activity occurs in ependymal progenitor stem cells from rats (epSPC), a cell model reported for spinal cord regeneration, which allows the progression of oligodendrocyte cell differentiation in a hypoxic environment, has created interest in its characterization for pharmacological research. Experiments using small interfering RNA showed a significant depletion in Sox2 protein only in the case of HIF2 alpha silencing, but not in HIF1 alpha-mediated ablation. Moreover, chromatin immunoprecipitation data, together with the significant presence of functional hypoxia response element consensus sequences in the promoter region of Sox2, strongly validated that this factor behaves as a target gene of HIF2 alpha in epSPCs. FM19G11 causes a reduction of overall histone acetylation with significant repression of p300, a histone acetyltransferase required as a co-factor for HIF-transcription activation. Arrays carried out in the presence and absence of the inhibitor showed the predominant involvement of epigenetic-associated events mediated by the drug.	[Sanchez-Puelles, Jose M.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Erceg, Slaven; Dopazo, Joaquin; Montaner, David; Stojkovic, Miodrag; Sanchez-Puelles, Jose M.] FV Ctr Invest Principe Felipe, E-46012 Valencia, Spain; [Fustero-Lardies, Santos] Univ Valencia, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Prince Felipe Research Center; University of Valencia	Sanchez-Puelles, JM (corresponding author), CSIC, Ctr Invest Biol, Plaza Murillo 2, E-28040 Madrid, Spain.	jmspuelles@cib.csic.es	RODRIGUEZ-JIMENEZ, FRANCISCO JAVIER/ABC-4979-2021; Sanchez-Puelles, J. M./E-4159-2018; Dopazo, Joaquin/A-9270-2014; Aceña, José Luis/F-2453-2016; Moreno, Victoria/B-4175-2014; Erceg, Slaven/ABC-4946-2021; Montaner, David/A-9362-2014	Sanchez-Puelles, J. M./0000-0002-4283-4885; Dopazo, Joaquin/0000-0003-3318-120X; Aceña, José Luis/0000-0002-1777-8199; Moreno, Victoria/0000-0002-6035-9491; Montaner, David/0000-0002-2484-3278; Erceg, Slaven/0000-0003-3208-7705; Stojkovic, Miodrag/0000-0001-7526-6573; Fustero, Santos/0000-0002-7575-9439	Fondo de Investigaciones Sanitarias; Instituto de Salud Carlos III (Spain); Ministerio de Educacion, Ciencia y Tecnologia, and Generalitat Valenciana (Spain) [PI051973 RD06/0010/1006, SAF2007-63714, GVRE/2008/254]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Ministerio de Educacion, Ciencia y Tecnologia, and Generalitat Valenciana (Spain)	This work was supported by the Fondo de Investigaciones Sanitarias, the Instituto de Salud Carlos III (Spain), the Ministerio de Educacion, Ciencia y Tecnologia, and Generalitat Valenciana (Spain) Projects PI051973 RD06/0010/1006, SAF2007-63714, and GVRE/2008/254.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Covello KL, 2005, CANCER RES, V65, P2277, DOI 10.1158/0008-5472.CAN-04-3246; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; Fedele Anthony O, 2002, Mol Interv, V2, P229, DOI 10.1124/mi.2.4.229; Fitz LJ, 1997, ONCOGENE, V15, P613, DOI 10.1038/sj.onc.1201191; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hu Y, 2005, MOL THER, V11, P906, DOI 10.1016/j.ymthe.2005.01.016; Rodriguez-Jimenez FJ, 2008, STEM CELLS, V26, P2052, DOI 10.1634/stemcells.2007-1016; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Koh MY, 2008, MOL CANCER THER, V7, P90, DOI 10.1158/1535-7163.MCT-07-0463; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyssiotis CA, 2007, P NATL ACAD SCI USA, V104, P14982, DOI 10.1073/pnas.0707044104; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Maynard MA, 2007, CELL CYCLE, V6, P2810, DOI 10.4161/cc.6.22.4947; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Ohori Y, 2006, J NEUROSCI, V26, P11948, DOI 10.1523/JNEUROSCI.3127-06.2006; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Studer L, 2000, J NEUROSCI, V20, P7377; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Zhang CP, 2006, NEUROSIGNALS, V15, P259, DOI 10.1159/000103385	44	92	99	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1333	1342		10.1074/jbc.M109.008326	http://dx.doi.org/10.1074/jbc.M109.008326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897487	Green Published, hybrid			2022-12-27	WOS:000273258200054
J	Sheppard, V; Poulsen, N; Kroger, N				Sheppard, Vonda; Poulsen, Nicole; Kroger, Nils			Characterization of an Endoplasmic Reticulum-associated Silaffin Kinase from the Diatom Thalassiosira pseudonana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTATING MAMMARY-GLAND; APPARATUS CASEIN KINASE; CELL-WALL; GOLGI-APPARATUS; SILICA BIOMINERALIZATION; MEMBRANE-PROTEINS; TARGETING SIGNALS; IN-VITRO; PHOSPHORYLATION; PLASTIDS	The formation of SiO2-based cell walls by diatoms (a large group of unicellular microalgae) is a well established model system for the study of molecular mechanisms of biological mineral morphogenesis (biomineralization). Diatom biomineralization involves highly phosphorylated proteins (silaffins and silacidins), analogous to other biomineralization systems, which also depend on diverse sets of phosphoproteins (e. g. mammalian teeth and bone, mollusk shells, and sponge silica). The phosphate moieties on biomineralization proteins play an essential role in mineral formation, yet the kinases catalyzing the phosphorylation of these proteins have remained poorly characterized. Recent functional genomics studies on the diatom Thalassiosira pseudonana have revealed > 100 proteins potentially involved in diatom silica formation. Here we have characterized the biochemical properties and biological function of one of these proteins, tpSTK1. Multiple tpSTK1-like proteins are encoded in diatom genomes, all of which exhibit low but significant sequence similarity to kinases from other organisms. We show that tpSTK1 has serine/threonine kinase activity capable of phosphorylating silaffins but not silacidins. Cell biological and biochemical analysis demonstrated that tpSTK1 is an abundant component of the lumen of the endoplasmic reticulum. The present study provides the first molecular structure of a kinase that appears to catalyze phosphorylation of biomineral forming proteins in vivo.	Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Kroger, N (corresponding author), 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	nils.kroger@chemistry.gatech.edu		Poulsen, Nicole/0000-0002-4533-8860	National Science Foundation [DMR 0845939]; Research Corporation for Science Advancement [7492]; U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN); Division Of Materials Research [0845939] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Research Corporation for Science Advancement(Research Corporation for Science Advancement); U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Georgia Institute of Technology, Grant DMR 0845939 from the National Science Foundation (to N.K.), Cottrell Scholar Award 7492 from the Research Corporation for Science Advancement (to N.K.), and a U.S. Department of Education Graduate Assistance in Areas of National Need (GAANN) fellowship (to V. S.).	Apt KE, 2002, J CELL SCI, V115, P4061, DOI 10.1242/jcs.00092; ARBER S, 1992, J CELL BIOL, V116, P113, DOI 10.1083/jcb.116.1.113; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; BHAYA D, 1991, MOL GEN GENET, V229, P400, DOI 10.1007/BF00267462; BINGHAM EW, 1974, J BIOL CHEM, V249, P3647; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brunati AM, 2000, FEBS LETT, V471, P151, DOI 10.1016/S0014-5793(00)01378-8; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; Crookes-Goodson WJ, 2008, CHEM SOC REV, V37, P2403, DOI 10.1039/b702825n; Drzymala L, 2000, BIOCHEMISTRY-US, V39, P2023, DOI 10.1021/bi9924213; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fischer H, 1999, J PHYCOL, V35, P113, DOI 10.1046/j.1529-8817.1999.3510113.x; Frasson M, 2009, BBA-MOL CELL RES, V1793, P239, DOI 10.1016/j.bbamcr.2008.10.001; Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200; GALBRAITH DW, 1995, METHODS PLANT CELL B, P137; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Kroger N, 1998, PROTIST, V149, P213, DOI 10.1016/S1434-4610(98)70029-X; Kroger N, 2006, ANGEW CHEM INT EDIT, V45, P7239, DOI 10.1002/anie.200601871; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroth PG, 2002, INT REV CYTOL, V221, P191; Lang M, 1998, J BIOL CHEM, V273, P30973, DOI 10.1074/jbc.273.47.30973; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; Lee SN, 2006, J BIOL CHEM, V281, P3312, DOI 10.1074/jbc.M506635200; Lowenstam HA, 1989, BIOMINERALIZATION; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Monnat J, 2000, MOL BIOL CELL, V11, P3469, DOI 10.1091/mbc.11.10.3469; PACKER L, 1997, BIOMEMBRANE, P214; Pasqualini E, 2000, BIOCHEM J, V345, P121, DOI 10.1042/0264-6021:3450121; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pimpl P, 2000, PLANT CELL, V12, P1517; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; Poulsen N, 2007, ANGEW CHEM INT EDIT, V46, P1843, DOI 10.1002/anie.200603928; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; Simkiss K, 1989, BIOMINERALIZATION CE; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Veis A, 1997, CRIT REV ORAL BIOL M, V8, P360, DOI 10.1177/10454411970080040101; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200	62	14	14	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1166	1176		10.1074/jbc.M109.039529	http://dx.doi.org/10.1074/jbc.M109.039529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889629	Green Published, hybrid			2022-12-27	WOS:000273258200039
J	Foster, KG; Acosta-Jaquez, HA; Romeo, Y; Ekim, B; Soliman, GA; Carriere, A; Roux, PP; Ballif, BA; Fingar, DC				Foster, Kathryn G.; Acosta-Jaquez, Hugo A.; Romeo, Yves; Ekim, Bilgen; Soliman, Ghada A.; Carriere, Audrey; Roux, Philippe P.; Ballif, Bryan A.; Fingar, Diane C.			Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser(863) and Multisite Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX-1; RICH AKT SUBSTRATE; 40 KDA PRAS40; MAMMALIAN TARGET; CELL-GROWTH; RAG GTPASES; PHOSPHOPROTEOME ANALYSIS; PROTEIN-PHOSPHORYLATION; BINDING PARTNER; RAPAMYCIN TOR	The rapamycin-sensitive mTOR complex 1 (mTORC1) promotes protein synthesis, cell growth, and cell proliferation in response to growth factors and nutritional cues. To elucidate the poorly defined mechanisms underlying mTORC1 regulation, we have studied the phosphorylation of raptor, an mTOR-interacting partner. We have identified six raptor phosphorylation sites that lie in two centrally localized clusters (cluster 1, Ser(696)/Thr(706) and cluster 2, Ser(855)/Ser(859)/Ser(863)/Ser(877)) using tandem mass spectrometry and generated phosphospecific antibodies for each of these sites. Here we focus primarily although not exclusively on raptor Ser(863) phosphorylation. We report that insulin promotes mTORC1-associated phosphorylation of raptor Ser(863) via the canonical PI3K/TSC/Rheb pathway in a rapamycin-sensitive manner. mTORC1 activation by other stimuli (e. g. amino acids, epidermal growth factor/MAPK signaling, and cellular energy) also promote raptor Ser(863) phosphorylation. Rheb overexpression increases phosphorylation on raptor Ser(863) as well as on the five other identified sites (e. g. Ser(859), Ser(855), Ser(877), Ser(696), and Thr(706)). Strikingly, raptor Ser(863) phosphorylation is absolutely required for raptor Ser(859) and Ser(855) phosphorylation. These data suggest that mTORC1 activation leads to raptor multisite phosphorylation and that raptor Ser(863) phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation (e. g. on Ser(859) and Ser(855)). Importantly, mTORC1 containing phosphorylation site-defective raptor exhibits reduced in vitro kinase activity toward the substrate 4EBP1, with a multisite raptor 6A mutant more strongly defective that single-site raptor S863A. Taken together, these data suggest that complex raptor phosphorylation functions as a biochemical rheostat that modulates mTORC1 signaling in accordance with environmental cues.	[Foster, Kathryn G.; Acosta-Jaquez, Hugo A.; Ekim, Bilgen; Soliman, Ghada A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Soliman, Ghada A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Romeo, Yves; Carriere, Audrey; Roux, Philippe P.] Univ Montreal, Dept Pathol & Cell Biol, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Ballif, Bryan A.] Univ Vermont, Vermont Genet Network, Prote Facil, Burlington, VT 05405 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universite de Montreal; University of Vermont; University of Vermont	Fingar, DC (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	dfingar@umich.edu	Roux, Philippe P./J-3996-2012; Soliman, Ghada A/U-6472-2017; Romeo, Yves/AAC-1669-2021	Roux, Philippe P./0000-0002-5962-0250; Soliman, Ghada A/0000-0002-8629-6062; Carriere, Audrey/0000-0002-4277-7905	National Institutes of Health [R01 DK078135]; NIDDK [P20 RR16462]; National Center for Research Resources; American Diabetes Association; American Heart Association; Cole Foundation; Terry Fox Foundation; Canadian Cancer Society Research Institute [018311]; Human Frontier Science Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R01DK078135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Cole Foundation; Terry Fox Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078135 from the NIDDK (to D. C. F.) and P20 RR16462 to the Vermont Genetics Network. This work was also supported by the Institutional Development Award Networks of the Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources (to B. A. B.), a Jr. Faculty Award from the American Diabetes Association (to D. C. F.), the American Heart Association (to G. A. S. and B. E.), the Cole Foundation (to A. C.), Terry Fox Foundation through the Canadian Cancer Society Research Institute Grant 018311, and a Career Development Award from the Human Frontier Science Program (to P. P. R.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gingras AC, 2001, GENE DEV, V15, P2852; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zinzalla V, 2008, NATURE, V454, P287, DOI 10.1038/454287a	73	130	135	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					80	94		10.1074/jbc.M109.029637	http://dx.doi.org/10.1074/jbc.M109.029637			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864431	hybrid, Green Published			2022-12-27	WOS:000273070100009
J	Hodish, I; Liu, M; Rajpal, G; Larkin, D; Holz, RW; Adams, A; Liu, L; Arvan, P				Hodish, Israel; Liu, Ming; Rajpal, Gautam; Larkin, Dennis; Holz, Ronald W.; Adams, Aaron; Liu, Leanza; Arvan, Peter			Misfolded Proinsulin Affects Bystander Proinsulin in Neonatal Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; INSULIN GENE; ER STRESS; TRANSGENIC MICE; MUTANT MICE; TYPE-2; APOPTOSIS; MUTATIONS; MELLITUS	It has previously been shown that misfolded mutant Akita proinsulin in the endoplasmic reticulum engages directly in protein complexes either with nonmutant proinsulin or with "hProCpepGFP" (human proinsulin bearing emerald-GFP within the C-peptide), impairing the trafficking of these "bystander" proinsulin molecules (Liu, M., Hodish, I., Rhodes, C. J., and Arvan, P. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 15841-15846). Herein, we generated transgenic mice, which, in addition to expressing endogenous proinsulin, exhibit beta-cell-specific expression of hProCpepGFP via the Ins1 promoter. In these mice, hProCpepGFP protein levels are physiologically regulated, and hProCpepGFP is packaged and processed to CpepGFP that is co-stored in beta-secretory granules. Visualization of CpepGFP fluorescence provides a quantifiable measure of pancreatic islet insulin content that can be followed in live animals in states of health and disease. We examined loss of pancreatic insulin in hProCpepGFP transgenic mice mated to Akita mice that develop neonatal diabetes because of the expression of misfolded proinsulin. Loss of bystander insulin in Akita animals is detected initially as a block in CpepGFP/insulin production with intracellular accumulation of the precursor, followed ultimately by loss of pancreatic beta-cells. The data support that misfolded proinsulin perturbs bystander proinsulin in the endoplasmic reticulum, leading to beta-cell failure.	[Hodish, Israel; Liu, Ming; Larkin, Dennis; Adams, Aaron; Liu, Leanza; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48109 USA; [Rajpal, Gautam; Arvan, Peter] Univ Michigan, Program Cell & Mol Biol, Med Ctr, Ann Arbor, MI 48109 USA; [Holz, Ronald W.] Univ Michigan, Dept Pharmacol, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu			National Institutes of Health [R01 DK48280, K99 DK077441A, R01 NS38129]; Michigan Diabetes Research and Training Center; University of Michigan; University of Michigan Cellular and Molecular Biology Program; University of Michigan Transgenic Mouse Core, Morphology and Image Analysis Core, and Molecular Biology and DNA Sequencing Core, NIH [P60 DK20572]; University of Michigan Cancer Center [P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK077441, P60DK020572, R01DK048280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; University of Michigan(University of Michigan System); University of Michigan Cellular and Molecular Biology Program(University of Michigan System); University of Michigan Transgenic Mouse Core, Morphology and Image Analysis Core, and Molecular Biology and DNA Sequencing Core, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK48280 (to P. A.), K99 DK077441A (to I. H.), and R01 NS38129 (to R. W. H.). This work was also supported by a pilot and feasibility grant from the Michigan Diabetes Research and Training Center (to M. L.), the University of Michigan (T32 Endocrinology Training Grant to L. L.), and a one-semester Rackham Regents Fellowship from the University of Michigan Cellular and Molecular Biology Program (to G. R.). This work was also supported by the University of Michigan Transgenic Mouse Core, Morphology and Image Analysis Core, and Molecular Biology and DNA Sequencing Core (these were supported in part by the NIH-funded Michigan Diabetes Research and Training Center (Grant P60 DK20572) and the University of Michigan Cancer Center (Grant P30 CA46592)).	Araki E, 2003, INTERNAL MED, V42, P7, DOI 10.2169/internalmedicine.42.7; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; Babaya N, 2006, DIABETOLOGIA, V49, P1222, DOI 10.1007/s00125-006-0241-4; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; FUJIWARA T, 1991, METABOLISM, V40, P1213, DOI 10.1016/0026-0495(91)90218-L; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Harris PE, 2008, J MOL MED, V86, P5, DOI 10.1007/s00109-007-0242-x; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Leroux Loic, 2003, Int J Exp Diabesity Res, V4, P7; LIKE AA, 1970, DIABETOLOGIA, V6, P216, DOI 10.1007/BF01212232; Lin M, 2008, FRONT BIOSCI-LANDMRK, V13, P4558, DOI 10.2741/3023; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; MATHEWS CE, 2005, JOSLINS DIABETES MEL, P1333; MAUNSBACH AB, 1964, NATURE, V202, P1131, DOI 10.1038/2021131b0; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; NEERMANARBEZ M, 1993, J BIOL CHEM, V268, P16248; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P1; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Seliverstova EV, 2007, COMP BIOCHEM PHYS A, V147, P1067, DOI 10.1016/j.cbpa.2007.03.019; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Takeshita S, 2006, MAMM GENOME, V17, P927, DOI 10.1007/s00335-005-0130-z; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; WASADA T, 1995, METABOLISM, V44, P1194, DOI 10.1016/0026-0495(95)90015-2; Watkins S, 2002, TRAFFIC, V3, P461, DOI 10.1034/j.1600-0854.2002.30703.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	50	61	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					685	694		10.1074/jbc.M109.038042	http://dx.doi.org/10.1074/jbc.M109.038042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880509	Green Published, hybrid			2022-12-27	WOS:000273070100069
J	Nishida, K; Hoshino, M; Kawaguchi, Y; Murakami, F				Nishida, Kazuhiko; Hoshino, Mikio; Kawaguchi, Yoshiya; Murakami, Fujio			Ptf1a Directly Controls Expression of Immunoglobulin Superfamily Molecules Nephrin and Neph3 in the Developing Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL SPINAL-CORD; SLIT DIAPHRAGM; PANCREATIC DEVELOPMENT; TRANSCRIPTION FACTORS; PROTEIN; GENE; CELLS; NEURONS; COMPLEX; BINDS	Ptf1a, a basic helix-loop-helix transcription factor, plays an indispensable role for cell fate specification of subsets of neurons in the developing central nervous system. However, downstream molecules induced by Ptf1a during neural development have not been well characterized. In the present study, we identified immunoglobulin superfamily molecules, Nephrin and Neph3, as direct downstream targets of Ptf1a. First, the expression domains of Nephrin and Neph3 closely resembled those of Ptf1a in the developing retina, hypothalamus, cerebellum, hind-brain, and spinal cord. Second, Ptf1a bound directly to a PTF-binding motif in the 5'-flanking region of Nephrin and Neph3 genes. Third, Ptf1a activated transcription driven by the 5'-flanking region of these genes. Finally, the expression of Nephrin and Neph3 was lost in Ptf1a-null mice, whereas ectopic expression of Nephrin and Neph3 was induced by forced expression of Ptf1a. We provided further evidence that Nephrin and Neph3 could interact homophilically and heterophilically, suggesting that Nephrin and Neph3 might regulate certain developmental aspects of Ptf1a-positive neurons as homo- or heterooligomers.	[Nishida, Kazuhiko; Murakami, Fujio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hoshino, Mikio] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo 1878502, Japan; [Kawaguchi, Yoshiya] Kyoto Univ, Grad Sch Med, Dept Surg & Surg Basic Sci, Sakyo Ku, Kyoto 6068507, Japan	Osaka University; National Center for Neurology & Psychiatry - Japan; Kyoto University	Nishida, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	nishidk@fbs.osaka-u.ac.jp; murakami@fbs.osaka-u.ac.jp		Nishida, Kazuhiko/0000-0001-8825-8441	Japan Science Technology Corporation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Science Technology Corporation(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Solution Oriented Research for Science and Technology from Japan Science Technology Corporation and grant-in-aids from the Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Beltcheva O, 2003, J AM SOC NEPHROL, V14, P352, DOI 10.1097/01.ASN.0000043081.65110.C4; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; COCKELL M, 1989, MOL CELL BIOL, V9, P2464, DOI 10.1128/MCB.9.6.2464; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Fujiyama T, 2009, DEVELOPMENT, V136, P2049, DOI 10.1242/dev.033480; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Gerke P, 2006, J COMP NEUROL, V498, P466, DOI 10.1002/cne.21064; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Helms AW, 2005, DEVELOPMENT, V132, P2709, DOI 10.1242/dev.01859; Henke RM, 2009, DEVELOPMENT, V136, P2945, DOI 10.1242/dev.035352; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kawauchi D, 2008, DEV BIOL, V322, P345, DOI 10.1016/j.ydbio.2008.08.005; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Li H, 2001, DEV BIOL, V240, P247, DOI 10.1006/dbio.2001.0440; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; Minaki Y, 2005, NEUROSCI RES, V52, P250, DOI 10.1016/j.neures.2005.03.014; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Palmen T, 2001, DIABETOLOGIA, V44, P1274, DOI 10.1007/s001250100641; Pascual M, 2007, P NATL ACAD SCI USA, V104, P5193, DOI 10.1073/pnas.0605699104; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Ristola M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-83; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Sun C, 2003, GENOMICS, V82, P130, DOI 10.1016/S0888-7543(03)00110-1; Sun YJ, 1999, J BIOCHEM, V125, P515, DOI 10.1093/oxfordjournals.jbchem.a022315; Tamura S, 2005, NEUROSCIENCE, V133, P615, DOI 10.1016/j.neuroscience.2005.03.030; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Wagner N, 2004, J AM SOC NEPHROL, V15, P3044, DOI 10.1097/01.ASN.0000146687.99058.25; Wiebe PO, 2007, MOL CELL BIOL, V27, P4093, DOI 10.1128/MCB.01978-06; Yamada M, 2007, J NEUROSCI, V27, P10924, DOI 10.1523/JNEUROSCI.1423-07.2007; Zhu Y, 2009, DEVELOPMENT, V136, P1919, DOI 10.1242/dev.032276	49	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					373	380		10.1074/jbc.M109.060657	http://dx.doi.org/10.1074/jbc.M109.060657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887377	hybrid, Green Published			2022-12-27	WOS:000273070100039
J	Mapingire, OS; Henderson, NS; Duret, G; Thanassi, DG; Delcour, AH				Mapingire, Owen S.; Henderson, Nadine S.; Duret, Guillaume; Thanassi, David G.; Delcour, Anne H.			Modulating Effects of the Plug, Helix, and N- and C-terminal Domains on Channel Properties of the PapC Usher	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; PILUS BIOGENESIS; STRUCTURAL BASIS; SECRETION; FORMS; RECOGNITION; ADHESIN; COMPLEX; SITE	The chaperone/usher system is one of the best characterized pathways for protein secretion and assembly of cell surface appendages in Gram-negative bacteria. In particular, this pathway is used for biogenesis of the P pilus, a key virulence factor used by uropathogenic Escherichia coli to adhere to the host urinary tract. The P pilus individual subunits bound to the periplasmic chaperone PapD are delivered to the outer membrane PapC usher, which serves as an assembly platform for subunit incorporation into the pilus and secretion of the pilus fiber to the cell surface. PapC forms a dimeric, twin pore complex, with each monomer composed of a 24-stranded transmembrane beta-barrel channel, an internal plug domain that occludes the channel, and globular N- and C-terminal domains that are located in the periplasm. Here we have used planar lipid bilayer electrophysiology to characterize the pore properties of wild type PapC and domain deletion mutants for the first time. The wild type pore is closed most of the time but displays frequent short-lived transitions to various open states. In comparison, PapC mutants containing deletions of the plug domain, an alpha-helix that caps the plug domain, or the N- and C-terminal domains form channels with higher open probability but still exhibiting dynamic behavior. Removal of the plug domain results in a channel with extremely large conductance. These observations suggest that the plug gates the usher channel closed and that the periplasmic domains and alpha-helix function to modulate the gating activity of the PapC twin pore.	[Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Mapingire, Owen S.; Duret, Guillaume; Delcour, Anne H.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Houston System; University of Houston	Thanassi, DG (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Ctr Infect Dis, Stony Brook, NY 11794 USA.	david.thanassi@stonybrook.edu; adelcour@uh.edu			National Institutes of Health [GM062987]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062987 ( to D. G. T.).	BAGA M, 1987, CELL, V49, P241, DOI 10.1016/0092-8674(87)90565-4; Basle A, 2004, BBA-BIOMEMBRANES, V1664, P100, DOI 10.1016/j.bbamem.2004.04.009; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Capitani G, 2006, PROTEINS, V65, P816, DOI 10.1002/prot.21147; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; Duret G, 2008, J BIOL CHEM, V283, P15771, DOI 10.1074/jbc.M708970200; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Li HL, 2004, J MOL BIOL, V344, P1397, DOI 10.1016/j.jmb.2004.10.008; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; NORGREN M, 1987, MOL MICROBIOL, V1, P169, DOI 10.1111/j.1365-2958.1987.tb00509.x; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; Thanassi DG, 2002, J BACTERIOL, V184, P6260, DOI 10.1128/JB.184.22.6260-6269.2002; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Yu X, 2009, BIOCHEM J, V418, P541, DOI 10.1042/BJ20080992; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	35	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36324	36333		10.1074/jbc.M109.055798	http://dx.doi.org/10.1074/jbc.M109.055798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850919	hybrid, Green Published			2022-12-27	WOS:000272970500034
J	Yan, BX; Yates, Z; Balland, A; Kleemann, GR				Yan, Boxu; Yates, Zac; Balland, Alain; Kleemann, Gerd R.			Human IgG1 Hinge Fragmentation as the Result of H2O2-mediated Radical Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT MONOCLONAL-ANTIBODY; PROTEIN-SULFENIC ACIDS; FREE AMINO-ACIDS; HYDROGEN-PEROXIDE; POSTTRANSLATIONAL MODIFICATIONS; HEART-MITOCHONDRIA; SINGLET DIOXYGEN; OXIDATIVE STRESS; REDOX REGULATION; HUMAN MYOGLOBIN	Hinge cleavage of a recombinant human IgG1 antibody, generated during production in a Chinese hamster ovary cell culture, was observed in the purified material. The cleavage products could be reproduced by incubation of the antibody with H2O2 and featured complementary ladders of the C-and N-terminal residues (Asp(226)-Lys(227)-Thr(228)-His(229)-Thr(230)) in the heavy chain of the Fab domain and the upper hinge of one of the Fc domains, respectively. Two adducts of +45 and +71 Da were also observed at the N-terminal residues of some Fc fragments and were identified as isocyanate and alpha-ketoacyl derivatives generated by radical cleavage at the alpha-carbon position through the diamide and alpha-amidation pathways. We determined that the hinge cleavage was initiated by radical-induced breakage of the disulfide bond between the two hinge cysteines at position 231 (Cys(231)-Pro-Pro-Cys-Pro), followed by the formation of a thiyl radical (Cys(231)-S-center dot) on one cysteine and sulfenic acid (Cys(231)-SOH) on the other. The location of the initial radical attack and the critical role of Cys(231) were demonstrated by the observation that 5,5-dimethyl-1-pyrroline N-oxide only reacted with the Cys(231) radical and completely blocked hinge cleavage, suggesting the necessity of an electron/radical transfer from the Cys(231) radical to the hinge residues where cleavage was observed. As a precursor of hydroxyl radicals, H2O2 is widely produced in healthy cells and tissues and therefore could be the source for the radical-induced fragmentation of human IgG1 antibodies in vivo.	[Yan, Boxu; Yates, Zac; Balland, Alain; Kleemann, Gerd R.] Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA	Amgen	Yan, BX (corresponding author), 1201 Amgen Ct W, Seattle, WA 98119 USA.	byan@amgen.com						Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Cordoba AJ, 2005, J CHROMATOGR B, V818, P115, DOI 10.1016/j.jchromb.2004.12.033; Datta D, 2002, P NATL ACAD SCI USA, V99, P2636, DOI 10.1073/pnas.052709399; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; DEAN RT, 1989, FREE RADICAL RES COM, V7, P97, DOI 10.3109/10715768909087929; Deterding LJ, 2004, J BIOL CHEM, V279, P11600, DOI 10.1074/jbc.M310704200; DeYulia GJ, 2005, P NATL ACAD SCI USA, V102, P5044, DOI 10.1073/pnas.0501154102; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Gaza-Bulseco G, 2008, PHARM RES-DORDR, V25, P1881, DOI 10.1007/s11095-008-9606-3; HORNE C, 1982, J IMMUNOL, V129, P660; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; KATO Y, 1992, J BIOL CHEM, V267, P23646; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Martinez T, 2008, BIOCHEMISTRY-US, V47, P7496, DOI 10.1021/bi800576c; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; POOLE LB, 1989, J BIOL CHEM, V264, P12330; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; PURDIE JW, 1967, J AM CHEM SOC, V89, P226, DOI 10.1021/ja00978a007; Reichert JM, 2006, NAT REV DRUG DISCOV, V5, P191, DOI 10.1038/nrd1987; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; STADTMAN ER, 1991, J BIOL CHEM, V266, P17201; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang PX, 2007, J AM SOC NEPHROL, V18, P1239, DOI 10.1681/ASN.2006111299; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2003, P NATL ACAD SCI USA, V100, P1490, DOI 10.1073/pnas.0437831100; Witting PK, 2000, J BIOL CHEM, V275, P20391, DOI 10.1074/jbc.M000373200; Witting PK, 2001, J BIOL CHEM, V276, P16540, DOI 10.1074/jbc.M011707200; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Xu X, 2002, P NATL ACAD SCI USA, V99, P3376, DOI 10.1073/pnas.052710099; Yan BX, 2007, J CHROMATOGR A, V1164, P153, DOI 10.1016/j.chroma.2007.06.063; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhu XY, 2004, P NATL ACAD SCI USA, V101, P2247, DOI 10.1073/pnas.0307311101	59	31	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35390	35402		10.1074/jbc.M109.064147	http://dx.doi.org/10.1074/jbc.M109.064147			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850927	hybrid, Green Published			2022-12-27	WOS:000272645600015
J	Zhang, HD; Beckman, JW; Guengerich, FP				Zhang, Huidong; Beckman, Jeff W.; Guengerich, F. Peter			Frameshift Deletion by Sulfolobus solfataricus P2 DNA Polymerase Dpo4 T239W Is Selective for Purines and Involves Normal Conformational Change Followed by Slow Phosphodiester Bond Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-BASE DELETIONS; NUCLEOTIDE MISINCORPORATION; TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURE; ABASIC LESION; ERROR-PRONE; FIDELITY; BYPASS; MISALIGNMENT; REPLICATION	The human DNA polymerase kappa homolog Sulfolobus solfataricus DNA polymerase IV (Dpo4) produces " -1" frameshift deletions while copying unmodified DNA and, more frequently, when bypassing DNA adducts. As judged by steady-state kinetics and mass spectrometry, bypass of purine template bases to produce these deletions occurred rarely but with 10-fold higher frequency than with pyrimidines. The DNA adduct 1, N-2-etheno-2'-deoxyguanosine, with a larger stacking surface than canonical purines, showed the highest frequency of formation of -1 frameshift deletions. Dpo4 T239W, a mutant we had previously shown to produce fluorescence changes attributed to conformational change following dNTP binding opposite cognate bases (Beckman, J. W., Wang, Q., and Guengerich, F. P. (2008) J. Biol. Chem. 283, 36711-36723), reported similar conformational changes when the incoming dNTP complemented the base following a templating purine base or bulky adduct (i.e. the "+1" base). However, in all mispairing cases, phosphodiester bond formation was inefficient. The frequency of -1 frameshift events and the associated conformational changes were not dependent on the context of the remainder of the sequence. Collectively, our results support a mechanism for -1 frameshift deletions by Dpo4 that involves formation of active complexes via a favorable conformational change that skips the templating base, without causing slippage or flipping out of the base, to incorporate a complementary residue opposite the +1 base, in a mechanism previously termed " dNTP-stabilized incorporation." The driving force is attributed to be the stacking potential between the templating base and the incoming dNTP base.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	zhang, huidong/B-5667-2011	Zhang, Huidong/0000-0001-7845-3331	USPHS [R01 ES010375, P30 ES000267]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES010375] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 and P30 ES000267 (to F.P.G.) from the USPHS.	Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BOND JA, 1981, J TOXICOL ENV HEALTH, V7, P327, DOI 10.1080/15287398109529983; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Efrati E, 1997, J BIOL CHEM, V272, P2559; Eoff RL, 2009, BIOCHEMISTRY-US, V48, P7079, DOI 10.1021/bi9003588; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Irimia A, 2007, J BIOL CHEM, V282, P36421, DOI 10.1074/jbc.M707267200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P979, DOI 10.1073/pnas.72.3.979; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang Y, 2008, BIOCHEMISTRY-US, V47, P7322, DOI 10.1021/bi800152j; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Wolfle WT, 2003, GENE DEV, V17, P2191, DOI 10.1101/gad.1108603; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J MOL BIOL, V392, P251, DOI 10.1016/j.jmb.2009.07.019; Zhang H, 2009, J BIOL CHEM, V284, P17687, DOI 10.1074/jbc.M109014274; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200	36	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35144	35153		10.1074/jbc.M109.067397	http://dx.doi.org/10.1074/jbc.M109.067397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837980	hybrid, Green Published			2022-12-27	WOS:000272439600068
J	Kurokawa, K; Mizumura, H; Takaki, T; Ishii, Y; Ichihashi, N; Lee, BL; Sekimizu, K				Kurokawa, Kenji; Mizumura, Hikaru; Takaki, Tohru; Ishii, Yumiko; Ichihashi, Norikazu; Lee, Bok Luel; Sekimizu, Kazuhisa			Rapid Exchange of Bound ADP on the Staphylococcus aureus Replication Initiation Protein DnaA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; BACILLUS-SUBTILIS; ATP-HYDROLYSIS; IN-VITRO; E. COLI; ORIGIN; GENE; HDA; MECHANISM; CYCLE	In Escherichia coli, regulatory inactivation of the replication initiator DnaA occurs after initiation as a result of hydrolysis of bound ATP to ADP, but it has been unknown how DnaA is controlled to coordinate cell growth and chromosomal replication in Gram-positive bacteria such as Staphylococcus aureus. This study examined the roles of ATP binding and its hydrolysis in the regulation of the S. aureus DnaA activity. In vitro, S. aureus DnaA melted S. aureus oriC in the presence of ATP but not ADP by a mechanism independent of ATP hydrolysis. Unlike E. coli DnaA, binding of ADP to S. aureus DnaA was unstable. As a result, at physiological concentrations of ATP, ADP bound to S. aureus DnaA was rapidly exchanged for ATP, thereby regenerating the ability of DnaA to form the open complex in vitro. Therefore, we examined whether formation of ADP-DnaA participates in suppression of replication initiation in vivo. Induction of the R318H mutant of the AAA+ sensor 2 protein, which has decreased intrinsic ATPase activity, caused over-initiation of chromosome replication in S. aureus, suggesting that formation of ADP-DnaA suppresses the initiation step in S. aureus. Together with the biochemical features of S. aureus DnaA, the weak ability to convert ATP-DnaA into ADP-DnaA and the instability of ADP-DnaA, these results suggest that there may be unidentified system(s) for reducing the cellular ratio of ATP-DnaA to ADP-DnaA in S. aureus and thereby delaying the reinitiation of DNA replication.	[Sekimizu, Kazuhisa] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kurokawa, Kenji; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea	University of Tokyo; Pusan National University	Kurokawa, K (corresponding author), Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kurokawa@mol.f.u-tokyo.ac.jp	Ichihashi, Norikazu/AAY-6897-2020		Japan Society for the Promotion of Science; NEDO of Japan; Kyorin Pharmaceutical Co., Ltd.; Genome Pharmaceuticals Co., Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NEDO of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Kyorin Pharmaceutical Co., Ltd.; Genome Pharmaceuticals Co., Ltd.	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, by the Industrial Technology Research Grant Program of the NEDO of Japan (2004), and by grants from Kyorin Pharmaceutical Co., Ltd. and Genome Pharmaceuticals Co., Ltd.	BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; BRENDLER T, 1995, EMBO J, V14, P4083, DOI 10.1002/j.1460-2075.1995.tb00080.x; BROYLES SS, 1986, J MOL BIOL, V187, P47, DOI 10.1016/0022-2836(86)90405-5; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; FUKUOKA T, 1990, J BIOCHEM-TOKYO, V107, P732, DOI 10.1093/oxfordjournals.jbchem.a123117; GEISSENDORFER M, 1990, APPL MICROBIOL BIOT, V33, P657, DOI 10.1007/BF00604933; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Ishikawa S, 2007, DNA RES, V14, P155, DOI 10.1093/dnares/dsm017; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kornberg A., 1992, DNA REPLICATION; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Li Y, 2004, MOL GENET GENOMICS, V271, P447, DOI 10.1007/s00438-004-0996-6; Li Y, 2007, MICROBIOL-SGM, V153, P3370, DOI 10.1099/mic.0.2007/009001-0; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; MAHAFFY JM, 1989, J THEOR BIOL, V140, P453, DOI 10.1016/S0022-5193(89)80109-2; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mizushima T, 1996, J BIOL CHEM, V271, P3633; MORIYA S, 1994, MOL MICROBIOL, V12, P469, DOI 10.1111/j.1365-2958.1994.tb01035.x; Moriya S, 1999, PLASMID, V41, P17, DOI 10.1006/plas.1998.1381; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Murai N, 2006, FEMS MICROBIOL LETT, V254, P19, DOI 10.1111/j.1574-6968.2005.00012.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; Ogata Y, 1997, BBA-GENE STRUCT EXPR, V1353, P298, DOI 10.1016/S0167-4781(97)00105-X; Ogura Y, 2001, J BACTERIOL, V183, P3833, DOI 10.1128/JB.183.13.3833-3841.2001; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Riber L, 2006, GENE DEV, V20, P2121, DOI 10.1101/gad.379506; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; Simmons LA, 2004, MOL MICROBIOL, V51, P349, DOI 10.1046/j.1365-2958.2003.03842.x; Skarstad K, 1995, METHOD ENZYMOL, V262, P604; SKARSTAD K, 1994, BBA-GENE STRUCT EXPR, V1217, P111, DOI 10.1016/0167-4781(94)90025-6; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; Soufo CD, 2008, DEV CELL, V15, P935, DOI 10.1016/j.devcel.2008.09.010; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2001, MOL MICROBIOL, V40, P376, DOI 10.1046/j.1365-2958.2001.02378.x; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; Takenaka H, 2004, J MOL BIOL, V340, P29, DOI 10.1016/j.jmb.2004.04.045; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; Yamagishi JI, 1996, ANTIMICROB AGENTS CH, V40, P1157, DOI 10.1128/AAC.40.5.1157; Zheng WD, 2001, EMBO J, V20, P1164, DOI 10.1093/emboj/20.5.1164	65	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34201	34210		10.1074/jbc.M109.060681	http://dx.doi.org/10.1074/jbc.M109.060681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19841480	Green Published, hybrid			2022-12-27	WOS:000272165200052
J	Kaczocha, M; Glaser, ST; Chae, J; Brown, DA; Deutsch, DG				Kaczocha, Martin; Glaser, Sherrye T.; Chae, Janiper; Brown, Deborah A.; Deutsch, Dale G.			Lipid Droplets Are Novel Sites of N-Acylethanolamine Inactivation by Fatty Acid Amide Hydrolase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; TRANSMEMBRANE DOMAIN; ANANDAMIDE UPTAKE; DEGRADATION; IDENTIFICATION; PROTEINS; PALMITOYLETHANOLAMIDE; TRIGLYCERIDE; HYDROLYSIS; ADIPOSOMES	Anandamide (AEA) and other bioactive N-acylethanolamines (NAEs) are primarily inactivated by the enzyme fatty acid amide hydrolase (FAAH). Recently, FAAH-2 was discovered in humans, suggesting an additional enzyme can mediate NAE inactivation in higher mammals. Here, we performed a biochemical characterization of FAAH-2 and explored its capacity to hydrolyze NAEs in cells. In homogenate activity assays, FAAH-2 hydrolyzed AEA and palmitoylethanolamide (PEA) with activities similar to 6 and similar to 20% those of FAAH, respectively. In contrast, FAAH-2 hydrolyzed AEA and PEA in intact cells with rates similar to 30-40% those of FAAH, highlighting a potentially greater contribution toward NAE catabolism in vivo than previously appreciated. In contrast to endoplasmic reticulum-localized FAAH, immunofluorescence revealed FAAH-2 was localized on lipid droplets. Supporting this distribution pattern, the putative N-terminal hydrophobic region of FAAH-2 was identified as a functional lipid droplet localization sequence. Lipid droplet localization was essential for FAAH-2 activity as chimeras excluded from lipid droplets lacked activity and/or were poorly expressed. Lipid droplets represent novel sites of NAE inactivation. Therefore, we examined substrate delivery to these organelles. AEA was readily trafficked to lipid droplets, confirming that lipid droplets constitute functional sites of NAE inactivation. Collectively, these results establish FAAH-2 as a bone fide NAE-catabolizing enzyme and suggest that NAE inactivation is spatially separated in cells of higher mammals.	[Kaczocha, Martin; Chae, Janiper; Brown, Deborah A.; Deutsch, Dale G.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Glaser, Sherrye T.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kaczocha, M (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Life Sci Bldg,Room 450, Stony Brook, NY 11794 USA.	MKaczoch@notes.sunysb.edu		Kaczocha, Martin/0000-0002-2527-1398	National Institutes of Health [DA9374, DA16419]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016419, R01DA009374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA9374 and DA16419.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Arreaza G, 1999, FEBS LETT, V454, P57, DOI 10.1016/S0014-5793(99)00774-7; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Batkai S, 2007, AM J PHYSIOL-HEART C, V293, pH909, DOI 10.1152/ajpheart.00373.2007; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Chebrou H, 1996, BBA-PROTEIN STRUCT M, V1298, P285, DOI 10.1016/S0167-4838(96)00145-8; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Glaser ST, 2003, P NATL ACAD SCI USA, V100, P4269, DOI 10.1073/pnas.0730816100; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Jacobsson SOP, 2001, BRIT J PHARMACOL, V132, P1743, DOI 10.1038/sj.bjp.0704029; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Lambert DM, 2005, J MED CHEM, V48, P5059, DOI 10.1021/jm058183t; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Oddi S, 2005, CELL MOL LIFE SCI, V62, P386, DOI 10.1007/s00018-004-4446-8; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Olofsson SO, 2008, CURR OPIN LIPIDOL, V19, P441, DOI 10.1097/MOL.0b013e32830dd09b; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; OMEIR RL, 1995, LIFE SCI, V56, P1999, DOI 10.1016/0024-3205(95)00181-5; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Sun YX, 2005, BBA-MOL CELL BIOL L, V1736, P211, DOI 10.1016/j.bbalip.2005.08.010; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Walker JM, 2002, CHEM PHYS LIPIDS, V121, P159, DOI 10.1016/S0009-3084(02)00152-4; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	38	70	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2796	2806		10.1074/jbc.M109.058461	http://dx.doi.org/10.1074/jbc.M109.058461			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926788	Green Published, hybrid			2022-12-27	WOS:000273697800056
J	Jacks, KA; Koch, CA				Jacks, Kellie A.; Koch, C. Anne			Differential Regulation of Mitogen- and Stress-activated Protein Kinase-1 and-2 (MSK1 and MSK2) by CK2 following UV Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED PHOSPHORYLATION; P38 MAPK; COMPLEX; FAMILY; CREB; P65; INFLAMMATION; EXPRESSION; SUBUNIT	Mitogen- and stress-activated protein kinases, MSK1 and the closely related isoform MSK2, are nuclear kinases that are activated following mitogen stimulation or cellular stress, including UV radiation, by the ERK1/2 and p38 MAPK signaling cascades, respectively. However, factors that differentially regulate MSK1 and MSK2 have not been well characterized. Here we report that the CK2 protein kinase, which contributes to NF-kappa B activation following UV radiation in a p38-dependent manner, physically interacts with MSK2 but not MSK1 and that CK2 inhibition specifically impairs UV-induced MSK2 kinase activation. A putative site of CK2 phosphorylation was mapped to MSK2 residue Ser(324) and when substituted to alanine (S324A) also compromised MSK2 activity. RNA interference-mediated depletion of MSK2 in human MDA-MB-231 cells, but not MSK1 depletion, resulted in impaired UV-induced phosphorylation of NF-kappa B p65 at Ser(276) in vivo, which was restored by the ectopic expression of MSK2 but not by MSK2-S324A. Furthermore, UV radiation led to the activation of NF-kappa B-responsive gene expression in MDA-MB-231 cells and induced p65 transactivation capacity that was dependent on MSK2, MSK2 residue Ser(324), and p65-Ser(276). These results suggest that MSK1 and MSK2 are differentially regulated by CK2 during the UV response and that MSK2 is the major protein kinase responsible for the UV-induced phosphorylation of p65 at Ser(276) that positively regulates NF-kappa B activity in MDA-MB-231 cells.	[Koch, C. Anne] Princess Margaret Hosp, Radiat Med Program, UHN, Toronto, ON M5G 2M9, Canada; [Jacks, Kellie A.; Koch, C. Anne] Princess Margaret Hosp, Ontario Canc Inst, UHN, Toronto, ON M5G 2M9, Canada; [Jacks, Kellie A.; Koch, C. Anne] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Koch, CA (corresponding author), Princess Margaret Hosp, Radiat Med Program, UHN, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	anne.koch@rmp.uhn.on.ca			Princess Margaret Hospital Foundation	Princess Margaret Hospital Foundation	This work was supported by the Princess Margaret Hospital Foundation (to C. A. K.).	Bibby AC, 2005, INT J BIOL SCI, V1, P67; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Canton DA, 2001, BIOCHEM J, V358, P87, DOI 10.1042/0264-6021:3580087; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hildesheim J, 2005, J BIOL CHEM, V280, P17221, DOI 10.1074/jbc.M410440200; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Li YP, 2005, J BIOL CHEM, V280, P11869, DOI 10.1074/jbc.M413944200; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002	31	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1661	1670		10.1074/jbc.M109.083808	http://dx.doi.org/10.1074/jbc.M109.083808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19933278	Green Published, hybrid			2022-12-27	WOS:000273429100012
J	Menon, BRK; Davison, PA; Hunter, CN; Scrutton, NS; Heyes, DJ				Menon, Binuraj R. K.; Davison, Paul A.; Hunter, C. Neil; Scrutton, Nigel S.; Heyes, Derren J.			Mutagenesis Alters the Catalytic Mechanism of the Light-driven Enzyme Protochlorophyllide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT RELEASE STEPS; DYNAMICS; KINETICS; PROTON; NADPH; STATE; CYCLE; TEMPERATURE; VISCOSITY	The light-activated enzyme protochlorophyllide oxidoreductase (POR) catalyzes an essential step in the synthesis of the most abundant pigment on Earth, chlorophyll. This unique reaction involves the sequential addition of a hydride and proton across the C17=C18 double bond of protochlorophyllide (Pchlide) by dynamically coupled quantum tunneling and is an important model system for studying the mechanism of hydrogen transfer reactions. In the present work, we have combined site-directed mutagenesis studies with a variety of sensitive spectroscopic and kinetic measurements to provide new insights into the mechanistic role of three universally conserved Cys residues in POR. We show that mutation of Cys-226 dramatically alters the catalytic mechanism of the enzyme. In contrast to wild-type POR, the characteristic charge-transfer intermediate, formed upon hydride transfer from NADPH to the C17 position of Pchlide, is absent in C226S variant enzymes. This suggests a concerted hydrogen transfer mechanism where proton transfer only is rate-limiting. Moreover, Pchlide reduction does not require the network of solvent-coupled conformational changes that play a key role in the proton transfer step of wild-type POR. We conclude that this globally important enzyme is finely tuned to facilitate efficient photochemistry, and the removal of a key interaction with Pchlide in the C226S variants significantly affects the local active site structure in POR, resulting in a shorter donor-acceptor distance for proton transfer.	[Menon, Binuraj R. K.; Scrutton, Nigel S.; Heyes, Derren J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Davison, Paul A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Manchester; University of Sheffield	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk; derren.heyes@manchester.ac.uk	menon, binuraj/D-6731-2015; Menon, Binuraj/AAO-7752-2021	Menon, Binuraj/0000-0001-6852-8053; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council (BBSRC), UK; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, BB/G021546/1] Funding Source: researchfish; BBSRC [BB/D01963X/1, BB/G021546/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC), UK.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Aronsson H, 2003, PLANT MOL BIOL, V51, P1, DOI 10.1023/A:1020795415631; Birve SJ, 1996, BIOCHEM J, V317, P549, DOI 10.1042/bj3170549; Buhr F, 2008, P NATL ACAD SCI USA, V105, P12629, DOI 10.1073/pnas.0803950105; Dietzek B, 2006, J PHYS CHEM B, V110, P4399, DOI 10.1021/jp0556456; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Hay S, 2008, ANGEW CHEM INT EDIT, V47, P537, DOI 10.1002/anie.200704484; Heyes DJ, 2008, BIOCHEMISTRY-US, V47, P10991, DOI 10.1021/bi801521c; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Heyes DJ, 2000, FEBS LETT, V483, P47, DOI 10.1016/S0014-5793(00)02081-0; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; IvkovicJensen MM, 1997, BIOCHEMISTRY-US, V36, P8135, DOI 10.1021/bi970327l; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; OLIVER RP, 1981, BIOCHEM J, V195, P93, DOI 10.1042/bj1950093; Pudney CR, 2006, J AM CHEM SOC, V128, P14053, DOI 10.1021/ja0614619; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	30	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2113	2119		10.1074/jbc.M109.071522	http://dx.doi.org/10.1074/jbc.M109.071522			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19850924	Green Published, hybrid			2022-12-27	WOS:000273429100055
J	Kim, D; Lee, J; Cheng, DH; Li, J; Carter, C; Richie, E; Bedford, MT				Kim, Daehoon; Lee, Jaeho; Cheng, Donghang; Li, Jia; Carter, Carla; Richie, Ellen; Bedford, Mark T.			Enzymatic Activity Is Required for the in Vivo Functions of CARM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLTRANSFERASE CARM1; TRANSCRIPTIONAL COACTIVATOR; PROTEIN METHYLTRANSFERASE; ANDROGEN RECEPTOR; GENE-EXPRESSION; HISTONE H3; METHYLATION; BINDING; REGULATOR; PRMT1	CARM1 is one of nine protein arginine methyltransferases that methylate arginine residues in proteins. CARM1 is recruited by many different transcription factors as a positive regulator. Gene targeting of CARM1 in mice has been performed, and knock-out mice, which are smaller than their wild-type littermates, die just after birth. It has been proposed that CARM1 has functions that are independent of its enzymatic activity. Indeed, CARM1 is found to interact with a number of proteins and may have a scaffolding function in this context. However, CARM1 methylates histone H3, PABP1, AIB1, and a number of splicing factors, which strongly suggests that its impact on transcription and splicing is primarily through its ability to modify these substrates. To unequivocally establish the importance of CARM1 enzymatic activity in vivo, we generated an enzyme-dead knock-in of this protein arginine methyltransferase. We determined that knock-in cells and mice have defects similar to those seen in their knock-out counterparts with respect to the time of embryo lethality, T cell development, adipocyte differentiation, and transcriptional coactivator activity. CARM1 requires its enzymatic activity for all of its known cellular functions. Thus, small molecule inhibitors of CARM1 will incapacitate all of the enzyme's cellular functions.	[Kim, Daehoon; Lee, Jaeho; Cheng, Donghang; Li, Jia; Carter, Carla; Richie, Ellen; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Bedford, Mark T/E-7856-2011	Richie, Ellen/0000-0003-0786-973X	NIEHS [ES07784]; NCI [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES07784 from NIEHS (to institutional core facilities) and National Institutes of Health Grant CA016672 from NCI (to the Genetically Engineered Mouse Facility).	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Chan R, 2002, MOL CELL BIOL, V22, P1073, DOI 10.1128/MCB.22.4.1073-1078.2002; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fauquier L, 2008, FASEB J, V22, P3337, DOI 10.1096/fj.07-104604; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Hong H, 2004, CANCER-AM CANCER SOC, V101, P83, DOI 10.1002/cncr.20327; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lee YH, 2004, MOL CELL BIOL, V24, P2103, DOI 10.1128/MCB.24.5.2103-2117.2004; Lupien M, 2009, MOL CELL BIOL, V29, P3413, DOI 10.1128/MCB.00020-09; Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438; Monroy MA, 2003, MOL ENDOCRINOL, V17, P2519, DOI 10.1210/me.2003-0208; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Weiss RS, 2000, GENE DEV, V14, P1886; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	37	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1147	1152		10.1074/jbc.M109.035865	http://dx.doi.org/10.1074/jbc.M109.035865			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897492	hybrid, Green Published			2022-12-27	WOS:000273258200037
J	Okemefuna, AI; Nan, R; Miller, A; Gor, J; Perkins, SJ				Okemefuna, Azubuike I.; Nan, Ruodan; Miller, Ami; Gor, Jayesh; Perkins, Stephen J.			Complement Factor H Binds at Two Independent Sites to C-reactive Protein in Acute Phase Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATOR FACTOR-H; SEDIMENTATION-VELOCITY; X-RAY; SCATTERING DATA; FACTOR-I; POLYMORPHISM; ACTIVATION; NEUTRON; ULTRACENTRIFUGATION; DISTRIBUTIONS	Factor H (FH) regulates the activation of C3b in the alternative complement pathway, both in serum and at host cell surfaces. It is composed of 20 short complement regulator (SCR) domains. The Y402H polymorphism in FH is a risk factor for age-related macular degeneration. C-reactive protein (CRP) is an acute phase protein that binds Ca2+. We established the FH-CRP interaction using improved analytical ultracentrifugation (AUC), surface plasmon resonance (SPR), and synchrotron x-ray scattering methods. Physiological FH and CRP concentrations were used in 137 mM NaCl and 2 mM Ca2+, in which the occurrence of denatured CRP was avoided. In solution, AUC revealed FH-CRP binding. The FH-CRP interaction inhibited the formation of higher FH oligomers, indicating that CRP blocked FH dimerization sites at both SCR-6/8 and SCR-16/20. SPR confirmed the FH-CRP interaction and its NaCl concentration dependence upon using either immobilized FH or CRP. The SCR-1/5 fragment of FH did not bind to CRP. In order of increasing affinity, SCR-16/20, SCR-6/8 (His-402), and SCR-6/8 (Tyr-402) fragments bound to CRP. X-ray scattering showed that FH became more compact when binding to CRP, which is consistent with CRP binding at two different FH sites. We concluded that FH and CRP bind at elevated acute phase concentrations of CRP in physiological buffer. The SCR-16/20 site is novel and indicates the importance of the FH-CRP interaction for both age-related macular degeneration and atypical hemolytic uremic syndrome.	[Okemefuna, Azubuike I.; Nan, Ruodan; Miller, Ami; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Biol Mol & Struct, London WC1E 6BT, England	University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Biol Mol & Struct, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@medsch.ucl.ac.uk			BBSRC [BB/E013104/1] Funding Source: UKRI; MRC [G0801724] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: Medline; Medical Research Council [G0801724] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blizniukov OP, 2003, MOL BIOL+, V37, P912, DOI 10.1023/B:MBIL.0000008361.22136.c8; Bonner A, 2007, J BIOL CHEM, V282, P16969, DOI 10.1074/jbc.M701281200; Bonner A, 2009, J BIOL CHEM, V284, P5077, DOI 10.1074/jbc.M807529200; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; DEBEER FC, 1982, J IMMUNOL METHODS, V50, P17, DOI 10.1016/0022-1759(82)90300-3; FARRIES TC, 1990, COMPLEMENT INFLAMMAT, V7, P30, DOI 10.1159/000463124; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; Glatter O., 1982, SMALL ANGLE XRAY SCA; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hurwitz S, 1996, CRIT REV BIOCHEM MOL, V31, P41, DOI 10.3109/10409239609110575; Jarva H, 1999, J IMMUNOL, V163, P3957; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; Nan RD, 2008, J MOL BIOL, V375, P891, DOI 10.1016/j.jmb.2007.11.015; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Okemefuna AI, 2009, J MOL BIOL, V391, P119, DOI 10.1016/j.jmb.2009.06.013; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PERKINS SJ, 1985, EUR J BIOCHEM, V147, P525; PERKINS SJ, 1991, BIOCHEMISTRY-US, V30, P2847, DOI 10.1021/bi00225a017; PERKINS SJ, 1986, PROTIDES BIOL FLUIDS, V34, P323; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SIM RB, 1993, METHOD ENZYMOL, V223, P13; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Tanious FA, 2008, METHOD CELL BIOL, V84, P53, DOI 10.1016/S009911-679X(07)84003-9; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a	57	96	97	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1053	1065		10.1074/jbc.M109.044529	http://dx.doi.org/10.1074/jbc.M109.044529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19850925	hybrid, Green Published			2022-12-27	WOS:000273258200026
J	Qin, HN; Noberini, R; Huan, XL; Shi, JH; Pasquale, EB; Song, JX				Qin, Haina; Noberini, Roberta; Huan, Xuelu; Shi, Jiahai; Pasquale, Elena B.; Song, Jianxing			Structural Characterization of the EphA4-Ephrin-B2 Complex Reveals New Features Enabling Eph-Ephrin Binding Promiscuity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RECEPTOR; LIGAND; NMR; DOMAIN; KINASES; SYSTEM; AXONS	EphA and EphB receptors preferentially bind ephrin-A and ephrin-B ligands, respectively, but EphA4 is exceptional for its ability to bind all ephrins. Here, we report the crystal structure of the EphA4 ligand-binding domain in complex with ephrin-B2, which represents the first structure of an EphA-ephrin-B interclass complex. A loose fit of the ephrin-B2 G-H loop in the EphA4 ligand-binding channel is consistent with a relatively weak binding affinity. Additional surface contacts also exist between EphA4 residues Gln(12) and Glu(14) and ephrin-B2. Mutation of Gln(12) and Glu(14) does not cause significant structural changes in EphA4 or changes in its affinity for ephrin-A ligands. However, the EphA4 mutant has similar to 10-fold reduced affinity for ephrin-B ligands, indicating that the surface contacts are critical for interclass but not intraclass ephrin binding. Thus, EphA4 uses different strategies to bind ephrin-A or ephrin-B ligands and achieve binding promiscuity. NMR characterization also suggests that the contacts of Gln(12) and Glu(14) with ephrin-B2 induce dynamic changes throughout the whole EphA4 ligand-binding domain. Our findings shed light on the distinctive features that enable the remarkable ligand binding promiscuity of EphA4 and suggest that diverse strategies are needed to effectively disrupt different Eph-ephrin complexes.	[Noberini, Roberta; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Qin, Haina; Shi, Jiahai; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 119260, Singapore; [Huan, Xuelu] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 119260, Singapore; [Song, Jianxing] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 119260, Singapore; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; National University of Singapore; National University of Singapore; National University of Singapore; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	elenap@burnham.org; bchsj@nus.edu.sg	Qin, Haina/AAB-7486-2020; Shi, Jiahai/AAH-1103-2019; shi, jiahai/D-7650-2013; Song, Jianxing/J-3617-2013; Noberini, Roberta/AAP-4527-2020; Song, Jianxing/H-8026-2012	Shi, Jiahai/0000-0002-6467-8289; shi, jiahai/0000-0002-6467-8289; Noberini, Roberta/0000-0002-7267-1079; Haina, Qin/0000-0002-9175-8014; Song, Jianxing/0000-0003-0224-6322	National Institutes of Health [CA116099, HD25938]; Singapore National Medical Research Council [NMRC/1216/2009, NMRC/1126/2007]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA116099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore National Medical Research Council(National Medical Research Council, Singapore); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA116099 and HD25938 (to E. B. P.). This work was also supported by Singapore National Medical Research Council Grants NMRC/1216/2009 and NMRC/1126/2007 (to J. S.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Goldgur Y, 2009, ACTA CRYSTALLOGR F, V65, P71, DOI 10.1107/S1744309108043078; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Jee J, 2008, J PHYS CHEM B, V112, P6008, DOI 10.1021/jp076094h; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lafont V, 2007, CHEM BIOL DRUG DES, V69, P413, DOI 10.1111/j.1747-0285.2007.00519.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Ran XY, 2008, PROTEINS, V72, P1019, DOI 10.1002/prot.21999; Ran XY, 2005, J BIOL CHEM, V280, P19205, DOI 10.1074/jbc.M500330200; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SHAO HN, 1994, J BIOL CHEM, V269, P26606; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	43	73	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					644	654		10.1074/jbc.M109.064824	http://dx.doi.org/10.1074/jbc.M109.064824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875447	Green Published, hybrid			2022-12-27	WOS:000273070100065
J	Sullivan, CP; Seidl, SE; Rich, CB; Raymondjean, M; Schreiber, BM				Sullivan, Christopher P.; Seidl, Stephanie E.; Rich, Celeste B.; Raymondjean, Michel; Schreiber, Barbara M.			Secretory Phospholipase A(2), Group IIA Is a Novel Serum Amyloid A Target Gene ACTIVATION OF SMOOTH MUSCLE CELL EXPRESSION BY AN INTERLEUKIN-1 RECEPTOR-INDEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; LOW-DENSITY LIPOPROTEINS; APOLIPOPROTEIN-A-I; C/EBP-BETA; TRANSCRIPTIONAL REGULATION; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR-DISEASE; MACROPHAGE CHOLESTEROL	Atherosclerosis is a multifactorial vascular disease characterized by formation of inflammatory lesions. Elevated circulating acute phase proteins indicate disease risk. Serum amyloid A (SAA) is one such marker but its function remains unclear. To determine the role of SAA on aortic smooth muscle cell gene expression, a preliminary screen of a number of genes was performed and a strong up-regulation of expression of secretory phospholipase A(2), group IIA (sPLA(2)) was identified. The SAA-induced increase in sPLA(2) was validated by real time PCR, Western blot analysis, and enzyme activity assays. Demonstrating that SAA increased expression of sPLA(2) heteronuclear RNA and that inhibiting transcription eliminated the effect of SAA on sPLA(2) mRNA suggested that the increase was transcriptional. Transient transfections and electrophoretic mobility shift assays identified CAAT enhancer-binding protein (C/EBP) and nuclear factor kappa B (NF kappa B) as key regulatory sites mediating the induction of sPLA2. Moreover, SAA activated the inhibitor of NF-kappa B kinase (IKK) in cultured smooth muscle cells. Previous reports showed that interleukin (IL)-1 beta up-regulates Pla2g2a gene transcription via C/EBP beta and NF kappa B. Interestingly, SAA activated smooth muscle cell IL-1 beta mRNA expression, however, blocking IL-1 receptors had no effect on SAA-mediated activation of sPLA(2) expression. Thus, the observed changes in sPLA(2) expression were not secondary to SAA-induced IL-1 receptor activation. The association of SAA with high density lipoprotein abrogated the SAA-induced increase in sPLA(2) expression. These data suggest that during atherogenesis, SAA can amplify the involvement of smooth muscle cells in vascular inflammation and that this can lead to deposition of sPLA(2) and subsequent local changes in lipid homeostasis.	[Sullivan, Christopher P.; Seidl, Stephanie E.; Rich, Celeste B.; Schreiber, Barbara M.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Raymondjean, Michel] Univ Paris 06, Physiol Physiopathol & Vieillissement UR4, F-75252 Paris, France	Boston University; UDICE-French Research Universities; Sorbonne Universite	Schreiber, BM (corresponding author), 72 E Concord St, Boston, MA 02118 USA.	schreibe@biochem.bumc.bu.edu		Schreiber, Barbara/0000-0001-8560-4249	National Institutes of Health [HL079201]; American Heart Association [0256215T, 0455846T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL079201 and American Heart Association Grants 0256215T and 0455846T.	Andreani M, 2000, BBA-MOL CELL BIOL L, V1488, P149, DOI 10.1016/S1388-1981(00)00117-7; Anthonsen MW, 2000, ARTERIOSCL THROM VAS, V20, P1276, DOI 10.1161/01.ATV.20.5.1276; Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; BAMBERGER M, 1985, BIOCHEMISTRY-US, V24, P3693, DOI 10.1021/bi00335a044; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Begbie M, 2000, THROMB HAEMOSTASIS, V84, P216; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; COLLET X, 1990, BIOCHIM BIOPHYS ACTA, V1043, P301, DOI 10.1016/0005-2760(90)90031-R; Couturier C, 1999, J BIOL CHEM, V274, P23085, DOI 10.1074/jbc.274.33.23085; Couturier C, 2000, ARTERIOSCL THROM VAS, V20, P2559, DOI 10.1161/01.ATV.20.12.2559; de Beer FC, 2000, J LIPID RES, V41, P1849; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Dorsam G, 2000, J PHARMACOL EXP THER, V292, P271; Elinder LS, 1997, ARTERIOSCL THROM VAS, V17, P2257, DOI 10.1161/01.ATV.17.10.2257; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Han CY, 2006, ARTERIOSCL THROM VAS, V26, P1806, DOI 10.1161/01.ATV.0000227472.70734.ad; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Houliston RA, 2001, BIOCHEM BIOPH RES CO, V287, P881, DOI 10.1006/bbrc.2001.5681; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P300, DOI 10.1161/01.ATV.17.2.300; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kisilevsky R, 2003, J LIPID RES, V44, P2257, DOI 10.1194/jlr.M300133-JLR200; Kitaoka Y, 2007, BRAIN RES, V1142, P247, DOI 10.1016/j.brainres.2007.01.097; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Kumon Y, 1997, SCAND J IMMUNOL, V46, P284, DOI 10.1046/j.1365-3083.1997.d01-128.x; LABEQUE R, 1993, P NATL ACAD SCI USA, V90, P3476, DOI 10.1073/pnas.90.8.3476; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Lee YM, 1996, MOL CELL BIOL, V16, P4257; LEMAHIEU RA, 1993, J MED CHEM, V36, P3029, DOI 10.1021/jm00072a025; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Mahmoudi M, 2007, HISTOPATHOLOGY, V50, P535, DOI 10.1111/j.1365-2559.2006.02503.x; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Menschikowski M, 2006, PROSTAG OTH LIPID M, V79, P1, DOI 10.1016/j.prostaglandins.2005.10.005; Menschikowski M, 2004, FEBS LETT, V577, P81, DOI 10.1016/j.febslet.2004.09.067; Menschikowski M, 1995, ATHEROSCLEROSIS, V118, P173, DOI 10.1016/0021-9150(95)05604-1; MITCHELL TI, 1991, J CLIN INVEST, V87, P1177, DOI 10.1172/JCI115116; Mounier CM, 1998, J BIOL CHEM, V273, P23764, DOI 10.1074/jbc.273.37.23764; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; O'Brien Kevin D, 2006, Curr Atheroscler Rep, V8, P62, DOI 10.1007/s11883-006-0066-0; Oestvang J, 2006, BBA-MOL CELL BIOL L, V1761, P1309, DOI 10.1016/j.bbalip.2006.06.003; OHARA O, 1990, NUCLEIC ACIDS RES, V18, P6997, DOI 10.1093/nar/18.23.6997; Okamoto H, 2008, J RHEUMATOL, V35, P752; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Peilot H, 2000, J BIOL CHEM, V275, P22895, DOI 10.1074/jbc.M002783200; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; PRUZANSKI W, 1995, BIOCHEM J, V309, P461, DOI 10.1042/bj3090461; Pruzanski W, 1998, J LIPID RES, V39, P2150; Pruzanski W, 2001, LAB INVEST, V81, P757, DOI 10.1038/labinvest.3780284; QIAO JH, 1994, ARTERIOSCLER THROMB, V14, P1480, DOI 10.1161/01.ATV.14.9.1480; Rawadi G, 1999, J IMMUNOL, V162, P2193; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; RAYMONDJEAN M, 1988, P NATL ACAD SCI USA, V85, P757, DOI 10.1073/pnas.85.3.757; Rich CB, 1999, J BIOL CHEM, V274, P33433, DOI 10.1074/jbc.274.47.33433; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROKITA H, 1994, J RHEUMATOL, V21, P400; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Schiering A, 1999, ATHEROSCLEROSIS, V144, P73, DOI 10.1016/S0021-9150(99)00045-3; Schreiber BM, 1999, BIOCHEM J, V344, P7, DOI 10.1042/0264-6021:3440007; Schreiber BM, 2002, AMYLOID, V9, P276, DOI 10.3109/13506120209114107; SCHREIBER BM, 1988, ATHEROSCLEROSIS, V69, P69, DOI 10.1016/0021-9150(88)90290-0; SCHREIBER BM, 1992, ATHEROSCLEROSIS, V95, P201, DOI 10.1016/0021-9150(92)90023-A; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tietge UJF, 2005, J LIPID RES, V46, P1604, DOI 10.1194/jlr.M400469-JLR200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 2002, BLOOD, V99, P1224, DOI 10.1182/blood.V99.4.1224; URIELISHOVAL S, 1994, AM J PATHOL, V145, P650; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Walker G, 1997, BRIT J PHARMACOL, V121, P787, DOI 10.1038/sj.bjp.0701170; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Xanthoulea S, 2005, CURR OPIN LIPIDOL, V16, P536, DOI 10.1097/01.mol.0000180167.15820.ae; Yamada T, 1996, PATHOL INT, V46, P797, DOI 10.1111/j.1440-1827.1996.tb03552.x	93	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					565	575		10.1074/jbc.M109.070565	http://dx.doi.org/10.1074/jbc.M109.070565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19850938	Green Published, hybrid			2022-12-27	WOS:000273070100058
J	Valadon, P; Darsow, B; Buss, TN; Czarny, M; Griffin, NM; Nguyen, HN; Oh, P; Borgstrom, P; Chrastina, A; Schnitzer, JE				Valadon, Philippe; Darsow, Bryan; Buss, Tim N.; Czarny, Malgorzata; Griffin, Noelle M.; Nguyen, Han N.; Oh, Phil; Borgstrom, Per; Chrastina, Adrian; Schnitzer, Jan E.			Designed Auto-assembly of Nanostreptabodies for Rapid Tissue-specific Targeting in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT PROTEIN-PRODUCTION; TRANSIENT GENE-EXPRESSION; ENZYMATIC BIOTINYLATION; MAMMALIAN-CELLS; ANTIBODY; FRAGMENTS; STREPTAVIDIN; MULTIVALENT; LIBRARIES; CAVEOLAE	Molecular medicine can benefit greatly from antibodies that deliver therapeutic and imaging agents to select organs and diseased tissues. Yet the development of complex and defined composite nanostructures remains a challenge that requires both designed stoichiometric assembly and superior in vivo testing ability. Here, we generate nanostructures called nanostreptabodies by controlled sequential assembly of biotin-engineered antibody fragments on a streptavidin scaffold with a defined capacity for additional biotinylated payloads such as other antibodies to create bispecific antibodies as well as organic and non-organic moieties. When injected intravenously, these novel and stable nanostructures exhibit exquisite targeting with tissue-specific imaging and delivery, including rapid transendothelial transport that enhances tissue penetration. This "tinkertoy construction" strategy provides a very flexible and efficient way to link targeting vectors with reporter and/or effector agents, thereby providing virtually endless combinations potentially useful for multipurpose molecular and functional imaging in vivo as well as therapies.	[Valadon, Philippe; Czarny, Malgorzata; Griffin, Noelle M.; Nguyen, Han N.; Oh, Phil; Chrastina, Adrian; Schnitzer, Jan E.] Proteogenom Res Inst Syst Med, San Diego, CA 92121 USA; [Valadon, Philippe; Darsow, Bryan; Buss, Tim N.; Czarny, Malgorzata; Griffin, Noelle M.; Nguyen, Han N.; Oh, Phil; Borgstrom, Per; Chrastina, Adrian; Schnitzer, Jan E.] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA		Schnitzer, JE (corresponding author), Proteogenom Res Inst Syst Med, 11107 Roselle St, San Diego, CA 92121 USA.	jschnitzer@prism-sd.org	Chrastina, Adrian/AHE-3296-2022	Chrastina, Adrian/0000-0002-4097-9773	National Institutes of Health, NCI [R01CA119378, PO1CA104898, R24CA95893]; National Institutes of Health, NHLBI [R01HL58216, RO1HL074063]; NATIONAL CANCER INSTITUTE [R24CA095893, R01CA119378, P01CA104898] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074063, R01HL058216] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA119378, PO1CA104898, and R24CA95893 from the NCI and Grants R01HL58216 and RO1HL074063 from the NHLBI.	Asai T, 2005, J IMMUNOL METHODS, V299, P63, DOI 10.1016/j.jim.2005.01.020; Backer MV, 2006, BIOCONJUGATE CHEM, V17, P912, DOI 10.1021/bc060037u; Baldi L, 2005, BIOTECHNOL PROGR, V21, P148, DOI 10.1021/bp049830x; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; Barat B, 2007, BIOMOL ENG, V24, P283, DOI 10.1016/j.bioeng.2007.02.003; Batchelor RH, 2007, BIOTECHNIQUES, V43, P503, DOI 10.2144/000112564; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Chinol M, 2000, RADIOIMMUNOTHERAPY OF CANCER, P169; Chinol M, 1998, BRIT J CANCER, V78, P189, DOI 10.1038/bjc.1998.463; Cloutier SM, 2000, MOL IMMUNOL, V37, P1067, DOI 10.1016/S0161-5890(01)00023-2; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; CULL MG, 1992, P NATL ACAD SCI USA, V89, P1865, DOI 10.1073/pnas.89.5.1865; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gaidamakova EK, 2001, J CONTROL RELEASE, V74, P341, DOI 10.1016/S0168-3659(01)00345-5; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Guo F, 2006, P NATL ACAD SCI USA, V103, P11009, DOI 10.1073/pnas.0603822103; Hodneland CD, 2002, P NATL ACAD SCI USA, V99, P5048, DOI 10.1073/pnas.072685299; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; JONES TD, 2009, METHOD MOL BIOL, V525, pR14; Jones Tim D., 2009, V525, P405, DOI 10.1007/978-1-59745-554-1_21; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kulman JD, 2007, PROTEIN EXPRES PURIF, V52, P320, DOI 10.1016/j.pep.2006.09.011; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Lee HS, 1999, MOL IMMUNOL, V36, P61, DOI 10.1016/S0161-5890(98)00109-6; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Marshall D, 1996, BRIT J CANCER, V73, P565, DOI 10.1038/bjc.1996.99; Marvin JS, 2005, ACTA PHARMACOL SIN, V26, P649, DOI 10.1111/j.1745-7254.2005.00119.x; McIntosh DP, 2002, P NATL ACAD SCI USA, V99, P1996, DOI 10.1073/pnas.251662398; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Pearce LA, 1997, BIOCHEM MOL BIOL INT, V42, P1179; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Pham PL, 2006, MOL BIOTECHNOL, V34, P225, DOI 10.1385/MB:34:2:225; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Saviranta P, 1998, BIOCONJUGATE CHEM, V9, P725, DOI 10.1021/bc9800217; Schnitzer JE, 1998, NEW ENGL J MED, V339, P472, DOI 10.1056/NEJM199808133390711; Scholler N, 2006, J IMMUNOL METHODS, V317, P132, DOI 10.1016/j.jim.2006.10.003; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Valadon P, 2006, P NATL ACAD SCI USA, V103, P407, DOI 10.1073/pnas.0506938103; Weiden PL, 2000, CANCER BIOTHER RADIO, V15, P15, DOI 10.1089/cbr.2000.15.15; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	49	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					713	722		10.1074/jbc.M109.061838	http://dx.doi.org/10.1074/jbc.M109.061838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19850928	hybrid, Green Published			2022-12-27	WOS:000273070100072
J	Cheng, XW; Kao, HY				Cheng, Xiwen; Kao, Hung-Ying			G Protein Pathway Suppressor 2 (GPS2) Is a Transcriptional Corepressor Important for Estrogen Receptor alpha-mediated Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT BREAST-CANCER; N-COR; HISTONE DEACETYLASE; SILENCING MEDIATOR; SMRT COREPRESSOR; RETINOIC ACID; COMPLEX; ACTIVATION; RECRUITMENT; REPRESSION	We have identified G protein suppressor 2 (GPS2) as a stable component of the SMRT corepressor complexes. GPS2 potently represses basal transcription, with the repression domain mapped to the N-terminal silencing mediator of retinoic acid and thyroid hormone receptor (SMRT)-interacting domain. Knockdown of GPS2 abrogates, whereas overexpression potentiates, SMRT-mediated repression activity. The SMRT complexes are involved in 4-hydroxyl-tamoxifen (4OHT)-mediated gene repression by estrogen receptor alpha (ER alpha). We show that 4OHT recruits SMRT and GPS2 to the promoter of pS2, an ER alpha target gene, in a dynamic manner. Unexpectedly, we also found that estradiol (E2) promotes promoter recruitment of the SMRT complexes. While knockdown of GPS2 compromised 4OHT-mediated repression, it enhanced E2-induced expression of a reporter gene and several endogenous ER alpha target genes, including pS2, cyclin D1 (CCND1), progesterone receptor (PR), and c-MYC. Finally, we show that depletion of GPS2 or SMRT by siRNA promotes cell proliferation in MCF-7 breast cancer cells. Thus, we concluded that GPS2 is an integral component of the SMRT complexes, important for ligand-dependent gene regulations by ER alpha and a suppressor for MCF-7 cell proliferation.	Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Biochem, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Cheng, Xiwen/B-8385-2014	Cheng, Xiwen/0000-0001-7398-1522	National Institutes of Health [R01 DK078965]; American Cancer Society; Ohio Cancer Research Associate [5302]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Ohio Cancer Research Associate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK078965. This work was also supported by grants from the Pardee Foundation, American Cancer Society, and Ohio Cancer Research Associate (5302).	Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Baniahmad A, 1998, MOL ENDOCRINOL, V12, P504, DOI 10.1210/me.12.4.504; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; De Amicis F, 2009, MOL ENDOCRINOL, V23, P454, DOI 10.1210/me.2008-0267; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Eriksson M, 2007, PHYSIOL BEHAV, V92, P54, DOI 10.1016/j.physbeh.2007.05.026; Fleming FJ, 2004, J CLIN ENDOCR METAB, V89, P375, DOI 10.1210/jc.2003-031048; Fujita T, 2003, J BIOL CHEM, V278, P26704, DOI 10.1074/jbc.M301031200; Graham JD, 2000, STEROIDS, V65, P579, DOI 10.1016/S0039-128X(00)00116-1; Graham JD, 2000, J STEROID BIOCHEM, V74, P255, DOI 10.1016/S0960-0760(00)00101-1; Guenther MG, 2000, GENE DEV, V14, P1048; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang EY, 2000, GENE DEV, V14, P45; Huang HJ, 2002, MOL ENDOCRINOL, V16, P1778, DOI 10.1210/me.2002-0089; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Kao HY, 2000, GENE DEV, V14, P55; Keeton EK, 2005, MOL ENDOCRINOL, V19, P1543, DOI 10.1210/me.2004-0395; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; Li H, 1997, MOL ENDOCRINOL, V11, P2025, DOI 10.1210/me.11.13.2025; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Stanya KJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-7; Takimoto GS, 1999, J STEROID BIOCHEM, V69, P45, DOI 10.1016/S0960-0760(98)00148-4; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yamamoto Y, 2001, J BIOL CHEM, V276, P42684, DOI 10.1074/jbc.M107844200; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	53	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36395	36404		10.1074/jbc.M109.062109	http://dx.doi.org/10.1074/jbc.M109.062109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858209	Green Published, hybrid			2022-12-27	WOS:000272970500041
J	Kleiger, G; Hao, B; Mohl, DA; Deshaies, RJ				Kleiger, Gary; Hao, Bing; Mohl, Dane A.; Deshaies, Raymond J.			The Acidic Tail of the Cdc34 Ubiquitin-conjugating Enzyme Functions in Both Binding to and Catalysis with Ubiquitin Ligase SCFCdc4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEINS; SACCHAROMYCES-CEREVISIAE; CYTOCHROME-C; SUBUNIT-VI; E2 ENZYME; SCF; COMPLEX; CULLIN; YEAST; DOMAIN	Ubiquitin ligases, together with their cognate ubiquitin-conjugating enzymes, are responsible for the ubiquitylation of proteins, a process that regulates a myriad of eukaryotic cellular functions. The first cullin-RING ligase discovered, yeast SCFCdc4, functions with the conjugating enzyme Cdc34 to regulate the cell cycle. Cdc34 orthologs are notable for their highly acidic C-terminal extension. Here we confirm that the Cdc34 acidic C-terminal tail has a role in Cdc34 binding to SCFCdc4 and makes a major contribution to the submicromolar K-m of Cdc34 for SCFCdc4. Moreover, we demonstrate that a key functional property of the tail is its acidity. Our analysis also uncovers an unexpected new function for the acidic tail in promoting catalysis. We demonstrate that SCF is functional when Cdc34 is fused to the C terminus of Cul1 and that this fusion retains partial function even when the acidic tail has been deleted. The Cdc34-SCF fusion proteins that lack the acidic tail must interact in a fundamentally different manner than unfused SCF and wild type Cdc34, demonstrating that distinct mechanisms of E2 recruitment to E3, as is seen in nature, can sustain substrate ubiquitylation. Finally, a search of the yeast proteome uncovered scores of proteins containing highly acidic stretches of amino acids, hinting that electrostatic interactions may be a common mechanism for facilitating protein assembly.	[Kleiger, Gary; Mohl, Dane A.; Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kleiger, Gary; Mohl, Dane A.; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Hao, Bing] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Connecticut	Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	National Institutes of Health Ruth Kirschstein [F32 GM074471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074471, R01GM065997] Funding Source: NIH RePORTER	National Institutes of Health Ruth Kirschstein(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth Kirschstein Postdoctoral Fellowship F32 GM074471-01.	Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Creighton T. E., 1993, PROTEINS STRUCTURES, P272; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; GILL G, 1990, P NATL ACAD SCI USA, V87, P2127, DOI 10.1073/pnas.87.6.2127; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KLEIGER G, 2009, CELL IN PRESS; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; KOPPENOL WH, 1982, J BIOL CHEM, V257, P4426; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; POHL C, 2008, E SCHERING FDN S P, V1, P115; Ruiz A, 2004, J BIOL CHEM, V279, P34421, DOI 10.1074/jbc.M400572200; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; SCHOPPINK PJ, 1989, BIOCHIM BIOPHYS ACTA, V974, P192, DOI 10.1016/S0005-2728(89)80372-X; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VANLOON APGM, 1984, EMBO J, V3, P1039, DOI 10.1002/j.1460-2075.1984.tb01924.x; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; YANG MJ, 1994, J BIOL CHEM, V269, P1270; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	45	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36012	36023		10.1074/jbc.M109.058529	http://dx.doi.org/10.1074/jbc.M109.058529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19875449	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000272970500003
J	Chebel, A; Rouault, JP; Urbanowicz, I; Baseggio, L; Chien, WW; Salles, G; Ffrench, M				Chebel, Amel; Rouault, Jean-Pierre; Urbanowicz, Iwona; Baseggio, Lucile; Chien, Wei-Wen; Salles, Gilles; Ffrench, Martine			Transcriptional Activation of hTERT, the Human Telomerase Reverse Transcriptase, by Nuclear Factor of Activated T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT HTERT; GENE PROMOTER; CANCER-CELLS; FACTOR NFAT1; C-MYC; REPRESSES TRANSCRIPTION; HUMAN-LYMPHOCYTES; EPITHELIAL-CELLS; TUMOR-CELLS; EXPRESSION	Telomerase is essential for telomere maintenance, and its activation is thought to be a critical step in cellular immortalization and tumorigenesis. Human telomerase reverse transcriptase (hTERT) is a major component of telomerase activity. We show here that hTERT is expressed soon after lymphocyte activation and that its expression is inhibited by rapamycin, wortmannin, and FK506, which was the most potent inhibitor. These results suggest a potential role for the transcription factor nuclear factor of activated T cells (NFAT) in the regulation of hTERT expression. Five putative NFAT-binding sites were identified in the hTERT promoter. In luciferase assays, the hTERT promoter was activated by overexpressed NFAT1. Moreover, serial deletions revealed that the promoter activation was mainly due to a -40 NFAT1-binding site flanked by two SP1-binding sites. Mutation of the -40 NFAT-binding site caused a 53% reduction in the transcriptional activity of hTERT promoter. Simultaneous mutations of the -40 NFAT-responsive element together with one or both SP1-binding sites led to a more dramatic decrease in luciferase activity than single mutations, suggesting a functional synergy between NFAT1 and SP1 in hTERT transcriptional regulation. NFAT1 overexpression in MCF7 and Jurkat cell lines induced an increase in endogenous hTERT mRNA expression. Inversely, its down-regulation was induced by NFAT1 silencing. Furthermore, chromatin immunoprecipitation assay demonstrated that NFAT1 directly binds to two sites (-40 and -775) in the endogenous hTERT promoter. Thus, we show for the first time the direct involvement of NFAT1 in the transcriptional regulation of hTERT.	[Baseggio, Lucile; Ffrench, Martine] Hosp Civils Lyon, CHLS, Hematol Lab, F-69310 Pierre Benite, France; [Ffrench, Martine] Univ Lyon 1, CNRS, ENS, Hosp Civils Lyon,UMR 5239,Fac Lyon Sud, F-69921 Oullins, France; [Rouault, Jean-Pierre] Univ Lyon 1, CNRS, INRA, ENS,Inst Genom Fonct Lyon,UMR 5242, F-69007 Lyon, France; [Salles, Gilles] Hosp Civils Lyon, CHLS, Serv Hematol, F-69310 Pierre Benite, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); CHU Lyon	Ffrench, M (corresponding author), Hosp Civils Lyon, CHLS, Hematol Lab, Chemin Grand Revoyet, F-69310 Pierre Benite, France.	martine.ffrench@chu-lyon.fr	Salles, Gilles/Z-2336-2019	Salles, Gilles/0000-0002-9541-8666	Ligues Contre le Cancer du Rhone, et de Saone et Loire; Region Rhones Alpes [00 81 60 45]; Canceropole Lyon Auvergne Rhone-Alpes	Ligues Contre le Cancer du Rhone, et de Saone et Loire; Region Rhones Alpes(Region Auvergne-Rhone-Alpes); Canceropole Lyon Auvergne Rhone-Alpes	This work was supported by the Ligues Contre le Cancer du Rhone, et de Saone et Loire, by the Region Rhones Alpes (Contract 00 81 60 45), and by the Canceropole Lyon Auvergne Rhone-Alpes.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Chebel A, 2007, LEUKEMIA RES, V31, P1649, DOI 10.1016/j.leukres.2007.03.021; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Fujimoto K, 2000, NUCLEIC ACIDS RES, V28, P2557, DOI 10.1093/nar/28.13.2557; Fujimoto R, 2003, ORAL ONCOL, V39, P445, DOI 10.1016/S1368-8375(03)00003-4; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guilleret I, 2004, BIOCHEM BIOPH RES CO, V325, P1037, DOI 10.1016/j.bbrc.2004.10.137; Guilleret I, 2003, EXP CELL RES, V289, P326, DOI 10.1016/S0014-4827(03)00281-7; Gunes C, 2000, CANCER RES, V60, P2116; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Horikawa I, 1999, CANCER RES, V59, P826; Hsiao RS, 1997, ANTICANCER RES, V17, P827; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Kyo S, 1999, CANCER RES, V59, P5917; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Liu KB, 2001, J IMMUNOL, V166, P4826, DOI 10.4049/jimmunol.166.8.4826; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; MCKEON F, 1991, CELL, V66, P823, DOI 10.1016/0092-8674(91)90426-Y; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Oh S, 1999, J BIOL CHEM, V274, P37473, DOI 10.1074/jbc.274.52.37473; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Ulaner GA, 1998, CANCER RES, V58, P4168; Urbanowicz-Kachnowicz I, 1999, INT J CANCER, V82, P98, DOI 10.1002/(SICI)1097-0215(19990702)82:1<98::AID-IJC17>3.0.CO;2-A; WELSHONS WV, 1988, MOL CELL ENDOCRINOL, V57, P169, DOI 10.1016/0303-7207(88)90072-X; Won JJ, 2002, FASEB J, V16, P1943, DOI 10.1096/fj.02-0311fje; Xiao S, 1999, EUR J IMMUNOL, V29, P3456, DOI 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.3.CO;2-2; Xiao XD, 2003, EXP MOL PATHOL, V75, P238, DOI 10.1016/S0014-4800(03)00092-3; Yasumoto S, 1996, ONCOGENE, V13, P433; Zhou CX, 2003, MOL CANCER THER, V2, P789	63	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35725	35734		10.1074/jbc.M109.009183	http://dx.doi.org/10.1074/jbc.M109.009183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843528	hybrid, Green Published			2022-12-27	WOS:000272645600050
J	Glauser, G; Dubugnon, L; Mousavi, SAR; Rudaz, S; Wolfender, JL; Farmer, EE				Glauser, Gaetan; Dubugnon, Lucie; Mousavi, Seyed A. R.; Rudaz, Serge; Wolfender, Jean-Luc; Farmer, Edward E.			Velocity Estimates for Signal Propagation Leading to Systemic Jasmonic Acid Accumulation in Wounded Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING GALACTOLIPIDS; GENE-EXPRESSION; LIPOXYGENASE; IDENTIFICATION; BIOSYNTHESIS; TRANSDUCTION; RESOLUTION; MOVEMENT; EXTRACTS; MUTATION	The wound response prohormone jasmonic acid (JA) accumulates rapidly in tissues both proximal and distal to injury sites in plants. Using quantitative liquid chromatography-mass spectrometry after flash freezing of tissues, we found that JA accumulated within 30 s of injury in wounded Arabidopsis leaves (p = 3.5 e(-7)). JA augmentation distal to wounds was strongest in unwounded leaves with direct vascular connections to wounded leaves wherein JA levels increased significantly within 120 s of wounding (p = 0.00027). This gave conservative and statistically robust temporal boundaries for the average velocity of the long distance signal leading to distal JA accumulation in unwounded leaves of 3.4-4.5 cm min(-1). Like JA, transcripts of the JA synthesis gene LIPOXYGENASE2 (LOX2) and the jasmonate response gene JAZ10.3 also accumulated to higher levels in directly interconnected leaves than in indirectly connected leaves. JA accumulation in a lox2-1 mutant plant was initiated rapidly after wounding then slowed progressively compared with the wild type (WT). Despite this, JAZ10.3 expression in the two genotypes was similar. Free cyclopentenone jasmonate levels were similar in both resting WT and lox2-1. In contrast, bound cyclopentenone jasmonates (arabidopsides) were far lower in lox2-1 than in the WT. The major roles of LOX2 are to generate arabidopsides and the large levels of JA that accumulate proximal to the wound. LOX2is not essential for some of the most rapid events elicited by wounding.	[Dubugnon, Lucie; Mousavi, Seyed A. R.; Farmer, Edward E.] Univ Lausanne, CH-1015 Lausanne, Switzerland; [Glauser, Gaetan; Rudaz, Serge; Wolfender, Jean-Luc] Univ Lausanne, Sch Pharmaceut Sci, Univ Geneva, CH-1211 Geneva 4, Switzerland	University of Lausanne; University of Geneva; University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Farmer, Edward E/H-1635-2011; Jean-Luc, Wolfender JLW/O-2163-2018; Mousavi, Seyed/H-9532-2012; Rudaz, Serge/AAB-2861-2021; Glauser, Gaetan/K-7574-2017; Jean-Luc, Wolfender JLW/EWV-1043-2022	Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Rudaz, Serge/0000-0002-4180-5417; Glauser, Gaetan/0000-0002-0983-8614; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Mousavi, Seyed Ali Reza/0000-0002-2948-1771	Swiss National Science Foundation [205320-124667/1, 3100A0-122441]; SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch	This work was supported in part by Swiss National Science Foundation Grants 205320-124667/1 ( to J.-L.W., S. R., and E. E. F.), 3100A0-122441 ( to E. E. F.) and SystemsX.ch ( to E. E. F.).	Andreu V, 2007, PLANT PHYSIOL, V145, P1336, DOI 10.1104/pp.107.109637; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Beyhl D, 2009, PLANT J, V58, P715, DOI 10.1111/j.1365-313X.2009.03820.x; Bottcher C, 2007, PLANTA, V226, P629, DOI 10.1007/s00425-007-0511-5; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DAVIS JM, 1991, P NATL ACAD SCI USA, V88, P2393, DOI 10.1073/pnas.88.6.2393; Dengler NG, 2006, CAN J BOT, V84, P1660, DOI 10.1139/B06-126; Farmer EE, 2007, NATURE, V448, P659, DOI 10.1038/448659a; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fisahn J, 2004, PLANT CELL PHYSIOL, V45, P456, DOI 10.1093/pcp/pch054; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Glauser G, 2008, RAPID COMMUN MASS SP, V22, P3154, DOI 10.1002/rcm.3716; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Glauser G, 2008, J CHROMATOGR A, V1180, P90, DOI 10.1016/j.chroma.2007.12.021; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Howe G.A., 2008, INDUCED PLANT RESIST, P349; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Howe Gregg A., 2008, P7, DOI 10.1007/978-1-4020-8182-8_1; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; KOO AJ, 2009, PHYTOCHEMIS IN PRESS; Kourtchenko O, 2007, PLANT PHYSIOL, V145, P1658, DOI 10.1104/pp.107.104752; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Mene-Saffrane L, 2007, J BIOL CHEM, V282, P35749, DOI 10.1074/jbc.M706838200; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mueller MJ, 2006, PLANT J, V45, P472, DOI 10.1111/j.1365-313X.2005.02614.x; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Roberts K, 2007, NEW PHYTOL, V175, P707, DOI 10.1111/j.1469-8137.2007.02136.x; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stork W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004697; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708	41	171	182	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34506	34513		10.1074/jbc.M109.061432	http://dx.doi.org/10.1074/jbc.M109.061432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846562	hybrid, Green Published			2022-12-27	WOS:000272439600004
J	Oesterholm, C; Barczyk, MM; Busse, M; Gronning, M; Reed, RK; Kusche-Gullberg, M				Oesterholm, Cecilia; Barczyk, Malgorzata M.; Busse, Marta; Gronning, Mona; Reed, Rolf K.; Kusche-Gullberg, Marion			Mutation in the Heparan Sulfate Biosynthesis Enzyme EXT1 Influences Growth Factor Signaling and Fibroblast Interactions with the Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC FIBROBLASTS; TUMOR SUPPRESSORS; MOUSE DEVELOPMENT; LIGAND-BINDING; IN-VIVO; COLLAGEN; ADHESION; COMPLEX; DIFFERENTIATION; PROTEOGLYCANS	Heparan sulfate (HS) chains bind and modulate the signaling efficiency of many ligands, including members of the fibroblast growth factor (FGF) and platelet-derived growth factor families. We previously reported the structure of HS synthesized by embryonic fibroblasts from mice with a gene trap mutation of Ext1 that encodes a glycosyltransferase involved in HS chain elongation. The gene trap mutation results in low expression of Ext1, and, as a consequence, HS chain length is substantially reduced. In the present study, Ext1 mutant and wild-type mouse embryonic fibroblasts were analyzed for the functional consequences of the Ext1 mutation for growth factor signaling and interaction with the extracellular matrix. Here, we show that the phosphorylation of ERK1/2 in response to FGF2 stimulation was markedly decreased in the Ext1 mutant fibroblasts, whereas neither PDGF-BB nor FGF10 signaling was significantly affected. Furthermore, Ext1 mutants displayed reduced ability to attach to collagen I and to contract collagen lattices, even though no differences in the expression of collagen-binding integrins were observed. Reintroduction of Ext1in the Ext1 mutant fibroblasts rescued HS chain length, FGF2 signaling, and the ability of the fibroblasts to contract collagen. These data suggest that the length of the HS chains is a critical determinant of HS-protein interactions and emphasize the essential role of EXT1 in providing specific binding sites for growth factors and extracellular matrix proteins.	[Oesterholm, Cecilia; Barczyk, Malgorzata M.; Gronning, Mona; Reed, Rolf K.; Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, NO-5009 Bergen, Norway; [Busse, Marta] Lincolns Inn Fields Labs, Canc Res UK, Vasc Biol Lab, London WC2A 3PX, England	University of Bergen; Cancer Research UK	Kusche-Gullberg, M (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, NO-5009 Bergen, Norway.	Marion.Kusche@biomed.uib.no	Reed, Rolf K./B-9422-2017; Corbascio, Cecilia Österholm/ABF-2213-2020; Kusche-Gullberg, Marion/P-4466-2016	Reed, Rolf K./0000-0002-2633-6595; Corbascio, Cecilia Österholm/0000-0001-7506-084X; Kusche-Gullberg, Marion/0000-0002-5636-1695	University of Bergen; Research Council of Norway; Norwegian Cancer Society [PK01-20080052]; Meltzer Foundation	University of Bergen; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Meltzer Foundation	This work was supported by grants from the University of Bergen, the Research Council of Norway, the Norwegian Cancer Society (PK01-20080052), and the Meltzer Foundation.	Abe M, 2007, J CELL BIOCHEM, V102, P1290, DOI 10.1002/jcb.21359; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Chen YL, 2008, ARTHRITIS RHEUM-US, V58, P577, DOI 10.1002/art.23146; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; GOODGER SJ, 2008, J BIOL CHEM; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Hecht JT, 2005, DIFFERENTIATION, V73, P212, DOI 10.1111/j.1432-0436.2005.00025.x; Hecht JT, 2002, BONE, V31, P199, DOI 10.1016/S8756-3282(02)00796-2; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; KATO M, 1994, J BIOL CHEM, V269, P18881; KODA JE, 1984, J BIOL CHEM, V259, P1763; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SOLOMON L, 1964, AM J HUM GENET, V16, P351; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Zhang WQ, 2006, J BIOL CHEM, V281, P37302, DOI 10.1074/jbc.M604905200	49	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34935	34943		10.1074/jbc.M109.005264	http://dx.doi.org/10.1074/jbc.M109.005264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850926	Green Published, hybrid			2022-12-27	WOS:000272439600049
J	Feng, YM; Hartig, SM; Bechill, JE; Blanchard, EG; Caudell, E; Corey, SJ				Feng, Yanming; Hartig, Sean M.; Bechill, John E.; Blanchard, Elisabeth G.; Caudell, Eva; Corey, Seth J.			The Cdc42-interacting Protein-4 (CIP4) Gene Knock-out Mouse Reveals Delayed and Decreased Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; MEMBRANE INVAGINATION; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PCH PROTEINS; N-WASP; BAR; DOMAIN; GLUT4; CELLS	The newly described F-BAR (Fer/CIP4 and Bin, amphiphysin, Rvs) family of proteins includes Cdc42-interacting protein-4 (CIP4), formin-binding protein-17 (FBP-17) and transactivator of cytoskeletal assembly-1 (Toca-1), and drives membrane deformation and invagination. Membrane remodeling affects endocytosis, vesicle budding, and cargo selection. The F-BAR family presents a novel family of proteins, which little is known about their in vivo function. We investigated the physiological role of CIP4, by creating Cip4-null mice through homologous recombination. Compared with their wild-type littermates, the Cip4-null mice displayed lower early post-prandial glucose levels. Adipocytes isolated from Cip4-null mice exhibited increased [C-14]2-deoxyglucose uptake compared with cells from wild-type mice. The enhanced insulin sensitivity was not due to higher levels of insulin or phospho-Akt, a critical player in insulin signaling. However, higher glucose transporter 4 (GLUT4) levels were detected in muscle membrane fractions in Cip4-null mice under insulin stimulation. Mouse embryonic fibroblasts from Cip4-null mice demonstrated decreased transferrin uptake, fluorescein isothiocyanate-dextran, and horseradish peroxidase uptake, indicating that CIP4 affects multiple modes of endocytosis. These studies demonstrate a physiological role for CIP4 in endocytosis leading to a whole animal phenotype.	[Feng, Yanming; Bechill, John E.; Corey, Seth J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Feng, Yanming; Bechill, John E.; Corey, Seth J.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Feng, Yanming; Bechill, John E.; Corey, Seth J.] Northwestern Univ, Dept Cellular & Mol Biol, Chicago, IL 60611 USA; [Feng, Yanming; Hartig, Sean M.; Blanchard, Elisabeth G.; Caudell, Eva; Corey, Seth J.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Hartig, Sean M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Corey, SJ (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Lurie 5-107,303 E Super St, Chicago, IL 60611 USA.	s-corey@northwestern.edu			National Institutes of Health [RO1HL080052]; American Heart Association; Charlotte Geyer Foundation; University of Texas M.D. Anderson Cancer Center Odyssey Fellowship; Tennessee Law Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Charlotte Geyer Foundation; University of Texas M.D. Anderson Cancer Center Odyssey Fellowship; Tennessee Law Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL080052 (to S. J. C.). This work was also supported by a grant-in-aid from the American Heart Association, Charlotte Geyer Foundation, and grants from the University of Texas M.D. Anderson Cancer Center Odyssey Fellowship and the Tennessee Law Foundation (to S. M. H.).	Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Chang L, 2002, P NATL ACAD SCI USA, V99, P12835, DOI 10.1073/pnas.202495599; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Dombrosky-Ferlan P, 2003, BLOOD, V101, P2804, DOI 10.1182/blood-2002-03-0851; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Hartig SM, 2009, J CELL SCI, V122, P2283, DOI 10.1242/jcs.041343; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Tengholm A, 2002, CURR BIOL, V12, P1871, DOI 10.1016/S0960-9822(02)01223-X; Tian L, 2000, J BIOL CHEM, V275, P7854, DOI 10.1074/jbc.275.11.7854; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wang L, 2002, BIOCHEM BIOPH RES CO, V293, P1426, DOI 10.1016/S0006-291X(02)00398-4; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhou M, 1998, AM J PHYSIOL-ENDOC M, V275, pE187, DOI 10.1152/ajpendo.1998.275.2.E187	29	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4348	4354		10.1074/jbc.M109.041038	http://dx.doi.org/10.1074/jbc.M109.041038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19920150	Green Published, hybrid			2022-12-27	WOS:000275274800011
J	Hammerich-Hille, S; Kaipparettu, BA; Tsimelzon, A; Creighton, CJ; Jiang, SM; Polo, JM; Melnick, A; Meyer, R; Oesterreich, S				Hammerich-Hille, Stephanie; Kaipparettu, Benny A.; Tsimelzon, Anna; Creighton, Chad J.; Jiang, Shiming; Polo, Jose M.; Melnick, Ari; Meyer, Rene; Oesterreich, Steffi			SAFB1 Mediates Repression of Immune Regulators and Apoptotic Genes in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX ATTACHMENT REGION; MAR-BINDING PROTEIN; RECEPTOR COREPRESSOR; DISTINCT CLASSES; HET/SAF-B; EXPRESSION; ESTROGEN; TRANSCRIPTION; SATB1; CHROMATIN	The scaffold attachment factors SAFB1 and SAFB2 are paralogs, which are involved in cell cycle regulation, apoptosis, differentiation, and stress response. They have been shown to function as estrogen receptor corepressors, and there is evidence for a role in breast tumorigenesis. To identify their endogenous target genes in MCF-7 breast cancer cells, we utilized a combined approach of chromatin immunoprecipitation (ChIP)-on-chip and gene expression array studies. By performing ChIP-on-chip on microarrays containing 24,000 promoters, we identified 541 SAFB1/SAFB2-binding sites in promoters of known genes, with significant enrichment on chromosomes 1 and 6. Gene expression analysis revealed that the majority of target genes were induced in the absence of SAFB1 or SAFB2 and less were repressed. Interestingly, there was no significant overlap between the genes identified by ChIP-on-chip and gene expression array analysis, suggesting regulation through regions outside the proximal promoters. In contrast to SAFB2, which shared most of its target genes with SAFB1, SAFB1 had many unique target genes, most of them involved in the regulation of the immune system. A subsequent analysis of the estrogen treatment group revealed that 12% of estrogen-regulated genes were dependent on SAFB1, with the majority being estrogen-repressed genes. These were primarily genes involved in apoptosis, such as BBC3, NEDD9, and OPG. Thus, this study confirms the primary role of SAFB1/SAFB2 as corepressors and also uncovers a previously unknown role for SAFB1 in the regulation of immune genes and in estrogen-mediated repression of genes.	[Hammerich-Hille, Stephanie; Kaipparettu, Benny A.; Tsimelzon, Anna; Creighton, Chad J.; Jiang, Shiming; Oesterreich, Steffi] Texas Childrens Canc Ctr, Dept Med & Mol & Cellular Biol, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Meyer, Rene] Texas Childrens Canc Ctr, Dept Pediat Hematol Oncol, Houston, TX 77030 USA; [Polo, Jose M.; Melnick, Ari] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Texas Children's Cancer Center; Texas Children's Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Oesterreich, S (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.	steffio@breastcenter.tmc.edu	Melnick, Ari/AAA-5763-2020	Polo, Jose M/0000-0002-2531-778X; Kaipparettu, Benny/0000-0003-3444-4307	National Institutes of Health [R01 CA9721305, P01 CA03019526, P30CA125123]; Dr. Mildred Scheel Stiftung, Deutsche Krebshilfe (German Cancer Aid); Baylor College of Medicine; NATIONAL CANCER INSTITUTE [R01CA097213, P30CA125123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Mildred Scheel Stiftung, Deutsche Krebshilfe (German Cancer Aid)(Deutsche Krebshilfe); Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA9721305 (to S. O.) and P01 CA03019526 (to S. O.). This work was also supported by Dr. Mildred Scheel Stiftung, Deutsche Krebshilfe (German Cancer Aid) (to S. H. H.).; We thank the Dan L. Duncan Cancer Center Protein Core (supported by National Institutes of Health Grant P30CA125123), Baylor College of Medicine, for generation of monoclonal SAFB1 antibodies. We also thank Dr. Adrian Lee for input and comments on the manuscript.	Acevedo ML, 2004, MOL CELL, V13, P725, DOI 10.1016/S1097-2765(04)00121-2; Alvarez JD, 2000, GENE DEV, V14, P521; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bergman A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-108; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Debril MB, 2005, J MOL ENDOCRINOL, V35, P503, DOI 10.1677/jme.1.01856; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Denegri M, 2001, MOL BIOL CELL, V12, P3502, DOI 10.1091/mbc.12.11.3502; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobrzycka KM, 2006, CANCER RES, V66, P7859, DOI 10.1158/0008-5472.CAN-06-1381; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; HAMMERICHHILLE S, 2009, BREAST CANC RES TREA; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; Ivanova M, 2005, MOL CELL BIOL, V25, P2995, DOI 10.1128/MCB.25.8.2995-3006.2005; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang SM, 2006, MOL ENDOCRINOL, V20, P311, DOI 10.1210/me.2005-0100; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lee YB, 2007, EXP CELL RES, V313, P3914, DOI 10.1016/j.yexcr.2007.06.023; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; Oesterreich S, 2000, MOL ENDOCRINOL, V14, P369, DOI 10.1210/me.14.3.369; Oesterreich S, 1997, J CELL BIOCHEM, V67, P275, DOI 10.1002/(SICI)1097-4644(19971101)67:2<275::AID-JCB13>3.0.CO;2-E; Oesterreich S, 2001, BRIT J CANCER, V84, P493, DOI 10.1054/bjoc.2000.1606; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Townson SM, 2004, J BIOL CHEM, V279, P26074, DOI 10.1074/jbc.M313726200; Townson SM, 2003, J BIOL CHEM, V278, P20059, DOI 10.1074/jbc.M212988200; Townson SM, 2000, CLIN CANCER RES, V6, P3788; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3608	3616		10.1074/jbc.M109.066431	http://dx.doi.org/10.1074/jbc.M109.066431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19901029	Green Published, hybrid			2022-12-27	WOS:000275254000012
J	Bom, APDA; Freitas, MS; Moreira, FS; Ferraz, D; Sanches, D; Gomes, AMO; Valente, AP; Cordeiro, Y; Silva, JL				Ano Bom, Ana Paula D.; Freitas, Monica S.; Moreira, Flavia S.; Ferraz, Danielly; Sanches, Daniel; Gomes, Andre M. O.; Valente, Ana Paula; Cordeiro, Yraima; Silva, Jerson L.			The p53 Core Domain Is a Molten Globule at Low pH FUNCTIONAL IMPLICATIONS OF A PARTIALLY UNFOLDED STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; DNA-BINDING DOMAIN; THERMODYNAMIC STABILITY; ALPHA-LACTALBUMIN; NMR-SPECTROSCOPY; ARC REPRESSOR; CELL-DEATH; WILD-TYPE; PROTEIN; STATE	p53 is a transcription factor that maintains genome integrity, and its function is lost in 50% of human cancers. The majority of p53 mutations are clustered within the core domain. Here, we investigate the effects of low pH on the structure of the wild-type (wt) p53 core domain (p53C) and the R248Q mutant. At low pH, the tryptophan residue is partially exposed to the solvent, suggesting a fluctuating tertiary structure. On the other hand, the secondary structure increases, as determined by circular dichroism. Binding of the probe bis-ANS (bis-8-anilinonaphthalene-1-sulfonate) indicates that there is an increase in the exposure of hydrophobic pockets for both wt and mutant p53C at low pH. This behavior is accompanied by a lack of cooperativity under urea denaturation and decreased stability under pressure when p53C is in acidic pH. Together, these results indicate that p53C acquires a partially unfolded conformation (molten-globule state) at low pH (5.0). The hydrodynamic properties of this conformation are intermediate between the native and denatured conformation. H-1-N-15 HSQC NMR spectroscopy confirms that the protein has a typical molten-globule structure at acidic pH when compared with pH 7.2. Human breast cells in culture (MCF-7) transfected with p53-GFP revealed localization of p53 in acidic vesicles, suggesting that the low pH conformation is present in the cell. Low pH stress also tends to favor high levels of p53 in the cells. Taken together, all of these data suggest that p53 may play physiological or pathological roles in acidic microenvironments.	[Ano Bom, Ana Paula D.; Freitas, Monica S.; Moreira, Flavia S.; Ferraz, Danielly; Sanches, Daniel; Gomes, Andre M. O.; Valente, Ana Paula; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941590 Rio De Janeiro, Brazil; [Ano Bom, Ana Paula D.; Freitas, Monica S.; Ferraz, Danielly; Sanches, Daniel; Gomes, Andre M. O.; Valente, Ana Paula; Cordeiro, Yraima; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estructural & Bio, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl Macromol, Bloco E Sala 10,Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	Valente, Ana Paula/J-3010-2017; SILVA, JERSON Lima/GRF-1442-2022; Cordeiro, Yraima/J-7619-2012; Gomes, Andre M.O./C-4009-2014; Silva, Jerson/J-8984-2014; de Freitas, Mônica Santos/E-8540-2015	Valente, Ana Paula/0000-0001-7219-1123; SILVA, JERSON Lima/0000-0001-9523-9441; Cordeiro, Yraima/0000-0003-4278-212X; Gomes, Andre M.O./0000-0003-1052-8004; Silva, Jerson/0000-0001-9523-9441; de Freitas, Mônica Santos/0000-0003-3105-7918	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP); Fundacao Universitaria Jose Bonifacio (FUJB) of Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao Universitaria Jose Bonifacio (FUJB) of Brazil	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), CNPq Millennium and National Insitute Programs, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos e Projetos (FINEP), and Fundacao Universitaria Jose Bonifacio (FUJB) of Brazil.	Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BALEJA JD, 1994, BIOCHEM CELL BIOL, V72, P95, DOI 10.1139/o94-016; BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; Buchhop S, 1997, NUCLEIC ACIDS RES, V25, P3868, DOI 10.1093/nar/25.19.3868; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; BURGERING MJM, 1995, BIOPOLYMERS, V35, P217, DOI 10.1002/bip.360350210; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Chai YL, 1999, ONCOGENE, V18, P263, DOI 10.1038/sj.onc.1202323; Choi EK, 2004, INT J RADIAT ONCOL, V60, P1264, DOI 10.1016/j.ijrobp.2004.04.043; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Chung CM, 2005, BIOPHYS J, V88, P4232, DOI 10.1529/biophysj.105.061317; Cordeiro Y, 2004, J BIOL CHEM, V279, P32354, DOI 10.1074/jbc.M404295200; Creighton TE, 1997, TRENDS BIOCHEM SCI, V22, P6, DOI 10.1016/S0968-0004(96)20030-1; Cremades N, 2008, J BIOL CHEM, V283, P2883, DOI 10.1074/jbc.M705677200; DAPOIAN AT, 1995, BIOCHEMISTRY-US, V34, P2672, DOI 10.1021/bi00008a034; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dial R, 2003, BIOCHEMISTRY-US, V42, P9937, DOI 10.1021/bi034989o; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; FINK AL, 1995, ANNU REV BIOPH BIOM, V24, P495, DOI 10.1146/annurev.bb.24.060195.002431; FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Gillespie JR, 2000, BBA-PROTEIN STRUCT M, V1480, P41, DOI 10.1016/S0167-4838(00)00104-7; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Ishimaru D, 2004, BIOPHYS J, V87, P2691, DOI 10.1529/biophysj.104.044685; Ishimaru D, 2003, J MOL BIOL, V333, P443, DOI 10.1016/j.jmb.2003.08.026; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamatari YO, 2004, METHODS, V34, P133, DOI 10.1016/j.ymeth.2004.03.010; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kim S, 1999, J MOL BIOL, V294, P551, DOI 10.1006/jmbi.1999.3250; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Lo MC, 1998, P NATL ACAD SCI USA, V95, P8455, DOI 10.1073/pnas.95.15.8455; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P3344, DOI 10.1021/bi00010a025; MILNER J, 1995, TRENDS BIOCHEM SCI, V20, P49, DOI 10.1016/S0968-0004(00)88954-9; Nam GH, 2002, EUR J BIOCHEM, V269, P5280, DOI 10.1046/j.1432-1033.2002.03242.x; NOZAKA M, 1978, BIOCHEMISTRY-US, V17, P3753, DOI 10.1021/bi00611a013; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Ohtsubo T, 1997, CANCER RES, V57, P3910; Pace C N, 1986, Methods Enzymol, V131, P266; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rawat U, 1998, J BIOL CHEM, V273, P9415, DOI 10.1074/jbc.273.16.9415; Rippin TM, 2002, J MOL BIOL, V319, P351, DOI 10.1016/S0022-2836(02)00326-1; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Silva JL, 2002, BBA-PROTEIN STRUCT M, V1595, P250, DOI 10.1016/S0167-4838(01)00348-X; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Sutovsky H, 2004, J BIOL CHEM, V279, P17190, DOI 10.1074/jbc.M311225200; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vassilenko KS, 2002, BBA-PROTEIN STRUCT M, V1594, P168, DOI 10.1016/S0167-4838(01)00303-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Williams AC, 1999, ONCOGENE, V18, P3199, DOI 10.1038/sj.onc.1202660; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu L, 2002, J BIOL CHEM, V277, P11368, DOI 10.1074/jbc.M108347200; Xu L, 2000, CANCER RES, V60, P4610; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zhang B, 1996, J BIOL CHEM, V271, P28734, DOI 10.1074/jbc.271.46.28734	84	50	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2857	2866		10.1074/jbc.M109.075861	http://dx.doi.org/10.1074/jbc.M109.075861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933157	Green Published, hybrid			2022-12-27	WOS:000273697800061
J	Oda, T; Hashimoto, H; Kuwabara, N; Akashi, S; Hayashi, K; Kojima, C; Wong, HL; Kawasaki, T; Shimamoto, K; Sato, M; Shimizu, T				Oda, Takashi; Hashimoto, Hiroshi; Kuwabara, Naoyuki; Akashi, Satoko; Hayashi, Kokoro; Kojima, Chojiro; Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko; Sato, Mamoru; Shimizu, Toshiyuki			Structure of the N-terminal Regulatory Domain of a Plant NADPH Oxidase and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; GTPASE-BINDING DOMAIN; PROTEIN; RAC; HOMOLOGS; REVEALS; CALCIUM; COMPLEX; CA2+; ACTIVATION	Plant NADPH oxidases (Rboh, for respiratory burst oxidase homolog) produce reactive oxygen species that are key regulators of various cellular events including plant innate immunity. Rbohs possess a highly conserved cytoplasmic N-terminal region containing two EF-hand motifs that regulate Rboh activity. Rice (Oryza sativa) RbohB (OsRbohB) is regulated by the direct binding of a small GTPase (Rac1) to this regulatory region as well as by Ca2+ binding to the EF-hands. Here, we present the atomic structure of the N-terminal region of OsRbohB. The structure reveals that OsRbohB forms a unique dimer stabilized by swapping the EF-hand motifs. We identified two additional EF-hand-like motifs that were not predicted from sequence data so far. These EF-hand-like motifs together with the swapped EF-hands form a structure similar to that found in calcineurin B. We observed conformational changes mediated by Ca2+ binding to only one EF-hand. Structure-based in vitro pulldown assays and NMR titration experiments defined the OsRac1 binding interface within the coiled-coil region created by swapping the EF-hands. In addition, we demonstrate a direct intramolecular interaction between the N and C terminus, and that the complete N-terminal cytoplasmic region is required for this interaction. The structural features and intramolecular interactions characterized here might be common elements shared by Rbohs that contribute to the regulation of reactive oxygen species production.	[Sato, Mamoru; Shimizu, Toshiyuki] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Kanagawa 2300045, Japan; [Hayashi, Kokoro; Kojima, Chojiro] Nara Inst Sci & Technol, Biophys Lab, Nara 6300192, Japan; [Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 6300192, Japan	Yokohama City University; Nara Institute of Science & Technology; Nara Institute of Science & Technology	Shimizu, T (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Kanagawa 2300045, Japan.	shimizu@tsurumi.yokohama-cu.ac.jp	Wong, Hann Ling/S-8148-2017; Kojima, Chojiro/AFV-4592-2022	Wong, Hann Ling/0000-0001-8903-1812; Kojima, Chojiro/0000-0003-2723-8249; Kuwabara, Naoyuki/0000-0002-1659-323X; Hashimoto, Hiroshi/0000-0003-1503-6789; Akashi, Satoko/0000-0002-8978-6358	Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Targeted Proteins Research Program (TPRP) and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Groom QJ, 1996, PLANT J, V10, P515, DOI 10.1046/j.1365-313X.1996.10030515.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Oda T, 2008, ACTA CRYSTALLOGR F, V64, P867, DOI 10.1107/S1744309108026535; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; POTTS BCM, 1995, NAT STRUCT BIOL, V2, P790, DOI 10.1038/nsb0995-790; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thao NP, 2007, PLANT CELL, V19, P4035, DOI 10.1105/tpc.107.055517; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Verdino P, 2002, EMBO J, V21, P5007, DOI 10.1093/emboj/cdf526; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Yoshioka H, 2001, MOL PLANT MICROBE IN, V14, P725, DOI 10.1094/MPMI.2001.14.6.725	46	111	117	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1435	1445		10.1074/jbc.M109.058909	http://dx.doi.org/10.1074/jbc.M109.058909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19864426	hybrid, Green Published			2022-12-27	WOS:000273258200063
J	Yamada, K; Osakabe, Y; Mizoi, J; Nakashima, K; Fujita, Y; Shinozaki, K; Yamaguchi-Shinozaki, K				Yamada, Kohji; Osakabe, Yuriko; Mizoi, Junya; Nakashima, Kazuo; Fujita, Yasunari; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Functional Analysis of an Arabidopsis thaliana Abiotic Stress-inducible Facilitated Diffusion Transporter for Monosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE GENE-EXPRESSION; PUTATIVE SUGAR TRANSPORTER; GLUCOSE-TRANSPORTER; MESOPHYLL PROTOPLASTS; SUCROSE TRANSPORTER; VACUOLAR INVERTASE; SIEVE ELEMENTS; ABSCISIC-ACID; IDENTIFICATION; PLANTS	Sugars play indispensable roles in biological reactions and are distributed into various tissues or organelles via transporters in plants. Under abiotic stress conditions, plants accumulate sugars as a means to increase stress tolerance. Here, we report an abiotic stress-inducible transporter for monosaccharides from Arabidopsis thaliana that is termed ESL1 (ERD six-like 1). Expression of ESL1 was induced under drought and high salinity conditions and with exogenous application of abscisic acid. Promoter analyses using beta-glucuronidase and green fluorescent protein reporters revealed that ESL1 is mainly expressed in peri-cycle and xylem parenchyma cells. The fluorescence of ESL1-green fluorescent protein-fused protein was detected at tonoplast in transgenic Arabidopsis plants and tobacco BY-2 cells. Furthermore, alanine-scanning mutagenesis revealed that an N-terminal LXXXLL motif in ESL1 was essential for its localization at the tonoplast. Transgenic BY-2 cells expressing mutated ESL1, which was localized at the plasma membrane, showed an uptake ability for monosaccharides. Moreover, the value of Km for glucose uptake activity of mutated ESL1 in the transgenic BY-2 cells was extraordinarily high, and the transport activity was independent from a proton gradient. These results indicate that ESL1 is a low affinity facilitated diffusion transporter. Finally, we detected that vacuolar invertase activity was increased under abiotic stress conditions, and the expression patterns of vacuolar invertase genes were similar to that of ESL1. Under abiotic stress conditions, ESL1 might function coordinately with the vacuolar invertase to regulate osmotic pressure by affecting the accumulation of sugar in plant cells.	[Yamada, Kohji; Osakabe, Yuriko; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan; [Yamada, Kohji; Mizoi, Junya; Nakashima, Kazuo; Fujita, Yasunari; Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Biol Resources Div, Tsukuba, Ibaraki 3058686, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Kanagawa 2030045, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; RIKEN	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Shinozaki, Kazuo/G-4202-2013; Fujita, Yasunari/P-9861-2018; Nakashima, Kazuo/ABD-9576-2021; Osakabe, Yuriko/GRI-9818-2022; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Mizoi, Junya/Y-6261-2019; Osakabe, Yuriko/Y-2507-2019; Yamada, Kohji/O-6731-2015; Shinozaki, Kazuo/AAB-4945-2019	Shinozaki, Kazuo/0000-0002-6317-9867; Fujita, Yasunari/0000-0002-5036-8319; Osakabe, Yuriko/0000-0001-5503-1427; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Mizoi, Junya/0000-0002-3383-8059; Osakabe, Yuriko/0000-0001-5503-1427; Yamada, Kohji/0000-0001-7779-9656; Shinozaki, Kazuo/0000-0002-6317-9867; Nakashima, Kazuo/0000-0001-6417-8316	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research in priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aluri S, 2007, P NATL ACAD SCI USA, V104, P2537, DOI 10.1073/pnas.0610278104; Augustin R, 2005, TRAFFIC, V6, P1196, DOI 10.1111/j.1600-0854.2005.00354.x; Barth I, 2003, PLANT CELL, V15, P1375, DOI 10.1105/tpc.010967; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BRISKIN DP, 1985, PLANT PHYSIOL, V78, P871, DOI 10.1104/pp.78.4.871; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Chiou TJ, 1996, PLANT PHYSIOL, V110, P511, DOI 10.1104/pp.110.2.511; HaouazineTakvorian N, 1997, GENE, V197, P239, DOI 10.1016/S0378-1119(97)00268-0; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Kiyosue T, 1998, BBA-BIOMEMBRANES, V1370, P187, DOI 10.1016/S0005-2736(98)00007-8; Klepek YS, 2005, PLANT CELL, V17, P204, DOI 10.1105/tpc.104.026641; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; MARTINOIA E, 1987, J PLANT PHYSIOL, V131, P467, DOI 10.1016/S0176-1617(87)80289-4; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; Meyer S, 2004, PLANT PHYSIOL, V134, P684, DOI 10.1104/pp.103.033399; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; OHYAMA A, 1995, PLANT CELL PHYSIOL, V36, P369, DOI 10.1093/oxfordjournals.pcp.a078769; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Pelleschi S, 1999, PLANT MOL BIOL, V39, P373, DOI 10.1023/A:1006116310463; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; RAUSCH T, 1987, PLANT PHYSIOL, V85, P996, DOI 10.1104/pp.85.4.996; Reinders A, 2005, J BIOL CHEM, V280, P1594, DOI 10.1074/jbc.M410831200; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sacchi GA, 2000, PLANT SOIL, V220, P1, DOI 10.1023/A:1004701912815; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; SAUER N, 1990, EMBO J, V9, P3045, DOI 10.1002/j.1460-2075.1990.tb07500.x; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tang XW, 1996, PLANTA, V198, P17; Toyofuku K, 2000, PLANT CELL PHYSIOL, V41, P940, DOI 10.1093/pcp/pcd016; Trouverie J, 2004, PLANTA, V219, P894, DOI 10.1007/s00425-004-1289-3; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Voitsekhovskaja OV, 2006, PLANT PHYSIOL, V140, P383, DOI 10.1104/pp.105.068312; Weise A, 2000, PLANT CELL, V12, P1345, DOI 10.1105/tpc.12.8.1345; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; Wormit A, 2006, PLANT CELL, V18, P3476, DOI 10.1105/tpc.106.047290; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	46	123	137	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1138	1146		10.1074/jbc.M109.054288	http://dx.doi.org/10.1074/jbc.M109.054288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19901034	hybrid, Green Published			2022-12-27	WOS:000273258200036
J	Jarman, KE; Moretti, PAB; Zebol, JR; Pitson, SM				Jarman, Kate E.; Moretti, Paul A. B.; Zebol, Julia R.; Pitson, Stuart M.			Translocation of Sphingosine Kinase 1 to the Plasma Membrane Is Mediated by Calcium- and Integrin-binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TRANSLOCATION; CYTOPLASMIC DOMAIN; ACTIVATION; CIB1; CELL; SPHINGOSINE-1-PHOSPHATE; CALMODULIN; INTERACTS; SENSOR; CA2+	SK1 (sphingosine kinase 1) plays an important role in many aspects of cellular regulation. Most notably, elevated cellular SK1 activity leads to increased cell proliferation, protection from apoptosis, and induction of neoplastic transformation. We have previously shown that translocation of SK1 from the cytoplasm to the plasma membrane is integral for oncogenesis mediated by this enzyme. The molecular mechanism mediating this translocation of SK1 has remained undefined. Here, we demonstrate a direct role for CIB1 (calcium and integrin-binding protein 1) in this process. We show that CIB1 interacts with SK1 in a Ca2+-dependent manner at the previously identified "calmodulin-binding site" of SK1. We also demonstrate that CIB1 functions as a Ca2+-myristoyl switch, providing a mechanism whereby it translocates SK1 to the plasma membrane. Both small interfering RNA knockdown of CIB1 and the use of a dominant-negative CIB1 we have generated prevent the agonist-dependent translocation of SK1. Furthermore, we demonstrate the requirement of CIB1-mediated translocation of SK1 in controlling cellular sphingosine 1-phosphate generation and associated anti-apoptotic signaling.	[Jarman, Kate E.; Moretti, Paul A. B.; Zebol, Julia R.; Pitson, Stuart M.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Jarman, Kate E.; Pitson, Stuart M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide	Pitson, SM (corresponding author), SA Pathol, Ctr Canc Biol, Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@health.sa.gov.au	Pitson, Stuart/B-9342-2009	Pitson, Stuart/0000-0002-9527-2740	Fay Fuller Foundation; Australian postgraduate award; Dawes postgraduate scholarship [453512]; National Health and Medical Research Council of Australia	Fay Fuller Foundation; Australian postgraduate award(Australian Government); Dawes postgraduate scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Fay Fuller Foundation, an Australian postgraduate award, and Dawes postgraduate scholarship (to K. E. J.), Project Grant 453512, and a senior research fellowship from the National Health and Medical Research Council of Australia (to S. M. P.).	Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BarPeled M, 1996, ANAL BIOCHEM, V241, P140, DOI 10.1006/abio.1996.0390; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blazejczyk M, 2006, BBA-MOL BASIS DIS, V1762, P66, DOI 10.1016/j.bbadis.2005.09.006; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; French KJ, 2003, CANCER RES, V63, P5962; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Himes SR, 1996, IMMUNITY, V5, P479, DOI 10.1016/S1074-7613(00)80503-8; Hollenbach AD, 2002, BBA-GENE STRUCT EXPR, V1574, P321, DOI 10.1016/S0167-4781(02)00230-0; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Leclercq TM, 2008, J BIOL CHEM, V283, P9606, DOI 10.1074/jbc.M708782200; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; Thorogate R, 2007, BIOCHEM J, V402, P71, DOI 10.1042/BJ20061111; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yamniuk AP, 2009, PROTEIN SCI, V18, P1128, DOI 10.1002/pro.104; Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Young KW, 2003, CELL CALCIUM, V33, P119, DOI 10.1016/S0143-4160(02)00205-1; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zebol JR, 2009, INT J BIOCHEM CELL B, V41, P822, DOI 10.1016/j.biocel.2008.08.012	40	106	112	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					483	492		10.1074/jbc.M109.068395	http://dx.doi.org/10.1074/jbc.M109.068395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19854831	hybrid, Green Published			2022-12-27	WOS:000273070100050
J	Matsumura, T; Suzuki, T; Aizawa, K; Sawaki, D; Munemasa, Y; Ishida, J; Nagai, R				Matsumura, Takayoshi; Suzuki, Toru; Aizawa, Kenichi; Sawaki, Daigo; Munemasa, Yoshiko; Ishida, Junichi; Nagai, Ryozo			Regulation of Transforming Growth Factor-beta-dependent Cyclooxygenase-2 Expression in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; METASTASIS SUPPRESSOR; HUMAN-DISEASE; PROTEIN; FIBROSIS; GENE; TRANSCRIPTION; MECHANISMS; NM23-H1; BINDING	Abnormal transforming growth factor-beta (TGF-beta) signaling is a critical contributor to the pathogenesis of various human diseases ranging from tissue fibrosis to tumor formation. Excessive TGF-beta signaling stimulates fibrotic responses. Recent research has focused in the main on the antiproliferative effects of TGF-beta in fibroblasts, and it is presently understood that TGF-beta-stimulated cyclooxygenase-2 (COX-2) induction in fibroblasts is essential for antifibroproliferative effects of TGF-beta. Both TGF-beta and COX-2 have been implicated in tumor growth, invasion, and metastasis, and therefore tumor-associated fibroblasts are a recent topic of interest. Here we report the identification of positive and negative regulatory factors of COX-2 expression induced by TGF-beta as determined using proteomic approaches. We show that TGF-beta coordinately up-regulates three factors, heterogeneous nuclear ribonucleoprotein A/B (HNRPAB), nucleotide diphosphate kinase A (NDPK A), and nucleotide diphosphate kinase A (NDPK B). Functional pathway analysis showed that HNRPAB augments mRNA and protein levels of COX-2 and subsequent prostaglandin E-2 (PGE(2)) production by suppressing degradation of COX-2 mRNA. In contrast, NDPK A and NDPK B attenuated mRNA and protein levels of COX-2 by affecting TGF-beta-Smad2/3/4 signaling at the receptor level. Collectively, we report on a new regulatory pathway of TGF-beta in controlling expression of COX-2 in fibroblasts, which advances our understanding of pathophysiological mechanisms of TGF-beta	[Suzuki, Toru; Aizawa, Kenichi] Univ Tokyo, Dept Ubiquitous Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan; [Nagai, Ryozo] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Ubiquitous Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	torusuzu-tky@umin.ac.jp; nagai-tky@umin.ac.jp	SAWAKI, Daigo/T-6871-2018	SAWAKI, Daigo/0000-0003-1417-2033; , Junichi/0000-0001-9703-9419; Suzuki, Toru/0000-0002-8371-664X	Ministry of Education, Culture, Sports, Science, and Technology; New Energy and Industrial Technology Development Organization; Ministry of Health, Labor, and Welfare	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology; the New Energy and Industrial Technology Development Organization; and the Ministry of Health, Labor, and Welfare.	Adegboyega PA, 2004, CLIN CANCER RES, V10, P5870, DOI 10.1158/1078-0432.CCR-0431-03; Benson JR, 2004, LANCET ONCOL, V5, P229, DOI 10.1016/S1470-2045(04)01426-3; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boissan M, 2006, J BIOENERG BIOMEMBR, V38, P169, DOI 10.1007/s10863-006-9031-4; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Dean JLE, 2002, BIOCHEM J, V366, P709, DOI 10.1042/BJ20020402; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; KAMADA S, 1992, GENE, V119, P229, DOI 10.1016/0378-1119(92)90276-U; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kaul R, 2006, J VIROL, V80, P1321, DOI 10.1128/JVI.80.3.1321-1331.2006; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lombardi D, 2006, J BIOENERG BIOMEMBR, V38, P177, DOI 10.1007/s10863-006-9032-3; Luo J, 1998, J NEUROCHEM, V71, P526; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; Matsumura T, 2006, BIOCHEM BIOPH RES CO, V351, P965, DOI 10.1016/j.bbrc.2006.10.137; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Roymans D, 2002, CLIN EXP METASTAS, V19, P465, DOI 10.1023/A:1020396722860; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sonoshita M, 2002, CANCER RES, V62, P6846; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Verrecchia F, 2006, AUTOIMMUN REV, V5, P563, DOI 10.1016/j.autrev.2006.06.001; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35861	35871		10.1074/jbc.M109.014639	http://dx.doi.org/10.1074/jbc.M109.014639			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837676	hybrid, Green Published			2022-12-27	WOS:000272645600062
J	Suzuki, Y; Minami, M; Suzuki, M; Abe, K; Zenno, SH; Tsujimoto, M; Matsumoto, K; Minami, Y				Suzuki, Yukari; Minami, Michiko; Suzuki, Miho; Abe, Keiko; Zenno, Shuhei; Tsujimoto, Masafumi; Matsumoto, Ken; Minami, Yasufumi			The Hsp90 Inhibitor Geldanamycin Abrogates Colocalization of eIF4E and eIF4E-Transporter into Stress Granules and Association of eIF4E with eIF4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DEPENDENT TRANSLATION; MESSENGER-RNA TRANSLATION; P-BODIES; BINDING PROTEIN; CHAPERONE; MECHANISMS; INITIATION; RICH; REPRESSION; HEAT-SHOCK-PROTEIN-90	The eukaryotic translation initiation factor eIF4E plays a critical role in the control of translation initiation through binding to the mRNA 5' cap structure. eIF4E is also a component of processing bodies and stress granules, which are two types of cytoplasmic RNA granule in which translationally inactivated mRNAs accumulate. We found that treatment with the Hsp90 inhibitor geldanamycin leads to a substantial reduction in the number of HeLa cells that contain processing bodies. In contrast, stress granules are not disrupted but seem to be only partially affected by the inhibition of Hsp90. However, it is striking that eIF4E as well as its binding partner eIF4E transporter (4E-T), which mediates the import of eIF4E into the nucleus, are obviously lost from stress granules. Furthermore, the amount of eIF4G that is associated with the cap via eIF4E is reduced by geldanamycin treatment. Thus, the chaperone activity of Hsp90 probably contributes to the correct localization of eIF4E and 4E-T to stress granules and also to the interaction between eIF4E and eIF4G, both of which may be needed for eIF4E to acquire the physiological functionality that underlies the mechanism of translation initiation.	[Tsujimoto, Masafumi; Matsumoto, Ken] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Suzuki, Yukari; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Minami, Michiko; Suzuki, Miho] Tokyo Gakugei Univ, Fac Educ, Dept Nat & Environm Sci, Tokyo 1848501, Japan; [Zenno, Shuhei; Minami, Yasufumi] Maebashi Inst Technol, Dept Biotechnol, Maebashi, Gunma 3710816, Japan; [Matsumoto, Ken] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; Tokyo Gakugei University; Japan Science & Technology Agency (JST)	Matsumoto, K (corresponding author), RIKEN, Lab Cellular Biochem, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumok@riken.jp; yminami@maebashi-it.ac.jp	Matsumoto, Ken/F-9083-2013	Matsumoto, Ken/0000-0002-7864-3394	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shinozaki F, 2006, J BIOL CHEM, V281, P16361, DOI 10.1074/jbc.M600891200; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Standart N, 2008, BIOCHEM SOC T, V36, P671, DOI 10.1042/BST0360671; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Tay WL, 2009, MODERN PATHOL, V22, P282, DOI 10.1038/modpathol.2008.181; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	63	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35597	35604		10.1074/jbc.M109.036285	http://dx.doi.org/10.1074/jbc.M109.036285			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850929	hybrid, Green Published			2022-12-27	WOS:000272645600037
J	Ishii, N; Matsumura, T; Kinoshita, H; Motoshima, H; Kojima, K; Tsutsumi, A; Kawasaki, S; Yano, M; Senokuchi, T; Asano, T; Nishikawa, T; Araki, E				Ishii, Norio; Matsumura, Takeshi; Kinoshita, Hiroyuki; Motoshima, Hiroyuki; Kojima, Kanou; Tsutsumi, Atsuyuki; Kawasaki, Shuji; Yano, Miyuki; Senokuchi, Takafumi; Asano, Tomoichiro; Nishikawa, Takeshi; Araki, Eiichi			Activation of AMP-activated Protein Kinase Suppresses Oxidized Low-density Lipoprotein-induced Macrophage Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; MUSCLE-CELL-PROLIFERATION; PHOSPHATIDYLINOSITOL 3-KINASE; MURINE MACROPHAGES; SKELETAL-MUSCLE; DNA-SYNTHESIS; GROWTH; INHIBITION; CANCER; P53	Macrophage-derived foam cells play important roles in the progression of atherosclerosis. We reported previously that ERK1/2-dependent granulocyte/macrophage colony-stimulating factor (GM-CSF) expression, leading to p38 MAPK/Akt signaling, is important for oxidized low density lipoprotein (Ox-LDL)-induced macrophage proliferation. Here, we investigated whether activation of AMP-activated protein kinase (AMPK) could suppress macrophage proliferation. Ox-LDL-induced proliferation of mouse peritoneal macrophages was assessed by [H-3] thymidine incorporation and cell counting assays. The proliferation was significantly inhibited by the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) and restored by dominant-negative AMPK alpha 1, suggesting that AMPK activation suppressed macrophage proliferation. AICAR partially suppressed Ox-LDL-induced ERK1/2 phosphorylation and GM-CSF expression, suggesting that another mechanism is also involved in the AICAR-mediated suppression of macrophage proliferation. AICAR suppressed GM-CSF-induced macrophage proliferation without suppressing p38 MAPK/Akt signaling. GM-CSF suppressed p53 phosphorylation and expression and induced Rb phosphorylation. Overexpression of p53 or p27(kip) suppressed GM-CSF-induced macrophage proliferation. AICAR induced cell cycle arrest, increased p53 phosphorylation and expression, and suppressed GM-CSF-induced Rb phosphorylation via AMPK activation. Moreover, AICAR induced p21(cip) and p27kip expression via AMPK activation, and small interfering RNA (siRNA) of p21cip and p27kip restored AICAR-mediated suppression of macrophage proliferation. In conclusion, AMPK activation suppressed Ox-LDL-induced macrophage proliferation by suppressing GM-CSF expression and inducing cell cycle arrest. These effects of AMPK activation may represent therapeutic targets for atherosclerosis.	[Ishii, Norio; Matsumura, Takeshi; Kinoshita, Hiroyuki; Motoshima, Hiroyuki; Kojima, Kanou; Tsutsumi, Atsuyuki; Kawasaki, Shuji; Yano, Miyuki; Senokuchi, Takafumi; Nishikawa, Takeshi; Araki, Eiichi] Kumamoto Univ, Dept Metab Med, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Asano, Tomoichiro] Hiroshima Univ, Dept Med Chem, Div Mol Med Sci, Grad Sch Biomed Sci, Hiroshima 7348551, Japan	Kumamoto University; Hiroshima University	Matsumura, T (corresponding author), Kumamoto Univ, Dept Metab Med, Grad Sch Med Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	takeshim@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science, Japan [21591144, 20390259]; Takeda Science Foundation; Advanced Education Program for Integrated Clinical, Basic and Social Medicine; Graduate School of Medical Sciences, Kumamoto University	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Advanced Education Program for Integrated Clinical, Basic and Social Medicine; Graduate School of Medical Sciences, Kumamoto University	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, Japan ( 21591144, to T. M. and 20390259, to E. A.), a grant from the Takeda Science Foundation ( to T. M.), and the Advanced Education Program for Integrated Clinical, Basic and Social Medicine, Graduate School of Medical Sciences, Kumamoto University ( Support Program for Improving Graduate School Education, MEXT, Japan).	Biwa T, 2000, J BIOL CHEM, V275, P5810, DOI 10.1074/jbc.275.8.5810; Biwa T, 1998, J BIOL CHEM, V273, P28305, DOI 10.1074/jbc.273.43.28305; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; CHODAKEWITZ JA, 1988, J IMMUNOL, V140, P832; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; GRANA X, 1995, ONCOGENE, V11, P211; Hamilton JA, 1999, ARTERIOSCL THROM VAS, V19, P98, DOI 10.1161/01.ATV.19.1.98; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Martens JS, 1998, J BIOL CHEM, V273, P4915, DOI 10.1074/jbc.273.9.4915; Matsumura T, 1997, ARTERIOSCL THROM VAS, V17, P3013, DOI 10.1161/01.ATV.17.11.3013; Matsumura T, 1999, J BIOL CHEM, V274, P37665, DOI 10.1074/jbc.274.53.37665; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; MUNKER R, 1986, NATURE, V323, P79, DOI 10.1038/323079a0; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAKAI M, 1994, J BIOL CHEM, V269, P31430; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V88, P87, DOI 10.1016/0021-9150(91)90260-A; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Young ME, 1996, FEBS LETT, V382, P43, DOI 10.1016/0014-5793(96)00129-9	39	37	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34561	34569		10.1074/jbc.M109.028043	http://dx.doi.org/10.1074/jbc.M109.028043			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19843515	Green Published, hybrid			2022-12-27	WOS:000272439600011
J	Oddoux, S; Brocard, J; Schweitzer, A; Szentesi, P; Giannesini, B; Brocard, J; Faure, J; Pernet-Gallay, K; Bendahan, D; Lunardi, J; Csernoch, L; Marty, I				Oddoux, Sarah; Brocard, Julie; Schweitzer, Annie; Szentesi, Peter; Giannesini, Benoit; Brocard, Jacques; Faure, Julien; Pernet-Gallay, Karine; Bendahan, David; Lunardi, Joel; Csernoch, Laszlo; Marty, Isabelle			Triadin Deletion Induces Impaired Skeletal Muscle Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM MEMBRANE; JUNCTIONAL FOOT PROTEIN; RYANODINE-RECEPTOR; DIHYDROPYRIDINE RECEPTOR; GLYCOPROTEIN TRIADIN; CARDIAC-MUSCLE; CALSEQUESTRIN; MICE; MYOTUBES; CA2+	Triadin is a multiple proteins family, some isoforms being involved in muscle excitation-contraction coupling, and some having still unknown functions. To obtain clues on triadin functions, we engineered a triadin knock-out mouse line and characterized the physiological effect of triadin ablation on skeletal muscle function. These mice presented a reduced muscle strength, which seemed not to alter their survival and has been characterized in the present work. We first checked in these mice the expression level of the different proteins involved in calcium homeostasis and observed in fast muscles an increase in expression of dihydropyridine receptor, with a large reduction in calsequestrin expression. Electron microscopy analysis of KO muscles morphology demonstrated the presence of triads in abnormal orientation and a reduction in the sarcoplasmic reticulum terminal cisternae volume. Using calcium imaging on cultured myotubes, we observed a reduction in the total amount of calcium stored in the sarcoplasmic reticulum. Physiological studies have been performed to evaluate the influence of triadin deletion on skeletal muscle function. Muscle strength has been measured both on the whole animal model, using hang test or electrical stimulation combined with NMR analysis and strength measurement, or on isolated muscle using electrical stimulation. All the results obtained demonstrate an important reduction in muscle strength, indicating that triadin plays an essential role in skeletal muscle function and in skeletal muscle structure. These results indicate that triadin alteration leads to the development of a myopathy, which could be studied using this new animal model.	[Oddoux, Sarah; Brocard, Julie; Faure, Julien; Lunardi, Joel; Marty, Isabelle] Equipe Muscle & Pathol, Grenoble Inst Neurosci, INSERM, U836, F-38000 Grenoble, France; [Oddoux, Sarah; Brocard, Julie; Faure, Julien; Lunardi, Joel; Marty, Isabelle] Univ Grenoble 1, F-38000 Grenoble, France; [Schweitzer, Annie; Brocard, Jacques; Pernet-Gallay, Karine] Equipe Physiopathol Cytosquelette, Grenoble Inst Neurosci, INSERM, U836, F-38000 Grenoble, France; [Szentesi, Peter; Csernoch, Laszlo] Univ Debrecen, Dept Physiol, Sch Med, H-4012 Debrecen, Hungary; [Szentesi, Peter; Csernoch, Laszlo] Univ Debrecen, Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Giannesini, Benoit; Bendahan, David] Fac Med Timone, CNRS, UMR 6612, Ctr Resonance Magnet Biol & Med, F-13000 Marseille, France; [Faure, Julien; Lunardi, Joel] Hop Michallon Biochim & Genet Mol, Ctr Hosp Reg Univ Grenoble, F-38000 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Debrecen; University of Debrecen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Marty, I (corresponding author), UJF, INSERM, U836, Grenoble Inst Neurosci,Eq Muscle & Pathol, Site Sante,BP 170, F-38042 Grenoble 9, France.	isabelle.marty@ujf-grenoble.fr	Fauré, julien/AAJ-1845-2020; Marty, Isabelle/N-7114-2017; Marty, Isabelle/ABF-5362-2020; Brocard, Jacques/I-3135-2017	Fauré, julien/0000-0002-3660-9809; Marty, Isabelle/0000-0003-3625-913X; Brocard, Jacques/0000-0002-0752-5737; Brocard, Julie/0000-0001-9345-5191; Csernoch, Laszlo/0000-0002-2446-1456; Szentesi, Peter/0000-0003-2621-2282; Oddoux, Sarah/0000-0002-2888-8430	Association Francaise contre les Myopathies; Agence Nationale de la Recherche-Maladies Rares; Hungarian Research Found [OTKA K75604]	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche-Maladies Rares(French National Research Agency (ANR)); Hungarian Research Found(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by grants from Association Francaise contre les Myopathies, the Agence Nationale de la Recherche-Maladies Rares, and the Hungarian Research Found (Grant OTKA K75604).	Ahern C A, 2001, BMC Physiol, V1, P8, DOI 10.1186/1472-6793-1-8; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; BRANDT NR, 1990, J MEMBRANE BIOL, V113, P237, DOI 10.1007/BF01870075; Caswell AH, 1999, BIOCHEMISTRY-US, V38, P90, DOI 10.1021/bi981306+; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Dupe V, 1997, DEVELOPMENT, V124, P399; FLUCHER BE, 1992, DEV BIOL, V154, P245, DOI 10.1016/0012-1606(92)90065-O; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Fodor J, 2008, J PHYSIOL-LONDON, V586, P5803, DOI 10.1113/jphysiol.2008.160457; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Groh S, 1999, J BIOL CHEM, V274, P12278, DOI 10.1074/jbc.274.18.12278; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; LIU GH, 1994, J BIOL CHEM, V269, P33028; LUNARDI J, 1989, FEBS LETT, V245, P223, DOI 10.1016/0014-5793(89)80226-1; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MARTY I, 1995, BIOCHEM J, V307, P769, DOI 10.1042/bj3070769; Marty I, 2000, J BIOL CHEM, V275, P8206, DOI 10.1074/jbc.275.11.8206; Marty I, 2009, J PHYSIOL-LONDON, V587, P3117, DOI 10.1113/jphysiol.2009.171892; MOUTIN MJ, 1994, J BIOL CHEM, V269, P11147; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Rezgui SS, 2005, J BIOL CHEM, V280, P39302, DOI 10.1074/jbc.M506566200; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Shin DW, 2000, FEBS LETT, V486, P178, DOI 10.1016/S0014-5793(00)02246-8; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Thevenon D, 2003, BIOCHEM BIOPH RES CO, V303, P669, DOI 10.1016/S0006-291X(03)00406-6; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Vassilopoulos S, 2007, CELL CALCIUM, V41, P179, DOI 10.1016/j.ceca.2006.06.003; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Westerblad H, 1998, J PHYSIOL-LONDON, V510, P269, DOI 10.1111/j.1469-7793.1998.269bz.x; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005	44	56	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34918	34929		10.1074/jbc.M109.022442	http://dx.doi.org/10.1074/jbc.M109.022442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19843516	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000272439600047
J	Fernau, NS; Fugmann, D; Leyendecker, M; Reimann, K; Grether-Beck, S; Galban, S; Ale-Agha, N; Krutmann, J; Klotz, LO				Fernau, Niklas S.; Fugmann, Dominik; Leyendecker, Martin; Reimann, Kerstin; Grether-Beck, Susanne; Galban, Stefanie; Ale-Agha, Niloofar; Krutmann, Jean; Klotz, Lars-Oliver			Role of HuR and p38(MAPK) in Ultraviolet B-induced Post-transcriptional Regulation of COX-2 Expression in the Human Keratinocyte Cell Line HaCaT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA STABILITY; EXTRACELLULAR GENERATION; P38; CYCLOOXYGENASE-2; PHOSPHORYLATION; STABILIZATION; INHIBITION; IRRADIATION; RECEPTOR	COX-2 (cyclooxygenase-2) is a pivotal player in inflammatory processes, and ultraviolet radiation is a known stimulus for COX-2 expression in skin cells. Here, an induction of COX-2 expression in HaCaT human keratinocytes was observed only upon exposure of cells to UVB (280-320 nm) but not to UVA radiation (320-400 nm), as demonstrated by reverse transcription-PCR and Western blotting. Prostaglandin E-2 levels were elevated in cell culture supernatants of HaCaT cells exposed to UVB. COX-2 mRNA stability was dramatically increased by UV Birradiation. Both the stabilization of COX-2 mRNA and the enhancement of COX-2 steady-state mRNA and protein levels caused by UVB were prevented both by inhibition and small interfering RNA-induced depletion of p38(MAPK), a kinase strongly activated upon exposure to UVB, suggesting p38MAPK-dependent mRNA stabilization as a mechanism of UVB-induced COX-2 expression. A dramatic decrease in COX-2 expression induced by UVB was elicited by small interfering RNA-based depletion of a stress-responsive mRNA stabilizing protein regulated by p38MAPK, i.e. HuR; UVB-induced elevation of COX-2 mRNA and protein levels coincided with an accumulation of HuR in the cytoplasm and was attenuated in cells depleted of HuR. Moreover, UVB-induced generation of prostaglandin E-2 by HaCaT cells was blunted by HuR depletion, suggesting that stress kinases (such as p38MAPK) as well as HuR are excellent targets for approaches aiming at interfering with induction of COX-2 expression by UVB.	[Fernau, Niklas S.; Fugmann, Dominik; Leyendecker, Martin; Reimann, Kerstin; Grether-Beck, Susanne; Galban, Stefanie; Ale-Agha, Niloofar; Krutmann, Jean; Klotz, Lars-Oliver] Leibniz Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Klotz, LO (corresponding author), Leibniz Inst Umweltmed Forsch, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.	LarsOliver.Klotz@uni-duesseldorf.de	Klotz, Lars Oliver/AAC-5051-2019	Klotz, Lars Oliver/0000-0002-1261-8911	Deutsche Forschungsgemeinschaft [SFB728]; Bundesministerium fur Bildung und Forschung [03NUK003C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067827] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB728 and by Bundesministerium fur Bildung und Forschung Grant 03NUK003C.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Bachelor MA, 2005, MOL CANCER RES, V3, P90, DOI 10.1158/1541-7786.MCR-04-0065; Bachelor MA, 2002, ONCOGENE, V21, P7092, DOI 10.1038/sj.onc.1205855; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bollig F, 2002, EUR J BIOCHEM, V269, P5830, DOI 10.1046/j.1432-1033.2002.03300.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brenneisen P, 1998, J BIOL CHEM, V273, P5279, DOI 10.1074/jbc.273.9.5279; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gowrishankar G, 2005, BIOL CHEM, V386, P1287, DOI 10.1515/BC.2005.146; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Klotz LO, 2002, BIOL CHEM, V383, P443, DOI 10.1515/BC.2002.047; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Mahns A, 2004, PHOTOCH PHOTOBIO SCI, V3, P257, DOI 10.1039/b309067a; Mahns A, 2003, FREE RADICAL RES, V37, P391, DOI 10.1080/1071576031000064702; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Rundhaug JE, 2008, PHOTOCHEM PHOTOBIOL, V84, P322, DOI 10.1111/j.1751-1097.2007.00261.x; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; von Montfort C, 2006, FREE RADICAL BIO MED, V41, P1478, DOI 10.1016/j.freeradbiomed.2006.08.005; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Zhang J, 2008, MOL CARCINOGEN, V47, P974, DOI 10.1002/mc.20450	35	43	45	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3896	3904		10.1074/jbc.M109.081430	http://dx.doi.org/10.1074/jbc.M109.081430			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19917608	Green Published, hybrid			2022-12-27	WOS:000275254000043
J	Eudes, A; Kunji, ERS; Noiriel, A; Klaus, SMJ; Vickers, TJ; Beverley, SM; Gregory, JF; Hanson, AD				Eudes, Aymerick; Kunji, Edmund R. S.; Noiriel, Alexandre; Klaus, Sebastian M. J.; Vickers, Tim J.; Beverley, Stephen M.; Gregory, Jesse F., III; Hanson, Andrew D.			Identification of Transport-critical Residues in a Folate Transporter from the Folate-Biopterin Transporter (FBT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE LEISHMANIA-MAJOR; P-AMINOBENZOYL-GLUTAMATE; ESCHERICHIA-COLI; METHOTREXATE RESISTANCE; MEMBRANE-TRANSPORT; LACTOSE PERMEASE; FOLIC-ACID; PROTEIN; METABOLISM; ARABIDOPSIS	The Synechocystis Slr0642 protein and its plastidial Arabidopsis (Arabidopsis thaliana) ortholog At2g32040 belong to the folate-biopterin transporter (FBT) family within the major facilitator superfamily. Both proteins transport folates when expressed in Escherichia coli. Because the structural requirements for transport activity are not known for any FBT protein, we applied mutational analysis to identify residues that are critical to transport and interpreted the results using a comparative structural model based on E. coli lactose permease. Folate transport was assessed via the growth of an E. coli pabA abgT strain, which cannot synthesize or take up folates or p-aminobenzoylglutamate. In total, 47 residues were replaced with Cys or Ala. Mutations at 22 positions abolished folate uptake without affecting Slr0642 expression in membranes, whereas other mutations had no effect. Residues important for function mostly line the predicted central cavity and are concentrated in the core alpha-helices H1, H4, H7, and H10. The essential residue locations are consistent with a folate-binding site lying roughly equidistant from both faces of the transporter. Arabidopsis has eight FBT proteins besides At2g32040, often lacking conserved critical residues. When six of these proteins were expressed in E. coli or in Leishmania folate or pterin transporter mutants, none showed evidence of folate or pterin transport activity, and only At2g32040 was isolated by functional screening of Arabidopsis cDNA libraries in E. coli. Such negative data could reflect roles in transport of other substrates. These studies provide the first insights into the native structure and catalytic mechanism of FBT family carriers.	[Eudes, Aymerick; Noiriel, Alexandre; Klaus, Sebastian M. J.; Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Gregory, Jesse F., III] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Vickers, Tim J.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL)	Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, POB 110690, Gainesville, FL 32611 USA.	adha@ufl.edu	Eudes, Aymerick/AAH-4909-2021; Kunji, Edmund/AAH-2362-2020	Eudes, Aymerick/0000-0002-1387-6111; Kunji, Edmund/0000-0002-0610-4500; Gregory, Jesse/0000-0002-9976-2085; Beverley, Stephen/0000-0001-5319-0811	National Institutes of Health [R01 GM071382, AI21903]; Medical Research Council UK; European Molecular Biology Organization [ALTF 106-2005]; C. V. Griffin, Sr. Foundation; MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078, R37AI021903, R01AI021903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); C. V. Griffin, Sr. Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM071382 and AI21903, by the Medical Research Council UK, by European Molecular Biology Organization Fellowship ALTF 106-2005, and by an endowment from the C. V. Griffin, Sr. Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; ARFMAN N, 1992, J BACTERIOL, V174, P7370, DOI 10.1128/jb.174.22.7370-7378.1992; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; Bekaert S, 2008, TRENDS PLANT SCI, V13, P28, DOI 10.1016/j.tplants.2007.11.001; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; Bibi E, 1998, METHOD ENZYMOL, V292, P370; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cappello AR, 2007, J MOL BIOL, V369, P400, DOI 10.1016/j.jmb.2007.03.048; Carter EL, 2007, J BACTERIOL, V189, P3329, DOI 10.1128/JB.01940-06; CROSTI P, 1993, PLANT SCI, V88, P97, DOI 10.1016/0168-9452(93)90114-F; Cunningham ML, 2001, MOL BIOCHEM PARASIT, V113, P199, DOI 10.1016/S0166-6851(01)00213-4; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Crecy-Lagard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-245; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; GREEN JM, 2002, CHEM BIOL PTERIDINES, P631; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hussein MJ, 1998, J BACTERIOL, V180, P6260; Jabrin S, 2003, PLANT PHYSIOL, V131, P1431, DOI 10.1104/pp.016915; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lemley C, 1999, MOL BIOCHEM PARASIT, V104, P93, DOI 10.1016/S0166-6851(99)00132-2; Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; Orsomando G, 2005, J BIOL CHEM, V280, P28877, DOI 10.1074/jbc.M504306200; Ouellette M, 2002, INT J PARASITOL, V32, P385, DOI 10.1016/S0020-7519(01)00346-0; Prabhu V, 1998, PLANT PHYSIOL, V116, P137, DOI 10.1104/pp.116.1.137; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Scott J, 2000, J SCI FOOD AGR, V80, P795, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;795::AID-JSFA599&gt;3.0.CO;2-K, 10.1002/(SICI)1097-0010(20000515)80:7<795::AID-JSFA599>3.0.CO;2-K]; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	47	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2867	2875		10.1074/jbc.M109.063651	http://dx.doi.org/10.1074/jbc.M109.063651			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923217	Green Published, hybrid			2022-12-27	WOS:000273697800062
J	Unciuleac, MC; Shuman, S				Unciuleac, Mihaela-Carmen; Shuman, Stewart			Characterization of the Mycobacterial AdnAB DNA Motor Provides Insights into the Evolution of Bacterial Motor-Nuclease Machines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASES DISPLACE STREPTAVIDIN; SINGLE-STRANDED-DNA; RECBCD ENZYME; BACILLUS-SUBTILIS; SALMONELLA VIRULENCE; REPAIR; TRANSLOCATION; BREAKS; NHEJ; OLIGONUCLEOTIDES	Mycobacterial AdnAB exemplifies a family of heterodimeric motor-nucleases involved in processing DNA double strand breaks (DSBs). The AdnA and AdnB subunits are each composed of an N-terminal UvrD-like motor domain and a C-terminal RecB-like nuclease module. Here we conducted a biochemical characterization of the AdnAB motor, using a nuclease-inactivated heterodimer. AdnAB is a vigorous single strand DNA (ssDNA)-dependent ATPase (k(cat) 415 s(-1)), and the affinity of the motor for the ssDNA cofactor increases 140-fold as DNA length is extended from 12 to 44 nucleotides. Using a streptavidin displacement assay, we demonstrate that AdnAB is a 3' -> 5' translocase on ssDNA. AdnAB binds stably to DSB ends. In the presence of ATP, the motor unwinds the DNA duplex without requiring an ssDNA loading strand. We integrate these findings into a model of DSB unwinding in which the "leading" AdnB and "lagging" AdnA motor domains track in tandem, 3' to 5', along the same DNA single strand. This contrasts with RecBCD, in which the RecB and RecD motors track in parallel along the two separated DNA single strands. The effects of 5' and 3' terminal obstacles on ssDNA cleavage by wild-type AdnAB suggest that the AdnA nuclease receives and processes the displaced 5' strand, while the AdnB nuclease cleaves the displaced 3' strand. We present evidence that the distinctive "molecular ruler" function of the ATP-dependent single strand DNase, whereby AdnAB measures the distance from the 5'-end to the sites of incision, reflects directional pumping of the ssDNA through the AdnAB motor into the AdnB nuclease. These and other findings suggest a scenario for the descent of the RecBCD-and AddAB-type DSB-processing machines from an ancestral AdnAB-like enzyme.	[Unciuleac, Mihaela-Carmen; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [AI64693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI64693.	Amundsen SK, 2008, MOL MICROBIOL, V69, P994, DOI 10.1111/j.1365-2958.2008.06336.x; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cano DA, 2002, J BACTERIOL, V184, P592, DOI 10.1128/JB.184.2.592-595.2002; Cromie GA, 2009, J BACTERIOL, V191, P5076, DOI 10.1128/JB.00254-09; Darwin KH, 2005, INFECT IMMUN, V73, P4581, DOI 10.1128/IAI.73.8.4581-4587.2005; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Farah JA, 1997, J MOL BIOL, V272, P699, DOI 10.1006/jmbi.1997.1259; Ghosh J, 2009, P NATL ACAD SCI USA, V106, P10781, DOI 10.1073/pnas.0904104106; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Haijema BJ, 1996, J BACTERIOL, V178, P5086, DOI 10.1128/jb.178.17.5086-5091.1996; Haijema BJ, 1996, J BACTERIOL, V178, P5130, DOI 10.1128/jb.178.17.5130-5137.1996; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2006, MOL CELL, V23, P743, DOI 10.1016/j.molcel.2006.07.009; Rigden DJ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-9; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053	37	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2632	2641		10.1074/jbc.M109.076133	http://dx.doi.org/10.1074/jbc.M109.076133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920138	Green Published, hybrid			2022-12-27	WOS:000273697800042
J	Okuya, M; Kurosawa, H; Kikuchi, J; Furukawa, Y; Matsui, H; Aki, D; Matsunaga, T; Inukai, T; Goto, H; Altura, RA; Sugita, K; Arisaka, O; Look, AT; Inaba, T				Okuya, Mayuko; Kurosawa, Hidemitsu; Kikuchi, Jiro; Furukawa, Yusuke; Matsui, Hirotaka; Aki, Daisuke; Matsunaga, Takayuki; Inukai, Takeshi; Goto, Hiroaki; Altura, Rachel A.; Sugita, Kenich; Arisaka, Osamu; Look, A. Thomas; Inaba, Toshiya			Up-regulation of Survivin by the E2A-HLF Chimera Is Indispensable for the Survival of t(17;19)-positive Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; ACUTE-LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC PROGENITOR CELLS; PRO-B LYMPHOCYTES; TRANSCRIPTION FACTOR; IN-VIVO; ANTIAPOPTOTIC ACTIVITY; DOWNSTREAM TARGET; GENE-EXPRESSION; E2A GENE	The E2A-HLF fusion transcription factor generated by t(17;19)(q22;p13) translocation is found in a small subset of pro-B cell acute lymphoblastic leukemias (ALLs) and promotes leukemogenesis by substituting for the antiapoptotic function of cytokines. Here we show that t(17;19)(+) ALL cells express Survivin at high levels and that a dominant negative mutant of E2A-HLF suppresses Survivin expression. Forced expression of E2A-HLF in t(17;19)(-) leukemia cells up-regulated Survivin expression, suggesting that Survivin is a downstream target of E2A-HLF. Analysis using a counterflow centrifugal elutriator revealed that t(17;19)(+) ALL cells express Survivin throughout the cell cycle. Reporter assays revealed that E2A-HLF induces survivin expression at the transcriptional level likely through indirect down-regulation of a cell cycle-dependent cis element in the promoter region. Down-regulation of Survivin function by a dominant negative mutant of Survivin or reduction of Survivin expression induced massive apoptosis throughout the cell cycle in t(17;19)(+) cells mainly through caspase-independent pathways involving translocation of apoptosis-inducing factor (AIF) from mitochondria to the nucleus. AIF knockdown conferred resistance to apoptosis caused by down-regulation of Survivin function. These data indicated that reversal of AIF translocation by Survivin, which is induced by E2A-HLF throughout the cell cycle, is one of the key mechanisms in the protection of t(17;19)(+) leukemia cells from apoptosis.	[Okuya, Mayuko; Kurosawa, Hidemitsu; Matsunaga, Takayuki; Sugita, Kenich; Arisaka, Osamu] Dokkyo Med Univ, Dept Pediat, Sch Med, Mibu, Tochigi 3210293, Japan; [Matsui, Hirotaka; Aki, Daisuke; Inaba, Toshiya] Hiroshima Univ, Dept Mol Oncol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Inukai, Takeshi] Univ Yamanashi, Sch Med, Dept Pediat, Yamanashi 4093898, Japan; [Goto, Hiroaki] Yokohama City Univ, Sch Med, Dept Pediat, Kanagawa 2360004, Japan; [Altura, Rachel A.] Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02903 USA; [Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Dokkyo Medical University; Hiroshima University; University of Yamanashi; Yokohama City University; Brown University; Harvard University; Dana-Farber Cancer Institute	Kurosawa, H (corresponding author), Dokkyo Med Univ, Dept Pediat, Sch Med, Mibu, Tochigi 3210293, Japan.	hidekuro@dokkyomed.ac.jp	Matsui, Hirotaka/AED-6669-2022; Furukawa, Yusuke/Y-1342-2018	Matsui, Hirotaka/0000-0002-6266-3227; Furukawa, Yusuke/0000-0002-7249-6418	Japan Society for Promotion of Science [18591201]; Dokkyo Medical University	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dokkyo Medical University	This work was supported by Grant-in-aid for Scientific Research (C) 18591201 from the Japan Society for Promotion of Science (to H. K.) and a young investigator award from Dokkyo Medical University (to M. O.).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Carter BZ, 2003, BLOOD, V102, P4179, DOI 10.1182/blood-2003-03-0960; Croci DO, 2008, J CELL BIOCHEM, V105, P381, DOI 10.1002/jcb.21836; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Gu CM, 2006, NEOPLASMA, V53, P206; Hunger SP, 1996, BLOOD, V87, P1211, DOI 10.1182/blood.V87.4.1211.bloodjournal8741211; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Inaba T, 1996, NATURE, V382, P541, DOI 10.1038/382541a0; INABA T, 1994, MOL CELL BIOL, V14, P3403, DOI 10.1128/MCB.14.5.3403; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Inukai T, 2007, LEUKEMIA, V21, P288, DOI 10.1038/sj.leu.2404496; Inukai T, 1998, MOL CELL BIOL, V18, P6035, DOI 10.1128/MCB.18.10.6035; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Kanwar JR, 2001, J NATL CANCER I, V93, P1541, DOI 10.1093/jnci/93.20.1541; Kikuchi J, 1997, BLOOD, V89, P3980, DOI 10.1182/blood.V89.11.3980; Kikuchi J, 2007, STEM CELLS, V25, P2439, DOI 10.1634/stemcells.2007-0207; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Kuribara R, 1999, MOL CELL BIOL, V19, P2754; Kurosawa H, 1999, BLOOD, V93, P321, DOI 10.1182/blood.V93.1.321.401k05_321_332; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liu T, 2004, ONCOGENE, V23, P39, DOI 10.1038/sj.onc.1206978; Liu T, 2006, J INVEST DERMATOL, V126, P2247, DOI 10.1038/sj.jid.5700381; Matsunaga T, 2004, BLOOD, V103, P3185, DOI 10.1182/blood-2003-09-3022; Metzstein MM, 1999, MOL CELL, V4, P309, DOI 10.1016/S1097-2765(00)80333-0; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Schimmer AD, 2004, CANCER RES, V64, P7183, DOI 10.1158/0008-5472.CAN-04-1918; Shinjyo T, 2008, TOHOKU J EXP MED, V216, P25, DOI 10.1620/tjem.216.25; Sommer KW, 2003, ONCOGENE, V22, P4266, DOI 10.1038/sj.onc.1206509; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tamm I, 1998, CANCER RES, V58, P5315; Tu SP, 2003, CANCER RES, V63, P7724; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	43	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1850	1860		10.1074/jbc.M109.023762	http://dx.doi.org/10.1074/jbc.M109.023762			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19887369	Green Published, hybrid			2022-12-27	WOS:000273429100031
J	Gupta, MK; Atkinson, J; McGlynn, P				Gupta, Milind K.; Atkinson, John; McGlynn, Peter			DNA Structure Specificity Conferred on a Replicative Helicase by Its Loader	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DNAB; DOUBLE-STRANDED DNA; GENE-PRODUCT; HEXAMERIC HELICASE; PROTEIN COMPLEX; NUCLEOTIDE COFACTORS; PHYSICAL-PROPERTIES; IN-VITRO; MECHANISM; FORK	Prokaryotic and eukaryotic replicative helicases can translocate along single-stranded and double-stranded DNA, with the central cavity of these multimeric ring helicases being able to accommodate both forms of DNA. Translocation by such helicases along single-stranded DNA results in the unwinding of forked DNA by steric exclusion and appears critical in unwinding of parental strands at the replication fork, whereas translocation over double-stranded DNA has no well-defined role. We have found that the accessory factor, DnaC, that promotes loading of the Escherichia coli replicative helicase DnaB onto single-stranded DNA may also act to confer DNA structure specificity on DnaB helicase. When present in excess, DnaC inhibits DnaB translocation over double-stranded DNA but not over single-stranded DNA. Inhibition of DnaB translocation over double-stranded DNA requires the ATP-bound form of DnaC, and this inhibition is relieved during translocation over single-stranded DNA indicating that stimulation of DnaC ATPase is responsible for this DNA structure specificity. These findings demonstrate that DnaC may provide the DNA structure specificity lacking in DnaB, limiting DnaB translocation to bona fide replication forks. The ability of other replicative helicases to translocate along single-stranded and double-stranded DNA raises the possibility that analogous regulatory mechanisms exist in other organisms.	[Gupta, Milind K.; Atkinson, John; McGlynn, Peter] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	McGlynn, P (corresponding author), Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.	p.mcglynn@abdn.ac.uk		McGlynn, Peter/0000-0001-8629-4713	Biotechnology and Biological Sciences Research Council [BB/E0020690]; Biotechnology and Biological Sciences Research Council [BB/E020690/1] Funding Source: researchfish; BBSRC [BB/E020690/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BB/E0020690).	ALLEN GC, 1991, J BIOL CHEM, V266, P22096; ARAI K, 1981, J BIOL CHEM, V256, P5253; BAKER TA, 1987, J BIOL CHEM, V262, P6877; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Biswas SB, 2004, BIOCHEM J, V379, P553, DOI 10.1042/BJ20031255; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Galletto R, 2000, BIOCHEMISTRY-US, V39, P12959, DOI 10.1021/bi0012484; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; KOBORI JA, 1982, J BIOL CHEM, V257, P13763; Learn BA, 1997, P NATL ACAD SCI USA, V94, P1154, DOI 10.1073/pnas.94.4.1154; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; PARSONS CA, 1990, J BIOL CHEM, V265, P9285; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; REHAKRANTZ LJ, 1978, J BIOL CHEM, V253, P4043; Roychowdhury A, 2009, BIOCHEMISTRY-US, V48, P6730, DOI 10.1021/bi9000529; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; SKARSTAD K, 1995, MOL MICROBIOL, V17, P825, DOI 10.1111/j.1365-2958.1995.mmi_17050825.x; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P783, DOI 10.1073/pnas.71.3.783	42	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					979	987		10.1074/jbc.M109.072520	http://dx.doi.org/10.1074/jbc.M109.072520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19880515	Green Published, hybrid			2022-12-27	WOS:000273258200018
J	Lopez-Bergami, P; Kim, H; Dewing, A; Goydos, J; Aaronson, S; Ronai, Z				Lopez-Bergami, Pablo; Kim, Hyungsoo; Dewing, Antimone; Goydos, James; Aaronson, Stuart; Ronai, Ze'ev			c-Jun Regulates Phosphoinositide-dependent Kinase 1 Transcription IMPLICATION FOR Akt AND PROTEIN KINASE C ACTIVITIES AND MELANOMA TUMORIGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; FUNCTIONAL INTERACTION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; HUMAN CANCER; ACTIVATION; PHOSPHORYLATION; PROMOTER; JNK; MUTATIONS	Mutations in N-RAS and B-RAF, which commonly occur in melanomas, result in constitutive activation of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated protein kinase (ERK) signaling. Active ERK increases expression and activity of the c-Jun transcription factor, linking ERK and Jun N-terminal kinase (JNK) cascades. Here, we show that c-Jun regulates transcription of phosphoinositide-dependent kinase 1 (PDK1) with a concomitant impact on Akt and protein kinase C (PKC) activity and related substrates. Inhibition of c-Jun reduces PDK1 expression and attenuates Akt and PKC activity, which can be restored by exogenous PDK1. c-Jun regulation of PDK1 in melanoma contributes to growth rate and the ability to form tumors in mice. Correspondingly, increased levels of c-Jun in melanoma cell lines coincide with up-regulation of PDK1 and phosphorylation of PKC and Akt. The identification of c-Jun as a transcriptional regulator of PDK1 expression highlights key mechanisms underlying c-Jun oncogenic activity, and provides new insight into the nature of up-regulated Akt and PKC in melanoma.	[Lopez-Bergami, Pablo; Kim, Hyungsoo; Dewing, Antimone; Ronai, Ze'ev] Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA 92037 USA; [Lopez-Bergami, Pablo; Aaronson, Stuart] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Goydos, James] Univ Med & Dent New Jersey, Div Surg Oncol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Sanford Burnham Prebys Medical Discovery Institute; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ronai, Z (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ronai@burnham.org	Goydos, James/AAR-8990-2020	Goydos, James/0000-0001-9811-939X; Kim, Hyungsoo/0000-0002-8189-5939; RONAI, ZEEV/0000-0002-3859-0400	NCI [RO1CA051995, PO1CA128814]; Roemmers Foundation; Harry J. Lloyd Charitable Trust; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2007-01010]; NATIONAL CANCER INSTITUTE [R01CA051995, P01CA128814] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roemmers Foundation; Harry J. Lloyd Charitable Trust; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA051995 and PO1CA128814 from the NCI (to Z.R.), grants from the Roemmers Foundation, The Harry J. Lloyd Charitable Trust, and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Grant PICT-2007-01010 (to P.L.B.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bhoumik A, 2004, P NATL ACAD SCI USA, V101, P4222, DOI 10.1073/pnas.0400195101; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; Chen BK, 2000, P NATL ACAD SCI USA, V97, P10406, DOI 10.1073/pnas.180321497; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Gorden A, 2003, CANCER RES, V63, P3955; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lopez-Bergami P, 2008, INT J BIOCHEM CELL B, V40, P1055, DOI 10.1016/j.biocel.2007.11.011; Lopez-Bergami P, 2008, PHOTOCHEM PHOTOBIOL, V84, P289, DOI 10.1111/j.1751-1097.2007.00254.x; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Maeno K, 2006, ONCOGENE, V25, P271, DOI 10.1038/sj.onc.1209018; MAJERUS MA, 1992, NUCLEIC ACIDS RES, V20, P2699, DOI 10.1093/nar/20.11.2699; Makris C, 2002, ONCOGENE, V21, P7891, DOI 10.1038/sj.onc.1205964; Mariani O, 2007, CANCER CELL, V11, P361, DOI 10.1016/j.ccr.2007.02.007; Matthews CP, 2007, CANCER RES, V67, P2430, DOI 10.1158/0008-5472.CAN-06-0522; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Melnikova IN, 2001, J BIOL CHEM, V276, P19040, DOI 10.1074/jbc.M010735200; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Storz P, 2002, FRONT BIOSCI-LANDMRK, V7, pD886, DOI 10.2741/storz; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200	40	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					903	913		10.1074/jbc.M109.075630	http://dx.doi.org/10.1074/jbc.M109.075630			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19910471	Green Published, hybrid			2022-12-27	WOS:000273258200010
J	Nguyen, HTT; Dalmasso, G; Yan, YT; Laroui, H; Dahan, S; Mayer, L; Sitaraman, SV; Merlin, D				Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V.; Merlin, Didier			MicroRNA-7 Modulates CD98 Expression during Intestinal Epithelial Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4F2 HEAVY-CHAIN; INFLAMMATORY BOWEL-DISEASE; AMINO-ACID TRANSPORTER; TRANSFERRIN RECEPTOR; ACTIVATION ANTIGEN; GENE-EXPRESSION; SURFACE-ANTIGEN; MESSENGER-RNA; PROTEINS; KINETICS	The transmembrane glycoprotein CD98 regulates multiple cellular functions, including extracellular signaling, epithelial cell adhesion/polarity, amino acid transport, and cell-cell interactions. MicroRNAs post-transcriptionally regulate gene expression, thereby functioning as modulators of numerous cellular processes, such as cell differentiation, proliferation, and apoptosis. Here, we investigated if microRNAs regulate CD98 expression during intestinal epithelial cell differentiation and inflammation. We found that microRNA-7 repressed CD98 expression in Caco2-BBE cells by directly targeting the 3'-untranslated region of human CD98 mRNA. Expression of CD98 was decreased, whereas that of microRNA-7 was increased in well-differentiated Caco2-BBE cells compared with undifferentiated cells. Undifferentiated crypt cells isolated from mouse jejunum showed higher CD98 levels and lower levels of mmu-microRNA-706, a murine original microRNA candidate for CD98, than well-differentiated villus cells. Importantly, microRNA-7 decreased Caco2-BBE cell attachment on laminin-1, and CD98 overexpression recovered this inhibition, suggesting that microRNA-7 modulates epithelial cell adhesion to extracellular matrix, which in turn could affect proliferation and differentiation during the migration of enterocytes across the crypt-villus axis, by regulating CD98 expression. In a pathological context, the pro-inflammatory cytokine interleukin 1-beta increased CD98 expression in Caco2-BBE cells by decreasing microRNA-7 levels. Consistent with the in vitro findings, microRNA-7 levels were decreased in actively inflamed Crohn disease colonic tissues, where CD98 expression was up-regulated, compared with normal tissues. Together, these results reveal a novel mechanism underlying regulation of CD98 expression during patho-physiological states. This study raises microRNAs as a promising target for therapeutic modulations of CD98 expression in intestinal inflammatory disorders.	[Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Dept Med, Div Digest Dis, Sch Med, Atlanta, GA 30322 USA; [Dahan, Stephanie; Mayer, Lloyd] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Emory University; Icahn School of Medicine at Mount Sinai	Nguyen, HTT (corresponding author), Emory Univ, Dept Med, Div Digest Dis, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	hnguye9@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health [R24-DK-064399, R01-DK-071594, R01-DK55850]; Crohn and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK055850, R01DK071594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R24-DK-064399 center grant, R01-DK-071594 (to D.M.), and R01DK55850 (to S.V.S.) from the NIDDK. This work was also supported by the Crohn and Colitis Foundation of America (a research fellowship award (to G.D.) and a research career development award (to S.D.)).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cantor JM, 2008, IMMUNOL REV, V223, P236, DOI 10.1111/j.1600-065X.2008.00640.x; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Charrier L, 2005, AM J PHYSIOL-GASTR L, V288, pG346, DOI 10.1152/ajpgi.00262.2004; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; COTNER T, 1983, J EXP MED, V157, P461, DOI 10.1084/jem.157.2.461; Deves R, 2000, J MEMBRANE BIOL, V173, P165, DOI 10.1007/s002320001017; Driss A, 2006, AM J PHYSIOL-GASTR L, V290, pG1228, DOI 10.1152/ajpgi.00378.2005; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; FAIS S, 1989, GASTROENTEROLOGY, V97, P1435, DOI 10.1016/0016-5085(89)90387-9; FERNANDEZHERRERA J, 1989, J INVEST DERMATOL, V92, P247, DOI 10.1111/1523-1747.ep12276789; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; GORDON JI, 1989, J CELL BIOL, V108, P1187, DOI 10.1083/jcb.108.4.1187; GOTTESDIENER KM, 1988, MOL CELL BIOL, V8, P3809, DOI 10.1128/MCB.8.9.3809; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Kageyama T, 2000, BRAIN RES, V879, P115, DOI 10.1016/S0006-8993(00)02758-X; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Kucharzik T, 2005, LAB INVEST, V85, P932, DOI 10.1038/labinvest.3700289; LEIDEN JM, 1989, J AUTOIMMUN, V2, P67, DOI 10.1016/0896-8411(89)90118-2; LINDSTEN T, 1988, MOL CELL BIOL, V8, P3820, DOI 10.1128/MCB.8.9.3820; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; Merlin D, 2001, J BIOL CHEM, V276, P39282, DOI 10.1074/jbc.M105077200; Nguyen HTT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003895; Novak DA, 1997, PLACENTA, V18, P643, DOI 10.1016/S0143-4004(97)90005-9; Ohkame H, 2001, J SURG ONCOL, V78, P265, DOI 10.1002/jso.1165; Okamoto Y, 2002, AM J PHYSIOL-CELL PH, V282, pC196, DOI 10.1152/ajpcell.2002.282.1.C196; PARMACEK MS, 1989, NUCLEIC ACIDS RES, V17, P1915, DOI 10.1093/nar/17.5.1915; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; QUACKENBUSH E, 1987, P NATL ACAD SCI USA, V84, P6526, DOI 10.1073/pnas.84.18.6526; QUACKENBUSH EJ, 1986, J IMMUNOL, V136, P118; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; SCHREIBER S, 1991, GASTROENTEROLOGY, V101, P1020, DOI 10.1016/0016-5085(91)90729-5; Shennan DB, 2004, BBA-BIOMEMBRANES, V1664, P206, DOI 10.1016/j.bbamem.2004.05.008; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; TEIXEIRA S, 1991, EUR J BIOCHEM, V202, P819, DOI 10.1111/j.1432-1033.1991.tb16438.x; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Yan YT, 2008, BBA-GEN SUBJECTS, V1780, P1087, DOI 10.1016/j.bbagen.2008.06.007; Yan Y, 2007, AM J PHYSIOL-GASTR L, V292, pG535, DOI 10.1152/ajpgi.00385.2006	41	91	96	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1479	1489		10.1074/jbc.M109.057141	http://dx.doi.org/10.1074/jbc.M109.057141			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19892711	Green Published, hybrid			2022-12-27	WOS:000273258200067
J	Chernov, KG; Barbet, A; Hamon, L; Ovchinnikov, LP; Curmi, PA; Pastre, D				Chernov, Konstantin G.; Barbet, Aurelie; Hamon, Loic; Ovchinnikov, Lev P.; Curmi, Patrick A.; Pastre, David			Role of Microtubules in Stress Granule Assembly MICROTUBULE DYNAMICAL INSTABILITY FAVORS THE FORMATION OF MICROMETRIC STRESS GRANULES IN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DNA MOBILITY; MESSENGER-RNA; FORCE GENERATION; ACTIN POLYMERIZATION; MOTILITY DRIVEN; CYTOPLASM; CELLS; DIFFUSION; TIA-1; PHOSPHORYLATION	Following exposure to various stresses (arsenite, UV, hyperthermia, and hypoxia), mRNAs are assembled into large cytoplasmic bodies known as "stress granules," in which mRNAs and associated proteins may be processed by specific enzymes for different purposes like transient storing, sorting, silencing, or other still unknown processes. To limit mRNA damage during stress, the assembly of micrometric granules has to be rapid, and, indeed, it takes only similar to 10-20 min in living cells. However, such a rapid assembly breaks the rules of hindered diffusion in the cytoplasm, which states that large cytoplasmic bodies are almost immobile. In the present work, using HeLa cells and YB-1 protein as a stress granule marker, we studied three hypotheses to understand how cells overcome the limitation of hindered diffusion: shuttling of small messenger ribonucleoprotein particles from small to large stress granules, sliding of messenger ribonucleoprotein particles along microtubules, microtubule-mediated stirring of large stress granules. Our data favor the two last hypotheses and underline that microtubule dynamic instability favors the formation of micrometric stress granules.	[Chernov, Konstantin G.; Barbet, Aurelie; Hamon, Loic; Curmi, Patrick A.; Pastre, David] Univ Evry Val Essonne, Lab Struct Act Biomol Normales & Pathol, EA3637, INSERM,U829, F-91025 Evry, France; [Chernov, Konstantin G.; Ovchinnikov, Lev P.] Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Russian Academy of Sciences	Curmi, PA (corresponding author), Univ Evry Val Essonne, Lab Struct Act Biomol Normales & Pathol, EA3637, INSERM,U829, F-91025 Evry, France.	pcurmi@univ-evry.fr; david.pastre@univ-evry.fr	Ovchinnikov, Lev/L-2397-2015; CURMI, Patrick/G-4036-2013; Pastre, David/B-2958-2014	Pastre, David/0000-0002-3348-9514; CURMI, Patrick A./0000-0001-5045-8501; hamon, loic/0000-0003-2032-7994	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by INSERM.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; BERSHADSKY AD, 1981, P NATL ACAD SCI-BIOL, V78, P3610, DOI 10.1073/pnas.78.6.3610; BOUCHARD P, 1981, P NATL ACAD SCI-BIOL, V78, P1033, DOI 10.1073/pnas.78.2.1033; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; CLARK TG, 1982, P NATL ACAD SCI-BIOL, V79, P4655, DOI 10.1073/pnas.79.15.4655; Dauty E, 2005, J BIOL CHEM, V280, P7823, DOI 10.1074/jbc.M412374200; Davydova EK, 1997, NUCLEIC ACIDS RES, V25, P2911, DOI 10.1093/nar/25.14.2911; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Finsy R, 2004, LANGMUIR, V20, P2975, DOI 10.1021/la035966d; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; JORDAN MA, 1992, J CELL SCI, V102, P401; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kolobova E, 2009, EXP CELL RES, V315, P542, DOI 10.1016/j.yexcr.2008.11.011; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nguyen TT, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031409; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pourroy B, 2004, MOL PHARMACOL, V66, P580; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai NP, 2009, NEUROSCIENCE, V159, P647, DOI 10.1016/j.neuroscience.2008.12.053; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; Vorobjev IA, 1999, J CELL SCI, V112, P2277; WEITZ DA, 1986, PHYS REV LETT, V57, P2037, DOI 10.1103/PhysRevLett.57.2037; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; YAO JH, 1993, PHYS REV B, V47, P14110, DOI 10.1103/PhysRevB.47.14110	55	80	82	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36569	36580		10.1074/jbc.M109.042879	http://dx.doi.org/10.1074/jbc.M109.042879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843517	Green Published, hybrid			2022-12-27	WOS:000272970500058
J	Liu, XQ; Martin, CT				Liu, Xiaoqing; Martin, Craig T.			Transcription Elongation Complex Stability THE TOPOLOGICAL LOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; VESICULAR STOMATITIS-VIRUS; ESCHERICHIA-COLI; THERMODYNAMIC ANALYSIS; HYBRID DUPLEXES; II ELONGATION; NASCENT RNA; DNA; TERMINATION; MECHANISM	Transcription machinery from a variety of organisms shows striking mechanistic similarity. Both multi- and single subunit RNA polymerases have evolved an 8 - 10-base pair RNA-DNA hybrid as a part of a stably transcribing elongation complex. Through characterization of halted complexes that can readily carry out homopolymeric slippage synthesis, this study reveals that T7 RNA polymerase elongation complexes containing only a 4-base pair hybrid can nevertheless be more stable than those with the normal 8-base pair hybrid. We propose that a key feature of this stability is the topological threading of RNA through the complex and/or around the DNA template strand. The data are consistent with forward translocation as a mechanism to allow unthreading of the topological lock, as can occur during programmed termination of transcription.	[Liu, Xiaoqing; Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, 710 N Pleasant St,Lederle Grad Res Tower 104, Amherst, MA 01003 USA.	CMartin@chem.umass.edu	Martin, Craig T/L-3596-2013	Martin, Craig T/0000-0003-1029-5239	National Institutes of Health [GM55002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55002.	AHN BY, 1989, J VIROL, V63, P226, DOI 10.1128/JVI.63.1.226-232.1989; CHAMBERLIN M, 1964, J MOL BIOL, V8, P708, DOI 10.1016/S0022-2836(64)80120-0; CUNNINGHAM PR, 1991, NUCLEIC ACIDS RES, V19, P4669, DOI 10.1093/nar/19.17.4669; GILL SC, 1990, BIOPHYS CHEM, V37, P239; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Gong P, 2006, J BIOL CHEM, V281, P23533, DOI 10.1074/jbc.M604023200; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Kuzmine I, 2001, NUCLEIC ACIDS RES, V29, P2601, DOI 10.1093/nar/29.12.2601; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; Martin CT, 2003, METHOD ENZYMOL, V371, P13; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MCGEOCH DJ, 1979, CELL, V17, P673, DOI 10.1016/0092-8674(79)90274-5; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Qi FX, 1996, METHOD ENZYMOL, V273, P71; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; ROSE JK, 1980, CELL, V19, P415, DOI 10.1016/0092-8674(80)90515-2; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; SCHUBERT M, 1980, J VIROL, V34, P550, DOI 10.1128/JVI.34.2.550-559.1980; SCHWER B, 1988, EMBO J, V7, P1183, DOI 10.1002/j.1460-2075.1988.tb02929.x; SCHWER B, 1987, CELL, V50, P163, DOI 10.1016/0092-8674(87)90212-1; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Wilson KS, 1999, J MOL BIOL, V289, P1179, DOI 10.1006/jmbi.1999.2814; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhou Y, 2007, P NATL ACAD SCI USA, V104, P10352, DOI 10.1073/pnas.0606306104; Zhou Y, 2006, J BIOL CHEM, V281, P24441, DOI 10.1074/jbc.M604369200	36	8	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36262	36270		10.1074/jbc.M109.056820	http://dx.doi.org/10.1074/jbc.M109.056820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846559	hybrid, Green Published			2022-12-27	WOS:000272970500028
J	Passero, CJ; Okumura, S; Carattino, MD				Passero, Christopher J.; Okumura, Sora; Carattino, Marcelo D.			Conformational Changes Associated with Proton-dependent Gating of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; EPITHELIAL SODIUM-CHANNELS; GATED CATION CHANNEL; SHAKER K+ CHANNEL; MOLECULAR-CLONING; NA+ CHANNELS; FUNCTIONAL EXPRESSION; EXTRACELLULAR DOMAIN; SURFACE EXPRESSION; VOLTAGE-CLAMP	Acid-sensing ion channels are proton-gated Na+ channels expressed predominantly in neurons. How channel structure translates an environmental stimulus into changes in pore permeability remains largely undefined. The pore of ASIC1 is defined by residues in the second transmembrane domain (TM2), although a segment of the outer vestibule is formed by residues of TM1. We used the voltage clamp fluorometry technique to define the role of the region preceding TM2 (pre-TM2) in activation and desensitization of mouse ASIC1a. Oocytes expressing E425C channels labeled with Alexa Fluor 488 C5-maleimide showed a change in the emission of the fluorescent probe in response to extracellular acidification. The time course of the change in fluorescence correlated with activation but not desensitization of E425C channels. The fluorescence emission did not change following extracellular acidification in oocytes carrying an inactivating mutation (W287G/E425C), although these channels were labeled and expressed at the plasma membrane. Our data indicate that pore opening occurs in conjunction with a conformational rearrangement of the pre-TM2. We observed a change in the emission of the fluorescent probe when labeled E425C channels transition from the desensitized to the resting state. The substituted-cysteine-accessibility method was used to determine whether the pre-TM2 has different conformations in the resting and desensitized states. State-dependent changes in accessibility to 2-[(trimethylammonium) ethyl] methanethiosulfonate bromide modification were observed in oocytes expressing K421C, K422C, Y424C, and E425C channels. Our results suggest that the pre-TM2 of ASIC1a undergoes dynamic conformational rearrangements during proton-dependent gating.	[Passero, Christopher J.; Okumura, Sora; Carattino, Marcelo D.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S834 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health [DK051391, F32 DK080574]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R37DK051391, F32DK080574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK051391. Supported by National Institutes of Health Postdoctoral Fellowship Award F32 DK080574. Supported by a Carl W. Gottschalk award from the American Society of Nephrology.	Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bannister JPA, 2005, P NATL ACAD SCI USA, V102, P18718, DOI 10.1073/pnas.0505766102; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2001, ANN NY ACAD SCI, V940, P96; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bubien JK, 2004, AM J PHYSIOL-CELL PH, V287, pC1282, DOI 10.1152/ajpcell.00077.2004; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1998, METHOD ENZYMOL, V296, P566; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke D C, 2001, ScientificWorldJournal, V1, P510; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V245, P589, DOI 10.1006/bbrc.1998.8483; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Mamet J, 2002, J NEUROSCI, V22, P10662; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Meinild AK, 2002, BIOCHEMISTRY-US, V41, P1250, DOI 10.1021/bi011661r; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Ugawa S, 2001, NEUROREPORT, V12, P2865, DOI 10.1097/00001756-200109170-00022; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Virkki LV, 2006, J BIOL CHEM, V281, P28837, DOI 10.1074/jbc.M603861200; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Voilley Nicolas, 2004, Current Drug Targets - Inflammation and Allergy, V3, P71, DOI 10.2174/1568010043483980; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; ZHENG J, 2003, SCI STKE, pPL7	55	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36473	36481		10.1074/jbc.M109.055418	http://dx.doi.org/10.1074/jbc.M109.055418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858190	hybrid, Green Published			2022-12-27	WOS:000272970500049
J	Sriskanthadevan, S; Lee, T; Lin, Z; Yang, DW; Siu, CH				Sriskanthadevan, Shrivani; Lee, Teresa; Lin, Zhi; Yang, Daiwen; Siu, Chi-Hung			Cell Adhesion Molecule DdCAD-1 Is Imported into Contractile Vacuoles by Membrane Invagination in a Ca2+- and Conformation-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL PROTEIN SECRETION; FIBROBLAST-GROWTH-FACTOR; DICTYOSTELIUM-DISCOIDEUM; PLASMA-MEMBRANE; FOLDED PROTEIN; MAMMALIAN-CELLS; BINDING PROTEIN; SIGNAL SEQUENCE; TAT PROTEIN; PATHWAY	The cadA gene in Dictyostelium encodes a Ca2+-dependent cell adhesion molecule DdCAD-1 that contains two beta-sandwich domains. DdCAD-1 is synthesized in the cytoplasm as a soluble protein and then transported by contractile vacuoles to the plasma membrane for surface presentation or secretion. DdCAD-1-green fluorescent protein (GFP) fusion protein was expressed in cadA-null cells for further investigation of this unconventional protein transport pathway. Both morphological and biochemical characterizations showed that DdCAD-1-GFP was imported into contractile vacuoles. Time-lapse microscopy of transfectants revealed the transient appearance of DdCAD-1-GFP-filled vesicular structures in the lumen of contractile vacuoles, suggesting that DdCAD-1 could be imported by invagination of contractile vacuole membrane. To assess the structural requirements in this transport process, the N-terminal and C-terminal domains of DdCAD-1 were expressed separately in cells as GFP fusion proteins. Both fusion proteins failed to enter the contractile vacuole, suggesting that the integrity of DdCAD-1 is required for import. Such a requirement was also observed in in vitro reconstitution assays using His(6)-tagged fusion proteins and purified contractile vacuoles. Import of DdCAD-1 was compromised when two of its three Ca2+-binding sites were mutated, indicating a role for Ca2+ in the import process. Spectral analysis showed that mutations in the Ca2+-binding sites resulted in subtle conformational changes. Indeed, proteins with altered conformation failed to enter the contractile vacuole, suggesting that the import signal is somehow integrated in the three-dimensional structure of DdCAD-1.	[Sriskanthadevan, Shrivani; Lee, Teresa; Siu, Chi-Hung] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; [Sriskanthadevan, Shrivani; Lee, Teresa; Siu, Chi-Hung] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Lin, Zhi; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	University of Toronto; University of Toronto; National University of Singapore	Siu, CH (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 100 Coll St, Toronto, ON M5S 1A8, Canada.	chi.hung.siu@utoronto.ca	LIN, ZHI/B-1254-2016; yang, daiwen/H-8408-2012	yang, daiwen/0000-0002-6804-0071; LIN, ZHI/0000-0002-8902-4935	Canadian Institutes of Health Research Operating [FRN-6140]	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Operating Grant FRN-6140.	Andersson D, 2001, EUR J BIOCHEM, V268, P1118, DOI 10.1046/j.1432-1327.2001.01981.x; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; BARONDES SH, 1985, J CELL BIOL, V100, P1825, DOI 10.1083/jcb.100.6.1825; BRAR SK, 1993, J BIOL CHEM, V268, P24902; Brocard CB, 2003, TRAFFIC, V4, P74, DOI 10.1034/j.1600-0854.2003.40203.x; Clark PL, 1996, PROTEIN SCI, V5, P1108; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; Cleves AE, 1997, CURR BIOL, V7, pR318, DOI 10.1016/S0960-9822(06)00148-5; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; CROWLEY TE, 1985, CELL, V43, P633, DOI 10.1016/0092-8674(85)90235-1; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Enrich C, 1996, HEPATOLOGY, V24, P226, DOI 10.1002/hep.510240136; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Gerisch G, 2002, CELL BIOL INT, V26, P845, DOI 10.1006/cbir.2002.0938; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Lin Z, 2004, J BIOMOL NMR, V30, P375, DOI 10.1007/s10858-005-2336-5; Lin Z, 2006, NAT STRUCT MOL BIOL, V13, P1016, DOI 10.1038/nsmb1162; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; Moniakis J, 1999, J CELL SCI, V112, P405; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; NIELSEN TB, 1987, J CELL SCI, V87, P327; ORCI L, 1991, CELL, V64, P1183; PADH H, 1989, BIOCHIM BIOPHYS ACTA, V982, P271, DOI 10.1016/0005-2736(89)90064-3; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Pohlschroder M, 2005, ANNU REV MICROBIOL, V59, P91, DOI 10.1146/annurev.micro.59.030804.121353; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; PUGSLEY AP, 1992, P NATL ACAD SCI USA, V89, P12058, DOI 10.1073/pnas.89.24.12058; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Sesaki H, 1997, J CELL BIOL, V138, P939, DOI 10.1083/jcb.138.4.939; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; SPRINGER WR, 1984, CELL, V39, P557, DOI 10.1016/0092-8674(84)90462-8; Sriskanthadevan Shrivani, 2007, Recent Research Developments in Cell Biology, V3, P9; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Teter SA, 1999, TRENDS CELL BIOL, V9, P428, DOI 10.1016/S0962-8924(99)01652-9; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wong EFS, 1996, J BIOL CHEM, V271, P16399, DOI 10.1074/jbc.271.27.16399; Yang CZ, 1997, DIFFERENTIATION, V61, P275, DOI 10.1046/j.1432-0436.1997.6150275.x; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yumura S, 1996, J CELL SCI, V109, P2673; ZHU QL, 1993, J CELL SCI, V104, P1119; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	63	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36377	36386		10.1074/jbc.M109.057257	http://dx.doi.org/10.1074/jbc.M109.057257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19875452	Green Published, hybrid			2022-12-27	WOS:000272970500039
J	Malik, S; Shukla, A; Sen, P; Bhaumik, SR				Malik, Shivani; Shukla, Abhijit; Sen, Payel; Bhaumik, Sukesh R.			The 19 S Proteasome Subcomplex Establishes a Specific Protein Interaction Network at the Promoter for Stimulated Transcriptional Initiation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; REGULATORY PARTICLE; 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ORGANIZATION; NUCLEOSOME ACETYLATION; MULTIUBIQUITIN CHAIN; UBIQUITINATED GCN4P; ATPASE COMPLEX	The 26 S proteasome complex that comprises the 20 S core and 19 S regulatory (with six ATPases) particles is engaged in an ATP-dependent degradation of a variety of key regulatory proteins and, thus, controls important cellular processes. Interestingly, several recent studies have implicated the 19 S regulatory particle in controlling eukaryotic transcriptional initiation or activation independently of the 20 S core particle. However, the mechanism of action of the 19 S proteasome subcomplex in regulation of eukaryotic transcriptional activation is not clearly understood in vivo. Here, using a chromatin immunoprecipitation assay in conjunction with mutational and transcriptional analyses in Saccharomyces cerevisiae, we show that the 19 S proteasomal subcomplex establishes a specific protein interaction network at the upstream activating sequence of the promoter. Such an interaction network is essential for formation of the preinitiation complex at the core promoter to initiate transcription. Furthermore, we demonstrate that the formation of the transcription complex assembly at the promoter is dependent on 19 S ATPase activity. Intriguingly, 19 S ATPases appear to cross-talk for stimulation of the assembly of transcription factors at the promoter. Together, these results provide significant insights as to how the 19 S proteasome subcomplex regulates the formation of the active transcription complex assembly and, hence, transcriptional initiation) at the promoter in vivo.	[Malik, Shivani; Shukla, Abhijit; Sen, Payel; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu	Sen, Payel/D-2835-2016	Sen, Payel/0000-0003-2809-0901	National Institutes of Health [1R15GM088798-01]; American Heart Association [0635008N]; American Cancer Society Research Scholar [06-52]; Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society Research Scholar(American Cancer Society); Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01. This work was also supported by American Heart Association National Scientist Development Grant 0635008N, American Cancer Society Research Scholar Grant 06-52, a Mallinckrodt Foundation award, and several internal grants from Southern Illinois University.	Auld KL, 2006, CELL CYCLE, V5, P1503, DOI 10.4161/cc.5.14.2979; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bhaumik SR, 2008, CRIT REV BIOCHEM MOL, V43, P419, DOI 10.1080/10409230802605914 ; Brachmann CB, 1998, YEAST, V14, P115; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Coux Olivier, 2002, Prog Mol Subcell Biol, V29, P85; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Dembla-Rajpal N, 2004, BBA-GENE STRUCT EXPR, V1680, P34, DOI 10.1016/j.bbaexp.2004.08.008; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.005; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; He HL, 1998, J BIOL CHEM, V273, P25015, DOI 10.1074/jbc.273.39.25015; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Makino Y, 1999, GENES CELLS, V4, P529, DOI 10.1046/j.1365-2443.1999.00277.x; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Seong KM, 2007, MOL CELLS, V24, P194; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Soond SM, 2008, J BIOL CHEM, V283, P16077, DOI 10.1074/jbc.M800384200; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; Yanagi S, 2000, BIOCHEM BIOPH RES CO, V279, P568, DOI 10.1006/bbrc.2000.3969; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zhu QZ, 2004, FEBS LETT, V556, P19, DOI 10.1016/S0014-5793(03)01347-4	81	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35714	35724		10.1074/jbc.M109.035709	http://dx.doi.org/10.1074/jbc.M109.035709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843524	Green Published, hybrid			2022-12-27	WOS:000272645600049
J	Peng, HZ; Ivanov, AV; Oh, HJ; Lau, YFC; Rauscher, FJ				Peng, Hongzhuang; Ivanov, Alexey V.; Oh, Hyun J.; Lau, Yun-Fai C.; Rauscher, Frank J., III			Epigenetic Gene Silencing by the SRY Protein Is Mediated by a KRAB-O Protein That Recruits the KAP1 Co-repressor Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DNA-BINDING SITE; TRANSCRIPTIONAL REPRESSION; SEX DETERMINATION; DOMAIN PROTEIN; A DOMAIN; BOX; COREPRESSOR; INTERACTS; COMPLEX	The sex determination transcription factor SRY is a cell fate-determining transcription factor that mediates testis differentiation during embryogenesis. It may function by repressing the ovarian determinant gene, RSPO1, action in the ovarian developmental pathway and activates genes, such as SOX9, important for testis differentiation at the onset of gonadogenesis. Further, altered expression of SRY and related SOX genes contribute to oncogenesis in many human cancers. Little is known of the mechanisms by which SRY regulates its target genes. Recently a KRAB domain protein (KRAB-O) that lacks a zinc finger motif has been demonstrated to interact with SRY and hypothesized to function as an adaptor molecule for SRY by tethering the KAP1-NuRD-SETDB1-HP1 silencing machinery to repress SRY targets. We have critically examined this hypothesis by reconstituting and characterizing SRY-KRAB-O-KAP1 interactions. These recombinant molecules can form a ternary complex by direct and high affinity interactions. The KRAB-O protein can simultaneously bind KAP1 and SRY in a noncompetitive but also noncooperative manner. An extensive mutagenesis analysis suggests that different surfaces on KRAB-O are utilized for these independent interactions. Transcriptional repression by SRY requires binding to KRAB-O, thus bridging to the KAP1 repression machinery. This repression machinery is recruited to SRY target promoters in chromatin templates via SRY. These results suggest that SRY has co-opted the KRAB-O protein to recruit the KAP1 repression machinery to sex determination target genes. Other KRAB domain proteins, which lack a zinc finger DNA-binding motif, may function in similar roles as adaptor proteins for epigenetic gene silencing.	[Peng, Hongzhuang; Rauscher, Frank J., III] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Ivanov, Alexey V.] W Virginia Univ, Sch Med, Dept Biochem, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Oh, Hyun J.; Lau, Yun-Fai C.] Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, Div Cell & Dev Genet, San Francisco, CA 94121 USA	The Wistar Institute; West Virginia University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Rauscher, FJ (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	Rauscher@wistar.org	Lau, Yun-Fai C/E-4465-2014; Ivanov, Alexey/I-9445-2012	Lau, Yun-Fai C/0000-0002-9119-7050; Oh, Kelly/0000-0001-8203-5247; Ivanov, Alexey/0000-0002-8617-4604	National Institutes of Health [CA 095561, CA 092088, DAMD 17-02-1-0631, HD38117]; Pardee Foundation; Samuel Waxman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038117] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095561, R01CA092088] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; Samuel Waxman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 095561, CA 092088, and DAMD 17-02-1-0631 ( to F.J.R.) and HD38117 ( to Y.-F.C.L.). This work was also supported by the Pardee Foundation and the Samuel Waxman Foundation ( to F.J.R.).	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; Bernard P, 2008, INT J BIOCHEM CELL B, V40, P2889, DOI 10.1016/j.biocel.2008.06.006; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Li YM, 2006, MOL CELL ENDOCRINOL, V257-8, P35, DOI 10.1016/j.mce.2006.06.008; Li ZB, 2003, EMBO J, V22, P1857, DOI 10.1093/emboj/cdg173; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nikulina K, 2006, BIOCHEM BIOPH RES CO, V348, P839, DOI 10.1016/j.bbrc.2006.07.150; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Oh HJ, 2006, MOL CELL ENDOCRINOL, V247, P47, DOI 10.1016/j.mce.2005.12.011; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peng HZ, 2007, J MOL BIOL, V370, P269, DOI 10.1016/j.jmb.2007.03.047; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Peng HZ, 2002, CANCER RES, V62, P3773; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; Polanco JC, 2009, BIOL CELL, V101, P55, DOI 10.1042/BC20080061; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tamashiro DAA, 2008, BBA-GEN SUBJECTS, V1780, P1395, DOI 10.1016/j.bbagen.2008.07.001; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	36	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35670	35680		10.1074/jbc.M109.032086	http://dx.doi.org/10.1074/jbc.M109.032086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850934	Green Published, hybrid			2022-12-27	WOS:000272645600045
J	Zhang, J; Li, SH; Musa, S; Zhou, H; Xiang, X				Zhang, Jun; Li, Shihe; Musa, Shamsideen; Zhou, Henry; Xiang, Xin			Dynein Light Intermediate Chain in Aspergillus nidulans Is Essential for the Interaction between Heavy and Intermediate Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DYNEIN; NUCLEAR MIGRATION; DYNACTIN INTERACTION; INTRACELLULAR-TRANSPORT; NEURITE OUTGROWTH; FILAMENTOUS FUNGI; MITOTIC SPINDLE; MOTOR; PROTEIN; TCTEX-1	Cytoplasmic dynein is a complex containing heavy chains (HCs), intermediate chains (ICs), light intermediate chains (LICs), and light chains (LCs). The HCs are responsible for motor activity. The ICs at the tail region of the motor interact with dynactin, which is essential for dynein function. However, functions of other subunits and how they contribute to the assembly of the core complex are not clearly defined. Here, we analyzed in the filamentous fungus Aspergillus nidulans functions of the only LIC and two LCs, RobA (Roadblock/LC7) and TctexA (Tctex1) in dynein-mediated nuclear distribution (nud). Whereas the deletion mutant of tctexA did not exhibit an apparent nud mutant phenotype, the deletion mutant of robA exhibited a nud phenotype at an elevated temperature, which is similar to the previously characterized nudG (LC8) deletion mutant. Remarkably, in contrast to the single mutants, the robA and nudG double deletion mutant exhibits a severe nud phenotype at various temperatures. Thus, functions of these two LC classes overlap to some extent, but the presence of both becomes important under specific conditions. The single LIC, however, is essential for dynein function in nuclear distribution. This is evidenced by the identification of the nudN gene as the LIC coding gene, and by the nud phenotype exhibited by the LIC down-regulating mutant, alcA-LIC. Without a functional LIC, the HC-IC association is significantly weakened, and the HCs could no longer accumulate at the microtubule plus end. Thus, the LIC is essential for the assembly of the core complex of dynein in Aspergillus.	[Zhang, Jun; Li, Shihe; Musa, Shamsideen; Zhou, Henry; Xiang, Xin] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Xiang, X (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	xxiang@usuhs.mil			National Institutes of Health [GM069527]; USUHS; CNP; USU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USUHS; CNP; USU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069527 (to X. X.). This work was also supported by a USUHS intramural grant (to X. X.), a grant from CNP (Comprehensive Neuroscience Program)DOD (to X. X.), and the USU Center for Health Disparities (to S. M.).	Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Davis L, 2005, GENETICS, V170, P581, DOI 10.1534/genetics.104.040253; Dick T, 1996, MOL GEN GENET, V251, P38; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Lee WL, 2005, J CELL BIOL, V168, P201, DOI 10.1083/jcb.200407036; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Levy JR, 2008, J CELL SCI, V121, P3187, DOI 10.1242/jcs.033878; Li MG, 2004, MOL BIOL CELL, V15, P3005, DOI 10.1091/mbc.E04-01-0013; Liu B, 2000, MOL GEN GENET, V263, P375, DOI 10.1007/s004380051181; Liu B, 2003, MOL MICROBIOL, V47, P291, DOI 10.1046/j.1365-2958.2003.03285.x; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Miller RK, 2006, CURR TOP DEV BIOL, V76, P49, DOI 10.1016/S0070-2153(06)76002-1; Mische S, 2008, MOL BIOL CELL, V19, P4918, DOI 10.1091/mbc.E08-05-0483; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Song J, 2005, J MOL BIOL, V354, P1043, DOI 10.1016/j.jmb.2005.10.017; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890; Yeh TY, 2006, TRAFFIC, V7, P1495, DOI 10.1111/j.1600-0854.2006.00482.x; Yoder JH, 2001, MOL BIOL CELL, V12, P2921, DOI 10.1091/mbc.12.10.2921; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2002, MOL MICROBIOL, V44, P381, DOI 10.1046/j.1365-2958.2002.02900.x; Zhang J, 2008, TRAFFIC, V9, P1073, DOI 10.1111/j.1600-0854.2008.00748.x; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013	56	13	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34760	34768		10.1074/jbc.M109.026872	http://dx.doi.org/10.1074/jbc.M109.026872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837669	Green Published, hybrid			2022-12-27	WOS:000272439600031
J	Fujiwara, I; Remmert, K; Hammer, JA				Fujiwara, Ikuko; Remmert, Kirsten; Hammer, John A., III			Direct Observation of the Uncapping of Capping Protein-capped Actin Filaments by CARMIL Homology Domain 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARBED END; ARP2/3 COMPLEX; BINDING; DYNAMICS; MOTILITY; YEAST; POLYMERIZATION; IDENTIFICATION; NUCLEATION; MECHANISM	Bulk solution assays have shown that the isolated CARMIL homology 3 (CAH3) domain from mouse and Acanthamoeba CARMIL rapidly and potently restores actin polymerization when added to actin filaments previously capped with capping protein (CP). To demonstrate this putative uncapping activity directly, we used total internal reflection microscopy to observe single, CP-capped actin filaments before and after the addition of the CAH3 domain from mouse CARMIL-1 (mCAH3). The addition of mCAH3 rapidly restored the polymerization of individual capped filaments, consistent with uncapping. To verify uncapping, filaments were capped with recombinant mouse CP tagged with monomeric green fluorescent protein (mGFP-CP). Restoration of polymerization upon the addition of mCAH3 was immediately preceded by the complete dissociation of mGFP-CP from the filament end, confirming the CAH3-driven uncapping mechanism. Quantitative analyses showed that the percentage of capped filaments that uncapped increased as the concentration of mCAH3 was increased, reaching a maximum of similar to 90% at similar to 250 nM mCAH3. Moreover, the time interval between mCAH3 addition and uncapping decreased as the concentration of mCAH3 increased, with the half-time of CP at the barbed end decreasing from similar to 30 min without mCAH3 to similar to 10 s with a saturating amount of mCAH3. Finally, using mCAH3 tagged with mGFP, we obtained direct evidence that the complex of CP and mCAH3 has a small but measurable affinity for the barbed end, as inferred from previous studies and kinetic modeling. We conclude that the isolated CAH3 domain of CARMIL (and presumably the intact molecule as well) possesses the ability to uncap CP-capped actin filaments.	[Fujiwara, Ikuko; Remmert, Kirsten; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hammer, JA (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2523,9000 Rockville Pike, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov	Fujiwara, Ikuko/H-5717-2016	Fujiwara, Ikuko/0000-0002-9361-636X; Hammer, John/0000-0002-2496-5179	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006120] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; KIELLEY WW, 1960, BIOCHIM BIOPHYS ACTA, V41, P401; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; KOUYAMA T, 1980, EUR J BIOCHEM, V105, P279, DOI 10.1111/j.1432-1033.1980.tb04499.x; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Matsuzaka Y, 2004, GENE, V343, P291, DOI 10.1016/j.gene.2004.09.004; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Remmert K, 2009, PROTEIN EXPRES PURIF, V67, P113, DOI 10.1016/j.pep.2009.05.002; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Vanderzalm PJ, 2009, DEVELOPMENT, V136, P1201, DOI 10.1242/dev.026666; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Wu XF, 2006, FEBS LETT, V580, P5863, DOI 10.1016/j.febslet.2006.09.047; Xu P, 1997, P NATL ACAD SCI USA, V94, P3685, DOI 10.1073/pnas.94.8.3685; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008	39	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2707	2720		10.1074/jbc.M109.031203	http://dx.doi.org/10.1074/jbc.M109.031203			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926785	Green Published, hybrid			2022-12-27	WOS:000273697800049
J	Ruas, JL; Berchner-Pfannschmidt, U; Malik, S; Gradin, K; Fandrey, J; Roeder, RG; Pereira, T; Poellinger, L				Ruas, Jorge L.; Berchner-Pfannschmidt, Utta; Malik, Sohail; Gradin, Katarina; Fandrey, Joachim; Roeder, Robert G.; Pereira, Teresa; Poellinger, Lorenz			Complex Regulation of the Transactivation Function of Hypoxia-inducible Factor-1 alpha by Direct Interaction with Two Distinct Domains of the CREB-binding Protein/p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; GENE-EXPRESSION; FACTOR 1-ALPHA; TRANSCRIPTIONAL REPRESSION; PROLYL HYDROXYLATION; STRUCTURAL BASIS; HIF-ALPHA; P53	Activation of transcription in response to low oxygen tension is mediated by the hypoxia-inducible factor-1 (HIF-1). HIF-1 is a heterodimer of two proteins: aryl hydrocarbon receptor nuclear translocator and the oxygen-regulated HIF-1 alpha. The C-terminal activation domain of HIF-1 alpha has been shown to interact with cysteine/histidine-rich region 1 (CH1) of the coactivator CBP/p300 in a hypoxia-dependent manner. However, HIF forms lacking C-terminal activation domain (naturally occurring or genetically engineered) are still able to activate transcription of target genes in hypoxia. Here, we demonstrate that the N-terminal activation domain (N-TAD) of HIF-1 alpha interacts with endogenous CBP and that this interaction facilitates its transactivation function. Our results show that interaction of HIF-1 alpha N-TAD with CBP/p300 is mediated by the CH3 region of CBP known to interact with, among other factors, p53. Using fluorescence resonance energy transfer experiments, we demonstrate that N-TAD interacts with CH3 in vivo. Coimmunoprecipitation assays using endogenous proteins showed that immunoprecipitation of CBP in hypoxia results in the recovery of a larger fraction of HIF-1 alpha than of p53. Chromatin immunoprecipitation demonstrated that at 1% O-2 CBP is recruited to a HIF-1 alpha but not to a p53 target gene. Upon activation of both pathways, lower levels of chromatin-associated CBP were detected at either target gene promoter. These results identify CBP as the coactivator directly interacting with HIF-1 alpha N-TAD and mediating the transactivation function of this domain. Thus, we suggest that in hypoxia HIF-1 alpha is a major CBP-interacting transcription factor that may compete with other CBP-dependent factors, including p53, for limiting amounts of this coactivator, underscoring the complexity in the regulation of gene expression by HIF-1 alpha.	[Ruas, Jorge L.; Gradin, Katarina; Pereira, Teresa; Poellinger, Lorenz] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Berchner-Pfannschmidt, Utta; Fandrey, Joachim] Univ Duisburg Essen, Inst Physiol, D-45122 Essen, Germany; [Malik, Sohail; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; [Poellinger, Lorenz] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore	Karolinska Institutet; University of Duisburg Essen; Rockefeller University; National University of Singapore	Poellinger, L (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Eulers Vag 3, S-17177 Stockholm, Sweden.	Lorenz.Poellinger@ki.se	Ruas, Jorge/AAE-6094-2019; Fandrey, Joachim/AAA-3524-2021; Pereira, Teresa/AAP-8197-2020	Ruas, Jorge/0000-0002-1110-2606; Pereira, Teresa/0000-0001-8654-2385; Fandrey, Joachim/0000-0001-9585-0531	National Institutes of Health [DK060764, DK071900, CA129325]; Swedish Medical Research Council; Swedish Cancer Foundation; Swedish Heart-Lung Foundation; European Union; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060764, R01DK071900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK060764 (to S. M.) and DK071900 and CA129325 (to R. G. R.). This work was also supported by grants from the Swedish Medical Research Council (to T. P. and L. P.) and from the Swedish Cancer Foundation, the Swedish Heart-Lung Foundation, and the European Union (to L. P.). 1 Supported in part by a short term grant from the Swedish Cancer Foundation. Present address: Dana-Farber Cancer Institute and Harvard Medical School, Dept. of Cancer Biology, Boston, MA 02115.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Berchner-Pfannschmidt U, 2004, J BIOL CHEM, V279, P44976, DOI 10.1074/jbc.M313995200; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Blobel GA, 2002, J LEUKOCYTE BIOL, V71, P545; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kaluzova M, 2004, MOL CELL BIOL, V24, P5757, DOI 10.1128/MCB.24.13.5757-5766.2004; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kim WY, 2006, SEMIN ONCOL, V33, P588, DOI 10.1053/j.seminoncol.2006.06.001; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Pereira T, 2003, J BIOL CHEM, V278, P6816, DOI 10.1074/jbc.M209297200; Ravi R, 2000, GENE DEV, V14, P34; Ruas JL, 2005, SEMIN CELL DEV BIOL, V16, P514, DOI 10.1016/j.semcdb.2005.04.001; Ruas JL, 2005, J CELL SCI, V118, P301, DOI 10.1242/jcs.01617; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Sang NL, 2002, MOL CELL BIOL, V22, P2984, DOI 10.1128/MCB.22.9.2984-2992.2002; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; SIEGEL RM, 2000, SCI STKE, pPL1; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Wadgaonkar R, 1999, J BIOL CHEM, V274, P13760, DOI 10.1074/jbc.274.20.13760; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	60	43	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2601	2609		10.1074/jbc.M109.021824	http://dx.doi.org/10.1074/jbc.M109.021824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19880525	Green Published, hybrid			2022-12-27	WOS:000273697800039
J	Bereta, G; Wang, BL; Kiser, PD; Baehr, W; Jang, GF; Palczewski, K				Bereta, Grzegorz; Wang, Benlian; Kiser, Philip D.; Baehr, Wolfgang; Jang, Geeng-Fu; Palczewski, Krzysztof			A Functional Kinase Homology Domain Is Essential for the Activity of Photoreceptor Guanylate Cyclase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; LEBER CONGENITAL AMAUROSIS; ACTIVATING PROTEINS GCAPS; CRYSTAL-STRUCTURE; CA2+-BINDING PROTEINS; EXTRACELLULAR DOMAIN; ADENINE-NUCLEOTIDES; MOLECULAR-CLONING; OUTER SEGMENTS; ALPHA-SUBUNIT	Phototransduction is carried out by a signaling pathway that links photoactivation of visual pigments in retinal photoreceptor cells to a change in their membrane potential. Upon photoactivation, the second messenger of phototransduction, cyclic GMP, is rapidly degraded and must be replenished during the recovery phase of phototransduction by photoreceptor guanylate cyclases (GCs) GC1 (or GC-E) and GC2 (or GC-F) to maintain vision. Here, we present data that address the role of the GC kinase homology (KH) domain in cyclic GMP production by GC1, the major cyclase in photoreceptors. First, experiments were done to test which GC1 residues undergo phosphorylation and whether such phosphorylation affects cyclase activity. Using mass spectrometry, we showed that GC1 residues Ser-530, Ser-532, Ser-533, and Ser-538, located within the KH domain, undergo light-and signal transduction-independent phosphorylation in vivo. Mutations in the putative Mg2+ binding site of the KH domain abolished phosphorylation, indicating that GC1 undergoes autophosphorylation. The dramatically reduced GC activity of these mutants suggests that a functional KH domain is essential for cyclic GMP production. However, evidence is presented that autophosphorylation does not regulate GC1 activity, in contrast to phosphorylation of other members of this cyclase family.	[Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Sch Med, Ctr Prote & Mass Spectrometry, Cleveland, OH 44106 USA; [Baehr, Wolfgang] Univ Utah, Dept Ophthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Jang, Geeng-Fu] Roswell Pk Canc Inst, Dept Cell Stress Biol, Prote Resources Lab, Buffalo, NY 14263 USA	Case Western Reserve University; Case Western Reserve University; Utah System of Higher Education; University of Utah; Roswell Park Cancer Institute	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY008061, EY08123, P30 EY11373]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R29EY008061, R01EY008061, R01EY008123, P30EY011373, T32EY007157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 (to K. P.) and EY08123 (to W. B.) and Core Grant P30 EY11373. This work was also supported by the Foundation Fighting Blindness.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; Aparicio JG, 1996, J BIOL CHEM, V271, P27083, DOI 10.1074/jbc.271.43.27083; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Bryan PM, 2006, BIOCHEMISTRY-US, V45, P1295, DOI 10.1021/bi051253d; Burczynska B, 2007, MOL CELL BIOCHEM, V301, P93, DOI 10.1007/s11010-006-9400-7; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; CHINKERS M, 1991, J BIOL CHEM, V266, P4088; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; Dizhoor A, 2002, ADV EXP MED BIOL, V514, P291; Dizhoor AM, 1999, METHODS, V19, P521, DOI 10.1006/meth.1999.0894; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; GORCZYCA WA, 1994, BIOCHEMISTRY-US, V33, P3217, DOI 10.1021/bi00177a011; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Joubert S, 2005, FEBS J, V272, P5572, DOI 10.1111/j.1742-4658.2005.04952.x; Koch KW, 2002, ADV EXP MED BIOL, V514, P349; KOLLER KJ, 1992, MOL CELL BIOL, V12, P2581, DOI 10.1128/MCB.12.6.2581; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; Krylov DM, 2001, J BIOL CHEM, V276, P30648, DOI 10.1074/jbc.M104121200; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Ogawa H, 2009, FEBS J, V276, P1347, DOI 10.1111/j.1742-4658.2009.06870.x; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P415, DOI 10.1021/bi00428a001; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Potter LR, 1999, MOL BIOL CELL, V10, P1811, DOI 10.1091/mbc.10.6.1811; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; ROBINSON WE, 1979, NATURE, V280, P398, DOI 10.1038/280398a0; Rosenzweig DH, 2009, BIOCHEM J, V417, P803, DOI 10.1042/BJ20081513; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; WONG SKF, 1992, J CLIN INVEST, V90, P299, DOI 10.1172/JCI115862; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	54	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1899	1908		10.1074/jbc.M109.061713	http://dx.doi.org/10.1074/jbc.M109.061713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19901021	Green Published, hybrid			2022-12-27	WOS:000273429100036
J	Glekas, GD; Foster, RM; Cates, JR; Estrella, JA; Wawrzyniak, MJ; Rao, CV; Ordal, GW				Glekas, George D.; Foster, Richard M.; Cates, Joseph R.; Estrella, Jeffrey A.; Wawrzyniak, Michael J.; Rao, Christopher V.; Ordal, George W.			A PAS Domain Binds Asparagine in the Chemotaxis Receptor McpB in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; LIGAND-BINDING; ASPARTATE RECEPTOR; BACTERIAL CHEMOTAXIS; CRYSTAL-STRUCTURES; I-TASSER; KINASE; ADAPTATION; SERVER; PHOSPHORYLATION	During chemotaxis toward asparagine by Bacillus subtilis, the ligand is thought to bind to the chemoreceptor McpB on the exterior of the cell and induce a conformational change. This change affects the degree of phosphorylation of the CheA kinase bound to the cytoplasmic region of the receptor. Until recently, the sensing domains of the B. subtilis receptors were thought to be structurally similar to the well studied Escherichia coli four-helical bundle. However, sequence analysis has shown the sensing domains of receptors from these two organisms to be vastly different. Homology modeling of the sensing domain of the B. subtilis asparagine receptor McpB revealed two tandem PAS domains. McpB mutants having alanine substitutions in key arginine and tyrosine residues of the upper PAS domain but not in any residues of the lower PAS domain exhibited a chemotactic defect in both swarm plates and capillary assays. Thus, binding does not appear to occur across any dimeric surface but within a monomer. A modified capillary assay designed to determine the concentration of attractant where chemotaxis is most sensitive showed that when Arg-111, Tyr-121, or Tyr-133 is mutated to an alanine, much more asparagine is required to obtain an active chemoreceptor. Isothermal titration calorimetry experiments on the purified sensing domain showed a K-D to asparagine of 14 mu M, with the three mutations leading to less efficient binding. Taken together, these results reveal not only a novel chemoreceptor sensing domain architecture but also, possibly, a different mechanism for chemoreceptor activation.	[Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Ordal, George W.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rao, CV (corresponding author), Univ Illinois, 600 S Mathews,211 RAL, Urbana, IL 61801 USA.	chris@scs.uiuc.edu; ordal@uiuc.edu			National Institutes of Health [R01GM54365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM54365.	Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Aizawa S., 2001, BACILLUS SUBTILIS IT, P437; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bjorkman AM, 2001, J BIOL CHEM, V276, P2808, DOI 10.1074/jbc.M009593200; BOURRET RB, 1989, J BIOL CHEM, V264, P7085; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; GOLDMAN DJ, 1982, BIOCHEMISTRY-US, V21, P915, DOI 10.1021/bi00534a016; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Jensen AA, 2000, EUR J PHARMACOL, V397, P247, DOI 10.1016/S0014-2999(00)00283-1; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MACNAB RM, 1978, CRC CR REV BIOCH MOL, V5, P291, DOI 10.3109/10409237809177145; MANSON MD, 1992, ADV MICROB PHYSIOL, V33, P277, DOI 10.1016/S0065-2911(08)60219-2; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; ORDAL GW, 1977, J BACTERIOL, V129, P156, DOI 10.1128/JB.129.1.156-165.1977; ORDAL GW, 1975, SCIENCE, V189, P802, DOI 10.1126/science.808854; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Paas Y, 2000, TRENDS PHARMACOL SCI, V21, P87, DOI 10.1016/S0165-6147(99)01443-1; Paas Y, 1996, NEURON, V17, P979, DOI 10.1016/S0896-6273(00)80228-7; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Rao CV, 2008, TRENDS MICROBIOL, V16, P480, DOI 10.1016/j.tim.2008.07.003; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Stock AM, 2006, NAT STRUCT MOL BIOL, V13, P862, DOI 10.1038/nsmb1006-862; Surette MG, 1996, J BIOL CHEM, V271, P17966, DOI 10.1074/jbc.271.30.17966; Szurmant H, 2004, J MOL BIOL, V344, P919, DOI 10.1016/j.jmb.2004.09.093; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WOLFF C, 1988, J BACTERIOL, V170, P4509, DOI 10.1128/jb.170.10.4509-4515.1988; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x	50	53	54	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1870	1878		10.1074/jbc.M109.072108	http://dx.doi.org/10.1074/jbc.M109.072108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19864420	hybrid, Green Published			2022-12-27	WOS:000273429100033
J	Rush, JS; Alaimo, C; Robbiani, R; Wacker, M; Waechter, CJ				Rush, Jeffrey S.; Alaimo, Cristina; Robbiani, Riccardo; Wacker, Michael; Waechter, Charles J.			A Novel Epimerase That Converts GlcNAc-P-P-undecaprenol to GalNAc-P-P-undecaprenol in Escherichia coli O157	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; ANTIGEN GENE-CLUSTER; O-ANTIGEN; CAMPYLOBACTER-JEJUNI; N-ACETYLGLUCOSAMINE; FUNCTIONAL-ANALYSIS; COLI; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; POLYSACCHARIDES	Escherichia coli strain O157 produces an O-antigen with the repeating tetrasaccharide unit alpha-D-PerNAc-alpha-L-Fuc-beta-D-Glc-alpha-D-GalNAc, preassembled on undecaprenyl pyrophosphate (Und-P-P). These studies were conducted to determine whether the biosynthesis of the lipid-linked repeating tetrasaccharide was initiated by the formation of GalNAc-P-P-Und by WecA. When membrane fractions from E. coli strains K12, O157, and PR4019, a WecA-overexpressing strain, were incubated with UDP-[H-3] GalNAc, neither the enzymatic synthesis of [H-3]GlcNAcP-P-Und nor [H-3] GalNAc-P-P-Und was detected. However, when membrane fractions from strain O157 were incubated with UDP-[H-3] GlcNAc, two enzymatically labeled products were observed with the chemical and chromatographic properties of [H-3] GlcNAc-P-P-Und and [H-3] GalNAc-P-P-Und, suggesting that strain O157 contained an epimerase capable of interconverting GlcNAc-P-P-Und and GalNAc-P-P-Und. The presence of a novel epimerase was demonstrated by showing that exogenous [H-3] GlcNAc-P-P-Und was converted to [H-3] GalNAc-P-P-Und when incubated with membranes from strain O157. When strain O157 was metabolically labeled with [H-3] GlcNAc, both [H-3] GlcNAc-P-P-Und and [H-3] GalNAc-P-P-Und were detected. Transformation of E. coli strain 21546 with the Z3206 gene enabled these cells to synthesize GalNAc-P-P-Und in vivo and in vitro. The reversibility of the epimerase reaction was demonstrated by showing that [H-3] GlcNAc-P-P-Und was reformed when membranes from strain O157 were incubated with exogenous [H-3] GalNAc-P-P-Und. The inability of Z3206 to complement the loss of the gne gene in the expression of the Campylobacter jejuni N-glycosylation system in E. coli indicated that it does not function as a UDP-GlcNAc/UDPGalNAc epimerase. Based on these results, GalNAc-P-P-Und is synthesized reversibly by a novel GlcNAc-P-P-Und epimerase after the formation of GlcNAc-P-P-Und by WecA in E. coli O157.	[Waechter, Charles J.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB, Lexington, KY 40536 USA; [Alaimo, Cristina; Robbiani, Riccardo; Wacker, Michael] GlycoVaxyn AG, CH-8952 Schlieren, Switzerland	University of Kentucky	Waechter, CJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB, 741 S Limestone St, Lexington, KY 40536 USA.	waechte@uky.edu			National Institutes of Health [GM36065]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM36065 (to C. J. W.).	Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803; Amor PA, 1997, MOL MICROBIOL, V26, P145, DOI 10.1046/j.1365-2958.1997.5631930.x; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; CARDINI CE, 1957, J BIOL CHEM, V225, P317; DUNPHY PJ, 1967, BIOCHIM BIOPHYS ACTA, V136, P136, DOI 10.1016/0304-4165(67)90329-7; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Field RA, 2003, BIOCHEMISTRY-US, V42, P7637, DOI 10.1021/bi0345079; GORDON HT, 1956, ANAL CHEM, V28, P849, DOI 10.1021/ac60113a020; Guan ZQ, 2005, ANAL BIOCHEM, V345, P336, DOI 10.1016/j.ab.2005.07.002; Guo HJ, 2007, BIOCHEM BIOPH RES CO, V356, P604, DOI 10.1016/j.bbrc.2007.03.015; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; KEAN EL, 1966, J LIPID RES, V7, P449; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; PERRY MB, 1986, BIOCHEM CELL BIOL, V64, P21, DOI 10.1139/o86-004; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rush JS, 1997, GLYCOBIOLOGY, V7, P315, DOI 10.1093/glycob/7.2.315; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SCHWIMMER S, 1956, SCIENCE, V123, P543, DOI 10.1126/science.123.3196.543; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Stephan R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-10; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WAECHTER CJ, 1976, ARCH BIOCHEM BIOPHYS, V174, P726, DOI 10.1016/0003-9861(76)90403-3; WAECHTER CJ, 1977, ARCH BIOCHEM BIOPHYS, V181, P185, DOI 10.1016/0003-9861(77)90497-0; Wang L, 2002, J BACTERIOL, V184, P2620, DOI 10.1128/JB.184.10.2620-2625.2002; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhang LJ, 1997, MOL MICROBIOL, V23, P63, DOI 10.1046/j.1365-2958.1997.1871558.x	38	61	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1671	1680		10.1074/jbc.M109.061630	http://dx.doi.org/10.1074/jbc.M109.061630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923219	Green Published, hybrid			2022-12-27	WOS:000273429100013
J	Webb, BN; Ballinger, JW; Kim, E; Belchik, SM; Lam, KS; Youn, B; Nissen, MS; Xun, LY; Kang, C				Webb, Brian N.; Ballinger, Jordan W.; Kim, Eunjung; Belchik, Sara M.; Lam, Ka-Sum; Youn, Buhyun; Nissen, Mark S.; Xun, Luying; Kang, ChulHee			Characterization of Chlorophenol 4-Monooxygenase (TftD) and NADH:FAD Oxidoreductase (TftC) of Burkholderia cepacia AC1100	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FMN-DEPENDENT MONOOXYGENASE; THERMUS-THERMOPHILUS HB8; CRYSTAL-STRUCTURE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; STREPTOMYCES-COELICOLOR; 2,4,5-TRICHLOROPHENOXYACETIC ACID; BIOCHEMICAL-CHARACTERIZATION; ESCHERICHIA-COLI; MOLECULAR-OXYGEN; REDUCED FLAVIN	Burkholderia cepacia AC1100 completely degrades 2,4,5-trichlorophenol, in which an FADH(2)-dependent monooxygenase (TftD) and an NADH: FAD oxidoreductase (TftC) catalyze the initial steps. TftD oxidizes 2,4,5-trichlorophenol (2,4,5-TCP) to 2,5-dichloro-p-benzoquinone, which is chemically reduced to 2,5-dichloro-p-hydroquinone (2,5-DiCHQ). Then, TftD oxidizes the latter to 5-chloro-2-hydroxy-p-benzoquinone. In those processes, TftC provides all the required FADH(2). We have determined the crystal structures of dimeric TftC and tetrameric TftD at 2.0 and 2.5 angstrom resolution, respectively. The structure of TftC was similar to those of related flavin reductases. The stacked nicotinamide: isoalloxazine rings in TftC and sequential reaction kinetics suggest that the reduced FAD leaves TftC after NADH oxidation. The structure of TftD was also similar to the known structures of FADH(2)-dependent monooxygenases. Its His-289 residue in the re-side of the isoalloxazine ring is within hydrogen bonding distance with a hydroxyl group of 2,5-DiCHQ. An H289 A mutation resulted in the complete loss of activity toward 2,5-DiCHQ and a significant decrease in catalytic efficiency toward 2,4,5-TCP. Thus, His-289 plays different roles in the catalysis of 2,4,5-TCP and 2,5-DiCHQ. The results support that free FADH(2) is generated by TftC, and TftD uses FADH(2) to separately transform 2,4,5-TCP and 2,5-DiCHQ. Additional experimental data also support the diffusion of FADH(2) between TftC and TftD without direct physical interaction between the two enzymes.	[Ballinger, Jordan W.; Kim, Eunjung; Belchik, Sara M.; Lam, Ka-Sum; Youn, Buhyun; Nissen, Mark S.; Xun, Luying; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Webb, Brian N.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Kang, C (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	chkang@wsu.edu		Kang, ChulHee/0000-0002-0693-7860	National Science Foundation [MCB-0323167]; United States Department of Agriculture, Agricultural Research Service/Cooperative State Research, Education; Extension Service, American Heart Association [0850084Z]; Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture, Agricultural Research Service/Cooperative State Research, Education(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Extension Service, American Heart Association(American Heart AssociationUnited States Department of Agriculture (USDA)National Institute of Food and Agriculture); Murdock Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation Grant MCB-0323167, the United States Department of Agriculture, Agricultural Research Service/Cooperative State Research, Education, and Extension Service, American Heart Association Grant 0850084Z, and The Murdock Charitable Trust.	Abdurachim K, 2006, J BACTERIOL, V188, P8153, DOI 10.1128/JB.00966-06; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell ZT, 2009, J BIOL CHEM, V284, P8322, DOI 10.1074/jbc.M808977200; Czaplicka M, 2004, SCI TOTAL ENVIRON, V322, P21, DOI 10.1016/j.scitotenv.2003.09.015; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gao BL, 2005, BIOCHEM BIOPH RES CO, V331, P1137, DOI 10.1016/j.bbrc.2005.04.033; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hubner A, 1998, APPL ENVIRON MICROB, V64, P2086; Jeffers CE, 2003, BIOCHEMISTRY-US, V42, P529, DOI 10.1021/bi026877n; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020; KELLOGG ST, 1981, SCIENCE, V214, P1133, DOI 10.1126/science.7302584; KILBANE JJ, 1982, APPL ENVIRON MICROB, V44, P72, DOI 10.1128/AEM.44.1.72-78.1982; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; Lee JK, 2007, J BACTERIOL, V189, P8556, DOI 10.1128/JB.01050-07; Li L, 2008, J MOL BIOL, V376, P453, DOI 10.1016/j.jmb.2007.11.069; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; Louie TM, 2002, J BACTERIOL, V184, P3492, DOI 10.1128/JB.184.13.3492-3500.2002; Low JC, 2003, PHOTOCHEM PHOTOBIOL, V77, P446, DOI 10.1562/0031-8655(2003)077<0446:ETEFIV>2.0.CO;2; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Martins BM, 2004, P NATL ACAD SCI USA, V101, P15645, DOI 10.1073/pnas.0403952101; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MCCOLLISTER D, 1961, TOXICOL APPL PHARM, V3, P63, DOI 10.1016/0041-008X(61)90009-6; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NEWMAN LM, 1995, BIOCHEMISTRY-US, V34, P14066, DOI 10.1021/bi00043a012; Nissen MS, 2008, J BIOL CHEM, V283, P28710, DOI 10.1074/jbc.M804535200; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tiirola MA, 2002, APPL ENVIRON MICROB, V68, P173, DOI 10.1128/AEM.68.1.173-180.2002; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Xun LY, 1996, J BACTERIOL, V178, P2645, DOI 10.1128/jb.178.9.2645-2649.1996; Youn BY, 2005, J BIOL CHEM, V280, P12917, DOI 10.1074/jbc.M413266200	50	56	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2014	2027		10.1074/jbc.M109.056135	http://dx.doi.org/10.1074/jbc.M109.056135			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915006	hybrid, Green Published			2022-12-27	WOS:000273429100047
J	Gach, JS; Furtmuller, PG; Quendler, H; Messner, P; Wagner, R; Katinger, H; Kunert, R				Gach, Johannes S.; Furtmueller, Paul G.; Quendler, Heribert; Messner, Paul; Wagner, Ralf; Katinger, Hermann; Kunert, Renate			Proline Is Not Uniquely Capable of Providing the Pivot Point for Domain Swapping in 2G12, a Broadly Neutralizing Antibody against HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIIDIOTYPIC ANTIBODY; 2F5; RECOGNITION; FRAGMENT; VACCINE; BINDING; REGION; GP120; LEVEL	The human monoclonal antibody 2G12 is a member of a small group of broadly neutralizing antibodies against human immunodeficiency virus type 1. 2G12 adopts a unique variable heavy domain-exchanged dimeric configuration that results in an extensive multivalent binding surface and the ability to bind with high affinity to densely clustered high mannose oligosaccharides on the "silent" face of the gp120 envelope glycoprotein. Here, we further define the amino acids responsible for this extraordinary domain-swapping event in 2G12.	[Gach, Johannes S.; Quendler, Heribert; Katinger, Hermann; Kunert, Renate] Univ Nat Resources & Appl Life Sci, Dept Biotechnol, A-1190 Vienna, Austria; [Furtmueller, Paul G.] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria; [Messner, Paul] Univ Nat Resources & Appl Life Sci, Ctr NanoBiotechnol, A-1190 Vienna, Austria; [Wagner, Ralf] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany; [Gach, Johannes S.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Regensburg; Scripps Research Institute	Gach, JS (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	renate.kunert@boku.ac.at	Furtmüller, Paul G./Y-5819-2018; Kunert, Renate E/B-9185-2018; Messner, Paul/Q-5345-2017	Furtmüller, Paul G./0000-0002-1199-2469; Kunert, Renate E/0000-0002-3397-3621; Messner, Paul/0000-0002-3246-5801; Gach, Johannes/0000-0002-5043-5710	European Union [019052]; Austrian Science Fund [J2845-B13]	European Union(European Commission); Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by European Union Project 019052, "HIVAB," and the Austrian Science Fund J2845-B13.	Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Bryson S, 2008, J MOL BIOL, V382, P910, DOI 10.1016/j.jmb.2008.07.057; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gach JS, 2007, AIDS RES HUM RETROV, V23, P1405, DOI 10.1089/aid.2007.0089; Gach JS, 2007, J BIOTECHNOL, V128, P735, DOI 10.1016/j.jbiotec.2006.12.020; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; KABAT EA, 1991, J IMMUNOL, V147, P1709; Kellenberger E, 1979, UNCONVENTIONAL ELECT, P49; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Marsche G, 2008, CARDIOVASC RES, V79, P187, DOI 10.1093/cvr/cvn051; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Reisinger H, 2008, APPL MICROBIOL BIOT, V81, P701, DOI 10.1007/s00253-008-1701-1; Roux KH, 2004, MOL IMMUNOL, V41, P1001, DOI 10.1016/j.molimm.2004.05.008; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995	20	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1122	1127		10.1074/jbc.M109.058792	http://dx.doi.org/10.1074/jbc.M109.058792			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19903812	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000273258200034
J	Meng, XW; Heldebrant, MP; Flatten, KS; Loegering, DA; Dai, HM; Schneider, PA; Gomez, TS; Peterson, KL; Trushin, SA; Hess, AD; Smith, BD; Karp, JE; Billadeau, DD; Kaufmann, SH				Meng, Xue Wei; Heldebrant, Michael P.; Flatten, Karen S.; Loegering, David A.; Dai, Haiming; Schneider, Paula A.; Gomez, Timothy S.; Peterson, Kevin L.; Trushin, Sergey A.; Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.; Billadeau, Daniel D.; Kaufmann, Scott H.			Protein Kinase C beta Modulates Ligand-induced Cell Surface Death Receptor Accumulation A MECHANISTIC BASIS FOR ENZASTAURIN-DEATH LIGAND SYNERGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTIC-LEUKEMIA CELLS; INDUCED APOPTOSIS; SELECTIVE INHIBITOR; MEDIATED APOPTOSIS; TRAIL RESISTANCE; BCL-XL; CANCER; ACTIVATION; FADD; FAS	Although treatment with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) is known to protect a subset of cells from induction of apoptosis by death ligands such as Fas ligand and tumor necrosis factor-alpha-related apoptosis-inducing ligand, the mechanism of this protection is unknown. This study demonstrated that protection in short term apoptosis assays and long term proliferation assays was maximal when Jurkat or HL-60 human leukemia cells were treated with 2-5 nM PMA. Immunoblotting demonstrated that multiple PKC isoforms, including PKC alpha, PKC beta, PKC epsilon, and PKC theta, translocated from the cytosol to a membrane-bound fraction at these PMA concentrations. When the ability of short hairpin RNA (shRNA) constructs that specifically down-regulated each of these isoforms was examined, PKC beta shRNA uniquely reversed PMA-induced protection against cell death. The PKC beta-selective small molecule inhibitor enzastaurin had a similar effect. Although mass spectrometry suggested that Fas is phosphorylated on a number of serines and threonines, mutation of these sites individually or collectively had no effect on Fas-mediated death signaling or PMA protection. Further experiments demonstrated that PMA diminished ligand-induced cell surface accumulation of Fas and DR5, and PKC beta shRNA or enzastaurin reversed this effect. Moreover, enzastaurin sensitized a variety of human tumor cell lines and clinical acute myelogenous leukemia isolates, which express abundant PKC beta, to tumor necrosis factor-alpha related apoptosis-inducing ligand-induced death in the absence of PMA. Collectively, these results identify a specific PKC isoform that modulates death receptor-mediated cytotoxicity as well as a small molecule inhibitor that mitigates the inhibitory effects of PKC activation on ligand-induced death receptor trafficking and cell death.	[Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Meng, Xue Wei; Flatten, Karen S.; Loegering, David A.; Dai, Haiming; Schneider, Paula A.; Gomez, Timothy S.; Peterson, Kevin L.; Billadeau, Daniel D.; Kaufmann, Scott H.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Trushin, Sergey A.; Kaufmann, Scott H.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Billadeau, Daniel D.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.] Johns Hopkins Sidney Kimmel Canc Ctr, Div Hematol Malignancies, Baltimore, MD 21231 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Dept Mol Pharmacol & Expt Therapeut, Gonda 19-212,200 1st St,SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu		Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407	National Institutes of Health [R01 CA69008]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA69008 (to S.H.K.). This work was also supported by a predoctoral fellowship (to M.P.H.) from the Mayo Foundation.	Abrams ST, 2007, BLOOD, V109, P1193, DOI 10.1182/blood-2006-03-012021; Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Busuttil V, 2002, ONCOGENE, V21, P3213, DOI 10.1038/sj.onc.1205433; Carducci MA, 2006, J CLIN ONCOL, V24, P4092, DOI 10.1200/JCO.2005.05.3447; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Eischen CM, 1997, BLOOD, V90, P935, DOI 10.1182/blood.V90.3.935.935_935_943; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gibson SB, 2000, MOL CELL BIOL, V20, P205, DOI 10.1128/MCB.20.1.205-212.2000; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gomez-Angelats M, 2001, J BIOL CHEM, V276, P44944, DOI 10.1074/jbc.M104919200; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Green LJ, 2006, CLIN CANCER RES, V12, P3408, DOI 10.1158/1078-0432.CCR-05-2231; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Harper N, 2003, J BIOL CHEM, V278, P44338, DOI 10.1074/jbc.M307376200; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; Hendrickson AW, 2008, J CLIN INVEST, V118, P3582, DOI 10.1172/JCI37553; Herbst RS, 2007, CLIN CANCER RES, V13, p4641S, DOI 10.1158/1078-0432.CCR-07-0538; Holmstrom TH, 2000, EMBO J, V19, P5418, DOI 10.1093/emboj/19.20.5418; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kaufmann SH, 1997, BLOOD, V89, P2098, DOI 10.1182/blood.V89.6.2098; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; Kim KH, 2000, CLIN CANCER RES, V6, P335; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Matharu AL, 2001, J BIOL CHEM, V276, P30199, DOI 10.1074/jbc.M010650200; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Mesner P W Jr, 1997, Adv Pharmacol, V41, P461, DOI 10.1016/S1054-3589(08)61069-8; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; PELCHENMATTHEWS A, 1989, EMBO J, V8, P3641, DOI 10.1002/j.1460-2075.1989.tb08538.x; PIKE BL, 1970, J CELL PHYSIOL, V76, P77, DOI 10.1002/jcp.1040760111; Podar K, 2007, EXPERT OPIN INV DRUG, V16, P1693, DOI 10.1517/13543784.16.10.1693; Qin JZ, 2002, EXP DERMATOL, V11, P573, DOI 10.1034/j.1600-0625.2002.110610.x; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Robertson MJ, 2007, J CLIN ONCOL, V25, P1741, DOI 10.1200/JCO.2006.09.3146; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Simonian PL, 1997, BLOOD, V90, P1208, DOI 10.1182/blood.V90.3.1208.1208_1208_1216; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Svingen PA, 2000, CLIN CANCER RES, V6, P237; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001; Ueffing N, 2009, BLOOD, V114, P572, DOI 10.1182/blood-2009-02-204230; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wajant H, 2006, CANC TREAT, V130, P141; Wajant H, 2004, VITAM HORM, V67, P101; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Wen JH, 2000, BLOOD, V96, P3900, DOI 10.1182/blood.V96.12.3900.h8003900_3900_3906; Werner MH, 2006, CELL CYCLE, V5, P2332, DOI 10.4161/cc.5.20.3385; Wu JJ, 2005, FEBS LETT, V579, P1940, DOI 10.1016/j.febslet.2005.02.041; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106	95	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					888	902		10.1074/jbc.M109.057638	http://dx.doi.org/10.1074/jbc.M109.057638			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887445	Green Published, hybrid			2022-12-27	WOS:000273258200009
J	Jedrychowski, MP; Gartner, CA; Gygi, SP; Zhou, L; Herz, J; Kandror, KV; Pilch, PF				Jedrychowski, Mark P.; Gartner, Carlos A.; Gygi, Steven P.; Zhou, Li; Herz, Joachim; Kandror, Konstantin V.; Pilch, Paul F.			Proteomic Analysis of GLUT4 Storage Vesicles Reveals LRP1 to Be an Important Vesicle Component and Target of Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; RECEPTOR-RELATED PROTEIN-1; 3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORT; GLUT4-CONTAINING VESICLES; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; KINETIC-ANALYSIS; PLASMA-MEMBRANE; AKT SUBSTRATE	Insulin stimulates the translocation of intracellular GLUT4 to the plasma membrane where it functions in adipose and muscle tissue to clear glucose from circulation. The pathway and regulation of GLUT4 trafficking are complicated and incompletely understood and are likely to be contingent upon the various proteins other than GLUT4 that comprise and interact with GLUT4-containing vesicles. Moreover, not all GLUT4 intracellular pools are insulin-responsive as some represent precursor compartments, thus posing a biochemical challenge to the purification and characterization of their content. To address these issues, we immunodepleted precursor GLUT4-rich vesicles and then immunopurified GLUT4 storage vesicle (GSVs) from primary rat adipocytes and subjected them to semi-quantitative and quantitative proteomic analysis. The purified vesicles translocate to the cell surface almost completely in response to insulin, the expected behavior for bona fide GSVs. In total, over 100 proteins were identified, about 50 of which are novel in this experimental context. LRP1 (low density lipoprotein receptor-related protein 1) was identified as a major constituent of GSVs, and we show it interacts with the lumenal domains of GLUT4 and other GSV constituents. Its cytoplasmic tail interacts with the insulin-signaling pathway target, AS160 (Akt substrate of 160 kDa). Depletion of LRP1 from 3T3-L1 adipocytes reduces GLUT4 expression and correspondingly results in decreased insulin-stimulated 2-[H-3] deoxyglucose uptake. Furthermore, adipose-specific LRP1 knock-out mice also exhibit decreased GLUT4 expression. These findings suggest LRP1 is an important component of GSVs, and its expression is needed for the formation of fully functional GSVs.	[Jedrychowski, Mark P.; Kandror, Konstantin V.; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Gartner, Carlos A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhou, Li; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Boston University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	ppilch@.edu		Pilch, Paul/0000-0003-1997-0499; Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health [DK30435]; American Diabetes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Foundation(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30435. This work was also supported by a grant from the American Diabetes Foundation (to P. F. P.).	APPELL KC, 1988, J BIOL CHEM, V263, P10824; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Belfort GM, 2005, J BIOL CHEM, V280, P7262, DOI 10.1074/jbc.M404851200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Brooks CC, 2000, J BIOL CHEM, V275, P2029, DOI 10.1074/jbc.275.3.2029; Carvalho E, 2004, J BIOL CHEM, V279, P21598, DOI 10.1074/jbc.M312269200; CORVERA S, 1989, J BIOL CHEM, V264, P10133; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; DESCAMPS O, 1993, J BIOL CHEM, V268, P974; El-Jack AK, 1999, MOL BIOL CELL, V10, P1581, DOI 10.1091/mbc.10.5.1581; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hubner K, 2002, INT REV CYTOL, V214, P103; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; KAHN BB, 1988, J CLIN INVEST, V82, P691, DOI 10.1172/JCI113649; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lee W, 2000, BIOCHEMISTRY-US, V39, P9358, DOI 10.1021/bi0007021; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Mastick CC, 1997, ENDOCRINOLOGY, V138, P2391, DOI 10.1210/en.138.6.2391; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; PILCH PF, 1979, J BIOL CHEM, V254, P3375; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Ramus C, 2006, MOL CELL PROTEOMICS, V5, P68, DOI 10.1074/mcp.M500205-MCP200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; THOIDIS G, 1993, J BIOL CHEM, V268, P11691; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; YANG J, 1993, J BIOL CHEM, V268, P4600; YEH JI, 1995, BIOCHEMISTRY-US, V34, P15523, DOI 10.1021/bi00047a018; Zhang HY, 2004, J BIOL CHEM, V279, P2221, DOI 10.1074/jbc.M310679200; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	70	102	103	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					104	114		10.1074/jbc.M109.040428	http://dx.doi.org/10.1074/jbc.M109.040428			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864425	Green Published, hybrid			2022-12-27	WOS:000273070100011
J	Kobayashi, E; Shimizu, R; Kikuchi, Y; Takahashi, S; Yamamoto, M				Kobayashi, Eri; Shimizu, Ritsuko; Kikuchi, Yuko; Takahashi, Satoru; Yamamoto, Masayuki			Loss of the Gata1 Gene IE Exon Leads to Variant Transcript Expression and the Production of a GATA1 Protein Lacking the N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT MYELOPROLIFERATIVE DISORDER; DOWN-SYNDROME; IN-VIVO; MEGAKARYOBLASTIC LEUKEMIA; ALTERNATIVE PROMOTERS; FUNCTIONAL-ANALYSIS; MOUSE; DIFFERENTIATION; MICE; ERYTHROPOIESIS	GATA1 is essential for the differentiation of erythroid cells and megakaryocytes. The Gata1 gene is composed of multiple untranslated first exons and five common coding exons. The erythroid first exon (IE exon) is important for Gata1 gene expression in hematopoietic lineages. Because previous IE exon knockdown analyses resulted in embryonic lethality, less is understood about the contribution of the IE exon to adult hematopoiesis. Here, we achieved specific deletion of the floxed IE exon in adulthood using an inducible Cre expression system. In this conditional knock-out mouse line, the Gata1 mRNA level was significantly down-regulated in the megakaryocyte lineage, resulting in thrombocytopenia with a marked proliferation of megakaryocytes. By contrast, in the erythroid lineage, Gata1 mRNA was expressed abundantly utilizing alternative first exons. Especially, the IEb/c and newly identified IEd exons were transcribed at a level comparable with that of the IE exon in control mice. Surprisingly, in the IE-null mouse, these transcripts failed to produce full-length GATA1 protein, but instead yielded GATA1 lacking the N-terminal domain inefficiently. With low level expression of the short form of GATA1, IE-null mice showed severe anemia with skewed erythroid maturation. Notably, the hematological phenotypes of adult IE-null mice substantially differ from those observed in mice harboring conditional ablation of the entire Gata1 gene. The present study demonstrates that the IE exon is instrumental to adult erythropoiesis by regulating the proper level of transcription and selecting the correct transcription start site of the Gata1 gene.	[Shimizu, Ritsuko] Tohoku Univ, Grad Sch Med, Dept Expt Hematol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kobayashi, Eri; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kikuchi, Yuko; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, ERATO Environm Response Project, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; University of Tsukuba	Shimizu, R (corresponding author), Tohoku Univ, Grad Sch Med, Dept Expt Hematol, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	rshimizu@m.tains.tohoku.ac.jp; masiyamamoto@m.tains.tohoku.ac.jp	Shimizu, Ritsuko/A-4877-2010; Yamamoto, Masayuki/A-4873-2010	Shimizu, Ritsuko/0000-0001-6672-7606; Yamamoto, Masayuki/0000-0002-9073-9436	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for Promotion of Science; JST-ERATO; Naito Foundation; Tohoku University Global COE	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST-ERATO(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Tohoku University Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from Ministry of Education, Culture, Sports, Science, and Technology and Japan Society for Promotion of Science (to R. S. and M. Y.), Scientific Research on Priority Areas (to R. S. and M. Y.) and Specially Promoted Research (to M. Y.), grants from the JST-ERATO project (to M. Y.), Naito Foundation (to M. Y.), and Tohoku University Global COE program for the Conquest of Diseases with Network Medicine (to M. Y.).	Aizencang GI, 2000, J BIOL CHEM, V275, P2295, DOI 10.1074/jbc.275.4.2295; Bishop TR, 1996, NUCLEIC ACIDS RES, V24, P2511, DOI 10.1093/nar/24.13.2511; Bose F, 2006, MOL CELL BIOL, V26, P3942, DOI 10.1128/MCB.26.10.3942-3954.2006; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chen D, 2009, CANCER LETT, V273, P15, DOI 10.1016/j.canlet.2008.05.038; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Dyer KD, 2007, J IMMUNOL, V179, P1693, DOI 10.4049/jimmunol.179.3.1693; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Greene ME, 2003, BLOOD CELL MOL DIS, V31, P351, DOI 10.1016/j.bcmd.2003.08.001; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lowry JA, 2006, INT J BIOCHEM CELL B, V38, P6, DOI 10.1016/j.biocel.2005.06.017; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Moroni E, 2000, J BIOL CHEM, V275, P10567, DOI 10.1074/jbc.275.14.10567; Muntean AG, 2005, BLOOD, V106, P1223, DOI 10.1182/blood-2005-02-0551; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; NIWA H, 1993, J BIOCHEM-TOKYO, V113, P343, DOI 10.1093/oxfordjournals.jbchem.a124049; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, 1997, J BIOCHEM, V121, P251; Pan XQ, 2005, J BIOL CHEM, V280, P22385, DOI 10.1074/jbc.M500081200; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; PISCHEDDA C, 1995, P NATL ACAD SCI USA, V92, P3511, DOI 10.1073/pnas.92.8.3511; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SAHR KE, 1994, GENOMICS, V24, P491, DOI 10.1006/geno.1994.1658; Shimizu R, 2004, MOL CELL BIOL, V24, P10814, DOI 10.1128/MCB.24.24.10814-10825.2004; Shimizu R, 2004, BLOOD, V103, P2560, DOI 10.1182/blood-2003-07-2514; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shimizu R, 2008, NAT REV CANCER, V8, P279, DOI 10.1038/nrc2348; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Vannucchi AM, 2005, AM J PATHOL, V167, P849, DOI 10.1016/S0002-9440(10)62056-1; Vannucchi AM, 2001, BLOOD, V97, P3040, DOI 10.1182/blood.V97.10.3040; Wakabayashi J, 2003, GENES CELLS, V8, P619, DOI 10.1046/j.1365-2443.2003.00658.x; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	47	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					773	783		10.1074/jbc.M109.030726	http://dx.doi.org/10.1074/jbc.M109.030726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19854837	Green Published, hybrid			2022-12-27	WOS:000273070100078
J	Nishimoto, Y; Ito, D; Yagi, T; Nihei, Y; Tsunoda, Y; Suzuki, N				Nishimoto, Yoshinori; Ito, Daisuke; Yagi, Takuya; Nihei, Yoshihiro; Tsunoda, Yoshiko; Suzuki, Norihiro			Characterization of Alternative Isoforms and Inclusion Body of the TAR DNA-binding Protein-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MAMMALIAN STRESS GRANULES; NUCLEAR FACTOR TDP-43; CFTR EXON-9; INTRANUCLEAR INCLUSIONS; AGGREGATE FORMATION; ALZHEIMERS-DISEASE; PROCESSING BODIES; MESSENGER-RNA	TAR DNA-binding protein-43 (TDP-43) has been recently identified as a major component of the ubiquitinated inclusions found in frontotemporal lobar degeneration with ubiquitin-positive inclusions and in amyotrophic lateral sclerosis, diseases that are collectively termed TDP-43 proteinopathies. Several amyotrophic lateral sclerosis-linked mutations of the TDP-43 gene have also been identified; however, the precise molecular mechanisms underlying the neurodegeneration remain unclear. To investigate the biochemical characteristics of TDP-43, we examined truncation, isoforms, and cytoplasmic inclusion (foci) formation using TDP-43-expressing cells. Under apoptosis, caspase-3 generates two 35-kDa (p35f) and 25-kDa (p25f) fragments. However, in caspase-3(-/-) cells, novel caspase-3-independent isoforms of these two variants (p35iso and p25iso) were also detected under normal conditions. With a deletion mutant series, the critical domains for generating both isoforms were determined and applied to in vitro transcription/translation, revealing alternate in-frame translation start sites downstream of the natural initiation codon. Subcellular localization analysis indicated that p35 (p35f and p35iso) expression leads to the formation of stress granules, cellular structures that package mRNA and RNA-binding proteins during cell stress. After applying proteasome inhibitors, aggresomes, which are aggregates of misfolded proteins, were formed in the cytoplasm of cells expressing p35. Collectively, this study demonstrates that the 35-kDa isoforms of TDP-43 assemble in stress granules, suggesting that TDP-43 plays an important role in translation, stability, and metabolism of mRNA. Our findings provide new biological and pathological insight into the development of TDP-43 proteinopathies.	[Nishimoto, Yoshinori; Ito, Daisuke; Yagi, Takuya; Nihei, Yoshihiro; Tsunoda, Yoshiko; Suzuki, Norihiro] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Ito, D (corresponding author), Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	d-ito@jk9.so-net.ne.jp	Ito, Daisuke/GXF-1648-2022; Suzuki, Norihiro/J-5125-2013; Ito, Daisuke/M-3608-2013	Suzuki, Norihiro/0000-0002-0399-6590; Ito, Daisuke/0000-0002-4740-1675	Eisai Co., Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan [18590955, 21790850]; ALS Foundation; Japan ALS Association; Keio Medical Science Fund	Eisai Co., Ltd.(Eisai Co Ltd); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ALS Foundation; Japan ALS Association; Keio Medical Science Fund	This work was supported by Eisai Co., Ltd., the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants 18590955 and 21790850), the ALS Foundation, the Japan ALS Association, and Keio Medical Science Fund Research Grants for Life Science and Medicine.	Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ito D, 2004, MOL CELL BIOL, V24, P9456, DOI 10.1128/MCB.24.21.9456-9469.2004; Ito D, 2008, NEUROBIOL DIS, V31, P266, DOI 10.1016/j.nbd.2008.05.004; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2008, NEUROSCI RES, V61, P201, DOI 10.1016/j.neures.2008.02.009; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Orr HT, 2004, NATURE, V431, P747, DOI 10.1038/431747a; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang HX, 2008, NEUROSCI LETT, V434, P170, DOI 10.1016/j.neulet.2008.01.060; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	56	105	107	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					608	619		10.1074/jbc.M109.022012	http://dx.doi.org/10.1074/jbc.M109.022012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887443	Green Published, hybrid			2022-12-27	WOS:000273070100062
J	Zhang, Y; Gladyshev, VN				Zhang, Yan; Gladyshev, Vadim N.			General Trends in Trace Element Utilization Revealed by Comparative Genomic Analyses of Co, Cu, Mo, Ni, and Se	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLYBDENUM COFACTOR; COPPER HOMEOSTASIS; EVOLUTIONARY DYNAMICS; NITRATE REDUCTASE; HEAVY-METALS; TRANSPORT; SELENIUM; PROTEIN; ZINC	Trace elements are used by all organisms and provide proteins with unique coordination and catalytic and electron transfer properties. Although many trace element-containing proteins are well characterized, little is known about the general trends in trace element utilization. We carried out comparative genomic analyses of copper, molybdenum, nickel, cobalt (in the form of vitamin B-12), and selenium (in the form of selenocysteine) in 747 sequenced organisms at the following levels: (i) transporters and transport-related proteins, (ii) cofactor biosynthesis traits, and (iii) trace element-dependent proteins. Few organisms were found to utilize all five trace elements, whereas many symbionts, parasites, and yeasts used only one or none of these elements. Investigation of metalloproteomes and selenoproteomes revealed examples of increased utilization of proteins that use copper in land plants, cobalt in Dehalococcoides and Dictyostelium, and selenium in fish and algae, whereas nematodes were found to have great diversity of copper transporters. These analyses also characterized trace element metabolism in common model organisms and suggested new model organisms for experimental studies of individual trace elements. Mismatches in the occurrence of user proteins and corresponding transport systems revealed deficiencies in our understanding of trace element biology. Biological interactions among some trace elements were observed; however, such links were limited, and trace elements generally had unique utilization patterns. Finally, environmental factors, such as oxygen requirement and habitat, correlated with the utilization of certain trace elements. These data provide insights into the general features of utilization and evolution of trace elements in the three domains of life.	[Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Gladyshev, VN (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, New Res Bldg,Rm 435,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [GM061603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061603 (to V. N. G.).	Ackland ML, 1996, BIOMETALS, V9, P29, DOI 10.1007/BF00188087; ALLEN RM, 1994, CRIT REV BIOTECHNOL, V14, P225, DOI 10.3109/07388554409079834; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreini C, 2004, BIOINFORMATICS, V20, P1373, DOI 10.1093/bioinformatics/bth095; Andreini C, 2008, J PROTEOME RES, V7, P209, DOI 10.1021/pr070480u; Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Barbier GG, 2004, PROTEIN EXPRES PURIF, V37, P61, DOI 10.1016/j.pep.2004.05.021; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P201, DOI 10.1081/CLT-100102420; Bartsevich VV, 1996, J BIOL CHEM, V271, P26057, DOI 10.1074/jbc.271.42.26057; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Burke D, 2002, ANIM COGN, V5, P79, DOI 10.1007/s10071-002-0131-1; Calafato S, 2008, TOXICOL SCI, V106, P384, DOI 10.1093/toxsci/kfn180; Chapple CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002968; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Degen O, 2002, J BACTERIOL, V184, P3569, DOI 10.1128/JB.184.13.3569-3577.2002; Eitinger T, 2000, ARCH MICROBIOL, V173, P1, DOI 10.1007/s002030050001; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Foster LH, 1997, CRIT REV FOOD SCI, V37, P211, DOI 10.1080/10408399709527773; Frassinetti S, 2006, J ENVIRON PATHOL TOX, V25, P597, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i3.40; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Goldhaber SB, 2003, REGUL TOXICOL PHARM, V38, P232, DOI 10.1016/S0273-2300(02)00020-X; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HEIDER J, 1993, ADV MICROB PHYSIOL, V35, P71, DOI 10.1016/S0065-2911(08)60097-1; HIPKIN CR, 1993, J GEN MICROBIOL, V139, P473, DOI 10.1099/00221287-139-3-473; HOGSTRAND C, 1991, COMP BIOCHEM PHYS C, V100, P137, DOI 10.1016/0742-8413(91)90140-O; Kim HY, 2009, PROTEINS, V74, P1008, DOI 10.1002/prot.22212; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Li JX, 2005, BIOCHEM BIOPH RES CO, V337, P179, DOI 10.1016/j.bbrc.2005.09.029; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Maguire Michael E., 2007, V394, P289, DOI 10.1007/978-1-59745-512-1_14; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; MAUPLNFURLOW JA, 1995, J BACTERIOL, V177, P4851, DOI 10.1128/jb.177.17.4851-4856.1995; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Mertz W, 1998, BIOL TRACE ELEM RES, V66, P185, DOI 10.1007/BF02783137; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Millson SH, 2009, YEAST, V26, P339, DOI 10.1002/yea.1670; Morrison MS, 2007, J BIOL INORG CHEM, V12, P1129, DOI 10.1007/s00775-007-0279-x; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; PATIL DS, 1994, METHOD ENZYMOL, V243, P68; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Permina EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-49; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Ridge PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001378; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Romero H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r66; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Suliman HS, 2005, ARCH BIOCHEM BIOPHYS, V441, P56, DOI 10.1016/j.abb.2005.06.016; SUMRADA RA, 1982, J BIOL CHEM, V257, P9119; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Valenzuela L, 2006, BIOTECHNOL ADV, V24, P197, DOI 10.1016/j.biotechadv.2005.09.004; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Van Gossum A, 1998, Curr Opin Clin Nutr Metab Care, V1, P499, DOI 10.1097/00075197-199811000-00004; VULPE CD, 1995, ANNU REV NUTR, V15, P293, DOI 10.1146/annurev.nu.15.070195.001453; Watt RK, 1999, CELL MOL LIFE SCI, V56, P604, DOI 10.1007/s000180050456; Zhang Y, 2005, BIOINFORMATICS, V21, P2580, DOI 10.1093/bioinformatics/bti400; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000095; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, P4952, DOI 10.1093/nar/gkm514; Zhang Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r94; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78	86	87	89	6	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3393	3405		10.1074/jbc.M109.071746	http://dx.doi.org/10.1074/jbc.M109.071746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19887375	Green Published, hybrid			2022-12-27	WOS:000273829000054
J	Kofoed, EM; Guerbadot, M; Schaufele, F				Kofoed, Eric M.; Guerbadot, Martin; Schaufele, Fred			Structure, Affinity, and Availability of Estrogen Receptor Complexes in the Cellular Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; ENTREZS 3D-STRUCTURE DATABASE; GREEN FLUORESCENT PROTEIN; NUCLEAR RECEPTOR; LIVING CELLS; SELECTIVE INTERACTIONS; COACTIVATOR BINDING; ALPHA; SRC-1; TRANSCRIPTION	An ability to measure the biochemical parameters and structures of protein complexes at defined locations within the cellular environment would improve our understanding of cellular function. Wedescribe widely applicable, calibrated Forster resonance energy transfer methods that quantify structural and biochemical parameters for interaction of the human estrogen receptor alpha-isoform (ER alpha) with the receptor interacting domains (RIDs) of three cofactors (SRC1, SRC2, SRC3) in living cells. The interactions of ER alpha with all three SRC-RIDs, measured throughout the cell nucleus, transitioned from structurally similar, high affinity complexes containing two ER alpha s at low free SRC-RID concentrations (<2 nM) to lower affinity complexes with an ER alpha monomer at higher SRC-RID concentrations (similar to 10 nM). The methods also showed that only a sub-population of ER alpha was available to form complexes with the SRC-RIDs in the cell. These methods represent a template for extracting unprecedented details of the biochemistry and structure of any complex that is capable of being measured by Forster resonance energy transfer in the cellular environment.	[Kofoed, Eric M.; Guerbadot, Martin; Schaufele, Fred] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Schaufele, Fred] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schaufele, F (corresponding author), S1230,513 Parnassus, San Francisco, CA 94143 USA.	freds@diabetes.ucsf.edu			Congressionally Directed Medical Research [PC040777]; National Institutes of Health [R01 DK54345, P30 DK63720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, R01DK054345] Funding Source: NIH RePORTER	Congressionally Directed Medical Research(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Congressionally Directed Medical Research Programs (Grant PC040777) and by the National Institutes of Health (Grant R01 DK54345) with infrastructure support from the National Institutes of Health (Grant P30 DK63720).	Acevedo ML, 2004, ESSAYS BIOCHEM, V40, P73, DOI 10.1042/bse0400073; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carpenter AE, 2007, NAT CHEM BIOL, V3, P461, DOI 10.1038/nchembio.2007.15; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Cheskis BJ, 2003, J BIOL CHEM, V278, P13271, DOI 10.1074/jbc.M211031200; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939093; Day RN, 2005, MOL ENDOCRINOL, V19, P1675, DOI 10.1210/me.2005-0028; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; FORSTER T, 1959, DISCUSS FARADAY SOC, V27, P1; Forster T., 1948, ANN PHYS, V6, P54; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Giuliano KA, 2006, METHOD ENZYMOL, V414, P601, DOI 10.1016/S0076-6879(06)14031-8; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Margeat E, 2001, J MOL BIOL, V306, P433, DOI 10.1006/jmbi.2000.4418; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Padron A, 2007, MOL ENDOCRINOL, V21, P49, DOI 10.1210/me.2006-0075; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pearce ST, 2004, CRIT REV ONCOL HEMAT, V50, P3, DOI 10.1016/j.critrevonc.2003.09.003; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; Valentine JE, 2000, J BIOL CHEM, V275, P25322, DOI 10.1074/jbc.M002497200; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103	51	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2428	2437		10.1074/jbc.M109.045203	http://dx.doi.org/10.1074/jbc.M109.045203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926790	Green Published, hybrid			2022-12-27	WOS:000273697800022
J	Anthonisen, EH; Berven, L; Holm, S; Nygard, M; Nebb, HI; Gronning-Wang, LM				Anthonisen, Elin Holter; Berven, Lise; Holm, Sverre; Nygard, Maria; Nebb, Hilde I.; Gronning-Wang, Line M.			Nuclear Receptor Liver X Receptor Is O-GlcNAc-modified in Response to Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-1C EXPRESSION; N-ACETYLGLUCOSAMINE; GENE-EXPRESSION; FATTY-ACID; LXR-ALPHA; ACTIVATION; PHOSPHORYLATION; GLYCOSYLATION; TRANSCRIPTION; INDUCTION	Post-translational modification of nucleocytoplasmic proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc) has for the last 25 years emerged as an essential glucose-sensing mechanism. The liver X receptors (LXRs) function as nutritional sensors for cholesterol-regulating lipid metabolism, glucose homeostasis, and inflammation. LXRs are shown to be posttranslationally modified by phosphorylation, acetylation, and sumoylation, affecting their target gene specificity, stability, and transactivating and transrepressional activity, respectively. In the present study, we show for the first time that LXR alpha and LXR beta are targets for glucose-hexosamine-derived O-GlcNAc modification in human Huh7 cells. Furthermore, we observed increased hepatic LXR alpha O-GlcNAcylation in vivo in refed mice and in streptozotocin-induced refed diabetic mice. Importantly, induction of LXR alpha O-GlcNAcylation in both mouse models was concomitant with increased expression of the lipogenic gene SREBP-1c (sterol regulatory element-binding protein 1c). Furthermore, glucose increased LXR/retinoic acid receptor-dependent activation of luciferase reporter activity driven by the mouse SREBP-1c promoter via the hexosamine biosynthetic pathway in Huh7 cells. Altogether, our results suggest that O-GlcNAcylation of LXR is a novel mechanism by which LXR acts as a glucose sensor affecting LXR-dependent gene expression, substantiating the crucial role of LXR as a nutritional sensor in lipid and glucose metabolism.	[Anthonisen, Elin Holter; Berven, Lise; Holm, Sverre; Nygard, Maria; Nebb, Hilde I.; Gronning-Wang, Line M.] Univ Oslo, Dept Nutr, Inst Basic Med Sci, N-0316 Oslo, Norway	University of Oslo	Nebb, HI (corresponding author), Univ Oslo, Dept Nutr, Inst Basic Med Sci, POB 1046, N-0316 Oslo, Norway.	h.i.nebb@medisin.uio.no; l.m.gronning-wang@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018	Holm, Sverre/0000-0003-1064-3926	Norwegian Research Council; Novo Nordic Foundation; Anders Jahres Foundation; Joh H. Andresens Medical Foundation; Aktieselskabet Freia Chocolade Fabriks Medical Foundation; Johan Throne Holst Foundation; European Union	Norwegian Research Council(Research Council of NorwayEuropean Commission); Novo Nordic Foundation(Novo Nordisk Foundation); Anders Jahres Foundation; Joh H. Andresens Medical Foundation; Aktieselskabet Freia Chocolade Fabriks Medical Foundation; Johan Throne Holst Foundation; European Union(European Commission)	This work was supported by the Norwegian Research Council, the Novo Nordic Foundation, Anders Jahres Foundation, Joh H. Andresens Medical Foundation, Aktieselskabet Freia Chocolade Fabriks Medical Foundation, Johan Throne Holst Foundation, and the European Union-granted project 6th framework, CRESCENDO.	APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen MY, 2006, FEBS LETT, V580, P4835, DOI 10.1016/j.febslet.2006.07.074; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lazar MA, 2007, CELL METAB, V5, P159, DOI 10.1016/j.cmet.2007.02.001; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Myhre AE, 2008, SHOCK, V29, P468, DOI 10.1097/SHK.0b013e31815073cb; Oberkofler H, 2004, BIOCHEM J, V381, P357, DOI 10.1042/BJ20040173; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shiota M, 2008, J CLIN INVEST, V118, P841, DOI 10.1172/JCI35137; STARR CM, 1990, J BIOL CHEM, V265, P6868; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Torra IP, 2008, MOL CELL BIOL, V28, P2626, DOI 10.1128/MCB.01575-07; Walcher D, 2006, ARTERIOSCL THROM VAS, V26, P1022, DOI 10.1161/01.ATV.0000210278.67076.8f; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	41	73	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1607	1615		10.1074/jbc.M109.082685	http://dx.doi.org/10.1074/jbc.M109.082685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19933273	hybrid, Green Published			2022-12-27	WOS:000273429100006
J	Sugiura, N; Baba, Y; Kawaguchi, Y; Iwatani, T; Suzuki, K; Kusakabe, T; Yamagishi, K; Kimata, K; Kakuta, Y; Watanabe, H				Sugiura, Nobuo; Baba, Yuichi; Kawaguchi, Yoshirou; Iwatani, Toru; Suzuki, Kiyoshi; Kusakabe, Takahiro; Yamagishi, Kiwamu; Kimata, Koji; Kakuta, Yoshimitsu; Watanabe, Hideto			Glucuronyltransferase Activity of KfiC from Escherichia coli Strain K5 Requires Association of KfiA KfiC AND KfiA ARE ESSENTIAL ENZYMES FOR PRODUCTION OF K5 POLYSACCHARIDE, N-ACETYLHEPAROSAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CAPSULE GENE-CLUSTER; CHONDROITIN POLYMERASE; HYALURONAN SYNTHASES; HEPAROSAN SYNTHASE; BINDING SITES; POLYSACCHARIDE; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; IDENTIFICATION	Heparan sulfate is a ubiquitous glycosaminoglycan in the extracellular matrix of most animals. It interacts with various molecules and exhibits important biological functions. K5 antigen produced by Escherichia coli strain K5 is a linear polysaccharide N-acetylheparosan consisting of GlcUA beta 1-4 and GlcNAc beta 1-4 repeating disaccharide, which forms the backbone of heparan sulfate. Region 2, located in the center of the K5-specific gene cluster, encodes four proteins, KfiA, KfiB, KfiC, and KfiD, for the biosynthesis of the K5 polysaccharide. Here, we expressed and purified the recombinant KfiA and KfiC proteins and then characterized these enzymes. Whereas the recombinant KfiC alone exhibited no GlcUA transferase activity, it did exhibit GlcUA transferase and polymerization activities in the presence of KfiA. In contrast, KfiA had GlcNAc transferase activity itself, which was unaffected by the presence of KfiC. The GlcNAc and GlcUA transferase activities were analyzed with various truncated and point mutants of KfiA and KfiC. The point mutants replacing aspartic acid of a DXD motif and lysine and glutamic acid of an ionic amino acid cluster, and the truncated mutants deleting the C-terminal and N-terminal sites, revealed the essential regions for GlcNAc and GlcUA transferase activity of KfiC and KfiA, respectively. The interaction of KfiC with KfiA is necessary for the GlcUA transferase activity of KfiC but not for the enzyme activity of KfiA. Together, these results indicate that the complex of KfiA and KfiC has polymerase activity to synthesize N-acetylheparosan, providing a useful tool toward bioengineering of defined heparan sulfate chains.	[Sugiura, Nobuo; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; [Baba, Yuichi; Kawaguchi, Yoshirou; Iwatani, Toru; Kakuta, Yoshimitsu] Kyushu Univ, Struct Biol Lab, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 8128581, Japan; [Kakuta, Yoshimitsu] Kyushu Univ, Biochem Lab, Dept Biosci & Biotechnol, Grad Sch,Fac Agr,Higashi Ku, Fukuoka 8128581, Japan; [Kusakabe, Takahiro] Kyushu Univ, Lab Silkworm Sci, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Suzuki, Kiyoshi; Yamagishi, Kiwamu] Seikagaku Corp, Cent Res Labs, Higashiyamato, Tokyo 2070021, Japan	Aichi Medical University; Kyushu University; Kyushu University; Kyushu University; Seikagaku Corporation	Sugiura, N (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	nsugiura@aichi-med-u.ac.jp; kakuta@agr.kyushu-u.ac.jp		Baba, Yuichi/0000-0002-6795-535X; Watanabe, Hideto/0000-0001-5291-0696; Kawaguchi, Yoshirou/0000-0003-0171-6476	New Energy and Industrial Technology Development Organization; Ministry of Education, Science, Sports and Culture	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the New Energy and Industrial Technology Development Organization and by the Ministry of Education, Science, Sports and Culture grant-in-aid (to Y. K., N. S., and H. W.).	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Boeggeman E, 2002, GLYCOBIOLOGY, V12, P395, DOI 10.1093/glycob/cwf045; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FINKE A, 1991, J BACTERIOL, V173, P4088, DOI 10.1128/jb.173.13.4088-4094.1991; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Hodson N, 2000, J BIOL CHEM, V275, P27311; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Minamisawa T, 2006, CARBOHYD RES, V341, P230, DOI 10.1016/J.CARRES.2005.11.013; Minamisawa T, 2006, RAPID COMMUN MASS SP, V20, P267, DOI 10.1002/rcm.2310; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; Rigg GP, 1998, MICROBIOL-SGM, V144, P2905, DOI 10.1099/00221287-144-10-2905; Roman E, 2003, BIOCHEM J, V374, P767, DOI 10.1042/BJ20030365; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sugiura N, 2007, ANAL BIOCHEM, V365, P62, DOI 10.1016/j.ab.2007.02.023; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x	32	23	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1597	1606		10.1074/jbc.M109.023002	http://dx.doi.org/10.1074/jbc.M109.023002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915003	hybrid, Green Published			2022-12-27	WOS:000273429100005
J	Couturier, J; Morel, M; Pontcharraud, R; Gontier, V; Fauconneau, B; Paccalin, M; Page, G				Couturier, Julien; Morel, Milena; Pontcharraud, Raymond; Gontier, Virginie; Fauconneau, Bernard; Paccalin, Marc; Page, Guylene			Interaction of Double-stranded RNA-dependent Protein Kinase (PKR) with the Death Receptor Signaling Pathway in Amyloid beta (A beta)-treated Cells and in APP(SL)PS1 Knock-in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EUKARYOTIC INITIATION FACTOR-2-ALPHA; ALZHEIMERS-DISEASE; NEURONAL DEGENERATION; NUCLEAR-LOCALIZATION; INDUCED APOPTOSIS; MOUSE MODEL; ACTIVATION; FAS; PHOSPHORYLATION	For 10 years, research has focused on signaling pathways controlling translation to explain neuronal death in Alzheimer Disease (AD). Previous studies demonstrated in different cellular and animal models and AD patients that translation is down-regulated by the activation of double-stranded RNA-dependent protein kinase (PKR). Among downstream factors of PKR, the Fas-associated protein with a death domain (FADD) and subsequent activated caspase-8 are responsible for PKR-induced apoptosis in recombinant virus-infected cells. However, no studies have reported the role of PKR in death receptor signaling in AD. The aim of this project is to determine physical and functional interactions of PKR with FADD in amyloid-beta peptide (A beta) neurotoxicity and in APP(SL)PS1 KI transgenic mice. In SH-SY5Y cells, results showed that A beta 42 induced a large increase in phosphorylated PKR and FADD levels and a physical interaction between PKR and FADD in the nucleus, also observed in the cortex of APP(SL)PS1 KI mice. However, PKR gene silencing or treatment with a specific PKR inhibitor significantly prevented the increase in pT(451)-PKR and pS(194)-FADD levels in SH-SY5Y nuclei and completely inhibited activities of caspase-3 and -8. The contribution of PKR in neurodegeneration through the death receptor signaling pathway may support the development of therapeutics targeting PKR to limit neuronal death in AD.	[Couturier, Julien; Morel, Milena; Pontcharraud, Raymond; Gontier, Virginie; Fauconneau, Bernard; Paccalin, Marc; Page, Guylene] Univ Poitiers, Res Grp Brain Aging, GReViC EA 3808, F-86034 Poitiers, France; [Paccalin, Marc] Univ Poitiers Hosp, Dept Geriatr, F-86021 Poitiers, France; [Paccalin, Marc] Univ Poitiers Hosp, Clin Invest Ctr, CIC INSERM 802, F-86021 Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers	Page, G (corresponding author), Univ Poitiers, Res Grp Brain Aging, GReViC EA 3808, 6 Rue Miletrie,BP 199, F-86034 Poitiers, France.	guylene.page@univ-poitiers.fr			Association Internationale pour la Recherche sur la Maladie d'Alzheimer (AIRMA); Association France Alzheimer	Association Internationale pour la Recherche sur la Maladie d'Alzheimer (AIRMA); Association France Alzheimer	This work was supported by grants from the Association Internationale pour la Recherche sur la Maladie d'Alzheimer (AIRMA) and Association France Alzheimer.	Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; BARRIER L, 2008, NEUROBIOL A IN PRESS; Bayer TA, 2008, NEURODEGENER DIS, V5, P140, DOI 10.1159/000113684; Bennett RL, 2004, J BIOL CHEM, V279, P42687, DOI 10.1074/jbc.M403321200; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Cantarella G, 2003, CELL DEATH DIFFER, V10, P134, DOI 10.1038/sj.cdd.4401143; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Christensen KD, 2008, GENET MED, V10, P207, DOI 10.1097/GIM.0b013e318164e4cf; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; DAMJANAC M, 2009, J CELL MOL IN PRESS; Damjanac M, 2008, NEUROBIOL DIS, V29, P354, DOI 10.1016/j.nbd.2007.09.008; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Engidawork E, 2001, BIOCHEM BIOPH RES CO, V281, P84, DOI 10.1006/bbrc.2001.4306; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; Gil J, 2000, ONCOGENE, V19, P1369, DOI 10.1038/sj.onc.1203448; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gomez-Angelats M, 2003, CELL DEATH DIFFER, V10, P791, DOI 10.1038/sj.cdd.4401237; Guerra S, 2006, J BIOL CHEM, V281, P18734, DOI 10.1074/jbc.M511983200; Ivins KJ, 1999, NEUROBIOL DIS, V6, P440, DOI 10.1006/nbdi.1999.0268; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; JEFFREY IW, 1995, EXP CELL RES, V218, P17, DOI 10.1006/excr.1995.1126; Kalai M, 2007, CELL DEATH DIFFER, V14, P1050, DOI 10.1038/sj.cdd.4402110; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; Onuki R, 2004, EMBO J, V23, P959, DOI 10.1038/sj.emboj.7600049; Paccalin M, 2006, DEMENT GERIATR COGN, V22, P320, DOI 10.1159/000095562; Page G, 2006, NEUROSCIENCE, V139, P1343, DOI 10.1016/j.neuroscience.2006.01.047; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peel AL, 2004, J NEUROPATH EXP NEUR, V63, P97, DOI 10.1093/jnen/63.2.97; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Screaton RA, 2003, P NATL ACAD SCI USA, V100, P5211, DOI 10.1073/pnas.0431215100; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Su JH, 2003, NEUROBIOL DIS, V12, P182, DOI 10.1016/S0969-9961(02)00019-0; Suen KC, 2003, J BIOL CHEM, V278, P49819, DOI 10.1074/jbc.M306503200; Uberti D, 2008, NEURODEGENER DIS, V5, P209, DOI 10.1159/000113704; Wu CK, 2005, EXP NEUROL, V195, P484, DOI 10.1016/j.expneurol.2005.06.020; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	51	38	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1272	1282		10.1074/jbc.M109.041954	http://dx.doi.org/10.1074/jbc.M109.041954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889624	Green Published, hybrid			2022-12-27	WOS:000273258200049
J	Edwards, J; Cole, LJ; Green, JB; Thomson, MJ; Wood, AJ; Whittingham, JL; Moir, JWB				Edwards, James; Cole, Lindsay J.; Green, Jasper B.; Thomson, Melanie J.; Wood, A. Jamie; Whittingham, Jean L.; Moir, James W. B.			Binding to DNA Protects Neisseria meningitidis Fumarate and Nitrate Reductase Regulator (FNR) from Oxygen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; BIOPHYSICAL CHARACTERIZATION; ESCHERICHIA-COLI; 4FE-4S CLUSTER; IN-VITRO; GENES; CONVERSION; REPRESSOR; SULFIDE; IRON	Here, we report the overexpression, purification, and characterization of the transcriptional activator fumarate and nitrate reductase regulator from the pathogenic bacterium Neisseria meningitidis (NmFNR). Like its homologue from Escherichia coli (EcFNR), NmFNR binds a 4Fe-4S cluster, which breaks down in the presence of oxygen to a 2Fe-2S cluster and subsequently to apo-FNR. The kinetics of NmFNR cluster disassembly in the presence of oxygen are 2-3x slower than those previously reported for wild-type EcFNR, but similar to constitutively active EcFNR* mutants, consistent with earlier work in which we reported that the activity of FNR-dependent promoters in N. meningitidis is only weakly inhibited by the presence of oxygen (Rock, J. D., Thomson, M. J., Read, R. C., and Moir, J. W. (2007) J. Bacteriol. 189, 1138-1144). NmFNR binds to DNA containing a consensus FNR box sequence, and this binding stabilizes the iron-sulfur cluster in the presence of oxygen. Partial degradation of the 4Fe-4S cluster to a 3Fe-4S occurs, and this form remains bound to the DNA. The 3Fe-4S cluster is converted spontaneously back to a 4Fe-4S cluster under subsequent anaerobic reducing conditions in the presence of ferrous iron. The finding that binding to DNA stabilizes FNR in the presence of oxygen such that it has a half-life of similar to 30 min on the DNA has implications for our appreciation of how oxygen switches off FNR activatable genes in vivo.	[Moir, James W. B.] Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England; [Whittingham, Jean L.] Univ York, York Struct Biol Lab, Dept Chem, York YO10 5YW, N Yorkshire, England; [Wood, A. Jamie] Univ York, York Ctr Complex Syst Anal, York YO10 5YW, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Moir, JWB (corresponding author), Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England.	jm46@york.ac.uk		Wood, Andrew James/0000-0002-6119-852X; Moir, James/0000-0003-2972-5235	Biotechnology and Biological Sciences Research Council [BB/F000952/1]; BBSRC [BB/F000952/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F000952/1 (to J. W. B. M.).	Bartolini E, 2006, MOL MICROBIOL, V60, P963, DOI 10.1111/j.1365-2958.2006.05163.x; Bonsor D, 2006, ORG BIOMOL CHEM, V4, P1252, DOI 10.1039/b517338h; Brook I, 2003, INT J PEDIATR OTORHI, V67, P1047, DOI 10.1016/S0165-5876(03)00203-9; BRUMBY PE, 1965, J BIOL CHEM, V240, P2222; CONDON C, 1985, J BIOL CHEM, V260, P9427; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; Crack JC, 2006, J BIOL CHEM, V281, P18909, DOI 10.1074/jbc.C600042200; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; Gao-Sheridan HS, 1998, J BIOL CHEM, V273, P33692, DOI 10.1074/jbc.273.50.33692; Gorodetsky AA, 2008, P NATL ACAD SCI USA, V105, P3684, DOI 10.1073/pnas.0800093105; Green J, 1996, BIOCHEM J, V316, P887, DOI 10.1042/bj3160887; Heurlier K, 2008, J BACTERIOL, V190, P2488, DOI 10.1128/JB.01869-07; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Liu A, 2000, J BIOL CHEM, V275, P12367, DOI 10.1074/jbc.275.17.12367; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; MELVILLE SB, 1990, J BIOL CHEM, V265, P18733; Moir JWB, 1996, BIOCHEM J, V319, P823, DOI 10.1042/bj3190823; Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200; Petoukhov MV, 2003, J BIOL CHEM, V278, P29933, DOI 10.1074/jbc.M304147200; Rock JD, 2005, MOL MICROBIOL, V58, P800, DOI 10.1111/j.1365-2958.2005.04866.x; Rock JD, 2007, J BACTERIOL, V189, P1138, DOI 10.1128/JB.01368-06; Sawers G, 1999, CURR OPIN MICROBIOL, V2, P181, DOI 10.1016/S1369-5274(99)80032-0; SHARROCKS AD, 1990, FEBS LETT, V270, P119, DOI 10.1016/0014-5793(90)81248-M; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	31	23	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1105	1112		10.1074/jbc.M109.057810	http://dx.doi.org/10.1074/jbc.M109.057810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19917602	Green Published, hybrid			2022-12-27	WOS:000273258200032
J	Owens, TW; Foster, FM; Valentijn, A; Gilmore, AP; Streuli, CH				Owens, Thomas W.; Foster, Fiona M.; Valentijn, Anthony; Gilmore, Andrew P.; Streuli, Charles H.			Role for X-linked Inhibitor of Apoptosis Protein Upstream of Mitochondrial Permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; SUBCELLULAR-LOCALIZATION; CASPASE ACTIVATION; EFFECTOR CASPASES; SERINE-PROTEASE; XIAP; BAX; ANOIKIS; IAPS; MICE	Apoptosis is controlled by a signaling equilibrium between prosurvival and proapoptotic pathways, such that unwanted apoptosis is avoided, but when required it occurs rapidly and efficiently. Many apoptosis regulators display dual roles, depending upon whether a cell has received an apoptotic stimulus or not. Here, we identify a novel and unexpected function for X-linked inhibitor of apoptosis (XIAP) that occurs when apoptosis is triggered under physiological conditions. We show that in response to loss of survival signals provided by cell adhesion, endogenous XIAP translocates from the cytosol into a mitochondrial 400-kDa complex and that this occurs very early in the apoptosis process. Membrane-associated XIAP induces mitochondrial outer membrane permeabilization leading to cytochrome c and Smac release, which is dependent on Bax and Bak. Thus, although XIAP suppresses apoptosis in healthy cells, our data indicate that XIAP may contribute to it in response to a proapoptotic signal such as loss of extracellular matrix-dependent survival signaling. We suggest that, as with Bcl-2 family proteins, more diverse functions for XIAP exist than previously identified. Moreover, switching the function of proteins from anti-to proapoptotic forms may be a common theme in the efficient execution of cell death.	[Owens, Thomas W.; Foster, Fiona M.; Valentijn, Anthony; Gilmore, Andrew P.; Streuli, Charles H.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Streuli, CH (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.	charles.streuli@manchester.ac.uk			Wellcome Trust; Cancer Research United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK)	This work was funded by the Wellcome Trust and Cancer Research United Kingdom.	Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Conte D, 2001, P NATL ACAD SCI USA, V98, P5049, DOI 10.1073/pnas.081547998; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Gilmore AP, 2009, CURR OPIN CELL BIOL, V21, P654, DOI 10.1016/j.ceb.2009.05.009; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Manara A, 2009, BBA-MOL CELL BIOL L, V1791, P997, DOI 10.1016/j.bbalip.2009.05.003; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Owens TW, 2009, CELL DEATH DIFFER, V16, P1551, DOI 10.1038/cdd.2009.102; Park HJ, 2006, J BIOL CHEM, V281, P34277, DOI 10.1074/jbc.M603443200; Pullan S, 1996, J CELL SCI, V109, P631; Sauerwald TM, 2002, BIOTECHNOL BIOENG, V77, P704, DOI 10.1002/bit.10154; Silke J, 2004, J BIOL CHEM, V279, P4313, DOI 10.1074/jbc.M305661200; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Upton JP, 2007, CELL DEATH DIFFER, V14, P932, DOI 10.1038/sj.cdd.4402092; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Valentijn AJ, 2003, J CELL BIOL, V162, P599, DOI 10.1083/jcb.200302154; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang PB, 2003, J BIOL CHEM, V278, P19917, DOI 10.1074/jbc.M210337200; Wang XY, 2004, NEUROBIOL DIS, V16, P179, DOI 10.1016/j.nbd.2004.01.014; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	39	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1081	1088		10.1074/jbc.M109.072322	http://dx.doi.org/10.1074/jbc.M109.072322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19875445	Green Published, hybrid			2022-12-27	WOS:000273258200029
J	Xu, GF; Tan, XJ; Wang, HM; Sun, WJ; Shi, Y; Burlingame, S; Gu, X; Cao, GW; Zhang, T; Qin, J; Yang, JH				Xu, Gufeng; Tan, Xiaojie; Wang, Hongmei; Sun, Wenjing; Shi, Yi; Burlingame, Susan; Gu, Xue; Cao, Guangwen; Zhang, Ting; Qin, Jun; Yang, Jianhua			Ubiquitin-specific Peptidase 21 Inhibits Tumor Necrosis Factor alpha-induced Nuclear Factor kappa B Activation via Binding to and Deubiquitinating Receptor-interacting Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EDITING ENZYME A20; TRANSCRIPTION FACTOR; KINASE COMPLEX; IKK-BETA; INTERLEUKIN-6 GENE; PHOSPHORYLATION; NEMO; DEUBIQUITYLATION; IDENTIFICATION; SUBUNIT	Ubiquitination and deubiquitination of receptor-interacting protein 1 (RIP1) play an important role in the positive and negative regulation of the tumor necrosis factor alpha (TNF alpha)-induced nuclear factor kappa B (NF-kappa B) activation. Using a combination of functional genomic and proteomic approaches, we have identified ubiquitin-specific peptidase 21 (USP21) as a deubiquitinase for RIP1. USP21 is constitutively associated with RIP1 and deubiquitinates RIP1 in vitro and in vivo. Notably, knockdown of USP21 in HeLa cells enhances TNF alpha-induced RIP1 ubiquitination, I kappa B kinase beta (IKK beta), and NF-kappa B phosphorylation, inhibitor of NF-kappa B alpha (I kappa B alpha) phosphorylation and ubiquitination, as well as NF-kappa B-dependent gene expression. Therefore, our results demonstrate that USP21 plays an important role in the down-regulation of TNF alpha-induced NF-kappa B activation through deubiquitinating RIP1.	[Xu, Gufeng; Tan, Xiaojie; Wang, Hongmei; Sun, Wenjing; Burlingame, Susan; Gu, Xue; Yang, Jianhua] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shi, Yi; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tan, Xiaojie; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai 200433, Peoples R China; [Gu, Xue; Zhang, Ting] Capital Inst Pediat, Beijing 100020, Peoples R China	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Naval Medical University; Capital Institute of Pediatrics (CIP)	Yang, JH (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Dan L Duncan Canc Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	jianhuay@bcm.edu	tan, xiao/GZL-0264-2022	Wang, Hongmei/0000-0002-5881-2488	National Institutes of Health [1R21CA106513-01A2]; American Cancer Society [RSG06- 070-01-TBE]; National Basic Research Program of China [2007CB511900]; NATIONAL CANCER INSTITUTE [R21CA106513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Basic Research Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA106513-01A2 (to J.Y.), American Cancer Society Grant RSG06- 070-01-TBE (to J.Y.), and National Basic Research Program of China Grant 2007CB511900 (to T.Z.).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Jacque E, 2009, EMBO J, V28, P455, DOI 10.1038/emboj.2009.18; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; O'Neill LAJ, 2009, J BIOL CHEM, V284, P8209, DOI 10.1074/jbc.R800070200; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	41	92	95	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					969	978		10.1074/jbc.M109.042689	http://dx.doi.org/10.1074/jbc.M109.042689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19910467	Green Published, hybrid			2022-12-27	WOS:000273258200017
J	Yasuhira, K; Shibata, N; Mongami, G; Uedo, Y; Atsumi, Y; Kawashima, Y; Hibino, A; Tanaka, Y; Lee, YH; Kato, D; Takeo, M; Higuchi, Y; Negoro, S				Yasuhira, Kengo; Shibata, Naoki; Mongami, Go; Uedo, Yuki; Atsumi, Yu; Kawashima, Yasuyuki; Hibino, Atsushi; Tanaka, Yusuke; Lee, Young-Ho; Kato, Dai-ichiro; Takeo, Masahiro; Higuchi, Yoshiki; Negoro, Seiji			X-ray Crystallographic Analysis of the 6-Aminohexanoate Cyclic Dimer Hydrolase CATALYTIC MECHANISM AND EVOLUTION OF AN ENZYME RESPONSIBLE FOR NYLON-6 BYPRODUCT DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAMASE FOLD; LYS CATALYTIC TRIAD; TRANSITION-STATE; CRYSTAL-STRUCTURE; DEGRADING ENZYME; MALONAMIDASE E2; NYLON OLIGOMERS; AMIDE HYDROLASE; GENERAL BASE; MECHANISM	We performed x-ray crystallographic analyses of the 6-aminohexanoate cyclic dimer (Acd) hydrolase (NylA) from Arthrobacter sp., an enzyme responsible for the degradation of the nylon-6 industry byproduct. The fold adopted by the 472-amino acid polypeptide generated a compact mixed alpha/beta fold, typically found in the amidase signature superfamily; this fold was especially similar to the fold of glutamyl-tRNAGln amidotransferase subunit A (z score, 49.4) and malonamidase E2 (z score, 44.8). Irrespective of the high degree of structural similarity to the typical amidase signature superfamily enzymes, the specific activity of NylA for glutamine, malonamide, and indoleacetamide was found to be lower than 0.5% of that for Acd. However, NylA possessed carboxylesterase activity nearly equivalent to the Acd hydrolytic activity. Structural analysis of the inactive complex between the activity-deficient S174A mutant of NylA and Acd, performed at 1.8 angstrom resolution, suggested the following enzyme/substrate interactions: a Ser(174)-cis-Ser(150)-Lys(72) triad constitutes the catalytic center; the backbone N in Ala(171) and Ala(172) are involved in oxyanion stabilization; Cys(316)-S-gamma forms a hydrogen bond with nitrogen (Acd-N-7) at the uncleaved amide bond in two equivalent amide bonds of Acd. A single S174A, S150A, or K72A substitution in NylA by site-directed mutagenesis decreased the Acd hydrolytic and esterolytic activities to undetectable levels, indicating that Ser(174)-cis-Ser(150)-Lys(72) is essential for catalysis. In contrast, substitutions at position 316 specifically affected Acd hydrolytic activity, suggesting that Cys(316) is responsible for Acd binding. On the basis of the structure and functional analysis, we discussed the catalytic mechanisms and evolution of NylA in comparison with other Ser-reactive hydrolases.	[Shibata, Naoki; Higuchi, Yoshiki] Hyogo Med Univ, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Shibata, Naoki; Higuchi, Yoshiki] RIKEN Harima Inst, Spring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Lee, Young-Ho] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	University of Hyogo; RIKEN; Osaka University	Higuchi, Y (corresponding author), Hyogo Med Univ, Dept Life Sci, Grad Sch Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	hig@sci.u-hyogo.ac.jp	Takeo, Masahiro/GYA-3639-2022; Shibata, Naoki/AFK-9971-2022	Shibata, Naoki/0000-0002-5096-1104; Higuchi, Yoshiki/0000-0001-8284-5709	Japan Society for Promotion of Science; Global Centers of Excellence Program; National Project on Protein Structural and Functional Analyses; Core Research for Evolutional Science and Technology Program; JST; Japan Aerospace Exploration Agency project	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology Program(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); Japan Aerospace Exploration Agency project	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for Promotion of Science and by grants from the Global Centers of Excellence Program, the National Project on Protein Structural and Functional Analyses, the Core Research for Evolutional Science and Technology Program, "Development of the Foundation for Nano-Interface Technology" from JST, and the Japan Aerospace Exploration Agency project.	Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Asano Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2141, DOI 10.1271/bbb.80210; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cilia E, 2005, FEBS J, V272, P4716, DOI 10.1111/j.1742-4658.2005.04887.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FERSHT A, 1984, ENZYME STRUCTURE MEC, P389; Hermann JC, 2003, J AM CHEM SOC, V125, P9590, DOI 10.1021/ja034434g; Heumann S, 2009, BIOTECHNOL BIOENG, V102, P1003, DOI 10.1002/bit.22139; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; KANAGAWA K, 1989, J BACTERIOL, V171, P3181, DOI 10.1128/jb.171.6.3181-3186.1989; KATO K, 1995, MICROBIOL-UK, V141, P2585, DOI 10.1099/13500872-141-10-2585; Kawashima Y, 2009, FEBS J, V276, P2547, DOI 10.1111/j.1742-4658.2009.06978.x; KINOSHITA S, 1977, EUR J BIOCHEM, V80, P489, DOI 10.1111/j.1432-1033.1977.tb11904.x; Kobayashi M, 1998, FEBS LETT, V439, P325, DOI 10.1016/S0014-5793(98)01406-9; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Negoro S, 2000, APPL MICROBIOL BIOT, V54, P461, DOI 10.1007/s002530000434; Negoro S, 2005, J BIOL CHEM, V280, P39644, DOI 10.1074/jbc.M505946200; Negoro S., 2002, 9 BIOPOLYMERS, P395; Negoro S, 2007, J MOL BIOL, V370, P142, DOI 10.1016/j.jmb.2007.04.043; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Nukaga M, 2004, J BIOL CHEM, V279, P9344, DOI 10.1074/jbc.M312356200; Ohki T, 2006, FEBS LETT, V580, P5054, DOI 10.1016/j.febslet.2006.08.031; Ohki T, 2009, PROTEIN SCI, V18, P1662, DOI 10.1002/pro.185; OKADA H, 1983, NATURE, V306, P203, DOI 10.1038/306203a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmitt E, 2005, STRUCTURE, V13, P1421, DOI 10.1016/j.str.2005.06.016; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Silvaggi NR, 2003, BIOCHEMISTRY-US, V42, P1199, DOI 10.1021/bi0268955; TSUCHIYA K, 1989, J BACTERIOL, V171, P3187, DOI 10.1128/jb.171.6.3187-3191.1989; Valina ALB, 2004, BIOCHEMISTRY-US, V43, P15657, DOI 10.1021/bi049025r; Wagner UG, 2002, PROTEIN SCI, V11, P467, DOI 10.1110/ps.33002; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; YAMADA T, 1985, P NATL ACAD SCI USA, V82, P6522, DOI 10.1073/pnas.82.19.6522; Yasuhira K, 2007, J BIOSCI BIOENG, V104, P521, DOI 10.1263/jbb.104.521; Yasuhira K, 2007, APPL ENVIRON MICROB, V73, P7099, DOI 10.1128/AEM.00777-07; Yasuhira K, 2006, ACTA CRYSTALLOGR F, V62, P1209, DOI 10.1107/S1744309106045076; Yun YS, 2006, J BIOL CHEM, V281, P40057, DOI 10.1074/jbc.M604515200; Zawadzke LE, 1996, BIOCHEMISTRY-US, V35, P16475, DOI 10.1021/bi962242a	45	30	31	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1239	1248		10.1074/jbc.M109.041285	http://dx.doi.org/10.1074/jbc.M109.041285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889645	Green Published, hybrid			2022-12-27	WOS:000273258200046
J	Huang, RJ; Grabarek, Z; Wang, CLA				Huang, Renjian; Grabarek, Zenon; Wang, Chih-Lueh Albert			Differential Effects of Caldesmon on the Intermediate Conformational States of Polymerizing Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CALDESMON; F-ACTIN; CALMODULIN-BINDING; GIZZARD CALDESMON; CHICKEN GIZZARD; FILAMENTS; TROPOMYOSIN; COMPLEX; SITES; LOCALIZATION	The actin-binding protein caldesmon (CaD) reversibly inhibits smooth muscle contraction. In non-muscle cells, a shorter CaD isoform co-exists with microfilaments in the stress fibers at the quiescent state, but the phosphorylated CaD is found at the leading edge of migrating cells where dynamic actin filament remodeling occurs. We have studied the effect of a C-terminal fragment of CaD (H32K) on the kinetics of the in vitro actin polymerization by monitoring the fluorescence of pyrene-labeled actin. Addition of H32K or its phosphorylated form either attenuated or accelerated the pyrene emission enhancement, depending on whether it was added at the early or the late phase of actin polymerization. However, the CaD fragment had no effect on the yield of sedimentable actin, nor did it affect the actin ATPase activity. Our findings can be explained by a model in which nascent actin filaments undergo a maturation process that involves at least two intermediate conformational states. If present at early stages of actin polymerization, CaD stabilizes one of the intermediate states and blocks the subsequent filament maturation. Addition of CaD at a later phase accelerates F-actin formation. The fact that CaD is capable of inhibiting actin filament maturation provides a novel function for CaD and suggests an active role in the dynamic reorganization of the actin cytoskeleton.	[Huang, Renjian; Grabarek, Zenon; Wang, Chih-Lueh Albert] Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Wang, CLA (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	wang@bbri.org		Grabarek, Zenon/0000-0002-3636-5701	National Institutes of Health [HL91162, HL92252]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL91162 (to Z. G.) and HL92252 (to C. L. A. W.).	Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; BRETSCHER A, 1985, J CELL BIOL, V100, P1656, DOI 10.1083/jcb.100.5.1656; Brooks FJ, 2008, BIOPHYS J, V95, P1050, DOI 10.1529/biophysj.107.123125; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; CARLIER MF, 1984, J BIOL CHEM, V259, P9983; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; COOKE R, 1973, BIOCHEMISTRY-US, V12, P3927, DOI 10.1021/bi00744a022; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; CROSBIE RH, 1994, BIOCHEMISTRY-US, V33, P3210, DOI 10.1021/bi00177a010; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Foster DB, 2004, J BIOL CHEM, V279, P53387, DOI 10.1074/jbc.M410109200; GALAZKIEWICZ B, 1985, FEBS LETT, V184, P144, DOI 10.1016/0014-5793(85)80671-2; Galinska-Rakoczy A, 2009, J MOL BIOL, V387, P869, DOI 10.1016/j.jmb.2009.02.011; Gao Y, 1999, BIOCHEMISTRY-US, V38, P15459, DOI 10.1021/bi991383k; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; GRACEFFA P, 1987, FEBS LETT, V218, P139, DOI 10.1016/0014-5793(87)81034-7; Gunst SJ, 2003, J APPL PHYSIOL, V95, P413, DOI 10.1152/japplphysiol.00277.2003; HAYASHI T, 1962, BIOCHEM BIOPH RES CO, V8, P20, DOI 10.1016/0006-291X(62)90227-9; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang RJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P175, DOI 10.1016/j.abb.2006.07.018; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; HUMPHREY MB, 1992, GENE, V112, P197, DOI 10.1016/0378-1119(92)90376-Z; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Kordowska J, 2005, EXP CELL RES, V312, P95, DOI 10.1016/j.yexcr.2005.09.021; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kudryashov DS, 2004, BIOPHYS J, V87, P1136, DOI 10.1529/biophysj.104.042242; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Lehman W, 1992, J Muscle Res Cell Motil, V13, P582, DOI 10.1007/BF01738000; LEVINE BA, 1990, EUR J BIOCHEM, V193, P687, DOI 10.1111/j.1432-1033.1990.tb19388.x; MABUCHI K, 1991, J MUSCLE RES CELL M, V12, P145, DOI 10.1007/BF01774033; MARSTON SB, 1996, CALDESMON; Matsumura F, 1993, CURR OPIN CELL BIOL, V5, P70, DOI 10.1016/S0955-0674(05)80010-9; MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785; MORNET D, 1988, BIOCHEM BIOPH RES CO, V155, P808, DOI 10.1016/S0006-291X(88)80567-9; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Orlova A, 2004, P NATL ACAD SCI USA, V101, P17664, DOI 10.1073/pnas.0407525102; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Seow CY, 2005, NATURE, V435, P1172, DOI 10.1038/4351172a; SMITH CWJ, 1987, J BIOL CHEM, V262, P116; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; VELAZ L, 1989, J BIOL CHEM, V264, P9602; WANG CLA, 1991, J BIOL CHEM, V266, P9166; WANG CLA, 1991, J BIOL CHEM, V266, P13958; Wang CLA, 2001, CELL BIOCHEM BIOPHYS, V35, P275, DOI 10.1385/CBB:35:3:275; Wang Z, 1997, P NATL ACAD SCI USA, V94, P11899, DOI 10.1073/pnas.94.22.11899; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Winder SJ, 2003, CURR OPIN CELL BIOL, V15, P14, DOI 10.1016/S0955-0674(02)00002-9; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; Zhuang SB, 1996, J BIOL CHEM, V271, P30242, DOI 10.1074/jbc.271.47.30242	54	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					71	79		10.1074/jbc.M109.065078	http://dx.doi.org/10.1074/jbc.M109.065078			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19889635	hybrid, Green Published			2022-12-27	WOS:000273070100008
J	Koo, BH; Apte, SS				Koo, Bon-Hun; Apte, Suneel S.			Cell-surface Processing of the Metalloprotease Pro-ADAMTS9 Is Influenced by the Chaperone GRP94/gp96	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK-PROTEIN GP96; MATRIX-METALLOPROTEINASE; FURIN INTERACTS; ACTIVATION; EXPRESSION; MATURATION; MEMBRANE; RECEPTOR; COMPLEX; GENE	A disintegrin-like and metalloprotease domain with thrombospondin type 1 motifs 9 (ADAMTS9) is a highly conserved metalloprotease that has been identified as a tumor suppressor gene and is required for normal mouse development. The secreted ADAMTS9 zymogen undergoes proteolytic excision of its N-terminal propeptide by the proprotein convertase furin. However, in contrast to other metalloproteases, propeptide excision occurs at the cell surface and leads to decreased activity of the zymogen. Here, we investigated the potential cellular mechanisms regulating ADAMTS9 biosynthesis and cell-surface processing by analysis of molecular complexes formed by a construct containing the propeptide and catalytic domain of pro-ADAMTS9 (Pro-Cat) in HEK293F cells. Cross-linking of cellular proteins bound to Pro-Cat followed by mass spectrometric analysis identified UDP-glucose: glycoprotein glucosyltransferase I, heat shock protein gp96 (GRP94), BiP (GRP78), and ERdj3 (Hsp40 homolog) as associated proteins. gp96 and BiP were present at the cell surface in an immunoprecipitable complex with pro-ADAMTS9 and furin. Treatment with geldanamycin, an inhibitor of the HSP90 alpha family (including gp96), led to decreased furin processing of pro-ADAMTS9 and accumulation of the unprocessed pro-ADAMTS9 at the cell surface. gp96 siRNA down-regulated the levels of cell-surface pro-ADAMTS9 and furin, whereas the levels of cell-surface pro-ADAMTS9, but not of cell-surface furin, were decreased upon treatment with BiP siRNA. These data identify for the first time the cellular chaperones associated with secretion of an ADAMTS protease and suggest a role for gp96 in modulating pro-ADAMTS9 processing.	[Koo, Bon-Hun; Apte, Suneel S.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Koo, Bon-Hun] Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea	Cleveland Clinic Foundation; Yonsei University	Apte, SS (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn ND20, 9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Apte, Suneel/0000-0001-8441-1226	National Institutes of Health [AR49930, AR53890]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890, R01AR049930, R56AR049930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR49930 and AR53890 (to S. A.).	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Creemers JWM, 2000, J BIOL CHEM, V275, P38842, DOI 10.1074/jbc.M006758200; Dai Jie, 2003, Cancer Immun, V3, P1; DEBOER C, 1970, J ANTIBIOT, V23, P442, DOI 10.7164/antibiotics.23.442; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Guzman-Ayala M, 2004, P NATL ACAD SCI USA, V101, P15656, DOI 10.1073/pnas.0405429101; Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Joseph K, 2002, P NATL ACAD SCI USA, V99, P896, DOI 10.1073/pnas.022626899; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Kuznetsov G, 1998, NEW ENGL J MED, V339, P1688, DOI 10.1056/NEJM199812033392307; LEDUC R, 1992, J BIOL CHEM, V267, P14304; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Lo PHY, 2007, ONCOGENE, V26, P148, DOI 10.1038/sj.onc.1209767; Lung HL, 2008, INT J CANCER, V123, P401, DOI 10.1002/ijc.23528; MARTENS GJM, 1994, P NATL ACAD SCI USA, V91, P5784, DOI 10.1073/pnas.91.13.5784; Mayer G, 2004, J HISTOCHEM CYTOCHEM, V52, P567, DOI 10.1177/002215540405200502; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Muller L, 1999, J BIOL CHEM, V274, P21471, DOI 10.1074/jbc.274.30.21471; Nakamura H, 1999, CANCER RES, V59, P467; Picard D, 2004, NAT CELL BIOL, V6, P479, DOI 10.1038/ncb0604-479; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Robert J, 1999, J IMMUNOL, V163, P4133; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Thimon V, 2006, REPRODUCTION, V132, P899, DOI 10.1530/REP-06-0077; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; TSUNEOKA M, 1993, J BIOL CHEM, V268, P26461; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Yang Y, 2005, MOL CELLS, V20, P173; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zheng H, 2001, J IMMUNOL, V167, P6731, DOI 10.4049/jimmunol.167.12.6731	52	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					197	205		10.1074/jbc.M109.039677	http://dx.doi.org/10.1074/jbc.M109.039677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875450	Green Published, hybrid			2022-12-27	WOS:000273070100021
J	Reilly, MC; Levery, SB; Castle, SA; Klutts, JS; Doering, TL				Reilly, Morgann C.; Levery, Steven B.; Castle, Sherry A.; Klutts, J. Stacey; Doering, Tamara L.			A Novel Xylosylphosphotransferase Activity Discovered in Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE MUTANT STRAINS; CAPSULE-ASSOCIATED GENE; GLUCURONIC ACID; VIRULENCE; GLYCOSYLTRANSFERASES; XYLOSE; BETA-1,2-XYLOSYLTRANSFERASE; GALACTOXYLOMANNAN; IDENTIFICATION; MECHANISMS	Cryptococcus neoformans is a fungal pathogen that causes serious disease in immunocompromised individuals. The organism produces a distinctive polysaccharide capsule that is necessary for its virulence, a predominantly polysaccharide cell wall, and a variety of protein- and lipid-linked glycans. The glycan synthetic pathways of this pathogen are of great interest. Here we report the detection of a novel glycosylphosphotransferase activity in C. neoformans, identification of the corresponding gene, and characterization of the encoded protein. The observed activity is specific for UDP-xylose as a donor and for mannose acceptors and forms a xylose-alpha-1-phosphate-6-mannose linkage. This is the first report of a xylosylphosphotransferase activity in any system.	[Reilly, Morgann C.; Klutts, J. Stacey; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Levery, Steven B.] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Castle, Sherry A.] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA; [Klutts, J. Stacey] Univ Iowa, Dept Pathol, Carver Coll Med & Pathol & Lab Med, Iowa City, IA 52246 USA	Washington University (WUSTL); University of Copenhagen; University System Of New Hampshire; University of New Hampshire; University of Iowa	Doering, TL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	doering@wustl.edu		Reilly, Morgann/0000-0002-5526-8245; Klutts, James/0000-0003-3788-1940	National Institutes of Health [RO1 GM071007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM071007 (in support of the studies of cryptococcal glycan synthesis in the Doering laboratory).	Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; BRAULKE T, 2008, J INHERIT METAB DIS; Brown T., 2004, CURR PROTOCOLS MOL B, V67, p4.9.1; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Castle SA, 2008, EUKARYOT CELL, V7, P1611, DOI 10.1128/EC.00458-07; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Chang YC, 1996, INFECT IMMUN, V64, P1977, DOI 10.1128/IAI.64.6.1977-1983.1996; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Cherniak R, 1998, INFECT IMMUN, V66, P2996, DOI 10.1128/IAI.66.6.2996-2998.1998; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; FROMTLING RA, 1982, MYCOPATHOLOGIA, V79, P23, DOI 10.1007/BF00636177; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Gutierrez ALS, 2007, GLYCOBIOLOGY, V17, p1C, DOI 10.1093/glycob/cwm030; Heise N, 2002, GLYCOBIOLOGY, V12, P409, DOI 10.1093/glycob/cwf053; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; JACOBSON ES, 1982, J BACTERIOL, V150, P1292, DOI 10.1128/JB.150.3.1292-1296.1982; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Kwon-Chung KJ, 1998, MED MYCOL, V36, P38; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P1869, DOI 10.1128/IAI.60.5.1869-1874.1992; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LI YT, 1967, J BIOL CHEM, V242, P5474; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Nelson RT, 2001, GENETICS, V157, P935; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Pohl S, 2009, BBA-MOL BASIS DIS, V1792, P221, DOI 10.1016/j.bbadis.2009.01.009; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schutzbach J, 2007, CARBOHYD RES, V342, P881, DOI 10.1016/j.carres.2007.01.002; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; WICKES BL, 1994, MICROBIOL-SGM, V140, P543, DOI 10.1099/00221287-140-3-543; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Yan Z, 2002, J CLIN MICROBIOL, V40, P965, DOI 10.1128/JCM.40.3.965-972.2002	44	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36118	36127		10.1074/jbc.M109.056226	http://dx.doi.org/10.1074/jbc.M109.056226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864415	hybrid, Green Published			2022-12-27	WOS:000272970500013
J	Crane, JM; Bennett, JL; Verkman, AS				Crane, Jonathan M.; Bennett, Jeffrey L.; Verkman, A. S.			Live Cell Analysis of Aquaporin-4 M1/M23 Interactions and Regulated Orthogonal Array Assembly in Glial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSENSITIVE WATER CHANNEL; NEUROMYELITIS-OPTICA; PLASMA-MEMBRANE; SQUARE ARRAYS; M23 ISOFORMS; BRAIN EDEMA; SPINAL-CORD; RAT-BRAIN; MICE; PARTICLES	Aquaporin-4 (AQP4) can assemble into supramolecular aggregates called orthogonal arrays of particles (OAPs). In cells expressing single AQP4 isoforms, we found previously that OAP formation by AQP4-M23 requires N terminus interactions just downstream of Met-23 and that the inability of AQP4-M1 to form OAPs involves blocking by residues upstream of Met-23. Here, we studied M1/M23 interactions and regulated OAP assembly by nanometer-resolution tracking of quantum dot-labeled AQP4 in live cells expressing differentially tagged AQP4 isoforms and in primary glial cell cultures in which native AQP4 was labeled with a monoclonal recombinant neuromyelitis optica autoantibody. OAP assembly was assessed independently by Blue Native gel electrophoresis. We found that OAPs in native glial cells could be reproduced in transfected cells expressing equal amounts of AQP4-M1 and -M23. Mutants of M23 that do not themselves form OAPs, including M23-F26Q and M23-G28P, were able to fully co-associate with native M23 to form large immobile OAPs. Analysis of a palmitoylation-null M1 mutant (C13A/C17A) indicated palmitoylation-dependent OAP assembly only in the presence of M23, with increased M1 palmitoylation causing progressive OAP disruption. Differential regulation of OAP assembly by palmitoylation, calcium elevation, and protein kinase C activation was found in primary glial cell cultures. Weconclude that M1 and M23 co-assemble in AQP4OAPs and that specific signaling events can regulateOAP assembly in glial cells.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus		Alan.Verkman@ucsf.edu			National Institutes of Health [EB00415, HL73856, DK35124, EY13574, DK72517]; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society [NMSSRG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EB00415, HL73856, DK35124, EY13574, and DK72517 and by a grant from the Guthy-Jackson Charitable Foundation (to A. S. V.). This work was also supported by Grant NMSSRG4320 from the National Multiple Sclerosis Society (to J. L. B.).	Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; BENNETT JL, 2009, ANN NEUROL IN PRESS; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Carmosino M, 2001, J CELL BIOL, V154, P1235, DOI 10.1083/jcb.200103010; CRANE JM, 2009, BIOPHYS J IN PRESS; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; FRIGERI A, 1995, J CELL SCI, V108, P2993; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Han ZQ, 1998, J BIOL CHEM, V273, P6001, DOI 10.1074/jbc.273.11.6001; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; HATTON JD, 1984, EPILEPSIA, V25, P145, DOI 10.1111/j.1528-1157.1984.tb04170.x; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; LANDIS DMD, 1974, J CELL BIOL, V60, P316, DOI 10.1083/jcb.60.1.316; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nielsen S, 1997, J NEUROSCI, V17, P171; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SCHOTLAND DL, 1981, ACTA NEUROPATHOL, V54, P189, DOI 10.1007/BF00687741; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sonnleitner A, 1999, BIOPHYS J, V77, P2638, DOI 10.1016/S0006-3495(99)77097-9; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Van Hoek AN, 2000, AM J PHYSIOL-RENAL, V278, pF310, DOI 10.1152/ajprenal.2000.278.2.F310; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; WOLBURG H, 1995, J BRAIN RES, V36, P239; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yang BX, 1996, J BIOL CHEM, V271, P4577; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907	48	65	70	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35850	35860		10.1074/jbc.M109.071670	http://dx.doi.org/10.1074/jbc.M109.071670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843522	hybrid, Green Published			2022-12-27	WOS:000272645600061
J	McLean, KJ; Lafite, P; Levy, C; Cheesman, MR; Mast, N; Pikuleva, IA; Leys, D; Munro, AW				McLean, Kirsty J.; Lafite, Pierre; Levy, Colin; Cheesman, Myles R.; Mast, Natalia; Pikuleva, Irina A.; Leys, David; Munro, Andrew W.			The Structure of Mycobacterium tuberculosis CYP125 MOLECULAR BASIS FOR CHOLESTEROL BINDING IN A P450 NEEDED FOR HOST INFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOPHYSICAL CHARACTERIZATION; CYTOCHROME-P450 46A1; AZOLE ANTIFUNGALS; CRYSTAL-STRUCTURE; GROWTH; IDENTIFICATION; PURIFICATION; HYDROXYLASE; DEGRADATION; FLAVODOXIN	We report characterization and the crystal structure of the Mycobacterium tuberculosis cytochrome P450 CYP125, a P450 implicated in metabolism of host cholesterol and essential for establishing infection in mice. CYP125 is purified in a high spin form and undergoes both type I and II spectral shifts with various azole drugs. The 1.4-angstrom structure of ligand-free CYP125 reveals a "letterbox" active site cavity of dimensions appropriate for entry of a polycyclic sterol. A mixture of hexa-coordinate and penta-coordinate states could be discerned, with water binding as the 6th heme-ligand linked to conformation of the I-helix Val(267) residue. Structures in complex with androstenedione and the antitubercular drug econazole reveal that binding of hydrophobic ligands occurs within the active site cavity. Due to the funnel shape of the active site near the heme, neither approaches the heme iron. A model of the cholesterol CYP125 complex shows that the alkyl side chain extends toward the heme iron, predicting hydroxylation of cholesterol C27. The alkyl chain is in close contact to Val(267), suggesting a substrate binding-induced low-to high-spin transition coupled to reorientation of the latter residue. Reconstitution of CYP125 activity with a redox partner system revealed exclusively cholesterol 27-hydroxylation, consistent with structure and modeling. This activity may enable catabolism of host cholesterol or generation of immunomodulatory compounds that enable persistence in the host. This study reveals structural and catalytic properties of a potential M. tuberculosis drug target enzyme, and the likely mode by which the host-derived substrate is bound and hydroxylated.	[McLean, Kirsty J.; Lafite, Pierre; Levy, Colin; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Cheesman, Myles R.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	University of Manchester; University of East Anglia; Case Western Reserve University	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Lafite, Pierre/F-6806-2011; Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Lafite, Pierre/0000-0003-1637-4966; Munro, Andrew/0000-0002-4642-180X; Pikuleva, Irina/0000-0001-9742-6232; Levy, Colin/0000-0002-9724-310X; McLean, Kirsty/0000-0002-7193-5044	United Kingdom Biotechnology and Biological Sciences Research Council [C19757]; European Union [NM4TB]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United Kingdom Biotechnology and Biological Sciences Research Council Grant C19757 and European Union Framework Programme VI project NM4TB.	Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dutton P L, 1978, Methods Enzymol, V54, P411; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Lafite P, 2007, BIOCHEMISTRY-US, V46, P10237, DOI 10.1021/bi700876a; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; McLean KJ, 2008, DRUG METAB REV, V40, P427, DOI 10.1080/03602530802186389 ; McLean KJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P228, DOI 10.1016/j.abb.2007.03.026; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	46	88	98	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35524	35533		10.1074/jbc.M109.032706	http://dx.doi.org/10.1074/jbc.M109.032706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19846552	Green Published, hybrid			2022-12-27	WOS:000272645600029
J	Reisenauer, MR; Anderson, M; Huang, L; Zhang, ZJ; Zhou, QL; Kone, BC; Morris, AP; LeSage, GD; Dryer, SE; Zhang, WZ				Reisenauer, Mary Rose; Anderson, Marc; Huang, Le; Zhang, Zhijing; Zhou, Qiaoling; Kone, Bruce C.; Morris, Andrew P.; LeSage, Gene D.; Dryer, Stuart E.; Zhang, Wenzheng			AF17 Competes with AF9 for Binding to Dot1a to Up-regulate Transcription of Epithelial Na+ Channel alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER PROTEIN; SODIUM-CHANNEL; SURFACE EXPRESSION; CELL-SURFACE; UBIQUITIN LIGASE; ACUTE-LEUKEMIA; ENAC-ALPHA; ALDOSTERONE; NEDD4-2; GENE	We previously reported that Dot1a center dot AF9 complex represses transcription of the epithelial Na+ channel subunit alpha (alpha-ENaC) gene in mouse inner medullary collecting duct mIMCD3 cells and mouse kidney. Aldosterone relieves this repression by down-regulating the complex through various mechanisms. Whether these mechanisms are sufficient and conserved in human cells or can be applied to other aldosterone-regulated genes remains largely unknown. Here we demonstrate that human embryonic kidney 293T cells express the three ENaC subunits and all of the ENaC transcriptional regulators examined. These cells respond to aldosterone and display benzamil-sensitive Na+ currents, as measured by whole-cell patch clamping. We also show that AF17 and AF9 competitively bind to the same domain of Dot1a in multiple assays and have antagonistic effects on expression of an alpha-ENaC promoter-luciferase construct. Overexpression of Dot1a or AF9 decreased mRNA expression of the ENaC subunits and their transcriptional regulators and reduced benzamil-sensitive Na+ currents. AF17 overexpression caused the opposite effects, accompanied by redirection of Dot1a from the nucleus to the cytoplasm and reduction in histone H3 K79 methylation. The nuclear export inhibitor leptomycin B blocked the effect of AF17 overexpression on H3 K79 hypomethylation. RNAi-mediated knockdown of AF17 yielded nuclear enrichment of Dot1a and histone H3 K79 hypermethylation. As with AF9, AF17 displays nuclear and cytoplasmic co-localization with Sgk1. Therefore, AF17 competes with AF9 to bind Dot1a, decreases Dot1a nuclear expression by possibly facilitating its nuclear export, and relieves Dot1a center dot AF9-mediated repression of alpha-ENaC and other target genes.	[Morris, Andrew P.; LeSage, Gene D.; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr, Dept Internal Med, Houston, TX 77030 USA; [Huang, Le; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Anderson, Marc; Dryer, Stuart E.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Zhou, Qiaoling] Cent S Univ, Xiangya Hosp, Dept Internal Med, Changsha 410008, Hunan, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; Central South University	Zhang, WZ (corresponding author), Univ Texas Med Sch Houston, Dept Internal Med, 6431 Fannin,MSB 1-150, Houston, TX 77030 USA.	wenzheng.zhang@uth.tmc.edu			National Institutes of Health [R01 DK080236, R01 DK082529, R01 DK075065]; American Heart Association [0865271F]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK070834, R01DK080236, R01DK075065, R01DK082529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK080236 ( to W.Z.), R01 DK082529 ( to S. E. D.), and R01 DK075065 ( to B. K.). This work was also supported by American Heart Association Beginning Grant-in-aid 0865271F ( to W.Z.) and an American Society of Nephrology Carl W. Gottschalk Research Scholar Grant ( to W.Z.).	Bangel N, 2008, J CYST FIBROS, V7, P197, DOI 10.1016/j.jcf.2007.07.012; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; CHAPLIN T, 1995, BLOOD, V85, P1435, DOI 10.1182/blood.V85.6.1435.bloodjournal8561435; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gilmore ES, 2001, J BIOL CHEM, V276, P42610, DOI 10.1074/jbc.M106919200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kim EY, 2007, NEUROSCIENCE, V146, P1652, DOI 10.1016/j.neuroscience.2007.03.038; Kim EY, 2007, MOL PHARMACOL, V72, P622, DOI 10.1124/mol.107.038026; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Lin YM, 2001, CANCER RES, V61, P6345; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; MARUNAKA Y, 1992, AM J PHYSIOL, V263, pF392, DOI 10.1152/ajprenal.1992.263.3.F392; Mastroberardino L, 1998, MOL BIOL CELL, V9, P3417, DOI 10.1091/mbc.9.12.3417; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; PRASAD R, 1994, P NATL ACAD SCI USA, V91, P8107, DOI 10.1073/pnas.91.17.8107; Rao US, 2004, CELL CALCIUM, V35, P21, DOI 10.1016/S0143-4160(03)00157-X; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; RUBNITZ JE, 1994, BLOOD, V84, P1747; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Suzukawa K, 2005, INT J HEMATOL, V82, P38, DOI 10.1532/IJH97.05025; Thomas CP, 2004, CURR OPIN NEPHROL HY, V13, P541, DOI 10.1097/00041552-200409000-00010; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; ZEIDEL ML, 1988, J CLIN INVEST, V82, P1067, DOI 10.1172/JCI113663; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2004, AM J PHYSIOL-RENAL, V286, pF1171, DOI 10.1152/ajprenal.00043.2003; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	49	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35659	35669		10.1074/jbc.M109.038448	http://dx.doi.org/10.1074/jbc.M109.038448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19864429	Green Published, hybrid			2022-12-27	WOS:000272645600044
J	Yamazaki, M; Fukushima, H; Shin, M; Katagiri, T; Doi, T; Takahashi, T; Jimi, E				Yamazaki, Masato; Fukushima, Hidefumi; Shin, Masashi; Katagiri, Takenobu; Doi, Takahiro; Takahashi, Tetsu; Jimi, Eijiro			Tumor Necrosis Factor alpha Represses Bone Morphogenetic Protein (BMP) Signaling by Interfering with the DNA Binding of Smads through the Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD MONONUCLEAR-CELLS; OSTEOBLAST DIFFERENTIATION; TNF-ALPHA; RHEUMATOID-ARTHRITIS; ESTROGEN DEFICIENCY; RESPONSIVE ELEMENT; C2C12 MYOBLASTS; INHIBITION; RECEPTOR; INFLAMMATION	Bone morphogenetic proteins (BMPs) induce not only bone formation in vivo but also osteoblast differentiation of mesenchymal cells in vitro. Tumor necrosis factor alpha (TNF alpha) inhibits both osteoblast differentiation and bone formation induced by BMPs. However, the molecular mechanisms of these inhibitions remain unknown. In this study, we found that TNF alpha inhibited the alkaline phosphatase activity and markedly reduced BMP2- and Smad-induced reporter activity in MC3T3-E1 cells. TNF alpha had no effect on the phosphorylation of Smad1, Smad5, and Smad8 or on the nuclear translocation of the Smad1-Smad4 complex. In p65-deficient mouse embryonic fibroblasts, overexpression of p65, a subunit of NF-kappa B, inhibited BMP2- and Smad-induced reporter activity in a dose-dependent manner. Furthermore, this p65-mediated inhibition of BMP2- and Smad-responsive promoter activity was restored after inhibition of NF-kappa B by the overexpression of the dominant negative I kappa B alpha. Although TNF alpha failed to affect receptor-dependent formation of the Smad1-Smad4 complex, p65 associated with the complex. Chromatin immunoprecipitation and electrophoresis mobility shift assays revealed that TNF alpha suppressed the DNA binding of Smad proteins to the target gene. Importantly, the specific NF-kappa B inhibitor, BAY11-7082, abolished these phenomena. These results suggest that TNF alpha inhibits BMP signaling by interfering with the DNA binding of Smads through the activation of NF-kappa B.	[Jimi, Eijiro] Kyushu Dent Coll, Div Mol Signaling & Biochem, Dept Biosci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Yamazaki, Masato; Takahashi, Tetsu] Kyushu Dent Coll, Dept Oral & Maxillofacial Surg, Kitakyushu, Fukuoka 8038580, Japan; [Jimi, Eijiro] Kyushu Dent Coll, Oral Biol Res Ctr, Kitakyushu, Fukuoka 8038580, Japan; [Katagiri, Takenobu] Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol & Translat Res, Hidaka, Saitama 3501241, Japan; [Doi, Takahiro] RIKEN BioResource Ctr, Technol & Dev Team, BioSignal Program, Subteam BioSignal Integrat, Tsukuba, Ibaraki 3050074, Japan	Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; Saitama Medical University; RIKEN	Jimi, E (corresponding author), Kyushu Dent Coll, Div Mol Signaling & Biochem, Dept Biosci, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	ejimi@kyu-dent.ac.jp			Kyushu Dental College; Ministry of Education, Culture, Sports, Science and Technology of Japan [20390473]; Astellas Foundation for Research on Metabolic Disorders	Kyushu Dental College(Kyushu Dental College); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a grant-in-aid from Kyushu Dental College Internal Grants (to H. F. and E. J.), a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E. J.: 20390473), and by the Astellas Foundation for Research on Metabolic Disorders (to E. J.).	Ammann P, 1997, J CLIN INVEST, V99, P1699, DOI 10.1172/JCI119333; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Buma P, 2008, J BIOMED MATER RES B, V84B, P231, DOI 10.1002/jbm.b.30865; CANALIS E, 1987, ENDOCRINOLOGY, V121, P1596, DOI 10.1210/endo-121-5-1596; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Eliseev RA, 2006, EXP CELL RES, V312, P40, DOI 10.1016/j.yexcr.2005.09.016; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Hay E, 2004, J BIOL CHEM, V279, P1650, DOI 10.1074/jbc.M300969200; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kusumoto K, 2002, J INT MED RES, V30, P251, DOI 10.1177/147323000203000305; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nakase T, 1997, BONE, V21, P17, DOI 10.1016/S8756-3282(97)00038-0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; RALSTON SH, 1990, J BONE MINER RES, V5, P983; Ranganathan P, 2008, CURR OPIN MOL THER, V10, P562; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325	41	95	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35987	35995		10.1074/jbc.M109.070540	http://dx.doi.org/10.1074/jbc.M109.070540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19854828	hybrid, Green Published			2022-12-27	WOS:000272645600073
J	Ma, JJ; Ren, ZJ; Ma, Y; Xu, L; Zhao, Y; Zheng, CG; Fang, YH; Xue, T; Sun, BL; Xiao, WH				Ma, Jiajia; Ren, Zijia; Ma, Yang; Xu, Lu; Zhao, Ying; Zheng, Chaogu; Fang, Yinghui; Xue, Ting; Sun, Baolin; Xiao, Weihua			Targeted Knockdown of EGR-1 Inhibits IL-8 Production and IL-8-mediated Invasion of Prostate Cancer Cells through Suppressing EGR-1/NF-kappa B Synergy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE PROTEIN EGR-1; ACTIVATED T-CELLS; NF-KAPPA-B; METHYLATION STATES; CXC-CHEMOKINES; EXPRESSION; GROWTH; INTERLEUKIN-8; GENE; TRANSCRIPTION	IL-8 produced by prostate cancer cells may be responsible for the androgen-independent growth of advanced prostate cancers. Accumulating evidence from microarray analyses and animal genetic models highlights the central involvement of the transcription factor early growth response-1 (EGR-1) in prostate carcinoma progression. It is unknown, however, whether knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated tumor metastasis. Here we show that EGR-1 knockdown by a specific shRNA-Egr1 inhibited gene transcription and production of IL-8 by the human prostate cancer cell line DU145. Conversely, enforced expression of EGR-1 in EGR-1-lacking PC3 prostate cancer cells markedly enhanced IL-8 transcription and secretion. By using wild type and a series of mutant IL-8 promoter luciferase constructs, we found that the NF-kappa B binding site is important for EGR-1 regulation of IL-8. Furthermore, silencing EGR-1 suppressed a synergistically functional interaction between EGR-1 and NF-kappa B. Consequently, knockdown of EGR-1 inhibited IL-8-mediated tumor colony formation and invasion. Thus, targeted knockdown of EGR-1 could be an effective therapeutic approach against prostate cancer.	[Xiao, Weihua] Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xiao, WH (corresponding author), Univ Sci & Technol China, Inst Immunol, Sch Life Sci, 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	xiaow@ustc.edu.cn	Xiao, Weihua/N-2775-2013; 薛, 挺/D-4799-2011; Sun, Baolin/C-8354-2014	Xiao, Weihua/0000-0001-9102-6326; 薛, 挺/0000-0002-5644-6613; Sun, Baolin/0000-0002-2896-3015	National Natural Science Foundation of China [30771973, 30721002]; National Basic Research Program of China (973 Program) [2007CB914503]; Ministry of Science and Technology of China [KSCX1-YW-R-58, KJCX2-YW-N38]; China Ministry of Education [20060358019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Ministry of Education(Ministry of Education, China)	This work was supported in part by grants from the National Natural Science Foundation of China (30771973, 30721002), National Basic Research Program of China (973 Program) (2007CB914503), Ministry of Science and Technology of China (KSCX1-YW-R-58 and KJCX2-YW-N38), and China Ministry of Education (20060358019).	Ahmed MM, 2001, AM J CLIN ONCOL-CANC, V24, P500, DOI 10.1097/00000421-200110000-00017; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Baron V, 2003, ANN NY ACAD SCI, V1002, P197, DOI 10.1196/annals.1281.024; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; Cogswell PC, 1997, J EXP MED, V185, P491, DOI 10.1084/jem.185.3.491; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Eid MA, 1998, CANCER RES, V58, P2461; Ferrer FA, 1998, UROLOGY, V51, P161, DOI 10.1016/S0090-4295(97)00491-3; Huang JT, 2005, AM J PATHOL, V166, P1807, DOI 10.1016/S0002-9440(10)62490-X; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Lehrer S, 2004, TECHNOL CANCER RES T, V3, P411, DOI 10.1177/153303460400300501; Lentsch Alex B, 2006, Future Oncol, V2, P651, DOI 10.2217/14796694.2.5.651; Liu CT, 1998, CANCER GENE THER, V5, P3; MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Moon Y, 2007, BIOCHEM BIOPH RES CO, V362, P256, DOI 10.1016/j.bbrc.2007.07.168; Moore BB, 1999, AM J PATHOL, V154, P1503, DOI 10.1016/S0002-9440(10)65404-1; Mora GR, 2005, PROSTATE, V63, P198, DOI 10.1002/pros.20153; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thigpen AE, 1996, J UROLOGY, V155, P975, DOI 10.1016/S0022-5347(01)66361-4; Uehara H, 2005, PROSTATE, V64, P40, DOI 10.1002/pros.20223; Uzzo RG, 2006, CARCINOGENESIS, V27, P1980, DOI 10.1093/carcin/bgl034; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Waugh DJJ, 2008, FRONT BIOSCI, V13, P4595, DOI 10.2741/3025; Xiao DM, 2005, CANCER RES, V65, P9934, DOI 10.1158/0008-5472.CAN-05-1830; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8	33	57	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34600	34606		10.1074/jbc.M109.016246	http://dx.doi.org/10.1074/jbc.M109.016246			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837667	Green Published, hybrid			2022-12-27	WOS:000272439600015
J	Tanner, DR; Cariello, DA; Woolstenhulme, CJ; Broadbent, MA; Buskirk, AR				Tanner, Douglas R.; Cariello, Daniel A.; Woolstenhulme, Christopher J.; Broadbent, Mark A.; Buskirk, Allen R.			Genetic Identification of Nascent Peptides That Induce Ribosome Stalling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER-RNA; PROLYL-TRANSFER-RNA; ESCHERICHIA-COLI; TRANSLATION ARREST; TRANSFERASE CENTER; TRYPTOPHAN INDUCTION; RARE CODONS; AMINO-ACID; A-SITE; SECM	Several nascent peptides stall ribosomes during their own translation in both prokaryotes and eukaryotes. Leader peptides that induce stalling can regulate downstream gene expression. Interestingly, stalling peptides show little sequence similarity and interact with the ribosome through distinct mechanisms. To explore the scope of regulation by stalling peptides and to better understand the mechanism of stalling, we identified and characterized new examples from random libraries. We created a genetic selection that ties the life of Escherichia coli cells to stalling at a specific site. This selection relies on the natural bacterial system that rescues arrested ribosomes. We altered transfer-messenger RNA, a key component of this rescue system, to direct the completion of a necessary protein if and only if stalling occurs. We identified three classes of stalling peptides: C-terminal Pro residues, SecM-like peptides, and the novel stalling sequence FXXYXIWPP. Like the leader peptides SecM and TnaC, the FXXYXIWPP peptide induces stalling efficiently by inhibiting peptidyl transfer. The nascent peptide exit tunnel and peptidyltransferase center are implicated in this stalling event, although mutations in the ribosome affect stalling on SecM and FXXYXIWPP differently. We conclude that ribosome stalling can be caused by numerous sequences and is more common than previously believed.	[Tanner, Douglas R.; Cariello, Daniel A.; Woolstenhulme, Christopher J.; Broadbent, Mark A.; Buskirk, Allen R.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Brigham Young University	Buskirk, AR (corresponding author), Brigham Young Univ, Dept Chem & Biochem, C203 BNSN, Provo, UT 84602 USA.	buskirk@chem.byu.edu			National Institutes of Health [GM77633]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM77633 (to A. B.).	Beringer M, 2008, RNA, V14, P795, DOI 10.1261/rna.980308; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; Collier J, 2004, J BIOL CHEM, V279, P54193, DOI 10.1074/jbc.M314012200; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; HENTZEN D, 1972, BIOCHIM BIOPHYS ACTA, V281, P228, DOI 10.1016/0005-2787(72)90174-8; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Miller J.H., 1972, EXPT MOL GENETICS; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; MOTTAGUITABAR S, 1994, EMBO J, V13, P249, DOI 10.1002/j.1460-2075.1994.tb06255.x; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Tanner DR, 2006, J BIOL CHEM, V281, P10561, DOI 10.1074/jbc.M600167200; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002	47	76	78	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34809	34818		10.1074/jbc.M109.039040	http://dx.doi.org/10.1074/jbc.M109.039040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840930	Green Published, hybrid			2022-12-27	WOS:000272439600036
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			Succeeding in Science Despite the Odds; Studying Metabolism with NMR by Mildred Cohn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item														Kresge, Nicole/0000-0003-1551-6627				COHN MA, PUBLICATION LIST	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45							e12					2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19891052				2022-12-27	WOS:000271378400074
J	Matsuda, JJ; Filali, MS; Collins, MM; Volk, KA; Lamb, FS				Matsuda, James J.; Filali, Mohammed S.; Collins, Malia M.; Volk, Kenneth A.; Lamb, Fred S.			The ClC-3 Cl-/H+ Antiporter Becomes Uncoupled at Low Extracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; SIGNALING ENDOSOMES; PROKARYOTIC HOMOLOG; PLASMA-MEMBRANE; CELLS; ACIDIFICATION; CURRENTS; TRANSPORTERS; SELECTIVITY; ACTIVATION	Adenovirus expressing ClC-3 (Ad-ClC-3) induces Cl-/H+ antiportcurrent (IClC-3) in HEK293 cells. The outward rectification and time dependence of IClC-3 closely resemble an endogenous HEK293 cell acid-activated Cl- current (IClacid) seen at extracellular pH <= 5.5. IClacid was present in smooth muscle cells from wildtype but not ClC-3 null mice. We therefore sought to determine whether these currents were related. IClacid was larger in cells expressing Ad-ClC-3. Protons shifted the reversal potential (E-rev) of IClC-3 between pH 8.2 and 6.2, but not pH 6.2 and 5.2, suggesting that Cl- and H+ transport become uncoupled at low pH. At pH 4.0 E-rev was completely Cl- dependent (55.8 +/- 2.3 mV/decade). Several findings linked ClC-3 with native IClacid; 1) RNA interference directed at ClC-3 message reduced native IClacid; 2) removal of the extracellular "fast gate" (E224A) produced large currents that were pH-insensitive; and 3) wild-type IClC-3 and IClacid were both inhibited by (2-sulfonatoethyl) methanethiosulfonate (MTSES; 10-500 mu M)-induced alkanethiolation at exposed cysteine residues. However, a ClC-3 mutant lacking four extracellular cysteine residues (C103_P130del) was completely resistant to MTSES. C103_P130del currents were still acid-activated, but could be distinguished from wild-type IClC-3 and from native IClacid by a much slower response to low pH. Thus, ClC-3 currents are activated by protons and ClC-3 protein may account for native IClacid. Low pH uncouples Cl-/H+ transport so that at pH 4.0 ClC-3 behaves as an anion-selective channel. These findings have important implications for the biology of Cl-/H+ antiporters and perhaps for pH regulation in highly acidic intracellular compartments.	[Matsuda, James J.; Filali, Mohammed S.; Collins, Malia M.; Volk, Kenneth A.; Lamb, Fred S.] Univ Iowa, Dept Pediat, Childrens Hosp, Iowa City, IA 52242 USA	University of Iowa	Lamb, FS (corresponding author), Univ Iowa, Dept Pediat, 7770-F JPP, Iowa City, IA 52242 USA.	fred-lamb@uiowa.edu		Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [R01 HL62483, T32 DK07690-15]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL62483 (to F. S. L.) and T32 DK07690-15 (to J. J. M.).	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Auzanneau C, 2003, J BIOL CHEM, V278, P19230, DOI 10.1074/jbc.M301096200; Barg S, 2001, J CELL SCI, V114, P2145; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Chen SF, 1997, J MEMBRANE BIOL, V155, P11, DOI 10.1007/s002329900154; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hayashi M, 2002, J NEUROCHEM, V82, P698, DOI 10.1046/j.1471-4159.2002.01025.x; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482, P19; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Lamb FS, 2009, ANTIOXID REDOX SIGN, V11, P1335, DOI [10.1089/ars.2008.2448, 10.1089/ARS.2009.2448]; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Lisal J, 2009, PHILOS T R SOC B, V364, P181, DOI 10.1098/rstb.2008.0123; Ma ZY, 2008, BIOCHEM BIOPH RES CO, V371, P437, DOI 10.1016/j.bbrc.2008.04.090; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Nobles M, 2004, AM J PHYSIOL-CELL PH, V287, pC1426, DOI 10.1152/ajpcell.00549.2002; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SchmidtRose T, 1997, P NATL ACAD SCI USA, V94, P7633, DOI 10.1073/pnas.94.14.7633; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P3879, DOI 10.1073/pnas.95.7.3879; Sile S, 2006, CURR OPIN NEPHROL HY, V15, P511, DOI 10.1097/01.mnh.0000242177.36953.be; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Vanoye CG, 2002, J PHYSIOL-LONDON, V539, P373, DOI 10.1113/jphysiol.2001.013115; Weng TX, 2002, AM J PHYSIOL-CELL PH, V283, pC839, DOI 10.1152/ajpcell.00445.2001; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200; Yamamoto S, 2006, AM J PHYSIOL-HEART C, V290, pH1905, DOI 10.1152/ajpheart.00965.2005; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zhang YY, 2006, BIOPHYS J, V91, P2901, DOI 10.1529/biophysj.106.087700; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	55	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2569	2579		10.1074/jbc.M109.018002	http://dx.doi.org/10.1074/jbc.M109.018002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926787	Green Published, hybrid			2022-12-27	WOS:000273697800036
J	Goruppi, S; Iovanna, JL				Goruppi, Sandro; Iovanna, Juan Lucio			Stress-inducible Protein p8 Is Involved in Several Physiological and Pathological Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MESANGIAL CELL HYPERTROPHY; BREAST-CANCER CELLS; GENE-EXPRESSION; LUTEINIZING-HORMONE; MICROARRAY ANALYSIS; INDUCED APOPTOSIS; PROSTATE-CANCER; MESSENGER-RNA; UP-REGULATION; GROWTH	p8 (NUPR1 (nuclear protein-1), Com1 (candidate of metastasis-1)) is a protein related to the high mobility group of transcriptional regulators. It is a key player in the cellular stress response and is involved in metastasis. p8 was first identified as a gene induced in pancreatitis but has been since found overexpressed in several cancers and pathological conditions. Despite its small size and apparently simple structure, p8 functions in several biochemical and genetic pathways, and its expression is crucial for in vivo metastasis in mice, for cytokine induction of metalloproteases, and for stress-induced cardiomyocyte hypertrophy. Understanding p8 functions will provide new opportunities for developing more effective therapeutic approaches to cancer and cardiovascular diseases.	[Goruppi, Sandro] Tufts Univ, Mol Cardiol Res Inst, Tufts Med Ctr, Sch Med, Boston, MA 02111 USA; [Goruppi, Sandro] Tufts Univ, Dept Med, Sch Med, Boston, MA 02111 USA; [Iovanna, Juan Lucio] INSERM, Unite Stress Cellulaire 624, F-13288 Marseille 9, France	Tufts Medical Center; Tufts University; Tufts University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Goruppi, S (corresponding author), Tufts Univ, Mol Cardiol Res Inst, Tufts Med Ctr, Sch Med, Boston, MA 02111 USA.	sgoruppi@tuftsmedicalcenter.org; juan.iovanna@inserm.fr	Iovanna, Juan/M-9805-2017	Iovanna, Juan/0000-0003-1822-2237	American Heart Association [SDG 0830359N]; La Ligue; INSERM; Institut National du Cancer (INCa)	American Heart Association(American Heart Association); La Ligue; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was supported by American Heart Association Grant SDG 0830359N (to S. G.) and by grants from La Ligue, INSERM, and Institut National du Cancer (INCa) (to J. L. I.).	Bratland A, 2000, CANCER RES, V60, P5578; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Carracedo A, 2006, FEBS LETT, V580, P1571, DOI 10.1016/j.febslet.2006.01.084; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; Garcia-Montero AC, 2001, BIOCHEM J, V357, P249, DOI 10.1042/0264-6021:3570249; Gironella M, 2009, J CELL PHYSIOL, V221, P594, DOI 10.1002/jcp.21889; Goruppi S, 2004, J BIOL CHEM, V279, P20950, DOI 10.1074/jbc.M312401200; Goruppi S, 2002, EMBO J, V21, P5427, DOI 10.1093/emboj/cdf535; Goruppi S, 2007, MOL CELL BIOL, V27, P993, DOI 10.1128/MCB.00996-06; Hoffmeister A, 2002, J BIOL CHEM, V277, P22314, DOI 10.1074/jbc.M201657200; Igarashi T, 2001, DEV GROWTH DIFFER, V43, P693; Ito Y, 2005, ANTICANCER RES, V25, P833; Ito Y, 2005, ANTICANCER RES, V25, P3419; Jiang WG, 2006, INT J MOL MED, V18, P1169; Jiang WG, 2006, INT J MOL MED, V18, P981; Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953; Kallwellis K, 2006, HORM METAB RES, V38, P570, DOI 10.1055/s-2006-950503; Malicet C, 2006, P NATL ACAD SCI USA, V103, P2671, DOI 10.1073/pnas.0508955103; Malicet C, 2006, BIOCHEM BIOPH RES CO, V339, P284, DOI 10.1016/j.bbrc.2005.11.018; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Mohammad HP, 2004, MOL ENDOCRINOL, V18, P2583, DOI 10.1210/me.2004-0163; Passe CMM, 2008, BIOL REPROD, V79, P598, DOI 10.1095/biolreprod.108.068304; Path G, 2004, DIABETES, V53, pS82, DOI 10.2337/diabetes.53.2007.S82; Plant SR, 2006, GLIA, V53, P529, DOI 10.1002/glia.20297; Quirk CC, 2003, J BIOL CHEM, V278, P1680, DOI 10.1074/jbc.M209906200; Ree AH, 1999, CANCER RES, V59, P4675; Ree AH, 2000, CLIN CANCER RES, V6, P1778; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sambasivan R, 2008, J BIOSCIENCES, V33, P27, DOI 10.1007/s12038-008-0019-6; Sambasivan R, 2009, J CELL SCI, V122, P3481, DOI 10.1242/jcs.048678; Su SB, 2001, CLIN CANCER RES, V7, P309; Su SB, 2001, PANCREAS, V23, P134, DOI 10.1097/00006676-200108000-00003; Taieb D, 2005, HEPATOLOGY, V42, P176, DOI 10.1002/hep.20759; Valacco MP, 2006, J CELL BIOCHEM, V97, P1066, DOI 10.1002/jcb.20682; Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj.onc.1205222; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Vasseur S, 1999, BIOCHEM J, V343, P377, DOI 10.1042/0264-6021:3430377; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	42	81	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1577	1581		10.1074/jbc.R109.080887	http://dx.doi.org/10.1074/jbc.R109.080887			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19926786	Green Published, hybrid			2022-12-27	WOS:000273429100002
J	Oda, K; Matoba, Y; Noda, M; Kumagai, T; Sugiyama, M				Oda, Kosuke; Matoba, Yasuyuki; Noda, Masafumi; Kumagai, Takanori; Sugiyama, Masanori			Catalytic Mechanism of Bleomycin N-Acetyltransferase Proposed on the Basis of Its Crystal Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE DETERMINANT; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCES-VERTICILLUS; KINETIC MECHANISM; SUBSTRATE-BINDING; ESCHERICHIA-COLI; COENZYME-A; PROTEINS; COMPLEX; CLEAVAGE	Bleomycin (Bm) N-acetyltransferase, BAT, is a self-resistance determinant in Bm-producing Streptomyces verticillus ATCC15003. In our present study, we crystallized BAT under both a terrestrial and a microgravity environment in the International Space Station. In addition to substrate-free BAT, the crystal structures of BAT in a binary complex with CoA and in a ternary complex with Bm and CoA were determined. BAT forms a dimer structure via interaction of its C-terminal domains in the monomers. However, each N-terminal domain in the dimer is positioned without mutual interaction. The tunnel observed in the N-terminal domain of BAT has two entrances: one that adopts a wide funnel-like structure necessary to accommodate the metal-binding domain of Bm, and another narrow entrance that accommodates acetyl-CoA (AcCoA). A groove formed on the dimer interface of two BAT C-terminal domains accommodates the DNA-binding domain of Bm. In a ternary complex of BAT, BmA2, and CoA, a thiol group of CoA is positioned near the primary amine of Bm at the midpoint of the tunnel. This proximity ensures efficient transfer of an acetyl group from AcCoA to the primary amine of Bm. Based on the BAT crystal structure and the enzymatic kinetic study, we propose that the catalytic mode of BAT takes an ordered-like mechanism.	[Oda, Kosuke; Matoba, Yasuyuki; Noda, Masafumi; Kumagai, Takanori; Sugiyama, Masanori] Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University	Sugiyama, M (corresponding author), Hiroshima Univ, Dept Mol Microbiol & Biotechnol, Grad Sch Biomed Sci, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	sugi@hiroshima-u.ac.jp	ODA, KOSUKE/ABD-2610-2021		National Project on Protein Structural and Functional Analyses, Japan; Ministry of Education, Science, and Culture of Japan	National Project on Protein Structural and Functional Analyses, Japan; Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the National Project on Protein Structural and Functional Analyses, Japan (to M.S.), and a grant-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (to Y.M.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergdoll M, 1998, PROTEIN SCI, V7, P1661, DOI 10.1002/pro.5560070801; BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGER RM, 1981, J BIOL CHEM, V256, P1636; CARTER BJ, 1990, J BIOL CHEM, V265, P4193; CARTER BJ, 1990, P NATL ACAD SCI USA, V87, P9373, DOI 10.1073/pnas.87.23.9373; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Garcia-Ruiz JM, 2002, ACTA CRYSTALLOGR D, V58, P1638, DOI 10.1107/S0907444902014464; GATIGNOL A, 1988, FEBS LETT, V230, P171, DOI 10.1016/0014-5793(88)80665-3; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; He HZ, 2003, J MOL BIOL, V325, P1019, DOI 10.1016/S0022-2836(02)01284-6; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KANE SA, 1994, J BIOL CHEM, V269, P10899; Kawano Y, 2000, J MOL BIOL, V295, P915, DOI 10.1006/jmbi.1999.3404; Kumagai T, 1999, FEBS LETT, V442, P34, DOI 10.1016/S0014-5793(98)01613-5; MAGLIOZZO RS, 1989, MOL PHARMACOL, V35, P428; Maruyama M, 2001, J BIOL CHEM, V276, P9992, DOI 10.1074/jbc.M009874200; Matsuo H, 1997, FEMS MICROBIOL LETT, V153, P83, DOI 10.1016/S0378-1097(97)00237-1; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; OPPENHEIMER NJ, 1979, BIOCHEMISTRY-US, V18, P3439, DOI 10.1021/bi00583a001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; STUBBE J, 1987, CHEM REV, V87, P1107, DOI 10.1021/cr00081a011; Sugiyama M, 2002, J BIOL CHEM, V277, P2311, DOI 10.1074/jbc.M103278200; SUGIYAMA M, 1994, FEMS MICROBIOL LETT, V121, P81, DOI 10.1111/j.1574-6968.1994.tb07079.x; SUGIYAMA M, 1994, GENE, V151, P11; SUGIYAMA M, 1995, FEBS LETT, V362, P80, DOI 10.1016/0014-5793(95)00218-X; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; UMEZAWA H, 1974, FED PROC, V33, P2296; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Vetting MW, 2003, PROTEIN SCI, V12, P1954, DOI 10.1110/ps.03153703; Vetting MW, 2002, NAT STRUCT BIOL, V9, P653, DOI 10.1038/nsb830; Wu W, 1996, J AM CHEM SOC, V118, P1281, DOI 10.1021/ja952497w; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7	42	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1446	1456		10.1074/jbc.M109.022277	http://dx.doi.org/10.1074/jbc.M109.022277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889644	Green Published, hybrid			2022-12-27	WOS:000273258200064
J	Orba, Y; Suzuki, T; Makino, Y; Kubota, K; Tanaka, S; Kimura, T; Sawa, H				Orba, Yasuko; Suzuki, Tadaki; Makino, Yoshinori; Kubota, Kanako; Tanaka, Shinya; Kimura, Takashi; Sawa, Hirofumi			Large T Antigen Promotes JC Virus Replication in G(2)-arrested Cells by Inducing ATM- and ATR-mediated G(2) Checkpoint Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; BINDING-ACTIVITY; NUCLEAR-MATRIX; SV40 ORIGIN; S-PHASE; KINASE; POLYOMAVIRUS; CYCLE; P53	Large T antigen (TAg) of the human polyomavirus JC virus (JCV) possesses DNA binding and helicase activities, which, together with various cellular proteins, are required for replication of the viral genome. We now show that JCV-infected cells expressing TAg accumulate in the G(2) phase of the cell cycle as a result of the activation of ATM- and ATR-mediated G(2) checkpoint pathways. Transient transfection of cells with a TAg expression vector also induced G(2) checkpoint signaling and G(2) arrest. Analysis of TAg mutants with different subnuclear localizations suggested that the association of TAg with cellular DNA contributes to the induction of G(2) arrest. Abrogation of G(2) arrest by inhibition of ATM and ATR, Chk1, and Wee1 suppressed JCV genome replication. In addition, abrogation of the G(2)-M transition by Cdc2 depletion disabled Wee1 depletion induced suppression of JCV genome replication, suggesting that JCV replication is facilitated by G(2) arrest resulting from G(2) checkpoint signaling. Moreover, inhibition of ATM and ATR by caffeine suppressed JCV production. The observation that oligodendrocytes productively infected with JCV in vivo also undergo G(2) arrest suggests that G(2) checkpoint inhibitors such as caffeine are potential therapeutic agents for JCV infection.	[Orba, Yasuko; Suzuki, Tadaki; Makino, Yoshinori; Kimura, Takashi; Sawa, Hirofumi] Hokkaido Univ, Dept Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Kubota, Kanako] Hokkaido Univ Hosp, Dept Surg Pathol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Canc Res Lab, Dept Pathol,Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Global COE Program, Kita Ku, Sapporo, Hokkaido 0600818, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Sawa, H (corresponding author), Hokkaido Univ, Dept Mol Pathobiol, Res Ctr Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.	h-sawa@czc.hokudai.ac.jp	Tanaka, Shinya/D-3586-2011; Sawa, Hirofumi/F-6954-2012; Suzuki, Tadaki/ABH-2661-2020; Kimura, Takashi/F-6880-2012; Orba, Yasuko/F-6888-2012; Sawa, Hirofumi/AAW-8816-2021	Sawa, Hirofumi/0000-0003-2569-2755; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Ministry of Health, Labor, and Welfare of Japan; Japan Health Science Foundation; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Ministry of Health, Labor, and Welfare of Japan, the Japan Health Science Foundation, and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, MEXT.	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Berger JR, 2007, CURR NEUROL NEUROSCI, V7, P461, DOI 10.1007/s11910-007-0072-9; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Caracciolo V, 2006, ONCOGENE, V25, P5294, DOI 10.1038/sj.onc.1209681; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; CHEN NN, 1995, J VIROL, V69, P5843, DOI 10.1128/JVI.69.9.5843-5848.1995; CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0; Dahl J, 2005, J VIROL, V79, P13007, DOI 10.1128/JVI.79.20.13007-13017.2005; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DICKMANNS A, 1994, J VIROL, V68, P5496, DOI 10.1128/JVI.68.9.5496-5508.1994; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jiao JF, 2003, J VIROL, V77, P12720, DOI 10.1128/JVI.77.23.12720-12728.2003; Komagome R, 2002, J VIROL, V76, P12992, DOI 10.1128/JVI.76.24.12992-13000.2002; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lehman JM, 2000, EXP CELL RES, V258, P215, DOI 10.1006/excr.2000.4927; LEHMAN JM, 1994, CYTOMETRY, V16, P138, DOI 10.1002/cyto.990160207; LIN HJL, 1992, J VIROL, V66, P5443, DOI 10.1128/JVI.66.9.5443-5452.1992; Liu QH, 2000, GENE DEV, V14, P1448; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; NELSON WG, 1986, ANNU REV BIOPHYS BIO, V15, P457, DOI 10.1146/annurev.bb.15.060186.002325; NUKUZUMA S, 1995, J MED VIROL, V47, P370, DOI 10.1002/jmv.1890470413; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Okada Y, 2002, ACTA NEUROPATHOL, V104, P130, DOI 10.1007/s00401-002-0526-8; Okubo E, 2003, J VIROL, V77, P1257, DOI 10.1128/JVI.77.2.1257-1267.2003; Orba Y, 2008, VIROLOGY, V370, P173, DOI 10.1016/j.virol.2007.08.034; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Raleigh JM, 2000, J CELL SCI, V113, P1727; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Robison JG, 2007, CELL CYCLE, V6, P2408, DOI 10.4161/cc.6.19.4773; SCHNEIDER C, 1994, MOL CELL BIOL, V14, P3176, DOI 10.1128/MCB.14.5.3176; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SIMMONS DT, 1990, J VIROL, V64, P4858, DOI 10.1128/JVI.64.10.4858-4865.1990; Sunden Y, 2006, ACTA NEUROPATHOL, V111, P379, DOI 10.1007/s00401-005-0025-9; Suzuki S, 2001, VIROLOGY, V286, P100, DOI 10.1006/viro.2001.0972; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wu CX, 2001, J VIROL, V75, P2839, DOI 10.1128/JVI.75.6.2839-2847.2001; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	50	60	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1544	1554		10.1074/jbc.M109.064311	http://dx.doi.org/10.1074/jbc.M109.064311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19903823	Green Published, hybrid			2022-12-27	WOS:000273258200073
J	Guthrie, C				Guthrie, Christine			From the Ribosome to the Spliceosome and Back Again	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-DEPENDENT ATPASE; SMALL NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; REQUIRES ATP; U6 SNRNA; YEAST; BOX; RECOGNITION; U2; MECHANISM		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	christineguthrie@gmail.com			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021119, R37GM021119] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM021119, R01 GM021119, GM21119] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abelson J, 2008, NAT STRUCT MOL BIOL, V15, P1235, DOI 10.1038/nsmb1208-1235; ARES M, 1986, CELL, V47, P49, DOI 10.1016/0092-8674(86)90365-X; Brenner TJ, 2005, GENETICS, V170, P1063, DOI 10.1534/genetics.105.042044; BRODY E, 1985, SCIENCE, V228, P963, DOI 10.1126/science.3890181; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; BURGESS S, 1990, CELL, V60, P705, DOI 10.1016/0092-8674(90)90086-T; BURGESS SM, 1993, TRENDS BIOCHEM SCI, V18, P381, DOI 10.1016/0968-0004(93)90094-4; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; COUTO JR, 1987, GENE DEV, V1, P445, DOI 10.1101/gad.1.5.445; Daniell E, 2008, EVERY OTHER THURSDAY; Fitzgerald F.Scott., 1925, GREAT GATSBY; GUTHRIE C, 1969, COLD SPRING HARB SYM, V34, P69, DOI 10.1101/SQB.1969.034.01.011; GUTHRIE C, 1968, NATURE, V219, P232, DOI 10.1038/219232a0; KANDELSLEWIS S, 1993, SCIENCE, V262, P2035, DOI 10.1126/science.8266100; KRETZNER L, 1987, CELL, V50, P593, DOI 10.1016/0092-8674(87)90032-8; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Maeder C, 2008, NAT STRUCT MOL BIOL, V15, P426, DOI 10.1038/nsmb0508-426; Noble SM, 1996, GENETICS, V143, P67; NOLLER HF, 1981, SCIENCE, V212, P403, DOI 10.1126/science.6163215; PARKER R, 1985, CELL, V41, P107, DOI 10.1016/0092-8674(85)90065-0; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PATTERSON B, 1987, CELL, V49, P613, DOI 10.1016/0092-8674(87)90537-X; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; RIEDEL N, 1987, SCIENCE, V235, P328, DOI 10.1126/science.2948278; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; SHUSTER EO, 1990, NATURE, V345, P270, DOI 10.1038/345270a0; Siatecka M, 1999, GENE DEV, V13, P1983, DOI 10.1101/gad.13.15.1983; SILICIANO PG, 1987, SCIENCE, V237, P1484, DOI 10.1126/science.3306922; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; STRAUSS EJ, 1991, GENE DEV, V5, P629, DOI 10.1101/gad.5.4.629; TOLLERVEY D, 1983, CELL, V35, P753, DOI 10.1016/0092-8674(83)90108-3; WISE JA, 1983, CELL, V35, P743, DOI 10.1016/0092-8674(83)90107-1; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	41	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					1	12		10.1074/jbc.X109.080580	http://dx.doi.org/10.1074/jbc.X109.080580			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880518	Green Published, hybrid			2022-12-27	WOS:000273070100002
J	Yang, Y; Wu, X; Gui, PC; Wu, JB; Sheng, JZ; Ling, SZ; Braun, AP; Davis, GE; Davis, MJ				Yang, Yan; Wu, Xin; Gui, Peichun; Wu, Jianbo; Sheng, Jian-Zhong; Ling, Shizhang; Braun, Andrew P.; Davis, George E.; Davis, Michael J.			alpha 5 beta 1 Integrin Engagement Increases Large Conductance, Ca2+-activated K+ Channel Current and Ca2+ Sensitivity through c-src-mediated Channel Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; VASCULAR SMOOTH-MUSCLE; RGD-CONTAINING PEPTIDE; PROTEIN-KINASE-A; EXTRACELLULAR-MATRIX; TYROSINE KINASE; ENDOTHELIAL-CELLS; INJURY; HSLO; ADHESION	Large conductance, calcium-activated K+ (BK) channels are important regulators of cell excitability and recognized targets of intracellular kinases. BK channel modulation by tyrosine kinases, including focal adhesion kinase and c-src, suggests their potential involvement in integrin signaling. Recently, we found that fibronectin, an endogenous alpha 5 beta 1 integrin ligand, enhances BK channel current through both Ca2+- and phosphorylation-dependent mechanisms in vascular smooth muscle. Here, we show that macroscopic currents from HEK 293 cells expressing murine BK channel alpha-subunits (mSlo) are acutely potentiated following alpha 5 beta 1 integrin activation. The effect occurs in a Ca2+-dependent manner, 1-3 min after integrin engagement. After integrin activation, normalized conductance-voltage relations for mSlo are left-shifted at free Ca2+ concentrations >= 1 mu M. Overexpression of human c-src with mSlo, in the absence of integrin activation, leads to similar shifts in mSlo Ca2+ sensitivity, whereas overexpression of catalytically inactive c-src blocks integrin-induced potentiation. However, neither integrin activation nor c-src overexpression potentiates current in BK channels containing a point mutation at Tyr-766. Biochemical tests confirmed the critical importance of residue Tyr-766 in integrin-induced channel phosphorylation. Thus, BK channel activity is enhanced by alpha 5 beta 1 integrin activation, likely through an intracellular signaling pathway involving c-src phosphorylation of the channel alpha-subunit at Tyr-766. The net result is increased current amplitude, enhanced Ca2+ sensitivity, and rate of activation of the BK channel, which would collectively promote smooth muscle hyperpolarization in response to integrin-extracellular matrix interactions.	[Yang, Yan; Gui, Peichun; Davis, George E.; Davis, Michael J.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Wu, Jianbo; Davis, Michael J.] Univ Missouri, Sch Med, Dalton CVRC, Columbia, MO 65212 USA; Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, College Stn, TX 77840 USA; [Sheng, Jian-Zhong; Ling, Shizhang; Braun, Andrew P.] Univ Calgary, Sch Med, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Calgary	Davis, MJ (corresponding author), Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, 1 Hosp Dr,Rm M451, Columbia, MO 65212 USA.	davismj@health.missouri.edu	Ling, Shizhang/J-6114-2014	Ling, Shizhang/0000-0002-6856-3577; wu, xin/0000-0002-5005-6358	National Institutes of Health [HL-72989, HL-71796, RR-017353]; Canadian Institutes of Health Research; The Heart and Stroke Foundation of Alberta; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017353] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072989, R01HL071796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The Heart and Stroke Foundation of Alberta; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-72989 and HL-71796 (to M. J. D.) and RR-017353 (to University of Missouri). This work was also supported by operating grant support (to A. P. B.) from the Canadian Institutes of Health Research and The Heart and Stroke Foundation of Alberta.	Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Arcangeli A, 2004, BIOCHEM SOC T, V32, P826, DOI 10.1042/BST0320826; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; Baron A, 1997, J PHYSIOL-LONDON, V504, P537, DOI 10.1111/j.1469-7793.1997.537bd.x; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cox DH, 1997, J GEN PHYSIOL, V109, P633, DOI 10.1085/jgp.109.5.633; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; DAngelo G, 1997, AM J PHYSIOL-HEART C, V272, pH2065, DOI 10.1152/ajpheart.1997.272.4.H2065; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Davis MJ, 2002, CELL BIOCHEM BIOPHYS, V36, P41, DOI 10.1385/CBB:36:1:41; Diaz F, 1996, J GEN PHYSIOL, V107, P399, DOI 10.1085/jgp.107.3.399; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Hall SM, 2000, J NEUROIMMUNOL, V106, P130, DOI 10.1016/S0165-5728(00)00213-7; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Herrera GM, 2000, AM J PHYSIOL-REG I, V279, pR60, DOI 10.1152/ajpregu.2000.279.1.R60; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Horrigan FT, 1999, J GEN PHYSIOL, V114, P305, DOI 10.1085/jgp.114.2.305; Hurley BR, 1999, AM J PHYSIOL-GASTR L, V276, pG843, DOI 10.1152/ajpgi.1999.276.4.G843; Intengan HD, 2000, HYPERTENSION, V36, P312, DOI 10.1161/01.HYP.36.3.312; Jeulin C, 2008, AM J PHYSIOL-LUNG C, V295, pL489, DOI 10.1152/ajplung.90282.2008; Juliano RL, 2001, METHOD ENZYMOL, V333, P151; Kawasaki J, 2004, J BIOL CHEM, V279, P12959, DOI 10.1074/jbc.M313791200; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Lewis A, 2002, J PHYSIOL-LONDON, V540, P771, DOI 10.1113/jphysiol.2001.013888; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Lindsey ML, 2003, ANN MED, V35, P316, DOI 10.1080/07853890310001285; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Martinez-Lemus LA, 2003, J VASC RES, V40, P211, DOI 10.1159/000071886; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Platts SH, 1998, AM J PHYSIOL-HEART C, V275, pH1449; Poolos NP, 1999, J NEUROSCI, V19, P5205; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Rezzonico R, 2002, J BONE MINER RES, V17, P869, DOI 10.1359/jbmr.2002.17.5.869; Sadeghi MM, 2007, TRENDS CARDIOVAS MED, V17, P5, DOI 10.1016/j.tcm.2006.07.003; SCORNIK FS, 1993, AM J PHYSIOL, V265, pH1460, DOI 10.1152/ajpheart.1993.265.4.H1460; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Tian L, 2008, J BIOL CHEM, V283, P3067, DOI 10.1074/jbc.M706826200; Tian LJ, 2001, J PHYSIOL-LONDON, V537, P57, DOI 10.1111/j.1469-7793.2001.0057k.x; Toychiev AH, 2009, AM J PHYSIOL-CELL PH, V297, pC990, DOI 10.1152/ajpcell.00131.2009; Upadhyay J, 2003, J UROLOGY, V169, P750, DOI 10.1016/S0022-5347(05)64007-4; Vulin AI, 2005, ENDOCRINOLOGY, V146, P3535, DOI 10.1210/en.2004-1386; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wang HQ, 2007, EUR J CELL BIOL, V86, P51, DOI 10.1016/j.ejcb.2006.09.001; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu X, 2001, J BIOL CHEM, V276, P30285, DOI 10.1074/jbc.M102436200; Wu X, 2008, J PHYSIOL-LONDON, V586, P1699, DOI 10.1113/jphysiol.2007.149500; Xu CQ, 2004, J BIOL CHEM, V279, P34562, DOI 10.1074/jbc.M312798200; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zhou R, 2005, CARDIOVASC RES, V68, P327, DOI 10.1016/j.cardiores.2005.06.005; Zhou XB, 2000, AM J PHYSIOL-CELL PH, V279, pC1751, DOI 10.1152/ajpcell.2000.279.6.C1751	60	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					131	141		10.1074/jbc.M109.033506	http://dx.doi.org/10.1074/jbc.M109.033506			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887442	Green Published, hybrid			2022-12-27	WOS:000273070100014
J	Forrester, MT; Seth, D; Hausladen, A; Eyler, CE; Foster, MW; Matsumoto, A; Benhar, M; Marshall, HE; Stamler, JS				Forrester, Michael T.; Seth, Divya; Hausladen, Alfred; Eyler, Christine E.; Foster, Matthew W.; Matsumoto, Akio; Benhar, Moran; Marshall, Harvey E.; Stamler, Jonathan S.			Thioredoxin-interacting Protein (Txnip) Is a Feedback Regulator of S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; NITROSATIVE STRESS; OXIDATIVE STRESS; MOLECULAR-WEIGHT; DENITROSYLATION; NITROSOTHIOLS; BINDING; EXPRESSION; NITROSOGLUTATHIONE	Nitric oxide exerts a plethora of biological effects via protein S-nitrosylation, a redox-based reaction that converts a protein Cys thiol to a S-nitrosothiol. However, although the regulation of protein S-nitrosylation has been the subject of extensive study, much less is known about the systems governing protein denitrosylation. Most recently, thioredoxin/thioredoxin reductases were shown to mediate both basal and stimulus-coupled protein denitrosylation. We now demonstrate that protein denitrosylation by thioredoxin is regulated dynamically by thioredoxin-interacting protein (Txnip), a thioredoxin inhibitor. Endogenously synthesized nitric oxide represses Txnip, thereby facilitating thioredoxin-mediated denitrosylation. Autoregulation of denitrosylation thus allows cells to survive nitrosative stress. Our findings reveal that denitrosylation of proteins is dynamically regulated, establish a physiological role for thioredoxin in protection from nitrosative stress, and suggest new approaches to manipulate cellular S-nitrosylation.	[Forrester, Michael T.; Stamler, Jonathan S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Seth, Divya; Hausladen, Alfred; Foster, Matthew W.; Matsumoto, Akio; Benhar, Moran; Marshall, Harvey E.; Stamler, Jonathan S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Forrester, Michael T.; Eyler, Christine E.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 2612, Durham, NC 27710 USA.	staml001@mc.duke.edu	Benhar, Moran/AAV-5764-2020; Eyler, Christine E/A-2921-2010	Benhar, Moran/0000-0002-7094-3456; Matsumoto, Akio/0000-0002-3402-6992; Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [R01 HL092994, R01 HL092994-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092994] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen PF, 1997, J BIOL CHEM, V272, P6114, DOI 10.1074/jbc.272.10.6114; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; FOSTER MW, 2009, BIOCHEMISTRY; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffmann J, 2001, J BIOL CHEM, V276, P41383, DOI 10.1074/jbc.M107566200; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Intaglietta M, 1996, CARDIOVASC RES, V32, P632; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim JE, 2004, J BIOL CHEM, V279, P9758, DOI 10.1074/jbc.M312722200; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kokkola T, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-21; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; LYONS CR, 1992, J BIOL CHEM, V267, P6370; Mani K, 2004, J BIOL CHEM, V279, P12918, DOI 10.1074/jbc.M313678200; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; McMahon TJ, 2005, P NATL ACAD SCI USA, V102, P14801, DOI 10.1073/pnas.0506957102; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nozik-Grayck E, 2006, AM J PHYSIOL-LUNG C, V290, pL136, DOI 10.1152/ajplung.00230.2005; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schulze PC, 2006, ARTERIOSCL THROM VAS, V26, P2666, DOI 10.1161/01.ATV.0000248914.21018.f1; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Tian J, 2008, P NATL ACAD SCI USA, V105, P10537, DOI 10.1073/pnas.0804852105; Tsai AG, 1998, P NATL ACAD SCI USA, V95, P6590, DOI 10.1073/pnas.95.12.6590; Tsikas D, 1999, ANAL BIOCHEM, V270, P231, DOI 10.1006/abio.1999.4084; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	58	65	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36160	36166		10.1074/jbc.M109.057729	http://dx.doi.org/10.1074/jbc.M109.057729			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19847012	Green Published, hybrid			2022-12-27	WOS:000272970500017
J	Eto, M				Eto, Masumi			Regulation of Cellular Protein Phosphatase-1 (PP1) by Phosphorylation of the CPI-17 Family, C-kinase-activated PP1 Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LIGHT-CHAIN PHOSPHATASE; ARTERIAL SMOOTH-MUSCLE; INTEGRIN-LINKED KINASE; MYOSIN PHOSPHATASE; CA2+ SENSITIZATION; PHOSPHOPROTEIN INHIBITOR; MEDIATED ACTIVATION; INDUCED CONTRACTION; STRUCTURAL BASIS; UP-REGULATION	The regulatory circuit controlling cellular protein phosphatase-1 (PP1), an abundant group of Ser/Thr phosphatases, involves phosphorylation of PP1-specific inhibitor proteins. Malfunctions of these inhibitor proteins have been linked to a variety of diseases, including cardiovascular disease and cancer. Upon phosphorylation at Thr(38), the 17-kDa PP1 inhibitor protein, CPI-17, selectively inhibits a specific form of PP1, myosin light chain phosphatase, which transduces multiple kinase signals into the phosphorylation of myosin II and other proteins. Here, the mechanisms underlying PP1 inhibition and the kinase/PP1 cross-talk mediated by CPI-17 and its related proteins, PHI, KEPI, and GBPI, are discussed.	[Eto, Masumi] Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA; [Eto, Masumi] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Eto, M (corresponding author), Thomas Jefferson Univ, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA.	masumi.eto@jefferson.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836	National Institutes of Health [HL083261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL083261. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bonnevier J, 2004, J BIOL CHEM, V279, P28998, DOI 10.1074/jbc.M404259200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chang SH, 2006, AM J PHYSIOL-RENAL, V290, pF650, DOI 10.1152/ajprenal.00235.2005; Cohen PTW, 2002, J CELL SCI, V115, P241; Dakshinamurti S, 2005, PEDIATR PULM, V40, P398, DOI 10.1002/ppul.20290; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Dubois T, 2003, BIOCHEM BIOPH RES CO, V302, P186, DOI 10.1016/S0006-291X(03)00130-X; El-Touhky A, 2005, FEBS LETT, V579, P4271, DOI 10.1016/j.febslet.2005.06.059; Erdodi F, 2003, BIOCHEM BIOPH RES CO, V306, P382, DOI 10.1016/S0006-291X(03)00976-8; Eto M, 1999, BIOCHEMISTRY-US, V38, P16952, DOI 10.1021/bi992030o; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Eto M, 2002, J BIOL CHEM, V277, P44013, DOI 10.1074/jbc.M208035200; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2001, J BIOL CHEM, V276, P29072, DOI 10.1074/jbc.M103206200; Eto M, 2007, STRUCTURE, V15, P1591, DOI 10.1016/j.str.2007.10.014; Etter EF, 2001, J BIOL CHEM, V276, P34681, DOI 10.1074/jbc.M104737200; Freitas MR, 2009, FUND CLIN PHARMACOL, V23, P169, DOI 10.1111/j.1472-8206.2008.00658.x; Gong JP, 2005, NEUROSCIENCE, V132, P713, DOI 10.1016/j.neuroscience.2004.11.052; Hayashi Y, 2001, J BIOL CHEM, V276, P39858, DOI 10.1074/jbc.M107302200; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kim JI, 2009, HISTOCHEM CELL BIOL, V132, P191, DOI 10.1007/s00418-009-0604-2; Kitazawa T, 2004, J PHYSIOL-LONDON, V557, P515, DOI 10.1113/jphysiol.2004.064543; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; Kitazawa T, 2009, J PHYSIOL-LONDON, V587, P3587, DOI 10.1113/jphysiol.2009.172189; Kolosova IA, 2004, AM J PHYSIOL-LUNG C, V287, pL970, DOI 10.1152/ajplung.00398.2003; Lagercrantz J, 1996, GENOMICS, V31, P380, DOI 10.1006/geno.1996.0063; Liu QR, 2004, BIOCHEM J, V377, P171, DOI 10.1042/BJ20030128; Liu QR, 2002, J BIOL CHEM, V277, P13312, DOI 10.1074/jbc.M107558200; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Morin C, 2008, AM J RESP CELL MOL, V39, P638, DOI 10.1165/rcmb.2008-0177RC; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Ohama T, 2003, J BIOL CHEM, V278, P48794, DOI 10.1074/jbc.M310166200; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Richards CT, 2002, J BIOL CHEM, V277, P4422, DOI 10.1074/jbc.M111047200; Sakai H, 2005, MOL PHARMACOL, V68, P145, DOI 10.1124/mol.104.004325; Senba S, 1999, J BIOCHEM-TOKYO, V125, P354, DOI 10.1093/oxfordjournals.jbchem.a022294; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takizawa N, 2002, FEBS LETT, V515, P127, DOI 10.1016/S0014-5793(02)02451-1; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Thurneysen C, 2009, LUNG CANCER, V64, P140, DOI 10.1016/j.lungcan.2008.08.014; Tountas NA, 2004, J CELL SCI, V117, P5905, DOI 10.1242/jcs.01506; Tountas NA, 2004, HISTOCHEM CELL BIOL, V121, P343, DOI 10.1007/s00418-004-0642-8; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Watanabe Y, 2001, BLOOD, V97, P3798, DOI 10.1182/blood.V97.12.3798; Wenzel K, 2007, BIOL CHEM, V388, P489, DOI 10.1515/BC.2007.062; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yamawaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1040, DOI 10.1006/bbrc.2001.5290; Zemlickova E, 2004, BIOCHEM BIOPH RES CO, V316, P39, DOI 10.1016/j.bbrc.2004.02.014	60	108	113	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35273	35277		10.1074/jbc.R109.059972	http://dx.doi.org/10.1074/jbc.R109.059972			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19846560	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000272645600002
J	Suenaga, Y; Ozaki, T; Tanaka, Y; Bu, YQ; Kamijo, T; Tokuhisa, T; Nakagawara, A; Tamura, T				Suenaga, Yusuke; Ozaki, Toshinori; Tanaka, Yuji; Bu, Youquan; Kamijo, Takehiko; Tokuhisa, Takeshi; Nakagawara, Akira; Tamura, Taka-aki			TATA-binding Protein (TBP)-like Protein Is Engaged in Etoposide-induced Apoptosis through Transcriptional Activation of Human TAp63 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TBP-LIKE PROTEIN; P53 FAMILY; DIFFERENT MECHANISMS; MUTATIONAL ANALYSIS; P63; P73; EXPRESSION; CANCER; TLP/TRF2/TLF; FACTOR-2	Accumulating evidence indicates that TBP (TATA-binding protein)-like protein (TLP) contributes to the regulation of stress-mediated cell cycle checkpoint and apoptotic pathways, although its physiological target genes have remained elusive. In the present study, we have demonstrated that human TAp63 is one of the direct transcriptional target genes of TLP. Enforced expression of TLP results in the transcriptional induction of the endogenous TAp63, but not of the other p53 family members such as TAp73 and p53. Consistent with these results, small interference RNA-mediated knockdown led to a significant down-regulation of the endogenous TAp63. Luciferase reporter assay and chromatin immunoprecipitation analysis revealed that the genomic region located at positions -487 to -29, where +1 represents the transcriptional initiation site of TAp63, is required for TLP-dependent transcriptional activation of TAp63 and also TLP is efficiently recruited onto this region. Additionally, cells treated with anti-cancer drug etoposide underwent apoptosis in association with the transcriptional enhancement of TAp63 in a p53-independent manner, and the knockdown of the endogenous TLP reduced etoposide-induced apoptosis through repression of TAp63 expression. Taken together, our present study identifies a TLP-TAp63 pathway that is further implicated in stress-induced apoptosis.	[Suenaga, Yusuke; Ozaki, Toshinori; Bu, Youquan; Kamijo, Takehiko; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem, Chuoh Ku, Chiba 2608717, Japan; [Suenaga, Yusuke; Tanaka, Yuji; Tamura, Taka-aki] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan; [Tokuhisa, Takeshi] Chiba Univ, Grad Sch Med, Dept Dev Genet, Chiba 2608670, Japan	Chiba Cancer Center; Chiba University; Chiba University	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp; ttamura@faculty.chiba-u.jp		Suenaga, Yusuke/0000-0001-6902-5386; Tanaka, Yuji/0000-0003-4494-759X	Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Uehara Memorial Foundation and Futaba Corporation; Grants-in-Aid for Scientific Research [20570123, 21390317] Funding Source: KAKEN	Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation and Futaba Corporation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer (to A.N.), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T.T. and A.N.), a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (to A.N.), and grants from Uehara Memorial Foundation and Futaba Corporation (to T.T. and A.N.).	Bush SD, 2008, MOL CELL BIOL, V28, P83, DOI 10.1128/MCB.00809-07; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Chong JA, 2005, MOL CELL BIOL, V25, P2632, DOI 10.1128/MCB.25.7.2632-2643.2005; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Hagiwara K, 1999, CANCER RES, V59, P4165; Ichikawa T, 2008, ONCOGENE, V27, P409, DOI 10.1038/sj.onc.1210658; Koster MI, 2006, CANCER RES, V66, P3981, DOI 10.1158/0008-5472.CAN-06-0027; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; Levrero M, 2000, J CELL SCI, V113, P1661; MARTIN DW, 1993, J BIOL CHEM, V268, P13062; Moore PA, 1999, MOL CELL BIOL, V19, P7610; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakadai T, 2004, J BIOL CHEM, V279, P7447, DOI 10.1074/jbc.M305412200; Ohbayashi T, 1999, BIOCHEM BIOPH RES CO, V255, P137, DOI 10.1006/bbrc.1999.0159; Ohbayashi T, 2003, NUCLEIC ACIDS RES, V31, P2127, DOI 10.1093/nar/gkg315; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Park BJ, 2000, CANCER RES, V60, P3370; Park KA, 2006, MOL CELLS, V22, P203; Perletti L, 1999, J BIOL CHEM, V274, P15301, DOI 10.1074/jbc.274.22.15301; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; Rocco JW, 2006, CELL CYCLE, V5, P936, DOI 10.4161/cc.5.9.2716; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Sunahara M, 1999, ONCOGENE, V18, P3761, DOI 10.1038/sj.onc.1202972; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	33	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35433	35440		10.1074/jbc.M109.050047	http://dx.doi.org/10.1074/jbc.M109.050047			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858204	hybrid, Green Published			2022-12-27	WOS:000272645600019
J	Banerji, S; Hide, BRS; James, JR; Noble, MEM; Jackson, DG				Banerji, Suneale; Hide, Branwen R. S.; James, John R.; Noble, Martin E. M.; Jackson, David G.			Distinctive Properties of the Hyaluronan-binding Domain in the Lymphatic Endothelial Receptor Lyve-1 and Their Implications for Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; SMOOTH-MUSCLE-CELLS; LEUKOCYTE ADHESION; CD44; PROTEIN; INFLAMMATION; MECHANISM; LYMPHANGIOGENESIS; GLYCOSYLATION; DEGRADATION	The lymphatic endothelial hyaluronan (HA) receptor Lyve-1 is a member of the Link protein superfamily most similar to the leukocyte HA receptor CD44. However, the structure of Lyve-1 and the nature of its interaction with ligand are obscure. Here we present new evidence that Lyve-1 is functionally distinct from CD44. Using truncation mutagenesis we confirm that Lyve-1 in common with CD44 contains an extended HA-binding unit, comprising elements flanking the N and C termini of the consensus lectin-like Link module, bridged by a third conserved disulfide linkage that is critical for HA binding. In addition, we identify six essential residues Tyr-87, Ile-97, Arg-99, Asn-103, Lys-105, and Lys-108 that define a compact HA-binding surface on Lyve-1, encompassing the epitope for an adhesion-blocking monoclonal antibody 3A, in an analogous position to the HA-binding surface in CD44. The overtly electrostatic character of HA binding in Lyve-1 and its sensitivity to ionic strength (IC50 of 150 mM NaCl) contrast markedly with CD44 (IC50 > 2 M NaCl) in which HA binding is mediated by hydrogen bonding and hydrophobic interactions. In addition, unlike the extended Link module in CD44, which binds HA efficiently when expressed as a soluble monomer (K-d = 65.7 mu M), that of Lyve-1 requires artificial dimerization, although the full ectodomain is active as a monomer (K-d = 35.6 mu M). Finally, full-length Lyve-1 did not form stable dimers in binding-competent 293T transfectants when assessed using bioluminescent resonance energy transfer. These results reveal that elements additional to the extended Link module are required to stabilize HA binding in Lyve-1 and indicate important structural and functional differences with CD44.	[Banerji, Suneale; Hide, Branwen R. S.; Jackson, David G.] John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford OX3 9DS, England; [James, John R.] John Radcliffe Hosp, Nuffield Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Noble, Martin E. M.] Lab Mol Biophys, Oxford OX1 3QU, England	University of Oxford; University of Oxford; University of Oxford	Jackson, DG (corresponding author), John Radcliffe Hosp, MRC, Human Immunol Unit, Oxford OX3 9DS, England.	david.jackson@imm.ox.ac.uk	James, John R/B-5547-2008; James, John/AAP-3607-2021	James, John R/0000-0003-1452-7578; James, John/0000-0003-1452-7578; banerji, suneale/0000-0002-1179-3152; , david/0000-0002-4133-9364; Noble, Martin/0000-0002-3595-9807	UK Medical Research Council; Medical Research Council [G1000800c, MC_U137884182] Funding Source: researchfish; MRC [MC_U137884182] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the UK Medical Research Council (to D. G. J.) and by a Medical Research Council D.Phil. studentship (to B. R. S. H.).	Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; BANERJI S, 2005, STRUCTURE CD44 HYALU, V2, P625; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bouyain S, 2001, GLYCOBIOLOGY, V11, P989, DOI 10.1093/glycob/11.11.989; Brissett NC, 1996, FEBS LETT, V388, P211, DOI 10.1016/0014-5793(96)00576-5; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DOUGHERTY WG, 1988, EMBO J, V7, P1281, DOI 10.1002/j.1460-2075.1988.tb02942.x; English NM, 1998, CANCER RES, V58, P3736; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; HUANG L, 1993, J BIOL CHEM, V268, P26725; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; JACKSON DG, 2004, GLYCOFORUM; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Katoh S, 1999, J IMMUNOL, V162, P5058; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Lesley J, 2000, J BIOL CHEM, V275, P26967; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Oliver G, 2005, ANNU REV CELL DEV BI, V21, P457, DOI 10.1146/annurev.cellbio.21.012704.132338; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Torgersen D, 1998, J BIOL CHEM, V273, P6254, DOI 10.1074/jbc.273.11.6254; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	48	42	44	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10724	10735		10.1074/jbc.M109.047647	http://dx.doi.org/10.1074/jbc.M109.047647			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	19887450	Green Published, hybrid			2022-12-27	WOS:000276264600059
J	Saugar, I; Irigoyen, N; Luque, D; Carrascosa, JL; Rodriguez, JF; Caston, JR				Saugar, Irene; Irigoyen, Nerea; Luque, Daniel; Carrascosa, Jose L.; Rodriguez, Jose F.; Caston, Jose R.			Electrostatic Interactions between Capsid and Scaffolding Proteins Mediate the Structural Polymorphism of a Double-stranded RNA Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURSAL-DISEASE-VIRUS; PANCREATIC NECROSIS VIRUS; CRYSTAL-STRUCTURE; NONENVELOPED VIRUS; MOLECULAR SWITCH; CATALYTIC DYAD; VP3; POLYMERASE; MATURATION; MECHANISM	Capsid proteins that adopt distinct conformations constitute a paradigm of the structural polymorphism of macromolecular assemblies. We show the molecular basis of the flexibility mechanism of VP2, the capsid protein of the double-stranded RNA virus infectious bursal disease virus. The initial assembly, a procapsid-like structure, is built by the protein precursor pVP2 and requires VP3, the other infectious bursal disease virus major structural protein, which acts as a scaffold. The pVP2 C-terminal region, which is proteolyzed during virus maturation, contains an amphipathic alpha-helix that acts as a molecular switch. In the absence of VP3, efficient virus-like particle assembly occurs when the structural unit is a VP2-based chimeric protein with an N-terminal-fused His(6) tag. The His tag has a positively charged N terminus and a negatively charged C terminus, both important for virion-like structure assembly. The charge distributions of the VP3 C terminus and His tag are similar. We tested whether the His tag emulates the role of VP3 and found that the presence of a VP3 C-terminal peptide in VP2-based chimeric proteins resulted in the assembly of virus-like particles. We analyzed the electrostatic interactions between these two charged morphogenetic peptides, in which a single residue was mutated to impede the predicted interaction, followed by a compensatory double mutation to rescue electrostatic interactions. The effects of these mutations were monitored by following the virus-like and/or virus-related assemblies. Our results suggest that the basic face of the pVP2 amphipathic alpha-helix interacts with the acidic region of the VP3 C terminus and that this interaction is essential for VP2 acquisition of competent conformations for capsid assembly.	[Saugar, Irene; Luque, Daniel; Carrascosa, Jose L.; Caston, Jose R.] CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid 28049, Spain; [Irigoyen, Nerea; Rodriguez, Jose F.] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Caston, JR (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Darwin 3,Cantoblanco, Madrid 28049, Spain.	jrcaston@cnb.csic.es	Irigoyen, Nerea/CAJ-2485-2022; Caston, Jose/AAB-8825-2021; Rodríguez, José F/T-8500-2017; Luque, Daniel/I-6467-2015; Irigoyen, Nerea/A-7925-2017; Caston, Jose R/L-5896-2014	Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose/0000-0003-2350-9048; Rodríguez, José F/0000-0001-7944-5341; Luque, Daniel/0000-0002-0151-6020; Irigoyen, Nerea/0000-0001-6346-3369; Caston, Jose R/0000-0003-2350-9048; Saugar, Irene/0000-0002-5576-5786	Spanish Ministry of Science and Innovation [BFU 2008-02328/BMC, S-0505-Mat-0238, BIO2006-09407, BIO2008-02361]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish Ministry of Science and Innovation Grants BFU 2008-02328/BMC and S-0505-Mat-0238 (to J. L. C.), BIO2006-09407 (to J. F. R.), and BIO2008-02361 (to J. R. C.).	Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bottcher B, 1997, J VIROL, V71, P325; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Caston J R, 2008, SEGMENTED DOUBLE STR; Caston JR, 2001, J VIROL, V75, P10815, DOI 10.1128/JVI.75.22.10815-10828.2001; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Chevalier C, 2004, J VIROL, V78, P3296, DOI 10.1128/JVI.78.7.3296-3303.2004; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DELMAS B, 2005, VIRUS TAXONOMY, P561; Dokland T, 2000, STRUCTURE, V8, pR157, DOI 10.1016/S0969-2126(00)00181-7; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; EARL PL, 1993, CURRENT PROTOCOLS MO; Fane BA, 2003, ADV PROTEIN CHEM, V64, P259; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Gertsman I, 2009, NATURE, V458, P646, DOI 10.1038/nature07686; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Johnson JE, 2008, J STRUCT BIOL, V163, P246, DOI 10.1016/j.jsb.2008.03.013; Kochan G, 2003, ARCH VIROL, V148, P723, DOI 10.1007/s00705-002-0949-5; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Maraver A, 2003, J VIROL, V77, P2459, DOI 10.1128/JVI.77.4.2459-2468.2003; Martinez-Torrecuadrada JL, 2000, VIROLOGY, V278, P322, DOI 10.1006/viro.2000.0559; Ona A, 2004, VIROLOGY, V322, P135, DOI 10.1016/j.virol.2004.01.025; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; Parent KN, 2005, VIROLOGY, V340, P33, DOI 10.1016/j.virol.2005.06.018; Parker MH, 2001, BIOCHEMISTRY-US, V40, P8962, DOI 10.1021/bi0026167; Pedersen T, 2007, J VIROL, V81, P6652, DOI 10.1128/JVI.02831-06; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Villanueva RA, 2004, J VIROL, V78, P13829, DOI 10.1128/JVI.78.24.13829-13838.2004; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773; Zlotnick A, 2005, J MOL RECOGNIT, V18, P479, DOI 10.1002/jmr.754; Zlotnick A, 2007, NAT PROTOC, V2, P490, DOI 10.1038/nprot.2007.60	45	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3643	3650		10.1074/jbc.M109.075994	http://dx.doi.org/10.1074/jbc.M109.075994			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19933276	hybrid, Green Published			2022-12-27	WOS:000275254000016
J	Lee, TV; Johnson, LJ; Johnson, RD; Koulman, A; Lane, GA; Lott, JS; Arcus, VL				Lee, T. Verne; Johnson, Linda J.; Johnson, Richard D.; Koulman, Albert; Lane, Geoffrey A.; Lott, J. Shaun; Arcus, Vickery L.			Structure of a Eukaryotic Nonribosomal Peptide Synthetase Adenylation Domain That Activates a Large Hydroxamate Amino Acid in Siderophore Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; DENSITY MODIFICATION; FIREFLY LUCIFERASE; PROTEIN-PRODUCTION; BINDING; MODEL; SELECTION; MODULE	Nonribosomal peptide synthetases (NRPSs) are large, multidomain proteins that are involved in the biosynthesis of an array of secondary metabolites. We report the structure of the third adenylation domain from the siderophore-synthesizing NRPS, SidN, from the endophytic fungus Neotyphodium lolii. This is the first structure of a eukaryotic NRPS domain, and it reveals a large binding pocket required to accommodate the unusual amino acid substrate, N-delta-cis-anhydromevalonyl-N-delta-hydroxy-L-ornithine (cis-AMHO). The specific activation of cis-AMHO was confirmed biochemically, and an AMHO moiety was unambiguously identified as a component of the fungal siderophore using mass spectroscopy. The protein structure shows that the substrate binding pocket is defined by 17 amino acid residues, in contrast to both prokaryotic adenylation domains and to previous predictions based on modeling. Existing substrate prediction methods for NRPS adenylation domains fail for domains from eukaryotes due to the divergence of their signature sequences from those of prokaryotes. Thus, this new structure will provide a basis for improving prediction methods for eukaryotic NRPS enzymes that play important and diverse roles in the biology of fungi.	[Arcus, Vickery L.] Univ Waikato, Dept Biol Sci, Hamilton 3240, New Zealand; [Johnson, Linda J.; Johnson, Richard D.; Koulman, Albert; Lane, Geoffrey A.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North 4442, New Zealand; [Lee, T. Verne; Lott, J. Shaun; Arcus, Vickery L.] Univ Auckland, Sch Biol Sci, AgRes Struct Biol Lab, Auckland 1142, New Zealand	University of Waikato; AgResearch - New Zealand; University of Auckland	Arcus, VL (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton 3240, New Zealand.	varcus@waikato.ac.nz	Lee, Verne/M-6283-2014; Koulman, Albert/B-2967-2009	Lee, Verne/0000-0002-5768-2781; Koulman, Albert/0000-0001-9998-051X; Johnson, Richard/0000-0003-2100-6658; Johnson, linda/0000-0002-3779-0902; Lott, Shaun/0000-0003-3660-452X	New Zealand Foundation for Research Science and Technology [CX10X0203]; Agricultural and Marketing Research and Development Trust; University of Auckland; MRC [MC_EX_G0800783] Funding Source: UKRI; Medical Research Council [MC_EX_G0800783] Funding Source: researchfish	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Agricultural and Marketing Research and Development Trust; University of Auckland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the New Zealand Foundation for Research Science and Technology Contract CX10X0203.; Supported by an Agricultural and Marketing Research and Development Trust doctoral scholarship and a University of Auckland doctoral scholarship.	Afonine PV, 2005, CCP4 NEWSL, V42; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bushley KE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-328; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Cole JC, 2005, VIRTUAL SCREENING IN DRUG DISCOVERY, P379; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DIEKMANN H, 1967, EUR J BIOCHEM, V3, P213, DOI 10.1111/j.1432-1033.1967.tb19518.x; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Gimenez C, 2007, CURR ORG CHEM, V11, P707, DOI 10.2174/138527207780598765; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; LARSEN IK, 1988, ACTA CRYSTALLOGR B, V44, P527, DOI 10.1107/S0108768188003556; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luo LS, 2001, J AM CHEM SOC, V123, P11208, DOI 10.1021/ja0166646; MANTLE PG, 1976, J GEN MICROBIOL, V93, P321, DOI 10.1099/00221287-93-2-321; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McCormack P, 2003, ANAL CHEM, V75, P2647, DOI 10.1021/ac0340105; Meekhof AE, 1998, J MOL BIOL, V282, P181, DOI 10.1006/jmbi.1998.2019; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rodriguez R, 2008, J EXP BOT, V59, P1109, DOI 10.1093/jxb/erm342; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schwecke T, 2006, CHEMBIOCHEM, V7, P612, DOI 10.1002/cbic.200500301; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; Shah MB, 2009, PROTEINS, V77, P685, DOI 10.1002/prot.22482; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stack D, 2007, MICROBIOL-SGM, V153, P1297, DOI 10.1099/mic.0.2006/006908-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Upson RH, 1996, ANAL BIOCHEM, V243, P41, DOI 10.1006/abio.1996.0479; Villiers BRM, 2009, CHEMBIOCHEM, V10, P671, DOI 10.1002/cbic.200800553; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	58	43	46	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2415	2427		10.1074/jbc.M109.071324	http://dx.doi.org/10.1074/jbc.M109.071324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923209	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000273697800021
J	White, GF; Schermann, SM; Bradley, J; Roberts, A; Greene, NP; Berks, BC; Thomson, AJ				White, Gaye F.; Schermann, Sonya M.; Bradley, Justin; Roberts, Andrew; Greene, Nicholas P.; Berks, Ben C.; Thomson, Andrew J.			Subunit Organization in the TatA Complex of the Twin Arginine Protein Translocase A SITE-DIRECTED EPR SPIN LABELING STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; TRANSPORT SYSTEM; MEMBRANE-PROTEINS; SIGNAL PEPTIDE; EXPORT PATHWAY; COMPONENT; RESONANCE; DYNAMICS; DISTINCT	The Tat system is used to transport folded proteins across the cytoplasmic membrane in bacteria and archaea and across the thylakoid membrane of plant chloroplasts. Multimers of the integral membrane TatA protein are thought to form the protein-conducting element of the Tat pathway. Nitroxide radicals were introduced at selected positions within the transmembrane helix of Escherichia coli TatA and used to probe the structure of detergent-solubilized TatA complexes by EPR spectroscopy. A comparison of spin label mobilities allowed classification of individual residues as buried within the TatA complex or exposed at the surface and suggested that residues Ile(12) and Val(14) are involved in interactions between helices. Analysis of inter-spin distances suggested that the transmembrane helices of TatA subunits are arranged as a single-walled ring containing a contact interface between Ile(12) on one subunit and Val(14) on an adjacent subunit. Experiments in which labeled and unlabeled TatA samples were mixed demonstrate that TatA subunits are exchanged between TatA complexes. This observation is consistent with the TatA dynamic polymerization model for the mechanism of Tat transport.	[Schermann, Sonya M.; Roberts, Andrew; Greene, Nicholas P.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [White, Gaye F.; Bradley, Justin; Thomson, Andrew J.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of Oxford; University of East Anglia	Berks, BC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ben.berks@bioch.ox.ac.uk; a.thomson@uea.ac.uk		Berks, Ben/0000-0001-9685-4067; Greene, Nicholas/0000-0002-3631-0380	Biotechnology and Biological Sciences Research Council [BBS/B/03637, BB/D012074/1, BB/D004578/1]; Engineering and Physical Sciences Research Council [GR/S57402/01]; National Research Council Canada Fellowship; Wellcome Trust; BBSRC [BB/D012074/1, BB/D004578/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Research Council Canada Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants BBS/B/03637, BB/D012074/1, and BB/D004578/1 from the Biotechnology and Biological Sciences Research Council, and Grant GR/S57402/01 from the Engineering and Physical Sciences Research Council, by a National Research Council Canada Fellowship (to S. M. S.), and by an equipment grant from the Wellcome Trust.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; BARTON LL, 2005, STRUCTURAL FUNCTIONA, P45; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BERLINER LJ, 1983, ANN NY ACAD SCI, V414, P153, DOI 10.1111/j.1749-6632.1983.tb31681.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266; BORDIGNON E, 2007, MEMBRANE PROTEIN STR, P129; CARL P, 2003, BRUKER BIOSPIN APPL; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; CLINE K, 2007, ENZYMES MOL MACHINES, V25, P455; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; FEIX JB, 1998, BIO MAGN RE, V14, P251; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; HUBBELL WL, 1994, MEMBRANE PROTEIN STR, P00224; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; MILES AJ, 2005, ESSAYS BIOINFORMATIC, V368, P96; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Muller SD, 2007, BBA-BIOMEMBRANES, V1768, P3071, DOI 10.1016/j.bbamem.2007.09.008; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Persson M, 2001, BIOPHYS J, V80, P2886, DOI 10.1016/S0006-3495(01)76254-6; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Radzwill N, 2001, BIOPHYS J, V80, P2856, DOI 10.1016/S0006-3495(01)76252-2; Ridder ANJA, 2009, J BACTERIOL, V191, P4410, DOI 10.1128/JB.00215-09; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6	47	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2294	2301		10.1074/jbc.M109.065458	http://dx.doi.org/10.1074/jbc.M109.065458			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920142	Green Published, hybrid			2022-12-27	WOS:000273697800008
J	Lagory, EL; Sitailo, LA; Denning, MF				Lagory, Edward L.; Sitailo, Leonid A.; Denning, Mitchell F.			The Protein Kinase C delta Catalytic Fragment Is Critical for Maintenance of the G(2)/M DNA Damage Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMAS; UV-INDUCED APOPTOSIS; HUMAN KERATINOCYTES; PKC-DELTA; TUMOR-SUPPRESSOR; INDUCED PHOSPHORYLATION; TRANSGENIC MICE; P53 MUTATIONS; HISTONE H2AX; ACTIVATION	Protein kinase C delta (PKC delta) is an essential component of the intrinsic apoptotic program. Following DNA damage, such as exposure to UV radiation, PKC delta is cleaved in a caspase-dependent manner, generating a constitutively active catalytic fragment (PKC delta-cat), which is necessary and sufficient for keratinocyte apoptosis. We found that in addition to inducing apoptosis, expression of PKC delta-cat caused a pronounced G(2)/M cell cycle arrest in both primary human keratinocytes and immortalized HaCaT cells. Consistent with a G(2)/M arrest, PKC delta-cat induced phosphorylation of Cdk1 (Tyr(15)), a critical event in the G(2)/M checkpoint. Treatment with the ATM/ATR inhibitor caffeine was unable to prevent PKC delta-cat-induced G(2)/M arrest, suggesting that PKC delta-cat is functioning downstream of ATM/ATR in the G(2)/M checkpoint. To better understand the role of PKC delta and PKC delta-cat in the cell cycle response to DNA damage, we exposed wild-type and PKC delta null mouse embryonic fibroblasts (MEFs) to UV radiation. Wild-type MEFs underwent a pronounced G(2)/M arrest, Cdk1 phosphorylation, and induction of apoptosis following UV exposure, whereas PKC delta null MEFs were resistant to these effects. Expression of PKC delta-green fluorescent protein, but not caspase-resistant or kinase-inactive PKC delta, was able to restore G(2)/M checkpoint integrity in PKC delta null MEFs. The function of PKC delta in the DNA damage-induced G(2)/M cell cycle checkpoint may be a critical component of its tumor suppressor function.	[Sitailo, Leonid A.; Denning, Mitchell F.] Loyola Univ Chicago, Dept Pathol, Maywood, IL 60153 USA; Loyola Univ Chicago, Mol & Cellular Biochem Program, Dept Cell Biol Neurobiol & Anat, Maywood, IL 60153 USA; [Lagory, Edward L.; Sitailo, Leonid A.; Denning, Mitchell F.] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Denning, MF (corresponding author), Loyola Univ Chicago, Dept Pathol, Rm 304,Bldg 112,2160 S 1st Ave, Maywood, IL 60153 USA.	mdennin@lumc.edu		LaGory, Edward/0000-0002-0552-1695	National Institutes of Health [CA083784]; NATIONAL CANCER INSTITUTE [R01CA083784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA083784 (to M. F. D.).	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Aziz MH, 2006, CANCER RES, V66, P713, DOI 10.1158/0008-5472.CAN-05-2684; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; D'Costa AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558; Denning MF, 1998, J BIOL CHEM, V273, P29995, DOI 10.1074/jbc.273.45.29995; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Heffernan TP, 2009, J INVEST DERMATOL, V129, P1805, DOI 10.1038/jid.2008.435; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Liu QH, 2000, GENE DEV, V14, P1448; Lu YP, 2008, CANCER RES, V68, P2523, DOI 10.1158/0008-5472.CAN-07-5955; MITRA R, 1994, KERATINOCYTE METHODS; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; Perletti G, 2005, INT J CANCER, V113, P42, DOI 10.1002/ijc.20535; Reddig PJ, 1999, CANCER RES, V59, P5710; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schmidt M, 2007, DRUG RESIST UPDATE, V10, P162, DOI 10.1016/j.drup.2007.06.003; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Sitailo LA, 2004, J INVEST DERMATOL, V123, P434, DOI 10.1111/j.0022-202X.2004.23403.x; Sitailo LA, 2002, J BIOL CHEM, V277, P19346, DOI 10.1074/jbc.M200401200; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibudan SS, 2002, J INVEST DERMATOL, V119, P1282, DOI 10.1046/j.1523-1747.2002.19625.x; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027	52	16	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1879	1887		10.1074/jbc.M109.055392	http://dx.doi.org/10.1074/jbc.M109.055392			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19917613	Green Published, hybrid			2022-12-27	WOS:000273429100034
J	Szigeti, A; Hocsak, E; Rapolti, E; Racz, B; Arpad, B; Pozsgai, E; Balazs, D; Bognar, Z; Bellyei, S; Balazs, S; Ferenc, G				Szigeti, Andras; Hocsak, Eniko; Rapolti, Edit; Racz, Boglarka; Arpad Boronkai; Pozsgai, Eva; Balazs Debreceni; Bognar, Zita; Bellyei, Szabolcs; Balazs Sumegi; Ferenc Gallyas, Jr.			Facilitation of Mitochondrial Outer and Inner Membrane Permeabilization and Cell Death in Oxidative Stress by a Novel Bcl-2 Homology 3 Domain Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; CYTOCHROME-C RELEASE; HEME-BINDING PROTEIN; FAMILY-MEMBERS; RAT-BRAIN; TRANSITION; BAX; APOPTOSIS; ACTIVATION; VDAC	We identified a sequence homologous to the Bcl-2 homology 3 (BH3) domain of Bcl-2 proteins in SOUL. Tissues expressed the protein to different extents. It was predominantly located in the cytoplasm, although a fraction of SOUL was associated with the mitochondria that increased upon oxidative stress. Recombinant SOUL protein facilitated mitochondrial permeability transition and collapse of mitochondrial membrane potential (MMP) and facilitated the release of proapoptotic mitochondrial intermembrane proteins (PMIP) at low calcium and phosphate concentrations in a cyclosporine A-dependent manner in vitro in isolated mitochondria. Suppression of endogenous SOUL by diced small interfering RNA in HeLa cells increased their viability in oxidative stress. Overexpression of SOUL in NIH3T3 cells promoted hydrogen peroxide-induced cell death and stimulated the release of PMIP but did not enhance caspase-3 activation. Despite the release of PMIP, SOUL facilitated predominantly necrotic cell death, as revealed by annexin V and propidium iodide staining. This necrotic death could be the result of SOUL-facilitated collapse of MMP demonstrated by JC-1 fluorescence. Deletion of the putative BH3 domain sequence prevented all of these effects of SOUL. Suppression of cyclophilin D prevented these effects too, indicating that SOUL facilitated mitochondrial permeability transition in vivo. Overexpression of Bcl-2 and Bcl-x(L), which can counteract the mitochondria-permeabilizing effect of BH3 domain proteins, also prevented SOUL-facilitated collapse of MMP and cell death. These data indicate that SOUL can be a novel member of the BH3 domain-only proteins that cannot induce cell death alone but can facilitate both outer and inner mitochondrial membrane permeabilization and predominantly necrotic cell death in oxidative stress.	[Szigeti, Andras; Hocsak, Eniko; Rapolti, Edit; Racz, Boglarka; Arpad Boronkai; Pozsgai, Eva; Balazs Debreceni; Bognar, Zita; Bellyei, Szabolcs; Balazs Sumegi; Ferenc Gallyas, Jr.] Univ Pecs, Dept Biochem & Med Chem, H-7624 Pecs, Hungary; [Szigeti, Andras; Arpad Boronkai; Bellyei, Szabolcs] Univ Pecs, Inst Oncotherapy, H-7624 Pecs, Hungary	University of Pecs; University of Pecs	Ferenc, G (corresponding author), Univ Pecs, Dept Biochem & Med Chem, 12 Szigeti St, H-7624 Pecs, Hungary.	ferenc.gallyas@aok.pte.hu	Szigeti, András/HGA-3522-2022; Gallyas, Ferenc/C-2272-2012	Gallyas, Ferenc/0000-0002-1906-4333; Szigeti, Andras/0000-0002-0132-5275	University of Pecs, Hungary; AOKKA [34039-1/2009, 34039-23/2009]; Hungarian Research Grants OTKA [68469, 67996, K-73738]	University of Pecs, Hungary; AOKKA; Hungarian Research Grants OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by University of Pecs, Hungary, AOKKA Grants 34039-1/2009 and 34039-23/2009 as well as Hungarian Research Grants OTKA 68469, 67996, and K-73738.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Banerjee J, 2004, BIOCHEM BIOPH RES CO, V323, P310, DOI 10.1016/j.bbrc.2004.08.094; Blackmon BJ, 2002, ARCH BIOCHEM BIOPHYS, V407, P196, DOI 10.1016/S0003-9861(02)00471-X; Bouillet P, 2002, J CELL SCI, V115, P1567; Brustovetsky N, 2003, J NEUROCHEM, V84, P196, DOI 10.1046/j.1471-4159.2003.01545.x; Carvalho ACP, 2004, CELL DEATH DIFFER, V11, P1265, DOI 10.1038/sj.cdd.4401508; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; HOGEBOOM GH, 1950, J BIOL CHEM, V186, P417; Hsu SY, 2000, PHYSIOL REV, V80, P593, DOI 10.1152/physrev.2000.80.2.593; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kyriakis JM, 2000, SCI STKE, V2000, DOI [DOI 10.1126/STKE.2000.63.PE1, 10.1126/stke.2000.48.pe1, DOI 10.1126/STKE.2000.48.PE1]; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Li T, 2008, BBA-BIOENERGETICS, V1777, P1409, DOI 10.1016/j.bbabio.2008.08.002; Lin CH, 2005, NEUROSCI LETT, V387, P22, DOI 10.1016/j.neulet.2005.06.070; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sato E, 2004, BIOCHEMISTRY-US, V43, P14189, DOI 10.1021/bi048742i; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; SHIN WS, 1994, BIOCHEM J, V304, P81, DOI 10.1042/bj3040081; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Simonian PL, 1997, ONCOGENE, V15, P1871, DOI 10.1038/sj.onc.1201350; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Soane L, 2005, J BIOENERG BIOMEMBR, V37, P179, DOI 10.1007/s10863-005-6590-8; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Szigeti A, 2006, FEBS LETT, V580, P6447, DOI 10.1016/j.febslet.2006.10.067; Tafani M, 2001, CANCER RES, V61, P2459; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Varbiro G, 2001, FREE RADICAL BIO MED, V31, P548, DOI 10.1016/S0891-5849(01)00616-5; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Wu SN, 2009, J CELL PHYSIOL, V218, P603, DOI 10.1002/jcp.21636; Zylka MJ, 1999, MOL BRAIN RES, V74, P175, DOI 10.1016/S0169-328X(99)00277-6	56	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2140	2151		10.1074/jbc.M109.015222	http://dx.doi.org/10.1074/jbc.M109.015222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19901022	hybrid, Green Published			2022-12-27	WOS:000273429100058
J	Chaudhri, VK; Kumar, D; Misra, M; Dua, R; Rao, KVS				Chaudhri, Virendra K.; Kumar, Dhiraj; Misra, Manjari; Dua, Raina; Rao, Kanury V. S.			Integration of a Phosphatase Cascade with the Mitogen-activated Protein Kinase Pathway Provides for a Novel Signal Processing Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-TYROSINE-KINASE; MAP-KINASE; SCAFFOLD PROTEINS; SYSTEMS BIOLOGY; FEEDBACK LOOP; CELL-FATE; SPECIFICITY; TRANSDUCTION; NETWORK; RAS	We mathematically modeled the receptor-dependent mitogenactivated protein kinase (MAPK) signaling by incorporating the regulation through cellular phosphatases. Activation induced the alignment of a phosphatase cascade in parallel with the MAPK pathway. A novel regulatory motif was, thus, generated, providing for the combinatorial control of each MAPK intermediate. This ensured a non-linear mode of signal transmission with the output being shaped by the balance between the strength of input signal and the activity gradient along the phosphatase axis. Shifts in this balance yielded modulations in topology of the motif, thereby expanding the repertoire of output responses. Thus, we identify an added dimension to signal processing wherein the output response to an external stimulus is additionally filtered through indicators that define the phenotypic status of the cell.	[Chaudhri, Virendra K.; Kumar, Dhiraj; Misra, Manjari; Dua, Raina; Rao, Kanury V. S.] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rao, KVS (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	Chaudhri, Virendra/S-9767-2019	Chaudhri, Virendra/0000-0003-3528-4667	Department of Biotechnology, Government of India; Council for Scientific and Industrial Research	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from Department of Biotechnology, Government of India (to K.V.S.R.).; Recipient of a Senior Research Fellowship from the Council for Scientific and Industrial Research.; Recipient of a Senior Research Fellowship from the Department of Biotechnology, Government of India.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bollen M, 2002, TRENDS CELL BIOL, V12, P138, DOI 10.1016/S0962-8924(01)02247-4; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dickinson RJ, 2002, MECH DEVELOP, V113, P193, DOI 10.1016/S0925-4773(02)00024-2; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Echevarria D, 2005, DEV BIOL, V277, P114, DOI 10.1016/j.ydbio.2004.09.011; Eungdamrong NJ, 2007, BIOPHYS J, V92, P808, DOI 10.1529/biophysj.106.093104; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Karlsson M, 2004, J BIOL CHEM, V279, P41882, DOI 10.1074/jbc.M406720200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kumar D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100197; Kumar Dhiraj, 2008, BMC Res Notes, V1, P81, DOI 10.1186/1756-0500-1-81; Kurosaki T, 2000, IMMUNOL REV, V176, P19; Kurosaki T, 2000, CURR OPIN IMMUNOL, V12, P276, DOI 10.1016/S0952-7915(00)00087-X; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Muda M, 1996, J BIOL CHEM, V271, P4319; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; UEKI K, 1994, J BIOL CHEM, V269, P15756; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; Zi ZK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-342	54	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1296	1310		10.1074/jbc.M109.055863	http://dx.doi.org/10.1074/jbc.M109.055863			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897477	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000273258200051
J	Nikandrova, YA; Jiao, YX; Baucum, AJ; Tavalin, SJ; Colbran, RJ				Nikandrova, Yelyzaveta A.; Jiao, Yuxia; Baucum, Anthony J.; Tavalin, Steven J.; Colbran, Roger J.			Ca2+/Calmodulin-dependent Protein Kinase II Binds to and Phosphorylates a Specific SAP97 Splice Variant to Disrupt Association with AKAP79/150 and Modulate alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid-type Glutamate Receptor (AMPAR) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; SYNAPSE-ASSOCIATED PROTEIN-97; POSTSYNAPTIC DENSITY PROTEIN; HUMAN DISCS LARGE; NR2B SUBUNIT; REGULATED INTERACTIONS; INHIBITOR PROTEIN; ALPHA-SUBUNIT; CAMKII; TRAFFICKING	Ca2+/calmodulin-dependent protein kinase II (CaMKII) promotes trafficking and activation of the GluR1 subunit of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors (AMPARs) during synaptic plasticity. GluR1 is also modulated in parallel by multiprotein complexes coordinated by synapse-associated protein 97 (SAP97) that contain A-kinase anchoring protein 79/150 (AKAP79/150), protein kinase A, and protein phosphatase 2B. Here we show that SAP97 is present in CaMKII immune complexes isolated from rodent brain as well as from HEK293 cells co-expressing CaMKII alpha and SAP97. CaMKII alpha phosphorylated recombinant SAP97 within immune complexes in vitro and in intact cells. Four alternative mRNA splice variants of SAP97 expressing combinations of four inserts (I2, I3, I4, I5) in the U5 region between Src homology 3 (SH3) and guanylyl kinase-like (GK) domains were identified in rat brain at postnatal day 21. CaMKII alpha preferentially phosphorylated a full-length SAP97 and a glutathione S-transferase (GST) fusion protein containing the I3 and I5 inserts (SAP97-I3I5 and GST-SH3-I3I5-GK, respectively) and also specifically interacted with GST-SH3-I3I5-GK compared with GST proteins containing other naturally occurring insert combinations. AKAP79/150 also directly and specifically bound only to GST-SH3-I3I5-GK, but CaMKII phosphorylation of GST-SH3-I3I5-GK prevented this interaction. AKAP79-dependent down-regulation of GluR1 AMPAR currents was ablated by overexpression of SAP97-I2I5 (which does not bind AKAP79) or by infusion of active CaMKII alpha. Collectively, the data suggest that CaMKII alpha targets a specific SAP97 splice variant to disengage AKAP79/150 from regulating GluR1 AMPARs, providing new insight into protein-protein interactions and phosphorylation events that are required for normal regulation of glutamatergic synaptic transmission, learning, and memory.	[Colbran, Roger J.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Baucum, Anthony J.; Colbran, Roger J.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Tavalin, Steven J.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Colbran, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Rm 702,Light Hall, Nashville, TN 37232 USA.	roger.colbran@vanderbilt.edu	Jiao, Yuxia/H-3300-2019; Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013	Jiao, Yuxia/0000-0002-8633-7047; Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865	National Institutes of Health [RO1-MH63232, PO1-NS044282, R01-NS046661, T32-MH65215]; UNCF-Merck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044282, R01NS046661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF-Merck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-MH63232 and PO1-NS044282 (to R.J.C.) and R01-NS046661 (to S.J.T.).; Supported by a Neurogenomics training grant funded by National Institutes of Health Grant T32-MH65215 and by a fellowship from the UNCF-Merck foundation.	Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Boehm J, 2006, LEARN MEMORY, V13, P562, DOI 10.1101/lm.253506; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Godreau D, 2003, J BIOL CHEM, V278, P47046, DOI 10.1074/jbc.M308463200; Gomez LL, 2002, J NEUROSCI, V22, P7027; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Mori K, 1998, J HUM GENET, V43, P123, DOI 10.1007/s100380050052; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Roberts S, 2007, EXP CELL RES, V313, P2521, DOI 10.1016/j.yexcr.2007.05.017; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Wu HJ, 1998, J CELL SCI, V111, P2365	63	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					923	934		10.1074/jbc.M109.033985	http://dx.doi.org/10.1074/jbc.M109.033985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19858198	Green Published, hybrid			2022-12-27	WOS:000273258200012
J	Qi, Y; Spong, MC; Nam, K; Karplus, M; Verdine, GL				Qi, Yan; Spong, Marie C.; Nam, Kwangho; Karplus, Martin; Verdine, Gregory L.			Entrapment and Structure of an Extrahelical Guanine Attempting to Enter the Active Site of a Bacterial DNA Glycosylase, MutM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE R-VALUE; MOLECULAR-DYNAMICS; SUBSTRATE-SPECIFICITY; INTRAHELICAL LESION; CROSS-VALIDATION; DUPLEX DNA; REPAIR; RECOGNITION; PROTEIN; 8-OXOGUANINE	MutM, a bacterial DNA glycosylase, protects genome integrity by catalyzing glycosidic bond cleavage of 8-oxoguanine (oxoG) lesions, thereby initiating base excision DNA repair. The process of searching for and locating oxoG lesions is especially challenging, because of the close structural resemblance of oxoG to its million-fold more abundant progenitor, G. Extrusion of the target nucleobase from the DNA double helix to an extrahelical position is an essential step in lesion recognition and catalysis by MutM. Although the interactions between the extruded oxoG and the active site of MutM have been well characterized, little is known in structural detail regarding the interrogation of extruded normal DNA bases by MutM. Here we report the capture and structural elucidation of a complex in which MutM is attempting to present an undamaged G to its active site. The structure of this MutM-extrahelical G complex provides insights into the mechanism MutM employs to discriminate against extrahelical normal DNA bases and into the base extrusion process in general.	[Qi, Yan; Verdine, Gregory L.] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA; [Spong, Marie C.; Nam, Kwangho; Karplus, Martin; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Karplus, Martin] Univ Strasbourg, Inst Sci & Ingn Supramol, F-67000 Strasbourg, France	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu			National Institutes of Health [GM044853, GM047467, CA100742, GM030804]; National Science Foundation; Howard Hughes Medical Institute; National Cancer Center; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030804, R01GM030804, R01GM044853, P01GM047467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044853, GM047467, and CA100742 (to G.L.V.) and GM030804 (to M.K.).; Supported by a predoctoral fellowship from the National Science Foundation.; Supported by a predoctoral fellowship from the Howard Hughes Medical Institute.; Supported by a postdoctoral fellowship from the National Cancer Center.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allen M.P., 1989, COMPUTER SIMULATION, P71; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Corn JE, 2007, STRUCTURE, V15, P773, DOI 10.1016/j.str.2007.05.006; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dornberger U, 1999, J BIOL CHEM, V274, P6957, DOI 10.1074/jbc.274.11.6957; Duguid EM, 2003, CHEM BIOL, V10, P827, DOI 10.1016/j.chembiol.2003.08.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hamm ML, 2007, J AM CHEM SOC, V129, P7724, DOI 10.1021/ja0716453; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jang YH, 2002, CHEM RES TOXICOL, V15, P1023, DOI 10.1021/tx010146r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Priyakumar UD, 2006, J AM CHEM SOC, V128, P678, DOI 10.1021/ja056445a; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; TCHOU J, 1994, J BIOL CHEM, V269, P15318; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Weiss JM, 2005, MOL CARCINOGEN, V42, P127, DOI 10.1002/mc.20067; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	49	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1468	1478		10.1074/jbc.M109.069799	http://dx.doi.org/10.1074/jbc.M109.069799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889642	Green Published, hybrid			2022-12-27	WOS:000273258200066
J	Yuan, JS; Chen, JJ				Yuan, Jingsong; Chen, Junjie			MRE11-RAD50-NBS1 Complex Dictates DNA Repair Independent of H2AX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; EARLY EMBRYONIC LETHALITY; S-PHASE CHECKPOINT; DAMAGE-RESPONSE PATHWAYS; MRE11 COMPLEX; TARGETED DISRUPTION; HISTONE H2AX; GENOMIC STABILITY; CHROMOSOMAL FRAGMENTATION; HUMAN RAD50/MRE11	DNA double-strand breaks (DSBs) represent one of the most serious forms of DNA damage that can occur in the genome. Here, we show that the DSB-induced signaling cascade and homologous recombination (HR)-mediated DSB repair pathway can be genetically separated. We demonstrate that the MRE11-RAD50-NBS1 (MRN) complex acts to promote DNA end resection and the generation of single-stranded DNA, which is critically important for HR repair. These functions of the MRN complex can occur independently of the H2AX-mediated DNA damage signaling cascade, which promotes stable accumulation of other signaling and repair proteins such as 53BP1 and BRCA1 to sites of DNA damage. Nevertheless, mild defects in HR repair are observed in H2AX-deficient cells, suggesting that the H2AX-dependent DNA damage-signaling cascade assists DNA repair. We propose that the MRN complex is responsible for the initial recognition of DSBs and works together with both CtIP and the H2AX-dependent DNA damage-signaling cascade to facilitate repair by HR and regulate DNA damage checkpoints.	[Yuan, Jingsong; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org	Yuan, Jingsong/G-4527-2011		National Institutes of Health [CA100109, CA092312, CA089239]; NATIONAL CANCER INSTITUTE [R01CA089239, R01CA092312, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health Grants CA100109, CA092312, and CA089239 (to J. C.).	Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Brown EJ, 2000, GENE DEV, V14, P397; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Jager M, 2002, NUCLEIC ACIDS RES, V30, P4425, DOI 10.1093/nar/gkf574; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lavin MF, 2004, DNA REPAIR, V3, P1515, DOI 10.1016/j.dnarep.2004.07.001; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu JS, 2006, J CELL BIOCHEM, V99, P1452, DOI 10.1002/jcb.21066; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wood JL, 2008, TRENDS CELL BIOL, V18, P451, DOI 10.1016/j.tcb.2008.07.006; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	73	72	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1097	1104		10.1074/jbc.M109.078436	http://dx.doi.org/10.1074/jbc.M109.078436			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19910469	Green Published, hybrid			2022-12-27	WOS:000273258200031
J	Hockert, JA; Yeh, HJ; MacDonald, CC				Hockert, J. Andrew; Yeh, Hsiang-Jui; MacDonald, Clinton C.			The Hinge Domain of the Cleavage Stimulation Factor Protein CstF-64 Is Essential for CstF-77 Interaction, Nuclear Localization, and Polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; LABELED POLYRIBOSOMAL RNA; MALE GERM-CELLS; POLYMERASE-II; TRANSCRIPTION TERMINATION; DOWNSTREAM ELEMENTS; CYTOPLASMIC POLYADENYLATION; 64-KILODALTON SUBUNIT; POLY(A) POLYMERASE; POINT MUTATIONS	Because polyadenylation is essential for cell growth, in vivo examination of polyadenylation protein function has been difficult. Here we describe a new in vivo assay that allows structure-function assays on CstF-64, a protein that binds to pre-mRNAs downstream of the cleavage site for accurate and efficient polyadenylation. In this assay (the stem-loop luciferase assay for polyadenylation, SLAP), expression of a luciferase pre-mRNA with a modified downstream sequence element was made dependent upon co-expression of an MS2-CstF-64 fusion protein. We show here that SLAP accurately reflects CstF-64-dependent polyadenylation, confirming the validity of this assay. Using SLAP, we determined that CstF-64 domains involved in RNA binding, interaction with CstF-77 (the "Hinge" domain), and coupling to transcription are critical for polyadenylation. Further, we showed that the Hinge domain is necessary for CstF-64 interaction with CstF-77 and consequent nuclear localization, suggesting that nuclear import of a preformed CstF complex is an essential step in polyadenylation.	[Hockert, J. Andrew; Yeh, Hsiang-Jui; MacDonald, Clinton C.] Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	MacDonald, CC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, 3601 4th St, Lubbock, TX 79430 USA.	clint.macdonald@ttuhsc.edu		MacDonald, Clinton/0000-0003-3209-1982	National Institutes of Health [R01 HD37109]; South Plains Foundation; Texas Tech University Health Sciences Center School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Plains Foundation; Texas Tech University Health Sciences Center School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD37109 (to C. C. M.). This work was also supported by grants from the South Plains Foundation and the Texas Tech University Health Sciences Center School of Medicine (to C. C. M.).	Bai Y, 2007, MOL CELL, V25, P863, DOI 10.1016/j.molcel.2007.01.034; Barbaux S, 1996, COMP BIOCHEM PHYS B, V114, P313, DOI 10.1016/0305-0491(96)00023-5; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Benoit B, 2002, P NATL ACAD SCI USA, V99, P10593, DOI 10.1073/pnas.162191899; Beyer K, 1997, J BIOL CHEM, V272, P26769, DOI 10.1074/jbc.272.42.26769; BONNEAUD N, 1994, J CELL SCI, V107, P913; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Chennathukuzhi VM, 2001, MOL REPROD DEV, V58, P460, DOI 10.1002/1098-2795(20010401)58:4&lt;460::AID-MRD15&gt;3.0.CO;2-F; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CHOU ZF, 1994, NUCLEIC ACIDS RES, V22, P2525, DOI 10.1093/nar/22.13.2525; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Cui MX, 2008, P NATL ACAD SCI USA, V105, P16665, DOI 10.1073/pnas.0807104105; DARNELL JE, 1971, P NATL ACAD SCI USA, V68, P1321, DOI 10.1073/pnas.68.6.1321; Dass B, 2002, GENOMICS, V80, P509, DOI 10.1006/geno.2002.6862; Dass B, 2007, P NATL ACAD SCI USA, V104, P20374, DOI 10.1073/pnas.0707589104; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; EDMONDS M, 1971, P NATL ACAD SCI USA, V68, P1336, DOI 10.1073/pnas.68.6.1336; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; EDMONDS M, 1960, J BIOL CHEM, V235, P1142; EDWALDSGILBERT G, 1995, MOL CELL BIOL, V15, P6420; Erkmann JA, 2004, EXP CELL RES, V296, P12, DOI 10.1016/j.yexcr.2004.03.015; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Hague Lisa K., 2008, V419, P171, DOI 10.1007/978-1-59745-033-1_12; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Hatton LS, 2000, NUCLEIC ACIDS RES, V28, P520, DOI 10.1093/nar/28.2.520; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Lago H, 1998, NUCLEIC ACIDS RES, V26, P1337, DOI 10.1093/nar/26.5.1337; LEE SY, 1971, P NATL ACAD SCI USA, V68, P1331, DOI 10.1073/pnas.68.6.1331; Legrand P, 2007, NUCLEIC ACIDS RES, V35, P4515, DOI 10.1093/nar/gkm458; Li L, 2006, MOL BIOL CELL, V17, P1126, DOI 10.1091/mbc.E05-08-0768; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; Maciolek NL, 2008, VIROLOGY, V374, P468, DOI 10.1016/j.virol.2008.01.012; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; MANN KP, 1993, MOL CELL BIOL, V13, P2411, DOI 10.1128/MCB.13.4.2411; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McGregor F, 1996, J VIROL, V70, P1931, DOI 10.1128/JVI.70.3.1931-1940.1996; MINVIELLESEBASTIA L, 1991, MOL CELL BIOL, V11, P3075, DOI 10.1128/MCB.11.6.3075; Mirkin N, 2008, NUCLEIC ACIDS RES, V36, P1792, DOI 10.1093/nar/gkn005; Monarez RR, 2007, BIOCHEM J, V401, P651, DOI 10.1042/BJ20061097; MOORE CL, 1988, EMBO J, V7, P3159, DOI 10.1002/j.1460-2075.1988.tb03183.x; Moreira A, 1998, GENE DEV, V12, P2522, DOI 10.1101/gad.12.16.2522; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; NIWA M, 1992, NATURE, V360, P277, DOI 10.1038/360277a0; Qu XP, 2007, J BIOL CHEM, V282, P2101, DOI 10.1074/jbc.M609981200; Rao S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-51; Richardson JM, 1999, BIOCHEMISTRY-US, V38, P12869, DOI 10.1021/bi990724r; Rouget C, 2006, J BIOL CHEM, V281, P28687, DOI 10.1074/jbc.M601116200; Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200; Salisbury J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-55; Schul W, 1996, EMBO J, V15, P2883, DOI 10.1002/j.1460-2075.1996.tb00649.x; Schul W, 1998, EXP CELL RES, V238, P1, DOI 10.1006/excr.1997.3808; Shankarling GS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-22; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; TAKAGAKI Y, 1990, GENE DEV, V4, P2112, DOI 10.1101/gad.4.12a.2112; TAKAGAKI Y, 1992, P NATL ACAD SCI USA, V89, P1403, DOI 10.1073/pnas.89.4.1403; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; TAKAGAKI Y, 1994, NATURE, V372, P471, DOI 10.1038/372471a0; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Uitte de Willige S, 2007, J THROMB HAEMOST, V5, P1243; Valegard K, 1997, J MOL BIOL, V270, P724, DOI 10.1006/jmbi.1997.1144; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wallace AM, 1999, P NATL ACAD SCI USA, V96, P6763, DOI 10.1073/pnas.96.12.6763; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; WILUSZ J, 1989, NUCLEIC ACIDS RES, V17, P3899, DOI 10.1093/nar/17.10.3899; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; Yang YS, 2009, BIOTECHNOL BIOENG, V102, P1152, DOI 10.1002/bit.22152; Yao YL, 2002, J EXP BOT, V53, P2277, DOI 10.1093/jxb/erf073; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Zhang ZQ, 2006, MOL CELL, V21, P65, DOI 10.1016/j.molcel.2005.11.002; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhu ZH, 2009, ONCOGENE, V28, P41, DOI 10.1038/onc.2008.359	84	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					695	704		10.1074/jbc.M109.061705	http://dx.doi.org/10.1074/jbc.M109.061705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887456	hybrid, Green Published			2022-12-27	WOS:000273070100070
J	Rao, F; See, RY; Zhang, DW; Toh, DC; Ji, Q; Liang, ZX				Rao, Feng; See, Rui Yin; Zhang, Dongwei; Toh, Delon Chengxu; Ji, Qiang; Liang, Zhao-Xun			YybT Is a Signaling Protein That Contains a Cyclic Dinucleotide Phosphodiesterase Domain and a GGDEF Domain with ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-GMP; BACILLUS-SUBTILIS; PSEUDOMONAS-AERUGINOSA; DIGUANYLATE CYCLASE; ALLOSTERIC CONTROL; CYTOSOLIC EXOPOLYPHOSPHATASE; INORGANIC PYROPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PROTEIN; CRYSTAL-STRUCTURE	The cyclic dinucleotide c-di-GMP synthesized by the diadenylate cyclase domain was recently discovered as a messenger molecule for signaling DNA breaks in Bacillus subtilis. By searching bacterial genomes, we identified a family of DHH/DHHA1 domain proteins (COG3387) that co-occur with a subset of the diadenylate cyclase domain proteins. Here we report that the B. subtilis protein YybT, a member of the COG3387 family proteins, exhibits phosphodiesterase activity toward cyclic dinucleotides. The DHH/DHHA1 domain hydrolyzes c-di-AMP and c-di-GMP to generate the linear dinucleotides 5'-pApA and 5'-pGpG. The data suggest that c-di-AMP could be the physiological substrate for YybT given the physiologically relevant Michaelis-Menten constant (K-m) and the presence of YybT family proteins in the bacteria lacking c-di-GMP signaling network. The bacterial regulator ppGpp was found to be a strong competitive inhibitor of the DHH/DHHA1 domain, suggesting that YybT is under tight control during stringent response. In addition, the atypical GGDEF domain of YybT exhibits unexpected ATPase activity, distinct from the common diguanylate cyclase activity for GGDEF domains. We further demonstrate the participation of YybT in DNA damage and acid resistance by characterizing the phenotypes of the Delta yybT mutant. The novel enzymatic activity and stress resistance together point toward a role for YybT in stress signaling and response.	[Rao, Feng; See, Rui Yin; Zhang, Dongwei; Toh, Delon Chengxu; Ji, Qiang; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	zxliang@ntu.edu.sg	Rao, Feng/AAD-4712-2019; Liang, Zhao-Xun/A-2191-2011; RAO, FENG/G-4529-2011	Rao, Feng/0000-0002-6038-6406; RAO, FENG/0000-0002-6038-6406; Liang, Zhao-Xun/0000-0002-3128-1330	Biomedical Research Council of Singapore [06/1/22/19/464]	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work is supported by Biomedical Research Council of Singapore Grant 06/1/22/19/464.	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; D'Angelo A, 2004, CANCER CELL, V5, P137, DOI 10.1016/S1535-6108(04)00021-2; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fabrichniy IP, 2004, BIOCHEMISTRY-US, V43, P14403, DOI 10.1021/bi0484973; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08; IKEHARA K, 1984, J BIOCHEM-TOKYO, V95, P895, DOI 10.1093/oxfordjournals.jbchem.a134684; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mechold U, 2007, NUCLEIC ACIDS RES, V35, P4552, DOI 10.1093/nar/gkm462; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; PLATEAU P, 1987, J BACTERIOL, V169, P419, DOI 10.1128/jb.169.1.419-422.1987; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Qi YN, 2009, BIOCHEMISTRY-US, V48, P10275, DOI 10.1021/bi901121w; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; RUIZ A, 1989, J BACTERIOL, V171, P6703, DOI 10.1128/jb.171.12.6703-6709.1989; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2009, ANAL BIOCHEM, V386, P53, DOI 10.1016/j.ab.2008.12.013; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Tammenkoski M, 2007, J BIOL CHEM, V282, P9302, DOI 10.1074/jbc.M609423200; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Ugochukwu E, 2007, J MOL BIOL, V371, P1007, DOI 10.1016/j.jmb.2007.05.066; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yamagata A, 2001, NUCLEIC ACIDS RES, V29, P4617, DOI 10.1093/nar/29.22.4617; Young TW, 1998, MICROBIOL-SGM, V144, P2563, DOI 10.1099/00221287-144-9-2563	55	171	185	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					473	482		10.1074/jbc.M109.040238	http://dx.doi.org/10.1074/jbc.M109.040238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19901023	hybrid, Green Published			2022-12-27	WOS:000273070100049
J	Berbey, C; Weiss, N; Legrand, C; Allard, B				Berbey, Celine; Weiss, Norbert; Legrand, Claude; Allard, Bruno			Transient Receptor Potential Canonical Type 1 (TRPC1) Operates as a Sarcoplasmic Reticulum Calcium Leak Channel in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MDX MICE; FIBERS; CELLS; DIFFERENTIATION; RELEASE; ENTRIES	Extensive studies performed in nonexcitable cells and expression systems have shown that type 1 transient receptor potential canonical (TRPC1) channels operate mainly in plasma membranes and open through phospholipase C-dependent processes, membrane stretch, or depletion of Ca2+ stores. In skeletal muscle, it is proposed that TRPC1 channels are involved in plasmalemmal Ca2+ influx and stimulated by store depletion or membrane stretch, but direct evidence for TRPC1 sarcolemmal channel activity is not available. We investigated here the functional role of TRPC1 using an overexpressing strategy in adult mouse muscle fibers. Immunostaining for endogenous TRPC1 revealed a striated expression pattern that matched sarcoplasmic reticulum (SR) Ca2+ pump immunolabeling. In cells expressing TRPC1-yellow fluorescent protein (YFP), the same pattern of expression was observed, compatible with a longitudinal SR localization. Resting electric properties, action potentials, and resting divalent cation influx were not altered in TRPC1-YFP-positive cells. Poisoning with the SR Ca2+ pump blocker cyclopiazonic acid elicited a contracture of the fiber at the level of the overexpression site in presence and absence of external Ca2+ which was not observed in control cells. Ca2+ measurements indicated that resting Ca2+ and the rate of Ca2+ increase induced by cyclopiazonic acid were higher in the TRPC1-YFP-positive zone than in the TRPC1-YFP-negative zone and control cells. Ca2+ transients evoked by 200-ms voltage clamp pulses decayed slower in TRPC1-YFP-positive cells. In contrast to previous hypotheses, these data demonstrate that TRPC1 operates as a SR Ca2+ leak channel in skeletal muscle.	[Berbey, Celine; Weiss, Norbert; Legrand, Claude; Allard, Bruno] Univ Lyon 1, CNRS, UMR 5123, Lab Physiol Integrat Cellulaire & Mol, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Allard, B (corresponding author), Univ Lyon 1, CNRS, UMR 5123, Lab Physiol Integrat Cellulaire & Mol, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France.	bruno.allard@univ-lyon1.fr	Weiss, Norbert/G-5330-2014	Weiss, Norbert/0000-0002-0040-1109; Allard, Bruno/0000-0002-7131-7828	Universite Lyon 1; Centre National de la Recherche Scientifique; Association Francaise contre les Myopathies; Agence Nationale de la Recherche	Universite Lyon 1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Universite Lyon 1, the Centre National de la Recherche Scientifique, the Association Francaise contre les Myopathies, and the Agence Nationale de la Recherche.	Allard B, 2006, J PHYSIOL-LONDON, V575, P69, DOI 10.1113/jphysiol.2006.112367; Berbey C, 2009, BIOPHYS J, V96, P2648, DOI 10.1016/j.bpj.2009.01.008; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Collet C, 1999, J PHYSIOL-LONDON, V520, P417, DOI 10.1111/j.1469-7793.1999.00417.x; Cusimano V, 2009, P NATL ACAD SCI USA, V106, P4695, DOI 10.1073/pnas.0810243106; Formigli L, 2009, J CELL SCI, V122, P1322, DOI 10.1242/jcs.035402; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Matsuoka H, 2009, AM J PHYSIOL-CELL PH, V296, pC889, DOI 10.1152/ajpcell.00439.2008; Pouvreau Sandrine, 2007, V403, P185, DOI 10.1007/978-1-59745-529-9_12; Rychkov G., 2007, V179, P23; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Xin H, 2005, BIOCHEM BIOPH RES CO, V332, P756, DOI 10.1016/j.bbrc.2005.05.016	19	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36387	36394		10.1074/jbc.M109.073221	http://dx.doi.org/10.1074/jbc.M109.073221			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19875453	hybrid, Green Published			2022-12-27	WOS:000272970500040
J	Cho, J; Rameshwar, P; Sadoshima, J				Cho, Jaeyeaon; Rameshwar, Pranela; Sadoshima, Junichi			Distinct Roles of Glycogen Synthase Kinase (GSK)-3 alpha and GSK-3 beta in Mediating Cardiomyocyte Differentiation in Murine Bone Marrow-derived Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; PROGENITOR CELLS; TOPCARE-AMI; HEART; REGULATOR; PATHWAY; CARDIOGENESIS; KINASE-3-BETA	The signaling mechanisms facilitating cardiomyocyte (CM) differentiation from bone marrow (BM)-derived mesenchymal stem cells (MSCs) are not well understood. 5-Azacytidine (5-Aza), a DNA demethylating agent, induces expression of cardiac-specific genes, such as Nkx2.5 and alpha-MHC, in mouse BM-derived MSCs. 5-Aza treatment caused significant up-regulation of glycogen synthase kinase (GSK)-3 beta and down-regulation of beta-catenin, whereas it stimulated GSK-3 alpha expression only modestly. The promoter region of GSK-3 beta was heavily methylated in control MSCs, but was demethylated by 5-Aza. Although overexpression of GSK-3 beta potently induced CM differentiation, that of GSK-3 alpha induced markers of neuronal and chondrocyte differentiation. GSK-3 inhibitors, including LiCl, SB 216743, and BIO, abolished 5-Aza-induced up-regulation of CM-specific genes, suggesting that GSK-3 is necessary and sufficient for CM differentiation in MSCs. Although specific knockdown of endogenous GSK-3 alpha abolished 5-Aza-induced expression of cardiac specific genes, surprisingly, that of GSK-3 alpha facilitated CM differentiation in MSCs. Although GSK-3 alpha is found in both the cytosol and nucleus in MSCs, GSK-3 alpha is localized primarily in the nucleus. Nuclear-specific overexpression of GSK-3 beta failed to stimulate CM differentiation. Down-regulation of beta-catenin mediates GSK-3 beta-induced CM differentiation in MSCs, whereas up-regulation of c-Jun plays an important role in mediating CM differentiation induced by GSK-3 alpha knockdown. These results suggest that GSK-3 alpha and GSK-3 beta have distinct roles in regulating CM differentiation in BM-derived MSCs. GSK-3 beta in the cytosol induces CM differentiation of MSCs through down-regulation of beta-catenin. In contrast, GSK-3 alpha in the nucleus inhibits CM differentiation through down-regulation of c-Jun.	[Cho, Jaeyeaon; Sadoshima, Junichi] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Inst Cardiovasc Res, Newark, NJ 07103 USA; [Rameshwar, Pranela] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), 185 S Orange Ave,MSB G609, Newark, NJ 07103 USA.	sadoshju@umdnj.edu		Sadoshima, Junichi/0000-0003-3724-4132	National Institutes of Health [HL 059139, HL067724, HL069020, AG023039, AG027211, HL91469]; United States Public Health Service; New Jersey Commission of Science and Technology Stem Cell Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067724, P01HL059139, P01HL069020, R01HL091469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211, R01AG023039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); New Jersey Commission of Science and Technology Stem Cell Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 059139, HL067724, HL069020, AG023039, AG027211, and HL91469 from the United States Public Health Service and grants from the New Jersey Commission of Science and Technology Stem Cell Research Grant Program.	Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hare JM, 2008, CURR OPIN ORGAN TRAN, V13, P536, DOI 10.1097/MOT.0b013e32830fdfc4; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Koyanagi M, 2005, J BIOL CHEM, V280, P16838, DOI 10.1074/jbc.M500323200; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	35	59	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36647	36658		10.1074/jbc.M109.019109	http://dx.doi.org/10.1074/jbc.M109.019109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858210	Green Published, hybrid			2022-12-27	WOS:000272970500065
J	Ellis, J; Gutierrez, A; Barsukov, IL; Huang, WC; Grossmann, JG; Roberts, GCK				Ellis, Jacqueline; Gutierrez, Aldo; Barsukov, Igor L.; Huang, Wei-Cheng; Grossmann, J. Guenter; Roberts, Gordon C. K.			Domain Motion in Cytochrome P450 Reductase CONFORMATIONAL EQUILIBRIA REVEALED BY NMR AND SMALL-ANGLE X-RAY SCATTERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FMN-BINDING DOMAIN; ELECTRON-TRANSFER; COENZYME BINDING; METHIONINE SYNTHASE; P450 OXIDOREDUCTASE; STRUCTURAL BASIS; NADPH; CLONING; PROTEIN	NADPH-cytochrome P450 reductase (CPR), a diflavin reductase, plays a key role in the mammalian P450 mono-oxygenase system. In its crystal structure, the two flavins are close together, positioned for interflavin electron transfer but not for electron transfer to cytochrome P450. A number of lines of evidence suggest that domain motion is important in the action of the enzyme. We report NMR and small-angle x-ray scattering experiments addressing directly the question of domain organization in human CPR. Comparison of the H-1-N-15 heteronuclear single quantum correlation spectrum of CPR with that of the isolated FMN domain permitted identification of residues in the FMN domain whose environment differs in the two situations. These include several residues that are solvent-exposed in the CPR crystal structure, indicating the existence of a second conformation in which the FMN domain is involved in a different interdomain interface. Small-angle x-ray scattering experiments showed that oxidized and NADPH-reduced CPRs have different overall shapes. The scattering curve of the reduced enzyme can be adequately explained by the crystal structure, whereas analysis of the data for the oxidized enzyme indicates that it exists as a mixture of approximately equal amounts of two conformations, one consistent with the crystal structure and one a more extended structure consistent with that inferred from the NMR data. The correlation between the effects of adenosine 2', 5'-bisphosphate and NADPH on the scattering curve and their effects on the rate of interflavin electron transfer suggests that this conformational equilibrium is physiologically relevant.	[Ellis, Jacqueline; Gutierrez, Aldo; Barsukov, Igor L.; Huang, Wei-Cheng; Roberts, Gordon C. K.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Grossmann, J. Guenter] Sci & Technol Facil Council, Daresbury Lab, Mol Biophys Grp, Warrington WA4 4AD, Cheshire, England	University of Leicester; STFC Daresbury Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC)	Roberts, GCK (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Henry Wellcome Bldg,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England.	gcr@le.ac.uk		Roberts, Gordon/0000-0001-6200-1373; Huang, Wei-Cheng/0000-0003-4437-3530	Biotechnology and Biological Sciences Research Council; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Biotechnology and Biological Sciences Research Council and the Wellcome Trust.	Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bailey SM, 2001, BIOCHEM PHARMACOL, V62, P461, DOI 10.1016/S0006-2952(01)00674-8; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Grossmann JG, 1998, J MOL BIOL, V279, P461, DOI 10.1006/jmbi.1998.1787; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Grunau A, 2007, BIOCHEMISTRY-US, V46, P8244, DOI 10.1021/bi700596s; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; ILAN Z, 1981, J BIOL CHEM, V256, P66; Iyanagi T, 2005, BIOCHEM BIOPH RES CO, V338, P520, DOI 10.1016/j.bbrc.2005.08.043; Jaffar M, 2001, ADV DRUG DELIVER REV, V53, P217, DOI 10.1016/S0169-409X(01)00228-9; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Mujacic M, 1999, GENE, V238, P325, DOI 10.1016/S0378-1119(99)00328-5; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Rooseboom M, 2004, PHARMACOL REV, V56, P53, DOI 10.1124/pr.56.1.3; Saunders MP, 2000, BIOCHEM PHARMACOL, V59, P993, DOI 10.1016/S0006-2952(99)00405-0; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; SEM DS, 1993, BIOCHEMISTRY-US, V32, P11548, DOI 10.1021/bi00094a011; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhao Q, 1999, PROTEIN SCI, V8, P298	48	110	112	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36628	36637		10.1074/jbc.M109.054304	http://dx.doi.org/10.1074/jbc.M109.054304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858215	Green Published, hybrid			2022-12-27	WOS:000272970500063
J	Schmidt, A; Harada, SI; Kimmel, DB; Bai, C; Chen, F; Rutledge, SJ; Vogel, RL; Scafonas, A; Gentile, MA; Nantermet, PV; McElwee-Witmer, S; Pennypacker, B; Masarachia, P; Sahoo, SP; Kim, Y; Meissner, RS; Hartman, GD; Duggan, ME; Rodan, GA; Towler, DA; Ray, WJ				Schmidt, Azriel; Harada, Shun-Ichi; Kimmel, Donald B.; Bai, Chang; Chen, Fang; Rutledge, Su Jane; Vogel, Robert L.; Scafonas, Angela; Gentile, Michael A.; Nantermet, Pascale V.; McElwee-Witmer, Sheila; Pennypacker, Brenda; Masarachia, Patricia; Sahoo, Soumya P.; Kim, Yuntae; Meissner, Robert S.; Hartman, George D.; Duggan, Mark E.; Rodan, Gideon A.; Towler, Dwight A.; Ray, William J.			Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; TERMINAL INTERACTIONS; PROTEIN-INTERACTION; PROMOTER ACTIVITY; GENETIC PATHWAYS; ER-ALPHA; INSENSITIVITY; TESTOSTERONE; MUTATIONS; EXPRESSION	Androgen replacement therapy is a promising strategy for the treatment of frailty; however, androgens pose risks for unwanted effects including virilization and hypertrophy of reproductive organs. Selective Androgen Receptor Modulators (SARMs) retain the anabolic properties of androgens in bone and muscle while having reduced effects in other tissues. We describe two structurally similar 4-aza-steroidal androgen receptor (AR) ligands, Cl-4AS-1, a full agonist, and TFM-4AS-1, which is a SARM. TFM-4AS-1 is a potent AR ligand (IC50, 38 nM) that partially activates an AR-dependent MMTV promoter (55% of maximal response) while antagonizing the N-terminal/C-terminal interaction within AR that is required for full receptor activation. Microarray analyses of MDA-MB-453 cells show that whereas Cl-4AS-1 behaves like 5 alpha-dihydrotestosterone (DHT), TFM-4AS-1 acts as a gene-selective agonist, inducing some genes as effectively as DHT and others to a lesser extent or not at all. This gene-selective agonism manifests as tissue-selectivity: in ovariectomized rats, Cl-4AS-1 mimics DHT while TFM-4AS-1 promotes the accrual of bone and muscle mass while having reduced effects on reproductive organs and sebaceous glands. Moreover, TFM-4AS-1 does not promote prostate growth and antagonizes DHT in seminal vesicles. To confirm that the biochemical properties of TFM-4AS-1 confer tissue selectivity, we identified a structurally unrelated compound, FTBU-1, with partial agonist activity coupled with antagonism of the N-terminal/C-terminal interaction and found that it also behaves as a SARM. TFM-4AS-1 and FTBU-1 represent two new classes of SARMs and will allow for comparative studies aimed at understanding the biophysical and physiological basis of tissue-selective effects of nuclear receptor ligands.	[Schmidt, Azriel; Harada, Shun-Ichi; Kimmel, Donald B.; Bai, Chang; Chen, Fang; Rutledge, Su Jane; Vogel, Robert L.; Scafonas, Angela; Gentile, Michael A.; Nantermet, Pascale V.; McElwee-Witmer, Sheila; Pennypacker, Brenda; Masarachia, Patricia; Rodan, Gideon A.; Towler, Dwight A.; Ray, William J.] Merck Res Labs, Dept Mol Endocrinol Bone Biol, West Point, PA 19486 USA; [Kim, Yuntae; Meissner, Robert S.; Hartman, George D.; Duggan, Mark E.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA; [Sahoo, Soumya P.] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company	Schmidt, A (corresponding author), Merck Res Labs, Dept Mol Endocrinol, POB 4, West Point, PA 19486 USA.	azriel_schmidt@merck.com	Ray, William J/E-9834-2016	Towler, Dwight/0000-0003-2107-7923; Ray, William/0000-0002-4491-167X				Bachmann GA, 1999, AM J OBSTET GYNECOL, V180, pS308, DOI 10.1016/S0002-9378(99)70724-6; Bain J, 2007, CLIN INTERV AGING, V2, P567; Beauchet O, 2006, EUR J ENDOCRINOL, V155, P773, DOI 10.1530/eje.1.02306; Bettoun DJ, 2005, J BIOL CHEM, V280, P38898, DOI 10.1074/jbc.C500324200; Bhasin S, 2003, J GERONTOL A-BIOL, V58, P1002; Bidder M, 2000, BIOCHEMISTRY-US, V39, P8917, DOI 10.1021/bi000343+; Carnahan RM, 2004, DRUG AGING, V21, P361, DOI 10.2165/00002512-200421060-00002; Chen F, 2004, J STEROID BIOCHEM, V91, P247, DOI 10.1016/j.jsbmb.2004.04.009; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Deeb A, 2008, J CLIN ENDOCR METAB, V93, P3691, DOI 10.1210/jc.2008-0737; Elhaji YA, 2004, MOL ENDOCRINOL, V18, P1876, DOI 10.1210/me.2004-0023; Gao WQ, 2007, DRUG DISCOV TODAY, V12, P241, DOI 10.1016/j.drudis.2007.01.003; Gao WQ, 2006, PHARM RES-DORDR, V23, P1641, DOI 10.1007/s11095-006-9024-3; Ghali SA, 2003, J CLIN ENDOCR METAB, V88, P2185, DOI 10.1210/jc.2002-021324; Gustafsson JA, 1998, CURR OPIN CHEM BIOL, V2, P508, DOI 10.1016/S1367-5931(98)80127-0; HALL RE, 1994, EUR J CANCER, V30A, P484, DOI 10.1016/0959-8049(94)90424-3; HALL RE, 1992, INT J CANCER, V52, P778, DOI 10.1002/ijc.2910520518; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Holterhus PM, 2005, EXP CLIN ENDOCR DIAB, V113, P457, DOI 10.1055/s-2005-865770; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Isidori A M, 2005, J Endocrinol Invest, V28, P73; Jaaskelainen J, 2006, J MOL ENDOCRINOL, V36, P361, DOI 10.1677/jme.1.01885; KALLIO PJ, 1995, MOL ENDOCRINOL, V9, P1017, DOI 10.1210/me.9.8.1017; Katzenellenbogen BS, 2002, SCIENCE, V295, P2380, DOI 10.1126/science.1070442; Kaufman J M, 2003, Aging Male, V6, P166, DOI 10.1080/713604787; Kilbourne EJ, 2007, CURR OPIN INVEST DR, V8, P821; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Marks LS, 2008, UROLOGY, V72, P247, DOI 10.1016/j.urology.2008.03.033; Matsumoto T, 2008, J STEROID BIOCHEM, V109, P236, DOI 10.1016/j.jsbmb.2008.03.023; MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659; MEISSNER RS, 2009, ACS NAT M, V32; Nantermet PV, 2005, ENDOCRINOLOGY, V146, P564, DOI 10.1210/en.2004-1132; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Nettleship JE, 2009, FRONT HORM RES, V37, P91, DOI 10.1159/000176047; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; Scafonas A, 2008, J STEROID BIOCHEM, V110, P197, DOI 10.1016/j.jsbmb.2007.10.013; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Schneikert J, 1996, J BIOL CHEM, V271, P23907, DOI 10.1074/jbc.271.39.23907; Stanworth RD, 2009, FRONT HORM RES, V37, P74, DOI 10.1159/000176046; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Tolman RL, 1997, J STEROID BIOCHEM, V60, P303, DOI 10.1016/S0960-0760(96)00199-9; Valenti G, 2007, Minerva Ginecol, V59, P43; Vermeulen A, 2003, ANN ENDOCRINOL-PARIS, V64, P109; YAMAMOTO M, 1993, CALCIFIED TISSUE INT, V53, P278, DOI 10.1007/BF01320914; Yamamoto M, 1998, ENDOCRINOLOGY, V139, P1411, DOI 10.1210/en.139.3.1411; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	48	30	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36367	36376		10.1074/jbc.M109.049734	http://dx.doi.org/10.1074/jbc.M109.049734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846549	Green Published, hybrid			2022-12-27	WOS:000272970500038
J	Vergarajauregui, S; Martina, JA; Puertollano, R				Vergarajauregui, Silvia; Martina, Jose A.; Puertollano, Rosa			Identification of the Penta-EF-hand Protein ALG-2 as a Ca2+-dependent Interactor of Mucolipin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNEL; CALCIUM-BINDING PROTEIN; APOPTOSIS-LINKED GENE-2; GROWTH-FACTOR RECEPTOR; RETICULUM EXIT SITES; CATION CHANNEL; CA2+-BINDING PROTEINS; MEMBRANE TRAFFICKING; LYSOSOMAL PATHWAY; EPITHELIAL-CELLS	Loss of function mutations in mucolipin-1 (MCOLN1) have been linked to mucolipidosis type IV (MLIV), a recessive lysosomal storage disease characterized by severe neurological and ophthalmological abnormalities. MCOLN1 is an ion channel that regulates membrane transport along the endolysosomal pathway. It has been suggested that MCOLN1 participates in several Ca2+-dependent processes, including fusion of lysosomes with the plasma membrane, fusion of late endosomes and autophagosomes with lysosomes, and lysosomal biogenesis. Here, we searched for proteins that interact with MCOLN1 in a Ca2+-dependent manner. We found that the penta-EF-hand protein ALG-2 binds to the NH-terminal cytosolic tail of MCOLN1. The interaction is direct, strictly dependent on Ca2+, and mediated by a patch of charged and hydrophobic residues located between MCOLN1 residues 37 and 49. We further show that MCOLN1 and ALG-2 co-localize to enlarged endosomes induced by overexpression of an ATPase-defective dominant-negative form of Vps4B (Vps4B(E235Q)). In agreement with the proposed role of MCOLN1 in the regulation of fusion/fission events, we found that overexpression of MCOLN1 caused accumulation of enlarged, aberrant endosomes that contain both early and late endosome markers. Interestingly, aggregation of abnormal endosomes was greatly reduced when the ALG-2-binding domain in MCOLN1 was mutated, suggesting that ALG-2 regulates MCOLN1 function. Overall, our data provide new insight into the molecular mechanisms that regulate MCOLN1 activity. We propose that ALG-2 acts as a Ca2+ sensor that modulates the function of MCOLN1 along the late endosomal-lysosomal pathway.	[Vergarajauregui, Silvia; Martina, Jose A.; Puertollano, Rosa] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Puertollano, R (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50-3537, Bethesda, MD 20892 USA.	puertolr@mail.nih.gov	Vergarajauregui, Silvia/ABG-8402-2020; Martina, Jose A/C-2772-2013	Vergarajauregui, Silvia/0000-0002-9247-6123; Martina, Jose/0000-0001-5814-8807	NHLBI Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZIAHL000140] Funding Source: NIH RePORTER	NHLBI Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by a National Institutes of Health grant from NHLBI Intramural Research.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; AMIR N, 1987, PEDIATRICS, V79, P953; Aukunuru JV, 2001, PHARM RES-DORDR, V18, P565, DOI 10.1023/A:1011060705599; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; BACH G, 1977, AM J HUM GENET, V29, P610; BACH G, 1975, BIOCHEM BIOPH RES CO, V66, P1483, DOI 10.1016/0006-291X(75)90526-4; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Cantiello HF, 2005, PFLUG ARCH EUR J PHY, V451, P304, DOI 10.1007/s00424-005-1448-9; Chen CM, 2005, BIOCHEM BIOPH RES CO, V333, P51, DOI 10.1016/j.bbrc.2005.05.074; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Christensen KA, 2002, J CELL SCI, V115, P599; CRANDALL BF, 1982, AM J MED GENET, V12, P301, DOI 10.1002/ajmg.1320120308; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Draeby I, 2007, ARCH BIOCHEM BIOPHYS, V467, P87, DOI 10.1016/j.abb.2007.07.028; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; FOLKERTH RD, 1995, J NEUROPATH EXP NEUR, V54, P154, DOI 10.1097/00005072-199503000-00002; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; Hwang IS, 2002, FEBS LETT, V529, P183, DOI 10.1016/S0014-5793(02)03329-X; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; LaPlante JM, 2004, BIOCHEM BIOPH RES CO, V322, P1384, DOI 10.1016/j.bbrc.2004.08.045; Lo KWH, 1999, BIOCHEMISTRY-US, V38, P7498, DOI 10.1021/bi990034n; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Miedel MT, 2006, J BIOL CHEM, V281, P12751, DOI 10.1074/jbc.M511104200; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Piper RC, 2004, TRENDS CELL BIOL, V14, P471, DOI 10.1016/j.tcb.2004.07.010; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Satoh H, 2002, BBA-PROTEINS PROTEOM, V1600, P61, DOI 10.1016/S1570-9639(02)00445-4; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Suzuki H, 2009, BIOCHEM SOC T, V37, P190, DOI 10.1042/BST0370190; Tarabykina S, 2004, FRONT BIOSCI-LANDMRK, V9, P1817, DOI 10.2741/1358; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; TELLEZNAGEL I, 1976, ARCH NEUROL-CHICAGO, V33, P828, DOI 10.1001/archneur.1976.00500120032005; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Vergarajauregui S, 2008, AUTOPHAGY, V4, P832, DOI 10.4161/auto.6567; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yan Q, 2004, J BIOL CHEM, V279, P18270, DOI 10.1074/jbc.M400093200; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914	80	64	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36357	36366		10.1074/jbc.M109.047241	http://dx.doi.org/10.1074/jbc.M109.047241			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864416	hybrid, Green Published			2022-12-27	WOS:000272970500037
J	D'Angelo, G; Prencipe, L; Iodice, L; Beznoussenko, G; Savarese, M; Marra, P; Di Tullio, G; Martire, G; De Matteis, MA; Bonatti, S				D'Angelo, Giovanni; Prencipe, Libera; Iodice, Luisa; Beznoussenko, Galina; Savarese, Marco; Marra, PierFrancesco; Di Tullio, Giuseppe; Martire, Gianluca; De Matteis, Maria Antonietta; Bonatti, Stefano			GRASP65 and GRASP55 Sequentially Promote the Transport of C-terminal Valine-bearing Cargos to and through the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM EXPORT; CELL-SURFACE; INTERMEDIATE COMPARTMENT; STRUCTURAL INTEGRITY; MEMBRANE-PROTEINS; SELECTIVE EXPORT; MAMMALIAN-CELLS; REGULATES GOLGI; PROTGF-ALPHA; ER EXPORT	The Golgi matrix proteins GRASP65 and GRASP55 have recognized roles in maintaining the architecture of the Golgi complex, in mitotic progression and in unconventional protein secretion whereas, surprisingly, they have been shown to be dispensable for the transport of commonly used reporter cargo proteins along the secretory pathway. However, it is becoming increasingly clear that many trafficking machineries operate in a cargo-specific manner, thus we have investigated whether GRASPs may control the trafficking of selected classes of cargo. We have taken into consideration the C-terminal valine-bearing receptors CD8 alpha and Frizzled4 that we show bind directly to the PSD95-DlgA-zo-1 (PDZ) domains of GRASP65 and GRASP55. We demonstrate that both GRASPs are needed sequentially for the efficient transport to and through the Golgi complex of these receptors, thus highlighting a novel role for the GRASPs in membrane trafficking. Our results open new perspectives for our understanding of the regulation of surface expression of a class of membrane proteins, and suggests the causal mechanisms of a dominant form of autosomal human familial exudative vitreoretinopathy that arises from the Frizzled4 mutation involving its C-terminal valine.	[D'Angelo, Giovanni; Prencipe, Libera; Iodice, Luisa; Savarese, Marco; Martire, Gianluca; Bonatti, Stefano] Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; [D'Angelo, Giovanni; Beznoussenko, Galina; Marra, PierFrancesco; Di Tullio, Giuseppe; De Matteis, Maria Antonietta] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; [Iodice, Luisa; Martire, Gianluca] Univ Molise, Dept Environm Sci & Technol, I-86090 Isernia, Italy; [Marra, PierFrancesco] Inst Canc Res, Chester Beatty Labs, Sect Cell & Mol Biol, London SW3 6JB, England	University of Naples Federico II; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Molise; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bonatti, S (corresponding author), Via S Pansini 5, I-80131 Naples, Italy.	bonatti@unina.it	De Matteis, Maria Antonietta/AHE-5161-2022; Savarese, Marco/J-8307-2016	De Matteis, Maria Antonietta/0000-0003-0053-3061; Savarese, Marco/0000-0002-2591-244X; D'Angelo, Giovanni/0000-0002-0734-4127; DANGELO, GIOVANNI/0000-0001-5466-8709	Ministero Universita Ricerca Scientifica e Tecnologica; Italian Association for Cancer Research and Telethon Italia; Fondazione Italiana Ricerca sul Cancro	Ministero Universita Ricerca Scientifica e Tecnologica; Italian Association for Cancer Research and Telethon Italia(Fondazione AIRC per la ricerca sul cancroFondazione Telethon); Fondazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Ministero Universita Ricerca Scientifica e Tecnologica (to S. B.), the Italian Association for Cancer Research and Telethon Italia (to A. D. M.), and the Telethon Electron Microscopy Core Facility and by a fellowship from the Fondazione Italiana Ricerca sul Cancro (to G. D. A.).	Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; BONATTI S, 1989, J BIOL CHEM, V264, P12590; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; DELONGH RU, 2006, FRONT BIOSCI, V11, P2442; Devine L, 2000, J IMMUNOL, V164, P833, DOI 10.4049/jimmunol.164.2.833; DIALYNAS DP, 1981, J EXP MED, V153, P595, DOI 10.1084/jem.153.3.595; DISANTO JP, 1988, EMBO J, V7, P3465, DOI 10.1002/j.1460-2075.1988.tb03221.x; Duran JM, 2008, MOL BIOL CELL, V19, P2579, DOI 10.1091/mbc.E07-10-0998; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; HENNECKE S, 1993, J BIOL CHEM, V268, P26607; HOBBIE L, 1994, J BIOL CHEM, V269, P20958; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kuehn MJ, 1997, CURR OPIN CELL BIOL, V9, P477, DOI 10.1016/S0955-0674(97)80022-1; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lotti LV, 1996, EXP CELL RES, V227, P323, DOI 10.1006/excr.1996.0281; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Martire G, 1996, J BIOL CHEM, V271, P3541; Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x; Mottola G, 2000, J BIOL CHEM, V275, P24070, DOI 10.1074/jbc.M910400199; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; Nufer O, 2002, J CELL SCI, V115, P619; PARNES JR, 1989, ADV IMMUNOL, V44, P265; PASCALE MC, 1992, J BIOL CHEM, V267, P9940; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; SCHMIDTULLRICH R, 1990, INT IMMUNOL, V2, P247, DOI 10.1093/intimm/2.3.247; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Spatuzza C, 2004, J BIOL CHEM, V279, P42535, DOI 10.1074/jbc.M401860200; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Urena JM, 1999, J CELL SCI, V112, P773; Vasile E, 2003, TRAFFIC, V4, P254, DOI 10.1034/j.1600-0854.2003.00080.x; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yao RJ, 2001, BIOCHEM BIOPH RES CO, V286, P771, DOI 10.1006/bbrc.2001.5430	58	52	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34849	34860		10.1074/jbc.M109.068403	http://dx.doi.org/10.1074/jbc.M109.068403			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840934	Green Published, hybrid			2022-12-27	WOS:000272439600040
J	Juge, N; Muroyama, A; Hiasa, M; Omote, H; Moriyama, Y				Juge, Narinobu; Muroyama, Akiko; Hiasa, Miki; Omote, Hiroshi; Moriyama, Yoshinori			Vesicular Inhibitory Amino Acid Transporter Is a Cl-/gamma-Aminobutyrate Co-transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLES; FUNCTIONAL RECONSTITUTION; GABA TRANSPORTER; RAT-BRAIN; IDENTIFICATION; GLYCINE; NEUROTRANSMITTER; NEURONS; PROTEIN; CARRIER	The vesicular inhibitory amino acid transporter (VIAAT) is a synaptic vesicle protein responsible for the vesicular storage of gamma-aminobutyrate (GABA) and glycine which plays an essential role in GABAergic and glycinergic neurotransmission. The transport mechanism of VIAAT remains largely unknown. Here, we show that proteoliposomes containing purified VIAAT actively took up GABA upon formation of membrane potential (Delta psi) (positive inside) but not Delta pH. VIAAT-mediated GABA uptake had an absolute requirement for Cl- and actually accompanied Cl- movement. Kinetic analysis indicated that one GABA molecule and two Cl- equivalents were transported during one transport cycle. VIAAT in which Glu(213) was specifically mutated to alanine completely lost the ability to take up both GABA and Cl-. Essentially the same results were obtained with glycine, another substrate of VIAAT. These results demonstrated that VIAAT is a vesicular Cl- transporter that co-transports Cl- with GABA or glycine in a Delta psi dependent manner. It is concluded that Cl- plays an essential role in vesicular storage of GABA and glycine.	[Juge, Narinobu; Muroyama, Akiko; Hiasa, Miki; Omote, Hiroshi; Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University	Moriyama, Y (corresponding author), Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp	OMOTE, Hiroshi/B-1635-2011; Juge, Narinobu/M-1125-2018	Juge, Narinobu/0000-0002-5825-6717	Ministry of Education, Science, Sports, and Culture of Japan; Ajinomoto 3A	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto 3A	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan and the Ajinomoto 3A Research grant (to Y.M.).	Bedet C, 2000, J NEUROCHEM, V75, P1654, DOI 10.1046/j.1471-4159.2000.0751654.x; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Dumoulin A, 1999, J CELL SCI, V112, P811; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FYKSE EM, 1989, J NEUROCHEM, V52, P946, DOI 10.1111/j.1471-4159.1989.tb02546.x; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; HELL JW, 1991, BIOCHEMISTRY-US, V30, P11795, DOI 10.1021/bi00115a009; HELL JW, 1990, J BIOL CHEM, V265, P2111; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; PATEL AJ, 1985, J NEUROCHEM, V44, P1816, DOI 10.1111/j.1471-4159.1985.tb07173.x; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SIEGHART W, 1992, TRENDS PHARMACOL SCI, V13, P446, DOI 10.1016/0165-6147(92)90142-S; Takamori S, 2000, J NEUROSCI, V20, P4904; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	26	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35073	35078		10.1074/jbc.M109.062414	http://dx.doi.org/10.1074/jbc.M109.062414			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19843525	Green Published, hybrid			2022-12-27	WOS:000272439600061
J	Bradley, SE; Johnson, AE; Le, IP; Oosterhouse, E; Hledin, MP; Marquez, GA; Burnatowska-Hledin, M				Bradley, Shirley E.; Johnson, Alyssa E.; Le, Isabelle P.; Oosterhouse, Elizabeth; Hledin, Michael P.; Marquez, Gabriel A.; Burnatowska-Hledin, Maria			Phosphorylation of VACM-1/Cul5 by Protein Kinase A Regulates Its Neddylation and Antiproliferative Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; CELL-CYCLE PROGRESSION; GENE FAMILY-MEMBER; ENDOTHELIAL-CELLS; CUL-5 GENE; DEPENDENT PHOSPHORYLATION; ADENOVIRUS E4ORF6; LIGASE ITCH; CULLIN; NEDD8	Expression of the VACM-1/cul5 gene in endothelial and in cancer cell lines in vitro inhibits cellular proliferation and decreases phosphorylation of MAPK. Structure-function analysis of the VACM-1 protein sequence identified consensus sites specific for phosphorylation by protein kinases A and C (PKA and PKC) and a Nedd8 protein modification site. Mutations at the PKA-specific site in VACM-1/Cul5 ((S730A)VACM-1) sequence resulted in increased cellular growth and the appearance of a Nedd8-modified VACM-1/Cul5. The aim of this study was to examine if PKA-dependent phosphorylation of VACM-1/Cul5 controls its neddylation status, phosphorylation by PKC, and ultimately growth. Our results indicate that in vitro transfection of rat adrenal medullary endothelial cells with anti-VACM-1-specific small interfering RNA oligonucleotides decreases endogenous VACM-1 protein concentration and increases cell growth. Western blot analysis of cell lysates immunoprecipitated with an antibody directed against a PKA-specific phosphorylation site and probed with anti-VACM-1-specific antibody showed that PKA-dependent phosphorylation of VACM-1 protein was decreased in cells transfected with (S730A)VACM-1cDNA when compared with the cytomegalovirus-transfected cells. This change was associated with increased modification of VACM-1 protein by Nedd8. Induction of PKA activity with forskolin reduced modification of VACM-1protein by Nedd8. Finally, rat adrenal medullary endothelial cells transfected with (S730A)VACM-1/cul5 cDNA and treated with phorbol 12-myristate 13-acetate (10 and 100 nM) to induce PKC activity grew significantly faster than the control cells. These results suggest that the antiproliferative effect of VACM-1/Cul5 is dependent on its posttranslational modifications and will help in the design of new anticancer therapeutics that target the Nedd8 pathway.	[Burnatowska-Hledin, Maria] Hope Coll, Ctr Sci, Dept Biol, Holland, MI 49422 USA; Hope Coll, Dept Chem, Holland, MI 49422 USA	Hope College; Hope College	Burnatowska-Hledin, M (corresponding author), Hope Coll, Ctr Sci, Dept Biol, Holland, MI 49422 USA.	hledin@hope.edu			National Institutes of Health (NIH) [RO1DK47199, R15CA104014]; Beckman Foundation; Merck Institute for Science Education; NATIONAL CANCER INSTITUTE [R15CA104014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047199] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Merck Institute for Science Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1DK47199 and NIH, NCI, Grant R15CA104014. This work was also supported by a Beckman Foundation Award (to S. E. B.), a Research Experience Across Cultures at Hope program award to high school student (G. A. M.), and a Merck/American Association for the Advancement of Science Undergraduate Science Research Program Award from the Merck Institute for Science Education.	Alappat EC, 2003, J BIOL CHEM, V278, P41585, DOI 10.1074/jbc.C300385200; Buchwalter A, 2008, MICROVASC RES, V75, P155, DOI 10.1016/j.mvr.2007.08.004; Burnatowska-Hledin M, 1999, AM J PHYSIOL-RENAL, V276, pF199, DOI 10.1152/ajprenal.1999.276.2.F199; Burnatowska-Hledin M, 2000, AM J PHYSIOL-CELL PH, V279, pC266, DOI 10.1152/ajpcell.2000.279.1.C266; Burnatowska-Hledin M, 2001, ENDOTHELIUM-J ENDOTH, V8, P49, DOI 10.3109/10623320109063157; Burnatowska-Hledin MA, 2004, BIOCHEM BIOPH RES CO, V319, P817, DOI 10.1016/j.bbrc.2004.05.057; BURNATOWSKAHLEDIN MA, 1995, AM J PHYSIOL-RENAL, V268, pF1198, DOI 10.1152/ajprenal.1995.268.6.F1198; Byrd PJ, 1997, GENOME RES, V7, P71, DOI 10.1101/gr.7.1.71; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Goyal P, 2005, J BIOL CHEM, V280, P27569, DOI 10.1074/jbc.M504448200; Herrmann J, 2004, CARDIOVASC RES, V61, P11, DOI 10.1016/j.cardiores.2003.09.033; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Johnson AE, 2007, MOL CELL BIOCHEM, V301, P13, DOI 10.1007/s11010-006-9392-3; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Luo K, 2007, FASEB J, V21, P1742, DOI 10.1096/fj.06-7241com; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; Norman JA, 2006, BIOCHEMISTRY-US, V45, P3014, DOI 10.1021/bi052435a; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Papadimitrio E., 1993, ENDOTHELIUM-J ENDOTH, V1, P207, DOI [10.3109/10623329309102698, DOI 10.3109/10623329309102698]; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Shimada K, 2005, J PATHOL, V206, P423, DOI 10.1002/path.1791; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sun Y, 2003, CANCER BIOL THER, V2, P623; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Van Dort C, 2003, AM J PHYSIOL-CELL PH, V285, pC1386, DOI 10.1152/ajpcell.00338.2002; Wada H, 1999, BIOCHEM BIOPH RES CO, V257, P100, DOI 10.1006/bbrc.1999.0339; Yoshiji H, 1999, CANCER RES, V59, P4413; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120	47	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4883	4895		10.1074/jbc.M109.085225	http://dx.doi.org/10.1074/jbc.M109.085225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19917606	hybrid, Green Published			2022-12-27	WOS:000275274800066
J	Kalyanasundaram, A; Bal, NC; Franzini-Armstrong, C; Knollmann, BC; Periasamy, M				Kalyanasundaram, Anuradha; Bal, Naresh C.; Franzini-Armstrong, Clara; Knollmann, Bjoern C.; Periasamy, Muthu			The Calsequestrin Mutation CASQ2(D307H) Does Not Affect Protein Stability and Targeting to the Junctional Sarcoplasmic Reticulum but Compromises Its Dynamic Regulation of Calcium Buffering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; HUMAN CARDIAC CALSEQUESTRIN; CHAIN GENE PROMOTER; RYANODINE RECEPTOR; MISSENSE MUTATION; BEDOUIN FAMILIES; RELEASE CHANNEL; CASQ2; SKELETAL; TRIADIN	Mutations in cardiac ryanodine receptor (RYR2) and cardiac calsequestrin (CASQ2) genes are linked to catecholaminergic polymorphic ventricular tachycardia, a life-threatening genetic disease. They predispose young individuals to cardiac arrhythmia in the absence of structural abnormalities. One such mutation that changes an aspartic residue to histidine at position 307 in CASQ2 has been linked to catecholaminergic polymorphic ventricular tachycardia. In this study we made a transgenic mouse model expressing the mutant CASQ2(D307H) protein in a CASQ2 null background and investigated if the disease is caused by accelerated degradation of the mutant protein. Our data suggest that the mutant protein can be expressed, is relatively stable, and targets appropriately to the junctional sarcoplasmic reticulum. Moreover, it partially normalizes the ultrastructure of the sarcoplasmic reticulum, which was altered in the CASQ2 null background. In addition, overexpression of the mutant protein does not cause any pathology and/or structural changes in the myocardium. We further demonstrate, using purified protein, that the mutant protein is very stable under chemical and thermal denaturation but shows abnormal Ca2+ buffering characteristics at high calcium concentrations. In addition, trypsin digestion studies reveal that the mutant protein is more susceptible to protease activity only in the presence of high Ca2+. These studies collectively suggest that the D307H mutation can compromise the dynamic behavior of CASQ2 including supramolecular rearrangement upon Ca2+ activation.	[Kalyanasundaram, Anuradha; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, Columbus, OH 43210 USA; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Knollmann, Bjoern C.] Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA; [Knollmann, Bjoern C.] Vanderbilt Univ, Div Clin Pharmacol, Dept Pharmacol, Nashville, TN 37232 USA	Ohio State University; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Periasamy, M (corresponding author), 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu		Periasamy, Muthu/0000-0001-8834-5975; Knollmann, Bjorn/0000-0003-4956-9735	National Institutes of Health [R0-1 HL64014]; American Heart Association pre-doctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association pre-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 HL64014 (to M. P.) and an American Heart Association pre-doctoral fellowship (to A. K.).	Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Dirksen WP, 2007, CARDIOVASC RES, V75, P69, DOI 10.1016/j.cardiores.2007.03.002; Eldar M, 2003, TRENDS CARDIOVAS MED, V13, P148, DOI 10.1016/S1050-1738(03)00025-2; Glover L, 2001, BBA-BIOMEMBRANES, V1515, P120, DOI 10.1016/S0005-2736(01)00406-0; GULICK J, 1991, J BIOL CHEM, V266, P9180; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke S, 2004, BIOL RES, V37, P603, DOI 10.4067/s0716-97602004000400014; Houle TD, 2004, CARDIOVASC RES, V64, P227, DOI 10.1016/j.cardiores.2004.09.009; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Kang ChulHee, 2002, Methods Mol Biol, V172, P281; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Lahat H, 2004, ANN MED, V36, P87, DOI 10.1080/17431380410032517; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Lahat H, 2001, CIRCULATION, V103, P2822; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Rizzi N, 2008, CIRC RES, V103, P298, DOI 10.1161/CIRCRESAHA.108.171660; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Song L, 2007, J CLIN INVEST, V117, P1814, DOI 10.1172/JCI31080; SUBRAMANIAM A, 1993, J BIOL CHEM, V268, P4331; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; Valle G, 2008, BIOCHEM J, V413, P291, DOI 10.1042/BJ20080163; Viatchenko-Karpinski S, 2004, CIRC RES, V94, P471, DOI 10.1161/01.RES.0000115944.10681.EB; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	35	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3076	10.1074/jbc.M109.053892	http://dx.doi.org/10.1074/jbc.M109.053892			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920148	Green Published, hybrid			2022-12-27	WOS:000273829000023
J	Tsai, JY; Kienesberger, PC; Pulinilkunnil, T; Sailors, MH; Durgan, DJ; Villegas-Montoya, C; Jahoor, A; Gonzalez, R; Garvey, ME; Boland, B; Blasier, Z; McElfresh, TA; Nannegari, V; Chow, CW; Heird, WC; Chandler, MP; Dyck, JRB; Bray, MS; Young, ME				Tsai, Ju-Yun; Kienesberger, Petra C.; Pulinilkunnil, Thomas; Sailors, Mary H.; Durgan, David J.; Villegas-Montoya, Carolina; Jahoor, Anil; Gonzalez, Raquel; Garvey, Merissa E.; Boland, Brandon; Blasier, Zachary; McElfresh, Tracy A.; Nannegari, Vijayalakshmi; Chow, Chi-Wing; Heird, William C.; Chandler, Margaret P.; Dyck, Jason R. B.; Bray, Molly S.; Young, Martin E.			Direct Regulation of Myocardial Triglyceride Metabolism by the Cardiomyocyte Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE FUNCTION; RHYTHMS; HEART; MICE; TRANSCRIPTION; DISRUPTION; BMAL1; LIVER	Maintenance of circadian alignment between an organism and its environment is essential to ensure metabolic homeostasis. Synchrony is achieved by cell autonomous circadian clocks. Despite a growing appreciation of the integral relation between clocks and metabolism, little is known regarding the direct influence of a peripheral clock on cellular responses to fatty acids. To address this important issue, we utilized a genetic model of disrupted clock function specifically in cardiomyocytes in vivo (termed cardiomyocyte clock mutant (CCM)). CCM mice exhibited altered myocardial response to chronic high fat feeding at the levels of the transcriptome and lipidome as well as metabolic fluxes, providing evidence that the cardiomyocyte clock regulates myocardial triglyceride metabolism. Time-of-day-dependent oscillations in myocardial triglyceride levels, net triglyceride synthesis, and lipolysis were markedly attenuated in CCM hearts. Analysis of key proteins influencing triglyceride turnover suggest that the cardiomyocyte clock inactivates hormone-sensitive lipase during the active/awake phase both at transcriptional and post-translational (via AMP-activated protein kinase) levels. Consistent with increased net triglyceride synthesis during the end of the active/awake phase, high fat feeding at this time resulted in marked cardiac steatosis. These data provide evidence for direct regulation of triglyceride turnover by a peripheral clock and reveal a potential mechanistic explanation for accelerated metabolic pathologies after prevalent circadian misalignment in Western society.	[Durgan, David J.; Young, Martin E.] Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, Birmingham, AL 35294 USA; [Villegas-Montoya, Carolina; Jahoor, Anil; Gonzalez, Raquel; Garvey, Merissa E.; Boland, Brandon; Blasier, Zachary] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Kienesberger, Petra C.; Pulinilkunnil, Thomas; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Fac Med & Dent, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada; [Bray, Molly S.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [McElfresh, Tracy A.; Chandler, Margaret P.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Alberta; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Yeshiva University; Albert Einstein College of Medicine	Young, ME (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, Dept Med, 703 19th St S,ZRB 308, Birmingham, AL 35294 USA.	meyoung@uab.edu	Pulinilkunnil, Thomas C/L-5511-2016; Pulinilkunnil, Thomas/H-4387-2019	Pulinilkunnil, Thomas C/0000-0003-1228-893X; Pulinilkunnil, Thomas/0000-0003-1228-893X; Boland, Brandon/0000-0003-1280-9547; Dyck, Jason/0000-0002-7045-2884; Kienesberger, Petra/0000-0001-9643-8338	National Institutes of Health [HL-074259]; DeBakey Heart Fund; National Science Foundation [GK-12]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DeBakey Heart Fund; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-074259 (NHLBI).; Supported by the DeBakey Heart Fund at Baylor College of Medicine.; Supported by a National Science Foundation GK-12 fellowship.	Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; CARSON FL, 1997, HISTOTECHNOLOGY SELF, P159; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Donsmark M, 2004, BIOCHEM BIOPH RES CO, V316, P867, DOI 10.1016/j.bbrc.2004.02.140; Durgan DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2385, DOI 10.1152/ajpheart.01361.2006; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2007, J BIOL RHYTHM, V22, P312, DOI 10.1177/0748730407302625; Kudo Takashi, 2009, J Circadian Rhythms, V7, P4, DOI 10.1186/1740-3391-7-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lockridge JB, 2008, J LIPID RES, V49, P1395, DOI 10.1194/jlr.M700517-JLR200; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; MORRISON WR, 1964, J LIPID RES, V5, P600; Pan XY, 2009, J LIPID RES, V50, P1800, DOI 10.1194/jlr.M900085-JLR200; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Taegtmeyer H, 2000, J AM COLL CARDIOL, V36, P1386, DOI 10.1016/S0735-1097(00)00870-6; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van den Buuse M, 1999, PHYSIOL BEHAV, V68, P9, DOI 10.1016/S0031-9384(99)00148-1; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Young ME, 2007, SLEEP MED, V8, P656, DOI 10.1016/j.sleep.2006.12.010; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741	34	72	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2918	10.1074/jbc.M109.077800	http://dx.doi.org/10.1074/jbc.M109.077800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19940111	hybrid, Green Published			2022-12-27	WOS:000273829000006
J	Herz, K; Rimon, A; Olkhova, E; Kozachkov, L; Padan, E				Herz, Katia; Rimon, Abraham; Olkhova, Elena; Kozachkov, Lena; Padan, Etana			Transmembrane Segment II of NhaA Na+/H+ Antiporter Lines the Cation Passage, and Asp(65) Is Critical for pH Activation of the Antiporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CONFORMATIONAL-CHANGE; SITE-DIRECTED MUTAGENESIS; LOOP-VIII-IX; ESCHERICHIA-COLI; ELECTRON-TRANSFER; STRUCTURAL INTERACTIONS; PHYSIOLOGICAL PH; ION-TRANSPORT; PROTEIN; PROTON	The crystal structure of Escherichia coli NhaA determined at pH 4 has provided insights into the mechanism of activity of a pH-regulated Na+/H+ antiporter. However, because NhaA is activated at physiological pH (pH 5.5-8.5), many questions related to the active state of NhaA have remained elusive. Our experimental results at physiological pH and computational analyses reveal that amino acid residues in transmembrane segment II contribute to the cation pathway of NhaA and its pH regulation: 1) transmembrane segment II is a highly conserved helix and the conserved amino acid residues are located on one side of the helix facing either the cytoplasmic or periplasmic funnels of NhaA structure. 2) Cys replacements of the conserved residues and measuring their antiporter activity in everted membrane vesicles showed that D65C, L67C, E78C, and E82C increased the apparent K-m to Na+ and Li+ and changed the pH response of the antiporter. 3) Introduced Cys replacements, L60C, N64C, F71C, F72C, and E78C, were significantly alkylated by [C-14]N-ethylmaleimide implying the presence of water-filled cavities in NhaA. 4) Several Cys replacements were modified by MTSES and/or MTSET, membrane impermeant, negatively and positively charged reagents, respectively, that could reach Cys replacements from the periplasm only via water-filled funnel(s). Remarkably, the reactivity of D65C to MTSES increased with increasing pH and chemical modification by MTSES but not by MTSET, decreased the apparent Km of the antiporter at pH 7.5 (10-fold) but not at pH 8.5, implying the importance of Asp(65) negative charge for pH activation of the antiporter.	[Herz, Katia; Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Olkhova, Elena] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Hebrew University of Jerusalem; Max Planck Society	Padan, E (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	etana@vms.huji.ac.il			USA-Israel Binational Science Foundation [501/03-16.2]; European Union [FP 7]; Max-Planck-Gesellschaft	USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Union(European Commission); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by USA-Israel Binational Science Foundation Grant 501/03-16.2 and European Union European Drug Initiative on Channels and Transporters Grant FP 7 (to E. P.) and a grant from the Max-Planck-Gesellschaft (to E.O.).	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Appel M, 2009, J MOL BIOL, V386, P351, DOI 10.1016/j.jmb.2008.12.042; BEROZA P, 1995, BIOPHYS J, V68, P2233, DOI 10.1016/S0006-3495(95)80406-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Fliegel L, 2008, J MOL CELL CARDIOL, V44, P228, DOI 10.1016/j.yjmcc.2007.11.016; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Gunner MR, 2000, BBA-BIOENERGETICS, V1458, P63, DOI 10.1016/S0005-2728(00)00060-8; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P17; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; PINNER E, 1993, J BIOL CHEM, V268, P1729; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Rothman A, 1996, J BIOL CHEM, V271, P32288, DOI 10.1074/jbc.271.50.32288; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; SITKOFF D, 1994, BIOPHYS J, V67, P2251, DOI 10.1016/S0006-3495(94)80709-X; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tsuboi Y, 2003, J BIOL CHEM, V278, P21467, DOI 10.1074/jbc.M301932200; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200	50	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2211	2220		10.1074/jbc.M109.047134	http://dx.doi.org/10.1074/jbc.M109.047134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923224	Green Published, hybrid			2022-12-27	WOS:000273429100065
J	Hoopes, JT; Liu, XY; Xu, XM; Demeler, B; Folta-Stogniew, E; Li, C; Ha, Y				Hoopes, James T.; Liu, Xuying; Xu, Xiaomeng; Demeler, Borries; Folta-Stogniew, Ewa; Li, Chris; Ha, Ya			Structural Characterization of the E2 Domain of APL-1, a Caenorhabditis elegans Homolog of Human Amyloid Precursor Protein, and Its Heparin Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CRYSTALLOGRAPHIC ANALYSIS; SURFACE; FAMILY; APP; PH; HOMODIMERIZATION; COLOCALIZES; EXPRESSION; SCATTERING	The amyloid beta-peptide deposit found in the brain tissue of patients with Alzheimer disease is derived from a large heparin-binding protein precursor APP. The biological function of APP and its homologs is not precisely known. Here we report the x-ray structure of the E2 domain of APL-1, an APP homolog in Caenorhabditis elegans, and compare it to the human APP structure. We also describe the structure of APL-1 E2 in complex with sucrose octasulfate, a highly negatively charged disaccharide, which reveals an unexpected binding pocket between the two halves of E2. Based on the crystal structure, we are able to map, using site-directed mutagenesis, a surface groove on E2 to which heparin may bind. Our biochemical data also indicate that the affinity of E2 for heparin is influenced by pH: at pH 5, the binding appears to be much stronger than that at neutral pH. This property is likely caused by histidine residues in the vicinity of the mapped heparin binding site and could be important for the proposed adhesive function of APL-1.	[Hoopes, James T.; Liu, Xuying; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Folta-Stogniew, Ewa] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA; [Xu, Xiaomeng; Li, Chris] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Ctr Analyt Ultracentrifugat Macromol Assemblies, San Antonio, TX 78229 USA	Yale University; Yale University; City University of New York (CUNY) System; City College of New York (CUNY); University of Texas System; University of Texas Health San Antonio	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu	liu, xuying/G-7258-2012; LI, chris/HDO-6232-2022	Demeler, Borries/0000-0002-2414-9518	National Institutes of Health [GM077547]; NCRR/RCMI [G12-RR03060]; Alzheimer Association; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077547 (to Y. H.) and NCRR/RCMI G12-RR03060 (City College) and by a grant from the Alzheimer Association (to C. L.).	Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; BROOKES E, 2009, EUR BIOPHYS IN PRESS; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Keil C, 2004, ACTA CRYSTALLOGR D, V60, P1614, DOI 10.1107/S0907444904015343; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamanna JC, 1996, ADV EXP MED BIOL, V388, P283; Lomakin A, 1999, METHOD ENZYMOL, V309, P429; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Storey E, 1996, BRAIN RES, V735, P217, DOI 10.1016/0006-8993(96)00608-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Yamazaki T, 1997, J NEUROSCI, V17, P1004	46	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2165	2173		10.1074/jbc.M109.018432	http://dx.doi.org/10.1074/jbc.M109.018432			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19906646	Green Published, hybrid			2022-12-27	WOS:000273429100060
J	Jia, Y; Lee, KW; Swerdloff, R; Hwang, D; Cobb, LJ; Hikim, AS; Lue, Y; Cohen, P; Wang, C				Jia, Yue; Lee, Kuk-Wha; Swerdloff, Ronald; Hwang, David; Cobb, Laura J.; Hikim, Amiya Sinha; Lue, YanHe; Cohen, Pinchas; Wang, Christina			Interaction of Insulin-like Growth Factor-binding Protein-3 and BAX in Mitochondria Promotes Male Germ Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PEPTIDE HUMANIN; DEATH; PATHWAYS; SPERMATOGENESIS; TESTOSTERONE; IGFBP-3; FAMILY; BCL-2; HYPERTHERMIA	Germ cell apoptosis is crucial for spermatogenesis and can be triggered by various stimuli, including intratesticular hormone deprivation. This study proposes a role for insulin-like growth factor binding protein-3 (IGFBP-3) in male germ cell apoptosis. Groups of adult Sprague-Dawley male rats received one of the following treatments for 5 days: (i) daily intratesticular (IT) injections with saline (control); (ii) a single subcutaneous injection of the gonadotropin-releasing hormone antagonist (GnRHA), acyline, on day 1 and a daily IT injection of saline; (iii) daily IT injection of IGFBP-3; and (iv) a GnRH-A injection on day 1 and a daily IT injection of IGFBP-3. Germ cell apoptosis increased significantly after IGFBP-3 or GnRH-A treatment which was further enhanced by the combined treatment. After co-immunoprecipitation with BAX antibody, IGFBP-3 association with BAX was demonstrated in total and mitochondrial fractions but not in the cytosol of testis extracts. BAX-associated IGFBP-3 expression was increased in mitochondria after treatment compared with control, which was confirmed by an IGFBP-3 enzyme-linked immunosorbent assay. Dot blot studies further validated the BAX-IGFBP-3 binding in vitro. IGFBP-3 as well as BAX induced release of cytochrome c and DIABLO from isolated testicular mitochondria in vitro. IGFBP-3, when combined with an ineffective dose of BAX, triggered release of these proteins from isolated mitochondria at a 4-fold lower dose than IGFBP-3 alone. Our data demonstrate that the IGFBP-3 and BAX interaction activates germ cell apoptosis via the mitochondria-dependent pathway. This represents a novel pathway regulating germ call homeostasis that may have significance for male fertility and testicular disease.	[Wang, Christina] Harbor UCLA Med Ctr, Gen Clin Res Ctr, Div Endocrinol, Los Angeles Biomed Res Inst,Dept Med, Torrance, CA 90509 USA; [Jia, Yue; Hwang, David; Cobb, Laura J.; Cohen, Pinchas] Univ Calif Los Angeles, Div Pediat Endocrinol, Dept Pediat, David Geffen Sch Med,Mattel Childrens Hosp, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, C (corresponding author), Harbor UCLA Med Ctr, Gen Clin Res Ctr, Div Endocrinol, Los Angeles Biomed Res Inst,Dept Med, Box 16,1000 W Carson St, Torrance, CA 90509 USA.	wang@labiomed.org	LUE, YANHE/AAN-4861-2021	LUE, YANHE/0000-0003-0458-7841				Ali O, 2003, HORM METAB RES, V35, P726; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Cohen P, 2006, ENDOCRINOLOGY, V147, P2109, DOI 10.1210/en.2006-0195; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Franklin SL, 2003, J CLIN ENDOCR METAB, V88, P900, DOI 10.1210/jc.2002-020472; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hikim APS, 1997, BIOL REPROD, V57, P1193, DOI 10.1095/biolreprod57.5.1193; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Hikim APS, 2003, ENDOCRINOLOGY, V144, P3167, DOI 10.1210/en.2003-0175; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jia Y, 2007, BIOL REPROD, V77, P83, DOI 10.1095/biolreprod.106.058594; Jia Y, 2009, BIOL REPROD, V80, P771, DOI 10.1095/biolreprod.108.072843; Johnson C, 2008, BIOL REPROD, V79, P806, DOI 10.1095/biolreprod.108.068833; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Lee KW, 2007, CARCINOGENESIS, V28, P1653, DOI 10.1093/carcin/bgm088; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee KW, 2002, J ENDOCRINOL, V175, P33, DOI 10.1677/joe.0.1750033; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Liu BR, 2005, CLIN CANCER RES, V11, P4851, DOI 10.1158/1078-0432.CCR-04-2160; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; LUE Y, 2010, ENDOCRINOLO IN PRESS; Lue YH, 2009, BIOL REPROD, V80, P484, DOI 10.1095/biolreprod.108.070839; Lue YH, 2006, J CLIN ENDOCR METAB, V91, P539, DOI 10.1210/jc.2005-1808; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; SINHAHIKIM AP, 1993, ENDOCRINOLOGY, V133, P2161, DOI 10.1210/en.133.5.2161; Vera Y, 2004, BIOL REPROD, V70, P1534, DOI 10.1095/biolreprod.103.024661; Vera Y, 2006, MOL ENDOCRINOL, V20, P1597, DOI 10.1210/me.2005-0395; Wang C, 2007, J CLIN ENDOCR METAB, V92, P3292, DOI 10.1210/jc.2007-0367; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; [No title captured]	39	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1726	1732		10.1074/jbc.M109.046847	http://dx.doi.org/10.1074/jbc.M109.046847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19887447	hybrid, Green Published			2022-12-27	WOS:000273429100018
J	Waetzig, GH; Chalaris, A; Rosenstiel, P; Suthaus, J; Holland, C; Karl, N; Uriarte, LV; Till, A; Scheller, J; Grotzinger, J; Schreiber, S; Rose-John, S; Seegert, D				Waetzig, Georg H.; Chalaris, Athena; Rosenstiel, Philip; Suthaus, Jan; Holland, Christin; Karl, Nadja; Uriarte, Lorena Valles; Till, Andreas; Scheller, Juergen; Groetzinger, Joachim; Schreiber, Stefan; Rose-John, Stefan; Seegert, Dirk			N-Linked Glycosylation Is Essential for the Stability but Not the Signaling Function of the Interleukin-6 Signal Transducer Glycoprotein 130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; EXTRACELLULAR DOMAINS; BIOLOGICAL FUNCTION; DESIGNER CYTOKINE; SOLUBLE RECEPTORS; GP130; COMPLEX; MEMBRANE; ACTIVATION; EXPRESSION	N-Linked glycosylation is an important determinant of protein structure and function. The interleukin-6 signal transducer glycoprotein 130 (gp130) is a common co-receptor for cytokines of the interleukin (IL)-6 family and is N-glycosylated at 9 of 11 potential sites. Whereas N-glycosylation of the extracellular domains D1-D3 of gp130 has been shown to be dispensable for binding of the gp130 ligand IL-6 and its cognate receptor in vitro, the role of the N-linked glycans on domains D4 and D6 is still unclear. We have mutated the asparagines of all nine functional N-glycosylation sites of gp130 to glutamine and systematically analyzed the consequences of deleted N-glycosylation (dNG) in both cellular gp130 and in a soluble gp130-IgG1-Fc fusion protein (sgp130Fc). Our results show that sgp130Fc-dNG is inherently unstable and degrades rapidly under conditions that do not harm wild-type sgp130Fc. Consistently, the bulk of cellular gp130-dNG is not transported to the plasma membrane but is degraded in the proteasome. However, the small quantities of gp130-dNG, which do reach the cell surface, are still able to activate the key gp130 signaling target signal transducer and activator of transcription-3 (STAT3) upon binding of the agonistic complex of IL-6 and soluble IL-6 receptor. In conclusion, N-linked glycosylation is required for the stability but not the signal-transducing function of gp130.	[Waetzig, Georg H.; Holland, Christin; Karl, Nadja; Uriarte, Lorena Valles; Seegert, Dirk] CONARIS Res Inst AG, D-24118 Kiel, Germany; [Chalaris, Athena; Suthaus, Jan; Scheller, Juergen; Groetzinger, Joachim; Rose-John, Stefan] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Rosenstiel, Philip; Till, Andreas; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24098 Kiel, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med 1, D-24105 Kiel, Germany	University of Kiel; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Waetzig, GH (corresponding author), CONARIS Res Inst AG, Schauenburgerstr 116, D-24118 Kiel, Germany.	g.waetzig@conaris.de	Waetzig, Georg/AAV-7486-2021; Till, Andreas/AAO-6375-2021; Seegert, Dirk/B-8826-2011; Till, Andreas/E-9661-2013; Rose-John, Stefan/A-7998-2010; Scheller, Jürgen/K-5290-2015; Rosenstiel, Philip/A-5137-2009	Till, Andreas/0000-0002-0139-9143; Rose-John, Stefan/0000-0002-7519-3279; Rosenstiel, Philip/0000-0002-9692-8828	German Excellence Initiative; Deutsche Forschungsgemeinschaft [SFB415]	German Excellence Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the German Excellence Initiative (Excellence Cluster "Inflammation at Interfaces") and by Deutsche Forschungsgemeinschaft, Collaborative Research Center SFB415.	Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Chow DC, 2001, BIOCHEMISTRY-US, V40, P7593, DOI 10.1021/bi010192q; DING DXH, 1995, J BIOL CHEM, V270, P24580, DOI 10.1074/jbc.270.41.24580; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hibi M, 1996, J MOL MED-JMM, V74, P1, DOI 10.1007/BF00202068; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Jung G, 2005, CHEMPHYSCHEM, V6, P1628, DOI 10.1002/cphc.200400653; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Kukolka F, 2004, ORG BIOMOL CHEM, V2, P2203, DOI 10.1039/b406492e; Kurth I, 2000, J IMMUNOL, V164, P273, DOI 10.4049/jimmunol.164.1.273; Meng J, 2008, J BIOL CHEM, V283, P3376, DOI 10.1074/jbc.M707640200; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moritz RL, 2001, J BIOL CHEM, V276, P8244, DOI 10.1074/jbc.M009979200; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Peters M, 1998, J IMMUNOL, V161, P3575; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; SLIEKER LJ, 1985, J BIOL CHEM, V260, P687; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Wenzel-Seifert K, 2003, BIOCHEM BIOPH RES CO, V301, P693, DOI 10.1016/S0006-291X(03)00023-8; Yanagisawa M, 2009, BIOCHEM BIOPH RES CO, V386, P101, DOI 10.1016/j.bbrc.2009.05.132; Zhou HP, 1999, ARCH BIOCHEM BIOPHYS, V369, P267, DOI 10.1006/abbi.1999.1368	39	34	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1781	1789		10.1074/jbc.M109.075952	http://dx.doi.org/10.1074/jbc.M109.075952			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915009	hybrid, Green Published			2022-12-27	WOS:000273429100024
J	Adekar, SP; Klyubin, I; Macy, S; Rowan, MJ; Solomon, A; Dessain, SK; O'Nuallain, B				Adekar, Sharad P.; Klyubin, Igor; Macy, Sally; Rowan, Michael J.; Solomon, Alan; Dessain, Scott K.; O'Nuallain, Brian			Inherent Anti-amyloidogenic Activity of Human Immunoglobulin gamma Heavy Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC A-BETA; HUMAN MONOCLONAL-ANTIBODY; ALZHEIMERS-DISEASE; LIGHT-CHAINS; IN-VIVO; INDUCED NEUROTOXICITY; PASSIVE-IMMUNIZATION; SYNAPTIC PLASTICITY; FIBRIL FORMATION; MOLECULAR-BASIS	We have previously shown that a subpopulation of naturally occurring human IgGs were cross-reactive against conformational epitopes on pathologic aggregates of A beta, a peptide that forms amyloid fibrils in the brains of patients with Alzheimer disease, inhibited amyloid fibril growth, and dissociated amyloid in vivo. Here, we describe similar anti-amyloidogenic activity that is a general property of free human Ig gamma heavy chains. A gamma(1) heavy chain, F1, had nanomolar binding to an amyloid fibril-related conformational epitope on synthetic oligomers and fibrils as well as on amyloid-laden tissue sections. F1 did not bind to native A beta monomers, further indicating the conformational nature of its binding site. The inherent anti-amyloidogenic activity of Ig gamma heavy chains was demonstrated by nanomolar amyloid fibril and oligomer binding by polyclonal and monoclonal human heavy chains that were isolated from inert or weakly reactive antibodies. Most importantly, the F1 heavy chain prevented in vitro fibril growth and reduced in vivo soluble A beta oligomer-induced impairment of rodent hippocampal long term potentiation, a cellular mechanism of learning and memory. These findings demonstrate that free human Ig gamma heavy chains comprise a novel class of molecules for developing potential therapeutics for Alzheimer disease and other amyloid disorders. Moreover, establishing the molecular basis for heavy chain-amyloidogenic conformer interactions should advance understanding on the types of interactions that these pathologic assemblies have with biological molecules.	[Adekar, Sharad P.; Dessain, Scott K.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Klyubin, Igor; Rowan, Michael J.] Trinity Coll Dublin, Trinty Coll Inst Neurosci, Dublin 2, Ireland; [Klyubin, Igor; Rowan, Michael J.] Trinity Coll Dublin, Dept Pharmacol & Therapeut, Dublin 2, Ireland; [Macy, Sally; Solomon, Alan; O'Nuallain, Brian] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Dept Med, Knoxville, TN 37920 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Trinity College Dublin; Trinity College Dublin; University of Tennessee System; University of Tennessee Health Science Center	Dessain, SK (corresponding author), Lankenau Inst Med Res, R227,100 Lancester Ave, Wynnewood, PA 19096 USA.	scott.dessain@gmail.com; brian.onuallain@ucd.ie		Rowan, Michael Joseph/0000-0002-3867-9536	PMERF; Science Foundation Ireland; Sharpe-Strumia Research Foundation of the Bryn Mawr Hospital	PMERF; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Sharpe-Strumia Research Foundation of the Bryn Mawr Hospital	This work was supported by a PMERF grant (to B.O'.N.), a Principal Investigator Award from Science Foundation Ireland (to M.J.R.), and the Sharpe-Strumia Research Foundation of the Bryn Mawr Hospital (to S.K.D.).	Adekar SP, 2008, J IMMUNOL METHODS, V333, P156, DOI 10.1016/j.jim.2008.01.015; Adekar SP, 2008, HYBRIDOMA, V27, P11, DOI 10.1089/hyb.2007.0536; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; CARROLL WL, 1988, MOL IMMUNOL, V25, P991, DOI 10.1016/0161-5890(88)90005-3; DAVIES DR, 1975, ANNU REV BIOCHEM, V44, P639, DOI 10.1146/annurev.bi.44.070175.003231; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dessain SK, 2004, J IMMUNOL METHODS, V291, P109, DOI 10.1016/j.jim.2004.05.005; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Fukuchi KI, 2006, BIOCHEM BIOPH RES CO, V344, P79, DOI 10.1016/j.bbrc.2006.03.145; Galeazzi L, 1999, AMYLOID, V6, P7, DOI 10.3109/13506129908993282; Giacomelli CE, 2005, MACROMOL BIOSCI, V5, P401, DOI 10.1002/mabi.200400189; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; GREY HM, 1965, J EXP MED, V122, P619, DOI 10.1084/jem.122.3.619; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Gruschus JM, 2008, AMYLOID, V15, P160, DOI 10.1080/13506120802193746; HAASS C, 1992, NATURE, V359, P325; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henkel AW, 2007, MOL PSYCHIATR, V12, P601, DOI 10.1038/sj.mp.4001947; Istrin G, 2006, J NEUROSCI RES, V84, P434, DOI 10.1002/jnr.20886; Kaminksy W, 2006, MICRON, V37, P324, DOI 10.1016/j.micron.2005.10.014; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MCLAUGHLIN CL, 1974, J IMMUNOL, V113, P1369; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Murphy CL, 2006, METHOD ENZYMOL, V412, P48, DOI 10.1016/S0076-6879(06)12004-2; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P13049, DOI 10.1021/bi701255m; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P1240, DOI 10.1021/bi0616605; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; PRAS M, 1968, J CLIN INVEST, V47, P924; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Robert R, 2009, PROTEIN ENG DES SEL, V22, P199, DOI 10.1093/protein/gzn052; Rowan MJ, 2007, BIOCHEM SOC T, V35, P1219, DOI 10.1042/BST0351219; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Solomon A, 2003, J LAB CLIN MED, V142, P348, DOI 10.1016/S0022-2143(03)00149-5; SOLOMON A, 1985, METHOD ENZYMOL, V116, P101; Solomon B, 2007, EXPERT OPIN INV DRUG, V16, P819, DOI 10.1517/13543784.16.6.819; Solomon Beka, 2004, Current Alzheimer Research, V1, P149, DOI 10.2174/1567205043332126; Solorzano-Vargas RS, 2008, MOL IMMUNOL, V45, P881, DOI 10.1016/j.molimm.2007.08.008; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Tamura Y, 2005, NEUROBIOL DIS, V20, P541, DOI 10.1016/j.nbd.2005.04.007; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler ME, 2005, IMMUNOL REV, V205, P244, DOI 10.1111/j.0105-2896.2005.00264.x; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068	68	17	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1066	1074		10.1074/jbc.M109.044321	http://dx.doi.org/10.1074/jbc.M109.044321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889627	hybrid, Green Published			2022-12-27	WOS:000273258200027
J	Hubmacher, D; Cirulis, JT; Miao, M; Keeley, FW; Reinhardt, DP				Hubmacher, Dirk; Cirulis, Judith T.; Miao, Ming; Keeley, Fred W.; Reinhardt, Dieter P.			Functional Consequences of Homocysteinylation of the Elastic Fiber Proteins Fibrillin-1 and Tropoelastin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SYNTHASE DEFICIENCY; EXTRACELLULAR MICROFIBRILS; STRUCTURAL CONSEQUENCES; SELF-AGGREGATION; BINDING; HYPERHOMOCYSTEINEMIA; COACERVATION; POLYPEPTIDES; DISULFIDE; FIBULINS	Homocystinuria caused by cystathionine-beta-synthase deficiency represents a severe form of homocysteinemias, which generally result in various degrees of elevated plasma homocysteine levels. Marfan syndrome is caused by mutations in fibrillin-1, which is one of the major constituents of connective tissue microfibrils. Despite the fundamentally different origins, both diseases share common clinical symptoms in the connective tissue such as long bone overgrowth, scoliosis, and ectopia lentis, whereas they differ in others. Fibrillin-1 contains similar to 13% cysteine residues and can be modified by homocysteine. We report here that homocysteinylation affects functional properties of fibrillin-1 and tropoelastin. We used recombinant fragments spanning the entire fibrillin-1 molecule to demonstrate that homocysteinylation, but not cysteinylation leads to abnormal self-interaction, which was attributed to a reduced amount of multimerization of the fibrillin-1 C terminus. The deposition of the fibrillin-1 network by human dermal fibroblasts was greatly reduced by homocysteine, but not by cysteine. Furthermore, homocysteinylation, but not cysteinylation of elastin-like polypeptides resulted in modified coacervation properties. In summary, the results provide new insights into pathogenetic mechanisms potentially involved in cystathionine-beta-synthasedeficient homocystinuria.	McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Div Biomed Sci, Montreal, PQ H3A 2B2, Canada; [Cirulis, Judith T.; Miao, Ming; Keeley, Fred W.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Reinhardt, DP (corresponding author), 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	dieter.reinhardt@mcgill.ca	Hubmacher, Dirk/AAE-1875-2020; Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872; Hubmacher, Dirk/0000-0003-1569-9451	Canadian Marfan Association; Canadian Institutes of Health Research [MOP-68836]; German Academic Exchange Service; Heart and Stroke Foundation of Ontario [T5451]	Canadian Marfan Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a grant from the Canadian Marfan Association (to D. P. R.), Canadian Institutes of Health Research Grant MOP-68836 (to D. P. R.), the German Academic Exchange Service (to D. H.), and Heart and Stroke Foundation of Ontario Grant T5451 (to F. W. K.).	Baumbach GL, 2002, CIRC RES, V91, P931, DOI 10.1161/01.RES.0000041408.64867.1D; Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X; Brinckmann J, 2005, ARTHRITIS RES THER, V7, pR1221, DOI 10.1186/ar1813; BROWN PL, 1992, BIOCHEM BIOPH RES CO, V186, P549, DOI 10.1016/S0006-291X(05)80843-5; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, J BIOL CHEM, V283, P27017, DOI 10.1074/jbc.M803373200; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charpiot P, 1998, MATRIX BIOL, V17, P559, DOI 10.1016/S0945-053X(98)90108-1; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; DUERRE JA, 1966, ANAL BIOCHEM, V17, P310, DOI 10.1016/0003-2697(66)90209-0; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gellekink Henkjan, 2005, Semin Vasc Med, V5, P98, DOI 10.1055/s-2005-872396; Giusti B, 2003, EUR HEART J, V24, P2038, DOI 10.1016/j.ehj.2003.08.020; Glushchenko AV, 2007, ANTIOXID REDOX SIGN, V9, P1883, DOI 10.1089/ars.2007.1809; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hill CH, 2002, J NUTR, V132, P2143, DOI 10.1093/jn/132.8.2143; Hubmacher D, 2005, J BIOL CHEM, V280, P34946, DOI 10.1074/jbc.M504748200; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Hutchinson S, 2005, J MOL BIOL, V346, P833, DOI 10.1016/j.jmb.2004.11.038; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Majors AK, 2000, MOL GENET METAB, V70, P252, DOI 10.1006/mgme.2000.3024; Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; SKOVBY F, 2002, CONNECTIVE TISSUE IT, P627; Starcher B, 2005, EXP LUNG RES, V31, P873, DOI 10.1080/01902140600611629; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; Sundaramoorthy E, 2008, PROTEINS, V71, P1475, DOI 10.1002/prot.21846; TANGEMANN K, 1995, FEBS LETT, V358, P179, DOI 10.1016/0014-5793(94)01411-S; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Tu YD, 2008, BIOMACROMOLECULES, V9, P1739, DOI 10.1021/bm7013153; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183; Urry D W, 1977, Adv Exp Med Biol, V79, P685; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wachi H, 2005, CLIN BIOCHEM, V38, P643, DOI 10.1016/j.clinbiochem.2005.04.006; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	60	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1188	1198		10.1074/jbc.M109.021246	http://dx.doi.org/10.1074/jbc.M109.021246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889633	Green Published, hybrid			2022-12-27	WOS:000273258200041
J	Bhuiya, MW; Liu, CJ				Bhuiya, Mohammad-Wadud; Liu, Chang-Jun			Engineering Monolignol 4-O-Methyltransferases to Modulate Lignin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAFFEIC ACID 3-O-METHYLTRANSFERASE; ADENOSYL-L-METHIONINE; O-METHYLTRANSFERASES; SUBSTRATE PREFERENCES; METHYLATION; ALFALFA; EVOLUTION; ALDEHYDE; ENZYME; POLYMERIZATION	Lignin is a complex polymer derived from the oxidative coupling of three classical monolignols. Lignin precursors are methylated exclusively at the meta-positions (i.e. 3/5-OH) of their phenyl rings by native O-methyltransferases, and are precluded from substitution of the para-hydroxyl (4-OH) position. Ostensibly, the para-hydroxyls of phenolics are critically important for oxidative coupling of phenoxy radicals to form polymers. Therefore, creating a 4-O-methyltransferase to substitute the para-hydroxyl of monolignols might well interfere with the synthesis of lignin. The phylogeny of plant phenolic O-methyltransferases points to the existence of a batch of evolutionarily "plastic" amino acid residues. Following one amino acid at a time path of directed evolution, and using the strategy of structure-based iterative site-saturation mutagenesis, we created a novel monolignol 4-O-methyltransferase from the enzyme responsible for methylating phenylpropenes. We show that two plastic residues in the active site of the parental enzyme are vital in dominating substrate discrimination. Mutations at either one of these separate the evolutionarily tightly linked properties of substrate specificity and regioselective methylation of native O-methyltransferase, thereby conferring the ability for para-methylation of the lignin monomeric precursors, primarily monolignols. Beneficial mutations at both sites have an additive effect. By further optimizing enzyme activity, we generated a triple mutant variant that may structurally constitute a novel phenolic substrate binding pocket, leading to its high binding affinity and catalytic efficiency on monolignols. The 4-O-methoxylation of monolignol efficiently impairs oxidative radical coupling in vitro, highlighting the potential for applying this novel enzyme in managing lignin polymerization in planta.	[Bhuiya, Mohammad-Wadud; Liu, Chang-Jun] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Liu, CJ (corresponding author), 50 Bell Ave, Upton, NY 11973 USA.	cliu@bnl.gov			Office of Basic Energy Science, Department of Energy [DEAC0298CH10886]	Office of Basic Energy Science, Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Basic Energy Science, Department of Energy Grant DEAC0298CH10886 (to C.J.L.).	Baerson SR, 2008, J BIOL CHEM, V283, P3231, DOI 10.1074/jbc.M706587200; Bhuiya MW, 2009, ANAL BIOCHEM, V384, P151, DOI 10.1016/j.ab.2008.09.031; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; BUGOS RC, 1991, PLANT MOL BIOL, V17, P1203, DOI 10.1007/BF00028736; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Davin LB, 2005, CURR OPIN BIOTECH, V16, P398, DOI 10.1016/j.copbio.2005.06.010; Dixon Richard A., 2003, Phytochemistry Reviews, V2, P289, DOI 10.1023/B:PHYT.0000045486.50637.37; EDWARDS R, 1991, ARCH BIOCHEM BIOPHYS, V287, P372, DOI 10.1016/0003-9861(91)90492-2; Fournand D, 2003, PHYTOCHEMISTRY, V62, P139, DOI 10.1016/S0031-9422(02)00573-3; Freudenberg K., 1968, CONSTITUTION BIOSYNT, P45; Gang DR, 2002, PLANT CELL, V14, P505, DOI 10.1105/tpc.010327; GOWRI G, 1991, PLANT PHYSIOL, V97, P7, DOI 10.1104/pp.97.1.7; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Inoue K, 2000, ARCH BIOCHEM BIOPHYS, V375, P175, DOI 10.1006/abbi.1999.1674; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Li HM, 2006, PLANT MOL BIOL, V61, P537, DOI 10.1007/s11103-006-0029-4; Li LG, 2000, J BIOL CHEM, V275, P6537, DOI 10.1074/jbc.275.9.6537; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Morreel K, 2004, PLANT PHYSIOL, V136, P3537, DOI 10.1104/pp.104.049304; Osakabe K, 1999, P NATL ACAD SCI USA, V96, P8955, DOI 10.1073/pnas.96.16.8955; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; Parvathi K, 2001, PLANT J, V25, P193, DOI 10.1046/j.1365-313x.2001.00956.x; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Sasaki S, 2004, FEBS LETT, V562, P197, DOI 10.1016/S0014-5793(04)00224-8; Schmidt DMZ, 2003, BIOCHEMISTRY-US, V42, P8387, DOI 10.1021/bi034769a; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Wang JH, 1999, ARCH BIOCHEM BIOPHYS, V368, P172, DOI 10.1006/abbi.1999.1304; Wang JH, 1998, ARCH BIOCHEM BIOPHYS, V349, P153, DOI 10.1006/abbi.1997.0452; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; YE ZH, 1994, PLANT CELL, V6, P1427, DOI 10.1105/tpc.6.10.1427; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412	35	47	50	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					277	285		10.1074/jbc.M109.036673	http://dx.doi.org/10.1074/jbc.M109.036673			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875443	Green Published, hybrid			2022-12-27	WOS:000273070100029
J	O'Hara, SP; Splinter, PL; Gajdos, GB; Trussoni, CE; Fernandez-Zapico, ME; Chen, XM; Larusso, NF				O'Hara, Steven P.; Splinter, Patrick L.; Gajdos, Gabriella B.; Trussoni, Christy E.; Fernandez-Zapico, Martin E.; Chen, Xian-Ming; Larusso, Nicholas F.			NF kappa B p50-CCAAT/Enhancer-binding Protein beta (C/EBP beta)-mediated Transcriptional Repression of MicroRNA let-7i following Microbial Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY EPITHELIAL-CELLS; CRYPTOSPORIDIUM-PARVUM; NUCLEAR-FACTOR; C/EBP-BETA; POSTTRANSCRIPTIONAL REGULATION; HUMAN CHOLANGIOCYTES; IMMUNE-RESPONSES; BREAST-CANCER; EXPRESSION; BINDING	MicroRNAs, central players of numerous cellular processes, regulate mRNA stability or translational efficiency. Although these molecular events are established, the mechanisms regulating microRNA function and expression remain largely unknown. The microRNA let-7i regulates Toll-like receptor 4 expression. Here, we identify a novel transcriptional mechanism induced by the protozoan parasite Cryptosporidium parvum and Gram(-) bacteria-derived lipopolysaccharide (LPS) mediating let-7i promoter silencing in human biliary epithelial cells (cholangiocytes). Using cultured cholangiocytes, we show that microbial stimulus decreased let-7i expression, and promoter activity. Analysis of the mechanism revealed that microbial infection promotes the formation of a NF kappa B p50-C/EBP beta silencer complex in the regulatory sequence. Chromatin immunoprecipitation assays (ChIP) demonstrated that the repressor complex binds to the let-7i promoter following microbial stimulus and promotes histone-H3 deacetylation. Our results provide a novel mechanism of transcriptional regulation of cholangiocyte let-7i expression following microbial insult, a process with potential implications for epithelial innate immune responses in general.	[O'Hara, Steven P.; Splinter, Patrick L.; Gajdos, Gabriella B.; Trussoni, Christy E.; Fernandez-Zapico, Martin E.; Larusso, Nicholas F.] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Chen, Xian-Ming] Creighton Univ, Med Ctr, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	Mayo Clinic; Mayo Clinic; Creighton University	O'Hara, SP (corresponding author), Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	ohara.steven@mayo.edu		Trussoni, Christy/0000-0002-4247-076X	National Institutes of Health [DK57993, DK76922, A2071321]; Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057993, P30DK084567, K01DK076922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57993 (to N. F. L.), DK76922 (to S. P. O.), and A2071321 (to X. C.). This work was also supported by a grant from the Mayo Foundation.	Agrawal A, 2003, IMMUNOLOGY, V108, P539, DOI 10.1046/j.1365-2567.2003.01608.x; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cha-Molstad H, 2007, MOL IMMUNOL, V44, P2933, DOI 10.1016/j.molimm.2007.01.015; Chen XM, 2008, IMMUNOL CELL BIOL, V86, P497, DOI 10.1038/icb.2008.37; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chen XM, 2000, GASTROENTEROLOGY, V118, P368, DOI 10.1016/S0016-5085(00)70219-8; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Chen XM, 2001, GASTROENTEROLOGY, V120, P1774, DOI 10.1053/gast.2001.24850; Cruickshank SM, 1998, J HEPATOL, V29, P550, DOI 10.1016/S0168-8278(98)80149-9; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; El-Asmar B, 2009, J MOL ENDOCRINOL, V42, P131, DOI 10.1677/JME-08-0016; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Harada K, 2004, HEPATOLOGY, V40, P925, DOI 10.1002/hep.20379; JOPLIN R, 1989, IN VITRO CELL DEV B, V25, P1189; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; MORITA M, 1994, HEPATOLOGY, V19, P426; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Park J, 1999, HEPATOLOGY, V29, P1037, DOI 10.1002/hep.510290423; Ralph WM, 2006, J GEN VIROL, V87, P51, DOI 10.1099/vir.0.81207-0; Scholz M, 1997, TISSUE ANTIGENS, V49, P640, DOI 10.1111/j.1399-0039.1997.tb02813.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x	29	83	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					216	225		10.1074/jbc.M109.041640	http://dx.doi.org/10.1074/jbc.M109.041640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19903813	Green Published, hybrid			2022-12-27	WOS:000273070100023
J	Seyrantepe, V; Iannello, A; Liang, F; Kanshin, E; Jayanth, P; Samarani, S; Szewczuk, MR; Ahmad, A; Pshezhetsky, AV				Seyrantepe, Volkan; Iannello, Alexandre; Liang, Feng; Kanshin, Evgeny; Jayanth, Preethi; Samarani, Suzanne; Szewczuk, Myron R.; Ahmad, Ali; Pshezhetsky, Alexey V.			Regulation of Phagocytosis in Macrophages by Neuraminidase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL SIALIDASE; BETA-GALACTOSIDASE; T-LYMPHOCYTES; CELL-SURFACE; ANTIGEN PRESENTATION; BINDING-PROTEIN; B-CELLS; COMPLEX; EXPRESSION; ACID	The differentiation of monocytes into macrophages and dendritic cells is accompanied by induction of cell-surface neuraminidase 1 (Neu1) and cathepsin A (CathA), the latter forming a complex with and activating Neu1. To clarify the biological importance of this phenomenon we have developed the gene-targeted mouse models of a CathA deficiency (CathA(S190A)) and a double CathA/Neu1 deficiency (CathA(S190A-Neo)). Macrophages of CathA(S190A-Neo) mice and their immature dendritic cells showed a significantly reduced capacity to engulf Gram-positive and Gram-negative bacteria and positively and negatively charged polymer beads as well as IgG-opsonized beads and erythrocytes. Properties of the cells derived from CathA(S190A) mice were indistinguishable from those of wild-type controls, suggesting that the absence of Neu1, which results in the increased sialylation of the cell surface proteins, probably affects multiple receptors for phagocytosis. Indeed, treatment of the cells with purified mouse Neu1 reduced surface sialylation and restored phagocytosis. Because Neu1-deficient cells showed reduced internalization of IgG-opsonized sheep erythrocytes whereas binding of the erythrocytes to the cells at 4 degrees C persisted, we speculate that the absence of Neu1 in particular affected transduction of signals from the Fc receptors for immunoglobulin G(Fc gamma R). Indeed the macrophages from the Neu1-deficient mice showed increased sialylation and impaired phosphorylation of Fc gamma R as well as markedly reduced phosphorylation of Syk kinase in response to treatment with IgG-opsonized beads. Altogether our data suggest that the cell surface Neu1 activates the phagocytosis in macrophages and dendritic cells through desialylation of surface receptors, thus, contributing to their functional integrity.	[Seyrantepe, Volkan; Iannello, Alexandre; Liang, Feng; Kanshin, Evgeny; Samarani, Suzanne; Ahmad, Ali; Pshezhetsky, Alexey V.] Univ Montreal, St Justine Univ Hosp Ctr, Montreal, PQ H3T 1C5, Canada; [Pshezhetsky, Alexey V.] Univ Montreal, Dept Paediat, Montreal, PQ H3T 1C5, Canada; [Ahmad, Ali] Univ Montreal, Dept Immunol, Montreal, PQ H3T 1C5, Canada; [Jayanth, Preethi; Szewczuk, Myron R.] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 3N6, Canada; [Pshezhetsky, Alexey V.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Queens University - Canada; McGill University	Pshezhetsky, AV (corresponding author), CHU St Justine, Serv Genet Med, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	alexei.pchejetski@umontreal.ca	Kanshin, Evgeny/GXM-7047-2022	Ahmad, Ali/0000-0001-7689-7115; A, Pshezhetsky/0000-0002-6612-1062	Canadian Institutes of Health Research Operating [MOP 15079, GOP 38107]; Canadian Foundation for Innovation	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported in part by Canadian Institutes of Health Research Operating Grants MOP 15079 and GOP 38107 and by an equipment grant from Canadian Foundation for Innovation (to A. V. P.).	AMITH SR, 2009, GLYCOCONJ J IN PRESS; Bagriacik EU, 1999, GLYCOBIOLOGY, V9, P267, DOI 10.1093/glycob/9.3.267; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; Berthier R, 2000, J IMMUNOL METHODS, V239, P95, DOI 10.1016/S0022-1759(00)00186-1; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carrillo MB, 1997, GLYCOBIOLOGY, V7, P975; Chen XP, 1997, J IMMUNOL, V158, P3070; Chen XP, 2000, CYTOKINE, V12, P972, DOI 10.1006/cyto.1999.0596; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; FROHMAN M, 1985, J IMMUNOL, V134, P2269; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; ITOH K, 1995, J BIOL CHEM, V270, P515, DOI 10.1074/jbc.270.2.515; KEARSE KP, 1988, J IMMUNOL, V140, P1770; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; KRIEGER J, 1988, J IMMUNOL, V140, P388; LANDOLFI NF, 1986, MOL IMMUNOL, V23, P297, DOI 10.1016/0161-5890(86)90057-X; LANDOLFI NF, 1985, IMMUNOGENETICS, V22, P159, DOI 10.1007/BF00563513; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Moran JL, 1999, NATURE, V399, P742, DOI 10.1038/21560; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; NARAPARAJU VR, 1994, IMMUNOL LETT, V43, P143, DOI 10.1016/0165-2478(94)90214-3; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Pshezhetsky AV, 1996, J BIOL CHEM, V271, P28359, DOI 10.1074/jbc.271.45.28359; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Sedlik C, 2003, J IMMUNOL, V170, P846, DOI 10.4049/jimmunol.170.2.846; Seyrantepe V, 2008, CIRCULATION, V117, P1973, DOI 10.1161/CIRCULATIONAHA.107.733212; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Thomas G.H., METABOLIC MOL BASES, V3, P3507; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Watanabe Y, 2004, MICROBIOL IMMUNOL, V48, P875, DOI 10.1111/j.1348-0421.2004.tb03619.x; YAMAMOTO N, 1993, J IMMUNOL, V151, P2794; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005	41	62	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					206	215		10.1074/jbc.M109.055475	http://dx.doi.org/10.1074/jbc.M109.055475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19889639	Green Published, hybrid			2022-12-27	WOS:000273070100022
J	Edington, AR; McKinzie, AA; Reynolds, AJ; Kassiou, M; Ryan, RM; Vandenberg, RJ				Edington, Amelia R.; McKinzie, Audra A.; Reynolds, Aaron J.; Kassiou, Michael; Ryan, Renae M.; Vandenberg, Robert J.			Extracellular Loops 2 and 4 of GLYT2 Are Required for N-Arachidonylglycine Inhibition of Glycine Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; GLUTAMATE TRANSPORTER; BACTERIAL HOMOLOG; PAIN; EXPRESSION; MOLECULES; CLONING; ACIDS; LEUT	Concentrations of extracellular glycine in the central nervous system are regulated by Na+/Cl--dependent glycine transporters, GLYT1 and GLYT2. N-Arachidonylglycine (NAGly) is an endogenous inhibitor of GLYT2 with little or no effect on GLYT1 and is analgesic in rat models of neuropathic and inflammatory pain. Understanding the molecular basis of NAGly interactions with GLYT2 may allow for the development of novel therapeutics. In this study, chimeric transporters were used to determine the structural basis for differences in NAGly sensitivity between GLYT1 and GLYT2 and also the actions of a series of related N-arachidonyl amino acids. Extracellular loops 2 and 4 of GLYT2 are important in the selective inhibition of GLYT2 by NAGly and by the related compounds N-arachidonyl-gamma-aminobutyric acid and N-arachidonyl-D-alanine, whereas only the extracellular loop 4 of GLYT2 is required for N-arachidonyl-L-alanine inhibition of transport. These observations suggest that the structure of the head group of these compounds is important in determining how they interact with extracellular loops 2 and 4 of GLYT2. Site-directed mutagenesis of GLYT2 EL4 residues was used to identify the key residues Arg(531), Lys(532), and Ile(545) that contribute to the differences in NAGly sensitivity.	[Edington, Amelia R.; McKinzie, Audra A.; Ryan, Renae M.; Vandenberg, Robert J.] Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Pharmacol,Transporter Biol Grp, Sydney, NSW 2006, Australia; [Kassiou, Michael] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia; [Reynolds, Aaron J.; Kassiou, Michael] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Reynolds, Aaron J.; Kassiou, Michael] Brain & Mind Res Inst, Camperdown, NSW 2050, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Vandenberg, RJ (corresponding author), Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Pharmacol,Transporter Biol Grp, Sydney, NSW 2006, Australia.	rvan9242@mail.usyd.edu.au	Vandenberg, Robert John/E-6018-2016; Ryan, Renae/AAC-3540-2021	Vandenberg, Robert John/0000-0003-1523-4814; Ryan, Renae/0000-0002-8680-4610; Kassiou, Michael/0000-0002-6655-0529	Australian National Health and Medical Research Council (NHMRC)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) Project Grant.	APRISON M. H., 1965, LIFE SCI, V4, P2075, DOI 10.1016/0024-3205(65)90325-5; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Betz H, 2006, BIOCHEM SOC T, V34, P55, DOI 10.1042/BST0340055; Bezuglov V, 2001, BIOORG MED CHEM LETT, V11, P447, DOI 10.1016/S0960-894X(00)00689-2; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; LIU QR, 1993, J BIOL CHEM, V268, P22802; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Morita K, 2008, J PHARMACOL EXP THER, V326, P633, DOI 10.1124/jpet.108.136267; Nelson N, 1998, J NEUROCHEM, V71, P1785; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Succar R, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-24; Vandenberg RJ, 1998, BRIT J PHARMACOL, V123, P1593, DOI 10.1038/sj.bjp.0701776; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wiles AL, 2006, J NEUROCHEM, V99, P781, DOI 10.1111/j.1471-4159.2006.04107.x; Wong LAQ, 2008, NEUROPHARMACOLOGY, V54, P189, DOI 10.1016/j.neuropharm.2007.05.004; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	23	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36424	36430		10.1074/jbc.M109.017509	http://dx.doi.org/10.1074/jbc.M109.017509			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19875446	Green Published, hybrid			2022-12-27	WOS:000272970500044
J	Journo, D; Mor, A; Abeliovich, H				Journo, Dikla; Mor, Angelika; Abeliovich, Hagai			Aup1-mediated Regulation of Rtg3 during Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; AUTOPHAGIC DEGRADATION; SELECTIVE AUTOPHAGY; AMINOPEPTIDASE-I; YEAST; MITOCHONDRIA; VACUOLE; TARGET; BIOGENESIS; RAPAMYCIN	Mitophagy is an autophagic process that degrades mitochondria by an intracellular engulfment that leads to their delivery into the lumen of the cell's hydrolytic compartment, such as the lysosome in animal cells or the vacuole in yeast. It is hypothesized that such processes serve a quality control function to prevent or slow the accumulation of malfunctioning mitochondria, which are thought in turn to underlie central aspects of the aging process in eukaryotic organisms. We recently identified a conserved mitochondrial protein phosphatase homolog, Aup1, which is required for efficient stationary phase mitophagy in yeast. In the present report, we demonstrate that the retrograde signaling pathway (RTG) is defective in aup1 Delta mutants. In agreement with a role for Aup1 in the regulation of the RTG pathway, we find that deletion of RTG3, a transcription factor that mediates the RTG response, causes a defect in stationary phase mitophagy and that deletion of AUP1 leads to changes in Rtg3 phosphorylation patterns under these conditions. In addition, we find that mitophagic conditions lead to induction of RTG pathway target genes in an Aup1-dependent fashion. Thus, our results suggest that the function of Aup1 in mitophagy could be explained through its regulation of Rtg3-dependent transcription.	[Journo, Dikla; Mor, Angelika; Abeliovich, Hagai] Hebrew Univ Jerusalem, Dept Biochem & Food Sci, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Abeliovich, H (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Food Sci, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.	ahagai@agri.huji.ac.il			Israel Science Foundation [1016/07]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1016/07 (to H.A.).	Abeliovich H, 1999, EMBO J, V18, P6005, DOI 10.1093/emboj/18.21.6005; Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Abeliovich H, 2007, AUTOPHAGY, V3, P275, DOI 10.4161/auto.3915; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Cohen R, 2007, FEMS MICROBIOL LETT, V273, P239, DOI 10.1111/j.1574-6968.2007.00798.x; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Deffieu M, 2009, J BIOL CHEM, V284, P14828, DOI 10.1074/jbc.M109.005181; Dilova I, 2006, FEMS YEAST RES, V6, P112, DOI 10.1111/j.1567-1364.2005.00008.x; Dunn WA, 2005, AUTOPHAGY, V1, P75; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Farre JC, 2004, TRENDS CELL BIOL, V14, P515, DOI 10.1016/j.tcb.2004.07.014; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Labbe S, 1999, METHOD ENZYMOL, V306, P145; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Winter G, 2008, AUTOPHAGY, V4, P28, DOI 10.4161/auto.5127; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102	60	62	66	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35885	35895		10.1074/jbc.M109.048140	http://dx.doi.org/10.1074/jbc.M109.048140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840933	Green Published, hybrid			2022-12-27	WOS:000272645600064
J	Postow, L; Woo, EM; Chait, BT; Funabiki, H				Postow, Lisa; Woo, Eileen M.; Chait, Brian T.; Funabiki, Hironori			Identification of SMARCAL1 as a Component of the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNO-OSSEOUS DYSPLASIA; BLOOMS-SYNDROME HELICASE; WERNER-SYNDROME PROTEIN; CHECKPOINT RESPONSE; REPLICATION FORKS; BINDING-PROTEIN; RECQ HELICASES; ATR; RECOMBINATION; REGRESSION	SMARCAL1 (also known as HARP) is a SWI/SNF family protein with an ATPase activity stimulated by DNA containing both single-stranded and double-stranded regions. Mutations in SMARCAL1 are associated with the disease Schimke immuno-osseous dysplasia, a multisystem autosomal recessive disorder characterized by Tcell immunodeficiency, growth inhibition, and renal dysfunction. The cellular function of SMARCAL1, however, is unknown. Here, using Xenopus egg extracts and mass spectrometry, we identify SMARCAL1 as a protein recruited to double-stranded DNA breaks. SMARCAL1 binds to double-stranded breaks and stalled replication forks in both egg extract and human cells, specifically colocalizing with the single-stranded DNA binding factor RPA. In addition, SMARCAL1 interacts physically with RPA independently of DNA. SMARCAL1 is phosphorylated in a caffeine-sensitive manner in response to double-stranded breaks and stalled replication forks. It has been suggested that stalled forks can be stabilized by a mechanism involving caffeine-sensitive kinases, or they collapse and subsequently recruit Rad51 to promote homologous recombination repair. We show that depletion of SMARCAL1 from U2OS cells leads to increased frequency of RAD51 foci upon generation of stalled replication forks, indicating that fork breakdown is more prevalent in the absence of SMARCAL1. We propose that SMARCAL1 is a novel DNA damage-binding protein involved in replication fork stabilization.	Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA; [Woo, Eileen M.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Postow, L (corresponding author), 1230 York Ave, New York, NY 10065 USA.	PostowL@rockefeller.edu		Funabiki, Hironori/0000-0003-4831-4087	National Institutes of Health [T32 CA09673, RR00862]; Leukemia and Lymphoma Society of America; Howard Hughes Medical Institute; Rockefeller University; Irma T. Hirschl/Monique Weill-Caulier Trust; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rockefeller University; Irma T. Hirschl/Monique Weill-Caulier Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 CA09673 (to L. P.) and RR00862 (to B. T. C.).; Supported by a fellowship from the Leukemia and Lymphoma Society of America.; Supported by a Howard Hughes Medical Institute predoctoral award.; Supported by the Rockefeller University and the Irma T. Hirschl/Monique Weill-Caulier Trust.	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Boerkoel CF, 2000, EUR J PEDIATR, V159, P1, DOI 10.1007/s004310050001; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Clewing JM, 2007, J MED GENET, V44, P122, DOI 10.1136/jmg.2006.044313; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HOCKENSMITH JW, 1986, BIOCHEMISTRY-US, V25, P7812, DOI 10.1021/bi00372a005; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Muthuswami R, 2000, J BIOL CHEM, V275, P7648, DOI 10.1074/jbc.275.11.7648; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Postow L, 2008, J CELL BIOL, V182, P467, DOI 10.1083/jcb.200802146; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Rivera T, 2009, CHROMOSOMA, V118, P223, DOI 10.1007/s00412-008-0190-4; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SPRANGER J, 1991, J PEDIATR-US, V119, P64, DOI 10.1016/S0022-3476(05)81040-6; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	52	87	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35951	35961		10.1074/jbc.M109.048330	http://dx.doi.org/10.1074/jbc.M109.048330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19841479	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000272645600070
J	Bohnsack, RN; Song, XZ; Olson, LJ; Kudo, M; Gotschall, RR; Canfield, WM; Cummings, RD; Smith, DF; Dahms, NM				Bohnsack, Richard N.; Song, Xuezheng; Olson, Linda J.; Kudo, Mariko; Gotschall, Russell R.; Canfield, William M.; Cummings, Richard D.; Smith, David F.; Dahms, Nancy M.			Cation-independent Mannose 6-Phosphate Receptor A COMPOSITE OF DISTINCT PHOSPHOMANNOSYL BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; ALPHA-N-ACETYLGLUCOSAMINIDASE; LYSOSOMAL-ENZYMES; CARBOHYDRATE-RECOGNITION; LIGAND-BINDING; PHOSPHORYLATED OLIGOSACCHARIDES; EXTRACYTOPLASMIC REGION; UNCOVERING ENZYME; IDENTIFICATION; LOCALIZATION	The 300-kDa cation-independent mannose 6-phosphate receptor (CI-MPR), which contains multiple mannose 6-phosphate (Man-6-P) binding sites that map to domains 3, 5, and 9 within its 15-domain extracytoplasmic region, functions as an efficient carrier of Man-6-P-containing lysosomal enzymes. To determine the types of phosphorylated N-glycans recognized by each of the three carbohydrate binding sites of the CI-MPR, a phosphorylated glycan microarray was probed with truncated forms of the CI-MPR. Surface plasmon resonance analyses using lysosomal enzymes with defined N-glycans were performed to evaluate whether multiple domains are needed to form a stable, high affinity carbohydrate binding pocket. Like domain 3, adjacent domains increase the affinity of domain 5 for phosphomannosyl residues, with domain 5 exhibiting similar to 60-fold higher affinity for lysosomal enzymes containing the phosphodiester Man-P-GlcNAc when in the context of a construct encoding domains 5-9. In contrast, domain 9 does not require additional domains for high affinity binding. The three sites differ in their glycan specificity, with only domain 5 being capable of recognizing Man-P-GlcNAc. In addition, domain 9, unlike domains 1-3, interacts with Man(8)GlcNAc(2) and Man(9)GlcNAc(2) oligosaccharides containing a single phosphomonoester. Together, these data indicate that the assembly of three unique carbohydrate binding sites allows the CI-MPR to interact with the structurally diverse phosphorylated N-glycans it encounters on newly synthesized lysosomal enzymes.	[Bohnsack, Richard N.; Olson, Linda J.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Song, Xuezheng; Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Kudo, Mariko; Gotschall, Russell R.; Canfield, William M.] Genzyme Corp, Oklahoma City, OK 73104 USA	Medical College of Wisconsin; Emory University; Sanofi-Aventis; Genzyme Corporation	Smith, DF (corresponding author), O Wayne Rollins Res Ctr, 1510 Clifton Rd NE,Rm 4035, Atlanta, GA 30322 USA.	dfsmith@emory.edu; ndahms@mcw.edu		Gotschall, Robert Russell/0000-0002-5050-1386	National Institutes of Health [R01DK42667, GM085448]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK42667 (to N.M.D.) and GM085448 (to D.F.S.).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BOBEK G, 1991, ENDOCRINOLOGY, V128, P2204, DOI 10.1210/endo-128-4-2204; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Byrd JC, 2000, J BIOL CHEM, V275, P18647, DOI 10.1074/jbc.M001273200; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; CLAIRMONT KB, 1991, J BIOL CHEM, V266, P12131; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Dell'Angelica EC, 2001, CELL, V106, P395, DOI 10.1016/S0092-8674(01)00470-6; Devi GR, 1998, MOL ENDOCRINOL, V12, P1661, DOI 10.1210/me.12.11.1661; DISTLER JJ, 1991, J BIOL CHEM, V266, P21687; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; Gary-Bobo M, 2007, CURR MED CHEM, V14, P2945, DOI 10.2174/092986707782794005; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; HASILIK A, 1980, P NATL ACAD SCI-BIOL, V77, P7074, DOI 10.1073/pnas.77.12.7074; HEFLER SK, 1987, BIOCHEM BIOPH RES CO, V146, P1173, DOI 10.1016/0006-291X(87)90771-6; HOFLACK B, 1987, J BIOL CHEM, V262, P123; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; Kornfeld S., 2001, METABOLIC MOL BASES, P3469; Kreiling JL, 2005, J BIOL CHEM, V280, P21067, DOI 10.1074/jbc.M412971200; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Linnell J, 2001, J BIOL CHEM, V276, P23986, DOI 10.1074/jbc.M100700200; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Marron-Terada PG, 2000, BIOCHEMISTRY-US, V39, P2243, DOI 10.1021/bi992226o; Marron-Terada PG, 1998, J BIOL CHEM, V273, P22358, DOI 10.1074/jbc.273.35.22358; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; MULLIS KG, 1992, ANAL BIOCHEM, V205, P200, DOI 10.1016/0003-2697(92)90424-6; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; NATOWICZ M, 1982, J BIOL CHEM, V257, P4412; Olson LJ, 1999, J BIOL CHEM, V274, P29889, DOI 10.1074/jbc.274.42.29889; Olson LJ, 1999, J BIOL CHEM, V274, P36905, DOI 10.1074/jbc.274.52.36905; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; Olson LJ, 2004, EMBO J, V23, P2019, DOI 10.1038/sj.emboj.7600215; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Reddy ST, 2004, J BIOL CHEM, V279, P38658, DOI 10.1074/jbc.M407474200; Reddy ST, 2002, PROTEIN EXPRES PURIF, V26, P290, DOI 10.1016/S1046-5928(02)00542-9; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Sleat DE, 1997, J BIOL CHEM, V272, P731, DOI 10.1074/jbc.272.2.731; Sohar I, 1998, BIOCHEM J, V330, P903, DOI 10.1042/bj3300903; Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Sun GJ, 2005, GLYCOBIOLOGY, V15, P1136, DOI 10.1093/glycob/cwi098; TOMODA H, 1991, CARBOHYD RES, V213, P37, DOI 10.1016/S0008-6215(00)90596-2; TONG PY, 1989, J BIOL CHEM, V264, P7970; Uson I, 2003, ACTA CRYSTALLOGR D, V59, P57, DOI 10.1107/S090744490201884X; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; VARKI A, 1983, J BIOL CHEM, V258, P2808; VARKI A, 1983, ARCH BIOCHEM BIOPHYS, V222, P145, DOI 10.1016/0003-9861(83)90511-8; VARKI A, 1980, J BIOL CHEM, V255, P847; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; WAHEED A, 1981, J BIOL CHEM, V256, P5717; WESTLUND B, 1991, J BIOL CHEM, V266, P23233; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164	64	49	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35215	35226		10.1074/jbc.M109.056184	http://dx.doi.org/10.1074/jbc.M109.056184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840944	Green Published, hybrid			2022-12-27	WOS:000272439600074
J	Sen, B; Styner, M; Xie, ZH; Case, N; Rubin, CT; Rubin, J				Sen, Buer; Styner, Maya; Xie, Zhihui; Case, Natasha; Rubin, Clinton T.; Rubin, Janet			Mechanical Loading Regulates NFATc1 and beta-Catenin Signaling through a GSK3 beta Control Node	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; GLYCOGEN-SYNTHASE KINASE-3; MESENCHYMAL STEM-CELLS; BINDING-PROTEIN-ALPHA; GENE-EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; ESTROGEN-RECEPTOR; NUCLEAR FACTOR; INHIBITS ADIPOGENESIS; CALCIUM OSCILLATIONS	Mechanical stimulation can prevent adipogenic and improve osteogenic lineage allocation of mesenchymal stem cells (MSC), an effect associated with the preservation of beta-catenin levels. We asked whether mechanical up-regulation of beta-catenin was critical to reduction in adipogenesis as well as other mechanical events inducing alternate MSC lineage selection. In MSC cultured under strong adipogenic conditions, mechanical load (3600 cycles/day, 2% strain) inactivated GSK3 beta in a Wnt-independent fashion. Small interfering RNA targeting GSK3 beta prevented both strain-induced induction of beta-catenin and an increase in COX2, a factor associated with increased osteoprogenitor phenotype. Small interfering RNA knockdown of beta-catenin blocked mechanical reduction of peroxisome proliferator-activated receptor gamma and adiponectin, implicating beta-catenin in strain inhibition of adipogenesis. In contrast, the effect of both mechanical and pharmacologic inhibition of GSK3 beta on the putative beta-catenin target, COX2, was unaffected by beta-catenin knockdown. GSK3 beta inhibition caused accumulation of nuclear NFATc1; mechanical strain increased nuclear NFATc1, independent of beta-catenin. NFATc1 knockdown prevented mechanical stimulation of COX2, implicating NFATc1 signaling. Finally, inhibition of GSK3 beta caused association of RNA polymerase II with the COX2 gene, suggesting transcription initiation. These results demonstrate that mechanical inhibition of GSK3 beta induces activation of both beta-catenin and NFATc1 signaling, limiting adipogenesis via the former and promoting osteoblastic differentiation via NFATc1/COX2. Our novel findings suggest that mechanical loading regulates mesenchymal stem cell differentiation through inhibition of GSK3 beta, which in turn regulates multiple downstream effectors.	[Sen, Buer; Styner, Maya; Xie, Zhihui; Case, Natasha; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rubin, Clinton T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sen, B (corresponding author), Univ N Carolina, Dept Med, 5030 Burnett Womack,CB 7170, Chapel Hill, NC 27599 USA.	buer_sen@med.unc.edu	Styner, Maya/I-2044-2019	Styner, Maya/0000-0001-9790-8645	National Institutes of Health [AR42360, AR52014]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052014, R56AR042360, R01AR042360, R01AR056655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR42360 and AR52014 (to J.R.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Araki Y, 2003, CANCER RES, V63, P728; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Aydemir ABC, 2007, ANN NY ACAD SCI, V1117, P138, DOI 10.1196/annals.1402.004; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; Cowin SC, 1998, AM J MED SCI, V316, P184, DOI 10.1097/00000441-199809000-00006; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Eisinger AL, 2006, J BIOL CHEM, V281, P20474, DOI 10.1074/jbc.M602859200; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; Fan X, 2004, J CELL BIOCHEM, V93, P807, DOI 10.1002/jcb.20217; Flockhart RJ, 2008, FASEB J, V22, P4218, DOI 10.1096/fj.08-113076; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Godin LM, 2007, BIOMECH MODEL MECHAN, V6, P391, DOI 10.1007/s10237-006-0059-5; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Lin TH, 2007, BONE, V41, P562, DOI 10.1016/j.bone.2007.06.017; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu JJ, 2004, J BIOL CHEM, V279, P45020, DOI 10.1074/jbc.M407050200; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; MINAIRE P, 1984, CALCIFIED TISSUE INT, V36, P338, DOI 10.1007/BF02405340; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; RAISZ LG, 1995, J NUTR, V125, pS2024, DOI 10.1093/jn/125.suppl_7.2024S; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Sauer H, 1998, EXP CELL RES, V238, P13, DOI 10.1006/excr.1997.3809; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shih TTF, 2004, SPINE, V29, P2844, DOI 10.1097/01.brs.0000147803.01224.5b; Tang QQ, 1997, P NATL ACAD SCI USA, V94, P13571, DOI 10.1073/pnas.94.25.13571; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Thiel A, 2006, J BIOL CHEM, V281, P4564, DOI 10.1074/jbc.M512722200; Wadleigh DJ, 1999, BIOCHEM BIOPH RES CO, V264, P865, DOI 10.1006/bbrc.1999.1606; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zmijewski JW, 2004, AGING CELL, V3, P309, DOI 10.1111/j.1474-9728.2004.00117.x	68	97	102	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34607	34617		10.1074/jbc.M109.039453	http://dx.doi.org/10.1074/jbc.M109.039453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840939	Green Published, hybrid			2022-12-27	WOS:000272439600016
J	Hsu, STD; Blaser, G; Behrens, C; Cabrita, LD; Dobson, CM; Jackson, SE				Hsu, Shang-Te Danny; Blaser, Georg; Behrens, Caroline; Cabrita, Lisa D.; Dobson, Christopher M.; Jackson, Sophie E.			Folding Study of Venus Reveals a Strong Ion Dependence of Its Yellow Fluorescence under Mildly Acidic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE FLUORESCENCE; BOUND NASCENT CHAIN; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; FUSION PROTEIN; LIVING CELLS; GFP; DYNAMICS; COMPLEMENTATION; VISUALIZATION	Venus is a yellow fluorescent protein that has been developed for its fast chromophore maturation rate and bright yellow fluorescence that is relatively insensitive to changes in pH and ion concentrations. Here, we present a detailed study of the stability and folding of Venus in the pH range from 6.0 to 8.0 using chemical denaturants and a variety of spectroscopic probes. By following hydrogen-deuterium exchange of N-15-labeled Venus using NMR spectroscopy over 13 months, residue-specific free energies of unfolding of some highly protected amide groups have been determined. Exchange rates of less than one per year are observed for some amide groups. A super-stable core is identified for Venus and compared with that previously reported for green fluorescent protein. These results are discussed in terms of the stability and folding of fluorescent proteins. Under mildly acidic conditions, we show that Venus undergoes a drastic decrease in yellow fluorescence at relatively low concentrations of guanidinium chloride. A detailed study of this effect establishes that it is due to pH-dependent, nonspecific interactions of ions with the protein. In contrast to previous studies on enhanced green fluorescence protein variant S65T/T203Y, which showed a specific halide ion-binding site, NMR chemical shift mapping shows no evidence for specific ion binding. Instead, chemical shift perturbations are observed for many residues primarily located in both lids of the beta-barrel structure, which suggests that small scale structural rearrangements occur on increasing ionic strength under mildly acidic conditions and that these are propagated to the chromophore resulting in fluorescence quenching.	[Hsu, Shang-Te Danny; Blaser, Georg; Behrens, Caroline; Cabrita, Lisa D.; Dobson, Christopher M.; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Hsu, STD (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	stdh2@cam.ac.uk; sej13@cam.ac.uk	Hsu, Shang-Te Danny/B-2324-2009; Hsu, Shang-Te Danny/L-2826-2014	Hsu, Shang-Te Danny/0000-0002-7231-0185; Cabrita, Lisa/0000-0003-2963-8078	EC [RII3-026145]; Human Frontier Science Program Long Term Fellowship [LT0798/2005]; National Science Council of the Republic of China, Taiwan [NSC97-2917-1-564-102]; Studienstiftung des Deutschen Volkes scholarship; National Health and Medical Research Council C. J. Martin Fellow; Leverhulme Trust; Biotechnology and Biological Sciences Research Council [BBF00219X1]; BBSRC [BB/F00219X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00219X/1] Funding Source: researchfish	EC(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program Long Term Fellowship(Human Frontier Science Program); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); Studienstiftung des Deutschen Volkes scholarship; National Health and Medical Research Council C. J. Martin Fellow(National Health and Medical Research Council (NHMRC) of Australia); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Access to Research Infrastructures Activity in the 6th Framework Program of the EC Contract RII3-026145, EU-NMR.; Recipient of Human Frontier Science Program Long Term Fellowship LT0798/2005 and supported by the Postdoctoral Research Abroad Program of National Science Council of the Republic of China, Taiwan, Grant NSC97-2917-1-564-102. To whom correspondence may be addressed. E-mail: stdh2@cam.ac.uk.; Recipient of a Studienstiftung des Deutschen Volkes scholarship and supported by the Erasmus/Sokrates Program.; National Health and Medical Research Council C. J. Martin Fellow.; Supported by The Leverhulme Trust.; Supported by Biotechnology and Biological Sciences Research Council Grant BBF00219X1. To whom correspondence may be addressed. E-mail: sej13@cam.ac.uk.	Andrews BT, 2008, P NATL ACAD SCI USA, V105, P12283, DOI 10.1073/pnas.0804039105; Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; Chirico G, 2006, EUR BIOPHYS J BIOPHY, V35, P663, DOI 10.1007/s00249-006-0075-5; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Enoki S, 2006, J MOL BIOL, V361, P969, DOI 10.1016/j.jmb.2006.07.009; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Goddard T.D., 2008, SPARKY NMR ASSIGNMEN; Helms V, 1999, J PHYS CHEM B, V103, P3263, DOI 10.1021/jp983120q; Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104; Hsu STD, 2009, J AM CHEM SOC, V131, P8366, DOI 10.1021/ja902778n; Hsu STD, 2009, BIOMOL NMR ASSIGN, V3, P67, DOI 10.1007/s12104-009-9143-y; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Huang JR, 2008, HFSP J, V2, P378, DOI 10.2976/1.2976660; Huang YM, 2009, BIOCHEMISTRY-US, V48, P929, DOI 10.1021/bi802027g; Jackson SE, 2006, EXPERT REV PROTEOMIC, V3, P545, DOI 10.1586/14789450.3.5.545; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Khan F, 2006, J AM CHEM SOC, V128, P10729, DOI 10.1021/ja060618u; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Li CJ, 1999, J CELL SCI, V112, P1567; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Millington M, 2007, BIOPHYS CHEM, V127, P155, DOI 10.1016/j.bpc.2007.01.008; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Orte A, 2008, J AM CHEM SOC, V130, P7898, DOI 10.1021/ja709973m; Ottmann C, 2009, BIOL CHEM, V390, P81, DOI 10.1515/BC.2009.008; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Rucker E, 2001, PROTEIN EXPRES PURIF, V21, P220, DOI 10.1006/prep.2000.1373; Seifert MH, 2002, J AM CHEM SOC, V124, P7932, DOI 10.1021/ja0257725; Seifert MHJ, 2003, BIOCHEMISTRY-US, V42, P2500, DOI 10.1021/bi026481b; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Wang HY, 2003, P NATL ACAD SCI USA, V100, P478, DOI 10.1073/pnas.0236088100; Xie JB, 2008, BIOCHEMISTRY-US, V47, P348, DOI 10.1021/bi7011838; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	54	18	19	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4859	4869		10.1074/jbc.M109.000695	http://dx.doi.org/10.1074/jbc.M109.000695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19901033	Green Published, hybrid			2022-12-27	WOS:000275274800064
J	Lendrihas, T; Hunter, GA; Ferreira, GC				Lendrihas, Thomas; Hunter, Gregory A.; Ferreira, Gloria C.			Serine 254 Enhances an Induced Fit Mechanism in Murine 5-Aminolevulinate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ASPARTATE-AMINOTRANSFERASE; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; HYDROGEN-BONDS; SWISS-MODEL; ENZYMES; ACID; STATE; DERIVATIVES; ENVIRONMENT	5-Aminolevulinate synthase (EC 2.3.1.37) (ALAS), a pyridoxal 5'-phosphate (PLP)-dependent enzyme, catalyzes the initial step of heme biosynthesis in animals, fungi, and some bacteria. Condensation of glycine and succinyl coenzyme A produces 5-aminolevulinate, coenzyme A, and carbon dioxide. X-ray crystal structures of Rhodobacter capsulatus ALAS reveal that a conserved active site serine moves to within hydrogen bonding distance of the phenolic oxygen of the PLP cofactor in the closed substrate-bound enzyme conformation and within 3-4 angstrom of the thioester sulfur atom of bound succinyl-CoA. To evaluate the role(s) of this residue in enzymatic activity, the equivalent serine in murine erythroid ALAS was substituted with alanine or threonine. Although both the K-m(SCoA) and k(cat) values of the S254A variant increased, by 25- and 2-fold, respectively, the S254T substitution decreased k(cat) without altering K-m(SCoA). Furthermore, in relation to wild-type ALAS, the catalytic efficiency of S254A toward glycine improved similar to 3-fold, whereas that of S254T diminished similar to 3-fold. Circular dichroism spectroscopy revealed that removal of the side chain hydroxyl group in the S254A variant altered the microenvironment of the PLP cofactor and hindered succinyl-CoA binding. Transient kinetic analyses of the variant-catalyzed reactions and protein fluorescence quenching upon 5-aminolevulinate binding demonstrated that the protein conformational transition step associated with product release was predominantly affected. We propose the following: 1) Ser-254 is critical for formation of a competent catalytic complex by coupling succinyl-CoA binding to enzyme conformational equilibria, and 2) the role of the active site serine should be extended to the entire alpha-oxoamine synthase family of PLP-dependent enzymes.	[Ferreira, Gloria C.] Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Ferreira, GC (corresponding author), Univ S Florida, Dept Mol Med, Coll Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	National Institutes of Health [DK63191]; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054317, R01DK063191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK63191 (to G.C.F.).	AKHTAR M, 1976, PHILOS T ROY SOC B, V273, P117, DOI 10.1098/rstb.1976.0005; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BOTTOMLEY SS, 2004, WINTROBES CLIN HEMAT, P1012; Bottomley Sylvia S, 2006, Curr Hematol Rep, V5, P41; Cellini B, 2005, BIOCHEMISTRY-US, V44, P13970, DOI 10.1021/bi051433n; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ferreira GC, 2002, CELL MOL BIOL, V48, P827; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; FUTAKI S, 1990, J BIOL CHEM, V265, P22306; GREGORET LM, 1991, PROTEINS, V9, P99, DOI 10.1002/prot.340090204; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius J N, 1984, Prog Clin Biol Res, V144B, P195; JANSONIUS JN, 1984, BIOCHEM SOC T, V12, P424, DOI 10.1042/bst0120424; KALLEN RG, 1985, TRANSAMINASES, P37; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KOSHLAND DE, 1968, ANNU REV BIOCHEM, V37, P359, DOI 10.1146/annurev.bi.37.070168.002043; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lendrihas T, 2009, PROTEIN SCI, V18, P1847, DOI 10.1002/pro.195; May A, 1998, HAEMATOLOGICA, V83, P56; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; PICOT D, 1991, EUR J BIOCHEM, V196, P329, DOI 10.1111/j.1432-1033.1991.tb15821.x; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rajagopal S, 2005, FEBS J, V272, P1819, DOI 10.1111/j.1742-4658.2005.04604.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSAI MD, 1978, BIOCHEMISTRY-US, V17, P3183, DOI 10.1021/bi00609a002; Zhang JS, 2005, PROTEIN SCI, V14, P1190, DOI 10.1110/ps.041258305; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	42	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3351	3359		10.1074/jbc.M109.066548	http://dx.doi.org/10.1074/jbc.M109.066548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19917609	Green Published, hybrid			2022-12-27	WOS:000273829000050
J	Earl, LA; Bi, SG; Baum, LG				Earl, Lesley A.; Bi, Shuguang; Baum, Linda G.			N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC EPITHELIAL-CELLS; TYROSINE-PHOSPHATASE; DIFFERENTIAL GLYCOSYLATION; ISOFORM EXPRESSION; ENDOGENOUS LECTIN; APOPTOSIS; THYMOCYTES; ACTIVATION; CD7; PHOSPHORYLATION	Galectin-1, a beta-galactoside-binding protein highly expressed in the thymus, induces apoptosis of specific thymocyte subsets and activated T cells. Galectin-1 binds to N- and O-glycans on several glycoprotein receptors, including CD7, CD43, and CD45. Here we show that galectin-1 signaling through CD45, which carries both N- and O-glycans, is regulated by CD45 isoform expression, core 2 O-glycan formation and the balance of N- glycan sialylation. Regulation of galectin-1 T cell death by O-glycans is mediated through CD45 phosphatase activity. While galectin-1 signaling in cells expressing low molecular weight isoforms of CD45 requires expression of core 2 O-glycans (high affinity ligands for galectin-1), galectin-1 signaling in cells expressing a high molecular weight isoform of CD45 does not require core 2 O-glycans, suggesting that a larger amount of core 1 O-glycans (low affinity ligands for galectin-1) is sufficient to overcome lack of core 2 O-glycans. Furthermore, regulation of galectin-1 signaling by alpha 2,6-sialylation of N-glycans is not solely dependent on CD45 phosphatase activity and can be modulated by the relative expression of enzymes that attach sialic acid in an alpha 2,6- or alpha 2,3-linkage. Thus, N- and O-glycans modulate galectin-1 T cell death by distinct mechanisms, and different glycosylation events can render thymocytes susceptible or resistant to galectin-1.	[Earl, Lesley A.; Bi, Shuguang; Baum, Linda G.] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baum, LG (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, 10833 LeConte Ave, Los Angeles, CA 90095 USA.	lbaum@mednet.ucla.edu			National Institutes of Health [GM63281]; National Institutes of Health Training [T32 AI52031]; University of California, Cancer Research Coordinating Committee; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, T32AI052031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063281, U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Cancer Research Coordinating Committee(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63281 (to L.G.B.) and National Institutes of Health Training Grant T32 AI52031 (to L.A.E.). This work was also supported by a grant from the University of California, Cancer Research Coordinating Committee (to L.G.B.).	Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Barran P, 1997, GLYCOBIOLOGY, V7, P129, DOI 10.1093/glycob/7.1.129; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Dawes R, 2006, J IMMUNOL, V176, P3417, DOI 10.4049/jimmunol.176.6.3417; Di Virgilio S, 1999, GLYCOBIOLOGY, V9, P353, DOI 10.1093/glycob/9.4.353; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Fortin M, 2002, J IMMUNOL, V168, P6084, DOI 10.4049/jimmunol.168.12.6084; Fouillit M, 2000, GLYCOBIOLOGY, V10, P413, DOI 10.1093/glycob/10.4.413; Furukawa K, 1998, EUR J BIOCHEM, V251, P288, DOI 10.1046/j.1432-1327.1998.2510288.x; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; HATHCOCK KS, 1992, J IMMUNOL, V148, P19; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hernandez JD, 2007, INT IMMUNOL, V19, P847, DOI 10.1093/intimm/dxm053; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; HOLLADAY S, 1993, IMMUNOL INVEST, V22, P517, DOI 10.3109/08820139309084180; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; JONES AT, 1994, J IMMUNOL, V153, P3426; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; McNeill L, 2004, IMMUNOL LETT, V92, P125, DOI 10.1016/j.imlet.2003.10.018; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Pace KE, 1999, J IMMUNOL, V163, P3801; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Pang MB, 2009, J IMMUNOL, V182, P7001, DOI 10.4049/jimmunol.0804329; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; Roberts AA, 2003, MODERN PATHOL, V16, P543, DOI 10.1097/01.MP.0000071840.84469.06; Sempowski GD, 1999, CRIT REV IMMUNOL, V19, P331; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Tackenberg B, 2003, AUTOIMMUNITY, V36, P117, DOI 10.1080/0891693031000084369; THOMAS ML, 1987, P NATL ACAD SCI USA, V84, P5360, DOI 10.1073/pnas.84.15.5360; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Vespa GNR, 1999, J IMMUNOL, V162, P799; Walzel H, 1999, IMMUNOL LETT, V67, P193, DOI 10.1016/S0165-2478(99)00012-7; Wang YN, 2005, J BIOL CHEM, V280, P14318, DOI 10.1074/jbc.M413265200; Windhagen A, 2007, CLIN EXP IMMUNOL, V150, P509, DOI 10.1111/j.1365-2249.2007.03508.x; Wu WY, 1996, J EXP MED, V184, P759, DOI 10.1084/jem.184.2.759; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zamoyska R, 2007, IMMUNITY, V27, P421, DOI 10.1016/j.immuni.2007.08.009	60	101	104	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2242	2254		10.1074/jbc.M109.066191	http://dx.doi.org/10.1074/jbc.M109.066191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920154	hybrid, Green Published			2022-12-27	WOS:000273697800004
J	Campbell, GR; Loret, EP; Spector, SA				Campbell, Grant R.; Loret, Erwann P.; Spector, Stephen A.			HIV-1 Clade B Tat, but Not Clade C Tat, Increases X4 HIV-1 Entry into Resting but Not Activated CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 HIV-1; SUBTYPE-C; DISEASE PROGRESSION; CORECEPTOR USAGE; DENDRITIC CELLS; VIRAL PHENOTYPE; LYMPH-NODES; FACTOR-I; INFECTION; CHEMOKINE	CXCR4-using human immunodeficiency virus, type 1 (HIV-1) variants emerge late in the course of infection in > 40% of individuals infected with clade B HIV-1 but are described less commonly with clade C isolates. Tat is secreted by HIV-1-infected cells where it acts on both uninfected bystander cells and infected cells. In this study, we show that clade B Tat, but not clade C Tat, increases CXCR4 surface expression on resting CD4(+) T cells through a CCR2b-dependent mechanism that does not involve de novo protein synthesis. The expression of plectin, a cytolinker protein that plays an important role as a scaffolding platform for proteins involved in cellular signaling including CXCR4 signaling and trafficking, was found to be significantly increased following B Tat but not C Tat treatment. Knockdown of plectin using RNA interference showed that plectin is essential for the B Tat-induced translocation of CXCR4 to the surface of resting CD4(+) T cells. The increased surface CXCR4 expression following B Tat treatment led to increased function of CXCR4 including increased chemoattraction toward CXCR4-using-gp120. Moreover, increased CXCR4 surface expression rendered resting CD4(+) T cells more permissive to X4 but not R5 HIV-1 infection. However, neither B Tat nor C Tat was able to up-regulate surface expression of CXCR4 on activated CD4(+) T cells, and both proteins inhibited the infection of activated CD4(+) T cells with X4 but not R5 HIV-1. Thus, B Tat, but not C Tat, has the capacity to render resting, but not activated, CD4(+) T cells more susceptible to X4 HIV-1 infection.	[Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Loret, Erwann P.] Univ Aix Marseille 2, Fac Pharm, INSERM, U911, F-13385 Marseille 5, France	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health [AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068632, U01AI068632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068632.	Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Albini A, 1998, J BIOL CHEM, V273, P15895, DOI 10.1074/jbc.273.26.15895; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bell CM, 2007, AIDS RES HUM RETROV, V23, P322, DOI 10.1089/aid.2006.0181; Berger EA, 1997, AIDS, V11, pS3; Bhoopat L, 2006, MODERN PATHOL, V19, P255, DOI 10.1038/modpathol.3800527; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Campbell GR, 2004, J BIOL CHEM, V279, P48197, DOI 10.1074/jbc.M406195200; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Campbell GR, 2007, VACCINE, V25, P8441, DOI 10.1016/j.vaccine.2007.09.070; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Cecilia D, 2000, VIROLOGY, V271, P253, DOI 10.1006/viro.2000.0297; Coetzer M, 2006, VIROLOGY, V356, P95, DOI 10.1016/j.virol.2006.07.030; Correa R, 2001, AIDS, V15, P1959, DOI 10.1097/00002030-200110190-00007; Curnock AP, 2003, J IMMUNOL, V170, P4021, DOI 10.4049/jimmunol.170.8.4021; Davenport MP, 2002, TRENDS MICROBIOL, V10, P275, DOI 10.1016/S0966-842X(02)02370-3; de Mareuil J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-5; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Ghezzi S, 2000, BIOCHEM BIOPH RES CO, V270, P992, DOI 10.1006/bbrc.2000.2523; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; Huigen MCDG, 2004, EUR J CLIN INVEST, V34, P57, DOI 10.1111/j.1365-2362.2004.01282.x; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kinter AL, 2003, J IMMUNOL, V170, P2449, DOI 10.4049/jimmunol.170.5.2449; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Kumar M, 2006, AIDS RES HUM RETROV, V22, P1206, DOI 10.1089/aid.2006.22.1206; Lane BR, 1999, J IMMUNOL, V163, P3653; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; Noraz N, 1997, AIDS, V11, P1671, DOI 10.1097/00002030-199714000-00003; Opi S, 2002, J BIOL CHEM, V277, P35915, DOI 10.1074/jbc.M204393200; Opi S, 2004, VACCINE, V22, P3105, DOI 10.1016/j.vaccine.2004.01.057; Pacyniak E, 2005, AIDS RES HUM RETROV, V21, P379, DOI 10.1089/aid.2005.21.379; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Peacock JW, 1999, J IMMUNOL, V162, P215; PELCHENMATTHEWS A, 1989, EMBO J, V8, P3641, DOI 10.1002/j.1460-2075.1989.tb08538.x; Peloponese JM, 1999, J BIOL CHEM, V274, P11473, DOI 10.1074/jbc.274.17.11473; Perez-Patrigeon S, 2009, AIDS, V23, P1197, DOI 10.1097/QAD.0b013e32832c4b0a; Philpott SM, 2003, CURR HIV RES, V1, P217, DOI 10.2174/1570162033485357; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Ranjbar S, 2006, J IMMUNOL, V176, P4182, DOI 10.4049/jimmunol.176.7.4182; Regulier EG, 2004, INT REV IMMUNOL, V23, P25, DOI 10.1080/08830180490265538; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Roof P, 2002, VIROLOGY, V296, P77, DOI 10.1006/viro.2001.1397; Secchiero P, 1999, J IMMUNOL, V162, P2427; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Stanners J, 1995, J BIOL CHEM, V270, P30635, DOI 10.1074/jbc.270.51.30635; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; WAINHOBSON S, 1991, SCIENCE, V252, P961, DOI 10.1126/science.2035026; Walker PR, 2007, AIDS RES HUM RETROV, V23, P204, DOI 10.1089/aid.2006.0080; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466	71	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1681	1691		10.1074/jbc.M109.049957	http://dx.doi.org/10.1074/jbc.M109.049957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19917610	Green Published, hybrid			2022-12-27	WOS:000273429100014
J	Friedrich, N; Santos, JM; Liu, Y; Palma, AS; Leon, E; Saouros, S; Kiso, M; Blackman, MJ; Matthews, S; Feizi, T; Soldati-Favre, D				Friedrich, Nikolas; Santos, Joana M.; Liu, Yan; Palma, Angelina S.; Leon, Ester; Saouros, Savvas; Kiso, Makoto; Blackman, Michael J.; Matthews, Stephen; Feizi, Ten; Soldati-Favre, Dominique			Members of a Novel Protein Family Containing Microneme Adhesive Repeat Domains Act as Sialic Acid-binding Lectins during Host Cell Invasion by Apicomplexan Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; IDENTIFICATION; RECOGNITION; MEMBRANE; INSIGHTS; RECEPTOR; LOCALIZATION; MICROARRAYS; DEFICIENT; INFECTION	Numerous intracellular pathogens exploit cell surface glyco-conjugates for host cell recognition and entry. Unlike bacteria and viruses, Toxoplasma gondii and other parasites of the phylum Apicomplexa actively invade host cells, and this process critically depends on adhesins (microneme proteins) released onto the parasite surface from intracellular organelles called micronemes (MIC). The microneme adhesive repeat (MAR) domain of T. gondii MIC1 (TgMIC1) recognizes sialic acid (Sia), a key determinant on the host cell surface for invasion by this pathogen. By complementation and invasion assays, we demonstrate that TgMIC1 is one important player in Sia-dependent invasion and that another novel Sia-binding lectin, designated TgMIC13, is also involved. Using BLAST searches, we identify a family of MAR-containing proteins in enteroparasitic coccidians, a subclass of apicomplexans, including T. gondii, suggesting that all these parasites exploit sialylated glycoconjugates on host cells as determinants for enteric invasion. Furthermore, this protein family might provide a basis for the broad host cell range observed for coccidians that form tissue cysts during chronic infection. Carbohydrate microarray analyses, corroborated by structural considerations, show that TgMIC13, TgMIC1, and its homologue Neospora caninum MIC1 (NcMIC1) share a preference for alpha 2-3-over alpha 2-6-linked sialyl-N-acetyllactosamine sequences. However, the three lectins also display differences in binding preferences. Intense binding of TgMIC13 to alpha 2-9-linked disialyl sequence reported on embryonal cells and relatively strong binding to 4-O-acetylated-Sia found on gut epithelium and binding of NcMIC1 to 6' sulfo-sialyl Lewis(x) might have implications for tissue tropism.	[Liu, Yan; Palma, Angelina S.; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Div Med, Glycosci Lab, Harrow HA1 3UJ, Middx, England; [Friedrich, Nikolas; Santos, Joana M.; Soldati-Favre, Dominique] Univ Geneva, Ctr Med Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland; [Leon, Ester; Saouros, Savvas; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 50111, Japan; [Blackman, Michael J.] Natl Inst Med Res, Div Parasitol, MRC, London NW7 1AA, England	Imperial College London; University of Geneva; Imperial College London; Gifu University; MRC National Institute for Medical Research	Feizi, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, Glycosci Lab, Northwick Pk Campus, Harrow HA1 3UJ, Middx, England.	t.feizi@imperial.ac.uk; dominique.soldati-favre@unige.ch	Palma, Angelina S/D-2052-2013; Santos, Joana M/W-4149-2018; Liu, Yan/D-9117-2013	Palma, Angelina S/0000-0001-5797-6555; Matthews, Steve/0000-0003-0676-0927; Feizi, Ten/0000-0001-6495-0329; Friedrich, Nikolas/0000-0003-0694-657X; Liu, Yan/0000-0002-2566-6867	Swiss National Foundation; UK Medical Research Council; UK Research Council Basic Technology and Translational [GR/S79268, EP/G037604/1]; European [LSHP-CT-2004-503578]; Priority 1 "Life Sciences, Genomics, and Biotechnology for Health"; Biotechnology and Biological Sciences Research Council [BB/E02520X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish; Medical Research Council [G0600512, MC_U117532063, G0800038] Funding Source: researchfish; BBSRC [BB/E02520X/1] Funding Source: UKRI; EPSRC [EP/G037604/1] Funding Source: UKRI; MRC [G0600512, MC_U117532063, G0800038] Funding Source: UKRI	Swiss National Foundation(Swiss National Science Foundation (SNSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Research Council Basic Technology and Translational; European(European Science Foundation (ESF)); Priority 1 "Life Sciences, Genomics, and Biotechnology for Health"; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Swiss National Foundation (to D. S.), the UK Medical Research Council, and UK Research Council Basic Technology Grant GR/S79268 and Translational Grant EP/G037604/1 (to T. F.). This work is part of the activities of the BioMalPar European Network of Excellence supported by a European Grant LSHP-CT-2004-503578 from the Priority 1 "Life Sciences, Genomics, and Biotechnology for Health" in the 6th Framework Programme.	Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Carruthers Vern B., 2008, V47, P33; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; Cerede O, 2002, EMBO J, V21, P2526, DOI 10.1093/emboj/21.11.2526; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Ellison SP, 2001, VET PARASITOL, V95, P251, DOI 10.1016/S0304-4017(00)00391-5; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; FUKUDA MN, 1985, J BIOL CHEM, V260, P6623; Garnett JA, 2009, PROTEIN SCI, V18, P1935, DOI 10.1002/pro.204; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; HASEGAWA A, 1992, CARBOHYD RES, V224, P185, DOI 10.1016/0008-6215(92)84104-Z; Hemphill A, 2006, PARASITOLOGY, V133, P261, DOI 10.1017/S0031182006000485; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Inoue S, 2003, J BIOL CHEM, V278, P8541, DOI 10.1074/jbc.M212799200; Iwersen M, 2003, BIOL CHEM, V384, P1035, DOI 10.1515/BC.2003.116; Keller N, 2002, INFECT IMMUN, V70, P3187, DOI 10.1128/IAI.70.6.3187-3198.2002; Labbe M, 2005, MOL BIOCHEM PARASIT, V140, P43, DOI 10.1016/j.molbiopara.2004.12.002; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; MATROSOVICH MN, 1992, VIROLOGY, V188, P854, DOI 10.1016/0042-6822(92)90541-V; Meissner M, 2002, J CELL SCI, V115, P563; MESSER M, 1974, BIOCHEM J, V139, P415, DOI 10.1042/bj1390415; Moire N, 2009, EXP PARASITOL, V123, P111, DOI 10.1016/j.exppara.2009.06.003; Monteiro VG, 1998, FEMS MICROBIOL LETT, V164, P323, DOI 10.1111/j.1574-6968.1998.tb13105.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Ortega-Barria E, 1999, J BIOL CHEM, V274, P1267, DOI 10.1074/jbc.274.3.1267; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Rinninger A, 2006, GLYCOCONJUGATE J, V23, P73, DOI 10.1007/s10719-006-5439-7; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Sawmynaden K, 2008, EMBO REP, V9, P1149, DOI 10.1038/embor.2008.179; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Takabatake N, 2007, VET PARASITOL, V148, P93, DOI 10.1016/j.vetpar.2007.06.011; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116	48	78	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2064	2076		10.1074/jbc.M109.060988	http://dx.doi.org/10.1074/jbc.M109.060988			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19901027	Green Published, hybrid			2022-12-27	WOS:000273429100051
J	Kleijn, RJ; Buescher, JM; Le Chat, L; Jules, M; Aymerich, S; Sauer, U				Kleijn, Roelco J.; Buescher, Joerg M.; Le Chat, Ludovic; Jules, Matthieu; Aymerich, Stephane; Sauer, Uwe			Metabolic Fluxes during Strong Carbon Catabolite Repression by Malate in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIDIRECTIONAL REACTION STEPS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; GENE ENCODES; QUANTITATIVE METABOLOMICS; GLUCOSE-METABOLISM; MALIC ENZYME; GC-MS; MUTANTS; NETWORKS	Commonly glucose is considered to be the only preferred substrate in Bacillus subtilis whose presence represses utilization of other alternative substrates. Because recent data indicate that malate might be an exception, we quantify here the carbon source utilization hierarchy. Based on physiology and transcriptional data during co-utilization experiments with eight carbon substrates, we demonstrate that malate is a second preferred carbon source for B. subtilis, which is rapidly co-utilized with glucose and strongly represses the uptake of alternative substrates. From the different hierarchy and degree of catabolite repression exerted by glucose and malate, we conclude that both substrates might act through different molecular mechanisms. To obtain a quantitative and functional network view of how malate is (co)metabolized, we developed a novel approach to metabolic flux analysis that avoids error-prone, intuitive, and ad hoc decisions on C-13 rearrangements. In particular, we developed a rigorous approach for deriving reaction reversibilities by combining in vivo intracellular metabolite concentrations with a thermodynamic feasibility analysis. The thus-obtained analytical model of metabolism was then used for network-wide isotopologue balancing to estimate the intracellular fluxes. These C-13-flux data revealed an extraordinarily high malate influx that is primarily catabolized via the gluconeogenic reactions and toward overflow metabolism. Furthermore, a considerable NADPH-producing malic enzyme flux is required to supply the biosynthetically required NADPH in the presence of malate. Co-utilization of glucose and malate resulted in a synergistic decrease of the respiratory tricarboxylic acid cycle flux.	[Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Le Chat, Ludovic; Jules, Matthieu; Aymerich, Stephane] INRA, UMR1238, CNRS, UMR2585, F-78850 Thiverval Grignon, France; [Le Chat, Ludovic; Jules, Matthieu; Aymerich, Stephane] AgroParisTech, Microbiol & Genet Mol, F-78850 Thiverval Grignon, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Sauer, U (corresponding author), ETH, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	sauer@imsb.biol.ethz.ch	Sauer, Uwe/Y-3556-2019; Jules, Matthieu/GVU-5315-2022	Jules, Matthieu/0000-0003-0817-8949; Buescher, Joerg/0000-0002-6547-0076	European Union [LSHG-CT-2006-037469]	European Union(European Commission)	This work was supported by European Union BaSysBio Program Grant LSHG-CT-2006-037469.	Alberty R. A., 2003, THERMODYNAMICS BIOCH; Asai K, 2000, MICROBIOL-UK, V146, P263, DOI 10.1099/00221287-146-2-263; AYMERICH S, 2007, GLOBAL REGULATORY NE, P39; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Collier DN, 1996, RES MICROBIOL, V147, P551, DOI 10.1016/0923-2508(96)84011-3; Commichau FM, 2007, J MOL MICROB BIOTECH, V12, P106, DOI 10.1159/000096465; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dauner M, 2001, BIOTECHNOL BIOENG, V76, P144, DOI 10.1002/bit.1154; Doan T, 2003, MICROBIOL-SGM, V149, P2331, DOI 10.1099/mic.0.26256-0; Ewald JC, 2009, ANAL CHEM, V81, P3623, DOI 10.1021/ac900002u; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; HENKIN TM, 1991, MOL MICROBIOL, V5, P575, DOI 10.1111/j.1365-2958.1991.tb00728.x; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; Jules M, 2009, J BACTERIOL, V191, P3168, DOI 10.1128/JB.01783-08; Kleijn RJ, 2005, FEBS J, V272, P4970, DOI 10.1111/j.1742-4658.2005.04907.x; Kleijn RJ, 2007, FEMS YEAST RES, V7, P216, DOI 10.1111/j.1567-1364.2006.00180.x; KRULWICH TA, 1969, J BACTERIOL, V97, P526, DOI 10.1128/JB.97.2.526-534.1969; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Lerondel G, 2006, J BACTERIOL, V188, P4727, DOI 10.1128/JB.00167-06; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Mollney M, 1999, BIOTECHNOL BIOENG, V66, P86, DOI 10.1002/(SICI)1097-0290(1999)66:2<86::AID-BIT2>3.0.CO;2-A; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Sauer U, 1999, J BACTERIOL, V181, P6679, DOI 10.1128/JB.181.21.6679-6688.1999; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schilling O, 2007, APPL ENVIRON MICROB, V73, P499, DOI 10.1128/AEM.02084-06; Schmidt K, 1999, J BIOTECHNOL, V71, P175, DOI 10.1016/S0168-1656(99)00021-8; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; SIEGEL LS, 1977, J BACTERIOL, V129, P87, DOI 10.1128/JB.129.1.87-96.1977; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Tannler S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-19; UCKER DS, 1978, J BACTERIOL, V136, P1197, DOI 10.1128/JB.136.3.1197-1200.1978; van Winden WA, 2005, FEMS YEAST RES, V5, P559, DOI 10.1016/j.femsyr.2004.10.007; Voets T, 1999, P NATL ACAD SCI USA, V96, P5298, DOI 10.1073/pnas.96.9.5298; Warner JB, 2000, J BACTERIOL, V182, P6099, DOI 10.1128/JB.182.21.6099-6105.2000; Warner JB, 2003, FEMS MICROBIOL LETT, V220, P277, DOI 10.1016/S0378-1097(03)00126-5; Wei Y, 2000, J BIOL CHEM, V275, P30287, DOI 10.1074/jbc.M001112200; Weisskopf L, 2008, SOIL BIOL BIOCHEM, V40, P1772, DOI 10.1016/j.soilbio.2008.02.018; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wiechert W, 2007, BIOPHYS J, V93, P2255, DOI 10.1529/biophysj.106.099895; WOLFF JA, 1991, J BACTERIOL, V173, P4700, DOI 10.1128/jb.173.15.4700-4706.1991; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zamboni N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-199; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	58	80	83	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1587	1596		10.1074/jbc.M109.061747	http://dx.doi.org/10.1074/jbc.M109.061747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19917605	Green Published, hybrid			2022-12-27	WOS:000273429100004
J	Yamakawa, H; Yagishita, S; Futai, E; Ishiura, S				Yamakawa, Hidekuni; Yagishita, Sosuke; Futai, Eugene; Ishiura, Shoichi			beta-Secretase Inhibitor Potency Is Decreased by Aberrant beta-Cleavage Location of the "Swedish Mutant" Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MEMORY DEFICITS; SYNAPTIC PLASTICITY; BACE1; APP; SORLA/LR11; REDUCTION; PHOSPHORYLATION; TRAFFICKING; METABOLISM	The amyloid-beta (A beta) peptide, widely known as the causative molecule of Alzheimer disease (AD), is generated by the sequential cleavage of amyloid precursor protein (APP) by the aspartyl proteases BACE1/beta-secretase and presenilin/gamma-secretase. Inhibition of BACE1, therefore, is a promising strategy for preventing the progression of AD. However, beta-secretase inhibitors (BSIs) exhibit unexpectedly low potency in cells expressing "Swedish mutant" APP (APPswe) and in the transgenic mouse Tg2576, an AD model overexpressing APPswe. The Swedish mutation dramatically accelerates beta-cleavage of APP and hence the generation of A beta; this acceleration has been assumed to underlie the poor inhibitory activity of BSI against APPswe processing. Here, we studied the mechanism by which the Swedish mutation causes this BSI potency decrease. Surprisingly, decreased BSI potency was not observed in an in vitro assay using purified BACE1 and substrates, indicating that the accelerated beta-cleavage resulting from the Swedish mutation is not its underlying cause. By focusing on differences between the cell-based and in vitro assays, we have demonstrated here that the potency decrease is caused by the aberrant subcellular localization of APPswe processing and not by accelerated beta-cleavage or the accumulation of the C-terminal fragment of beta-cleaved APP. Because most patients with sporadic AD express wild type APP, our findings suggest that the wild type mouse is superior to the Tg2576 mouse as a model for determining the effective dose of BSI for AD patients. This work provides novel insights into the potency decrease of BSI and valuable suggestions for its development as a disease-modifying agent.	[Yamakawa, Hidekuni; Yagishita, Sosuke; Futai, Eugene; Ishiura, Shoichi] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Ishiura, S (corresponding author), 3-8-1 Komaba,Meguro Ku, Tokyo 1538902, Japan.	cishiura@mail.ecc.u-tokyo.ac.jp		Futai, Eugene/0000-0002-0879-6117				Asai M, 2006, J NEUROCHEM, V96, P533, DOI 10.1111/j.1471-4159.2005.03576.x; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cai ZY, 2009, NEUROCHEM RES, V34, P1226, DOI 10.1007/s11064-008-9899-y; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Harada H, 2006, NEUROSCI RES, V54, P24, DOI 10.1016/j.neures.2005.10.001; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Ma QL, 2009, ARCH NEUROL-CHICAGO, V66, P448, DOI 10.1001/archneurol.2009.22; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; MALAMAS M, 2008, INT C ALZH DIS CHIC, V4, P515; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Meredith JE, 2008, J PHARMACOL EXP THER, V326, P502, DOI 10.1124/jpet.108.138974; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Ono Y, 1997, J BIOCHEM-TOKYO, V121, P585; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrak BL, 2005, ANAL BIOCHEM, V342, P144, DOI 10.1016/j.ab.2005.04.019; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; RIDDELL D, 2009, INT C ALZH DIS VIENN; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHITAKA Y, 2008, INT C ALZH DIS CHIC; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Stachel SJ, 2009, BIOORG MED CHEM LETT, V19, P2977, DOI 10.1016/j.bmcl.2009.04.033; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Takahashi K, 2008, BIOCHEM BIOPH RES CO, V377, P544, DOI 10.1016/j.bbrc.2008.10.013; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200	49	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1634	1642		10.1074/jbc.M109.066753	http://dx.doi.org/10.1074/jbc.M109.066753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19926793	Green Published, hybrid			2022-12-27	WOS:000273429100009
J	Ismail, TM; Zhang, S; Fernig, DG; Gross, S; Martin-Fernandez, ML; See, V; Tozawa, K; Tynan, CJ; Wang, GZ; Wilkinson, MC; Rudland, PS; Barraclough, R				Ismail, Thamir M.; Zhang, Shu; Fernig, David G.; Gross, Stephane; Martin-Fernandez, Marisa L.; See, Violaine; Tozawa, Kaeko; Tynan, Christopher J.; Wang, Guozheng; Wilkinson, Mark C.; Rudland, Philip S.; Barraclough, Roger			Self-association of Calcium-binding Protein S100A4 and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; NONMUSCLE MYOSIN; PROGNOSTIC-SIGNIFICANCE; BREAST-CANCER; E-CADHERIN; IN-VITRO; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; BLADDER-CANCER; HEAVY-CHAIN	Elevated levels of the calcium-binding protein S100A4 promote metastasis and in carcinoma cells are associated with reduced survival of cancer patients. S100A4 interacts with target proteins that affect a number of activities associated with metastatic cells. However, it is not known how many of these interactions are required for S100A4-promoted metastasis, thus hampering the design of specific inhibitors of S100A4-induced metastasis. Intracellular S100A4 exists as a homodimer through previously identified, well conserved, predominantly hydrophobic key contacts between the sub-units. Here it is shown that mutating just one key residue, phenylalanine 72, to alanine is sufficient to reduce the metastasis-promoting activity of S100A4 to 50% that of the wild type protein, and just 2 or 3 specific mutations reduces the metastasis-promoting activity of S100A4 to less than 20% that of the wild type protein. These mutations inhibit the self-association of S100A4 in vivo and reduce markedly the affinity of S100A4 for at least two of its protein targets, a recombinant fragment of non-muscle myosin heavy chain isoform A, and p53. Inhibition of the self-association of S100 proteins might be a novel means of inhibiting their metastasis-promoting activities.	[Ismail, Thamir M.; Zhang, Shu; Fernig, David G.; See, Violaine; Tozawa, Kaeko; Wang, Guozheng; Wilkinson, Mark C.; Rudland, Philip S.; Barraclough, Roger] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Gross, Stephane] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England; [Martin-Fernandez, Marisa L.; Tynan, Christopher J.] Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	University of Liverpool; Liverpool John Moores University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Barraclough, R (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	brb@liverpool.ac.uk	Barraclough, Roger/AAH-6516-2020; Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293; Barraclough, Roger/0000-0002-7203-1194; Tynan, Christopher/0000-0002-4553-7018; martin-fernandez, marisa/0000-0001-5496-6300; Wilkinson, Mark/0000-0003-3109-6888; gross, stephane/0000-0002-0867-8866	North West Cancer Research Fund [CR655]; Cancer and Polio Research; David Phillips Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom [BBC5204711]; Biotechnology and Biological Sciences Research Council [BB/C51464X/1] Funding Source: researchfish	North West Cancer Research Fund; Cancer and Polio Research; David Phillips Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by North West Cancer Research Fund CR655 and the Cancer and Polio Research Fund.; Recipient of a David Phillips Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom Fellowship BBC5204711.	Agerbaek M, 2006, EUR UROL, V50, P777, DOI 10.1016/j.eururo.2006.02.027; Andersen K, 2004, MODERN PATHOL, V17, P990, DOI 10.1038/modpathol.3800151; BAUDIER J, 1986, J BIOL CHEM, V261, P8192; Chen HL, 2001, BIOCHEM BIOPH RES CO, V286, P1212, DOI 10.1006/bbrc.2001.5517; DAVIES BR, 1993, ONCOGENE, V8, P999; Davies BR, 2002, J PATHOL, V196, P292, DOI 10.1002/path.1051; DUNNINGTON DJ, 1983, J NATL CANCER I, V71, P1227; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; FORD HL, 1995, ONCOGENE, V11, P2067; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; FORD HL, 1995, ONCOGENE, V10, P1597; GIBBS FEM, 1994, J BIOL CHEM, V269, P18992; Gongoll S, 2002, GASTROENTEROLOGY, V123, P1478, DOI 10.1053/gast.2002.36606; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Hemandas AK, 2006, J SURG ONCOL, V93, P498, DOI 10.1002/jso.20460; Ismail TM, 2008, CARCINOGENESIS, V29, P2259, DOI 10.1093/carcin/bgn217; Jenkinson SR, 2004, BRIT J CANCER, V90, P253, DOI 10.1038/sj.bjc.6601483; Kim EJ, 2003, J BIOL CHEM, V278, P30063, DOI 10.1074/jbc.M304909200; Kimura K, 2000, INT J ONCOL, V16, P1125; Kriajevska M, 1998, J BIOL CHEM, V273, P9852, DOI 10.1074/jbc.273.16.9852; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Lee WY, 2004, ONCOLOGY-BASEL, V66, P429, DOI 10.1159/000079496; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Lloyd BH, 1998, ONCOGENE, V17, P465, DOI 10.1038/sj.onc.1201948; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Matsubara D, 2005, CANCER SCI, V96, P844, DOI 10.1111/j.1349-7006.2005.00121.x; Moriyama-Kita M, 2004, ORAL ONCOL, V40, P496, DOI 10.1016/j.oraloncology.2003.10.003; Nakamura T, 2002, INT J ONCOL, V20, P937; Ninomiya I, 2001, INT J ONCOL, V18, P715; PEDROCCHI M, 1994, BIOCHEMISTRY-US, V33, P6732, DOI 10.1021/bi00187a045; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; Rudland PS, 2000, CANCER RES, V60, P1595; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; TAKENAGA K, 1994, J CELL BIOL, V124, P757, DOI 10.1083/jcb.124.5.757; Tarabykina S, 2001, J BIOL CHEM, V276, P24212, DOI 10.1074/jbc.M009477200; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Yonemura Y, 2000, CLIN CANCER RES, V6, P4234; Zhang S, 2005, ONCOGENE, V24, P4401, DOI 10.1038/sj.onc.1208663; Zhang S, 2005, EUR BIOPHYS J BIOPHY, V34, P19, DOI 10.1007/s00249-004-0428-x	41	30	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					914	922		10.1074/jbc.M109.010892	http://dx.doi.org/10.1074/jbc.M109.010892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19917604	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000273258200011
J	Rao, SNR; Sharma, J; Maity, R; Jana, NR				Rao, Sudheendra N. R.; Sharma, Jaiprakash; Maity, Ranjan; Jana, Nihar Ranjan			Co-chaperone CHIP Stabilizes Aggregate-prone Malin, a Ubiquitin Ligase Mutated in Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; PROTEIN AGGREGATION; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; GLYCOGEN-SYNTHESIS; PROTEASOME SYSTEM; UNFOLDED PROTEIN; E3 LIGASE; MUTATIONS; AGGRESOMES	Lafora disease (LD) is an autosomal recessive neurodegenerative disorder caused by mutation in either the dual specificity phosphatase laforin or ubiquitin ligase malin. A pathological hallmark of LD is the accumulation of cytoplasmic polyglucosan inclusions commonly known as Lafora bodies in both neuronal and non-neuronal tissues. How mutations in these two proteins cause disease pathogenesis is not well understood. Malin interacts with laforin and recruits to aggresomes upon proteasome inhibition and was shown to degrade misfolded proteins. Here we report that malin is spontaneously misfolded and tends to be aggregated, degraded by proteasomes, and forms not only aggresomes but also other cytoplasmic and nuclear aggregates in all transfected cells upon proteasomal inhibition. Malin also interacts with Hsp70. Several disease-causing mutants of malin are comparatively more unstable than wild type and form aggregates in most transfected cells even without the inhibition of proteasome function. These cytoplasmic and nuclear aggregates are immunoreactive to ubiquitin and 20 S proteasome. Interestingly, progressive proteasomal dysfunction and cell death is also most frequently observed in the mutant malin-overexpressed cells compared with the wild-type counterpart. Finally, we demonstrate that the co-chaperone carboxyl terminus of the Hsc70-interacting protein (CHIP) stabilizes malin by modulating the activity of Hsp70. All together, our results suggest that malin is unstable, and the aggregate-prone protein and co-chaperone CHIP can modulate its stability.	[Rao, Sudheendra N. R.; Sharma, Jaiprakash; Maity, Ranjan; Jana, Nihar Ranjan] Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in	Rao, Sudheendra/K-3017-2014	Rao, Sudheendra/0000-0001-7576-1718; Jana, Nihar/0000-0002-6549-4211	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India.	ACHARYA JN, 1993, EPILEPSIA, V34, P476, DOI 10.1111/j.1528-1157.1993.tb02588.x; Ardley HC, 2003, MOL BIOL CELL, V14, P4541, DOI 10.1091/mbc.E03-02-0078; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CARPENTER S, 1981, NEUROLOGY, V31, P1564, DOI 10.1212/WNL.31.12.1564; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Ianzano Leonarda, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9376; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Liu Y, 2009, HUM MOL GENET, V18, P2622, DOI 10.1093/hmg/ddp196; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mittal S, 2007, HUM MOL GENET, V16, P753, DOI 10.1093/hmg/ddm006; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; NERON B, 2008, BIOOP SOURC C BOSC T; NISHIMURA RN, 1980, ANN NEUROL, V8, P409, DOI 10.1002/ana.410080412; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Singh S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039479; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Wilkins MR, 1999, METH MOL B, V112, P531; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200	47	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1404	1413		10.1074/jbc.M109.006312	http://dx.doi.org/10.1074/jbc.M109.006312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19892702	hybrid, Green Published			2022-12-27	WOS:000273258200060
J	Dzamko, N; van Denderen, BJW; Hevener, AL; Jorgensen, SB; Honeyman, J; Galic, S; Chen, ZP; Watt, MJ; Campbell, DJ; Steinberg, GR; Kemp, BE				Dzamko, Nicolas; van Denderen, Bryce J. W.; Hevener, Andrea L.; Jorgensen, Sebastian Beck; Honeyman, Jane; Galic, Sandra; Chen, Zhi-Ping; Watt, Matthew J.; Campbell, Duncan J.; Steinberg, Gregory R.; Kemp, Bruce E.			AMPK beta 1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; INTERLEUKIN-6 RELEASE; CATALYTIC SUBUNIT; FOOD-INTAKE; LIVER; METABOLISM; ADIPONECTIN; DISEASE; YEAST	The AMP-activated protein kinase (AMPK) is an alpha beta gamma heterotrimer that regulates appetite and fuel metabolism. We have generated AMPK beta 1(-/-) mice on a C57Bl/6 background that are viable, fertile, survived greater than 2 years, and display no visible brain developmental defects. These mice have a 90% reduction in hepatic AMPK activity due to loss of the catalytic alpha subunits, with modest reductions of activity detected in the hypothalamus and white adipose tissue and no change in skeletal muscle or heart. On a low fat or an obesity-inducing high fat diet, beta 1(-/-) mice had reduced food intake, reduced adiposity, and reduced total body mass. Metabolic rate, physical activity, adipose tissue lipolysis, and lipogenesis were similar to wild type littermates. The reduced appetite and body mass of beta 1(-/-) mice were associated with protection from high fat diet-induced hyperinsulinemia, hepatic steatosis, and insulin resistance. We demonstrate that the loss of beta 1 reduces food intake and protects against the deleterious effects of an obesity-inducing diet.	[Dzamko, Nicolas; van Denderen, Bryce J. W.; Jorgensen, Sebastian Beck; Honeyman, Jane; Galic, Sandra; Chen, Zhi-Ping; Campbell, Duncan J.; Steinberg, Gregory R.; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Dzamko, Nicolas; van Denderen, Bryce J. W.; Jorgensen, Sebastian Beck; Honeyman, Jane; Galic, Sandra; Chen, Zhi-Ping; Campbell, Duncan J.; Steinberg, Gregory R.; Kemp, Bruce E.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Hevener, Andrea L.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Jorgensen, Sebastian Beck] Univ Copenhagen, Sect Human Physiol, Copenhagen Muscle Res Ctr, Dept Exercise & Sport Sci, DK-2100 Copenhagen, Denmark; [Watt, Matthew J.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada	St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; University of California System; University of California Los Angeles; University of Copenhagen; Monash University; McMaster University	Kemp, BE (corresponding author), Univ Melbourne, St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	bkemp@svi.edu.au	Watt, Matthew J/B-2089-2014; van Denderen, Bryce/AAW-5454-2021; Kemp, Bruce E/L-2633-2014; Galic, Sandra/C-6098-2014; Kemp, Bruce/G-9602-2019; Dzamko, Nicolas/AAD-6922-2019	Kemp, Bruce E/0000-0001-6735-5082; Galic, Sandra/0000-0002-7611-5619; Kemp, Bruce/0000-0001-6735-5082; Dzamko, Nicolas/0000-0002-9121-0294; Steinberg, Gregory/0000-0001-5425-8275	Australian Research Council; National Health and Medical Research Council; Diabetes Australia Research Trust; National Heart Foundation of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; National Heart Foundation of Australia(National Heart Foundation of Australia)	This study was supported by grants from the Australian Research Council (to B. E. K.), the National Health and Medical Research Council (to M. J. W., D. J. C., B. E. K., and G. R. S.), the Diabetes Australia Research Trust (to G. R. S.), and the National Heart Foundation of Australia (to B. E. K. and D. J. C.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; CARLING D, 1994, J BIOL CHEM, V269, P11442; Chen MB, 2005, J CLIN ENDOCR METAB, V90, P3665, DOI 10.1210/jc.2004-1980; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; Folmes CDL, 2007, CARDIOVASC RES, V73, P278, DOI 10.1016/j.cardiores.2006.10.008; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Glund S, 2009, ENDOCRINOLOGY, V150, P600, DOI 10.1210/en.2008-1204; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Iseli TJ, 2008, J BIOL CHEM, V283, P4799, DOI 10.1074/jbc.M708298200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; MacDonald C, 2003, J APPL PHYSIOL, V95, P2273, DOI 10.1152/japplphysiol.00242.2003; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Sell H, 2006, BIOCHEM BIOPH RES CO, V343, P700, DOI 10.1016/j.bbrc.2006.03.010; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Steinberg GR, 2006, ENDOCRINOLOGY, V147, P3906, DOI 10.1210/en.2005-1587; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383	43	129	134	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					115	122		10.1074/jbc.M109.056762	http://dx.doi.org/10.1074/jbc.M109.056762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19892703	Green Published, hybrid			2022-12-27	WOS:000273070100012
J	Kohler, S; Cirillo, LA				Kohler, Sarah; Cirillo, Lisa Ann			Stable Chromatin Binding Prevents FoxA Acetylation, Preserving FoxA Chromatin Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; IN-VITRO; NUCLEOSOME-BINDING; CRYSTAL-STRUCTURE; GLOBULAR DOMAIN; HISTONE H5; HEPATOCYTE; PROTEIN; DIFFERENTIATION	FoxA1-3 (formerly HNF3 alpha, -beta, and -gamma), members of the FoxA subfamily of forkhead transcription factors, function as initial chromatin-binding and chromatin-remodeling factors in a variety of tissues, including liver and pancreas. Despite essential roles in development and metabolism, regulation of FoxA factors is not well understood. This study examines a potential role for acetylation in the regulation of FoxA chromatin binding and remodeling. Using in silico analysis, we have identified 11 putative p300 acetylation sites within FoxA1, five of which are located within wings 1 and 2 of its winged-helix DNA-binding domain. These polypeptide structures stabilize FoxA DNA and chromatin binding, and we have demonstrated that acetylation attenuates FoxA binding to DNA and diminishes its ability to remodel chromatin. FoxA acetylation is inhibited by chromatin binding. We propose a model whereby stable chromatin binding protects the FoxA DNA-binding domain from acetylation to preserve chromatin binding and remodeling by FoxA factors in the absence of extracellular cues.	[Kohler, Sarah; Cirillo, Lisa Ann] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Cirillo, LA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	lcirillo@mcw.edu			National Institutes of Health [R01DK073641, F32DK079649]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK079649, R01DK073641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK073641 (to L. A. C.) and F32DK079649 (to S. K.).	Bossard P, 1998, DEVELOPMENT, V125, P4909; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; CASCIO S, 1991, DEVELOPMENT, V113, P217; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Dormeyer W, 2003, ANAL BIOANAL CHEM, V376, P994, DOI 10.1007/s00216-003-2058-z; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hatta M, 2009, BIOCHEM BIOPH RES CO, V379, P1005, DOI 10.1016/j.bbrc.2009.01.014; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Hernandez-Hernandez A, 2006, EMBO J, V25, P3264, DOI 10.1038/sj.emboj.7601228; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Kaestner KH, 2000, GENE DEV, V14, P142; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; Kalb JM, 1998, DEVELOPMENT, V125, P2171; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; LIU JK, 1988, GENE DEV, V2, P528, DOI 10.1101/gad.2.5.528; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; McPherson CE, 1996, NUCLEIC ACIDS RES, V24, P397, DOI 10.1093/nar/24.3.397; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Rausa FM, 2003, MOL CELL BIOL, V23, P437, DOI 10.1128/MCB.23.2.437-449.2003; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Wang JCW, 2000, J BIOL CHEM, V275, P18418, DOI 10.1074/jbc.M910211199; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	52	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					464	472		10.1074/jbc.M109.063149	http://dx.doi.org/10.1074/jbc.M109.063149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19897491	Green Published, hybrid			2022-12-27	WOS:000273070100048
J	Stadtmueller, BM; Ferrell, K; Whitby, FG; Heroux, A; Robinson, H; Myszka, DG; Hill, CP				Stadtmueller, Beth M.; Ferrell, Katherine; Whitby, Frank G.; Heroux, Annie; Robinson, Howard; Myszka, David G.; Hill, Christopher P.			Structural Models for Interactions between the 20S Proteasome and Its PAN/19S Activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PARTICLE; S-PROTEASOME; ATPASES; ATP; PURIFICATION; COMPLEX; YEAST; GATE; PAN; IDENTIFICATION	Proteasome activity is regulated by sequestration of its proteolytic centers in a barrel-shaped structure that limits substrate access. Substrates enter the proteasome by means of activator complexes that bind to the end rings of proteasome alpha subunits and induce opening of an axial entrance/exit pore. The PA26 activator binds in a pocket on the proteasome surface using main chain contacts of its C-terminal residues and uses an internal activation loop to trigger gate opening by repositioning the proteasome Pro-17 reverse turn. Subunits of the unrelated PAN/19S activators bind with their C termini in the same pockets but can induce proteasome gate opening entirely from interactions of their C-terminal peptides, which are reported to cause gate opening by inducing a rocking motion of proteasome alpha subunits rather than by directly contacting the Pro-17 turn. Here we report crystal structures and binding studies of proteasome complexes with PA26 constructs that display modified C-terminal residues, including those corresponding to PAN. These findings suggest that PA26 and PAN/19S C-terminal residues bind superimposably and that both classes of activator induce gate opening by using direct contacts to residues of the proteasome Pro-17 reverse turn. In the case of the PAN and 19S activators, a penultimate tyrosine/phenylalanine residue contacts the proteasome Gly-19 carbonyl oxygen to stabilize the open conformation.	[Stadtmueller, Beth M.; Ferrell, Katherine; Whitby, Frank G.; Myszka, David G.; Hill, Christopher P.] Univ Utah, Dept Biochem, Sch Med, Salt Lake City, UT 84112 USA; [Heroux, Annie; Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Hill, CP (corresponding author), Univ Utah, Dept Biochem, Sch Med, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu		Stadtmueller, Beth/0000-0003-0637-3206	National Institutes of Health [R01 GM59135]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM59135 (to C. P. H.).	Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Groll M, 2003, J MOL BIOL, V327, P75, DOI 10.1016/S0022-2836(03)00080-9; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, J BIOL CHEM, V267, P10515; Medalia N, 2006, J STRUCT BIOL, V156, P84, DOI 10.1016/j.jsb.2006.03.015; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao Y, 1999, J BIOL CHEM, V274, P33921, DOI 10.1074/jbc.274.48.33921; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008; Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187	36	41	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					13	17		10.1074/jbc.C109.070425	http://dx.doi.org/10.1074/jbc.C109.070425			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19889631	Green Published, hybrid			2022-12-27	WOS:000273070100003
J	Capyk, JK; Kalscheuer, R; Stewart, GR; Liu, J; Kwon, H; Zhao, R; Okamoto, S; Jacobs, WR; Eltis, LD; Mohn, WW				Capyk, Jenna K.; Kalscheuer, Rainer; Stewart, Gordon R.; Liu, Jie; Kwon, Hyukin; Zhao, Rafael; Okamoto, Sachi; Jacobs, William R., Jr.; Eltis, Lindsay D.; Mohn, William W.			Mycobacterial Cytochrome P450 125 (Cyp125) Catalyzes the Terminal Hydroxylation of C27 Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-KETOSTEROID 9-ALPHA-HYDROXYLASE; BETA-CYCLODEXTRIN; TUBERCULOSIS; CHOLESTEROL; MACROPHAGES; SURVIVAL; 27-HYDROXYLASE; IDENTIFICATION; REQUIREMENTS; ADAPTATION	Cyp125 (Rv3545c), a cytochrome P450, is encoded as part of the cholesterol degradation gene cluster conserved among members of the Mycobacterium tuberculosis complex. This enzyme has been implicated in mycobacterial pathogenesis, and a homologue initiates cholesterol catabolism in the soil actinomycete Rhodococcus jostii RHA1. In Mycobacterium bovis BCG, cyp125 was up-regulated 7.1-fold with growth on cholesterol. A cyp125 deletion mutant of BCG did not grow on cholesterol and accumulated 4-cholesten-3-one when incubated in the presence of cholesterol. Wild-type BCG grew on this metabolite. By contrast, a parallel cyp125 deletion mutation of M. tuberculosis H37Rv did not affect growth on cholesterol. Purified Cyp125 from M. tuberculosis, heterologously produced in R. jostii RHA1, bound cholesterol and 4-cholesten-3-one with apparent dissociation constants of 0.20 +/- 0.02 mu M and 0.27 +/- 0.05 mu M, respectively. When reconstituted with KshB, the cognate reductase of the ketosteroid 9 alpha-hydroxylase, Cyp125 catalyzed the hydroxylation of these steroids. MS and NMR analyses revealed that hydroxylation occurred at carbon 26 of the steroid side chain, allowing unambiguous classification of Cyp125 as a steroid C26-hydroxylase. This study establishes the catalytic function of Cyp125 and, in identifying an important difference in the catabolic potential of M. bovis and M. tuberculosis, suggests that Cyp125 may have an additional function in pathogenesis.	[Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Stewart, Gordon R.; Liu, Jie; Kwon, Hyukin; Okamoto, Sachi; Eltis, Lindsay D.; Mohn, William W.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Kalscheuer, Rainer; Jacobs, William R., Jr.] Yeshiva Univ Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA	University of British Columbia; University of British Columbia; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca; wmohn@interchange.ubc.ca	Kalscheuer, Rainer/A-2852-2015; Kalscheuer, Rainer/AAF-1381-2020; Eltis, Lindsay D/J-8272-2015	Kalscheuer, Rainer/0000-0002-3378-2067; Eltis, Lindsay D/0000-0002-6774-8158; Jacobs, William/0000-0003-3321-3080	Canadian Institute for Health Research; British Columbia Lung Association; Michael Smith Foundation for Health Research (MSFHR)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported in part by grants from the Canadian Institute for Health Research ( to L. D. E.), the British Columbia Lung Association ( to W. W. M.), and the Michael Smith Foundation for Health Research (MSFHR) Emerging Team programs.	Alcalde MA, 2009, J INCL PHENOM MACRO, V63, P309, DOI 10.1007/s10847-008-9524-3; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BETSHOLTZ IH, 1995, J STEROID BIOCHEM, V55, P115, DOI 10.1016/0960-0760(95)00147-R; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; ELTIS LD, 1993, EUR J BIOCHEM, V213, P211, DOI 10.1111/j.1432-1033.1993.tb17750.x; Goncalves ER, 2006, APPL ENVIRON MICROB, V72, P6183, DOI 10.1128/AEM.00947-06; Gunsalus I C, 1978, Methods Enzymol, V52, P166; Hansson M, 2003, BBA-MOL CELL RES, V1593, P283, DOI 10.1016/S0167-4889(02)00398-1; Javitt NB, 2002, J LIPID RES, V43, P665; LACK NA, 2009, J BIOL CHEM IN PRESS; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Munro AW, 2003, BIOCHEM SOC T, V31, P625, DOI 10.1042/BST0310625; NESBITT NM, 2009, INFECT IMMU IN PRESS; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; ROSLONIEC K, 2009, MOL MICROBI IN PRESS; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Souidi M, 1998, CLIN CHIM ACTA, V269, P201, DOI 10.1016/S0009-8981(97)00201-5; Team RC., 2022, LANG ENV STAT COMP; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; *WHO, 2008, 4 WHO, P14; YAM K, 2010, BIOL RHODOC IN PRESS; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	35	122	130	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35534	35542		10.1074/jbc.M109.072132	http://dx.doi.org/10.1074/jbc.M109.072132			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19846551	Green Published, hybrid			2022-12-27	WOS:000272645600030
J	Stoltz, DA; Ozer, EA; Recker, TJ; Estin, M; Yang, X; Shih, DM; Lusis, AJ; Zabner, J				Stoltz, David A.; Ozer, Egon A.; Recker, Thomas J.; Estin, Miriam; Yang, Xia; Shih, Diana M.; Lusis, Aldons J.; Zabner, Joseph			A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING SIGNAL; GENE POLYMORPHISMS; OXIDATIVE STRESS; PON1 STATUS; DISEASE; ASSOCIATION; EXPRESSION; RISK; INACTIVATION; PURIFICATION	Paraoxonases (PONs) are a family of lactonases with promiscuous enzyme activity that has been implicated in multiple diseases. PON2 is intracellularly located, is the most ubiquitously expressed PON, and has the highest lactonase activity of the PON family members. Whereas some single-nucleotide poly-morphisms (SNPs) in PON1 have resulted in altered enzymatic activity in serum, to date the functional consequences of SNPs on PON2 function remain unknown. We hypothesized that a common PON2 SNP would result in impaired lactonase activity. Substitution of cysteine for serine at codon 311 in recombinant PON2 resulted in normal protein production and localization but altered glycosylation and decreased lactonase activity. Moreover, we screened 200 human lung samples for the PON2 Cys(311) variant and found that in vivo this mutation impaired lactonase activity. These data suggest that impaired lactonase activity may play a role in innate immunity, atherosclerosis, and other diseases associated with the PON2 311 SNP.	[Zabner, Joseph] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ozer, Egon A.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Yang, Xia] Rosetta Inpharmat Inc, Seattle, WA 98109 USA; [Shih, Diana M.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of Iowa; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zabner, J (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 440 EMRB, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu	Ozer, Egon/HHN-7954-2022; Ozer, Egon/W-9662-2019	Ozer, Egon/0000-0002-7131-3691; Zabner, Joseph/0000-0002-9606-1339; Stoltz, David/0000-0003-0893-9015	National Institutes of Health [DK54759, AI076671, HL61234-09]; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL061234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54759, AI076671, HL61234-09. This work was also supported by the Cystic Fibrosis Foundation.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Brushia RJ, 2001, J LIPID RES, V42, P951; Camps J, 2009, CRIT REV CL LAB SCI, V46, P83, DOI 10.1080/10408360802610878; Chen Q, 2003, AM J HUM GENET, V72, P13, DOI 10.1086/345312; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Erlich PM, 2006, HUM MOL GENET, V15, P77, DOI 10.1093/hmg/ddi428; Furlong CE, 2005, NEUROTOXICOLOGY, V26, P651, DOI 10.1016/j.neuro.2004.08.002; Furlong CE, 2007, J BIOCHEM MOL TOXIC, V21, P197, DOI 10.1002/jbt.20181; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Josse D, 1999, BIOCHEMISTRY-US, V38, P2816, DOI 10.1021/bi982281h; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; KUO CL, 1995, DRUG METAB DISPOS, V23, P935; Leus FR, 2001, ATHEROSCLEROSIS, V154, P641, DOI 10.1016/S0021-9150(00)00440-8; Martinelli N, 2004, EUR J CLIN INVEST, V34, P14, DOI 10.1111/j.1365-2362.2004.01292.x; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Shi JJ, 2004, MOL BRAIN RES, V120, P201, DOI 10.1016/j.molbrainres.2003.10.018; Slowik A, 2007, CEREBROVASC DIS, V23, P395, DOI 10.1159/000101462; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Teiber JF, 2003, BIOCHEM PHARMACOL, V66, P887, DOI 10.1016/S0006-2952(03)00401-5; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Wills AM, 2008, NEUROLOGY, V70, P929, DOI 10.1212/01.wnl.0000305956.37931.dd; Zintzaras E, 2004, J HUM GENET, V49, P474, DOI 10.1007/s10038-004-0176-x	40	47	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35564	35571		10.1074/jbc.M109.051706	http://dx.doi.org/10.1074/jbc.M109.051706			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840942	Green Published, hybrid			2022-12-27	WOS:000272645600033
J	Watt, B; van Niel, G; Fowler, DM; Hurbain, I; Luk, KC; Stayrook, SE; Lemmon, MA; Raposo, G; Shorter, J; Kelly, JW; Marks, MS				Watt, Brenda; van Niel, Guillaume; Fowler, Douglas M.; Hurbain, Ilse; Luk, Kelvin C.; Stayrook, Steven E.; Lemmon, Mark A.; Raposo, Graca; Shorter, James; Kelly, Jeffery W.; Marks, Michael S.			N-terminal Domains Elicit Formation of Functional Pmel17 Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILVER COAT COLOR; MELANOMA-CELLS; EARLY MELANOSOMES; ALPHA-SYNUCLEIN; REPEAT DOMAIN; PROTEIN; YEAST; BIOGENESIS; GENE; MELANOCYTES	Pmel17 is a transmembrane protein that mediates the early steps in the formation of melanosomes, the subcellular organelles of melanocytes in which melanin pigments are synthesized and stored. In melanosome precursor organelles, proteolytic fragments of Pmel17 form insoluble, amyloid-like fibrils upon which melanins are deposited during melanosome maturation. The mechanism(s) by which Pmel17 becomes competent to form amyloid are not fully understood. To better understand how amyloid formation is regulated, we have defined the domains within Pmel17 that promote fibril formation in vitro. Using purified recombinant fragments of Pmel17, we show that two regions, an N-terminal domain of unknown structure and a downstream domain with homology to a polycystic kidney disease-1 repeat, efficiently form amyloid in vitro. Analyses of fibrils formed in melanocytes confirm that the polycystic kidney disease-1 domain forms at least part of the physiological amyloid core. Interestingly, this same domain is also required for the intracellular trafficking of Pmel17 to multivesicular compartments within which fibrils begin to form. Although a domain of imperfect repeats (RPT) is required for fibril formation in vivo and is a component of fibrils in melanosomes, RPT is not necessary for fibril formation in vitro and in isolation is unable to adopt an amyloid fold in a physiologically relevant time frame. These data define the structural core of Pmel17 amyloid, imply that the RPT domain plays a regulatory role in timing amyloid conversion, and suggest that fibril formation might be physically linked with multivesicular body sorting.	[Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Stayrook, Steven E.; Lemmon, Mark A.; Shorter, James] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [van Niel, Guillaume; Hurbain, Ilse; Raposo, Graca] Inst Curie, F-75005 Paris, France; [van Niel, Guillaume; Hurbain, Ilse; Raposo, Graca] CNRS, UMR144, F-75005 Paris, France; [Fowler, Douglas M.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Chem, La Jolla, CA 92037 USA; [Fowler, Douglas M.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of Pennsylvania; University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Scripps Research Institute; Scripps Research Institute	Marks, MS (corresponding author), Univ Penn, Dept Pathol & Lab Med, 513 Stellar Chance Labs 6100,422 Curie Blvd, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	van Niel, Guillaume/A-6585-2011; Luk, Kelvin/AAZ-4202-2020; Marks, Michael S/Q-7223-2019; van Niel, Guillaume/HCI-8445-2022; Shorter, James/E-8207-2011; Shorter, James/ABE-7307-2020	van Niel, Guillaume/0000-0002-8651-9705; Luk, Kelvin/0000-0002-6591-6269; Marks, Michael S/0000-0001-7435-7262; Shorter, James/0000-0001-5269-8533; Raposo, graca/0000-0001-9590-1298; Lemmon, Mark/0000-0002-3379-5319; Stayrook, Steven/0000-0002-1677-8293	National Institutes of Health [R01 AR048155]; NIAMS [R01 AG018917]; NIA; Director's New Innovator Award [1DP2OD002177-01]; CNRS; Institut Curie; Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018917] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Director's New Innovator Award; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR048155 from the NIAMS ( to M. S. M.), Grant R01 AG018917 from the NIA ( to J.W.K.), and Director's New Innovator Award 1DP2OD002177-01 ( to J.S.). This work was also supported by CNRS, Institut Curie, Fondation pour la Recherche Medicale, and Association pour la Recherche sur le Cancer ( to G. R.).	Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; BIRBECK MSC, 1963, ANN NY ACAD SCI, V100, P540, DOI 10.1111/j.1749-6632.1963.tb42871.x; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Chakraborty AK, 1996, EUR J BIOCHEM, V236, P180, DOI 10.1111/j.1432-1033.1996.t01-1-00180.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; DIMENT S, 1995, J BIOL CHEM, V270, P4213, DOI 10.1074/jbc.270.9.4213; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Hamilton HL, 1940, ANAT REC, V78, P525, DOI 10.1002/ar.1090780407; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; Koo HJ, 2008, BIOCHEM BIOPH RES CO, V368, P772, DOI 10.1016/j.bbrc.2008.01.140; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; MAUL GG, 1969, J ULTRA MOL STRUCT R, V26, P163, DOI 10.1016/S0022-5320(69)90042-2; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Mobius W, 2003, TRAFFIC, V4, P222; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; MOYER FH, 1966, AM ZOOL, V6, P43; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; PALMER I, 2000, CURRENT PROTOCOLS PR; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Robila V, 2008, J IMMUNOL, V181, P7843, DOI 10.4049/jimmunol.181.11.7843; SAEKI H, 1978, J CELL PHYSIOL, V94, P139, DOI 10.1002/jcp.1040940203; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; SPANAKIS E, 1992, DEVELOPMENT, V114, P675; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	60	78	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35543	35555		10.1074/jbc.M109.047449	http://dx.doi.org/10.1074/jbc.M109.047449			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840945	Green Published, hybrid			2022-12-27	WOS:000272645600031
J	Fan, XJ; Zhang, JY; Theves, M; Strauch, C; Nemet, I; Liu, XQ; Qian, J; Giblin, FJ; Monnier, VM				Fan, Xingjun; Zhang, Jianye; Theves, Mathilde; Strauch, Christopher; Nemet, Ina; Liu, Xiaoqin; Qian, Juan; Giblin, Frank J.; Monnier, Vincent M.			Mechanism of Lysine Oxidation in Human Lens Crystallins during Aging and in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-CATALYZED OXIDATION; METHIONINE SULFOXIDE; PROTEIN OXIDATION; MAILLARD REACTION; EYE LENS; GLYCATION; CATARACT; SPECTROMETRY; ASCORBATE; PRODUCTS	Oxidative mechanisms during nuclear sclerosis of the lens are poorly understood, in particular metal-catalyzed oxidation. The lysyl oxidation product adipic semialdehyde (allysine, ALL) and its oxidized end-product 2-aminoadipic acid (2-AAA) were determined as a function of age and presence of diabetes. Surprisingly, whereas both ALL and 2-AAA increased with age and strongly correlated with cataract grade and protein absorbance at 350 nm, only ALL formation but not 2-AAA was increased by diabetes. To clarify the mechanism of oxidation, rabbit lenses were treated with hyperbaric oxygen (HBO) for 48 h, and proteins were analyzed by gas and liquid chromatography mass spectrometry for ALL, 2-AAA, and multiple glycation products. Upon exposure to HBO, rabbit lenses were swollen, and nuclei were yellow. Protein-bound ALL increased 8-fold in the nuclear protein fractions versus controls. A dramatic increase in methylglyoxal hydroimidazolone and carboxyethyl-lysine but no increase of 2-AAA occurred, suggesting more drastic conditions are needed to oxidize ALL into 2-AAA. Indeed the latter formed only upon depletion of glutathione and was catalyzed by H2O2. Neither carboxymethyl-lysine nor glyoxal hydroimidazolone, two markers of glyco-/lipoxidation, nor markers of lenticular glycemia (fructose-lysine, glucospane) were elevated by HBO, excluding significant lipid peroxidation and glucose involvement. The findings strongly implicate dicarbonyl/metal catalyzed oxidation of lysine to allysine, whereby low GSH combined with ascorbate-derived H2O2 likely contributes toward 2-AAA formation, since virtually no 2-AAA formed in the presence of methylglyoxal instead of ascorbate. An important translational conclusion is that chelating agents might help delay nuclear sclerosis.	[Fan, Xingjun; Zhang, Jianye; Theves, Mathilde; Strauch, Christopher; Nemet, Ina; Liu, Xiaoqin; Qian, Juan; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Zhang, Jianye] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Giblin, Frank J.] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Oakland University	Monnier, VM (corresponding author), Case Western Reserve Univ, Dept Pathol, Wolstein Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	vmm3@case.edu	Nemet, Ina/ABG-2855-2021	Nemet, Ina/0000-0002-0657-7121	National Institutes of Health [EY07099, EY 02027, EY 014803]; NATIONAL EYE INSTITUTE [R01EY002027, R01EY007099, R24EY014803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY07099 (to V.M.M.), EY 02027 (to F.J.G.), and EY 014803 (to F.J.G.).	Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Akagawa M, 2002, EUR J BIOCHEM, V269, P5451, DOI 10.1046/j.1432-1033.2002.03243.x; AMICI A, 1989, J BIOL CHEM, V264, P3341; Biemel KM, 2003, BIOCONJUGATE CHEM, V14, P619, DOI 10.1021/bc025653e; Boscia F, 2000, INVEST OPHTH VIS SCI, V41, P2461; Brennan LA, 2009, MOL VIS, V15, P985; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; DEVAMANOHARAN PS, 1995, OPHTHALMIC RES, V27, P39, DOI 10.1159/000267837; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Fu SL, 1998, J BIOL CHEM, V273, P28603, DOI 10.1074/jbc.273.44.28603; GARLAND D, 1988, OXYGEN RADICALS BIOL, V49, P347; GARNER MH, 1980, P NATL ACAD SCI-BIOL, V77, P1274, DOI 10.1073/pnas.77.3.1274; Hazell Linda J, 2002, Clin Exp Optom, V85, P97; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; Kyselova Z, 2005, PHYSIOL RES, V54, P49, DOI 10.33549/physiolres.930613; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; LOU MF, 1990, EXP EYE RES, V50, P819, DOI 10.1016/0014-4835(90)90133-F; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P8727, DOI 10.1073/pnas.86.22.8727; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Padgaonkar VA, 2000, EXP EYE RES, V71, P371, DOI 10.1006/exer.2000.0887; PAOLISSO G, 1992, AM J PHYSIOL, V263, pE435, DOI 10.1152/ajpendo.1992.263.3.E435; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; PIRIE A, 1968, INVEST OPHTH VISUAL, V7, P634; Reddy VN, 2001, INVEST OPHTH VIS SCI, V42, P3247; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Saxena P, 2000, INVEST OPHTH VIS SCI, V41, P1473; Sell DR, 2007, BIOCHEM J, V404, P269, DOI 10.1042/BJ20061645; SELLIN S, 1983, J BIOL CHEM, V258, P8872; Sochaski MA, 2001, ANAL CHEM, V73, P4662, DOI 10.1021/ac010228k; Thiagarajan G, 2004, INVEST OPHTH VIS SCI, V45, P2115, DOI 10.1167/iovs.03-0929; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; YU NT, 1985, P NATL ACAD SCI USA, V82, P7965, DOI 10.1073/pnas.82.23.7965	36	44	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34618	34627		10.1074/jbc.M109.032094	http://dx.doi.org/10.1074/jbc.M109.032094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19854833	hybrid, Green Published			2022-12-27	WOS:000272439600017
J	Zhang, Y; Yamada, Y; Fan, MM; Bangaru, SD; Lin, BC; Yang, J				Zhang, Yun; Yamada, Yoichi; Fan, Mingming; Bangaru, Saroja D.; Lin, Bochao; Yang, Jian			The beta Subunit of Voltage-gated Ca2+ Channels Interacts with and Regulates the Activity of a Novel Isoform of Pax6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; CALCIUM-CHANNEL; EYE DEVELOPMENT; NUCLEAR EXPORT; TRANSACTIVATION PROPERTIES; PANCREAS DEVELOPMENT; PROTEIN INTERACTIONS; ECTOPIC EYES; DNA-BINDING; GENE PAX6	Ca2+ channel beta subunits (Ca-v beta s) are essential for regulating the surface expression and gating of high voltage-activated Ca2+ channels through their interaction with Ca2+ channel alpha(1) subunits. In efforts to uncover new interacting partners and new functions for Ca-v beta, we identified a new splicing isoform of Pax6, a transcription factor crucial for the development of the eye, nose, brain, and pancreas. Pax6 contains two DNA binding domains (paired domain and homeodomain), a glycine-rich linker connecting these two domains and a C-terminal proline-, serine-, and threonine-rich transactivation domain. The protein sequence and function of Pax6 are highly conserved from invertebrate to human. The newly isolated isoform, named Pax6(S), retains the paired domain, linker, and homeodomain of Pax6, but its C terminus is composed of a truncated classic proline, serine, and threonine domain and a unique S tail. Pax6(S) shows a similar level of transcriptional activity in vitro as does Pax6, but only in primates is the protein sequence highly conserved. Its spatial-temporal expression profiles are also different from those of Pax6. These divergences suggest a noncanonical role of Pax6(S) during development. The interaction between Pax6(S) and Ca-v beta is mainly endowed by the S tail. Co-expression of Pax6(S) with a Ca2+ channel complex containing the beta(3) subunit in Xenopus oocytes does not affect channel properties. Conversely, however, beta(3) is able to suppress the transcriptional activity of Pax6(S). Furthermore, in the presence of Pax6(S), beta(3) is translocated from the cytoplasm to the nucleus. These results suggest that full-length Ca-v beta may act directly as a transcription regulator independent of its role in regulating Ca2+ channel activity.	[Zhang, Yun; Yamada, Yoichi; Fan, Mingming; Bangaru, Saroja D.; Lin, Bochao; Yang, Jian] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, 917 Fairchild Ctr,MC2462, New York, NY 10027 USA.	jy160@columbia.edu			National Institutes of Health [NS045819, NS053494]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053494, R01NS045819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045819 and NS053494 (to J. Y.). This work was also supported by an Established Investigator award from the American Heart Association (to J. Y.).	Altmann CR, 1997, DEV BIOL, V185, P119, DOI 10.1006/dbio.1997.8573; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Brink C, 2003, CELL MOL LIFE SCI, V60, P1033, DOI 10.1007/s00018-003-2247-0; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Chow RL, 1999, DEVELOPMENT, V126, P4213; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; de Silanes IL, 2007, CELL ONCOL, V29, P1; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Evans Thomas C, 2005, WormBook, P1, DOI 10.1895/wormbook.1.34.1; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Guinez C, 2005, INT J BIOCHEM CELL B, V37, P765, DOI 10.1016/j.biocel.2004.12.001; Haase H, 2005, FASEB J, V19, P1969, DOI 10.1096/fj.05-3997com; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; Habener JF, 1998, P ASSOC AM PHYSICIAN, V110, P12; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kozmik Z, 2008, BRAIN RES BULL, V75, P335, DOI 10.1016/j.brainresbull.2007.10.046; Lefebvre T, 2002, J CELL BIOCHEM, V85, P208, DOI 10.1002/jcb.10119; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Monsigny M, 2004, BBA-GEN SUBJECTS, V1673, P94, DOI 10.1016/j.bbagen.2004.03.015; Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Singh S, 2001, HUM MOL GENET, V10, P911, DOI 10.1093/hmg/10.9.911; Stanescu D, 2007, EYE, V21, P90, DOI 10.1038/sj.eye.6702166; Steinman RA, 2007, LEUKEMIA, V21, P1158, DOI 10.1038/sj.leu.2404656; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; TAKAHASHI K, 1993, INT J CANCER, V55, P453, DOI 10.1002/ijc.2910550322; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yan Q, 2007, J BIOL CHEM, V282, P13954, DOI 10.1074/jbc.M611476200; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Ziman MR, 2001, HISTOL HISTOPATHOL, V16, P239, DOI 10.14670/HH-16.239	69	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2527	2536		10.1074/jbc.M109.022236	http://dx.doi.org/10.1074/jbc.M109.022236			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19917615	Green Published, hybrid			2022-12-27	WOS:000273697800031
J	Armishaw, CJ; Singh, N; Medina-Franco, JL; Clark, RJ; Scott, KCM; Houghten, RA; Jensen, AA				Armishaw, Christopher J.; Singh, Narender; Medina-Franco, Jose L.; Clark, Richard J.; Scott, Krystle C. M.; Houghten, Richard A.; Jensen, Anders A.			A Synthetic Combinatorial Strategy for Developing alpha-Conotoxin Analogs as Potent alpha(7) Nicotinic Acetylcholine Receptor Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE LIBRARIES; MOLECULAR-DYNAMICS; CALCIUM-CHANNELS; HOMOLOG ACHBP; AMINO-ACIDS; BINDING; IMI; LIGANDS; NMR; SELECTIVITY	alpha-Conotoxins are peptide neurotoxins isolated from venomous cone snails that display exquisite selectivity for different subtypes of nicotinic acetylcholine receptors (nAChR). They are valuable research tools that have profound implications in the discovery of new drugs for a myriad of neuropharmacological conditions. They are characterized by a conserved two-disulfide bond framework, which gives rise to two intervening loops of extensively mutated amino acids that determine their selectivity for different nAChR subtypes. We have used a multistep synthetic combinatorial approach using alpha-conotoxin ImI to develop potent and selective alpha(7) nAChR antagonists. A positional scan synthetic combinatorial library was constructed based on the three residues of the n-loop of Alpha-conotoxin ImI to give a total of 10,648 possible combinations that were screened for functional activity in an alpha(7) nAChR Fluo-4/Ca2+ assay, allowing amino acids that confer antagonistic activity for this receptor to be identified. A second series of individual alpha-conotoxin analogs based on the combinations of defined active amino acid residues from positional scan synthetic combinatorial library screening data were synthesized. Several analogs exhibited significantly improved antagonist activity for the alpha(7) nAChR compared with WT-ImI. Binding interactions between the analogs and the alpha(7) nAChR were explored using a homology model of the amino-terminal domain based on a crystal structure of an acetylcholine-binding protein. Finally, a third series of refined analogs was synthesized based on modeling studies, which led to several analogs with refined pharmacological properties. Of the 96 individual alpha-conotoxin analogs synthesized, three displayed >= 10-fold increases in antagonist potency compared with WT-ImI.	[Armishaw, Christopher J.; Singh, Narender; Medina-Franco, Jose L.; Scott, Krystle C. M.; Houghten, Richard A.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Clark, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Jensen, Anders A.] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark	Torrey Pines Institute for Molecular Studies, Florida; University of Queensland; University of Copenhagen	Armishaw, CJ (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	carmishaw@tpims.org	Medina-Franco, Jose/AAJ-1633-2020; Jensen, Anders/AAJ-3335-2020; Clark, Richard J/G-8848-2012	Medina-Franco, Jose/0000-0003-4940-1107; Jensen, Anders/0000-0002-7927-5052; Clark, Richard J/0000-0002-6807-5426	State of Florida and the Arthritis; Chronic Pain Research Institute	State of Florida and the Arthritis; Chronic Pain Research Institute	This work was supported in part by the State of Florida and the Arthritis and Chronic Pain Research Institute.	Armishaw C, 2009, J BIOL CHEM, V284, P9498, DOI 10.1074/jbc.M806136200; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brust A, 2007, J PEPT SCI, V13, P133, DOI 10.1002/psc.825; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dooley CT, 1998, J BIOL CHEM, V273, P18848, DOI 10.1074/jbc.273.30.18848; DOOLEY CT, 1993, LIFE SCI, V52, P1509, DOI 10.1016/0024-3205(93)90113-H; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Ellison M, 2007, CHEM REC, V7, P341, DOI 10.1002/tcr.20131; Feuerbach D, 2005, NEUROPHARMACOLOGY, V48, P215, DOI 10.1016/j.neuropharm.2004.10.003; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Gehrmann J, 1999, J MED CHEM, V42, P2364, DOI 10.1021/jm990114p; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jensen AA, 2007, J MED CHEM, V50, P4616, DOI 10.1021/jm070574f; Karadsheh MS, 2004, J NEUROCHEM, V91, P1138, DOI 10.1111/j.1471-4159.2004.02801.x; Kasheverov IE, 2006, FEBS J, V273, P4470, DOI 10.1111/j.1742-4658.2006.05453.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Millard EL, 2009, J BIOL CHEM, V284, P4944, DOI 10.1074/jbc.M804950200; Nielsen JS, 2004, J PEPT SCI, V10, P249, DOI 10.1002/psc.531; Nino-Vasquez JJ, 2004, MOL IMMUNOL, V40, P1063, DOI 10.1016/j.molimm.2003.11.005; OSTRESH JM, 1994, BIOPOLYMERS, V34, P1681, DOI 10.1002/bip.360341212; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PINILLA C, 1992, BIOTECHNIQUES, V13, P901; Pinilla C, 2001, CANCER RES, V61, P5153; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; Rogers JP, 1999, BIOCHEMISTRY-US, V38, P3874, DOI 10.1021/bi9826254; Rogers JP, 2000, J MOL BIOL, V304, P911, DOI 10.1006/jmbi.2000.4247; Sasaki T, 2000, FEBS LETT, V466, P125, DOI 10.1016/S0014-5793(99)01772-X; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SCHRODINGER LLC, 2008, PRIME VERSION 2 0 11; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; TALY A, 2009, J NAT REV DRUG DISCO, V8, P733; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Utkin YN, 1999, TOXICON, V37, P1683, DOI 10.1016/S0041-0101(99)00111-7; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322	54	34	37	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1809	1821		10.1074/jbc.M109.071183	http://dx.doi.org/10.1074/jbc.M109.071183			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19901032	Green Published, hybrid			2022-12-27	WOS:000273429100027
J	Chevtzoff, C; Yoboue, ED; Galinier, A; Casteilla, L; Daignan-Fornier, B; Rigoulet, M; Devin, A				Chevtzoff, Cyrille; Yoboue, Edgar D.; Galinier, Anne; Casteilla, Louis; Daignan-Fornier, Bertrand; Rigoulet, Michel; Devin, Anne			Reactive Oxygen Species-mediated Regulation of Mitochondrial Biogenesis in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; GENE-EXPRESSION; PSEUDOHYPHAL DIFFERENTIATION; CATABOLITE REPRESSION; TRANSCRIPTION FACTOR; HEART-MITOCHONDRIA; GROWTH-YIELD; ACTIVATION; METABOLISM; CELLS	Mitochondrial biogenesis is a complex process. It necessitates the participation of both the nuclear and the mitochondrial genomes. This process is highly regulated, and mitochondrial content within a cell varies according to energy demand. In the yeast Saccharomyces cerevisiae, the cAMP pathway is involved in the regulation of mitochondrial biogenesis. An overactivation of this pathway leads to an increase in mitochondrial enzymatic content. Of the three yeast cAMP protein kinases, we have previously shown that Tpk3p is the one involved in the regulation of mitochondrial biogenesis. In this paper, we investigated the molecular mechanisms that govern this process. We show that in the absence of Tpk3p, mitochondria produce large amounts of reactive oxygen species that signal to the HAP2/3/4/5 nuclear transcription factors involved in mitochondrial biogenesis. We establish that an increase in mitochondrial reactive oxygen species production down-regulates mitochondrial biogenesis. It is the first time that a redox sensitivity of the transcription factors involved in yeast mitochondrial biogenesis is shown. Such a process could be seen as a mitochondria quality control process.	[Devin, Anne] CNRS, IBGC, Bioenerget Lab, UMR 5095, F-33077 Bordeaux, France; [Chevtzoff, Cyrille; Yoboue, Edgar D.; Daignan-Fornier, Bertrand; Rigoulet, Michel; Devin, Anne] Univ Bordeaux 2, F-33077 Bordeaux, France; [Galinier, Anne; Casteilla, Louis] Ctr Hosp Univ Rangueil, CNRS, IFR31, UMR 5241,UPS, F-31059 Toulouse 9, France; [Galinier, Anne] Ctr Hosp Univ Rangueil, Biochim Lab, F-31059 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Devin, A (corresponding author), CNRS, IBGC, Bioenerget Lab, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	anne.devin@ibgc.u-bordeaux2.fr	YOBOUE, Edgar D./AAA-7706-2019	Galinier, Anne/0000-0003-2454-5681; Casteilla, Louis/0000-0001-9647-3248	Agence Nationale de la Recherche [NT05-2_42268]; Conseil Regional D'Aquitaine	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional D'Aquitaine(Region Nouvelle-Aquitaine)	This work was supported in part by Agence Nationale de la Recherche Grant NT05-2_42268 and the Conseil Regional D'Aquitaine.	Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; DANG VD, 1994, YEAST, V10, P1273, DOI 10.1002/yea.320101004; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Dejean L, 2002, BIOCHEM BIOPH RES CO, V293, P1383, DOI 10.1016/S0006-291X(02)00391-1; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Fabrizio P, 2003, GENETICS, V163, P35; Fondrat C, 1996, COMPUT APPL BIOSCI, V12, P363; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Galinier A, 2004, FEBS LETT, V578, P53, DOI 10.1016/j.febslet.2004.10.067; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GRIVELL LA, 1989, NATURE, V341, P569, DOI 10.1038/341569a0; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Guerin B, 1979, Methods Enzymol, V55, P149; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Noubhani A, 2009, J BIOL CHEM, V284, P27229, DOI 10.1074/jbc.M109.029454; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; OSCAI LB, 1971, J BIOL CHEM, V246, P6968; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Velot C, 1996, GENETICS, V144, P893; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wood MJ, 2004, NATURE, V430, P917, DOI 10.1038/nature02790	53	41	44	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1733	1742		10.1074/jbc.M109.019570	http://dx.doi.org/10.1074/jbc.M109.019570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19897478	Green Published, hybrid			2022-12-27	WOS:000273429100019
J	Hou, HT; Wang, Y; Kallgren, SP; Thompson, J; Yates, JR; Jia, ST				Hou, Haitong; Wang, Yu; Kallgren, Scott P.; Thompson, James; Yates, John R., III; Jia, Songtao			Histone Variant H2A.Z Regulates Centromere Silencing and Chromosome Segregation in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-C; CHROMATIN-STRUCTURE; PLANT HOMEODOMAIN; PHD FINGER; HETEROCHROMATIN; KINETOCHORE; PROTEIN; GENE; METHYLATION; COMPONENT	The incorporation of histone variant H2A.Z into nucleosomes plays essential roles in regulating chromatin structure and gene expression. A multisubunit complex containing chromatin remodeling protein Swr1 is responsible for the deposition of H2A.Z in budding yeast and mammals. Here, we show that the JmjC domain protein Msc1 is a novel component of the fission yeast Swr1 complex and is required for Swr1-mediated incorporation of H2A.Z into nucleosomes at gene promoters. Loss of Msc1, Swr1, or H2A.Z results in loss of silencing at centromeres and defective chromosome segregation, although centromeric levels of CENP-A, a centromere-specific histone H3 variant that is required for setting up the chromatin structure at centromeres, remain unchanged. Intriguingly, H2A.Z is required for the expression of another centromere protein, CENP-C, and overexpression of CENP-Crescues centromere silencing defects associated with H2A.Z loss. These results demonstrate the importance of H2A.Z and CENP-C in maintaining a silenced chromatin state at centromeres.	[Jia, Songtao] Columbia Univ, Dept Biol Sci, Fairchild Ctr 1114, New York, NY 10027 USA; [Thompson, James; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Columbia University; Scripps Research Institute	Jia, ST (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr 1114, MC2458, New York, NY 10027 USA.	jia@biology.columbia.edu	Hou, Haitong/E-8416-2013; hou, haitong/D-5188-2019	hou, haitong/0000-0003-4493-9645; Jia, Songtao/0000-0002-7927-0227; Kallgren, Scott/0000-0002-6318-3268	National Institutes of Health [R01 GM085145]; National Center for Research Resources [P41 RR11823]; March of Dimes Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); March of Dimes Foundation(March of Dimes); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM085145 (to S. J.) and Grant P41 RR11823 from the National Center for Research Resources (to T. N. Davis). This work was also supported by a Basil O'Connor Starter Scholar Award from the March of Dimes Foundation.	Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Ahmed S, 2007, GENETICS, V177, P1487, DOI 10.1534/genetics.107.078691; Allis C. D., 2006, EPIGENETICS; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Anders A, 2008, YEAST, V25, P913, DOI 10.1002/yea.1639; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2009, CELL, V136, P610, DOI 10.1016/j.cell.2009.02.004; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hayashi A, 2006, MOL BIOL CELL, V17, P5173, DOI 10.1091/mbc.E06-05-0388; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Holland S, 2005, CHROMOSOME RES, V13, P73, DOI 10.1007/s10577-005-7062-z; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Huarte M, 2007, J BIOL CHEM, V282, P21662, DOI 10.1074/jbc.M703897200; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lawrence RJ, 2009, P NATL ACAD SCI USA, V106, P1163, DOI 10.1073/pnas.0811161106; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	92	42	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1909	1918		10.1074/jbc.M109.058487	http://dx.doi.org/10.1074/jbc.M109.058487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19910462	Green Published, hybrid			2022-12-27	WOS:000273429100037
J	Patel, VA; Lee, DJ; Feng, LF; Antoni, A; Lieberthal, W; Schwartz, JH; Rauch, J; Ucker, DS; Levine, JS				Patel, Vimal A.; Lee, Daniel J.; Feng, Lanfei; Antoni, Angelika; Lieberthal, Wilfred; Schwartz, John H.; Rauch, Joyce; Ucker, David S.; Levine, Jerrold S.			Recognition of Apoptotic Cells by Epithelial Cells CONSERVED VERSUS TISSUE-SPECIFIC SIGNALING RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; NECROTIC CELLS; MACROPHAGES; CLEARANCE; BETA; ACTIVATION; PHAGOCYTES; SURVIVAL; EVENTS; MOUSE	During apoptosis, cells acquire new activities that enable them to modulate the fate and function of interacting phagocytes, particularly macrophages (m phi). Although the best known of these activities is anti-inflammatory, apoptotic targets also influencem phi survival and proliferation by modulating proximal signaling events, such as MAPK modules and Akt. We asked whether modulation of these same signaling events extends to epithelial cells, a minimally phagocytic cell type. We used BU.MPT cells, a mouse kidney epithelial cell line, as our primary model, but we also evaluated several epithelial cell lines of distinct tissue origins. Like m phi, mouse kidney epithelial cells recognized apoptotic and necrotic targets through distinct non-competing receptors, albeit with lower binding capacity and markedly reduced phagocytosis. Also, modulation of inflammatory activity and MAPK-dependent signaling by apoptotic and necrotic targets was indistinguishable in kidney epithelial cells and m phi. In contrast, modulation of Akt-dependent signaling differed dramatically between kidney epithelial cells and m phi. In kidney epithelial cells, modulation of Akt was linked to target cell recognition, independently of phagocytosis, whereas in m phi, modulation was linked to phagocytosis. Moreover, recognition of apoptotic and necrotic targets by kidney epithelial cells elicited opposite responses; apoptotic targets inhibited whereas necrotic targets stimulated Akt activity. These data confirm that nonprofessional phagocytes recognize and respond to dying cells, albeit in a manner partially distinct from m phi. By acting as sentinels of environmental change, apoptotic and necrotic targets may permit neighboring viable cells, especially non-migratory epithelial cells, to monitor and adapt to local stresses.	[Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Coll Med, Chicago, IL 60612 USA; [Ucker, David S.; Levine, Jerrold S.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Patel, Vimal A.; Lee, Daniel J.; Feng, Lanfei; Levine, Jerrold S.] Jesse Brown Vet Affairs Hosp, Nephrol Sect, Dept Med, Chicago, IL 60612 USA; [Antoni, Angelika] Kutztown Univ Penn, Dept Biol, Kutztown, PA 19530 USA; [Lieberthal, Wilfred] SUNY Stony Brook, Dept Med, Nephrol Sect, Med Ctr, Stony Brook, NY 11794 USA; [Lieberthal, Wilfred] Northport Vet Affairs Hosp, Northport, NY 11768 USA; [Schwartz, John H.] Boston Univ, Dept Med, Sch Med, Renal Sect, Boston, MA 02118 USA; [Rauch, Joyce] McGill Univ, Ctr Hlth, Res Inst, Dept Med,Div Rheumatol, Montreal, PQ H3G 1A4, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Boston University; McGill University	Levine, JS (corresponding author), Univ Illinois, Dept Med, Nephrol Sect, Coll Med, MC793,820 S Wood St, Chicago, IL 60612 USA.	jslevine@uic.edu	Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681	National Institutes of Health [DK071678, AG024234, DK059529]; Genzyme, Inc.; Veterans Affairs Merit Award; Pennsylvania State System of Higher Education Faculty Professional Development Grant; Canadian Institutes of Health [MOP-67101, MOP-42391]; Institute of Musculoskeletal Health and Arthritis Priority Announcement [MUS-67101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071678, R01DK059529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029633, R21AG024234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme, Inc.(Sanofi-AventisGenzyme Corporation); Veterans Affairs Merit Award(US Department of Veterans Affairs); Pennsylvania State System of Higher Education Faculty Professional Development Grant; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Priority Announcement; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071678(to V. A. P.), AG024234(to D. S. U.), and DK059529(to J. H. S.). This work was also supported by a GRIP Renal Innovations Program Award from Genzyme, Inc. (to J. S. L.), a Veterans Affairs Merit Award (to W. L.), a Pennsylvania State System of Higher Education Faculty Professional Development Grant (to A. L.), and Canadian Institutes of Health Research Grants MOP-67101 (to J. R.) and MOP-42391 (to J. R.) and Institute of Musculoskeletal Health and Arthritis Priority Announcement MUS-67101 (to J. R.).	Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; El-Achkar TM, 2006, NAT CLIN PRACT NEPHR, V2, P568, DOI 10.1038/ncpneph0300; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; McDonald PP, 1999, J IMMUNOL, V163, P6164; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Sinha D, 2003, AM J PHYSIOL-RENAL, V284, pF488, DOI 10.1152/ajprenal.00172.2002; THURAU K, 1976, AM J MED, V61, P308, DOI 10.1016/0002-9343(76)90365-X; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wood W, 2000, DEVELOPMENT, V127, P5245	23	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1829	1840		10.1074/jbc.M109.018440	http://dx.doi.org/10.1074/jbc.M109.018440			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19910463	Green Published, hybrid			2022-12-27	WOS:000273429100029
J	Strickland, KC; Hoeferlin, LA; Oleinik, NV; Krupenko, NI; Krupenko, SA				Strickland, Kyle C.; Hoeferlin, L. Alexis; Oleinik, Natalia V.; Krupenko, Natalia I.; Krupenko, Sergey A.			Acyl Carrier Protein-specific 4 '-Phosphopantetheinyl Transferase Activates 10-Formyltetrahydrofolate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; CARBOXYL-TERMINAL DOMAIN; ALDEHYDE DEHYDROGENASE; CRYSTAL-STRUCTURES; ENZYME; RAT; MECHANISM; BINDING; TRANSFORMYLASE; IDENTIFICATION	4'-Phosphopantetheinyl transferases (PPTs) catalyze the transfer of 4'-phosphopantetheine (4-PP) from coenzyme A to a conserved serine residue of their protein substrates. In humans, the number of pathways utilizing the 4-PP posttranslational modification is limited and may only require a single broad specificity PPT for all phosphopantetheinylation reactions. Recently, we have shown that one of the enzymes of folate metabolism, 10-formyltetrahydrofolate dehydrogenase (FDH), requires a 4-PP prosthetic group for catalysis. This moiety acts as a swinging arm to couple the activities of the two catalytic domains of FDH and allows the conversion of 10-formyltetrahydrofolate to tetrahydrofolate and CO2. In the current study, we demonstrate that the broad specificity human PPT converts apo-FDH to holoenzyme and thus activates FDH catalysis. Silencing PPT by small interfering RNA in A549 cells prevents FDH modification, indicating the lack of alternative enzymes capable of accomplishing this transferase reaction. Interestingly, PPT-silenced cells demonstrate significantly reduced proliferation and undergo strong G(1) arrest, suggesting that the enzymatic function of PPT is essential and nonredundant. Our study identifies human PPT as the FDH-modifying enzyme and supports the hypothesis that mammals utilize a single enzyme for all phosphopantetheinylation reactions.	[Strickland, Kyle C.; Hoeferlin, L. Alexis; Oleinik, Natalia V.; Krupenko, Natalia I.; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu	Strickland, Kyle/Q-7135-2019	Hoeferlin, L. Alexis/0000-0001-7569-8712; Strickland, Kyle/0000-0003-1636-5277	National Institutes of Health [DK54388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54388.	Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179; Boger DL, 1998, BIOORGAN MED CHEM, V6, P643, DOI 10.1016/S0968-0896(98)00040-6; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Chirgadze NY, 2000, EMBO J, V19, P5281, DOI 10.1093/emboj/19.20.5281; Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200; Donato H, 2007, J BIOL CHEM, V282, P34159, DOI 10.1074/jbc.M707627200; ELOVSON J, 1968, J BIOL CHEM, V243, P3603; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fu TF, 1999, ARCH BIOCHEM BIOPHYS, V367, P161, DOI 10.1006/abbi.1999.1262; Gehring AM, 1997, CHEM BIOL, V4, P17, DOI 10.1016/S1074-5521(97)90233-7; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; JOHLIN FC, 1989, MOL PHARMACOL, V35, P745; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kisliuk RL, 1999, CANC DRUG DISC DEV, P13; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; Krupenko SA, 1997, J BIOL CHEM, V272, P10266; Krupenko SA, 1997, J BIOL CHEM, V272, P10273; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Min H, 2005, ALCOHOL CLIN EXP RES, V29, P2188, DOI 10.1097/01.alc.0000191756.02856.a8; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Mun Ju-Ae, 2008, Nutr Res Pract, V2, P195, DOI 10.4162/nrp.2008.2.4.195; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Praphanphoj V, 2001, MOL GENET METAB, V72, P336, DOI 10.1006/mgme.2000.3138; Pumford NR, 1997, J PHARMACOL EXP THER, V280, P501; Reuland SN, 2006, PROTEIN SCI, V15, P1076, DOI 10.1110/ps.052062806; SCHIRCH D, 1994, J BIOL CHEM, V269, P24728; SMITH GK, 1981, BIOCHEMISTRY-US, V20, P4034, DOI 10.1021/bi00517a013; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Wagner C, 1995, FOLATE HLTH DIS, P23; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1	38	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1627	1633		10.1074/jbc.M109.080556	http://dx.doi.org/10.1074/jbc.M109.080556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19933275	hybrid, Green Published			2022-12-27	WOS:000273429100008
J	Fish, JE; Yan, MS; Matouk, CC; Bernard, RS; Ho, JJD; Gavryushova, A; Srivastava, D; Marsden, PA				Fish, Jason E.; Yan, Matthew S.; Matouk, Charles C.; Bernard, Rosanne St.; Ho, J. J. David, Jr.; Gavryushova, Anna; Srivastava, Deepak; Marsden, Philip A.			Hypoxic Repression of Endothelial Nitric-oxide Synthase Transcription Is Coupled with Eviction of Promoter Histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CELL-SPECIFIC EXPRESSION; MISMATCH REPAIR GENE; GROWTH-FACTOR; PULMONARY-HYPERTENSION; REDUCED EXPRESSION; RESPONSE ELEMENT; HEME OXYGENASE-1; MAMMALIAN-CELLS; SWI/SNF COMPLEX	Hypoxia elicits endothelial dysfunction, in part, through reduced expression of endothelial nitric-oxide synthase (eNOS). Here we present evidence that hypoxia causes a rapid decrease in the transcription of the eNOS/NOS3 gene, accompanied by decreased acetylation and lysine 4 (histone H3) methylation of eNOS proximal promoter histones. Surprisingly, we demonstrate that histones are rapidly evicted from the eNOS proximal promoter during hypoxia. We also demonstrate endothelium-specific H2A.Z incorporation at the eNOS promoter and find that H2A.Z is also evicted by hypoxic stimulation. After longer durations of hypoxia, histones are reincorporated at the eNOS promoter, but these histones lack substantial histone acetylation. Additionally, we identify a key role for the chromatin remodeler, BRG1, in re-establishing eNOS expression following reoxygenation of hypoxic cells. We posit that post-translational histone modifications are required to maintain constitutive eNOS transcriptional activity and that histone eviction rapidly resets histone marks and is a proximal event in the hypoxic repression of eNOS. Although nucleosome eviction has been reported in models of transcriptional activation, the observation that eviction can also accompany transcriptional repression in hypoxic mammalian cells argues that eviction may be broadly relevant to both positive and negative changes in transcription.	[Marsden, Philip A.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Yan, Matthew S.; Matouk, Charles C.; Bernard, Rosanne St.; Ho, J. J. David, Jr.; Gavryushova, Anna; Marsden, Philip A.] St Michaels Hosp, Div Renal, Toronto, ON M5B 1W8, Canada; [Yan, Matthew S.; Matouk, Charles C.; Bernard, Rosanne St.; Ho, J. J. David, Jr.; Gavryushova, Anna; Marsden, Philip A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Yan, Matthew S.; Matouk, Charles C.; Bernard, Rosanne St.; Ho, J. J. David, Jr.; Gavryushova, Anna; Marsden, Philip A.] Univ Toronto, Toronto, ON M5B 1W8, Canada; [Fish, Jason E.; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Fish, Jason E.; Srivastava, Deepak] Univ Calif San Francisco, San Francisco, CA 94158 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Marsden, PA (corresponding author), Univ Toronto, Dept Med Biophys, Rm 7358,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	p.marsden@utoronto.ca	Matouk, Charles/AAF-7694-2019; Marsden, Philip A/B-1441-2012	Fish, Jason/0000-0003-0640-7277	Canadian Institutes of Health Research (CIHR) [CIHR MOP 79475]; Natural Sciences and Engineering Research Council Canada; CIHR Frederick Banting; Charles Best Canada; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Frederick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best Canada; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by Grant CIHR MOP 79475 from the Canadian Institutes of Health Research (CIHR).; Recipient of an Natural Sciences and Engineering Research Council Canada Graduate Scholarship.; The recipient of a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship.; Recipient of a Career Investigator Award from the Heart and Stroke Foundation of Canada. To whom correspondence should be addressed: Rm. 7358, Medical Sciences Bldg., University of Toronto, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada. Tel.: 416-978-2441; Fax: 416-978-8765; E-mail: p. marsden@ utoronto. ca.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Baker KM, 2003, J BIOL CHEM, V278, P17876, DOI 10.1074/jbc.M209480200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Bindra RS, 2004, MOL CELL BIOL, V24, P8504, DOI 10.1128/MCB.24.19.8504-8518.2004; Castano E, 2000, P NATL ACAD SCI USA, V97, P7184, DOI 10.1073/pnas.140202297; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Champion HC, 2002, P NATL ACAD SCI USA, V99, P13248, DOI 10.1073/pnas.182225899; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Coulet F, 2003, J BIOL CHEM, V278, P46230, DOI 10.1074/jbc.M305420200; Denko N, 2003, J BIOL CHEM, V278, P5744, DOI 10.1074/jbc.M212534200; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Fish JE, 2007, J BIOL CHEM, V282, P15652, DOI 10.1074/jbc.M608318200; Fish JE, 2006, CELL MOL LIFE SCI, V63, P144, DOI 10.1007/s00018-005-5421-8; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Flavin M, 2004, MOL CELL BIOL, V24, P7891, DOI 10.1128/MCB.24.18.7891-7901.2004; Gan YH, 2005, J BIOL CHEM, V280, P16467, DOI 10.1074/jbc.M412960200; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hu CJ, 2006, J CEREBR BLOOD F MET, V26, P1519, DOI 10.1038/sj.jcbfm.9600304; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; Lemos FBC, 2003, J AM SOC NEPHROL, V14, P3278, DOI 10.1097/01.ASN.0000098683.92538.66; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li Q, 2009, BIOCHIMIE, V91, P1307, DOI 10.1016/j.biochi.2009.07.001; Li ZB, 2003, EMBO J, V22, P1857, DOI 10.1093/emboj/cdg173; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Mazure NM, 2002, CANCER RES, V62, P1158; McQuillan Lynda P., 1994, American Journal of Physiology, V267, pH1921; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Nakamura H, 2008, ONCOGENE, V27, P4200, DOI 10.1038/onc.2008.58; Ozaki M, 2001, HYPERTENSION, V37, P322, DOI 10.1161/01.HYP.37.2.322; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Pearson DL, 2001, NEW ENGL J MED, V344, P1832, DOI 10.1056/NEJM200106143442404; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Phelan MW, 1996, J CELL PHYSIOL, V167, P469, DOI 10.1002/(SICI)1097-4652(199606)167:3<469::AID-JCP11>3.3.CO;2-C; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Robb GB, 2004, J BIOL CHEM, V279, P37982, DOI 10.1074/jbc.M400271200; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Teichert AM, 2000, AM J PHYSIOL-HEART C, V278, pH1352, DOI 10.1152/ajpheart.2000.278.4.H1352; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Ward ME, 2005, J CLIN INVEST, V115, P3128, DOI 10.1172/JCI20806; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	83	104	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					810	826		10.1074/jbc.M109.067868	http://dx.doi.org/10.1074/jbc.M109.067868			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19880524	Green Published, hybrid			2022-12-27	WOS:000273258200002
J	Okemefuna, AI; Stach, L; Rana, S; Buetas, AJZ; Gor, J; Perkins, SJ				Okemefuna, Azubuike I.; Stach, Lasse; Rana, Sudeep; Buetas, Akim J. Ziai; Gor, Jayesh; Perkins, Stephen J.			C-reactive Protein Exists in an NaCl Concentration-dependent Pentamer-Decamer Equilibrium in Physiological Buffer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-P COMPONENT; NEOANTIGEN NEO-CRP; NEUTRON-SCATTERING; HYDRODYNAMIC PROPERTIES; SEDIMENTATION-VELOCITY; COMPLEMENT ACTIVATION; X-RAY; 3-DIMENSIONAL STRUCTURE; LAMM EQUATION; CALCIUM	C-reactive protein (CRP) is an acute phase protein of the pentraxin family that binds ligands in a Ca2+-dependent manner, and activates complement. Knowledge of its oligomeric state in solution and at surfaces is essential for functional studies. Analytical ultracentrifugation showed that CRP in 2 mM Ca2+ exhibits a rapid pentamer-decamer equilibrium. The proportion of decamer decreased with an increase in NaCl concentration. The sedimentation coefficients s(20,w)(0) of pentameric and decameric CRP were 6.4 S and in excess of 7.6 S, respectively. In the absence of Ca2+, CRP partially dissociates into its protomers and the NaCl concentration dependence of the pentamer-decamer equilibrium is much reduced. By x-ray scattering, the radius of gyration R-G values ranged from 3.7 nm for the pentamer to above 4.0 nm for the decamer. An averaged K-D value of 21 mu M in solution (140 mM NaCl, 2 mM Ca2+) was determined by x-ray scattering and modeling based on crystal structures for the pentamer and decamer. Surface plasmon resonance showed that CRP self-associates on a surface with immobilized CRP with a similar K-D value of 23 mu M (140 mM NaCl, 2 mM Ca2+), whereas CRP aggregates in low salt. It is concluded that CRP is reproducibly observed in a pentamer-decamer equilibrium in physiologically relevant concentrations both in solution and on surfaces. Both 2 mM Ca2+ and 140 mM NaCl are essential for the integrity of CRP in functional studies and understanding the role of CRP in the acute phase response.	[Okemefuna, Azubuike I.; Stach, Lasse; Rana, Sudeep; Buetas, Akim J. Ziai; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Biol Mol & Struct, London WC1E 6BT, England	University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Biol Mol & Struct, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@medsch.ucl.ac.uk			Uppsala University, Sweden; University College London; Overseas Research Scholarship; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; BBSRC [BB/E013104/1] Funding Source: UKRI	Uppsala University, Sweden; University College London(General Electric); Overseas Research Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was awarded a poster prize at the 18th International Analytical Ultracentrifugation Conference, Uppsala University, Sweden (September 13-18, 2009).; Supported by a Graduate School Research Scholarship from University College London and an Overseas Research Scholarship.	Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blizniukov OP, 2003, MOL BIOL+, V37, P912, DOI 10.1023/B:MBIL.0000008361.22136.c8; Bonner A, 2007, J BIOL CHEM, V282, P16969, DOI 10.1074/jbc.M701281200; Bonner A, 2009, J BIOL CHEM, V284, P5077, DOI 10.1074/jbc.M807529200; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; CLAUS DR, 1977, J IMMUNOL, V118, P83; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEBEER FC, 1982, J IMMUNOL METHODS, V50, P17, DOI 10.1016/0022-1759(82)90300-3; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; Diehl EE, 2000, AM J MED SCI, V319, P79, DOI 10.1097/00000441-200002000-00002; EGENHOFER C, 1993, HEPATOLOGY, V18, P1216; FILEP J, 1989, LIFE SCI, V44, P517, DOI 10.1016/0024-3205(89)90613-9; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; Glatter O., 1982, SMALL ANGLE XRAY SCA; Hurwitz S, 1996, CRIT REV BIOCHEM MOL, V31, P41, DOI 10.3109/10409239609110575; JIANG HX, 1991, J IMMUNOL, V146, P2324; Khreiss T, 2002, J BIOL CHEM, V277, P40775, DOI 10.1074/jbc.M205378200; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; Mori, 1999, SIZE EXCLUSION CHROM; Motie M, 1996, J IMMUNOL, V156, P4435; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P739, DOI 10.1073/pnas.74.2.739; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; PERKINS SJ, 1986, PROTIDES BIOL FLUIDS, V34, P323; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; POTEMPA LA, 1988, INFLAMMATION, V12, P391, DOI 10.1007/BF00915774; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Ramadan MAM, 2002, ACTA CRYSTALLOGR D, V58, P992, DOI 10.1107/S0907444902005693; REES RF, 1988, CLIN IMMUNOL IMMUNOP, V48, P95, DOI 10.1016/0090-1229(88)90160-2; ROWE IF, 1984, CLIN EXP IMMUNOL, V58, P237; SAMOLS D, 1985, BIOCHEM J, V227, P759, DOI 10.1042/bj2270759; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SIEGEL J, 1974, J EXP MED, V140, P631, DOI 10.1084/jem.140.3.631; SIEGEL J, 1975, J EXP MED, V142, P709, DOI 10.1084/jem.142.3.709; Tanious FA, 2008, METHOD CELL BIOL, V84, P53, DOI 10.1016/S009911-679X(07)84003-9; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; VOLANAKIS JE, 1982, ANN NY ACAD SCI, V389, P235, DOI 10.1111/j.1749-6632.1982.tb22140.x; VOLANAKIS JE, 1978, J IMMUNOL METHODS, V23, P285, DOI 10.1016/0022-1759(78)90203-X; Wang HW, 2001, BIOCHEM BIOPH RES CO, V288, P75, DOI 10.1006/bbrc.2001.5733; Wu Y, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1377, DOI 10.1023/A:1021862027061	57	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1041	1052		10.1074/jbc.M109.044495	http://dx.doi.org/10.1074/jbc.M109.044495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19903811	Green Published, hybrid			2022-12-27	WOS:000273258200025
J	Castellani, M; Covian, R; Kleinschroth, T; Anderka, O; Ludwig, B; Trumpower, BL				Castellani, Michela; Covian, Raul; Kleinschroth, Thomas; Anderka, Oliver; Ludwig, Bernd; Trumpower, Bernard L.			Direct Demonstration of Half-of-the-sites Reactivity in the Dimeric Cytochrome bc(1) Complex ENZYME WITH ONE INACTIVE MONOMER IS FULLY ACTIVE BUT UNABLE TO ACTIVATE THE SECOND UBIQUINOL OXIDATION SITE IN RESPONSE TO LIGAND BINDING AT THE UBIQUINONE REDUCTION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; IRON-SULFUR PROTEIN; ELECTRON-TRANSFER; PARACOCCUS-DENITRIFICANS; Q-CYCLE; REGULATORY INTERACTIONS; CENTER-N; MECHANISM; COMMUNICATION; KINETICS	We previously proposed that the dimeric cytochrome bc(1) complex exhibits half-of-the-sites reactivity for ubiquinol oxidation and rapid electron transfer between bc(1) monomers (Covian, R., Kleinschroth, T., Ludwig, B., and Trumpower, B. L. (2007) J. Biol. Chem. 282, 22289-22297). Here, we demonstrate the previously proposed half-of-the-sites reactivity and intermonomeric electron transfer by characterizing the kinetics of ubiquinol oxidation in the dimeric bc(1) complex from Paracoccus denitrificans that contains an inactivating Y147S mutation in one or both cytochrome b subunits. The enzyme with a Y147S mutation in one cytochrome b subunit was catalytically fully active, whereas the activity of the enzyme with a Y147S mutation in both cytochrome b subunits was only 10-16% of that of the enzyme with fully wild-type or heterodimeric cytochrome b subunits. Enzyme with one inactive cytochrome b subunit was also indistinguishable from the dimer with two wild-type cytochrome b subunits in rate and extent of reduction of cytochromes b and c(1) by ubiquinol under pre-steady-state conditions in the presence of antimycin. However, the enzyme with only one mutated cytochrome b subunit did not show the stimulation in the steady-state rate that was observed in the wildtype dimeric enzyme at low concentrations of antimycin, confirming that the half-of-the-sites reactivity for ubiquinol oxidation can be regulated in the wild-type dimer by binding of inhibitor to one ubiquinone reduction site.	[Castellani, Michela; Kleinschroth, Thomas; Anderka, Oliver; Ludwig, Bernd] Goethe Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Castellani, Michela; Kleinschroth, Thomas; Anderka, Oliver; Ludwig, Bernd] Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany; [Covian, Raul; Trumpower, Bernard L.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Goethe University Frankfurt; Dartmouth College	Ludwig, B (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	ludwig@em.uni-frankfurt.de; trumpower@dartmouth.edu			National Institutes of Health Research [GM 20379]; Deutsche Forschungsgemeinschaft [SFB 472]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Research Grant GM 20379 and Deutsche Forschungsgemeinschaft Grant SFB 472.	ANDERKA O, 2005, THESIS J WOLFGANGGOE; ANTOINE R, 1992, MOL MICROBIOL, V6, P1785, DOI 10.1111/j.1365-2958.1992.tb01351.x; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Cooley JW, 2009, BIOCHEMISTRY-US, V48, P1888, DOI 10.1021/bi802216h; Covian R, 2005, J BIOL CHEM, V280, P22732, DOI 10.1074/jbc.M413592200; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1044, DOI 10.1016/j.bbabio.2008.04.008; Covian R, 2007, J BIOL CHEM, V282, P22289, DOI 10.1074/jbc.M702132200; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Covian R, 2009, J BIOL CHEM, V284, P8605, DOI 10.1074/jbc.M808914200; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; GERHUS E, 1992, THESIS LUBECK MED U; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Margoliash E, 1967, METHOD ENZYMOL, V10, P339; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Saribas AS, 1995, BIOCHEMISTRY-US, V34, P16004, DOI 10.1021/bi00049a014; Schroter T, 1998, EUR J BIOCHEM, V255, P100, DOI 10.1046/j.1432-1327.1998.2550100.x; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yang SQ, 2008, J BIOL CHEM, V283, P28767, DOI 10.1074/jbc.M803013200; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	33	56	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					502	510		10.1074/jbc.M109.072959	http://dx.doi.org/10.1074/jbc.M109.072959			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19892700	Green Published, hybrid			2022-12-27	WOS:000273070100052
J	Chawla, B; Jhingran, A; Singh, S; Tyagi, N; Park, MH; Srinivasan, N; Roberts, SC; Madhubala, R				Chawla, Bhavna; Jhingran, Anupam; Singh, Sushma; Tyagi, Nidhi; Park, Myung Hee; Srinivasan, N.; Roberts, Sigrid C.; Madhubala, Rentala			Identification and Characterization of a Novel Deoxyhypusine Synthase in Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-SUBSTRATE INTERMEDIATE; CELL VIABILITY; AMINO-ACID; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURES; HYPUSINE FORMATION; CRYSTAL-STRUCTURE; PROTEIN; SPERMIDINE; INHIBITION	Deoxyhypusine synthase, an NAD(+)-dependent enzyme, catalyzes the first step in the post-translational synthesis of an unusual amino acid, hypusine (N-epsilon-(4-amino-2-hydroxybutyl)lysine), in the eukaryotic initiation factor 5A precursor protein. Two putative deoxyhypusine synthase (DHS) sequences have been identified in the Leishmania donovani genome, which are present on chromosomes 20: DHSL20 (DHS-like gene from chromosome 20) and DHS34 (DHS from chromosome 34). Although both sequences exhibit an overall conservation of key residues, DHSL20 protein lacks a critical lysine residue, and the recombinant protein showed no DHS activity in vitro. However, DHS34 contains the critical lysine residue, and the recombinant DHS34 effectively catalyzed deoxyhypusine synthesis. Furthermore, in vivo labeling confirmed that hypusination of eukaryotic initiation factor 5A occurs in intact Leishmania parasites. Interestingly, the DHS34 is much longer, with 601 amino acids, compared with the human DHS enzyme (369 amino acids) and contains several unique insertions. To study the physiological role of DHS34 in Leishmania, gene deletion mutations were attempted via targeted gene replacement. However, chromosomal null mutants of DHS34 could only be obtained in the presence of a DHS34-containing episome. The present data provide evidence that DHS34 is essential for L. donovani and that structural differences in the human and leishmanial DHS enzyme may be exploited for designing selective inhibitors against the parasite.	[Chawla, Bhavna; Jhingran, Anupam; Singh, Sushma; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Tyagi, Nidhi; Srinivasan, N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Roberts, Sigrid C.] Pacific Univ, Sch Pharm, Portland, OR 97123 USA	Jawaharlal Nehru University, New Delhi; Indian Institute of Science (IISC) - Bangalore; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Madhubala, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	madhubala@mail.jnu.ac.in	madhubala, Rentala/C-3445-2015	Tyagi, Nidhi/0000-0002-2065-9051; Singh, Sushma/0000-0002-7089-6442; madhubala, rentala/0000-0002-0034-399X	National Institutes of Health; Council of Scientific and Industrial Research, India; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was authored, in whole or in part, by National Institutes of Health staff. This work is supported by a grant from the Council of Scientific and Industrial Research, India ( to R. M.).	ABBRUZZESE A, 1986, J BIOL CHEM, V261, P3085; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; Brochier C, 2004, GENE, V330, P169, DOI 10.1016/j.gene.2004.01.018; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; CHEN KY, 1988, FEBS LETT, V229, P325, DOI 10.1016/0014-5793(88)81149-9; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Gowri VS, 2006, NUCLEIC ACIDS RES, V34, pD243, DOI 10.1093/nar/gkj043; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HANAUSKEABEL HM, 1994, BBA-MOL CELL RES, V1221, P115, DOI 10.1016/0167-4889(94)90003-5; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; JAKUS J, 1993, J BIOL CHEM, V268, P13151; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; Joe YA, 1997, J BIOL CHEM, V272, P32679, DOI 10.1074/jbc.272.51.32679; KANG KR, 1995, J BIOL CHEM, V270, P18408, DOI 10.1074/jbc.270.31.18408; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee GH, 2001, BIOCHEM J, V355, P841, DOI 10.1042/bj3550841; Liao DI, 1998, STRUCTURE, V6, P23, DOI 10.1016/S0969-2126(98)00004-5; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muller S, 2001, TRENDS PARASITOL, V17, P242, DOI 10.1016/S1471-4922(01)01908-0; MURPHEY RJ, 1987, J BIOL CHEM, V262, P15033; Murray HW, 2001, ANTIMICROB AGENTS CH, V45, P2185, DOI 10.1128/AAC.45.8.2185-2197.2001; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Ober D, 2003, J BIOL CHEM, V278, P12805, DOI 10.1074/jbc.M207112200; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1982, J BIOL CHEM, V257, P7217; PARK MH, 1994, J BIOL CHEM, V269, P27827; PARK MH, 1988, J BIOL CHEM, V263, P15264; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Roberts SC, 2001, MOL BIOCHEM PARASIT, V115, P217, DOI 10.1016/S0166-6851(01)00293-6; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SHIBA T, 1971, BIOCHIM BIOPHYS ACTA, V244, P523, DOI 10.1016/0304-4165(71)90069-9; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; WOHL T, 1993, MOL GEN GENET, V241, P305; Wolff EC, 1999, YEAST, V15, P43; WOLFF EC, 1990, J BIOL CHEM, V265, P4793; Wolff EC, 1997, J BIOL CHEM, V272, P15865, DOI 10.1074/jbc.272.25.15865; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170	51	38	42	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					453	463		10.1074/jbc.M109.048850	http://dx.doi.org/10.1074/jbc.M109.048850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880510	hybrid, Green Published			2022-12-27	WOS:000273070100047
J	Lee, SW; Cho, YS; Na, JM; Park, UH; Kang, M; Kim, EJ; Um, SJ				Lee, Sang-Wang; Cho, Yang-Sook; Na, Jung-Min; Park, Ui-Hyun; Kang, Myengmo; Kim, Eun-Joo; Um, Soo-Jong			ASXL1 Represses Retinoic Acid Receptor-mediated Transcription through Associating with HP1 and LSD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND NUCLEAR RECEPTORS; SEX-COMBS GENE; HISTONE H3; DEPENDENT TRANSCRIPTION; ANDROGEN-RECEPTOR; POLYCOMB GROUP; CO-REPRESSOR; LYSINE 9; CHROMATIN; PROTEIN	We previously suggested that ASXL1 (additional sex comb-like 1) functions as either a coactivator or corepressor for the retinoid receptors retinoic acid receptor (RAR) and retinoid X receptor in a cell type-specific manner. Here, we provide clues toward the mechanism underlying ASXL1-mediated repression. Transfection assays in HEK293 or H1299 cells indicated that ASXL1 alone possessing autonomous transcriptional repression activity significantly represses RAR- or retinoid X receptor-dependent transcriptional activation, and the N-terminal portion of ASXL1 is responsible for the repression. Amino acid sequence analysis identified a consensus HP1 (heterochromatin protein 1)-binding site (HP1 box, PXVXL) in that region. Systematic in vitro and in vivo assays revealed that the HP1 box in ASXL1 is critical for the interaction with the chromoshadow domain of HP1. Transcription assays with HP1 box deletion or HP1 alpha knockdown indicated that HP1 alpha is required for ASXL1-mediated repression. Furthermore, we found a direct interaction of ASXL1 with histone H3 demethylase LSD1 through the N-terminal region nearby the HP1-binding site. ASXL1 binding to LSD1 was greatly increased by HP1 alpha, resulting in the formation of a ternary complex. LSD1 cooperates with ASXL1 in transcriptional repression, presumably by removing H3K4 methylation, an active histone mark, but not H3K9 methylation, a repressive histone mark recognized by HP1. This possibility was supported by chromatin immunoprecipitation assays followed by ASXL1 overexpression or knockdown. Overall, this study provides the first evidence that ASXL1 cooperates with HP1 to modulate LSD1 activity, leading to a change in histone H3 methylation and thereby RAR repression.	[Kim, Eun-Joo] Dankook Univ, Dept Mol Biol, Grad Program BK21, Yongin 448701, Gyeonggi Do, South Korea; [Lee, Sang-Wang; Cho, Yang-Sook; Na, Jung-Min; Park, Ui-Hyun; Kang, Myengmo; Um, Soo-Jong] Sejong Univ, Dept Biosci & Biotechnol, Grad Program BK21, Seoul 143747, South Korea	Dankook University; Sejong University	Kim, EJ (corresponding author), Dankook Univ, Dept Mol Biol, Grad Program BK21, 126 Jukjeon Dong, Yongin 448701, Gyeonggi Do, South Korea.	nbrejk@dankook.ac.kr; umsj@sejong.ac.kr			National Research Foundation of Korea; Ministry of Education, Science, and Technology [R11-2005-009-04005-0, R012007-000-10308-0, 2009-0079104]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grants R11-2005-009-04005-0, R012007-000-10308-0, and 2009-0079104 (to S.-J. U.).	Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bel-Vialar S, 2000, DEV BIOL, V224, P238, DOI 10.1006/dbio.2000.9791; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Carbone R, 2006, MOL CELL BIOL, V26, P1288, DOI 10.1128/MCB.26.4.1288-1296.2006; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen YT, 2004, MOL CELL BIOL, V24, P9930, DOI 10.1128/MCB.24.22.9930-9941.2004; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Davie JK, 2002, CURR BIOL, V12, pR59, DOI 10.1016/S0960-9822(01)00674-1; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Fernandes I, 2003, J MOL ENDOCRINOL, V31, P1, DOI 10.1677/jme.0.0310001; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Khetchoumian K, 2008, CELL CYCLE, V7, P3647, DOI 10.4161/cc.7.23.7123; Kinyamu HK, 2004, BBA-GENE STRUCT EXPR, V1677, P30, DOI 10.1016/j.bbaexp.2003.09.015; Kishimoto M, 2006, ENDOCR J, V53, P157, DOI 10.1507/endocrj.53.157; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwon SH, 2008, MOL CELLS, V26, P217; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LANGSTON AW, 1994, CURR OPIN GENET DEV, V4, P550, DOI 10.1016/0959-437X(94)90071-A; LE DB, 1996, EMBO J, V15, P6701; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lee CH, 1999, J BIOL CHEM, V274, P31320, DOI 10.1074/jbc.274.44.31320; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Stallcup MR, 2001, ONCOGENE, V20, P3014, DOI 10.1038/sj.onc.1204325; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wei LN, 2003, ANNU REV PHARMACOL, V43, P47, DOI 10.1146/annurev.pharmtox.43.100901.140301; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; White JH, 2004, VITAM HORM, V68, P123; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	56	70	81	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					18	29		10.1074/jbc.M109.065862	http://dx.doi.org/10.1074/jbc.M109.065862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880879	Green Published, hybrid			2022-12-27	WOS:000273070100004
J	Nakamura, T; Meshitsuka, S; Kitagawa, S; Abe, N; Yamada, J; Ishino, T; Nakano, H; Tsuzuki, T; Doi, T; Kobayashi, Y; Fujii, S; Sekiguchi, M; Yamagata, Y				Nakamura, Teruya; Meshitsuka, Sachiko; Kitagawa, Seiju; Abe, Nanase; Yamada, Junichi; Ishino, Tetsuya; Nakano, Hiroaki; Tsuzuki, Teruhisa; Doi, Takefumi; Kobayashi, Yuji; Fujii, Satoshi; Sekiguchi, Mutsuo; Yamagata, Yuriko			Structural and Dynamic Features of the MutT Protein in the Recognition of Nucleotides with the Mutagenic 8-Oxoguanine Base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSE PYROPHOSPHATASE; ESCHERICHIA-COLI MUTT; X-RAY ANALYSIS; NUDIX HYDROLASE; CRYSTAL-STRUCTURES; HUMAN MTH1; NUCLEOSIDE TRIPHOSPHATASE; DEINOCOCCUS-RADIODURANS; OXIDIZED NUCLEOTIDES; NH EXCHANGE	Escherichia coli MutT hydrolyzes 8-oxo-dGTP to 8-oxo-dGMP, an event that can prevent the misincorporation of 8-oxoguanine opposite adenine in DNA. Of the several enzymes that recognize 8-oxoguanine, MutT exhibits high substrate specificity for 8-oxoguanine nucleotides; however, the structural basis for this specificity is unknown. The crystal structures of MutT in the apo and holo forms and in the binary and ternary forms complexed with the product 8-oxo-dGMP and 8-oxo-dGMP plus Mn2+, respectively, were determined. MutT strictly recognizes the overall conformation of 8-oxo-dGMP through a number of hydrogen bonds. This recognition mode revealed that 8-oxoguanine nucleotides are discriminated from guanine nucleotides by not only the hydrogen bond between the N7-H and O delta(N119) atoms but also by the syn glycosidic conformation that 8-oxoguanine nucleotides prefer. Nevertheless, these discrimination factors cannot by themselves explain the roughly 34,000-fold difference between the affinity of MutT for 8-oxo-dGMP and dGMP. When the binary complex of MutT with 8-oxo-dGMP is compared with the ligand-free form, ordering and considerable movement of the flexible loops surrounding 8-oxo-dGMP in the binary complex are observed. These results indicate that MutT specifically recognizes 8-oxoguanine nucleotides by the ligand-induced conformational change.	[Nakamura, Teruya; Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Meshitsuka, Sachiko; Kitagawa, Seiju; Abe, Nanase; Yamada, Junichi; Ishino, Tetsuya; Nakano, Hiroaki; Doi, Takefumi; Kobayashi, Yuji] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Tsuzuki, Teruhisa] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Fujii, Satoshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Sekiguchi, Mutsuo] Fukuoka Dent Coll, Fukuoka 8140193, Japan	Kumamoto University; Osaka University; Kyushu University; University of Shizuoka; Fukuoka Dental College (FDC)	Yamagata, Y (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	yamagata@gpo.kumamoto-u.ac.jp		Nakamura, Teruya/0000-0003-2013-3057	Ministry of Education, Culture, Sports, Sciences and Technology of Japan	Ministry of Education, Culture, Sports, Sciences and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and the National Project for Protein Structural and Functional Analysis from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan.	ABEYGUNAWARDANA C, 1995, BIOCHEMISTRY-US, V34, P14997, DOI 10.1021/bi00046a006; AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; AU KG, 1988, P NATL ACAD SCI USA, V85, P9163, DOI 10.1073/pnas.85.23.9163; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Brunger A. T., 1992, SYSTEM XRAY CRYSTALL; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CABRERA M, 1988, J BACTERIOL, V170, P5405, DOI 10.1128/jb.170.11.5405-5407.1988; CAMBILLAU C, 1984, J MOL GRAPHICS, V2, P53, DOI 10.1016/0263-7855(84)80036-3; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W.L, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; FRICK DN, 1994, J BIOL CHEM, V269, P1794; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Funahashi J, 2002, J BIOL CHEM, V277, P21792, DOI 10.1074/jbc.M110728200; Gabelli SB, 2007, STRUCTURE, V15, P1014, DOI 10.1016/j.str.2007.06.018; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Harris TK, 2000, BIOCHEMISTRY-US, V39, P1655, DOI 10.1021/bi9918745; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kamiya H, 2001, BIOCHEM BIOPH RES CO, V288, P499, DOI 10.1006/bbrc.2001.5781; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kang LW, 2003, J BACTERIOL, V185, P4110, DOI 10.1128/JB.185.14.4110-4118.2003; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Massiah MA, 2003, BIOCHEMISTRY-US, V42, P10140, DOI 10.1021/bi030105p; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mishima M, 2004, J BIOL CHEM, V279, P33806, DOI 10.1074/jbc.M402393200; Nakamura T, 2004, ACTA CRYSTALLOGR D, V60, P1641, DOI 10.1107/S0907444904016403; Nakamura T, 2006, ACTA CRYSTALLOGR F, V62, P1283, DOI 10.1107/S1744309106049529; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Ranatunga W, 2004, J MOL BIOL, V339, P103, DOI 10.1016/j.jmb.2004.01.065; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; Saenger W., 1984, PRINCIPLES NUCL ACID; Saraswat V, 2004, BIOCHEMISTRY-US, V43, P3404, DOI 10.1021/bi030216o; Saraswat V, 2002, BIOCHEMISTRY-US, V41, P15566, DOI 10.1021/bi020552p; Scarsdale JN, 2006, STRUCTURE, V14, P331, DOI 10.1016/j.str.2005.11.010; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; Shen BW, 2003, J MOL BIOL, V332, P385, DOI 10.1016/S0022-2836(03)00954-9; Shimokawa H, 2000, NUCLEIC ACIDS RES, V28, P3240, DOI 10.1093/nar/28.17.3240; Steyert SR, 2008, J BACTERIOL, V190, P8215, DOI 10.1128/JB.01009-08; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; Takano K, 1999, BIOCHEMISTRY-US, V38, P12698, DOI 10.1021/bi9910169; TCHOU J, 1994, J BIOL CHEM, V269, P15318; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UESUGI S, 1977, J AM CHEM SOC, V99, P2313, DOI 10.1021/ja00449a049; Wakamatsu T, 2008, J BACTERIOL, V190, P1108, DOI 10.1128/JB.01522-07; Wang SS, 2002, ACTA CRYSTALLOGR D, V58, P571, DOI 10.1107/S0907444902001191; Xu WL, 2004, J BACTERIOL, V186, P8380, DOI 10.1128/JB.186.24.8380-8384.2004; Yoshiba S, 2004, J BIOL CHEM, V279, P37163, DOI 10.1074/jbc.M403817200; Zha MW, 2008, J MOL BIOL, V379, P568, DOI 10.1016/j.jmb.2008.04.006; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078	72	38	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					444	452		10.1074/jbc.M109.066373	http://dx.doi.org/10.1074/jbc.M109.066373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864691	hybrid, Green Published			2022-12-27	WOS:000273070100046
J	Poleshko, A; Einarson, MB; Shalginskikh, N; Zhang, RG; Adams, PD; Skalka, AM; Katz, RA				Poleshko, Andrey; Einarson, Margret B.; Shalginskikh, Natalia; Zhang, Rugang; Adams, Peter D.; Skalka, Anna Marie; Katz, Richard A.			Identification of a Functional Network of Human Epigenetic Silencing Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; CHROMATIN MODIFICATIONS; DNA METHYLATION; BINDING MODULES; CANCER; METHYLTRANSFERASE; TRANSCRIPTION; SETDB1; CELLS; H3	Epigenetic silencing is mediated by families of factors that place, remove, read, and transmit repressive histone and DNA methylation marks on chromatin. How the roles for these functionally diverse factors are specified and integrated is the subject of intense study. To address these questions, HeLa cells harboring epigenetically silent green fluorescent protein reporter genes were interrogated with a small interference RNA library targeting 200 predicted epigenetic regulators, including potential activators, silencers, chromatin remodelers, and ancillary factors. Using this approach, individual, or combinatorial requirements for specific epigenetic silencing factors could be detected by measuring green fluorescent protein reactivation after small interference RNA-based factor knockdown. In our analyses, we identified a specific subset of 15 epigenetic factors that are candidates for participation in a functional epigenetic silencing network in human cells. These factors include histone deacetylase 1, de novo DNA methyltransferase 3A, components of the polycomb PRC1 complex (RING1 and HPH2), and the histone lysine methyltransferases KMT1E and KMT5C. Roles were also detected for two TRIM protein family members, the cohesin component Rad21, and the histone chaperone CHAF1A (CAF-1 p150). Remarkably, combinatorial knockdown of factors was not required for reactivation, indicating little functional redundancy. Consistent with this interpretation, knockdown of either KMT1E or CHAF1A resulted in a loss of multiple histone-repressive marks and concomitant gain of activation marks on the promoter during reactivation. These results reveal how functionally diverse factors may cooperate to maintain gene silencing during normal development or in disease. Furthermore, the findings suggest an avenue for discovery of new targets for epigenetic therapies.	[Poleshko, Andrey; Einarson, Margret B.; Shalginskikh, Natalia; Zhang, Rugang; Adams, Peter D.; Skalka, Anna Marie; Katz, Richard A.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Katz, RA (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Richard.Katz@fccc.edu		Poleshko, Andrey/0000-0002-6656-2941; Adams, Peter/0000-0002-0684-1770	National Institutes of Health [CA71515, CA06927, NS053666, DK082498]; Commonwealth of Pennsylvania; American Association for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA071515, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA71515 and CA06927. This work was also supported by an appropriation from the Commonwealth of Pennsylvania.; Recipient of an American Association for Cancer Research Centennial Predoctoral Fellowship in Cancer Research.; Supported by the Pennsylvania Department of Health and by NIH Grants NS053666 and DK082498. Towhomcorrespondence should be addressed: Institute for Cancer Research, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111. Tel.: 215-728-3668; Fax: 215-728-2778; E-mail: Richard.Katz@fccc.edu.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fischle W, 2008, GENE DEV, V22, P3375, DOI 10.1101/gad.1759708; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Groothuis TAM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-21; Hake S B, 2007, Br J Cancer, V96 Suppl, pR31; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Katz RA, 2007, J VIROL, V81, P2592, DOI 10.1128/JVI.01643-06; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lieberman PM, 2006, TRENDS MICROBIOL, V14, P132, DOI 10.1016/j.tim.2006.01.001; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Narezkina A, 2004, J VIROL, V78, P11656, DOI 10.1128/JVI.78.21.11656-11663.2004; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Poleshko A, 2008, J VIROL, V82, P2313, DOI 10.1128/JVI.01882-07; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	51	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					422	433		10.1074/jbc.M109.064667	http://dx.doi.org/10.1074/jbc.M109.064667			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880521	Green Published, hybrid			2022-12-27	WOS:000273070100044
J	Stifanese, R; Averna, M; De Tullio, R; Pedrazzi, M; Beccaria, F; Salamino, F; Milanese, M; Bonanno, G; Pontremoli, S; Melloni, E				Stifanese, Roberto; Averna, Monica; De Tullio, Roberta; Pedrazzi, Marco; Beccaria, Francesco; Salamino, Franca; Milanese, Marco; Bonanno, Giambattista; Pontremoli, Sandro; Melloni, Edon			Adaptive Modifications in the Calpain/Calpastatin System in Brain Cells after Persistent Alteration in Ca2+ Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDE SYNTHASE ISOFORMS; TRANSGENIC-MOUSE MODEL; SUPEROXIDE-DISMUTASE; NITRIC-OXIDE; RAT-BRAIN; CALPASTATIN LOCALIZATION; CALPAIN ACTIVATION; INACTIVE CALPAIN; ALTERED CALCIUM	Persistent dysregulation in Ca2+ homeostasis is a pervasive pathogenic mechanism in most neurodegenerative diseases, and accordingly, calpain activation has been implicated in neuronal cells dysfunction and death. In this study we examined the intracellular functional state of the calpain-calpastatin system in -G93A(+) SOD1 transgenic mice to establish if and how uncontrolled activation of calpain can be prevented in vivo during the course of prolonged [Ca2+](i) elevation. The presented data indicate that 1) calpain activation is more extensive in motor cortex, in lumbar, and sacral spinal cord segments compared with the lower or almost undetectable activation of the protease in other brain areas, 2) direct measurements of the variations of Ca2+ levels established that the degree of the protease activation is correlated to the extent of elevation of [Ca2+](i), 3) intracellular activation of calpain is always associated with diffusion of calpastatin from perinuclear aggregated forms into the cytosol and the formation of a calpain-calpastatin complex, and 4) a conservative fragmentation of calpastatin is accompanied by its increased expression and inhibitory capacity in conditions of prolonged increase in [Ca2+](i). Thus, calpastatin diffusion and formation of the calpain-calpastatin complex together with an increased synthesis of the inhibitor protein represent a cellular defense response to conditions of prolonged dysregulation in intracellular Ca2+ homeostasis. Altogether these findings provide a new understanding of the in vivo molecular mechanisms governing calpain activation that can be extended to many neurodegenerative diseases, potentially useful for the development of new therapeutic approaches.	[Stifanese, Roberto; Averna, Monica; De Tullio, Roberta; Pedrazzi, Marco; Beccaria, Francesco; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Stifanese, Roberto; Averna, Monica; De Tullio, Roberta; Pedrazzi, Marco; Beccaria, Francesco; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Milanese, Marco; Bonanno, Giambattista] Univ Genoa, Dept Expt Med, Pharmacol & Toxicol Sect, I-16147 Genoa, Italy; [Milanese, Marco; Bonanno, Giambattista] Univ Genoa, Ctr Excellence Biomed Res, I-16147 Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa	Melloni, E (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto XV, I-16132 Genoa, Italy.	melloni@unige.it	Milanese, Marco/C-4444-2013; AVERNA, MONICA/R-5719-2019; Bonanno, Giambattista/C-5856-2008; Averna, Maurizio/U-9527-2017; Milanese, Marco/AAB-2238-2021	Milanese, Marco/0000-0003-3384-0666; AVERNA, MONICA/0000-0002-9463-7533; Milanese, Marco/0000-0003-3384-0666; Bonanno, Giambattista/0000-0003-3744-5786	Ministero dell'Istruzione dell'Universita e della Ricerca; University of Genoa	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Genoa	This work was supported in part by grants from Ministero dell'Istruzione dell'Universita e della Ricerca and from the University of Genoa.	Appel SH, 2000, AMYOTROPH LATERAL SC, V1, P27; Araujo IM, 2005, CNS NEUROL DISORD-DR, V4, P319, DOI 10.2174/1568007054546126; Averna M, 2006, FEBS J, V273, P1660, DOI 10.1111/j.1742-4658.2006.05180.x; Averna M, 2003, CELL MOL LIFE SCI, V60, P2669, DOI 10.1007/s00018-003-3288-0; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Averna M, 2001, J BIOL CHEM, V276, P38426, DOI 10.1074/jbc.M101936200; Averna M, 2007, FEBS J, V274, P6116, DOI 10.1111/j.1742-4658.2007.06133.x; Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Averna M, 2009, J NEUROCHEM, V110, P412, DOI 10.1111/j.1471-4159.2009.06149.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coligan JE, 1991, CURRENT PROTOCOL IMM; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; De Tullio R, 1998, FEBS LETT, V422, P113, DOI 10.1016/S0014-5793(97)01588-3; De Tullio R, 2000, FEBS LETT, V475, P17, DOI 10.1016/S0014-5793(00)01613-6; De Tullio R, 2007, ARCH BIOCHEM BIOPHYS, V465, P148, DOI 10.1016/j.abb.2007.05.007; De Tullio R, 2009, BBA-GEN SUBJECTS, V1790, P182, DOI 10.1016/j.bbagen.2008.11.002; ELLIOTT JL, 1995, NEUROREPORT, V6, P449, DOI 10.1097/00001756-199502000-00011; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Higgins Linda S., 1996, Methods (Orlando), V10, P384, DOI 10.1006/meth.1996.0116; Jourdi H, 2009, NEUROPHARMACOLOGY, V56, P876, DOI 10.1016/j.neuropharm.2009.01.015; Kim HJ, 2007, EXP MOL MED, V39, P574, DOI 10.1038/emm.2007.63; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laine R, 1998, MOL PHARMACOL, V54, P305, DOI 10.1124/mol.54.2.305; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; MartinezZaguilan R, 1996, CELL CALCIUM, V19, P337, DOI 10.1016/S0143-4160(96)90074-3; MELLONI E, 1982, BIOCHEM BIOPH RES CO, V106, P731, DOI 10.1016/0006-291X(82)91772-7; Melloni E, 2006, J BIOL CHEM, V281, P24945, DOI 10.1074/jbc.M601449200; PALEJWALA S, 1992, P NATL ACAD SCI USA, V89, P4202, DOI 10.1073/pnas.89.9.4202; Parr T, 2004, ARCH BIOCHEM BIOPHYS, V427, P8, DOI 10.1016/j.abb.2004.04.001; PONTREMOLI S, 1988, J BIOL CHEM, V263, P1915; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; Ray SK, 2006, CURR MED CHEM, V13, P3425, DOI 10.2174/092986706779010342; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Samantaray S, 2008, CNS NEUROL DISORD-DR, V7, P305, DOI 10.2174/187152708784936680; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005; Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210; Simon J., 2000, CALPAIN METHODS PROT, P109; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stifanese R, 2008, ARCH BIOCHEM BIOPHYS, V479, P145, DOI 10.1016/j.abb.2008.09.002; Stifanese R, 2006, ARCH BIOCHEM BIOPHYS, V456, P48, DOI 10.1016/j.abb.2006.09.022; Towbin H, 1992, Biotechnology, V24, P145; TULLIO RD, 1999, BIOCHEM J, V343, P467; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Vanselow BK, 2000, J PHYSIOL-LONDON, V525, P433, DOI 10.1111/j.1469-7793.2000.t01-1-00433.x; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Watson C., 2008, SPINAL CORD; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Zhou MO, 2009, EXP NEUROL, V218, P75, DOI 10.1016/j.expneurol.2009.04.006	61	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					631	643		10.1074/jbc.M109.031674	http://dx.doi.org/10.1074/jbc.M109.031674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880516	hybrid, Green Published			2022-12-27	WOS:000273070100064
J	Yoon, CH; Kim, MJ; Park, MJ; Park, IC; Hwang, SG; An, S; Choi, YH; Yoon, G; Lee, SJ				Yoon, Chang-Hwan; Kim, Min-Jung; Park, Myung-Jin; Park, In-Chul; Hwang, Sang-Gu; An, Sungkwan; Choi, Yung-Hyun; Yoon, Gyesoon; Lee, Su-Jae			Claudin-1 Acts through c-Abl-Protein Kinase C delta (PKC delta) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; REDUCED EXPRESSION; GLIOMA-CELLS; IN-VITRO; METASTASIS; GROWTH; ACTIVATION; RECEPTOR; PATHWAY	Claudins are identified as members of the tetraspanin family of proteins, which are integral to the structure and function of tight junction. Recent studies showed an increase in expression of claudins during tumorigenesis, which is associated with loss of cell-cell contact, dedifferentiation, and invasiveness. However, the molecular basis for the causal relationship between claudin expression and cancer progression is not fully understood yet. In this study, we show that claudin-1 plays a causal role in the acquisition of invasive capacity in human liver cells and that c-Abl-protein kinase C delta (PKC delta) signaling is critical for the malignant progression induced by claudin-1. Overexpression of claudin-1 clearly induced expression of matrix metalloproteinase-2 (MMP-2) and cell invasion and migration in normal liver cells as well as in non-invasive human hepatocellular carcinoma (HCC) cells. Conversely, small interfering RNA targeting of claudin-1 in invasive HCC cells completely inhibited cell invasion. Both c-Abl and PKC delta are found to be activated in normal liver cell line clones that stably overexpress claudin-1. Inhibition of either c-Abl or PKC delta alone clearly attenuated MMP-2 activation and impeded cell invasion and migration in both human HCC and normal liver cells expressing claudin-1. These results indicate that claudin-1 is both necessary and sufficient to induce invasive behavior in human liver cells and that activation of c-Abl-PKC delta signaling pathway is critically required for the claudin-1-induced acquisition of the malignant phenotype. The present observations raise the possibility of exploiting claudin-1 as a potential biomarker for the spread of liver cancer and might provide pivotal points for therapeutic intervention in HCC.	[Yoon, Chang-Hwan; Kim, Min-Jung; Lee, Su-Jae] Hanyang Univ, Dept Chem, Res Inst Nat Sci, Seoul 133791, South Korea; [Park, Myung-Jin; Park, In-Chul; Hwang, Sang-Gu] Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul 139706, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea; [Choi, Yung-Hyun] Dong Eui Univ, Dept Biochem, Coll Oriental Med, Pusan 614052, South Korea; [Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea	Hanyang University; Korea Institute of Radiological & Medical Sciences; Konkuk University; Dong-Eui University; Ajou University	Lee, SJ (corresponding author), Hanyang Univ, Dept Chem, Res Inst Nat Sci, 17 Haengdang Dong, Seoul 133791, South Korea.	sj0420@hanyang.ac.kr	Yoon, Changhwan/AAK-7842-2021	Yoon, Changhwan/0000-0002-8420-9818	Korea Science and Engineering Foundation; Ministry of Education, Science and Technology, Korean government; National Nuclear Technology Program; Program of Basic Atomic Energy Research Institute	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology, Korean government; National Nuclear Technology Program; Program of Basic Atomic Energy Research Institute	This work was supported by grants from the Korea Science and Engineering Foundation and Ministry of Education, Science and Technology, Korean government, through its National Nuclear Technology Program and Program of Basic Atomic Energy Research Institute.	AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bello IO, 2008, HUM PATHOL, V39, P1212, DOI 10.1016/j.humpath.2007.12.015; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; Brenner W, 2008, INT J ONCOL, V32, P1125; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheung ST, 2005, CLIN CANCER RES, V11, P551; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Ip YC, 2007, MOL CANCER THER, V6, P2858, DOI 10.1158/1535-7163.MCT-07-0453; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kharait S, 2006, BIOCHEM BIOPH RES CO, V343, P848, DOI 10.1016/j.bbrc.2006.03.044; Kiley SC, 1999, CANCER RES, V59, P3230; Kim TH, 2008, HISTOPATHOLOGY, V53, P48, DOI 10.1111/j.1365-2559.2008.03052.x; Koch A, 2008, ONCOGENE, V27, P4678, DOI 10.1038/onc.2008.107; Koizumi JI, 2008, MOL PHARMACOL, V74, P432, DOI 10.1124/mol.107.043711; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Li WQ, 2000, CANCER RES, V60, P3909; Mandil R, 2001, CANCER RES, V61, P4612; Michl P, 2003, CANCER RES, V63, P6265; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Miyata Y, 2004, MOL CANCER THER, V3, P839; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Oshima T, 2008, ONCOL REP, V19, P953; Park MJ, 2000, NEUROSCI LETT, V290, P201, DOI 10.1016/S0304-3940(00)01358-6; Paschoud S, 2007, MODERN PATHOL, V20, P947, DOI 10.1038/modpathol.3800835; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Podtcheko A, 2003, J CLIN ENDOCR METAB, V88, P1889, DOI 10.1210/jc.2002-021230; Sakaguchi T, 2008, J SURG RES, V147, P123, DOI 10.1016/j.jss.2007.07.013; Soini Y, 2005, HISTOPATHOLOGY, V46, P551, DOI 10.1111/j.1365-2559.2005.02127.x; Soini Y, 2004, HUM PATHOL, V35, P1531, DOI 10.1016/j.humpath.2004.09.015; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Suzuki J, 2007, J BIOCHEM, V141, P453, DOI 10.1093/jb/mvm059; Szmydynger-Chodobska Joanna, 2007, Cerebrospinal Fluid Res, V4, P11, DOI 10.1186/1743-8454-4-11; Usami Y, 2006, HUM PATHOL, V37, P569, DOI 10.1016/j.humpath.2005.12.018; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F	43	75	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					226	233		10.1074/jbc.M109.054189	http://dx.doi.org/10.1074/jbc.M109.054189			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19897486	Green Published, hybrid			2022-12-27	WOS:000273070100024
J	Kupka, M; Zhang, J; Fu, WL; Tu, JM; Bohm, S; Su, P; Chen, Y; Zhou, M; Scheer, H; Zhao, KH				Kupka, Michaela; Zhang, Juan; Fu, Wei-Lei; Tu, Jun-Ming; Boehm, Stephan; Su, Ping; Chen, Yu; Zhou, Ming; Scheer, Hugo; Zhao, Kai-Hong			Catalytic Mechanism of S-type Phycobiliprotein Lyase CHAPERONE-LIKE ACTION AND FUNCTIONAL AMINO ACID RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO ATTACHMENT; CHROMOPHORE ATTACHMENT; ALPHA-SUBUNIT; BILIN LYASE; BETA-PHYCOCYANIN; GAF DOMAIN; CPCS-I; PHYTOCHROME; CYANOBACTERIUM; PHYCOERYTHROCYANIN	The phycobilin: cysteine 84-phycobiliprotein lyase, CpcS1, catalyzes phycocyanobilin (PCB) and phycoerythrobilin (PEB) attachment at nearly all cysteine 82 binding sites (consensus numbering) of phycoerythrin, phycoerythrocyanin, phycocyanin, and allophycocyanin (Zhao, K. H., Su, P., Tu, J. M., Wang, X., Liu, H., Ploscher, M., Eichacker, L., Yang, B., Zhou, M., and Scheer, H. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 14300-14305). We now show that CpcS1 binds PCB and PEB rapidly with bi-exponential kinetics (38/119 and 12/8300 ms, respectively). Chromophore binding to the lyase is reversible and much faster than the spontaneous, but low fidelity chromophore addition to the apo-protein in the absence of the lyase. This indicates kinetic control by the enzyme, which then transfers the chromophore to the apo-protein in a slow (tens of minutes) but stereo-and regioselectively corrects the reaction. This mode of action is reminiscent of chaperones but does not require ATP. The amino acid residues Arg-18 and Arg-149 of the lyase are essential for chromophore attachment in vitro and in Escherichia coli, mutations of His-21, His-22, Trp-75, Trp140, and Arg-147 result in reduced activity (<30% of wild type in vitro). Mutants R147Q and W69M were active but had reduced capacity for PCB binding; additionally, with W69M there was loss of fidelity in chromophore attachment. Imidazole is a noncompetitive inhibitor, supporting a bilin-binding function of histidine. Evidence was obtained that CpcS1 also catalyzes exchange of C-beta 84-bound PCB in biliproteins by PEB.	[Zhang, Juan; Tu, Jun-Ming; Su, Ping; Chen, Yu; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Kupka, Michaela; Tu, Jun-Ming; Boehm, Stephan; Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany; [Fu, Wei-Lei; Chen, Yu; Zhou, Ming] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Tu, Jun-Ming; Su, Ping] Hubei Normal Univ, Coll Life Sci, Huangshi 435002, Hubei, Peoples R China	Huazhong Agricultural University; University of Munich; Huazhong University of Science & Technology; Hubei Normal University	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com			Chinese Scholarship Council; Volkswagen Foundation [I/77900]; Deutsche Forschungsgemeinschaft [SFB 533/TPA1]; National Natural Science Foundation of China [30670489, 30870541]	Chinese Scholarship Council(China Scholarship Council); Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the Chinese Scholarship Council for a Ph. D. stipendium.; Supported by the Volkswagen Foundation for a Partnership (I/77900).; Supported by the Deutsche Forschungsgemeinschaft (Grant SFB 533/TPA1).; Supported by the National Natural Science Foundation of China (Grants 30670489 and 30870541).	ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; ARCIERO DM, 1988, J BIOL CHEM, V263, P18350; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; BISWAS A, 2010, RECENT ADV IN PRESS; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; BOGORAD L, 1975, ANNU REV PLANT PHYS, V26, P369, DOI 10.1146/annurev.pp.26.060175.002101; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; Dammeyer T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1121, DOI 10.1039/b807209b; DEFORCE L, 1993, BIOCHEMISTRY-US, V32, P14165, DOI 10.1021/bi00214a014; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Falk H., 1989, CHEM LINEAR OLIGOPYR; FLOWER DR, 1995, J MOL RECOGNIT, V8, P185, DOI 10.1002/jmr.300080304; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; FUGLISTALLER P, 1981, ARCH MICROBIOL, V129, P268, DOI 10.1007/BF00414696; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; Glazer A. N, 1994, ADV MOL CELL BIOL, V10, P119; GLAZER AN, 1973, J BIOL CHEM, V248, P659; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; LING MF, 1995, ANAL BIOCHEM, V230, P167, DOI 10.1006/abio.1995.1452; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; SCHEER H, 1977, H-S Z PHYSIOL CHEM, V358, P185, DOI 10.1515/bchm2.1977.358.1.185; Scheer H, 2003, LIGHT HARVESTING ANT, P29; Scheer H., 1982, LIGHT REACTION PATH, P7; Schluchter W.M., 2002, HEME CHLOROPHYLL BIL, P311, DOI DOI 10.1385/1-59259-243-0:311; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; SCHMIDT G, 1988, PHOTOSYNTHETIC LIGHT, P77; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; STORF M, 2004, THESIS L MAXIMILIANS; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; Tu JM, 2008, PHOTOSYNTH RES, V95, P163, DOI 10.1007/s11120-007-9251-4; Tu JM, 2009, J AM CHEM SOC, V131, P5399, DOI 10.1021/ja9002348; Turkarslan S, 2006, MOL MICROBIOL, V60, P537, DOI 10.1111/j.1365-2958.2006.05148.x; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X	62	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36405	36414		10.1074/jbc.M109.056382	http://dx.doi.org/10.1074/jbc.M109.056382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864423	Green Published, hybrid			2022-12-27	WOS:000272970500042
J	Sakuraba, Y; Tanaka, R; Yamasato, A; Tanaka, A				Sakuraba, Yasuhito; Tanaka, Ryouichi; Yamasato, Akihiro; Tanaka, Ayumi			Determination of a Chloroplast Degron in the Regulatory Domain of Chlorophyllide a Oxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE RECOGNITION; DEGRADE PROTEINS; B BIOSYNTHESIS; HEMA PROTEIN; CLP PROTEASE; BINDING; GENE; CAO; PROTEOLYSIS; EXPRESSION	Chlorophyll b is one of the major photosynthetic pigments of plants. The regulation of chlorophyll b biosynthesis is important for plants in order to acclimate to changing environmental conditions. In the chloroplast, chlorophyll b is synthesized from chlorophyll a by chlorophyllide a oxygenase (CAO), a Rieske-type monooxygenase. The activity of this enzyme is regulated at the level of protein stability via a feedback mechanism through chlorophyll b. The Clp protease and the N-terminal domain (designated the A domain) of CAO are essential for the regulatory mechanism. In this study, we aimed to identify the specific amino acid residue or the sequence within the A domain that is essential for this regulation. To accomplish this goal, we randomly introduced base substitutions into the A domain and searched for potentially important residues by analyzing 1,000 transformants of Arabidopsis thaliana. However, none of the single amino acid substitutions significantly stabilized CAO. Therefore, we generated serial deletions in the A domain and expressed these deletions in the background of CAO-deficient Arabidopsis mutant. We found that the amino acid sequence (97)QDLLTIMILH(106) is essential for the regulation of the protein stability. We furthermore determined that this sequence induces the destabilization of green fluorescent protein. These results suggest that this sequence serves as a degradation signal that is recognized by proteases functioning in the chloroplast.	[Sakuraba, Yasuhito; Tanaka, Ryouichi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Yamasato, Akihiro] Res Inst Biol Sci Okayama, Okayama 7161241, Japan	Hokkaido University	Sakuraba, Y (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19 W8, Sapporo, Hokkaido 0600819, Japan.	sakuraba@pop.lowtem.hokudai.ac.jp	Tanaka, Ryouichi/A-4030-2012; Tanaka, Ayumi/D-9003-2012	Tanaka, Ryouichi/0000-0002-5858-5326; Sakuraba, Yasuhito/0000-0002-0432-6767	Ministry of Education, Culture, Sports, Science and Technology, Japan [17770027, 17GS0314]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant-in-aid for Scientific Research 17770027 (to R. T.) and Grant-in-Aid for Creative Scientific Research 17GS0314 (to A. T.).	Adam Z, 2000, BIOCHIMIE, V82, P647, DOI 10.1016/S0300-9084(00)00612-X; Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Bechtold N, 1998, METH MOL B, V82, P259; BELLEMARE G, 1982, J BIOL CHEM, V257, P7762; BOGUSKI MS, 1986, J LIPID RES, V27, P1011; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; GAUBIER P, 1995, MOL GEN GENET, V249, P58, DOI 10.1007/BF00290236; Gonzalez M, 1998, ACTA BIOCHIM POL, V45, P163, DOI 10.18388/abp.1998_4298; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Harper AL, 2004, PHOTOSYNTH RES, V79, P149, DOI 10.1023/B:PRES.0000015375.40167.76; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; HUMPHREYS GO, 1976, MOL GEN GENET, V145, P101, DOI 10.1007/BF00331564; Kanematsu S, 2008, PHOTOCH PHOTOBIO SCI, V7, P1196, DOI 10.1039/b802584n; Kato Y, 2004, PLANTA, V220, P97, DOI 10.1007/s00425-004-1328-0; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kuttkat A, 1997, J BIOL CHEM, V272, P20451, DOI 10.1074/jbc.272.33.20451; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Majeran W, 2000, PLANT CELL, V12, P137; Masuda T, 2003, PLANT MOL BIOL, V51, P757, DOI 10.1023/A:1022545118212; MELIS A, 1991, BIOCHIM BIOPHYS ACTA, V1058, P87, DOI 10.1016/S0005-2728(05)80225-7; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Nagata N, 2004, PLANTA, V218, P1019, DOI 10.1007/s00425-003-1181-6; Nakagawara E, 2007, PLANT J, V49, P800, DOI 10.1111/j.1365-313X.2006.02996.x; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Oster U, 1997, J BIOL CHEM, V272, P9671; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Pattanayak GK, 2005, BIOCHEM BIOPH RES CO, V326, P466, DOI 10.1016/j.bbrc.2004.11.049; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Sakuraba Y, 2007, PLANT PHYSIOL BIOCH, V45, P740, DOI 10.1016/j.plaphy.2007.07.016; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Wang LY, 1999, J BACTERIOL, V181, P6033, DOI 10.1128/JB.181.19.6033-6041.1999; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518	44	42	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36689	36699		10.1074/jbc.M109.008144	http://dx.doi.org/10.1074/jbc.M109.008144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843523	Green Published, hybrid			2022-12-27	WOS:000272970500069
J	Shi, HF; Chamond, N; Djikeng, A; Tschudi, C; Ullu, E				Shi, Huafang; Chamond, Nathalie; Djikeng, Appolinaire; Tschudi, Christian; Ullu, Elisabetta			RNA Interference in Trypanosoma brucei ROLE OF THE N-TERMINAL RGG DOMAIN AND THE POLYRIBOSOME ASSOCIATION OF ARGONAUTE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ARGININE METHYLTRANSFERASE; MESSENGER-RNAS; ARGONAUTE PROTEIN; PASSENGER-STRAND; FAMILY-MEMBERS; HUMAN-CELLS; IN-VITRO; DROSOPHILA; SIRNA; TRANSLATION	Argonaute proteins (AGOs) are central to RNA interference (RNAi) and related silencing pathways. At the core of the RNAi pathway in the ancient parasitic eukaryote Trypanosoma brucei is a single Argonaute protein, TbAGO1, with an established role in the destruction of potentially harmful retroposon transcripts. One notable feature of TbAGO1 is that a fraction sediments with polyribosomes, and this association is facilitated by an arginine/glycine-rich domain (RGG domain) at the N terminus of the protein. Here we report that reducing the size of the RGG domain and, in particular, mutating all arginine residues severely reduced the association of TbAGO1 with polyribosomes and RNAi-induced cleavage of mRNA. However, these mutations did not change the cellular localization of Argonaute and did not affect the accumulation of single-stranded siRNAs, an essential step in the activation of the RNA-induced silencing complex. We further show that mRNA on polyribosomes can be targeted for degradation, although this alliance is not a pre-requisite. Finally, sequestering tubulin mRNAs from translation with antisense morpholino oligonucleotides reduced the RNAi response indicating that mRNAs not engaged in translation may be less accessible to the RNAi machinery. We conclude that the association of the RNAi machinery and target mRNA on polyribosomes promotes an efficient RNAi response. This mechanism may represent an ancient adaptation to ensure that retroposon transcripts are efficiently destroyed, if they become associated with the translational apparatus.	[Shi, Huafang; Chamond, Nathalie; Djikeng, Appolinaire; Ullu, Elisabetta] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Tschudi, Christian] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06536 USA; [Ullu, Elisabetta] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University; Yale University	Tschudi, C (corresponding author), 295 Congress Ave,BCMM 136C,Box 9812, New Haven, CT 06536 USA.	christian.tschudi@yale.edu	Chamond, Nathalie/C-5907-2018	Djikeng, Appolinaire/0000-0001-9271-3419; Chamond, Nathalie/0000-0002-0518-2929	National Institutes of Health [AI28798, AI43594]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028798, R01AI028798, R01AI043594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI28798 (to E. U.) and AI43594 (to C. T.).	BANGS JD, 1993, J CELL SCI, V105, P1101; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Djikeng A, 2003, RNA, V9, P802, DOI 10.1261/rna.5270203; Djikeng A, 2001, RNA, V7, P1522; Durand-Dubief M, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-2; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207; Kinch LN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-2; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Pasternack DA, 2007, EUKARYOT CELL, V6, P1665, DOI 10.1128/EC.00133-07; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Sen GL, 2005, DIFFERENTIATION, V73, P287, DOI 10.1111/j.1432-0436.2005.00029.x; Shi HF, 2004, J BIOL CHEM, V279, P49889, DOI 10.1074/jbc.M409280200; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Shi HF, 2007, RNA, V13, P1132, DOI 10.1261/rna.474707; Shi H, 2006, RNA, V12, P943, DOI 10.1261/rna.20806; STIEGER J, 1984, J BIOL CHEM, V259, P4596; Stoica C, 2006, J BIOL CHEM, V281, P37646, DOI 10.1074/jbc.M604476200; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Ullu E, 2002, PHILOS T ROY SOC B, V357, P65, DOI 10.1098/rstb.2001.0952; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460	54	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36511	36520		10.1074/jbc.M109.073072	http://dx.doi.org/10.1074/jbc.M109.073072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19880512	Green Published, hybrid			2022-12-27	WOS:000272970500053
J	Guillot-Sestier, MV; Sunyach, C; Druon, C; Scarzello, S; Checler, F				Guillot-Sestier, Marie-Victoire; Sunyach, Claire; Druon, Charlotte; Scarzello, Sabine; Checler, Frederic			The alpha-Secretase-derived N-terminal Product of Cellular Prion, N1, Displays Neuroprotective Function in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; PRIMARY CULTURED NEURONS; HEK293 HUMAN-CELLS; CASPASE-3 ACTIVATION; TRANSGENIC MICE; WILD-TYPE; ISCHEMIC TOLERANCE; APOPTOTIC STIMULI; SERUM DEPRIVATION; TUMOR SUPPRESSION	Cellular prion protein (PrPc) undergoes a disintegrin-mediated physiological cleavage, generating a soluble amino-terminal fragment (N1), the function of which remained unknown. Recombinant N1 inhibits staurosporine-induced caspase-3 activation by modulating p53 transcription and activity, whereas the PrPc-derived pathological fragment (N2) remains biologically inert. Furthermore, N1 protects retinal ganglion cells from hypoxia-induced apoptosis, reduces the number of terminal deoxynucleotidyltransferase-mediated biotinylated UTP nick end labeling-positive and p53-immunoreactive neurons in a pressure-induced ischemia model of the rat retina and triggers a partial recovery of b-waves but not a-waves of rat electroretino-grams. Our work is the first demonstration that the alpha-secretase-derived PrPc fragment N1, but not N2, displays in vivo and in vitro neuroprotective function by modulating p53 pathway. It further demonstrates that distinct N-terminal cleavage products of PrPc harbor different biological activities underlying the various phenotypes linking PrPc to cell survival.	[Checler, Frederic] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; CNRS, Inst Neuromed Mol, UMR6097, UNSA,Equipe Labellisee Fdn Rech Med, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Checler, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750; Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114	CNRS; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by CNRS, the Federation pour la Recherche sur le Cerveau, and the Fondation pour la Recherche Medicale.	Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cui QL, 2006, NEUROCHEM INT, V48, P383, DOI 10.1016/j.neuint.2005.11.014; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; De Sarno P, 2003, J BIOL CHEM, V278, P11086, DOI 10.1074/jbc.M212157200; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Dupiereux I, 2008, J NEUROSCI RES, V86, P653, DOI 10.1002/jnr.21506; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Ettaiche M, 1999, INVEST OPHTH VIS SCI, V40, P729; Ettaiche M, 2001, BRAIN RES, V890, P118, DOI 10.1016/S0006-8993(00)03152-8; Ettaiche M, 2006, J NEUROSCI, V26, P5800, DOI 10.1523/JNEUROSCI.0344-06.2006; Gougoumas DD, 2007, J CELL PHYSIOL, V211, P551, DOI 10.1002/jcp.20969; Grabb MC, 1999, J NEUROSCI, V19, P1657; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lee DC, 2006, MICROBIOL IMMUNOL, V50, P203, DOI 10.1111/j.1348-0421.2006.tb03787.x; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; LINDENBOIM L, 1995, J NEUROCHEM, V64, P2491; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Paitel E, 2002, J NEUROCHEM, V83, P1208, DOI 10.1046/j.1471-4159.2002.01234.x; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rosenbaum DM, 1998, INVEST OPHTH VIS SCI, V39, P2132; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Sunyach C, 2005, J NEUROCHEM, V92, P1399, DOI 10.1111/j.1471-4159.2004.02989.x; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Vassallo N, 2005, BIOCHEM BIOPH RES CO, V332, P75, DOI 10.1016/j.bbrc.2005.04.099; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 1996, J NEUROSCI, V16, P5049; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V349, P759, DOI 10.1016/j.bbrc.2006.08.116	59	117	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35973	35986		10.1074/jbc.M109.051086	http://dx.doi.org/10.1074/jbc.M109.051086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850936	hybrid, Green Published			2022-12-27	WOS:000272645600072
J	Tadokoro, T; Ikekita, M; Toda, T; Ito, H; Sato, T; Nakatani, R; Hamaguchi, Y; Furukawa, K				Tadokoro, Tomomi; Ikekita, Masahiko; Toda, Tosifusa; Ito, Hiroko; Sato, Takeshi; Nakatani, Ryunosuke; Hamaguchi, Yu; Furukawa, Kiyoshi			Involvement of Galectin-3 with Vascular Cell Adhesion Molecule-1 in Growth Regulation of Mouse BALB/3T3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING PROTEIN-35; PSATHYRELLA-VELUTINA LECTIN; BREAST-CARCINOMA CELLS; LINKED OLIGOSACCHARIDES; PHOSPHATIDYLINOSITOL 3-KINASE; STRUCTURAL DETERMINANTS; MEMBRANE-GLYCOPROTEINS; NEUROTROPHIC FACTOR; ENDOGENOUS LECTINS; PROTEOMIC ANALYSIS	beta-Galactose residues on N-glycans have been implicated to be involved in growth regulation of cells. In the present study we compared the galactosylation of cell surface N-glycans of mouse Balb/3T3 cells between 30 and 100% densities and found the beta-1,4-galactosylation of N-glycans increases predominantly in a 100-kDa protein band on lectin blot analysis in combination with digestions by diplococcal beta-galactosidase and N-glycanase. When cells at 100% density were treated with jack bean beta-galactosidase, the incorporation of 5-bromodeoxyuridine into the cells was stimulated in a dose-dependent manner, suggesting the involvement of the galactose residues in growth regulation of cells. A galactose-binding protein was isolated from the plasma membranes of cells at 100% density by affinity chromatography using an asialo-transferrin-Sepharose column and found to be galectin-3 as revealed by mass spectrometric analysis. The addition of recombinant galectin-3 into cells at 50% density inhibited the incorporation of 5-bromodeoxyuridine in a dose-dependent manner, but the inhibition was prevented with haptenic sugar. An immunocytochemical study showed that galectin-3 is present at the surface of cells at 100% density but not at 30% density where it locates inside the cells. Several glycoproteins bind to a galectin-3-immobilized column, a major of which was identified as vascular cell adhesion molecule (VCAM)-1. Immunocytochemical studies showed that some galectin-3 and VCAM-1 co-localize at the surface of cells at 100% density, indicating that the binding of galectin-3 secreted from cells to VCAM-1 is one of the pathways involved in the growth regulation of Balb/3T3 cells.	[Hamaguchi, Yu; Furukawa, Kiyoshi] Nagaoka Univ Technol, Dept Bioengn, Lab Glycobiol, Nagaoka, Niigata 9402188, Japan; [Tadokoro, Tomomi] Japan Sci & Technol Agcy Innovat Plaza Niigata, Nagaoka, Niigata 9402127, Japan; [Ikekita, Masahiko] Tokyo Univ Sci, Grad Sch Sci & Technol, Noda, Chiba 2780022, Japan; [Toda, Tosifusa] Tokyo Metropolitan Inst Gerontol, Prote Collaborat Ctr, Itabashi Ku, Tokyo 1730015, Japan; [Ito, Hiroko] Tokyo Metropolitan Inst Gerontol, Dept Biosignal Res, Itabashi Ku, Tokyo 1730015, Japan	Nagaoka University of Technology; Japan Science & Technology Agency (JST); Tokyo University of Science; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology	Furukawa, K (corresponding author), Nagaoka Univ Technol, Dept Bioengn, Lab Glycobiol, Kamitomioka 1603-1, Nagaoka, Niigata 9402188, Japan.	furukawa@vos.nagaokaut.ac.jp			Ministry of Education, Science, Culture, and Sports of Japan [10680696, 09240104, 14580707]; Japan Science Technology Agency; Nagaoka University of Technology	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Nagaoka University of Technology	This work was supported by Grants-in-aid for Scientific Research 10680696, 09240104, and 14580707 from the Ministry of Education, Science, Culture, and Sports of Japan, by the Research Promotion Fund from the Japan Science Technology Agency, and by Institutional Grants in 2006 and 2007 from Nagaoka University of Technology ( to K. F.).	BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Bullock SL, 2001, J AM SOC NEPHROL, V12, P515, DOI 10.1681/ASN.V123515; COWLES EA, 1990, J BIOL CHEM, V265, P17706; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DWEK RA, 1995, SCIENCE, V269, P1234, DOI 10.1126/science.7652569; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; ENDO T, 1992, J BIOL CHEM, V267, P707; Fischer C, 2005, J BIOL CHEM, V280, P37266, DOI 10.1074/jbc.M411580200; FRIGERI LG, 1990, J BIOL CHEM, V265, P20763; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; FURUKAWA K, 1990, INT IMMUNOL, V2, P105, DOI 10.1093/intimm/2.1.105; GRADL G, 1995, CURR BIOL, V5, P526, DOI 10.1016/S0960-9822(95)00105-9; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; HAHN TJ, 1992, J BIOL CHEM, V267, P23982; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Hughes RC, 2001, BIOCHIMIE, V83, P667; Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jiang JH, 2006, J BIOL CHEM, V281, P9482, DOI 10.1074/jbc.M504489200; John CM, 2003, CLIN CANCER RES, V9, P2374; Kitamura N, 2004, J NEUROSCI RES, V75, P384, DOI 10.1002/jnr.10870; Kitamura N, 2005, P NATL ACAD SCI USA, V102, P2796, DOI 10.1073/pnas.0409344102; Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200; Lazaar AL, 2001, J IMMUNOL, V166, P155, DOI 10.4049/jimmunol.166.1.155; LI SC, 1975, J BIOL CHEM, V250, P6786; Maeda N, 2003, J BIOL CHEM, V278, P18938, DOI 10.1074/jbc.M209673200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MERKLE RK, 1987, METHOD ENZYMOL, V138, P232; MOUTSATSOS IK, 1986, J CELL BIOL, V102, P477, DOI 10.1083/jcb.102.2.477; MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PAULSON JC, 1978, J BIOL CHEM, V253, P5617; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; SANTER UV, 1984, CANCER RES, V44, P3730; Sasaki T, 2004, GLYCOBIOLOGY, V14, P357, DOI 10.1093/glycob/cwh043; SATO S, 1992, J BIOL CHEM, V267, P6983; SATO T, 1993, J BIOCHEM-TOKYO, V114, P890, DOI 10.1093/oxfordjournals.jbchem.a124273; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Toda T, 2000, ELECTROPHORESIS, V21, P1814, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1814::AID-ELPS1814>3.3.CO;2-R; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; VONDERHEIDE RH, 1992, J EXP MED, V175, P1433, DOI 10.1084/jem.175.6.1433; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; WIESER RJ, 1990, J CELL BIOL, V111, P2681, DOI 10.1083/jcb.111.6.2681; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737	54	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35556	35563		10.1074/jbc.M109.063339	http://dx.doi.org/10.1074/jbc.M109.063339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858221	Green Published, hybrid			2022-12-27	WOS:000272645600032
J	Challand, MR; Martins, FT; Roach, PL				Challand, Martin R.; Martins, Filipa T.; Roach, Peter L.			Catalytic Activity of the Anaerobic Tyrosine Lyase Required for Thiamine Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SAM SUPERFAMILY; S-ADENOSYLMETHIONINE; THIAZOLE SYNTHASE; BACILLUS-SUBTILIS; IN-VITRO; PROTEIN SUPERFAMILY; BIOTIN SYNTHASE; PRODUCT; IDENTIFICATION; COMPLEX	Thiazole synthase in Escherichia coli is an alpha beta heterodimer of ThiG and ThiH. ThiH is a tyrosine lyase that cleaves the C alpha-C beta bond of tyrosine, generating p-cresol as a by-product, to form dehydroglycine. This reactive intermediate acts as one of three substrates for the thiazole cyclization reaction catalyzed by ThiG. ThiH is a radical S-adenosylmethionine (AdoMet) enzyme that utilizes a [4Fe-4S](+) cluster to reductively cleave AdoMet, forming methionine and a 5'-deoxyadenosyl radical. Analysis of the time-dependent formation of the reaction products 5'-deoxyadenosine (DOA) and p-cresol has demonstrated catalytic behavior of the tyrosine lyase. The kinetics of product formation showed a pre-steady state burst phase, and the involvement of DOA in product inhibition was identified by the addition of 5'-methylthioadenosine/ S-adenosylhomocysteine nucleosidase to activity assays. This hydrolyzed the DOA and changed the rate-determining step but, in addition, substantially increased the uncoupled turnover of AdoMet. Addition of glyoxylate and ammonium inhibited the tyrosine cleavage reaction, but the reductive cleavage of AdoMet continued in an uncoupled manner. Tyrosine analogues were incubated with ThiGH, which showed a strong preference for phenolic substrates. 4-Hydroxyphenylpropionic acid analogues allowed uncoupled AdoMet cleavage but did not result in further reaction (C alpha-C beta bond cleavage). The results of the substrate analogue studies and the product inhibition can be explained by a mechanistic hypothesis involving two reaction pathways, a product-forming pathway and a futile cycle.	[Challand, Martin R.; Martins, Filipa T.; Roach, Peter L.] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England	University of Southampton	Roach, PL (corresponding author), Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England.	plr2@soton.ac.uk	Challand, Martin/C-6395-2015; Roach, Peter/C-6248-2013; Roach, Peter/AAW-7071-2021	Challand, Martin/0000-0002-9685-3504; Roach, Peter/0000-0001-9880-2877	Biotechnology and Biological Sciences Research Council; Royal Society; University of Southampton	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); University of Southampton	This work was supported by the Biotechnology and Biological Sciences Research Council, the Royal Society, and the University of Southampton.	Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Challand MR, 2009, FEBS LETT, V583, P1358, DOI 10.1016/j.febslet.2009.03.044; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee A, 2006, ANGEW CHEM INT EDIT, V45, P3507, DOI 10.1002/anie.200504614; Cornell KA, 1998, BBA-GENE STRUCT EXPR, V1396, P8, DOI 10.1016/S0167-4781(97)00169-3; Dorrestein PC, 2004, J AM CHEM SOC, V126, P3091, DOI 10.1021/ja039616p; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fossey J, 1995, FREE RADICALS ORGANI; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Hanes JW, 2007, J AM CHEM SOC, V129, P4860, DOI 10.1021/ja0679634; Hazra A, 2009, J AM CHEM SOC, V131, P3225, DOI 10.1021/ja806752h; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Leonardi R, 2003, FEBS LETT, V539, P95, DOI 10.1016/S0014-5793(03)00204-7; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Martinez-Gomez NC, 2004, J BIOL CHEM, V279, P40505, DOI 10.1074/jbc.M403985200; McCulloch KM, 2008, BIOCHEMISTRY-US, V47, P3810, DOI 10.1021/bi800041h; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; Park JH, 2003, BIOCHEMISTRY-US, V42, P12430, DOI 10.1021/bi034902z; Pohl M, 2004, CURR OPIN BIOTECH, V15, P335, DOI 10.1016/j.copbio.2004.06.002; Segel I.H, 1993, ENZYME KINETICS; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; Settembre EC, 2004, BIOCHEMISTRY-US, V43, P11647, DOI 10.1021/bi0488911; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Taylor AM, 2008, BIOCHEMISTRY-US, V47, P9309, DOI 10.1021/bi801035b; Ugulava NB, 2003, BIOCHEMISTRY-US, V42, P2708, DOI 10.1021/bi0261084; Wang SC, 2007, BIOCHEMISTRY-US, V46, P12889, DOI 10.1021/bi701745h; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002	33	46	48	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5240	5248		10.1074/jbc.M109.056606	http://dx.doi.org/10.1074/jbc.M109.056606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19923213	Green Published, hybrid			2022-12-27	WOS:000275327200017
J	Sunami, T; Byrne, N; Diehl, RE; Funabashi, K; Hall, DL; Ikuta, M; Patel, SB; Shipman, JM; Smith, RF; Takahashi, I; Zugay-Murphy, J; Iwasawa, Y; Lumb, KJ; Munshi, SK; Sharma, S				Sunami, Tomoko; Byrne, Noel; Diehl, Ronald E.; Funabashi, Kaoru; Hall, Dawn L.; Ikuta, Mari; Patel, Sangita B.; Shipman, Jennifer M.; Smith, Robert F.; Takahashi, Ikuko; Zugay-Murphy, Joan; Iwasawa, Yoshikazu; Lumb, Kevin J.; Munshi, Sanjeev K.; Sharma, Sujata			Structural Basis of Human p70 Ribosomal S6 Kinase-1 Regulation by Activation Loop Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASES; DOMAIN; EXPRESSION; INHIBITORS; MECHANISM; CLONING; SELECTIVITY; P70(S6K); SOFTWARE	p70 ribosomal S6 kinase (p70S6K) is a downstream effector of the mTOR signaling pathway involved in cell proliferation, cell growth, cell-cycle progression, and glucose homeostasis. Multiple phosphorylation events within the catalytic, autoinhibitory, and hydrophobic motif domains contribute to the regulation of p70S6K. We report the crystal structures of the kinase domain of p70S6K1 bound to staurosporine in both the unphosphorylated state and in the 3'-phosphoinositide-dependent kinase-1-phosphorylated state in which Thr-252 of the activation loop is phosphorylated. Unphosphorylated p70S6K1 exists in two crystal forms, one in which the p70S6K1 kinase domain exists as a monomer and the other as a domain-swapped dimer. The crystal structure of the partially activated kinase domain that is phosphorylated within the activation loop reveals conformational ordering of the activation loop that is consistent with a role in activation. The structures offer insights into the structural basis of the 3'-phosphoinositide-dependent kinase-1-induced activation of p70S6K and provide a platform for the rational structure-guided design of specific p70S6K inhibitors.	[Sunami, Tomoko; Ikuta, Mari; Iwasawa, Yoshikazu] Banyu Pharmaceut Co Ltd, Dept Chem, Tsukuba, Ibaraki 3002611, Japan; [Funabashi, Kaoru; Takahashi, Ikuko] Banyu Pharmaceut Co Ltd, Dept Canc Res, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan; [Byrne, Noel; Diehl, Ronald E.; Hall, Dawn L.; Patel, Sangita B.; Shipman, Jennifer M.; Smith, Robert F.; Zugay-Murphy, Joan; Lumb, Kevin J.; Munshi, Sanjeev K.; Sharma, Sujata] Merck Res Labs, West Point, PA 19486 USA	Merck & Company; Merck & Company; Novartis; Merck & Company	Sunami, T (corresponding author), Japan Atom Energy Agcy, Mol Struct Biol Grp, Neutron Biol Res Ctr, Quantum Beam Sci Directorate, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	sunami.tomoko@jaea.go.jp; sujata_sharma@merck.com		Lumb, Kevin/0000-0003-2778-9956				Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Breitenlechner CB, 2005, J MED CHEM, V48, P163, DOI 10.1021/jm049701n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Kornienko M, 2005, ASSAY DRUG DEV TECHN, V3, P661, DOI 10.1089/adt.2005.3.661; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Le XF, 2003, ONCOGENE, V22, P484, DOI 10.1038/sj.onc.1206175; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mol CD, 2004, CURR OPIN DRUG DISC, V7, P639; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhang WG, 2006, PROTEIN EXPRES PURIF, V46, P414, DOI 10.1016/j.pep.2005.08.012; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	33	39	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4587	4594		10.1074/jbc.M109.040667	http://dx.doi.org/10.1074/jbc.M109.040667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19864428	Green Published, hybrid			2022-12-27	WOS:000275274800036
J	Groves, E; Rittinger, K; Amstutz, M; Berry, S; Holden, DW; Cornelis, GR; Caron, E				Groves, Eleanor; Rittinger, Katrin; Amstutz, Marlise; Berry, Sara; Holden, David W.; Cornelis, Guy R.; Caron, Emmanuelle			Sequestering of Rac by the Yersinia Effector YopO Blocks Fc gamma Receptor-mediated Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; RHO-GTPASES; PLASMA-MEMBRANE; SER/THR KINASE; ACTIN-BINDING; INNER SURFACE; ACTIVATION; VIRULENCE; TARGET; IDENTIFICATION	Pathogenic Yersinia species neutralize innate immune mechanisms by injecting type three secretion effectors into immune cells, altering cell signaling. Our study elucidates how one of these effectors, YopO, blocks phagocytosis. We demonstrate using different phagocytic models that YopO specifically blocks Rac-dependent Fc gamma receptor internalization pathway but not complement receptor 3-dependent uptake, which is controlled by Rho activity. We show that YopO prevents Rac activation but does not affect Rac accumulation at the phagocytic cup. In addition, we show that plasma membrane localization and the guanine-nucleotide dissociation inhibitor (GDI)-like domain of YopO cooperate for maximal anti-phagocytosis. Although YopO has the same affinity for Rac1, Rac2, and RhoA in vitro, it selectively interacts with Rac isoforms in cells. This is due to the differential localization of the Rho family G proteins in resting cells; Rac isoforms partially exist as a GDI-free pool at the membrane of resting cells, whereas RhoA is trapped in the cytosol by RhoGDI alpha. We propose that YopO exploits this basic difference in localization and availability to selectively inhibit Rac-dependent phagocytosis.	[Caron, Emmanuelle] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Rittinger, Katrin] Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Imperial College London; MRC National Institute for Medical Research; University of Basel	Groves, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, CMMI2, Flowers Bldg, London SW15 3SH, England.	e.groves@imperial.ac.uk	Rittinger, Katrin/D-2586-2014; Rittinger, Katrin/N-3344-2019	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435	Medical Research Council studentship; Medical Research Council and the Biotechnology and Biological Sciences Council; Medical Research Council [G0800148, MC_U117565398] Funding Source: researchfish; MRC [G0800148, MC_U117565398] Funding Source: UKRI	Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council and the Biotechnology and Biological Sciences Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council studentship (to E. G.) and a core grant (to K. R.). Work in the Caron laboratory was funded by grants from the Medical Research Council and the Biotechnology and Biological Sciences Council.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Gorvel JP, 1998, FEBS LETT, V422, P269, DOI 10.1016/S0014-5793(98)00020-9; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Nejedlik L, 2004, YEAST, V21, P759, DOI 10.1002/yea.1135; Park H, 2007, J IMMUNOL, V178, P6426, DOI 10.4049/jimmunol.178.10.6426; Patel JC, 2000, METHOD ENZYMOL, V325, P462; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	38	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4087	4098		10.1074/jbc.M109.071035	http://dx.doi.org/10.1074/jbc.M109.071035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19926792	Green Published, hybrid			2022-12-27	WOS:000275254000061
J	Kanchan, K; Linder, J; Winkler, K; Hantke, K; Schultz, A; Schultz, JE				Kanchan, Kajal; Linder, Juergen; Winkler, Karin; Hantke, Klaus; Schultz, Anita; Schultz, Joachim E.			Transmembrane Signaling in Chimeras of the Escherichia coli Aspartate and Serine Chemotaxis Receptors and Bacterial Class III Adenylyl Cyclases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; CYTOPLASMIC DOMAIN; HISTIDINE KINASE; HAMP DOMAINS; CYCLIC-AMP; CHEMORECEPTOR; LINKER; BINDING; LIGAND	The Escherichia coli chemoreceptors for serine (Tsr) and aspartate (Tar) and several bacterial class III adenylyl cyclases (ACs) share a common molecular architecture; that is, a membrane anchor that is linked via a cytoplasmic HAMP domain to a C-terminal signal output unit. Functionality of both proteins requires homodimerization. The chemotaxis receptors are well characterized, whereas the typical hexahelical membrane anchor (6TM) of class III ACs, suggested to operate as a channel or transporter, has no known function beyond a membrane anchor. We joined the intramolecular networks of Tsr or Tar and two bacterial ACs, Rv3645 from Mycobacterium tuberculosis and CyaG from Arthrospira platensis, across their signal transmission sites, connecting the chemotaxis receptors via different HAMP domains to the catalytic AC domains. AC activity in the chimeras was inhibited by micromolar concentrations of L-serine or L-aspartate in vitro and in vivo. Single point mutations known to abolish ligand binding in Tar (R69E or T154I) or Tsr (R69E or T156K) abrogated AC regulation. Co-expression of mutant pairs, which functionally complement each other, restored regulation in vitro and in vivo. Taken together, these studies demonstrate chemotaxis receptor-mediated regulation of chimeric bacterial ACs and connect chemical sensing and AC regulation.	[Kanchan, Kajal; Linder, Juergen; Winkler, Karin; Hantke, Klaus; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de	Kanchan, Kajal/AAO-4013-2020	Kanchan, Kajal/0000-0003-4711-5588	Deutsche Forschungsgemeinschaft [SFB 766-B8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 766-B8).	ADLER J, 1965, COLD SPRING HARB SYM, V30, P289, DOI 10.1101/SQB.1965.030.01.030; AMES P, 1994, J BACTERIOL, V176, P6340, DOI 10.1128/jb.176.20.6340-6348.1994; Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; BOYD A, 1983, NATURE, V301, P623, DOI 10.1038/301623a0; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Khursigara CM, 2008, P NATL ACAD SCI USA, V105, P16555, DOI 10.1073/pnas.0806401105; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kim SH, 2002, P NATL ACAD SCI USA, V99, P11611, DOI 10.1073/pnas.132376499; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Linder JU, 2004, EUR J BIOCHEM, V271, P2446, DOI 10.1111/j.1432-1033.2004.04172.x; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MATIN A, 1982, J BACTERIOL, V149, P801, DOI 10.1128/JB.149.3.801-807.1982; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Miller J. H, 1972, EXPT MOL GENETICS; MILLIGAN DL, 1988, J BIOL CHEM, V263, P6268; MOWBRAY SL, 1990, J BIOL CHEM, V265, P15638; PETERKOFSKY A, 1971, P NATL ACAD SCI USA, V68, P2794, DOI 10.1073/pnas.68.11.2794; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; SUTHERLAND E W, 1960, Acta Endocrinol Suppl (Copenh), V34(Suppl 50), P171; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; YANG Y, 1993, J MOL BIOL, V232, P493, DOI 10.1006/jmbi.1993.1405; Yoshida T, 2007, METHOD ENZYMOL, V423, P184, DOI 10.1016/S0076-6879(07)23008-3; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	40	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2090	2099		10.1074/jbc.M109.051698	http://dx.doi.org/10.1074/jbc.M109.051698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923210	Green Published, hybrid			2022-12-27	WOS:000273429100053
J	Lepesheva, GI; Park, HW; Hargrove, TY; Vanhollebeke, B; Wawrzak, Z; Harp, JM; Sundaramoorthy, M; Nes, WD; Pays, E; Chaudhuri, M; Villalta, F; Waterman, MR				Lepesheva, Galina I.; Park, Hee-Won; Hargrove, Tatiana Y.; Vanhollebeke, Benoit; Wawrzak, Zdzislaw; Harp, Joel M.; Sundaramoorthy, Munirathinam; Nes, W. David; Pays, Etienne; Chaudhuri, Minu; Villalta, Fernando; Waterman, Michael R.			Crystal Structures of Trypanosoma brucei Sterol 14 alpha-Demethylase and Implications for Selective Treatment of Human Infections	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ACTIVE-SITE; CYP51; CRUZI; TARGETS; P450; INHIBITION; MECHANISMS	Sterol 14 alpha-demethylase (14DM, the CYP51 family of cytochrome P450) is an essential enzyme in sterol biosynthesis in eukaryotes. It serves as a major drug target for fungal diseases and can potentially become a target for treatment of human infections with protozoa. Here we present 1.9 angstrom resolution crystal structures of 14DM from the protozoan pathogen Trypanosoma brucei, ligand-free and complexed with a strong chemically selected inhibitor N-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadi-azol-2-yl)benzamide that we previously found to produce potent antiparasitic effects in Trypanosomatidae. This is the first structure of a eukaryotic microsomal 14DM that acts on sterol biosynthesis, and it differs profoundly from that of the water-soluble CYP51 family member from Mycobacterium tuberculosis, both in organization of the active site cavity and in the substrate access channel location. Inhibitor binding does not cause large scale conformational rearrangements, yet induces unanticipated local alterations in the active site, including formation of a hydrogen bond network that connects, via the inhibitor amide group fragment, two remote functionally essential protein segments and alters the heme environment. The inhibitor binding mode provides a possible explanation for both its functionally irreversible effect on the enzyme activity and its selectivity toward the 14DM from human pathogens versus the human 14DM ortholog. The structures shed new light on 14DM functional conservation and open an excellent opportunity for directed design of novel antiparasitic drugs.	[Lepesheva, Galina I.; Hargrove, Tatiana Y.; Harp, Joel M.; Sundaramoorthy, Munirathinam; Waterman, Michael R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada; [Vanhollebeke, Benoit; Pays, Etienne] Univ Libre Bruxelles, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Wawrzak, Zdzislaw] Northwestern Univ, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Dept Biochem Mol Biol & Cell Biol, Argonne, IL 60439 USA; [Nes, W. David] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Chaudhuri, Minu; Villalta, Fernando] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Vanderbilt University; University of Toronto; Structural Genomics Consortium; University of Toronto; Universite Libre de Bruxelles; Northwestern University; Texas Tech University System; Texas Tech University; Meharry Medical College	Lepesheva, GI (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville 622 RRB,23rd Pierce, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu		Vanhollebeke, Benoit/0000-0002-0353-365X; Villalta, Fernando/0000-0002-6232-0574	National Institutes of Health [GM 067871, P30ES00267, AI 080580, GM 081146, WF D-1276]; American Heart Association [0535121N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI080580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871, SC1GM081146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 067871 (to M. R. W. and G. I. L.), P30ES00267 (to M. R. W.), AI 080580 (to F. V.), GM 081146 (to M. C.), and WF D-1276 (to W. D. N.). The work was also supported by American Heart Association Grant 0535121N (to G. I. L.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bellamine A, 2004, J LIPID RES, V45, P2000, DOI 10.1194/jlr.M400239-JLR200; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BRUN R, 1977, Acta Tropica, V34, P21; Buckner F, 2003, P NATL ACAD SCI USA, V100, P15149, DOI 10.1073/pnas.2535442100; COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407; Coppens I, 2000, ANNU REV MICROBIOL, V54, P129, DOI 10.1146/annurev.micro.54.1.129; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; Cruz AK, 2009, CURR DRUG TARGETS, V10, P178, DOI 10.2174/138945009787581177; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; GOODPASTURE HC, 1985, ARCH INTERN MED, V145, P879, DOI 10.1001/archinte.145.5.879; Guallar V, 2003, P NATL ACAD SCI USA, V100, P6998, DOI 10.1073/pnas.0732000100; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, ARCH BIOCHEM BIOPHYS, V464, P221, DOI 10.1016/j.abb.2007.05.017; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva G, 2008, LIPIDS, V43, P1117, DOI 10.1007/s11745-008-3225-y; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Matsuura K, 2005, J BIOL CHEM, V280, P9088, DOI 10.1074/jbc.M413042200; McLean KJ, 2006, BIOCHEM SOC T, V34, P1178, DOI 10.1042/BST0341178; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; OTNINOWSKI Z, 1995, HKL MANUAL; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Podust LM, 2004, STRUCTURE, V12, P1937, DOI 10.1016/j.str.2004.08.009; Poulos TL, 2007, DRUG METAB REV, V39, P557, DOI 10.1080/03602530701498240; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thompson GR, 2009, CLIN CHEST MED, V30, P203, DOI 10.1016/j.ccm.2009.02.001; VANDEN BOSSCHE H, 1995, PHARMACOL THERAPEUT, V67, P79; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; vonWachenfeldt C, 1997, ARCH BIOCHEM BIOPHYS, V339, P107, DOI 10.1006/abbi.1996.9859; Williams D, 2000, PERFORM RES, V5, P131; Zhou WX, 2007, J LIPID RES, V48, P665, DOI 10.1194/jlr.M600404-JLR200	48	105	106	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1773	1780		10.1074/jbc.M109.067470	http://dx.doi.org/10.1074/jbc.M109.067470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923211	Green Published, hybrid			2022-12-27	WOS:000273429100023
J	Buas, MF; Kabak, S; Kadesch, T				Buas, Matthew F.; Kabak, Shara; Kadesch, Tom			The Notch Effector Hey1 Associates with Myogenic Target Genes to Repress Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; TRANSCRIPTION FACTOR; GATA3 EXPRESSION; PROGENITOR CELLS; BHLH; BINDING; DIFFERENTIATION; ACTIVATION; PROMOTER; PATHWAY	Members of the Hey family of transcriptional repressors are basic helix-loop-helix proteins that are thought to act downstream of Notch in diverse tissues. Although forced expression of Hey1, a target of Notch in myoblasts, is sufficient to recapitulate inhibitory effects of the pathway on differentiation, how Hey1 interferes with myogenic transcription has not been fully elucidated. We provide multiple lines of evidence that Hey1 does not target the intrinsic transcriptional activity of the skeletal muscle master regulator MyoD. Our results indicate instead that Hey1 is recruited to the promoter regions of myogenin and Mef2C, two genes whose induction is critical for myogenesis. Expression of Hey1 in C2C12 myoblasts correlates with reduced recruitment of MyoD to these promoters, arguing that Hey1 inhibits myogenesis by associating with and repressing expression of key myogenic targets.	[Buas, Matthew F.; Kabak, Shara; Kadesch, Tom] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kadesch, T (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kadesch@mail.med.upenn.edu		Buas, Matthew F/0000-0002-8524-3428	National Institutes of Health Training [5-T32-GM-008216-20, F32GM068394-01A1]; Muscular Dystrophy Association [MDA 3888]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216, F32GM068394] Funding Source: NIH RePORTER	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grants 5-T32-GM-008216-20 (to M. B.) and F32GM068394-01A1 (NRSA; to S. K.). This work was also supported by funds from the Muscular Dystrophy Association (MDA 3888).	Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Berghella L, 2008, GENE DEV, V22, P2125, DOI 10.1101/gad.468508; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2002, COLD SPRING HARB SYM, V67, P63, DOI 10.1101/sqb.2002.67.63; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Ghosh B, 2006, BIOCHEM J, V393, P679, DOI 10.1042/BJ20051063; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Kathiriya IS, 2004, J BIOL CHEM, V279, P54937, DOI 10.1074/jbc.M409879200; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Kokubo H, 2007, DEVELOPMENT, V134, P747, DOI 10.1242/dev.02777; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Pichon B, 2004, BBA-GENE STRUCT EXPR, V1680, P46, DOI 10.1016/j.bbaexp.2004.08.010; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Sun JX, 2001, J BIOL CHEM, V276, P18591, DOI 10.1074/jbc.M101163200; Taelman V, 2004, DEV BIOL, V276, P47, DOI 10.1016/j.ydbio.2004.08.019; Taelman V, 2006, DEVELOPMENT, V133, P2961, DOI 10.1242/dev.02458; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2003, BIOTECHNIQUES, V35, P346; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	60	65	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1249	1258		10.1074/jbc.M109.046441	http://dx.doi.org/10.1074/jbc.M109.046441			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19917614	hybrid, Green Published			2022-12-27	WOS:000273258200047
J	Trottier, J; Husseini, D; Perreault, M; Paquet, S; Caron, P; Bourassa, S; Verreault, M; Inaba, TT; Poirier, GG; Belanger, A; Guillemette, C; Trauner, M; Barbier, O				Trottier, Jocelyn; El Husseini, Diala; Perreault, Martin; Paquet, Sophie; Caron, Patrick; Bourassa, Sylvie; Verreault, Melanie; Inaba, Ted T.; Poirier, Guy G.; Belanger, Alain; Guillemette, Chantal; Trauner, Michael; Barbier, Olivier			The Human UGT1A3 Enzyme Conjugates Norursodeoxycholic Acid into a C-23-ester Glucuronide in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GLUCURONOSYLTRANSFERASE ENZYMES; BILE-ACIDS; MASS-SPECTROMETRY; SIDE-CHAIN; EXPRESSION; LOCUS; MICE; BIOTRANSFORMATION; PHARMACOGENOMICS; CHROMATOGRAPHY	Norursodeoxycholic acid (norUDCA) exhibits efficient anti-cholestatic properties in an animal model of sclerosing cholangitis. norUDCA is eliminated as a C-23-ester glucuronide (norUDCA-23G) in humans. The present study aimed at identifying the human UDP-glucuronosyltransferase (UGT) enzyme(s) involved in hepatic norUDCA glucuronidation and at evaluating the consequences of single nucleotide polymorphisms in the coding region of UGT genes on norUDCA-23G formation. The effects of norUDCA on the formation of the cholestatic lithocholic acid-glucuronide derivative and of rifampicin on hepatic norUDCA glucuronidation were also explored. In vitro glucuronidation assays were performed with microsomes from human tissues (liver and intestine) and HEK293 cells expressing human UGT enzymes and variant allozymes. UGT1A3 was identified as the major hepatic UGT enzyme catalyzing the formation of norUDCA-23G. Correlation studies using samples from a human liver bank (n = 16) indicated that the level of UGT1A3 protein is a strong determinant of in vitro norUDCA glucuronidation. Analyses of the nor UDCA-conjugating activity by 11 UGT1A3 variant allozymes identified three phenotypes with high, low, and intermediate capacity. norUDCA is also identified as a competitive inhibitor for the hepatic formation of the pro-cholestatic lithocholic acid-glucuronide derivative, whereas norUDCA glucuronidation is weakly stimulated by rifampicin. This study identifies human UGT1A3 as the major enzyme for the hepatic norUDCA glucuronidation and supports that some coding polymorphisms affecting the conjugating activity of UGT1A3 in vitro may alter the pharmacokinetic properties of norUDCA in cholestasis treatment.	[Verreault, Melanie] Univ Laval, Mol Pharmacol Lab, CHUQ Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Verreault, Melanie; Guillemette, Chantal] Univ Laval, Fac Pharm, Quebec City, PQ G1V 4G2, Canada; [Bourassa, Sylvie; Poirier, Guy G.] Univ Laval, Quebec Genom Ctr, CHUQ Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Bourassa, Sylvie; Poirier, Guy G.; Belanger, Alain] Univ Laval, Fac Med, Quebec City, PQ G1V 4G2, Canada; [Guillemette, Chantal] CHUL, CHUQ Res Ctr, Pharmacogenom Lab, Quebec City, PQ G1V 4G2, Canada; [Inaba, Ted T.] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; [Trauner, Michael] Med Univ Graz Med, Div Gastroenterol & Hepatol, Dept Internal Med, Lab Expt & Mol Med, A-8010 Graz, Austria	Laval University; Laval University; Laval University; Laval University; Laval University; University of Toronto	Barbier, O (corresponding author), CHUL, CHUQ Res Ctr, Mol Pharmacol Lab, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	olivier.barbier@crchul.ulaval.ca	Guillemette, Chantal/AAT-6246-2020; Guillemette, Chantal/J-6463-2012	Guillemette, Chantal/0000-0002-1113-1212; Barbier, Olivier/0000-0002-3067-1134; Trauner, Michael/0000-0002-1275-6425; Poirier, Guy/0000-0002-4869-1424	Canadian Institute of Health Research [MOP-84338]; Canadian Foundation for Innovation [10469]; Austrian Science Foundation [P19118-B05]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Austrian Science Foundation(Austrian Science Fund (FWF))	This work was supported by Canadian Institute of Health Research Grant MOP-84338, Canadian Foundation for Innovation Grant 10469, and Austrian Science Foundation Grant P19118-B05.	Barbier O, 2001, MOL PHARMACOL, V59, P636, DOI 10.1124/mol.59.3.636; Barbier O, 2009, MOL CELL BIOCHEM, V326, P3, DOI 10.1007/s11010-008-0001-5; Beaulieu M, 1996, J BIOL CHEM, V271, P22855, DOI 10.1074/jbc.271.37.22855; Belanger A, 2003, TRENDS ENDOCRIN MET, V14, P473, DOI 10.1016/j.tem.2003.10.005; Belanger AS, 2009, DRUG METAB DISPOS, V37, P1793, DOI 10.1124/dmd.109.027706; Caillier B, 2007, PHARMACOGENET GENOM, V17, P481, DOI 10.1097/FPC.0b013e32806d87a4; CAMPBELL ME, 1987, DRUG METAB DISPOS, V15, P237; Caron P, 2006, MOL PHARMACEUT, V3, P293, DOI 10.1021/mp060021l; Chouinard S, 2004, ENDOCR RES, V30, P717, DOI 10.1081/ERC-200044014; Dutton G.F., 1980, GLUCURONIDATION DRUG; Fickert P, 2006, GASTROENTEROLOGY, V130, P465, DOI 10.1053/j.gastro.2005.10.018; Gall WE, 1999, J STEROID BIOCHEM, V70, P101, DOI 10.1016/S0960-0760(99)00088-6; Gardner-Stephen D, 2004, DRUG METAB DISPOS, V32, P340, DOI 10.1124/dmd.32.3.340; Girard H, 2007, PHARMACOGENET GENOM, V17, P1077, DOI 10.1097/FPC.0b013e3282f1f118; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; GONG Y, 2009, COCHRANE LIB; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; Guillemette C, 2003, PHARMACOGENOMICS J, V3, P136, DOI 10.1038/sj.tpj.6500171; Halilbasic E, 2009, HEPATOLOGY, V49, P1972, DOI 10.1002/hep.22891; Hansen SH, 2004, ELECTROPHORESIS, V25, P3277, DOI 10.1002/elps.200406036; Hofmann AF, 2005, HEPATOLOGY, V42, P1391, DOI 10.1002/hep.20943; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Kaeding J, 2008, MOL CANCER THER, V7, P380, DOI 10.1158/1535-7163.MCT-07-0455; Kremer AE, 2008, DRUGS, V68, P2163, DOI 10.2165/00003495-200868150-00006; Levesque E, 2007, HEPATOLOGY, V45, P128, DOI 10.1002/hep.21464; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; OELBERG DG, 1984, J CLIN INVEST, V73, P1507, DOI 10.1172/JCI111356; Paumgartner G, 2008, CLIN LIVER DIS, V12, P53, DOI 10.1016/j.cld.2007.11.013; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; SCHTEINGART CD, 1988, J LIPID RES, V29, P1387; Shipkova M, 2003, THER DRUG MONIT, V25, P1, DOI 10.1097/00007691-200302000-00001; TAKIKAWA H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P39, DOI 10.1016/0005-2760(91)90247-F; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Trottier J, 2008, HEPATOLOGY, V48, p667A; Verreault M, 2006, HEPATOLOGY, V44, P368, DOI 10.1002/hep.21259; Zollner G, 2009, BRIT J PHARMACOL, V156, P7, DOI 10.1111/j.1476-5381.2008.00030.x	36	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1113	1121		10.1074/jbc.M109.073908	http://dx.doi.org/10.1074/jbc.M109.073908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889628	Green Published, hybrid			2022-12-27	WOS:000273258200033
J	Hughes, S; Jenkins, V; Dar, MJ; Engelman, A; Cherepanov, P				Hughes, Siobhan; Jenkins, Victoria; Dar, Mohd Jamal; Engelman, Alan; Cherepanov, Peter			Transcriptional Co-activator LEDGF Interacts with Cdc7-Activator of S-phase Kinase (ASK) and Stimulates Its Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; CELL-CYCLE REGULATION; DNA HELICASE ACTIVITY; HIV-1 INTEGRASE; PROTEIN-KINASE; REGULATORY SUBUNIT; CHROMATIN-BINDING; CDC7 KINASE; SACCHAROMYCES-CEREVISIAE	Lens epithelium-derived growth factor (LEDGF) is an important co-factor of human immunodeficiency virus DNA integration; however, its cellular functions are poorly characterized. We now report identification of the Cdc7-activator of S-phase kinase (ASK) heterodimer as a novel interactor of LEDGF. Both kinase subunits co-immunoprecipitated with endogenous LEDGF from human cell extracts. Truncation analyses identified the integrase-binding domain of LEDGF as essential and minimally sufficient for the interaction with Cdc7-ASK. Reciprocally, the interaction required autophosphorylation of the kinase and the presence of 50 C-terminal residues of ASK. The kinase phosphorylated LEDGF in vitro, with Ser-206 being the major target, and LEDGF phosphorylated at this residue could be detected during S phase of the cell cycle. LEDGF potently stimulated the enzymatic activity of Cdc7-ASK, increasing phosphorylation of MCM2 in vitro by more than 10-fold. This enzymatic stimulation as well as phosphorylation of LEDGF depended on the protein-protein interaction. Intriguingly, removing the C-terminal region of ASK, involved in the interaction with LEDGF, resulted in a hyperactive kinase. Our results indicate that the interaction with LEDGF relieves autoinhibition of Cdc7-ASK kinase, imposed by the C terminus of ASK.	[Hughes, Siobhan; Jenkins, Victoria; Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England; [Dar, Mohd Jamal; Engelman, Alan] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Imperial College London; Harvard University; Dana-Farber Cancer Institute	Cherepanov, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.cherepanov@imperial.ac.uk	Cherepanov, Peter P/F-6859-2010	Cherepanov, Peter P/0000-0002-0634-538X	National Institutes of Health [AI039394]; United Kingdom Medical Research Council [G0600009]; Medical Research Council [G0600009] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394, R01AI039394] Funding Source: NIH RePORTER; MRC [G0600009] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI039394 (to A. E.). This work was also supported by United Kingdom Medical Research Council Grant G0600009 (to P. C.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; Brown GW, 1999, P NATL ACAD SCI USA, V96, P8443, DOI 10.1073/pnas.96.15.8443; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Furukohri A, 2003, J BIOCHEM, V134, P447, DOI 10.1093/jb/mvg163; Ganapathy V, 2003, AUTOIMMUN REV, V2, P290, DOI 10.1016/S1568-9972(03)00063-6; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Hussey DJ, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-20; Ishimi Y, 2001, J BIOL CHEM, V276, P42744, DOI 10.1074/jbc.M106861200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Jares P, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-5; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Yamashita N, 2005, GENES CELLS, V10, P551, DOI 10.1111/j.1365-2443.2005.00857.x; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200	78	50	50	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					541	554		10.1074/jbc.M109.036491	http://dx.doi.org/10.1074/jbc.M109.036491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864417	Green Published, hybrid			2022-12-27	WOS:000273070100056
J	Underwood, CR; Garibay, P; Knudsen, LB; Hastrup, S; Peters, GH; Rudolph, R; Reedtz-Runge, S				Underwood, Christina Rye; Garibay, Patrick; Knudsen, Lotte Bjerre; Hastrup, Sven; Peters, Gunther H.; Rudolph, Rainer; Reedtz-Runge, Steffen			Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLP-1 RECEPTOR; MOLECULAR RECOGNITION; TERMINAL DOMAIN; LIGAND-BINDING; N-TERMINUS; EXENDIN-4; HORMONE; CONFORMATION; EXPRESSION; AMIDE	GLP-1 (glucagon-like peptide-1) is an incretin released from intestinal L-cells in response to food intake. Activation of the GLP-1 receptor potentiates the synthesis and release of insulin from pancreatic beta-cells in a glucose-dependent manner. The GLP-1 receptor belongs to class B of the G-protein-coupled receptors, a subfamily characterized by a large N-terminal extracellular ligand binding domain. Exendin-4 and GLP-1 are 50% identical, and exendin-4 is a full agonist with similar affinity and potency for the GLP-1 receptor. We recently solved the crystal structure of the GLP-1 receptor extracellular domain in complex with the competitive antagonist exendin-4(9-39). Interestingly, the isolated extra-cellular domain binds exendin-4 with much higher affinity than the endogenous agonist GLP-1. Here, we have solved the crystal structure of the extracellular domain in complex with GLP-1 to 2.1 angstrom resolution. The structure shows that important hydrophobic ligand-receptor interactions are conserved in agonist-and antagonist-bound forms of the extracellular domain, but certain residues in the ligand-binding site adopt a GLP-1-specific conformation. GLP-1 is a kinked but continuous alpha-helix from Thr(13) to Val(33) when bound to the extracellular domain. We supplemented the crystal structure with site-directed mutagenesis to link the structural information of the isolated extracellular domain with the binding properties of the full-length receptor. The data support the existence of differences in the binding modes of GLP-1 and exendin-4 on the full-length GLP-1 receptor.	[Underwood, Christina Rye] Novo Nordisk AS, Dept GLP & Obes Biol 1, DK-2760 Malov, Denmark; [Garibay, Patrick] Novo Nordisk AS, Dept Prot & Peptide Chem, DK-2760 Malov, Denmark; [Knudsen, Lotte Bjerre] Novo Nordisk AS, Dept Diabet Biol & Pharmacol, DK-2760 Malov, Denmark; [Hastrup, Sven] Novo Nordisk AS, Dept Prot Express, DK-2760 Malov, Denmark; [Reedtz-Runge, Steffen] Novo Nordisk AS, Dept Struct & Biophys Chem, DK-2760 Malov, Denmark; [Underwood, Christina Rye; Peters, Gunther H.] Tech Univ Denmark, Dept Chem, MEMPHYS Ctr Biomembrane Phys, DK-2800 Lyngby, Denmark; [Rudolph, Rainer] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Technical University of Denmark; Martin Luther University Halle Wittenberg	Reedtz-Runge, S (corresponding author), Novo Nordisk Pk,G8-S-439, DK-2760 Malov, Denmark.	sffr@novonordisk.com	Peters, Günther H.J./T-7100-2017	Peters, Günther H.J./0000-0001-9754-2663; Knudsen, Lotte Bjerre/0000-0002-2439-7116; Underwood, Christina Rye/0000-0002-2333-2177	Novo Nordisk A/S; European Membrane Protein Consortium; Federal State of Saxony-Anhalt [3324 A/0021 L]; Deutsche Forschungsgemeinshaft [SFRB 610/TP A11]	Novo Nordisk A/S(Novo Nordisk); European Membrane Protein Consortium; Federal State of Saxony-Anhalt; Deutsche Forschungsgemeinshaft(German Research Foundation (DFG))	This work was supported in part by a scholarship from Novo Nordisk A/S (to C. R. U.), European Membrane Protein Consortium, the Federal State of Saxony-Anhalt Grant 3324 A/0021 L, and the Deutsche Forschungsgemeinshaft Grant SFRB 610/TP A11.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; BRAUN W, 1983, J MOL BIOL, V169, P921, DOI 10.1016/S0022-2836(83)80143-0; Chang XQ, 2001, MAGN RESON CHEM, V39, P477, DOI 10.1002/mrc.880; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG J, 1992, J BIOL CHEM, V267, P7402; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; GOKE R, 1988, J ENDOCRINOL, V116, P357, DOI 10.1677/joe.0.1160357; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Miller LJ, 2007, BIOCHEM SOC T, V35, P709, DOI 10.1042/BST0350709; Miranda LP, 2008, J MED CHEM, V51, P2758, DOI 10.1021/jm701522b; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Murage EN, 2008, BIOORGAN MED CHEM, V16, P10106, DOI 10.1016/j.bmc.2008.10.006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; ORSKOV C, 1988, ENDOCRINOLOGY, V123, P2009, DOI 10.1210/endo-123-4-2009; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; SCHMIDT WE, 1985, DIABETOLOGIA, V28, P704, DOI 10.1007/BF00291980; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; THORNTON K, 1994, BIOCHEMISTRY-US, V33, P3532, DOI 10.1021/bi00178a009; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; WETTERGREN A, 1993, DIGESTION, V54, P384; Xiao Q, 2001, BIOCHEMISTRY-US, V40, P2860, DOI 10.1021/bi0014498; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	46	217	256	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					723	730		10.1074/jbc.M109.033829	http://dx.doi.org/10.1074/jbc.M109.033829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861722	Green Published, hybrid			2022-12-27	WOS:000273070100073
J	Wayne, N; Lai, YS; Pullen, L; Bolon, DN				Wayne, Natalie; Lai, YuShuan; Pullen, Les; Bolon, Daniel N.			Modular Control of Cross-oligomerization ANALYSIS OF SUPERSTABILIZED Hsp90 HOMODIMERS IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; HEAT-SHOCK-PROTEIN; IN-VIVO FUNCTION; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; CONFORMATIONAL-CHANGES; STEROID-RECEPTOR; YEAST; BINDING; DESIGN	Homo-oligomeric proteins fulfill numerous functions in all cells. The ability to co-express subunits of these proteins that preferentially self-assemble without cross-oligomerizing provides for controlled experiments to analyze the function of mutant homo-oligomers in vivo. Hsp90 is a dimeric chaperone involved in the maturation of many kinases and steroid hormone receptors. We observed that co-expression of different Hsp90 subunits in Saccharomyces cerevisiae caused unpredictable synthetic growth defects due to cross-dimerization. We engineered superstabilized Hsp90 dimers that resisted cross-dimerization with endogenous Hsp90 and alleviated the synthetic growth defect. Superstabilized Hsp90 dimers supported robust growth of S. cerevisiae, indicating that dissociation of Hsp90 dimers could be hindered without compromising essential function. We utilized superstabilized dimers to analyze the activity of ATPase mutant homodimers in a temperature-sensitive yeast background where elevated temperature inactivated all other Hsp90 species. We found that ATP binding and hydrolysis by Hsp90 are both required for the efficient maturation of glucocorticoid receptor and v-Src, confirming the critical role of ATP hydrolysis in the maturation of steroid hormone receptors and kinases in vivo.	[Wayne, Natalie; Lai, YuShuan; Pullen, Les; Bolon, Daniel N.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Bolon, DN (corresponding author), LRB 922,364 Plantat St, Worcester, MA 01605 USA.	dan.bolon@umassmed.edu		Bolon, Daniel/0000-0001-5857-6676	National Institutes of Health [R01-GM083038-01A]; American Cancer Society [RSG-08-17301-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM083038-01A and by American Cancer Society Grant RSG-08-17301-GMC.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; Cox MB, 2002, TOXICOL LETT, V129, P13, DOI 10.1016/S0378-4274(01)00465-9; DELANO WL, 1994, PROTEINS, V20, P105, DOI 10.1002/prot.340200202; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Ozbek S, 2002, EMBO J, V21, P5960, DOI 10.1093/emboj/cdf628; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	36	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					234	241		10.1074/jbc.M109.060129	http://dx.doi.org/10.1074/jbc.M109.060129			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19906642	Green Published, hybrid			2022-12-27	WOS:000273070100025
J	La, P; Fernando, AP; Wang, Z; Salahudeen, A; Yang, G; Lin, Q; Wright, CJ; Dennery, PA				La, Ping; Fernando, Amal P.; Wang, Zhi; Salahudeen, Ameen; Yang, Guang; Lin, Qing; Wright, Clyde J.; Dennery, Phyllis A.			Zinc Protoporphyrin Regulates Cyclin D1 Expression Independent of Heme Oxygenase Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; OXIDATIVE STRESS; BREAST-CANCER; MESSENGER-RNA; RECEPTOR GENE; CELLS; BINDING; TRANSCRIPTION; PROMOTER; PROTEIN	Zinc protoporphyrin IX (ZnPP), an endogenous heme analogue that inhibits heme oxygenase (HO) activity, represses tumor growth. It can also translocate into the nucleus and up-regulate heme oxygenase 1 (HMOX1) gene expression. Here, we demonstrate that tumor cell proliferation was inhibited by ZnPP, whereas tin protoporphyrin (SnPP), another equally potent HO-1 inhibitor, had no effect. Microarray analysis on 128 tumorigenesis related genes showed that ZnPP suppressed genes involved in cell proliferation and angiogenesis. Among these genes, CYCLIN D1 (CCND1) was specifically inhibited as were its mRNA and protein levels. Additionally, ZnPP inhibited CCND1 promoter activity through an Sp1 and Egr1 overlapping binding site (S/E). We confirmed that ZnPP modulated the S/E site, at least partially by associating with Sp1 and Egr1 proteins rather than direct binding to DNA targets. Furthermore, administration of ZnPP significantly inhibited cyclin D1 expression and progression of a B-cell leukemia/lymphoma 1 tumor in mice by preferentially targeting tumor cells. These observations show HO independent effects of ZnPP on cyclin D1 expression and tumorigenesis.	[La, Ping; Fernando, Amal P.; Wang, Zhi; Salahudeen, Ameen; Yang, Guang; Lin, Qing; Wright, Clyde J.; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Lin, Qing; Dennery, Phyllis A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Dennery, PA (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	dennery@email.chop.edu	Dennery, Phyllis/GQG-9113-2022	Dennery, Phyllis/0000-0001-5745-1855; A Salahudeen, Ameen/0000-0001-9037-3481	National Institutes of Health [HL70285-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL70285-01 ( to P. A. D.).	Akuzawa N, 2000, ARTERIOSCL THROM VAS, V20, P377, DOI 10.1161/01.ATV.20.2.377; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Aref S, 2006, HEMATOLOGY, V11, P31, DOI 10.1080/10245330500322321; Argyris EG, 1999, J BIOL CHEM, V274, P1549, DOI 10.1074/jbc.274.3.1549; Bahouth SW, 2002, MOL PHARMACOL, V61, P379, DOI 10.1124/mol.61.2.379; Barbieri F, 2004, ONCOLOGY-BASEL, V66, P310, DOI 10.1159/000078332; Callanan M, 1996, CRIT REV ONCOGENESIS, V7, P191, DOI 10.1615/CritRevOncog.v7.i3-4.30; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Fang J, 2003, CANCER RES, V63, P3567; Fang J, 2004, INT J CANCER, V109, P1, DOI 10.1002/ijc.11644; Fukada T, 2001, J BIOL CHEM, V276, P25512, DOI 10.1074/jbc.M101354200; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Hou WH, 2008, BBA-GENE REGUL MECH, V1779, P195, DOI 10.1016/j.bbagrm.2008.01.006; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; Hurley LH, 2006, SEMIN ONCOL, V33, P498, DOI 10.1053/j.seminoncol.2006.04.012; Ikehara M, 2003, ONCOL REP, V10, P137; Iyer JK, 2003, MOL MED, V9, P175, DOI 10.1007/BF03402182; LABBE RF, 1992, CLIN CHEM, V38, P2167; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Lutton JD, 1997, P NATL ACAD SCI USA, V94, P1432, DOI 10.1073/pnas.94.4.1432; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Mayerhofer M, 2008, BLOOD, V111, P2200, DOI 10.1182/blood-2006-11-055723; Nenoi M, 2001, CANCER RES, V61, P5885; Nilsson T, 2001, J VIROL, V75, P5796, DOI 10.1128/JVI.75.13.5796-5811.2001; NY L, 1995, BRIT J PHARMACOL, V115, P186, DOI 10.1111/j.1476-5381.1995.tb16337.x; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; PALMA JF, 1994, BLOOD, V84, P1288; Petty WJ, 2003, LUNG CANCER, V41, pS155, DOI 10.1016/S0169-5002(03)00159-4; Ravandi-Kashani F, 2000, LEUKEMIA RES, V24, P469, DOI 10.1016/S0145-2126(00)00008-4; Rodgers PA, 1996, PEDIATR RES, V39, P1041, DOI 10.1203/00006450-199606000-00018; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Serfas L, 1998, ARCH BIOCHEM BIOPHYS, V359, P8, DOI 10.1006/abbi.1998.0887; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Silverman ES, 1997, AM J PHYSIOL-HEART C, V273, pH1415, DOI 10.1152/ajpheart.1997.273.3.H1415; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; Tong AJ, 2003, SPECTROCHIM ACTA A, V59, P2967, DOI 10.1016/S1386-1425(03)00132-X; VREMAN HJ, 1988, CLIN CHEM, V34, P2562; Xu Jian-min, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P26; Yan YX, 1997, J BIOL CHEM, V272, P33181, DOI 10.1074/jbc.272.52.33181; Yang G, 2001, BLOOD, V97, P1306, DOI 10.1182/blood.V97.5.1306; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF1216, DOI 10.1152/ajprenal.00426.2002	50	40	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36302	36311		10.1074/jbc.M109.031641	http://dx.doi.org/10.1074/jbc.M109.031641			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850937	Green Published, hybrid			2022-12-27	WOS:000272970500032
J	Pedotti, M; Rosini, E; Molla, G; Moschetti, T; Savino, C; Vallone, B; Pollegioni, L				Pedotti, Mattia; Rosini, Elena; Molla, Gianluca; Moschetti, Tommaso; Savino, Carmelinda; Vallone, Beatrice; Pollegioni, Loredano			Glyphosate Resistance by Engineering the Flavoenzyme Glycine Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; MOLECULAR-BASIS; EVOLUTION; PROTEIN	Glycine oxidase from Bacillus subtilis is a homotetrameric flavoprotein of great potential biotechnological use because it catalyzes the oxidative deamination of various amines and D-isomer of amino acids to yield the corresponding alpha-keto acids, ammonia/amine, and hydrogen peroxide. Glyphosate (N-phosphonomethylglycine), a broad spectrum herbicide, is an interesting synthetic amino acid: this compound inhibits 5-enolpyruvylshikimate-3-phosphate synthase in the shikimate pathway, which is essential for the biosynthesis of aromatic amino acids in plants and certain bacteria. In recent years, transgenic crops resistant to glyphosate were mainly generated by overproducing the plant enzyme or by introducing a 5-enolpyruvylshikimate-3- phosphate synthase insensitive to this herbicide. In this work, we propose that the enzymatic oxidation of glyphosate could be an effective alternative to this important biotechnological process. To reach this goal, we used a rational design approach (together with site saturation mutagenesis) to generate a glycine oxidase variant more active on glyphosate than on the physiological substrate glycine. The glycine oxidase containing three point mutations (G51S/A54R/H244A) reaches an up to a 210-fold increase in catalytic efficiency and a 15,000-fold increase in the specificity constant (the k(cat)/K-m ratio between glyphosate and glycine) as compared with wild-type glycine oxidase. The inspection of its three-dimensional structure shows that the alpha 2-alpha 3 loop (comprising residues 50-60 and containing two of the mutated residues) assumes a novel conformation and that the newly introduced residue Arg(54) could be the key residue in stabilizing glyphosate binding and destabilizing glycine positioning in the binding site, thus increasing efficiency on the herbicide.	[Pedotti, Mattia; Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, DBSM, I-21100 Varese, Italy; [Pedotti, Mattia; Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, Politecn Milan, Ctr Interuniv Ric Biotecnol Prote Prot Factory, I-21100 Varese, Italy; [Moschetti, Tommaso; Vallone, Beatrice] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Savino, Carmelinda] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Pollegioni, L (corresponding author), Univ Insubria, DBSM, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it	Rosini, Elena/H-3474-2012; Vallone, Beatrice/F-4174-2012	Rosini, Elena/0000-0001-8384-7992; VALLONE, Beatrice/0000-0003-0058-9049; Molla, Gianluca/0000-0003-3688-3397; POLLEGIONI, LOREDANO/0000-0003-1733-7243; SAVINO, CARMELINDA/0000-0002-1602-4838	Fondo di Ateneo per la Ricerca; Consorzio Interuniversitario per le Biotecnologie; Centro di Ricerca in Biotecnologie per la Salute Umana	Fondo di Ateneo per la Ricerca; Consorzio Interuniversitario per le Biotecnologie; Centro di Ricerca in Biotecnologie per la Salute Umana	This work was supported by grants from the Fondo di Ateneo per la Ricerca (to L. P. and G. M.) and by the Consorzio Interuniversitario per le Biotecnologie and the Centro di Ricerca in Biotecnologie per la Salute Umana.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boselli A, 2007, BIOCHIMIE, V89, P1372, DOI 10.1016/j.biochi.2007.04.019; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; DeLano W, 2002, PYMOL 0 99; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; GOLDSBROUGH PB, 1990, PLANT SCI, V72, P53, DOI 10.1016/0168-9452(90)90186-R; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; HOAGLAND RE, 1980, WEED SCI, V28, P393, DOI 10.1017/S0043174500055545; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; Pline-Srnic W, 2006, WEED TECHNOL, V20, P290, DOI 10.1614/WT-04-131R.1; Pollegioni L, 2005, PROTEIN SCI, V14, P3064, DOI 10.1110/ps.051671705; REDDY KN, 2004, WSSA ABSTR, V44, P116; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; Siehl DL, 2007, J BIOL CHEM, V282, P11446, DOI 10.1074/jbc.M610267200; Siehl DL, 2005, PEST MANAG SCI, V61, P235, DOI 10.1002/ps.1014; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z	26	52	57	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36415	36423		10.1074/jbc.M109.051631	http://dx.doi.org/10.1074/jbc.M109.051631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864430	Green Published, hybrid			2022-12-27	WOS:000272970500043
J	Vogel, N; Kluck, CJ; Melzer, N; Schwarzinger, S; Breitinger, U; Seeber, S; Becker, CM				Vogel, Nicolas; Kluck, Christoph J.; Melzer, Nima; Schwarzinger, Stephan; Breitinger, Ulrike; Seeber, Silke; Becker, Cord-Michael			Mapping of Disulfide Bonds within the Amino-terminal Extracellular Domain of the Inhibitory Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; GATED ION-CHANNEL; LIGAND-BINDING; CRYSTAL-STRUCTURE; REDOX AGENTS; SUBUNIT; MODULATION; HOMOLOGY	The strychnine-sensitive glycine receptor (GlyR) is a ligand-gated chloride channel and a member of the superfamily of cysteine loop (Cys-loop) neurotransmitter receptors, which also comprises the nicotinic acetylcholine receptor (nAChR). Within the extracellular domain (ECD), the eponymous Cys-loop harbors two conserved cysteines, assumed to be linked by a superfamily-specific disulfide bond. The GlyR ECD carries three additional cysteine residues, two are predicted to form a second, GlyR-specific bond. The configuration of none of the cysteines of GlyR, however, had been determined directly. Based on a crystal structure of the nAChR alpha 1 ECD, we generated a model of the human GlyR alpha 1 where close proximity of the respective cysteines was consistent with the formation of both the Cys-loop and the GlyR-specific disulfide bonds. To identify native disulfide bonds, the GlyR alpha 1 ECD was heterologously expressed and refolded under oxidative conditions. By matrix-assisted laser desorption ionization time-of-flight mass spectrometry, we detected tryptic fragments of the ECD indicative of disulfide bond formation for both pairs of cysteines, as proposed by modeling. The identity of tryptic fragments was confirmed using chemical modification of cysteine and lysine residues. As evident from circular dichroism spectroscopy, mutagenesis of single cysteines did not impair refolding of the ECD in vitro, whereas it led to partial or complete intracellular retention and consequently to a loss of function of full-length GlyR subunits in human embryonic kidney 293 cells. Our results indicate that the GlyR ECD forms both a Cys-loop and a GlyR-specific disulfide bond. In addition, cysteine residues appear to be important for protein maturation in vivo.	[Vogel, Nicolas; Kluck, Christoph J.; Melzer, Nima; Breitinger, Ulrike; Seeber, Silke; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Schwarzinger, Stephan] Univ Bayreuth, Lehrstuhl Biopolymere, D-95440 Bayreuth, Germany	University of Erlangen Nuremberg; University of Bayreuth	Becker, CM (corresponding author), Fahrstr 17, D-91054 Erlangen, Germany.	cmb@biochem.uni-erlangen.de	Schwarzinger, Stephan/O-4318-2014; Schwarzinger, Stephan/GWV-5819-2022	Schwarzinger, Stephan/0000-0002-0894-5290	European Union [HEALTH-F42008-202088]; Elitenetzwerk Bayern, Lead Structures of Cell Function [K-BM-2003-85]; Deutsche Forschungsgemeinschaft	European Union(European Commission); Elitenetzwerk Bayern, Lead Structures of Cell Function; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by European Union Grant Neurocypres, HEALTH-F42008-202088, Elitenetzwerk Bayern, Lead Structures of Cell Function, Grant K-BM-2003-85, and the Deutsche Forschungsgemeinschaft.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BECKER CM, 1992, HDB EXPT PHARM, P539; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Breitinger U, 2004, J BIOL CHEM, V279, P1627, DOI 10.1074/jbc.M303811200; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Gay EA, 2007, J PHYSIOL-LONDON, V584, P727, DOI 10.1113/jphysiol.2007.142554; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; KAO PN, 1986, J BIOL CHEM, V261, P8085; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Legendre P, 2002, MOL PHARMACOL, V62, P817, DOI 10.1124/mol.62.4.817; Liu Z, 2008, BIOCHEMISTRY-US, V47, P9803, DOI 10.1021/bi800659x; Oertel J, 2007, J BIOL CHEM, V282, P2798, DOI 10.1074/jbc.M608941200; PAN ZH, 1995, J NEUROSCI, V15, P1384; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; ROJAS L, 1991, BRAIN RES, V551, P10, DOI 10.1016/0006-8993(91)90906-C; RUIZGOMEZ A, 1991, J BIOL CHEM, V266, P559; SUMIKAWA K, 1992, J BIOL CHEM, V267, P6286; Thio LL, 2006, NEUROSCIENCE, V139, P1315, DOI 10.1016/j.neuroscience.2006.01.013; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	29	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36128	36136		10.1074/jbc.M109.043448	http://dx.doi.org/10.1074/jbc.M109.043448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861413	Green Published, hybrid			2022-12-27	WOS:000272970500014
J	Yu, HB; Kielczewska, A; Rozek, A; Takenaka, S; Li, YL; Thorson, L; Hancock, REW; Guarna, MM; North, JR; Foster, LJ; Donini, O; Finlay, BB				Yu, Hong Bing; Kielczewska, Agnieszka; Rozek, Annett; Takenaka, Shunsuke; Li, Yuling; Thorson, Lisa; Hancock, Robert E. W.; Guarna, M. Marta; North, John R.; Foster, Leonard J.; Donini, Oreola; Finlay, B. Brett			Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN P62; SIGNALING ADAPTER P62; KAPPA-B ACTIVATION; KINASE; DOMAIN; MACROPHAGES; APOPTOSIS; ISOFORMS; MEDIATOR; RECEPTOR	Innate defense regulator-1 (IDR-1) is a synthetic peptide with no antimicrobial activity that enhances microbial infection control while suppressing inflammation. Previously, the effects of IDR-1 were postulated to impact several regulatory pathways including mitogen-activated protein kinase (MAPK) p38 and CCAAT-enhancer-binding protein, but how this was mediated was unknown. Using a combined stable isotope labeling by amino acids in cell culture-proteomics methodology, we identified the cytoplasmic scaffold protein p62 as the molecular target of IDR-1. Direct IDR-1 binding to p62 was confirmed by several biochemical binding experiments, and the p62 ZZ-type zinc finger domain was identified as the IDR-1 binding site. Co-immunoprecipitation analysis of p62 molecular complexes demonstrated that IDR-1 enhanced the tumor necrosis factor alpha-induced p62 receptor-interacting protein 1 (RIP1) complex formation but did not affect tumor necrosis factor alpha-induced p62-protein kinase zeta complex formation. In addition, IDR-1 induced p38 MAPK activity in a p62-dependent manner and increased CCAAT-enhancer-binding protein beta activity, whereas NF-kappa B activity was unaffected. Collectively, these results demonstrate that IDR-1 binding to p62 specifically affects protein-protein interactions and subsequent downstream events. Our results implicate p62 in the molecular mechanisms governing innate immunity and identify p62 as a potential therapeutic target in both infectious and inflammatory diseases.	[Yu, Hong Bing; Li, Yuling; Thorson, Lisa; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Hancock, Robert E. W.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Kielczewska, Agnieszka; Rozek, Annett; Takenaka, Shunsuke; North, John R.; Donini, Oreola] Inimex Pharmaceut, Vancouver, BC V5A 4T8, Canada; [Guarna, M. Marta; Foster, Leonard J.] Ctr High Throughput Biol, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, 2185 E Mall, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Guarna, Maria Marta/0000-0002-4638-9475	Canadian Institutes of Health Research (CIHR); Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative	This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR) and the Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative (to B.B.F.).	Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Hiruma Y, 2009, BLOOD, V113, P4894, DOI 10.1182/blood-2008-08-173948; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kawai K, 2008, J BIOCHEM, V143, P765, DOI 10.1093/jb/mvn027; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Lee TH, 2003, MOL CELL BIOL, V23, P8377, DOI 10.1128/MCB.23.22.8377-8385.2003; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235	24	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36007	36011		10.1074/jbc.C109.073627	http://dx.doi.org/10.1074/jbc.C109.073627			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850933	Green Published, hybrid			2022-12-27	WOS:000272970500002
J	Hannemann, A; Christie, JK; Flatman, PW				Hannemann, Anke; Christie, Jenny K.; Flatman, Peter W.			Functional Expression of the Na-K-2Cl Cotransporter NKCC2 in Mammalian Cells Fails to Confirm the Dominant-negative Effect of the AF Splice Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL-COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; NA+-K+-2CL(-) COTRANSPORTER; REGULATORY PHOSPHORYLATION; SURFACE EXPRESSION; ION-TRANSPORT; TERMINUS; PROTEIN; BUMETANIDE; ISOFORMS	The renal bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2) is the major salt transport pathway in the apical membrane of the mammalian thick ascending limb. It is differentially spliced and the three major variants (A, B, and F) differ in their localization and transport characteristics. Most knowledge about its regulation comes from experiments in Xenopus oocytes as NKCC2 proved difficult to functionally express in a mammalian system. Here we report the cloning and functional expression of untagged and unmodified versions of the major splice variants from ferret kidney (fNKCC2A, -B, and -F) in human embryonic kidney (HEK) 293 cells. Many NKCC2 antibodies used in this study detected high molecular weight forms of the transfected proteins, probably NKCC2 dimers, but not the monomers. Interestingly, monomers were strongly detected by phosphospecific antibodies directed against phosphopeptides in the regulatory N terminus. Bumetanide-sensitive Rb-86 uptake was significantly higher in transfected HEK-293 cells and could be stimulated by incubating cells in a medium containing a low chloride concentration prior the uptake measurements. fNKCC2 was less sensitive to the reduction in chloride concentration than NKCC1. Using HEK-293 cells stably expressing fNKCC2A we also show that co-expression of variant NKCC2AF does not have the dominant-negative effect on NKCC2 Aactivity that was seen in Xenopus oocytes, nor is it trafficked to the cell surface. In addition, fNKCC2AF is neither complex glycosylated nor phosphorylated in its N terminus regulatory region like other variants.	[Hannemann, Anke; Christie, Jenny K.; Flatman, Peter W.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Flatman, PW (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	peter.flatman@ed.ac.uk	Hannemann, Anke/AAE-2445-2019	Hannemann, Anke/0000-0002-2925-1124	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Brunet GM, 2005, J GEN PHYSIOL, V126, P325, DOI 10.1085/jgp.200509334; Castrop H, 2008, AM J PHYSIOL-RENAL, V295, pF859, DOI 10.1152/ajprenal.00106.2008; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Flatman PW, 2007, CLIN SCI, V112, P203, DOI 10.1042/CS20060225; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gagnon E, 2005, J BIOL CHEM, V280, P32555, DOI 10.1074/jbc.M505511200; Gagnon E, 2002, AM J PHYSIOL-RENAL, V283, pF1046, DOI 10.1152/ajprenal.00107.2002; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gimenez I, 2002, J BIOL CHEM, V277, P8767, DOI 10.1074/jbc.C200021200; Gimenez I, 2007, J BIOL CHEM, V282, P6540, DOI 10.1074/jbc.M610780200; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Khoudoli G.A., 2004, PROTEOME SCI, V2, P6, DOI DOI 10.1186/1477-5956-2-6; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Maglova LM, 2004, AM J PHYSIOL-CELL PH, V286, pC1324, DOI 10.1152/ajpcell.00404.2003; Matskevich L, 2005, BBA-BIOMEMBRANES, V1714, P25, DOI 10.1016/j.bbamem.2005.06.001; Moore-Hoon ML, 1998, BBA-BIOMEMBRANES, V1373, P261, DOI 10.1016/S0005-2736(98)00112-6; Oppermann M, 2006, J AM SOC NEPHROL, V17, P2143, DOI 10.1681/ASN.2006040384; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Plata C, 2002, J BIOL CHEM, V277, P11004, DOI 10.1074/jbc.M110442200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Yang TX, 1996, AM J PHYSIOL-RENAL, V271, pF931, DOI 10.1152/ajprenal.1996.271.4.F931; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679	41	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35348	35358		10.1074/jbc.M109.060004	http://dx.doi.org/10.1074/jbc.M109.060004			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19854835	Green Published, hybrid			2022-12-27	WOS:000272645600011
J	Batisse, J; Batisse, C; Budd, A; Bottcher, B; Hurt, E				Batisse, Julien; Batisse, Claire; Budd, Aidan; Boettcher, Bettina; Hurt, Ed			Purification of Nuclear Poly(A)-binding Protein Nab2 Reveals Association with the Yeast Transcriptome and a Messenger Ribonucleoprotein Core Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; ANGSTROM RESOLUTION; RIBOSOMAL-SUBUNIT; EXPORT; COMPLEX; LOCALIZATION; TRANSPORT; PARTICLE; PORE; CYTOPLASM	Nascent mRNAs produced by transcription in the nucleus are subsequently processed and packaged into mRNA ribonucleoprotein particles (messenger ribonucleoproteins (mRNPs)) before export to the cytoplasm. Here, we have used the poly(A)binding protein Nab2 to isolate mRNPs from yeast under conditions that preserve mRNA integrity. Upon Nab2-tandem affinity purification, several mRNA export factors were co-enriched (Yra1, Mex67, THO-TREX) that were present in mRNPs of different size and mRNA length. High-throughput sequencing of the co-precipitated RNAs indicated that Nab2 is associated with the bulk of yeast transcripts with no specificity for different mRNA classes. Electron microscopy revealed that many of the mRNPs have a characteristic elongated structure. Our data suggest that mRNPs, although associated with different mRNAs, have a unifying core structure.	[Batisse, Julien; Hurt, Ed] Univ Heidelberg BZH, Zentrum Biochem, D-69120 Heidelberg, Germany; [Batisse, Claire; Budd, Aidan] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Boettcher, Bettina] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); University of Edinburgh	Hurt, E (corresponding author), Univ Heidelberg BZH, Zentrum Biochem, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Batisse, Julien/A-4338-2012; Bottcher, Bettina/E-9397-2010; Budd, Aidan/F-8550-2013; Ed Hurt, Dr./AAE-8874-2019	Batisse, Julien/0000-0003-1285-1083; Bottcher, Bettina/0000-0002-7962-4849; Budd, Aidan/0000-0003-0196-9051; Ed Hurt, Dr./0000-0002-4535-8255; BATISSE, Claire/0000-0003-3064-6569	European Grant 3D [LSHG-CT-2005-512028]; Wellcome Trust [087658]	European Grant 3D; Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the European Grant 3D repertoire (LSHG-CT-2005-512028) and by Wellcome Trust Grant 087658.	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; de Heredia Miguel Lopez, 2004, BMC Biochemistry, V5, P14, DOI 10.1186/1471-2091-5-14; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsumoto K, 2003, BIOCHEM BIOPH RES CO, V306, P53, DOI 10.1016/S0006-291X(03)00909-4; MEHLIN H, 1991, EXP CELL RES, V193, P72, DOI 10.1016/0014-4827(91)90539-7; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; van den Bogaart G, 2009, NAT CELL BIOL, V11, P350, DOI 10.1038/ncb1844; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WU WW, 2009, J VIS EXP, V24, P1105; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	40	79	79	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34911	34917		10.1074/jbc.M109.062034	http://dx.doi.org/10.1074/jbc.M109.062034			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840948	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000272439600046
J	Mandapathil, M; Hilldorfer, B; Szczepanski, MJ; Czystowska, M; Szajnik, M; Ren, J; Lang, S; Jackson, EK; Gorelik, E; Whiteside, TL				Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J.; Czystowska, Malgorzata; Szajnik, Marta; Ren, Jin; Lang, Stephan; Jackson, Edwin K.; Gorelik, Elieser; Whiteside, Theresa L.			Generation and Accumulation of Immunosuppressive Adenosine by Human CD4(+)CD25(high)FOXP3(+) Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSE; AUTOIMMUNE-DISEASE; EXTRACELLULAR ATP; PERIPHERAL-BLOOD; DENDRITIC CELLS; TISSUE-DAMAGE; RECEPTORS; CD73; SUPPRESSION; EXPRESSION	Naturally occurring regulatory T cells (nTreg) are crucial for maintaining tolerance to self and thus preventing autoimmune diseases and allograft rejections. In cancer, Treg down-regulate antitumor responses by several distinct mechanisms. This study analyzes the role the adenosinergic pathway plays in suppressive activities of human nTreg. Human CD4(+)CD25(high)FOXP3(+) Treg overexpress CD39 and CD73, ectonucleotidases sequentially converting ATP into AMP and adenosine, which then binds to A(2a) receptors on effector T cells, suppressing their functions. CD4(+)CD39(+) and CD4(+)CD25(high) T cells express low levels of adenosine deaminase (ADA), the enzyme responsible for adenosine breakdown, and of CD26, a surface-bound glycoprotein associated with ADA. In contrast, T effector cells are enriched in CD26/ADA but express low levels of CD39 and CD73. Inhibitors of ectonucleotidase activity (e.g. ARL67156) and antagonists of the A(2a) receptor (e.g. ZM241385) blocked Treg-mediated immunosuppression. The inhibition of ADA activity on effector T cells enhanced Treg-mediated immunosuppression. Thus, human nTreg characterized by the presence of CD39 and the low expression of CD26/ADA are responsible for the generation of adenosine, which plays a major role in Treg-mediated immunosuppression. The data suggest that the adenosinergic pathway represents a potential therapeutic target for regulation of immunosuppression in a broad variety of human diseases.	[Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J.; Czystowska, Malgorzata; Szajnik, Marta; Gorelik, Elieser; Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Dept Pathol, Pittsburgh, PA 15213 USA; [Ren, Jin; Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA; [Mandapathil, Magis; Lang, Stephan] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45147 Essen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Duisburg Essen	Whiteside, TL (corresponding author), Univ Pittsburgh, Inst Canc, Dept Pathol, Res Pavil,Hillman Canc Ctr,5117 Ctr Ave,Suite 1-2, Pittsburgh, PA 15213 USA.	whitesidetl@upmc.edu	Mandapathil, Magis/AFL-3260-2022; Czystowska-Kuźmicz, Małgorzata/ABH-3220-2020; Czystowska-Kuzmicz, Malgorzata/AAC-6989-2020; Czystowska-Kuźmicz, Małgorzata/U-7933-2018	Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Jackson, Edwin/0000-0002-8101-6009	National Institutes of Health [DK079307, DK068575, PO-1 DE12321, PO-1 CA109688]; Philip Morris USA, Inc.; Philip Morris International; Department of Defense [BC051720]; Hillman Foundation; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK068575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA, Inc.; Philip Morris International; Department of Defense(United States Department of Defense); Hillman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079307 and DK068575 (to E. K. J.) and PO-1 DE12321 and PO-1 CA109688 (to T. W.). This work was also supported by Philip Morris USA, Inc. and Philip Morris International (to M. M.), Department of Defense Grant BC051720, and the Hillman Foundation (to E. G.).	Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bergmann C, 2007, CANCER IMMUNOL IMMUN, V56, P1429, DOI 10.1007/s00262-007-0280-9; Beyer M, 2008, CURR ONCOL REP, V10, P130, DOI 10.1007/s11912-008-0021-z; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Dong RP, 1996, J IMMUNOL, V156, P1349; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kline J, 2008, BONE MARROW TRANSPL, V41, P505, DOI 10.1038/sj.bmt.1705931; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Raskovalova T, 2007, CANCER RES, V67, P5949, DOI 10.1158/0008-5472.CAN-06-4249; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; SCHRADER WP, 1990, J BIOL CHEM, V265, P19312; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; Verbsky JW, 2007, CURR OPIN RHEUMATOL, V19, P252, DOI 10.1097/BOR.0b013e3280ad46bb; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	43	283	297	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7176	7186		10.1074/jbc.M109.047423	http://dx.doi.org/10.1074/jbc.M109.047423			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19858205	hybrid, Green Published			2022-12-27	WOS:000275415600031
J	Flozak, AS; Lam, AP; Russell, S; Jain, M; Peled, ON; Sheppard, KA; Beri, R; Mutlu, GM; Budinger, GRS; Gottardi, CJ				Flozak, Annette S.; Lam, Anna P.; Russell, Susan; Jain, Manu; Peled, Ofra N.; Sheppard, Kerry A.; Beri, Rohinee; Mutlu, Goekhan M.; Budinger, G. R. Scott; Gottardi, Cara J.			beta-Catenin/T-cell Factor Signaling Is Activated during Lung Injury and Promotes the Survival and Migration of Alveolar Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; DUAL-KINASE MECHANISM; PHENOTYPE IN-VITRO; II CELLS; STEM-CELLS; DIFFERENTIAL EXPRESSION; ARTICULAR-CARTILAGE; C-MYC; WNT; PROTEIN	The Wnt/beta-catenin signaling cascade activates genes that allow cells to adopt particular identities throughout development. In adult self-renewing tissues like intestine and blood, activation of the Wnt pathway maintains a progenitor phenotype, whereas forced inhibition of this pathway promotes differentiation. In the lung alveolus, type 2 epithelial cells (AT2) have been described as progenitors for the type 1 cell (AT1), but whether AT2 progenitors use the same signaling mechanisms to control differentiation as rapidly renewing tissues is not known. Weshow that adult AT2 cells do not exhibit constitutive beta-catenin signaling in vivo, using the AXIN2(+/LacZ) reporter mouse, or after fresh isolation of an enriched population of AT2 cells. Rather, this pathway is activated in lungs subjected to bleomycin-induced injury, as well as upon placement of AT2 cells in culture. Forced inhibition of beta-catenin/T-cell factor signaling in AT2 cultures leads to increased cell death. Cells that survive show reduced migration after wounding and reduced expression of AT1 cell markers (T1 alpha and RAGE). These results suggest that AT2 cells may function as facultative progenitors, where activation of Wnt/beta-catenin signaling during lung injury promotes alveolar epithelial survival, migration, and differentiation toward an AT1-like phenotype.	[Flozak, Annette S.; Lam, Anna P.; Russell, Susan; Jain, Manu; Sheppard, Kerry A.; Beri, Rohinee; Mutlu, Goekhan M.; Budinger, G. R. Scott; Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA; [Peled, Ofra N.] Natl Louis Univ, Dept Nat Sci, Chicago, IL 60603 USA	Northwestern University; Feinberg School of Medicine; National Louis University	Gottardi, CJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA.	c-gottardi@northwestern.edu	Gottardi, Cara J./AAU-4691-2021; Mutlu, Gokhan/HIR-2545-2022	Gottardi, Cara J./0000-0003-0912-7617; 	National Institutes of Health [GM076561, T32 HL076139]; NHLBI [HL78145]; Northwestern Memorial Faculty Foundation [HL071643, ES015024]; NIEHS, NIH ONES Award [HL071643, ES013995]; Schweppe Foundation; American Heart Association [0530304Z]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139, P01HL071643, P30HL101292, F32HL078145, K08HL093216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015024, R01ES013995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Northwestern Memorial Faculty Foundation; NIEHS, NIH ONES Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Schweppe Foundation; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076561 (to C.J.G.). This work was also supported by a National Research Service Award (HL78145) from NHLBI, NIH (to A.P.L.), by Grant T32 HL076139 (to S.R.), by the Northwestern Memorial Faculty Foundation (to M.J.), by Grants HL071643 and ES015024 and an NIEHS, NIH ONES Award (to G.M.M.), by Grants HL071643 and ES013995 (to G.R.S.B.), and by Career Development Awards from the Schweppe Foundation and the American Heart Association (Grant 0530304Z).	ADAMSON IYR, 1974, LAB INVEST, V30, P35; ASO Y, 1976, LAB INVEST, V35, P558; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; Borok Z, 2006, PEDIATR RES, V59, p84R, DOI 10.1203/01.pdr.0000203563.37626.77; Borok Z, 1998, AM J RESP CELL MOL, V18, P554, DOI 10.1165/ajrcmb.18.4.2838; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; BRODY JS, 1992, ANNU REV PHYSIOL, V54, P351, DOI 10.1146/annurev.physiol.54.1.351; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Chen JW, 2004, LAB INVEST, V84, P727, DOI 10.1038/labinvest.3700095; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniels CB, 2003, NEWS PHYSIOL SCI, V18, P151, DOI 10.1152/nips.01438.2003; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; DeBiase PJ, 2006, J HISTOCHEM CYTOCHEM, V54, P665, DOI 10.1369/jhc.5A6889.2006; Dell'Accio F, 2008, ARTHRITIS RHEUM-US, V58, P1410, DOI 10.1002/art.23444; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; DOBBS LG, 1985, BIOCHIM BIOPHYS ACTA, V846, P155, DOI 10.1016/0167-4889(85)90121-1; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; George CLS, 2008, INFECT IMMUN, V76, P380, DOI 10.1128/IAI.01043-07; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Isakson BE, 2001, AM J PHYSIOL-CELL PH, V281, pC1291, DOI 10.1152/ajpcell.2001.281.4.C1291; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-5; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Okuse T, 2005, WOUND REPAIR REGEN, V13, P491, DOI 10.1111/j.1067-1927.2005.00069.x; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; PEIFER M, 1994, DEVELOPMENT, V120, P369; Polakis P, 2000, GENE DEV, V14, P1837; Ramirez MI, 1997, J BIOL CHEM, V272, P26285, DOI 10.1074/jbc.272.42.26285; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reynolds SD, 2008, STEM CELLS, V26, P1337, DOI 10.1634/stemcells.2008-0053; Ridge KM, 1997, AM J PHYSIOL-LUNG C, V273, pL246, DOI 10.1152/ajplung.1997.273.1.L246; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Sheppard D, 2001, J CLIN INVEST, V107, P1501, DOI 10.1172/JCI13318; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Tago K, 2000, GENE DEV, V14, P1741; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; WEIBEL ER, 1986, B EUR PHYSIOPATH RES, V22, pS235; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Wofford JA, 2007, AM J PHYSIOL-LUNG C, V293, pL1437, DOI 10.1152/ajplung.00239.2007; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	70	86	89	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3157	3167		10.1074/jbc.M109.070326	http://dx.doi.org/10.1074/jbc.M109.070326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933277	Green Published, hybrid			2022-12-27	WOS:000273829000031
J	Karpurapu, M; Wang, D; Van Quyen, D; Kim, TK; Kundumani-Sridharan, V; Pulusani, S; Rao, GN				Karpurapu, Manjula; Wang, Dong; Van Quyen, Dong; Kim, Tae-Kang; Kundumani-Sridharan, Venkatesh; Pulusani, Srinidhi; Rao, Gadiparthi N.			Cyclin D1 Is a Bona Fide Target Gene of NFATc1 and Is Sufficient in the Mediation of Injury-induced Vascular Wall Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; RECEPTOR TYROSINE KINASE; SMOOTH-MUSCLE; TRANSCRIPTION FACTOR; NEOINTIMA FORMATION; NUCLEAR FACTOR; IN-VITRO; EXPRESSION; GROWTH; PROLIFERATION	Platelet-derived growth factor BB induced cyclin D1 expression in a time-and nuclear factor of activated T cells (NFAT)dependent manner in human aortic smooth muscle cells (HASMCs), and blockade of NFATs prevented HASMC DNA synthesis and their cell cycle progression from G(1) to S phase. Selective inhibition of NFATc1 by its small interfering RNA also blocked HASMC proliferation and migration. Characterization of the cyclin D1 promoter revealed the presence of several NFAT binding sites, and the site at nucleotide -1333 was found to be sufficient in mediating platelet-derived growth factor BB-induced cyclin D1 promoter-luciferase reporter gene activity. In addition to its role in cell cycle progression, cyclin D1 mediated HASMC migration in an NFATc1-dependent manner. Balloon injury-induced cyclin D1-CDK4 activity requires NFAT activation, and adenovirus-mediated transduction of cyclin D1 was found to be sufficient to overcome the blockade effect of NFATs by VIVIT on balloon injury-induced vascular wall remodeling events, including smooth muscle cell migration from the medial to luminal region, their proliferation in the intimal region, and neointima formation. Together, these results provide more mechanistic evidence for the role of NFATs, particularly NFATc1, in the regulation of HASMC proliferation and migration as well as vascular wall remodeling. NFATc1 could be a potential therapeutic target against the renarrowing of artery after angioplasty.	[Karpurapu, Manjula; Wang, Dong; Van Quyen, Dong; Kim, Tae-Kang; Kundumani-Sridharan, Venkatesh; Pulusani, Srinidhi; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	grao@physio1.utmem.edu	Kundumani-Sridharan, Venkatesh/I-4799-2016	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Quyen, Dong Van/0000-0003-1002-7517	National Institutes of Health [HL069908]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL069908 (to G. N. R.).	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; CASSCELLS W, 1992, CIRCULATION, V86, P723, DOI 10.1161/01.CIR.86.3.723; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HERBER B, 1994, ONCOGENE, V9, P1295; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Johnson EN, 2003, J BIOL CHEM, V278, P1686, DOI 10.1074/jbc.M210250200; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347	49	44	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3510	3523		10.1074/jbc.M109.063727	http://dx.doi.org/10.1074/jbc.M109.063727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933579	Green Published, hybrid			2022-12-27	WOS:000273829000065
J	Nakada, T; Westhoff, CM; Yamaguchi, Y; Hyodo, S; Li, XJ; Muro, T; Kato, A; Nakamura, N; Hirose, S				Nakada, Tsutomu; Westhoff, Connie M.; Yamaguchi, Yoko; Hyodo, Susumu; Li, Xiaojin; Muro, Takayuki; Kato, Akira; Nakamura, Nobuhiro; Hirose, Shigehisa			Rhesus Glycoprotein P2 (Rhp2) Is a Novel Member of the Rh Family of Ammonia Transporters Highly Expressed in Shark Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROUT ONCORHYNCHUS-MYKISS; D-GLUCOSE COTRANSPORTER; ZEBRAFISH DANIO-RERIO; THICK ASCENDING LIMB; RED-CELL MEMBRANE; RAINBOW-TROUT; SQUALUS-ACANTHIAS; UREA TRANSPORTER; FRESH-WATER; MOLECULAR-IDENTIFICATION	Rhesus (Rh) glycoproteins are a family of membrane proteins capable of transporting ammonia. We isolated the full-length cDNA of a novel Rh glycoprotein, Rhp2, from a kidney cDNA library from the banded hound shark, Triakis scyllium. Molecular cloning and characterization indicated that Rhp2 consists of 476 amino acid residues and has 12 putative transmembrane spans, consistent with the structure of other family members. The shark Rhp2 gene was found to consist of only one coding exon. Northern blotting and in situ hybridization revealed that Rhp2 mRNA is exclusively expressed in the renal tubules of the sinus zone but not in the bundle zone and renal corpuscles. Immunohistochemical staining with a specific antiserum showed that Rhp2 is localized in the basolateral membranes of renal tubule cells. Double fluorescence labeling with phalloidin or labeling of the Na+/K+-ATPase further narrowed the location to the second and fourth loops in the sinus zone. Vacuolar type H+-ATPase was localized in apical membranes of the Rhp2-expressing tubule cells. Quantitative real-time PCR analysis and Western blotting showed that expression of Rhp2 was increased in response to elevation of environmental salinity. Functional analysis using the Xenopus oocyte expression system showed that Rhp2 has transport activity for methylammonium, an analog of ammonia. This transport activity was inhibited by NH4Cl but not trimethylamine-N-oxide and urea. These results suggested that Rhp2 is involved in ammonia reabsorption in the kidney of the elasmobranch group of cartilaginous fish comprising the sharks and rays.	[Nakada, Tsutomu; Muro, Takayuki; Kato, Akira; Nakamura, Nobuhiro; Hirose, Shigehisa] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; [Westhoff, Connie M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Yamaguchi, Yoko; Hyodo, Susumu] Univ Tokyo, Ocean Res Inst, Physiol Lab, Tokyo 1648639, Japan; [Westhoff, Connie M.; Li, Xiaojin] Amer Red Cross, Philadelphia, PA 19130 USA	Tokyo Institute of Technology; University of Pennsylvania; University of Tokyo; American Red Cross	Westhoff, CM (corresponding author), 700 Spring Garden St, Philadelphia, PA 19130 USA.	westhoffc@usa.redcross.org; shirose@bio.titech.ac.jp	Nakamura, Nobuhiro/C-4265-2015; Kato, Akira/E-6328-2010	Nakamura, Nobuhiro/0000-0002-0249-2665; Kato, Akira/0000-0002-9083-1443; Yamaguchi, Yoko/0000-0002-0526-0069; Hyodo, Susumu/0000-0001-8146-2386	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT) [14104002, 18059010, 18-5667]; Japan Society for the Promotion of Science Research Fellowships; Grants-in-Aid for Scientific Research [22370029] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Research Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 14104002 and 18059010 (to S. H.) and 18-5667 (to T. N.) from the Ministry of Education, Culture, Sport, Science and Technology of Japan (MEXT), the Japan Society for the Promotion of Science Research Fellowships for Young Scientists, and the 21st Century and Global Centers of Excellence Program of MEXT.	Althoff T, 2006, AM J PHYSIOL-REG I, V290, pR1094, DOI 10.1152/ajpregu.00334.2005; Althoff T, 2007, AM J PHYSIOL-REG I, V292, pR2391, DOI 10.1152/ajpregu.00454.2006; *AM PHYS SOC, 2002, AM J PHYSIOL-REG I, V283, pR281, DOI DOI 10.1152/AJPREGU.00279.2002; Attmane-Elakeb A, 2001, AM J PHYSIOL-RENAL, V280, pF1, DOI 10.1152/ajprenal.2001.280.1.F1; Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; Biemesderfer D, 1996, AM J PHYSIOL-RENAL, V270, pF927, DOI 10.1152/ajprenal.1996.270.6.F927; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Braun MH, 2009, AM J PHYSIOL-RENAL, V296, pF994, DOI 10.1152/ajprenal.90656.2008; Cai SY, 2003, AM J PHYSIOL-REG I, V284, pR125, DOI 10.1152/ajpregu.00392.2002; DEETJEN P, 1974, PFLUG ARCH EUR J PHY, V346, P25, DOI 10.1007/BF00592647; Endeward V, 2006, TRANSFUS CLIN BIOL, V13, P123, DOI 10.1016/j.tracli.2006.02.007; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; Evans David H., 1993, P315; GOOD DW, 1984, AM J PHYSIOL, V247, pF35, DOI 10.1152/ajprenal.1984.247.1.F35; Handlogten ME, 2004, AM J PHYSIOL-RENAL, V287, pF628, DOI 10.1152/ajprenal.00363.2003; Hazon N, 2003, COMP BIOCHEM PHYS B, V136, P685, DOI 10.1016/S1096-4959(03)00280-X; Hirata T, 2003, AM J PHYSIOL-REG I, V284, pR1199, DOI 10.1152/ajpregu.00267.2002; HODLER J, 1955, AM J PHYSIOL, V183, P155, DOI 10.1152/ajplegacy.1955.183.1.155; Huang CH, 2001, BLOOD CELL MOL DIS, V27, P90, DOI 10.1006/bcmd.2000.0355; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Hung CYC, 2007, J EXP BIOL, V210, P2419, DOI 10.1242/jeb.002568; Hung CC, 2008, J EXP ZOOL PART A, V309A, P262, DOI 10.1002/jez.456; Hyodo S, 2004, GEN COMP ENDOCR, V138, P97, DOI 10.1016/j.ygcen.2004.05.009; Hyodo S, 2004, J EXP BIOL, V207, P347, DOI 10.1242/jeb.00773; Ji QM, 2006, P NATL ACAD SCI USA, V103, P5881, DOI 10.1073/pnas.0600901103; KING PA, 1983, AM J PHYSIOL, V245, pR581, DOI 10.1152/ajpregu.1983.245.4.R581; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; LACY ER, 1985, ANAT EMBRYOL, V173, P163, DOI 10.1007/BF00316299; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; McDonald MD, 2006, J MEMBRANE BIOL, V212, P93, DOI 10.1007/s00232-006-0869-5; Mistry AC, 2001, AM J PHYSIOL-REG I, V281, pR1594, DOI 10.1152/ajpregu.2001.281.5.R1594; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakada T, 2005, AM J PHYSIOL-REG I, V289, pR575, DOI 10.1152/ajpregu.00725.2004; Nakada T, 2007, FASEB J, V21, P1067, DOI 10.1096/fj.06-6834com; Nakada T, 2007, AM J PHYSIOL-REG I, V293, pR1743, DOI 10.1152/ajpregu.00248.2007; Nawata CM, 2008, J EXP BIOL, V211, P3226, DOI 10.1242/jeb.020396; Nawata CM, 2007, PHYSIOL GENOMICS, V31, P463, DOI 10.1152/physiolgenomics.00061.2007; POULSEN JM, 1981, SPHYRNA TIBURO COMP, V70, P127; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Shih TH, 2008, AM J PHYSIOL-CELL PH, V295, pC1625, DOI 10.1152/ajpcell.00255.2008; Smith HW, 1931, AM J PHYSIOL, V98, P279, DOI 10.1152/ajplegacy.1931.98.2.279; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599; SWENSON ER, 1994, AM J PHYSIOL-RENAL, V267, pF639, DOI 10.1152/ajprenal.1994.267.4.F639; THORSON TB, 1962, SCIENCE, V138, P688, DOI 10.1126/science.138.3541.688; Tsui TKN, 2009, J EXP BIOL, V212, P878, DOI 10.1242/jeb.021899; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Westhoff CM, 2004, J BIOL CHEM, V279, P17443, DOI 10.1074/jbc.M311853200; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; WOOD CM, 1995, J EXP BIOL, V198, P1545; Yamaguchi Y, 2009, J EXP ZOOL PART A, V311A, P705, DOI 10.1002/jez.558	59	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2653	2664		10.1074/jbc.M109.052068	http://dx.doi.org/10.1074/jbc.M109.052068			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19926789	hybrid, Green Published			2022-12-27	WOS:000273697800044
J	Kovacs, E; Toth, J; Vertessy, BG; Liliom, K				Kovacs, Erika; Toth, Judit; Vertessy, Beata G.; Liliom, Karoly			Dissociation of Calmodulin-Target Peptide Complexes by the Lipid Mediator Sphingosylphosphorylcholine IMPLICATIONS IN CALCIUM SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; RYANODINE RECEPTOR; PLASMA-MEMBRANE; BINDING DOMAIN; HIGH-AFFINITY; RELEASE; RECOGNITION; BRAIN; CELLS; LOCALIZATION	Previously we have identified the lipid mediator sphingosylphosphorylcholine (SPC) as the first potentially endogenous inhibitor of the ubiquitous Ca2+ sensor calmodulin(CaM) (Kovacs, E., and Liliom, K. (2008) Biochem. J. 410, 427-437). Here we give mechanistic insight into CaM inhibition by SPC, based on fluorescence stopped-flow studies with the model CaM-binding domain melittin. We demonstrate that both the peptide and SPC micelles bind to CaM in a rapid and reversible manner with comparable affinities. Furthermore, we present kinetic evidence that both species compete for the same target site on CaM, and thus SPC can be considered as a competitive inhibitor of CaM-target peptide interactions. We also show that SPC disrupts the complex of CaM and the CaM-binding domain of ryanodine receptor type 1, inositol 1,4,5-trisphosphate receptor type 1, and the plasma membrane Ca2+ pump. By interfering with these interactions, thus inhibiting the negative feedback that CaM has on Ca2+ signaling, we hypothesize that SPC could lead to Ca2+ mobilization in vivo. Hence, we suggest that the action of the sphingolipid on CaM might explain the previously recognized phenomenon that SPC liberates Ca2+ from intracellular stores. Moreover, we demonstrate that unlike traditional synthetic CaM inhibitors, SPC disrupts the complex between not only the Ca2+-saturated but also the apo form of the protein and the target peptide, suggesting a completely novel regulation for target proteins that constitutively bind CaM, such as ryanodine receptors.	[Kovacs, Erika; Toth, Judit; Vertessy, Beata G.; Liliom, Karoly] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Kovacs, E (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary.	kovacs@enzim.hu	Vertessy, Beata G/H-6202-2012; Liliom, Karoly/A-6563-2011	Liliom, Karoly/0000-0002-7177-6872; Vertessy, Beata G./0000-0002-1288-2982	National Institutes of Health [1R01TW008130-01]; OTKA [61501, 72008, K68229, CK-78646]; National Development Agency [KMOP-1.1.2-07/1-20080003]; Howard Hughes Medical Institutes [55005628, 55000342]; Alexander von Humboldt Foundation; National Office for Research and Technology, Hungary [JAP_TSZ_071128_TB_INTER]; European Union [LSHG-CT-2006-031220, TEACH-SG LSSG-CT-2007-037198]; FOGARTY INTERNATIONAL CENTER [R01TW008130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Office for Research and Technology, Hungary(National Office for Research and Technology); European Union(European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01TW008130-01 (to J. T.), Hungarian Scientific Research Fund OTKA Grants 61501 (to K. L.), 72008 (to J. T.), K68229 and CK-78646 (to B. G. V.), National Development Agency Grant KMOP-1.1.2-07/1-20080003, Howard Hughes Medical Institutes Grants 55005628 and 55000342 (to B. G. V.), the Alexander von Humboldt Foundation, National Office for Research and Technology, Hungary, Grant JAP_TSZ_071128_TB_INTER, and European Union Grants FP6 SPINE2c LSHG-CT-2006-031220 and TEACH-SG LSSG-CT-2007-037198 (to B. G. V.).	Balshaw DM, 2002, J MEMBRANE BIOL, V185, P1, DOI 10.1007/s00232-001-0111-4; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Betto R, 1997, BIOCHEM J, V322, P327, DOI 10.1042/bj3220327; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; Bunemann M, 1996, EMBO J, V15, P5527, DOI 10.1002/j.1460-2075.1996.tb00937.x; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chiulli N, 2007, EUR J NEUROSCI, V26, P875, DOI 10.1111/j.1460-9568.2007.05732.x; COMTE M, 1983, BIOCHEM J, V209, P269, DOI 10.1042/bj2090269; DESAI NN, 1991, BIOCHEM BIOPH RES CO, V181, P361, DOI 10.1016/S0006-291X(05)81427-5; DETTBARN C, 1995, BRAIN RES, V669, P79, DOI 10.1016/0006-8993(94)01234-9; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; Heringdorf DMZ, 2004, J CELL BIOCHEM, V92, P937, DOI 10.1002/jcb.20107; Heringdorf DMZ, 1998, EUR J PHARMACOL, V354, P113, DOI 10.1016/S0014-2999(98)00436-1; HERINGDORF MZ, 2002, BIOCHIM BIOPHYS ACTA, V1582, P178; Kovacs E, 2008, BIOCHEM J, V410, P427, DOI 10.1042/BJ20071019; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189; Lucas JL, 2006, PHARM RES-DORDR, V23, P647, DOI 10.1007/s11095-006-9784-9; Mao CG, 1996, P NATL ACAD SCI USA, V93, P1993, DOI 10.1073/pnas.93.5.1993; Martinez-Luis S, 2007, PHYTOCHEMISTRY, V68, P1882, DOI 10.1016/j.phytochem.2007.02.025; MASSOM L, 1990, BIOCHEMISTRY-US, V29, P671, DOI 10.1021/bi00455a012; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MOLNAR A, 1995, EUR J PHARM-MOLEC PH, V291, P73; Murase T, 2002, BIOCHEMISTRY-US, V41, P1618, DOI 10.1021/bi011782r; Nixon GF, 2008, PROG LIPID RES, V47, P62, DOI 10.1016/j.plipres.2007.11.001; Okamoto R, 2003, J LIPID RES, V44, P93, DOI 10.1194/jlr.M200225-JLR200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Rodriguez-Lafrasse C, 1999, NEUROCHEM RES, V24, P199, DOI 10.1023/A:1022501702403; Schnurbus R, 2002, BIOCHEM J, V362, P183, DOI 10.1042/0264-6021:3620183; Sienaert I, 2002, BIOCHEM J, V365, P269, DOI 10.1042/BJ20020144; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083	40	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1799	1808		10.1074/jbc.M109.053116	http://dx.doi.org/10.1074/jbc.M109.053116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19910470	Green Published, hybrid			2022-12-27	WOS:000273429100026
J	Takai, KK; Hooper, S; Blackwood, S; Gandhi, R; de Lange, T				Takai, Kaori K.; Hooper, Sarah; Blackwood, Stephanie; Gandhi, Rita; de Lange, Titia			In Vivo Stoichiometry of Shelterin Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERE LENGTH CONTROL; HUMAN-CHROMOSOMES; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; PROTECTS TELOMERES; DAMAGE RESPONSE; FISSION YEAST; POT1 PROTEINS	Human telomeres bind shelterin, the six-subunit protein complex that protects chromosome ends from the DNA damage response and regulates telomere length maintenance by telomerase. We used quantitative immunoblotting to determine the abundance and stoichiometry of the shelterin proteins in the chromatin-bound protein fraction of human cells. The abundance of shelterin components was similar in primary and transformed cells and was not correlated with telomere length. The duplex telomeric DNA binding factors in shelterin, TRF1 and TRF2, were sufficiently abundant to cover all telomeric DNA in cells with short telomeres. The TPP1.POT1 heterodimer was present 50-100 copies/telomere, which is in excess of its single-stranded telomeric DNA binding sites, indicating that some of the TPP1.POT1 in shelterin is not associated with the single-stranded telomeric DNA. TRF2 and Rap1 were present at 1:1 stoichiometry as were TPP1 and POT1. The abundance of TIN2 was sufficient to allow each TRF1 and TRF2 to bind to TIN2. Remarkably, TPP1 and POT1 were similar to 10-fold less abundant than their TIN2 partner in shelterin, raising the question of what limits the accumulation of TPP1.POT1 at telomeres. Finally, we report that a 10-fold reduction in TRF2 affects the regulation of telomere length but not the protection of telomeres in tumor cell lines.	[Takai, Kaori K.; Hooper, Sarah; Blackwood, Stephanie; Gandhi, Rita; de Lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	National Institutes of Health [CA076027, GM09046, AG016642]; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health grants CA076027, GM09046, and AG016642 (to T.d.L.).	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Churikov D, 2008, NAT STRUCT MOL BIOL, V15, P79, DOI 10.1038/nsmb1331; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Donigian JR, 2007, J BIOL CHEM, V282, P22662, DOI 10.1074/jbc.M702620200; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	54	163	167	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1457	1467		10.1074/jbc.M109.038026	http://dx.doi.org/10.1074/jbc.M109.038026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19864690	hybrid, Green Published			2022-12-27	WOS:000273258200065
J	Grimaldi, S; Arias-Cartin, R; Lanciano, P; Lyubenova, S; Endeward, B; Prisner, TF; Magalon, A; Guigliarelli, B				Grimaldi, Stephane; Arias-Cartin, Rodrigo; Lanciano, Pascal; Lyubenova, Sevdalina; Endeward, Burkhard; Prisner, Thomas F.; Magalon, Axel; Guigliarelli, Bruno			Direct Evidence for Nitrogen Ligation to the High Stability Semiquinone Intermediate in Escherichia coli Nitrate Reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-ECHO; PRIMARY ACCEPTOR QUINONE; REACTION CENTERS; BINDING-SITE; PARAMAGNETIC-RESONANCE; RHODOBACTER-SPHAEROIDES; ENVELOPE MODULATION; A NARGHI; Q(H)(CENTER-DOT-) UBISEMIQUINONE; INHIBITOR BINDING	The membrane-bound heterotrimeric nitrate reductase A (NarGHI) catalyzes the oxidation of quinols in the cytoplasmic membrane of Escherichia coli and reduces nitrate to nitrite in the cytoplasm. The enzyme strongly stabilizes a menasemiquinone intermediate at a quinol oxidation site (Q(D)) located in the vicinity of the distal heme b(D). Here molecular details of the interaction between the semiquinone radical and the protein environment have been provided using advanced multifrequency pulsed EPR methods. N-14 and N-15 ESEEM and HYSCORE measurements carried out at X-band (similar to 9.7 GHz) on the wild-type enzyme or the enzyme uniformly labeled with N-15 nuclei reveal an interaction between the semiquinone and a single nitrogen nucleus. The isotropic hyperfine coupling constant A(iso)(N-14) similar to 0.8 MHz shows that it occurs via an H-bond to one of the quinone carbonyl group. Using N-14 ESEEM and HYSCORE spectroscopies at a lower frequency (S-band, similar to 3.4 GHz), the N-14 nuclear quadrupolar parameters of the interacting nitrogen nucleus (kappa = 0.49, eta = 0.50) were determined and correspond to those of a histidine N-delta, assigned to the heme b(D) ligand His-66 residue. Moreover S-band N-15 ESEEM spectra enabled us to directly measure the anisotropic part of the nitrogen hyperfine interaction (T(N-15) = 0.16 MHz). A distance of similar to 2.2 angstrom between the carbonyl oxygen and the nitrogen could then be calculated. Mechanistic implications of these results are discussed in the context of the peculiar properties of the menasemiquinone intermediate stabilized at the Q(D) site of NarGHI.	[Grimaldi, Stephane; Lanciano, Pascal; Guigliarelli, Bruno] CNRS, Unite Bioenerget & Ingn Prot UPR9036, Inst Microbiol Mediterrane, F-13402 Marseille 20, France; [Arias-Cartin, Rodrigo; Magalon, Axel] CNRS, Lab Chim Bacterienne UPR9043, Inst Microbiol Mediterrane, F-13402 Marseille 20, France; Aix Marseille Univ, F-13402 Marseille 20, France; [Lyubenova, Sevdalina; Endeward, Burkhard; Prisner, Thomas F.] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Goethe University Frankfurt	Grimaldi, S (corresponding author), CNRS, Unite Bioenerget & Ingn Prot UPR9036, Inst Microbiol Mediterrane, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	grimaldi@ifr88.cnrs-mrs.fr	Grimaldi, Stephane/G-9884-2013; Grimaldi, Stephane/AAF-7138-2020	Grimaldi, Stephane/0000-0002-9559-6112; Prisner, Thomas F./0000-0003-2850-9573; Magalon, Axel/0000-0002-3375-738X; Arias-Cartin, Rodrigo/0000-0001-5008-6437	CNRS; ANR; Universite de Provence; European Community [RII3-026145]; Short-Term Scientific Mission funding	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); Universite de Provence; European Community(European Commission); Short-Term Scientific Mission funding	This work was supported by the CNRS, the ANR(program PCV 2006), and the Universite de Provence (Aix-Marseille I). The Access to Research Infrastructures Activity in the 6th Framework Programme of the European Community (Contract RII3-026145, EU-NMR) is also acknowledged for financial support (to S. G. and P. L.), as well as COST P15 for Short-Term Scientific Mission funding (to S. G.).	ASTASHKIN AV, 1995, J CHEM PHYS, V102, P5583, DOI 10.1063/1.469289; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; BOSCH MK, 1995, CHEM PHYS LETT, V239, P306, DOI 10.1016/0009-2614(95)00481-I; BRITO F, 1995, J BACTERIOL, V177, P3728, DOI 10.1128/jb.177.13.3728-3735.1995; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Deligiannakis Y, 1999, J AM CHEM SOC, V121, P7653, DOI 10.1021/ja984209c; Dikanov S. A., 1992, ELECT SPIN ECHO ENVE; Dikanov SA, 2004, J BIOL CHEM, V279, P15814, DOI 10.1074/jbc.M313417200; DikanovO SA, 2007, J BIOL CHEM, V282, P25831, DOI 10.1074/jbc.M702333200; EDMONDS DT, 1971, PHYS LETT A, VA 34, P325, DOI 10.1016/0375-9601(71)90894-2; Flores M, 2007, BIOPHYS J, V92, P671, DOI 10.1529/biophysj.106.092460; Fritscher J, 2006, APPL MAGN RESON, V30, P251, DOI 10.1007/BF03166200; Fritscher J, 2004, PHYS CHEM CHEM PHYS, V6, P4950, DOI 10.1039/b408764j; Giordani R, 2004, EUR J BIOCHEM, V271, P2400, DOI 10.1111/j.1432-1033.2004.04159.x; Giordani R, 1997, EUR J BIOCHEM, V250, P567, DOI 10.1111/j.1432-1033.1997.0567a.x; Grimaldi S, 2005, BIOCHEMISTRY-US, V44, P1300, DOI 10.1021/bi048009r; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Grimaldi S, 2001, BIOCHEMISTRY-US, V40, P1037, DOI 10.1021/bi001641+; GRIMALDI S, 2002, THESIS GOETHE U FRAN; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; Hanley J, 1997, BIOCHEMISTRY-US, V36, P11543, DOI 10.1021/bi971360a; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; Jormakka M, 2003, FEBS LETT, V545, P25, DOI 10.1016/S0014-5793(03)00389-2; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; LAI A, 1988, J CHEM PHYS, V89, P7161, DOI 10.1063/1.455293; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, BIOCHEMISTRY-US, V46, P5323, DOI 10.1021/bi700074y; Lendzian F, 1996, BER BUNSEN PHYS CHEM, V100, P2036, DOI 10.1002/bbpc.19961001219; Lin MT, 2008, J AM CHEM SOC, V130, P15768, DOI 10.1021/ja805906a; Lubitz W, 1999, APPL MAGN RESON, V17, P1, DOI 10.1007/BF03162067; MacMillan F, 1995, MAGN RESON CHEM, V33, pS81, DOI 10.1002/mrc.1260331314; Magalon A, 1997, J BACTERIOL, V179, P5037, DOI 10.1128/jb.179.16.5037-5045.1997; Magalon A, 1998, J BIOL CHEM, V273, P10851, DOI 10.1074/jbc.273.18.10851; Maniatis T., 1982, MOL CLONING LAB MANU; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; MORPETH FF, 1985, BIOCHEMISTRY-US, V24, P40, DOI 10.1021/bi00322a007; MORTON JR, 1978, J MAGN RESON, V30, P577, DOI 10.1016/0022-2364(78)90284-6; Peloquin JM, 1999, BIOCHEMISTRY-US, V38, P2057, DOI 10.1021/bi982033l; ROBERTSON DE, 1984, J BIOL CHEM, V259, P1758; Rothery RA, 2001, J MOL MICROB BIOTECH, V3, P273; Rothery RA, 1999, BIOCHEMISTRY-US, V38, P12747, DOI 10.1021/bi990533o; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; SATOWATANABE M, 1995, FEBS LETT, V374, P265, DOI 10.1016/0014-5793(95)01125-X; Schweiger A., 2001, PRINCIPLES PULSE ELE; Spoyalov AP, 1996, CHEM PHYS LETT, V263, P715, DOI 10.1016/S0009-2614(96)01255-9; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; WEBER A, 1998, P 29 C AMPERE 13 ISM, V2, P1138; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200; Zhao ZW, 2003, BIOCHEMISTRY-US, V42, P5403, DOI 10.1021/bi027221x	57	33	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					179	187		10.1074/jbc.M109.060251	http://dx.doi.org/10.1074/jbc.M109.060251			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19892705	hybrid, Green Published			2022-12-27	WOS:000273070100019
J	Schiller, M; Dennler, S; Anderegg, U; Kokot, A; Simon, JC; Luger, TA; Mauviel, A; Bohm, M				Schiller, Meinhard; Dennler, Sylviane; Anderegg, Ulf; Kokot, Agatha; Simon, Jan C.; Luger, Thomas A.; Mauviel, Alain; Boehm, Markus			Increased cAMP Levels Modulate Transforming Growth Factor-beta/Smad-induced Expression of Extracellular Matrix Components and Other Key Fibroblast Effector Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DERMAL FIBROBLASTS; MELANOCYTE-STIMULATING HORMONE; COLLAGEN GEL CONTRACTION; DIBUTYRYL-CYCLIC-AMP; GENE COL7A1 PROMOTER; NUCLEAR-PROTEIN CBP; FACTOR-BETA; TGF-BETA; CELL-MIGRATION; TRANSCRIPTIONAL ACTIVATION	cAMP is a key messenger of many hormones and neuropeptides, some of which modulate the composition of extracellular matrix. Treatment of human dermal fibroblasts with dibutyryl cyclic AMP and forskolin antagonized the inductive effects of transforming growth factor-beta (TGF-beta) on the expression of collagen, connective tissue growth factor, tissue inhibitor of matrix metalloproteinase-1, and plasminogen activator inhibitor type I, four prototypical TGF-beta-responsive genes. Increased intracellular cAMP prevented TGF-beta-induced Smad-specific gene transactivation, although TGF-beta-mediated Smad phosphorylation and nuclear translocation remained unaffected. However, increased cAMP levels abolished TGF-beta-induced interaction of Smad3 with its transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)/p300. Overexpression of the transcriptional co-activator CBP/p300 rescued Smad-specific gene transcription in the presence of cAMP suggesting that sequestration of limited amounts of CBP/p300 by the activated cAMP/CREB pathway is the molecular basis of this inhibitory effect. These findings were extended by two functional assays. Increased intracellular cAMP levels suppressed the inductive activity of TGF-beta to contract mechanically unloaded collagen lattices and resulted in an attenuation of fibroblast migration of mechanically induced cell layer wounds. Of note, cAMP and TGF-beta synergistically induced hyaluronan synthase 2 (HAS2) expression and hyaluronan secretion, presumably via putative CREB-binding sites adjacent to Smad-binding sites within the HAS2 promoter. Our findings identify the cAMP pathway as a potent but differential and promoter-specific regulator of TGF-beta-mediated effects involved in extracellular matrix homeostasis.	[Schiller, Meinhard; Kokot, Agatha; Luger, Thomas A.; Boehm, Markus] Ludwig Boltzmann Inst Cell Biol & Immunobiol Skin, Dept Dermatol, D-48149 Munster, Germany; [Dennler, Sylviane; Mauviel, Alain] Univ Paris 07, INSERM, U697, F-75011 Paris, France; [Anderegg, Ulf; Simon, Jan C.] Univ Leipzig, Med Ctr, Dept Dermatol, D-04103 Leipzig, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leipzig University	Schiller, M (corresponding author), Univ Hosp Munster, Dept Dermatol, Von Esmarch Str 58, D-48149 Munster, Germany.	schillm@uni-muenster.de; alain.mauviel@inserm.fr	MAUVIEL, Alain/F-6251-2013	Mauviel, Alain/0000-0002-0438-2793	Deutsche Forschungsgemeinschaft Postdoctoral Fellowship Schi [585/2-1]; Institut National du Cancer; Region Ile-de-France; Donation Henriette et Emile Goutiere; Canceropole Ile-de-France; INSERM, France; Deutsche Forschungsgemeinschaft (DFG) [BO 1075/5-1, BO 1075/5-3]	Deutsche Forschungsgemeinschaft Postdoctoral Fellowship Schi(German Research Foundation (DFG)); Institut National du Cancer(Institut National du Cancer (INCA) France); Region Ile-de-France(Region Ile-de-France); Donation Henriette et Emile Goutiere; Canceropole Ile-de-France(Region Ile-de-France); INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Recipient of Deutsche Forschungsgemeinschaft Postdoctoral Fellowship Schi 585/2-1. Towhomcorrespondencemaybe addressed: University Hospital Munster, Dept. of Dermatology; Von-Esmarch-Str. 58, 48149 Munster, Germany. Tel.: 11-49-251-8356501; Fax: 11-49-251-8356522; E-mail: schillm@uni-muenster.de.; Recipient of a postdoctoral fellowship from Institut National du Cancer and Region Ile-de-France.; Supported by the Donation Henriette et Emile Goutiere, Canceropole Ile-de-France, and INSERM, France. To whom correspondence may be addressed: INSERM U697, Hopital Saint-Louis, 1 Ave. Claude Vellefaux, 75010 Paris, France. Tel.: 33-153-722-069; Fax: 33-153-722-051; E-mail: alain.mauviel@inserm.fr.; Supported by grants from the Deutsche Forschungsgemeinschaft (DFG) BO 1075/5-1 and BO 1075/5-3.	Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Atfi A, 1997, J BIOL CHEM, V272, P24731, DOI 10.1074/jbc.272.40.24731; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bohm M, 2004, J BIOL CHEM, V279, P6959, DOI 10.1074/jbc.M312549200; Bohm MB, 2005, ENDOCRINOLOGY, V146, P4635, DOI 10.1210/en.2005-0665; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; Choung J, 1998, J CELL BIOCHEM, V71, P254, DOI 10.1002/(SICI)1097-4644(19981101)71:2<254::AID-JCB10>3.3.CO;2-L; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 2005, ONCOGENE, V24, P1936, DOI 10.1038/sj.onc.1208343; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; Ghosh AK, 2009, FASEB J, V23, P2968, DOI 10.1096/fj.08-128736; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; HONDA A, 1993, BIOCHEM J, V292, P497, DOI 10.1042/bj2920497; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; IMAI Y, 1994, ENDOCR J, V41, P645, DOI 10.1507/endocrj.41.645; Ionescu AM, 2004, J CELL PHYSIOL, V198, P428, DOI 10.1002/jcp.10421; Itoh H, 2001, AM J PHYSIOL-HEART C, V281, pH359, DOI 10.1152/ajpheart.2001.281.1.H359; IWASAKI T, 1994, J INVEST DERMATOL, V102, P891, DOI 10.1111/1523-1747.ep12383031; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; KEETON MR, 1991, J BIOL CHEM, V266, P23048; KLEWES L, 1994, J CELL PHYSIOL, V160, P539, DOI 10.1002/jcp.1041600317; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kokot A, 2009, ARTHRITIS RHEUM-US, V60, P592, DOI 10.1002/art.24228; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Liu XD, 2003, CELL MOTIL CYTOSKEL, V54, P248, DOI 10.1002/cm.10098; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Mukai M, 2000, FEBS LETT, V484, P69, DOI 10.1016/S0014-5793(00)02129-3; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Pullar CE, 2005, WOUND REPAIR REGEN, V13, P405, DOI 10.1111/j.1067-1927.2005.130408.x; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Sawaji Y, 2000, CLIN EXP METASTAS, V18, P131, DOI 10.1023/A:1006760021997; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Schiller M, 2001, J INVEST DERMATOL, V117, P227, DOI 10.1046/j.0022-202x.2001.01412.x; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Spurzem JR, 2002, AM J PHYSIOL-LUNG C, V282, pL1108, DOI 10.1152/ajplung.00148.2001; Sumiyoshi K, 2003, BRIT J DERMATOL, V149, P464, DOI 10.1046/j.1365-2133.2003.05490.x; Tanimoto K, 2004, J DENT RES, V83, P40, DOI 10.1177/154405910408300108; Uchio K, 2004, WOUND REPAIR REGEN, V12, P60, DOI 10.1111/j.1067-1927.2004.012112.x-1; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Verrecchia Franck, 2002, Curr Rheumatol Rep, V4, P143, DOI 10.1007/s11926-002-0010-4; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Vindevoghel L, 1998, P NATL ACAD SCI USA, V95, P14769, DOI 10.1073/pnas.95.25.14769; WESTERGRENTHORSSON G, 1990, EXP CELL RES, V186, P192, DOI 10.1016/0014-4827(90)90227-2; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200; Zhou XX, 2007, J ALLERGY CLIN IMMUN, V119, P1388, DOI 10.1016/j.jaci.2007.02.011	77	57	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					409	421		10.1074/jbc.M109.038620	http://dx.doi.org/10.1074/jbc.M109.038620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858184	hybrid, Green Published			2022-12-27	WOS:000273070100043
J	Yoon, Y; Tong, JS; Lee, PJ; Albanese, A; Bhardwaj, N; Kallberg, M; Digman, MA; Lu, H; Gratton, E; Shin, YK; Cho, W				Yoon, Youngdae; Tong, Jiansong; Lee, Park Joo; Albanese, Alexandra; Bhardwaj, Nitin; Kaellberg, Morten; Digman, Michelle A.; Lu, Hui; Gratton, Enrico; Shin, Yeon-Kyun; Cho, Wonhwa			Molecular Basis of the Potent Membrane-remodeling Activity of the Epsin 1 N-terminal Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAR DOMAINS; PROTEIN INTERACTIONS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; ENTH DOMAIN; CLATHRIN; CURVATURE; BINDING; INVAGINATION; MECHANISMS	The mechanisms by which cytosolic proteins reversibly bind the membrane and induce the curvature for membrane trafficking and remodeling remain elusive. The epsin N-terminal homology (ENTH) domain has potent vesicle tubulation activity despite a lack of intrinsic molecular curvature. EPR revealed that the N-terminal alpha-helix penetrates the phosphatidylinositol 4,5-bisphosphate-containing membrane at a unique oblique angle and concomitantly interacts closely with helices from neighboring molecules in an antiparallel orientation. The quantitative fluorescence microscopy showed that the formation of highly ordered ENTH domain complexes beyond a critical size is essential for its vesicle tubulation activity. The mutations that interfere with the formation of large ENTH domain complexes abrogated the vesicle tubulation activity. Furthermore, the same mutations in the intact epsin 1 abolished its endocytic activity in mammalian cells. Collectively, these results show that the ENTH domain facilitates the cellular membrane budding and fission by a novel mechanism that is distinct from that proposed for BAR domains.	[Yoon, Youngdae; Lee, Park Joo; Albanese, Alexandra; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Bhardwaj, Nitin; Kaellberg, Morten; Lu, Hui] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Tong, Jiansong; Shin, Yeon-Kyun] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Digman, Michelle A.; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Iowa State University; University of California System; University of California Irvine	Cho, W (corresponding author), Univ Illinois, Dept Chem MC 111, 845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu	TONG, JIANSONG/C-9232-2012; Lu, Hui/K-3264-2019	, Michelle/0000-0003-4611-7100; Lu, Hui/0000-0001-8347-0830	National Institutes of Health [GM68849, GM51290, PHS 5 P41-RR03155]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051290, R01GM068849, R01GM051290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM68849 (to W. C.), GM51290 (to Y.-K. S.), and PHS 5 P41-RR03155 (to E. G.).	ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blood PD, 2008, BIOPHYS J, V95, P1866, DOI 10.1529/biophysj.107.121160; Brady RJ, 2008, J CELL SCI, V121, P3433, DOI 10.1242/jcs.032573; Chen Y, 2004, EMBO J, V23, P681, DOI 10.1038/sj.emboj.7600083; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Heath RJW, 2008, J CELL SCI, V121, P1951, DOI 10.1242/jcs.023895; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kay BK, 1999, PROTEIN SCI, V8, P435; Kweon DH, 2006, MOL CELLS, V21, P428; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P5449, DOI 10.1021/bi0256476; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Macosko JC, 1997, J MOL BIOL, V267, P1139, DOI 10.1006/jmbi.1997.0931; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	46	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					531	540		10.1074/jbc.M109.068015	http://dx.doi.org/10.1074/jbc.M109.068015			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880963	Green Published, hybrid			2022-12-27	WOS:000273070100055
J	Anthis, NJ; Haling, JR; Oxley, CL; Memo, M; Wegener, KL; Lim, CJ; Ginsberg, MH; Campbell, ID				Anthis, Nicholas J.; Haling, Jacob R.; Oxley, Camilla L.; Memo, Massimiliano; Wegener, Kate L.; Lim, Chinten J.; Ginsberg, Mark H.; Campbell, Iain D.			beta Integrin Tyrosine Phosphorylation Is a Conserved Mechanism for Regulating Talin-induced Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; CYTOPLASMIC DOMAIN; SIGNAL-TRANSDUCTION; ALPHA-V-BETA-3 INTEGRIN; ADHESION KINASE; INSIDE-OUT; BINDING; PATHWAYS; CELLS; TAIL	Integrins are large membrane-spanning receptors fundamental to cell adhesion and migration. Integrin adhesiveness for the extracellular matrix is activated by the cytoskeletal protein talin via direct binding of its phosphotyrosine-binding-like F3 domain to the cytoplasmic tail of the beta integrin subunit. The phosphotyrosine-binding domain of the signaling protein Dok1, on the other hand, has an inactivating effect on integrins, a phenomenon that is modulated by integrin tyrosine phosphorylation. Using full-length tyrosine-phosphorylated N-15-labeled beta 3, beta 1A, and beta 7 integrin tails and an NMR-based protein-protein interaction assay, we show that talin1 binds to the NPXY motif and the membrane-proximal portion of beta 3, beta 1A, and beta 7 tails, and that the affinity of this interaction is decreased by integrin tyrosine phosphorylation. Dok1 only interacts weakly with unphosphorylated tails, but its affinity is greatly increased by integrin tyrosine phosphorylation. The Dok1 interaction remains restricted to the integrin NPXY region, thus phosphorylation inhibits integrin activation by increasing the affinity of beta integrin tails for a talin competitor that does not form activating membrane-proximal interactions with the integrin. Key residues governing these specificities were identified by detailed structural analysis, and talin1 was engineered to bind preferentially to phosphorylated integrins by introducing the mutation D372R. As predicted, this mutation affects talin1 localization in live cells in an integrin phosphorylation-specific manner. Together, these results indicate that tyrosine phosphorylation is a common mechanism for regulating integrin activation, despite subtle differences in how these integrins interact with their binding proteins.	[Anthis, Nicholas J.; Oxley, Camilla L.; Memo, Massimiliano; Wegener, Kate L.; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3DR, England; [Haling, Jacob R.; Lim, Chinten J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Oxford; University of California System; University of California San Diego	Anthis, NJ (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	nick.anthis@gmail.com; iain.campbell@bioch.ox.ac.uk	Lim, Chinten James/G-3777-2013; Wegener, Kate/E-5077-2010	Lim, Chinten James/0000-0001-6381-7585; Wegener, Kate/0000-0002-1562-6060; Anthis, Nicholas/0000-0002-1881-450X	National Institutes of Health; Wellcome Trust; Rhodes Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust	This work was supported, in whole or in part, by a National Institutes of Health grant (to M. H. G., I. D. C., and K. L. W.). This work was also supported by grants from the Wellcome Trust (to I. D. C. and C. L. O.) and the Rhodes Trust (to N. J. A.).	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Chen H, 2006, GENE DEV, V20, P927, DOI 10.1101/gad.1408306; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gao CL, 2005, J BIOL CHEM, V280, P15422, DOI 10.1074/jbc.M414457200; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hussain A, 2007, PLANTA, V226, P475, DOI 10.1007/s00425-007-0497-z; Huveneers S, 2008, J BIOL CHEM, V283, P13243, DOI 10.1074/jbc.M800927200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; JOHANSSON MW, 1994, J CELL BIOL, V126, P1299, DOI 10.1083/jcb.126.5.1299; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissansen GW, 2006, EUR J IMMUNOL, V36, P2203, DOI 10.1002/eji.200535324; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200; Liu SC, 2000, J CELL SCI, V113, P3563; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Miller LA, 1999, EUR J IMMUNOL, V29, P1426, DOI 10.1002/(SICI)1521-4141(199905)29:05<1426::AID-IMMU1426>3.0.CO;2-J; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Senis YA, 2009, J THROMB HAEMOST, V7, P1718, DOI 10.1111/j.1538-7836.2009.03565.x; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; TAPLEY P, 1989, ONCOGENE, V4, P325; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	61	94	97	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36700	36710		10.1074/jbc.M109.061275	http://dx.doi.org/10.1074/jbc.M109.061275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843520	Green Published, hybrid			2022-12-27	WOS:000272970500070
J	Byrne, RS; Hansch, R; Mendel, RR; Hille, R				Byrne, Robert S.; Haensch, Robert; Mendel, Ralf R.; Hille, Russ			Oxidative Half-reaction of Arabidopsis thaliana Sulfite Oxidase GENERATION OF SUPEROXIDE BY A PEROXISOMAL ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILK XANTHINE OXIDASE; RADICAL GENERATION; OXIDIZING ENZYMES; MOLYBDENUM CENTER; LEAF PEROXISOMES; CYTOCHROME-C; DISMUTASE; OXYGEN; IDENTIFICATION; MOLYBDOPTERIN	Vertebrate forms of the molybdenum-containing enzyme sulfite oxidase possess a b-type cytochrome prosthetic group that accepts reducing equivalents from the molybdenum center and passes them on to cytochrome c. The plant form of the enzyme, on the other hand, lacks a prosthetic group other than its molybdenum center and utilizes molecular oxygen as the physiological oxidant. Hydrogen peroxide is the ultimate product of the reaction. Here, we present data demonstrating that superoxide is produced essentially quantitatively both in the course of the reaction of reduced enzyme with O-2 and during steady-state turnover and only subsequently decays (presumably noncatalytically) to form hydrogen peroxide. Rapid-reaction kinetic studies directly following the reoxidation of reduced enzyme demonstrate a linear dependence of the rate constant for the reaction on [O-2] with a second-order rate constant of k(ox) = 8.7 x 10(4) +/- 0.5 x 10(4) M-1 s(-1). When the reaction is carried out in the presence of cytochrome c to follow superoxide generation, biphasic time courses are observed, indicating that a first equivalent of superoxide is generated in the oxidation of the fully reduced Mo(IV) state of the enzyme to Mo(V), followed by a slower oxidation of the Mo(V) state to Mo(VI). The physiological implications of plant sulfite oxidase as a copious generator of superoxide are discussed.	[Byrne, Robert S.; Hille, Russ] Univ Calif Riverside, Dept Mol & Cellular Biochem, Riverside, CA 92521 USA; [Haensch, Robert; Mendel, Ralf R.] Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38106 Braunschweig, Germany	University of California System; University of California Riverside; Braunschweig University of Technology	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1462 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu		Hansch, Robert/0000-0003-1310-8419	National Institutes of Health [ES R01 012658]; Deutsche Forschungsgemeinschaft [Ha 3107/4-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES R01 012658 (to R. H.) and Deutsche Forschungsgemeinschaft Grant Ha 3107/4-1 (to R. H. and R. R. M).	Aguey-Zinsou KF, 2003, J AM CHEM SOC, V125, P530, DOI 10.1021/ja028293e; BOLANN BJ, 1992, BIOCHIM BIOPHYS ACTA, V1156, P27, DOI 10.1016/0304-4165(92)90091-8; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; COHEN HJ, 1971, J BIOL CHEM, V246, P359; del Rio LA, 1998, PHYSIOL PLANTARUM, V104, P673, DOI 10.1034/j.1399-3054.1998.1040422.x; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Fridovich, 1977, SUPEROXIDE SUPEROXID, P11; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Garton SD, 1997, J AM CHEM SOC, V119, P2590, DOI 10.1021/ja963931c; Hansch R, 2007, PLANT BIOLOGY, V9, P589, DOI 10.1055/s-2007-965433; *HANS ISNTR LTD, 1996, OX PLUS V1 01; Hansch R, 2006, J BIOL CHEM, V281, P6884, DOI 10.1074/jbc.M513054200; Hemann C, 2005, J AM CHEM SOC, V127, P16567, DOI 10.1021/ja0530873; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; KLUG D, 1972, J BIOL CHEM, V247, P4839; Lopez-Huertas E, 1999, BIOCHEM J, V337, P531, DOI 10.1042/0264-6021:3370531; LopezHuertas E, 1997, FREE RADICAL RES, V26, P497, DOI 10.3109/10715769709097820; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Niknahad H, 2008, CHEM-BIOL INTERACT, V174, P147, DOI 10.1016/j.cbi.2008.05.032; Nowak K, 2004, PLANT CELL PHYSIOL, V45, P1889, DOI 10.1093/pcp/pch212; Schindelin H, 2001, ADV PROTEIN CHEM, V58, P47; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; STEWART RC, 1985, J BIOL CHEM, V260, P8892; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089	30	31	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35479	35484		10.1074/jbc.M109.067355	http://dx.doi.org/10.1074/jbc.M109.067355			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19875441	hybrid, Green Published			2022-12-27	WOS:000272645600024
J	Kocik, E; Skowronek, KJ; Kasprzak, AA				Kocik, Elzbieta; Skowronek, Krzysztof J.; Kasprzak, Andrzej A.			Interactions between Subunits in Heterodimeric Ncd Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE MOTOR PROTEIN; CRYSTAL-STRUCTURE; PROCESSIVE MOVEMENT; ATP HYDROLYSIS; DIMERIC NCD; IN-VITRO; ONE HEAD; KINESIN; DOMAIN; BINDING	The nonprocessive minus-end-directed kinesin-14 Ncd is involved in the organization of the microtubule (MT) network during mitosis. Only one of the two motor domains is involved in the interaction with the MT. The other head is tethered to the bound one. Here we prepared, purified, and characterized mutated Ncd molecules carrying point mutations in one of the heads, thus producing heterodimeric motors. The mutations tested included substitutions in Switch I and II: R552A, E585A, and E585D; the decoupling mutant N600K; and a deletion in the motor domain in one of the subunits resulting in a single-headed molecule (NcN). These proteins were isolated by two sequential affinity chromatography steps, followed by measurements of their affinities to MT, enzymatic properties, and the velocity of the microtubule gliding test in vitro. Astriking observation is a low affinity of the single-headed NcN for MT both without nucleotides and in the presence of 5'-adenylyl-beta,gamma-imidodiphosphate, implying that the tethered head has a profound effect on the structure of the Ncd-MT complex. Mutated homodimers had no MT-activated ATPase and no motility, whereas NcN had motility comparable with that of the wild type Ncd. Although the heterodimers had one fully active and one inactive head, the ATPase and motility of Ncd heterodimers varied dramatically, clearly demonstrating that interactions between motor domains exist in Ncd. We also show that the bulk property of dimeric proteins that interact with the filament with only one of its heads depends also on the distribution of the filament-interacting subunits.	M Nencki Inst Expt Biol, Dept Biochem, Motor Prot Lab, PL-02093 Warsaw, Poland; [Skowronek, Krzysztof J.] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej		a.kasprzak@nencki.gov.pl	Skowronek, Krzysztof/G-2855-2010; Kasprzak, Andrzej A. A/R-4476-2016	Skowronek, Krzysztof/0000-0001-9973-7085; Kasprzak, Andrzej A. A/0000-0002-3602-5379	Polish Ministry of Science and Higher Education [2P04C 131 29, N301 294137]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported in part by Polish Ministry of Science and Higher Education Grants 2P04C 131 29 and N301 294137.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hajdo L, 2004, ARCH BIOCHEM BIOPHYS, V421, P217, DOI 10.1016/j.abb.2003.11.009; Han Y, 1999, J STRUCT BIOL, V128, P26, DOI 10.1006/jsbi.1999.4162; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; HATSUMI M, 1992, J CELL SCI, V101, P547; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kaseda K, 2008, EMBO REP, V9, P761, DOI 10.1038/embor.2008.96; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Kull FJ, 2002, J CELL SCI, V115, P15; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Marx A, 2008, BIOCHEMISTRY-US, V47, P1848, DOI 10.1021/bi701483h; Naber N, 1997, BIOCHEMISTRY-US, V36, P9681, DOI 10.1021/bi9706881; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Reuther C, 2006, NANO LETT, V6, P2177, DOI 10.1021/nl060922l; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Skowronek K, 2002, ANAL BIOCHEM, V300, P185, DOI 10.1006/abio.2001.5456; Smyczynski C, 2000, J MOL BIOL, V295, P325, DOI 10.1006/jmbi.1999.3356; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; TAWADA K, 1991, BIOPHYS J, V59, P343, DOI 10.1016/S0006-3495(91)82228-7; Thoresen T, 2008, BIOCHEMISTRY-US, V47, P9514, DOI 10.1021/bi800747e; Vilfan A, 2001, J MOL BIOL, V312, P1011, DOI 10.1006/jmbi.2001.5020; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; Wendt T, 2003, J MOL BIOL, V333, P541, DOI 10.1016/j.jmb.2003.08.051; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	47	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35735	35745		10.1074/jbc.M109.024240	http://dx.doi.org/10.1074/jbc.M109.024240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858211	Green Published, hybrid			2022-12-27	WOS:000272645600051
J	Iwabu, Y; Fujita, H; Kinomoto, M; Kaneko, K; Ishizaka, Y; Tanaka, Y; Sata, T; Tokunaga, K				Iwabu, Yukie; Fujita, Hideaki; Kinomoto, Masanobu; Kaneko, Keiko; Ishizaka, Yukihito; Tanaka, Yoshitaka; Sata, Tetsutaro; Tokunaga, Kenzo			HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VPU; SIMIAN IMMUNODEFICIENCY VIRUS; CLATHRIN-MEDIATED ENDOCYTOSIS; DOWN-MODULATION; PLASMA-MEMBRANE; INHIBITS HIV-1; LIPID RAFTS; RESTRICTION FACTOR; MOLECULAR-CLONING; RAPID DEGRADATION	Bone marrow stromal antigen 2 (BST-2, also known as tetherin) is a recently identified interferon-inducible host restriction factor that can block the production of enveloped viruses by trapping virus particles at the cell surface. This antiviral effect is counteracted by the human immunodeficiency virus type 1 (HIV-1) accessory protein viral protein U (Vpu). Here we show that HIV-1 Vpu physically interacts with BST-2 through their mutual transmembrane domains and leads to the degradation of this host factor via a lysosomal, not proteasomal, pathway. The degradation is partially controlled by a cellular protein, beta-transducin repeat-containing protein (beta TrCP), which is known to be required for the Vpu-induced degradation of CD4. Importantly, targeting of BST-2 by Vpu occurs at the plasma membrane followed by the active internalization of this host protein by Vpu independently of constitutive endocytosis. Thus, the primary site of action of Vpu is the plasma membrane, where Vpu targets and internalizes cell-surface BST-2 through transmembrane interactions, leading to lysosomal degradation, partially in a beta TrCP-dependent manner. Also, we propose the following configuration of BST-2 in tethering virions to the cell surface; each of the dimerized BST-2 molecules acts as a bridge between viral and cell membranes.	[Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Fujita, Hideaki; Tanaka, Yoshitaka] Kyushu Univ, Div Pharmaceut Cell Biol, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Ishizaka, Yukihito] Int Med Ctr Japan, Dept Intractable Dis, Tokyo 1628655, Japan	National Institute of Infectious Diseases (NIID); Kyushu University; National Center for Global Health & Medicine - Japan	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan.	tokunaga@nih.go.jp	Tokunaga, Kenzo/Q-9914-2018	Tokunaga, Kenzo/0000-0002-2625-5322; Fujita, Hideaki/0000-0002-4105-4430	Ministry of Health, Labor, and Welfare of Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant from the Ministry of Health, Labor, and Welfare of Japan.	Barlow KL, 2003, J VIROL, V77, P6879, DOI 10.1128/JVI.77.12.6879-6888.2003; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Butticaz C, 2007, J VIROL, V81, P1502, DOI 10.1128/JVI.01711-06; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; Cortes MJ, 2002, J BIOL CHEM, V277, P1770, DOI 10.1074/jbc.M109807200; Courgnaud V, 2002, J VIROL, V76, P8298, DOI 10.1128/JVI.76.16.8298-8309.2002; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FRIBORG J, 1995, J ACQ IMMUN DEF SYND, V8, P10; Fujita K, 1997, J GEN VIROL, V78, P619, DOI 10.1099/0022-1317-78-3-619; GERAGHTY RJ, 1994, J MED PRIMATOL, V23, P146, DOI 10.1111/j.1600-0684.1994.tb00115.x; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOTO T, 1994, BLOOD, V84, P1922; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kumar KGS, 2003, EMBO J, V22, P5480; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Paul M, 1998, J VIROL, V72, P1270, DOI 10.1128/JVI.72.2.1270-1279.1998; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; SAKAI H, 1995, J GEN VIROL, V76, P2717, DOI 10.1099/0022-1317-76-11-2717; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; Volanti C, 2004, ONCOGENE, V23, P8649, DOI 10.1038/sj.onc.1207871; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; YAO XJ, 1992, J VIROL, V66, P5119, DOI 10.1128/JVI.66.8.5119-5126.1992; YAO XJ, 1993, J ACQ IMMUN DEF SYND, V6, P135	64	181	186	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35060	35072		10.1074/jbc.M109.058305	http://dx.doi.org/10.1074/jbc.M109.058305			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837671	Green Published, hybrid			2022-12-27	WOS:000272439600060
J	Taniguchi, N				Taniguchi, Naoyuki			From the gamma-Glutamyl Cycle to the Glycan Cycle: A Road with Many Turns and Pleasant Surprises	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; CDNA CLONING; FUCOSYL-TRANSFERASE; RECEPTOR ACTIVATION; CORE FUCOSYLATION; GENE TRANSFECTION; CELL-MIGRATION; RAT-LIVER; CANCER; GROWTH		[Taniguchi, Naoyuki] Osaka Univ, Dept Dis Glyc, Inst Sci & Ind Res, Osaka 5670047, Japan; [Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Dept Biol Chem, Adv Sci Inst, Wako, Saitama 3510198, Japan	Osaka University; RIKEN	Taniguchi, N (corresponding author), Osaka Univ, Dept Dis Glyc, Inst Sci & Ind Res, Osaka 5670047, Japan.	tani@sanken.osaka-u.ac.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968	Ministry of Education, Sports, Culture, Science, and Technology, Japan	Ministry of Education, Sports, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	I thank my many colleagues who collaborated with me over three decades, many whose names also appear in the list of literature citations. During my stay at Osaka University, many eminent scientists came to visit as visiting professors and contributed to our research and education in our M. D./ Ph. D. program as well. Among them, I thank Professors Dirk van den Eijnden, John Gutteridge, Kunihiko Suzuki, Harold F. Deutsch, Kosaku Uyeda, Takashi Yonetani, Peng George Wong, Mary Anderson, Owen W. Griffith, and William Lennarz, who spent from three weeks to one year as visiting professors and supported our research and the M. D./ Ph. D. program in our faculty. I thank Drs. Vincent C. Hascall, Etorre Appella, Milton Feather, Jianguo Gu, and Eiji Miyoshi and Lisa Jenkins for reading this manuscript prior to submission and for valuable suggestions. I thank Dr. Kazuki Nakajima and Fumi Ota for help in preparing this manuscript. I acknowledge continued grant support from the Japan Society for the Promotion of Science and the Ministry of Education, Sports, Culture, Science, and Technology, Japan ( from 1973 to the present).	Akama R, 2008, PROTEOMICS, V8, P3221, DOI 10.1002/pmic.200800038; GASA S, 1987, J BIOL CHEM, V262, P1230; Granovsky M, 2000, NAT MED, V6, P306; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Guo HB, 2002, CANCER RES, V62, P6837; HIRAI H, 1973, GANN MONOGRAPH CANCE, V14, P19; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; IKEDA Y, 1995, J BIOL CHEM, V270, P22223, DOI 10.1074/jbc.270.38.22223; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lee SH, 2006, J BIOCHEM, V139, P391, DOI 10.1093/jb/mvj039; LINAKAGAWA T, 2008, J PROTEOME RES, V7, P2222; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1986, MOL PERSPECTIVES CLI, P3; MEISTER A, 1998, GLUTATHIONE CENTENNI, P3; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; OHNO M, 1992, INT J CANCER, V51, P315, DOI 10.1002/ijc.2910510223; Packer NH, 2008, PROTEOMICS, V8, P8, DOI 10.1002/pmic.200700917; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; TAKETA K, 1993, CANCER RES, V53, P5419; TANIGUCHI N, 1974, GANN, V65, P381; Taniguchi N, 1996, GLYCOBIOLOGY, V6, P691, DOI 10.1093/glycob/6.7.691; TANIGUCHI N, 1992, ADV CLIN CHEM, V29, P1, DOI 10.1016/S0065-2423(08)60221-8; Taniguchi N, 1998, ADV ENZYMOL RAMB, V72, P239; Taniguchi N, 2004, P JPN ACAD B-PHYS, V80, P82, DOI 10.2183/pjab.80.82; Taniguchi N, 2001, GLYCOCONJUGATE J, V18, P859, DOI 10.1023/A:1022292223878; TANIGUCHI N, 1989, METHOD ENZYMOL, V179, P397; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; TANIGUCHI N, 1983, GANN MONOGRAPH CANC, V29, P263; Taniguchi N, 2008, IUBMB LIFE, V60, P703, DOI 10.1002/iub.119; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Taniguchi N, 2007, NAT CHEM BIOL, V3, P307, DOI 10.1038/nchembio0607-307; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; YAMASHITA K, 1983, CANCER RES, V43, P5059; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; YOKOSAWA N, 1981, ONCODEV BIOL MED, V2, P165; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	46	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34469	34478		10.1074/jbc.X109.023150	http://dx.doi.org/10.1074/jbc.X109.023150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840938	hybrid, Green Published			2022-12-27	WOS:000272439600001
J	Varfolomeev, E; Alicke, B; Elliott, JM; Zobel, K; West, K; Wong, H; Scheer, JM; Ashkenazi, A; Gould, SE; Fairbrother, WJ; Vucic, D				Varfolomeev, Eugene; Alicke, Bruno; Elliott, J. Michael; Zobel, Kerry; West, Kristina; Wong, Harvey; Scheer, Justin M.; Ashkenazi, Avi; Gould, Stephen E.; Fairbrother, Wayne J.; Vucic, Domagoj			X Chromosome-linked Inhibitor of Apoptosis Regulates Cell Death Induction by Proapoptotic Receptor Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; KAPPA-B ACTIVATION; CASPASE ACTIVATION; CANCER-CELLS; ANTIBODY APOMAB; IAP PROTEINS; SMAC; XIAP; MECHANISM; SURVIVAL	Proapoptotic receptor agonists cause cellular demise through the activation of the extrinsic and intrinsic apoptotic pathways. Inhibitor of apoptosis (IAP) proteins block apoptosis induced by diverse stimuli. Here, we demonstrate that IAP antagonists in combination with Fas ligand (FasL) or the death receptor 5 (DR5) agonist antibody synergistically stimulate death in cancer cells and inhibit tumor growth. Single-agent activity of IAP antagonists relies on tumor necrosis factor-alpha signaling. By contrast, blockade of tumor necrosis factor-alpha does not affect the synergistic activity of IAP antagonists with FasL or DR5 agonist antibody. In most cancer cells, proapoptotic receptor agonist-induced cell death depends on amplifying the apoptotic signal via caspase-8-mediated activation of Bid and subsequent activation of the caspase-9-dependent mitochondrial apoptotic pathway. In the investigated cancer cell lines, induction of apoptosis by FasL or DR5 agonist antibody can be inhibited by knockdown of Bid. However, knockdown of X chromosome-linked IAP (XIAP) or antagonism of XIAP allows FasL or DR5 agonist antibody to induce activation of effector caspases efficiently without the need for mitochondrial amplification of the apoptotic signal and thus rescues the effect of Bid knockdown in these cells.	[Varfolomeev, Eugene; Zobel, Kerry; Fairbrother, Wayne J.; Vucic, Domagoj] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Alicke, Bruno; West, Kristina; Gould, Stephen E.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Elliott, J. Michael; Scheer, Justin M.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Wong, Harvey] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Fairbrother, WJ (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	fairbro@gene.com; domagoj@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Flygare JA, 2009, FUTURE ONCOL, V5, P141, DOI 10.2217/14796694.5.2.141; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jin HK, 2008, CLIN CANCER RES, V14, P7733, DOI 10.1158/1078-0432.CCR-08-0670; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	41	47	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34553	34560		10.1074/jbc.M109.040139	http://dx.doi.org/10.1074/jbc.M109.040139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19854829	Green Published, hybrid			2022-12-27	WOS:000272439600010
J	Kowlessur, D; Tobacman, LS				Kowlessur, Devanand; Tobacman, Larry S.			Troponin Regulatory Function and Dynamics Revealed by H/D Exchange-Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC TROPONIN; AMIDE HYDROGEN-EXCHANGE; SKELETAL-MUSCLE; THIN-FILAMENTS; STRUCTURAL-CHANGES; BINDING; DOMAIN; ACTIN; THERMODYNAMICS; ACTIVATION	Muscle contraction is tightly regulated by Ca2+ binding to the thin filament protein troponin. The mechanism of this regulation was investigated by detailed mapping of the dynamic properties of cardiac troponin using amide hydrogen exchange-mass spectrometry. Results were obtained in the presence of either saturation or non-saturation of the regulatory Ca2+ binding site in the NH2 domain of subunit TnC. Troponin was found to be highly dynamic, with 60% of amides exchanging H for D within seconds of exposure to D2O. In contrast, portions of the TnT-TnI coiled-coil exhibited high protection from exchange, despite 6 h in D2O. The data indicate that the most stable portion of the trimeric troponin complex is the coiled-coil. Regulatory site Ca2+ binding altered dynamic properties (i.e. H/D exchange protection) locally, near the binding site and in the TnI switch helix that attaches to the Ca2+-saturated TnC NH2 domain. More notably, Ca2+ also altered the dynamic properties of other parts of troponin: the TnI inhibitory peptide region that binds to actin, the TnT-TnI coiled-coil, and the TnC COOH domain that contains the regulatory Ca2+ sites in many invertebrate as opposed to vertebrate troponins. Mapping of these affected regions onto the troponin highly extended structure suggests that cardiac troponin switches between alternative sets of intramolecular interactions, similar to previous intermediate resolution x-ray data of skeletal muscle troponin.	[Kowlessur, Devanand; Tobacman, Larry S.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Tobacman, Larry S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, LS (corresponding author), 1853 W Polk St,MC 784, Chicago, IL 60612 USA.	LST@uic.edu			National Institutes of Health [HL063774, HL038834]; Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063774, R29HL038834, R01HL038834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL063774 and HL038834. This work was also supported by the CBC/UIC Proteomics and Informatics Facility, established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium.	Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Arrington CB, 2000, METHOD ENZYMOL, V323, P104; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Doi T, 2005, ARCH BIOCHEM BIOPHYS, V436, P83, DOI 10.1016/j.abb.2005.01.004; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Gafurov B, 2007, FEBS J, V274, P2287, DOI 10.1111/j.1742-4658.2007.05765.x; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Li MX, 1997, BIOCHEMISTRY-US, V36, P12519, DOI 10.1021/bi971222l; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Matsumoto F, 2009, BIOCHEM BIOPH RES CO, V382, P205, DOI 10.1016/j.bbrc.2009.03.009; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Qiu F, 2003, BIOCHEM J, V371, P811, DOI 10.1042/BJ20021814; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Spyracopoulos L, 1998, BIOCHEMISTRY-US, V37, P18032, DOI 10.1021/bi9816960; Sun YB, 2006, P NATL ACAD SCI USA, V103, P17771, DOI 10.1073/pnas.0605430103; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang F, 1999, J AM SOC MASS SPECTR, V10, P703, DOI 10.1016/S1044-0305(99)00039-2; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	34	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2686	2694		10.1074/jbc.M109.062349	http://dx.doi.org/10.1074/jbc.M109.062349			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920153	Green Published, hybrid			2022-12-27	WOS:000273697800047
J	Peng, XM; Zhou, ZG; Hu, J; Fink, DJ; Mata, M				Peng, Xiangmin; Zhou, Zhigang; Hu, Jian; Fink, David J.; Mata, Marina			Soluble Nogo Receptor Down-regulates Expression of Neuronal Nogo-A to Enhance Axonal Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; MYELIN-ASSOCIATED GLYCOPROTEIN; NECROSIS-FACTOR-ALPHA; HSV-MEDIATED TRANSFER; DORSAL-ROOT GANGLIA; PROTEIN-KINASE-A; RHO-KINASE; NEURITE OUTGROWTH; DEPENDENT MECHANISM; NERVOUS-SYSTEM	Nogo-A, a member of the reticulon family, is present in neurons and oligodendrocytes. Nogo-A in central nervous system (CNS) myelin prevents axonal regeneration through interaction with Nogo receptor 1, but the function of Nogo-A in neurons is less known. We found that after axonal injury, Nogo-A is increased in dorsal root ganglion (DRG) neurons unable to regenerate following a dorsal root injury or a sciatic nerve ligation-cut injury and that exposure in vitro to CNS myelin dramatically enhanced neuronal Nogo-A mRNA and protein through activation of RhoA while inhibiting neurite growth. Knocking down neuronal Nogo-A by small interfering RNA results in a marked increase of neurite outgrowth. We constructed a nonreplicating herpes simplex virus vector (QHNgSR) to express a truncated soluble fragment of Nogo receptor 1 (NgSR). NgSR released from QHNgSR prevented myelin inhibition of neurite extension by hippocampal and DRG neurons in vitro. NgSR prevents RhoA activation by myelin and decreases neuronal Nogo-A. Subcutaneous inoculation of QHNgSR to transduce DRG neurons resulted in improved regeneration of myelinated fibers in both the dorsal root and the spinal dorsal root entry zone, with concomitant improvement in sensory behavior. The results indicate that neuronal Nogo-A is an important intermediate in neurite growth dynamics and its expression is regulated by signals related to axonal injury and regeneration, that CNS myelin appears to activate signaling events that mimic axonal injury, and that NgSR released from QHNgSR may be used to improve recovery after injury.	Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Healthcare Syst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Mata, M (corresponding author), 5027 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	mmata@umich.edu			National Institutes of Health; Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grants (to D.J.F. and M. M.). This work was also supported by grants from the Department of Veterans Affairs (to D.J.F. and M. M.).	Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Alabed YZ, 2006, J NEUROCHEM, V96, P1616, DOI 10.1111/j.1471-4159.2006.03670.x; Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Balasubramanian N, 2001, BIOCHEMISTRY-US, V40, P12619, DOI 10.1021/bi015624b; Bras JMA, 1998, J NEUROCHEM, V70, P1299; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Chattopadhyay M, 2005, GENE THER, V12, P1377, DOI 10.1038/sj.gt.3302533; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Ellezam B, 2002, PROG BRAIN RES, V137, P371; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Freund P, 2007, J COMP NEUROL, V502, P644, DOI 10.1002/cne.21321; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hasegawa T, 2005, MOL BRAIN RES, V133, P119, DOI 10.1016/j.molbrainres.2004.10.004; Huber AB, 2002, J NEUROSCI, V22, P3553; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kubo T, 2008, J NEUROCHEM, V105, P113, DOI 10.1111/j.1471-4159.2007.05125.x; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Li SX, 2003, J NEUROSCI, V23, P4219; Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Liu J, 2006, BRAIN RES, V1073, P297, DOI 10.1016/j.brainres.2005.12.091; Liu J, 2004, MOL THER, V10, P57, DOI 10.1016/j.ymthe.2004.04.017; MacDermid VE, 2004, EUR J NEUROSCI, V20, P2567, DOI 10.1111/j.1460-9568.2004.03715.x; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Mata Marina, 2004, Curr Neurol Neurosci Rep, V4, P1, DOI 10.1007/s11910-004-0001-0; Meier S, 2003, FASEB J, V17, P1153, DOI 10.1096/fj.02-0453fje; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Peng XM, 2006, ANN NEUROL, V59, P843, DOI 10.1002/ana.20855; Pot C, 2002, J CELL BIOL, V159, P29, DOI 10.1083/jcb.200206068; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang R, 2008, NAT NEUROSCI, V11, P488, DOI 10.1038/nn2069; Yu PP, 2008, NEUROBIOL DIS, V32, P535, DOI 10.1016/j.nbd.2008.09.012; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zhou Z, 2008, GENE THER, V15, P183, DOI 10.1038/sj.gt.3303054; Zhou ZG, 2009, MOL THER, V17, P1173, DOI 10.1038/mt.2009.52	64	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2783	2795		10.1074/jbc.M109.046425	http://dx.doi.org/10.1074/jbc.M109.046425			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19901030	Green Published, hybrid			2022-12-27	WOS:000273697800055
J	Alper, S; McElwee, MK; Apfeld, J; Lackford, B; Freedman, JH; Schwartz, DA				Alper, Scott; McElwee, Matthew K.; Apfeld, Javier; Lackford, Brad; Freedman, Jonathan H.; Schwartz, David A.			The Caenorhabditis elegans Germ Line Regulates Distinct Signaling Pathways to Control Lifespan and Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; POLYMORPHIC VARIANTS; SERRATIA-MARCESCENS; RESISTANT MUTANTS; VIRULENCE FACTORS; I RECEPTOR; LONGEVITY; INSULIN	The relationship between the mechanisms that control an organism's lifespan and its ability to respond to environmental challenges are poorly understood. In Caenorhabditis elegans, an insulin-like signaling pathway modulates lifespan and the innate immune response to bacterial pathogens via a common mechanism involving transcriptional regulation by the DAF-16/FOXO transcription factor. The C. elegans germ line also modulates lifespan in a daf-16-dependent manner. Here, we show that the germ line controls the innate immune response of C. elegans somatic cells to two different Gram-negative bacteria. In contrast to the insulin-like signaling pathway, the germ line acts via distinct signaling pathways to control lifespan and innate immunity. Under standard nematode culture conditions, the germ line regulates innate immunity in parallel to a known p38 MAPK signaling pathway, via a daf-16-independent pathway. Our findings indicate that a complex regulatory network integrates inputs from insulin-like signaling, p38 MAPK signaling, and germ line stem cells to control innate immunity in C. elegans. We also confirm that innate immunity and lifespan in C. elegans are distinct processes, as nonoverlapping regulatory networks control survival in the presence of pathogenic and nonpathogenic bacteria. Finally, we demonstrate that the p38 MAPK pathway in C. elegans is activated to a similar extent by both pathogenic and nonpathogenic bacteria, suggesting that both can induce the nematode innate immune response.	[Alper, Scott] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Schwartz, David A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [McElwee, Matthew K.; Freedman, Jonathan H.] NIEHS, Mol Toxicol Lab, NIH, Durham, NC 27709 USA; [Lackford, Brad] NIEHS, Mol Carcinogenesis Lab, NIH, Durham, NC 27709 USA; [Apfeld, Javier] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [McElwee, Matthew K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27707 USA	National Jewish Health; National Jewish Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School; Duke University	Alper, S (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, 1400 Jackson St,A640, Denver, CO 80206 USA.	alpers@njhealth.org		Apfeld, Javier/0000-0001-9897-5671; McElwee, Matthew/0000-0003-1659-6112	NHLBI; National Institutes of Health, NIEHS; National Institutes of Health; National Toxicology Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102045] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Toxicology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of NHLBI, National Institutes of Health, NIEHS, National Institutes of Health, and the National Toxicology Program.	Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berkowitz LA, 2000, DEVELOPMENT, V127, P4419; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Choy RKM, 1999, MOL CELL, V4, P143, DOI 10.1016/S1097-2765(00)80362-7; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 1998, GENETICS, V150, P129; Gems D, 2000, GENETICS, V154, P1597; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; Kojima T, 2004, EXP GERONTOL, V39, P1595, DOI 10.1016/j.exger.2004.05.007; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Murakami S, 1996, GENETICS, V143, P1207; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reinhart BJ, 2001, GENETICS, V157, P199; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; STROME S, 1995, DEVELOPMENT, V121, P2961; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wood WB, 1988, NEMATODE CAENORHABDI; Yamawaki TM, 2008, GENETICS, V178, P513, DOI 10.1534/genetics.107.083253	61	46	51	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1822	1828		10.1074/jbc.M109.057323	http://dx.doi.org/10.1074/jbc.M109.057323			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923212	hybrid, Green Published			2022-12-27	WOS:000273429100028
J	Mitrofan, LM; Castells, FB; Pelkonen, J; Monkkonen, J				Mitrofan, Laura M.; Castells, Ferran B.; Pelkonen, Jukka; Monkkonen, Jukka			Lysosomal-Mitochondrial Axis in Zoledronic Acid-induced Apoptosis in Human Follicular Lymphoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CANCER CELLS; MEMBRANE PERMEABILIZATION; INDEPENDENT ACTIVATION; PROTEIN PRENYLATION; MEVALONATE PATHWAY; BONE-RESORPTION; BCL-XL; DEATH; BISPHOSPHONATES	Bisphosphonates (BPs) are potent inhibitors of osteoclast function, widely used to treat excessive bone resorption associated with bone metastases, that also have anti-tumor activity. Zoledronic acid (ZOL) represents a potential chemotherapeutic agent for the treatment of cancer. ZOL is the most potent nitrogen-containing BPs, and it inhibits cell growth and induces apoptosis in a variety of cancer cells. Recently we demonstrated that accumulation of isopentenyl pyrophosphate and the consequent formation of a new type of ATP analog (ApppI) after mevalonate pathway inhibition by nitrogen-containing BPs strongly correlates with ZOL-induced cell death in cancer cells in vitro. In this study we show that ZOL-induced apoptosis in HF28RA human follicular lymphoma cells occurs exclusively via the mitochondrial pathway, involves lysosomes, and is dependent on mevalonate pathway inhibition. To define the exact signaling pathway connecting them, we used modified HF28RA cell lines overexpressing either BclXL or dominant-negative caspase-9. In both mutant cells, mitochondrial and lysosomal membrane permeabilization (MMP and LMP) were totally prevented, indicating signaling between lysosomes and mitochondria and, additionally, an amplification loop for MMP and/or LMP regulated by caspase-9 in association with farnesyl pyrophosphate synthetase inhibition. Additionally, the lysosomal pathway in ZOL-induced apoptosis plays an additional/amplification role of the intrinsic pathway independently of caspase-3 activation. Moreover, we show a potential regulation by Bcl-XL and caspase-9 on cell cycle regulators of S-phase. Our findings provide a molecular basis for new strategies concomitantly targeting cell death pathways from multiple sites.	Univ Kuopio, Dept Pharmaceut, Fac Pharm, FIN-70211 Kuopio, Finland; [Pelkonen, Jukka] Univ Kuopio, Dept Clin Microbiol, Fac Med, FIN-70211 Kuopio, Finland; [Mitrofan, Laura M.; Monkkonen, Jukka] Bioctr, FIN-70211 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Mitrofan, LM (corresponding author), POB 1627, FIN-70211 Kuopio, Finland.	laura_mitrofan@yahoo.com			NOVARTIS AG, Basel, Switzerland	NOVARTIS AG, Basel, Switzerland	This work was supported by NOVARTIS AG, Basel, Switzerland (to L. M.).	Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Aparicio A, 1998, LEUKEMIA, V12, P220, DOI 10.1038/sj.leu.2400892; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chuah C, 2005, LEUKEMIA, V19, P1896, DOI 10.1038/sj.leu.2403949; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Coleman RE, 2004, BREAST, V13, pS19, DOI 10.1016/j.breast.2004.09.004; Coxon JP, 2004, BJU INT, V94, P164, DOI 10.1111/j.1464-4096.2004.04831.x; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Dickson PV, 2006, SURGERY, V140, P227, DOI 10.1016/j.surg.2006.02.004; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Dunford JE, 2006, J BONE MINER RES, V21, P684, DOI 10.1359/JBMR.060118; Eeva J, 2009, APOPTOSIS, V14, P687, DOI 10.1007/s10495-009-0337-7; Evdokiou A, 2003, BONE, V33, P216, DOI 10.1016/S8756-3282(03)00223-0; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; FLANAGAN AM, 1991, CALCIFIED TISSUE INT, V49, P407, DOI 10.1007/BF02555852; Fromigue O, 2000, J BONE MINER RES, V15, P2211, DOI 10.1359/jbmr.2000.15.11.2211; Fulda S, 2001, ONCOGENE, V20, P1063, DOI 10.1038/sj.onc.1204141; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gyrd-Hansen M, 2006, MOL CELL BIOL, V26, P7880, DOI 10.1128/MCB.00716-06; Hasmim M, 2007, J THROMB HAEMOST, V5, P166, DOI 10.1111/j.1538-7836.2006.02259.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Jagdev SP, 2001, BRIT J CANCER, V84, P1126, DOI 10.1054/bjoc.2001.1727; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Katunuma N, 2001, ADV ENZYME REGUL, V41, P237, DOI 10.1016/S0065-2571(00)00018-2; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; MASSAIA M, 2005, HAEMATOL REP, V1, P77; Mitrofan LM, 2009, BONE, V45, P1153, DOI 10.1016/j.bone.2009.08.010; Monkkonen H, 2006, BRIT J PHARMACOL, V147, P437, DOI 10.1038/sj.bjp.0706628; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nuutinen U, 2009, LEUKEMIA RES, V33, P829, DOI 10.1016/j.leukres.2008.09.025; Ory B, 2007, MOL PHARMACOL, V71, P333, DOI 10.1124/mol.106.028837; Paquet C, 2005, LEUKEMIA, V19, P784, DOI 10.1038/sj.leu.2403717; Paris C, 2007, APOPTOSIS, V12, P1257, DOI 10.1007/s10495-007-0052-1; Ravagnan L, 2002, J CELL PHYSIOL, V192, P131, DOI 10.1002/jcp.10111; Roux C, 1999, DRUGS, V58, P823, DOI 10.2165/00003495-199958050-00005; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; Scheper MA, 2009, BRIT J HAEMATOL, V144, P667, DOI 10.1111/j.1365-2141.2008.07504.x; Schmitt E, 2007, ONCOGENE, V26, P5851, DOI 10.1038/sj.onc.1210396; Sewing L, 2008, APOPTOSIS, V13, P782, DOI 10.1007/s10495-008-0211-z; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; Terman Alexei, 2006, Molecular Aspects of Medicine, V27, P471, DOI 10.1016/j.mam.2006.08.006; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; van Beek E, 1999, BIOCHEM BIOPH RES CO, V264, P108, DOI 10.1006/bbrc.1999.1499; Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030; ZDOLSEK JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P67, DOI 10.1111/j.1751-1097.1990.tb01685.x; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x	65	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1967	1979		10.1074/jbc.M109.038935	http://dx.doi.org/10.1074/jbc.M109.038935			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19875454	Green Published, hybrid			2022-12-27	WOS:000273429100043
J	Wu, BH; Yin, J; Texier, C; Roussel, M; Tan, KSW				Wu, Binhui; Yin, Jing; Texier, Catherine; Roussel, Michael; Tan, Kevin Shyong-Wei			Blastocystis Legumain Is Localized on the Cell Surface, and Specific Inhibition of Its Activity Implicates a Pro-survival Role for the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC MONOCLONAL-ANTIBODY; CYSTEINE PROTEASES; MAMMALIAN LEGUMAIN; DEATH; ENDOPEPTIDASE; IDENTIFICATION; HOMINIS; ANTIGEN; CLAN; DEGRADATION	Programmed cell death (PCD) is crucial for cellular growth and development in multicellular organisms. Although distinct PCD features have been described for unicellular eukaryotes, homology searches have failed to reveal clear PCD-related orthologues among these organisms. Our previous studies revealed that a surface-reactive monoclonal antibody (mAb) 1D5 could induce multiple PCD pathways in the protozoan Blastocystis. In this study, we identified, by two-dimensional gel electrophoresis and mass spectrometry, the target of mAb 1D5 as a surface-localized legumain, an asparagine endopeptidase that is usually found in lysosomal/acidic compartments of other organisms. Recombinant Blastocystis legumain displayed biphasic pH optima in substrate assays, with peaks at pH 4 and 7.5. Activity of Blastocystis legumain was greatly inhibited by the legumain-specific inhibitor carbobenzyloxy-Ala-Ala-AAsn-epoxycarboxylate ethyl ester (APE-RR) (where AAsn is aza-asparagine) and moderately inhibited by mAb 1D5, cystatin, and caspase-1 inhibitor. Interestingly, inhibition of legumain activity induced PCD in Blastocystis, observed by increased externalization of phosphatidylserine residues and in situ DNA fragmentation. In contrast to plants, in which legumains have been shown to play a pro-death role, legumain appears to display a pro-survival role in Blastocystis.	[Wu, Binhui; Yin, Jing; Tan, Kevin Shyong-Wei] Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Tan, Kevin Shyong-Wei] Natl Univ Singapore, Program Infect Dis, Inst Life Sci, Singapore 117597, Singapore; [Texier, Catherine; Roussel, Michael] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France; [Texier, Catherine; Roussel, Michael] CNRS, UMR 6023, Lab Microorganismes Genome & Environm, F-63173 Aubiere, France	National University of Singapore; National University of Singapore; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Tan, KSW (corresponding author), 5 Sci Dr 2, Singapore 117597, Singapore.	mictank@nus.edu.sg	Tan, Kevin/C-9653-2014		Biomedical Research Council [05/1/21/19/378]; National Medical Research Council [06May107]; Infectious Disease Program	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Infectious Disease Program	This work was supported by Biomedical Research Council Grant 05/1/21/19/378, the National Medical Research Council (06May107), and the Infectious Disease Program. Downloaded from www.jbc.org at unknown institution, on January 11, 2010	AKSOY K, 1987, HUM GENET, V76, P199, DOI 10.1007/BF00284922; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Asgian JL, 2002, J MED CHEM, V45, P4958, DOI 10.1021/jm025581c; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Chen JM, 2000, BIOCHEM J, V352, P327, DOI 10.1042/0264-6021:3520327; Claveau D, 2000, BIOCHEM PHARMACOL, V60, P759, DOI 10.1016/S0006-2952(00)00381-6; Dalton JP, 1995, PARASITOLOGY, V111, P575, DOI 10.1017/S0031182000077052; Gelboin HV, 2006, J CLIN PHARMACOL, V46, P353, DOI 10.1177/0091270005285200; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Iwata H, 2007, BIOSCI BIOTECH BIOCH, V71, P1279, DOI 10.1271/bbb.60682; Ju JW, 2009, PROTEOMICS, V9, P3066, DOI 10.1002/pmic.200700613; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Lam E, 2005, TRENDS CELL BIOL, V15, P124, DOI 10.1016/j.tcb.2005.01.001; Leon-Felix J, 2004, GENE, V335, P25, DOI 10.1016/j.gene.2004.03.002; Liu C, 2003, CANCER RES, V63, P2957; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MCCANN SR, 1980, J MED GENET, V17, P191, DOI 10.1136/jmg.17.3.191; Nasirudeen AMA, 2005, BIOCHIMIE, V87, P489, DOI 10.1016/j.biochi.2005.03.003; Nasirudeen AMA, 2004, EUR J CELL BIOL, V83, P477, DOI 10.1078/0171-9335-00411; Nasirudeen AMA, 2001, PARASITOL RES, V87, P559, DOI 10.1007/s004360100427; Nasirudeen AMA, 2001, PARASITOLOGY, V123, P235, DOI 10.1017/S0031182001008332; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Oliver EM, 2006, PARASITOLOGY, V133, P237, DOI 10.1017/S0031182006000229; Puthia MK, 2008, EUKARYOT CELL, V7, P435, DOI 10.1128/EC.00371-07; Puthia MK, 2005, PARASITOL RES, V97, P386, DOI 10.1007/s00436-005-1461-0; Rotari VI, 2001, BIOL CHEM, V382, P953, DOI 10.1515/BC.2001.119; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan KSW, 2005, TRENDS PARASITOL, V21, P547, DOI 10.1016/j.pt.2005.09.006; Tan KSW, 2001, PARASITOL RES, V87, P534, DOI 10.1007/s004360000365; Tan SW, 1997, INT J PARASITOL, V27, P947, DOI 10.1016/S0020-7519(97)00066-0; Tan SW, 1996, INT J PARASITOL, V26, P375, DOI 10.1016/0020-7519(96)00016-1	37	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1790	1798		10.1074/jbc.M109.049064	http://dx.doi.org/10.1074/jbc.M109.049064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915007	hybrid, Green Published			2022-12-27	WOS:000273429100025
J	Chang, CL; Park, JI; Hsu, SYT				Chang, Chia Lin; Park, Jae-Il; Hsu, Sheau Yu Teddy			Activation of Calcitonin Receptor and Calcitonin Receptor-like Receptor by Membrane-anchored Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GENE-RELATED PEPTIDE; ACTIVITY-MODIFYING PROTEINS; INTERNATIONAL UNION; TETHERED LIGANDS; HYDROPS-FETALIS; DRUG DISCOVERY; BONE-FORMATION; MICE LACKING; ADRENOMEDULLIN	G protein-coupled receptors (GPCRs) are the most important pharmaceutical targets, and more than 40% of drugs in use today modulate GPCR signaling. A major hurdle in the development of therapies targeting GPCRs is the drug candidate's nonselective actions in multiple tissues. The ability to spatially control GPCR signaling would provide a venue for developing therapies that require targeted GPCR signaling. Here, we show that the fusion of a RAMP1 co-receptor with the calcitonin gene-related peptide (CGRP), or calcitonin, transforms the RAMP1 from a co-receptor to bona fide membrane-anchored ligands (CGRP-RAMP1 and CAL-RAMP1). The CAL-RAMP1 selectively activates the calcitonin receptor (CR), whereas, the CGRP-RAMP1 activates both the calcitonin receptor-like receptor (CLR) and CR. Unlike a free peptide, which moves freely in the extracellular space and differentiates targets based on molecular affinity, the anchored CGRP-RAMP1 and CAL-RAMP1 ligands confine their activities to individual cells. In addition, our study showed that a CGRP8-37-RAMP1 chimera, but not RAMP1, functions as an antagonist for CGRP-RAMP1-mediated signaling, suggesting that the activation of CLR by CGRP-RAMP1 shares similar molecular mechanisms with the CGRP-mediated activation of CLR/RAMP1 receptor complexes. Taken together, our finding thus provides a novel class of ligands that activate CR and CLR exclusively in an autocrine manner and a proof-of-concept demonstration for future development of targeted therapies aimed at these receptors in specific cell populations.	[Chang, Chia Lin; Park, Jae-Il; Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, Stanford, CA 94305 USA; [Chang, Chia Lin] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan 333, Taiwan	Stanford University; Chang Gung Memorial Hospital; Chang Gung University	Hsu, SYT (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, 300 Pasteur Dr,Rm A344D, Stanford, CA 94305 USA.	teddyhsu@stanford.edu			National Institutes of Health [R01 DK70652]; New Century Health Care Promotion Foundation, Taiwan [NCH-CPF-94001]; Chang Gung Memorial Hospital [CMRPG34002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Century Health Care Promotion Foundation, Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK70652 (to S. Y. T. H.). This work was also supported by grants from the New Century Health Care Promotion Foundation, Taiwan (NCH-CPF-94001, to C. L. C.) and Chang Gung Memorial Hospital (CMRPG34002, to C. L. C.).	Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bouschet T, 2008, TRENDS PHARMACOL SCI, V29, P633, DOI 10.1016/j.tips.2008.09.002; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; DUNNING BE, 1987, ENDOCRINOLOGY, V120, P1774, DOI 10.1210/endo-120-5-1774; Fitzsimmons TJ, 2003, J BIOL CHEM, V278, P14313, DOI 10.1074/jbc.M211946200; Flahaut M, 2003, BIOCHEMISTRY-US, V42, P10333, DOI 10.1021/bi0347508; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Heroux M, 2007, BIOCHEMISTRY-US, V46, P7022, DOI 10.1021/bi0622470; Hilairet S, 2001, J BIOL CHEM, V276, P29575, DOI 10.1074/jbc.M102722200; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MIYAZATO M, 1991, BIOCHEM BIOPH RES CO, V181, P293, DOI 10.1016/S0006-291X(05)81416-0; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Park JI, 2008, GENOME RES, V18, P974, DOI 10.1101/gr.7119108; Parnot C, 2004, NAT STRUCT MOL BIOL, V11, P691, DOI 10.1038/nsmb0804-691; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Semyonov J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001903; WESTERMARK P, 1987, AM J PATHOL, V127, P414; Wu CB, 1996, J BIOL CHEM, V271, P31638, DOI 10.1074/jbc.271.49.31638; Zaidi M, 2002, J CLIN INVEST, V110, P1769, DOI 10.1172/JCI200217425	36	4	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1075	1080		10.1074/jbc.M109.020040	http://dx.doi.org/10.1074/jbc.M109.020040			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19903822	Green Published, hybrid			2022-12-27	WOS:000273258200028
J	Fujioka, Y; Noda, NN; Nakatogawa, H; Ohsumi, Y; Inagaki, F				Fujioka, Yuko; Noda, Nobuo N.; Nakatogawa, Hitoshi; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Dimeric Coiled-coil Structure of Saccharomyces cerevisiae Atg16 and Its Functional Significance in Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LIPIDATION; CRYSTAL-STRUCTURE; YEAST; COMPLEX; MEMBRANE; SYSTEM; CONJUGATE; DISSECTION; MECHANISMS; STATE	Atg16 interacts with the Atg12-Atg5 protein conjugate through its N-terminal domain and self-assembles through its coiled-coil domain (CCD). Formation of the Atg12-Atg5.Atg16 complex is essential for autophagy, the bulk degradation process conserved among most eukaryotes. Here, we report the crystal structures of full-length Saccharomyces cerevisiae Atg16 at 2.8 angstrom resolution and its CCD at 2.5 angstrom resolution. The CCD and full-length Atg16 each exhibit an extended alpha-helix, 90 and 130 angstrom, respectively, and form a parallel coiled-coil dimer in the crystals. Although the apparent molecular weight of Atg16 observed by gel-filtration chromatography suggests that Atg16 is tetrameric, an analytical ultracentrifugation study showed Atg16 as a dimer in solution, consistent with the crystal structure. Evolutionary conserved surface residues clustered at the C-terminal half of Atg16 CCD were shown to be crucial for autophagy. These results will give a structural basis for understanding the molecular functions and significance of Atg16 in autophagy.	[Inagaki, Fuyuhiko] Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan; [Nakatogawa, Hitoshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Inagaki, F (corresponding author), Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Nakatogawa, Hitoshi/D-5155-2015; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Nakatogawa, Hitoshi/0000-0002-5828-0741; Fujioka, Yuko/0000-0002-6905-0669; Noda, Nobuo/0000-0002-6940-8069	Ministry of Education, Science and Culture of Japan	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research on Priority Areas and Targeted Proteins Research Program from the Ministry of Education, Science and Culture of Japan.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujioka Y, 2008, ACTA CRYSTALLOGR F, V64, P1046, DOI 10.1107/S1744309108031898; Fujioka Y, 2008, J BIOL CHEM, V283, P1921, DOI 10.1074/jbc.M706214200; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2009, CHEM REV, V109, P1587, DOI 10.1021/cr800459r; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072	35	90	95	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1508	1515		10.1074/jbc.M109.053520	http://dx.doi.org/10.1074/jbc.M109.053520			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889643	Green Published, hybrid			2022-12-27	WOS:000273258200070
J	Sahu, G; Wang, DF; Chen, CB; Zhurkin, VB; Harrington, RE; Appella, E; Hager, GL; Nagaich, AK				Sahu, Geetaram; Wang, Difei; Chen, Claudia B.; Zhurkin, Victor B.; Harrington, Rodney E.; Appella, Ettore; Hager, Gordon L.; Nagaich, Akhilesh K.			p53 Binding to Nucleosomal DNA Depends on the Rotational Positioning of DNA Response Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR; TUMOR-SUPPRESSOR; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REGULATION; STRUCTURAL BASIS; DOMAIN PEPTIDES; CORE DOMAIN; COMPLEX; PROTEIN; RECOGNITION	The sequence-specific binding to DNA is crucial for the p53 tumor suppressor function. To investigate the constraints imposed on p53-DNA recognition by nucleosomal organization, we studied binding of the p53 DNA binding domain (p53DBD) and full-length wild-type p53 protein to a single p53 response element (p53RE) placed near the nucleosomal dyad in six rotational settings. We demonstrate that the strongest p53 binding occurs when the p53RE in the nucleosome is bent in the same direction as observed for the p53-DNA complexes in solution and in co-crystals. The p53RE becomes inaccessible, however, if its orientation in the core particle is changed by similar to 180 degrees. Our observations indicate that the orientation of the binding sites on a nucleosome may play a significant role in the initial p53-DNA recognition and subsequent cofactor recruitment.	[Nagaich, Akhilesh K.] US FDA, Chem Lab, Div Therapeut Prot, OBP,OPS,CDER, Bethesda, MD 20892 USA; [Wang, Difei; Zhurkin, Victor B.; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Harrington, Rodney E.] Arizona State Univ, Dept Microbiol, Tempe, AZ 85287 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Arizona State University; Arizona State University-Tempe	Nagaich, AK (corresponding author), US FDA, Chem Lab, Div Therapeut Prot, OBP,OPS,CDER, 29 Lincoln Dr, Bethesda, MD 20892 USA.	akhilesh.nagaich@fda.hhs.gov	Wang, Difei/E-7066-2010		Oak Ridge Institute for Science and Education through an intraagency agreement between the United States Department of Energy and the United States Food and Drug Administration; National Institutes of Health [R01 CA 70274]; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC005599, ZIABC010845, R01CA070274, ZIABC005450] Funding Source: NIH RePORTER	Oak Ridge Institute for Science and Education through an intraagency agreement between the United States Department of Energy and the United States Food and Drug Administration; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by an appointment of G. Sahu to the Postgraduate Research Program at the Center for Drug Evaluation and Research administered by the Oak Ridge Institute for Science and Education through an intraagency agreement between the United States Department of Energy and the United States Food and Drug Administration. This work was also supported in part by National Institutes of Health Grant R01 CA 70274 (to R.E.H.) and by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUKNER I, 1993, NUCLEIC ACIDS RES, V21, P1025, DOI 10.1093/nar/21.4.1025; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; CUI F, 2006, BIOMOLECULAR PATHWAY, P48; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; Durell SR, 1998, STRUCTURE, MOTION, INTERACTION AND EXPRESSION OF BIOLOGICAL MACROMOLECULES, VOL 2, P277; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; FITZGERALD DJ, 1994, J BIOL CHEM, V269, P21303; Fitzgerald DJ, 1998, NUCLEIC ACIDS RES, V26, P2526, DOI 10.1093/nar/26.11.2526; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Hainaut P, 2000, ADV CANCER RES, V77, P81; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LI BY, 1994, J BIOL CHEM, V269, P7756; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LI Q, 1995, MOL CELL BIOL, V15, P4375; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nagaich AK, 1999, P NATL ACAD SCI USA, V96, P1875, DOI 10.1073/pnas.96.5.1875; Nagaich AK, 1997, J BIOL CHEM, V272, P14830, DOI 10.1074/jbc.272.23.14830; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nagaich AK, 1997, J BIOL CHEM, V272, P14842, DOI 10.1074/jbc.272.23.14842; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rippin TM, 2002, J MOL BIOL, V319, P351, DOI 10.1016/S0022-2836(02)00326-1; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Staples OD, 2008, SURG-J R COLL SURG E, V6, P240, DOI 10.1016/S1479-666X(08)80034-0; Studitsky VM, 1999, METH MOL B, V119, P17; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Zhao KH, 2001, J BIOL CHEM, V276, P12120, DOI 10.1074/jbc.M011644200; ZHURKIN VB, 1991, P NATL ACAD SCI USA, V88, P7046, DOI 10.1073/pnas.88.16.7046	57	39	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1321	1332		10.1074/jbc.M109.081182	http://dx.doi.org/10.1074/jbc.M109.081182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887449	Green Published, hybrid			2022-12-27	WOS:000273258200053
J	Hansson, MJ; Morota, S; Teilum, M; Mattiasson, G; Uchino, H; Elmer, E				Hansson, Magnus J.; Morota, Saori; Teilum, Maria; Mattiasson, Gustav; Uchino, Hiroyuki; Elmer, Eskil			Increased Potassium Conductance of Brain Mitochondria Induces Resistance to Permeability Transition by Enhancing Matrix Volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; RAT-LIVER MITOCHONDRIA; ISCHEMIC TOLERANCE; HEART-MITOCHONDRIA; REPERFUSION INJURY; INNER MEMBRANE; CYCLOSPORINE-A; CARDIAC MITOCHONDRIA; CEREBRAL-ISCHEMIA; CYCLOPHILIN-D	Modulation of K+ conductance of the inner mitochondrial membrane has been proposed to mediate preconditioning in ischemia-reperfusion injury. The mechanism is not entirely understood, but it has been linked to a decreased activation of mitochondrial permeability transition (mPT). In the present study K+ channel activity was mimicked by picomolar concentrations of valinomycin. Isolated brain mitochondria were exposed to continuous infusions of calcium. Monitoring of extramitochondrial Ca2+ and mitochondrial respiration provided a quantitative assay for mPT sensitivity by determining calcium retention capacity (CRC). Valinomycin and cyclophilin D inhibition separately and additively increased CRC. Comparable degrees of respiratory uncoupling induced by increased K+ or H+ conductance had opposite effects on mPT sensitivity. Protonophores dose-dependently decreased CRC, demonstrating that so-called mild uncoupling was not beneficial per se. The putative mitoKATP channel opener diazoxide did not mimic the effect of valinomycin. An alkaline matrix pH was required for mitochondria to retain calcium, but increased K+ conductance did not result in augmented Delta pH. The beneficial effect of valinomycin on CRC was not mediated by H2O2-induced protein kinase C epsilon activation. Rather, increased K+ conductance reduced H2O2 generation during calcium infusion. Lowering the osmolarity of the buffer induced an increase in mitochondrial volume and improved CRC similar to valinomycin without inducing uncoupling or otherwise affecting respiration. We propose that increased potassium conductance in brain mitochondria may cause a direct physiological effect on matrix volume inducing resistance to pathological calcium challenges.	[Hansson, Magnus J.; Morota, Saori; Teilum, Maria; Mattiasson, Gustav; Elmer, Eskil] Lund Univ, Expt Brain Res Lab, Mitochondrial Pathophysiol Unit, Dept Clin Sci, SE-22184 Lund, Sweden; [Uchino, Hiroyuki] Tokyo Med Univ, Dept Anesthesiol, Tokyo 1600023, Japan; [Hansson, Magnus J.] Univ Lund Hosp, Dept Clin Physiol, SE-22184 Lund, Sweden; [Elmer, Eskil] Univ Lund Hosp, Dept Clin Neurophysiol, SE-22184 Lund, Sweden	Lund University; Tokyo Medical University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Hansson, MJ (corresponding author), Lund Univ, Expt Brain Res Lab, Mitochondrial Pathophysiol Unit, Dept Clin Sci, BMC A13, SE-22184 Lund, Sweden.	magnus.hansson@med.lu.se	Elmér, Eskil/F-9341-2014; Hansson, Magnus/G-4486-2014	Elmér, Eskil/0000-0001-7901-1826; Hansson, Magnus/0000-0002-0201-0638	Swedish Research Council [2008-2634]; Japanese Ministry of Health and Labor and Welfare [18591724]; Swedish Society of Medicine; Stohne; Segerfalk; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Japanese Ministry of Health and Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Swedish Society of Medicine; Stohne; Segerfalk; Royal Physiographic Society in Lund	This work was supported by the Swedish Research Council (reference number 2008-2634), by the Japanese Ministry of Health and Labor and Welfare Grant 18591724, by the Swedish Society of Medicine, and by the foundations of Stohne, Segerfalk, and the Royal Physiographic Society in Lund. E. Elmer is co-founder and officer of Maas Biolab, LLC and NeuroVive Pharmaceutical AB, which hold intellectual property rights and develop the use of cyclosporins as cyclophilin D inhibitors for neurological treatment.	Andrukhiv A, 2006, AM J PHYSIOL-HEART C, V291, pH2067, DOI 10.1152/ajpheart.00272.2006; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; BAYSAL K, 1994, AM J PHYSIOL, V266, pC800, DOI 10.1152/ajpcell.1994.266.3.C800; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; BRIERLEY GP, 1994, J BIOENERG BIOMEMBR, V26, P519, DOI 10.1007/BF00762736; Brustovetsky T, 2005, J PHYSIOL-LONDON, V568, P47, DOI 10.1113/jphysiol.2005.091199; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHOPP M, 1989, NEUROLOGY, V39, P1396, DOI 10.1212/WNL.39.10.1396; Costa ADT, 2006, AM J PHYSIOL-HEART C, V290, pH406, DOI 10.1152/ajpheart.00794.2005; Costa ADT, 2006, J BIOL CHEM, V281, P20801, DOI 10.1074/jbc.M600959200; Costa ADT, 2009, J BIOENERG BIOMEMBR, V41, P123, DOI 10.1007/s10863-009-9213-y; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; DODGSON SJ, 1982, J BIOL CHEM, V257, P1705; Domoki F, 1999, STROKE, V30, P2713, DOI 10.1161/01.STR.30.12.2713; Dos Santos P, 2002, AM J PHYSIOL-HEART C, V283, pH284, DOI 10.1152/ajpheart.00034.2002; Drose S, 2006, J BIOL CHEM, V281, P23733, DOI 10.1074/jbc.M602570200; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Garlid KD, 1996, J BIOL CHEM, V271, P8796, DOI 10.1074/jbc.271.15.8796; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; HALESTRAP AP, 1991, BIOCHEM J, V278, P715, DOI 10.1042/bj2780715; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hausenloy DJ, 2004, AM J PHYSIOL-HEART C, V287, pH841, DOI 10.1152/ajpheart.00678.2003; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Holmuhamedov EL, 1999, J PHYSIOL-LONDON, V519, P347, DOI 10.1111/j.1469-7793.1999.0347m.x; HUTSON SM, 1987, J BIOL CHEM, V262, P9629; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3; JANOFF A, 1964, Int Anesthesiol Clin, V2, P251, DOI 10.1097/00004311-196402000-00008; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Liu YG, 1998, CIRCULATION, V97, P2463, DOI 10.1161/01.CIR.97.24.2463; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Morota S, 2009, EXP NEUROL, V218, P353, DOI 10.1016/j.expneurol.2009.03.036; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NICHOLLS DG, 1972, FEBS LETT, V25, P61, DOI 10.1016/0014-5793(72)80454-X; Nogueira V, 2005, J BIOENERG BIOMEMBR, V37, P25, DOI 10.1007/s10863-005-4120-3; Pain T, 2000, CIRC RES, V87, P460; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Ping PP, 2002, J CLIN INVEST, V109, P499, DOI 10.1172/JCI200213200; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; PRESSMAN BC, 1967, P NATL ACAD SCI USA, V58, P1949, DOI 10.1073/pnas.58.5.1949; Saurin AT, 2002, CARDIOVASC RES, V55, P672, DOI 10.1016/S0008-6363(02)00325-5; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; WIELOCH T, 2007, HDB NEUROCHEMISTRY M, P667; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; ZOCCARATO F, 1982, EUR J BIOCHEM, V127, P333, DOI 10.1111/j.1432-1033.1982.tb06875.x; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	68	37	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					741	750		10.1074/jbc.M109.017731	http://dx.doi.org/10.1074/jbc.M109.017731			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880514	Green Published, hybrid			2022-12-27	WOS:000273070100075
J	Kim, SY; Cho, BH; Kim, UH				Kim, Seon-Young; Cho, Baik Hwan; Kim, Uh-Hyun			CD38-mediated Ca2+ Signaling Contributes to Angiotensin II-induced Activation of Hepatic Stellate Cells ATTENUATION OF HEPATIC FIBROSIS BY CD38 ABLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; LIVER FIBROSIS; RECEPTOR ANTAGONIST; CYCLING ASSAY; UP-REGULATION; EXPRESSION; RELEASE; CALCIUM; NAADP; MECHANISMS	CD38 is a type II glycoprotein that is responsible for the synthesis and hydrolysis of cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP), Ca2+-mobilizing second messengers. The activation of hepatic stellate cells (HSCs) is a critical event in hepatic fibrosis because these cells are the main producers of extracellular matrix proteins in the liver. Recent evidence indicates that the renin-angiotensin system plays a major role in liver fibrosis. In this study, we showed that angiotensin II (Ang II) evoked long lasting Ca2+ rises and induced NAADP or cADPR productions via CD38 in HSCs. Inositol 1,4,5-trisphosphate as well as NAADP-induced initial Ca2+ transients were prerequisite for the production of cADPR, which was responsible for later sustained Ca2+ rises in the Ang II-treated HSCs. Ang II-mediated inositol 1,4,5-trisphosphate- and NAADP-stimulated Ca2+ signals cross-talked in a dependent manner with each other. We also demonstrated that CD38 plays an important role in Ang II-induced proliferation and overproduction of extracellular matrix proteins in HSCs, which were reduced by an antagonistic cADPR analog, 8-bromo-cADPR, or in CD38(-/-) HSCs. Moreover, we presented evidence to implicate CD38 in the bile duct ligation-induced liver fibrogenesis; infiltration of inflammatory cells and expressions of alpha-smooth muscle actin, transforming growth factor-beta 1, collagen alpha I(1), and fibronectin were reduced in CD38(-/-) mice compared with those in CD38(-/-) mice. These results demonstrate that CD38-mediated Ca2+ signals contribute to liver fibrosis via HSCs activation, suggesting that intervention of CD38 activation may help prevent hepatic fibrosis.	[Kim, Seon-Young; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; [Cho, Baik Hwan] Chonbuk Natl Univ, Sch Med, Dept Surg, Jeonju 561182, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr		Kim, Uh-Hyun/0000-0003-3304-7190	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A090476]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A090476; to U.-H. K.).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Abdeen SM, 2009, ACTA HISTOCHEM, V111, P520, DOI 10.1016/j.acthis.2008.04.008; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Breitkopf K, 2005, CYTOKINE, V31, P349, DOI 10.1016/j.cyto.2005.06.005; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; da Silva CP, 2000, BBA-MOL CELL RES, V1498, P122, DOI 10.1016/S0167-4889(00)00089-6; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gul R, 2008, AM J PHYSIOL-HEART C, V295, pH77, DOI 10.1152/ajpheart.01355.2007; Gul R, 2009, CARDIOVASC RES, V81, P582, DOI 10.1093/cvr/cvn232; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Kim SY, 2008, AM J PHYSIOL-RENAL, V294, pF982, DOI 10.1152/ajprenal.00483.2007; Kim SY, 2009, AM J PHYSIOL-RENAL, V296, pF291, DOI 10.1152/ajprenal.90381.2008; KIM UH, 1991, J BIOL CHEM, V266, P1359; Kurikawa N, 2003, BRIT J PHARMACOL, V139, P1085, DOI 10.1038/sj.bjp.0705339; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mao TK, 2002, AUTOIMMUNITY, V35, P521, DOI 10.1080/0891693021000057784; March S, 2007, AM J PATHOL, V170, P176, DOI 10.2353/ajpath.2007.051212; Marra F, 1998, HEPATOLOGY, V27, P462, DOI 10.1002/hep.510270221; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; Potter BVL, 2004, CURR MOL MED, V4, P303, DOI 10.2174/1566524043360744; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Russo MW, 2005, LIVER TRANSPLANT, V11, P1235, DOI 10.1002/lt.20432; Yokohama S, 2004, HEPATOLOGY, V40, P1222, DOI 10.1002/hep.20420; Yoshiji H, 2001, HEPATOLOGY, V34, P745, DOI 10.1053/jhep.2001.28231	33	49	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					576	582		10.1074/jbc.M109.076216	http://dx.doi.org/10.1074/jbc.M109.076216			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19910464	Green Published, hybrid			2022-12-27	WOS:000273070100059
J	Zhou, JS; Yi, JX; Fu, RG; Liu, ED; Siddique, T; Rios, E; Deng, HX				Zhou, Jingsong; Yi, Jianxun; Fu, Ronggen; Liu, Erdong; Siddique, Teepu; Rios, Eduardo; Deng, Han-Xiang			Hyperactive Intracellular Calcium Signaling Associated with Localized Mitochondrial Defects in Skeletal Muscle of an Animal Model of Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MOTOR TERMINALS; CA2+ SPARKS; MAMMALIAN MUSCLE; PRIMARY TARGET; UP-REGULATION; MUTANT SOD1; WILD-TYPE; MDX MICE; FIBERS; DEGENERATION	Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disorder characterized by degeneration of motor neurons and atrophy of skeletal muscle. Mutations in the superoxide dismutase (SOD1) gene are linked to 20% cases of inherited ALS. Mitochondrial dysfunction has been implicated in the pathogenic process, but how it contributes to muscle degeneration of ALS is not known. Here we identify a specific deficit in the cellular physiology of skeletal muscle derived from an ALS mouse model (G93A) with transgenic overexpression of the human SOD1(G93A) mutant. The G93A skeletal muscle fibers display localized loss of mitochondrial inner membrane potential in fiber segments near the neuromuscular junction. These defects occur in young G93A mice prior to disease onset. Fiber segments with depolarized mitochondria show greater osmotic stress-induced Ca2+ release activity, which can include propagating Ca2+ waves. These Ca2+ waves are confined to regions of depolarized mitochondria and stop propagating shortly upon entering the regions of normal, polarized mitochondria. Uncoupling of mitochondrial membrane potential with FCCP or inhibition of mitochondrial Ca2+ uptake by Ru360 lead to cell-wide propagation of such Ca2+ release events. Our data reveal that mitochondria regulate Ca2+ signaling in skeletal muscle, and loss of this capacity may contribute to the progression of muscle atrophy in ALS.	[Zhou, Jingsong; Yi, Jianxun; Rios, Eduardo] Rush Univ, Sch Med, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA; [Fu, Ronggen; Liu, Erdong; Siddique, Teepu; Deng, Han-Xiang] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Rush University; Northwestern University; Feinberg School of Medicine	Zhou, JS (corresponding author), 1750 W Harrison St, Chicago, IL 60612 USA.	jzhou1@rush.edu	Siddique, Teepu/AAT-8166-2021	Siddique, Teepu/0000-0001-7293-9146; Deng, Han-Xiang/0000-0002-0030-8465	Muscular Dystrophy Association [MDA4351]; National Institutes of Health through NIAMS [AR032808, AR049184]; National Institutes of Health through NINDS [NS050641, NS046535, NS040308]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049184, R01AR032808, R01AR057404, R37AR032808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040308, R01NS050641, R01NS046535] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health through NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in whole by Research Grant MDA4351 from the Muscular Dystrophy Association (to J. Z.) and in part by National Institutes of Health Grants AR032808 and AR049184 (to E. R.) through NIAMS and NS050641 and NS046535 (to T. S.) and NS040308 (to H. X. D.) through NINDS.	Appel SH, 2006, EXP NEUROL, V198, P1, DOI 10.1016/j.expneurol.2005.12.025; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; De Backer F, 2002, J PHYSIOL-LONDON, V542, P855, DOI 10.1113/jphysiol.2002.020487; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Han RZ, 2006, CELL CALCIUM, V40, P299, DOI 10.1016/j.ceca.2006.04.016; Hopf FW, 1996, AM J PHYSIOL-CELL PH, V271, pC1325, DOI 10.1152/ajpcell.1996.271.4.C1325; Kim HJ, 2007, EXP MOL MED, V39, P574, DOI 10.1038/emm.2007.63; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kong JM, 1998, J NEUROSCI, V18, P3241; Launikonis BS, 2005, J PHYSIOL-LONDON, V567, P523, DOI 10.1113/jphysiol.2005.087973; Leclerc N, 2001, NEUROMUSCULAR DISORD, V11, P722, DOI 10.1016/S0960-8966(01)00240-1; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Nguyen KT, 2009, P NATL ACAD SCI USA, V106, P2007, DOI 10.1073/pnas.0810934106; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Park KHJ, 2008, BBA-MOL BASIS DIS, V1782, P462, DOI 10.1016/j.bbadis.2008.04.001; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Payne AM, 2009, EXP GERONTOL, V44, P261, DOI 10.1016/j.exger.2008.09.013; Rossi AE, 2009, EXERC SPORT SCI REV, V37, P29, DOI 10.1097/JES.0b013e3181911fa4; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Shkryl VM, 2009, PFLUG ARCH EUR J PHY, V458, P915, DOI 10.1007/s00424-009-0670-2; Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571, DOI 10.1097/00005072-199806000-00005; Teichmann MDH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003644; Vila L, 2003, J PHYSIOL-LONDON, V549, P719, DOI 10.1113/jphysiol.2003.041905; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhou J, 2003, J GEN PHYSIOL, V122, P95, DOI 10.1085/jgp.200308796; Zhou JS, 2006, AM J PHYSIOL-CELL PH, V290, pC539, DOI 10.1152/ajpcell.00592.2004	41	93	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					705	712		10.1074/jbc.M109.041319	http://dx.doi.org/10.1074/jbc.M109.041319			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19889637	hybrid, Green Published			2022-12-27	WOS:000273070100071
J	Maiti, A; Morgan, MT; Drohat, AC				Maiti, Atanu; Morgan, Michael T.; Drohat, Alexander C.			Role of Two Strictly Conserved Residues in Nucleotide Flipping and N-Glycosylic Bond Cleavage by Human Thymine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; CRYSTAL-STRUCTURE; TRANSITION-STATE; MISMATCH RECOGNITION; MUTATIONAL ANALYSIS; CPG SITES; URACIL; METHYLATION; HYDROLYSIS; MECHANISM	Thymine DNA glycosylase (TDG) promotes genomic integrity by excising thymine from mutagenic G.T mismatches arising by deamination of 5-methylcytosine, and follow-on base excision repair enzymes restore a G.C pair. TDG cleaves the N-glycosylic bond of dT and some other nucleotides, including 5-substituted 2'-deoxyuridine analogs, once they have been flipped from the helix into its active site. We examined the role of two strictly conserved residues; Asn(140), implicated in the chemical step, and Arg(275), implicated in nucleotide flipping. The N140A variant binds substrate DNA with the same tight affinity as wild-type TDG, but it has no detectable base excision activity for a G.T substrate, and its excision rate is vastly diminished (by similar to 10(4.4)-fold) for G.U, G.FU, and G.BrU substrates. Thus, Asn(140) does not contribute substantially to substrate binding but is essential for the chemical step, where it stabilizes the transition state by similar to 6 kcal/mol (compared with 11.6 kcal/mol stabilization provided by TDG overall). Our recent crystal structure revealed that Arg(275) penetrates the DNA minor groove, filling the void created by nucleotide flipping. We found that the R275A and R275L substitutions weaken substrate binding and substantially decrease the base excision rate for G.T and G.BrU substrates. Our results indicate that Arg(275) promotes and/or stabilizes nucleotide flipping, a role that is most important for target nucleotides that are relatively large (dT and bromodeoxyuridine) and/or have a stable N-glycosylic bond (dT). Arg(275) does not contribute substantially to the binding of TDG to abasic DNA product, and it cannot account for the slow product release exhibited by TDG.	[Maiti, Atanu; Morgan, Michael T.; Drohat, Alexander C.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Drohat, AC (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, 108 N Greene St, Baltimore, MD 21201 USA.	adroh001@umaryland.edu	Maiti, Atanu/E-9968-2012	Drohat, Alex/0000-0002-7458-8770; Maiti, Atanu/0000-0002-9080-1025	National Institutes of Health [R01-GM72711]; University of Maryland Marlene; Stewart Greenebaum Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Marlene; Stewart Greenebaum Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM72711 (to A. C. D.). This work was also supported by the University of Maryland Marlene and Stewart Greenebaum Cancer Center.	Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Bellacosa A, 1999, P NATL ACAD SCI USA, V96, P3969, DOI 10.1073/pnas.96.7.3969; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Berger I, 1998, NUCLEIC ACIDS RES, V26, P2473, DOI 10.1093/nar/26.10.2473; Berti PJ, 2006, CHEM REV, V106, P506, DOI 10.1021/cr040461t; Bianchet MA, 2003, BIOCHEMISTRY-US, V42, P12455, DOI 10.1021/bi035372+; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jiang YL, 2003, BIOCHEMISTRY-US, V42, P1922, DOI 10.1021/bi027014x; Jiang YL, 2002, J BIOL CHEM, V277, P15385, DOI 10.1074/jbc.M200634200; Jiang YL, 2002, BIOCHEMISTRY-US, V41, P11236, DOI 10.1021/bi026226r; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Leatherbarrow R, 1998, GRAFIT 5 0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; McCann JAB, 2008, J AM CHEM SOC, V130, P5789, DOI 10.1021/ja711363s; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Pfeifer GP, 2000, MUTAT RES-FUND MOL M, V450, P155, DOI 10.1016/S0027-5107(00)00022-1; POZHARSKI E, 2009, PYITC; Privalov PL, 2007, J MOL BIOL, V365, P1, DOI 10.1016/j.jmb.2006.09.059; Przybylski JL, 2009, J PHYS CHEM B, V113, P6533, DOI 10.1021/jp810472q; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; SIBGHATULLAH GP, 1996, BIOCHEMISTRY-US, V35, P12926; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Waters TR, 2000, MUTAT RES-REV MUTAT, V462, P137, DOI 10.1016/S1383-5742(00)00031-4; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; Wilds CJ, 2000, NUCLEIC ACIDS RES, V28, P3625, DOI 10.1093/nar/28.18.3625; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017	53	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36680	36688		10.1074/jbc.M109.062356	http://dx.doi.org/10.1074/jbc.M109.062356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19880517	Green Published, hybrid			2022-12-27	WOS:000272970500068
J	Ryu, HY; Lee, J; Yang, S; Park, H; Choi, S; Jung, KC; Lee, ST; Seong, JK; Han, IO; Oh, ES				Ryu, Heui-Young; Lee, Jiseon; Yang, Sanghwa; Park, Haein; Choi, Sojoong; Jung, Kyeong-Cheon; Lee, Seung-Taek; Seong, Je-Kyung; Han, Inn-Oc; Oh, Eok-Soo			Syndecan-2 Functions as a Docking Receptor for Pro-matrix Metalloproteinase-7 in Human Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELLS; TUMOR INVASION; INTESTINAL TUMORIGENESIS; MESSENGER-RNA; EXPRESSION; MATRILYSIN; METASTASIS; ADHESION; TRANSFORMATION; FIBRONECTIN	Although elevated syndecan-2 expression is known to be crucial for the tumorigenic activity in colon carcinoma cells, how syndecan-2 regulates colon cancer is unclear. In human colon adenocarcinoma tissue samples, we found that both mRNA and protein expression of syndecan-2 were increased, compared with the neighboring normal epithelium, suggesting that syndecan-2 plays functional roles in human colon cancer cells. Consistent with this notion, syndecan-2-overexpressing HT-29 colon adenocarcinoma cells showed enhanced migration/invasion, anchorage-independent growth, and primary tumor formation in nude mice, paralleling their morphological changes into highly tumorigenic cells. In addition, our experiments revealed that syndecan-2 enhanced both expression and secretion of matrix metalloproteinase-7 (MMP-7), directly interacted with pro-MMP-7, and potentiated the enzymatic activity of pro-MMP-7 by activating its processing into the active MMP-7. Collectively, these data strongly suggest that syndecan-2 functions as a docking receptor for pro-MMP-7 in colon cancer cells.	[Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Yang, Sanghwa] Yonsei Univ, Coll Med, Canc Metastasis Res Ctr, Seoul 120749, South Korea; [Jung, Kyeong-Cheon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea; [Lee, Seung-Taek] Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea; [Seong, Je-Kyung] Seoul Natl Univ, Coll Vet Med, Dept Anat & Cell Biol, Seoul 151742, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 400712, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	OhES@ewha.ac.kr	Jung, Kyeong Choen/C-6068-2011	Jung, Kyeong Choen/0000-0002-7741-7184; Lee, Seung-Taek/0000-0001-7300-9784; Seong, Je Kyung/0000-0003-1177-6958	Ministry of Health & Welfare, Republic of Korea [0420070-1]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A090165]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea ( Grant 0420070-1 to E.S.O.) and a grant of the Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea ( Grant A090165).	Anttonen A, 2001, LUNG CANCER, V32, P297, DOI 10.1016/S0169-5002(00)00230-0; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Carey DJ, 1997, BIOCHEM J, V327, P1; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Fingleton BM, 1999, APMIS, V107, P102, DOI 10.1111/j.1699-0463.1999.tb01532.x; Han I, 2004, J MOL HISTOL, V35, P319; Jayson GC, 1999, INT J CANCER, V82, P298, DOI 10.1002/(SICI)1097-0215(19990719)82:2<298::AID-IJC23>3.3.CO;2-0; Kim TM, 2005, CLIN CANCER RES, V11, P79; Kim Y, 2003, ONCOGENE, V22, P826, DOI 10.1038/sj.onc.1206068; Lee KH, 2007, EUR SURG RES, V39, P208, DOI 10.1159/000101452; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Matsuda K, 2001, CANCER RES, V61, P5562; Miyazaki K, 1999, CANCER CHEMOTH PHARM, V43, pS52, DOI 10.1007/s002800051098; Munesue S, 2002, BIOCHEM J, V363, P201, DOI 10.1042/0264-6021:3630201; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Nanki N, 2001, TUMOR BIOL, V22, P390, DOI 10.1159/000050642; Numa F, 2002, INT J ONCOL, V20, P39; Ougolkov AV, 2002, GASTROENTEROLOGY, V122, P60, DOI 10.1053/gast.2002.30306; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Wielockx B, 2004, CYTOKINE GROWTH F R, V15, P111, DOI 10.1016/j.cytogfr.2003.12.001; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Woods A, 1998, MATRIX BIOL, V17, P477, DOI 10.1016/S0945-053X(98)90095-6; YAMAMOTO H, 1994, BIOCHEM BIOPH RES CO, V201, P657, DOI 10.1006/bbrc.1994.1751; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zellweger T, 2003, PROSTATE, V55, P20, DOI 10.1002/pros.10209	34	57	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35692	35701		10.1074/jbc.M109.054254	http://dx.doi.org/10.1074/jbc.M109.054254			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858218	Green Published, hybrid			2022-12-27	WOS:000272645600047
J	Stepanova, E; Wang, MS; Severinov, K; Borukhov, S				Stepanova, Ekaterina; Wang, Minshi; Severinov, Konstantin; Borukhov, Sergei			Early Transcriptional Arrest at Escherichia coli rplN and ompX Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CLEAVAGE FACTORS GREA; IN-VIVO; ELONGATION COMPLEXES; TERNARY COMPLEXES; SIGMA(70) SUBUNIT; DNA-REPLICATION; MECHANISM; INITIATION; VITRO	Bacterial transcription elongation factors GreA and GreB stimulate the intrinsic RNase activity of RNA polymerase (RNAP), thus helping the enzyme to read through pausing and arresting sites on DNA. Gre factors also accelerate RNAP transition from initiation to elongation. Here, we characterized the molecular mechanism by which Gre factors facilitate transcription at two Escherichia coli promoters, PrplN and PompX, that require GreA for optimal in vivo activity. Using in vitro transcription assays, KMnO4 footprinting, and Fe2+-induced hydroxyl radical mapping, we show that during transcription initiation at PrplN and PompX in the absence of Gre factors, RNAP falls into a condition of promoter-proximal transcriptional arrest that prevents production of full-length transcripts both in vitro and in vivo. Arrest occurs when RNAP synthesizes 9-14-nucleotide-long transcripts and backtracks by 5-7 (PrplN) or 2-4 (PompX) nucleotides. Initiation factor sigma(70) contributes to the formation of arrested complexes at both promoters. The signal for promoter-proximal arrest at PrplN is bipartite and requires two elements: the extended -10 promoter element and the initial transcribed region from positions +2 to +6. GreA and GreB prevent arrest at PrplN and PompX by inducing cleavage of the 3'-proximal backtracked portion of RNA at the onset of arrested complex formation and stimulate productive transcription by allowing RNAP to elongate the 5'-proximal transcript cleavage products in the presence of substrates. We propose that promoter-proximal arrest is a common feature of many bacterial promoters and may represent an important physiological target of regulation by transcript cleavage factors.	[Stepanova, Ekaterina; Wang, Minshi; Borukhov, Sergei] Univ Med & Dent New Jersey, Sch Osteopath Med Stratford, Dept Cell Biol, Stratford, NJ 08084 USA; [Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Stepanova, Ekaterina; Severinov, Konstantin] Russian Acad Sci, Inst Biol Gene, Moscow 119334, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences	Borukhov, S (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med Stratford, Dept Cell Biol, 2 Med Ctr Dr,Rm 108B, Stratford, NJ 08084 USA.	s.borukhov@umdnj.edu	Severinov, Konstantin/C-8545-2016; Borukhov, Sergei/AAF-3195-2019	Borukhov, Sergei/0000-0002-3517-3003	National Institutes of Health [GM54098, GM59295]; University of Medicine and Dentistry of New Jersey Research Foundation; Presidium of Russian Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054098, R01GM059295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey Research Foundation; Presidium of Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54098 ( to S. B.) and GM59295 ( to K. S.), by University of Medicine and Dentistry of New Jersey Research Foundation ( to S. B.), and by the Molecular and Cell Biology Program Grant of the Presidium of Russian Academy of Sciences ( to K. S.).	Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; BORUKHOV S, 1993, J BIOL CHEM, V268, P23477; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; FENG GH, 1994, J BIOL CHEM, V269, P22282; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Hatoum A, 2008, MOL MICROBIOL, V68, P17, DOI 10.1111/j.1365-2958.2008.06138.x; HAWLEY DK, 1993, CELL MOL BIOL RES, V39, P339; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; Hsu LM, 2006, BIOCHEMISTRY-US, V45, P8841, DOI 10.1021/bi060247u; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Ko DC, 1998, GENE DEV, V12, P3276, DOI 10.1101/gad.12.20.3276; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Loizos N, 1999, J BIOL CHEM, V274, P23378, DOI 10.1074/jbc.274.33.23378; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Stepanova E, 2007, J BACTERIOL, V189, P8772, DOI 10.1128/JB.00911-07; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; Susa M, 2006, MOL MICROBIOL, V59, P1807, DOI 10.1111/j.1365-2958.2006.05058.x; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	48	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35702	35713		10.1074/jbc.M109.053983	http://dx.doi.org/10.1074/jbc.M109.053983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19854830	hybrid, Green Published			2022-12-27	WOS:000272645600048
J	Meares, GP; Hughes, KJ; Jaimes, KF; Salvatori, AS; Rhodes, CJ; Corbett, JA				Meares, Gordon P.; Hughes, Katherine J.; Jaimes, Kimberly F.; Salvatori, Alison S.; Rhodes, Christopher J.; Corbett, John A.			AMP-activated Protein Kinase Attenuates Nitric Oxide-induced beta-Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; ISLET DESTRUCTION; DNA-DAMAGE; RAT ISLETS; LANGERHANS; INTERLEUKIN-1-BETA; INHIBITION; APOPTOSIS; ENERGY; STRESS	During the initial autoimmune response in type 1 diabetes, islets are exposed to a damaging mix of pro-inflammatory molecules that stimulate the production of nitric oxide by beta-cells. Nitric oxide causes extensive but reversible cellular damage. In response to nitric oxide, the cell activates pathways for functional recovery and adaptation as well as pathways that direct beta-cell death. The molecular events that dictate cellular fate following nitric oxide-induced damage are currently unknown. In this study, we provide evidence that AMPK plays a primary role controlling the response of beta-cells to nitric oxide-induced damage. AMPK is transiently activated by nitric oxide in insulinoma cells and rat islets following IL-1 treatment or by the exogenous addition of nitric oxide. Active AMPK promotes the functional recovery of beta-cell oxidative metabolism and abrogates the induction of pathways that mediate cell death such as caspase-3 activation following exposure to nitric oxide. Overall, these data show that nitric oxide activates AMPK and that active AMPK suppresses apoptotic signaling allowing the beta-cell to recover from nitric oxide-mediated cellular stress.	[Meares, Gordon P.; Corbett, John A.] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Corbett, John A.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Salvatori, Alison S.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63401 USA; [Rhodes, Christopher J.] Univ Chicago, Dept Med, Kovler Diabet Ctr, Chicago, IL 60637 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Saint Louis University; University of Chicago	Meares, GP (corresponding author), Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, SHEL 1271A,1825 Univ Blvd, Birmingham, AL 35294 USA.	mearegp@uab.edu; corbettj@uab.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155	National Institutes of Health-UAB program in Immunology Training [T32AI007051-31A1, R01-DK52194, AI 44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194, R01DK055267] Funding Source: NIH RePORTER	National Institutes of Health-UAB program in Immunology Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health-UAB program in Immunology Training Grant T32AI007051-31A1 (to G.P.M.) and Grants R01-DK52194 and AI 44458 (to J.A.C.).	BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carrasco RA, 2003, BIOTECHNIQUES, V34, P1064, DOI 10.2144/03345dd02; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; CUNNINGHAM JM, 1994, GROWTH REGULAT, V4, P173; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; FEHSEL K, 1993, DIABETES, V42, P496, DOI 10.2337/diabetes.42.3.496; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hohmeier HE, 2003, INT J OBESITY, V27, pS12, DOI 10.1038/sj.ijo.0802493; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; LACY PE, 1991, AM J PATHOL, V138, P1183; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; NybIorn HK, 2008, J MOL ENDOCRINOL, V41, P187, DOI 10.1677/JME-08-0006; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200	41	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3191	3200		10.1074/jbc.M109.047365	http://dx.doi.org/10.1074/jbc.M109.047365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933272	Green Published, hybrid			2022-12-27	WOS:000273829000034
J	Palencia, A; Camara-Artigas, A; Pisabarro, MT; Martinez, JC; Luque, I				Palencia, Andres; Camara-Artigas, Ana; Pisabarro, M. Teresa; Martinez, Jose C.; Luque, Irene			Role of Interfacial Water Molecules in Proline-rich Ligand Recognition by the Src Homology 3 Domain of Abl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN-INTERACTION; SH3 DOMAINS; CRYSTAL-STRUCTURE; BINDING-AFFINITY; ABL-SH3 DOMAIN; FAMILY; THERMODYNAMICS; COMPLEXES; PEPTIDES; TARGETS	The interaction of Abl-Src homology 3 domain (SH3) with the high affinity peptide p41 is the most notable example of the inconsistency existing between the currently accepted description of SH3 complexes and their binding thermodynamic signature. We had previously hypothesized that the presence of interfacial water molecules is partially responsible for this thermodynamic behavior. We present here a thermodynamic, structural, and molecular dynamics simulation study of the interaction of p41 with Abl-SH3 and a set of mutants designed to alter the water-mediated interaction network. Our results provide a detailed description of the dynamic properties of the interfacial water molecules and a molecular interpretation of the thermodynamic effects elicited by the mutations in terms of the modulation of the water-mediated hydrogen bond network. In the light of these results, a new dual binding mechanism is proposed that provides a better description of proline-rich ligand recognition by Abl-SH3 and that has important implications for rational design.	[Palencia, Andres; Martinez, Jose C.; Luque, Irene] Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain; [Palencia, Andres; Martinez, Jose C.; Luque, Irene] Univ Granada, Fac Sci, Inst Biotechnol, E-18071 Granada, Spain; [Camara-Artigas, Ana] Univ Almeria, Dept Phys Chem Biochem & Inorgan Chem, Almeria 04120, Spain; [Pisabarro, M. Teresa] BIOTEC TU Dresden, D-01307 Dresden, Germany	University of Granada; University of Granada; Universidad de Almeria; Technische Universitat Dresden	Luque, I (corresponding author), Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain.	iluque@ugr.es	Martinez, Jose C./J-8721-2012; Pisabarro, M. Teresa/D-4270-2012; Luque, Irene/K-4758-2012; Luque, Inmaculada/K-9464-2014; Palencia, Andrés/F-4257-2017; Camara-Artigas, Ana/M-2252-2019	Martinez, Jose C./0000-0003-2657-2456; Luque, Irene/0000-0003-2757-4779; Luque, Inmaculada/0000-0003-1838-2636; Palencia, Andrés/0000-0002-1805-319X; Camara-Artigas, Ana/0000-0003-2197-726X	Spanish Ministry of Education and Sciences [BIO2006-15517-C02-01, BIO2006-15517-C02-02]; European Union [03-51-5569 INTAS]; Andalusian Government [FQM-171, BIO-292]; Klaus Tschira Stiftung; Spanish Ministry of Education and Sciences; FEBS fellowship	Spanish Ministry of Education and Sciences(Spanish Government); European Union(European Commission); Andalusian Government; Klaus Tschira Stiftung; Spanish Ministry of Education and Sciences(Spanish Government); FEBS fellowship	This work was supported in part by Grants BIO2006-15517-C02-01 and BIO2006-15517-C02-02 from the Spanish Ministry of Education and Sciences, 03-51-5569 INTAS from the European Union, grants to the research teams FQM-171 and BIO-292 from the Andalusian Government, and the Klaus Tschira Stiftung.; Supported by a predoctoral research contract from the Spanish Ministry of Education and Sciences and the recipient of a short term FEBS fellowship. Present address: European Molecular Biology Laboratory, 6 Rue Jules Horowitz, BP 181, 38042 Grenoble, France.	Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Camara-Artigas A, 2007, ACTA CRYSTALLOGR D, V63, P646, DOI 10.1107/S0907444907011109; Casares S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-22; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller SM, 2006, CURR PHARM DESIGN, V12, P529, DOI 10.2174/138161206775474369; Ferreon JC, 2004, BIOCHEMISTRY-US, V43, P7787, DOI 10.1021/bi049752m; Filimonov VV, 1999, BIOPHYS CHEM, V77, P195, DOI 10.1016/S0301-4622(99)00025-3; Garcia-Sosa AT, 2003, J MOL MODEL, V9, P172, DOI 10.1007/s00894-003-0129-x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lafont V, 2007, CHEM BIOL DRUG DES, V69, P413, DOI 10.1111/j.1747-0285.2007.00519.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; Li Z, 2005, J PHYS CHEM B, V109, P662, DOI 10.1021/jp0477912; Luque I, 2002, PROTEINS, V49, P181, DOI 10.1002/prot.10208; Mayer BJ, 2001, J CELL SCI, V114, P1253; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Oneyama C, 2003, CHEM BIOL, V10, P443, DOI 10.1016/S1074-5521(03)00101-7; Palencia A, 2004, J MOL BIOL, V336, P527, DOI 10.1016/j.jmb.2003.12.030; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Posern G, 1998, ONCOGENE, V16, P1903, DOI 10.1038/sj.onc.1201714; Raymer ML, 1997, J MOL BIOL, V265, P445, DOI 10.1006/jmbi.1996.0746; Renzoni DA, 1996, BIOCHEMISTRY-US, V35, P15646, DOI 10.1021/bi9620969; Sadqi M, 1999, BIOCHEMISTRY-US, V38, P8899, DOI 10.1021/bi990413g; Sharrow SD, 2005, PROTEIN SCI, V14, P249, DOI 10.1110/ps.04912605; Teyra J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-104; Teyra J, 2007, PROTEINS, V67, P1087, DOI 10.1002/prot.21394; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Velazquez-Campoy A, 2001, THERMOCHIM ACTA, V380, P217, DOI 10.1016/S0040-6031(01)00671-2; Vidal M, 2001, CRIT REV ONCOL HEMAT, V40, P175, DOI 10.1016/S1040-8428(01)00142-1; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P2142, DOI 10.1021/bi00174a022; Wang CY, 2001, J MOL BIOL, V313, P873, DOI 10.1006/jmbi.2001.5083; WITTEKIND M, 1994, BIOCHEMISTRY-US, V33, P13531, DOI 10.1021/bi00250a004	40	25	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2823	2833		10.1074/jbc.M109.048033	http://dx.doi.org/10.1074/jbc.M109.048033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19906645	Green Published, hybrid			2022-12-27	WOS:000273697800058
J	Bunch, TA				Bunch, Thomas A.			Integrin alpha IIb beta 3 Activation in Chinese Hamster Ovary Cells and Platelets Increases Clustering Rather than Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-LIKE DOMAIN; CONFORMATIONAL-CHANGE; FIBRINOGEN RECEPTOR; STRUCTURAL BASIS; LIGAND-BINDING; LIVING CELLS; GPIIB-IIIA; TALIN; ALPHA(IIB)BETA(3); AGGREGATION	Integrin alpha III beta 3 affinity regulation by talin binding to the cytoplasmic tail of beta 3 is a generally accepted model for explaining activation of this integrin in Chinese hamster ovary cells and human platelets. Most of the evidence for this model comes from the use of multivalent ligands. This raises the possibility that the activation being measured is that of increased clustering of the integrin rather than affinity. Using a newly developed assay that probes integrins on the surface of cells with only monovalent ligands prior to fixation, I do not find increases in affinity of alpha III beta 3 integrins by talin head fragments in Chinese hamster ovary cells, nor do I observe affinity increases in human platelets stimulated with thrombin. Binding to a multivalent ligand does increase in both of these cases. This assay does report affinity increases induced by either Mn2+, a cytoplasmic domain mutant (D723R) in the cytoplasmic domain of beta 3, or preincubation with a peptide ligand. These results reconcile the previously observed differences between talin effects on integrin activation in Drosophila and vertebrate systems and suggest new models for talin regulation of integrin activity in human platelets.	Arizona Canc Ctr, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA	Arizona Center Cancer Care	Bunch, TA (corresponding author), Arizona Canc Ctr, Dept Mol & Cellular Biol, Rm 3951A,1515 N Campbell Ave, Tucson, AZ 85724 USA.	tbunch@email.arizona.edu			National Institutes of Health [R01GM42474]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM42474 (to D. Bower and T. B.).	ABRAMS C, 1994, J BIOL CHEM, V269, P18781; ALBERTS B, 2007, MOL BIOL CELL, P1172; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; Bunch TA, 2006, J BIOL CHEM, V281, P5050, DOI 10.1074/jbc.M508550200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; FROJMOVIC MM, 1991, BLOOD, V78, P369; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Helsten TL, 2008, MOL BIOL CELL, V19, P3589, DOI 10.1091/mbc.E08-01-0085; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; ISENBERG WM, 1987, J CELL BIOL, V104, P1655, DOI 10.1083/jcb.104.6.1655; Konstandin MH, 2006, J IMMUNOL METHODS, V310, P67, DOI 10.1016/j.jim.2005.12.005; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MARGUERIE GA, 1980, J BIOL CHEM, V255, P154; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Peerschke EIB, 1999, J LAB CLIN MED, V134, P398, DOI 10.1016/S0022-2143(99)90155-5; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Simmons SR, 1997, ARTERIOSCL THROM VAS, V17, P3311, DOI 10.1161/01.ATV.17.11.3311; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; TAUB R, 1989, J BIOL CHEM, V264, P259; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085	42	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1841	1849		10.1074/jbc.M109.057349	http://dx.doi.org/10.1074/jbc.M109.057349			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19917607	hybrid, Green Published			2022-12-27	WOS:000273429100030
J	Erdmann, F; Weiwad, M; Kilka, S; Karanik, M; Patzel, M; Baumgrass, R; Liebscher, J; Fischer, G				Erdmann, Frank; Weiwad, Matthias; Kilka, Susann; Karanik, Magdalena; Paetzel, Michael; Baumgrass, Ria; Liebscher, Juergen; Fischer, Gunter			The Novel Calcineurin Inhibitor CN585 Has Potent Immunosuppressive Properties in Stimulated Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; PROLYL CIS/TRANS ISOMERASES; KEY SIGNALING ENZYME; CYCLOSPORINE-A; PROTEIN PHOSPHATASES; ESCHERICHIA-COLI; CYCLOPHILIN-A; MECHANISM; DERIVATIVES; SUBSTRATE	The Ca2+/calmodulin-dependent protein phosphatase calcineurin is a key mediator in antigen-specific T cell activation. Thus, inhibitors of calcineurin, such as cyclosporin A or FK506, can block T cell activation and are used as immunosuppressive drugs to prevent graft-versus-host reactions and autoimmune diseases. In this study we describe the identification of 2,6-diaryl-substituted pyrimidine derivatives as a new class of calcineurin inhibitors, obtained by screening of a substance library. By rational design of the parent compound we have attained the derivative 6-(3,4-dichloro-phenyl)-4-(N,N-dimethylaminoethylthio)-2-phenyl-pyrimidine (CN585) that noncompetitively and reversibly inhibits calcineurin activity with a K-i value of 3.8 mu M. This derivative specifically inhibits calcineurin without affecting other Ser/Thr protein phosphatases or peptidyl prolyl cis/trans isomerases. CN585 shows potent immunosuppressive effects by inhibiting NFAT nuclear translocation and transactivation, cytokine production, and T cell proliferation. Moreover, the calcineurin inhibitor exhibits no cytotoxicity in the effective concentration range. Therefore, calcineurin inhibition by CN585 may represent a novel promising strategy for immune intervention.	[Fischer, Gunter] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany; [Karanik, Magdalena; Paetzel, Michael; Liebscher, Juergen] Humboldt Univ, Dept Chem, D-12489 Berlin, Germany; [Baumgrass, Ria] Deutsch Rheuma Forschungszentrum Berlin, D-10117 Berlin, Germany	Max Planck Society; Humboldt University of Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)		erdmann@enzyme-halle.mpg.de	Liebscher, Jürgen/R-1689-2019; Erdmann, Frank/AAF-1091-2021; Liebscher, Jürgen/A-8964-2012	Liebscher, Jürgen/0000-0002-1802-5543; Erdmann, Frank/0000-0001-5261-0984; Liebscher, Jürgen/0000-0002-1802-5543; Baumgrass, Ria/0000-0002-3289-1608	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft.	Arora PD, 2001, J BIOL CHEM, V276, P14100, DOI 10.1074/jbc.M010298200; Ban M, 1998, BIOORGAN MED CHEM, V6, P1057, DOI 10.1016/S0968-0896(98)00064-9; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Baumgrass R, 2001, J BIOL CHEM, V276, P47914, DOI 10.1074/jbc.M103273200; Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brill GM, 1996, J ANTIBIOT, V49, P124, DOI 10.7164/antibiotics.49.124; Caramelo C, 2004, NEPHROL DIAL TRANSPL, V19, P285, DOI 10.1093/ndt/gfg516; Carruthers NJ, 2006, FASEB J, V20, pA1123; Ciancio G, 2000, Expert Opin Pharmacother, V1, P1307, DOI 10.1517/14656566.1.7.1307; CIRILLO R, 1995, BRIT J PHARMACOL, V114, P1117, DOI 10.1111/j.1476-5381.1995.tb13323.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CLIPSTONE NA, 1994, J BIOL CHEM, V269, P26431; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Dlugosz A, 1996, FARMACO, V51, P367; Enz A, 1997, BIOORG MED CHEM LETT, V7, P2513, DOI 10.1016/S0960-894X(97)10005-1; Enz A, 1997, BIOCHEM PHARMACOL, V54, P321, DOI 10.1016/S0006-2952(97)00175-5; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gualberto A, 1998, J BIOL CHEM, V273, P7088, DOI 10.1074/jbc.273.12.7088; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; Hong F, 2004, BIOCHEM BIOPH RES CO, V316, P1073, DOI 10.1016/j.bbrc.2004.02.160; Hong F, 2002, FASEB J, V16, P1633, DOI 10.1096/fj.02-0060fje; HOWS JM, 1983, BRIT J HAEMATOL, V54, P69, DOI 10.1111/j.1365-2141.1983.tb02068.x; IWATANI Y, 1982, J IMMUNOL METHODS, V54, P31, DOI 10.1016/0022-1759(82)90110-7; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jindal RM, 1997, DRUG SAFETY, V16, P242, DOI 10.2165/00002018-199716040-00002; Kilka S, 2009, BIOCHEMISTRY-US, V48, P1900, DOI 10.1021/bi8019355; KLINTMALM G, 1984, LANCET, V2, P950; Kolar F, 1996, MOL CELL BIOCHEM, V164, P253, DOI 10.1007/BF00408666; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; LOHSE DL, 1995, STRUCTURE, V3, P987, DOI 10.1016/S0969-2126(01)00234-9; Mai A, 2005, BIOORGAN MED CHEM, V13, P2065, DOI 10.1016/j.bmc.2005.01.005; Martin BL, 1998, BIOCHEM PHARMACOL, V56, P483, DOI 10.1016/S0006-2952(98)00181-6; Miskin JE, 1998, SCIENCE, V281, P562, DOI 10.1126/science.281.5376.562; Mokroz MJ, 1995, ARCH PHARM, V328, P659, DOI 10.1002/ardp.19953280906; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Moore R, 2001, DRUG SAFETY, V24, P755, DOI 10.2165/00002018-200124100-00004; Nakayama GR, 1998, J BIOMOL SCREEN, V3, P43, DOI 10.1177/108705719800300106; NITTA Y, 1965, CHEM PHARM BULL, V13, P901; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Quintela JM, 1998, BIOORGAN MED CHEM, V6, P1911, DOI 10.1016/S0968-0896(98)00150-3; REGO A, 1990, J PHARMACOL EXP THER, V254, P799; Reis F, 2009, TRANSPL P, V41, P868, DOI 10.1016/j.transproceed.2009.02.005; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Shah AK, 1999, CLIN NEUROPHARMACOL, V22, P67, DOI 10.1097/00002826-199903000-00001; SOLDIN SJ, 1993, THER DRUG MONIT, V15, P468, DOI 10.1097/00007691-199312000-00002; Sullivan E, 1997, J BIOMOL SCREEN, V2, P19, DOI 10.1177/108705719700200105; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Thiel A, 1999, ARTHRITIS RES, V1, P25, DOI 10.1186/ar7; Tradler T, 1997, FEBS LETT, V407, P184, DOI 10.1016/S0014-5793(97)00345-1; TUNG HYL, 1985, EUR J BIOCHEM, V148, P253, DOI 10.1111/j.1432-1033.1985.tb08833.x; Wang H, 2008, IUBMB LIFE, V60, P549, DOI 10.1002/iub.94; Wang WG, 2005, CANCER BIOL THER, V4, P893, DOI 10.4161/cbt.4.8.2134	65	24	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1888	1898		10.1074/jbc.M109.024844	http://dx.doi.org/10.1074/jbc.M109.024844			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923214	Green Published, hybrid			2022-12-27	WOS:000273429100035
J	Steinberg, F; Zhuang, L; Beyeler, M; Kalin, RE; Mullis, PE; Brandli, AW				Steinberg, Florian; Zhuang, Lei; Beyeler, Michael; Kaelin, Roland E.; Mullis, Primus E.; Braendli, Andre W.			The FGFRL1 Receptor Is Shed from Cell Membranes, Binds Fibroblast Growth Factors (FGFs), and Antagonizes FGF Signaling in Xenopus Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN SYNDROME; GENE-EXPRESSION; MESODERM; IDENTIFICATION; INACTIVATION; RESPONSES; FAMILY; MOUSE	FGFRL1 (fibroblast growth factor receptor like 1) is the fifth and most recently discovered member of the fibroblast growth factor receptor (FGFR) family. With up to 50% amino acid similarity, its extracellular domain closely resembles that of the four conventional FGFRs. Its intracellular domain, however, lacks the split tyrosine kinase domain needed for FGF-mediated signal transduction. During embryogenesis of the mouse, FGFRL1 is essential for the development of parts of the skeleton, the diaphragm muscle, the heart, and the metanephric kidney. Since its discovery, it has been hypothesized that FGFRL1 might act as a decoy receptor for FGF ligands. Here we present several lines of evidence that support this notion. We demonstrate that the FGFRL1 ectodomain is shed from the cell membrane of differentiating C2C12 myoblasts and from HEK293 cells by an as yet unidentified protease, which cuts the receptor in the membrane-proximal region. As determined by ligand dot blot analysis, cell-based binding assays, and surface plasmon resonance analysis, the soluble FGFRL1 ectodomain as well as the membrane-bound receptor are capable of binding to some FGF ligands with high affinity, including FGF2, FGF3, FGF4, FGF8, FGF10, and FGF22. We furthermore show that ectopic expression of FGFRL1 in Xenopus embryos antagonizes FGFR signaling during early development. Taken together, our data provide strong evidence that FGFRL1 is indeed a decoy receptor for FGFs.	[Steinberg, Florian; Zhuang, Lei; Beyeler, Michael; Braendli, Andre W.] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Braendli, Andre W.] Univ Hosp Bern, Dept Rheumatol, CH-3010 Bern, Switzerland; [Mullis, Primus E.] Univ Childrens Hosp, Dept Pediat, CH-3010 Bern, Switzerland; [Kaelin, Roland E.; Mullis, Primus E.] ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Brandli, AW (corresponding author), Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland.	beat.trueb@dkf.unibe.ch	Trueb, Beat/AAL-9621-2020; Brandli, Andre/N-1620-2013; Kälin, Roland/AAG-9161-2020	Trueb, Beat/0000-0001-8684-6856; Brandli, Andre/0000-0002-8932-3644; 	Swiss National Science Foundation [31003A0-113806, 31003A-127046, 3100A0-101964]; European Community [LSHG-CT-2004-005085]; Swiss Foundation for Research on Muscular Diseases	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); Swiss Foundation for Research on Muscular Diseases	This work was supported by Swiss National Science Foundation Grants 31003A0-113806, 31003A-127046, and 3100A0-101964; European Community Grant LSHG-CT-2004-005085; and funds from the Swiss Foundation for Research on Muscular Diseases.	AMAYA E, 1993, DEVELOPMENT, V118, P477; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Armand AS, 2006, BBA-MOL CELL RES, V1763, P773, DOI 10.1016/j.bbamcr.2006.06.005; Baertschi S, 2007, FEBS J, V274, P6241, DOI 10.1111/j.1742-4658.2007.06143.x; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; BRANDLI AW, 1995, DEV DYNAM, V203, P119; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Catela C, 2009, DIS MODEL MECH, V2, P283, DOI 10.1242/dmm.002287; Engbers H, 2009, EUR J HUM GENET, V17, P129, DOI 10.1038/ejhg.2008.168; GERBER SD, 2009, DEV BIOL IN PRESS; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Hayashi S, 2004, DEV DYNAM, V230, P700, DOI 10.1002/dvdy.20040; Helbling PM, 1999, DEV DYNAM, V216, P361, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<361::AID-DVDY5>3.0.CO;2-W; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Mantovani A, 2003, INT ARCH ALLERGY IMM, V132, P109, DOI 10.1159/000073711; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Miller DL, 2000, MOL CELL BIOL, V20, P2260, DOI 10.1128/MCB.20.6.2260-2268.2000; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rieckmann T, 2009, BBA-MOL BASIS DIS, V1792, P112, DOI 10.1016/j.bbadis.2008.11.006; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Sugi Y, 2003, DEV BIOL, V258, P252, DOI 10.1016/S0012-1606(03)00099-X; Trueb B, 2006, INT J MOL MED, V17, P617; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; von Scheven G, 2006, DEVELOPMENT, V133, P2731, DOI 10.1242/dev.02426; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332; Yu SJ, 2004, LAB INVEST, V84, P1571, DOI 10.1038/labinvest.3700187; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	39	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2193	2202		10.1074/jbc.M109.058248	http://dx.doi.org/10.1074/jbc.M109.058248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920134	Green Published, hybrid			2022-12-27	WOS:000273429100063
J	Vukelic, S; Stojadinovic, O; Pastar, I; Vouthounis, C; Krzyzanowska, A; Das, S; Samuels, HH; Tomic-Canic, M				Vukelic, Sasa; Stojadinovic, Olivera; Pastar, Irena; Vouthounis, Constantinos; Krzyzanowska, Agata; Das, Sharmistha; Samuels, Herbert H.; Tomic-Canic, Marjana			Farnesyl Pyrophosphate Inhibits Epithelialization and Wound Healing through the Glucocorticoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; PERMEABILITY BARRIER DISRUPTION; MESSENGER-RNA LEVELS; BETA-CATENIN; ACTIVATION; APOPTOSIS; STATINS; PATHWAY; SKIN; PHOSPHORYLATION	Farnesyl pyrophosphate (FPP), a key intermediate in the mevalonate pathway and protein farnesylation, can act as an agonist for several nuclear hormone receptors. Here we show a novel mechanism by which FPP inhibits wound healing acting as an agonist for glucocorticoid receptor (GR). Elevation of endogenous FPP by the squalene synthetase inhibitor zaragozic acid A (ZGA) or addition of FPP to the cell culture medium results in activation and nuclear translocation of the GR, a known wound healing inhibitor. We used functional studies to evaluate the effects of FPP on wound healing. Both FPP and ZGA inhibited keratinocyte migration and epithelialization in vitro and ex vivo. These effects were independent of farnesylation and indicate that modulation of FPP levels in skin may be beneficial for wound healing. FPP inhibition of keratinocyte migration and wound healing proceeds, in part, by repression of the keratin 6 gene. Furthermore, we show that the 3-hydroxy-3-methylglutaryl-CoA-reductase inhibitor mevastatin, which blocks FPP formation, not only promotes epithelialization in acute wounds but also reverses the effect of ZGA on activation of the GR and inhibition of epithelialization. We conclude that FPP inhibits wound healing by acting as a GR agonist. Of special interest is that FPP is naturally present in cells prior to glucocorticoid synthesis and that FPP levels can be further altered by the statins. Therefore, our findings may provide a better understanding of the pleiotropic effects of statins as well as molecular mechanisms by which they may accelerate wound healing.	[Tomic-Canic, Marjana] Hosp Special Surg, Tissue Engn Regenerat & Repair Program, New York, NY 10021 USA; [Stojadinovic, Olivera; Pastar, Irena; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Das, Sharmistha; Samuels, Herbert H.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	University of Miami; New York University	Tomic-Canic, M (corresponding author), 1600 NW 10th Ave,RMSB,Rm 2023-A, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	National Institutes of Health [AR45974, NR08029, AG030673, DK16636]; Entertainment Industry Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK016636, R37DK016636, R01DK016636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR008029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Entertainment Industry Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AR45974 (to M. T.-C.), NR08029 (to M. T.-C.), AG030673 (to M. T.-C.), and DK16636 (to H. H. S.). This work was also supported by the Entertainment Industry Foundation (to H. H. S.).	Bauer DC, 2003, OSTEOPOROSIS INT, V14, P273, DOI 10.1007/s00198-002-1323-x; Bitto A, 2008, PHARMACOL RES, V57, P159, DOI 10.1016/j.phrs.2008.01.005; Brem H, 2007, EXP GERONTOL, V42, P523, DOI 10.1016/j.exger.2006.11.018; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Das S, 2007, MOL ENDOCRINOL, V21, P2672, DOI 10.1210/me.2007-0080; FEINGOLD KR, 1982, J LAB CLIN MED, V100, P405; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Fukuyama R, 2004, BIOCHEM BIOPH RES CO, V315, P636, DOI 10.1016/j.bbrc.2004.01.104; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Harris IR, 1997, J INVEST DERMATOL, V109, P783, DOI 10.1111/1523-1747.ep12340962; Harris IR, 2000, J INVEST DERMATOL, V114, P83, DOI 10.1046/j.1523-1747.2000.00822.x; JACKSON SM, 1992, J LIPID RES, V33, P1307; Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1; Kiliccoglu SS, 2007, J TRAUMA, V63, P187, DOI 10.1097/01.TA.0000240974.07999.bc; Lahera V, 2007, CURR MED CHEM, V14, P243, DOI 10.2174/092986707779313381; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pastar Irena, 2008, Surg Technol Int, V17, P105; PROKSCH E, 1990, J CLIN INVEST, V85, P874, DOI 10.1172/JCI114514; Rabkin SW, 2007, CARDIOVASC TOXICOL, V7, P1, DOI 10.1007/s12012-007-0003-7; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; Rego Amália Cínthia Meneses do, 2007, Acta Cir. Bras., V22, P57, DOI 10.1590/S0102-86502007000700012; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Schiefelbein D, 2008, J BIOL CHEM, V283, P15479, DOI 10.1074/jbc.M709841200; Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785; SHEARES BT, 1989, BIOCHEMISTRY-US, V28, P8129, DOI 10.1021/bi00446a025; Skoglund B, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-98; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Takayama S, 2006, J BIOL CHEM, V281, P17856, DOI 10.1074/jbc.M602290200; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; Tomic-Canic M, 2004, DERM CLIN BAS SCI, P25; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Tong HX, 2005, ANAL BIOCHEM, V336, P51, DOI 10.1016/j.ab.2004.09.024; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Weber MS, 2008, CURR TOP MICROBIOL, V318, P313; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Wicke C, 2000, ARCH SURG-CHICAGO, V135, P1265, DOI 10.1001/archsurg.135.11.1265; WOLDA SL, 1988, J BIOL CHEM, V263, P5997; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	44	49	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1980	1988		10.1074/jbc.M109.016741	http://dx.doi.org/10.1074/jbc.M109.016741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19903814	Green Published, hybrid			2022-12-27	WOS:000273429100044
J	Zhuge, R; Bao, RF; Fogarty, KE; Lifshitz, LM				ZhuGe, Ronghua; Bao, Rongfeng; Fogarty, Kevin E.; Lifshitz, Lawrence M.			Ca2+ Sparks Act as Potent Regulators of Excitation-Contraction Coupling in Airway Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED CL-CHANNELS; K+ CHANNEL; CALCIUM SPARKS; BK CHANNELS; RYANODINE RECEPTORS; INWARD CURRENTS; URINARY-BLADDER; BETA-1 SUBUNIT; CELLS; MYOCYTES	Ca2+ sparks are short lived and localized Ca2+ transients resulting from the opening of ryanodine receptors in sarcoplasmic reticulum. These events relax certain types of smooth muscle by activating big conductance Ca2+-activated K+ channels to produce spontaneous transient outward currents (STOCs) and the resultant closure of voltage-dependent Ca2+ channels. But in many smooth muscles from a variety of organs, Ca2+ sparks can additionally activate Ca2+-activated Cl- channels to generate spontaneous transient inward current (STICs). To date, the physiological roles of Ca2+ sparks in this latter group of smooth muscle remain elusive. Here, we show that in airway smooth muscle, Ca2+ sparks under physiological conditions, activating STOCs and STICs, induce biphasic membrane potential transients (BiMPTs), leading to membrane potential oscillations. Paradoxically, BiMPTs stabilize the membrane potential by clamping it within a negative range and prevent the generation of action potentials. Moreover, blocking either Ca2+ sparks or hyperpolarization components of BiMPTs activates voltage-dependent Ca2+ channels, resulting in an increase in global [Ca2+](i) and cell contraction. Therefore, Ca2+ sparks in smooth muscle presenting both STICs and STOCs act as a stabilizer of membrane potential, and altering the balance can profoundly alter the status of excitability and contractility. These results reveal a novel mechanism underlying the control of excitability and contractility in smooth muscle.	[ZhuGe, Ronghua; Bao, Rongfeng] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; [ZhuGe, Ronghua; Bao, Rongfeng; Fogarty, Kevin E.; Lifshitz, Lawrence M.] Univ Massachusetts, Sch Med, Biomed Imaging Grp, Worcester, MA 01655 USA; [Fogarty, Kevin E.; Lifshitz, Lawrence M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zhuge, R (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.	Ronghua.zhuge@umassmed.edu			National Institutes of Health [HL73875]; American Heart Association; Charles Hood Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Charles Hood Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL73875. This work was also supported by the American Heart Association and Charles Hood Foundation.	Algara-Suarez P, 2007, AM J PHYSIOL-LUNG C, V293, pL191, DOI 10.1152/ajplung.00485.2006; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; Bao R, 2008, J GEN PHYSIOL, V132, P145, DOI 10.1085/jgp.200709933; BECKER PL, 1987, AM J PHYSIOL, V253, pC613, DOI 10.1152/ajpcell.1987.253.4.C613; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burdyga T, 2005, NATURE, V436, P559, DOI 10.1038/nature03834; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Chipperfield AR, 2000, PROG BIOPHYS MOL BIO, V74, P175, DOI 10.1016/S0079-6107(00)00024-9; Drummond RM, 1999, J PHYSIOL-LONDON, V516, P139, DOI 10.1111/j.1469-7793.1999.139aa.x; Eghbali M, 2003, J BIOL CHEM, V278, P45311, DOI 10.1074/jbc.M306564200; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Herrera GM, 2001, AM J PHYSIOL-CELL PH, V280, pC481, DOI 10.1152/ajpcell.2001.280.3.C481; Janssen LJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1161, DOI 10.1152/ajplung.00452.2001; JANSSEN LJ, 1994, PFLUG ARCH EUR J PHY, V427, P473, DOI 10.1007/BF00374263; Karkanis T, 2003, J APPL PHYSIOL, V94, P301, DOI 10.1152/japplphysiol.00660.2002; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Ohi Y, 2001, J PHYSIOL-LONDON, V534, P313, DOI 10.1111/j.1469-7793.2001.t01-3-00313.x; OTTOLIA M, 1994, BIOPHYS J, V67, P2272, DOI 10.1016/S0006-3495(94)80712-X; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Rubart M, 1996, J GEN PHYSIOL, V107, P459, DOI 10.1085/jgp.107.4.459; Sausbier M, 2007, FASEB J, V21, P812, DOI 10.1096/fj.06-7167com; Snetkov VA, 1999, EXP PHYSIOL, V84, P835, DOI 10.1111/j.1469-445X.1999.01887.x; VANHELDEN DF, 1993, J PHYSIOL-LONDON, V471, P465, DOI 10.1113/jphysiol.1993.sp019910; WANG Q, 1992, J PHYSIOL-LONDON, V451, P525, DOI 10.1113/jphysiol.1992.sp019177; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wang YX, 1997, AM J PHYSIOL-CELL PH, V272, pC1151, DOI 10.1152/ajpcell.1997.272.4.C1151; YAGI S, 1988, P NATL ACAD SCI USA, V85, P4109, DOI 10.1073/pnas.85.11.4109; ZhuGe R, 2000, J GEN PHYSIOL, V116, P845, DOI 10.1085/jgp.116.6.845; ZhuGe R, 2002, J GEN PHYSIOL, V120, P15, DOI 10.1085/jgp.20028571; ZhuGe RH, 2004, AM J PHYSIOL-CELL PH, V287, pC1577, DOI 10.1152/ajpcell.00153.2004; ZhuGe RH, 1998, J PHYSIOL-LONDON, V513, P711, DOI 10.1111/j.1469-7793.1998.711ba.x	34	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2203	2210		10.1074/jbc.M109.067546	http://dx.doi.org/10.1074/jbc.M109.067546			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920135	Green Published, hybrid			2022-12-27	WOS:000273429100064
J	Hammel, M; Yu, YP; Mahaney, BL; Cai, B; Ye, RQ; Phipps, BM; Rambo, RP; Hura, GL; Pelikan, M; So, S; Abolfath, RM; Chen, DJ; Lees-Miller, SP; Tainer, JA				Hammel, Michal; Yu, Yaping; Mahaney, Brandi L.; Cai, Brandon; Ye, Ruiqiong; Phipps, Barry M.; Rambo, Robert P.; Hura, Greg L.; Pelikan, Martin; So, Sairei; Abolfath, Ramin M.; Chen, David J.; Lees-Miller, Susan P.; Tainer, John A.			Ku and DNA-dependent Protein Kinase Dynamic Conformations and Assembly Regulate DNA Binding and the Initial Non-homologous End Joining Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; X-RAY-SCATTERING; CATALYTIC SUBUNIT; 3-DIMENSIONAL STRUCTURE; PHOSPHORYLATION SITES; IN-VIVO; AUTOPHOSPHORYLATION; PKCS; DOMAIN; HETERODIMER	DNA double strand break (DSB) repair by non-homologous end joining (NHEJ) is initiated by DSB detection by Ku70/80 (Ku) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) recruitment, which promotes pathway progression through poorly defined mechanisms. Here, Ku and DNA-PKcs solution structures alone and in complex with DNA, defined by x-ray scattering, reveal major structural reorganizations that choreograph NHEJ initiation. The Ku80 C-terminal region forms a flexible arm that extends from the DNA-binding core to recruit and retain DNA-PKcs at DSBs. Furthermore, Ku- and DNA-promoted assembly of a DNA-PKcs dimer facilitates transautophosphorylation at the DSB. The resulting site-specific autophosphorylation induces a large conformational change that opens DNA-PKcs and promotes its release from DNA ends. These results show how protein and DNA interactions initiate large Ku and DNA-PKcs rearrangements to control DNA-PK biological functions as a macromolecular machine orchestrating assembly and disassembly of the initial NHEJ complex on DNA.	[Hammel, Michal; Rambo, Robert P.; Hura, Greg L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol Biol, Phys Biosci Div, Berkeley, CA 94720 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol Biol, Div Life Sci, Berkeley, CA 94720 USA; [Yu, Yaping; Mahaney, Brandi L.; Cai, Brandon; Ye, Ruiqiong; Phipps, Barry M.; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Yu, Yaping; Mahaney, Brandi L.; Cai, Brandon; Ye, Ruiqiong; Phipps, Barry M.; Lees-Miller, Susan P.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Pelikan, Martin] Univ Missouri, Dept Math & Comp Sci, St Louis, MO 63121 USA; [So, Sairei; Abolfath, Ramin M.; Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Tainer, John A.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Calgary; University of Calgary; University of Missouri System; University of Missouri Saint Louis; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute	Hammel, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol Biol, Phys Biosci Div, Berkeley, CA 94720 USA.	mhammel@lbl.gov; leesmill@ucalgary.ca	Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020; Phipps, Barry M/F-2388-2013; Pelikan, Martin/A-8547-2012	Tainer, John/0000-0003-1659-2429; Lees-Miller, Susan/0000-0001-5809-2516; Hura, Greg/0000-0003-0501-8464; Hammel, Michal/0000-0002-5610-9289	National Institutes of Health Structural Cell Biology of DNA Repair Machines P01 [CA92584]; Canadian Institutes of Health Research [13639]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health Structural Cell Biology of DNA Repair Machines P01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or in part, by National Institutes of Health Structural Cell Biology of DNA Repair Machines P01 Grant CA92584 (to J.A.T., G.L.H., and S.P.L.-M.). This work was also supported by Canadian Institutes of Health Research Grant 13639 (to S.P.L.-M.).	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernstein NK, 2009, NUCLEIC ACIDS RES, V37, P6161, DOI 10.1093/nar/gkp597; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chiu CY, 1998, J MOL BIOL, V284, P1075, DOI 10.1006/jmbi.1998.2212; Convery E, 2005, P NATL ACAD SCI USA, V102, P1345, DOI 10.1073/pnas.0406466102; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Forster F, 2008, J MOL BIOL, V382, P1089, DOI 10.1016/j.jmb.2008.07.074; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Guinier A., 1955, SMALL ANGLE SCATTERI; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, P16; Harris R, 2004, J MOL BIOL, V335, P573, DOI 10.1016/j.jmb.2003.10.047; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hopfner KP, 2002, CURR OPIN STRUC BIOL, V12, P115, DOI 10.1016/S0959-440X(02)00297-X; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jovanovic M, 2006, NUCLEIC ACIDS RES, V34, P1112, DOI 10.1093/nar/gkj504; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Mo XM, 2002, MOL CELL BIOL, V22, P8088, DOI 10.1128/MCB.22.22.8088-8099.2002; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; PAILLARD S, 1993, PROTEINS, V15, P330, DOI 10.1002/prot.340150310; Pawelczak KS, 2008, NUCLEIC ACIDS RES, V36, P4022, DOI 10.1093/nar/gkn344; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Shin DS, 2004, DNA REPAIR, V3, P863, DOI 10.1016/j.dnarep.2004.03.022; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Zhang ZM, 2004, STRUCTURE, V12, P495, DOI 10.1016/j.str.2004.02.007; Zhang ZM, 2001, J BIOL CHEM, V276, P38231; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	61	157	165	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1414	1423		10.1074/jbc.M109.065615	http://dx.doi.org/10.1074/jbc.M109.065615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19893054	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000273258200061
J	Liang, KW; Yang, LQ; Yin, C; Xiao, ZM; Zhang, JJ; Liu, YM; Huang, J				Liang, Kaiwei; Yang, Liuqing; Yin, Chen; Xiao, Zhimin; Zhang, Junjian; Liu, Yumin; Huang, Jian			Estrogen Stimulates Degradation of beta-Amyloid Peptide by Up-regulating Neprilysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; RECEPTOR-ALPHA; A-BETA; MESSENGER-RNA; DEGRADING ENZYMES; OLDER WOMEN; RAT-BRAIN; EXPRESSION; NEURONS; CELLS	Postmenopausal estrogen depletion is a characterized risk factor for Alzheimer disease (AD), a human disorder linked to high levels of beta-amyloid peptide (A beta) in brain tissue. Previous studies suggest that estrogen negatively regulates the level of A beta in the brain, but the molecular mechanism is unknown. Here, we provide evidence that estrogen promotes A beta degradation mainly through a principal A beta degrading enzyme, neprilysin, in neuroblastoma SH-SY5Y cells. We also demonstrate that up-regulation of neprilysin by estrogen is dependent on both estrogen receptor alpha and beta (ER alpha and ER beta), and ligand-activated ER regulates expression of neprilysin through physical interactions between ER and estrogen response elements (EREs) identified in the neprilysin gene. These results were confirmed by in vitro gel shift and in vivo chromatin immunoprecipitation analyses, which demonstrate specific binding of ER alpha and ER beta to two putative EREs in the neprilysin gene. The EREs also enhance ER alpha- and ER beta-dependent reporter gene expression in a yeast model system. Therefore, the study described here provides a putative mechanism by which estrogen positively regulates expression of neprilysin to promote degradation of A beta, reducing risk for AD. These results may lead to novel approaches to prevent or treat AD.	[Liang, Kaiwei; Yang, Liuqing; Yin, Chen; Xiao, Zhimin; Huang, Jian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China; [Zhang, Junjian; Liu, Yumin] Wuhan Univ, Dept Neurol, Zhongnan Hosp, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Huang, J (corresponding author), Wuhan Univ, Coll Life Sci, Rm 5105, Wuhan 430072, Hubei, Peoples R China.	jianhuang@whu.edu.cn		Xiao, Zhimin/0000-0003-4843-9736; Liang, Kaiwei/0000-0002-6021-353X	Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry of China [2004527]; National Basic Science Foundation for Talent Education [J0630648]; National Natural Science Foundation of China [30670647, 30970914]	Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry of China(Ministry of Education, China); National Basic Science Foundation for Talent Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China Grant 2004527, National Basic Science Foundation for Talent Education Grant J0630648, and National Natural Science Foundation of China Grants 30670647 and 30970914.	Bang OY, 2004, NEUROBIOL DIS, V16, P21, DOI 10.1016/j.nbd.2003.12.017; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Brandi ML, 1999, BIOCHEM BIOPH RES CO, V265, P335, DOI 10.1006/bbrc.1999.1665; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Fisk L, 2007, NEUROCHEM RES, V32, P1741, DOI 10.1007/s11064-007-9349-2; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Hellstrom-Lindahl E, 2008, NEUROBIOL AGING, V29, P210, DOI 10.1016/j.neurobiolaging.2006.10.010; Huang J, 2004, NEUROSCI LETT, V367, P85, DOI 10.1016/j.neulet.2004.05.085; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kim H, 2001, NEUROSCI LETT, V302, P58, DOI 10.1016/S0304-3940(01)01659-7; Liang KW, 2009, MOL BIOTECHNOL, V41, P53, DOI 10.1007/s12033-008-9097-9; Marr RA, 2003, J NEUROSCI, V23, P1992; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pirskanen M, 2005, EUR J HUM GENET, V13, P1000, DOI 10.1038/sj.ejhg.5201447; Rissman EF, 2002, P NATL ACAD SCI USA, V99, P3996, DOI 10.1073/pnas.012032699; Schupf N, 2008, DEMENT GERIATR COGN, V25, P476, DOI 10.1159/000126495; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Shughrue PJ, 1998, ENDOCRINOLOGY, V139, P5267, DOI 10.1210/en.139.12.5267; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Sun M, 2001, CANCER RES, V61, P5985; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Treeck O, 2007, J ENDOCRINOL, V193, P421, DOI 10.1677/JOE-07-0087; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yaffe K, 2002, BIOL PSYCHIAT, V51, P677, DOI 10.1016/S0006-3223(01)01289-6; Yamaguchi-Shima N, 2007, BRAIN RES, V1155, P34, DOI 10.1016/j.brainres.2007.04.016; Yao MZ, 2008, J NEUROCHEM, V105, P2477, DOI 10.1111/j.1471-4159.2008.05341.x; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066	43	76	81	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					935	942		10.1074/jbc.M109.051664	http://dx.doi.org/10.1074/jbc.M109.051664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897485	hybrid, Green Published			2022-12-27	WOS:000273258200013
J	Kaspar, JW; Jaiswal, AK				Kaspar, James W.; Jaiswal, Anil K.			Antioxidant-induced Phosphorylation of Tyrosine 486 Leads to Rapid Nuclear Export of Bach1 That Allows Nrf2 to Bind to the Antioxidant Response Element and Activate Defensive Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR BACH1; HEME OXYGENASE-1 GENE; LOCUS-CONTROL REGION; SMALL MAF; INDUCTION; DEGRADATION; FACTOR-2; CLONING; FAMILY	Antioxidants cause stabilization and nuclear translocation of NF-E2-related factor 2 (Nrf2), where it binds to the antioxidant response element (ARE) and induces up-regulation of defensive genes that protect cells against oxidative and electrophilic stress. Bach1, the negative regulator of Nrf2, competes with Nrf2 for binding to the ARE in the human NQO1 promoter. In this study, we demonstrate that Bach1 exits the nucleus within 1-2 h upon antioxidant treatment. Genistein, an inhibitor of tyrosine kinases, blocked nuclear export of Bach1. Site-directed mutagenesis and immunoprecipitation assays identified tyrosine 486 that was phosphorylated in response to the antioxidant and was essential for nuclear export of Bach1. Chromatin immunoprecipitation assays revealed a competitive interplay between Bach1 and Nrf2 at 1-2 and 4 h for binding to the human NQO1 ARE. Luciferase and real time PCR assays showed a significant decrease in antioxidant induction of reporter activity and mRNA levels in cells transfected with mutant Bach1 compared with wild type. This decrease was due to the absence of nuclear export of the mutant protein. Bach1 levels inside the nucleus returned to normal at 4 h after antioxidant treatment in the absence but not in the presence of protein synthesis inhibitor cycloheximide. In addition, antioxidant treatment increased the transcription of Bach1 as shown by pulse chase and real time PCR experiments. Taken together, these results indicate that increased synthesis of Bach1 restored its nuclear levels to normal at 4 h. In conclusion, antioxidant-induced tyrosine 486 phosphorylation leads to nuclear exit of Bach1, thus allowing Nrf2 access to the ARE.	[Kaspar, James W.; Jaiswal, Anil K.] Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Dept Pharmacol & Expt Therapeut, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu			National Institutes of Health [R01 GM047466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM047466.	CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHOI SY, 1996, J PARODONTOL IMPLANT, V15, P19; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dohl Y, 2006, ANTIOXID REDOX SIGN, V8, P60, DOI 10.1089/ars.2006.8.60; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; MOHLER J, 1991, MECH DEVELOP, V34, P3, DOI 10.1016/0925-4773(91)90086-L; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Tembe V, 2007, CELL SIGNAL, V19, P1113, DOI 10.1016/j.cellsig.2007.03.001; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	25	93	103	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					153	162		10.1074/jbc.M109.040022	http://dx.doi.org/10.1074/jbc.M109.040022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19897490	Green Published, hybrid			2022-12-27	WOS:000273070100016
J	Kubota, C; Torii, S; Hou, N; Saito, N; Yoshimoto, Y; Imai, H; Takeuchi, T				Kubota, Chisato; Torii, Seiji; Hou, Ni; Saito, Nobuhito; Yoshimoto, Yuhei; Imai, Hideaki; Takeuchi, Toshiyuki			Constitutive Reactive Oxygen Species Generation from Autophagosome/Lysosome in Neuronal Oxidative Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; STRESS; GLUTAMATE; ACTIVATION; AUTOPHAGY; IRON; DEGRADATION; EBSELEN; KINASE; MITOCHONDRIA	Reactive oxygen species (ROS) are involved in several cell death processes, including cerebral ischemic injury. We found that glutamate-induced ROS accumulation and the associated cell death in mouse hippocampal cell lines were delayed by pharmacological inhibition of autophagy or lysosomal activity. Glutamate, however, did not stimulate autophagy, which was assessed by a protein marker, LC3, and neither changes in organization of mitochondria nor lysosomal membrane permeabilization were observed. Fluorescent analyses by a redox probe PF-H(2)TMRos revealed that autophagosomes and/or lysosomes are the major sites for basal ROS generation in addition to mitochondria. Treatments with inhibitors for autophagy and lysosomes decreased their basal ROS production and caused a burst of mitochondrial ROS to be delayed. On the other hand, attenuation of mitochondrial activity by serum depletion or by high cell density culture resulted in the loss of both constitutive ROS production and an ROS burst in mitochondria. Thus, constitutive ROS production within mitochondria and lysosomes enables cells to be susceptible to glutamate-induced oxidative cytotoxicity. Likewise, inhibitors for autophagy and lysosomes reduced neural cell death in an ischemia model in rats. We suggest that cell injury during periods of ischemia is regulated by ROS-generating activity in autophagosomes and/or lysosomes as well as in mitochondria.	[Torii, Seiji] Gunma Univ, Secret Biol Lab, Inst Mol & Cellular Regulat, Dept Mol Med, Maebashi, Gunma 3718512, Japan; [Kubota, Chisato; Saito, Nobuhito; Yoshimoto, Yuhei; Imai, Hideaki] Gunma Univ, Grad Sch Med, Dept Neurosurg, Maebashi, Gunma 3718512, Japan	Gunma University; Gunma University	Torii, S (corresponding author), Gunma Univ, Secret Biol Lab, Inst Mol & Cellular Regulat, Dept Mol Med, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan.	storii@showa.gunma-u.ac.jp; tstake@showa.gunma-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [22591577] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants-in-aid and the Global Center of Excellence Program from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; Chen SR, 2000, FREE RADICAL BIO MED, V28, P1266, DOI 10.1016/S0891-5849(00)00265-3; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056; Harraz MM, 2008, STROKE, V39, P286, DOI 10.1161/STROKEAHA.107.511857; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Johnson SC, 2005, NEUROLOGY, V64, P654; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Ringleb PA, 2002, STROKE, V33, P1437, DOI 10.1161/01.STR.0000015555.21285.DB; SAKAIDA I, 1990, MOL PHARMACOL, V37, P435; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Satoh T, 2004, NEUROSCI LETT, V371, P1, DOI 10.1016/j.neulet.2004.04.055; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Selim MH, 2004, AGEING RES REV, V3, P345, DOI 10.1016/j.arr.2004.04.001; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Tan SL, 1998, J NEUROCHEM, V71, P95; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Torii S, 2005, TRAFFIC, V6, P1213, DOI 10.1111/j.1600-0854.2005.00353.x; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6	44	112	114	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					667	674		10.1074/jbc.M109.053058	http://dx.doi.org/10.1074/jbc.M109.053058			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19850931	Green Published, hybrid			2022-12-27	WOS:000273070100067
J	Duchardt, F; Ruttekolk, IR; Verdurmen, WPR; Lortat-Jacob, H; Burck, J; Hufnagel, H; Fischer, R; van den Heuvel, M; Lowik, DWPM; Vuister, GW; Ulrich, A; de Waard, M; Brock, R				Duchardt, Falk; Ruttekolk, Ivo R.; Verdurmen, Wouter P. R.; Lortat-Jacob, Hugues; Buerck, Jochen; Hufnagel, Hansjoerg; Fischer, Rainer; van den Heuvel, Maaike; Loewik, Dennis W. P. M.; Vuister, Geerten W.; Ulrich, Anne; de Waard, Michel; Brock, Roland			A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; SOLID-STATE NMR; TACHYPLESIN-I; ANTIMICROBIAL ACTIVITY; HUMAN LACTOTRANSFERRIN; CATIONIC PEPTIDE; PLASMA-MEMBRANE; HOST-DEFENSE; AMINO-ACID	The molecular events that contribute to the cellular uptake of cell-penetrating peptides (CPP) are still a matter of intense research. Here, we report on the identification and characterization of a 22-amino acid CPP derived from the human milk protein, lactoferrin. The peptide exhibits a conformation-dependent uptake efficiency that is correlated with efficient binding to heparan sulfate and lipid-induced conformational changes. The peptide contains a disulfide bridge formed by terminal cysteine residues. At concentrations exceeding 10 mu M, this peptide undergoes the same rapid entry into the cytoplasm that was described previously for the arginine-rich CPPs nona-arginine and Tat. Cytoplasmic entry strictly depends on the presence of the disulfide bridge. To better understand this conformation dependence, NMR spectroscopy was performed for the free peptide, and CD measurements were performed for free and lipid-bound peptide. In solution, the peptides showed only slight differences in secondary structure, with a predominantly disordered structure both in the presence and absence of the disulfide bridge. In contrast, in complex with large unilamellar vesicles, the conformation of the oxidized and reduced forms of the peptide clearly differed. Moreover, surface plasmon resonance experiments showed that the oxidized form binds to heparan sulfate with a considerably higher affinity than the reduced form. Consistently, membrane binding and cellular uptake of the peptide were reduced when heparan sulfate chains were removed.	[Ruttekolk, Ivo R.; Verdurmen, Wouter P. R.; de Waard, Michel] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [Duchardt, Falk; Hufnagel, Hansjoerg; Fischer, Rainer; Brock, Roland] Univ Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Lortat-Jacob, Hugues] Univ Grenoble 1, CEA CNRS, Inst Biol Struct, UMR 5075, F-38027 Grenoble 1, France; [Buerck, Jochen; Ulrich, Anne] Forschungszentrum Karlsruhe, Karlsruhe Inst Technol, D-76131 Karlsruhe, Germany; [van den Heuvel, Maaike; Loewik, Dennis W. P. M.] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Bioorgan Chem, NL-6525 AJ Nijmegen, Netherlands; [Vuister, Geerten W.] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Prot Biophys, NL-6525 AJ Nijmegen, Netherlands; [de Waard, Michel] Univ Grenoble 1, INSERM, Grenoble Neurosci Inst, Grp 3,U836, F-38027 Grenoble 1, France	Radboud University Nijmegen; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Helmholtz Association; Karlsruhe Institute of Technology; Radboud University Nijmegen; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Brock, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 286, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	R.Brock@ncmls.ru.nl	Lowik, Dennis/P-3500-2019; Brock, Roland/O-9411-2019; Ulrich, Anne S/H-5519-2013; De Waard, Michel/G-7406-2014; Brock, Roland/K-2590-2012; Verdurmen, Wouter/H-7457-2016; Lowik, Dennis WPM/D-6913-2012	Lowik, Dennis/0000-0002-9284-837X; Ulrich, Anne S/0000-0001-5571-9483; De Waard, Michel/0000-0002-2782-9615; Brock, Roland/0000-0003-1395-6127; Verdurmen, Wouter/0000-0002-2463-277X; Lowik, Dennis WPM/0000-0002-9284-837X; Vuister, Geerten/0000-0001-6172-5097	Agence Nationale pour la Recherche; Commissariat a l'Energie Atomique; Volkswagen Foundation (Nachwuchsgruppen an Universitaten)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Volkswagen Foundation (Nachwuchsgruppen an Universitaten)(Volkswagen)	Supported by the Agence Nationale pour la Recherche (PNANO program) and the Commissariat a l'Energie Atomique (TIMOMA2 program).; Supported by the Volkswagen Foundation (Nachwuchsgruppen an Universitaten).	BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Buffy JJ, 2003, BIOCHEMISTRY-US, V42, P13725, DOI 10.1021/bi035187w; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Doherty T, 2008, BIOCHEMISTRY-US, V47, P1105, DOI 10.1021/bi701390t; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; ElassRochard E, 1995, BIOCHEM J, V312, P839, DOI 10.1042/bj3120839; Fischer PM, 2001, BIOCONJUGATE CHEM, V12, P825, DOI 10.1021/bc0155115; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Gidwani P, 2008, CHEMOTHERAPY, V54, P120, DOI 10.1159/000118664; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Groenink J, 1999, FEMS MICROBIOL LETT, V179, P217, DOI 10.1016/S0378-1097(99)00414-0; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hallbrink M, 2005, INT J PEPT RES THER, V11, P249, DOI 10.1007/s10989-005-9393-1; Hunter HN, 2005, ANTIMICROB AGENTS CH, V49, P3387, DOI 10.1128/AAC.49.8.3387-3395.2005; Jarvert P, 2007, BIOCHEM SOC T, V35, P770; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; LEGRAND D, 1992, BIOCHEMISTRY-US, V31, P9243, DOI 10.1021/bi00153a018; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; LEVEUGLE B, 1993, EUR J BIOCHEM, V213, P1205, DOI 10.1111/j.1432-1033.1993.tb17871.x; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P9799, DOI 10.1021/bi970588v; METZBOUTIGUE MH, 1984, EUR J BIOCHEM, V145, P659, DOI 10.1111/j.1432-1033.1984.tb08607.x; Nekhotiaeva N, 2003, FASEB J, V17, P394, DOI 10.1096/fj.03-0449fje; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Peterson NA, 2000, BIOCHEMISTRY-US, V39, P6625, DOI 10.1021/bi0001224; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramamoorthy A, 2006, BIOCHEMISTRY-US, V45, P6529, DOI 10.1021/bi052629q; Rojas M, 1998, NAT BIOTECHNOL, V16, P370, DOI 10.1038/nbt0498-370; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Sonnevend A, 2004, PEPTIDES, V25, P29, DOI 10.1016/j.peptides.2003.11.011; Sun XL, 1999, ACTA CRYSTALLOGR D, V55, P403, DOI 10.1107/S0907444998011226; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadhwani P, 2006, J ORG CHEM, V71, P55, DOI 10.1021/jo051519m; Ward PP, 2004, BIOMETALS, V17, P203, DOI 10.1023/B:BIOM.0000027693.60932.26; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29	49	94	105	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36099	36108		10.1074/jbc.M109.036426	http://dx.doi.org/10.1074/jbc.M109.036426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858187	Green Published, hybrid			2022-12-27	WOS:000272970500011
J	Galkin, A; Abramov, AY; Frakich, N; Duchen, MR; Moncada, S				Galkin, Alexander; Abramov, Andrey Y.; Frakich, Nanci; Duchen, Michel R.; Moncada, Salvador			Lack of Oxygen Deactivates Mitochondrial Complex I IMPLICATIONS FOR ISCHEMIC INJURY?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; CYTOCHROME-C-OXIDASE; ACTIVE-INACTIVE TRANSITION; NITRIC-OXIDE; ENZYME TRANSITION; S-NITROSATION; ANAEROBIC METABOLISM; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; INTACT-CELLS	For S-nitrosothiols and peroxynitrite to interfere with the activity of mitochondrial complex I, prior transition of the enzyme from its active (A) to its deactive, dormant (D) state is necessary. We now demonstrate accumulation of the D-form of complex I in human epithelial kidney cells after prolonged hypoxia. Upon reoxygenation after hypoxia there was an initial delay in the return of the respiration rate to normal. This was due to the accumulation of the D-form and its slow, substrate-dependent reconversion to the A-form. Reconversion to the A-form could be prevented by prolonged incubation with endogenously generated NO. We propose that the hypoxic transition from the A-form to the D-form of complex I may be protective, because it would act to reduce the electron burst and the formation of free radicals during reoxygenation. However, this may become an early pathophysiological event when NO-dependent formation of S-nitrosothiols or peroxynitrite structurally modifies complex I in its D-form and impedes its return to the active state. These observations provide a mechanism to account for the severe cell injury that follows hypoxia and reoxygenation when accompanied by NO generation.	[Duchen, Michel R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Galkin, Alexander; Frakich, Nanci; Moncada, Salvador] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Abramov, Andrey Y.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Galkin, A (corresponding author), Queens Univ Belfast, Sch Biol Sci, MBC, Belfast BT9 7BL, Antrim, North Ireland.	a.galkin@qub.ac.uk	Abramov, Andrey/AAC-6712-2019; Abramov, Andrey Y/H-9053-2012; duchen, michael/A-2116-2009	Abramov, Andrey/0000-0002-7646-7235; Abramov, Andrey Y/0000-0002-7646-7235; duchen, michael/0000-0003-2548-4294	MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Andersson U, 1998, BIOCHEM BIOPH RES CO, V249, P512, DOI 10.1006/bbrc.1998.9171; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Borutaite V, 2006, BBA-BIOENERGETICS, V1757, P562, DOI 10.1016/j.bbabio.2006.02.014; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; Budinger GRS, 1998, J BIOL CHEM, V273, P3320, DOI 10.1074/jbc.273.6.3320; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0; CHANCE B, 1988, FEBS LETT, V226, P343, DOI 10.1016/0014-5793(88)81451-0; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; CHAPPELL JB, 1968, BRIT MED BULL, V24, P150, DOI 10.1093/oxfordjournals.bmb.a070618; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cooper CE, 2003, BBA-BIOENERGETICS, V1607, P27, DOI 10.1016/j.bbabio.2003.08.003; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Dezfulian C, 2009, CIRCULATION, V120, P897, DOI 10.1161/CIRCULATIONAHA.109.853267; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P1792, DOI 10.1016/j.biocel.2008.01.012; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Gostimskaya IS, 2006, BBA-BIOENERGETICS, V1757, P1155, DOI 10.1016/j.bbabio.2006.04.016; Gostimskaya IS, 2003, ANAL BIOCHEM, V313, P46, DOI 10.1016/S0003-2697(02)00534-1; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hagos Y, 2004, AM J PHYSIOL-RENAL, V286, pF86, DOI 10.1152/ajprenal.00161.2003; Hollis VS, 2003, BBA-BIOENERGETICS, V1607, P191, DOI 10.1016/j.bbabio.2003.09.012; KIMMICH GA, 1991, AM J PHYSIOL, V260, pC1151, DOI 10.1152/ajpcell.1991.260.6.C1151; Kissner R, 2003, IUBMB LIFE, V55, P567, DOI 10.1080/15216540310001628690; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Lesnefsky EJ, 2006, FASEB J, V20, P1543, DOI 10.1096/fj.05-4535fje; Loskovich MV, 2005, BIOCHEM J, V387, P677, DOI 10.1042/BJ20041703; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2004, FEBS LETT, V556, P64, DOI 10.1016/S0014-5793(03)01369-3; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; Palacios-Callender M, 2007, J CELL SCI, V120, P160, DOI 10.1242/jcs.03308; Park LCH, 1999, J NEUROCHEM, V72, P1948, DOI 10.1046/j.1471-4159.1999.0721948.x; Passarella S, 2003, MITOCHONDRION, V2, P319, DOI 10.1016/S1567-7249(03)00008-4; PASSARELLA S, 1987, NEUROCHEM RES, V12, P255, DOI 10.1007/BF00972135; Pearce LL, 2005, NITRIC OXIDE-BIOL CH, V13, P254, DOI 10.1016/j.niox.2005.07.010; Pich MM, 2004, FEBS LETT, V558, P19, DOI 10.1016/S0014-5793(03)01520-5; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; SANADI DR, 1963, BIOCHEMISTRY-US, V2, P523, DOI 10.1021/bi00903a023; Sanz A, 2006, J BIOENERG BIOMEMBR, V38, P121, DOI 10.1007/s10863-006-9011-8; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; WINGO WJ, 1975, ANAL CHEM, V47, P351, DOI 10.1021/ac60352a009	54	102	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36055	36061		10.1074/jbc.M109.054346	http://dx.doi.org/10.1074/jbc.M109.054346			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861410	hybrid, Green Published			2022-12-27	WOS:000272970500007
J	Niu, WL; Chen, ZW; Bush-Pelc, LA; Bah, A; Gandhi, PS; Di Cera, E				Niu, Weiling; Chen, Zhiwei; Bush-Pelc, Leslie A.; Bah, Alaji; Gandhi, Prafull S.; Di Cera, Enrico			Mutant N143P Reveals How Na+ Activates Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MONO-VALENT CATIONS; SODIUM-BINDING-SITE; RESOLUTION CRYSTAL-STRUCTURES; HUMAN ALPHA-THROMBIN; PLASMA PROTEIN-C; SERINE PROTEASES; FACTOR-XA; CATALYTIC-ACTIVITY; S1 SITE; PROTHROMBINASE COMPLEX	The molecular mechanism of thrombin activation by Na+ remains elusive. Its kinetic formulation requires extension of the classical Botts-Morales theory for the action of a modifier on an enzyme to correctly account for the contribution of the E*, E, and E:Na+ forms. The extended scheme establishes that analysis of k(cat) unequivocally identifies allosteric transduction of Na+ binding into enhanced catalytic activity. The thrombin mutant N143P features no Na+-dependent enhancement of k(cat) yet binds Na+ with an affinity comparable to that of wild type. Crystal structures of the mutant in the presence and absence of Na+ confirm that Pro(143) abrogates the important H-bond between the backbone N atom of residue 143 and the carbonyl O atom of Glu(192), which in turn controls the orientation of the Glu(192)-Gly(193) peptide bond and the correct architecture of the oxyanion hole. We conclude that Na+ activates thrombin by securing the correct orientation of the Glu192-Gly193 peptide bond, which is likely flipped in the absence of cation. Absolute conservation of the 143-192 H-bond in trypsin-like proteases and the importance of the oxyanion hole in protease function suggest that this mechanism of Na+ activation is present in all Na+-activated trypsin-like proteases.	[Niu, Weiling; Chen, Zhiwei; Bush-Pelc, Leslie A.; Bah, Alaji; Gandhi, Prafull S.; Di Cera, Enrico] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231, St Louis, MO 63110 USA.	enrico@wustl.edu	Niu, Weiling/B-2997-2011		National Institutes of Health [HL49413, HL58141, HL73813, HL95315]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058141, R29HL049413, R01HL073813, R01HL049413, R44HL095315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL58141 HL73813, and HL95315 (to E. D. C.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to W. N.)	Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; BANNER DW, 1991, J BIOL CHEM, V266, P20085; Barrette-Ng IH, 2002, J BIOL CHEM, V277, P39960, DOI 10.1074/jbc.M206978200; BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0; Bobofchak KM, 2005, J BIOL CHEM, V280, P25644, DOI 10.1074/jbc.M503499200; BODE W, 1992, PROTEIN SCI, V1, P426; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; Boyer Paul D., 1942, JOUR BIOL CHEM, V146, P673; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Carrell CJ, 2006, BIOPHYS CHEM, V121, P177, DOI 10.1016/j.bpc.2005.12.008; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; COHN M, 1951, BIOCHIM BIOPHYS ACTA, V7, P153, DOI 10.1016/0006-3002(51)90013-3; CURRAGH EF, 1964, BIOCHEM J, V93, P163, DOI 10.1042/bj0930163; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; De Filippis V, 2005, BIOCHEM J, V390, P485, DOI 10.1042/BJ20050252; DEGEN SJF, 1995, THROMB HAEMOSTASIS, V73, P203; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FEHLHAMMER H, 1975, J MOL BIOL, V98, P683, DOI 10.1016/S0022-2836(75)80004-0; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; FERSHT AR, 1972, J MOL BIOL, V64, P497, DOI 10.1016/0022-2836(72)90513-X; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gandhi PS, 2009, J BIOL CHEM, V284, P24098, DOI 10.1074/jbc.M109.025403; Gianni S, 2007, BIOPHYS CHEM, V131, P111, DOI 10.1016/j.bpc.2007.09.009; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; Griffon N, 2001, BIOPHYS CHEM, V90, P89, DOI 10.1016/S0301-4622(01)00129-6; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; Guinto ER, 1996, BIOCHEMISTRY-US, V35, P8800, DOI 10.1021/bi9608828; He XH, 1999, J BIOL CHEM, V274, P4970, DOI 10.1074/jbc.274.8.4970; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henriksen RA, 1998, BLOOD, V91, P2026, DOI 10.1182/blood.V91.6.2026.2026_2026_2031; Hill T.L., 1977, FREE ENERGY TRANSDUC; IBERS JA, 1980, SCIENCE, V209, P223, DOI 10.1126/science.7384796; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; KACHMAR JF, 1953, J BIOL CHEM, V200, P669; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lai MT, 1997, J BIOL CHEM, V272, P30275, DOI 10.1074/jbc.272.48.30275; Levigne S, 2007, J BIOL CHEM, V282, P31569, DOI 10.1074/jbc.M704837200; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Marciano DC, 2008, J MOL BIOL, V384, P151, DOI 10.1016/j.jmb.2008.09.009; MIYATA T, 1992, BIOCHEMISTRY-US, V31, P7457, DOI 10.1021/bi00148a005; Monnaie D, 2000, BIOCHEMISTRY-US, V39, P5349, DOI 10.1021/bi9926781; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NEURATH H, 1957, FED PROC, V16, P791; Nogami K, 2005, J BIOL CHEM, V280, P18476, DOI 10.1074/jbc.M412778200; ORTHNER CL, 1978, ARCH BIOCHEM BIOPHYS, V185, P400, DOI 10.1016/0003-9861(78)90182-0; ORTHNER CL, 1980, ARCH BIOCHEM BIOPHYS, V202, P63, DOI 10.1016/0003-9861(80)90406-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Petrovan RJ, 2000, BIOCHEMISTRY-US, V39, P14457, DOI 10.1021/bi0009486; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200; Reiling KK, 2003, BIOCHEMISTRY-US, V42, P2616, DOI 10.1021/bi020594d; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P1817, DOI 10.1021/bi992006a; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; Rouy S, 2006, BRIT J HAEMATOL, V132, P770, DOI 10.1111/j.1365-2141.2005.05920.x; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Scharer K, 2005, ANGEW CHEM INT EDIT, V44, P4400, DOI 10.1002/anie.200500883; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; Schmidt AE, 2004, J BIOL CHEM, V279, P29485, DOI 10.1074/jbc.M402971200; Schmidt AE, 2002, J BIOL CHEM, V277, P28987, DOI 10.1074/jbc.M201892200; Stanchev H, 2006, THROMB HAEMOSTASIS, V95, P195; STEINER SA, 1985, BIOCHEMISTRY-US, V24, P1136, DOI 10.1021/bi00326a011; STEINER SA, 1982, BIOCHEMISTRY-US, V21, P4609, DOI 10.1021/bi00262a015; STEINER SA, 1985, BIOCHEMISTRY-US, V24, P609, DOI 10.1021/bi00324a011; STEINER SA, 1980, BIOCHEM BIOPH RES CO, V94, P340, DOI 10.1016/S0006-291X(80)80226-9; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Sun WY, 2001, THROMB HAEMOSTASIS, V85, P651, DOI 10.1055/s-0037-1615648; TAINER J A, 1992, Current Opinion in Biotechnology, V3, P378, DOI 10.1016/0958-1669(92)90166-G; Timm DE, 1997, PROTEIN SCI, V6, P1418, DOI 10.1002/pro.5560060706; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; Vindigni A, 1996, BIOCHEMISTRY-US, V35, P4417, DOI 10.1021/bi952834d; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; WORKMAN EF, 1978, ARCH BIOCHEM BIOPHYS, V185, P544, DOI 10.1016/0003-9861(78)90199-6; Yun TH, 2003, J BIOL CHEM, V278, P48112, DOI 10.1074/jbc.M306925200; Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200	105	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36175	36185		10.1074/jbc.M109.069500	http://dx.doi.org/10.1074/jbc.M109.069500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846563	Green Published, hybrid			2022-12-27	WOS:000272970500019
J	Shih, PC; Yang, MS; Lin, SC; Ho, Y; Hsiao, JC; Wang, DR; Yu, SSF; Chang, W; Tzou, DLM				Shih, Ping-Chen; Yang, Min-Shiang; Lin, Su-Ching; Ho, Yu; Hsiao, Jye-Chian; Wang, Da-Rong; Yu, Steve S. -F.; Chang, Wen; Tzou, Der-Lii M.			A Turn-like Structure "KKPE" Segment Mediates the Specific Binding of Viral Protein A27 to Heparin and Heparan Sulfate on Cell Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HERPES-SIMPLEX-VIRUS; VACCINIA VIRUS; ENVELOPE PROTEIN; ENTRY; PROTEOGLYCANS; FUSION; SEQUENCE; VIRION; DOMAIN	Vaccinia viral envelope protein A27 (110 amino acids) specifically interacts with heparin (HP) or heparan sulfate (HS) proteoglycans for cell surface attachment. To examine the binding mechanism, a truncated soluble form of A27 (sA27-aa; residues 21 - 84 of A27) with Cys(71) and Cys(72) mutated to Ala was used as the parent molecule. sA27-aa consists of two structurally distinct domains, a flexible Arg/Lys-rich heparin-binding site (HBS) (residues 21 - 32; (21)STKAAKKPEAKR(32)) and a rigid coiled-coil domain (residues 43 - 84), both essential for the specific binding. As shown by surface plasmon resonance (SPR), the binding affinity of sA27-aa for HP (K-A = 1.25 x 10(8) M-1) was approximately 3 orders of magnitude stronger than that for nonspecific binding, such as to chondroitin sulfate (K-A = 1.65 x 10(5) M-1). Using site-directed mutagenesis of HBS and solution NMR, we identified a "KKPE" segment with a turn-like conformation that mediates specific HP binding. In addition, a double mutant T22K/A25K in which the KKPE segment remained intact showed an extremely high affinity for HP (K-A = 1.9 x 10(11) M-1). Importantly, T22K/A25K retained the binding specificity for HP and HS but not chondroitin sulfate, as shown by in vitro SPR and in vivo cell adhesion and competitive binding assays. Molecular modeling of the HBS was performed by dynamics simulations and provides an explanation of the specific binding mechanism in good agreement with the site-directed mutagenesis and SPR results. We conclude that a turn-like structure introduced by the KKPE segment in vaccinia viral envelope protein A27 is responsible for its specific binding to HP and to HS on cell surfaces.	[Shih, Ping-Chen; Yang, Min-Shiang; Lin, Su-Ching; Ho, Yu; Yu, Steve S. -F.; Tzou, Der-Lii M.] Acad Sinica, Inst Chem, Taipei 11529, Taiwan; [Hsiao, Jye-Chian; Chang, Wen] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Wang, Da-Rong] Fu Jen Catholic Univ, Dept Chem, Taipei 242, Taiwan; [Tzou, Der-Lii M.] Natl Chia Yi Univ, Dept Appl Chem, Chiayi 60004, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Fu Jen Catholic University; National Chiayi University	Tzou, DLM (corresponding author), 128 Acad Rd, Taipei 11529, Taiwan.	tzou@ccvax.sinica.edu.tw	Chang, Wen/AAA-5076-2021; Lin, Su-Ching/E-3571-2015; Yu, Steve Sheng-Fa/E-4866-2015; Tzou, Der-Lii M/E-9499-2015	Chang, Wen/0000-0003-3369-083X; Yu, Steve Sheng-Fa/0000-0002-3462-065X; Tzou, Der-Lii M/0000-0002-3755-8230	National Science Council [97-2113-M-001-020-MY3]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant 97-2113-M-001-020-MY3 and by the Academia Sinica.	Adamson A. W., 1960, PHYS CHEM SURFACES, P457; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; BERMAN P, 1987, CELL, V51, P135, DOI 10.1016/0092-8674(87)90018-3; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Ching YC, 2009, J VIROL, V83, P6464, DOI 10.1128/JVI.02295-08; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GOSPODAROWICZ D, 1986, ENDOCRINOLOGY, V118, P82, DOI 10.1210/endo-118-1-82; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Hakansson S, 2003, BIOCHEMISTRY-US, V42, P8999, DOI 10.1021/bi020715+; Ho Y, 2005, J MOL BIOL, V349, P1060, DOI 10.1016/j.jmb.2005.04.024; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Izmailyan RA, 2006, J VIROL, V80, P8402, DOI 10.1128/JVI.00624-06; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Kay LE, 1997, BIOCHEM CELL BIOL, V75, P1, DOI 10.1139/o97-023; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lin TH, 2002, J BIOL CHEM, V277, P20949, DOI 10.1074/jbc.M110403200; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Moss B, 2007, FIELDS VIROLOGY; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NEWCOMER ME, 1984, J BIOL CHEM, V259, P5230; Nichols RJ, 2008, J VIROL, V82, P10247, DOI 10.1128/JVI.01035-08; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; RODRIGUEZ D, 1993, J VIROL, V67, P3435, DOI 10.1128/JVI.67.6.3435-3440.1993; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; TAKAHASHI T, 1994, VIROLOGY, V202, P844, DOI 10.1006/viro.1994.1406; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	43	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36535	36546		10.1074/jbc.M109.037267	http://dx.doi.org/10.1074/jbc.M109.037267			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858217	Green Published, hybrid			2022-12-27	WOS:000272970500055
J	Zhao, B; Lei, L; Vassylyev, DG; Lin, X; Cane, DE; Kelly, SL; Yuan, H; Lamb, DC; Waterman, MR				Zhao, Bin; Lei, Li; Vassylyev, Dmitry G.; Lin, Xin; Cane, David E.; Kelly, Steven L.; Yuan, Hang; Lamb, David C.; Waterman, Michael R.			Crystal Structure of Albaflavenone Monooxygenase Containing a Moonlighting Terpene Synthase Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); TRANS-BETA-FARNESENE; SESQUITERPENE SYNTHASES; ARISTOLOCHENE SYNTHASE; BIFUNCTIONAL ENZYMES; ALARM PHEROMONE; IDENTIFICATION; BIOSYNTHESIS; CYCLIZATION; VOLATILES	Albaflavenone synthase (CYP170A1) is a monooxygenase catalyzing the final two steps in the biosynthesis of this antibiotic in the soil bacterium, Streptomyces coelicolor A3(2). Interestingly, CYP170A1 shows no stereo selection forming equal amounts of two albaflavenol epimers, each of which is oxidized in turn to albaflavenone. To explore the structural basis of the reaction mechanism, we have studied the crystal structures of both ligand-free CYP170A1 (2.6 angstrom) and complex of endogenous substrate (epi-isozizaene) with CYP170A1 (3.3 angstrom). The structure of the complex suggests that the proximal epi-isozizaene molecules may bind to the heme iron in two orientations. In addition, much to our surprise, we have found that albaflavenone synthase also has a second, completely distinct catalytic activity corresponding to the synthesis of farnesene isomers from farnesyl diphosphate. Within the cytochrome P450 alpha-helical domain both the primary sequence and x-ray structure indicate the presence of a novel terpene synthase active site that is moonlighting on the P450 structure. This includes signature sequences for divalent cation binding and an alpha-helical barrel. This barrel is unusual because it consists of only four helices rather than six found in all other terpene synthases. Mutagenesis establishes that this barrel is essential for the terpene synthase activity of CYP170A1 but not for the monooxygenase activity. This is the first bifunctional P450 discovered to have another active site moonlighting on it and the first time a terpene synthase active site is found moonlighting on another protein.	[Zhao, Bin; Lei, Li; Yuan, Hang; Waterman, Michael R.] Vanderbilt Univ, Dept Biochem, Sch Med, Struct Biol Ctr, Nashville, TN 37232 USA; [Zhao, Bin; Lei, Li; Yuan, Hang; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Biochem, Birmingham, AL 35294 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Mol Genet, Birmingham, AL 35294 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Mol Genet, Birmingham, AL 35294 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Biochem, Birmingham, AL 35294 USA; [Lin, Xin; Cane, David E.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Kelly, Steven L.; Lamb, David C.] Swansea Univ, Sch Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales	Vanderbilt University; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Brown University; Swansea University	Zhao, B (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Struct Biol Ctr, 864 Robinson Res Bldg,23rd & Pierce Ave, Nashville, TN 37232 USA.	bin.zhao@vanderbilt.edu	Vassylyev, Dmitry/A-9005-2008		National Institutes of Health [GM69970, ES00267, GM30301, GM75252, GM74840]; Royal Society; Leverhulme Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030301, R01GM074840, R01GM075252, R01GM069970, R37GM030301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69970 (to M. R. W.), ES00267 (to M. R. W.), GM30301 (to D. E. C.), and GM75252 and GM74840 (to D. G. V.) and by the Royal Society and a Leverhulme Trust fellowship (to D. C. L.).	Agger SA, 2008, J BACTERIOL, V190, P6084, DOI 10.1128/JB.00759-08; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; DUFFIELD RM, 1983, J CHEM ECOL, V9, P277, DOI 10.1007/BF00988045; EDWARDS LJ, 1973, NATURE, V241, P126, DOI 10.1038/241126b0; GELB MH, 1982, BIOCHEMISTRY-US, V21, P370, DOI 10.1021/bi00531a026; Gomez A, 2003, BIOINFORMATICS, V19, P895, DOI 10.1093/bioinformatics/btg111; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; James CL, 2002, BIOCHEMISTRY-US, V41, P3720, DOI 10.1021/bi015909o; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jiang JY, 2007, NAT CHEM BIOL, V3, P711, DOI 10.1038/nchembio.2007.29; Jurgens A, 2004, AM J BOT, V91, P1969, DOI 10.3732/ajb.91.12.1969; Juuti JT, 1998, J MOL BIOL, V279, P347, DOI 10.1006/jmbi.1998.1772; Khandeparker R, 2008, J IND MICROBIOL BIOT, V35, P635, DOI 10.1007/s10295-008-0342-9; Krings U, 2006, J AGR FOOD CHEM, V54, P9079, DOI 10.1021/jf062089j; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lin X, 2006, J AM CHEM SOC, V128, P6022, DOI 10.1021/ja061292s; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Nagradova N, 2003, IUBMB LIFE, V55, P459, DOI 10.1080/15216540310001602805; NARHI LO, 1987, J BIOL CHEM, V262, P6683; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2370; Picaud S, 2005, PHYTOCHEMISTRY, V66, P961, DOI 10.1016/j.phytochem.2005.03.027; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; TESH RB, 1992, J MED ENTOMOL, V29, P226, DOI 10.1093/jmedent/29.2.226; TURLINGS TCJ, 1991, J CHEM ECOL, V17, P2235, DOI 10.1007/BF00988004; Zhao B, 2008, J BIOL CHEM, V283, P8183, DOI 10.1074/jbc.M710421200	41	61	65	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36711	36719		10.1074/jbc.M109.064683	http://dx.doi.org/10.1074/jbc.M109.064683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858213	hybrid, Green Published			2022-12-27	WOS:000272970500071
J	Brown, LJ; Longacre, MJ; Hasan, NM; Kendrick, MA; Stoker, SW; MacDonald, MJ				Brown, Laura J.; Longacre, Melissa J.; Hasan, Noaman M.; Kendrick, Mindy A.; Stoker, Scott W.; MacDonald, Michael J.			Chronic Reduction of the Cytosolic or Mitochondrial NAD(P)-malic Enzyme Does Not Affect Insulin Secretion in a Rat Insulinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; NAD(P)&-DEPENDENT MALIC ENZYME; SHORT-INTERFERING RNAS; ATP-CITRATE LYASE; PENTOSE CYCLE; PYRUVATE-CARBOXYLASE; GLUCOSE-METABOLISM; METHYL SUCCINATE; MAMMALIAN-CELLS; ISLET CELLS	The cytosolic malic enzyme (ME1) has been suggested to augment insulin secretion via the malate-pyruvate and/or citrate-pyruvate shuttles, through the production of NADPH or other metabolites. We used selectable vectors expressing short hairpin RNA (shRNA) to stably decrease Me1 mRNA levels by 80-86% and ME1 enzyme activity by 78-86% with either of two shRNAs in the INS-1 832/13 insulinoma cell line. Contrary to published short term ME1 knockdown experiments, our long term targeted cells showed normal insulin secretion in response to glucose or to glutamine plus 2-aminobicyclo[2,2,1]heptane-2- carboxylic acid. We found no increase in the mRNAs and enzyme activities of the cytosolic isocitrate dehydrogenase or glucose-6-phosphate dehydrogenase, which also produce cytosolic NADPH. There was no compensatory induction of the mRNAs for the mitochondrial malic enzymes Me2 or Me3. Interferon pathway genes induced in preliminary small interfering RNA experiments were not induced in the long term shRNA experiments. We repeated our study with an improved vector containing Tol2 transposition sequences to produce a higher rate of stable transferents and shortened time to testing, but this did not alter the results. We similarly used stably expressed shRNA to reduce mitochondrial NAD(P)-malic enzyme (Me2) mRNA by up to 95%, with severely decreased ME2 protein and a 90% decrease in enzyme activity. Insulin release to glucose or glutamine plus 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid remained normal. The maintenance of robust insulin secretion after lowering expression of either one of these malic enzymes is consistent with the redundancy of pathways of pyruvate cycling and/ or cytosolic NADPH production in insulinoma cells.	[Brown, Laura J.; Longacre, Melissa J.; Hasan, Noaman M.; Kendrick, Mindy A.; Stoker, Scott W.; MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Brown, LJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA.	ljbrown@pediatrics.wisc.edu		MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Oscar C. Rennebohm Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oscar C. Rennebohm Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by the Oscar C. Rennebohm Foundation.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT SJ, 1970, BIOCHEM J, V119, P5, DOI 10.1042/bj1190005; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fedorov Y, 2005, NAT METHODS, V2, P241, DOI 10.1038/nmeth0405-241; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; GARDNER RS, 1974, ANAL BIOCHEM, V59, P272, DOI 10.1016/0003-2697(74)90033-5; GIROIX MH, 1985, FEBS LETT, V185, P1, DOI 10.1016/0014-5793(85)80728-6; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jiang N, 2007, MAMM GENOME, V18, P508, DOI 10.1007/s00335-007-9011-y; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Koga A, 2001, GENES GENET SYST, V76, P1, DOI 10.1266/ggs.76.1; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P100, DOI 10.1016/j.abb.2009.07.004; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MATSCHIN.FM, 1968, DIABETES, V17, P475, DOI 10.2337/diab.17.8.475; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; NAGEL WO, 1980, J BIOL CHEM, V255, P3849; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Robbins MA, 2006, NAT BIOTECHNOL, V24, P566, DOI 10.1038/nbt1206; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1984, BIOCHEM J, V220, P433, DOI 10.1042/bj2200433; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; SNYDER PJ, 1970, AM J PHYSIOL, V219, P876, DOI 10.1152/ajplegacy.1970.219.4.876; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209	62	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35359	35367		10.1074/jbc.M109.040394	http://dx.doi.org/10.1074/jbc.M109.040394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858194	Green Published, hybrid			2022-12-27	WOS:000272645600012
J	Firtina, Z; Danysh, BP; Bai, XY; Gould, DB; Kobayashi, T; Duncan, MK				Firtina, Zeynep; Danysh, Brian P.; Bai, Xiaoyang; Gould, Douglas B.; Kobayashi, Takehiro; Duncan, Melinda K.			Abnormal Expression of Collagen IV in Lens Activates Unfolded Protein Response Resulting in Cataract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; MESSENGER-RNA; COL4A1 MUTATION; TRANSLATIONAL CONTROL; CONGENITAL CATARACT; MOLECULAR-GENETICS; ALPORT-SYNDROME; ATF6; XBP1	Human diseases caused by mutations in extracellular matrix genes are often associated with an increased risk of cataract and lens capsular rupture. However, the underlying mechanisms of cataract pathogenesis in these conditions are still unknown. Using two different mouse models, we show that the accumulation of collagen chains in the secretory pathway activates the stress signaling pathway termed unfolded protein response (UPR). Transgenic mice expressing ectopic Col4a3 and Col4a4 genes in the lens exhibited activation of IRE1, ATF6, and PERK associated with expansion of the endoplasmic reticulum and attenuation of general protein translation. The expression of the transgenes had adverse effects on lens fiber cell differentiation and eventually induced cell death in a group of transgenic fiber cells. In Col4a1(+/Delta ex40) mutant mice, the accumulation of mutant chains also caused low levels of UPR activation. However, cell death was not induced in mutant lenses, suggesting that low levels of UPR activation are not proapoptotic. Collectively, the results provide in vivo evidence for a role of UPR in cataract formation in response to accumulation of terminally unfolded proteins in the endoplasmic reticulum.	[Duncan, Melinda K.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Bai, Xiaoyang; Gould, Douglas B.] Univ Calif San Francisco, Inst Human Genet, Dept Ophthalmol & Anat, San Francisco, CA 94143 USA; [Kobayashi, Takehiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Niigata 9518510, Japan	University of Delaware; University of California System; University of California San Francisco; Niigata University	Duncan, MK (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	duncanm@udel.edu	KARAGONLAR, ZEYNEP FIRTINA/AAB-1723-2020; Longo, Kenneth A/A-5631-2010	KARAGONLAR, ZEYNEP FIRTINA/0000-0002-6608-365X; Danysh, Brian/0000-0001-6839-6337; Duncan, Melinda/0000-0003-1570-322X	National Institutes of Health, NEI [EY015279, EY02162]; Idea Networks of Biomedical Research Excellence Program [P20 RR16472]; Sigma Xi-NAS; That Man May See and Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162, R01EY015279] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Idea Networks of Biomedical Research Excellence Program; Sigma Xi-NAS; That Man May See and Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants EY015279 (to M. K. D.) and EY02162 (to D. B. G.). The University of Delaware Core Imaging facility was supported by Idea Networks of Biomedical Research Excellence Program Grant P20 RR16472.; Recipient of a Sigma Xi-NAS grant-in-aid.; Recipient of grants from That Man May See and Research to Prevent Blindness.	Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; BASSNETT S, 2004, DEV OCULAR LENS, P214; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Breedveld G, 2006, J MED GENET, V43, P490, DOI 10.1136/jmg.2005.035584; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brian G, 2001, B WORLD HEALTH ORGAN, V79, P249; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; Colville DJ, 1997, OPHTHALMIC GENET, V18, P161, DOI 10.3109/13816819709041431; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; Duncan MK, 2000, INVEST OPHTH VIS SCI, V41, P464; Duncan MK, 2004, INVEST OPHTH VIS SCI, V45, P3589, DOI 10.1167/iovs.04-0151; Ellwein LB, 2002, ARCH OPHTHALMOL-CHIC, V120, P804; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; FUHRMANN C, 1984, HISTOCHEMISTRY, V80, P153, DOI 10.1007/BF00679990; GARADI R, 1984, INVEST OPHTH VIS SCI, V25, P147; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Hutnik C M, 1999, Curr Opin Ophthalmol, V10, P22, DOI 10.1097/00055735-199902000-00005; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Imaizumi K, 2001, BBA-MOL BASIS DIS, V1536, P85, DOI 10.1016/S0925-4439(01)00049-7; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Junk AK, 2000, ARCH OPHTHALMOL-CHIC, V118, P895; Kato T, 1998, JPN J OPHTHALMOL, V42, P401, DOI 10.1016/S0021-5155(98)00031-8; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kelley PB, 2002, MATRIX BIOL, V21, P415, DOI 10.1016/S0945-053X(02)00014-8; Knowlton AA, 2007, CARDIOVASC RES, V73, P1, DOI 10.1016/j.cardiores.2006.11.002; Kobayashi T, 2003, KIDNEY INT, V64, P1986, DOI 10.1046/j.1523-1755.2003.00323.x; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kuemmel TA, 1996, J SUBMICR CYTOL PATH, V28, P537; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mitchell CA, 1998, DEV DYNAM, V213, P322, DOI 10.1002/(SICI)1097-0177(199811)213:3<322::AID-AJA8>3.0.CO;2-E; Moore AT, 2004, BRIT J OPHTHALMOL, V88, P2, DOI 10.1136/bjo.88.1.2; Mulhern ML, 2006, INVEST OPHTH VIS SCI, V47, P3951, DOI 10.1167/iovs.06-0193; Opdenaker LM, 2009, J CELL BIOCHEM, V107, P473, DOI 10.1002/jcb.22145; PAPACONSTANTINOU J, 1967, SCIENCE, V156, P338, DOI 10.1126/science.156.3773.338; PIATIGORSKY J, 1972, J CELL BIOL, V55, P82, DOI 10.1083/jcb.55.1.82; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; PIATIGORSKY J, 1992, J BIOL CHEM, V267, P4277; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Reed NA, 2001, J IMMUNOL METHODS, V253, P243, DOI 10.1016/S0022-1759(01)00374-X; Reneker LW, 2004, INVEST OPHTH VIS SCI, V45, P4083, DOI 10.1167/iovs.03-1270; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sargon MF, 1999, OPHTHALMOLOGICA, V213, P30, DOI 10.1159/000027390; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; SEERY CM, 1990, AM J OPHTHALMOL, V110, P143, DOI 10.1016/S0002-9394(14)76982-X; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; Snead MP, 1999, J MED GENET, V36, P353; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Spierer A, 1998, J PEDIAT OPHTH STRAB, V35, P281; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Thomas M, 2005, J BIOL CHEM, V280, P21264, DOI 10.1074/jbc.M500144200; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Vahedi K, 2007, STROKE, V38, P1461, DOI 10.1161/STROKEAHA.106.475194; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; van der Knaap MS, 2006, ANN NEUROL, V59, P504, DOI 10.1002/ana.20715; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wilson ME, 2006, J AAPOS, V10, P182, DOI 10.1016/j.jaapos.2005.09.008; Wilson R, 2005, J BIOL CHEM, V280, P15544, DOI 10.1074/jbc.M410758200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; ZIGMAN S, 1985, BIOL BULL, V189, P213	95	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35872	35884		10.1074/jbc.M109.060384	http://dx.doi.org/10.1074/jbc.M109.060384			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858219	Green Published, hybrid			2022-12-27	WOS:000272645600063
J	Martinez, GJ; Zhang, ZM; Chung, Y; Reynolds, JM; Lin, X; Jetten, AM; Feng, XH; Dong, C				Martinez, Gustavo J.; Zhang, Zhengmao; Chung, Yeonseok; Reynolds, Joseph M.; Lin, Xia; Jetten, Anton M.; Feng, Xin-Hua; Dong, Chen			Smad3 Differentially Regulates the Induction of Regulatory and Inflammatory T Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; GENERATION; PATHWAY	Transforming growth factor beta (TGF-beta) is a crucial cytokine with pleiotropic functions on immune cells. In CD4(+) T cells, TGF-beta is required for induction of both regulatory T and Th17 cells. However, the molecular mechanism underlying this differential T cell fate decision remains unclear. In this study, we have evaluated the role of Smad3 in the development of Th17 and regulatory T cells. Smad3 was found to be dispensable for natural regulatory T cell function. However, induction of Foxp3 expression by TGF-beta in naive T cells was significantly reduced in the absence of this molecule. On the contrary, Smad3 deficiency led to enhanced Th17 differentiation in vitro and in vivo. Moreover, Smad3 was found to interact with retinoid acid receptor-related orphan receptor gamma t (ROR gamma t) and decrease its transcriptional activity. These results demonstrate that Smad3 is differentially involved in the reciprocal regulatory and inflammatory T cell generation.	[Zhang, Zhengmao; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Martinez, Gustavo J.; Chung, Yeonseok; Reynolds, Joseph M.; Dong, Chen] MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Martinez, Gustavo J.; Feng, Xin-Hua] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Zhang, Zhengmao; Jetten, Anton M.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Xia] NIEHS, Cell Biol Sect, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Feng, XH (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	xfeng@bcm.edu; cdong@mdanderson.org	dong, chen/B-3181-2009; Huang, Xiaoyan/N-2561-2014; Jetten, Anton/C-3736-2019; Zhang, Zhengmao/C-4566-2014	dong, chen/0000-0002-0084-9130; Jetten, Anton/0000-0003-0954-4445; Zhang, Zhengmao/0000-0002-7968-9968; Chung, Yeonseok/0000-0001-5780-4841; ZHANG, ZHENGMAO/0000-0003-4035-0331; Reynolds, Joseph/0000-0003-3490-0544; Martinez, Gustavo/0000-0003-0178-3329	National Institutes of Health Research [RO1AR050772, RC2AR059010-01, RO1AR053591, RO1CA108454, RO1DK073932]; Division of Intramural Research at the NIEHS [Z01-ES-101586]; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591, R01AR050772, RC2AR059010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research at the NIEHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grants RO1AR050772 and RC2AR059010-01 (to C. D.), RO1AR053591 and RO1CA108454 (to X. H. F.), RO1DK073932 (to X. L.), and by National Institutes of Health Grant Z01-ES-101586 (to A. J.) through the Division of Intramural Research at the NIEHS.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Datto MB, 1999, MOL CELL BIOL, V19, P2495; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	14	76	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35283	35286		10.1074/jbc.C109.078238	http://dx.doi.org/10.1074/jbc.C109.078238			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19887374	Green Published, hybrid			2022-12-27	WOS:000272645600004
J	Michailidis, E; Marchand, B; Kodama, EN; Singh, K; Matsuoka, M; Kirby, KA; Ryan, EM; Sawani, AM; Nagy, E; Ashida, N; Mitsuya, H; Parniak, MA; Sarafianos, SG				Michailidis, Eleftherios; Marchand, Bruno; Kodama, Eiichi N.; Singh, Kamlendra; Matsuoka, Masao; Kirby, Karen A.; Ryan, Emily M.; Sawani, Ali M.; Nagy, Eva; Ashida, Noriyuki; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.			Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4 '-Ethynyl-2-fluoro-2 '-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-POLYMERASE; NUCLEOSIDE ANALOGS; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; MOLECULAR-MECHANISMS; EXCISION PHENOTYPE; SELECTIVE ACTION; IN-VITRO; TYPE-1; RESISTANCE	Nucleoside reverse transcriptase inhibitors (NRTIs) are employed in first line therapies for the treatment of human immunodeficiency virus (HIV) infection. They generally lack a 3'-hydroxyl group, and thus when incorporated into the nascent DNA they prevent further elongation. In this report we show that 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA), a nucleoside analog that retains a 3'-hydroxyl moiety, inhibited HIV-1 replication in activated peripheral blood mononuclear cells with an EC50 of 0.05 nM, a potency several orders of magnitude better than any of the current clinically used NRTIs. This exceptional antiviral activity stems in part from a mechanism of action that is different from approved NRTIs. Reverse transcriptase (RT) can use EFdA-5'-triphosphate (EFdA-TP) as a substrate more efficiently than the natural substrate, dATP. Importantly, despite the presence of a 3'-hydroxyl, the incorporated EFdA monophosphate (EFdA-MP) acted mainly as a de facto terminator of further RT-catalyzed DNA synthesis because of the difficulty of RT translocation on the nucleic acid primer possessing 3'-terminal EFdA-MP. EFdA-TP is thus a translocation-defective RT inhibitor (TDRTI). This diminished translocation kept the primer 3'-terminal EFdA-MP ideally located to undergo phosphorolytic excision. However, net phosphorolysis was not substantially increased, because of the apparently facile reincorporation of the newly excised EFdA-TP. Our molecular modeling studies suggest that the 4'-ethynyl fits into a hydrophobic pocket defined by RT residues Ala-114, Tyr-115, Phe-160, and Met-184 and the aliphatic chain of Asp-185. These interactions, which contribute to both enhanced RT utilization of EFdA-TP and difficulty in the translocation of 3'-terminal EFdA-MP primers, underlie the mechanism of action of this potent antiviral nucleoside.	[Michailidis, Eleftherios; Marchand, Bruno; Singh, Kamlendra; Kirby, Karen A.; Ryan, Emily M.; Sawani, Ali M.; Sarafianos, Stefan G.] Univ Missouri, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Kodama, Eiichi N.; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Nagy, Eva; Parniak, Michael A.] Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; [Ashida, Noriyuki] Yamasa Corp, Chiba 2880056, Japan; [Mitsuya, Hiroaki] Kumamoto Univ, Dept Hematol & Infect Dis, Kumamoto 8608556, Japan; [Mitsuya, Hiroaki] NIH, Expt Retrovirol Sect, HIV AIDS Malignancy Branch, Bethesda, MD 20892 USA	University of Missouri System; University of Missouri Columbia; Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kumamoto University; National Institutes of Health (NIH) - USA	Sarafianos, SG (corresponding author), 471D Christopher S Bond Life Sci Ctr,1201 Rollins, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Michailidis, Eleftherios/0000-0002-9907-4346; Kirby, Karen A./0000-0003-2468-4796; Sarafianos, Stefan G/0000-0002-5840-154X; Matsuoka, Masao/0000-0002-0473-754X	National Institutes of Health [AI076119, AI074389, AI076119-S1, AI076119-02S1, AI079801]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074389, R21AI079801, R33AI079801, R01AI076119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119, AI074389, AI076119-S1, and AI076119-02S1 ( to S. G. S.) and AI079801 ( to M. A. P.).	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Biaglow JE, 1997, RADIAT RES, V148, P181, DOI 10.2307/3579576; Boyer PL, 2007, J MOL BIOL, V371, P873, DOI 10.1016/j.jmb.2007.05.043; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; CHEN MS, 1992, J BIOL CHEM, V267, P257; CHEN MS, 1993, BIOCHEMISTRY-US, V32, P6002, DOI 10.1021/bi00074a011; De Clercq E, 2007, Verh K Acad Geneeskd Belg, V69, P81; Deval J, 2009, DRUGS, V69, P151, DOI 10.2165/00003495-200969020-00002; Di Pasquale F, 2008, J AM CHEM SOC, V130, P10748, DOI 10.1021/ja8028284; Feng JY, 2004, ANTIMICROB AGENTS CH, V48, P1300, DOI 10.1128/AAC.48.4.1300-1306.2004; Gallois-Montbrun S, 2002, J BIOL CHEM, V277, P39953, DOI 10.1074/jbc.M206360200; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hattori S, 2009, ANTIMICROB AGENTS CH, V53, P3887, DOI 10.1128/AAC.00270-09; Hsu CH, 2007, ANTIMICROB AGENTS CH, V51, P1687, DOI 10.1128/AAC.01432-06; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; MAAG H, 1994, J MED CHEM, V37, P431, DOI 10.1021/jm00030a001; MAAG H, 1992, J MED CHEM, V35, P1440, DOI 10.1021/jm00086a013; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Moscolini M, 2008, ANTIVIR THER, V13, P1097; Nakata H, 2007, ANTIMICROB AGENTS CH, V51, P2701, DOI 10.1128/AAC.00277-07; Nitanda T, 2005, ANTIMICROB AGENTS CH, V49, P3355, DOI 10.1128/AAC.49.8.3355-3360.2005; Ohrui Hiroshi, 2001, Current Drug Targets - Infectious Disorders, V1, P1, DOI 10.2174/1568005013343218; Ohrui Hiroshi, 2006, Nucleic Acids Symp Ser (Oxf), P1; Parniak M A, 2000, Adv Pharmacol, V49, P67; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; Sharma PL, 2004, CURR TOP MED CHEM, V4, P895, DOI 10.2174/1568026043388484; Siddiqui MA, 2004, J MED CHEM, V47, P5041, DOI 10.1021/jm049550o; Sluis-Cremer N, 2005, J BIOL CHEM, V280, P29047, DOI 10.1074/jbc.M503166200; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Strerath M, 2002, J AM CHEM SOC, V124, P11230, DOI 10.1021/ja027060k; Summerer D, 2005, BIOORG MED CHEM LETT, V15, P869, DOI 10.1016/j.bmcl.2004.12.072; Tanaka Hiromichi, 2005, Antiviral Chemistry & Chemotherapy, V16, P217; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; White KL, 2006, ANTIVIR THER, V11, P155; Yang GW, 2008, ANTIMICROB AGENTS CH, V52, P2035, DOI 10.1128/AAC.00083-08; Yang GW, 2007, ANTIVIR RES, V73, P185, DOI 10.1016/j.antiviral.2006.10.002	50	98	100	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35681	35691		10.1074/jbc.M109.036616	http://dx.doi.org/10.1074/jbc.M109.036616			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837673	Green Published, hybrid			2022-12-27	WOS:000272645600046
J	Villalonga, P; de Mattos, SF; Ridley, AJ				Villalonga, Priam; Fernandez de Mattos, Silvia; Ridley, Anne J.			RhoE Inhibits 4E-BP1 Phosphorylation and eIF4E Function Impairing Cap-dependent Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; ROCK-I; ACTIN CYTOSKELETON; PROTEIN-SYNTHESIS; BINDING PARTNER; MTOR; EIF-4E; EXPRESSION; RAPTOR; OVEREXPRESSION	The Rho GTPase family member RhoE inhibits RhoA/ROCK signaling to promote actin stress fiber and focal adhesion disassembly. We have previously reported that RhoE also inhibits cell cycle progression and Ras-induced transformation, specifically preventing cyclin D1 translation. Here we investigate the molecular mechanisms underlying those observations. RhoE inhibits the phosphorylation of the translational repressor 4E-BP1 in response to extracellular stimuli. However, RhoE does not affect the activation of mTOR, the major kinase regulating 4E-BP1 phosphorylation, as indicated by the phosphorylation levels of the mTOR substrate S6K, the dynamics of mTOR/Raptor association, and the observation that RhoE, as opposed to rapamycin, does not impair cellular growth. Interestingly, RhoE prevents the release of the eukaryotic initiation factor eIF4E from 4E-BP1, inhibiting cap-dependent translation. Accordingly, RhoE also inhibits the expression and the transcriptional activity of the eIF4E target c-Myc. Consistent with its crucial role in cell proliferation, we show that eIF4E can rescue both cell cycle progression and Ras-induced transformation in RhoE-expressing cells, indicating that the inhibition of eIF4E function is critical to mediate the anti-proliferative effects of RhoE.	[Villalonga, Priam; Fernandez de Mattos, Silvia] Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Canc Cell Biol Grp, E-07122 Illes Balears, Spain; UCL, Ludwig Inst Canc Res, London W1W 7BS, England; [Villalonga, Priam; Fernandez de Mattos, Silvia] Univ Illes Balears, Dept Biol Fonamental, E-07122 Illes Balears, Spain; [Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	Universitat de les Illes Balears; Ludwig Institute for Cancer Research; University of London; University College London; Universitat de les Illes Balears; University of London; King's College London	Villalonga, P (corresponding author), Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Canc Cell Biol Grp, Edifici Cient Tecn,Ctra Valldemossa Km 7-5, E-07122 Illes Balears, Spain.	priam.villalonga@uib.es	Villalonga, Priam/K-4350-2014; de Mattos, Silvia Fernández/K-5153-2014	Villalonga, Priam/0000-0002-7190-6884; de Mattos, Silvia Fernández/0000-0003-4144-3687; Ridley, Anne/0000-0001-8186-5708	AICR Project Grant; Spanish "Ministerio de Educacion y Ciencia"; "Junta de Balears-AECC"; BBSRC [BB/E004083/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E004083/2] Funding Source: researchfish	AICR Project Grant; Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); "Junta de Balears-AECC"; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an AICR Project Grant (to A.J.R. and P.V.), a Ramon y Cajal fellowship from the Spanish "Ministerio de Educacion y Ciencia" (to P. V.), and funding from the "Junta de Balears-AECC" (to P.V.).; <SUP>1</SUP> A Ramon y Cajal Fellow (Ministerio de Ciencia e Innovacion, Spain). To whom correspondence should be addressed: Institut Universitari d'Investigacio en Ciencies de la Salut (IUNICS), Edifici Cientificotecnic, Ctra. Valldemossa Km7.5, Illes Balears, Spain. Tel.: 34-971-173004; Fax: 34-971-259501; E-mail: priam.villalonga@uib.es.; <SUP>2</SUP> A Ramon y Cajal Fellow (Ministerio de Ciencia e Innovacion, Spain).	Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter PS, 1999, ONCOGENE, V18, P4326, DOI 10.1038/sj.onc.1202890; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chardin P, 2003, CURR BIOL, V13, pR702, DOI 10.1016/j.cub.2003.08.042; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Heesom KJ, 2001, CURR BIOL, V11, P1374, DOI 10.1016/S0960-9822(01)00422-5; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; Li BDL, 1997, CANCER-AM CANCER SOC, V79, P2385; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Zhang CY, 2007, ANN SURG ONCOL, V14, P2628, DOI 10.1245/s10434-007-9457-x	46	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35287	35296		10.1074/jbc.M109.050120	http://dx.doi.org/10.1074/jbc.M109.050120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850923	hybrid, Green Published			2022-12-27	WOS:000272645600005
J	Wilczek, C; Chayka, O; Plachetka, A; Klempnauer, KH				Wilczek, Carola; Chayka, Olesya; Plachetka, Annette; Klempnauer, Karl-Heinz			Myb-induced Chromatin Remodeling at a Dual Enhancer/Promoter Element Involves Non-coding RNA Transcription and Is Disrupted by Oncogenic Mutations of v-myb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; C-MYB; POINT MUTATIONS; MIM-1 GENE; C/EBP-BETA; SYNERGISTIC ACTIVATION; TARGET GENE; A-MYB; CELLS; DIFFERENTIATION	The oncogene v-myb of avian myeloblastosis virus (AMV) encodes a transcription factor (v-Myb) that transforms myelomonocytic cells by deregulating the expression of specific target genes. v-myb has acquired its oncogenic potential by truncation as well as by a number of point mutations of its cellular progenitor c-myb. As a result of these changes, the target gene spectrum v-Myb differs from that of c-Myb. We recently showed that the chicken mim-1 gene, a c-Myb target gene that is not activated by v-Myb harbors a powerful cell type-specific and Myb-inducible enhancer in addition to a Myb-responsive promoter. We now show that Myb-dependent activation of the mim-1 gene is accompanied by extensive remodeling of the nucleosomal architecture at the enhancer. We found that the mim-1 enhancer region also harbors a promoter whose activity is stimulated by Myb and which directs the transcription of an apparently non-coding RNA. Furthermore, our data show that the oncogenic mutations of AMV have disrupted the ability of v-Myb to induce remodeling of chromatin structure at the mim-1 enhancer. Together, our results demonstrate for the first time directly that Myb induces alterations of the nucleosomal organization at a relevant target site and provide new insight into the functional consequences of the oncogenic amino acid substitutions.	[Wilczek, Carola; Chayka, Olesya; Plachetka, Annette; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhlem Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de			Deutsche Forschungsgemeinschaft; Graduate School of Chemistry (GSC-MS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of Chemistry (GSC-MS)	This work was supported in part by the Deutsche Forschungsgemeinschaft and by fellowships from the Graduate School of Chemistry (GSC-MS) (to O.C. and A.P.).	BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Brendeford EM, 1997, J BIOL CHEM, V272, P4436, DOI 10.1074/jbc.272.7.4436; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; BURK O, 1991, EMBO J, V10, P3713, DOI 10.1002/j.1460-2075.1991.tb04939.x; Burk O, 1997, EMBO J, V16, P1371, DOI 10.1093/emboj/16.6.1371; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chayka O, 2005, MOL CELL BIOL, V25, P499, DOI 10.1128/MCB.25.1.499-511.2005; Chen J, 2006, ONCOGENE, V25, P2758, DOI 10.1038/sj.onc.1209295; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; DINI PW, 1995, J VIROL, V69, P2515, DOI 10.1128/JVI.69.4.2515-2524.1995; Facchinetti V, 1997, BIOCHEM J, V324, P729, DOI 10.1042/bj3240729; IBANEZ CE, 1990, MOL CELL BIOL, V10, P2285, DOI 10.1128/MCB.10.5.2285; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Ivanova O, 2007, NUCLEIC ACIDS RES, V35, P7237, DOI 10.1093/nar/gkm675; KLEMPNAUER KH, 1989, GENE DEV, V3, P1582, DOI 10.1101/gad.3.10.1582; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lang G, 2005, ONCOGENE, V24, P1375, DOI 10.1038/sj.onc.1208301; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Mink S, 1996, MOL CELL BIOL, V16, P1316; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Worpenberg S, 1997, ONCOGENE, V15, P213, DOI 10.1038/sj.onc.1201179; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	37	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35314	35324		10.1074/jbc.M109.066175	http://dx.doi.org/10.1074/jbc.M109.066175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19841477	hybrid, Green Published			2022-12-27	WOS:000272645600008
J	Zhu, K; Zhang, YM; Rock, CO				Zhu, Kun; Zhang, Yong-Mei; Rock, Charles O.			Transcriptional Regulation of Membrane Lipid Homeostasis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID BIOSYNTHESIS; ANTIBIOTIC-ACTIVITY; ENZYMATIC-SYNTHESIS; DEACETYLASE LPXC; GENE-EXPRESSION; COENZYME-A; FADR; INHIBITION; METABOLISM	The biophysical properties of membrane phospholipids are controlled by the composition of their constituent fatty acids and are tightly regulated in Escherichia coli. The FabR (fatty acid biosynthesis repressor) transcriptional repressor controls the proportion of unsaturated fatty acids in the membrane by regulating the expression of the fabB (beta-ketoacyl-ACP synthase I) and fabA (beta-hydroxydecanoyl-ACP dehydratase/isomerase) genes. FabR binding to a DNA palindrome located within the promoters of the fabB and fabA genes required the presence of an unsaturated acyl-acyl carrier protein (ACP) or acyl-CoA and was antagonized by saturated acyl-ACP or acyl-CoA. The FabR-dependent repression of fabB and fabA by exogenous unsaturated fatty acids confirmed the role for FabR in responding to the acyl-CoA pool composition, and the perturbation of the unsaturated: saturated acyl-ACP ratio using a specific inhibitor of lipid A formation verified FabR-dependent regulation of fabB by the acyl-ACP composition in vivo. Thus, FabR plays a key role in controlling the membrane biophysical properties by regulating gene expression in response to the composition of the long-chain acyl-thioester pool. This mechanism ensures that a balanced composition of fatty acids is available for incorporation into the membrane via the PlsB/PlsC acyltransferases.	[Zhu, Kun; Zhang, Yong-Mei; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.rock@stjude.org			National Institutes of Health [GM 34496]; Cancer Center (CORE) [CA 21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 34496, Cancer Center (CORE) Support Grant CA 21765, and the American Lebanese Syrian Associated Charities.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOOTH BR, 1980, BIOCHEM BIOPH RES CO, V94, P1029, DOI 10.1016/0006-291X(80)90522-7; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; CRONAN JE, 2008, ECOSALESCHERICHIA CO; DAGNOLO G, 1973, BIOCHIM BIOPHYS ACTA, V326, P155, DOI 10.1016/0005-2760(73)90241-5; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; JACKOWSKI S, 1987, J BIOL CHEM, V262, P7927; Jerga A, 2009, J BIOL CHEM, V284, P15364, DOI 10.1074/jbc.C109.002410; KASS LR, 1967, P NATL ACAD SCI USA, V58, P1168, DOI 10.1073/pnas.58.3.1168; LAU C, 1983, J BIOL CHEM, V258, P3027; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; RAMAN N, 1995, J BIOL CHEM, V270, P1092, DOI 10.1074/jbc.270.3.1092; ROCK CO, 1979, J BIOL CHEM, V254, P7123; ROCK CO, 1982, J BIOL CHEM, V257, P10759; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2008, MOL MICROBIOL, V68, P987, DOI 10.1111/j.1365-2958.2008.06202.x; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2007, MOL MICROBIOL, V66, P622, DOI 10.1111/j.1365-2958.2007.05934.x; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x	37	54	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34880	34888		10.1074/jbc.M109.068239	http://dx.doi.org/10.1074/jbc.M109.068239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19854834	hybrid, Green Published			2022-12-27	WOS:000272439600043
J	Hosy, E; Dupuis, JP; Vivaudou, M				Hosy, Eric; Dupuis, Julien P.; Vivaudou, Michel			Impact of Disease-causing SUR1 Mutations on the K-ATP Channel Subunit Interface Probed with a Rhodamine Protection Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONYLUREA RECEPTOR; MOLECULAR-BASIS; KIR6.2; TRAFFICKING; OPENERS; DOMAIN; ABCC8; HYPERINSULINISM; STOICHIOMETRY; NUCLEOTIDES	The function of the ATP-sensitive potassium (K-ATP) channel relies on the proper coupling between its two subunits: the pore-forming Kir6.2 and the regulator SUR. The conformation of the interface between these two subunits can be monitored using a rhodamine 123 (Rho) protection assay because Rho blocks Kir6.2 with an efficiency that depends on the relative position of transmembrane domain (TMD) 0 of the associated SUR (Hosy, E., Derand, R., Revilloud, J., and Vivaudou, M. (2007) J. Physiol. 582, 27-39). Here we find that the natural and synthetic K-ATP channel activators MgADP, zinc, and SR47063 induced a Rhoinsensitive conformation. The activating mutation F132L in SUR1, which causes neonatal diabetes, also rendered the channel resistant to Rho block, suggesting that it stabilized an activated conformation by uncoupling TMD0 from the rest of SUR1. At a nearby residue, the SUR1 mutation E128K impairs trafficking, thereby reducing surface expression and causing hyperinsulinism. To augment channel density at the plasma membrane to investigate the effect of mutating this residue on channel function, we introduced the milder mutation E126A at the matching residue of SUR2A. Mutation E126A imposed a hypersensitive Rho phenotype indicative of a functional uncoupling between TMD0 and Kir6.2. These results suggest that the TMD0-Kir6.2 interface is mobile and that the gating modes of Kir6.2 correlate with distinct positions of TMD0. They further demonstrate that the second intracellular loop of SUR, which contains the two residues studied here, is a key structural element of the TMD0-Kir6.2 interface.	[Hosy, Eric; Dupuis, Julien P.; Vivaudou, Michel] UJF, CNRS, CEA, IBS,LPM, F-38027 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Vivaudou, M (corresponding author), UJF, CNRS, CEA, IBS,LPM, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	vivaudou@cea.fr	Dupuis, Julien/M-7092-2017; Vivaudou, Michel/C-5338-2008	Vivaudou, Michel/0000-0002-9777-3127; hosy, eric/0000-0002-2479-5915; Dupuis, Julien P./0000-0003-1660-7782	Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by grants (to M. V.) and a postdoctoral fellowship (to E. H.) from the Program Toxicologie Nucleaire Environnementale of the Commissariat a l'Energie Atomique.	Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Dupuis JP, 2008, J PHYSIOL-LONDON, V586, P3075, DOI 10.1113/jphysiol.2008.152744; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Hosy E, 2007, J PHYSIOL-LONDON, V582, P27, DOI 10.1113/jphysiol.2007.134288; Karger AB, 2008, J GEN PHYSIOL, V131, P185, DOI 10.1085/jgp.200709852; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Moreau C, 2005, J MOL CELL CARDIOL, V38, P951, DOI 10.1016/j.yjmcc.2004.11.030; Moreau C, 2005, MOL PHARMACOL, V67, P1026, DOI 10.1124/mol.104.008698; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Moreau CJ, 2008, NAT NANOTECHNOL, V3, P620, DOI 10.1038/nnano.2008.242; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pratt EB, 2009, J BIOL CHEM, V284, P7951, DOI 10.1074/jbc.M807012200; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Prost AL, 2004, J PHYSIOL-LONDON, V559, P157, DOI 10.1113/jphysiol.2004.065094; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Rainbow RD, 2004, BIOCHEM J, V379, P173, DOI 10.1042/BJ20031087; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Ribalet B, 2003, BIOPHYS J, V84, P266, DOI 10.1016/S0006-3495(03)74847-4; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; VIVAUDOU M, 1995, J PHYSIOL-LONDON, V486, P629, DOI 10.1113/jphysiol.1995.sp020840; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	31	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3084	10.1074/jbc.M109.043307	http://dx.doi.org/10.1074/jbc.M109.043307			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933268	Green Published, hybrid			2022-12-27	WOS:000273829000024
J	Le Saux, S; Rousseau, F; Barbier, F; Ravon, E; Grimaud, L; Danger, Y; Froger, J; Chevalier, S; Gascan, H				Le Saux, Sabine; Rousseau, Francois; Barbier, Fabien; Ravon, Elisa; Grimaud, Linda; Danger, Yannic; Froger, Josy; Chevalier, Sylvie; Gascan, Hugues			Molecular Dissection of Human Interleukin-31-mediated Signal Transduction through Site-directed Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; IMMUNOGLOBULIN-LIKE DOMAIN; CELL STIMULATORY FACTOR; CYTOKINE RECEPTOR; ONCOSTATIN-M; T-CELLS; ATOPIC-DERMATITIS; EPITHELIAL-CELLS; LIF RECEPTOR; NC/NGA MICE	Interleukin (IL)-31 is a recently described cytokine, preferentially produced by T helper 2 lymphocytes and associated with skin diseases, such as atopic dermatitis. IL-31 is a member of the four alpha-helix bundle cytokine family and is related to the IL-6 subgroup. Its heterodimeric membrane receptor is composed of the gp130-like receptor (GPL) subunit associated to the oncostatin M receptor subunit. We identified critical amino acids implicated in the ligand receptor interaction by computational analysis combined with site-directed mutagenesis. Six IL-31 residues selected for their putative involvement in cytokine receptor contact sites were alanine-substituted, and the corresponding proteins were expressed in mammalian and bacterial systems. Biochemical, membrane binding, cell signaling, and cell proliferation analyses showed that mutation E44A, E106A, or H110A abolished IL-31 binding to GPL and the subsequent signaling events. A second ligand receptor-binding site involved Lys(134), with alanine substitution leading to a protein that still binds GPL, but is unable to recruit the second receptor subunit and the subsequent signaling pathways. The results indicate that IL-31 recognizes its receptor complex through two different binding sites, and we propose a three-dimensional model for IL-31.	[Gascan, Hugues] INSERM, U564, Unite Mixte 564, F-49933 Angers 09, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Gascan, H (corresponding author), INSERM, U564, Unite Mixte 564, Batiment Monteclair,4 Rue Larrey, F-49933 Angers 09, France.	hugues.gascan@univ-angers.fr		Danger, Yannic/0000-0002-5611-5048	Association pour la Recherche contre le Cancer [5176]; Region Pays de la Loire	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Region Pays de la Loire(Region Pays de la Loire)	This work was supported by Grant 5176 from the Association pour la Recherche contre le Cancer and by the Ciblage Moleculaire et Applications Therapeutiques Program of the Region Pays de la Loire.	Aasland D, 2002, J MOL BIOL, V315, P637, DOI 10.1006/jmbi.2001.5282; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200; Diveu C, 2004, EUR CYTOKINE NETW, V15, P291; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Hammacher A, 1998, J BIOL CHEM, V273, P22701, DOI 10.1074/jbc.273.35.22701; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Jawa RS, 2008, J INTERF CYTOK RES, V28, P207, DOI 10.1089/jir.2007.0057; Layton JE, 1999, J BIOL CHEM, V274, P17445, DOI 10.1074/jbc.274.25.17445; Layton JE, 2001, J BIOL CHEM, V276, P36779, DOI 10.1074/jbc.M104787200; Lei Z, 2008, ALLERGY, V63, P327, DOI 10.1111/j.1398-9995.2007.01566.x; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Plun-Favreau H, 2001, EMBO J, V20, P1692, DOI 10.1093/emboj/20.7.1692; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Schulz F, 2007, J ALLERGY CLIN IMMUN, V120, P1097, DOI 10.1016/j.jaci.2007.07.065; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Takaoka A, 2005, EUR J PHARMACOL, V516, P180, DOI 10.1016/j.ejphar.2005.04.040; THOMA B, 1994, J BIOL CHEM, V269, P6215; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; WOLF SF, 1991, J IMMUNOL, V146, P3074	48	14	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3470	3477		10.1074/jbc.M109.049189	http://dx.doi.org/10.1074/jbc.M109.049189			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920145	Green Published, hybrid			2022-12-27	WOS:000273829000061
J	Mera, PE; Escalante-Semerena, JC				Mera, Paola E.; Escalante-Semerena, Jorge C.			Dihydroflavin-driven Adenosylation of 4-Coordinate Co(II) Corrinoids ARE COBALAMIN REDUCTASES ENZYMES OR ELECTRON TRANSFER PROTEINS?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SYNTHASE REDUCTASE; SEROVAR TYPHIMURIUM LT2; SALMONELLA-ENTERICA; ATP-COB(I)ALAMIN ADENOSYLTRANSFERASE; LACTOBACILLUS-REUTERI; TEV PROTEASE; ADENOSYLCOBALAMIN BIOSYNTHESIS; INITIAL-CHARACTERIZATION; ENZYMATIC CONVERSION; FUSION PROTEINS	The identity of the source of the biological reductant needed to convert cobalamin to its biologically active form adenosylcobalamin has remained elusive. Here we show that free or protein-bound dihydroflavins can serve as the reductant of Co2+ Cbl bound in the active site of PduO-type ATP-dependent corrinoid adenosyltransferase enzymes. Free dihydroflavins (dihydroriboflavin, FMNH2, and FADH(2)) effectively drove the adenosylation of Co2+ Cbl by the human and bacterial PduO-type enzymes at very low concentrations (1 mu M). These data show that adenosyltransferase enzymes lower the thermodynamic barrier of the Co2+ -> Co+ reduction needed for the formation of the unique organometalic Co-C bond of adenosylcobalamin. Collectively, our in vivo and in vitro data suggest that cobalamin reductases identified thus far are most likely electron transfer proteins, not enzymes.	[Mera, Paola E.; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	escalante@bact.wisc.edu			National Institutes of Health Grant [GM40313]; Predoctoral National Research Service [F31-GM081979]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040313, F31GM081979, R37GM040313] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40313 from USPHS (to J. C. E.- S.).; Supported in part by Predoctoral National Research Service Award Fellowship F31-GM081979.	BANDARIAN V, 1999, CHEM BIOCH B, V12, P811; Banerjee R., 1999, Chemistry and biochemistry of B12., P707; BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Buan NR, 2006, J BIOL CHEM, V281, P16971, DOI 10.1074/jbc.M603069200; Buan NR, 2005, J BIOL CHEM, V280, P40948, DOI 10.1074/jbc.M506713200; Buan NR, 2004, J BACTERIOL, V186, P5708, DOI 10.1128/JB.186.17.5708-5714.2004; Buckel W., 1999, Chemistry and biochemistry of B12., P757; Choi JW, 2008, J MOL BIOL, V377, P258, DOI 10.1016/j.jmb.2008.01.004; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; Fonseca MV, 2001, J BIOL CHEM, V276, P32101, DOI 10.1074/jbc.M102510200; Fonseca MV, 2000, J BACTERIOL, V182, P4304, DOI 10.1128/JB.182.15.4304-4309.2000; Fontecave M, 1998, CELL MOL LIFE SCI, V54, P684, DOI 10.1007/s000180050195; Fontecave M., 1999, Chemistry and biochemistry of B12., P731; FREY PA, 2007, ENZYMATIC REACTION M, P189; Froese DS, 2008, MOL GENET METAB, V94, P68, DOI 10.1016/j.ymgme.2007.11.019; Hall DA, 2000, BIOCHEMISTRY-US, V39, P10711, DOI 10.1021/bi001096c; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; Haspel J, 2001, BIOTECHNIQUES, V30, P60, DOI 10.2144/01301st01; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Johnson CLV, 2004, J BACTERIOL, V186, P7881, DOI 10.1128/JB.186.23.7881-7887.2004; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Leclerc D, 1999, GENE, V240, P75, DOI 10.1016/S0378-1119(99)00431-X; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; Mera PE, 2009, BIOCHEMISTRY-US, V48, P3138, DOI 10.1021/bi9000134; OTOOLE GA, 1993, J BACTERIOL, V175, P6328, DOI 10.1128/JB.175.19.6328-6336.1993; Park K, 2008, BIOCHEMISTRY-US, V47, P9007, DOI 10.1021/bi800419e; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; Shih YP, 2005, PROTEIN SCI, V14, P936, DOI 10.1110/ps.041129605; St Maurice M, 2008, BIOCHEMISTRY-US, V47, P5755, DOI 10.1021/bi800132d; St Maurice M, 2007, J BIOL CHEM, V282, P2596, DOI 10.1074/jbc.M609557200; Stich TA, 2005, J AM CHEM SOC, V127, P7660, DOI 10.1021/ja050546r; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Stich TA, 2004, J AM CHEM SOC, V126, P9735, DOI 10.1021/ja0481631; SUH SJ, 1995, J BACTERIOL, V177, P921, DOI 10.1128/jb.177.4.921-925.1995; Toraya T., 1999, Chemistry and biochemistry of B12., P783; WALKER GA, 1969, ARCH BIOCHEM BIOPHYS, V134, P95, DOI 10.1016/0003-9861(69)90255-0; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Watanabe F, 1997, METHOD ENZYMOL, V281, P295; Wohlfarth G., 1999, Chemistry and biochemistry of B12., P871	45	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							2911	10.1074/jbc.M109.059485	http://dx.doi.org/10.1074/jbc.M109.059485			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933577	Green Published, hybrid			2022-12-27	WOS:000273829000005
J	Koren, J; Jinwal, UK; Jin, Y; O'Leary, J; Jones, JR; Johnson, AG; Blair, LJ; Abisambra, JF; Chang, L; Miyata, Y; Cheng, AM; Guo, JP; Cheng, JQ; Gestwicki, JE; Dickey, CA				Koren, John, III; Jinwal, Umesh K.; Jin, Ying; O'Leary, John; Jones, Jeff R.; Johnson, Amelia G.; Blair, Laura J.; Abisambra, Jose F.; Chang, Lyra; Miyata, Yoshinari; Cheng, Anna M.; Guo, Jianping; Cheng, Jin Q.; Gestwicki, Jason E.; Dickey, Chad A.			Facilitating Akt Clearance via Manipulation of Hsp70 Activity and Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; HSP90 MOLECULAR CHAPERONE; BREAST-CANCER CELLS; QUALITY CONTROL; ATPASE ACTIVITY; METHYLENE-BLUE; CHIP; INHIBITOR; STRESS; APOPTOSIS	Members of the 70-kDa heat shock family can control and manipulate a host of oncogenic client proteins. This role of Hsp70 in both the folding and degradation of these client proteins makes it a potential drug target for certain forms of cancer. The phenothiazine family of compounds, as well as the flavonoid myricetin, was recently shown to inhibit Hsp70-ATPase activity, whereas members of the dihydropyrimidine family stimulated ATPase function. Akt, a major survival kinase, was found to be under the regulation of Hsp70, and when the ATPase activity of Hsp70 was increased or decreased by these compounds, Akt levels were also increased or decreased. Also, increasing Hsp70 levels concurrent with inhibition of its ATPase function synergistically reduced Akt levels to a greater extent than either manipulation alone, providing new insights about client fate decisions. Akt reductions mediated by Hsp70 inhibitors were prevented when Hsp70 expression was silenced with small interfering RNA. Inhibiting Hsp70 ATPase function produced cytotoxic events only in breast cancer cell lines where Akt dysfunction was previously shown, suggesting therapeutic specificity depending on the Hsp70 client profile. Thus, increasing Hsp70 levels combined with inhibiting its ATPase function may serve to dramatically reduce Akt levels and facilitate cell death in certain types of cancer.	[Koren, John, III; Jinwal, Umesh K.; Jin, Ying; O'Leary, John; Jones, Jeff R.; Johnson, Amelia G.; Blair, Laura J.; Abisambra, Jose F.; Cheng, Anna M.; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Chang, Lyra; Miyata, Yoshinari; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Gestwicki, Jason E.] Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Cheng, Anna M.; Guo, Jianping; Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; H Lee Moffitt Cancer Center & Research Institute	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Dickey, Chad A/H-4441-2011; Abisambra, Joe/AAP-3269-2020; Chang, Lyra/A-9516-2012; Abisambra, Jose/V-6860-2019	Abisambra, Jose/0000-0001-6341-679X; Jones, Jeffrey/0000-0002-7570-2571; Koren, John/0000-0002-6017-1763; Blair, Laura/0000-0002-4981-5564; Chang, Chia Yin/0000-0002-9608-4952	National Institutes of Health, NIA [R00AG031291]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R00AG031291 from NIA.	Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; Boulton DW, 1999, J PHARM PHARMACOL, V51, P353, DOI 10.1211/0022357991772367; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; CIOCCA DR, 1993, J NATL CANCER I, V85, P570, DOI 10.1093/jnci/85.7.570; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Dickey Chad A., 2005, Current Alzheimer Research, V2, P231, DOI 10.2174/1567205053585927; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Havik B, 2007, ONCOL REP, V17, P1501; Jiang BM, 2009, FEBS J, V276, P2615, DOI 10.1111/j.1742-4658.2009.06989.x; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kelner M J, 1988, Basic Life Sci, V49, P895; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Munster PN, 2001, CANCER RES, V61, P2945; Ohnishi K, 2004, INT J RADIAT BIOL, V80, P607, DOI 10.1080/09553000412331283470; Pelicano H, 2006, LEUKEMIA, V20, P610, DOI 10.1038/sj.leu.2404140; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; VargasRoig LM, 1997, CANCER DETECT PREV, V21, P441; Visarius TM, 1997, FEBS LETT, V412, P157, DOI 10.1016/S0014-5793(97)00767-9; Voyer J, 2008, COMP BIOCHEM PHYS A, V151, P253, DOI 10.1016/j.cbpa.2008.07.004; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yano M, 1996, JPN J CANCER RES, V87, P908, DOI 10.1111/j.1349-7006.1996.tb02119.x; Yokota S, 2000, CANCER RES, V60, P2942; Zhang MC, 2007, CANCER LETT, V252, P244, DOI 10.1016/j.canlet.2006.12.035; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	39	62	62	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2498	2505		10.1074/jbc.M109.057208	http://dx.doi.org/10.1074/jbc.M109.057208			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19889640	Green Published, hybrid			2022-12-27	WOS:000273697800028
J	Demidyuk, IV; Gromova, TY; Polyakov, KM; Melik-Adamyan, WR; Kuranova, IP; Kostrov, SV				Demidyuk, Ilya V.; Gromova, Tania Yu.; Polyakov, Konstantin M.; Melik-Adamyan, William R.; Kuranova, Inna P.; Kostrov, Sergey V.			Crystal Structure of the Protealysin Precursor INSIGHTS INTO PROPEPTIDE FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOLYSIN-LIKE PROTEASES; SUBTILIS NEUTRAL-PROTEASE; AMINO-ACID-SEQUENCE; PSEUDOMONAS-AERUGINOSA; 3-DIMENSIONAL STRUCTURE; BACILLUS-CEREUS; INTRAMOLECULAR CHAPERONE; MOLECULAR-REPLACEMENT; THERMAL-STABILITY; DIFFRACTION DATA	Protealysin (PLN) belongs to the M4 family of peptidases that are commonly known as thermolysin-like proteases (TLPs). All TLPs are synthesized as precursors containing N-terminal propeptides. According to the primary structure of the N-terminal propeptides, the family is divided into two distinct groups. Representatives of the first group including thermolysin and all TLPs with known three-dimensional structures have long prosequences (similar to 200 amino acids). Enzymes of the second group, whose prototype is protealysin, have short (similar to 50 amino acids) propeptides. Here, we present the 1.8 angstrom crystal structure of PLN precursor (proPLN), which is the first three-dimensional structure of a TLP precursor. Whereas the structure of the catalytic domain of proPLN is similar overall to previously reported structures of mature TLPs, it has specific features, including the absence of calcium-binding sites, and different structures of the N-terminal region and substrate-binding site. PLN propeptide forms a separate domain in the precursor and likely acts as an inhibitor that blocks the substrate-binding site and fixes the "open" conformation of the active site, which is unfavorable for catalysis. Furthermore the conserved PPL motif identified in our previous studies directly interacts with the S' subsites of the active center being a critical element of the propeptide-catalytic domain interface. Comparison of the primary structures of TLPs with short propeptides suggests that the specific features revealed in the proPLN crystal structure are typical for all protealysin-like enzymes. Thus, such proteins can be considered as a separate subfamily of TLPs.	[Demidyuk, Ilya V.; Gromova, Tania Yu.; Kostrov, Sergey V.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Polyakov, Konstantin M.] Kurchatov Ctr Synchrotron Radiat & Nanotechnol, Moscow 123182, Russia; [Melik-Adamyan, William R.; Kuranova, Inna P.] Russian Acad Sci, AV Shubnikov Crystallog Inst, Moscow 119333, Russia	Russian Academy of Sciences; National Research Centre - Kurchatov Institute; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Demidyuk, IV (corresponding author), Kurchatov Sq 2, Moscow 123182, Russia.	duk@img.ras.ru	Kostrov, Sergey/J-6612-2018; Demidyuk, Ilya V/D-1245-2009; Kuranova, Inna P/B-1349-2014	Demidyuk, Ilya V/0000-0001-8140-2287; Polyakov, Konstantin/0000-0001-7718-4336	Russian Foundation for Basic Research [09-04-00734, 09-04-00870]; Russian Academy of Sciences; Russian Scientific-Technological Complex Development [02.512.12.2050]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Scientific-Technological Complex Development	This work was supported in part by the Russian Foundation for Basic Research (Projects 09-04-00734 and 09-04-00870), the Program for Molecular and Cell Biology of the Russian Academy of Sciences, and the Federal Program" R & D in Priority Directions of the Russian Scientific-Technological Complex Development in 2007-2012" (State Contract 02.512.12.2050).	Adekoya OA, 2009, CHEM BIOL DRUG DES, V73, P7, DOI 10.1111/j.1747-0285.2008.00757.x; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Banbula A, 1998, STRUCTURE, V6, P1185, DOI 10.1016/S0969-2126(98)00118-X; Bozhokina E, 2008, BIOCHEM BIOPH RES CO, V367, P888, DOI 10.1016/j.bbrc.2008.01.003; Braun P, 1996, MOL MICROBIOL, V19, P297, DOI 10.1046/j.1365-2958.1996.381908.x; CORBETT RJT, 1983, BIOPOLYMERS, V22, P101, DOI 10.1002/bip.360220116; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAHLQUIST FW, 1976, BIOCHEMISTRY-US, V15, P1103, DOI 10.1021/bi00650a024; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Demidyuk IV, 2008, PROTEIN J, V27, P343, DOI 10.1007/s10930-008-9143-2; Demidyuk IV, 2006, PROTEIN EXPRES PURIF, V47, P551, DOI 10.1016/j.pep.2005.12.005; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dodonov AF, 2000, EUR J MASS SPECTROM, V6, P481, DOI 10.1255/ejms.378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEDER J, 1967, BIOCHEMISTRY-US, V6, P2088, DOI 10.1021/bi00859a028; FEDER J, 1970, BIOCHEMISTRY-US, V9, P2784, DOI 10.1021/bi00816a005; Gromova TY, 2008, CRYSTALLOGR REP+, V53, P793, DOI 10.1134/S1063774508050118; Gromova TY, 2009, BIOCHIMIE, V91, P639, DOI 10.1016/j.biochi.2009.03.008; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANGAUER DG, 1984, BIOCHEMISTRY-US, V23, P5730, DOI 10.1021/bi00319a011; Hausrath AC, 2002, ACTA CRYSTALLOGR D, V58, P1002, DOI 10.1107/S090744490200584X; HOLLAND DR, 1992, BIOCHEMISTRY-US, V31, P11310, DOI 10.1021/bi00161a008; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KESSLER E, 1994, J BIOL CHEM, V269, P22726; KHAITLINA SY, 1988, FEBS LETT, V228, P172, DOI 10.1016/0014-5793(88)80610-0; Kheiker DM, 2007, CRYSTALLOGR REP+, V52, P358, DOI 10.1134/S1063774507020320; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Marie-Claire C, 1999, J MOL BIOL, V285, P1911, DOI 10.1006/jmbi.1998.2449; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; McKay D B, 1992, Matrix Suppl, V1, P112; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ODonohue MJ, 1996, J BIOL CHEM, V271, P26477, DOI 10.1074/jbc.271.43.26477; PAUPTIT RA, 1988, J MOL BIOL, V199, P525, DOI 10.1016/0022-2836(88)90623-7; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROCHE RS, 1978, CRC CR REV BIOCH MOL, V5, P1; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Serkina AV, 1999, FEBS LETT, V456, P215, DOI 10.1016/S0014-5793(99)00791-7; STARK W, 1992, EUR J BIOCHEM, V207, P781, DOI 10.1111/j.1432-1033.1992.tb17109.x; Tang B, 2003, BIOCHEM BIOPH RES CO, V301, P1093, DOI 10.1016/S0006-291X(03)00084-6; THAYER MM, 1991, J BIOL CHEM, V266, P2864; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TITANI K, 1972, BIOCHEMISTRY-US, V11, P2427, DOI 10.1021/bi00763a007; Tsaplina OA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P648, DOI 10.1134/S0006297909060091; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veltman OR, 1998, BIOCHEMISTRY-US, V37, P5312, DOI 10.1021/bi9725879; WETMORE DR, 1992, MOL MICROBIOL, V6, P1593, DOI 10.1111/j.1365-2958.1992.tb00884.x	52	24	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2003	2013		10.1074/jbc.M109.015396	http://dx.doi.org/10.1074/jbc.M109.015396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915005	Green Published, hybrid			2022-12-27	WOS:000273429100046
J	Meyer, AE; Hoover, LA; Craig, EA				Meyer, Alison E.; Hoover, Lindsey A.; Craig, Elizabeth A.			The Cytosolic J-protein, Jjj1, and Rei1 Function in the Removal of the Pre-60 S Subunit Factor Arx1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							60S RIBOSOMAL-SUBUNIT; NUCLEAR EXPORT RECEPTOR; SACCHAROMYCES-CEREVISIAE; PRERIBOSOMAL FACTORS; MATURATION; CHAPERONE; YEAST; RNA; ASSOCIATION; NUCLEOLUS	Although the biogenesis of ribosomal subunits occurs predominantly in the nucleus, final remodeling steps take place in the cytosol. One cytosolic step has two components: 1) the removal of the maturation factor Arx1, which transits from the nucleus to the cytosol with the pre-60 S subunit, and 2) its subsequent transport back into the nucleus. Two cytosolic proteins, Rei1 and Jjj1, are required, but their individual contributions to this step are not understood. Here we report that Rei1 and Jjj1 directly interact. This interaction is mediated by a C-terminal segment of Jjj1 encompassing a region rich in charged residues, flanked by C2H2-type zinc fingers. Deletion of the charged region results in defects in 60 S subunit biogenesis in vivo. In addition, we report resolution of an apparent contradiction in the literature regarding the association of Arx1 with the pre-60 S subunit in the absence of Rei1. The association of Arx1 with ribosomes is sensitive to the concentration of magnesium ions when Rei1 is absent. At near physiological concentrations, Arx1 remains associated with the pre-60 S particle, as it does in the absence of Jjj1; at higher concentrations, Arx1 dissociates in the absence of Rei1 but not in the absence of Jjj1. As both Rei1 and Jjj1 are required for dissociation of Arx1 from the pre-60 S subunit, and the region of Jjj1 that mediates interaction with Rei1 is required in vivo for 60 S subunit biogenesis, our data support the idea that the primary role of both Rei1 and Jjj1 is the first step of the Arx1 removal/recycling process.	[Meyer, Alison E.; Hoover, Lindsey A.; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu			National Institutes of Health [GM31107, T32GM0721532]; Genetech Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031107, R37GM031107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetech Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31107 (to E.A.C.) and University of Wisconsin Molecular Biosciences Training Grant T32GM0721532 from the National Institutes of Health (to L.A.H.). This work was also supported by a grant from the Genetech Foundation (to A.E.M.).	Beeler T, 1997, BBA-BIOMEMBRANES, V1323, P310, DOI 10.1016/S0005-2736(96)00199-X; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Demoinet E, 2007, RNA, V13, P1570, DOI 10.1261/rna.585007; ELSON D, 1979, NUCLEIC ACIDS RES, V7, P465, DOI 10.1093/nar/7.2.465; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; GHYSEN A, 1970, EUR J BIOCHEM, V13, P132, DOI 10.1111/j.1432-1033.1970.tb00908.x; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; HELSER TL, 1981, MOL CELL BIOL, V1, P51, DOI 10.1128/MCB.1.1.51; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hung NJ, 2008, MOL BIOL CELL, V19, P735, DOI 10.1091/mbc.E07-09-0968; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Iwase M, 2004, CELL STRUCT FUNCT, V29, P1, DOI 10.1247/csf.29.1; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Noah JW, 1998, BIOCHEMISTRY-US, V37, P15442, DOI 10.1021/bi981148m; Parnell KM, 2009, MOL CELL BIOL, V29, P4014, DOI 10.1128/MCB.01582-08; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; SIKORSKI RS, 1989, GENETICS, V122, P19; SPERRAZZA JM, 1983, NUCLEIC ACIDS RES, V11, P2665, DOI 10.1093/nar/11.9.2665; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809; Zamir A, 1974, Methods Enzymol, V30, P406; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	32	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					961	968		10.1074/jbc.M109.038349	http://dx.doi.org/10.1074/jbc.M109.038349			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19901025	Green Published, hybrid			2022-12-27	WOS:000273258200016
J	Tomilov, AA; Bicocca, V; Schoenfeld, RA; Giorgio, M; Migliaccio, E; Ramsey, JJ; Hagopian, K; Pelicci, PG; Cortopassi, GA				Tomilov, Alexey A.; Bicocca, Vincent; Schoenfeld, Robert A.; Giorgio, Marco; Migliaccio, Enrica; Ramsey, Jon J.; Hagopian, Kevork; Pelicci, Pier Giuseppe; Cortopassi, Gino A.			Decreased Superoxide Production in Macrophages of Long-lived p66Shc Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; METHIONYL-LEUCYL-PHENYLALANINE; AMYOTROPHIC-LATERAL-SCLEROSIS; RESPIRATORY BURST OXIDASE; NEUTROPHIL NADPH OXIDASE; TRANSGENIC MOUSE MODEL; OXIDATIVE STRESS; LIFE-SPAN; ADAPTER PROTEIN; TYROSINE KINASE	A decrease in reactive oxygen species (ROS) production has been associated with extended life span in animal models of longevity. Mice deficient in the p66Shc gene are long-lived, and their cells are both resistant to oxidative stress and produce less ROS. Our microarray analysis of p66Shc(-/-) mouse tissues showed alterations in transcripts involved in heme and superoxide production and insulin signaling. Thus, we carried out analysis of ROS production by NADPH oxidase (PHOX) in macrophages of control and p66Shc knock-out mice. p66Shc(-/-) mice had a 40% reduction in PHOX-dependent superoxide production. To confirm whether the defect in superoxide production was a direct consequence of p66Shc deficiency, p66Shc was knocked down with siRNA in the macrophage cell line RAW264, and a 30% defect in superoxide generation was observed. The pathway of PHOX-dependent superoxide generation was investigated. PHOX protein levels were not decreased in mutant macrophages; however, the rate and extent of phosphorylation of p47phox was decreased in mutants, as was membrane translocation of the complex. Consistently, phosphorylation of protein kinase C delta, Akt, and ERK (the kinases responsible for phosphorylation of p47phox) was decreased. Thus, p66Shc deficiency causes a defect in activation of the PHOX complex that results in decreased superoxide production. p66Shc-deficient mice have recently been observed to be resistant to atherosclerosis and to oxidant injury in kidney and brain. Because phagocyte-derived superoxide is often a component of oxidant injury and inflammation, we suggest that the decreased superoxide production by PHOX in p66Shc-deficient mice could contribute significantly to their relative protection from oxidant injury and consequent longevity.	[Hagopian, Kevork; Cortopassi, Gino A.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Giorgio, Marco; Migliaccio, Enrica; Pelicci, Pier Giuseppe] European Inst Oncol, I-20139 Milan, Italy	University of California System; University of California Davis; IRCCS European Institute of Oncology (IEO)	Cortopassi, GA (corresponding author), 1120 Haring Hall, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu	Migliaccio, Enrica/AAQ-8880-2020; Giorgio, Marco/I-9425-2012; Pelicci, Pier Giuseppe/AAL-6572-2020	Giorgio, Marco/0000-0002-5842-6042; Bicocca, Vincent/0000-0002-5702-4586	National Institutes of Health [AG025532, AG16719, EY12245]; NATIONAL EYE INSTITUTE [R01EY012245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025532, R01AG016719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG025532, AG16719, and EY12245.	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ahmed S, 1998, J BIOL CHEM, V273, P15693, DOI 10.1074/jbc.273.25.15693; Bankers-Fulbright JL, 2001, J CELL PHYSIOL, V189, P306, DOI 10.1002/jcp.10022; Bartke A, 2008, EXP GERONTOL, V43, P11, DOI 10.1016/j.exger.2007.10.009; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Berry A, 2008, EXP GERONTOL, V43, P200, DOI 10.1016/j.exger.2007.10.016; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; BOKOCH GM, 1995, TRENDS CELL BIOL, V5, P109, DOI 10.1016/S0962-8924(00)88960-6; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Caruso C, 2004, ANN NY ACAD SCI, V1028, P1, DOI 10.1196/annals.1322.001; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Dhahbi J, 2007, EXP GERONTOL, V42, P772, DOI 10.1016/j.exger.2007.04.004; Didichenko SA, 1996, CURR BIOL, V6, P1271, DOI 10.1016/S0960-9822(02)70713-6; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; ElBenna J, 1996, J BIOL CHEM, V271, P6374; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Erdreich-Epstein A, 1999, J LEUKOCYTE BIOL, V65, P523, DOI 10.1002/jlb.65.4.523; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Finch CE, 2005, NEUROBIOL AGING, V26, P281, DOI 10.1016/j.neurobiolaging.2004.03.015; Franceschi C, 2005, MECH AGEING DEV, V126, P351, DOI 10.1016/j.mad.2004.08.028; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fumagalli L, 2007, J IMMUNOL, V178, P3874, DOI 10.4049/jimmunol.178.6.3874; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; Hibbs ML, 1997, INT J BIOCHEM CELL B, V29, P397, DOI 10.1016/S1357-2725(96)00104-5; Hu YY, 2007, CELL SIGNAL, V19, P410, DOI 10.1016/j.cellsig.2006.07.017; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Khatri P, 2004, NUCLEIC ACIDS RES, V32, pW449, DOI 10.1093/nar/gkh409; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kiaei M, 2005, NEURODEGENER DIS, V2, P246, DOI 10.1159/000090364; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Legan SK, 2008, J BIOL CHEM, V283, P32492, DOI 10.1074/jbc.M805832200; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; LEUSEN JHW, 1996, FRONT BIOSCI, V1, P72; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Luchak JM, 2007, ANN NY ACAD SCI, V1119, P260, DOI 10.1196/annals.1404.000; Martin-Padura I, 2008, ENDOTHELIUM-J ENDOTH, V15, P276, DOI 10.1080/10623320802487791; Martyn KD, 2005, BLOOD, V106, P3962, DOI 10.1182/blood-2005-03-0859; Mele J, 2006, ANTIOXID REDOX SIGN, V8, P628, DOI 10.1089/ars.2006.8.628; Menini S, 2007, DIABETOLOGIA, V50, P1997, DOI 10.1007/s00125-007-0728-7; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miura K, 2000, BLOOD, V96, P2199, DOI 10.1182/blood.V96.6.2199.h8002199_2199_2205; Morgan T. E., 2007, V35, P83; Morita M, 2008, J BIOCHEM, V143, P31, DOI 10.1093/jb/mvm190; Murakami S, 2006, EXP GERONTOL, V41, P1014, DOI 10.1016/j.exger.2006.06.061; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nishida S, 2005, INFECT IMMUN, V73, P235, DOI 10.1128/IAI.73.1.235-244.2005; OKAMURA N, 1988, BLOOD, V72, P811; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Ostan R, 2008, NEUROIMMUNOMODULAT, V15, P224, DOI 10.1159/000156466; Pace A, 2006, BBA-MOL CELL RES, V1763, P356, DOI 10.1016/j.bbamcr.2006.03.004; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; Radyuk SN, 2009, BIOCHEM J, V419, P437, DOI 10.1042/BJ20082003; Remijsen QFM, 2006, FEBS LETT, V580, P6206, DOI 10.1016/j.febslet.2006.10.024; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Taille C, 2004, J BIOL CHEM, V279, P28681, DOI 10.1074/jbc.M310661200; Torres M, 1996, J BIOL CHEM, V271, P13244, DOI 10.1074/jbc.271.22.13244; Treuting PM, 2008, J GERONTOL A-BIOL, V63, P813, DOI 10.1093/gerona/63.8.813; Tsunawaki S, 2004, INFECT IMMUN, V72, P3373, DOI 10.1128/IAI.72.6.3373-3382.2004; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wientjes FB, 2001, BIOCHEM BIOPH RES CO, V289, P382, DOI 10.1006/bbrc.2001.5982; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Yoshida LS, 2000, BIOCHEM BIOPH RES CO, V268, P716, DOI 10.1006/bbrc.2000.2192; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zoja C, 2007, ARTHRITIS RHEUM, V56, P1629, DOI 10.1002/art.22593	91	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1153	1165		10.1074/jbc.M109.017491	http://dx.doi.org/10.1074/jbc.M109.017491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19892704	hybrid, Green Published			2022-12-27	WOS:000273258200038
J	Boeing, S; Rigault, C; Heidemann, M; Eick, D; Meisterernst, M				Boeing, Stefan; Rigault, Caroline; Heidemann, Martin; Eick, Dirk; Meisterernst, Michael			RNA Polymerase II C-terminal Heptarepeat Domain Ser-7 Phosphorylation Is Established in a Mediator-dependent Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; REPEAT DOMAIN; IN-VITRO; TFIIH; KINASE; CTD; RECRUITMENT	The largest subunit of RNA polymerase II (RNAPII) C-terminal heptarepeat domain (CTD) is subject to phosphorylation during initiation and elongation of transcription by RNA polymerase II. Here we study the molecular mechanisms leading to phosphorylation of Ser-7 in the human enzyme. Ser-7 becomes phosphorylated before initiation of transcription at promoter regions. We identify cyclin-dependent kinase 7 (CDK7) as one responsible kinase. Phosphorylation of both Ser-5 and Ser-7 is fully dependent on the cofactor complex Mediator. A subform of Mediator associated with an active RNAPII is critical for preinitiation complex formation and CTD phosphorylation. The Mediator-RNAPII complex independently recruits TFIIB and CDK7 to core promoter regions. CDK7 phosphorylates Ser-7 selectively in the context of an intact preinitiation complex. CDK7 is not the only kinase that can modify Ser-7 of the CTD. ChIP experiments with chemical inhibitors provide evidence that other yet to be identified kinases further phosphorylate Ser-7 in coding regions.	[Boeing, Stefan; Rigault, Caroline; Meisterernst, Michael] Univ Munster, Inst Mol Tumor Biol, D-48149 Munster, Germany; [Heidemann, Martin; Eick, Dirk] Ctr Integrated Prot Sci, Helmholtz Ctr Environm Hlth, Inst Clin Mol Biol & Tumor Genet, D-81377 Munich, Germany	University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Meisterernst, M (corresponding author), Univ Munster, Inst Mol Tumor Biol, Robert Koch Str 43, D-48149 Munster, Germany.	meisterernst@uni-muenster.de			Bundesministerium fur Bildung und Forschung; QuantPro Grant [0313860D]; European Commission [EuTRACC 037445]; Deutsche Forschungsgemeinschaft [ME 967/2-1, SPP1356]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); QuantPro Grant; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Bundesministerium fur Bildung und Forschung Grant QuantPro Grant 0313860D, European Commission Grant EuTRACC 037445, and Deutsche Forschungsgemeinschaft Grants ME 967/2-1 and SPP1356 (to M. M.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Albert TK, 2007, P NATL ACAD SCI USA, V104, P10000, DOI 10.1073/pnas.0703490104; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Blazek E, 2005, CHROMOSOMA, V113, P399, DOI 10.1007/s00412-005-0329-5; Bonnet F, 1999, NUCLEIC ACIDS RES, V27, P4399, DOI 10.1093/nar/27.22.4399; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Furumoto T, 2007, GENES CELLS, V12, P119, DOI 10.1111/j.1365-2443.2007.01036.x; Gebara MM, 1997, J CELL BIOCHEM, V64, P390; Gilfillan S, 2005, J BIOL CHEM, V280, P6222, DOI 10.1074/jbc.M406343200; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KRETZSCHMAR M, 1994, MOL CELL BIOL, V14, P3927, DOI 10.1128/MCB.14.6.3927; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; STELZER G, 1994, MOL CELL BIOL, V14, P4712, DOI 10.1128/MCB.14.7.4712; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Uhlmann T, 2007, J BIOL CHEM, V282, P2163, DOI 10.1074/jbc.M608451200; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015	46	43	45	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					188	196		10.1074/jbc.M109.046565	http://dx.doi.org/10.1074/jbc.M109.046565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19901026	hybrid, Green Published			2022-12-27	WOS:000273070100020
J	Poulin, MB; Nothaft, H; Hug, I; Feldman, MF; Szymanski, CM; Lowary, TL				Poulin, Myles B.; Nothaft, Harald; Hug, Isabelle; Feldman, Mario F.; Szymanski, Christine M.; Lowary, Todd L.			Characterization of a Bifunctional Pyranose-Furanose Mutase from Campylobacter jejuni 11168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GALACTOPYRANOSE MUTASE; ESCHERICHIA-COLI O52; STD-NMR SPECTROSCOPY; O-ANTIGEN; KLEBSIELLA-PNEUMONIAE; CATALYTIC MECHANISM; CHEMICAL-STRUCTURE; GALACTOFURANOSE; BIOSYNTHESIS; LIPOPOLYSACCHARIDE	UDP-galactopyranose mutases (UGM) are the enzymes responsible for the synthesis of UDP-galactofuranose (UDP-Galf) from UDP-galactopyranose (UDP-Galp). The enzyme, encoded by the glf gene, is present in bacteria, parasites, and fungi that express Galf in their glycoconjugates. Recently, a UGM homologue encoded by the cj1439 gene has been identified in Campylobacter jejuni 11168, an organism possessing no Galf-containing glycoconjugates. However, the capsular polysaccharide from this strain contains a 2-acetamido-2-deoxy-D-galactofuranose (GalfNAc) moiety. Using an in vitro high performance liquid chromatography assay and complementation studies, we characterized the activity of this UGM homologue. The enzyme, which we have renamed UDP-N-acetylgalactopyranose mutase (UNGM), has relaxed specificity and can use either UDP-Gal or UDP-GalNAc as a substrate. Complementation studies of mutase knock-outs in C. jejuni 11168 and Escherichia coli W3110, the latter containing Galf residues in its lipopolysaccharide, demonstrated that the enzyme recognizes both UDP-Gal and UDP-GalNAc in vivo. A homology model of UNGM and site-directed mutagenesis led to the identification of two active site amino acid residues involved in the recognition of the UDP-GalNAc substrate. The specificity of UNGM was characterized using a two-substrate co-incubation assay, which demonstrated, surprisingly, that UDP-Gal is a better substrate than UDP-GalNAc.	[Nothaft, Harald; Hug, Isabelle; Feldman, Mario F.; Szymanski, Christine M.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada; [Poulin, Myles B.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2R3, Canada; [Poulin, Myles B.; Nothaft, Harald; Hug, Isabelle; Feldman, Mario F.; Szymanski, Christine M.; Lowary, Todd L.] Univ Alberta, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB T6G 2R3, Canada	University of Alberta; University of Alberta; University of Alberta	Szymanski, CM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada.	cszymans@ualberta.ca; tlowary@ualberta.ca	Feldman, Mario/A-2637-2014; Lowary, Todd L/F-9608-2019; Szymanski, Christine/A-3763-2014	Feldman, Mario/0000-0003-4497-0976; Lowary, Todd L/0000-0002-8331-8211; Szymanski, Christine/0000-0002-8464-1352; Hug, Isabelle/0000-0002-4524-9569; Poulin, Myles/0000-0002-3789-703X	Alberta Ingenuity Centre for Carbohydrate Science; National Sciences and Engineering Research Council of Canada	Alberta Ingenuity Centre for Carbohydrate Science; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by the Alberta Ingenuity Centre for Carbohydrate Science and National Sciences and Engineering Research Council of Canada.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Arbatsky NP, 1998, CARBOHYD RES, V310, P85, DOI 10.1016/S0008-6215(98)00157-8; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Belanova M, 2008, J BACTERIOL, V190, P1141, DOI 10.1128/JB.01326-07; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Bian XL, 2007, J VIROL, V81, P2899, DOI 10.1128/JVI.01850-06; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Caravano A, 2006, BIOORG MED CHEM LETT, V16, P1123, DOI 10.1016/j.bmcl.2005.11.106; Carlson EE, 2006, CHEM BIOL, V13, P825, DOI 10.1016/j.chembiol.2006.06.007; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; CHA S, 1968, MOL PHARMACOL, V4, P621; Chad JM, 2007, BIOCHEMISTRY-US, V46, P6723, DOI 10.1021/bi7002795; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; DELEDERKREMER RM, 1994, J ORG CHEM, V59, P690, DOI 10.1021/jo00082a037; DELEDERKREMER RM, 1995, GLYCOBIOLOGY, V5, P547, DOI 10.1093/glycob/5.6.547; Eppe G, 2009, BIOORG MED CHEM LETT, V19, P814, DOI 10.1016/j.bmcl.2008.12.014; Errey JC, 2009, ORG BIOMOL CHEM, V7, P1009, DOI 10.1039/b815549f; Errey JC, 2004, CHEM COMMUN, P2706, DOI 10.1039/b410184g; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Feng L, 2004, J BACTERIOL, V186, P4510, DOI 10.1128/JB.186.14.4510-4519.2004; Fersht A., 1999, STRUCTURE MECH PROTE, P116; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Gruber TD, 2009, J MOL BIOL, V391, P327, DOI 10.1016/j.jmb.2009.05.081; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Hanniffy OM, 1999, CARBOHYD RES, V319, P124, DOI 10.1016/S0008-6215(99)00129-9; Itoh K, 2007, ORG LETT, V9, P879, DOI 10.1021/ol0631408; KALDOR J, 1984, BRIT MED J, V288, P1867, DOI 10.1136/bmj.288.6434.1867; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lee R, 1996, ANAL BIOCHEM, V242, P1, DOI 10.1006/abio.1996.0419; Lee RE, 1997, TETRAHEDRON LETT, V38, P6733, DOI 10.1016/S0040-4039(97)01539-6; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; Marolda Cristina L., 2006, V347, P237; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Rose NL, 2005, J CHEM EDUC, V82, P1846, DOI 10.1021/ed082p1846; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Wang Q, 2008, MOL MICROBIOL, V70, P1358, DOI 10.1111/j.1365-2958.2008.06449.x; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Yao XH, 2009, PROTEINS, V74, P972, DOI 10.1002/prot.22206; Yuan Y, 2005, BIOCHEMISTRY-US, V44, P14080, DOI 10.1021/bi0513406; Yuan Y, 2008, J AM CHEM SOC, V130, P3157, DOI 10.1021/ja7104152; Zhang QB, 2001, J AM CHEM SOC, V123, P6756, DOI 10.1021/ja010473l; Zhang QB, 2000, J AM CHEM SOC, V122, P9065, DOI 10.1021/ja001333z	62	24	24	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					493	501		10.1074/jbc.M109.072157	http://dx.doi.org/10.1074/jbc.M109.072157			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887444	Green Published, hybrid			2022-12-27	WOS:000273070100051
J	Fernandez-Zapico, ME; van Velkinburgh, JC; Gutierrez-Aguilar, R; Neve, B; Froguel, P; Urrutia, R; Stein, R				Fernandez-Zapico, Martin E.; van Velkinburgh, Jennifer C.; Gutierrez-Aguilar, Ruth; Neve, Bernadette; Froguel, Philippe; Urrutia, Raul; Stein, Roland			MODY7 Gene, KLF11, Is a Novel p300-dependent Regulator of Pdx-1 (MODY4) Transcription in Pancreatic Islet beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN PROTEIN IDX-1; NUCLEAR FACTOR 3-BETA; GROWTH-REGULATION; P300 COACTIVATOR; EXPRESSION; PROMOTER; DIFFERENTIATION; REGION; MICE; REPRESSORS	Pdx-1 (pancreatic-duodenal homeobox-1), a MODY4 homeodomain transcription factor, serves as a master regulator in the pancreas because of its importance during organogenesis and in adult islet insulin-producing beta cell activity. Here, we show that KLF11, an SP/Kruppel-like (SP/KLF) transcription factor, mutated in French maturity onset diabetes of the young patients (MODY7), regulates Pdx-1 transcription in beta cells through two evolutionarily conserved GC-rich motifs in conserved Area II, a control region essential to islet beta cell-enriched expression. These regulatory elements, termed GC1 (human base pair -2061/-2055) and GC2 (-2036/-2027), are also nearly identical to the consensus KLF11 binding sequence defined here by random oligonucleotide binding analysis. KLF11 specifically associates with Area II in chromatin immunoprecipitation assays, while preventing binding to GC1- and/or GC2-compromised Pdx1-driven reporter activity in beta cell lines. Mechanistically, we find that KLF11 interacts with the coactivator p300 via its zinc finger domain in vivo to mediate Pdx-1 activation. Together, our data identified a hierarchical regulatory cascade for these two MODY genes, suggesting that gene regulation in MODY is more complex than anticipated previously. Furthermore, because KLF11 like most MODY-associated transcription factors uses p300, these data further support a role for this coactivator as a critical chromatin link in forms of type 2 diabetes.	[Fernandez-Zapico, Martin E.; Stein, Roland] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [van Velkinburgh, Jennifer C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Gutierrez-Aguilar, Ruth; Neve, Bernadette; Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS, UMR 8090, F-59019 Lille, France; [Neve, Bernadette; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London SW7 2AZ, England; [Urrutia, Raul] Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Vanderbilt University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Mayo Clinic	Stein, R (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	roland.stein@vanderbilt.edu	FROGUEL, Philippe/O-6799-2017; Neve, Bernadette/J-6008-2014; van Velkinburgh, Jennifer/D-7205-2015	FROGUEL, Philippe/0000-0003-2972-0784; Neve, Bernadette/0000-0003-1516-1379; van Velkinburgh, Jennifer/0000-0002-4592-2397	USPHS [P60 DK20593]; French National Research Agency [ANR-06-BLAN-0236]; European Regional Development Fund; Region Nord-Pas de Calais grants;  [RO1 DK-50203];  [5T32 CA09385-18];  [CA125127];  [CA136526];  [DK 52913]; MRC [G0600331] Funding Source: UKRI; Medical Research Council [G0600331] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA136526, T32CA009385, R03CA125127, P50CA102701, P50CA097274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052913, R01DK050203, R01DK052913, P60DK020593] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); French National Research Agency(French National Research Agency (ANR)); European Regional Development Fund(European Commission); Region Nord-Pas de Calais grants(Region Hauts-de-France); ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P60 DK20593 from USPHS and Grant RO1 DK-50203 (to R. S.), Training Grant 5T32 CA09385-18 (to J. C. V. V.), Grants CA125127 and CA136526 (to M. E. F.-Z.), and Grant DK 52913 (to R. U.). This work was also supported by French National Research Agency Grant ANR-06-BLAN-0236, European Regional Development Fund, and Region Nord-Pas de Calais grants (to P. F. and B. N.).	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Ban N, 2002, DIABETES, V51, P1409, DOI 10.2337/diabetes.51.5.1409; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Clocquet AR, 2000, DIABETES, V49, P1856, DOI 10.2337/diabetes.49.11.1856; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; Eeckhoute J, 2001, MOL ENDOCRINOL, V15, P1200, DOI 10.1210/me.15.7.1200; Ellenrieder V, 2004, GASTROENTEROLOGY, V127, P607, DOI 10.1053/j.gastro.2004.05.018; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Katz JP, 2002, DEVELOPMENT, V129, P2619; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Offield MF, 1996, DEVELOPMENT, V122, P983; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1999, ENDOCRINOLOGY, V140, P5374, DOI 10.1210/en.140.11.5374; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Wiebe PO, 2007, MOL CELL BIOL, V27, P4093, DOI 10.1128/MCB.01978-06; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	39	75	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36482	36490		10.1074/jbc.M109.028852	http://dx.doi.org/10.1074/jbc.M109.028852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843526	hybrid, Green Published			2022-12-27	WOS:000272970500050
J	Liu, RR; Murphy, TH				Liu, Ran R.; Murphy, Timothy H.			Reversible Cyclosporin A-sensitive Mitochondrial Depolarization Occurs within Minutes of Stroke Onset in Mouse Somatosensory Cortex in Vivo A TWO-PHOTON IMAGING STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; TRANSIENT FOREBRAIN ISCHEMIA; CEREBRAL-ARTERY OCCLUSION; CEREBELLAR GRANULE CELLS; IN-VIVO; GLUTAMATE EXCITOTOXICITY; DENDRITIC STRUCTURE; LIVER-MITOCHONDRIA; OXIDATIVE STRESS; CYCLOPHILIN-D	Neuronal structure and function are rapidly damaged during global ischemia but can in part recover during reperfusion. Despite apparent recovery in the hours/days following an ischemic episode, delayed cell death can be initiated, making it important to understand how initial ischemic events affect potential mediators of apoptosis. Mitochondrial dysfunction and the opening of the mitochondrial permeability transition pore (mPTP) are proposed to link ischemic ionic imbalance to mitochondrially mediated cell death pathways. Using two-photon microscopy, we monitored mitochondrial transmembrane potential (Delta psi(m)) in vivo within the somatosensory cortex during ischemia and reperfusion in a mouse global ischemia model. Our results indicated a synchronous loss of Delta psi(m) within 1-3 min of ischemic onset that was linked to within seconds of plasma membrane potential (Delta psi(p)) depolarization. Delta psi(m) recovered rapidly upon reperfusion, and no delayed depolarization was observed over 2 h. Cyclosporin A treatment largely blocked Delta psi(m) collapse during ischemia, suggesting a role for the mPTP. Blocking Delta psi(m) depolarization did not affect structural damage to dendrites, indicating that the opening of the mPTP and damage to dendrites are separable pathways that are activated during Delta psi(p) depolarization. Our findings using in vivo imaging suggest that mitochondrial dysfunction and specifically the activation of the mPTP are early reversible events during brain ischemia that could trigger delayed cell death.	[Liu, Ran R.; Murphy, Timothy H.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Murphy, Timothy H.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Murphy, TH (corresponding author), Univ British Columbia, Dept Psychiat, 4N1-2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	thmurphy@interchange.ubc.ca	Murphy, Timothy/AAW-1975-2021; Murphy, Timothy H/I-4982-2014	Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Stroke Network	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Stroke Network	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon (to T.H.M.) and grants from the Canadian Stroke Network (to T.H.M.).	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Andreyev A, 1999, CELL DEATH DIFFER, V6, P825, DOI 10.1038/sj.cdd.4400565; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BENEL L, 1989, BASIC APPL HISTOCHEM, V33, P71; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frantseva MV, 2001, FREE RADICAL BIO MED, V31, P1216, DOI 10.1016/S0891-5849(01)00705-5; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Gao TM, 1998, NEUROSCIENCE, V87, P371, DOI 10.1016/S0306-4522(98)00150-X; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Iyirhiaro GO, 2008, J NEUROCHEM, V105, P703, DOI 10.1111/j.1471-4159.2007.05166.x; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mayevsky A, 2007, MITOCHONDRION, V7, P330, DOI 10.1016/j.mito.2007.05.001; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Nicholls DG, 2003, CELL CALCIUM, V34, P407, DOI 10.1016/S0143-4160(03)00144-1; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Sheldon C, 2002, J NEUROPHYSIOL, V87, P2209, DOI 10.1152/jn.2002.87.5.2209; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Vergun O, 2005, BBA-BIOENERGETICS, V1709, P127, DOI 10.1016/j.bbabio.2005.07.006; Ward MW, 2000, J NEUROSCI, V20, P7208; White RJ, 1996, J NEUROSCI, V16, P5688; Yonekura I, 2004, J CEREBR BLOOD F MET, V24, P151, DOI 10.1097/01.WCB.0000096063.84070.C1; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	44	46	46	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36109	36117		10.1074/jbc.M109.055301	http://dx.doi.org/10.1074/jbc.M109.055301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19892710	Green Published, hybrid			2022-12-27	WOS:000272970500012
J	Hsu, TL; Cheng, SC; Yang, WB; Chin, SW; Chen, BH; Huang, MT; Hsieh, SL; Wong, CH				Hsu, Tsui-Ling; Cheng, Shih-Chin; Yang, Wen-Bin; Chin, See-Wen; Chen, Bo-Hua; Huang, Ming-Ting; Hsieh, Shie-Liang; Wong, Chi-Huey			Profiling Carbohydrate-Receptor Interaction with Recombinant Innate Immunity Receptor-Fc Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE MANNOSE RECEPTOR; BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; FUCOSE-CONTAINING GLYCOPROTEINS; LUCIDUM REISHI POLYSACCHARIDES; PATTERN-RECOGNITION RECEPTOR; FUNGUS GANODERMA-LUCIDUM; HUMAN DENDRITIC CELLS; TOLL-LIKE RECEPTORS; DC-SIGN	The recognition of bacteria, viruses, fungi, and other microbes is controlled by host immune cells, which are equipped with many innate immunity receptors, such as Toll-like receptors, C-type lectin receptors, and immunoglobulin-like receptors. Our studies indicate that the immune modulating properties of many herbal drugs, for instance, the medicinal fungus Reishi (Ganoderma lucidum) and Cordyceps sinensis, could be attributed to their polysaccharide components. These polysaccharides specifically interact with and activate surface receptors involved in innate immunity. However, due to the complexity of polysaccharides and their various sources from medicinal fungi, quantitative analysis of medicinal polysaccharide extracts with regard to their functions represents a major challenge. To profile carbohydrate-immune receptor interactions, the extracellular domains of 17 receptors were cloned as Fc-fusion proteins, such that their interactions with immobilized polysaccharides could be probed in an enzyme-linked immunosorbent assay. The results show that several innate immune receptors, including Dectin-1, DC-SIGN, Langerin, Kupffer cell receptor, macrophage mannose receptor, TLR2, and TLR4, interact with the polysaccharide extracts from G. lucidum (GLPS). This analysis revealed distinct polysaccharide profiles from different sources of medicinal fungi, and the innate immune receptor-based enzyme-linked immunosorbent assay described here can serve as a high-throughput profiling method for the characterization and quality control of medicinal polysaccharides. It also provides a means to dissect the molecular mechanism of medicinal polysaccharide-induced immunomodulation events.	[Cheng, Shih-Chin; Huang, Ming-Ting; Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsu, Tsui-Ling; Yang, Wen-Bin; Chin, See-Wen; Chen, Bo-Hua; Hsieh, Shie-Liang; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Hsieh, Shie-Liang] Taipei Vet Gen Hosp, Immunol Res Ctr, Taipei 112, Taiwan; [Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wong, Chi-Huey] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; Scripps Research Institute; Scripps Research Institute	Hsieh, SL (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, 155 Li Nong St,Sect 2, Taipei 112, Taiwan.	slhsieh@ym.edu.tw; chwong@gate.sinica.edu.tw	Hsieh, Shie-Liang Edmond/ABA-9184-2021; CHENG, SHIH-CHIN/M-3773-2019; Hsu, Tsui-Ling/H-6704-2015; Hsu, Tsui-Ling/AAE-8821-2019	CHENG, SHIH-CHIN/0000-0003-1251-8774; Hsu, Tsui-Ling/0000-0002-2912-3261	National Sciences Council, Taiwan [95-2320-B-010-040-MY3]; Taipei Veterans General Hospital, Taiwan [V96S5-001]; Taiwan Merit Scholarship [TMS-094-1-B-003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Sciences Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); Taiwan Merit Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Sciences Council, Taiwan, Grant 95-2320-B-010-040-MY3, Taipei Veterans General Hospital, Taiwan, Grant V96S5-001 ( to S. L. H.), and Taiwan Merit Scholarship TMS-094-1-B-003 ( to T. L. H.).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Athman R, 2004, CURR OPIN MICROBIOL, V7, P25, DOI 10.1016/j.mib.2003.12.013; Balon TW, 2002, J ALTERN COMPLEM MED, V8, P315, DOI 10.1089/10755530260128005; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Chan WK, 2007, INT IMMUNOL, V19, P891, DOI 10.1093/intimm/dxm061; Chen HS, 2004, BIOORGAN MED CHEM, V12, P5595, DOI 10.1016/j.bmc.2004.08.003; Chen ML, 2008, ANGEW CHEM INT EDIT, V47, P8627, DOI 10.1002/anie.200803377; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7412; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7426; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Lien E J, 1990, Prog Drug Res, V34, P395; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; MIYAZAKI T, 1982, CARBOHYD RES, V109, P290, DOI 10.1016/0008-6215(82)84047-0; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Shao BM, 2004, BIOCHEM BIOPH RES CO, V323, P133, DOI 10.1016/j.bbrc.2004.08.069; Sheikh H, 2000, J CELL SCI, V113, P1021; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; STAHL PD, 1990, AM J RESP CELL MOL, V2, P317, DOI 10.1165/ajrcmb/2.4.317; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; USUI T, 1983, CARBOHYD RES, V115, P273, DOI 10.1016/0008-6215(83)88159-2; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Watson AA, 2007, J BIOL CHEM, V282, P3165, DOI 10.1074/jbc.M610383200; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429	59	58	61	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34479	34489		10.1074/jbc.M109.065961	http://dx.doi.org/10.1074/jbc.M109.065961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837675	hybrid, Green Published			2022-12-27	WOS:000272439600002
J	Lee, C; Tibbetts, AS; Kramer, G; Appling, DR				Lee, Changkeun; Tibbetts, Anne S.; Kramer, Gisela; Appling, Dean R.			Yeast AEP3p Is an Accessory Factor in Initiation of Mitochondrial Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; TRANSFER-RNA TRANSFORMYLASE; MESSENGER-RNA; PROTEIN-SYNTHESIS; RIBONUCLEIC-ACID; TERMINAL DOMAIN; GENE; PURIFICATION; BINDING; COX1	Initiation of protein synthesis in mitochondria and chloroplasts normally uses a formylated initiator methionyl-tRNA (fMet-tRNA(f)(Met)). However, mitochondrial protein synthesis in Saccharomyces cerevisiae can initiate with nonformylated Met-tRNA(f)(Met), as demonstrated in yeast mutants in which the nuclear gene encoding mitochondrial methionyl-tRNA formyltransferase (FMT1) has been deleted. The role of formylation of the initiator tRNA is not known, but in vitro formylation increases binding of Met-tRNA(f)(Met) to translation initiation factor 2 (IF2). We hypothesize the existence of an accessory factor that assists mitochondrial IF2 (mIF2) in utilizing unformylated Met-tRNA(f)(Met). This accessory factor might be unnecessary when formylated Met-tRNA(f)(Met) is present but becomes essential when only the unformylated species are available. Using a synthetic petite genetic screen in yeast, we identified a mutation in the AEP3 gene that caused a synthetic respiratory-defective phenotype together with Delta fmt1. The same aep3 mutation also caused a synthetic respiratory defect in cells lacking formylated Met-tRNA(f)(Met) due to loss of the MIS1 gene that encodes the mitochondrial C-1-tetrahydrofolate synthase. The AEP3 gene encodes a peripheral mitochondrial inner membrane protein that stabilizes mitochondrially encoded ATP6/8 mRNA. Here we show that the AEP3 protein (Aep3p) physically interacts with yeast mIF2 both in vitro and in vivo and promotes the binding of unformylated initiator tRNA to yeast mIF2. We propose that Aep3p functions as an accessory initiation factor in mitochondrial protein synthesis.	[Appling, Dean R.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.	dappling@mail.utexas.edu			United States Army Research Office [W911NF-07-1-0040]	United States Army Research Office	This work was supported by United States Army Research Office Grant W911NF-07-1-0040.	Allen GS, 2007, MOL MICROBIOL, V63, P941, DOI 10.1111/j.1365-2958.2006.05574.x; APPLING DR, 1985, J BIOL CHEM, V260, P1248; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan SY, 2003, J BIOL CHEM, V278, P43051, DOI 10.1074/jbc.M308696200; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; DICKERMA.HW, 1967, J BIOL CHEM, V242, P1522; Ellis TP, 2004, J BIOL CHEM, V279, P15728, DOI 10.1074/jbc.M314162200; EPLER JL, 1970, BIOCHEMISTRY-US, V9, P3575, DOI 10.1021/bi00820a011; FELDMAN F, 1974, J BIOL CHEM, V249, P3702; GALPER JB, 1969, BIOCHEM BIOPH RES CO, V34, P205, DOI 10.1016/0006-291X(69)90633-0; Garofalo C, 2005, ARCH BIOCHEM BIOPHYS, V439, P113, DOI 10.1016/j.abb.2005.05.003; Garofalo C, 2003, ARCH BIOCHEM BIOPHYS, V413, P243, DOI 10.1016/S0003-9861(03)00119-X; Gaur R, 2008, MOL CELL, V29, P180, DOI 10.1016/j.molcel.2007.11.021; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; GUALERZI CO, 1991, J BIOL CHEM, V266, P16356; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; HALBREICH A, 1971, P NATL ACAD SCI USA, V68, P294, DOI 10.1073/pnas.68.2.294; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kirksey TJ, 1996, ARCH BIOCHEM BIOPHYS, V333, P251, DOI 10.1006/abbi.1996.0388; Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200; Krause K, 2004, MOL BIOL CELL, V15, P2674, DOI 10.1091/mbc.E04-02-0126; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; LAALAMI S, 1991, BIOCHIMIE, V73, P1557, DOI 10.1016/0300-9084(91)90191-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIAO HX, 1991, J BIOL CHEM, V266, P20714; Ma JH, 1996, J BIOL CHEM, V271, P5805, DOI 10.1074/jbc.271.10.5805; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Moreno JI, 2009, CURR GENET, V55, P475, DOI 10.1007/s00294-009-0260-z; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nouet C, 2007, GENETICS, V175, P1105, DOI 10.1534/genetics.106.063883; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Pearson BM, 2002, YEAST, V19, P123, DOI 10.1002/yea.809; Perez-Martinez X, 2008, CURR TOP MED CHEM, V8, P1335, DOI 10.2174/156802608786141124; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Ray P, 2008, J BIOL CHEM, V283, P9681, DOI 10.1074/jbc.M710294200; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Spencer AC, 2005, BBA-PROTEINS PROTEOM, V1750, P69, DOI 10.1016/j.bbapap.2005.03.009; Spremulli LL, 2004, PROG NUCLEIC ACID RE, V77, P211, DOI 10.1016/S0079-6603(04)77006-3; SUNDARI RM, 1976, J BIOL CHEM, V251, P3338; Szkaradkiewicz K, 2000, EUR J BIOCHEM, V267, P4290, DOI 10.1046/j.1432-1327.2000.01480.x; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Tavares-Carreon F, 2008, J BIOL CHEM, V283, P1472, DOI 10.1074/jbc.M708437200; Tibbetts AS, 2003, J BIOL CHEM, V278, P31774, DOI 10.1074/jbc.M304962200; Tibbetts AS, 2000, J BIOL CHEM, V275, P20920, DOI 10.1074/jbc.M909851199; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Vial L, 2003, BIOCHEMISTRY-US, V42, P932, DOI 10.1021/bi026901x; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Williams EH, 2007, GENETICS, V175, P1117, DOI 10.1534/genetics.106.064576; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348	63	15	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34116	34125		10.1074/jbc.M109.055350	http://dx.doi.org/10.1074/jbc.M109.055350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19843529	hybrid, Green Published			2022-12-27	WOS:000272165200044
J	Lukey, MJ; Parkin, A; Roessler, MM; Murphy, BJ; Harmer, J; Palmer, T; Sargent, F; Armstrong, FA				Lukey, Michael J.; Parkin, Alison; Roessler, Maxie M.; Murphy, Bonnie J.; Harmer, Jeffrey; Palmer, Tracy; Sargent, Frank; Armstrong, Fraser A.			How Escherichia coli Is Equipped to Oxidize Hydrogen under Different Redox Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND HYDROGENASE; RALSTONIA-EUTROPHA H16; IRON-SULFUR CLUSTER; DESULFOVIBRIO-VULGARIS HILDENBOROUGH; ELECTRON-PARAMAGNETIC-RESONANCE; NICKEL-CONTAINING HYDROGENASE; DEPENDENT GENE-EXPRESSION; NIFE HYDROGENASE; CHROMATIUM-VINOSUM; ENZYME ELECTROKINETICS	The enterobacterium Escherichia coli synthesizes two H-2 uptake enzymes, Hyd-1 and Hyd-2. We show using precise electrochemical kinetic measurements that the properties of Hyd-1 and Hyd-2 contrast strikingly, and may be individually optimized to function under distinct environmental conditions. Hyd-2 is well suited for fast and efficient catalysis in more reducing environments, to the extent that in vitro it behaves as a bidirectional hydrogenase. In contrast, Hyd-1 is active for H-2 oxidation under more oxidizing conditions and cannot function in reverse. Importantly, Hyd-1 is O-2 tolerant and can oxidize H-2 in the presence of air, whereas Hyd-2 is ineffective for H-2 oxidation under aerobic conditions. The results have direct relevance for physiological roles of Hyd-1 and Hyd-2, which are expressed in different phases of growth. The properties that we report suggest distinct technological applications of these contrasting enzymes.	[Palmer, Tracy; Sargent, Frank] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Armstrong, Fraser A.] Univ Oxford, Dept Inorgan Chem, Oxford OX1 3QR, England	University of Dundee; University of Oxford	Sargent, F (corresponding author), Univ Dundee, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	F.Sargent@dundee.ac.uk; fraser.armstrong@chem.ox.ac.uk	Harmer, Jeffrey R/B-7417-2011; Harmer, Jeffrey/AAR-1851-2021; Parkin, Alison/E-4508-2011	Harmer, Jeffrey R/0000-0003-4583-2401; Harmer, Jeffrey/0000-0003-4583-2401; Parkin, Alison/0000-0003-4715-7200; Roessler, Maxie/0000-0002-5291-4328; Lukey, Michael/0000-0003-3608-3883; Sargent, Frank/0000-0002-6841-3624; Palmer, Tracy/0000-0001-9043-2592; Murphy, Bonnie/0000-0001-6341-9368	United Kingdom Biotechnology and Biological Sciences Research Council [P15018, BB/H001190/1, BB/D52222X, BB/H003878/1]; Engineering and Physical Sciences Research Council; Centre for Advanced Electron Spin Resonance [EP/D0448559/1]; Royal Society; Merton College, Oxford; Biotechnology and Biological Sciences Research Council [BB/D52222X/1, BB/H003878/1, BB/H001190/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D047943/1, EP/D048559/1] Funding Source: researchfish; Medical Research Council [G117/519] Funding Source: researchfish; BBSRC [BB/H001190/1, BB/H003878/1] Funding Source: UKRI; EPSRC [EP/D048559/1, EP/D047943/1] Funding Source: UKRI; MRC [G117/519] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Centre for Advanced Electron Spin Resonance; Royal Society(Royal Society of London); Merton College, Oxford; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grants P15018 and BB/H001190/1 (to F. S.) and BB/D52222X and BB/H003878/1 (to F. A. A.), the Engineering and Physical Sciences Research Council (Supergen V (to F. A. A.) and EP/D0448559/1 supporting the Centre for Advanced Electron Spin Resonance), the Royal Society through a University Research Fellowship (to F. S.), and a Merton College, Oxford, Junior Research Fellowship (to A. P.).	ADAMS MWW, 1979, BIOCHEM J, V183, P11, DOI 10.1042/bj1830011; ALBRACHT SPJ, 1983, BIOCHIM BIOPHYS ACTA, V724, P309, DOI 10.1016/0005-2728(83)90089-0; ALBRACHT SPJ, 1985, BIOCHIM BIOPHYS ACTA, V832, P89, DOI 10.1016/0167-4838(85)90177-3; ALBRACHT SPJ, 1984, BIOCHIM BIOPHYS ACTA, V766, P245, DOI 10.1016/0005-2728(84)90238-X; ALBRACHT SPJ, 1982, BIOCHIM BIOPHYS ACTA, V681, P330, DOI 10.1016/0005-2728(82)90041-X; Armstrong FA, 2005, CURR OPIN CHEM BIOL, V9, P110, DOI 10.1016/j.cbpa.2005.02.011; ARMSTRONG FA, 2005, PHILOS T A, V363; Atlung T, 1997, J BACTERIOL, V179, P2141, DOI 10.1128/jb.179.7.2141-2146.1997; ATLUNG T, 1989, J BACTERIOL, V171, P1683, DOI 10.1128/jb.171.3.1683-1691.1989; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Bard A.J., 2000, ELECTROCHEMICAL METH; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; BRONDSTED L, 1994, J BACTERIOL, V176, P5423; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Caffrey SA, 2007, J BACTERIOL, V189, P6159, DOI 10.1128/JB.00747-07; CAMMACK R, 1982, FEBS LETT, V142, P289, DOI 10.1016/0014-5793(82)80154-3; CAMMACK R, 1989, EUR J BIOCHEM, V182, P363, DOI 10.1111/j.1432-1033.1989.tb14839.x; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; DerVartanian ME, 1996, BIOCHEM BIOPH RES CO, V227, P211, DOI 10.1006/bbrc.1996.1491; Dubini A, 2002, INT J HYDROGEN ENERG, V27, P1413, DOI 10.1016/S0360-3199(02)00112-X; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Goldet G, 2008, J AM CHEM SOC, V130, P11106, DOI 10.1021/ja8027668; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HATCHIKIAN CE, 1990, EUR J BIOCHEM, V187, P635, DOI 10.1111/j.1432-1033.1990.tb15347.x; Jones AK, 2003, J AM CHEM SOC, V125, P8505, DOI 10.1021/ja035296y; King PW, 1999, J BACTERIOL, V181, P5250, DOI 10.1128/JB.181.17.5250-5256.1999; LALLAMAHARAJH WV, 1983, BIOCHEM J, V209, P445, DOI 10.1042/bj2090445; Lamle SE, 2004, J AM CHEM SOC, V126, P14899, DOI 10.1021/ja047939v; Larminie J, 2003, FUEL CELL SYSTEMS EX; Laurinavichene TV, 2001, FEMS MICROBIOL LETT, V202, P121, DOI 10.1111/j.1574-6968.2001.tb10790.x; Lazarus O, 2009, J AM CHEM SOC, V131, P14154, DOI 10.1021/ja905797w; Leger C, 2003, BIOCHEMISTRY-US, V42, P8653, DOI 10.1021/bi034789c; Leger C, 2002, J PHYS CHEM B, V106, P13058, DOI 10.1021/jp0265687; Leger C, 2008, CHEM REV, V108, P2379, DOI 10.1021/cr0680742; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Maier RJ, 2004, INFECT IMMUN, V72, P6294, DOI 10.1128/IAI.72.11.6294-6299.2004; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Parkin A, 2008, J AM CHEM SOC, V130, P13410, DOI 10.1021/ja803657d; Reda T, 2006, J PHYS CHEM B, V110, P1394, DOI 10.1021/jp054783s; Richard DJ, 1999, MICROBIOL-SGM, V145, P2903, DOI 10.1099/00221287-145-10-2903; Romao CV, 1997, BIOCHEM BIOPH RES CO, V240, P75, DOI 10.1006/bbrc.1997.7598; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Sargent F, 1998, EUR J BIOCHEM, V255, P746, DOI 10.1046/j.1432-1327.1998.2550746.x; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; SAWERS RG, 1986, EUR J BIOCHEM, V156, P265, DOI 10.1111/j.1432-1033.1986.tb09577.x; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; TEIXEIRA M, 1985, J BIOL CHEM, V260, P8942; van Gastel M, 2006, J BIOL INORG CHEM, V11, P41, DOI 10.1007/s00775-005-0048-7; van Gastel M, 2005, BIOCHEM SOC T, V33, P7, DOI 10.1042/BST0330007; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u	60	179	183	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3928	3938		10.1074/jbc.M109.067751	http://dx.doi.org/10.1074/jbc.M109.067751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19917611	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000275254000046
J	Andersen, J; Olsen, L; Hansen, KB; Taboureau, O; Jorgensen, FS; Jorgensen, AM; Bang-Andersen, B; Egebjerg, J; Stromgaard, K; Kristensen, AS				Andersen, Jacob; Olsen, Lars; Hansen, Kasper B.; Taboureau, Olivier; Jorgensen, Flemming S.; Jorgensen, Anne Marie; Bang-Andersen, Benny; Egebjerg, Jan; Stromgaard, Kristian; Kristensen, Anders S.			Mutational Mapping and Modeling of the Binding Site for (S)-Citalopram in the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIES-SCANNING MUTAGENESIS; HIGH-AFFINITY RECOGNITION; TRANSMEMBRANE DOMAIN-I; DEPENDENT NEUROTRANSMITTER TRANSPORTERS; ANTIDEPRESSANT BINDING; SUBSTRATE RECOGNITION; MONOAMINE TRANSPORTERS; REUPTAKE INHIBITORS; PERMEATION PATHWAY; BACTERIAL HOMOLOG	The serotonin transporter (SERT) regulates extracellular levels of the neurotransmitter serotonin (5-hydroxytryptamine) in the brain by facilitating uptake of released 5-hydroxytryptamine into neuronal cells. SERT is the target for widely used antidepressant drugs, including imipramine, fluoxetine, and (S)-citalopram, which are competitive inhibitors of the transport function. Knowledge of the molecular details of the antidepressant binding sites in SERT has been limited due to lack of structural data on SERT. Here, we present a characterization of the (S)citalopram binding pocket in human SERT (hSERT) using mutational and computational approaches. Comparative modeling and ligand docking reveal that (S)-citalopram fits into the hSERT substrate binding pocket, where (S)-citalopram can adopt a number of different binding orientations. We find, however, that only one of these binding modes is functionally relevant from studying the effects of 64 point mutations around the putative substrate binding site. The mutational mapping also identify novel hSERT residues that are crucial for (S)-citalopram binding. The model defines the molecular determinants for (S)citalopram binding to hSERT and demonstrates that the antidepressant binding site overlaps with the substrate binding site.	[Stromgaard, Kristian; Kristensen, Anders S.] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Taboureau, Olivier] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Hansen, Kasper B.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Jorgensen, Anne Marie; Bang-Andersen, Benny; Egebjerg, Jan] H Lundbeck & Co AS, Lundbeck Res Denmark, DK-2500 Valby, Denmark	University of Copenhagen; Technical University of Denmark; Emory University; Lundbeck Corporation	Kristensen, AS (corresponding author), Univ Copenhagen, Dept Med Chem, Univ Pk 2, DK-2100 Copenhagen, Denmark.	ask@farma.ku.dk	Hansen, Kasper B/C-4062-2008; Olsen, Lars/C-9706-2010; Kristensen, Anders Skov/B-4414-2009; Stromgaard, Kristian/E-3380-2010; Olsen, Lars/AAY-8278-2020; Bang-Andersen, Benny/D-3006-2009; Andersen, Jacob/B-7768-2016	Hansen, Kasper B/0000-0002-3303-4819; Kristensen, Anders Skov/0000-0001-8955-6790; Bang-Andersen, Benny/0000-0001-5150-7168; Andersen, Jacob/0000-0002-8067-3074; Olsen, Lars/0000-0002-7607-7130; Stromgaard, Kristian/0000-0003-2206-4737; Jorgensen, Flemming Steen/0000-0001-8040-2998	Drug Research Academy; Danish Ministry of Science, Technology and Innovation; Danish Council for Strategic Research; Danish Council for Independent Research, Medical Sciences	Drug Research Academy; Danish Ministry of Science, Technology and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF))	This work was supported by the Drug Research Academy (Ph. D. stipend to J. A.), H. Lundbeck A/S, the Danish Ministry of Science, Technology and Innovation (Industrial Ph. D. stipend to A. M. J.), the Danish Council for Strategic Research NABIIT programme (to O. T.), and The Danish Council for Independent Research, Medical Sciences (to L. O.).	Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; GRAHAM D, 1989, BIOCHEM PHARMACOL, V38, P3819, DOI 10.1016/0006-2952(89)90591-1; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2006, NEURON, V49, P791, DOI 10.1016/j.neuron.2006.03.002; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; HUMPHREYS CJ, 1988, MOL PHARMACOL, V33, P657; HYTTEL J, 1992, J NEURAL TRANSM-GEN, V88, P157, DOI 10.1007/BF01244820; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P827, DOI 10.1002/cmdc.200600243; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Kristensen AS, 2004, EUR J NEUROSCI, V19, P1513, DOI 10.1111/j.1460-9568.2004.03202.x; Larsen MB, 2004, J BIOL CHEM, V279, P42147, DOI 10.1074/jbc.M405579200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Masson J, 1999, PHARMACOL REV, V51, P439; Moltzen EK, 2006, CURR TOP MED CHEM, V6, P1801, DOI 10.2174/156802606778249810; Mortensen OV, 2001, J NEUROCHEM, V79, P237, DOI 10.1046/j.1471-4159.2001.00587.x; Paczkowski FA, 2007, J BIOL CHEM, V282, P17837, DOI 10.1074/jbc.M610813200; Ravna AW, 2006, WORLD J BIOL PSYCHIA, V7, P99, DOI 10.1080/15622970500402144; Ravna AW, 2006, BIOORGAN MED CHEM, V14, P666, DOI 10.1016/j.bmc.2005.08.054; Ravna AW, 2003, J PHARMACOL EXP THER, V307, P34, DOI 10.1124/jpet.103.054593; Ravna AW, 2001, J MOL GRAPH MODEL, V20, P133, DOI 10.1016/S1093-3263(01)00112-7; Rudnick G, 2007, ACS CHEM BIOL, V2, P606, DOI 10.1021/cb7001818; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Walline CC, 2008, J PHARMACOL EXP THER, V325, P791, DOI 10.1124/jpet.108.136200; Wein T, 2010, J MOL MODEL, V16, P155, DOI 10.1007/s00894-009-0520-3; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	54	78	79	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2051	2063		10.1074/jbc.M109.072587	http://dx.doi.org/10.1074/jbc.M109.072587			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19892699	Green Published, hybrid			2022-12-27	WOS:000273429100050
J	Baraibar, MA; Muhoberac, BB; Garringer, HJ; Hurley, TD; Vidal, R				Baraibar, Martin A.; Muhoberac, Barry B.; Garringer, Holly J.; Hurley, Thomas D.; Vidal, Ruben			Unraveling of the E-helices and Disruption of 4-Fold Pores Are Associated with Iron Mishandling in a Mutant Ferritin Causing Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-CHAIN; FUNCTIONAL-PROPERTIES; CLINICAL-FEATURES; JAPANESE FAMILY; H-CHAINS; MUTATION; NEUROFERRITINOPATHY; POLYPEPTIDE; EXPRESSION; MECHANISM	Mutations in the coding sequence of the ferritin light chain (FTL) gene cause a neurodegenerative disease known as neuro-ferritinopathy or hereditary ferritinopathy, which is characterized by the presence of intracellular inclusion bodies containing the mutant FTL polypeptide and by abnormal accumulation of iron in the brain. Here, we describe the x-ray crystallographic structure and report functional studies of ferritin homopolymers formed from the mutant FTL polypeptide p. Phe167SerfsX26, which has a C terminus that is altered in amino acid sequence and length. The structure was determined and refined to 2.85A resolution and was very similar to the wild type between residues Ile-5 and Arg-154. However, instead of the E-helices normally present in wild type ferritin, the C-terminal sequences of all 24 mutant subunits showed substantial amounts of disorder, leading to multiple C-terminal polypeptide conformations and a large disruption of the normally tiny 4-fold axis pores. Functional studies underscored the importance of the mutant C-terminal sequence in iron-induced precipitation and revealed iron mishandling by soluble mutant FTL homopolymers in that only wild type incorporated iron when in direct competition in solution with mutant ferritin. Even without competition, the amount of iron incorporation over the first few minutes differed severalfold. Our data suggest that disruption at the 4-fold pores may lead to direct iron mishandling through attenuated iron incorporation by the soluble form of mutant ferritin and that the disordered C-terminal polypeptides may play a major role in iron-induced precipitation and formation of ferritin inclusion bodies in hereditary ferritinopathy.	[Muhoberac, Barry B.] Indiana Univ Purdue Univ, Dept Chem & Biol Chem, Indianapolis, IN 46202 USA; [Baraibar, Martin A.; Garringer, Holly J.; Vidal, Ruben] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Hurley, Thomas D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Muhoberac, BB (corresponding author), Indiana Univ Purdue Univ, Dept Chem & Biol Chem, 402 N Blackford St LD 326, Indianapolis, IN 46202 USA.	bmuhober@iupui.edu; rvidal@iupui.edu		HURLEY, THOMAS/0000-0002-5942-1163	National Institutes of Health [NS050227, NS050227-04S1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS050227 and NS050227-04S1. Results shown in this study are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source.	Baes C.F., 1976, HYDROLYSIS CATIONS, P489; Baraibar MA, 2008, J BIOL CHEM, V283, P31679, DOI 10.1074/jbc.M805532200; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DeLano W.L, PYMOL MOL GRAPHICS S; Devos D, 2009, BRAIN, V132, DOI 10.1093/brain/awn274; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; Granier T, 2001, ACTA CRYSTALLOGR D, V57, P1491, DOI 10.1107/S0907444901008897; HARRISON PM, 1991, BIOL MET, V4, P95, DOI 10.1007/BF01135385; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; Kubota A, 2009, MOVEMENT DISORD, V24, P441, DOI 10.1002/mds.22435; LEVI S, 1989, BIOCHEMISTRY-US, V28, P5179, DOI 10.1021/bi00438a040; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; Santambrogio P, 1996, BIOCHEM J, V314, P139, DOI 10.1042/bj3140139; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 2003, J NEUROL SCI, V207, P110, DOI 10.1016/S0022-510X(02)00435-5; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294	34	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1950	1956		10.1074/jbc.M109.042986	http://dx.doi.org/10.1074/jbc.M109.042986			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19923220	Green Published, hybrid			2022-12-27	WOS:000273429100041
J	Cao, YX; Vo, T; Millien, G; Tagne, JB; Kotton, D; Mason, RJ; Williams, MC; Ramirez, MI				Cao, Yuxia; Vo, Tiffany; Millien, Guetchyn; Tagne, Jean-Bosco; Kotton, Darrell; Mason, Robert J.; Williams, Mary C.; Ramirez, Maria I.			Epigenetic Mechanisms Modulate Thyroid Transcription Factor 1-mediated Transcription of the Surfactant Protein B Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; MEDIATES CRITICAL INTERACTIONS; GLUCOCORTICOID-RECEPTOR; DNA METHYLATION; EPITHELIAL-CELLS; FACTOR-I; CYTOSINE METHYLATION; RESPIRATORY-DISTRESS; INCREASED EXPRESSION; LUNG MORPHOGENESIS	Epigenetic regulation of transcription plays an important role in cell-specific gene expression by altering chromatin structure and access of transcriptional regulators to DNA binding sites. Surfactant protein B (Sftpb) is a developmentally regulated lung epithelial gene critical for lung function. Thyroid transcription factor 1 (Nkx2-1) regulates Sftpb gene expression in various species. We show that Nkx2-1 binds to the mouse Sftpb (mSftpb) promoter in the lung. In a mouse lung epithelial cell line (MLE-15), Nkx2-1 knockdown reduces Sftpb expression, and mutation of Nkx2-1 cis-elements significantly reduces mSftpb promoter activity. Whether chromatin structure modulates Nkx2-1 regulation of Sftpb transcription is unknown. We found that DNA methylation of the mSftpb promoter inversely correlates with known patterns of Sftpb expression in vivo. The mSftpb promoter activity can be manipulated by altering its cytosine methylation status in vitro. Nkx2-1 activation of the mSftpb promoter is impaired by DNA methylation. The unmethylated Sftpb promoter shows an active chromatin structure enriched in the histone modification H3K4me3 (histone 3-lysine 4 trimethylated). The ATP-dependent chromatin remodeling protein Brg1 is recruited to the Sftpb promoter in Sftpb-expressing, but not in non-expressing tissues and cell lines. Brg1 knockdown in MLE-15 cells greatly decreases H3K4me3 levels at the Sftpb promoter region and expression of the Sftpb gene. Brg1 can be co-immunoprecipitated with Nkx2-1 protein. Last, Nkx2-1 and Brg1 with intact ATPase activity are required for mSftpb promoter activation in vitro. Our findings suggest that DNA methylation and chromatin modifications cooperate with Nkx2-1 to regulate Sftpb gene cell specific expression.	[Cao, Yuxia; Vo, Tiffany; Millien, Guetchyn; Tagne, Jean-Bosco; Kotton, Darrell; Williams, Mary C.; Ramirez, Maria I.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Mason, Robert J.] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA	Boston University; National Jewish Health	Cao, YX (corresponding author), 80 E Concord St,R-304, Boston, MA 02118 USA.	yxcao@bu.edu		Cao, Yu-Xia/0000-0001-7396-9988; Tagne, Jean-Bosco/0000-0003-1830-9156; Kotton, Darrell/0000-0002-9604-8476; Ramirez, Maria Isabel/0000-0001-6294-4419	National Institutes of Health [P01 HL047049, HL 029891]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029891, P01HL047049, R37HL029891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL047049 and HL 029891.	Amin RS, 2001, J PEDIATR-US, V139, P85, DOI 10.1067/mpd.2001.114545; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; Berhane K, 2000, AM J PHYSIOL-LUNG C, V279, pL806, DOI 10.1152/ajplung.2000.279.5.L806; BOHINSKI RJ, 1993, J BIOL CHEM, V268, P11160; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155, DOI 10.1152/ajplung.1998.275.1.L155; BRUNO MA, 1995, AM J PHYSIOL-LUNG C, V268, pL381; Cao YX, 2000, BIOCHEM J, V350, P883, DOI 10.1042/0264-6021:3500883; Cao YX, 2003, J CELL BIOCHEM, V89, P887, DOI 10.1002/jcb.10555; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; DAMOREBRUNO MA, 1992, AM J PHYSIOL, V262, pL40, DOI 10.1152/ajplung.1992.262.1.L40; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; HAWGOOD S, 1991, ANNU REV PHYSIOL, V53, P375, DOI 10.1146/annurev.ph.53.030191.002111; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson CN, 2005, BIOCHEM CELL BIOL, V83, P405, DOI 10.1139/O05-115; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kathuria H, 2004, J BIOL CHEM, V279, P30028, DOI 10.1074/jbc.M402236200; Kathuria H, 2007, J CELL BIOCHEM, V102, P13, DOI 10.1002/jcb.21270; Kerr MH, 1999, AM J RESP CRIT CARE, V159, P1115, DOI 10.1164/ajrccm.159.4.9709065; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kimura S, 1999, BIOCHIMIE, V81, P321, DOI 10.1016/S0300-9084(99)80077-7; Kolla V, 2007, AM J RESP CELL MOL, V36, P213, DOI 10.1165/rcmb.2006-0207OC; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; LEWIS JF, 1993, AM REV RESPIR DIS, V147, P218, DOI 10.1164/ajrccm/147.1.218; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Marmorstein R, 2001, GENE, V272, P1, DOI 10.1016/S0378-1119(01)00519-4; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millien G, 2008, GENE EXPR PATTERNS, V8, P124, DOI 10.1016/j.modgep.2007.09.003; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Minoo P, 2008, NUCLEIC ACIDS RES, V36, P179, DOI 10.1093/nar/gkm871; Naltner A, 2000, J BIOL CHEM, V275, P56, DOI 10.1074/jbc.275.1.56; Naltner A, 2000, AM J PHYSIOL-LUNG C, V279, pL1066, DOI 10.1152/ajplung.2000.279.6.L1066; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Pryhuber GS, 1996, AM J PHYSIOL-LUNG C, V270, pL714, DOI 10.1152/ajplung.1996.270.5.L714; Ramirez MI, 1997, J BIOL CHEM, V272, P26285, DOI 10.1074/jbc.272.42.26285; Ramirez MI, 1999, DEV DYNAM, V215, P319, DOI 10.1002/(SICI)1097-0177(199908)215:4<319::AID-AJA4>3.0.CO;2-B; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Salinas D, 2003, AM J PHYSIOL-LUNG C, V285, pL1153, DOI 10.1152/ajplung.00084.2003; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Schug J, 2008, CURR PROTOC BIOINFOR; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Sif S, 2004, J CELL BIOCHEM, V91, P1087, DOI 10.1002/jcb.20005; Singh M, 2007, CHEMBIOCHEM, V8, P1308, DOI 10.1002/cbic.200600562; SMITH GJ, 1985, CELL BIOL INT REP, V9, P1115, DOI 10.1016/S0309-1651(85)80009-6; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Tredano M, 2003, AM J MED GENET A, V119A, P324, DOI 10.1002/ajmg.a.20058; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; Valinluck V, 2007, CANCER RES, V67, P5583, DOI 10.1158/0008-5472.CAN-07-0846; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; Wert SE, 2002, DEV BIOL, V242, P75, DOI 10.1006/dbio.2001.0540; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wunderlich S, 2008, HUM GENE THER, V19, P39, DOI 10.1089/hum.2006.0180; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; Yang L, 2004, BIOCHEMISTRY-US, V43, P12489, DOI 10.1021/bi049283o; Yang L, 2003, AM J PHYSIOL-LUNG C, V284, pL481, DOI 10.1152/ajplung.00280.2002; Zhou BY, 2008, AM J RESP CELL MOL, V38, P750, DOI 10.1165/rcmb.2007-0350OC; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	82	26	28	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2152	2164		10.1074/jbc.M109.039172	http://dx.doi.org/10.1074/jbc.M109.039172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19906647	Green Published, hybrid			2022-12-27	WOS:000273429100059
J	Fazakerley, DJ; Holman, GD; Marley, A; James, DE; Stockli, J; Coster, ACF				Fazakerley, Daniel J.; Holman, Geoffrey D.; Marley, Anna; James, David E.; Stoeckli, Jacqueline; Coster, Adelle C. F.			Kinetic Evidence for Unique Regulation of GLUT4 Trafficking by Insulin and AMP-activated Protein Kinase Activators in L6 Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLES; GLUCOSE-TRANSPORT; SURFACE GLUT4; SUBCELLULAR TRAFFICKING; STORAGE COMPARTMENTS; PLASMA-MEMBRANE; CONTRACTION; ENDOCYTOSIS; INCREASES; EXOCYTOSIS	In L6 myotubes, redistribution of a hemagglutinin (HA) epitope-tagged GLUT4 (HA-GLUT4) to the cell surface occurs rapidly in response to insulin stimulation and AMP-activated protein kinase (AMPK) activation. We have examined whether these separate signaling pathways have a convergent mechanism that leads to GLUT4 mobilization and to changes in GLUT4 recycling. HA antibody uptake on GLUT4 in the basal steady state reached a final equilibrium level that was only 81% of the insulin-stimulated level. AMPK activators (5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) and A-769662) led to a similar level of antibody uptake to that found in insulin-stimulated cells. However, the combined responses to insulin stimulation and AMPK activation led to an antibody uptake level of similar to 20% above the insulin level. Increases in antibody uptake due to insulin, but not AICAR or A-769662, treatment were reduced by both wortmannin and Akt inhibitor. The GLUT4 internalization rate constant in the basal steady state was very rapid (0.43 min(-1)) and was decreased during the steady-state responses to insulin (0.18 min(-1)), AICAR (0.16 min(-1)), and A-769662 (0.24 min(-1)). This study has revealed a nonconvergent mobilization of GLUT4 in response to activation of Akt and AMPK signaling. Furthermore, GLUT4 trafficking in L6 muscle cells is very reliant on regulated endocytosis for control of cell surface GLUT4 levels.	[Fazakerley, Daniel J.; James, David E.; Stoeckli, Jacqueline; Coster, Adelle C. F.] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW 2010, Australia; [Fazakerley, Daniel J.; Holman, Geoffrey D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia; [Marley, Anna] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England	Garvan Institute of Medical Research; University of Bath; University of New South Wales Sydney; AstraZeneca	Stockli, J (corresponding author), Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW 2010, Australia.	j.stoeckli@garvan.org.au	Stoeckli, Jacqueline/D-7053-2016; Fazakerley, Daniel/J-2652-2019; Coster, Adelle/AAX-4829-2020; Stoeckli, Jacqueline/Z-4443-2019; Coster, Adelle CF/A-7234-2013	Stoeckli, Jacqueline/0000-0002-6446-7350; Fazakerley, Daniel/0000-0001-8241-2903; Coster, Adelle/0000-0002-5572-6832; Stoeckli, Jacqueline/0000-0002-6446-7350; Coster, Adelle CF/0000-0002-5572-6832; Holman, Geoffrey/0000-0001-7045-1358; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia; Medical Research Council United Kingdom; Wellcome Trust; AstraZeneca; MRC [G9225018, G0300415] Funding Source: UKRI; Medical Research Council [G0300415, G9225018] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); AstraZeneca(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the National Health and Medical Research Council of Australia (to J. S. and D. E. J.), by grants from the Medical Research Council United Kingdom, the Wellcome Trust (to G. D. H.), and a CASE studentship from AstraZeneca (to D. J. F.).	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Fazakerley DJ, 2009, J CELL SCI, V122, P727, DOI 10.1242/jcs.041178; Fisher JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE18, DOI 10.1152/ajpendo.2002.282.1.E18; GAO JP, 1994, J APPL PHYSIOL, V77, P1597, DOI 10.1152/jappl.1994.77.4.1597; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; HENRIKSEN EJ, 1991, J APPL PHYSIOL, V70, P2322, DOI 10.1152/jappl.1991.70.5.2322; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lemieux K, 2000, DIABETES, V49, P183, DOI 10.2337/diabetes.49.2.183; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; RODNICK KJ, 1992, AM J PHYSIOL, V262, pC9, DOI 10.1152/ajpcell.1992.262.1.C9; SATOH S, 1993, J BIOL CHEM, V268, P17820; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; YANG J, 1993, J BIOL CHEM, V268, P4600; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433	33	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1653	1660		10.1074/jbc.M109.051185	http://dx.doi.org/10.1074/jbc.M109.051185			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915010	hybrid, Green Published			2022-12-27	WOS:000273429100011
J	Messaritou, G; Grammenoudi, S; Skoulakis, EMC				Messaritou, Georgia; Grammenoudi, Sofia; Skoulakis, Efthimios M. C.			Dimerization Is Essential for 14-3-3 zeta Stability and Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; C-RAF; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN; DROSOPHILA; PHOSPHORYLATION; LEONARDO; LOCALIZATION; SPECIFICITY	Members of the conserved 14-3-3 protein family spontaneously self-assemble as homo-and heterodimers via conserved sequences in the first four (alpha A-alpha D) of the nine helices that comprise them. Dimeric 14-3-3s bind conserved motifs in diverse protein targets involved in multiple essential cellular processes including signaling, intracellular trafficking, cell cycle regulation, and modulation of enzymatic activities. However, recent mostly in vitro evidence has emerged, suggesting functional and regulatory roles for monomeric 14-3-3s. We capitalized on the simplicity of the 14-3-3 family in Drosophila to investigate in vivo 14-3-3 zeta monomer properties and functionality. We report that dimerization is essential for the stability and function of 14-3-3 zeta in neurons. Moreover, we reveal the contribution of conserved amino acids in helices A and D to homo-and heterodimerization and their functional consequences on the viability of animals devoid of endogenous 14-3-3 zeta. Finally, we present evidence suggesting endogenous homeostatic adjustment of the levels of the second family member in Drosophila, D14-3-3 epsilon, to transgenic monomeric and dimerization-competent 14-3-3 zeta.	[Messaritou, Georgia; Grammenoudi, Sofia; Skoulakis, Efthimios M. C.] Alexander Fleming, Inst Mol Biol & Genet, Biomed Sci Res Ctr, Vari 16672, Greece		Skoulakis, EMC (corresponding author), 34 Fleming Str, Vari 16672, Greece.	skoulakis@fleming.gr			Research and Technology PENED [01Edelta207]; European Union [003141]	Research and Technology PENED; European Union(European Commission)	This work was supported in part by Hellenic General Secretariat for Research and Technology PENED Grant 01E Delta 207 (to S. G.) and European Union Marie Curie TOK Grant 003141 (to G. M. and E. M. C. S.).	Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280; Acevedo SF, 2007, MOL CELL NEUROSCI, V34, P378, DOI 10.1016/j.mcn.2006.11.011; Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Grammenoudi S, 2006, FEBS LETT, V580, P4602, DOI 10.1016/j.febslet.2006.07.045; Gu MY, 1998, J BIOL CHEM, V273, P33465, DOI 10.1074/jbc.273.50.33465; Gu YM, 2006, FEBS LETT, V580, P305, DOI 10.1016/j.febslet.2005.12.024; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Ichimura T, 1997, FEBS LETT, V413, P273, DOI 10.1016/S0014-5793(97)00910-1; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Li W, 1997, DEVELOPMENT, V124, P4163; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Megidish T, 1998, J BIOL CHEM, V273, P21834, DOI 10.1074/jbc.273.34.21834; Messaritou G, 2009, FEBS LETT, V583, P2934, DOI 10.1016/j.febslet.2009.08.003; Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhang SS, 1999, J BIOL CHEM, V274, P24865, DOI 10.1074/jbc.274.35.24865; Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200	50	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1692	1700		10.1074/jbc.M109.045989	http://dx.doi.org/10.1074/jbc.M109.045989			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920133	hybrid, Green Published			2022-12-27	WOS:000273429100015
J	Damerow, S; Lamerz, AC; Haselhorst, T; Fuhring, J; Zarnovican, P; von Itzstein, M; Routier, FH				Damerow, Sebastian; Lamerz, Anne-Christin; Haselhorst, Thomas; Fuehring, Jana; Zarnovican, Patricia; von Itzstein, Mark; Routier, Francoise H.			Leishmania UDP-sugar Pyrophosphorylase THE MISSING LINK IN GALACTOSE SALVAGE?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE PYROPHOSPHORYLASE; TRYPANOSOMA-BRUCEI; LIGAND-BINDING; MOLECULAR ARCHITECTURE; SUBSTRATE-SPECIFICITY; NMR; TRANSPORTERS; METABOLISM; GENE; SUPPRESSION	The Leishmania parasite glycocalyx is rich in galactose-containing glycoconjugates that are synthesized by specific glycosyltransferases that use UDP-galactose as a glycosyl donor. UDP-galactose biosynthesis is thought to be predominantly a de novo process involving epimerization of the abundant nucleotide sugar UDP-glucose by the UDP-glucose 4-epimerase, although galactose salvage from the environment has been demonstrated for Leishmania major. Here, we present the characterization of an L. major UDP-sugar pyrophosphorylase able to reversibly activate galactose 1-phosphate into UDP-galactose thus proving the existence of the Isselbacher salvage pathway in this parasite. The ordered bisubstrate mechanism and high affinity of the enzyme for UTP seem to favor the synthesis of nucleotide sugar rather than their pyrophosphorolysis. Although L. major UDP-sugar pyrophosphorylase preferentially activates galactose 1-phosphate and glucose 1-phosphate, the enzyme is able to act on a variety of hexose 1-phosphates as well as pentose 1-phosphates but not hexosamine 1-phosphates and hence presents a broad in vitro specificity. The newly identified enzyme exhibits a low but significant homology with UDP-glucose pyrophosphorylases and conserved in particular is the pyrophosphorylase consensus sequence and residues involved in nucleotide and phosphate binding. Saturation transfer difference NMR spectroscopy experiments confirm the importance of these moieties for substrate binding. The described leishmanial enzyme is closely related to plant UDP-sugar pyrophosphorylases and presents a similar substrate specificity suggesting their common origin.	[Damerow, Sebastian; Lamerz, Anne-Christin; Fuehring, Jana; Zarnovican, Patricia; Routier, Francoise H.] Hannover Med Sch, Dept Cellular Chem, D-30625 Hannover, Germany; [Haselhorst, Thomas; von Itzstein, Mark] Griffith Univ, Inst Glycom, Southport, Qld 4222, Australia	Hannover Medical School; Griffith University	Routier, FH (corresponding author), Hannover Med Sch, Dept Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Routier.Francoise@mh-hannover.de	Haselhorst, Thomas/A-5066-2015; Routier, Francoise/O-1611-2019; von Itzstein, Mark/E-4823-2010	Haselhorst, Thomas/0000-0002-3373-8680; Routier, Francoise/0000-0002-7163-0590	Australian Research Council; National Health and Medical Research Council; National Science Foundation [0090281]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Science Foundation(National Science Foundation (NSF))	Recipient of support from the Australian Research Council and the National Health and Medical Research Council.; We thank Nikolay Nifant'ev (Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences) for gift of xylose 1-phosphate. UDP-galacturonic acid and UDP-L-arabinose were purchased by CarboSource, supported in part by National Science Foundation RCN Grant 0090281.	Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Barrett MP, 1998, MOL BIOCHEM PARASIT, V91, P195, DOI 10.1016/S0166-6851(97)00192-8; Bearne SL, 2001, BIOCHEM J, V356, P223, DOI 10.1042/0264-6021:3560223; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; de Jongh WA, 2008, BIOTECHNOL BIOENG, V101, P317, DOI 10.1002/bit.21890; Duggleby RG, 1996, EUR J BIOCHEM, V235, P173, DOI 10.1111/j.1432-1033.1996.00173.x; Feng XH, 2009, MOL MICROBIOL, V71, P369, DOI 10.1111/j.1365-2958.2008.06531.x; Fridovich-Keil JL, 2006, J CELL PHYSIOL, V209, P701, DOI 10.1002/jcp.20820; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Gruber TD, 2009, J MOL BIOL, V391, P327, DOI 10.1016/j.jmb.2009.05.081; Haselhorst T, 2008, ANGEW CHEM INT EDIT, V47, P1910, DOI 10.1002/anie.200704872; Haselhorst T, 2009, NAT CHEM BIOL, V5, P91, DOI 10.1038/nchembio.134; ISSELBACHER KJ, 1958, J BIOL CHEM, V232, P429; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; Kotake T, 2007, BIOSCI BIOTECH BIOCH, V71, P761, DOI 10.1271/bbb.60605; Lamerz AC, 2006, GLYCOBIOLOGY, V16, P1143; Lamerz AC, 2006, J BIOL CHEM, V281, P16314, DOI 10.1074/jbc.M600076200; Litterer LA, 2006, PLANT PHYSIOL BIOCH, V44, P171, DOI 10.1016/j.plaphy.2006.04.004; MacRae JI, 2006, MOL BIOCHEM PARASIT, V147, P126, DOI 10.1016/j.molbiopara.2006.02.011; Maggioni A, 2008, CHEMBIOCHEM, V9, P2784, DOI 10.1002/cbic.200800526; Martz F, 2002, BIOCHEM J, V367, P295, DOI 10.1042/BJ20020772; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meng M, 2008, BBA-PROTEINS PROTEOM, V1784, P967, DOI 10.1016/j.bbapap.2008.02.021; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; Ohashi T, 2006, ANAL BIOCHEM, V352, P182, DOI 10.1016/j.ab.2006.02.026; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; PENG HL, 1993, FEBS LETT, V329, P153, DOI 10.1016/0014-5793(93)80213-E; Roper JR, 2005, J BIOL CHEM, V280, P19728, DOI 10.1074/jbc.M502370200; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; Steiner T, 2007, J BIOL CHEM, V282, P13003, DOI 10.1074/jbc.M609984200; Tetaud E, 1997, BIOCHEM J, V325, P569, DOI 10.1042/bj3250569; Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007; TURCO SJ, 1984, J BIOL CHEM, V259, P3883; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Urbaniak MD, 2006, EUKARYOT CELL, V5, P1906, DOI 10.1128/EC.00156-06	42	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					878	887		10.1074/jbc.M109.067223	http://dx.doi.org/10.1074/jbc.M109.067223			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19906649	Green Published, hybrid			2022-12-27	WOS:000273258200008
J	Evans, RM; You, H; Hameed, S; Altier, C; Mezghrani, A; Bourinet, E; Zamponi, GW				Evans, Rhian M.; You, Haitao; Hameed, Shahid; Altier, Christophe; Mezghrani, Alexandre; Bourinet, Emmanuel; Zamponi, Gerald W.			Heterodimerization of ORL1 and Opioid Receptors and Its Consequences for N-type Calcium Channel Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CENTRAL-NERVOUS-SYSTEM; NOCICEPTIN/ORPHANIN FQ; ORPHANIN FQ/NOCICEPTIN; INDUCED TRAFFICKING; INFLAMMATORY PAIN; MESSENGER-RNA; SPINAL-CORD; MU; RAT	We have investigated the heterodimerization of ORL1 receptors and classical members of the opioid receptor family. All three classes of opioid receptors could be co-immunoprecipitated with ORL1 receptors from both transfected tsA-201 cell lysate and rat dorsal root ganglia lysate, suggesting that these receptors can form heterodimers. Consistent with this hypothesis, in cells expressing either one of the opioid receptors together with ORL1, prolonged ORL1 receptor activation via nociceptin application resulted in internalization of the opioid receptors. Conversely, mu-, delta-, and kappa-opioid receptor activation with the appropriate ligands triggered the internalization of ORL1. The mu-opioid receptor/ORL1 receptor heterodimers were shown to associate with N-type calcium channels, with activation of mu-opioid receptors triggering N-type channel internalization, but only in the presence of ORL1. Furthermore, the formation of opioid receptor/ORL1 receptor heterodimers attenuated the ORL1 receptor-mediated inhibition of N-type channels, in part because of constitutive opioid receptor activity. Collectively, our data support the existence of heterodimers between ORL1 and classical opioid receptors, with profound implications for effectors such as N-type calcium channels.	[Evans, Rhian M.; You, Haitao; Hameed, Shahid; Altier, Christophe; Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Mezghrani, Alexandre; Bourinet, Emmanuel] CNRS, Inst Genom Fonctionnelle, F-34094 Montpellier, France	University of Calgary; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066	Canadian Institutes of Health Research; Agence Nationale de la Recherche [ANR Neuro 2005-031]; Alberta Heritage Foundation for Medical Research; Government of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Government of Canada(CGIAR)	This work was supported by an operating grant from the Canadian Institutes of Health Research (to G.W.Z.), Agence Nationale de la Recherche Grant ANR Neuro 2005-031 (to E.B.), and an Alberta Heritage Foundation for Medical Research fellowship and a Canadian Commonwealth postdoctoral fellowship from the Government of Canada (to R.M.E.).	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Beedle AM, 2004, NAT NEUROSCI, V7, P118, DOI 10.1038/nn1180; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Chen Y, 2007, J NEUROSCI RES, V85, P1478, DOI 10.1002/jnr.21272; Chen Y, 2006, J PERIPHER NERV SYST, V11, P232, DOI 10.1111/j.1529-8027.2006.0093.x; Connor M, 1998, J PHYSIOL-LONDON, V509, P47, DOI 10.1111/j.1469-7793.1998.047bo.x; Dang VC, 2009, J NEUROSCI, V29, P3322, DOI 10.1523/JNEUROSCI.4749-08.2009; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gouarderes C, 1999, BRAIN RES, V838, P85, DOI 10.1016/S0006-8993(99)01713-8; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Harding PJ, 2009, BIOPHYS J, V96, P964, DOI 10.1016/j.bpj.2008.09.054; Homberg JR, 2009, NEUROSCIENCE, V163, P308, DOI 10.1016/j.neuroscience.2009.06.021; Inoue M, 1999, J PHARMACOL EXP THER, V291, P308; Jenck F, 2000, P NATL ACAD SCI USA, V97, P4938, DOI 10.1073/pnas.090514397; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kaneko S, 1997, BRIT J PHARMACOL, V121, P806, DOI 10.1038/sj.bjp.0701181; Kisilevsky AE, 2008, CHANNELS, V2, P269, DOI 10.4161/chan.2.4.6402; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Ko MCH, 2002, BRIT J PHARMACOL, V135, P943, DOI 10.1038/sj.bjp.0704535; Kolesnikov YA, 1999, LIFE SCI, V64, P2021, DOI 10.1016/S0024-3205(99)00149-6; Kotlinska J, 2000, LIFE SCI, V66, pPL119, DOI 10.1016/S0024-3205(99)00648-7; Lipsky R, 2008, J BIOL CHEM, V283, P17221, DOI 10.1074/jbc.C800061200; Mandyam CD, 2003, J PHARMACOL EXP THER, V306, P965, DOI 10.1124/jpet.103.051599; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Matsushita H, 2009, ENDOCRINOLOGY, V150, P2668, DOI 10.1210/en.2008-1515; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Neal CR, 1999, J COMP NEUROL, V406, P503; Neal CR, 1999, J COMP NEUROL, V412, P563; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Pettersson LME, 2002, BRAIN RES, V945, P266, DOI 10.1016/S0006-8993(02)02817-2; Polidori C, 2000, PEPTIDES, V21, P1051, DOI 10.1016/S0196-9781(00)00224-2; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Rawls SM, 2008, NEUROPEPTIDES, V42, P229, DOI 10.1016/j.npep.2008.03.005; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; RHIM H, 1994, J NEUROSCI, V14, P7608; Simen AA, 2000, MOL PHARMACOL, V57, P1064; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200; Ueda H, 2000, J NEUROSCI, V20, P7640; Wang HL, 2005, J NEUROCHEM, V92, P1285, DOI 10.1111/j.1471-4159.2004.02921.x; Williams AJK, 2006, J IMMUNOL METHODS, V314, P170, DOI 10.1016/j.jim.2006.06.003; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Zhang GH, 2009, PAIN, V143, P233, DOI 10.1016/j.pain.2009.03.007	49	63	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1032	1040		10.1074/jbc.M109.040634	http://dx.doi.org/10.1074/jbc.M109.040634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887453	Green Published, hybrid			2022-12-27	WOS:000273258200024
J	Ohsu, T; Amino, Y; Nagasaki, H; Yamanaka, T; Takeshita, S; Hatanaka, T; Maruyama, Y; Miyamura, N; Eto, Y				Ohsu, Takeaki; Amino, Yusuke; Nagasaki, Hiroaki; Yamanaka, Tomohiko; Takeshita, Sen; Hatanaka, Toshihiro; Maruyama, Yutaka; Miyamura, Naohiro; Eto, Yuzuru			Involvement of the Calcium-sensing Receptor in Human Taste Perception	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; PROTEIN-COUPLED RECEPTORS; GAMMA-GLUTAMYL PEPTIDES; GASTROINTESTINAL-TRACT; GLUTATHIONE; FAMILY; CLONING; ROLES; WATER; RATS	By human sensory analyses, we found that various extracellular calcium-sensing receptor (CaSR) agonists enhance sweet, salty, and umami tastes, although they have no taste themselves. These characteristics are known as "kokumi taste" and often appear in traditional Japanese cuisine. Although GSH is a typical kokumi taste substance (taste enhancer), its mode of action is poorly understood. Here, we demonstrate how the kokumi taste is enhanced by the CaSR, a close relative of the class C G-protein-coupled receptors T1R1, T1R2, and T1R3 (sweet and umami receptors). We identified a large number of CaSR agonist gamma-glutamyl peptides, including GSH (gamma-Glu-Cys-Gly) and gamma-Glu-Val-Gly, and showed that these peptides elicit the kokumi taste. Further analyses revealed that some known CaSR agonists such as Ca2+, protamine, polylysine, L-histidine, and cinacalcet (a calcium-mimetic drug) also elicit the kokumi taste and that the CaSR-specific antagonist, NPS-2143, significantly suppresses the kokumi taste. This is the first report indicating a distinct function of the CaSR in human taste perception.	[Eto, Yuzuru] Ajinomoto Co Inc, Inst Life Sci, Kawasaki Ku, Kawasaki, Kanagawa 2108681, Japan; [Ohsu, Takeaki; Takeshita, Sen; Hatanaka, Toshihiro; Eto, Yuzuru] Pharmaceut Res Labs, Kawasaki, Kanagawa 2108681, Japan; [Amino, Yusuke] AminoSci Labs, Kawasaki, Kanagawa 2108681, Japan; [Nagasaki, Hiroaki; Yamanaka, Tomohiko; Miyamura, Naohiro] Food Prod Co, Kawasaki, Kanagawa 2108681, Japan	Ajinomoto Co Inc	Eto, Y (corresponding author), Ajinomoto Co Inc, Inst Life Sci, Kawasaki Ku, 1-1 Suzuki Cho, Kawasaki, Kanagawa 2108681, Japan.	yuzuru_eto@ajinomoto.com						Aaslyng MD, 1998, J AGR FOOD CHEM, V46, P5225, DOI 10.1021/jf9806816; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2006, TRENDS ENDOCRIN MET, V17, P398, DOI 10.1016/j.tem.2006.10.012; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; Dunkel A, 2007, J AGR FOOD CHEM, V55, P6712, DOI 10.1021/jf071276u; Gabriel AS, 2009, BIOCHEM BIOPH RES CO, V378, P414, DOI 10.1016/j.bbrc.2008.11.060; Hebert SC, 2004, CELL CALCIUM, V35, P239, DOI 10.1016/j.ceca.2003.10.015; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; KANAZAWA A, 1965, BIOCHIM BIOPHYS ACTA, V111, P90, DOI 10.1016/0304-4165(65)90475-7; KRISTENSEN I, 1974, PHYTOCHEMISTRY, V13, P2803, DOI 10.1016/0031-9422(74)80245-1; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; McCaughey SA, 2005, PHYSIOL BEHAV, V84, P335, DOI 10.1016/j.physbeh.2004.12.010; MECCHI EP, 1964, J FOOD SCI, V29, P393, DOI 10.1111/j.1365-2621.1964.tb01750.x; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Reed DR, 2003, MAMM GENOME, V14, P302, DOI 10.1007/s00335-002-2170-y; Rodriguez M, 2005, AM J PHYSIOL-RENAL, V288, pF253, DOI 10.1152/ajprenal.00302.2004; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; Rybczynska A, 2006, J ENDOCRINOL, V191, P189, DOI 10.1677/joe.1.06924; SCHEFFE H, 1952, J AM STAT ASSOC, V47, P381, DOI 10.2307/2281310; Toelstede S, 2009, J AGR FOOD CHEM, V57, P1440, DOI 10.1021/jf803376d; Tordoff MG, 2008, GENES BRAIN BEHAV, V7, P618, DOI 10.1111/j.1601-183X.2008.00398.x; Tordoff MG, 2008, PHYSIOL GENOMICS, V34, P338, DOI 10.1152/physiolgenomics.90200.2008; UEDA Y, 1990, AGR BIOL CHEM TOKYO, V54, P163, DOI 10.1080/00021369.1990.10869909; Ueda Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1977, DOI 10.1271/bbb.61.1977; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; ZHANG YG, 1988, J AGR FOOD CHEM, V36, P992, DOI 10.1021/jf00083a022	34	174	194	5	94	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1016	1022		10.1074/jbc.M109.029165	http://dx.doi.org/10.1074/jbc.M109.029165			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19892707	Green Published, hybrid			2022-12-27	WOS:000273258200022
J	Page, KM; Heblich, F; Margas, W; Pratt, WS; Nieto-Rostro, M; Chaggar, K; Sandhu, K; Davies, A; Dolphin, AC				Page, Karen M.; Heblich, Fay; Margas, Wojciech; Pratt, Wendy S.; Nieto-Rostro, Manuela; Chaggar, Kanchan; Sandhu, Kieran; Davies, Anthony; Dolphin, Annette C.			N Terminus Is Key to the Dominant Negative Suppression of Ca(V)2 Calcium Channels IMPLICATIONS FOR EPISODIC ATAXIA TYPE 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; ENDOPLASMIC-RETICULUM; TRUNCATED CONSTRUCTS; MUTATIONS; ALPHA-1B; IDENTIFICATION; TRAFFICKING; SUBUNITS; MUTANTS; GENE	Expression of the calcium channels Ca(V)2.1 and Ca(V)2.2 is markedly suppressed by co-expression with truncated constructs containing Domain I. This is the basis for the phenomenon of dominant negative suppression observed for many of the episodic ataxia type 2 mutations in Ca(V)2.1 that predict truncated channels. The process of dominant negative suppression has been shown previously to stem from interaction between the full-length and truncated channels and to result in downstream consequences of the unfolded protein response and endoplasmic reticulum-associated protein degradation. We have now identified the specific domain that triggers this effect. For both Ca(V)2.1 and Ca(V)2.2, the minimum construct producing suppression was the cytoplasmic N terminus. Suppression was enhanced by tethering the N terminus to the membrane with a CAAX motif. The 11-amino acid motif (including Arg(52) and Arg(54)) within the N terminus, which we have previously shown to be required for G protein modulation, is also essential for dominant negative suppression. Suppression is prevented by addition of an N-terminal tag (XFP) to the full-length and truncated constructs. We further show that suppression of Ca(V)2.2 currents by the N terminus-CAAX construct is accompanied by a reduction in Ca(V)2.2 protein level, and this is also prevented by mutation of Arg(52) and Arg(54) to Ala in the truncated construct. Taken together, our evidence indicates that both the extreme N terminus and the Arg(52), Arg(54) motif are involved in the processes underlying dominant negative suppression.	[Page, Karen M.; Heblich, Fay; Margas, Wojciech; Pratt, Wendy S.; Nieto-Rostro, Manuela; Chaggar, Kanchan; Sandhu, Kieran; Davies, Anthony; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Dolphin, AC (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	a.dolphin@ucl.ac.uk	Tuluc, Petronel/C-2527-2011; Dolphin, Annette C/F-7416-2010	Dolphin, Annette C/0000-0003-4626-4856	Wellcome Trust [077883]; Medical Research Coucil [G0700368]; Medical Research Council [G0700368] Funding Source: researchfish; MRC [G0700368] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Coucil; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 077883 and Medical Research Coucil Grant G0700368.	Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; CAMPBELL V, 1995, FEBS LETT, V370, P135, DOI 10.1016/0014-5793(95)00813-O; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Jen JC, 2007, BRAIN, V130, P2484, DOI 10.1093/brain/awm126; Jeng CJ, 2008, J CELL PHYSIOL, V214, P422, DOI 10.1002/jcp.21216; Jeng CJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1209, DOI 10.1152/ajpcell.00247.2005; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Page KM, 1998, J NEUROSCI, V18, P4815; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Raghib A, 2001, J NEUROSCI, V21, P8495, DOI 10.1523/JNEUROSCI.21-21-08495.2001; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200	26	38	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					835	844		10.1074/jbc.M109.065045	http://dx.doi.org/10.1074/jbc.M109.065045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19903821	hybrid, Green Published			2022-12-27	WOS:000273258200004
J	Safadi, SS; Shaw, GS				Safadi, Susan S.; Shaw, Gary S.			Differential Interaction of the E3 Ligase Parkin with the Proteasomal Subunit S5a and the Endocytic Protein Eps15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE DOMAIN; TRIPLE-RESONANCE NMR; JUVENILE PARKINSONISM; BINDING DOMAINS; ALPHA-SYNUCLEIN; GENE-PRODUCT; DISEASE; MOTIF; SPECTROSCOPY; RECOGNITION	Parkin is a multidomain E3 ligase associated with autosomal recessive Parkinson disease. The N-terminal ubiquitin-like domain (Ubld) of parkin functions with the S5a proteasomal subunit, positioning substrate proteins for degradation. In addition the parkin Ubld recruits the endocytotic protein Eps15, allowing the E3 ligase to ubiquinate Eps15 distal from its parkin-interacting site. The recognition sequences in the S5a subunit and Eps15 for the parkin Ubld are ubiquitin-interacting motifs (UIM). Each protein has two UIM sequences separated by a 50-residue spacer in S5a, but only similar to 5 residues in Eps15. In this work we used NMR spectroscopy to determine how the parkin Ubld recognizes the proteasomal subunit S5a compared with Eps15, a substrate for ubiquitination. We show that Eps15 contains two flexible alpha-helices each encompassing a UIM sequence. The alpha-helix surrounding UIM II is longer than that for UIM I, a situation that is reversed from S5a. Furthermore, we show the parkin Ubld preferentially binds to UIM I in the S5a subunit. This interaction is strongly diminished in a K48A substitution, found near the center of the S5a interacting surface on the parkin Ubld. In contrast to S5a, parkin recruits Eps15 using both its UIM sequences resulting in a larger interaction surface that includes residues from beta 1 and beta 2, not typically known to interact with UIM sequences. These results show that the parkin Ubld uses differential surfaces to recruit UIM regions from the S5a proteasomal subunit compared with Eps15 involved in cell signaling.	[Safadi, Susan S.; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625	Canadian Institutes of Health Research; Canada Research Chairs Program; Canadian Institutes of Health Research Doctoral Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canadian Institutes of Health Research Doctoral Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by research and maintenance grants from the Canadian Institutes of Health Research (to G.S.S.), an award from the Canada Research Chairs Program (to G.S.S.), and a Canadian Institutes of Health Research Doctoral Scholarship (to S.S.S.).	Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Harris RK, 2002, SOLID STATE NUCL MAG, V22, P458, DOI 10.1006/snmr.2002.0063; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; Matsumine H, 1997, AM J HUM GENET, V60, P588; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tashiro M, 2003, J BIOMOL NMR, V25, P153, DOI 10.1023/A:1022254432039; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Wang QH, 2004, J BIOMOL NMR, V30, P231, DOI 10.1023/B:JNMR.0000048944.73308.6c; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	52	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1424	1434		10.1074/jbc.M109.041970	http://dx.doi.org/10.1074/jbc.M109.041970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19875440	hybrid, Green Published			2022-12-27	WOS:000273258200062
J	Yuan, Q; Kaylor, JJ; Miu, A; Bassilian, S; Whitelegge, JP; Travis, GH				Yuan, Quan; Kaylor, Joanna J.; Miu, Anh; Bassilian, Sara; Whitelegge, Julian P.; Travis, Gabriel H.			Rpe65 Isomerase Associates with Membranes through an Electrostatic Interaction with Acidic Phospholipid Headgroups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; IONIZATION MASS-SPECTROMETRY; VISUAL CYCLE; SUBCELLULAR-LOCALIZATION; BINDING-PROTEIN; ISOMEROHYDROLASE; SUBSTRATE; BIOSYNTHESIS; CARDIOLIPIN; EXPRESSION	Opsins are light-sensitive pigments in the vertebrate retina, comprising a G protein-coupled receptor and an 11-cis-retinaldehyde chromophore. Absorption of a photon by an opsin pigment induces isomerization of its chromophore to all-trans-retinaldehyde. After a brief period of activation, opsin releases all-trans-retinaldehyde and becomes insensitive to light. Restoration of light sensitivity to the apo-opsin involves the conversion of all-trans-retinaldehyde back to 11-cis-retinaldehyde via an enzyme pathway called the visual cycle. The critical isomerization step in this pathway is catalyzed by Rpe65. Rpe65 is strongly associated with membranes but contains no membrane-spanning segments. It was previously suggested that the affinity of Rpe65 for membranes is due to palmitoylation of one or more Cys residues. In this study, we re-examined this hypothesis. By two independent strategies involving mass spectrometry, we show that Rpe65 is not palmitoylated nor does it appear to undergo other post-translational modifications at significant stoichiometry. Instead, we show that Rpe65 binds the acidic phospholipids, phosphatidylserine, phosphatidylglycerol, and cardiolipin, but not phosphatidic acid. No binding of Rpe65 to basic phospholipids or neutral lipids was observed. The affinity of Rpe65 to acidic phospholipids was strongly pH-dependent, suggesting an electrostatic interaction of basic residues in Rpe65 with negatively charged phospholipid headgroups. Binding of Rpe65 to liposomes containing phosphatidylserine or phosphatidylglycerol, but not the basic or neutral phospholipids, allowed the enzyme to extract its insoluble substrate, all-trans-retinyl palmitate, from the lipid bilayer for synthesis of 11-cis-retinol. The interaction of Rpe65 with acidic phospholipids is therefore biologically relevant.	[Yuan, Quan; Kaylor, Joanna J.; Miu, Anh; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Bassilian, Sara; Whitelegge, Julian P.] Univ Calif Los Angeles, Sch Med, Pasarow Mass Spectrometry Lab, Neuropsychiat Inst,Semel Inst, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.	travis@jsei.ucla.edu	Kaylor, Joanna/Y-5184-2019; Travis, Gabriel Harvey/AIF-1062-2022; yuan, quan/GZM-5597-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; 	NEI [EY01584, EY11713]; NATIONAL EYE INSTITUTE [R01EY011713] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY01584 and EY11713 from NEI.	BLEASDALE JE, 1985, LUNG, V163, P345, DOI 10.1007/BF02713835; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; Choo DW, 1998, FEBS LETT, V440, P195, DOI 10.1016/S0014-5793(98)01459-8; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; Hauss T, 2005, BBA-BIOENERGETICS, V1710, P57, DOI 10.1016/j.bbabio.2005.08.007; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Huang J, 2009, MOL VIS, V15, P223; JACKSON CS, 2002, CURRENT PROTOCOLS PR, V2; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kuge O, 2003, J BIOCHEM, V133, P397, DOI 10.1093/jb/mvg052; Liden M, 2001, J BIOL CHEM, V276, P49251, DOI 10.1074/jbc.M107337200; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; MATSUZAWA Y, 1980, J LIPID RES, V21, P202; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; POORTHUIS BJHM, 1976, J BIOL CHEM, V251, P4596; RANDO RR, 1991, BIOCHEMISTRY-US, V30, P595, DOI 10.1021/bi00217a001; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ruegg U T, 1977, Methods Enzymol, V47, P111; Saari JC, 2009, MOL VIS, V15, P844; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Takahashi Y, 2006, INVEST OPHTH VIS SCI, V47, P5191, DOI 10.1167/iovs.06-0614; Takahashi Y, 2009, J BIOL CHEM, V284, P3211, DOI 10.1074/jbc.M807248200; Tsilou E, 1997, ARCH BIOCHEM BIOPHYS, V346, P21, DOI 10.1006/abbi.1997.0276; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge Julian P, 2004, Methods Mol Biol, V251, P323; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016	40	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					988	999		10.1074/jbc.M109.025643	http://dx.doi.org/10.1074/jbc.M109.025643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19892706	Green Published, hybrid			2022-12-27	WOS:000273258200019
J	Jung, HY; Seong, HA; Manoharan, R; Ha, HJ				Jung, Haiyoung; Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung			Serine-Threonine Kinase Receptor-associated Protein Inhibits Apoptosis Signal-regulating Kinase 1 Function through Direct Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NM23-H1 TUMOR-SUPPRESSOR; CELL-DEATH; PHYSICAL INTERACTION; ASK1; STRESS; GROWTH; ACTIVATION; PHOSPHORYLATION; STRAP; THIOREDOXIN	Serine-threonine kinase receptor-associated protein (STRAP) interacts with transforming growth factor beta (TGF-beta) receptors and inhibits TGF-beta signaling. Here, we identify STRAP as an interacting partner of ASK1 (apoptosis signal-regulating kinase 1). The association between ASK1 and STRAP is mediated through the C-terminal domain of ASK1 and the fourth and sixth WD40 repeats of STRAP. Using cysteine-to-serine amino acid substitution mutants of ASK1 (C1005S, C1351S, C1360S, and C1351S/C1360S) and STRAP (C152S, C270S, and C152S/ C270S), we demonstrated that Cys(1351) and Cys(1360) of ASK1 and Cys(152) and Cys(270) of STRAP are required for ASK1-STRAP binding. ASK1 phosphorylated STRAP at Thr(175) and Ser(179), suggesting a potential role for STRAP phosphorylation in ASK1 activity regulation. Expression of wild-type STRAP, but not STRAP mutants (C152S/C270S and T175A/S179A), inhibited ASK1-mediated signaling to both JNK and p38 kinases by stabilizing complex formation between ASK1 and its negative regulators, thioredoxin and 14-3-3, or decreasing complex formation between ASK1 and its substrate MKK3. In addition, STRAP suppressed H2O2-mediated apoptosis in a dose-dependent manner by inhibiting ASK1 activity through direct interaction. These results suggest that STRAP can act as a negative regulator of ASK1.	[Jung, Haiyoung; Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung] Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Biotechnol Res Inst, Cheongju 361763, South Korea	Chungbuk National University	Ha, HJ (corresponding author), Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Biotechnol Res Inst, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr	Manoharan, Ravi/AAI-4139-2021	Manoharan, Ravi/0000-0002-3494-2173	Korea Science and Engineering Foundation [R0A-2007-000-20006-0]; Chungbuk National University	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Chungbuk National University	This work was supported by Korea Science and Engineering Foundation Grant R0A-2007-000-20006-0 and in part by Chungbuk National University Grant 2008.	Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; Garg S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-1; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Haider SK, 2006, CANCER RES, V66, P6156, DOI 10.1158/0008-5472.CAN-05-3261; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	33	30	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					54	70		10.1074/jbc.M109.045229	http://dx.doi.org/10.1074/jbc.M109.045229			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880523	Green Published, hybrid			2022-12-27	WOS:000273070100007
J	Phelps, CB; Wang, RR; Choo, SS; Gaudet, R				Phelps, Christopher B.; Wang, Ruiqi R.; Choo, Shelly S.; Gaudet, Rachelle			Differential Regulation of TRPV1, TRPV3, and TRPV4 Sensitivity through a Conserved Binding Site on the Ankyrin Repeat Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNEL; GATED ION-CHANNEL; INTRACELLULAR ATP; 2-AMINOETHOXYDIPHENYL BORATE; ACTIVATION; CALMODULIN; CALCIUM; THERMOSENSATION; RESIDUES; PROTEIN	Transient receptor potential vanilloid (TRPV) channels, which include the thermosensitive TRPV1-V4, have large cytoplasmic regions flanking the transmembrane domain, including an N-terminal ankyrin repeat domain. We show that a multiligand binding site for ATP and calmodulin previously identified in the TRPV1 ankyrin repeat domain is conserved in TRPV3 and TRPV4, but not TRPV2. Accordingly, TRPV2 is insensitive to intracellular ATP, while, as previously observed with TRPV1, a sensitizing effect of ATP on TRPV4 required an intact binding site. In contrast, ATP reduced TRPV3 sensitivity and potentiation by repeated agonist stimulations. Thus, ATP and calmodulin, acting through this conserved binding site, are key players in generating the different sensitivity and adaptation profiles of TRPV1, TRPV3, and TRPV4. Our results suggest that competing interactions of ATP and calmodulin influence channel sensitivity to fluctuations in calcium concentration and perhaps even metabolic state. Different feedback mechanisms likely arose because of the different physiological stimuli or temperature thresholds of these channels.	[Phelps, Christopher B.; Wang, Ruiqi R.; Choo, Shelly S.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gaudet, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	gaudet@mcb.harvard.edu	Gaudet, Rachelle/I-4133-2014; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X; Wang, Ruiqi Rachel/0000-0002-5099-8177	National Institutes of Health [R01GM081340]; American Heart Association [0335134N]; Klingenstein Award; McKnight Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Klingenstein Award(Klingenstein Philanthropies); McKnight Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081340. This work was also supported by American Heart Association Grant (Scientist Development Grant 0335134N) and a Klingenstein Award and a McKnight Scholar Award (to R. G.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Accardi A, 2008, J GEN PHYSIOL, V131, P104, DOI 10.1085/jgp.200709953; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Dattilo M, 2008, MOL PHARMACOL, V73, P42, DOI 10.1124/mol.107.040899; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Guler AD, 2002, J NEUROSCI, V22, P6408; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Koplas PA, 1997, J NEUROSCI, V17, P3525; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	44	121	123	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					731	740		10.1074/jbc.M109.052548	http://dx.doi.org/10.1074/jbc.M109.052548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864432	hybrid, Green Published			2022-12-27	WOS:000273070100074
J	Kobori, T; Smith, GD; Sandford, R; Edwardson, JM				Kobori, Toshiro; Smith, Graham D.; Sandford, Richard; Edwardson, J. Michael			The Transient Receptor Potential Channels TRPP2 and TRPC1 Form a Heterotetramer with a 2:2 Stoichiometry and an Alternating Subunit Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSCOPY REVEALS; GENE; POLYCYSTIN-1; RELEASE; ENCODES; PKD2	There is functional evidence that polycystin-2 (TRPP2) interacts with other members of the transient receptor potential family, including TRPC1 and TRPV4. Here we have used atomic force microscopy to study the structure of the TRPP2 homomer and the interaction between TRPP2 and TRPC1. The molecular volumes of both Myc-tagged TRPP2 and V5-tagged TRPC1 isolated from singly transfected tsA 201 cells indicated that they assembled as homotetramers. The molecular volume of the protein isolated from cells expressing both TRPP2 and TRPC1 was intermediate between the volumes of the two homomers, suggesting that a heteromer was being formed. The distribution of angles between pairs of anti-Myc antibodies bound to TRPP2 particles had a large peak close to 90 degrees and a smaller peak close to 180 degrees, consistent with the assembly of TRPP2 as a homotetramer. In contrast, the corresponding angle distributions for decoration of the TRPP2-TRPC1 heteromer by either anti-Myc or anti-V5 antibodies had predominant peaks close to 180 degrees. This decoration pattern indicates a TRPP2: TRPC1 subunit stoichiometry of 2:2 and an alternating subunit arrangement.	[Kobori, Toshiro; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Smith, Graham D.; Sandford, Richard] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk			National Agriculture and Food Research Organization (Japan); National Institutes of Health Research Cambridge medical Research Centre	National Agriculture and Food Research Organization (Japan); National Institutes of Health Research Cambridge medical Research Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a National Agriculture and Food Research Organization (Japan) Overseas Research Grant.; Supported by the National Institutes of Health Research Cambridge medical Research Centre.	Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2007, BIOPHYS J, V93, P505, DOI 10.1529/biophysj.106.101048; Barrera NP, 2007, BIOCHEM BIOPH RES CO, V358, P1086, DOI 10.1016/j.bbrc.2007.05.039; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Boumechache M, 2009, J BIOL CHEM, V284, P13446, DOI 10.1074/jbc.M901255200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Yoder Bradley K., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010362; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024	32	67	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35507	35513		10.1074/jbc.M109.060228	http://dx.doi.org/10.1074/jbc.M109.060228			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850920	hybrid, Green Published			2022-12-27	WOS:000272645600027
J	Shen, B; Smith, RS; Hsu, YT; Chao, L; Chao, J				Shen, Bo; Smith, Robert S., Jr.; Hsu, Yi-Te; Chao, Lee; Chao, Julie			Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALLIKREIN-BINDING PROTEIN; TNF-ALPHA; IDENTIFICATION; CELLS; ANGIOGENESIS; APOPTOSIS; RECEPTOR; TISSUES; CLONING; FLUIDS	Kallistatin is a plasma protein that exhibits pleiotropic effects in vasodilation, anti-angiogenesis, and anti-inflammation. To isolate a kallistatin-binding protein that mediates the vascular actions of kallistatin, we screened and identified a positive clone from a human heart cDNA expression library by using an alkaline phosphatase-kallistatin fusion protein binding assay. Sequence analysis revealed that kallistatin-binding protein is human Kruppel-like factor 4 (KLF4). KLF4 was localized on the plasma membrane of HEK-293 cells and endothelial cells over-expressing KLF4. KLF4 and kallistatin complex formation was identified in endothelial cells by immunoprecipitation followed by immunoblotting. We showed that kallistatin inhibits tumor necrosis factor-alpha-induced NF-kappa B activation, as well as vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression in endothelial cells, whereas knockdown of KLF4 by small interfering RNA oligonucleotide abolished the effect of kallistatin. Kallistatin increased endothelial nitric-oxide synthase (eNOS) expression and nitric oxide levels, and these effects were also blocked by KLF4 small interfering RNA oligonucleotide. Moreover, inhibition of eNOS by RNA interference or by NOS inhibitor abolished the blocking effect of kallistatin on vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression. In summary, we identified KLF4 as a kallistatin-binding protein, which has a novel role in mediating the anti-inflammatory actions of kallistatin via increasing eNOS expression in endothelial cells. This study provides a new target for modulating endothelial function in vascular disease.	[Shen, Bo; Smith, Robert S., Jr.; Hsu, Yi-Te; Chao, Lee; Chao, Julie] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Chao, J (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	chaoj@musc.edu			National Institutes of Health [HL-44083, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-44083 and C06 RR015455.	Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; BAUTISTA AP, 1994, AM J PHYSIOL, V266, pG783, DOI 10.1152/ajpgi.1994.266.5.G783; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; CARLOS TM, 1994, BLOOD, V84, P2068; CHAI KX, 1993, J BIOL CHEM, V268, P24498; Chao J, 1992, Agents Actions Suppl, V38 ( Pt 1), P174; CHAO J, 1986, BIOCHEM J, V239, P325, DOI 10.1042/bj2390325; Chao JL, 1996, J LAB CLIN MED, V127, P612, DOI 10.1016/S0022-2143(96)90152-3; Chao JL, 1997, J CLIN INVEST, V100, P11, DOI 10.1172/JCI119502; Chao J, 2006, HUM GENE THER, V17, P1201, DOI 10.1089/hum.2006.17.1201; Chen LM, 1997, LIFE SCI, V60, P1431, DOI 10.1016/S0024-3205(97)00094-5; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; DE CR, 1995, J CLIN INVEST, V96, P60; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Gao L, 2008, LAB INVEST, V88, P1157, DOI 10.1038/labinvest.2008.85; Goebeler M, 1997, IMMUNOLOGY, V91, P450, DOI 10.1046/j.1365-2567.1997.00263.x; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hatcher HC, 1997, INVEST OPHTH VIS SCI, V38, P658; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Ma JX, 1996, CURR EYE RES, V15, P1117, DOI 10.3109/02713689608995143; Martin J, 2007, CURR PHARM DESIGN, V13, P1751, DOI 10.2174/138161207780831248; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Miao RQ, 2000, CIRC RES, V86, P418, DOI 10.1161/01.RES.86.4.418; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Ortiz PA, 2003, AM J PHYSIOL-REG I, V284, pR628, DOI 10.1152/ajpregu.00401.2002; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Wang CR, 2005, ARTHRITIS RHEUM-US, V52, P1319, DOI 10.1002/art.20991; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026; Zhang CH, 2006, ARTERIOSCL THROM VAS, V26, P475, DOI 10.1161/01.ATV.0000201932.32678.7e	42	70	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35471	35478		10.1074/jbc.M109.046813	http://dx.doi.org/10.1074/jbc.M109.046813			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858207	Green Published, hybrid			2022-12-27	WOS:000272645600023
J	Granneman, JG; Moore, HPH; Krishnamoorthy, R; Rathod, M				Granneman, James G.; Moore, Hsiao-Ping H.; Krishnamoorthy, Rukmani; Rathod, Miloni			Perilipin Controls Lipolysis by Regulating the Interactions of AB-hydrolase Containing 5 (Abhd5) and Adipose Triglyceride Lipase (Atgl)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; CHANARIN-DORFMAN-SYNDROME; LIPID DROPLETS; STIMULATED LIPOLYSIS; PROTEIN TRAFFICKING; MEDIATED LIPOLYSIS; ADIPOCYTES; CGI-58; TISSUE; PHOSPHORYLATION	The mobilization of stored lipid by hormones is a fundamental function of fat cells, and there is strong evidence that perilipin (Plin), a lipid droplet scaffold, and adipose tissue triglyceride lipase (Atgl), a triglyceride-specific lipase, play critical roles. Previous work suggested that Abhd5, a protein activator of Atgl, coordinates with Plin in controlling basal and stimulated lipolysis; however, the underlying mechanism is controversial. The present experiments investigated protein trafficking and interactions among Plin, Atgl, and Abhd5 in live cells. The results demonstrate that Plin binds Abhd5 with high affinity and thereby suppresses the interaction of Abhd5 with Atgl. Sequestration of Abhd5 appears to a major mechanism by which Plin reduces basal lipolysis. Phosphorylation of Plin on serine 492 or serine 517 rapidly releases Abhd5 from Plin, allowing Abhd5 to directly interact with Atgl. Imaging experiments demonstrated that the Plin-dependent interaction of Abhd5 and Atgl occurs mainly, but not exclusively, on lipid droplets that contain Plin.	[Granneman, James G.; Krishnamoorthy, Rukmani; Rathod, Miloni] Wayne State Univ, Sch Med, CIMER, Detroit, MI 48201 USA; [Moore, Hsiao-Ping H.] Lawrence Technol Univ, Southfield, MI 48075 USA	Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, CIMER, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			National Institutes of Health [DK 62292, DK76629]; American Diabetes Association [RA29]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062292, R56DK062292, R01DK076629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 62292 and DK76629. This work was also supported by American Diabetes Association Grant RA29 and by a grant from the Department of Veterans Affairs.	Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	27	251	260	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34538	34544		10.1074/jbc.M109.068478	http://dx.doi.org/10.1074/jbc.M109.068478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850935	Green Published, hybrid			2022-12-27	WOS:000272439600008
J	Jarnaess, E; Stokka, AJ; Kvissel, AK; Skalhegg, BS; Torgersen, KM; Scott, JD; Carlson, CR; Tasken, K				Jarnaess, Elisabeth; Stokka, Anne Jorunn; Kvissel, Anne-Katrine; Skalhegg, Bjorn S.; Torgersen, Knut Martin; Scott, John D.; Carlson, Cathrine R.; Tasken, Kjetil			Splicing Factor Arginine/Serine-rich 17A (SFRS17A) Is an A-kinase Anchoring Protein That Targets Protein Kinase A to Splicing Factor Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT RII; CATALYTIC SUBUNIT; SIGNALING PATHWAY; MOLECULAR-BASIS; SITE SELECTION; BINDING; LOCALIZATION; EXPRESSION; SPECIFICITY; IDENTIFICATION	Protein kinase A (PKA) is targeted to distinct subcellular localizations by specific protein kinase A anchoring proteins (AKAPs). AKAPs are divided into subclasses based on their ability to bind type I or type II PKA or both. Dual-specificity AKAPs were recently reported to have an additional PKA binding determinant called the RI specifier region. A bioinformatic search with the consensus RI specifier region identified a novel AKAP, the splicing factor arginine/serine-rich 17A (SFRS17A). Here, we show by a variety of protein interaction assays that SFRS17A binds both type I and type II PKA in vitro and inside cells, demonstrating that SFRS17A is a dual-specific AKAP. Moreover, immunofluorescence experiments show that SFRS17A colocalizes with the catalytic subunit of PKA as well as the splicing factor SC35 in splicing factor compartments. Using the E1A minigene splicing assay, we found that expression of wild type SFRS17A conferred regulation of E1A alternative splicing, whereas the mutant SFRS17A, which is unable to bind PKA, did not. Our data suggest that SFRS17A is an AKAP involved in regulation of pre-mRNA splicing possibly by docking a pool of PKA in splicing factor compartments.	[Jarnaess, Elisabeth; Stokka, Anne Jorunn; Torgersen, Knut Martin; Carlson, Cathrine R.; Tasken, Kjetil] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Jarnaess, Elisabeth; Stokka, Anne Jorunn; Torgersen, Knut Martin; Tasken, Kjetil] Univ Oslo, Ctr Mol Med Norway, Nord European Mol Biol Lab Partnership, N-0317 Oslo, Norway; [Kvissel, Anne-Katrine; Skalhegg, Bjorn S.] Univ Oslo, Dept Nutr, N-0317 Oslo, Norway; [Kvissel, Anne-Katrine; Skalhegg, Bjorn S.] Univ Oslo, Dept Biochem, Inst Basic Med Sci, N-0317 Oslo, Norway; [Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Tasken, K (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, POB 1125, N-0317 Oslo, Norway.	kjetil.tasken@biotek.uio.no	Skålhegg, Bjørn Steen/AAZ-2976-2021	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Tasken, Kjetil/0000-0003-2841-4697	Norwegian Functional Genomics Program; Research Council of Norway; Norwegian Cancer Society; Novo Nordic Foundation; European Union [037189]; National Institutes of Health [DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	Norwegian Functional Genomics Program(Research Council of Norway); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Novo Nordic Foundation(Novo Nordisk Foundation); European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Norwegian Functional Genomics Program, the Research Council of Norway, the Norwegian Cancer Society, Novo Nordic Foundation, and European Union Grant 037189 (thera-cAMP). This work was also supported, in part by National Institutes of Health Grant DK54441 (to J.D.S.).	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Angelo R, 1998, J BIOL CHEM, V273, P14633, DOI 10.1074/jbc.273.23.14633; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1991, J BIOL CHEM, V266, P14188; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; CUMMING R, 1981, NEUROSCIENCE, V6, P953, DOI 10.1016/0306-4522(81)90176-7; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; DURGERIAN S, 1989, J BIOL CHEM, V264, P9807; Ellison Jay W., 1992, Human Molecular Genetics, V1, P691; FLETCHER WH, 1986, J BIOL CHEM, V261, P5504; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gronholm M, 2003, J BIOL CHEM, V278, P41167, DOI 10.1074/jbc.M306149200; Gupte RS, 2006, EXP CELL RES, V312, P796, DOI 10.1016/j.yexcr.2005.11.033; Gupte RS, 2005, CANCER BIOL THER, V4, P429; Gupte RS, 2005, CELL CYCLE, V4, P323; Hausken ZE, 1998, METH MOL B, V88, P47; Hausken ZE, 1996, BIOCHEM SOC T, V24, P986, DOI 10.1042/bst0240986; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; KUETTEL MR, 1985, J CELL BIOL, V101, P965, DOI 10.1083/jcb.101.3.965; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lau YFC, 2000, MOL CARCINOGEN, V27, P308, DOI 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Mangs AH, 2006, NUCLEIC ACIDS RES, V34, P4976, DOI 10.1093/nar/gkl660; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; ULFENDAHL PJ, 1987, EMBO J, V6, P2037, DOI 10.1002/j.1460-2075.1987.tb02468.x; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100	56	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35154	35164		10.1074/jbc.M109.056465	http://dx.doi.org/10.1074/jbc.M109.056465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840947	Green Published, hybrid			2022-12-27	WOS:000272439600069
J	Cole, HA; Tabor-Godwin, JM; Hayes, JJ				Cole, Hope A.; Tabor-Godwin, Jenna M.; Hayes, Jeffrey J.			Uracil DNA Glycosylase Activity on Nucleosomal DNA Depends on Rotational Orientation of Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; HISTONE TAIL DOMAINS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; LINKER HISTONES; GLOBULAR DOMAIN; IN-VIVO; CHROMATIN; MECHANISM	The activity of uracil DNA glycosylases (UDGs), which recognize and excise uracil bases from DNA, has been well characterized on naked DNA substrates but less is known about activity in chromatin. We therefore prepared a set of model nucleosome substrates in which single thymidine residues were replaced with uracil at specific locations and a second set of nucleosomes in which uracils were randomly substituted for all thymidines. We found that UDG efficiently removes uracil from internal locations in the nucleosome where the DNA backbone is oriented away from the surface of the histone octamer, without significant disruption of histone-DNA interactions. However, uracils at sites oriented toward the histone octamer surface were excised at much slower rates, consistent with a mechanism requiring spontaneous DNA unwrapping from the nucleosome. In contrast to the nucleosome core, UDG activity on DNA outside the core DNA region was similar to that of naked DNA. Association of linker histone reduced activity of UDG at selected sites near where the globular domain of H1 is proposed to bind to the nucleosome as well as within the extra-core DNA. Our results indicate that some sites within the nucleosome core and the extra-core (linker) DNA regions represent hot spots for repair that could influence critical biological processes.	[Cole, Hope A.; Tabor-Godwin, Jenna M.; Hayes, Jeffrey J.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Hayes, JJ (corresponding author), Univ Rochester, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [RO1GM52426]; American Cancer Society [RPG GMC-99742]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM52426 and American Cancer Society Grant RPG GMC-99742.	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; Angelov D, 2001, P NATL ACAD SCI USA, V98, P6599, DOI 10.1073/pnas.121171498; Annunziato AT, 2000, GENE EXPRESSION, V9, P37; Aoyagi S, 2002, MOL CELL BIOL, V22, P7484, DOI 10.1128/MCB.22.21.7484-7490.2002; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Beard BC, 2005, DNA REPAIR, V4, P203, DOI 10.1016/j.dnarep.2004.09.011; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK DJ, 1986, J MOL BIOL, V187, P569, DOI 10.1016/0022-2836(86)90335-9; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; CraneRobinson C, 1997, TRENDS BIOCHEM SCI, V22, P75, DOI 10.1016/S0968-0004(97)01013-X; DODSON ML, 1994, J BIOL CHEM, V269, P32709; DUNCAN BK, 1982, J BACTERIOL, V151, P750, DOI 10.1128/JB.151.2.750-755.1982; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; FURRER P, 1995, J STRUCT BIOL, V114, P177, DOI 10.1006/jsbi.1995.1017; GODDE JS, 1995, J BIOL CHEM, V270, P27399, DOI 10.1074/jbc.270.46.27399; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hayes JJ, 1997, METHODS, V12, P2, DOI 10.1006/meth.1997.0441; HAYES JJ, 1993, P NATL ACAD SCI USA, V90, P6415, DOI 10.1073/pnas.90.14.6415; Hayes JJ, 1996, BIOCHEMISTRY-US, V35, P11931, DOI 10.1021/bi961590+; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; Ishlbashi T, 2008, MOL CELL BIOL, V28, P4734, DOI 10.1128/MCB.00588-08; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu PF, 2002, CHEM RES TOXICOL, V15, P1001, DOI 10.1021/tx020030a; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Nakanishi S, 2007, NUCLEIC ACIDS RES, V35, P4313, DOI 10.1093/nar/gkm436; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Otterlei M, 2000, EMBO J, V19, P5542, DOI 10.1093/emboj/19.20.5542; Otterlei M, 1998, NUCLEIC ACIDS RES, V26, P4611, DOI 10.1093/nar/26.20.4611; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 2000, MUTAT RES-DNA REPAIR, V460, P183, DOI 10.1016/S0921-8777(00)00026-4; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Smerdon MJ, 1999, PROG NUCLEIC ACID RE, V62, P227; Stivers JT, 2001, ARCH BIOCHEM BIOPHYS, V396, P1, DOI 10.1006/abbi.2001.2605; Thiriet C, 1998, J BIOL CHEM, V273, P21352, DOI 10.1074/jbc.273.33.21352; Ura K, 2002, EUR J BIOCHEM, V269, P2288, DOI 10.1046/j.1432-1033.2002.02888.x; van Holde KE., 1989, SPRINGER SERIES MOL; Wolffe A., 1998, CHROMATIN STRUCTURE; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Xiao GY, 1999, PROTEINS, V35, P13; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200	72	69	70	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2876	2885		10.1074/jbc.M109.073544	http://dx.doi.org/10.1074/jbc.M109.073544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933279	hybrid, Green Published			2022-12-27	WOS:000273697800063
J	Esselens, C; Malapeira, J; Colome, N; Casal, C; Rodriguez-Manzaneque, JC; Canals, F; Arribas, J				Esselens, Cary; Malapeira, Jordi; Colome, Nuria; Casal, Carmen; Carlos Rodriguez-Manzaneque, Juan; Canals, Francesc; Arribas, Joaquin			The Cleavage of Semaphorin 3C Induced by ADAMTS1 Promotes Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-GENE-EXPRESSION; EXTRACELLULAR-MATRIX; TUMOR PROGRESSION; PROTEIN; IDENTIFICATION; CANCER; FAMILY; GROWTH; METALLOELASTASE; DISINTEGRIN	Metastasis is a sequential process that allows cells to move from the primary tumor and grow elsewhere. Because of their ability to cleave a variety of extracellular signaling and adhesion molecules, metalloproteases have been long considered key components of the metastatic program. However, the function of certain metalloproteases, such as ADAMTS1, is not clear and seems to depend on the cellular environment and/or the stage of tumor progression. To characterize the function of ADAMTS1, we performed two alternative proteomic approaches, difference gel electrophoresis and stable isotope labeling by amino acids in cell culture, to identify novel substrates of the metalloprotease. Both techniques showed that overexpression of ADAMTS1 leads to the release of semaphorin 3C from the extracellular matrix. Although semaphorins are well known regulators of axon guidance, accumulating evidence shows that they may also participate in tumor progression. Here, we show that the cleavage of semaphorin 3C induced by ADAMTS1 promotes the migration of breast cancer cells, indicating that the co-expression of these molecules in tumors may contribute to the metastatic program.	[Canals, Francesc] Vall Hebron Univ Hosp, Med Oncol Res Program, Vall Hebron Inst Oncol, Barcelona 08035, Spain; [Colome, Nuria; Canals, Francesc] Vall Hebron Univ Hosp, Res Inst Fdn, Prote Lab, Barcelona 08035, Spain; [Arribas, Joaquin] Autonomous Univ Barcelona, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Arribas, Joaquin] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Casal, Carmen; Carlos Rodriguez-Manzaneque, Juan] Genyo Pfizer Univ Granada, Andalusian Govt Ctr Genom & Oncol Res, Granada 18100, Spain	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; ICREA; Pfizer; University of Granada	Canals, F (corresponding author), Vall Hebron Univ Hosp, Med Oncol Res Program, Vall Hebron Inst Oncol, Psg Vall Hebron 119-129, Barcelona 08035, Spain.	fcanals@ir.vhebron.net; jarribas@vhio.net	Rodriguez-Manzaneque, Juan Carlos/F-3899-2012; Arribas, Joaquin/M-4482-2014; Malapeira, Jordi/I-7956-2014	Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029; Arribas, Joaquin/0000-0002-0504-0664; Esselens, Cary/0000-0001-8876-634X; Malapeira, Jordi/0000-0003-3503-1272; Casal Moreno, Carmen/0000-0002-4898-7671	Instituto de Salud Carlos III [PI081154]; network of cooperative cancer research [RTICC-RD06/0020/0022, CP06/00304, P1071058]; Breast Cancer Research Foundation; La Marato de TV3 [CP06/00304, PI071058]; ICREA Funding Source: Custom	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); network of cooperative cancer research; Breast Cancer Research Foundation; La Marato de TV3; ICREA(ICREA)	This work was supported by grants from the Instituto de Salud Carlos III (Intrasalud PI081154 and the network of cooperative cancer research (RTICC-RD06/0020/0022)) (to J.A.) and CP06/00304 and P1071058 (to F.C.) and the Breast Cancer Research Foundation and La Marato de TV3 (to J.A.) and Grants CP06/00304 and PI071058 (to F.C.).	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Bachelder RE, 2003, CANCER RES, V63, P5230; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Beckers J, 2005, INT J CANCER, V114, P590, DOI 10.1002/ijc.20798; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Canals F, 2006, PROTEOMICS, V6, pS28, DOI 10.1002/pmic.200500446; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Rodriguez-Manzaneque JC, 2009, INT J BIOCHEM CELL B, V41, P800, DOI 10.1016/j.biocel.2008.08.014; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Esselens CW, 2008, BIOL CHEM, V389, P1075, DOI 10.1515/BC.2008.121; Everley PA, 2005, ANN NY ACAD SCI, V1059, P1, DOI 10.1196/annals.1339.001; Galani E, 2002, ANTICANCER RES, V22, P2275; Gorrin-Rivas MJ, 2000, CLIN CANCER RES, V6, P1647; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuno K, 2004, BIOCHEM BIOPH RES CO, V319, P1327, DOI 10.1016/j.bbrc.2004.05.105; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Martin-Satue M, 1999, J SURG ONCOL, V72, P18; Masui T, 2001, CLIN CANCER RES, V7, P3437; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Porter S, 2004, CLIN CANCER RES, V10, P2429, DOI 10.1158/1078-0432.CCR-0398-3; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Rocks N, 2008, CANCER RES, V68, P9541, DOI 10.1158/0008-5472.CAN-08-0548; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Smith GN, 1999, ARTHRITIS RHEUM, V42, P1140, DOI 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Torres-Collado AX, 2006, J BIOL CHEM, V281, P17827, DOI 10.1074/jbc.M513465200; Van den Bergh G, 2004, CURR OPIN BIOTECH, V15, P38, DOI 10.1016/j.copbio.2003.12.001; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713	52	76	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2463	2473		10.1074/jbc.M109.055129	http://dx.doi.org/10.1074/jbc.M109.055129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19915008	Green Published, hybrid			2022-12-27	WOS:000273697800025
J	Gonda, K; Watanabe, TM; Ohuchi, N; Higuchi, H				Gonda, Kohsuke; Watanabe, Tomonobu M.; Ohuchi, Noriaki; Higuchi, Hideo			In Vivo Nano-imaging of Membrane Dynamics in Metastatic Tumor Cells Using Quantum Dots	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; PROTEASE-ACTIVATED RECEPTOR; PLASMA-MEMBRANE; MAMMARY-TUMORS; PROTEINS; MOLECULE; INVASION; MICE; TRACKING; MOTILITY	Changes in membrane morphology and membrane protein dynamics based on its fluidity are critical for cancer metastasis. However, this subject has remained unclear, because the spatial precision of previous in vivo imaging has been limited to the micrometer level and single molecule imaging is impossible. Here, we have imaged the membrane dynamics of tumor cells in mice with a spatial precision of 7-9 nm under a confocal microscope. A metastasis-promoting factor on the cell membrane, protease-activated receptor 1 (PAR1), was labeled with quantum dots conjugated with an anti-PAR1 antibody. Movements of cancer cells and PAR1 during metastasis were clearly observed in vivo. Images used to assess PAR1 dynamics were taken of representative cells for four stages of metastasis; i.e. cancer cells far from blood vessels in tumor, near the vessel, in the bloodstream, and adherent to the inner vascular surface in the normal tissues near tumor were photographed. The diffusion constant of PAR1 in static cells far from tumor blood vessels was smaller than in moving cells near the vessels and in the bloodstream. The diffusion constant of cells adhering to the inner vascular surface in the normal tissues was also very small. Cells formed membrane protrusion during migration. The PAR1 diffusion constant on these pseudopodia was greater than in other membrane regions in the same cell. Thus, the dynamics of PAR1 movement showed that membrane fluidity increases during intravasation, reaches a peak in the vessel, decreases during extravasation, and is also higher at locally formed pseudopodia.	[Gonda, Kohsuke; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Gonda, Kohsuke; Watanabe, Tomonobu M.; Higuchi, Hideo] Tohoku Univ, Biomed & Engn Res Org, Sendai, Miyagi 9808575, Japan; [Watanabe, Tomonobu M.] Osaka Univ, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Higuchi, Hideo] Univ Tokyo, Dept Phys, Grad Sch Sci, Bunkyou Ku, Tokyo 1138654, Japan	Tohoku University; Tohoku University; Osaka University; Tohoku University; University of Tokyo	Gonda, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan.	gonda@m.tains.tohoku.ac.jp; higuchi@phys.s.u-tokyo.ac.jp	Watanabe, Tomonobu/J-4812-2013	Watanabe, Tomonobu/0000-0002-2420-4230	Japan MEXT; Ministry of Health, Labor, and Welfare of Japan [H18-Nano-001]; JST; Tohoku University Graduate School of Medicine; Tohoku University; Konica Minolta Medical Graphic, Inc.	Japan MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JST(Japan Science & Technology Agency (JST)); Tohoku University Graduate School of Medicine; Tohoku University; Konica Minolta Medical Graphic, Inc.(Konica Minolta Science and Technology Foundation)	This work was supported by Grants-in-Aid for Scientific Research in Priority Areas from the Japan MEXT (to H. H. and K. G.), a Grants-in-aid for Research Project, Promotion of Advanced Medical Technology (H18-Nano-001) from the Ministry of Health, Labor, and Welfare of Japan (to N.O.), Special Coordination Funds for Promoting Science and Technology of JST (to K. G., T. M. W., and H. H.), Research for Promoting Technological Seeds of JST (to K. G.), and CREST of JST (to H. H.). We also acknowledge the support of the Biomedical Research Core of Tohoku University Graduate School of Medicine, the Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Center," and Konica Minolta Medical & Graphic, Inc.	Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li-Shishido S, 2006, BIOCHEM BIOPH RES CO, V351, P7, DOI 10.1016/j.bbrc.2006.09.159; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Nguyen VT, 2003, EMBO J, V22, P4968, DOI 10.1093/emboj/cdg498; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; SAKO Y, 1995, J CELL BIOL, V129, P1559, DOI 10.1083/jcb.129.6.1559; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Tada H, 2007, CANCER RES, V67, P1138, DOI 10.1158/0008-5472.CAN-06-1185; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Wang WG, 2002, CANCER RES, V62, P6278; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Ybo J, 2008, EXP CELL RES, V314, P3563, DOI 10.1016/j.yexcr.2008.09.014; Zeisig R, 2007, ARCH BIOCHEM BIOPHYS, V459, P98, DOI 10.1016/j.abb.2006.09.030	38	69	72	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2750	2757		10.1074/jbc.M109.075374	http://dx.doi.org/10.1074/jbc.M109.075374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19917603	Green Published, hybrid			2022-12-27	WOS:000273697800052
J	Singh, MK; Li, Y; Li, SR; Cobb, RM; Zhou, D; Lu, MM; Epstein, JA; Morrisey, EE; Gruber, PJ				Singh, Manvendra K.; Li, Yan; Li, Shanru; Cobb, Ryan M.; Zhou, Diane; Lu, Min Min; Epstein, Jonathan A.; Morrisey, Edward E.; Gruber, Peter J.			Gata4 and Gata5 Cooperatively Regulate Cardiac Myocyte Proliferation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOMYOCYTE CELL-CYCLE; HEART TUBE FORMATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CARDIOVASCULAR-SYSTEM; VENTRAL MORPHOGENESIS; HEMATOPOIETIC-CELLS; MOUSE EMBRYO; DIFFERENTIATION; ZEBRAFISH	GATA5 is a member of the zinc finger transcription factor GATA family (GATA1-6) that plays a wide variety of roles in embryonic and adult development. Experiments in multiple model systems have emphasized the importance of the GATA family members 4-6 in the development of the endoderm and mesoderm. Yet despite overlapping expression patterns, there is little evidence of an important role for GATA5 in mammalian cardiac development. We have generated a new Gata5 mutant allele lacking exons 2 and 3 that encodes both zinc finger domains (Gata5(tm2Eem)), and we show that although Gata5(-/-) mice are viable, Gata4(+/-)5(-/-) mutants die at mid-gestation and exhibit profound cardiovascular defects, including abnormalities of cardiomyocyte proliferation and cardiac chamber maturation. These results demonstrate functional redundancy between Gata4 and Gata5 during cardiac development and implicate Gata5 as a candidate modifier gene for congenital heart disease.	[Zhou, Diane; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Li, Yan; Li, Shanru; Zhou, Diane; Lu, Min Min; Epstein, Jonathan A.; Morrisey, Edward E.; Gruber, Peter J.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.; Morrisey, Edward E.; Gruber, Peter J.] Univ Penn, Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Singh, Manvendra K.; Cobb, Ryan M.; Gruber, Peter J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Sch Med, 956 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	emorrisse@mail.med.upenn.edu; pgruber@mail.med.upenn.edu	Cobb, Ryan/L-7655-2019; Singh, Manvendra K./AHE-0676-2022	Cobb, Ryan/0000-0002-8364-7103; Singh, Manvendra K./0000-0002-2884-0074; Epstein, Jonathan/0000-0001-8637-4465	Pliezowicz Family Foundation; National Institutes of Health [R01-HL064632, R01-HL071546]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546, R01HL064632] Funding Source: NIH RePORTER	Pliezowicz Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Pliezowicz Family Foundation (to P. J. G.) and National Institutes of Health Grants R01-HL064632 (to E. E. M.) and R01-HL071546 (to J. A. E.).	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Brewer A, 1999, J BIOL CHEM, V274, P38004, DOI 10.1074/jbc.274.53.38004; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen JN, 1996, DEVELOPMENT, V123, P293; Dubart A, 1996, BLOOD, V87, P3711, DOI 10.1182/blood.V87.9.3711.bloodjournal8793711; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Haworth KE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-74; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; MacNeill C, 1997, J BIOL CHEM, V272, P8396, DOI 10.1074/jbc.272.13.8396; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Molkentin JD, 2000, MOL CELL BIOL, V20, P5256, DOI 10.1128/MCB.20.14.5256-5260.2000; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; ORKIN SH, 1992, BLOOD, V80, P575; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Perlman H, 1998, J BIOL CHEM, V273, P13713, DOI 10.1074/jbc.273.22.13713; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wawersik S, 2000, METH MOL B, V137, P87; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	45	68	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1765	1772		10.1074/jbc.M109.038539	http://dx.doi.org/10.1074/jbc.M109.038539			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19889636	hybrid, Green Published			2022-12-27	WOS:000273429100022
J	Beretta, M; Gorren, ACF; Wenzl, MV; Weis, R; Russwurm, M; Koesling, D; Schmidt, K; Mayer, B				Beretta, Matteo; Gorren, Antonius C. F.; Wenzl, M. Verena; Weis, Robert; Russwurm, Michael; Koesling, Doris; Schmidt, Kurt; Mayer, Bernd			Characterization of the East Asian Variant of Aldehyde Dehydrogenase-2 BIOACTIVATION OF NITROGLYCERIN AND EFFECTS OF Alda-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; GLYCERYL TRINITRATE; NITROGLYCERIN BIOACTIVATION; NITRATE TOLERANCE; GUANYLATE-CYCLASE; COENZYME BINDING; MITOCHONDRIAL; NITROPRUSSIDE; POLYMORPHISM; SPECIFICITY	The East Asian variant of mitochondrial aldehyde dehydrogenase (ALDH2) exhibits significantly reduced dehydrogenase, esterase, and nitroglycerin (GTN) denitrating activities. The small molecule Alda-1 was reported to partly restore low acetaldehyde dehydrogenase activity of this variant. In the present study we compared the wild type enzyme (ALDH2*1) with the Asian variant (ALDH2*2) regarding GTN bioactivation and the effects of Alda-1. Alda-1 increased acetaldehyde oxidation by ALDH2*1 and ALDH2*2 approximately 1.5- and 6-fold, respectively, and stimulated the esterase activities of both enzymes to similar extent as the coenzyme NAD. The effect of NAD was biphasic with pronounced inhibition occurring at >= 5 mM. In the presence of 1 mM NAD, Alda-1 stimulated ALDH2*2-catalyzed ester hydrolysis 73-fold, whereas the NAD-stimulated activity of ALDH2*1 was inhibited because of 20-fold increased inhibitory potency of NAD in the presence of the drug. Although ALDH2*2 exhibited 7-fold lower GTN denitrating activity and GTN affinity than ALDH2*1, the rate of nitric oxide formation was only reduced 2-fold, and soluble guanylate cyclase (sGC) activation was more pronounced than with wild type ALDH2 at saturating GTN. Alda-1 caused slight inhibition of GTN denitration and did not increase GTN-induced sGC activation in the presence of either variant. The present results indicate that Alda-1 stimulates established ALDH2 activities by improving NAD binding but does not improve the GTN binding affinity of the Asian variant. In addition, our data revealed an unexpected discrepancy between GTN reductase activity and sGC activation, suggesting that GTN denitration and bioactivation may reflect independent pathways of ALDH2-catalyzed GTN biotransformation.	[Beretta, Matteo; Gorren, Antonius C. F.; Wenzl, M. Verena; Schmidt, Kurt; Mayer, Bernd] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Weis, Robert] Karl Franzens Univ Graz, Dept Pharmaceut Chem, A-8010 Graz, Austria; [Russwurm, Michael; Koesling, Doris] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany	University of Graz; University of Graz; Ruhr University Bochum	Mayer, B (corresponding author), Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	mayer@uni-graz.at	Mayer, Bernd/B-9391-2008; Beretta, Matteo/D-8573-2012	Mayer, Bernd/0000-0002-2921-3494; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Weis, Robert/0000-0002-7174-6673; Beretta, Matteo/0000-0001-5564-4282	Fonds zur Forderung der Wissenschaftlichen Forschung in Austria W901 DK Molecular Enzymology [P20669, P21693]; Deutsche Forschungsgemeinschaft [KO1157/4-1]; Austrian Science Fund (FWF) [P 21693, W 901] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung in Austria W901 DK Molecular Enzymology(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fonds zur Forderung der Wissenschaftlichen Forschung in Austria W901 DK Molecular Enzymology Grants P20669 and P21693 (to B.M.) and by Deutsche Forschungsgemeinschaft Grant KO1157/4-1 (to D.K. and M.R.).	Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; BRIEN JF, 1986, J PHARMACOL EXP THER, V237, P608; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; Difabio J, 2003, MOL PHARMACOL, V64, P1109, DOI 10.1124/mol.64.5.1109; FARRES J, 1994, J BIOL CHEM, V269, P13854; GOEDDE HW, 1983, AM J HUM GENET, V35, P769; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; HART GJ, 1978, BIOCHEM J, V175, P899, DOI 10.1042/bj1750899; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; Kleschyov AL, 2003, CIRC RES, V93, pE104, DOI 10.1161/01.RES.0000100067.62876.50; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4457, DOI 10.1021/bi9521102; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; Li YF, 2006, J CLIN INVEST, V116, P506, DOI 10.1172/JCI26564; Mackenzie IS, 2005, ARTERIOSCL THROM VAS, V25, P1891, DOI 10.1161/01.ATV.0000179599.71086.89; Mayer B, 2008, BRIT J PHARMACOL, V155, P170, DOI 10.1038/bjp.2008.263; MAYER B, 1995, J BIOL CHEM, V270, P655, DOI 10.1074/jbc.270.2.655; Miller MR, 2008, J VASC RES, V45, P375, DOI 10.1159/000121407; MUKERJEE N, 1992, ARCH BIOCHEM BIOPHYS, V299, P23, DOI 10.1016/0003-9861(92)90239-S; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; Sage PR, 2000, CIRCULATION, V102, P2810; Schultz G., 1984, METHOD ENZYMAT AN, P379; Tanaka F, 1997, ALCOHOL CLIN EXP RES, V21, P596, DOI 10.1111/j.1530-0277.1997.tb03808.x; TU GC, 1988, J BIOL CHEM, V263, P1218; Wang MF, 2009, CHEM-BIOL INTERACT, V178, P36, DOI 10.1016/j.cbi.2008.10.002; Wang RS, 2002, DRUG METAB DISPOS, V30, P69, DOI 10.1124/dmd.30.1.69; Wenzel P, 2007, BRIT J PHARMACOL, V150, P526, DOI 10.1038/sj.bjp.0707116; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wenzl MV, 2009, BRIT J PHARMACOL, V156, P1248, DOI 10.1111/j.1476-5381.2009.00126.x; Wenzl MV, 2009, J BIOL CHEM, V284, P19878, DOI 10.1074/jbc.M109.005652; Xiao Q, 1996, J CLIN INVEST, V98, P2027, DOI 10.1172/JCI119007; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	41	42	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					943	952		10.1074/jbc.M109.014548	http://dx.doi.org/10.1074/jbc.M109.014548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19906643	Green Published, hybrid			2022-12-27	WOS:000273258200014
J	Warren, DT; Tajsic, T; Mellad, JA; Searles, R; Zhang, QP; Shanahan, CM				Warren, Derek T.; Tajsic, Tamara; Mellad, Jason A.; Searles, Richelle; Zhang, Qiuping; Shanahan, Catherine M.			Novel Nuclear Nesprin-2 Variants Tether Active Extracellular Signal-regulated MAPK1 and MAPK2 at Promyelocytic Leukemia Protein Nuclear Bodies and Act to Regulate Smooth Muscle Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; RETINOBLASTOMA GENE-PRODUCT; LAMIN-A; SPATIOTEMPORAL CONTROL; BINDING-PROTEIN; ENVELOPE; CYTOSKELETON; KINASE; ANCHORAGE; MEMBRANE	Nuclear and cytoplasmic scaffold proteins have been shown to be essential for temporal and spatial organization, as well as the fidelity, of MAPK signaling pathways. In this study we show that nesprin-2 is a novel extracellular signal-regulated MAPK 1 and 2 (ERK1/2) scaffold protein that serves to regulate nuclear signaling by tethering these kinases at promyelocytic leukemia protein nuclear bodies (PML NBs). Using immunofluorescence microscopy, GST pull-down and immunoprecipitation, we show that nesprin-2, ERK1/2, and PML colocalize and bind to form a nuclear complex. Interference of nesprin-2 function, by either siRNA-mediated knockdown or overexpression of a dominant negative nesprin-2 fragment, augmented ERK1/2 nuclear signaling shown by increased SP1 activity and ELK1 phosphorylation. The functional outcome of nesprin-2 disruption and the resultant sustained ERK1/2 signal was increased proliferation. Importantly, these activities were not induced by previously identified nuclear envelope (NE)-targeted nesprin-2 isoforms but rather were mediated by novel nuclear isoforms that lacked the KASH domain. Taken together, this study suggests that nesprin-2 is a novel intranuclear scaffold, essential for nuclear ERK1/2 signaling fidelity and cell cycle progression.	[Warren, Derek T.; Mellad, Jason A.; Searles, Richelle; Zhang, Qiuping; Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc Med, British Heart Fdn Ctr, London SE5 9NU, England; [Tajsic, Tamara] Addenbrookes Hosp, Dept Med, Cambridge CB2 ZQQ, England	University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Warren, DT (corresponding author), Kings Coll London, Div Cardiovasc Med, James Black Ctr, 125 Coldharbour Lane, London SE5 9NU, England.	derek.warren@kcl.ac.uk	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Shanahan, Catherine/0000-0002-8352-8171; Warren, Derek/0000-0003-0346-7450	British Heart Foundation (BHF) Program [RG/05/001]; British Heart Foundation [RG/09/008/27923] Funding Source: researchfish	British Heart Foundation (BHF) Program(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation (BHF) Program Grant RG/05/001 (to C.M.S.).	Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Locher R, 2002, HYPERTENSION, V39, P645, DOI 10.1161/hy0202.103473; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; OZAKI T, 1994, ONCOGENE, V9, P2649; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhen YY, 2002, J CELL SCI, V115, P3207	36	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1311	1320		10.1074/jbc.M109.032557	http://dx.doi.org/10.1074/jbc.M109.032557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19861416	hybrid, Green Published			2022-12-27	WOS:000273258200052
J	Wielemans, K; Jean, C; Vissers, S; Andre, B				Wielemans, Kevin; Jean, Cathy; Vissers, Stephan; Andre, Bruno			Amino Acid Signaling in Yeast: Post-genome Duplication Divergence of the Stp1 and Stp2 Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER GENE BAP3; SACCHAROMYCES-CEREVISIAE; ENDOPROTEOLYTIC ACTIVATION; SENSING PATHWAY; AGP1 GENE; PROTEIN; EXPRESSION; SENSOR; INDUCTION; SEQUENCE	When yeast cells detect external amino acids via their permease-like Ssy1 sensor, the cytosolic precursor forms of Stp1 and Stp2 transcription factors are activated by endoproteolytic removal of their N-terminal domains, a reaction catalyzed by the Ssy5 endoprotease. The processed Stp factors then migrate into the nucleus, where they activate transcription of several amino acid permease genes including AGP1. We report here that the STP1 and STP2 genes most likely derive from the whole genome duplication that occurred in a yeast ancestor. Although Stp1 and Stp2 have been considered redundant, we provide evidence that they functionally diverged during evolution. Stp2 is the only factor processed when amino acids are present at low concentration, and the transcriptional activation of AGP1 promoted by Stp2 is moderate. Furthermore, only Stp2 can sustain Agp1-dependent utilization of amino acids at low concentration. In contrast, Stp1 is only processed when amino acids are present at high concentration, and it promotes higher level transcriptional activation of AGP1. Domain swapping experiments show that the N-terminal domains of Stp1 and Stp2 are responsible for these proteins being cleaved at different amino acid concentrations. Last, induction of the DIP5 permease gene by amino acids depends on Stp2 but not Stp1. We propose that post-whole genome duplication co-conservation of the STP1 and STP2 genes was favored by functional divergence of their products, likely conferring to cells an increased ability to adapt to various amino acid supply conditions.	[Wielemans, Kevin; Jean, Cathy; Vissers, Stephan; Andre, Bruno] Univ Libre Bruxelles, Lab Physiol Mol Cellule, Inst Biol & Med Mol, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles	Andre, B (corresponding author), Inst Biol & Med Mol, Lab Physiol Mol Cellule CP300, 11 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	bran@ulb.ac.be	André, Bruno/D-1725-2010		Communaute Francaise de Belgique [3.4.592.08.F, 04/09-307]; Region Wallonne de Belgique [716760]	Communaute Francaise de Belgique(Australian Research Council); Region Wallonne de Belgique	This work was supported by Fonds de la Recherche Scientifique Medicale Grant 3.4.592.08.F and Actions de Recherche Concertee Grant 04/09-307 of the Communaute Francaise de Belgique and by CIBLES Grant 716760 of the Region Wallonne de Belgique.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; ANDRE B, 1990, MOL GEN GENET, V220, P269; ANDRE B, 1990, NUCLEIC ACIDS RES, V18, P7136, DOI 10.1093/nar/18.23.7136; ANDRE B, 1993, MOL GEN GENET, V237, P17; Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Barnes D, 1998, MOL MICROBIOL, V29, P297, DOI 10.1046/j.1365-2958.1998.00931.x; Bernard F, 2001, MOL MICROBIOL, V41, P489, DOI 10.1046/j.1365-2958.2001.02538.x; Bernard F, 2001, FEBS LETT, V496, P81, DOI 10.1016/S0014-5793(01)02412-7; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Boles E, 2004, TOP CURR GENET, V9, P121; BRICMONT PA, 1991, MOL CELL BIOL, V11, P1161, DOI 10.1128/MCB.11.2.1161; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; COORNAERT D, 1991, GENE, V97, P163, DOI 10.1016/0378-1119(91)90048-G; de Boer M, 2000, NUCLEIC ACIDS RES, V28, P974; de Boer M, 1998, MOL MICROBIOL, V30, P603, DOI 10.1046/j.1365-2958.1998.01094.x; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; DORRINGTON RA, 1993, NUCLEIC ACIDS RES, V21, P3777, DOI 10.1093/nar/21.16.3777; Eckert-Boulet N, 2006, EUKARYOT CELL, V5, P174, DOI 10.1128/EC.5.1.174-179.2006; Gaber RF, 2003, EUKARYOT CELL, V2, P922, DOI 10.1128/EC.2.5.922-929.2003; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Iraqui I, 1999, MOL CELL BIOL, V19, P989; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Jorgensen MU, 1998, YEAST, V14, P103, DOI 10.1002/(SICI)1097-0061(19980130)14:2<103::AID-YEA203>3.0.CO;2-C; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Nielsen PS, 2001, MOL GEN GENET, V264, P613, DOI 10.1007/s004380000347; Sabina J, 2009, J BIOL CHEM, V284, P29635, DOI 10.1074/jbc.M109.032102; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wery M, 2009, RNA, V15, P406, DOI 10.1261/rna.1402709; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089	41	18	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					855	865		10.1074/jbc.M109.015263	http://dx.doi.org/10.1074/jbc.M109.015263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19906648	Green Published, hybrid			2022-12-27	WOS:000273258200006
J	Huang, CJ; Gurlo, T; Haataja, L; Costes, S; Daval, M; Ryazantsev, S; Wu, XJ; Butler, AE; Butler, PC				Huang, Chang-jiang; Gurlo, Tatyana; Haataja, Leena; Costes, Safia; Daval, Marie; Ryazantsev, Sergey; Wu, Xiuji; Butler, Alexandra E.; Butler, Peter C.			Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET AMYLOID POLYPEPTIDE; ENDOPLASMIC-RETICULUM STRESS; ALPHA-II-SPECTRIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MOUSE MODEL; MEMBRANE DISRUPTION; MECHANISM; RELEASE; CHANNEL	The islet in type 2 diabetes (T2DM) and the brain in neurodegenerative diseases share progressive cell dysfunction, increased apoptosis, and accumulation of locally expressed amyloidogenic proteins (islet amyloid polypeptide (IAPP) in T2DM). Excessive activation of the Ca2+-sensitive protease calpain-2 has been implicated as a mediator of oligomer-induced cell death and dysfunction in neurodegenerative diseases. To establish if human IAPP toxicity is mediated by a comparable mechanism, we overexpressed human IAPP in rat insulinoma cells and freshly isolated human islets. Pancreas was also obtained at autopsy from humans with T2DM and nondiabetic controls. We report that overexpression of human IAPP leads to the formation of toxic oligomers and increases beta cell apoptosis mediated by increased cytosolic Ca2+ and hyperactivation of calpain-2. Cleavage of alpha-spectrin, a marker of calpain hyperactivation, is increased in beta cells in T2DM. We conclude that overactivation of Ca2+-calpain pathways contributes to beta cell dysfunction and apoptosis in T2DM.	[Huang, Chang-jiang; Gurlo, Tatyana; Haataja, Leena; Costes, Safia; Daval, Marie; Wu, Xiuji; Butler, Alexandra E.; Butler, Peter C.] Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, Los Angeles, CA 90024 USA; [Ryazantsev, Sergey] Univ Calif Los Angeles, Calif Nano Syst Inst, Electron Imaging Ctr Nanomachines, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Butler, PC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, 900 Vet Ave,24-130 Warren Hall, Los Angeles, CA 90095 USA.	pbutler@mednet.ucla.edu	, Costes/AAC-2820-2020	, Costes/0000-0001-8323-1207; Butler, Alexandra/0000-0002-5762-3917; butler, peter/0000-0002-2981-8979	National Institutes of Health [DK059579]; Larry L. Hillblom Foundation [2007-D-003-NET]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK059579. This work was also supported by The Larry L. Hillblom Foundation Grant 2007-D-003-NET.	Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Cowan CM, 2008, J NEUROSCI, V28, P12725, DOI 10.1523/JNEUROSCI.4619-08.2008; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DUMM CLAG, 1994, VIRCHOWS ARCH, V425, P73; Dutta S, 2002, BIOL CHEM, V383, P785, DOI 10.1515/BC.2002.082; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; EPSTEIN PN, 1992, ENDOCRINOLOGY, V130, P1387, DOI 10.1210/en.130.3.1387; Ferreiro E, 2008, NEUROBIOL DIS, V30, P331, DOI 10.1016/j.nbd.2008.02.003; Giunti R, 2007, ARCH BIOCHEM BIOPHYS, V462, P115, DOI 10.1016/j.abb.2007.03.039; Grant RJ, 2009, NEUROSCIENCE, V158, P558, DOI 10.1016/j.neuroscience.2008.10.023; GURLO T, 2010, AM J PATHOL; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Johnson GVW, 1997, BIOESSAYS, V19, P1011, DOI 10.1002/bies.950191111; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Kuwako K, 2002, MOL BRAIN RES, V107, P166, DOI 10.1016/S0169-328X(02)00489-8; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Matveyenko AV, 2006, ILAR J, V47, P225, DOI 10.1093/ilar.47.3.225; MICHELANGELI F, 1995, J VIROL, V69, P3838, DOI 10.1128/JVI.69.6.3838-3847.1995; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; NAGATA E, 1994, NEUROSCIENCE, V61, P983, DOI 10.1016/0306-4522(94)90418-9; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Paschen W, 2003, CELL CALCIUM, V33, P83, DOI 10.1016/S0143-4160(02)00195-1; Pereira C, 2004, J MOL NEUROSCI, V23, P97, DOI 10.1385/JMN:23:1-2:097; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Piwocka K, 2006, BLOOD, V107, P4003, DOI 10.1182/blood-2005-04-1523; Rajgopal Y, 2002, NEUROSCI LETT, V321, P187, DOI 10.1016/S0304-3940(02)00063-0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RARDON DP, 1990, CIRC RES, V67, P84, DOI 10.1161/01.RES.67.1.84; Resende R, 2008, J NEUROSCI RES, V86, P2091, DOI 10.1002/jnr.21648; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; Saisho Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE89, DOI 10.1152/ajpendo.90697.2008; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Song YQ, 2007, HUM MOL GENET, V16, P2960, DOI 10.1093/hmg/ddm256; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Young SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1204, DOI 10.1152/ajpgi.1999.276.5.G1204	56	71	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					339	348		10.1074/jbc.M109.024190	http://dx.doi.org/10.1074/jbc.M109.024190			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861418	Green Published, hybrid			2022-12-27	WOS:000273070100035
J	Hata, S; Fujishige, S; Araki, Y; Kato, N; Araseki, M; Nishimura, M; Hartmann, D; Saftig, P; Fahrenholz, F; Taniguchi, M; Urakami, K; Akatsu, H; Martins, RN; Yamamoto, K; Maeda, M; Yamamoto, T; Nakaya, T; Gandy, S; Suzuki, T				Hata, Saori; Fujishige, Sayaka; Araki, Yoichi; Kato, Naoko; Araseki, Masahiko; Nishimura, Masaki; Hartmann, Dieter; Saftig, Paul; Fahrenholz, Falk; Taniguchi, Miyako; Urakami, Katsuya; Akatsu, Hiroyasu; Martins, Ralph N.; Yamamoto, Kazuo; Maeda, Masahiro; Yamamoto, Tohru; Nakaya, Tadashi; Gandy, Sam; Suzuki, Toshiharu			Alcadein Cleavages by Amyloid beta-Precursor Protein (APP) alpha- and gamma-Secretases Generate Small Peptides, p3-Alcs, Indicating Alzheimer Disease-related gamma-Secretase Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESENILIN-1 MUTATIONS; EARLY-ONSET; CONVERTING-ENZYME; METABOLISM; ASSOCIATION; MEMBRANE; FAMILY; PHOSPHORYLATION; DIFFERENTIATION; A-BETA(42)	Alcadeins (Alcs) constitute a family of neuronal type I membrane proteins, designated Alc(alpha), Alc(beta), and Alc(gamma). The Alcs express in neurons dominantly and largely colocalize with the Alzheimer amyloid precursor protein (APP) in the brain. Alcs and APP show an identical function as a cargo receptor of kinesin-1. Moreover, proteolytic processing of Alc proteins appears highly similar to that of APP. We found that APP alpha-secretases ADAM 10 and ADAM 17 primarily cleave Alc proteins and trigger the subsequent secondary intramembranous cleavage of Alc C-terminal fragments by a presenilin-dependent gamma-secretase complex, thereby generating "APP p3-like" and non-aggregative Alc peptides (p3-Alcs). Wedetermined the complete amino acid sequence of p3-Alc(alpha), p3-Alc(beta), and p3-Alc(gamma), whose major species comprise 35, 37, and 31 amino acids, respectively, in human cerebrospinal fluid. We demonstrate here that variant p3-Alc C termini are modulated by FAD-linked presenilin 1 mutations increasing minor beta-amyloid species A beta 42, and these mutations alter the level of minor p3-Alc species. However, the magnitudes of C-terminal alteration of p3-Alc(alpha), p3-Alc(beta), and p3-Alc(gamma) were not equivalent, suggesting that one type of gamma-secretase dysfunction does not appear in the phenotype equivalently in the cleavage of type I membrane proteins. Because these C-terminal alterations are detectable in human cerebrospinal fluid, the use of a substrate panel, including Alcs and APP, may be effective to detect gamma-secretase dysfunction in the prepathogenic state of Alzheimer disease subjects.	[Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10029 USA; [Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, Dept Psychiat, New York, NY 10029 USA; [Hata, Saori; Fujishige, Sayaka; Araki, Yoichi; Kato, Naoko; Araseki, Masahiko; Yamamoto, Tohru; Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Neurosci, Sapporo, Hokkaido 0600812, Japan; [Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Neurol Unit, Otsu, Shiga 5202192, Japan; [Hartmann, Dieter] Univ Bonn, Dept Anat, D-53115 Bonn, Germany; [Saftig, Paul] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany; [Fahrenholz, Falk] Johannes Gutenberg Univ Mainz, Inst Biochem, D-6500 Mainz, Germany; [Taniguchi, Miyako; Urakami, Katsuya] Tottori Univ, Fac Med, Sch Hlth Sci, Dept Regulat Biol, Yonago, Tottori 6838503, Japan; [Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan; [Martins, Ralph N.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Sir James McCusker Alzheimers Dis Res Unit, Joondalup, WA 6027, Australia; [Martins, Ralph N.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA 6027, Australia; [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Maeda, Masahiro] Immunobiol Labs Co Ltd, Fujioka 3750005, Japan; [Gandy, Sam] James J Peters Vet Adm Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Hokkaido University; Shiga University of Medical Science; University of Bonn; University of Kiel; Johannes Gutenberg University of Mainz; Tottori University; Edith Cowan University; Edith Cowan University; University of Tokyo; Immuno-Biological Laboratories Co. Ltd.; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Gandy, S (corresponding author), Mt Sinai Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10029 USA.	samuel.gandy@mssm.edu; tsuzuki@pharm.hokudai.ac.jp	Saftig, Paul/A-7966-2010; Yamamoto, Tohru/A-3801-2012; Suzuki, Toshiharu/B-5342-2013; Hata, Saori/A-3829-2012; Hata, Saori/AAP-9634-2020	Yamamoto, Tohru/0000-0002-1652-0233; Martins, Ralph/0000-0002-4828-9363	National Institutes of Health, NIA [R01 AG23611, P01 AG10491, P50 AG005138]; Ministry of Education, Science, Culture, Sports, and Technology, Japan [20023001]; NATIONAL INSTITUTE ON AGING [P50AG005138, P01AG010491, R01AG023611] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ministry of Education, Science, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grants R01 AG23611, P01 AG10491, and P50 AG005138 (to S. G.). This work was also supported in part by Grants-in-aid for Scientific Research on Priority Areas 20023001 (to T. S.) from the Ministry of Education, Science, Culture, Sports, and Technology, Japan.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Ando K, 1999, J NEUROSCI, V19, P4421; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P1454, DOI 10.1001/archneur.57.10.1454; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Goddard DR, 2001, GLIA, V34, P267, DOI 10.1002/glia.1060; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kanai M, 1998, ANN NEUROL, V44, P17, DOI 10.1002/ana.410440108; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937	31	39	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36024	36033		10.1074/jbc.M109.057497	http://dx.doi.org/10.1074/jbc.M109.057497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864413	hybrid, Green Published			2022-12-27	WOS:000272970500004
J	Hu, JC; Bengrine, A; Lis, A; Awayda, MS				Hu, John Cong; Bengrine, Abderrahmane; Lis, Agnieszka; Awayda, Mouhamed S.			Alternative Mechanism of Activation of the Epithelial Na+ Channel by Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; SODIUM-CHANNELS; GAMMA-SUBUNIT; SUBSTRATE-SPECIFICITY; FEEDBACK-REGULATION; ENAC; TRYPSIN; PEPTIDE; SERINE; FURIN	We examined activation of the human epithelial sodium channel (ENaC) by cleavage. We focused on cleavage of alpha ENaC using the serine protease subtilisin. Trimeric channels formed with alpha FM, a construct with point mutations in both furin cleavage sites (R178A/R204A), exhibited marked reduction in spontaneous cleavage and an similar to 10-fold decrease in amiloride-sensitive whole cell conductance as compared with alpha WT (2.2 versus 21.2 microsiemens (mu S)). Both alpha WT and alpha FM were activated to similar levels by subtilisin cleavage. Channels formed with alpha FD, a construct that deleted the segment between the two furin sites (Delta 175-204), exhibited an intermediate conductance of 13.2 mu S. More importantly, alpha FD retained the ability to be activated by subtilisin to 108.8 +/- 20.9 mu S, a level not significantly different from that of subtilisin activated alpha WT (125.6 +/- 23.9). Therefore, removal of the tract between the two furin sites is not the main mechanism of channel activation. In these experiments the levels of the cleaved 22-kDa N-terminal fragment of alpha was low and did not match those of the C-terminal 65-kDa fragment. This indicated that cleavage may activate ENaC by the loss of the smaller fragment and the first transmembrane domain. This was confirmed in channels formed with alpha LD, a construct that extended the deleted sequence of alpha FD by 17 amino acids (Delta 175-221). Channels with alpha LD were uncleaved, exhibited low baseline activity (4.1 mu S), and were insensitive to subtilisin. Collectively, these data support an alternative hypothesis of ENaC activation by cleavage that may involve the loss of the first transmembrane domain from the channel complex.	[Hu, John Cong; Bengrine, Abderrahmane; Lis, Agnieszka; Awayda, Mouhamed S.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Awayda, MS (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall,3435 Main St, Buffalo, NY 14214 USA.	awayda@buffalo.edu			National Institutes of Health [DK55626]; John R. Oishei Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John R. Oishei Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55626. This work was also supported by the John R. Oishei Foundation.	Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Andersen Olaf S., 2007, V400, P543; Awayda Mouhamed S., 2006, V337, P101; Awayda MS, 2000, J GEN PHYSIOL, V115, P559, DOI 10.1085/jgp.115.5.559; Awayda MS, 2002, AM J PHYSIOL-CELL PH, V283, pC1122, DOI 10.1152/ajpcell.00142.2002; Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; Bengrine A, 2007, FASEB J, V21, P1189, DOI 10.1096/fj.06-6046com; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Frindt G, 1996, AM J PHYSIOL-RENAL, V270, pF371, DOI 10.1152/ajprenal.1996.270.2.F371; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hedstrom L, 1996, BIOL CHEM, V377, P465; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; KAM CM, 1995, ARCH BIOCHEM BIOPHYS, V316, P808, DOI 10.1006/abbi.1995.1108; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P1103, DOI 10.1016/j.bbamem.2007.01.016; Lee KJB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031917; Lee KJB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.021909; Liu W, 2005, J STRUCT BIOL, V150, P23, DOI 10.1016/j.jsb.2004.12.007; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Ruan B, 2008, BIOCHEMISTRY-US, V47, P6628, DOI 10.1021/bi800089f; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; SVENNINGSEN P, 2009, AM J PHYSL IN PRESS; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588	42	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36334	36345		10.1074/jbc.M109.032870	http://dx.doi.org/10.1074/jbc.M109.032870			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858199	hybrid, Green Published			2022-12-27	WOS:000272970500035
J	Jiang, R; Kim, EH; Gong, JH; Kwon, HM; Kim, CH; Ryu, KH; Park, JW; Kurokawa, K; Zhang, JH; Gubb, D; Lee, BL				Jiang, Rui; Kim, Eun-Hye; Gong, Ji-Hee; Kwon, Hyun-Mi; Kim, Chan-Hee; Ryu, Kyoung-Hwa; Park, Ji-Won; Kurokawa, Kenji; Zhang, Jinghai; Gubb, David; Lee, Bok-Luel			Three Pairs of Protease-Serpin Complexes Cooperatively Regulate the Insect Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; GRAM-POSITIVE BACTERIA; INHIBITORY SPECIFICITY; PROTEOLYTIC CASCADE; MANDUCA-SEXTA; HOST-DEFENSE; TOLL PATHWAY; DROSOPHILA; ACTIVATION; MELANIZATION	Serpins are known to be necessary for the regulation of several serine protease cascades. However, the mechanisms of how serpins regulate the innate immune responses of invertebrates are not well understood due to the uncertainty of the identity of the serine proteases targeted by the serpins. We recently reported the molecular activation mechanisms of three serine protease-mediated Toll and melanin synthesis cascades in a large beetle, Tenebrio molitor. Here, we purified three novel serpins (SPN40, SPN55, and SPN48) from the hemolymph of T. molitor. These serpins made specific serpin-serine protease pairs with three Toll cascade-activating serine proteases, such as modular serine protease, Spatzle-processing enzyme-activating enzyme, and Spatzle-processing enzyme and cooperatively blocked the Toll signaling cascade and beta-1,3-glucan-mediated melanin biosynthesis. Also, the levels of SPN40 and SPN55 were dramatically increased in vivo by the injection of a Toll ligand, processed Spatzle, into Tenebrio larvae. This increase in SPN40 and SPN55 levels indicates that these serpins function as inducible negative feedback inhibitors. Unexpectedly, SPN55 and SPN48 were cleaved at Tyr and Glu residues in reactive center loops, respectively, despite being targeted by trypsin-like Spatzle-processing enzyme-activating enzyme and Spatzle-processing enzyme. These cleavage patterns are also highly similar to those of unusual mammalian serpins involved in blood coagulation and blood pressure regulation, and they may contribute to highly specific and timely inactivation of detrimental serine proteases during innate immune responses. Taken together, these results demonstrate the specific regulatory evidences of innate immune responses by three novel serpins.	[Kurokawa, Kenji; Lee, Bok-Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Jiang, Rui; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China; [Gubb, David] CIC bioGUNE, Funct Genom Unit, Derio 48160, Spain	Pusan National University; Shenyang Pharmaceutical University; CIC bioGUNE	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Jiang, Rui/F-9248-2011; Gubb, David/F-9793-2011	Jiang, Rui/0000-0002-5580-9822	National Research Foundation of Korea [M10861020001-08N6102-00110, 20080576001]; BK21 program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071945, P01HL060231] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant M10861020001-08N6102-00110 and Bioscience Grant 20080576001 from the National Research Foundation of Korea. This work was also partially supported by the BK21 program.	Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; BJORK I, 1982, J BIOL CHEM, V257, P2406; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Han JH, 2000, FEBS LETT, V468, P194, DOI 10.1016/S0014-5793(00)01224-2; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JESTY J, 1979, J BIOL CHEM, V254, P44; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Nash P, 1998, J BIOL CHEM, V273, P20982, DOI 10.1074/jbc.273.33.20982; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Richer MJ, 2004, P NATL ACAD SCI USA, V101, P10560, DOI 10.1073/pnas.0401406101; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; SALVESEN GS, 1985, J BIOL CHEM, V260, P2432; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200	32	81	91	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35652	35658		10.1074/jbc.M109.071001	http://dx.doi.org/10.1074/jbc.M109.071001			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858208	Green Published, hybrid			2022-12-27	WOS:000272645600043
J	Maitra, U; Singh, N; Gan, L; Ringwood, L; Li, LW				Maitra, Urmila; Singh, Neeraj; Gan, Lu; Ringwood, Lorna; Li, Liwu			IRAK-1 Contributes to Lipopolysaccharide-induced Reactive Oxygen Species Generation in Macrophages by Inducing NOX-1 Transcription and Rac1 Activation and Suppressing the Expression of Antioxidative Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE-1; NF-KAPPA-B; GENE-EXPRESSION; IL-1 RECEPTOR; NADPH OXIDASE; INNATE-IMMUNITY; DEPENDENT PHOSPHORYLATION; INTERLEUKIN-1; MICROGLIA; PROTEIN	Inflammatory stimulants such as bacterial endotoxin (lipopolysaccharide (LPS)) are known to induce tissue damage and injury partly through the induction of reactive oxygen species (ROS). Although it is recognized that the induction of ROS in macrophages by LPS depends upon the expression and activation of NADPH oxidase, as well as the suppression of antioxidative enzymes involved in ROS clearance, the underlying molecular mechanisms are poorly defined. In this study, we examined the contribution of the interleukin-1 receptor-associated kinase 1 (IRAK-1) to LPS-induced generation of ROS. We observed that LPS induced significantly less ROS in IRAK-1(-/-) macrophages, indicating that IRAK-1 is critically involved in the induction of ROS. Mechanistically, we observed that IRAK-1 is required for LPS-induced expression of NOX-1, a key component of NADPH oxidase, via multiple transcription factors, including p65/RelA, C/EBP beta, and C/EBP delta. On the other hand, we demonstrated that IRAK-1 associated with and activated small GTPase Rac1, a known activator of NOX-1 oxidase enzymatic activity. IRAK-1 forms a close complex with Rac1 via a novel LWPPPP motif within the variable region of IRAK-1. On the other hand, we also observed that IRAK-1 is required for LPS-mediated suppression of peroxisome proliferator-activated receptor alpha and PGC-1 alpha, nuclear factors essential for the expression of antioxidative enzymes such as GPX3 and catalase. Consequently, injection of LPS causes significantly less plasma lipid peroxidation in IRAK-1(-/-) mice compared with wild type mice. Taken together, our study reveals IRAK-1 as a novel component involved in the generation of ROS induced by LPS.	[Maitra, Urmila; Gan, Lu; Ringwood, Lorna; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Singh, Neeraj; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	Gan, Lu/L-5395-2014	Li, Liwu/0000-0001-8870-5299	National Institutes of Health [AI50089, AI64414]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050089, R01AI064414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI50089 and AI64414.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Bol GF, 2000, FEBS LETT, V477, P73, DOI 10.1016/S0014-5793(00)01759-2; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Ciarrocchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004404; Cooke EL, 2001, BIOCHEM J, V359, P403, DOI 10.1042/0264-6021:3590403; Deng C, 2003, J IMMUNOL, V170, P2833, DOI 10.4049/jimmunol.170.6.2833; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Jefferies C, 2001, MOL CELL BIOL, V21, P4544, DOI 10.1128/MCB.21.14.4544-4552.2001; Kawahara T, 2005, AM J PHYSIOL-CELL PH, V288, pC450, DOI 10.1152/ajpcell.00319.2004; KLUCIS E, 1984, MOL CELL BIOCHEM, V65, P73; Knop J, 1998, EUR J IMMUNOL, V28, P3100, DOI 10.1002/(SICI)1521-4141(199810)28:10<3100::AID-IMMU3100>3.0.CO;2-7; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Lakoski SG, 2007, EXP MOL PATHOL, V82, P280, DOI 10.1016/j.yexmp.2007.02.002; Li Liwu, 2004, Curr Drug Targets Inflamm Allergy, V3, P81, DOI 10.2174/1568010043483863; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; Nguyen H, 2003, J INTERF CYTOK RES, V23, P183, DOI 10.1089/107999003765027384; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Pietila TE, 2007, J IMMUNOL, V178, P253, DOI 10.4049/jimmunol.178.1.253; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Singh A, 2009, J IMMUNOL, V182, P6410, DOI 10.4049/jimmunol.0802512; Song YJ, 2006, P NATL ACAD SCI USA, V103, P2689, DOI 10.1073/pnas.0511096103; Su JM, 2007, CELL SIGNAL, V19, P1596, DOI 10.1016/j.cellsig.2007.02.009; Thomas JA, 2003, AM J PHYSIOL-HEART C, V285, pH597, DOI 10.1152/ajpheart.0655.2001; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang DM, 2008, MOL IMMUNOL, V45, P3902, DOI 10.1016/j.molimm.2008.06.023; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; YOSHIKAWA T, 1994, CIRC SHOCK, V42, P53	41	84	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35403	35411		10.1074/jbc.M109.059501	http://dx.doi.org/10.1074/jbc.M109.059501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850916	Green Published, hybrid			2022-12-27	WOS:000272645600016
J	Nowak, DG; Amin, EM; Rennel, ES; Hoareau-Aveilla, C; Gammons, M; Damodoran, G; Hagiwara, M; Harper, SJ; Woolard, J; Ladomery, MR; Bates, DO				Nowak, Dawid G.; Amin, Elianna Mohamed; Rennel, Emma S.; Hoareau-Aveilla, Coralie; Gammons, Melissa; Damodoran, Gopinath; Hagiwara, Masatoshi; Harper, Steven J.; Woolard, Jeanette; Ladomery, Michael R.; Bates, David O.			Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FACTOR-I; MESSENGER-RNA; COLORECTAL-CARCINOMA; CELL CARCINOMA; BETA-II; EXPRESSION; INSULIN; VEGF(165)B; PHOSPHORYLATION	Vascular endothelial growth factor (VEGF) is produced either as a pro-angiogenic or anti-angiogenic protein depending upon splice site choice in the terminal, eighth exon. Proximal splice site selection (PSS) in exon 8 generates pro-angiogenic isoforms such as VEGF165, and distal splice site selection (DSS) results in anti-angiogenic isoforms such as VEGF165b. Cellular decisions on splice site selection depend upon the activity of RNA-binding splice factors, such as ASF/SF2, which have previously been shown to regulate VEGF splice site choice. To determine the mechanism by which the pro-angiogenic splice site choice is mediated, we investigated the effect of inhibition of ASF/SF2 phosphorylation by SR protein kinases (SRPK1/2) on splice site choice in epithelial cells and in in vivo angiogenesis models. Epithelial cells treated with insulin-like growth factor-1 (IGF-1) increased PSS and produced more VEGF165 and less VEGF165b. This down-regulation of DSS and increased PSS was blocked by protein kinase C inhibition and SRPK1/2 inhibition. IGF-1 treatment resulted in nuclear localization of ASF/SF2, which was blocked by SPRK1/2 inhibition. Pull-down assay and RNA immunoprecipitation using VEGF mRNA sequences identified an 11-nucleotide sequence required for ASF/SF2 binding. Injection of an SRPK1/2 inhibitor reduced angiogenesis in a mouse model of retinal neovascularization, suggesting that regulation of alternative splicing could be a potential therapeutic strategy in angiogenic pathologies.	[Amin, Elianna Mohamed; Ladomery, Michael R.] Univ W England, Sch Life Sci, Ctr Biomed Res, Bristol BS16 1QY, Avon, England; [Nowak, Dawid G.; Rennel, Emma S.; Hoareau-Aveilla, Coralie; Gammons, Melissa; Damodoran, Gopinath; Harper, Steven J.; Woolard, Jeanette; Bates, David O.] Univ Bristol, Sch Vet Sci, Dept Physiol & Pharmacol, Microvasc Res Labs,Bristol Heart Inst, Bristol BS2 8EJ, Avon, England; [Hagiwara, Masatoshi] Univ Tokyo, Sch Dent Med, Dept Genet, Tokyo 1138510, Japan	University of West England; University of Bristol; University of Tokyo	Ladomery, MR (corresponding author), Univ W England, Sch Life Sci, Ctr Biomed Res, Bristol BS16 1QY, Avon, England.	michael.Ladomery@uwe.ac.uk; Dave.Bates@bris.ac.uk	Hoareau-Aveilla, Coralie/G-3787-2017	Hoareau-Aveilla, Coralie/0000-0001-5506-4552; gammons, melissa/0000-0001-9661-9331; Bates, David/0000-0003-4850-2360; Woolard, Jeanette/0000-0001-5406-6847	British Heart Foundation [FS/04/09, BS/06/005]; Wellcome Trust [79633]; University of West of England; Richard Bright VEGF Research Trust, Fight for Sight, Cancer Research UK [C11392/A10484]; Skin Cancer Research Fund	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); University of West of England; Richard Bright VEGF Research Trust, Fight for Sight, Cancer Research UK(Cancer Research UK); Skin Cancer Research Fund	This work was supported by the British Heart Foundation (FS/04/09 and BS/06/005), the Wellcome Trust (79633), a University of West of England Bristol PhD Studentship, the Richard Bright VEGF Research Trust, Fight for Sight, Cancer Research UK (C11392/A10484), and the Skin Cancer Research Fund.	Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Bates DO, 2002, CANCER RES, V62, P4123; Beckert S, 2006, BIOCHEM BIOPH RES CO, V341, P67, DOI 10.1016/j.bbrc.2005.12.148; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blaustein M, 2004, J BIOL CHEM, V279, P21029, DOI 10.1074/jbc.M314260200; Bruno IG, 2004, HUM MOL GENET, V13, P2409, DOI 10.1093/hmg/ddh272; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Dieudonne SC, 2007, OPHTHALMIC RES, V39, P148, DOI 10.1159/000103234; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Ergorul C, 2008, MOL VIS, V14, P1517; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; GRANT M, 1986, DIABETES, V35, P416, DOI 10.2337/diabetes.35.4.416; GRANT MB, 1993, DIABETOLOGIA, V36, P282, DOI 10.1007/BF00400229; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Hovhannisyan RH, 2006, NUCLEIC ACIDS RES, V34, P373, DOI 10.1093/nar/gkj407; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Konopatskaya O, 2006, MOL VIS, V12, P626; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Ma CT, 2008, J MOL BIOL, V376, P55, DOI 10.1016/j.jmb.2007.08.029; Miele C, 2000, J BIOL CHEM, V275, P21695, DOI 10.1074/jbc.M000805200; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; NAKAOHAYASHI J, 1992, ATHEROSCLEROSIS, V92, P141, DOI 10.1016/0021-9150(92)90273-J; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Oh JS, 2002, NEOPLASIA, V4, P204, DOI 10.1038/sj.neo.7900229; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Pilch B, 2001, CANCER RES, V61, P6876; Poulaki V, 2003, J CLIN ENDOCR METAB, V88, P5392, DOI 10.1210/jc.2003-030389; Pritchard-Jones RO, 2007, BRIT J CANCER, V97, P223, DOI 10.1038/sj.bjc.6603839; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schumacher VA, 2007, J AM SOC NEPHROL, V18, P719, DOI 10.1681/ASN.2006020124; Shigematsu Satoshi, 1999, Endocrine Journal, V46, pS59, DOI 10.1507/endocrj.46.Suppl_S59; Slomiany MG, 2006, BIOCHEM BIOPH RES CO, V342, P851, DOI 10.1016/j.bbrc.2006.02.043; Slomiany MG, 2004, INVEST OPHTH VIS SCI, V45, P2838, DOI 10.1167/iovs.03-0565; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang YZ, 1998, PROSTATE, V35, P165; Warren RS, 1996, J BIOL CHEM, V271, P29483, DOI 10.1074/jbc.271.46.29483; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934	53	162	173	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2010	285	8					5532	5540		10.1074/jbc.M109.074930	http://dx.doi.org/10.1074/jbc.M109.074930			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565WQ	19906640	Green Published, hybrid			2022-12-27	WOS:000275327200046
J	Amunts, A; Toporik, H; Borovikova, A; Nelson, N				Amunts, Alexey; Toporik, Hila; Borovikova, Anna; Nelson, Nathan			Structure Determination and Improved Model of Plant Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARVESTING-COMPLEX-II; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; RESOLUTION STRUCTURE; STATE TRANSITIONS; LIGHT; PSI; SUBUNIT; ANTENNA; ARABIDOPSIS	Photosystem I functions as a sunlight energy converter, catalyzing one of the initial steps in driving oxygenic photosynthesis in cyanobacteria, algae, and higher plants. Functionally, Photosystem I captures sunlight and transfers the excitation energy through an intricate and precisely organized antenna system, consisting of a pigment network, to the center of the molecule, where it is used in the transmembrane electron transfer reaction. Our current understanding of the sophisticated mechanisms underlying these processes has profited greatly from elucidation of the crystal structures of the Photosystem I complex. In this report, we describe the developments that ultimately led to enhanced structural information of plant Photosystem I. In addition, we report an improved crystallographic model at 3.3-angstrom resolution, which allows analysis of the structure in more detail. An improved electron density map yielded identification and tracing of subunit PsaK. The location of an additional ten beta-carotenes as well as five chlorophylls and several loop regions, which were previously uninterpretable, are now modeled. This represents the most complete plant Photosystem I structure obtained thus far, revealing the locations of and interactions among 17 protein subunits and 193 non-covalently bound photochemical cofactors. Using the new crystal structure, we examine the network of contacts among the protein subunits from the structural perspective, which provide the basis for elucidating the functional organization of the complex.	[Amunts, Alexey; Toporik, Hila; Borovikova, Anna; Nelson, Nathan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Amunts, A./AAZ-2279-2020	Amunts, A./0000-0002-5302-1740; Nelson, Nathan/0000-0003-3588-7265	Israel Science Foundation [356/06]; United States-Israel Binational Agricultural Research and Development [IS-4229-09]	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Agricultural Research and Development	This work was supported by The Israel Science Foundation (Grant 356/06) and by the United States-Israel Binational Agricultural Research and Development Fund (Grant IS-4229-09).	Alboresi A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-71; Amunts A, 2005, PHOTOCH PHOTOBIO SCI, V4, P1011, DOI 10.1039/b506132f; Amunts A, 2008, PLANT PHYSIOL BIOCH, V46, P228, DOI 10.1016/j.plaphy.2007.12.013; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2009, STRUCTURE, V17, P637, DOI 10.1016/j.str.2009.03.006; ANDERSEN B, 1994, STRUCTURE FUNCTION P; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Forsberg J, 2001, PHOTOSYNTH RES, V68, P71, DOI 10.1023/A:1011891017067; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Fromme P, 2004, PHOTOSYNTH RES, V80, P109, DOI 10.1023/B:PRES.0000030657.88242.e1; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Fromme Petra, 2008, V45, P33, DOI 10.1007/400_2007_044; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hansson A, 2007, FEBS J, V274, P1734, DOI 10.1111/j.1742-4658.2007.05722.x; HE WZ, 1992, FEBS LETT, V308, P298, DOI 10.1016/0014-5793(92)81297-Y; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jolley C, 2005, J BIOL CHEM, V280, P33627, DOI 10.1074/jbc.M500937200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; KJAERULFF S, 1993, J BIOL CHEM, V268, P18912; Klimmek F, 2005, BIOCHEMISTRY-US, V44, P3065, DOI 10.1021/bi047873g; Knoetzel H, 2002, FEBS LETT, V510, P145, DOI 10.1016/S0014-5793(01)03253-7; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Muh F, 2008, PLANT PHYSIOL BIOCH, V46, P238, DOI 10.1016/j.plaphy.2008.01.003; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nield J, 2004, EUKARYOT CELL, V3, P1370, DOI 10.1128/EC.3.6.1370-1380.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PASLLON LO, 1995, BIOCHIM BIOPHYS ACTA, V1230, P1; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Qin XC, 2006, PHOTOSYNTH RES, V90, P195, DOI 10.1007/s11120-006-9104-6; Schottler MA, 2007, BIOCHEM J, V403, P251, DOI 10.1042/BJ20061573; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Storf S, 2005, J BIOL CHEM, V280, P5163, DOI 10.1074/jbc.M411248200; Storf S, 2004, BIOCHEMISTRY-US, V43, P9214, DOI 10.1021/bi0498196; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Vacha F, 2005, MICRON, V36, P483, DOI 10.1016/j.micron.2005.04.004; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Vanselow C, 2009, BBA-BIOENERGETICS, V1787, P46, DOI 10.1016/j.bbabio.2008.10.004; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wientjes E, 2009, J BIOL CHEM, V284, P7803, DOI 10.1074/jbc.M808395200	70	213	222	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3478	3486		10.1074/jbc.M109.072645	http://dx.doi.org/10.1074/jbc.M109.072645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19923216	Green Published, hybrid			2022-12-27	WOS:000273829000062
J	Lindahl, E; Nyman, U; Zaman, F; Palmberg, C; Cascante, A; Shafqat, J; Takigawa, M; Savendahl, L; Jorvall, H; Joseph, B				Lindahl, Emma; Nyman, Ulrika; Zaman, Farasat; Palmberg, Carina; Cascante, Anna; Shafqat, Jawed; Takigawa, Masaharu; Savendahl, Lars; Jorvall, Hans; Joseph, Bertrand			Proinsulin C-peptide Regulates Ribosomal RNA Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 DIABETIC-NEUROPATHY; RDNA TRANSCRIPTION; INSULIN; ACETYLATION; CELLS; PROLIFERATION; METHYLATION; APOPTOSIS; CHROMATIN; MELLITUS	Proinsulin C-peptide is internalized into cells, but a function of its intracellular localization has not been established. We now demonstrate that, upon cellular entry, C-peptide is localized to the nucleoli, where it promotes transcription of genes encoding for ribosomal RNA. We find that C-peptide binds to histones and enhances acetylation of lysine residue 16 of histone H4 at the promoter region of genes for ribosomal RNA. In agreement with synchrony of ribosomal RNA synthesis and cell proliferation, we show that C-peptide stimulates proliferation in chondrocytes and HEK-293 cells. This regulation of ribosomal RNA provides a mechanism by which C-peptide can exert transcriptional effects and implies that the peptide has growth factor activity.	[Lindahl, Emma; Palmberg, Carina; Shafqat, Jawed; Jorvall, Hans] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Nyman, Ulrika; Joseph, Bertrand] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden; [Zaman, Farasat; Savendahl, Lars] Karolinska Inst, Dept Woman & Child Hlth, Astrid Lindgren Childrens Hosp, SE-17177 Stockholm, Sweden; [Nyman, Ulrika; Joseph, Bertrand] Karolinska Inst, Dept Pathol & Oncol, SE-17177 Stockholm, Sweden; [Cascante, Anna] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama 7008525, Japan	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Okayama University	Jorvall, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.	Hans.Jornvall@ki.se	Lindahl, Emma/HHM-4459-2022; Zaman, Farasat/AAE-1144-2020; Nyman, Ulrika/D-3708-2013	Savendahl, Lars/0000-0003-1067-4976; Joseph, Bertrand/0000-0001-5655-9979; Cascante, Anna/0000-0002-8272-3098	Swedish Research Council; Ramon Areces Foundation; Swedish Cancer Society; Swedish Medical Society; Swedish Children's Cancer Foundation; Karolinska Institutet; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ramon Areces Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Society; Swedish Children's Cancer Foundation; Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council, the Ramon Areces Foundation, the Swedish Cancer Society, the Swedish Medical Society, the Swedish Children's Cancer Foundation, Karolinska Institutet, and the Knut and Alice Wallenberg Foundation.	Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; ANTONETTI DA, 1993, J BIOL CHEM, V268, P25277; CAHILL GF, 1973, NEW ENGL J MED, V288, P1181, DOI 10.1056/NEJM197305312882210; Calzuola I, 2005, PEPTIDES, V26, P2074, DOI 10.1016/j.peptides.2005.04.008; Chagin AS, 2006, J ENDOCRINOL, V188, P193, DOI 10.1677/joe.1.06364; Covelo G, 2006, J BIOCHEM, V140, P627, DOI 10.1093/jb/mvj197; Ekberg K, 2007, DIABETES CARE, V30, P71, DOI 10.2337/dc06-1274; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grossso S, 2008, BIOCHEM BIOPH RES CO, V376, P65, DOI 10.1016/j.bbrc.2008.08.118; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; Jagerbrink T, 2007, CELL MOL LIFE SCI, V64, P1310, DOI 10.1007/s00018-007-7136-5; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Johansson BL, 2000, DIABETIC MED, V17, P181, DOI 10.1046/j.1464-5491.2000.00274.x; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li ZG, 2003, DIABETES-METAB RES, V19, P375, DOI 10.1002/dmrr.389; Lindahl E, 2007, CELL MOL LIFE SCI, V64, P479, DOI 10.1007/s00018-007-6467-6; Luppi P, 2009, DIABETOLOGIA, V52, P2218, DOI 10.1007/s00125-009-1476-7; Ohtomo Y, 1996, DIABETOLOGIA, V39, P199, DOI 10.1007/BF00403963; PAPAMARCAKI T, 1994, FEBS LETT, V345, P71, DOI 10.1016/0014-5793(94)00439-0; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; RE RN, 1989, J MOL CELL CARDIOL, V21, P63, DOI 10.1016/0022-2828(89)90772-4; Rebsomen L, 2006, DIABETES METAB, V32, P223, DOI 10.1016/S1262-3636(07)70272-0; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; RUBENSTEIN AH, 1969, NATURE, V224, P697, DOI 10.1038/224697a0; Santana RB, 2003, DIABETES, V52, P1502, DOI 10.2337/diabetes.52.6.1502; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Shafqat J, 2006, CELL MOL LIFE SCI, V63, P1805, DOI 10.1007/s00018-006-6204-6; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sima AAF, 2004, EXP DIABESITY RES, V5, P65, DOI 10.1080/15438600490424541; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Wahren J, 2007, DIABETOLOGIA, V50, P503, DOI 10.1007/s00125-006-0559-y	35	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3462	3469		10.1074/jbc.M109.053587	http://dx.doi.org/10.1074/jbc.M109.053587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19917601	hybrid, Green Published			2022-12-27	WOS:000273829000060
J	Ravimohan, S; Gama, L; Barber, SA; Clements, JE				Ravimohan, Shruthi; Gama, Lucio; Barber, Sheila A.; Clements, Janice E.			Regulation of SIV(mac)239 Basal Long Terminal Repeat Activity and Viral Replication in Macrophages FUNCTIONAL ROLES OF TWO CCAAT/ENHANCER-BINDING PROTEIN beta SITES IN ACTIVATION AND INTERFERON beta-MEDIATED SUPPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL INHIBITORY PROTEIN; LEUCINE ZIPPER PROTEINS; C/EBP-BETA; HIV-1 REPLICATION; CEREBROSPINAL-FLUID; GENE-EXPRESSION; MESSENGER-RNA; DNA-BINDING	CCAAT/enhancer-binding protein (C/EBP) beta and C/EBP sites in the HIV-1 long terminal repeat (LTR) are crucial for HIV-1 replication in monocyte/macrophages and for the ability of interferon beta(IFN beta) to inhibit ongoing active HIV replication in these cells. This IFN beta-mediated down-regulation involves induction of the truncated, dominant-negative isoform of C/EBP beta referred to as liver-enriched transcriptional inhibitory protein (LIP). Although binding of the C/EBP beta isoform to C/EBP sites in the simian immunodeficiency virus (SIV) LTR has previously been examined, the importance of these sites in core promoter-mediated transcription, virus replication, IFN beta-mediated regulation, and the relative binding of the two isoforms (C/EBP beta and LIP) has not been investigated. Here, we specifically examine two C/EBP sites, JC1 (-100 bp) and DS1 (+134 bp), located within the minimal region of the SIV LTR, required for core promoter-mediated transcription and virus replication in macrophages. Our studies revealed that the JC1 but not DS1 C/EBP site is important for basal level transcription, whereas the DS1 C/EBP site is imperative for productive virus replication in primary macrophages. In contrast, either JC1 or DS1 C/EBP site is sufficient to mediate IFN beta-induced down-regulation of SIV LTR activity and virus replication in these cells. We also characterized the differential binding properties of C/EBP beta and LIP to the JC1 and DS1 sites. In conjunction with previous studies from our laboratory, we demonstrate the importance of these sites in virus gene expression, and we propose a model for their role in establishing latency and persistence in macrophages in the brain.	[Ravimohan, Shruthi; Gama, Lucio; Barber, Sheila A.; Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Clements, Janice E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Ravimohan, Shruthi] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Clements, JE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, 733 N Broadway,BRB831, Baltimore, MD 21205 USA.	jclement@jhmi.edu		Gama, Lucio/0000-0001-9511-012X	National Institutes of Health [NS047984, MH070306, HL75840]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047984, MH070306, and HL75840.	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; ANDERSON MG, 1992, VIROLOGY, V191, P559, DOI 10.1016/0042-6822(92)90231-D; ANDERSON MG, 1991, J VIROL, V65, P51, DOI 10.1128/JVI.65.1.51-60.1991; Aweeka F, 1999, J ACQ IMMUN DEF SYND, V20, P39, DOI 10.1097/00042560-199901010-00006; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; BERKHOUT B, 1992, NUCLEIC ACIDS RES, V20, P27, DOI 10.1093/nar/20.1.27; Bouazzaoui A, 2006, VIROLOGY, V356, P79, DOI 10.1016/j.virol.2006.07.025; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CARLBERG K, 1988, J VIROL, V62, P1617, DOI 10.1128/JVI.62.5.1617-1624.1988; Centlivre M, 2008, J VIROL, V82, P9171, DOI 10.1128/JVI.00530-08; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Coyle-Rink J, 2002, VIROLOGY, V299, P240, DOI 10.1006/viro.2002.1439; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; FENRICK R, 1989, J VIROL, V63, P5006, DOI 10.1128/JVI.63.12.5006-5012.1989; Flaherty MT, 1997, J VIROL, V71, P5790, DOI 10.1128/JVI.71.8.5790-5798.1997; Foudraine NA, 1998, LANCET, V351, P1547, DOI 10.1016/S0140-6736(98)07333-4; Gama Lucio, 2002, Methods Mol Biol, V182, P77; GARTNER S, 1990, AIDS RES HUM RETROV, V6, P1017, DOI 10.1089/aid.1990.6.1017; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Henderson AJ, 1996, IMMUNITY, V5, P91, DOI 10.1016/S1074-7613(00)80313-1; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; JAKOBOVITS A, 1988, MOL CELL BIOL, V8, P2555, DOI 10.1128/MCB.8.6.2555; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; Kravcik S, 1999, J ACQ IMMUN DEF SYND, V21, P371; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; Liu CY, 2004, CYTOKINE, V27, P93, DOI 10.1016/j.cyto.2004.02.003; Mameli G, 2007, J GEN VIROL, V88, P631, DOI 10.1099/vir.0.82487-0; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nonnemacher MR, 2003, BIOMED PHARMACOTHER, V57, P34, DOI 10.1016/S0753-3322(02)00334-7; Osada S, 1996, J BIOL CHEM, V271, P3891; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Pilipuk GP, 2003, J BIOL CHEM, V278, P35668, DOI 10.1074/jbc.M305182200; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Roos JW, 2000, VIROLOGY, V273, P307, DOI 10.1006/viro.2000.0431; Rue SM, 2005, J VIROL, V79, P2484, DOI 10.1128/JVI.79.4.2484-2492.2005; Rue SM, 2003, J VIROL, V77, P8009, DOI 10.1128/JVI.77.14.8009-8018.2003; RYDEN TA, 1989, MOL CELL BIOL, V9, P1155, DOI 10.1128/MCB.9.3.1155; RYDEN TA, 1993, J VIROL, V67, P2862, DOI 10.1128/JVI.67.5.2862-2870.1993; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schneider-Merck T, 2006, J BIOL CHEM, V281, P269, DOI 10.1074/jbc.M503459200; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; Tesmer VM, 1996, J MOL BIOL, V262, P327, DOI 10.1006/jmbi.1996.0516; TESMER VM, 1993, P NATL ACAD SCI USA, V90, P7298, DOI 10.1073/pnas.90.15.7298; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Weiden M, 2000, J IMMUNOL, V165, P2028, DOI 10.4049/jimmunol.165.4.2028; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; WITWER KW, 2009, PLOS ONE IN PRESS; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999	75	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2268	2283		10.1074/jbc.M109.075929	http://dx.doi.org/10.1074/jbc.M109.075929			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933495	Green Published, hybrid			2022-12-27	WOS:000273697800006
J	Hamma, T; Ferre-D'Amare, AR				Hamma, Tomoko; Ferre-D'Amare, Adrian R.			The Box H/ACA Ribonucleoprotein Complex: Interplay of RNA and Protein Structures in Post-transcriptional RNA Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PSEUDOURIDINE SYNTHASE; CRYSTAL-STRUCTURE; SUBSTRATE RNA; DYSKERATOSIS-CONGENITA; BINDING MOTIF; GUIDED RNA; MUTAGENESIS; DATABASE; C/D	The box H/ACA ribonucleoproteins (RNPs) are protein-RNA complexes responsible for pseudouridylation, the most abundant post-transcriptional modification of cellular RNAs. Integrity of its box H/ACA domain is also essential for assembly and stability of the human telomerase RNP. The recent publication of the complete box H/ACA RNP structures combined with the previously reported structures of the protein and RNA components makes it possible to deduce the structural accommodation that accompanies assembly of the full particle. This analysis reveals how the protein components distort the RNA component of the RNP, enabling productive docking of the substrate RNA into the enzymatic active site.	[Hamma, Tomoko; Ferre-D'Amare, Adrian R.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA.	aferre@fhcrc.org			National Institutes of Health [GM063576]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063576 (to A.R.F.). This work was also supported by a special fellowship from the Leukemia and Lymphoma Society (to T.H.).	Auffinger P, 1998, Modification and Editing of RNA, P103, DOI [10.1128/9781555818296.ch6, DOI 10.1128/9781555818296.CH6]; Charette M, 2000, IUBMB LIFE, V49, P341; Charpentier B, 2005, NUCLEIC ACIDS RES, V33, P3133, DOI 10.1093/nar/gki630; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Duan JQ, 2009, MOL CELL, V34, P427, DOI 10.1016/j.molcel.2009.05.005; Eliceiri GL, 2006, J CELL BIOCHEM, V98, P486, DOI 10.1002/jcb.20821; Ferre-D'Amare AR, 2003, CURR OPIN STRUC BIOL, V13, P49, DOI 10.1016/S0959-440X(02)00002-7; Hamma T, 2004, STRUCTURE, V12, P893, DOI 10.1016/S0969-2126(04)00096-6; Hamma T, 2005, NAT STRUCT MOL BIOL, V12, P1101, DOI 10.1038/nsmb1036; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hoang C, 2005, PROTEIN SCI, V14, P2201, DOI 10.1110/ps.051493605; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Hoang C, 2004, RNA, V10, P1026, DOI 10.1261/rna.7240504; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Jin H, 2007, MOL CELL, V26, P205, DOI 10.1016/j.molcel.2007.03.014; Khanna M, 2006, RNA, V12, P40, DOI 10.1261/rna.2221606; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Le Hir H, 2008, CURR OPIN STRUC BIOL, V18, P112, DOI 10.1016/j.sbi.2007.11.002; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; Liang B, 2008, RNA, V14, P2086, DOI 10.1261/rna.1109808; Liang B, 2007, NAT STRUCT MOL BIOL, V14, P1189, DOI 10.1038/nsmb1336; Liang B, 2009, NAT STRUCT MOL BIOL, V16, P740, DOI 10.1038/nsmb.1624; LUBBEN B, 1995, J BIOL CHEM, V270, P11549, DOI 10.1074/jbc.270.19.11549; Manival X, 2006, NUCLEIC ACIDS RES, V34, P826, DOI 10.1093/nar/gkj482; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Mueller EG, 2009, DNA RNA MODIFICATION, P363; Muller S, 2007, NUCLEIC ACIDS RES, V35, P5610, DOI 10.1093/nar/gkm606; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; OFFENGAND J, 1998, MODIFICATION EDITING, P229; Pan H, 2007, J MOL BIOL, V367, P1459, DOI 10.1016/j.jmb.2007.01.084; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; Perez-Arellano I, 2007, FEBS J, V274, P4972, DOI 10.1111/j.1742-4658.2007.06031.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Reichow SL, 2008, BIOCHEMISTRY-US, V47, P6148, DOI 10.1021/bi800418p; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Spedaliere CJ, 2000, BIOCHEMISTRY-US, V39, P9459, DOI 10.1021/bi001079n; Terns M, 2006, COLD SPRING HARB SYM, V71, P395, DOI 10.1101/sqb.2006.71.034; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Wild K, 2002, CURR OPIN STRUC BIOL, V12, P72, DOI 10.1016/S0959-440X(02)00292-0; Wu HH, 2007, P NATL ACAD SCI USA, V104, P6655, DOI 10.1073/pnas.0701534104	49	63	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					805	809		10.1074/jbc.R109.076893	http://dx.doi.org/10.1074/jbc.R109.076893			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19917616	Green Published, hybrid			2022-12-27	WOS:000273258200001
J	Hernandez, A; Madina, BR; Ro, K; Wohlschlegel, JA; Willard, B; Kinter, MT; Cruz-Reyes, J				Hernandez, Alfredo; Madina, Bhaskara Reddy; Ro, Kevin; Wohlschlegel, James A.; Willard, Belinda; Kinter, Mike T.; Cruz-Reyes, Jorge			REH2 RNA Helicase in Kinetoplastid Mitochondria RIBONUCLEOPROTEIN COMPLEXES AND ESSENTIAL MOTIFS FOR UNWINDING AND GUIDE RNA (gRNA) BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; PENTATRICOPEPTIDE REPEAT PROTEINS; TRYPANOSOMA-BRUCEI MITOCHONDRIA; DIRECTED ENDONUCLEASE CLEAVAGE; INDUCIBLE EXPRESSION SYSTEM; ROUND-U-INSERTION; MESSENGER-RNA; EDITING COMPLEX; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY	Regulation of gene expression in kinetoplastid mitochondria is largely post-transcriptional and involves the orchestration of polycistronic RNA processing, 3'-terminal maturation, RNA editing, turnover, and translation; however, these processes remain poorly studied. Core editing complexes and their U-insertion/deletion activities are relatively well characterized, and a battery of ancillary factors has recently emerged. This study characterized a novel DExH-box RNA helicase, termed here REH2 (RNA editing associated helicase 2), in unique ribonucleoprotein complexes that exhibit unwinding and guide RNA binding activities, both of which required a double-stranded RNA-binding domain (dsRBD) and a functional helicase motif I of REH2. REH2 complexes and recently identified related particles share a multiprotein core but are distinguished by several differential polypeptides. Finally, REH2 associates transiently, via RNA, with editing complexes, mitochondrial ribosomes, and several ancillary factors that control editing and RNA stability. We propose that these putative higher order structures coordinate mitochondrial gene expression.	[Cruz-Reyes, Jorge] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ro, Kevin; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Willard, Belinda; Kinter, Mike T.] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation	Cruz-Reyes, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	cruzrey@tamu.edu	Cruz-Reyes, Jorge/GQP-1338-2022; Hernandez, Alfredo/AAV-5584-2021; Hernandez, Alfredo J/ABC-8311-2020	Hernandez, Alfredo J/0000-0002-0903-8932; Kinter, Michael/0000-0001-7409-8918; Cruz-Reyes, Jorge/0000-0003-0545-1508	National Institutes of Health [GM067130]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067130 (to J.C.-R.).	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Carnes J, 2007, METHOD ENZYMOL, V424, P25, DOI 10.1016/S0076-6879(07)24002-9; Cifuentes-Rojas C, 2005, NUCLEIC ACIDS RES, V33, P6610, DOI 10.1093/nar/gki943; Cifuentes-Rojas C, 2007, J BIOL CHEM, V282, P4265, DOI 10.1074/jbc.M605554200; Cruz-Reyes J, 2007, METHOD ENZYMOL, V424, P107, DOI 10.1016/S0076-6879(07)24005-4; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; CRUZREYES J, 2008, PROTEIN PROTEIN RNA, P71; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; FABRE A, 1990, PHOTOBIOCHEMISTRY NU, P379; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Jankowsky E, 2000, NUCLEIC ACIDS RES, V28, P333, DOI 10.1093/nar/28.1.333; Jankowsky E, 2007, NATURE, V449, P999, DOI 10.1038/449999a; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Koslowsky DJ, 2009, TRENDS PARASITOL, V25, P252, DOI 10.1016/j.pt.2009.03.008; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; Mingler MK, 2006, MOL BIOCHEM PARASIT, V150, P37, DOI 10.1016/j.molbiopara.2006.06.006; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Muller UF, 2001, EMBO J, V20, P1394, DOI 10.1093/emboj/20.6.1394; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2007, METHOD ENZYMOL, V424, P3, DOI 10.1016/S0076-6879(07)24001-7; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Reifur L, 2008, RNA, V14, P2195, DOI 10.1261/rna.1144508; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Sacharidou A, 2006, RNA, V12, P1219, DOI 10.1261/rna.2295706; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; SIMPSON L, 2009, PROTIST IN PRESS; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yu LE, 2006, RNA, V12, P1050, DOI 10.1261/rna.3406; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	56	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1220	1228		10.1074/jbc.M109.051862	http://dx.doi.org/10.1074/jbc.M109.051862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19850921	Green Published, hybrid			2022-12-27	WOS:000273258200044
J	Thomsen, T; Moeller, JB; Schlosser, A; Sorensen, GL; Moestrup, SK; Palaniyar, N; Wallis, R; Mollenhauer, J; Holmskov, U				Thomsen, Theresa; Moeller, Jesper B.; Schlosser, Anders; Sorensen, Grith L.; Moestrup, Soren K.; Palaniyar, Nades; Wallis, Russell; Mollenhauer, Jan; Holmskov, Uffe			The Recognition Unit of FIBCD1 Organizes into a Noncovalently Linked Tetrameric Structure and Uses a Hydrophobic Funnel (S1) for Acetyl Group Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING LECTIN; CA2+-DEPENDENT ANIMAL LECTINS; HUMAN M-FICOLIN; SWISS-MODEL; CRYSTAL-STRUCTURE; INNATE IMMUNITY; SUGAR LIGANDS; PROTEIN; MOLECULE; RECEPTOR	We have recently identified FIBCD1 (Fibrinogen C domain containing 1) as a type II transmembrane endocytic receptor located primarily in the intestinal brush border. The ectodomain of FIBCD1 comprises a coiled coil, a polycationic region, and a C-terminal FReD (fibrinogen-related domain) that assembles into disulfide-linked homotetramers. The FIBCD1-FReD binds Ca2+ dependently to acetylated structures like chitin, N-acetylated carbohydrates, and amino acids. FReDs are present in diverse innate immune pattern recognition proteins including the ficolins and horseshoe crab TL5A. Here, we use chemical cross-linking, combined with analytical ultracentrifugation and electron microscopy of the negatively stained recombinant FIBCD1-FReD to show that it assembles into noncovalent tetramers in the absence of the coiled coil. We use surface plasmon resonance, carbohydrate binding, and pulldown assays combined with site-directed mutagenesis to define the binding site involved in the interaction of FIBCD1 with acetylated structures. We show that mutations of central residues (A432V and H415G) in the hydrophobic funnel (S1) abolish the binding of FIBCD1 to acetylated bovine serum albumin and chitin. The double mutations (D393N/D395A) at the putative calcium-binding site reduce the ability of FIBCD1 to bind ligands. We conclude that the FReDs of FIBCD1 forms noncovalent tetramers and that the acetyl-binding site of FReDs of FIBCD1 is homologous to that of tachylectin 5A and M-ficolin but not to the FReD of L-ficolin. We suggest that the spatial organization of the FIBCD1-FReDs determine the molecular pattern recognition specificity and subsequent biological functions.	[Thomsen, Theresa; Moeller, Jesper B.; Schlosser, Anders; Sorensen, Grith L.; Mollenhauer, Jan; Holmskov, Uffe] Univ So Denmark, Ctr Med Biotechnol, DK-5000 Odense C, Denmark; [Moestrup, Soren K.] Univ Aarhus, Dept Med Biochem, DK-8000 Aarhus, Denmark; [Palaniyar, Nades] Hosp Sick Children, Toronto, ON M5G 2M9, Canada; [Palaniyar, Nades] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; [Wallis, Russell] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; [Wallis, Russell] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Southern Denmark; Aarhus University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Leicester; University of Leicester	Holmskov, U (corresponding author), Univ So Denmark, Ctr Med Biotechnol, Winsloevpk 25, DK-5000 Odense C, Denmark.	uholmskov@health.sdu.dk	Moestrup, Søren Kragh/A-1403-2014; Holmskov, Uffe/AAA-3056-2022; Mollenhauer, Jan/G-4452-2012; Moeller, Jesper B/E-6377-2015; Moestrup, Søren Kragh/AAD-1735-2019	Moestrup, Søren Kragh/0000-0003-3862-2107; Holmskov, Uffe/0000-0002-2391-9445; Moeller, Jesper B/0000-0001-8786-8037; Palaniyar, Nades/0000-0002-2170-8548; Sorensen, Grith Lykke/0000-0002-5273-1097; Wallis, Russell/0000-0002-8705-5295	Danish Council for Independent Research, Medical Sciences; Novo Nordisk Foundation; Lundbeck Foundation, Fonden; Canadian Institutes of Health Research [MOP-84312]; MRC [G0501425] Funding Source: UKRI; Lundbeck Foundation [R5-2006-446] Funding Source: researchfish; Medical Research Council [G0501425] Funding Source: researchfish	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation, Fonden(Lundbeckfonden); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was partially supported by the Danish Council for Independent Research, Medical Sciences; the Novo Nordisk Foundation; the Lundbeck Foundation, Fonden for L gevidenskabens Fremme; and Canadian Institutes of Health Research (MOP-84312; to N. P.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barton WA, 2005, STRUCTURE, V13, P825, DOI 10.1016/j.str.2005.03.009; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P1085, DOI 10.1016/j.biocel.2004.01.007; Farrell DH, 2004, CURR OPIN HEMATOL, V11, P151, DOI 10.1097/01.moh.0000131440.02397.a4; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; IOBST ST, 1994, J BIOL CHEM, V269, P15512; IOBST ST, 1994, J BIOL CHEM, V269, P15505; Jones PF, 2003, J PATHOL, V201, P515, DOI 10.1002/path.1452; Kairies N, 2001, P NATL ACAD SCI USA, V98, P13519, DOI 10.1073/pnas.201523798; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Krarup A, 2008, IMMUNOL LETT, V118, P152, DOI 10.1016/j.imlet.2008.03.014; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Runza VL, 2006, J ENDOTOXIN RES, V12, P120, DOI 10.1179/096805106X102147; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Strong P, 2002, CLIN EXP ALLERGY, V32, P1794, DOI 10.1046/j.1365-2222.2002.01551.x; Tanio M, 2007, J BIOL CHEM, V282, P3889, DOI 10.1074/jbc.M608627200; Tanio M, 2009, BIOCHEM J, V417, P485, DOI 10.1042/BJ20081640; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Yee VC, 1997, STRUCTURE, V5, P125, DOI 10.1016/S0969-2126(97)00171-8; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282; Zhang PN, 2001, J BIOL CHEM, V276, P19862, DOI 10.1074/jbc.M100597200	47	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1229	1238		10.1074/jbc.M109.061523	http://dx.doi.org/10.1074/jbc.M109.061523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19892701	Green Published, hybrid			2022-12-27	WOS:000273258200045
J	Haimi, P; Hermansson, M; Batchu, KC; Virtanen, JA; Somerharju, P				Haimi, Perttu; Hermansson, Martin; Batchu, Krishna Chaithanya; Virtanen, Jorma A.; Somerharju, Pentti			Substrate Efflux Propensity Plays a Key Role in the Specificity of Secretory A-type Phospholipases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAUROCHOLATE MIXED MICELLES; TRANSITION-STATE ANALOG; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; INTERFACIAL CATALYSIS; ACTIVE-SITE; FATTY-ACID; ELECTROSPRAY-IONIZATION; VENOM PHOSPHOLIPASE-A2; UNILAMELLAR VESICLES	To better understand the principles underlying the substrate specificity of A-type phospholipases (PLAs), a high throughput mass spectrometric assay was employed to study the effect of acyl chain length and unsaturation of phospholipids on their rate of hydrolysis by three different secretory PLAs in micelles and vesicle bilayers. With micelles, each enzyme responded differently to substrate acyl chain unsaturation and double bond position, probably reflecting differences in the accommodative properties of their substrate binding sites. Experiments with saturated acyl positional isomers indicated that the length of the sn2 chain was more critical than that of the sn1 chain, suggesting tighter association of the former with the enzyme. Only the first 9-10 carbons of the sn2 acyl chain seem to interact intimately with the active site. Strikingly, no discrimination between positional isomers was observed with vesicles, and the rate of hydrolysis decreased far more with increasing chain length than with micelles, suggesting that translocation of the phospholipid substrate to the active site is rate-limiting with bilayers. Supporting this conclusion, acyl chain structure affected hydrolysis and spontaneous intervesicle transfer, which correlates with lipid efflux propensity, analogously. We conclude that substrate efflux propensity plays a more important role in the specificity of secretory PLA(2)s than commonly thought and could also be a key attribute in phospholipid homeostasis in which ( unknown) PLA2s are key players.	[Haimi, Perttu; Hermansson, Martin; Batchu, Krishna Chaithanya; Virtanen, Jorma A.; Somerharju, Pentti] Univ Helsinki, Inst Biomed, Dept Med Biochem & Dev Biol, FIN-00014 Helsinki, Finland	University of Helsinki	Hermansson, M (corresponding author), Univ Helsinki, Inst Biomed, Dept Med Biochem & Dev Biol, PL 63, FIN-00014 Helsinki, Finland.	martin.hermansson@helsinki.fi	Hermansson, Martin/B-7854-2008	Hermansson, Martin/0000-0003-3387-8365; Haimi, Perttu/0000-0002-9585-7968	Finnish Academy; University Helsinki Funds; Sigrid Juselius Foundation	Finnish Academy(Academy of Finland); University Helsinki Funds; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Finnish Academy, University Helsinki Funds, and Sigrid Juselius Foundation.	ALMGREN M, 1980, J AM CHEM SOC, V102, P7882, DOI 10.1021/ja00547a010; Asai K, 2003, J BIOL CHEM, V278, P8809, DOI 10.1074/jbc.M212117200; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BLOW D, 1991, NATURE, V351, P444, DOI 10.1038/351444a0; BURDGE GC, 1995, INT J BIOCHEM CELL B, V27, P1027, DOI 10.1016/1357-2725(95)00083-2; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; DEBOSE CD, 1985, BIOCHEMISTRY-US, V24, P1298, DOI 10.1021/bi00327a005; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; DIEZ E, 1994, BIOCHEM J, V301, P721, DOI 10.1042/bj3010721; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; FOLCH J, 1957, J BIOL CHEM, V226, P497; FULLINGTON DA, 1993, BIOCHEMISTRY-US, V32, P12678, DOI 10.1021/bi00210a017; GHOMASHCHI F, 1991, BIOCHEMISTRY-US, V30, P7318, DOI 10.1021/bi00243a037; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Ile KE, 2006, NAT CHEM BIOL, V2, P576, DOI 10.1038/nchembio835; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; JAIN MK, 1993, BIOCHEMISTRY-US, V32, P8360, DOI 10.1021/bi00083a040; JONES JD, 1990, BIOCHEMISTRY-US, V29, P1593, DOI 10.1021/bi00458a034; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kakela R, 2003, J NEUROCHEM, V84, P1051, DOI 10.1046/j.1471-4159.2003.01602.x; KUCERA GL, 1988, J BIOL CHEM, V263, P1920; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; KUMAR A, 1984, BIOCHIM BIOPHYS ACTA, V769, P419, DOI 10.1016/0005-2736(84)90326-2; LEWIS KA, 1990, BIOCHEMISTRY-US, V29, P9962, DOI 10.1021/bi00494a029; Lin Y, 1998, SCIENCE, V279, P1925, DOI 10.1126/science.279.5358.1925; LOMBARDO D, 1986, J BIOL CHEM, V261, P1663; MacCallum JL, 2006, J AM CHEM SOC, V128, P125, DOI 10.1021/ja0535099; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; MASSEY JB, 1984, BIOCHIM BIOPHYS ACTA, V794, P274, DOI 10.1016/0005-2760(84)90156-5; MCLEAN LR, 1984, BIOCHEMISTRY-US, V23, P4624, DOI 10.1021/bi00315a017; MERKL I, 1963, J BIOL CHEM, V238, P905; Miyamoto S, 2003, LIPIDS, V38, P641, DOI 10.1007/s11745-003-1109-6; Mousley CJ, 2007, BBA-MOL CELL BIOL L, V1771, P727, DOI 10.1016/j.bbalip.2007.04.002; NICHOLS JW, 1988, BIOCHEMISTRY-US, V27, P3925, DOI 10.1021/bi00411a006; OTTEN D, 1995, BIOPHYS J, V68, P584, DOI 10.1016/S0006-3495(95)80220-1; Pan YH, 2002, BIOCHEMISTRY-US, V41, P14790, DOI 10.1021/bi026922r; PATEL KM, 1979, LIPIDS, V14, P596, DOI 10.1007/BF02533539; PATTUS F, 1979, BIOCHEMISTRY-US, V18, P2691, DOI 10.1021/bi00580a001; PLESNIAK LA, 1995, BIOCHEMISTRY-US, V34, P4943, DOI 10.1021/bi00015a005; Pruzanski W, 2007, BBA-MOL CELL BIOL L, V1771, P5, DOI 10.1016/j.bbalip.2006.11.008; ROBERTS MF, 1978, J BIOL CHEM, V253, P1252; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305; Sekar K, 1997, BIOCHEMISTRY-US, V36, P14186, DOI 10.1021/bi971370b; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Silversand C, 1997, J CHROMATOGR B, V703, P7, DOI 10.1016/S0378-4347(97)00385-X; SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P13318, DOI 10.1021/bi00211a045; SOLTYS CE, 1994, BIOCHEMISTRY-US, V33, P11608, DOI 10.1021/bi00204a023; SOLTYS CE, 1993, BIOCHEMISTRY-US, V32, P9545, DOI 10.1021/bi00088a005; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; Tatulian SA, 2005, J MOL BIOL, V351, P939, DOI 10.1016/j.jmb.2005.06.080; Thomas MJ, 1999, BBA-BIOMEMBRANES, V1417, P144, DOI 10.1016/S0005-2736(98)00254-5; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; VANDENBERG JJM, 1993, BIOCHEMISTRY-US, V32, P4962, DOI 10.1021/bi00069a035; Wee CL, 2008, BIOPHYS J, V95, P1649, DOI 10.1529/biophysj.107.123190; Wenk MR, 1997, BIOPHYS J, V72, P1719, DOI 10.1016/S0006-3495(97)78818-0; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; Wilkins WP, 2008, CURR DRUG TARGETS, V9, P683, DOI 10.2174/138945008785132385; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; WINKLER H, 1967, BIOCHEM J, V105, pC38, DOI 10.1042/bj1050038C; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; WU SK, 1993, BIOCHEMISTRY-US, V32, P13902, DOI 10.1021/bi00213a020; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; YU L, 1992, J AM CHEM SOC, V114, P8757, DOI 10.1021/ja00049a001	75	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					751	760		10.1074/jbc.M109.061218	http://dx.doi.org/10.1074/jbc.M109.061218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887372	Green Published, hybrid			2022-12-27	WOS:000273070100076
J	O'Callaghan, KM; Ayllon, V; O'Keeffe, J; Wang, YR; Cox, OT; Loughran, G; Forgac, M; O'Connor, R				O'Callaghan, Katie M.; Ayllon, Veronica; O'Keeffe, Jean; Wang, Yanru; Cox, Orla T.; Loughran, Gary; Forgac, Michael; O'Connor, Rosemary			Heme-binding Protein HRG-1 Is Induced by Insulin-like Growth Factor I and Associates with the Vacuolar H+-ATPase to Control Endosomal pH and Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; CELL-MIGRATION; SUBUNIT; CANCER; EXPRESSION; IDENTIFICATION; TRANSPORTER; HOMEOSTASIS; GENE; INTEGRIN	Endocytosis and trafficking of receptors and nutrient transporters are dependent on an acidic intra-endosomal pH that is maintained by the vacuolar H+-ATPase (V-ATPase) proton pump. V-ATPase activity has also been associated with cancer invasiveness. Here, we report on a new V-ATPase-associated protein, which we identified in insulin-like growth factor I (IGF-I) receptor-transformed cells, and which was separately identified in Caenorhabditis elegans as HRG-1, a member of a family of heme-regulated genes. We found that HRG-1 is present in endosomes but not in lysosomes, and it is trafficked to the plasma membrane upon nutrient withdrawal in mammalian cells. Suppression of HRG-1 with small interfering RNA causes impaired endocytosis of transferrin receptor, decreased cell motility, and decreased viability of HeLa cells. HRG-1 interacts with the c subunit of the V-ATPase and enhances V-ATPase activity in isolated yeast vacuoles. Endosomal acidity and V-ATPase assembly are decreased in cells with suppressed HRG-1, whereas transferrin receptor endocytosis is enhanced in cells that over-express HRG-1. Cellular uptake of a fluorescent heme analogue is enhanced by HRG-1 in a V-ATPase-dependent manner. Our findings indicate that HRG-1 regulates V-ATPase activity, which is essential for endosomal acidification, heme binding, and receptor trafficking in mammalian cells. Thus, HRG-1 may facilitate tumor growth and cancer progression.	[O'Callaghan, Katie M.; Ayllon, Veronica; O'Keeffe, Jean; Cox, Orla T.; Loughran, Gary; O'Connor, Rosemary] Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland; [Wang, Yanru; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	University College Cork; Tufts University	O'Connor, R (corresponding author), Univ Coll Cork, BioSci Inst, Dept Biochem, Cell Biol Lab, Cork, Ireland.	r.oconnor@ucc.ie	O'Connor, Rosemary/B-7902-2014; Ayllon, Veronica/L-7069-2014; Loughran, Gary/AAQ-8791-2020	O'Connor, Rosemary/0000-0002-0687-3422; Ayllon, Veronica/0000-0002-7322-9282; Loughran, Gary/0000-0002-2683-5597; Atkins, John/0000-0001-7933-0165	Science Foundation Ireland; Irish Research Council for Science, Engineering, and Technology; Health Research Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Science Foundation Ireland, the Irish Research Council for Science, Engineering, and Technology, and the Health Research Board.	ARAI H, 1987, J BIOL CHEM, V262, P11006; ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; GOLDSTEIN DJ, 1991, NATURE, V352, P347, DOI 10.1038/352347a0; Hamza I, 2006, ACS CHEM BIOL, V1, P627, DOI 10.1021/cb600442b; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kepczynski M, 2002, PHOTOCHEM PHOTOBIOL, V76, P486, DOI 10.1562/0031-8655(2002)076<0486:IODMWL>2.0.CO;2; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lee I, 2004, J BIOL CHEM, V279, P53007, DOI 10.1074/jbc.M405717200; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Loughran G, 2005, ONCOGENE, V24, P6185, DOI 10.1038/sj.onc.1208772; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Mauro L, 2003, J CELL PHYSIOL, V194, P108, DOI 10.1002/jcp.10207; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nakhoul NK, 2002, J NEPHROL, V15, pS22; Nilsson Cathrine, 2003, Methods Cell Sci, V25, P185; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Vasilyeva E, 1996, J BIOL CHEM, V271, P12775, DOI 10.1074/jbc.271.22.12775; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; West AR, 2008, J GASTROEN HEPATOL, V23, P150, DOI 10.1111/j.1440-1746.2007.05047.x	37	53	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					381	391		10.1074/jbc.M109.063248	http://dx.doi.org/10.1074/jbc.M109.063248			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875448	Green Published, hybrid			2022-12-27	WOS:000273070100040
J	Qualley, DF; Stewart-Maynard, KM; Wang, F; Mitra, M; Gorelick, RJ; Rouzina, I; Williams, MC; Musier-Forsyth, K				Qualley, Dominic F.; Stewart-Maynard, Kristen M.; Wang, Fei; Mitra, Mithun; Gorelick, Robert J.; Rouzina, Ioulia; Williams, Mark C.; Musier-Forsyth, Karin			C-terminal Domain Modulates the Nucleic Acid Chaperone Activity of Human T-cell Leukemia Virus Type 1 Nucleocapsid Protein via an Electrostatic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED DNA; GENOMIC RNA DIMERIZATION; ZINC-FINGER STRUCTURES; INTEGRATION IN-VITRO; PRIMER BINDING-SITE; REVERSE TRANSCRIPTION; GENE-32 PROTEIN; VIRAL-RNA; STRUCTURAL DETERMINANTS; THERMODYNAMIC ANALYSIS	Retroviral nucleocapsid (NC) proteins are molecular chaperones that facilitate nucleic acid (NA) remodeling events critical in viral replication processes such as reverse transcription. Surprisingly, theNCprotein from human T-cell leukemia virus type 1 (HTLV-1) is an extremely poor NA chaperone. Using bulk and single molecule methods, we find that removal of the anionic C-terminal domain (CTD) of HTLV-1 NC results in a protein with chaperone properties comparable with that of other retroviral NCs. Increasing the ionic strength of the solution also improves the chaperone activity of full-length HTLV-1 NC. To determine how the CTD negatively modulates the chaperone activity of HTLV-1 NC, we quantified the thermodynamics and kinetics of wild-type and mutant HTLV-1 NC/NA interactions. The wild-type protein exhibits very slow dissociation kinetics, and removal of the CTD or mutations that eliminate acidic residues dramatically increase the protein/DNA interaction kinetics. Taken together, these results suggest that the anionic CTD interacts with the cationic N-terminal domain intramolecularly when HTLV-1 NC is not bound to nucleic acids, and similar interactions occur between neighboring molecules when NC is NA-bound. The intramolecular N-terminal domain-CTD attraction slows down the association of the HTLV-1 NC with NA, whereas the intermolecular interaction leads to multimerization of HTLV-1 NC on the NA. The latter inhibits both NA/NC aggregation and rapid protein dissociation from single-stranded DNA. These features make HTLV-1 NC a poor NA chaperone, despite its robust duplex destabilizing capability.	[Qualley, Dominic F.; Mitra, Mithun; Musier-Forsyth, Karin] Ohio State Univ, Ctr Retrovirus Res, Dept Chem, Columbus, OH 43210 USA; [Qualley, Dominic F.; Mitra, Mithun; Musier-Forsyth, Karin] Ohio State Univ, Ctr Retrovirus Res, Dept Biochem, Columbus, OH 43210 USA; [Qualley, Dominic F.; Mitra, Mithun; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Stewart-Maynard, Kristen M.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Stewart-Maynard, Kristen M.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Rouzina, Ioulia] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Wang, Fei; Williams, Mark C.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Gorelick, Robert J.] NCI, AIDS & Canc Virus Program, Sci Applicat Int Corp Frederick Inc, NIH, Ft Detrick, MD 21702 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Northeastern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Rouzina, I (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 321 Church St SE, Minneapolis, MN 55455 USA.	rouzi002@umn.edu; ma.williams@neu.edu; musier@chemistry.ohio-state.edu	Mitra, Mithun/O-6711-2019; Mitra, Mithun/A-2133-2015	Williams, Mark C./0000-0003-3219-376X; Mitra, Mithun/0000-0001-8056-8963	National Institutes of Health [GM065056, GM072462]; Ruth L. Kirschstein National Service Award [GM072396]; NCI [N01-CO-12400, HHSN261200800001E]; National Science Foundation [MCB-0744456]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072462, F32GM072396, R01GM065056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065056 (to K. M. -F.) and GM072462 (to M. C. W.), Ruth L. Kirschstein National Service Award GM072396 (to K. M. S.- M.), and Contracts N01-CO-12400 and HHSN261200800001E from the NCI. This work was also supported by National Science Foundation Grant MCB-0744456 (to M. C. W.).	Askjaer P, 1998, J BIOL CHEM, V273, P11463, DOI 10.1074/jbc.273.19.11463; Beltz H, 2005, J MOL BIOL, V348, P1113, DOI 10.1016/j.jmb.2005.02.042; Bernacchi S, 2002, J MOL BIOL, V317, P385, DOI 10.1006/jmbi.2002.5429; Buckman JS, 2003, J VIROL, V77, P1469, DOI 10.1128/JVI.77.2.1469-1480.2003; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Carteau S, 1997, J VIROL, V71, P6225, DOI 10.1128/JVI.71.8.6225-6229.1997; Chan B, 1997, P NATL ACAD SCI USA, V94, P13530, DOI 10.1073/pnas.94.25.13530; Chan BD, 1999, P NATL ACAD SCI USA, V96, P459, DOI 10.1073/pnas.96.2.459; Coren LV, 2007, J VIROL, V81, P10047, DOI 10.1128/JVI.02496-06; Cristofari G, 2002, PROG NUCLEIC ACID RE, V72, P223, DOI 10.1016/S0079-6603(02)72071-0; Cruceanu M, 2006, NUCLEIC ACIDS RES, V34, P593, DOI 10.1093/nar/gkj458; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; Derse D, 2004, FRONT BIOSCI-LANDMRK, V9, P2495, DOI 10.2741/1411; DERSE D, 1995, J VIROL, V69, P1907, DOI 10.1128/JVI.69.3.1907-1912.1995; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Feng YX, 1996, P NATL ACAD SCI USA, V93, P7577, DOI 10.1073/pnas.93.15.7577; Fisher RJ, 2006, NUCLEIC ACIDS RES, V34, P472, DOI 10.1093/nar/gkj442; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; Gao K, 2003, J VIROL, V77, P1598, DOI 10.1128/JVI.77.2.1598-1603.2003; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Golinelli MP, 2001, VIROLOGY, V285, P278, DOI 10.1006/viro.2001.0970; Guo F, 2009, J VIROL, V83, P8099, DOI 10.1128/JVI.00488-09; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Hargittai MRS, 2004, J MOL BIOL, V337, P951, DOI 10.1016/j.jmb.2004.01.054; Hargittai MRS, 2001, J MOL BIOL, V312, P985, DOI 10.1006/jmbi.2001.5021; Heath MJ, 2003, J BIOL CHEM, V278, P30755, DOI 10.1074/jbc.M303819200; HENDERSON LE, 1992, J VIROL, V66, P1856, DOI 10.1128/JVI.66.4.1856-1865.1992; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hong MK, 2003, J MOL BIOL, V325, P1, DOI 10.1016/S0022-2836(02)01177-4; Johnson PE, 2000, BIOCHEMISTRY-US, V39, P9084, DOI 10.1021/bi000841i; Kafaie J, 2008, VIROLOGY, V375, P592, DOI 10.1016/j.virol.2008.02.001; Kankia BI, 2005, NUCLEIC ACIDS RES, V33, P4395, DOI 10.1093/nar/gki741; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Laughrea M, 2001, VIROLOGY, V281, P109, DOI 10.1006/viro.2000.0778; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Liang C, 1998, J VIROL, V72, P6629, DOI 10.1128/JVI.72.8.6629-6636.1998; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Martin SL, 2008, NUCLEIC ACIDS RES, V36, P5845, DOI 10.1093/nar/gkn554; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Mazurov D, 2006, VIROLOGY, V346, P194, DOI 10.1016/j.virol.2005.10.033; Mazurov D, 2007, J BIOL CHEM, V282, P3896, DOI 10.1074/jbc.M607322200; McCauley MJ, 2007, BIOPOLYMERS, V85, P154, DOI 10.1002/bip.20622; MCGHEE JD, 1976, BIOPOLYMERS, V15, P1345, DOI 10.1002/bip.1976.360150710; Mirambeau G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000669; Mirambeau G, 2006, J MOL BIOL, V364, P496, DOI 10.1016/j.jmb.2006.08.065; Morcock DR, 2000, BBA-PROTEIN STRUCT M, V1481, P381, DOI 10.1016/S0167-4838(00)00181-3; Narayanan N, 2006, BIOCHEMISTRY-US, V45, P12617, DOI 10.1021/bi060925c; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nyborg Jennifer K, 2004, Biochem J, V381, pe3; Pant K, 2005, J MOL BIOL, V349, P317, DOI 10.1016/j.jmb.2005.03.065; Pant K, 2004, J MOL BIOL, V336, P851, DOI 10.1016/j.jmb.2003.12.025; Pant K, 2003, J MOL BIOL, V327, P571, DOI 10.1016/S0022-2836(03)00153-0; Pettit SC, 1998, AIDS RES HUM RETROV, V14, P1007, DOI 10.1089/aid.1998.14.1007; PRATS AC, 1988, EMBO J, V7, P1777, DOI 10.1002/j.1460-2075.1988.tb03008.x; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rouzina I, 2005, BIOPHYS J, V89, P1941, DOI 10.1529/biophysj.105.063776; Rouzina I, 2001, BIOPHYS J, V80, P882, DOI 10.1016/S0006-3495(01)76067-5; Saadatmand J, 2009, VIROLOGY, V391, P334, DOI 10.1016/j.virol.2009.06.036; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Shokri L, 2008, NUCLEIC ACIDS RES, V36, P5668, DOI 10.1093/nar/gkn551; Shokri L, 2008, BIOPHYS J, V95, P1248, DOI 10.1529/biophysj.108.132688; Stewart-Maynard KM, 2008, J VIROL, V82, P10129, DOI 10.1128/JVI.01169-08; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Thomas JA, 2006, VIROLOGY, V353, P41, DOI 10.1016/j.virol.2006.05.014; TOYOSHIMA H, 1990, J VIROL, V64, P2825, DOI 10.1128/JVI.64.6.2825-2832.1990; TSUCHIHASHI Z, 1994, J VIROL, V68, P5863, DOI 10.1128/JVI.68.9.5863-5870.1994; Urbaneja MA, 1999, J MOL BIOL, V287, P59, DOI 10.1006/jmbi.1998.2521; Vo MN, 2006, J MOL BIOL, V363, P244, DOI 10.1016/j.jmb.2006.08.039; Vo MN, 2009, J MOL BIOL, V386, P773, DOI 10.1016/j.jmb.2008.12.073; Vo MN, 2009, J MOL BIOL, V386, P789, DOI 10.1016/j.jmb.2008.12.070; Wang HT, 2003, J VIROL, V77, P9431, DOI 10.1128/JVI.77.17.9431-9438.2003; Williams MC, 2002, ACCOUNTS CHEM RES, V35, P159, DOI 10.1021/ar010045k; Williams MC, 2002, P NATL ACAD SCI USA, V99, P8614, DOI 10.1073/pnas.132128999; Williams MC, 2002, CURR OPIN STRUC BIOL, V12, P330, DOI 10.1016/S0959-440X(02)00340-8; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	85	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					295	307		10.1074/jbc.M109.051334	http://dx.doi.org/10.1074/jbc.M109.051334			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887455	Green Published, hybrid			2022-12-27	WOS:000273070100031
J	Shi, FX; Cheng, YF; Wang, XL; Edge, ASB				Shi, Fuxin; Cheng, Yen-fu; Wang, Xiaohui L.; Edge, Albert S. B.			beta-Catenin Up-regulates Atoh1 Expression in Neural Progenitor Cells by Interaction with an Atoh1 3 ' Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING NERVOUS-SYSTEM; EAR HAIR-CELLS; INNER-EAR; WNT/BETA-CATENIN; STEM-CELLS; NEURONAL DIFFERENTIATION; INTESTINAL CRYPTS; COLON-CANCER; MATH1; MORPHOGENESIS	Atoh1, a basic helix-loop-helix transcription factor, plays a critical role in the differentiation of several epithelial and neural cell types. We found that beta-catenin, the key mediator of the canonical Wnt pathway, increased expression of Atoh1 in mouse neuroblastoma cells and neural progenitor cells, and baseline Atoh1 expression was decreased by siRNA directed at beta-catenin. The up-regulation of Atoh1 was caused by an interaction of beta-catenin with the Atoh1 enhancer that could be demonstrated by chromatin immunoprecipitation. We found that two putative Tcf-Lef sites in the 3' enhancer of the Atoh1 gene displayed an affinity for beta-catenin and were critical for the activation of Atoh1 transcription because mutation of either site decreased expression of a reporter gene downstream of the enhancer. Tcf-Lef co-activators were found in the complex that bound to these sites in the DNA together with beta-catenin. Inhibition of Notch signaling, which has previously been shown to induce bHLH transcription factor expression, increased beta-catenin expression in progenitor cells of the nervous system. Because this could be a mechanism for up-regulation of Atoh1 after inhibition of Notch, we tested whether siRNA to beta-catenin prevented the increase in Atoh1 and found that beta-catenin expression was required for increased expression of Atoh1 after Notch inhibition.	[Shi, Fuxin; Cheng, Yen-fu; Edge, Albert S. B.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Shi, Fuxin; Edge, Albert S. B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Cheng, Yen-fu; Edge, Albert S. B.] Harvard & MIT, Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA; [Wang, Xiaohui L.] Boston Univ, Sch Med, Dept Internal Med, Boston, MA 02118 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Boston University	Edge, ASB (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	albert_edge@meei.harvard.edu	Edge, Albert/Q-5448-2019	Cheng, Yen-Fu/0000-0003-1995-5854	National Institutes of Health [R01 DC007174, P30 DC05209]; NIDCD; Hamilton H. Kellogg and Mildred H. Kellogg Charitable Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007174, P30DC005209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Hamilton H. Kellogg and Mildred H. Kellogg Charitable Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC007174 and P30 DC05209 from the NIDCD and by the Hamilton H. Kellogg and Mildred H. Kellogg Charitable Trust.	Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Fritzsch B, 2005, HEARING RES, V206, P52, DOI 10.1016/j.heares.2004.11.025; Helms AW, 2000, DEVELOPMENT, V127, P1185; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stevens CB, 2003, DEV BIOL, V261, P149, DOI 10.1016/S0012-1606(03)00297-5; Tsuchiya K, 2007, GASTROENTEROLOGY, V132, P208, DOI 10.1053/j.gastro.2006.10.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	36	87	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					392	400		10.1074/jbc.M109.059055	http://dx.doi.org/10.1074/jbc.M109.059055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864427	Green Published, hybrid			2022-12-27	WOS:000273070100041
J	Yarotskyy, V; Gao, GF; Du, L; Ganapathi, SB; Peterson, BZ; Elmslie, KS				Yarotskyy, Viktor; Gao, Guofeng; Du, Lei; Ganapathi, Sindura B.; Peterson, Blaise Z.; Elmslie, Keith S.			Roscovitine Binds to Novel L-channel (Ca(V)1.2) Sites That Separately Affect Activation and Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; CALCIUM-CHANNELS; CA2+ CHANNELS; ANGINA-PECTORIS; R-ROSCOVITINE; CA2+-DEPENDENT INACTIVATION; ESSENTIAL-HYPERTENSION; TRANSMITTER RELEASE; GATING MECHANISMS; DRUG-BINDING	L-type (Ca(V)1.2) calcium channel antagonists play an important role in the treatment of cardiovascular disease. (R)-Roscovitine, a trisubstituted purine, has been shown to inhibit L-currents by slowing activation and enhancing inactivation. This study utilized molecular and pharmacological approaches to determine whether these effects result from (R)-roscovitine binding to a single site. Using the S enantiomer, we find that (S)-roscovitine enhances inactivation without affecting activation, which suggests multiple sites. This was further supported in studies using chimeric channels comprised of N- and L-channel domains. Those chimeras containing L-channel domains I and IV showed (R)- roscovitine-induced slowed activation like that of wild type L-channels, whereas chimeric channels containing L-channel domain I responded to (R)-roscovitine with enhanced inactivation. We conclude that (R)-roscovitine binds to distinct sites on L-type channels to slow activation and enhance inactivation. These sites appear to be unique from other calcium channel antagonist sites that reside within domains III and IV and are thus novel sites that could be exploited for future drug development. Trisubstituted purines could become a new class of drugs for the treatment of diseases related to hyperfunction of L-type channels, such as Torsades de Pointes.	[Yarotskyy, Viktor; Elmslie, Keith S.] Penn State Univ, Penn State Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA; [Gao, Guofeng; Du, Lei; Peterson, Blaise Z.] Penn State Univ, Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Ganapathi, Sindura B.; Elmslie, Keith S.] Penn State Univ, Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Elmslie, KS (corresponding author), Penn State Coll Med, Dept Anesthesiol H187, 500 Univ Dr, Hershey, PA 17033 USA.			Elmslie, Keith/0000-0002-2988-4482	National Institutes of Health [HL074143]; American Heart Association Predoctoral Fellowship [0715336U]; Department of Anesthesiology at the Penn State College of Medicine; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); Department of Anesthesiology at the Penn State College of Medicine; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL074143 (to B. Z. P.). This work was also supported in part by American Heart Association Predoctoral Fellowship 0715336U (to S. B. G.), startup funds from the Department of Anesthesiology at the Penn State College of Medicine (to K. S. E.), and grants from the Pennsylvania Department of Health using Tobacco Settlement Funds (to K. S. E. and B. Z. P.).	Bai R, 2005, CLIN CARDIOL, V28, P343, DOI 10.1002/clc.4960280708; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Bourinet E, 2004, J CLIN INVEST, V113, P1382, DOI 10.1172/JCI200421815; Buraei Z, 2005, BIOPHYS J, V89, P1681, DOI 10.1529/biophysj.104.052837; Buraei Z, 2008, J NEUROCHEM, V105, P1450, DOI 10.1111/j.1471-4159.2008.05248.x; Buraei Z, 2007, NEUROPHARMACOLOGY, V52, P883, DOI 10.1016/j.neuropharm.2006.10.006; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Cho S, 2006, EUR J NEUROSCI, V23, P3200, DOI 10.1111/j.1460-9568.2006.04849.x; Elmslie KS, 2004, J NEUROSCI RES, V75, P733, DOI 10.1002/jnr.10872; Ganapathi SB, 2009, AM J PHYSIOL-CELL PH, V296, pC701, DOI 10.1152/ajpcell.00633.2008; Glasser SP, 2003, AM J HYPERTENS, V16, P51, DOI 10.1016/S0895-7061(02)03153-9; Goo YS, 2006, J NEUROPHYSIOL, V96, P1075, DOI 10.1152/jn.01294.2005; Grabner M, 1996, NEURON, V16, P207, DOI 10.1016/S0896-6273(00)80037-9; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; Meijer L, 1996, TRENDS CELL BIOL, V6, P393, DOI 10.1016/0962-8924(96)10034-9; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; PELLINEN TJ, 1992, ANN MED, V24, P49, DOI 10.3109/07853899209164144; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Roden DM, 2002, ANNU REV PHYSIOL, V64, P431, DOI 10.1146/annurev.physiol.64.083101.145105; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; Suzuki S, 2003, HYPERTENS RES, V26, P193, DOI 10.1291/hypres.26.193; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Thomas G, 2007, J PHYSIOL-LONDON, V578, P85, DOI 10.1113/jphysiol.2006.121921; THOMAS MG, 1990, J CLIN PHARMACOL, V30, P24, DOI 10.1002/j.1552-4604.1990.tb03433.x; Vitali L, 2002, CANCER LETT, V180, P7, DOI 10.1016/S0304-3835(01)00827-8; Wesierska-Gadek J, 2007, J CELL BIOCHEM, V100, P865, DOI 10.1002/jcb.21211; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761; Yarotskyy V, 2007, BRIT J PHARMACOL, V152, P386, DOI 10.1038/sj.bjp.0707414; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737	40	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					43	53		10.1074/jbc.M109.076448	http://dx.doi.org/10.1074/jbc.M109.076448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887376	Green Published			2022-12-27	WOS:000273070100006
J	Yasuhara, R; Yuasa, T; Williams, JA; Byers, SW; Shah, S; Pacifici, M; Iwamoto, M; Enomoto-Iwamoto, M				Yasuhara, Rika; Yuasa, Takahito; Williams, Julie A.; Byers, Stephen W.; Shah, Salim; Pacifici, Maurizio; Iwamoto, Masahiro; Enomoto-Iwamoto, Motomi			Wnt/beta-Catenin and Retinoic Acid Receptor Signaling Pathways Interact to Regulate Chondrocyte Function and Matrix Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; NUCLEAR RECEPTORS; GROWTH-PLATE; DEVELOPMENTAL REGULATION; ARTICULAR CHONDROCYTES; MOUSE EMBRYO; WNT; DIFFERENTIATION; CELLS; EXPRESSION	Activation of the Wnt/beta-catenin and retinoid signaling pathways is known to tilt cartilage matrix homeostasis toward catabolism. Here, we investigated possible interactions between these pathways. We found that all-trans-retinoic acid (RA) treatment of mouse epiphyseal chondrocytes in culture did increase Wnt/beta-catenin signaling in the absence or presence of exogenous Wnt3a, as revealed by lymphoid enhancer factor/T-cell factor/beta-catenin reporter activity and beta-catenin nuclear accumulation. This stimulation was accompanied by increased gene expression of Wnt proteins and receptors and was inhibited by co-treatment with Dickkopf-related protein-1, an extracellular inhibitor of Wnt/beta-catenin signaling, suggesting that RA modulates Wnt signaling at Wnt cell surface receptor level. RA also enhanced matrix loss triggered by Wnt/beta-catenin signaling, whereas treatment with a retinoid antagonist reduced it. Interestingly, overexpression of retinoic acid receptor gamma (RAR gamma) strongly inhibited Wnt/beta-catenin signaling in retinoid-free cultures, whereas small interfering RNA-mediated silencing of endogenous RAR gamma expression strongly increased it. Small interfering RNA-mediated silencing of RAR alpha or RAR beta had minimal effects. Co-immunoprecipitation and two-hybrid assays indicated that RAR gamma interacts with beta-catenin and induces dissociation of beta-catenin from lymphoid enhancer factor in retinoid-free cultures. The N-terminal domain (AF-1) of RAR gamma but not the C-terminal domain (AF-2) was required for association with beta-catenin, whereas both AF-1 and AF-2 were necessary for inhibition of beta-catenin transcriptional activity. Taken together, our data indicate that the Wnt and retinoid signaling pathways do interact in chondrocytes, and their cross-talks and cross-regulation play important roles in the regulation of cartilage matrix homeostasis.	[Yasuhara, Rika; Yuasa, Takahito; Williams, Julie A.; Pacifici, Maurizio; Iwamoto, Masahiro; Enomoto-Iwamoto, Motomi] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Byers, Stephen W.; Shah, Salim] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Byers, Stephen W.; Shah, Salim] Georgetown Univ, Sch Med, Dept Oncol, Mol & Cellular Biol Div, Washington, DC 20007 USA; [Byers, Stephen W.; Shah, Salim] Georgetown Univ, Sch Med, Dept Biochem, Mol & Cellular Biol Div, Washington, DC 20007 USA	Jefferson University; Georgetown University; Georgetown University; Georgetown University	Iwamoto, M (corresponding author), 1015 Walnut St,Curtis 501, Philadelphia, PA 19107 USA.	Masahiro.iwamoto@jefferson.edu; Motomi.iwamoto@jefferson.edu		Yasuhara, Rika/0000-0003-2282-6295	National Institutes of Health [AR050507, AG025868, AR056837, CA129813]; NATIONAL CANCER INSTITUTE [R01CA129813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056837, R01AR050507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050507 (to M. E. I.), AG025868 (to M. P.), AR056837 (to M. I.), and CA129813 (to S. W. B.).	Ballock R. Tracy, 2003, Birth Defects Research, V69, P123, DOI 10.1002/bdrc.10014; BALLOCK RT, 1994, J CELL PHYSIOL, V159, P340, DOI 10.1002/jcp.1041590217; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Beehler BC, 2003, J RHEUMATOL, V30, P355; Byers S, 1996, ENDOCRINOLOGY, V137, P3265, DOI 10.1210/en.137.8.3265; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DOLLE P, 1989, NATURE, V342, P702, DOI 10.1038/342702a0; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Evans CH, 2004, GENE THER, V11, P379, DOI 10.1038/sj.gt.3302196; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Flannery CR, 1999, MATRIX BIOL, V18, P225, DOI 10.1016/S0945-053X(99)00024-4; FUKUO K, 1986, J BIOCHEM-TOKYO, V99, P385, DOI 10.1093/oxfordjournals.jbchem.a135493; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hartmann C, 2007, MOL CELLS, V24, P177; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; HORTON JE, 1978, SCIENCE, V199, P1342, DOI 10.1126/science.204011; IWAMOTO M, 1994, MICROSC RES TECHNIQ, V28, P483, DOI 10.1002/jemt.1070280604; IWAMOTO M, 1993, EXP CELL RES, V207, P413, DOI 10.1006/excr.1993.1209; Katoh M, 2002, INT J MOL MED, V10, P683; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Kawakami Y, 1996, DEVELOPMENT, V122, P3557; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Liu T, 2002, J BIOL CHEM, V277, P30887, DOI 10.1074/jbc.M203852200; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Lu DS, 2005, P NATL ACAD SCI USA, V102, P18567, DOI 10.1073/pnas.0509316102; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; MENDELSOHN C, 1992, DEV BIOL, V152, P50, DOI 10.1016/0012-1606(92)90155-A; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mollard R, 2000, MECH DEVELOP, V94, P223, DOI 10.1016/S0925-4773(00)00303-8; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rodriguez-Leon J, 1999, NAT CELL BIOL, V1, P125, DOI 10.1038/10098; Rodriguez-Lopez J, 2007, ANN RHEUM DIS, V66, P1052, DOI 10.1136/ard.2006.065938; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Shah S, 2003, J BIOL CHEM, V278, P48137, DOI 10.1074/jbc.M307154200; Shum ASW, 1999, MECH DEVELOP, V84, P17, DOI 10.1016/S0925-4773(99)00059-3; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; von Schroeder HP, 1998, J ORTHOP RES, V16, P355, DOI 10.1002/jor.1100160312; Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117; Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	60	68	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					317	327		10.1074/jbc.M109.053926	http://dx.doi.org/10.1074/jbc.M109.053926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858186	hybrid, Green Published			2022-12-27	WOS:000273070100033
J	Armstrong, SP; Caunt, CJ; Fowkes, RC; Tsaneva-Atanasova, K; McArdle, CA				Armstrong, Stephen P.; Caunt, Christopher J.; Fowkes, Robert C.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Pulsatile and Sustained Gonadotropin-releasing Hormone (GnRH) Receptor Signaling DOES THE Ca2+/NFAT SIGNALING PATHWAY DECODE GnRH PULSE FREQUENCY?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-DEPENDENT INTERNALIZATION; DUAL-SPECIFICITY PHOSPHATASES; SUBUNIT GENE-TRANSCRIPTION; C-TERMINAL TAIL; LUTEINIZING-HORMONE; DIFFERENTIAL REGULATION; PULSE-FREQUENCY; SPATIOTEMPORAL REGULATION; ALPHA-T3-1 GONADOTROPES; RECOMBINANT ADENOVIRUS	Gonadotropin-releasing hormone (GnRH) acts via 7 transmembrane region receptors on gonadotrophs to stimulate synthesis and secretion of the luteinizing hormone and follicle-stimulating hormone. It is secreted in pulses, and its effects depend on pulse frequency, but decoding mechanisms are unknown. Here we have used (nuclear factor of activated T-cells 2 (NFAT2)-emerald fluorescent protein) to monitor GnRH signaling. Increasing [Ca2+](i) causes calmodulin/calcineurin-dependent nuclear NFAT translocation, a response involving proteins (calmodulins and NFATs) that decode frequency in other systems. Using live cell imaging, pulsatile GnRH caused dose- and frequency-dependent increases in nuclear NFAT2-emerald fluorescent protein, and at low frequency, translocation simply tracked GnRH exposure (albeit with slower kinetics). At high frequency (30-min intervals), failure to return to basal conditions before repeat stimulation caused integrative tracking, illustrating how the relative dynamics of up- and downstream signals can increase efficiency of GnRH action. Mathematical modeling predicted desensitization of GnRH effects on [Ca2+](i) and that desensitization would increase with dose, frequency, and receptor number, but no such desensitization was seen in HeLa and/or L beta T2 cells possibly because pulsatile GnRH did not reduce receptor expression (measured by immunofluorescence). GnRH also caused dose-and frequency-dependent activation of alpha GSU, luteinizing hormone beta, and follicle-stimulating hormone beta luciferase reporters, effects that were blocked by calcineurin inhibition. Pulsatile GnRH also activated an NFAT-responsive luciferase reporter, but this response was directly related to cumulative pulse duration. This together with the lack of desensitization of translocation responses suggests that NFAT may mediate GnRH action but is not a genuine decoder of GnRH pulse frequency.	[Armstrong, Stephen P.; Caunt, Christopher J.; McArdle, Craig A.] Univ Bristol, Dept Clin Sci S Bristol, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Fowkes, Robert C.] Univ London Royal Vet Coll, Endocrine Signalling Grp, London NW1 0TU, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol Ctr Appl Nonlinear Math, Bristol BS8 1TR, Avon, England	University of Bristol; University of London; University of London Royal Veterinary College; University of Bristol	McArdle, CA (corresponding author), Univ Bristol, Dept Clin Sci S Bristol, Labs Integrat Neurosci & Endocrinol, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	McArdle, Craig/AAQ-5660-2021; Fowkes, Robert/HHT-0664-2022; Fowkes, Robert/AAI-4756-2020; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019	McArdle, Craig/0000-0003-4836-5351; Fowkes, Robert/0000-0002-2222-2056; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051	Wellcome Trust [084588, 078407]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grants 084588 and 078407 (to C.A.M.) and a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom doctoral training grant award (to the University of Bristol Laboratories for Integrative Neuroscience and Endocrinology).	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Berridge MJ, 2006, BIOCHEM SOC T, V34, P228, DOI 10.1042/BST0340228; Burger LL, 2008, BIOL REPROD, V79, P947, DOI 10.1095/biolreprod.108.070987; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; BURGER LL, 2009, BIOL REPROD; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Craske H, 1999, P NATL ACAD SCI USA, V96, P4426, DOI 10.1073/pnas.96.8.4426; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Finch AR, 2008, J ENDOCRINOL, V196, P353, DOI 10.1677/JOE-07-0471; Finch AR, 2009, AM J PHYSIOL-CELL PH, V297, pC591, DOI 10.1152/ajpcell.00166.2009; Finch AR, 2004, J CLIN ENDOCR METAB, V89, P1823, DOI 10.1210/jc.2003-030787; Gardner S, 2009, NEUROENDOCRINOLOGY, V89, P241, DOI 10.1159/000165377; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Haisenleder DJ, 2003, ENDOCRINOLOGY, V144, P2768, DOI 10.1210/en.2002-0168; Haisenleder DJ, 2003, ENDOCRINOLOGY, V144, P2409, DOI 10.1210/en.2002-0013; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Hislop JN, 2001, J BIOL CHEM, V276, P39685, DOI 10.1074/jbc.M104542200; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Holdstock JG, 1996, MOL ENDOCRINOL, V10, P1308, DOI 10.1210/me.10.11.1308; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Karakoula A, 2008, EUR J PHARMACOL, V587, P16, DOI 10.1016/j.ejphar.2008.03.047; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Maru BS, 2009, BONE, V44, P102, DOI 10.1016/j.bone.2008.09.016; MCARDLE CA, 1992, MOL CELL NEUROSCI, V3, P124, DOI 10.1016/1044-7431(92)90016-U; Mermelstein PG, 2001, P NATL ACAD SCI USA, V98, P15342, DOI 10.1073/pnas.211563998; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Oosterom J, 2005, ASSAY DRUG DEV TECHN, V3, P143, DOI 10.1089/adt.2005.3.143; Schally AV, 1999, PEPTIDES, V20, P1247, DOI 10.1016/S0196-9781(99)00130-8; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; WEISS J, 1990, MOL ENDOCRINOL, V4, P557, DOI 10.1210/mend-4-4-557; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Zhang T, 2006, J MOL ENDOCRINOL, V36, P41, DOI 10.1677/jme.1.01881	60	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35746	35757		10.1074/jbc.M109.063917	http://dx.doi.org/10.1074/jbc.M109.063917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858197	Green Published, hybrid			2022-12-27	WOS:000272645600052
J	Jacobson, AD; Zhang, NY; Xu, P; Han, KJ; Noone, S; Peng, JM; Liu, CW				Jacobson, Andrew D.; Zhang, Nan-Yan; Xu, Ping; Han, Ke-Jun; Noone, Seth; Peng, Junmin; Liu, Chang-Wei			The Lysine 48 and Lysine 63 Ubiquitin Conjugates Are Processed Differently by the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; LINEAR POLYUBIQUITIN CHAINS; ANAPHASE-PROMOTING COMPLEX; DEUBIQUITINATING ENZYME; QUANTITATIVE-ANALYSIS; PROTEOLYTIC PATHWAY; MASS-SPECTROMETRY; DNA-REPAIR; RECOGNITION; DEGRADATION	The role of Lys-63 ubiquitin chains in targeting proteins for proteasomal degradation is still obscure. We systematically compared proteasomal processing of Lys-63 ubiquitin chains with that of the canonical proteolytic signal, Lys-48 ubiquitin chains. Quantitative mass spectrometric analysis of ubiquitin chains in HeLa cells determines that the levels of Lys-63 ubiquitin chains are insensitive to short-time proteasome inhibition. Also, the Lys-48/Lys-63 ratio in the 26 S proteasome-bound fraction is 1.7-fold more than that in the cell lysates, likely because some cellular Lys-63 ubiquitin conjugates are sequestered by Lys-63 chain-specific binding proteins. In vitro, Lys-48 and Lys-63 ubiquitin chains bind the 26 S proteasome comparably, whereas Lys-63 chains are deubiquitinated 6-fold faster than Lys- 48 chains. Also, Lys-63 tetraubiquitin-conjugated UbcH10 is rapidly deubiquitinated into the monoubiquitinated form, whereas Lys- 48 tetraubiquitin targets UbcH10 for degradation. Furthermore, we found that both the ubiquitin aldehyde- and 1,10-phenanthroline- sensitive deubiquitinating activities of the 26 S proteasome contribute to Lys-48- and Lys-63-linkage deubiquitination, albeit the inhibitory extents are different. Together, our findings suggest that compared with Lys-48 chains, cellular Lys-63 chains have less proteasomal accessibility, and proteasome-bound Lys-63 chains are more rapidly deubiquitinated, which could cause inefficient degradation of Lys-63 conjugates.	[Liu, Chang-Wei] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Xu, Ping; Peng, Junmin] Emory Univ, Ctr Neurodegenerat Dis, Dept Human Genet, Atlanta, GA 30322 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Emory University	Liu, CW (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, 12801 E 17th Ave,Box 6511,Mail Stop 8101, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648	National Institutes of Health [AG025688]; American Heart Association; March of Dimes Basil O'Connor Award; American Cancer Society; Cancer League of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Basil O'Connor Award(March of Dimes); American Cancer Society(American Cancer Society); Cancer League of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG025688 (to J. P.). This work was also supported by grants from the American Heart Association, a March of Dimes Basil O'Connor Award, the American Cancer Society, and the Cancer League of Colorado (to C.-W.L.).	Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; MA CP, 1994, J BIOL CHEM, V269, P3539; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu P, 2006, BBA-PROTEINS PROTEOM, V1764, P1940, DOI 10.1016/j.bbapap.2006.09.004; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	46	95	97	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35485	35494		10.1074/jbc.M109.052928	http://dx.doi.org/10.1074/jbc.M109.052928			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858201	hybrid, Green Published			2022-12-27	WOS:000272645600025
J	Guo, HB; Johnson, H; Randolph, M; Pierce, M				Guo, Hua-Bei; Johnson, Heather; Randolph, Matthew; Pierce, Michael			Regulation of Homotypic Cell-Cell Adhesion by Branched N-Glycosylation of N-cadherin Extracellular EC2 and EC3 Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROPELLER DOMAIN; SIGNALING PATHWAY; BREAST-CANCER; INTERCELLULAR-ADHESION; HOMOPHILIC ADHESION; BIOLOGICAL FUNCTION; CONTACT-INHIBITION; EXPRESSION; METASTASIS; RECEPTOR	The effects of altering N-cadherin N-glycosylation on several cadherin-mediated cellular behaviors were investigated using small interfering RNA and site-directed mutagenesis. In HT1080 fibrosarcoma cells, small interfering RNA-directed knockdown of N-acetylglucosaminyltransferase V (GnT-V), a glycosyltransferase up-regulated by oncogene signaling, caused decreased expression of N-linked beta(1,6)-branched glycans expressed on N-cadherin, resulting in enhanced N-cadherin-mediated cell-cell adhesion, but had no effect on N-cadherin expression on the cell surface. This effect on adhesion was accompanied by decreased cell migration and invasion, opposite of the effects observed when GnT-V was overexpressed in these cells (Guo, H. B., Lee, I., Kamar, M., and Pierce, M. (2003) J. Biol. Chem. 278, 52412-52424). A detailed study using site-directed mutagenesis demonstrated that three of the eight putative N-glycosylation sites in the N-cadherin sequence showed N-glycan expression. Moreover, all three of these sites, located in the extracellular domains EC2 and EC3, were shown by leucoagglutinating phytohemagglutinin binding to express at least some beta(1,6)-branched glycans, products of GnT-V activity. Deletion of these sites had no effect on cadherin levels on the cell surface but led to increased stabilization of cell-cell contacts, cell-cell adhesion-mediated intracellular signaling, and reduced cell migration. We show for the first time that these deletions had little effect on formation of the N-cadherin-catenin complex but instead resulted in increased N-cadherin cis-dimerization. Branched N-glycan expression at three sites in the EC2 and -3 domains regulates N-cadherin-mediated cell-cell contact formation, outside-in signaling, and cell migration and is probably a significant contributor to the increase in the migratory/invasive phenotype of cancer cells that results when GnT-V activity is up-regulated by oncogene signaling.	[Guo, Hua-Bei; Johnson, Heather; Randolph, Matthew; Pierce, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30605 USA	University System of Georgia; University of Georgia	Guo, HB (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	hbguo@uga.edu; hawkeye@uga.edu			National Institutes of Health, NCI [RO1CA64462]; NATIONAL CANCER INSTITUTE [R01CA064462] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, NCI, Grant RO1CA64462.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BROCKHAUSEN I, 1988, BIOCHEM CELL BIOL, V66, P1134, DOI 10.1139/o88-131; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; CHANEY W, 1989, J CELL BIOL, V109, P2089, DOI 10.1083/jcb.109.5.2089; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Granovsky M, 2000, NAT MED, V6, P306; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hazan RB, 1996, CELL ADHES COMMUN, V4, P399, DOI 10.3109/15419069709004457; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Irby RB, 2002, CANCER RES, V62, P2669; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4; Levenberg S, 1998, CELL ADHES COMMUN, V6, P161, DOI 10.3109/15419069809004473; Levenberg S, 1999, ONCOGENE, V18, P869, DOI 10.1038/sj.onc.1202396; Li G, 2001, CANCER RES, V61, P3819; Li Ke, 2009, Ai Zheng, V28, P8; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Rappl A, 2008, J CELL SCI, V121, P4089, DOI 10.1242/jcs.027995; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; SALOMON D, 1992, J CELL SCI, V102, P7; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Seelentag WKF, 1998, CANCER RES, V58, P5559; Shan WS, 2004, J BIOL CHEM, V279, P55914, DOI 10.1074/jbc.M407827200; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Shan WS, 1999, BIOPHYS CHEM, V82, P157, DOI 10.1016/S0301-4622(99)00115-5; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Yagi T, 2000, GENE DEV, V14, P1169; Yamamoto H, 2000, CANCER RES, V60, P134; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Youn YH, 2006, INVEST OPHTH VIS SCI, V47, P2675, DOI 10.1167/iovs.05-1335; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106; Zhao HB, 2008, ACTA BIOCH BIOPH SIN, V40, P140, DOI 10.1111/j.1745-7270.2008.00380.x	64	64	67	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34986	34997		10.1074/jbc.M109.060806	http://dx.doi.org/10.1074/jbc.M109.060806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846557	Green Published, hybrid			2022-12-27	WOS:000272439600054
J	Li, DQ; Reddy, SDN; Pakala, SB; Wu, XF; Zhang, YP; Rayala, SK; Kumar, R				Li, Da-Qiang; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Wu, Xifeng; Zhang, Yanping; Rayala, Suresh K.; Kumar, Rakesh			MTA1 Coregulator Regulates p53 Stability and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE COP1; METASTASIS-ASSOCIATED PROTEIN-1; SQUAMOUS-CELL CARCINOMA; DNA-DAMAGE; INDIVIDUAL CELLS; GENOTOXIC STRESS; MDM2; APOPTOSIS; EXPRESSION	Although metastasis-associated protein 1 (MTA1) has recently been shown as a DNA damage responsive protein, the underlying mechanism for its role in DNA double-strand break (DSB) repair remains unknown. Here, we show that MTA1 controls p53 stability through inhibiting its ubiquitination by E3 ubiquitin ligases mouse double minute 2 (Mdm2) and constitutive photomorphogenic protein 1 (COP1). The underlying mechanisms involve the ability of MTA1 to compete with COP1 to bind to p53 and/or to destabilize COP1 and Mdm2. Consequently, MTA1 regulates the p53-dependent transcription of p53R2, a direct p53 target gene for supplying nucleotides to repair damaged DNA. Depletion of MTA1 impairs p53-dependent p53R2 transcription and compromises DNA repair. Interestingly, these events could be reversed by MTA1 reintroduction, indicating that MTA1 interjects into the p53-dependent DNA repair. Given the fact that MTA1 is widely up-regulated in human cancers, these findings in conjunction with our earlier finding of a crucial role of MTA1 in DSB repair suggest an inherent role of the MTA1-p53-p53R2 pathway in DNA damage response in cancer cells.	[Li, Da-Qiang; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Rayala, Suresh K.; Kumar, Rakesh] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Li, Da-Qiang; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Rayala, Suresh K.; Kumar, Rakesh] George Washington Univ, Inst Coregulator Biol, Washington, DC 20037 USA; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zhang, Yanping] Univ N Carolina, Radiat Oncol & Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	George Washington University; George Washington University; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Kumar, R (corresponding author), George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010; sirigiri, divijendra reddy/E-1031-2017	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Rayala, Suresh/0000-0003-4394-4450; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA100302, R01CA127770, R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 ( to R. K.).	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Colman MS, 2000, MUTAT RES-REV MUTAT, V462, P179, DOI 10.1016/S1383-5742(00)00035-1; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Li G, 1996, AM J PATHOL, V148, P1113; Li W, 2008, FEBS LETT, V582, P869, DOI 10.1016/j.febslet.2008.02.013; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McMasters KM, 1996, ONCOGENE, V13, P1731; MIYASHITA T, 1995, CELL, V80, P293; Moon HE, 2007, ONCOL REP, V18, P1311; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Qian HL, 2005, CLIN EXP METASTAS, V22, P653, DOI 10.1007/s10585-006-9005-2; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; TOH Y, 1994, J BIOL CHEM, V269, P22958; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yokomakura N, 2007, ONCOL REP, V18, P561; Zurer I, 2004, CARCINOGENESIS, V25, P11, DOI 10.1093/carcin/bgg186	44	40	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34545	34552		10.1074/jbc.M109.056499	http://dx.doi.org/10.1074/jbc.M109.056499			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837670	hybrid, Green Published			2022-12-27	WOS:000272439600009
J	Bradford, HN; Micucci, JA; Krishnaswamy, S				Bradford, Harlan N.; Micucci, Joseph A.; Krishnaswamy, Sriram			Regulated Cleavage of Prothrombin by Prothrombinase REPOSITIONING A CLEAVAGE SITE REVEALS THE UNIQUE KINETIC BEHAVIOR OF THE ACTION OF PROTHROMBINASE ON ITS COMPOUND SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VA HEAVY-CHAIN; FACTOR-XA; MACROMOLECULAR SUBSTRATE; CATALYZED ACTIVATION; EXOSITE BINDING; MEIZOTHROMBIN; COMPLEX; SPECIFICITY; CONFORMATIONS; SELECTIVITY	Prothrombinase converts prothrombin to thrombin via cleavage at Arg(320) followed by cleavage at Arg(271). Exosite-dependent binding of prothrombin to prothrombinase facilitates active site docking by Arg(320) and initial cleavage at this site. Precise positioning of the Arg(320) site for cleavage is implied by essentially normal cleavage at Arg(320) in recombinant prothrombin variants bearing additional Arg side chains either one or two residues away. However, mutation of Arg(320) to Gln reveals that prothrombinase can cleave prothrombin following Arg side chains shifted by as many as two residues N-terminal to the 320 position at near normal rates. Further repositioning leads to a loss in cleavage at this region with an abrupt shift toward slow cleavage at Arg(271). In contrast, the binding constant for the active site docking step is strongly dependent on the sequence preceding the scissile bond as well as position. Large effects on binding only yield minor changes in rate until the binding constant passes a threshold value. This behavior is expected for a substrate that can engage the enzyme through mutually exclusive active site docking reactions followed by cleavage to yield different products. Cleavage site specificity as well as the ordered action of prothrombinase on its compound substrate is regulated by the thermodynamics of active site engagement of the individual sites as well as competition between alternate cleavage sites for active site docking.	[Bradford, Harlan N.; Micucci, Joseph A.; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Joseph Stokes Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	National Institutes of Health [HL-74124, HL-47465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL047465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-74124 and HL-47465 (to S. K.).	Akhavan S, 1999, BRIT J HAEMATOL, V105, P667, DOI 10.1046/j.1365-2141.1999.01423.x; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Boskovic DS, 2004, J BIOL CHEM, V279, P20786, DOI 10.1074/jbc.M400469200; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; Camire R.M., 2006, HEMOSTASIS THROMBOSI, P59; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; Collados MT, 1997, THROMB RES, V85, P465, DOI 10.1016/S0049-3848(97)00036-4; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; EVANS SA, 1982, J BIOL CHEM, V257, P3014; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hsu HJ, 2008, J BIOL CHEM, V283, P12343, DOI 10.1074/jbc.M708843200; Khan AR, 1998, PROTEIN SCI, V7, P815; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; LOTTENBERG R, 1986, BIOCHIM BIOPHYS ACTA, V874, P326, DOI 10.1016/0167-4838(86)90032-4; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lu WP, 2003, ANAL BIOCHEM, V316, P58, DOI 10.1016/S0003-2697(03)00034-4; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; ROSING J, 1988, THROMB HAEMOSTASIS, V60, P355; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; WALKER RK, 1994, J BIOL CHEM, V269, P27441	44	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					328	338		10.1074/jbc.M109.070334	http://dx.doi.org/10.1074/jbc.M109.070334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858193	hybrid, Green Published			2022-12-27	WOS:000273070100034
J	Kimura, J; Abe, H; Kamitani, S; Toshima, H; Fukui, A; Miyake, M; Kamata, Y; Sugita-Konishi, Y; Yamamoto, S; Horiguchi, Y				Kimura, Jun; Abe, Hiroyuki; Kamitani, Shigeki; Toshima, Hirono; Fukui, Aya; Miyake, Masami; Kamata, Yoichi; Sugita-Konishi, Yoshiko; Yamamoto, Shigeki; Horiguchi, Yasuhiko			Clostridium perfringens Enterotoxin Interacts with Claudins via Electrostatic Attraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; TIGHT JUNCTION; MEMBRANE-PROTEINS; BINDING; COMPLEX; REGION; TOXIN; DETERMINANTS; MUTAGENESIS; MODULATION	Clostridium perfringens enterotoxin (CPE), a causative agent of food poisoning, is a pore-forming toxin disrupting the selective permeability of the plasma membrane of target cells, resulting in cell death. We previously identified claudin as the cell surface receptor for CPE. Claudin, a component of tight junctions, is a tetratransmembrane protein and constitutes a large family of more than 20 members, not all of which serve as the receptor for CPE. The mechanism by which the toxin distinguishes the sensitive claudins is unknown. In this study, we localized the region of claudin responsible for interaction with CPE to the C-terminal part of the second extracellular loop and found that the isoelectric point of this region in sensitive claudins was higher than insensitive claudins. Amino acid substitutions to lower the pI resulted in reduced sensitivity to CPE among sensitive claudins, whereas substitutions to raise the pI endowed CPE-insensitive claudins with sensitivity. The steric structure of the claudin-binding domain of CPE reveals an acidic cleft surrounded by Tyr(306), Tyr(310), Tyr(312), and Leu(315), which were reported to be essential for interaction with the sensitive claudins. These results imply that an electrostatic attraction between the basic claudin region and the acidic CPE cleft is involved in their interaction.	[Kimura, Jun; Abe, Hiroyuki; Kamitani, Shigeki; Toshima, Hirono; Fukui, Aya; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Suita, Osaka 5650871, Japan; [Miyake, Masami] Osaka Prefecture Univ, Dept Vet Environm Sci, Lab Vet Publ Hlth, Osaka 5988531, Japan; [Kamata, Yoichi; Sugita-Konishi, Yoshiko] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan; [Yamamoto, Shigeki] Natl Inst Hlth Sci, Div Biomed Food Res, Setagaya Ku, Tokyo 1588501, Japan	Osaka University; Osaka Metropolitan University; National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan	Horiguchi, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	horiguti@biken.osaka-u.ac.jp		Kamitani, Shigeki/0000-0002-1268-4652	Ministry of Education, Culture, Science, and Technology of Japan	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Science, and Technology of Japan.	ALOUF JE, 2006, COMPREHENSIVE SOURCE, P643, DOI DOI 10.1016/B978-012088445-2/50041-X; ALOUF JE, 2006, COMPREHENSIVE SOURCE, P507; Ebihara C, 2007, BIOCHEM PHARMACOL, V73, P824, DOI 10.1016/j.bcp.2006.11.013; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; HANNA PC, 1991, J BIOL CHEM, V266, P11037; HANNA PC, 1992, INFECT IMMUN, V60, P2110, DOI 10.1128/IAI.60.5.2110-2114.1992; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; HORIGUCHI Y, 1985, FEMS MICROBIOL LETT, V28, P131; HORIGUCHI Y, 1987, INFECT IMMUN, V55, P2912, DOI 10.1128/IAI.55.12.2912-2915.1987; Horiguchi Y, 1997, P NATL ACAD SCI USA, V94, P11623, DOI 10.1073/pnas.94.21.11623; Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kokai-Kun JF, 1999, INFECT IMMUN, V67, P5634, DOI 10.1128/IAI.67.11.5634-5641.1999; KokaiKun JF, 1997, INFECT IMMUN, V65, P1014, DOI 10.1128/IAI.65.3.1014-1022.1997; Kominsky Scott L., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000056; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; McClane BA, 2001, TOXICON, V39, P1781, DOI 10.1016/S0041-0101(01)00164-7; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Watanabe R, 1996, J BIOL CHEM, V271, P26868, DOI 10.1074/jbc.271.43.26868; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623	28	46	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					401	408		10.1074/jbc.M109.051417	http://dx.doi.org/10.1074/jbc.M109.051417			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19903817	Green Published, hybrid			2022-12-27	WOS:000273070100042
J	Kobayashi, S; Volden, P; Timm, D; Mao, K; Xu, XM; Liang, QR				Kobayashi, Satoru; Volden, Paul; Timm, Derek; Mao, Kai; Xu, Xianmin; Liang, Qiangrong			Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSGENIC MICE; HEART-FAILURE; CELL-SURVIVAL; IN-VIVO; ADRIAMYCIN CARDIOMYOPATHY; CARDIAC DYSFUNCTION; HEMODYNAMIC STRESS; PATHOGENIC ROLE; APOPTOSIS	Doxorubicin (DOX) is a potent anti-tumor drug known to cause heart failure. The transcription factor GATA4 antagonizes DOX-induced cardiotoxicity. However, the protective mechanism remains obscure. Autophagy is the primary cellular pathway for lysosomal degradation of long-lived proteins and organelles, and its activation could be either protective or detrimental depending on specific pathophysiological conditions. Here we investigated the ability of GATA4 to inhibit autophagy as a potential mechanism underlying its protection against DOX toxicity in cultured neonatal rat cardiomyocytes. DOX markedly increased autophagic flux in cardiomyocytes as indicated by the difference in protein levels of LC3-II (microtubule-associated protein light chain 3 form 2) or numbers of autophagic vacuoles in the absence and presence of the lysosomal inhibitor bafilomycin A1. DOX-induced cardiomyocyte death determined by multiple assays was aggravated by a drug or genetic approach that activates autophagy, but it was attenuated by manipulations that inhibit autophagy, suggesting that autophagy contributes to DOX cardiotoxicity. DOX treatment depleted GATA4 protein levels, which predisposed cardiomyocytes to DOX toxicity. Indeed, GATA4 gene silencing triggered autophagy that rendered DOX more toxic, whereas GATA4 overexpression inhibited DOX-induced autophagy, reducing cardiomyocyte death. Mechanistically, GATA4 up-regulated gene expression of the survival factor Bcl2 and suppressed DOX-induced activation of autophagy-related genes, which may likely be responsible for the anti-apoptotic and anti-autophagic effects of GATA4. Together, these findings suggest that activation of autophagy mediates DOX cardiotoxicity, and preservation of GATA4 attenuates DOX cardiotoxicity by inhibiting autophagy through modulation of the expression of Bcl2 and autophagy-related genes.	[Kobayashi, Satoru; Volden, Paul; Timm, Derek; Mao, Kai; Xu, Xianmin; Liang, Qiangrong] Univ S Dakota, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57105 USA	University of South Dakota	Liang, QR (corresponding author), Univ S Dakota, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57105 USA.	liangq@sanfordhealth.org			National Institutes of Health [2P20RR017662-06A1]; American Heart Association; Juvenile Diabetes Research Foundation; Juvenile Diabetes Research Foundation [1-2007-741]; American Diabetes Association Career Development [1-09-CD-09]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association Career Development(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 2P20RR017662-06A1 (Project 3; National Center for Research Resources (to Q. L.)).; Supported by an American Heart Association postdoctoral fellowship and a Juvenile Diabetes Research Foundation advanced postdoctoral fellowship.; Supported by an American Heart Association predoctoral fellowship.; Supported by Juvenile Diabetes Research Foundation Research Grant 1-2007-741 and American Diabetes Association Career Development Grant 1-09-CD-09.	Agnihotri S, 2009, ONCOGENE, V28, P3033, DOI 10.1038/onc.2009.159; Akazawa H, 2004, J BIOL CHEM, V279, P41095, DOI 10.1074/jbc.M313084200; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dorr RT, 1996, SEMIN ONCOL, V23, P23; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Kaneoka H, 2008, CYTOTECHNOLOGY, V57, P123, DOI 10.1007/s10616-007-9120-1; Kang CH, 2008, AUTOPHAGY, V4, P82, DOI 10.4161/auto.5154; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Kitta K, 2003, J BIOL CHEM, V278, P4705, DOI 10.1074/jbc.M211616200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kumar D, 2001, ANTIOXID REDOX SIGN, V3, P135, DOI 10.1089/152308601750100641; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P841, DOI 10.1016/j.yjmcc.2005.07.019; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; LEGHA SS, 1982, ANN NY ACAD SCI, V393, P411, DOI 10.1111/j.1749-6632.1982.tb31279.x; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; MARCILLAT O, 1989, BIOCHEM J, V259, P181, DOI 10.1042/bj2590181; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; MYERS C, 1983, SEMIN ONCOL, V10, P53; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oliveira PJ, 2006, TOXICOLOGY, V220, P160, DOI 10.1016/j.tox.2005.12.009; Olson RD, 2005, CARDIOVASC TOXICOL, V5, P269, DOI 10.1385/CT:5:3:269; OLSON RD, 1990, FASEB J, V4, P3076, DOI 10.1096/fasebj.4.13.2210154; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Semenov DE, 2001, B EXP BIOL MED+, V131, P505, DOI 10.1023/A:1017956922385; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; SIVESKIILISKOVIC N, 1995, CIRCULATION, V91, P10, DOI 10.1161/01.CIR.91.1.10; Sun XH, 2001, CANCER RES, V61, P3382; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Trainor CD, 2009, BLOOD, V114, P165, DOI 10.1182/blood-2008-10-180489; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yuan JY, 2008, AUTOPHAGY, V4, P249, DOI 10.4161/auto.5438; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	63	196	200	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					793	804		10.1074/jbc.M109.070037	http://dx.doi.org/10.1074/jbc.M109.070037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19901028	Green Published, hybrid			2022-12-27	WOS:000273070100080
J	Malhotra, S; Kovats, S; Zhang, WG; Coggeshall, KM				Malhotra, Shikha; Kovats, Susan; Zhang, Weiguo; Coggeshall, K. Mark			Vav and Rac Activation in B Cell Antigen Receptor Endocytosis Involves Vav Recruitment to the Adapter Protein LAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; INOSITOL PHOSPHATASE SHIP; FC-GAMMA-RIIB; T-CELLS; TYROSINE PHOSPHORYLATION; DIFFERENTIAL REGULATION; SIGNALING PATHWAYS; SH2 DOMAIN; GTPASES; INTERNALIZATION	The signal transduction events supporting B cell antigen receptor (BCR) endocytosis are not well understood. We have identified a pathway supporting BCR internalization that begins with tyrosine phosphorylation of the adapter protein LAB. Phosphorylated LAB recruits a complex of Grb2-dynamin and the guanine nucleotide exchange factor Vav. Vav is required for activation of the small GTPases Rac1 and Rac2. All these proteins contribute to (and dynamin, Vav, and Rac1/2 are required for) BCR endocytosis and presentation of antigen to T cells. This is the first description of a sequential signal transduction pathway from BCR to internalization and antigen presentation.	[Malhotra, Shikha; Coggeshall, K. Mark] Univ Oklahoma, Immunobiol & Canc Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Malhotra, Shikha; Coggeshall, K. Mark] Univ Oklahoma, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Kovats, Susan] Oklahoma Med Res Fdn, Arthritis & Immunol Program, Oklahoma City, OK 73104 USA; [Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; Duke University	Coggeshall, KM (corresponding author), Univ Oklahoma, Immunobiol & Canc Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA.	mark-coggeshall@omrf.ouhsc.edu		Kovats, Susan/0000-0001-5479-9952	NIAID NIH HHS [R01 AI056156] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056156] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Davanture S, 2005, J IMMUNOL, V175, P3140, DOI 10.4049/jimmunol.175.5.3140; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Jacob A, 1999, J BIOL CHEM, V274, P13704, DOI 10.1074/jbc.274.19.13704; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KATZAV S, 1994, J BIOL CHEM, V269, P32579; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Koonpaew S, 2004, J BIOL CHEM, V279, P11229, DOI 10.1074/jbc.M311394200; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; McGee K, 2001, FEBS LETT, V509, P59, DOI 10.1016/S0014-5793(01)03139-8; MIKI H, 1994, J BIOL CHEM, V269, P5489; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Montagnac G, 2005, J IMMUNOL, V174, P5562, DOI 10.4049/jimmunol.174.9.5562; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Mutch CM, 2007, INT IMMUNOL, V19, P19, DOI 10.1093/intimm/dxl118; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang Y, 2005, MOL CELL BIOL, V25, P4455, DOI 10.1128/MCB.25.11.4455-4465.2005; WEBB CF, 1989, J IMMUNOL, V143, P3934; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Yohannan J, 1999, J BIOL CHEM, V274, P18769, DOI 10.1074/jbc.274.26.18769; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943	60	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36202	36212		10.1074/jbc.M109.040089	http://dx.doi.org/10.1074/jbc.M109.040089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858206	hybrid, Green Published			2022-12-27	WOS:000272970500022
J	Liu, MY; Khachigian, LM				Liu, Mary Y.; Khachigian, Levon M.			RETRACTED: Histone Deacetylase-1 Is Enriched at the Platelet-derived Growth Factor-D Promoter in Response to Interleukin-1 beta and Forms a Cytokine-inducible Gene-silencing Complex with NF-kappa B p65 and Interferon Regulatory Factor-1 (Retracted Article. See vol 285, pg 21902, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NECROSIS-FACTOR-ALPHA; CELL-ADHESION MOLECULE-1; SMOOTH-MUSCLE-CELLS; HUMAN ENDOTHELIAL-CELLS; FACTOR-A CHAIN; PDGF-D; DOWN-REGULATION; ANGIOTENSIN-II; CARDIOVASCULAR-DISEASE; TRANSCRIPTION FACTORS	Understanding the mechanisms governing cytokine control of growth factor expression in smooth muscle cells would provide invaluable insight into the molecular regulation of vascular phenotypes and create future opportunities for therapeutic intervention. Here, we report that the proinflammatory cytokine interleukin (IL)-1 beta suppresses platelet-derived growth factor (PDGF)-D promoter activity and mRNA and protein expression in smooth muscle cells. NF-kappa B p65, induced by IL-1 beta, interacts with a novel element in the PDGF-D promoter and inhibits PDGF-D transcription. Interferon regulatory factor-1 (IRF-1) is also induced by IL-1 beta and binds to a different element upstream in the promoter. Immunoprecipitation and chromatin immunoprecipitation experiments showed that IL-1 beta stimulates p65 interaction with IRF-1 and the accumulation of both factors at the PDGF-D promoter. Mutation of the IRF-1 and p65 DNA-binding elements relieved the promoter from IL-1 beta-mediated repression. PDGF-D repression by IL-1 beta involves histone deacetylation and interaction of HDAC-1 with IRF-1 and p65. HDAC-1 small interfering RNA ablates complex formation with IRF-1 and p65 and abrogates IRF-1 and p65 occupancy of the PDGF-D promoter. Thus, HDAC- 1 is enriched at the PDGF-D promoter in cells exposed to IL-1 beta and forms a cytokine-inducible gene-silencing complex with p65 and IRF-1.	[Liu, Mary Y.; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Khachigian, LM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.	L.Khachigian@unsw.edu.au	Khachigian, Levon/AAZ-7458-2020	Khachigian, Levon/0000-0003-3446-0323	National Health and Medical Research Council of Australia; Australian Research Council; National Heart Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia, Australian Research Council, and National Heart Foundation of Australia.	Aizawa K, 2004, J BIOL CHEM, V279, P70, DOI 10.1074/jbc.M306621200; Anwar A, 2002, CIRCULATION, V105, P1220, DOI 10.1161/hc1002.105187; Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Chamberlain J, 1999, CARDIOVASC RES, V44, P156, DOI 10.1016/S0008-6363(99)00175-3; Changsirikulchai S, 2002, KIDNEY INT, V62, P2043, DOI 10.1046/j.1523-1755.2002.00662.x; Chen JZ, 2005, BIOCHEM BIOPH RES CO, V329, P976, DOI 10.1016/j.bbrc.2005.02.062; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Delbridge GJ, 1997, CIRC RES, V81, P282, DOI 10.1161/01.RES.81.2.282; Englesbe MJ, 2004, J VASC SURG, V39, P1091, DOI 10.1016/j.jvs.2004.01.041; Isoda K, 2003, CIRCULATION, V108, P516, DOI 10.1161/01.CIR.0000085567.18648.21; Jiang BB, 2001, ARTERIOSCL THROM VAS, V21, P1915, DOI 10.1161/hq1201.099424; Jung Young D., 2001, Angiogenesis, V4, P155, DOI 10.1023/A:1012291524723; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; Kenagy RD, 2000, J VASC RES, V37, P381, DOI 10.1159/000025754; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; KHACHIGIAN LM, 1995, BIOCHEM BIOPH RES CO, V206, P462, DOI 10.1006/bbrc.1995.1065; KHACHIGIAN LM, 1993, PLATELETS, V4, P304, DOI 10.3109/09537109309013233; LaRochelle WJ, 2002, CANCER RES, V62, P2468; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Li R, 2007, INVEST OPHTH VIS SCI, V48, P5722, DOI 10.1167/iovs.07-0327; Liu MYX, 2006, BLOOD, V107, P2322, DOI 10.1182/blood-2005-06-2377; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Mitchell A, 2004, NUCLEIC ACIDS RES, V32, P3065, DOI 10.1093/nar/gkh626; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Morton AC, 2005, CARDIOVASC RES, V68, P493, DOI 10.1016/j.cardiores.2005.06.026; Mountain DJH, 2008, J CELL PHYSIOL, V215, P337, DOI 10.1002/jcp.21315; Nakano N, 1998, HYPERTENSION, V32, P444, DOI 10.1161/01.HYP.32.3.444; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ponten A, 2005, CIRC RES, V97, P1036, DOI 10.1161/01.RES.0000190590.31545.d4; Rafty LA, 1998, J BIOL CHEM, V273, P5758, DOI 10.1074/jbc.273.10.5758; Raines E.W., 1990, PEPTIDE GROWTH FACTO, DOI [10.1007/978-3-642-49295-2_5, DOI 10.1007/978-3-642-49295-2_5]; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Resnick N, 1997, ADV EXP MED BIOL, V430, P155; Saijonmaa O, 2001, J VASC RES, V38, P370, DOI 10.1159/000051068; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Saura M, 1999, J MOL BIOL, V289, P459, DOI 10.1006/jmbi.1999.2752; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Shi JR, 2004, J CARDIOVASC PHARM, V44, P26; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Sumpio BE, 1998, ARTERIOSCL THROM VAS, V18, P349, DOI 10.1161/01.ATV.18.3.349; Tan NY, 2008, CIRC RES, V102, pE38, DOI 10.1161/CIRCRESAHA.107.167395; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Wang ZW, 2009, CURR DRUG TARGETS, V10, P38, DOI 10.2174/138945009787122914; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Zhang N, 2009, J BIOL CHEM, V284, P27933, DOI 10.1074/jbc.M109.025742	51	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35101	35112		10.1074/jbc.M109.061903	http://dx.doi.org/10.1074/jbc.M109.061903			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19843519	Green Published, hybrid			2022-12-27	WOS:000272439600064
J	Chen, X; Stitt, BL				Chen, Xin; Stitt, Barbara L.			ADP but Not P-i Dissociation Contributes to Rate Limitation for Escherichia coli Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINATION FACTOR-RHO; TRANSCRIPTION TERMINATION; RNA-BINDING; PROTEIN-RHO; OLIGONUCLEOTIDE COFACTORS; CONFORMATIONAL-CHANGES; ATPASE ACTIVATION; HYDROLYTIC SITES; RELEASE; PROTECTION	To define the molecular mechanism by which ATP hydrolysis powers the 5'-> 3' travel of homohexameric Escherichia coli transcription termination factor Rho along RNA, rates for association and dissociation of non-RNA substrates and products were measured. Rapid mix/chemical quench and stopped-flow spectrofluorometry measurements were carried out with Rho and [gamma-P-32] ATP, mantADP, or fluorescently tagged E. coli phosphate-binding protein. The results indicate that the Pi off-rate is not rate limiting, but at similar to 90 s(-1), the ADP dissociation rate is comparable to the 30 s(-1) k(cat). Previous results indicate that the chemistry step of ATP hydrolysis by Rho is at least 10-fold faster than the overall catalytic cycle. The as yet unmeasured RNA dissociation step, which could be associated with a protein conformation change, might also be a rate-limiting factor.	[Stitt, Barbara L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Stitt, BL (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3440 N Broad St, Philadelphia, PA 19140 USA.	stitt@temple.edu			National Institutes of Health [GM60247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60247.	Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Banerjee S, 2006, J MICROBIOL, V44, P11; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; Browne RJ, 2005, J BIOL CHEM, V280, P13300, DOI 10.1074/jbc.M500222200; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; Chen X, 2004, J BIOL CHEM, V279, P16301, DOI 10.1074/jbc.M313640200; CHEN X, 2004, THESIS TEMPLE U; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P564; Jeong YJ, 2004, J BIOL CHEM, V279, P18370, DOI 10.1074/jbc.M309162200; Johnson K. A., 1992, ENZYMES, P1; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; MOTT JE, 1985, P NATL ACAD SCI USA, V82, P88, DOI 10.1073/pnas.82.1.88; NEHRKE KW, 1992, NUCLEIC ACIDS RES, V20, P6107, DOI 10.1093/nar/20.22.6107; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; Penefsky H S, 1979, Methods Enzymol, V56, P527; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Rose I A, 1980, Methods Enzymol, V64, P47; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; STITT BL, 1988, J BIOL CHEM, V263, P11130; Sukal S, 2001, BIOCHEMISTRY-US, V40, P15009, DOI 10.1021/bi015735a; WANG Y, 1993, J BIOL CHEM, V268, P13940; WANG Y, 1993, J BIOL CHEM, V268, P13947; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x	41	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33773	33780		10.1074/jbc.M109.056473	http://dx.doi.org/10.1074/jbc.M109.056473			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837672	hybrid, Green Published			2022-12-27	WOS:000272165200007
J	Fiaux, J; Horst, J; Scior, A; Preissler, S; Koplin, A; Bukau, B; Deuerling, E				Fiaux, Jocelyne; Horst, Janina; Scior, Annika; Preissler, Steffen; Koplin, Ansgar; Bukau, Bernd; Deuerling, Elke			Structural Analysis of the Ribosome-associated Complex (RAC) Reveals an Unusual Hsp70/Hsp40 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETHERED MOLECULAR CHAPERONES; AMIDE HYDROGEN-EXCHANGE; CONFORMATIONAL-CHANGES; MASS-SPECTROMETRY; HSP70 CHAPERONES; J-PROTEIN; MECHANISM; DYNAMICS; ZUOTIN; HSP110	Yeast Zuotin and Ssz are members of the conserved Hsp40 and Hsp70 chaperone families, respectively, but compared with canonical homologs, they atypically form a stable heterodimer termed ribosome-associated complex (RAC). RAC acts as cochaperone for another Hsp70 to assist de novo protein folding. In this study, we identified the molecular basis for the unusual Hsp70/Hsp40 pairing using amide hydrogen exchange (HX) coupled with mass spectrometry and mutational analysis. Association of Ssz with Zuotin strongly decreased the conformational dynamics mainly in the C-terminal domain of Ssz, whereas Zuotin acquired strong conformational stabilization in its N-terminal segment. Deletion of the highly flexible N terminus of Zuotin abolished stable association with Ssz in vitro and caused a phenotype resembling the loss of Ssz function in vivo. Thus, the C-terminal domain of Ssz, the N-terminal extension of Zuotin, and their mutual stabilization are the major structural determinants for RAC assembly. We furthermore found dynamic changes in the J-domain of Zuotin upon complex formation that might be crucial for RAC co-chaperone function. Taken together, we present a novel mechanism for converting Zuotin and Ssz chaperones into a functionally active dimer.	Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Horst, Janina; Scior, Annika; Preissler, Steffen] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Horst, Janina; Scior, Annika; Preissler, Steffen; Koplin, Ansgar; Deuerling, Elke] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Konstanz; University of Konstanz		bukau@zmbh.uni-heidelberg.de; Elke.Deuerling@uni-konstanz.de		Bukau, Bernd/0000-0003-0521-7199; Preissler, Steffen/0000-0001-7936-9836	Konstanz Graduate School Chemical Biology; Interdisciplinary Research Center Proteostasis; Zukunftskolleg; HFSP; DFG [DE-783/3-1, SFB638]	Konstanz Graduate School Chemical Biology; Interdisciplinary Research Center Proteostasis; Zukunftskolleg; HFSP(Human Frontier Science Program); DFG(German Research Foundation (DFG))	This work was supported in part by the Konstanz Graduate School Chemical Biology and the Interdisciplinary Research Center Proteostasis, a fellowship of the Zukunftskolleg (to S.P.), an HFSP fellowship (to J.F.), and DFG Grants DE-783/3-1 (to E.D.) and SFB638 (to B.B.).	Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; GUTHRIE C, 2004, GUIDE YEAST GENETICS; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Kim SY, 2005, EUKARYOT CELL, V4, P82, DOI 10.1128/EC.4.1.82-89.2005; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Rist W, 2005, ANAL BIOCHEM, V342, P160, DOI 10.1016/j.ab.2004.11.043; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	23	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3227	3234		10.1074/jbc.M109.075804	http://dx.doi.org/10.1074/jbc.M109.075804			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920147	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000273829000037
J	Hewitt, SC; Li, Y; Li, LP; Korach, KS				Hewitt, Sylvia C.; Li, Yin; Li, Leping; Korach, Kenneth S.			Estrogen-mediated Regulation of Igf1 Transcription and Uterine Growth Involves Direct Binding of Estrogen Receptor alpha to Estrogen-responsive Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I GENE-TRANSCRIPTION; BREAST-CANCER; CROSS-TALK; SIGNAL TRANSDUCERS; PROLIFERATION; EXPRESSION; STAT5A; PHOSPHORYLATION; ACTIVATOR; UTERUS	Estrogen enables uterine proliferation, which depends on synthesis of the IGF1 growth factor. This proliferation and IGF1 synthesis requires the estrogen receptor (ER), which binds directly to target DNA sequences (estrogen-responsive elements or EREs), or interacts with other transcription factors, such as AP1, to impact transcription. We observe neither uterine growth nor an increase in Igf1 transcript in a mouse with a DNA-binding mutated ER alpha (KIKO), indicating that both Igf1 regulation and uterine proliferation require the DNA binding function of the ER. We identified several potential EREs in the Igf1 gene, and chromatin immunoprecipitation analysis revealed ER alpha binding to these EREs in wild type but not KIKO chromatin. STAT5 is also reported to regulate Igf1; uterine Stat5a transcript is increased by estradiol (E-2), but not in KIKO or alpha ERKO uteri, indicating ER alpha- and ERE-dependent regulation. ER alpha binds to a potential Stat5a ERE. We hypothesize that E2 increases Stat5a transcript through ERE binding; that ER alpha, either alone or together with STAT5, then acts to increase Igf1 transcription; and that the resulting lack of IGF1 impairs KIKO uterine growth. Treatment with exogenous IGF1, alone or in combination with E2, induces proliferation in wild type but not KIKO uteri, indicating that IGF1 replacement does not rescue the KIKO proliferative response. Together, these observations suggest in contrast to previous in vitro studies of IGF-1 regulation involving AP1 motifs that direct ER alpha-DNA interaction is required to increase Igf1 transcription. Additionally, full ER alpha function is needed to mediate other cellular signals of the growth factor for uterine growth.	[Hewitt, Sylvia C.; Li, Yin; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Li, Leping] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hewitt, SC (corresponding author), NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, NIH, 111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	curtiss@niehs.nih.gov	Li, Leping/F-6497-2019; Hewitt, Sylvia/W-8752-2019	Li, Leping/0000-0003-4208-0259; Hewitt, Sylvia/0000-0001-7713-0805; Korach, Kenneth/0000-0002-7765-418X	National Institutes of Health [Z01ES70065, Z01ES101765]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101765, ZIAES070065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01ES70065 (to K. S. K., S. C. H., and Y. L.) and Z01ES101765 (to L. L.).	Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Ahlbory-Dieker DL, 2009, MOL ENDOCRINOL, V23, P1544, DOI 10.1210/me.2009-0045; Bjornstrom L, 2001, J MOL ENDOCRINOL, V27, P93, DOI 10.1677/jme.0.0270093; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Cao JS, 2004, ENDOCRINOLOGY, V145, P1739, DOI 10.1210/en.2003-0752; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; Faulds MH, 2001, MOL ENDOCRINOL, V15, P1929, DOI 10.1210/me.15.11.1929; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hewitt SC, 2006, ENDOCRINOLOGY, V147, P2203, DOI 10.1210/en.2005-1292; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2009, MOL ENDOCRINOL, V23, P2111, DOI 10.1210/me.2009-0356; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Jin VX, 2004, NUCLEIC ACIDS RES, V32, P6627, DOI 10.1093/nar/gkh1005; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Kajimoto Y, 1998, ENDOCR J, V45, P1, DOI 10.1507/endocrj.45.1; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Klotz DM, 2000, ENDOCRINOLOGY, V141, P3430, DOI 10.1210/en.141.9.3430; LAHOOTI H, 1994, MOL ENDOCRINOL, V8, P182, DOI 10.1210/me.8.2.182; LEROITH D, 1991, MOL CELL ENDOCRINOL, V77, pC57, DOI 10.1016/0303-7207(91)90054-V; Li LP, 2009, J COMPUT BIOL, V16, P317, DOI 10.1089/cmb.2008.16TT; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Moyano P, 2004, GROWTH HORM IGF RES, V14, P431, DOI 10.1016/j.ghir.2004.09.001; MURPHY LJ, 1987, MOL ENDOCRINOL, V1, P445, DOI 10.1210/mend-1-7-445; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajkumar K, 1996, ENDOCRINOLOGY, V137, P1258, DOI 10.1210/en.137.4.1258; Ray S, 2008, MOL ENDOCRINOL, V22, P1125, DOI 10.1210/me.2007-0445; Richards RG, 1996, P NATL ACAD SCI USA, V93, P12002, DOI 10.1073/pnas.93.21.12002; Rudnik V, 2008, J CELL BIOCHEM, V103, P896, DOI 10.1002/jcb.21459; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Santos SJ, 2008, ENDOCRINOLOGY, V149, P329, DOI 10.1210/en.2007-0594; Sato T, 2002, ENDOCRINOLOGY, V143, P2673, DOI 10.1210/en.143.7.2673; Shao WL, 2004, BREAST CANCER RES, V6, P39, DOI 10.1186/bcr742; Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001; Silva CM, 2007, MOL ENDOCRINOL, V21, P1499, DOI 10.1210/me.2007-0109; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Wang Y, 2004, FEBS LETT, V572, P238, DOI 10.1016/j.febslet.2004.06.098; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	46	93	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2676	2685		10.1074/jbc.M109.043471	http://dx.doi.org/10.1074/jbc.M109.043471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920132	Green Published, hybrid			2022-12-27	WOS:000273697800046
J	Tokhunts, R; Singh, S; Chu, TY; D'Angelo, G; Baubet, V; Goetz, JA; Huang, Z; Yuan, ZQ; Ascano, M; Zavros, Y; Therond, PP; Kunes, S; Dahmane, N; Robbins, DJ				Tokhunts, Robert; Singh, Samer; Chu, Tehyen; D'Angelo, Gisela; Baubet, Valerie; Goetz, John A.; Huang, Zhen; Yuan, Ziqiang; Ascano, Manuel; Zavros, Yana; Therond, Pascal P.; Kunes, Sam; Dahmane, Nadia; Robbins, David J.			The Full-length Unprocessed Hedgehog Protein Is an Active Signaling Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; LONG-RANGE; CHOLESTEROL MODIFICATION; DROSOPHILA EYE; GENE HEDGEHOG; TOUT-VELU; MUTATIONS; CLEAVAGE; PRODUCT; CELLS	The hedgehog (HH) family of ligands plays an important instructional role in metazoan development. HH proteins are initially produced as similar to 45-kDa full-length proteins, which undergo an intramolecular cleavage to generate an amino-terminal product that subsequently becomes cholesterol-modified (HH-Np). It is well accepted that this cholesterol-modified amino-terminal cleavage product is responsible for all HH-dependent signaling events. Contrary to this model we show here that full-length forms of HH proteins are able to traffic to the plasma membrane and participate directly in cell-cell signaling, both in vitro and in vivo. We were also able to rescue a Drosophila eye-specific hh loss of function phenotype by expressing a full-length form of hh that cannot be processed into HH-Np. These results suggest that in some physiological contexts full-length HH proteins may participate directly in HH signaling and that this novel activity of full-length HH may be evolutionarily conserved.	[Tokhunts, Robert; Singh, Samer; Goetz, John A.; Huang, Zhen; Yuan, Ziqiang; Ascano, Manuel; Robbins, David J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Robbins, David J.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Chu, Tehyen; Kunes, Sam] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Baubet, Valerie; Dahmane, Nadia] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Zavros, Yana] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [D'Angelo, Gisela; Therond, Pascal P.] Univ Nice Sophia Antipolis, Inst Signaling Dev Biol & Canc Res, CNRS, Ctr Biochim,UMR 6543, F-06108 Nice 02, France	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Harvard University; The Wistar Institute; University System of Ohio; University of Cincinnati; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Robbins, DJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	David.J.Robbins@Dartmouth.edu	Ascano, Manuel/ABA-3586-2020; Therond, pascal/AAE-4811-2019; Singh, Samer/H-8468-2013	Ascano, Manuel/0000-0002-9370-5493; Singh, Samer/0000-0002-0921-1686; D'ANGELO, Gisela/0000-0003-3150-2241	National Institutes of Health [GM64011]; American Lung Association/LUNGevity Foundation; Graduate Assistance in Areas of National Need; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064011, R56GM064011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association/LUNGevity Foundation; Graduate Assistance in Areas of National Need; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM64011 (to D. J. R.). This work was also supported by an award from the American Lung Association/LUNGevity Foundation (to D. J. R.) and a Graduate Assistance in Areas of National Need (GAANN) predoctoral fellowship in nanomedicine (to R. T.).	Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chu TY, 2006, DEV CELL, V10, P635, DOI 10.1016/j.devcel.2006.03.003; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; El-Zaatari M, 2009, CURR OPIN ENDOCRINOL, V16, P60, DOI 10.1097/MED.0b013e328320a821; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Hehr U, 2004, EUR J PEDIATR, V163, P347, DOI 10.1007/s00431-004-1459-0; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1995, CURR BIOL, V5, P432, DOI 10.1016/S0960-9822(95)00084-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Scott WJ, 2005, REPROD TOXICOL, V19, P479, DOI 10.1016/j.reprotox.2004.11.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Zavros Y, 2008, AM J PHYSIOL-GASTR L, V295, pG99, DOI 10.1152/ajpgi.00389.2007; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	36	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2562	2568		10.1074/jbc.M109.078626	http://dx.doi.org/10.1074/jbc.M109.078626			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920144	Green Published, hybrid			2022-12-27	WOS:000273697800035
J	Bommer, GT; Feng, Y; Iura, A; Giordano, TJ; Kuick, R; Kadikoy, H; Sikorski, D; Wu, R; Cho, KR; Fearon, ER				Bommer, Guido T.; Feng, Ying; Iura, Ayaka; Giordano, Thomas J.; Kuick, Rork; Kadikoy, Hueseyin; Sikorski, Deanna; Wu, Rong; Cho, Kathleen R.; Fearon, Eric R.			IRS1 Regulation by Wnt/beta-Catenin Signaling and Varied Contribution of IRS1 to the Neoplastic Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; COLORECTAL-CANCER CELLS; BETA-CATENIN; C-MYC; NUCLEAR TRANSLOCATION; GENE-EXPRESSION; INSULIN-RECEPTOR-SUBSTRATE-1 IRS-1; TUMOR-SUPPRESSOR; BINDING-SITES; COLON-CANCER	Dysregulation of beta-catenin levels and localization and constitutive activation of beta-catenin/TCF (T cell factor)-regulated gene expression occur in many cancers, including the majority of colorectal carcinomas and a subset of ovarian endometrioid adenocarcinomas. Based on the results of microarray-based gene expression profiling we found the insulin receptor substrate 1 (IRS1) gene as one of the most highly up-regulated genes upon ectopic expression of a mutant, constitutively active form of beta-catenin in the rat kidney epithelial cell line RK3E. We demonstrate expression of IRS1 can be directly activated by beta-catenin, likely in part via beta-catenin/TCF binding to TCF consensus binding elements located in the first intron and downstream of the IRS1 transcriptional start site. Consistent with the proposal that beta-catenin is an important regulator of IRS1 expression in vivo, we observed that IRS1 is highly expressed in many cancers with constitutive stabilization of beta-catenin, such as colorectal carcinomas and ovarian endometrioid adenocarcinomas. Using a short hairpin RNA approach to abrogate IRS1 expression and function, we found that IRS1 function is required for efficient de novo neoplastic transformation by beta-catenin in RK3E cells. Our findings add to the growing body of data implicating IRS1 as a critical signaling component in cancer development and progression.	[Fearon, Eric R.] Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Iura, Ayaka; Giordano, Thomas J.; Wu, Rong; Cho, Kathleen R.; Fearon, Eric R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Giordano, Thomas J.; Kuick, Rork; Cho, Kathleen R.; Fearon, Eric R.] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fearon, ER (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, 109 Zina Pitcher Pl,1504 BSRB, Ann Arbor, MI 48109 USA.	fearon@umich.edu	Bommer, Guido/A-8425-2011	Bommer, Guido/0000-0001-6898-4884; Cho, Kathleen/0000-0003-0500-9998; Giordano, Thomas/0000-0003-0641-8873; Saito, Ayaka/0000-0002-9916-0463	National Institutes of Health [CA085463, CA094172, RO1CA94172, CA046592]; Region Bruxelles-Capitale [IRSIB BB2B 2008-1-01]; NATIONAL CANCER INSTITUTE [R01CA094172, R01CA085463, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region Bruxelles-Capitale; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA085463 (to E. R. F.), CA094172 and RO1CA94172 (to K. R. C.), and CA046592 (to the University of Michigan Comprehensive Cancer Center core facility support), and the Region Bruxelles-Capitale Grant IRSIB BB2B 2008-1-01 (to G. T. B.).	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Chang Q, 2002, CANCER RES, V62, P6035; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cristofanelli B, 2000, ONCOGENE, V19, P3245, DOI 10.1038/sj.onc.1203664; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; DAMBROSIO C, 1995, CELL GROWTH DIFFER, V6, P557; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Drakas R, 2004, P NATL ACAD SCI USA, V101, P9272, DOI 10.1073/pnas.0403328101; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Feng Y, 2003, CANCER RES, V63, P8726; Feng Y, 2007, CANCER RES, V67, P482, DOI 10.1158/0008-5472.CAN-06-2314; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Hassan AB, 2000, CANCER RES, V60, P1070; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Herbst A, 2009, GASTROENTEROLOGY, V137, P639, DOI 10.1053/j.gastro.2009.04.049; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kolligs FT, 2000, GENE DEV, V14, P1319; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Louro ID, 2002, CANCER RES, V62, P5867; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prisco M, 2002, J BIOL CHEM, V277, P32078, DOI 10.1074/jbc.M204658200; Prokunina-Olsson L, 2009, HUM MOL GENET, V18, P3795, DOI 10.1093/hmg/ddp321; Ramocki NM, 2008, ENDOCRINOLOGY, V149, P261, DOI 10.1210/en.2007-0869; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Shi B, 2006, J CELL PHYSIOL, V207, P706, DOI 10.1002/jcp.20613; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P1206; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Sun HZ, 2008, J CELL PHYSIOL, V215, P725, DOI 10.1002/jcp.21352; Surmacz E, 1995, CLIN CANCER RES, V1, P1429; Tanaka S, 1996, J CLIN INVEST, V98, P2100, DOI 10.1172/JCI119016; Tanaka S, 1996, CANCER RES, V56, P3391; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tseng YH, 2002, J BIOL CHEM, V277, P31601, DOI 10.1074/jbc.M202932200; Tu X, 2003, HORM METAB RES, V35, P734; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Wu A, 2003, J CELL PHYSIOL, V195, P453, DOI 10.1002/jcp.10261; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08	56	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1928	1938		10.1074/jbc.M109.060319	http://dx.doi.org/10.1074/jbc.M109.060319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19843521	hybrid, Green Published			2022-12-27	WOS:000273429100039
J	Edwin, F; Anderson, K; Patel, TB				Edwin, Francis; Anderson, Kimberly; Patel, Tarun B.			HECT Domain-containing E3 Ubiquitin Ligase Nedd4 Interacts with and Ubiquitinates Sprouty2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR STIMULATION; TUMOR-SUPPRESSOR PTEN; WW DOMAIN; C-TERMINUS; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; GENE-EXPRESSION; B-RAF; GROWTH; INHIBITION	Sprouty (Spry) proteins are important regulators of receptor tyrosine kinase signaling in development and disease. Alterations in cellular Spry content have been associated with certain forms of cancers and also in cardiovascular diseases. Thus, understanding the mechanisms that regulate cellular Spry levels are important. Herein, we demonstrate that Spry1 and Spry2, but not Spry3 or Spry4, associate with the HECT domain family E3 ubiquitin ligase, Nedd4. The Spry2/Nedd4 association involves the WW domains of Nedd4 and requires phosphorylation of the Mnk2 kinase sites, Ser(112) and Ser(121), on Spry2. The phospho-Ser(112/121) region on Spry2 that binds WW domains of Nedd4 is a novel non-canonical WW domain binding region that does not contain Pro residues after phospho-Ser. Endogenous and overexpressed Nedd4 polyubiquitinate Spry2 via Lys(48) on ubiquitin and decrease its stability. Silencing of endogenous Nedd4 increased the cellular Spry2 content and attenuated fibroblast growth factor-elicited ERK1/2 activation that was reversed when elevations in Spry2 levels were prevented by Spry2-specific small interfering RNA. Mnk2 silencing decreased Spry2-Nedd4 interactions and also augmented the ability of Spry2 to inhibit fibroblast growth factor signaling. This is the first report demonstrating the regulation of cellular Spry content and its ability to modulate receptor tyrosine kinase signaling by a HECT domain-containing E3 ubiquitin ligase.	[Edwin, Francis; Anderson, Kimberly; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM 073181]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 073181.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Ahn Y, 2008, BIOCHEM J, V412, P331, DOI 10.1042/BJ20071403; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Brady SC, 2009, CANCER RES, V69, P6773, DOI 10.1158/0008-5472.CAN-08-4447; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chrestensen CA, 2007, GENES CELLS, V12, P1133, DOI 10.1111/j.1365-2443.2007.01122.x; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guo CS, 2008, CELL SIGNAL, V20, P1471, DOI 10.1016/j.cellsig.2008.04.001; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Laziz I, 2007, GROWTH FACTORS, V25, P151, DOI 10.1080/08977190701723166; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lin W, 2002, MECH DEVELOP, V113, P163, DOI 10.1016/S0925-4773(02)00018-7; Lito P, 2009, J BIOL CHEM, V284, P848, DOI 10.1074/jbc.M808045200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Minowada G, 1999, DEVELOPMENT, V126, P4465; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Sweet SMM, 2008, ANAL CHEM, V80, P6650, DOI 10.1021/ac800963a; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Weston AD, 2000, MECH DEVELOP, V94, P247, DOI 10.1016/S0925-4773(00)00299-9; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	64	35	35	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					255	264		10.1074/jbc.M109.030882	http://dx.doi.org/10.1074/jbc.M109.030882			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864419	Green Published, hybrid			2022-12-27	WOS:000273070100027
J	Maddodi, N; Bhat, KMR; Devi, S; Zhang, SC; Setaluri, V				Maddodi, Nityanand; Bhat, Kumar M. R.; Devi, Sulochana; Zhang, Su-Chun; Setaluri, Vijayasaradhi			Oncogenic BRAF(V600E) Induces Expression of Neuronal Differentiation Marker MAP2 in Melanoma Cells by Promoter Demethylation and Down-regulation of Transcription Repressor HES1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; EPIGENETIC REGULATION; GROWTH-FACTOR; B-RAF; NOTCH; GENE; BRAF; ACTIVATION; PATHWAY; TUMORS	MAP2 is a neuron-specific microtubule-associated protein that binds and stabilizes dendritic microtubules. Previously, we showed that MAP2 expression is (a) activated in cutaneous primary melanoma and (b) inversely associated with melanoma tumor progression. We also showed that ectopic expression of MAP2 in metastatic melanoma cells inhibits cell growth by inducing mitotic spindle defects and apoptosis. However, molecular mechanisms of regulation of MAP2 gene expression in melanoma are not understood. Here, we show that in melanoma cells MAP2 expression is induced by the demethylating agent 5-aza-2'-cytidine, and MAP2 promoter is progressively methylated during melanoma progression, indicating that epigenetic mechanisms are involved in silencing of MAP2 in melanoma. In support of this, methylation of MAP2 promoter DNA in vitro inhibits its activity. Because MAP2 promoter activity levels in melanoma cell lines also correlated with activating mutation in BRAF, a gene that is highly expressed in neurons, we hypothesized that BRAF signaling is involved in MAP2 expression. We show that hyperactivation of BRAF-MEK signaling activates MAP2 expression in melanoma cells by two independent mechanisms, promoter demethylation or down-regulation of neuronal transcription repressor HES1. Our data suggest that BRAF oncogene levels can regulate melanoma neuronal differentiation and tumor progression.	[Maddodi, Nityanand; Bhat, Kumar M. R.; Devi, Sulochana; Setaluri, Vijayasaradhi] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Setaluri, V (corresponding author), 1300 Univ Ave,B25, Madison, WI 53706 USA.	setaluri@wisc.edu	Bhat, Kumar/AAD-8831-2019	Bhat, Kumar/0000-0003-1805-3453	National Institutes of Health [R21CA125091, R01NS045926]; Wisconsin Alumni Research Foundation; NATIONAL CANCER INSTITUTE [R21CA125091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Alumni Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21CA125091 (to V.S.) and R01NS045926 ( to S.-C. Z.). This work was also supported by the Wisconsin Alumni Research Foundation.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; Bhat KMR, 2006, NUCLEIC ACIDS RES, V34, P3819, DOI 10.1093/nar/gkl476; Busam KJ, 2005, ADV ANAT PATHOL, V12, P92, DOI 10.1097/01.pap.0000155071.86944.a6; Checchi PM, 2003, TRENDS PHARMACOL SCI, V24, P361, DOI 10.1016/S0165-6147(03)00161-5; Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442; Dai ZY, 2004, ONCOGENE, V23, P3521, DOI 10.1038/sj.onc.1207441; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DHILLON AP, 1982, HISTOPATHOLOGY, V6, P81, DOI 10.1111/j.1365-2559.1982.tb02704.x; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; Fang D, 2001, AM J PATHOL, V158, P2107, DOI 10.1016/S0002-9440(10)64682-2; Frebel K, 2007, NEURODEGENER DIS, V4, P261, DOI 10.1159/000101850; GABBARA S, 1995, BIOCHEM J, V307, P87, DOI 10.1042/bj3070087; GOOVAERTS G, 1988, AM J DERMATOPATH, V10, P20, DOI 10.1097/00000372-198802000-00003; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hinselwood DC, 2005, ELECTROPHORESIS, V26, P2553, DOI 10.1002/elps.200410427; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; HORRIGAN E, 2006, SURGERY, V24, P5; Howell PM, 2009, CANCER CONTROL, V16, P200, DOI 10.1177/107327480901600302; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Jang H, 2007, J BIOL CHEM, V282, P11172, DOI 10.1074/jbc.M611199200; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kalcheva N, 1998, CELL MOTIL CYTOSKEL, V40, P272, DOI 10.1002/(SICI)1097-0169(1998)40:3<272::AID-CM6>3.0.CO;2-F; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Khare VK, 1998, J CUTAN PATHOL, V25, P2, DOI 10.1111/j.1600-0560.1998.tb01682.x; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Laggner U, 2007, HISTOPATHOLOGY, V50, P949, DOI 10.1111/j.1365-2559.2007.02696.x; LammerdingKoppel M, 1997, J CUTAN PATHOL, V24, P137, DOI 10.1111/j.1600-0560.1997.tb01567.x; LEE HJ, 1991, BRAIN RES, V558, P197, DOI 10.1016/0006-8993(91)90769-R; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nguyen HL, 1997, J CELL SCI, V110, P281; Nickoloff BJ, 2005, J INVEST DERM SYMP P, V10, P95, DOI 10.1111/j.1087-0024.2005.200404.x; Prieto VG, 1997, J CUTAN PATHOL, V24, P145, DOI 10.1111/j.1600-0560.1997.tb01568.x; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Reed JA, 1999, AM J PATHOL, V155, P549, DOI 10.1016/S0002-9440(10)65150-4; Satyamoorthy K, 2003, CANCER RES, V63, P756; Schinstine M, 1997, EXP NEUROL, V144, P315, DOI 10.1006/exnr.1996.6370; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; SMITH TW, 1993, CLIN NEUROPATHOL, V12, P335; Soltani MH, 2005, AM J PATHOL, V166, P1841, DOI 10.1016/S0002-9440(10)62493-5; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; STORM SM, 1990, ONCOGENE, V5, P345; Tanami H, 2004, ONCOGENE, V23, P8796, DOI 10.1038/sj.onc.1208152; Vater I, 2009, BRIT J HAEMATOL, V144, P317, DOI 10.1111/j.1365-2141.2008.07443.x; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Zhiqi S, 2004, MELANOMA RES, V14, P509, DOI 10.1097/00008390-200412000-00011	64	31	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					242	254		10.1074/jbc.M109.068668	http://dx.doi.org/10.1074/jbc.M109.068668			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880519	Green Published, hybrid			2022-12-27	WOS:000273070100026
J	Bruske, EI; Sendfeld, F; Schneider, A				Bruske, Ellen Inga; Sendfeld, Franziska; Schneider, Andre			Thiolated tRNAs of Trypanosoma brucei Are Imported into Mitochondria and Dethiolated after Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC TRANSFER-RNA; THIO-MODIFICATION; ANTICODON; SYSTEM; CODON; EUKARYOTES; BIOGENESIS; EXPRESSION; REQUIRES; BASE	All mitochondrial tRNAs in Trypanosoma brucei derive from cytosolic tRNAs that are in part imported into mitochondria. Some trypanosomal tRNAs are thiolated in a compartment-specific manner. We have identified three proteins required for the thio modification of cytosolic tRNA(Gln), tRNA(Glu), and tRNA(Lys). RNA interference-mediated ablation of these proteins results in the cytosolic accumulation non-thio-modified tRNAs but does not increase their import. Moreover, in vitro import experiments showed that both thio-modified and non-thio-modified tRNA(Glu) can efficiently be imported into mitochondria. These results indicate that unlike previously suggested the cytosol-specific thio modifications do not function as antideterminants for mitochondrial tRNA import. Consistent with these results we showed by using inducible expression of a tagged tRNA(Glu) that it is mainly the thiolated form that is imported in vivo. Unexpectedly, the imported tRNA becomes dethiolated after import, which explains why the non-thiolated form is enriched in mitochondria. Finally, we have identified two genes required for thiolation of imported tRNA(Trp) whose wobble nucleotide is subject to mitochondrial C to U editing. Interestingly, down-regulation of thiolation resulted in an increase of edited tRNA(Trp) but did not affect growth.	[Bruske, Ellen Inga; Sendfeld, Franziska; Schneider, Andre] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@ibc.unibe.ch			Swiss National Foundation [3100A0_121937]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Grant 3100A0_121937 (to A. S.) from the Swiss National Foundation.	Adhya S, 2008, INT J BIOCHEM CELL B, V40, P2681, DOI 10.1016/j.biocel.2007.10.025; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Esseiva AC, 2004, MOL BIOL CELL, V15, P2750, DOI 10.1091/mbc.E03-11-0821; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; HAUSER R, 1995, EMBO J, V14, P4212, DOI 10.1002/j.1460-2075.1995.tb00095.x; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; IGLOI GL, 1987, METHOD ENZYMOL, V155, P433; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kapushoc ST, 2000, J BIOL CHEM, V275, P37907, DOI 10.1074/jbc.M007838200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Paris Z, 2009, RNA, V15, P1398, DOI 10.1261/rna.1589109; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; SCHNEIDER A, 1994, NUCLEIC ACIDS RES, V22, P3699, DOI 10.1093/nar/22.18.3699; Schneider A, 1996, NUCLEIC ACIDS RES, V24, P1225, DOI 10.1093/nar/24.7.1225; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Vinogradova E, 2009, NUCLEIC ACIDS RES, V37, P1521, DOI 10.1093/nar/gkn1073; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wohlgamuth-Benedum JM, 2009, J BIOL CHEM, V284, P23947, DOI 10.1074/jbc.M109.029421; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794	44	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36491	36499		10.1074/jbc.M109.064527	http://dx.doi.org/10.1074/jbc.M109.064527			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19875444	hybrid, Green Published			2022-12-27	WOS:000272970500051
J	Charron, CE; Chou, PC; Coutts, DJC; Kumar, V; To, M; Akashi, K; Pinhu, L; Griffiths, M; Adcock, IM; Barnes, PJ; Ito, K				Charron, Catherine E.; Chou, Pai-Chien; Coutts, David J. C.; Kumar, Vaibhav; To, Masako; Akashi, Kenichi; Pinhu, Liao; Griffiths, Mark; Adcock, Ian M.; Barnes, Peter J.; Ito, Kazuhiro			Hypoxia-inducible Factor 1 alpha Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; RHEUMATOID-ARTHRITIS; PROTEIN; EXPRESSION; CELLS; ACETYLATION; HIF-1-ALPHA; MACROPHAGES; COMPLEX	Corticosteroids are potent anti-inflammatory agents, but corticosteroid insensitivity is a major barrier for the treatment of some chronic inflammatory diseases. Here, we show that hypoxia induces corticosteroid-insensitive inflammation via reduced transcription of histone deacetylase-2 (HDAC2) in lung epithelial and macrophage cells. HDAC2 mRNA and protein expression was reduced under hypoxic conditions (1% O-2). Hypoxia enhanced interleukin-1 beta-induced interleukin-8 (CXCL8) production in A549 cells and decreased the ability of dexamethasone to suppress the CXCL8 production. Deletion or point mutation studies revealed that binding of the transcription factor hypoxia-inducible factor (HIF) 1 alpha to a HIF response element at position -320, but not HIF-1 beta or HIF-2 alpha, results in reduced polymerase II binding at the site, leading to reduced promoter activity of HDAC2. Our results suggest that activation of HIF-1 alpha by hypoxia decreases HDAC2 levels, resulting in amplified inflammation and corticosteroid resistance.	[Charron, Catherine E.; Chou, Pai-Chien; Coutts, David J. C.; Kumar, Vaibhav; To, Masako; Akashi, Kenichi; Adcock, Ian M.; Barnes, Peter J.; Ito, Kazuhiro] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Airway Dis, London SW3 6LY, England; [Pinhu, Liao; Griffiths, Mark] Imperial Coll Royal Brompton Hosp Campus, Crit Care Unit, London SW3 6LY, England; [Chou, Pai-Chien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Thorac Med, Taipei 10507, Taiwan	Imperial College London; Imperial College London; Royal Brompton Hospital; Chang Gung Memorial Hospital; Chang Gung University	Charron, CE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Airway Dis, London SW3 6LY, England.	c.charron@imperial.ac.uk	Ito, Kazuhiro/AAF-5994-2019; Adcock, Ian/L-3217-2019; To, Masako/V-4051-2019; Akashi, Kenichi/AAY-6923-2021; Kumar, Vaibhav/ABG-5515-2020	Kumar, Vaibhav/0000-0002-5594-9497; Barnes, Peter/0000-0002-5122-4018; Adcock, Ian/0000-0003-2101-8843; Akashi, Kenichi/0000-0002-3867-0769; Griffiths, Mark/0000-0002-1615-1896	Wellcome Trust [076472/Z/05/Z]; Medical Research Council [G0401662]; MRC [G0401662] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 076472/Z/05/Z and Medical Research Council Grant G0401662.	Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Brindicci C, 2005, EUR RESPIR J, V26, P52, DOI 10.1183/09031936.04.00125304; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kim JH, 2001, COMPOS INTERFACE, V7, P443, DOI 10.1163/156855400750262932; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Lee K, 2007, PHARMACOL THERAPEUT, V113, P229, DOI 10.1016/j.pharmthera.2006.08.001; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Nagy G, 2008, IMMUNOL LETT, V118, P55, DOI 10.1016/j.imlet.2008.02.009; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wyrwicz LS, 2007, ACTA BIOCHIM POL, V54, P89, DOI 10.18388/abp.2007_3273	30	39	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36047	36054		10.1074/jbc.M109.025387	http://dx.doi.org/10.1074/jbc.M109.025387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19880520	Green Published, hybrid			2022-12-27	WOS:000272970500006
J	Lechauve, C; Bouzhir-Sima, L; Yamashita, T; Marden, MC; Vos, MH; Lieb, U; Kiger, L				Lechauve, Christophe; Bouzhir-Sima, Latifa; Yamashita, Taku; Marden, Michael C.; Vos, Marten H.; Lieb, Ursula; Kiger, Laurent			Heme Ligand Binding Properties and Intradimer Interactions in the Full-length Sensor Protein Dos from Escherichia coli and Its Isolated Heme Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT OXYGEN SENSOR; REGULATED PHOSPHODIESTERASE; EC DOS; RESONANCE RAMAN; PAS DOMAIN; BRADYRHIZOBIUM-JAPONICUM; CRYSTAL-STRUCTURE; DISTAL SIDE; CATALYSIS; MUTANTS	Dos from Escherichia coli is a bacterial gas sensor protein comprising a heme-containing gas sensor domain and a phosphodiesterase catalytic domain. Using a combination of static light scattering and gel filtration experiments, we established that, as are many other sensor proteins, the full-length protein is dimeric. The full-length dimer (association constant < 10 nM) is more stable than the dimeric heme domain (association constant similar to 1 mu M), and the dimer interface presumably includes both sensor and catalytic domains. Ultrafast spectroscopic studies showed little influence of the catalytic domain on kinetic processes in the direct vicinity of the heme. By contrast, the properties of ligand (CO and O-2) binding to the heme in the sensor domain, occurring on a microsecond to second time scale, were found to be influenced by (i) the presence of the catalytic domain, (ii) the dimerization state, and in dimers, (iii) the ligation state of the other subunit. These results imply allosteric interactions within dimers. Steady-state titrations demonstrated marked cooperativity in oxygen binding to both the full-length protein and the isolated heme domain, a feature not reported to date for any dimeric sensor protein. Analysis of a variety of time-resolved experiments showed that Met-95 plays a major role in the intradimer interactions. The intrinsic binding and dissociation rates of Met-95 to the heme were modulated similar to 10-fold by intradimer and sensor-catalytic domain interactions. Dimerization effects were also observed for cyanide binding to the ferric heme domains, suggesting a similar role for Met-95 in ferric proteins.	[Bouzhir-Sima, Latifa; Yamashita, Taku; Vos, Marten H.; Lieb, Ursula] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Lechauve, Christophe; Marden, Michael C.; Kiger, Laurent] Univ Paris 06, INSERM, U779, F-94276 Le Kremlin Bicetre, France; [Lechauve, Christophe; Marden, Michael C.; Kiger, Laurent] Univ Paris 11, INSERM, U779, F-94276 Le Kremlin Bicetre, France; [Bouzhir-Sima, Latifa; Yamashita, Taku; Vos, Marten H.; Lieb, Ursula] INSERM, U696, F-91228 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vos, MH (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France.	marten.vos@polytechnique.edu; Laurent.Kiger@inserm.fr	Marden, Michael C/G-3139-2012; Lechauve, Christophe/AAH-8873-2019; Kiger, Laurent/Q-1686-2018; Marden, Michael/AAA-5923-2020	Marden, Michael C/0000-0002-5254-6385; Vos, Marten/0000-0003-0493-4831; LIEBL, Ursula/0000-0003-0869-4388	INSERM; De legation Generale pour l'Armement (DGA) [07.34.004]; Universites Paris VI et XI	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); De legation Generale pour l'Armement (DGA); Universites Paris VI et XI	This work was supported by INSERM, De legation Generale pour l'Armement (DGA) Contract 07.34.004, and Universites Paris VI et XI.	Ayers RA, 2008, BIOCHEMISTRY-US, V47, P12078, DOI 10.1021/bi801254c; Balland V, 2005, J BIOL CHEM, V280, P15279, DOI 10.1074/jbc.M413928200; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Cusanovich MA, 2003, BIOCHEMISTRY-US, V42, P4759, DOI 10.1021/bi020690e; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; El-Mashtoly SF, 2008, J BIOL CHEM, V283, P19000, DOI 10.1074/jbc.M801262200; El-Mashtoly SF, 2007, J AM CHEM SOC, V129, P3556, DOI 10.1021/ja0669777; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gonzalez G, 2002, BIOCHEMISTRY-US, V41, P8414, DOI 10.1021/bi025845x; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hirata S, 2003, EUR J BIOCHEM, V270, P4771, DOI 10.1046/j.1432-1033.2003.03879.x; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Ito S, 2009, J INORG BIOCHEM, V103, P989, DOI 10.1016/j.jinorgbio.2009.04.009; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Liebl U, 2003, BIOCHEMISTRY-US, V42, P6527, DOI 10.1021/bi027359f; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Royer WE, 1997, J BIOL CHEM, V272, P5689, DOI 10.1074/jbc.272.9.5689; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sato A, 2002, J BIOL CHEM, V277, P32650, DOI 10.1074/jbc.M204559200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taguchi S, 2004, J BIOL CHEM, V279, P3340, DOI 10.1074/jbc.M301013200; Takahashi H, 2006, CHEM LETT, V35, P970, DOI 10.1246/cl.2006.970; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Tanaka A, 2008, BIOCHEMISTRY-US, V47, P13438, DOI 10.1021/bi8012017; Tomita T, 2002, BIOCHEMISTRY-US, V41, P4819, DOI 10.1021/bi0158831; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; Watanabe M, 2002, BIOCHEM BIOPH RES CO, V299, P169, DOI 10.1016/S0006-291X(02)02621-9; Yamashita T, 2008, J BIOL CHEM, V283, P2344, DOI 10.1074/jbc.M708123200; Yoshimura T, 2003, J BIOL CHEM, V278, P53105, DOI 10.1074/jbc.M304408200; Yoshimura-Suzuki T, 2005, J BACTERIOL, V187, P6678, DOI 10.1128/JB.187.19.6678-6682.2005	38	23	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36146	36159		10.1074/jbc.M109.066811	http://dx.doi.org/10.1074/jbc.M109.066811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864414	Green Published, hybrid			2022-12-27	WOS:000272970500016
J	Yi, SJ; Groffen, J; Heisterkamp, N				Yi, Sun-Ju; Groffen, John; Heisterkamp, Nora			Transglutaminase 2 Regulates the GTPase-activating Activity of Bcr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; RHO-GTPASES; TRANSAMIDATION ACTIVITY; SIGNALING PATHWAY; IN-VIVO; PROTEIN; BINDING; CELLS; ABR; MACROPHAGES	Transglutaminase 2 (TG2) is a multifunctional protein that has been implicated in numerous pathologies including that of neurodegeneration and celiac disease, but the molecular interactions that mediate its diverse activities are largely unknown. Bcr and the closely related Abr negatively regulate the small G-protein Rac:loss of their combined function in vivo results in increased reactivity of innate immune cells. Bcr and Abr are GTPase-activating proteins that catalyze the hydrolysis of the GTP bound to Rac. However, how the Bcr and Abr GTPase-activating activity is regulated is not precisely understood. We here report a novel mechanism of regulation through direct protein-protein interaction with TG2. TG2 bound to the Rac-binding pocket in the GTPase-activating domains of Bcr and Abr, blocked Bcr activity and, through this mechanism, increased levels of active GTP-bound Rac and EGF-stimulated membrane ruffling. TG2 exists in at least two different conformations. Interestingly, experiments using TG2 mutants showed that Bcr exhibits preferential binding to the non-compacted conformation of TG2, in which its catalytic domain is exposed, but trans-amidation is not needed for the interaction. Thus, TG2 regulates levels of cellular GTP-bound Rac and actin cytoskeletal reorganization through a new mechanism involving direct inhibition of Bcr GTPase-activating activity.	[Yi, Sun-Ju; Groffen, John; Heisterkamp, Nora] Childrens Hosp Los Angeles, Div Hematol Oncol, Sect Mol Carcinogenesis, Los Angeles, CA 90027 USA; [Yi, Sun-Ju; Groffen, John; Heisterkamp, Nora] Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA; [Groffen, John; Heisterkamp, Nora] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California	Heisterkamp, N (corresponding author), Childrens Hosp Los Angeles, Div Hematol Oncol, Sect Mol Carcinogenesis, Ms 54,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu	Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273	Public Health Service, National Institutes of Health [HL071945, HL060231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060231, R01HL071945] Funding Source: NIH RePORTER	Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Public Health Service, National Institutes of Health, Grants HL071945 and HL060231.	Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Baek KJ, 2001, J BIOL CHEM, V276, P5591, DOI 10.1074/jbc.M008252200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Cho YJ, 2005, BIOCHEM BIOPH RES CO, V333, P1276, DOI 10.1016/j.bbrc.2005.06.030; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Cunnick JM, 2009, MOL CELL BIOL, V29, P5742, DOI 10.1128/MCB.00357-09; Dai Y, 2008, J PHARMACOL EXP THER, V326, P153, DOI 10.1124/jpet.107.135046; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; Feng JF, 1999, BIOCHEMISTRY-US, V38, P10743, DOI 10.1021/bi9905009; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HEISTERKAMP N, 2001, CHRONIC MYELOID LEUK, P3; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Kweon SM, 2008, J BIOL CHEM, V283, P3023, DOI 10.1074/jbc.M705513200; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Mishra S, 2003, ONCOGENE, V22, P8255, DOI 10.1038/sj.onc.1207156; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Toth B, 2009, J IMMUNOL, V182, P2084, DOI 10.4049/jimmunol.0803444; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Yi SJ, 2004, BIOCHEM BIOPH RES CO, V325, P819, DOI 10.1016/j.bbrc.2004.10.122; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	36	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35645	35651		10.1074/jbc.M109.062240	http://dx.doi.org/10.1074/jbc.M109.062240			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840940	Green Published, hybrid			2022-12-27	WOS:000272645600042
J	Liu, M; Wan, ZL; Chu, YC; Aladdin, H; Klaproth, B; Choquette, M; Hua, QX; Mackin, RB; Rao, JS; De Meyts, P; Katsoyannis, PG; Arvan, P; Weiss, MA				Liu, Ming; Wan, Zhu-li; Chu, Ying-Chi; Aladdin, Hassan; Klaproth, Birgit; Choquette, Meredith; Hua, Qing-xin; Mackin, Robert B.; Rao, J. Sunil; De Meyts, Pierre; Katsoyannis, Panayotis G.; Arvan, Peter; Weiss, Michael A.			Crystal Structure of a "Nonfoldable" Insulin IMPAIRED FOLDING EFFICIENCY DESPITE NATIVE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GROWTH-FACTOR-I; DISULFIDE-FORMING PATHWAY; RECEPTOR-BINDING SURFACE; PANCREATIC BETA-CELLS; A20-A21 PEPTIDE-BOND; AKITA DIABETIC MOUSE; ENDOPLASMIC-RETICULUM; BIOLOGICAL-ACTIVITY; HUMAN PROINSULIN; POSSIBLE INVOLVEMENT	Protein evolution is constrained by folding efficiency ("foldability") and the implicit threat of toxic misfolding. A model is provided by proinsulin, whose misfolding is associated with beta-cell dysfunction and diabetes mellitus. An insulin analogue containing a subtle core substitution (Leu(A16) -> Val) is biologically active, and its crystal structure recapitulates that of the wild-type protein. As a seeming paradox, however, Val(A16) blocks both insulin chain combination and the in vitro refolding of proinsulin. Disulfide pairing in mammalian cell culture is likewise inefficient, leading to misfolding, endoplasmic reticular stress, and proteosome-mediated degradation. Val(A16) destabilizes the native state and so presumably perturbs a partial fold that directs initial disulfide pairing. Substitutions elsewhere in the core similarly destabilize the native state but, unlike Val(A16), preserve folding efficiency. We propose that Leu(A16) stabilizes nonlocal interactions between nascent alpha-helices in the A-and B-domains to facilitate initial pairing of Cys(A20) and Cys(B19), thus surmounting their wide separation in sequence. Although Val(A16) is likely to destabilize this proto-core, its structural effects are mitigated once folding is achieved. Classical studies of insulin chain combination in vitro have illuminated the impact of off-pathway reactions on the efficiency of native disulfide pairing. The capability of a polypeptide sequence to fold within the endoplasmic reticulum may likewise be influenced by kinetic or thermodynamic partitioning among on-and off-pathway disulfide intermediates. The properties of [Val(A16)] insulin and [Val(A16)] proinsulin demonstrate that essential contributions of conserved residues to folding may be inapparent once the native state is achieved.	[Liu, Ming; Arvan, Peter] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Wan, Zhu-li; Hua, Qing-xin; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Chu, Ying-Chi; Katsoyannis, Panayotis G.] NYU, Dept Pharmacol & Biol Chem, Mt Sinai Sch Med, New York, NY 10029 USA; [Aladdin, Hassan; Klaproth, Birgit; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [Choquette, Meredith; Mackin, Robert B.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Rao, J. Sunil] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Case Western Reserve University; Icahn School of Medicine at Mount Sinai; New York University; Novo Nordisk; Hagedorn Research Institute; Creighton University; Case Western Reserve University	Arvan, P (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umichigan.edu; michael.weiss@case.edu		De Meyts, Pierre/0000-0001-6214-0824; Liu, Ming/0000-0003-2665-4072	National Institutes of Health [DK052085, DK48280, DK56673, DK0697674]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, R01DK052085, R01DK056673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052085 (to R.B.M.), DK48280 (to P.A.), DK56673 (to P.G.K.), and DK0697674 (to M.A.W.). This work was also supported by the American Diabetes Association (to M.A.W.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology.	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BALDWIN TO, 1993, J BIOL CHEM, V268, P10766; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BREMS DN, 1990, BIOCHEMISTRY-US, V29, P9289, DOI 10.1021/bi00491a026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Chance R. E., 1981, PEPTIDES SYNTHESIS S, P721; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6966, DOI 10.1021/bi00396a016; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6975, DOI 10.1021/bi00396a018; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Creighton TE, 1997, BIOL CHEM, V378, P731; Dai Y, 1996, BBA-PROTEIN STRUCT M, V1296, P63, DOI 10.1016/0167-4838(96)00054-4; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Dinner AR, 1999, PROTEINS, V35, P34, DOI 10.1002/(SICI)1097-0134(19990401)35:1<34::AID-PROT4>3.0.CO;2-Q; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Feng YG, 2003, J MOL BIOL, V330, P821, DOI 10.1016/S0022-2836(03)00660-0; FRANK BH, 1972, DIABETES, V21, P486, DOI 10.2337/diab.21.2.S486; FRANK BH, 1968, BIOCHEM BIOPH RES CO, V32, P155, DOI 10.1016/0006-291X(68)90362-8; FRANK BH, 1983, MUNCH MED WSCHR S1, V125, pS14; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Guo ZY, 2001, BIOL CHEM, V382, P443, DOI 10.1515/BC.2001.054; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; HOBER S, 1994, BIOCHEMISTRY-US, V33, P6758, DOI 10.1021/bi00188a003; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; HUANG XF, 1994, J BIOL CHEM, V269, P20838; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jia XY, 2003, PROTEIN SCI, V12, P2412, DOI 10.1110/ps.0389303; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; Milner SJ, 1999, BIOTECHNOL BIOENG, V62, P693; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NARHI LO, 1993, BIOCHEMISTRY-US, V32, P5214, DOI 10.1021/bi00070a033; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pace CN, 2000, PROTEINS, P1; PADMANABHAN S, 1990, NATURE, V344, P268, DOI 10.1038/344268a0; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Qiao ZS, 2003, J BIOL CHEM, V278, P17800, DOI 10.1074/jbc.M300906200; Qiao ZS, 2001, BIOCHEMISTRY-US, V40, P2662, DOI 10.1021/bi001613r; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; ROY M, 1990, J BIOL CHEM, V265, P5448; SHAKHNOVICH E, 1991, PHYS REV LETT, V67, P1665, DOI 10.1103/PhysRevLett.67.1665; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SNELL CR, 1975, J BIOL CHEM, V250, P6291; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; STEINER DF, 1978, DIABETES, V27, P145, DOI 10.2337/diab.27.1.S145; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; Tiana G, 2000, PROTEINS, V39, P244, DOI 10.1002/(SICI)1097-0134(20000515)39:3<244::AID-PROT70>3.0.CO;2-#; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; van den Akker F, 1999, ACTA CRYSTALLOGR D, V55, P206, DOI 10.1107/S0907444998007161; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yan H, 2003, PROTEIN SCI, V12, P768, DOI 10.1110/ps.0237203; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang ZJ, 2008, PROTEIN J, V27, P192, DOI 10.1007/s10930-007-9124-x; Zuber C, 2004, FASEB J, V18, P917, DOI 10.1096/fj.03-1210fje	107	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35259	35272		10.1074/jbc.M109.046888	http://dx.doi.org/10.1074/jbc.M109.046888			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850922	hybrid, Green Published			2022-12-27	WOS:000272439600078
J	Nahid, MA; Pauley, KM; Satoh, M; Chan, EKL				Nahid, Md A.; Pauley, Kaleb M.; Satoh, Minoru; Chan, Edward K. L.			miR-146a Is Critical for Endotoxin-induced Tolerance IMPLICATION IN INNATE IMMUNITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; RECEPTOR-ASSOCIATED KINASE; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; HUMAN MONOCYTES; SIGNALING PROTEINS; MONONUCLEAR-CELLS; DOWN-REGULATION; INDUCTION; LIPOPOLYSACCHARIDE	The human toll-like receptor 4 (TLR4) pathway is activated in response to lipopolysaccharide (LPS), and subsequent signal transductions lead to the production of cytokines such as tumor necrosis factor-alpha (TNF-alpha) by innate immune cells. Defects in innate immune response may contribute to the overproduction of TNF-alpha leading to systemic inflammation and diseases. Thus, the innate immune response needs to be tightly regulated by elaborate mechanisms to control its onset and termination. LPS tolerance is a state of hyporesponsiveness to subsequent LPS challenge and is achieved by monocytic cells after prolonged exposure to LPS. In this report, kinetics of endotoxin-responsive microRNAs expression analysis revealed a unique pattern of gradual increase for miR-146a starting 4 h after LPS stimulation in THP-1 cells and continued up to 35-fold over 24 h. Conversely, TNF-alpha increased up to 4 h and then decreased gradually implicating a negative correlation with miR-146a progression. The characteristic up-regulation of miR-146a toward subsequent LPS challenge in THP-1 cells was studied. Strikingly, microRNA expression analysis during the tolerized state of THP-1 cells showed only miR-146a overexpression suggesting its important role in LPS tolerance. In addition, LPS tolerance was dependent on a LPS-priming dose and associated miR-146a up-regulation. LPS-tolerized cells were observed to regain responsiveness in TNF-alpha production 22 h after LPS removal correlating with a decrease in miR-146a level. Transfection of miR-146a into THP-1 cells mimicked LPS priming, whereas transfection of miR-146a inhibitor largely abolished LPS tolerance. Thus our studies demonstrated that miR-146a is critical for the in vitro monocytic cell-based endotoxin tolerance.	[Nahid, Md A.; Pauley, Kaleb M.; Chan, Edward K. L.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Pauley, Kaleb M.] Univ Florida, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Med, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Pathol, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Immunol, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Lab Med, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chan, EKL (corresponding author), 1600 SW Archer Rd, Gainesville, FL 32610 USA.	echan@ufl.edu	Satoh, Minoru/E-2421-2011; Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503	National Institutes of Health (NIH) [AI47859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047859, R21AI047859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health (NIH) Grant AI47859. This work was also supported by a grant from the Lupus Research Institute.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chan EKL, 2009, ARTHRITIS RHEUM, V60, P912, DOI 10.1002/art.24421; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; HAAS JG, 1990, P NATL ACAD SCI USA, V87, P9563, DOI 10.1073/pnas.87.24.9563; Heagy W, 2003, SHOCK, V19, P321, DOI 10.1097/00024382-200304000-00005; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jacinto R, 2002, J IMMUNOL, V168, P6136, DOI 10.4049/jimmunol.168.12.6136; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONNEMANN G, 1989, EUR J IMMUNOL, V19, P1531, DOI 10.1002/eji.1830190903; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306; Medvedev AE, 2001, J IMMUNOL, V167, P2257, DOI 10.4049/jimmunol.167.4.2257; Murphey ED, 2007, SHOCK, V27, P289, DOI 10.1097/01.shk.0000245024.93740.28; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Ulevitch R J, 1989, Prog Clin Biol Res, V299, P193; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; ZIEGLERHEITBROCK HWL, 1992, IMMUNOLOGY, V75, P264; ZUCKERMAN SH, 1989, J IMMUNOL, V143, P1223	45	312	331	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34590	34599		10.1074/jbc.M109.056317	http://dx.doi.org/10.1074/jbc.M109.056317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840932	Green Published, hybrid			2022-12-27	WOS:000272439600014
J	Nelson, TJ; Cui, CH; Luo, Y; Alkon, DL				Nelson, Thomas J.; Cui, Changhai; Luo, Yuan; Alkon, Daniel L.			Reduction of beta-Amyloid Levels by Novel Protein Kinase C epsilon Activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; REGULATED SECRETION; CONVERTING-ENZYME; PKC-EPSILON; ALPHA; CLEAVAGE; BINDING; DELTA; PHOSPHORYLATION; BRYOSTATIN-1	Isoform-specific protein kinase C (PKC) activators may be useful as therapeutic agents for the treatment of Alzheimer disease. Three new epsilon-specific PKC activators, made by cyclopropanation of polyunsaturated fatty acids, have been developed. These activators, AA-CP4, EPA-CP5, and DHA-CP6, activate PKC epsilon in a dose-dependent manner. Unlike PKC activators that bind to the 1,2-diacylglycerol-binding site, such as bryostatin and phorbol esters, which produce prolonged down-regulation, the new activators produced sustained activation of PKC. When applied to cells expressing human APPSwe/PS1 delta, which produce large quantities of beta-amyloid peptide (A beta), DCP-LA and DHA-CP6 reduced the intracellular and secreted levels of A beta by 60-70%. In contrast to the marked activation of alpha-secretase produced by PKC activators in fibroblasts, the PKC activators produced only a moderate and transient activation of alpha-secretase in neuronal cells. However, they activated endothelin-converting enzyme to 180% of control levels, suggesting that the A beta-lowering ability of these PKC epsilon activators is caused by increasing the rate of A beta degradation by endothelin-converting enzyme and not by activating nonamyloidogenic amyloid precursor protein metabolism.	[Nelson, Thomas J.; Cui, Changhai; Alkon, Daniel L.] Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA; [Luo, Yuan] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Nelson, TJ (corresponding author), Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26506 USA.	tjnelson@brneurosci.org						Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Barnes PJ, 1997, LIFE SCI, V60, P1015, DOI 10.1016/S0024-3205(97)00042-8; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Choi DS, 2006, P NATL ACAD SCI USA, V103, P8215, DOI 10.1073/pnas.0509725103; Silva OABDE, 2009, J NEUROCHEM, V108, P319, DOI 10.1111/j.1471-4159.2008.05770.x; DENMARK SE, 1991, J ORG CHEM, V56, P6974, DOI 10.1021/jo00025a007; Du XY, 1997, J NEUROCHEM, V68, P564; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; ETCHEBERRIGARAY R, 1992, P NATL ACAD SCI USA, V89, P7184, DOI 10.1073/pnas.89.15.7184; FURUKAWA J, 1968, TETRAHEDRON, V24, P53, DOI 10.1016/0040-4020(68)89007-6; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kuzirian AM, 2006, BIOL BULL-US, V210, P201, DOI 10.2307/4134558; Lallemend F, 2005, J CELL SCI, V118, P4511, DOI 10.1242/jcs.02572; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; LEACH KL, 1985, CANCER RES, V45, P1958; Lee HW, 1997, MOL PHARMACOL, V51, P439; Lorenzo PS, 1999, CANCER RES, V59, P6137; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; NELSON TJ, 1995, J NEUROCHEM, V65, P2350; Petanceska SS, 2000, J NEUROCHEM, V74, P1878, DOI 10.1046/j.1471-4159.2000.0741878.x; Racchi M, 2003, MOL PSYCHIATR, V8, P209, DOI 10.1038/sj.mp.4001204; Rankin SL, 2008, BRAIN RES, V1217, P10, DOI 10.1016/j.brainres.2008.03.076; Rossner S, 1998, J NEUROCHEM, V71, P757; Rossner S, 1998, PROG NEUROBIOL, V56, P541, DOI 10.1016/S0301-0082(98)00044-6; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Sun MK, 2005, EUR J PHARMACOL, V512, P43, DOI 10.1016/j.ejphar.2005.02.028; Tanaka A, 2003, BIOORG MED CHEM LETT, V13, P1037, DOI 10.1016/S0960-894X(03)00089-1; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; van Kolen K, 2008, J NEUROCHEM, V104, P1, DOI 10.1111/j.1471-4159.2007.04986.x; VanDeMark KL, 2009, J PHARMACOL EXP THER, V329, P532, DOI 10.1124/jpet.108.150128; Wang DH, 2008, BEHAV PHARMACOL, V19, P245, DOI 10.1097/FBP.0b013e3282feb0d2; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607; Zhu GF, 2001, BIOCHEM BIOPH RES CO, V285, P997, DOI 10.1006/bbrc.2001.5273	44	51	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34514	34521		10.1074/jbc.M109.016683	http://dx.doi.org/10.1074/jbc.M109.016683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850930	Green Published, hybrid			2022-12-27	WOS:000272439600005
J	Holst, B; Nygaard, R; Valentin-Hansen, L; Bach, A; Engelstoft, MS; Petersen, PS; Frimurer, TM; Schwartz, TW				Holst, Birgitte; Nygaard, Rie; Valentin-Hansen, Louise; Bach, Anders; Engelstoft, Maja S.; Petersen, Pia S.; Frimurer, Thomas M.; Schwartz, Thue W.			A Conserved Aromatic Lock for the Tryptophan Rotameric Switch in TM-VI of Seven-transmembrane Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; METAL-ION SITE; CRYSTAL-STRUCTURE; GHRELIN RECEPTOR; TOGGLE SWITCHES; HELIX MOVEMENT; BINDING-SITE; RHODOPSIN; ACTIVATION; AGONIST	The conserved tryptophan in position 13 of TM-VI (Trp-VI:13 or Trp-6.48) of the CWXP motif located at the bottom of the main ligand-binding pocket in TM-VI is believed to function as a rotameric microswitch in the activation process of seven-transmembrane (7TM) receptors. Molecular dynamics simulations in rhodopsin demonstrated that rotation around the chi1 torsion angle of Trp-VI:13 brings its side chain close to the equally highly conserved Phe-V:13 (Phe-5.47) in TM-V. In the ghrelin receptor, engineering of high affinity metal-ion sites between these positions confirmed their close spatial proximity. Mutational analysis was performed in the ghrelin receptor with multiple substitutions and with Ala substitutions in GPR119, GPR39, and the beta(2)-adrenergic receptor as well as the NK1 receptor. In all of these cases, it was found that mutation of the Trp-VI:13 rotameric switch itself eliminated the constitutive signaling and strongly impaired agonist-induced signaling without affecting agonist affinity and potency. Ala substitution of Phe-V:13, the presumed interaction partner for Trp-VI:13, also in all cases impaired both the constitutive and the agonist-induced receptor signaling, but not to the same degree as observed in the constructs where Trp-VI:13 itself was mutated, but again without affecting agonist potency. In a proposed active receptor conformation generated by molecular simulations, where the extracellular segment of TM-VI is tilted inwards in the main ligand-binding pocket, Trp-VI:13 could rotate into a position where it obtained an ideal aromatic-aromatic interaction with Phe-V: 13. It is concluded that Phe-V:13 can serve as an aromatic lock for the proposed active conformation of the Trp-VI:13 rotameric switch, being involved in the global movement of TM-V and TM-VI in 7TM receptor activation.	[Schwartz, Thue W.] Univ Copenhagen, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; [Nygaard, Rie; Frimurer, Thomas M.; Schwartz, Thue W.] 7TM Pharma AS, DK-5700 Horsholm, Denmark	University of Copenhagen	Holst, B (corresponding author), Univ Copenhagen, Dept Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	holst@sund.ku.dk; tws@sund.ku.dk	Nygaard, Rie/B-7351-2013	Bach, Anders/0000-0003-4305-9910; Schwartz, Thue W./0000-0002-0261-6904; Holst, Birgitte/0000-0001-7432-097X; Frimruer, Thomas/0000-0002-9682-8245	Danish Medical Research Council; NovoNordisk Foundation; Lundbeck Foundation; Alfred Benzon Foundation; Danish Diabetes Association; European Union [223057]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NovoNordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; Danish Diabetes Association; European Union(European Commission)	This work was supported by grants from the Danish Medical Research Council, the NovoNordisk Foundation, the Lundbeck Foundation, the Alfred Benzon Foundation, the Danish Diabetes Association, and the European Union's Seventh Framework Programme (Grant Agreement 223057).	Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Colson AO, 1998, MOL PHARMACOL, V54, P968, DOI 10.1124/mol.54.6.968; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Dinner AR, 1999, PROTEIN ENG, V12, P909, DOI 10.1093/protein/12.11.909; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jongejan A, 2005, NAT CHEM BIOL, V1, P98, DOI 10.1038/nchembio714; Joubert L, 2002, J BIOL CHEM, V277, P25502, DOI 10.1074/jbc.M202539200; Klein-Seetharaman J, 2004, P NATL ACAD SCI USA, V101, P3409, DOI 10.1073/pnas.0308713101; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Marie J, 2001, J BIOL CHEM, V276, P41100, DOI 10.1074/jbc.M104875200; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schertler GFX, 2005, CURR OPIN STRUC BIOL, V15, P408, DOI 10.1016/j.sbi.2005.07.010; Schwartz TW, 2008, NATURE, V455, P473, DOI 10.1038/455473a; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; Semple G, 2008, J MED CHEM, V51, P5172, DOI 10.1021/jm8006867; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Sun YH, 2002, ENDOCRINOLOGY, V143, P2886, DOI 10.1210/en.143.8.2886; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; Thirstrup K, 1996, J BIOL CHEM, V271, P7875, DOI 10.1074/jbc.271.14.7875; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	56	107	108	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3973	3985		10.1074/jbc.M109.064725	http://dx.doi.org/10.1074/jbc.M109.064725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19920139	Green Published, hybrid			2022-12-27	WOS:000275254000051
J	Haque, F; Mazzeo, D; Patel, JT; Smallwood, DT; Ellis, JA; Shanahan, CM; Shackleton, S				Haque, Farhana; Mazzeo, Daniela; Patel, Jennifer T.; Smallwood, Dawn T.; Ellis, Juliet A.; Shanahan, Catherine M.; Shackleton, Sue			Mammalian SUN Protein Interaction Networks at the Inner Nuclear Membrane and Their Role in Laminopathy Disease Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS-MUSCULAR-DYSTROPHY; GILFORD-PROGERIA-SYNDROME; LAMIN-A; ACTIN CYTOSKELETON; TRANSMEMBRANE PROTEIN; PARTIAL LIPODYSTROPHY; MECHANICAL STIFFNESS; ENVELOPE INTEGRITY; SKELETAL-MUSCLE; IN-VITRO	The nuclear envelope (NE) LINC complex, in mammals comprised of SUN domain and nesprin proteins, provides a direct connection between the nuclear lamina and the cytoskeleton, which contributes to nuclear positioning and cellular rigidity. SUN1 and SUN2 interact with lamin A, but lamin A is only required for NE localization of SUN2, and it remains unclear how SUN1 is anchored. Here, we identify emerin and short nesprin-2 isoforms as novel nucleoplasmic binding partners of SUN1/2. These have overlapping binding sites distinct from the lamin A binding site. However, we demonstrate that tight association of SUN1 with the nuclear lamina depends upon a short motif within residues 209-228, a region that does not interact significantly with known SUN1 binding partners. Moreover, SUN1 localizes correctly in cells lacking emerin. Importantly then, the major determinant of SUN1 NE localization has yet to be identified. We further find that a subset of lamin A mutations, associated with laminopathies Emery-Dreifuss muscular dystrophy (EDMD) and Hutchinson-Gilford progeria syndrome (HGPS), disrupt lamin A interaction with SUN1 and SUN2. Despite this, NE localization of SUN1 and SUN2 is not impaired in cell lines from either class of patients. Intriguingly, SUN1 expression at the NE is instead enhanced in a significant proportion of HGPS but not EDMD cells and strongly correlates with pre-lamin A accumulation due to preferential interaction of SUN1 with pre-lamin A. We propose that these different perturbations in lamin A-SUN protein interactions may underlie the opposing effects of EDMD and HGPS mutations on nuclear and cellular mechanics.	[Haque, Farhana; Mazzeo, Daniela; Patel, Jennifer T.; Smallwood, Dawn T.; Shackleton, Sue] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Ellis, Juliet A.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Shanahan, Catherine M.] Kings Coll London, James Black Ctr, Div Cardiovasc, London SE5 9NU, England	University of Leicester; University of London; King's College London; University of London; King's College London	Shackleton, S (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	ss115@le.ac.uk		Patel, Jennifer/0000-0002-5378-035X; Shanahan, Catherine/0000-0002-8352-8171	Wellcome Trust; British Heart Foundation; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; British Heart Foundation [RG/09/008/27923] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was funded by Wellcome Trust and British Heart Foundation grants (to S. S.) and a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom studentship awarded (to J. T. P.).	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Cartegni L, 1997, HUM MOL GENET, V6, P2257, DOI 10.1093/hmg/6.13.2257; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Denecke J, 2006, HUM MUTAT, V27, P524, DOI 10.1002/humu.20315; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Ellis JA, 1998, J CELL SCI, V111, P781; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fukuchi K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014688; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Holt I, 2003, J CELL SCI, V116, P3027, DOI 10.1242/jcs.00599; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Hutchison CJ, 2001, J CELL SCI, V114, P9; Kandert S, 2007, HUM MOL GENET, V16, P2944, DOI 10.1093/hmg/ddm255; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; Motsch I, 2005, EUR J CELL BIOL, V84, P765, DOI 10.1016/j.ejcb.2005.04.004; Muchir A, 2007, CURR NEUROL NEUROSCI, V7, P78, DOI 10.1007/s11910-007-0025-3; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Ostlund C, 1999, J CELL SCI, V112, P1709; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Shackleton S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029751; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Talkop UA, 2002, NEUROMUSCULAR DISORD, V12, P878, DOI 10.1016/S0960-8966(02)00134-7; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wilkinson FL, 2003, EUR J BIOCHEM, V270, P2459, DOI 10.1046/j.1432-1033.2003.03617.x; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207	66	189	204	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3487	3498		10.1074/jbc.M109.071910	http://dx.doi.org/10.1074/jbc.M109.071910			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19933576	Green Published, hybrid			2022-12-27	WOS:000273829000063
J	McGuire, RM; Liu, HY; Pereira, FA; Raphael, RM				McGuire, Ryan M.; Liu, Haiying; Pereira, Fred A.; Raphael, Robert M.			Cysteine Mutagenesis Reveals Transmembrane Residues Associated with Charge Translocation in Prestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; MOTOR PROTEIN PRESTIN; COCHLEAR AMPLIFIER; PLASMA-MEMBRANE; GENE FAMILY; ELECTROMOTILITY; LOCALIZATION; CHOLESTEROL; CAPACITANCE; INHIBITION	The solute carrier transmembrane protein prestin (SLC26A5) drives an active electromechanical transduction process in cochlear outer hair cells that increases hearing sensitivity and frequency discrimination in mammals. A large intramembraneous charge movement, the nonlinear capacitance (NLC), is the electrical signature of prestin function. The transmembrane domain (TMD) helices and residues involved in the intramembrane charge displacement remain unknown. We have performed cysteine-scanning mutagenesis with serine or valine replacement to investigate the importance of cysteine residues to prestin structure and function. The distribution of oligomeric states and membrane abundance of prestin was also probed to investigate whether cysteine residues participate in prestin oligomerization and/or NLC. Our results reveal that 1) Cys-196 (TMD 4) and Cys-415 (TMD 10) do not tolerate serine replacement, and thus maintaining hydrophobicity at these locations is important for the mechanism of charge movement; 2) Cys-260 (TMD 6) and Cys-381 (TMD 9) tolerate serine replacement and are probably water-exposed; and 3) if disulfide bonds are present, they do not serve a functional role as measured via NLC. These novel findings are consistent with a recent structural model, which proposes that prestin contains an occluded aqueous pore, and we posit that the orientations of transmembrane domain helices 4 and 10 are essential for proper prestin function.	[Liu, Haiying; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Liu, Haiying; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University	Pereira, FA (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Dept Otolaryngol Head & Neck Surg, 1 Baylor Plaza, Houston, TX 77030 USA.	fpereira@bcm.edu; rraphael@rice.edu		Pereira, Fred/0000-0003-2100-0280	National Institutes of Health; NIDCD [R01 DC009622, DC00354]; National Institutes of Health, NIDCD [R21 DC008134]; National Science Foundation [044379]; National Science Foundation Major Research Instrumentation [BES 0321275]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000354, R01DC009622, R21DC008134, R01DC000354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health, NIDCD, Grants R01 DC009622 (to R.M.R. and F.A.P.) and DC00354 (to F.A.P.) and National Institutes of Health, NIDCD, Grant R21 DC008134 (to R.M.R. and F.A.P.). This work was also supported by National Science Foundation Career Award BES 044379 (to R.M.R.) and National Science Foundation Major Research Instrumentation Grant BES 0321275 (to R.M.R.).	Ashmore J F, 1990, Neurosci Res Suppl, V12, pS39, DOI 10.1016/0921-8696(90)90007-P; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; Deak L, 2005, J PHYSIOL-LONDON, V563, P483, DOI 10.1113/jphysiol.2004.078857; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Fakler B, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P110, DOI 10.1142/9789812704931_0014; Greeson JN, 2009, BIOPHYS J, V96, P510, DOI 10.1016/j.bpj.2008.09.016; KALINEC F, 1993, NEUROSCI LETT, V157, P231, DOI 10.1016/0304-3940(93)90744-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Matsuda K, 2004, J NEUROCHEM, V89, P928, DOI 10.1111/j.1471-4159.2004.02377.x; MCGUIRE RM, 2006, ASS RES OT ABS, P125; Mio K, 2008, J BIOL CHEM, V283, P1137, DOI 10.1074/jbc.M702681200; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Organ LE, 2009, JARO-J ASSOC RES OTO, V10, P383, DOI 10.1007/s10162-009-0171-1; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rotman-Pikielny P, 2002, HUM MOL GENET, V11, P2625, DOI 10.1093/hmg/11.21.2625; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Sfondouris J, 2008, J BIOL CHEM, V283, P22473, DOI 10.1074/jbc.M803722200; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Waldegger S, 2001, GENOMICS, V72, P43, DOI 10.1006/geno.2000.6445; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zacharias D. A., 2002, SCI STKE, V2002, ppe23; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	40	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3103	3113		10.1074/jbc.M109.053249	http://dx.doi.org/10.1074/jbc.M109.053249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19926791	Green Published, hybrid			2022-12-27	WOS:000273829000026
J	Song, YH; Ahn, SH				Song, Young-Ha; Ahn, Seong Hoon			A Bre1-associated Protein, Large 1 (Lge1), Promotes H2B Ubiquitylation during the Early Stages of Transcription Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES H3 METHYLATION; HISTONE H2B; SACCHAROMYCES-CEREVISIAE; SYSTEMATIC IDENTIFICATION; UBIQUITINATION; SAGA; MONOUBIQUITINATION; ASSOCIATION; RECRUITMENT; ACTIVATION	Transcription activation has been proposed to require both ubiquitylation and deubiquitylation of histone H2B. Here, we show that Lge1 (Large 1) is found in a complex containing Rad6.Bre1 and that it controls the recruitment of Bre1, a ubiquitin ligase, and Ubp8, a deubiquitylase, to promote ubiquitylation during the early steps in elongation. Chromatin immuno-precipitation experiments showed that Lge1 associates with promoter and coding regions of actively transcribed genes in a transcription-dependent manner. Disruption of Lge1 abolished ubiquitylation of histone H2B on lysine 123 and H3 methylation on lysines 4 and 79 and resulted in significant sensitivity to 6-azauracil and mycophenolic acid. In particular, in Lge1-deficient cells, Bre1 recruitment was attenuated, whereas recruitment of Ubp8 was facilitated. These alterations were coincident with changes in the interaction between Bre1.Ubp8 and RNA polymerase II phosphorylated at serine 5 of the C-terminal domain. We propose that Lge1 has a novel function in disrupting the balance between the recruitment of Bre1 and Ubp8, thus promoting transcription elongation.	[Song, Young-Ha; Ahn, Seong Hoon] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan 426791, Gyeonggi Do, South Korea	Hanyang University	Ahn, SH (corresponding author), Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, 1271 Sa 3 Dong, Ansan 426791, Gyeonggi Do, South Korea.	hoon320@hanyang.ac.kr		Ahn, Seong-Hoon/0000-0002-9174-4966	Korea Research Foundation [KRF-2007521-C00200]; Korea Science and Engineering Foundation [2009-0079344]; Korean government	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean government(Korean Government)	This work was supported by Korea Research Foundation Grant KRF-2007521-C00200 and by Korea Science and Engineering Foundation Grant 2009-0079344 funded by the Korean government (Ministry of Education, Science, and Technology) (to S.H.A.).	Ahn SH, 2009, EMBO J, V28, P205, DOI 10.1038/emboj.2008.280; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Foster ER, 2009, J CELL BIOL, V184, P631, DOI 10.1083/jcb.200812088; Game JC, 2006, GENETICS, V173, P1951, DOI 10.1534/genetics.106.057794; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang XT, 2005, J BIOL CHEM, V280, P2759, DOI 10.1074/jbc.M408333200	43	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2361	2367		10.1074/jbc.M109.039255	http://dx.doi.org/10.1074/jbc.M109.039255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923226	hybrid, Green Published			2022-12-27	WOS:000273697800016
J	Lohoff, M; Giaisi, M; Kohler, R; Casper, B; Krammer, PH; Li-Weber, M				Lohoff, Michael; Giaisi, Marco; Koehler, Rebecca; Casper, Baerbel; Krammer, Peter H.; Li-Weber, Min			Early Growth Response Protein-1 (Egr-1) Is Preferentially Expressed in T Helper Type 2 (Th2) Cells and Is Involved in Acute Transcription of the Th2 Cytokine Interleukin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON REGULATORY FACTOR-4; IMMEDIATE-EARLY GENE; HUMAN IL-4 PROMOTER; POSITIVE SELECTION; THYMIC SELECTION; NUCLEAR FACTORS; NGFI-A; BINDING; DIFFERENTIATION	The early growth response gene product Egr-1 has been shown to have great impact on growth, proliferation, and differentiation in a wide variety of cells, including T cells. In this study, we show that Egr-1 is rapidly induced upon T cell stimulation and is expressed predominantly in T helper type 2 (Th2) compared with type 1 (Th1) cells. We further investigate the role of Egr-1 in regulation of the Th2 cytokine interleukin-4 (IL-4) expression. IL-4 is a key Th2 cytokine that regulates humoral immunity and also causes allergic inflammation. Regulation of IL-4 gene transcription in Th2 cells has been shown to be controlled by multiple T cell receptor (TCR)-induced transcription factors. However, only a few transcription factors were shown to be selectively induced in differentiated Th2 cells in response to TCR stimulation. Chromatin immunoprecipitation analysis demonstrates that Egr-1 binds to the IL-4 promoter in vivo upon T cell stimulation. Ectopic expression of Egr-1 enhances endogenous IL-4 mRNA expression and elevates IL-4 promoter activity. We also show that Egr-1, nuclear factor of activated T cell, and NF-kappa B cooperatively bind to an NFAT/NF-kappa B-overlapping IL-4 enhancer element and activate the IL-4 promoter synergistically. Furthermore, we show that antisense oligonucleotides that knock down Egr-1 expression attenuate IL-4 transcription. Our study provides the first evidence that Egr-1 protein is differentially expressed in Th1 and Th2 cells and is involved in the acute phase of the IL-4 transcription in response to TCR stimulation.	[Giaisi, Marco; Koehler, Rebecca; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany; [Lohoff, Michael; Casper, Baerbel] Univ Marburg, Inst Med Microbiol, D-35037 Marburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Philipps University Marburg	Li-Weber, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program G0300, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de			Spitzencluster Initiative with Apogenix [BioRN-INA-10]; Deutsche Forschungsgemeinschaft [SFB TA22]	Spitzencluster Initiative with Apogenix; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Spitzencluster Initiative with Apogenix BioRN-INA-10 (to M. L.-W.) and by Deutsche Forschungsgemeinschaft Grant SFB TA22 (to M. L.).	ABE E, 1992, P NATL ACAD SCI USA, V89, P2864, DOI 10.1073/pnas.89.7.2864; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Basson MA, 2000, J IMMUNOL, V165, P2444, DOI 10.4049/jimmunol.165.5.2444; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; BRUHN KW, 1993, P NATL ACAD SCI USA, V90, P9707, DOI 10.1073/pnas.90.20.9707; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Jankovic D, 2001, CURR OPIN IMMUNOL, V13, P403, DOI 10.1016/S0952-7915(00)00234-X; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Li-Weber M, 2001, EUR J IMMUNOL, V31, P3694, DOI 10.1002/1521-4141(200112)31:12<3694::AID-IMMU3694>3.0.CO;2-S; Li-Weber M, 2004, EUR J IMMUNOL, V34, P1111, DOI 10.1002/eji.200324687; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Li-Weber M, 1998, J IMMUNOL, V161, P1380; Li-Weber M, 1998, J BIOL CHEM, V273, P32460, DOI 10.1074/jbc.273.49.32460; LIM RW, 1987, ONCOGENE, V1, P263; Lin JX, 1997, MOL CELL BIOL, V17, P3714, DOI 10.1128/MCB.17.7.3714; LiWeber M, 1997, J IMMUNOL, V158, P1194; Lohoff M, 2000, J EXP MED, V192, P325, DOI 10.1084/jem.192.3.325; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Luo C, 1996, MOL CELL BIOL, V16, P3955; MAGES HW, 1993, INT IMMUNOL, V5, P63, DOI 10.1093/intimm/5.1.63; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Miyazaki T, 1998, J EXP MED, V188, P715, DOI 10.1084/jem.188.4.715; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Proksch P, 2005, J IMMUNOL, V174, P7075, DOI 10.4049/jimmunol.174.11.7075; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Ricci M, 1997, J INVEST ALLERG CLIN, V7, P144; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3; Wenner CA, 1997, J IMMUNOL, V158, P765; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989; Zelenika D, 2002, J IMMUNOL, V168, P1069, DOI 10.4049/jimmunol.168.3.1069; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zipfel PF, 1997, BBA-GENE STRUCT EXPR, V1354, P134, DOI 10.1016/S0167-4781(97)00084-5	55	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1643	1652		10.1074/jbc.M109.011585	http://dx.doi.org/10.1074/jbc.M109.011585			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19915002	Green Published, hybrid			2022-12-27	WOS:000273429100010
J	Salameh, MA; Robinson, JL; Navaneetham, D; Sinha, D; Madden, BJ; Walsh, PN; Radisky, ES				Salameh, Moh'd A.; Robinson, Jessica L.; Navaneetham, Duraiswamy; Sinha, Dipali; Madden, Benjamin J.; Walsh, Peter N.; Radisky, Evette S.			The Amyloid Precursor Protein/Protease Nexin 2 Kunitz Inhibitor Domain Is a Highly Specific Substrate of Mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN-PRECURSOR; HUMAN CATIONIC TRYPSINOGEN; COAGULATION-FACTOR-XIA; ALZHEIMERS-DISEASE; PLASMINOGEN-ACTIVATOR; CATALYTIC DOMAIN; MESSENGER-RNA; HUMAN BRAIN; CHYMOTRYPSIN INHIBITOR-2; CEREBRAL THROMBOSIS	The amyloid precursor protein (APP) is a ubiquitously expressed transmembrane adhesion protein and the progenitor of amyloid-beta peptides. The major splice isoforms of APP expressed by most tissues contain a Kunitz protease inhibitor domain; secreted APP containing this domain is also known as protease nexin 2 and potently inhibits serine proteases, including trypsin and coagulation factors. The atypical human trypsin isoform mesotrypsin is resistant to inhibition by most protein protease inhibitors and cleaves some inhibitors at a substantially accelerated rate. Here, in a proteomic screen to identify potential physiological substrates of mesotrypsin, we find that APP/protease nexin 2 is selectively cleaved by mesotrypsin within the Kunitz protease inhibitor domain. In studies employing the recombinant Kunitz domain of APP (APPI), we show that mesotrypsin cleaves selectively at the Arg15-Ala16 reactive site bond, with kinetic constants approaching those of other proteases toward highly specific protein substrates. Finally, we show that cleavage of APPI compromises its inhibition of other serine proteases, including cationic trypsin and factor XIa, by 2 orders of magnitude. Because APP/protease nexin 2 and mesotrypsin are coexpressed in a number of tissues, we suggest that processing by mesotrypsin may ablate the protease inhibitory function of APP/protease nexin 2 in vivo and may also modulate other activities of APP/protease nexin 2 that involve the Kunitz domain.	[Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Madden, Benjamin J.] Mayo Clin, Mayo Prote Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Mayo Clinic	Radisky, ES (corresponding author), 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Paditz, Ekkehart/F-5351-2015	Radisky, Evette S/0000-0003-3121-109X; 	National Institutes of Health [P50 CA091956-08, HL74124, HL46213]; Bankhead-Coley Florida Biomedical Research Program [07BN-07]; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046213, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Florida Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA091956-08 (to E. S. R.) and HL74124 and HL46213 (to P. N. W.). This work was also supported by Bankhead-Coley Florida Biomedical Research Program Award 07BN-07 (to E. S. R.).	Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Badellino KO, 2000, BIOCHEMISTRY-US, V39, P4769, DOI 10.1021/bi9925468; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Galliers B, 2001, J STRATEGIC INF SYST, V10, P1, DOI 10.1016/S0963-8687(01)00045-2; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; ITOH H, 1991, INT J CANCER, V49, P436, DOI 10.1002/ijc.2910490322; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATAOKA H, 1995, INT J CANCER, V60, P123, DOI 10.1002/ijc.2910600118; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; KITAGUCHI N, 1990, BIOCHIM BIOPHYS ACTA, V1038, P105, DOI 10.1016/0167-4838(90)90017-A; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LIJNEN HR, 1984, EUR J BIOCHEM, V144, P541, DOI 10.1111/j.1432-1033.1984.tb08499.x; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Nemoda Z, 2005, J BIOL CHEM, V280, P29645, DOI 10.1074/jbc.M505661200; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; Schmitz A, 2002, HISTOCHEM CELL BIOL, V117, P171, DOI 10.1007/s00418-001-0351-5; Seguchi K, 1999, BIOL CHEM, V380, P473, DOI 10.1515/BC.1999.061; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; Walsh P, 2006, HEMOSTASIS THROMBOSI, P221; Wang YF, 2006, J NEUROCHEM, V99, P759, DOI 10.1111/j.1471-4159.2006.04105.x; Webber MM, 2001, PROSTATE, V47, P1; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; WRIGHT HT, 1977, EUR J BIOCHEM, V73, P567, DOI 10.1111/j.1432-1033.1977.tb11352.x; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Xu F, 2007, STROKE, V38, P2598, DOI 10.1161/STROKEAHA.106.480103; Xu F, 2009, J NEUROSCI, V29, P5666, DOI 10.1523/JNEUROSCI.0095-09.2009; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang L, 2008, J BIOL CHEM, V283, P35295, DOI 10.1074/jbc.M806965200	68	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1939	1949		10.1074/jbc.M109.057216	http://dx.doi.org/10.1074/jbc.M109.057216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19920152	Green Published, hybrid			2022-12-27	WOS:000273429100040
J	Voolstra, O; Oberhauser, V; Sumser, E; Meyer, NE; Maguire, ME; Huber, A; von Lintig, J				Voolstra, Olaf; Oberhauser, Vitus; Sumser, Emerich; Meyer, Nina E.; Maguire, Michael E.; Huber, Armin; von Lintig, Johannes			NinaB Is Essential for Drosophila Vision but Induces Retinal Degeneration in Opsin-deficient Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL PIGMENT CHROMOPHORE; CELL-SURFACE RECEPTOR; VITAMIN-A; BINDING-PROTEIN; BETA-CAROTENE; RHODOPSIN; CYCLE; MICE; GENE; MUTANTS	In animals, visual pigments are essential for photoreceptor function and survival. These G-protein-coupled receptors consist of a protein moiety (opsin) and a covalently bound 11-cis-retinylidene chromophore. The chromophore is derived from dietary carotenoids by oxidative cleavage and trans-to-cis isomerization of double bonds. In vertebrates, the necessary chemical transformations are catalyzed by two distinct but structurally related enzymes, the carotenoid oxygenase beta-carotenoid-15,15'-monooxygenase and the retinoid isomerase RPE65(retinal pigment epithelium protein of 65 kDa). Recently, we provided biochemical evidence that these reactions in insects are catalyzed by a single enzyme family member named NinaB. Here we show that in the fly pathway, carotenoids are mandatory precursors of the chromophore. After chromophore formation, the retinoid-binding protein Pinta acts downstream of NinaB and is required to supply photoreceptors with chromophore. Like ninaE encoding the opsin, ninaB expression is eye-dependent and is activated as a downstream target of the eyeless/pax6 and sine oculis master control genes for eye development. The requirement for coordinated synthesis of chromophore and opsin is evidenced by analysis of ninaE mutants. Retinal degeneration in opsin-deficient photoreceptors is caused by the chromophore and can be prevented by restricting its supply as seen in an opsin and chromophore-deficient double mutant. Thus, our study identifies NinaB as a key component for visual pigment production and provides evidence that chromophore in opsin-deficient photoreceptors can elicit retinal degeneration.	[Maguire, Michael E.; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44160 USA; [Voolstra, Olaf; Meyer, Nina E.; Huber, Armin] Univ Hohenheim, Inst Physiol & Biosensor, D-70599 Hohenheim, Germany; [Voolstra, Olaf; Oberhauser, Vitus; Sumser, Emerich] Univ Freiburg, Inst Biol Neurobiol & Tiephysiol 1, D-79102 Freiburg, Germany	Case Western Reserve University; University Hohenheim; University of Freiburg	von Lintig, J (corresponding author), Case Western Reserve Univ, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44160 USA.	Johannes.vonlintig@case.edu	Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X; von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health [EY019641]; Ministry of Science and Art Baden-Wurttemberg (Germany); NATIONAL EYE INSTITUTE [R01EY019641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Art Baden-Wurttemberg (Germany); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY019641 (to J. v. L.). This work was also supported by a grant from the Ministry of Science and Art Baden-Wurttemberg (Germany).	Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Daniel A, 1999, DEVELOPMENT, V126, P2945; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Giovannucci DR, 1999, VISION RES, V39, P219, DOI 10.1016/S0042-6989(98)00184-9; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Gu G, 2004, J BIOL CHEM, V279, P18608, DOI 10.1074/jbc.M400323200; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HARRIS WA, 1977, NATURE, V266, P648, DOI 10.1038/266648a0; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Kumar JP, 1997, DEV BIOL, V188, P43, DOI 10.1006/dbio.1997.8636; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; OZAKI K, 1993, NEURON, V10, P1113, DOI 10.1016/0896-6273(93)90059-Z; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAULSEN R, 1983, EUR J BIOCHEM, V137, P609, DOI 10.1111/j.1432-1033.1983.tb07869.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sprecher SG, 2007, GENE DEV, V21, P2182, DOI 10.1101/gad.1565407; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u; Wang T, 2005, J NEUROSCI, V25, P5187, DOI 10.1523/JNEUROSCI.0995-05.2005; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	46	33	34	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2130	2139		10.1074/jbc.M109.056101	http://dx.doi.org/10.1074/jbc.M109.056101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19889630	Green Published, hybrid			2022-12-27	WOS:000273429100057
J	George, NM; Targy, N; Evans, JJD; Zhang, LQ; Luo, X				George, Nicholas M.; Targy, Natalie; Evans, Jacquelynn J. D.; Zhang, Liqiang; Luo, Xu			Bax Contains Two Functional Mitochondrial Targeting Sequences and Translocates to Mitochondria in a Conformational Change- and Homo-oligomerization-driven Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 PROTEIN FAMILY; CELL-DEATH; BH3-ONLY PROTEINS; MEMBRANE PERMEABILIZATION; CYTOCHROME-C; INTRACELLULAR-LOCALIZATION; APOPTOTIC ACTIVITY; ACTIVATION; LIFE; BH3	The apoptosis gateway protein Bax normally exists in the cytosol as a globular shaped monomer composed of nine alpha-helices. During apoptosis, Bax translocates to the mitochondria, forms homo-oligomers, and subsequently induces mitochondrial damage. The mechanism of Bax mitochondrial translocation remains unclear. Among the nine alpha-helices of Bax, helices 4, 5, 6, and 9 are capable of targeting a heterologous protein to mitochondria. However, only helices 6 and 9 can independently direct the oligomerized Bax to the mitochondria. Although Bax mitochondrial translocation can still proceed with mutations in either helix 6 or helix 9, combined mutations completely abolished mitochondrial targeting in response to activating signals. Using a proline mutagenesis scanning analysis, we demonstrated that conformational changes were sufficient to cause Bax to move from the cytosol to the mitochondria. Moreover, we found that homo-oligomerization of Bax contributed to its mitochondrial translocation. These results suggest that Bax is targeted to the mitochondria through the exposure of one or both of the two functional mitochondrial targeting sequences in a conformational change-driven and homo-oligomerization-aided process.	[George, Nicholas M.; Targy, Natalie; Evans, Jacquelynn J. D.; Zhang, Liqiang; Luo, Xu] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Luo, X (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	xuluo@unmc.edu	Zhang, Liqiang/B-6889-2011		National Institutes of Health [GM76237, CA009476]; NCCS [5P20RR018759]; University of Nebraska Medical Center; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCS; University of Nebraska Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM76237. This work was also supported by a pilot grant from the Nebraska Center for Cellular Signaling (NCSS) (to X.L.).; Supported by National Institutes of Health Training Grant CA009476, Graduate Fellowship 5P20RR018759 from the NCCS, and the University of Nebraska Medical Center.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1996, MOL CELL BIOL, V16, P1367; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Ma YL, 2002, J BIOL CHEM, V277, P27328, DOI 10.1074/jbc.M201421200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Ruffolo SC, 2000, CELL DEATH DIFFER, V7, P1101, DOI 10.1038/sj.cdd.4400739; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Valentijn AJ, 2003, J CELL BIOL, V162, P599, DOI 10.1083/jcb.200302154; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	57	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1384	1392		10.1074/jbc.M109.049924	http://dx.doi.org/10.1074/jbc.M109.049924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19880508	Green Published, hybrid			2022-12-27	WOS:000273258200058
J	Lack, NA; Yam, KC; Lowe, ED; Horsman, GP; Owen, RL; Sim, E; Eltis, LD				Lack, Nathan A.; Yam, Katherine C.; Lowe, Edward D.; Horsman, Geoff P.; Owen, Robin L.; Sim, Edith; Eltis, Lindsay D.			Characterization of a Carbon-Carbon Hydrolase from Mycobacterium tuberculosis Involved in Cholesterol Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-BOND HYDROLASE; POLYCHLORINATED-BIPHENYLS; DEGRADATION PATHWAY; CATALYTIC MECHANISM; L-PHOTOINTERMEDIATE; GENE-CLUSTER; BPHD; SUPERFAMILY; MACROPHAGES; SURVIVAL	In the recently identified cholesterol catabolic pathway of Mycobacterium tuberculosis, 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (HsaD) is proposed to catalyze the hydrolysis of a carbon-carbon bond in 4,5-9,10-diseco-3-hydroxy-5,9,17-tri-oxoandrosta-1(10),2-diene-4-oic acid (DSHA), the cholesterol meta-cleavage product (MCP) and has been implicated in the intracellular survival of the pathogen. Herein, purified HsaD demonstrated 4-33 times higher specificity for DSHA (k(cat)/K-m = 3.3 +/- 0.3 x 10(4) M-1 s(-1)) than for the biphenyl MCP 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid (HOPDA) and the synthetic analogue 8-(2-chlorophenyl)-2-hydroxy-5-methyl-6-oxoocta-2,4-dienoic acid (HOPODA), respectively. The S114A variant of HsaD, in which the active site serine was substituted with alanine, was catalytically impaired and bound DSHA with a K-d of 51 +/- 2 mu M. The S114A center dot DSHA species absorbed maximally at 456 nm, 60 nm red-shifted versus the DSHA enolate. Crystal structures of the variant in complex with HOPDA, HOPODA, or DSHA to 1.8-1.9 angstrom indicate that this shift is due to the enzyme-induced strain of the enolate. These data indicate that the catalytic serine catalyzes tautomerization. A second role for this residue is suggested by a solvent molecule whose position in all structures is consistent with its activation by the serine for the nucleophilic attack of the substrate. Finally, the alpha-helical lid covering the active site displayed a ligand-dependent conformational change involving differences in side chain carbon positions of up to 6.7 A, supporting a two-conformation enzymatic mechanism. Overall, these results provide novel insights into the determinants of specificity in a mycobacterial cholesterol-degrading enzyme as well as into the mechanism of MCP hydrolases.	[Lack, Nathan A.; Sim, Edith] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Lowe, Edward D.] Univ Oxford, Dept Mol Biophys, Oxford OX1 3QT, England; [Yam, Katherine C.; Horsman, Geoff P.; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Owen, Robin L.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	University of Oxford; University of Oxford; University of British Columbia; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015; Lowe, Edward/AAP-5381-2021; Horsman, Geoff/AAQ-2349-2020	Eltis, Lindsay D/0000-0002-6774-8158; Lowe, Edward/0000-0002-1757-0208; Horsman, Geoff/0000-0002-2023-2349	Wellcome Trust; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Medical Research Council [G0802079] Funding Source: researchfish; MRC [G0802079] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust (to E. S.) and the Canadian Institutes of Health Research (to L. D. E.).; Recipient of a studentship from the Natural Sciences and Engineering Research Council of Canada.; Recipient of studentships from the Natural Sciences and Engineering Research Council and the Michael Smith Foundation for Health Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bhowmik S, 2007, J BIOL CHEM, V282, P36377, DOI 10.1074/jbc.M707035200; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DEREWENDA U, 1992, BIOCHEMISTRY-US, V31, P1532, DOI 10.1021/bi00120a034; Dunn G, 2005, J MOL BIOL, V346, P253, DOI 10.1016/j.jmb.2004.11.033; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERMAN JE, 1980, J BIOL CHEM, V255, P6224; Fleming SM, 2000, BIOCHEMISTRY-US, V39, P1522, DOI 10.1021/bi9923095; Gruber K, 2004, J BIOL CHEM, V279, P20501, DOI 10.1074/jbc.M401575200; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P4421, DOI 10.1128/AEM.69.8.4421-4430.2003; Horsman GP, 2007, J BIOL CHEM, V282, P19894, DOI 10.1074/jbc.M702237200; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; Hu JGG, 1997, BIOCHEMISTRY-US, V36, P9316, DOI 10.1021/bi970416y; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; Lack N, 2008, ACTA CRYSTALLOGR F, V64, P2, DOI 10.1107/S1744309107065931; Lack NA, 2009, BIOCHEM J, V418, P369, DOI 10.1042/BJ20082011; Lam WWY, 1997, BIOCHEMISTRY-US, V36, P12242, DOI 10.1021/bi971115r; Lanyi JK, 2007, J MOL BIOL, V365, P1379, DOI 10.1016/j.jmb.2006.11.016; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li C, 2005, J MOL BIOL, V346, P241, DOI 10.1016/j.jmb.2004.11.032; Li C, 2008, CHEMBIOCHEM, V9, P71, DOI 10.1002/cbic.200700428; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; Nandhagopal N, 2001, J MOL BIOL, V309, P1139, DOI 10.1006/jmbi.2001.4737; Nerdinger S, 2007, J ORG CHEM, V72, P5960, DOI 10.1021/jo062543i; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pagel W, 1925, VIRCHOWS ARCH A, V256, P629, DOI 10.1007/BF01891650; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seah SYK, 2007, J BACTERIOL, V189, P4038, DOI 10.1128/JB.01950-06; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; SOBEL H, 1949, J BACTERIOL, V57, P377, DOI 10.1128/JB.57.3.377-382.1949; VAGIN AA, 1994, ACTA CRYSTALLOGR D, V50, P760; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Williams DH., 1995, SPECTROSCOPIC METHOD, P63; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	42	77	82	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					434	443		10.1074/jbc.M109.058081	http://dx.doi.org/10.1074/jbc.M109.058081			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875455	Green Published, hybrid			2022-12-27	WOS:000273070100045
J	Qiu, LY; Pashkova, N; Walker, JR; Winistorfer, S; Allali-Hassani, A; Akutsu, M; Piper, R; Dhe-Paganon, S				Qiu, Liyan; Pashkova, Natasha; Walker, John R.; Winistorfer, Stanley; Allali-Hassani, Abdellah; Akutsu, Masato; Piper, Robert; Dhe-Paganon, Sirano			Structure and Function of the PLAA/Ufd3-p97/Cdc48 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN HOMEOSTASIS; PROTEIN; CDC48; P97; BINDING; YEAST; DEGRADATION; PATHWAY; DOA1	PLAA (ortholog of yeast Doa1/Ufd3, also know as human PLAP or phospholipase A2-activating protein) has been implicated in a variety of disparate biological processes that involve the ubiquitin system. It is linked to the maintenance of ubiquitin levels, but the mechanism by which it accomplishes this is unclear. The C-terminal PUL (PLAP, Ufd3p, and Lub1p) domain of PLAA binds p97, an AAA ATPase, which among other functions helps transfer ubiquitinated proteins to the proteasome for degradation. In yeast, loss of Doa1 is suppressed by altering p97/Cdc48 function indicating that physical interaction between PLAA and p97 is functionally important. Although the overall regions of interaction between these proteins are known, the structural basis has been unavailable. We solved the high resolution crystal structure of the p97-PLAA complex showing that the PUL domain forms a 6-mer Armadillo-containing domain. Its N-terminal extension folds back onto the inner curvature forming a deep ridge that is positively charged with residues that are phylogenetically conserved. The C terminus of p97 binds in this ridge, where the side chain of p97-Tyr(805), implicated in phosphorylation-dependent regulation, is buried. Expressed in doa1 Delta null cells, point mutants of the yeast ortholog Doa1 that disrupt this interaction display slightly reduced ubiquitin levels, but unlike doa1 Delta null cells, showed only some of the growth phenotypes. These data suggest that the p97-PLAA interaction is important for a subset of PLAA-dependent biological processes and provides a framework to better understand the role of these complex molecules in the ubiquitin system.	[Pashkova, Natasha; Winistorfer, Stanley; Piper, Robert] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Qiu, Liyan; Walker, John R.; Allali-Hassani, Abdellah; Akutsu, Masato; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Qiu, Liyan; Akutsu, Masato; Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	University of Iowa; University of Toronto; Structural Genomics Consortium; University of Toronto	Piper, R (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	robert-piper@uiowa.edu; sirano.dhepaganon@utoronto.ca	akutsu, masato/L-4095-2016	akutsu, masato/0000-0002-9839-3345; Piper, Robert/0000-0001-9995-5699; Pashkova, Natalya/0000-0002-2191-4683; /0000-0002-5255-895X	National Institutes of Health [RO1 GM58202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM58202 (to R. C. P.).	Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; CLARK MA, 1991, P NATL ACAD SCI USA, V88, P5418, DOI 10.1073/pnas.88.12.5418; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kunze D, 2007, MICROBIOL-SGM, V153, P1026, DOI 10.1099/mic.0.2006/002741-0; Li GT, 2008, BIOCHEM BIOPH RES CO, V375, P247, DOI 10.1016/j.bbrc.2008.08.018; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ren JH, 2008, J BIOL CHEM, V283, P21599, DOI 10.1074/jbc.M802982200; Ribardo DA, 2002, TOXICON, V40, P519, DOI 10.1016/S0041-0101(01)00247-1; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Wolfe D, 1999, MOL CELL BIOL, V19, P8254; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104; Zhao G, 2009, P NATL ACAD SCI USA, V106, P16197, DOI 10.1073/pnas.0908321106	34	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					365	372		10.1074/jbc.M109.044685	http://dx.doi.org/10.1074/jbc.M109.044685			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887378	Green Published, hybrid			2022-12-27	WOS:000273070100038
J	South, PF; Fingerman, IM; Mersman, DP; Du, HN; Briggs, SD				South, Paul F.; Fingerman, Ian M.; Mersman, Douglas P.; Du, Hai-Ning; Briggs, Scott D.			A Conserved Interaction between the SDI Domain of Bre2 and the Dpy-30 Domain of Sdc1 Is Required for Histone Methylation and Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3-LYS(4) METHYLTRANSFERASE COMPLEX; ELEGANS DOSAGE COMPENSATION; CXXC FINGER PROTEIN-1; C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; MOLECULAR REGULATION; H3K4 TRIMETHYLATION; ESSENTIAL COMPONENT; TRITHORAX FAMILY	In Saccharomyces cerevisiae, lysine 4 on histone H3 (H3K4) is methylated by the Set1 complex (Set1C or COMPASS). Besides the catalytic Set1 subunit, several proteins that form the Set1C (Swd1, Swd2, Swd3, Spp1, Bre2, and Sdc1) are also needed to mediate proper H3K4 methylation. Until this study, it has been unclear how individual Set1C members interact and how this interaction may impact histone methylation and gene expression. In this study, Bre2 and Sdc1 are shown to directly interact, and it is shown that the association of this heteromeric complex is needed for proper H3K4 methylation and gene expression to occur. Interestingly, mutational and biochemical analysis identified the C terminus of Bre2 as a critical protein-protein interaction domain that binds to the Dpy-30 domain of Sdc1. Using the human homologs of Bre2 and Sdc1, ASH2L and DPY-30, respectively, we demonstrate that the C terminus of ASH2L also interacts with the Dpy-30 domain of DPY-30, suggesting that this protein-protein interaction is maintained from yeast to humans. Because of the functionally conserved nature of the C terminus of Bre2 and ASH2L, this region was named the SDI (Sdc1 Dpy-30 interaction) domain. Finally, we show that the SDI-Dpy-30 domain interaction is physiologically important for the function of Set1 in vivo, because specific disruption of this interaction prevents Bre2 and Sdc1 association with Set1, resulting in H3K4 methylation defects and decreases in gene expression. Overall, these and other mechanistic studies on how H3K4 methyltransferase complexes function will likely provide insights into how human MLL and SET1-like complexes or overexpression of ASH2L leads to oncogenesis.	[Briggs, Scott D.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Briggs, SD (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ, W Lafayette, IN 47907 USA.	sdbriggs@purdue.edu	South, Paul/AAG-2634-2020; du, hai-ning/AAE-5626-2022; South, Paul/H-2636-2017; Du, Hai-Ning/AAI-2020-2021	South, Paul/0000-0001-7885-7096; South, Paul/0000-0001-7885-7096; Du, Hai-Ning/0000-0001-8062-5411; Briggs, Scott D/0000-0003-2852-3594	National Institutes of Health [GM74183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM74183 (to S. D. B.).	Boa S, 2003, YEAST, V20, P827, DOI 10.1002/yea.995; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cui Y, 2008, MOL GENET GENOMICS, V279, P323, DOI 10.1007/s00438-007-0314-1; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dong XH, 2005, BBA-PROTEINS PROTEOM, V1753, P257, DOI 10.1016/j.bbapap.2005.08.011; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morikis D, 2002, EUR J BIOCHEM, V269, P2040, DOI 10.1046/j.1432-1033.2002.02852.x; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Subramaniam S, 1998, PROTEINS, V32, P1; Tate CM, 2009, MOL CELL BIOL, V29, P3817, DOI 10.1128/MCB.00243-09; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Wang XP, 2009, J MOL BIOL, V390, P530, DOI 10.1016/j.jmb.2009.05.061; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	57	37	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					595	607		10.1074/jbc.M109.042697	http://dx.doi.org/10.1074/jbc.M109.042697			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19897479	Green Published, hybrid			2022-12-27	WOS:000273070100061
J	Koczor, CA; Shokolenko, IN; Boyd, AK; Balk, SP; Wilson, GL; LeDoux, SP				Koczor, Christopher A.; Shokolenko, Inna N.; Boyd, Amy K.; Balk, Shawn P.; Wilson, Glenn L.; LeDoux, Susan P.			Mitochondrial DNA Damage Initiates a Cell Cycle Arrest by a Chk2-associated Mechanism in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE GLYCOSYLASE; INDUCED OXIDATIVE STRESS; PROTEIN-KINASE; INDUCED APOPTOSIS; MTDNA DAMAGE; PATHWAY; OLIGODENDROCYTES; ACTIVATION; RADIATION	Previous work from our laboratory has focused on mitochondrial DNA (mtDNA) repair and cellular viability. However, other events occur prior to the initiation of apoptosis in cells. Because of the importance of mtDNA in ATP production and of ATP in fuel cell cycle progression, we asked whether mtDNA damage was an upstream signal leading to cell cycle arrest. Using quantitative alkaline Southern blot technology, we found that exposure to menadione produced detectable mtDNA damage in HeLa cells that correlated with an S phase cell cycle arrest. To determine whether mtDNA damage was causatively linked to the observed cell cycle arrest, experiments were performed utilizing a MTS-hOGG1-Tat fusion protein to target the hOGG1 repair enzyme to mitochondria and enhance mtDNA repair. The results revealed that the transduction of MTS-hOGG1-Tat into HeLa cells alleviated the cell cycle block following an oxidative insult. Furthermore, mechanistic studies showed that Chk2 phosphorylation was enhanced following menadione exposure. Treatment of the HeLa cells with the hOGG1 fusion protein prior to menadione exposure resulted in an increase in the rate of Chk2 dephosphorylation. These results strongly support a direct link between mtDNA damage and cell cycle arrest.	[Koczor, Christopher A.; Shokolenko, Inna N.; Boyd, Amy K.; Balk, Shawn P.; Wilson, Glenn L.; LeDoux, Susan P.] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA	University of South Alabama	LeDoux, SP (corresponding author), 307 Univ Blvd,MSB1200, Mobile, AL 36688 USA.	sledoux@usouthal.edu		Koczor, Christopher/0000-0003-3565-7953				Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Dobson AW, 2000, J BIOL CHEM, V275, P37518, DOI 10.1074/jbc.M000831200; Druzhyna NM, 2005, J BIOL CHEM, V280, P21673, DOI 10.1074/jbc.m411531200; Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230; Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Harrison JF, 2005, NUCLEIC ACIDS RES, V33, P4660, DOI 10.1093/nar/gki759; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8; LeDoux SP, 1998, GLIA, V24, P304, DOI 10.1002/(SICI)1098-1136(199811)24:3<304::AID-GLIA4>3.3.CO;2-J; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Martinez-Alvarado P, 2001, BIOCHEM BIOPH RES CO, V283, P1069, DOI 10.1006/bbrc.2001.4907; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Paris I, 2005, J NEUROCHEM, V92, P1021, DOI 10.1111/j.1471-4159.2004.02931.x; Paris I, 2008, NEUROTOX RES, V13, P221, DOI 10.1007/BF03033505; Rachek LI, 2002, J BIOL CHEM, V277, P44932, DOI 10.1074/jbc.M208770200; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Shokolenko IN, 2005, DNA REPAIR, V4, P511, DOI 10.1016/j.dnarep.2004.11.009; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Spiteller G, 2002, ANN NY ACAD SCI, V959, P30, DOI 10.1111/j.1749-6632.2002.tb02080.x; Tombes RM, 1998, BIOCHEM J, V330, P1451; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001	25	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36191	36201		10.1074/jbc.M109.036020	http://dx.doi.org/10.1074/jbc.M109.036020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19840931	hybrid, Green Published			2022-12-27	WOS:000272970500021
J	Zhang, X; Shephard, F; Kim, HB; Palmer, IR; McHarg, S; Fowler, GJS; O'Neill, LAJ; Kiss-Toth, E; Qwarnstrom, EE				Zhang, Xiao; Shephard, Freya; Kim, Hong B.; Palmer, Ian R.; McHarg, Selina; Fowler, Gregory J. S.; O'Neill, Luke A. J.; Kiss-Toth, Endre; Qwarnstrom, Eva E.			TILRR, a Novel IL-1RI Co-receptor, Potentiates MyD88 Recruitment to Control Ras-dependent Amplification of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; HEPARAN-SULFATE; EXTRACELLULAR-MATRIX; CELLS; MECHANOTRANSDUCTION; INTERLEUKIN-1-BETA; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION	Host defense against infection is induced by Toll-like and interleukin (IL)-1 receptors, and controlled by the transcription factor NF-kappa B. Our earlier studies have shown that IL-1 activation impacts cytoskeletal structure and that IL-1 receptor (IL-1RI) function is substrate-dependent. Here we identify a novel regulatory component, TILRR, which amplifies activation of IL-1RI and coordinates IL-1-induced control with mechanotransduction. We show that TILRR is a highly conserved and widely expressed enhancer of IL-1-regulated inflammatory responses and, further, that it is a membrane-bound glycosylated protein with sequence homology to members of the FRAS-1 family. We demonstrate that TILRR is recruited to the IL-1 receptor complex and magnifies signal amplification by increasing receptor expression and ligand binding. In addition, we show that the consequent potentiation of NF-kappa B is controlled through IL-1RI-associated signaling components in coordination with activation of the Ras GTPase. Using mutagenesis, we demonstrate that TILRR function is dependent on association with its signaling partner and, further, that formation of the TILRR-containing IL-1RI complex imparts enhanced association of the MyD88 adapter during ligand-induced activation of NF-kappa B. We conclude that TILRR is an IL-1RI co-receptor, which associates with the signaling receptor complex to enhance recruitment of MyD88 and control Ras-dependent amplification of NF-kappa B and inflammatory responses.	[Qwarnstrom, Eva E.] Univ Sheffield, Sch Med & Biomed Sci, Cell Biol Unit, Sheffield S10 2RX, S Yorkshire, England; [Kiss-Toth, Endre] Univ Sheffield, Sch Med & Biomed Sci, Cardiovasc Res Unit, Sheffield S10 2RX, S Yorkshire, England; [O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Qwarnstrom, Eva E.] Univ Washington, Affiliated Dept Pathol, Seattle, WA 98195 USA	University of Sheffield; University of Sheffield; Trinity College Dublin; University of Washington; University of Washington Seattle	Qwarnstrom, EE (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Cell Biol Unit, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	e.qwarnstrom@sheffield.ac.uk	Kiss-Toth, Endre/A-8596-2014; Kiss-Toth, Endre/AAC-4252-2020	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Fowler, Gregory/0000-0002-0420-7661; Qwarnstrom, Eva/0000-0003-4417-8663; Palmer, Ian Roy/0000-0002-6884-8900; O'Neill, Luke/0000-0002-4333-2748; Zhang, Xiao/0000-0002-3894-8513	Biotechnology and Biological Sciences Research Council [BB/C515798/1, BBS/B/04056]; British Heart Foundation [PG/2000094, PG/07/094/23742]; Engineering and Physical Sciences Research Council [EP/E036252/1] Funding Source: researchfish; EPSRC [EP/E036252/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/C515798/1 and BBS/B/04056 and British Heart Foundation Grants PG/2000094 and PG/07/094/23742 (to E. E. Q.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Ashcroft AE, 2003, NAT PROD REP, V20, P202, DOI 10.1039/b201368c; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Caunt CJ, 2001, J BIOL CHEM, V276, P6280, DOI 10.1074/jbc.M006772200; Cumberbatch M, 1997, IMMUNOLOGY, V92, P388, DOI 10.1046/j.1365-2567.1997.00360.x; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Fukushima K, 2005, J BIOL CHEM, V280, P18056, DOI 10.1074/jbc.M413297200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pogson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002367; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Valles S, 2002, LAB INVEST, V82, P855, DOI 10.1097/01.LAB.0000020420.07575.3F; Valles S, 1999, J BIOL CHEM, V274, P20103, DOI 10.1074/jbc.274.29.20103; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Yang L, 2003, J BIOL CHEM, V278, P30881, DOI 10.1074/jbc.M212216200; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393	36	30	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7222	7232		10.1074/jbc.M109.073429	http://dx.doi.org/10.1074/jbc.M109.073429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19940113	hybrid, Green Published			2022-12-27	WOS:000275415600035
J	Xiao, LP; Naganawa, T; Lorenzo, J; Carpenter, TO; Coffin, JD; Hurley, MM				Xiao, Liping; Naganawa, Takahiro; Lorenzo, Joseph; Carpenter, Thomas O.; Coffin, J. Douglas; Hurley, Marja M.			Nuclear Isoforms of Fibroblast Growth Factor 2 Are Novel Inducers of Hypophosphatemia via Modulation of FGF23 and KLOTHO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; BONE MINERALIZATION; FACTOR FGF-2; GENE; PROTEIN; EXPRESSION; DISORDERS; RECEPTOR; MATRIX; LOCALIZATION	FGF2 transgenic mice were developed in which type I collagen regulatory sequences drive the nuclear high molecular weight FGF2 isoforms in osteoblasts (TgHMW). The phenotype of TgHMW mice included dwarfism, decreased bone mineral density (BMD), osteomalacia, and decreased serum phosphate (P-i). When TgHMW mice were fed a high P-i diet, BMD was increased, and dwarfism was partially reversed. The TgHMW phenotype was similar to mice overexpressing FGF23. Serum FGF23 was increased in TgHMW mice. Fgf23 mRNA in bones and fibroblast growth factor receptors 1c and 3c and Klotho mRNAs in kidneys were increased in TgHMW mice, whereas the renal Na+/P-i co-transporter Npt2a mRNA was decreased. Immunohistochemistry and Western blot analyses of TgHMW kidneys showed increased KLOTHO and decreased NPT2a protein. The results suggest that overexpression of HMW FGF2 increases FGF23/FGFR/KLOTHO signaling to down-regulate NPT2a, causing P-i wasting, osteomalacia, and decreased BMD. We assessed whether HMW FGF2 expression was altered in the Hyp mouse, a mouse homolog of the human disease X-linked hypophosphatemic rickets/osteomalacia. Fgf2 mRNA was increased in bones, and Western blots showed increased FGF2 protein in nuclear fractions from osteoblasts of Hyp mice. In addition, immunohistochemistry demonstrated co-localization of FGF23 and HMW FGF2 protein in osteoblasts and osteocytes from Hyp mice. This study reveals a novel mechanism of regulation of the FGF23-P-i homeostatic axis.	[Hurley, Marja M.] Univ Connecticut, Sch Med, Div Endocrinol & Metab, Dept Med,Hlth Ctr, Farmington, CT 06030 USA; [Carpenter, Thomas O.] Yale Univ, Sch Med, Dept Pediat Endocrinol, New Haven, CT 06520 USA; [Coffin, J. Douglas] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA	University of Connecticut; Yale University; University of Montana System; University of Montana	Hurley, MM (corresponding author), Univ Connecticut, Sch Med, Div Endocrinol & Metab, Dept Med,Hlth Ctr, 263 Farmington Ave, Farmington, CT 06030 USA.	hurley@exchange.uchc.edu			National Institutes of Health [AG021189]; NATIONAL INSTITUTE ON AGING [R01AG021189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021189 (to M. M. H.).	Arese M, 1999, MOL BIOL CELL, V10, P1429, DOI 10.1091/mbc.10.5.1429; Beck L, 1997, J CLIN INVEST, V99, P1200, DOI 10.1172/JCI119276; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; DeMoerlooze L, 1997, CURR OPIN GENET DEV, V7, P378, DOI 10.1016/S0959-437X(97)80152-9; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FLORKIEWICZ RZ, 1991, ANN NY ACAD SCI, V638, P109, DOI 10.1111/j.1749-6632.1991.tb49022.x; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Fukumoto S, 2008, INTERNAL MED, V47, P337, DOI 10.2169/internalmedicine.47.0730; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Hollberg K, 2008, BONE, V42, P1111, DOI 10.1016/j.bone.2008.01.019; HURLEY MM, 2002, PRINCIPLES BONE BIOL, P825; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jiang ZS, 2007, J MOL CELL CARDIOL, V42, P222, DOI 10.1016/j.yjmcc.2006.09.002; Korpela J, 2006, ANTICANCER RES, V26, P3127; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Liao SY, 2007, J MOL CELL CARDIOL, V42, P106, DOI 10.1016/j.yjmcc.2006.10.005; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Lizarraga G, 2002, DEV BIOL, V243, P44, DOI 10.1006/dbio.2001.0559; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Ma X, 2007, J CELL PHYSIOL, V213, P690, DOI 10.1002/jcp.21139; MARIE PJ, 1983, CALCIFIED TISSUE INT, V35, P443, DOI 10.1007/BF02405074; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Quarles LD, 2003, J CLIN INVEST, V112, P642, DOI 10.1172/JC1200319687; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sobue T, 2005, J CELL BIOCHEM, V95, P83, DOI 10.1002/jcb.20389; Suttamanatwong S, 2007, J CELL BIOCHEM, V102, P496, DOI 10.1002/jcb.21314; Terashima Y, 2008, J CELL PHYSIOL, V216, P640, DOI 10.1002/jcp.21443; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wamsley HL, 2005, TOXICOL PATHOL, V33, P577, DOI 10.1080/01926230500243060; Wang JS, 1996, ACTA ORTHOP SCAND, V67, P1; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xiao LP, 2009, J BIOL CHEM, V284, P3170, DOI 10.1074/jbc.M804900200; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002	50	50	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2834	2846		10.1074/jbc.M109.030577	http://dx.doi.org/10.1074/jbc.M109.030577			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933269	Green Published, hybrid			2022-12-27	WOS:000273697800059
J	Zhao, LL; Jin, CJ; Chu, YJ; Varghese, C; Hua, SS; Yan, F; Miao, Y; Liu, J; Mann, D; Ding, X; Zhang, JC; Wang, ZY; Dou, Z; Yao, XB				Zhao, Lingli; Jin, Changjiang; Chu, Youjun; Varghese, Chris; Hua, Shasha; Yan, Feng; Miao, Yong; Liu, Jing; Mann, David; Ding, Xia; Zhang, Jiancun; Wang, Zhiyong; Dou, Zhen; Yao, Xuebiao			Dimerization of CPAP Orchestrates Centrosome Cohesion Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE-REGULATED PROTEIN; CELL-CYCLE; BRAIN SIZE; C-ELEGANS; NEK2; KINASE; DUPLICATION; INTERACTS; CDK5RAP2; CENPJ	Centrosome cohesion and segregation are accurately regulated to prevent an aberrant separation of duplicated centrosomes and to ensure the correct formation of bipolar spindles by a tight coupling with cell cycle machinery. CPAP is a centrosome protein with five coiled-coil domains and plays an important role in the control of brain size in autosomal recessive primary microcephaly. Previous studies showed that CPAP interacts with tubulin and controls centriole length. Here, we reported that CPAP forms a homodimer during interphase, and the fifth coiled-coil domain of CPAP is required for its dimerization. Moreover, this self-interaction is required for maintaining centrosome cohesion and preventing the centrosome from splitting before the G2/M phase. Our biochemical studies show that CPAP forms homodimers in vivo. In addition, both monomeric and dimeric CPAP are required for accurate cell division, suggesting that the temporal dynamics of CPAP homodimerization is tightly regulated during the cell cycle. Significantly, our results provide evidence that CPAP is phosphorylated during mitosis, and this phosphorylation releases its intermolecular interaction. Taken together, these results suggest that cell cycle-regulated phosphorylation orchestrates the dynamics of CPAP molecular interaction and centrosome splitting to ensure genomic stability in cell division.	[Zhao, Lingli; Jin, Changjiang; Chu, Youjun; Hua, Shasha; Yan, Feng; Miao, Yong; Liu, Jing; Wang, Zhiyong; Dou, Zhen; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Zhao, Lingli; Jin, Changjiang; Chu, Youjun; Hua, Shasha; Yan, Feng; Miao, Yong; Liu, Jing; Wang, Zhiyong; Dou, Zhen; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Varghese, Chris; Yan, Feng; Mann, David; Dou, Zhen] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Ding, Xia] Beijing Univ Chinese Med, Dept Med, Beijing 100029, Peoples R China; [Zhang, Jiancun] Guangzhou Inst Hlth Sci, Guangzhou 510515, Guangdong, Peoples R China	Morehouse School of Medicine; Beijing University of Chinese Medicine	Dou, Z (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn; yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; MIAO, YONG/D-4244-2015; DOU, ZHEN/N-2022-2013	DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK-56292, CA89019, CA92080, CA118948, G12RR03034]; Chinese Academy of Science [KSCX1YW-R65, KSCX2-YW-H10]; Chinese 973 Project [2002CB713700, 2006CB943600, 2007CB914503, 2010CB912103, 2006AA02A247]; Chinese Natural Science Foundation [30270654, 30070349, 90508002, 30121001, 30871236, 90813008, 30870990]; China National Key Projects for Infectious Disease [2008ZX10002-021]; American Cancer Society [RPG-99-173-01]; Georgia Cancer Coalition Breast Cancer; Atlanta Clinical and Translational Science Award Chemical Biology [P20RR011104]; NATIONAL CANCER INSTITUTE [U54CA118948, U56CA092080, P50CA089019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011104, G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China National Key Projects for Infectious Disease; American Cancer Society(American Cancer Society); Georgia Cancer Coalition Breast Cancer; Atlanta Clinical and Translational Science Award Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-56292, CA89019, CA92080, and CA118948 and Grant G12RR03034 from the NCRR for work performed in the facilities used. This work was also supported by Chinese Academy of Science Grants KSCX1YW-R65 and KSCX2-YW-H10, Chinese 973 Project Grants 2002CB713700, 2006CB943600, 2007CB914503, and 2010CB912103, Chinese 863 Project Grant 2006AA02A247, Chinese Natural Science Foundation Grants 30270654, 30070349, 90508002, 30121001, and 30871236 (to C. J.), 90813008 (to Z. W.), and 30870990 (to X. D.), China National Key Projects for Infectious Disease Grant 2008ZX10002-021, American Cancer Society Grant RPG-99-173-01, a research grant from Georgia Cancer Coalition Breast Cancer, and Atlanta Clinical and Translational Science Award Chemical Biology Grant P20RR011104.	Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Evans PD, 2006, GENE, V375, P75, DOI 10.1016/j.gene.2006.02.019; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Gul A, 2006, J HUM GENET, V51, P760, DOI 10.1007/s10038-006-0017-1; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Peng B, 2002, MOL ENDOCRINOL, V16, P2019, DOI 10.1210/me.2002-0108; Salisbury JL, 2003, TRENDS CELL BIOL, V13, P340, DOI 10.1016/S0962-8924(03)00126-0; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yang J, 2006, MOL BIOL CELL, V17, P1033, DOI 10.1091/mbc.E05-10-0943; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	40	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2488	2497		10.1074/jbc.M109.042614	http://dx.doi.org/10.1074/jbc.M109.042614			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19889632	Green Published, hybrid			2022-12-27	WOS:000273697800027
J	Lee, YS; Lee, S; Demeler, B; Molineux, IJ; Johnson, KA; Yin, YW				Lee, Young-Sam; Lee, Sujin; Demeler, Borries; Molineux, Ian J.; Johnson, Kenneth A.; Yin, Y. Whitney			Each Monomer of the Dimeric Accessory Protein for Human Mitochondrial DNA Polymerase Has a Distinct Role in Conferring Processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; III HOLOENZYME; SUBUNIT; GAMMA; PURIFICATION; BACTERIOPHAGE-T7; MUTATIONS; BINDING; PRIMASE	The accessory protein polymerase (pol) gamma B of the human mitochondrial DNA polymerase stimulates the synthetic activity of the catalytic subunit. pol gamma B functions by both accelerating the polymerization rate and enhancing polymerase-DNA interaction, thereby distinguishing itself from the accessory subunits of other DNA polymerases. The molecular basis for the unique functions of human pol gamma B lies in its dimeric structure, where the pol gamma B monomer proximal to pol gamma A in the holoenzyme strengthens the interaction with DNA, and the distal pol gamma B monomer accelerates the reaction rate. We further show that human pol gamma B exhibits a catalytic subunit- and substrate DNA-dependent dimerization. By duplicating the monomeric pol gamma B of lower eukaryotes, the dimeric mammalian proteins confer additional processivity to the holoenzyme polymerase.	[Lee, Young-Sam; Lee, Sujin; Molineux, Ian J.; Johnson, Kenneth A.; Yin, Y. Whitney] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Molineux, Ian J.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Johnson, Kenneth A.; Yin, Y. Whitney] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Yin, YW (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway,MBB 3-422, Austin, TX 78712 USA.	whitney.yin@mail.utexas.edu		Demeler, Borries/0000-0002-2414-9518	National Institutes of Health [GM032095, GM044613, GM083703]; Welch Foundation [F-1604, F-1592]; NIH [RR022200]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032095, R01GM083703, R01GM044613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM032095 (to I.J.M.), GM044613 (to K.A.J.), and GM083703 (to Y.W.Y.). This work was also supported by Welch Foundation Grants F-1604 and F-1592 (to K.A.J. and Y.W.Y., respectively). Continuing development of the UltraScan software is supported by NIH Grant RR022200 (to B.D.).	Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018; BROOKES E, 2009, EUR BIOPHYS J; BROOKES E, 2007, GECCO P ACM NEW YORK; Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DURCHSCHLAG H, 1986, SPECIFIC VOLUMES BIO, P45; Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; HORI K, 1979, J BIOL CHEM, V254, P1591; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yan L, 2004, J MOL CELL CARDIOL, V37, P921, DOI 10.1016/j.yjmcc.2004.06.012; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	30	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1490	1499		10.1074/jbc.M109.062752	http://dx.doi.org/10.1074/jbc.M109.062752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19858216	hybrid, Green Published			2022-12-27	WOS:000273258200068
J	Chowanadisai, W; Bauerly, KA; Tchaparian, E; Wong, A; Cortopassi, GA; Rucker, RB				Chowanadisai, Winyoo; Bauerly, Kathryn A.; Tchaparian, Eskouhie; Wong, Alice; Cortopassi, Gino A.; Rucker, Robert B.			Pyrroloquinoline Quinone Stimulates Mitochondrial Biogenesis through cAMP Response Element-binding Protein Phosphorylation and Increased PGC-1 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; COACTIVATOR PGC-1; HEPATIC GLUCONEOGENESIS; GENE-EXPRESSION; FATTY-ACIDS; MICE; CREB; CELLS; TRANSCRIPTION; BRAIN	Bioactive compounds reported to stimulate mitochondrial biogenesis are linked to many health benefits such increased longevity, improved energy utilization, and protection from reactive oxygen species. Previously studies have shown that mice and rats fed diets lacking in pyrroloquinoline quinone (PQQ) have reduced mitochondrial content. Therefore, we hypothesized that PQQ can induce mitochondrial biogenesis in mouse hepatocytes. Exposure of mouse Hepa1-6 cells to 10-30 mu M PQQ for 24-48 h resulted in increased citrate synthase and cytochrome c oxidase activity, Mitotracker staining, mitochondrial DNA content, and cellular oxygen respiration. The induction of this process occurred through the activation of cAMP response element-binding protein (CREB) and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), a pathway known to regulate mitochondrial biogenesis. PQQ exposure stimulated phosphorylation of CREB at serine 133, activated the promoter of PGC-1 alpha, and increased PGC-1 alpha mRNA and protein expression. PQQ did not stimulate mitochondrial biogenesis after small interfering RNA-mediated reduction in either PGC-1 alpha or CREB expression. Consistent with activation of the PGC-1 alpha pathway, PQQ increased nuclear respiratory factor activation (NRF-1 and NRF-2) and Tfam, TFB1M, and TFB2M mRNA expression. Moreover, PQQ protected cells from mitochondrial inhibition by rotenone, 3-nitro-propionic acid, antimycin A, and sodium azide. The ability of PQQ to stimulate mitochondrial biogenesis accounts in part for action of this compound and suggests that PQQ may be beneficial in diseases associated with mitochondrial dysfunction.	[Chowanadisai, Winyoo; Bauerly, Kathryn A.; Rucker, Robert B.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Tchaparian, Eskouhie] Amgen Inc, San Francisco, CA 94080 USA; [Wong, Alice] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Cortopassi, Gino A.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis; Amgen; University of California System; University of California Davis; University of California System; University of California Davis	Rucker, RB (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	rbrucker@ucdavis.edu			Mitsubishi Gas Chemical Co; University of California Davis Center for Health and Nutrition Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035747] Funding Source: NIH RePORTER	Mitsubishi Gas Chemical Co; University of California Davis Center for Health and Nutrition Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Mitsubishi Gas Chemical Co. and the University of California Davis Center for Health and Nutrition Research.	AIZENMAN E, 1992, J NEUROSCI, V12, P2362; Bauerly KA, 2006, BBA-GEN SUBJECTS, V1760, P1741, DOI 10.1016/j.bbagen.2006.07.009; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carter CS, 2007, APPL PHYSIOL NUTR ME, V32, P954, DOI 10.1139/H07-085; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Choi YS, 2002, BBA-GENE STRUCT EXPR, V1574, P200, DOI 10.1016/S0167-4781(01)00361-X; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Das S, 2008, PHARM RES-DORDR, V25, P2593, DOI 10.1007/s11095-008-9677-1; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; Felton LM, 2005, NATURE, V433, pE10, DOI 10.1038/nature03322; GALLOP PM, 1989, TRENDS BIOCHEM SCI, V14, P343, DOI 10.1016/0968-0004(89)90169-2; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hara H, 2007, NEUROCHEM RES, V32, P489, DOI 10.1007/s11064-006-9257-x; He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; JENSEN FE, 1994, NEUROSCIENCE, V62, P399, DOI 10.1016/0306-4522(94)90375-1; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liang HY, 2007, ANN NY ACAD SCI, V1100, P264, DOI 10.1196/annals.1395.028; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161; Liu ZB, 2007, J NEUROCHEM, V103, P2690, DOI 10.1111/j.1471-4159.2007.04954.x; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MARTIN PM, 1978, ENDOCRINOLOGY, V103, P1860, DOI 10.1210/endo-103-5-1860; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Nunome K, 2008, BIOL PHARM BULL, V31, P1321, DOI 10.1248/bpb.31.1321; Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Rantanen A, 2001, MAMM GENOME, V12, P787, DOI 10.1007/s00335-001-2052-8; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Rasbach KA, 2007, BIOCHEM BIOPH RES CO, V355, P734, DOI 10.1016/j.bbrc.2007.02.023; Rucker R, 2005, NATURE, V433, pE10, DOI 10.1038/nature03323; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; SMIDT CR, 1991, P SOC EXP BIOL MED, V197, P27; Smith TS, 1997, BRAIN RES, V765, P183, DOI 10.1016/S0006-8993(97)00429-0; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stancanelli R, 2007, J PHARMACEUT BIOMED, V44, P980, DOI 10.1016/j.jpba.2007.03.025; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Stites TE, 2000, J NUTR, V130, P719, DOI 10.1093/jn/130.4.719; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111	72	151	170	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					142	152		10.1074/jbc.M109.030130	http://dx.doi.org/10.1074/jbc.M109.030130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861415	Green Published, hybrid			2022-12-27	WOS:000273070100015
J	Sarkar, MK; Paul, K; Blair, DF				Sarkar, Mayukh K.; Paul, Koushik; Blair, David F.			Subunit Organization and Reversal-associated Movements in the Flagellar Switch of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; PROTEIN FLIG; C-RING; REGULATED UNDEREXPRESSION; MUTATIONAL ANALYSIS; BACTERIAL FLAGELLA; GENERATING UNITS; MOTB PROTEIN	Bacterial flagella contain a rotor-mounted protein complex termed the switch complex that functions in flagellar assembly, rotation, and clockwise/counterclockwise direction control. In Escherichia coli and Salmonella, the switch complex contains the proteins FliG, FliM, and FliN and corresponds structurally with the C-ring in the flagellar basal body. Certain features of subunit organization in the switch complex have been deduced previously, but details of subunit organization in the lower part of the C-ring and the molecular movements responsible for motor switching remain unclear. In this study, we use cross-linking, binding, and mutational experiments to examine subunit organization in the bottom of the C-ring and to probe movements that occur upon switching. The results show that FliN tetramers alternate with FliM C-terminal domains to form the bottom of the C-ring in an arrangement that closely reproduces the major features observed in electron microscopic reconstructions. When motors were switched to clockwise rotation by a repellent stimulus, cross-link yields were altered in a pattern indicating relative movement of FliN and FliM(C). These results are discussed in the framework of a structurally grounded hypothesis for the switching mechanism.	[Sarkar, Mayukh K.; Paul, Koushik; Blair, David F.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Blair, DF (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	blair@bioscience.utah.edu	Sarkar, Mayukh/AAH-3655-2021	Sarkar, Mayukh/0000-0002-7974-2300	National Institutes of Health, NIGMS [R01 GM64664, GM64116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064664] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64664 from NIGMS and Grant GM64116.	BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BLAIR DF, 1991, J BACTERIOL, V173, P4049, DOI 10.1128/jb.173.13.4049-4055.1991; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; BROWN D A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1388, DOI 10.1073/pnas.71.4.1388; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; CHUN SY, 1988, SCIENCE, V239, P276, DOI 10.1126/science.2447650; DEAN GE, 1984, J BACTERIOL, V159, P991, DOI 10.1128/JB.159.3.991-999.1984; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; GLAGOLEV AN, 1978, NATURE, V272, P280, DOI 10.1038/272280a0; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; HIROTA N, 1983, J BIOL CHEM, V258, P577; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; KAWAGISHI I, 1995, J BACTERIOL, V177, P5158, DOI 10.1128/jb.177.17.5158-5160.1995; KHAN IH, 1992, P NATL ACAD SCI USA, V89, P5956, DOI 10.1073/pnas.89.13.5956; Kihara M, 1996, J BACTERIOL, V178, P4582, DOI 10.1128/jb.178.15.4582-4589.1996; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239; LEE GF, 1994, J BIOL CHEM, V269, P29920; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; Lowder BJ, 2005, J BACTERIOL, V187, P5640, DOI 10.1128/JB.187.16.5640-5647.2005; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Mathews MAA, 1998, J BACTERIOL, V180, P5580, DOI 10.1128/JB.180.21.5580-5590.1998; McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890; MORRISON TB, 1994, P NATL ACAD SCI USA, V91, P5485, DOI 10.1073/pnas.91.12.5485; OOSAWA K, 1994, J BACTERIOL, V176, P3683, DOI 10.1128/JB.176.12.3683-3691.1994; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Paul K, 2006, J BACTERIOL, V188, P2502, DOI 10.1128/JB.188.7.2502-2511.2006; Paul K, 2006, J BACTERIOL, V188, P5240, DOI 10.1128/JB.00110-06; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; STADER J, 1986, J BACTERIOL, V166, P244, DOI 10.1128/jb.166.1.244-252.1986; Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453; TANG H, 1995, J BACTERIOL, V177, P3496, DOI 10.1128/jb.177.12.3496-3503.1995; TANG H, 1995, J BACTERIOL, V177, P3485, DOI 10.1128/jb.177.12.3485-3495.1995; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; VOGLER AP, 1991, J BACTERIOL, V173, P3564, DOI 10.1128/jb.173.11.3564-3572.1991; YAMAGUCHI S, 1986, J BACTERIOL, V168, P1172, DOI 10.1128/jb.168.3.1172-1179.1986; YAMAGUCHI S, 1986, J BACTERIOL, V166, P187, DOI 10.1128/jb.166.1.187-193.1986; ZHAO RB, 1995, J MOL BIOL, V251, P400, DOI 10.1006/jmbi.1995.0443; Zhao RH, 1996, J MOL BIOL, V261, P195, DOI 10.1006/jmbi.1996.0452; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Zhou JD, 1998, J BACTERIOL, V180, P2729, DOI 10.1128/JB.180.10.2729-2735.1998	51	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					675	684		10.1074/jbc.M109.068676	http://dx.doi.org/10.1074/jbc.M109.068676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858188	Green Published, hybrid			2022-12-27	WOS:000273070100068
J	Abelson, J				Abelson, John			From Molecular Biology to Geology: A Surprising Trajectory (Reprinted)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Reprint									Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94131 USA	University of California System; University of California San Francisco	Abelson, J (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94131 USA.	johnabelson@gmail.com						ABELSON J, 2007, B AM ACAD ARTS SCI; Cohen PA, 2009, J PALEONTOL, V83, P110, DOI 10.1666/09-040R.1; DICKSON RC, 1977, J MOL BIOL, V111, P65, DOI 10.1016/S0022-2836(77)80132-0; KNOLL A, 2009, PRECAMBRIAN RES, V169; VILLAFRANCA JE, 1983, SCIENCE, V222, P782, DOI 10.1126/science.6356360	5	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					35997	36006		10.1074/jbc.X109.076836	http://dx.doi.org/10.1074/jbc.X109.076836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19854832	Green Published, hybrid			2022-12-27	WOS:000272970500001
J	Bedhomme, M; Zaffagnini, M; Marchand, CH; Gao, XH; Moslonka-Lefebvre, M; Michelet, L; Decottignies, P; Lemaire, SD				Bedhomme, Mariette; Zaffagnini, Mirko; Marchand, Christophe H.; Gao, Xing-Huang; Moslonka-Lefebvre, Mathieu; Michelet, Laure; Decottignies, Paulette; Lemaire, Stephane D.			Regulation by Glutathionylation of Isocitrate Lyase from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-GLUTATHIONYLATION; ESCHERICHIA-COLI; THIOREDOXIN REDUCTASE; SACCHAROMYCES-CEREVISIAE; ACTIVE-SITE; ACID CYCLE; GLUTAREDOXINS; ARABIDOPSIS; MECHANISMS; REVEALS	Post-translational modification of protein cysteine residues is emerging as an important regulatory and signaling mechanism. We have identified numerous putative targets of redox regulation in the unicellular green alga Chlamydomonas reinhardtii. One enzyme, isocitrate lyase (ICL), was identified both as a putative thioredoxin target and as an S-thiolated protein in vivo. ICL is a key enzyme of the glyoxylate cycle that allows growth on acetate as a sole source of carbon. The aim of the present study was to clarify the molecular mechanism of the redox regulation of Chlamydomonas ICL using a combination of biochemical and biophysical methods. The results clearly show that purified C. reinhardtii ICL can be inactivated by glutathionylation and reactivated by glutaredoxin, whereas thioredoxin does not appear to regulate ICL activity, and no inter-or intramolecular disulfide bond could be formed under any of the conditions tested. Glutathionylation of the protein was investigated by mass spectrometry analysis, Western blotting, and site-directed mutagenesis. The enzyme was found to be protected from irreversible oxidative inactivation by glutathionylation of its catalytic Cys(178), whereas a second residue, Cys(247), becomes artifactually glutathionylated after prolonged incubation with GSSG. The possible functional significance of this post-translational modification of ICL in Chlamydomonas and other organisms is discussed.	[Bedhomme, Mariette; Zaffagnini, Mirko; Gao, Xing-Huang; Moslonka-Lefebvre, Mathieu; Michelet, Laure; Lemaire, Stephane D.] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, F-91405 Orsay, France; [Marchand, Christophe H.; Decottignies, Paulette] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lemaire, SD (corresponding author), Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, Batiment 630, F-91405 Orsay, France.	stephane.lemaire@u-psud.fr	Gao, XingHuang/G-8579-2017; Lemaire, Stéphane D/A-3530-2008; MARCHAND, Christophe H/B-5854-2008	Lemaire, Stéphane D/0000-0001-6442-0547; MARCHAND, Christophe H/0000-0002-0729-3841; Zaffagnini, Mirko/0000-0001-5115-0859	Agence Nationale de la Recherche [ANR-08-BLAN-0153]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grant ANR-08-BLAN-0153.	Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Britton KL, 2001, ACTA CRYSTALLOGR D, V57, P1209, DOI 10.1107/S0907444901008642; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chaves RS, 1997, GENE, V198, P165, DOI 10.1016/S0378-1119(97)00311-9; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DIEHL P, 1994, J BACTERIOL, V176, P927, DOI 10.1128/jb.176.3.927-931.1994; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; DURRANT I, 1990, NATURE, V346, P297, DOI 10.1038/346297a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gao XH, 2009, MOL PLANT, V2, P218, DOI 10.1093/mp/ssn072; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Gelhaye E, 2003, FEBS LETT, V555, P443, DOI 10.1016/S0014-5793(03)01301-2; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Koh CS, 2008, J BIOL CHEM, V283, P23062, DOI 10.1074/jbc.M802093200; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Marchand C, 2006, PROTEOMICS, V6, P6528, DOI 10.1002/pmic.200600443; Marteyn B, 2009, MOL MICROBIOL, V71, P520, DOI 10.1111/j.1365-2958.2008.06550.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; MONTRICHARD F, 2009, PROTEOMICS, V72, P452; NIMMO HG, 1989, BIOCHEM J, V261, P431, DOI 10.1042/bj2610431; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Petridou S, 1997, PLANT MOL BIOL, V33, P381, DOI 10.1023/A:1005728411921; Popova TN, 1998, BBA-BIOENERGETICS, V1364, P307, DOI 10.1016/S0005-2728(98)00008-5; Rehman A, 1997, CURR MICROBIOL, V35, P267, DOI 10.1007/s002849900251; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; ROBERTSON AGS, 1995, BIOCHEM J, V305, P239, DOI 10.1042/bj3050239; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rua J, 2002, FUNGAL GENET BIOL, V35, P223, DOI 10.1006/fgbi.2001.1324; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Serrano JA, 2001, BBA-GENE STRUCT EXPR, V1520, P154, DOI 10.1016/S0167-4781(01)00263-9; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Sicard-Roselli C, 2004, EUR J BIOCHEM, V271, P3481, DOI 10.1111/j.1432-1033.2004.04279.x; STEIN M, 1995, PLANT MOL BIOL, V28, P487, DOI 10.1007/BF00020396; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Taylor KM, 1996, BIOCHEM J, V319, P255, DOI 10.1042/bj3190255; VANNI P, 1990, COMP BIOCHEM PHYS B, V95, P431, DOI 10.1016/0305-0491(90)90002-B; Watanabe S, 2004, MICROBIOL-SGM, V150, P3393, DOI 10.1099/mic.0.27201-0; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x; ZHANG JZ, 1993, MOL GEN GENET, V238, P177, DOI 10.1007/BF00279545	57	36	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36282	36291		10.1074/jbc.M109.064428	http://dx.doi.org/10.1074/jbc.M109.064428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19847013	Green Published, hybrid			2022-12-27	WOS:000272970500030
J	Igarashi, K; Koivula, A; Wada, M; Kimura, S; Penttila, M; Samejima, M				Igarashi, Kiyohiko; Koivula, Anu; Wada, Masahisa; Kimura, Satoshi; Penttila, Merja; Samejima, Masahiro			High Speed Atomic Force Microscopy Visualizes Processive Movement of Trichoderma reesei Cellobiohydrolase I on Crystalline Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; PHANEROCHAETE-CHRYSOSPORIUM; BINDING MODULES; HYDROLYSIS; CEL7A; CLASSIFICATION; IDENTIFICATION; MICROCRYSTALS; DEGRADATION; CELLOBIOSE	Fungal cellobiohydrolases act at liquid-solid interfaces. They have the ability to hydrolyze cellulose chains of a crystalline substrate because of their two-domain structure, i.e. cellulose-binding domain and catalytic domain, and unique active site architecture. However, the details of the action of the two domains on crystalline cellulose are still unclear. Here, we present real time observations of Trichoderma reesei (Tr) cellobiohydrolase I (Cel7A) molecules sliding on crystalline cellulose, obtained with a high speed atomic force microscope. The average velocity of the sliding movement on crystalline cellulose was 3.5 nm/s, and interestingly, the catalytic domain without the cellulose-binding domain moved with a velocity similar to that of the intact TrCel7A enzyme. However, no sliding of a catalytically inactive enzyme (mutant E212Q) or a variant lacking tryptophan at the entrance of the active site tunnel (mutant W40A) could be detected. This indicates that, besides the hydrolysis of glycosidic bonds, the loading of a cellulose chain into the active site tunnel is also essential for the enzyme movement.	[Igarashi, Kiyohiko; Wada, Masahisa; Kimura, Satoshi; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Koivula, Anu; Penttila, Merja] VTT Tech Res Ctr Finland, Espoo 02044, VTT, Finland	University of Tokyo; VTT Technical Research Center Finland	Igarashi, K (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1138657, Japan.	aquarius@mail.ecc.u-tokyo.ac.jp	Penttilä, Merja E/A-4710-2013; Igarashi, Kiyohiko/E-6799-2016	Igarashi, Kiyohiko/0000-0001-5152-7177; Penttila, Merja/0000-0002-6929-1032; Koivula, Anu/0000-0002-7600-5700	Japanese Ministry of Education, Culture, Sports, and Technology [19688016, 21688023]; Shin-Nippon Oil Co., Ltd.; Japan Society for the Promotion of Science [17380102]; New Energy and Industrial Technology Development Organization [07003004-0]	Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shin-Nippon Oil Co., Ltd.; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grants-in-aid for Scientific Research 19688016 and 21688023 from the Japanese Ministry of Education, Culture, Sports, and Technology (to K. I.), a grant for feasibility study from Shin-Nippon Oil Co., Ltd. (to K. I.), Grant-in-aid for Scientific Research 17380102 from the Japan Society for the Promotion of Science (to M. S.), and Grant for Development of Technology for High Efficiency Bioenergy Conversion Project 07003004-0 from the New Energy and Industrial Technology Development Organization (to M. S.).	ABUJA PM, 1989, BIOCHEM BIOPH RES CO, V165, P615, DOI 10.1016/S0006-291X(89)80010-5; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HON DNS, 1994, CELLULOSE, V1, P1, DOI 10.1007/BF00818796; Igarashi K, 1998, EUR J BIOCHEM, V253, P101, DOI 10.1046/j.1432-1327.1998.2530101.x; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; KAMMERMEIER H, 1993, BASIC RES CARDIOL, V88, P380, DOI 10.1007/BF00795405; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Sinnott ML, 1998, BIOCHEM SOC T, V26, P160, DOI 10.1042/bst0260160; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Teeri TT, 1998, BIOCHEM SOC T, V26, P173, DOI 10.1042/bst0260173; TEWARI YB, 1989, J BIOL CHEM, V264, P3966; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; VRSANSKA M, 1992, CARBOHYD RES, V227, P19, DOI 10.1016/0008-6215(92)85058-8; Wolfenden R, 2008, J AM CHEM SOC, V130, P7548, DOI 10.1021/ja802206s	37	207	215	2	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36186	36190		10.1074/jbc.M109.034611	http://dx.doi.org/10.1074/jbc.M109.034611			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858200	Green Published, hybrid			2022-12-27	WOS:000272970500020
J	Nishimura, T; Kohara, M; Izumi, K; Kasama, Y; Hirata, Y; Huang, Y; Shuda, M; Mukaidani, C; Takano, T; Tokunaga, Y; Nuriya, H; Satoh, M; Saito, M; Kai, C; Tsukiyama-Kohara, K				Nishimura, Tomohiro; Kohara, Michinori; Izumi, Kosuke; Kasama, Yuri; Hirata, Yuichi; Huang, Ying; Shuda, Masahiro; Mukaidani, Chise; Takano, Takashi; Tokunaga, Yuko; Nuriya, Hideko; Satoh, Masaaki; Saito, Makoto; Kai, Chieko; Tsukiyama-Kohara, Kyoko			Hepatitis C Virus Impairs p53 via Persistent Overexpression of 3 beta-Hydroxysterol Delta 24-Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; ALZHEIMERS-DISEASE; VIRAL-HEPATITIS; LIVER-CANCER; APOPTOSIS; MDM2; EXPRESSION; INFECTION; GENE	Persistent infection with hepatitis C virus (HCV) induces tumorigenicity in hepatocytes. To gain insight into the mechanisms underlying this process, we generated monoclonal antibodies on a genome-wide scale against an HCV-expressing human hepatoblastoma-derived cell line, RzM6-LC, showing augmented tumorigenicity. We identified 3 beta-hydroxysterol Delta 24-reductase (DHCR24) from this screen and showed that its expression reflected tumorigenicity. HCV induced the DHCR24 overexpression in human hepatocytes. Ectopic or HCV-induced DHCR24 overexpression resulted in resistance to oxidative stress-induced apoptosis and suppressed p53 activity. DHCR24 overexpression in these cells paralleled the increased interaction between p53 and MDM2 (also known as HDM2), a p53-specific E3 ubiquitin ligase, in the cytoplasm. Persistent DHCR24 overexpression did not alter the phosphorylation status of p53 but resulted in decreased acetylation of p53 at lysine residues 373 and 382 in the nucleus after treatment with hydrogen peroxide. Taken together, these results suggest that DHCR24 is elevated in response to HCV infection and inhibits the p53 stress response by stimulating the accumulation of the MDM2-p53 complex in the cytoplasm and by inhibiting the acetylation of p53 in the nucleus.	[Nishimura, Tomohiro; Kasama, Yuri; Tokunaga, Yuko; Satoh, Masaaki; Saito, Makoto; Tsukiyama-Kohara, Kyoko] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Expt Phylaxiol, Kumamoto 8608556, Japan; [Nishimura, Tomohiro] Kikuchi Res Ctr, Chemoserotherapeut Res Inst, Kumamoto 8691298, Japan; [Kohara, Michinori; Hirata, Yuichi; Shuda, Masahiro; Takano, Takashi; Nuriya, Hideko] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan; [Izumi, Kosuke; Huang, Ying; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 1088639, Japan; [Mukaidani, Chise] PhoenixBio Co Ltd, Study Serv Dept, Higashihiroshima 7390046, Japan	Kumamoto University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; PHOENIXBIO CO. LTD.	Tsukiyama-Kohara, K (corresponding author), Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Expt Phylaxiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	kkohara@kumamoto-u.ac.jp	SHUDA, MASAHIRO/F-5505-2011; SHUDA, MASAHIRO/N-8239-2019	SHUDA, MASAHIRO/0000-0003-0595-2572; SHUDA, MASAHIRO/0000-0003-0595-2572	Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Disease; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Disease; Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Health and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, the Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases, and the Hayashi Memorial Foundation for Female Natural Scientists.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonaccorsi L, 2008, LAB INVEST, V88, P1049, DOI 10.1038/labinvest.2008.80; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Greeve I, 2000, J NEUROSCI, V20, P7345; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Iivonen S, 2002, NEUROSCIENCE, V113, P301, DOI 10.1016/S0306-4522(02)00180-X; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuehnle K, 2008, MOL CELL BIOL, V28, P539, DOI 10.1128/MCB.00584-07; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; MIYASHITA T, 1995, CELL, V80, P293; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tanaka T, 2004, J MED VIROL, V72, P223, DOI 10.1002/jmv.10566; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yamamoto H, 2007, GENES CELLS, V12, P461, DOI 10.1111/j.1365-2443.2007.01065.x; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883	41	50	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36442	36452		10.1074/jbc.M109.043232	http://dx.doi.org/10.1074/jbc.M109.043232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861417	hybrid, Green Published			2022-12-27	WOS:000272970500046
J	Mancuso, DJ; Kotzbauer, P; Wozniak, DF; Sims, HF; Jenkins, CM; Guan, SP; Han, XL; Yang, K; Sun, G; Malik, I; Conyers, S; Green, KG; Schmidt, RE; Gross, RW				Mancuso, David J.; Kotzbauer, Paul; Wozniak, David F.; Sims, Harold F.; Jenkins, Christopher M.; Guan, Shaoping; Han, Xianlin; Yang, Kui; Sun, Gang; Malik, Ibrahim; Conyers, Sara; Green, Karen G.; Schmidt, Robert E.; Gross, Richard W.			Genetic Ablation of Calcium-independent Phospholipase A(2)gamma Leads to Alterations in Hippocampal Cardiolipin Content and Molecular Species Distribution, Mitochondrial Degeneration, Autophagy, and Cognitive Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SHOTGUN LIPIDOMICS; CALORIC RESTRICTION; MASS-SPECTROMETRY; BARTH-SYNDROME; UBIQUITIN; BRAIN; A(2); ACCUMULATION; INVOLVEMENT	Genetic ablation of calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) results in profound alterations in hippocampal phospholipid metabolism and mitochondrial phospholipid homeostasis resulting in enlarged and degenerating mitochondria leading to autophagy and cognitive dysfunction. Shotgun lipidomics demonstrated multiple alterations in hippocampal lipid metabolism in iPLA(2)gamma(-/-) mice including: 1) a markedly elevated hippocampal cardiolipin content with an altered molecular species composition characterized by a shift to shorter chain length molecular species; 2) alterations in both choline and ethanolamine glycerophospholipids, including a decreased plasmenylethanolamine content; 3) increased oxidized phosphatidylethanolamine molecular species; and 4) an increased content of ceramides. Electron microscopic examination demonstrated the presence of enlarged heteromorphic lamellar structures undergoing degeneration accompanied by the presence of ubiquitin positive spheroid inclusion bodies. Purification of these enlarged heteromorphic lamellar structures by buoyant density centrifugation and subsequent SDS-PAGE and proteomics identified them as degenerating mitochondria. Collectively, these results identify the obligatory role of iPLA(2)gamma in neuronal mitochondrial lipid metabolism and membrane structure demonstrating that iPLA(2)gamma loss of function results in a mitochondrial neurodegenerative disorder characterized by degenerating mitochondria, autophagy, and cognitive dysfunction.	[Mancuso, David J.; Sims, Harold F.; Jenkins, Christopher M.; Guan, Shaoping; Han, Xianlin; Yang, Kui; Sun, Gang; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Kotzbauer, Paul; Wozniak, David F.; Schmidt, Robert E.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA; [Mancuso, David J.; Sims, Harold F.; Jenkins, Christopher M.; Guan, Shaoping; Han, Xianlin; Yang, Kui; Sun, Gang; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Kotzbauer, Paul; Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Green, Karen G.; Schmidt, Robert E.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kotzbauer, Paul; Malik, Ibrahim] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wozniak, David F.; Conyers, Sara] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63105 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu		Malik, Ibrahim/0000-0003-2048-2097	National Institutes of Health [PO1 HL57278, RO1 HL41250, DK19645-28, P60 DK020579, NS48924]; Juvenile Diabetes Research Foundation [1-2005-1085, 1-2008-193]; NIA, NIH [R01 AG23168]; NIH Neuroscience Blueprint Center Core [P30 NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK056341, R37DK019645, R01DK019645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048924, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH Neuroscience Blueprint Center Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL57278 (to R. W. G.), RO1 HL41250 (to R. W. G.), DK19645-28 (to R. E. S.), P60 DK020579 (to R. E. S.), and NS48924 (to P. T. K.). This work was also supported by Juvenile Diabetes Research Foundation Grants 1-2005-1085 and 1-2008-193 (to R. E. S.), NIA, NIH Grant R01 AG23168 (to X. H.), and NIH Neuroscience Blueprint Center Core Grant P30 NS057105 (to D. F. W.). Downloaded from www.jbc.org at unknown institution, on December 14, 2009	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Ando H, 2006, BIOCHEM J, V394, P43, DOI 10.1042/BJ20051419; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beckett CS, 2008, LIPIDS, V43, P775, DOI 10.1007/s11745-008-3201-6; Breen EP, 2006, J BIOL CHEM, V281, P2114, DOI 10.1074/jbc.M511575200; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Cedars A, 2009, J CARDIOVASC PHARM, V53, P277; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Domingues MRM, 2008, CHEM PHYS LIPIDS, V156, P1, DOI 10.1016/j.chemphyslip.2008.07.003; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Fukuyama R, 2002, J BIOL CHEM, V277, P41455, DOI 10.1074/jbc.M204176200; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Ginsberg L, 1998, J NEUROCHEM, V70, P2533; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Green JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200; Gross RW, 2005, PROSTAG OTH LIPID M, V77, P52, DOI 10.1016/j.prostaglandins.2004.09.005; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Lehtinen MK, 2006, CURR MOL MED, V6, P871, DOI 10.2174/156652406779010786; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Mazzocco MMM, 2007, J DEV BEHAV PEDIATR, V28, P22, DOI 10.1097/01.DBP.0000257519.79803.90; Menard C, 2007, HIPPOCAMPUS, V17, P1109, DOI 10.1002/hipo.20343; Mokhova EN, 2005, BIOCHEMISTRY-MOSCOW+, V70, P159, DOI 10.1007/s10541-005-0096-1; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201; Schaeffer EL, 2005, J NEURAL TRANSM, V112, P641, DOI 10.1007/s00702-005-0301-9; SCHERRER LA, 1989, MOL CELL BIOCHEM, V88, P97; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; St-Gelais F, 2004, HIPPOCAMPUS, V14, P319, DOI 10.1002/hipo.10176; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Wakabayashi T, 2000, PATHOL INT, V50, P20, DOI 10.1046/j.1440-1827.2000.01002.x; Wolf MJ, 1995, FEBS LETT, V377, P358, DOI 10.1016/0014-5793(95)01371-7; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236	77	74	74	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35632	35644		10.1074/jbc.M109.055194	http://dx.doi.org/10.1074/jbc.M109.055194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840936	hybrid, Green Published			2022-12-27	WOS:000272645600041
J	Ogura, K; Yamasaki, M; Yamada, T; Mikami, B; Hashimoto, W; Murata, K				Ogura, Kohei; Yamasaki, Masayuki; Yamada, Takashi; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Crystal Structure of Family 14 Polysaccharide Lyase with pH-dependent Modes of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALIOTIS-DISCUS-HANNAI; ALGINATE LYASE; CELL-WALL; PSEUDOMONAS-AERUGINOSA; SUBSTRATE RECOGNITION; CDNA CLONING; VIRUS PBCV-1; PROTEIN; ACID; ABALONE	The Chlorella virus enzyme vAL-1 (38 kDa), a member of polysaccharide lyase family 14, degrades the Chlorella cell wall by cleaving the glycoside bond of the glucuronate residue (GlcA) through a beta-elimination reaction. The enzyme consists of an N-terminal cell wall-attaching domain (11 kDa) and a C-terminal catalytic module (27 kDa). Here, we show the enzyme characteristics of vAL-1, especially its pH-dependent modes of action, and determine the structure of the catalytic module. vAL-1 also exhibited alginate lyase activity at alkaline pH, and truncation of the N-terminal domain increased the lyase activity by 50-fold at pH 7.0. The truncated form vAL-1(S) released di- to hexasaccharides from alginate at pH 7.0, whereas disaccharides were preferentially generated at pH 10.0. This indicates that vAL-1(S) shows two pH-dependent modes of action: endo-and exotypes. The x-ray crystal structure of vAL-1(S) at 1.2 angstrom resolution showed two antiparallel beta-sheets with a deep cleft showing a beta-jelly roll fold. The structure of GlcA-bound vAL-1(S) at pH 7.0 and 10.0 was determined: GlcA was found to be bound outside and inside the cleft at pH 7.0 and 10.0, respectively. This suggests that the electric charges at the active site greatly influence the binding mode of substrates and regulate endo/exo activity. Site-directed mutagenesis demonstrated that vAL-1(S) has a specific amino acid arrangement distinct from other alginate lyases crucial for catalysis. This is, to our knowledge, the first study in which the structure of a family 14 polysaccharide lyase with two different modes of action has been determined.	[Ogura, Kohei; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan; [Yamasaki, Masayuki; Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Uji, Kyoto 6110011, Japan; [Yamada, Takashi] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan	Kyoto University; Kyoto University; Hiroshima University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Basic Research Activities for Innovative Bioscience in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Bioscience in Japan	This work was supported, in part, by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists ( to K.O.) and by Grants-in-aid ( to W. H., B. M., and K. M.) and Targeted Proteins Research Program funding ( to W. H., B. M., and K. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. A part of this work was supported by the funds from Program for Promotion of Basic Research Activities for Innovative Bioscience in Japan ( to K. M.).	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Gazzarrini S, 2004, J BIOL CHEM, V279, P28443, DOI 10.1074/jbc.M401184200; HASHIMOTO W, 2009, BIOENGINEER IN PRESS; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; KAPAUN E, 1992, PHYTOCHEMISTRY, V31, P3103, DOI 10.1016/0031-9422(92)83453-6; Konno N, 2009, FEBS LETT, V583, P1323, DOI 10.1016/j.febslet.2009.03.034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; May Thomas B., 1994, Trends in Microbiology, V2, P151, DOI 10.1016/0966-842X(94)90664-5; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; MEINTS RH, 1988, VIROLOGY, V164, P15, DOI 10.1016/0042-6822(88)90614-9; MEINTS RH, 1984, VIROLOGY, V138, P341, DOI 10.1016/0042-6822(84)90358-1; Mikami B, 2002, ACTA CRYSTALLOGR A, V58, pC271, DOI 10.1107/S0108767302095831; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Onimatsu H, 2004, VIROLOGY, V319, P71, DOI 10.1016/j.virol.2003.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; PREISS J, 1962, J BIOL CHEM, V237, P309; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suda K, 1999, FEMS MICROBIOL LETT, V180, P45, DOI 10.1016/S0378-1097(99)00459-0; Sugimoto I, 2004, FEBS LETT, V559, P51, DOI 10.1016/S0014-5793(04)00022-5; Sugimoto I, 2000, VIROLOGY, V277, P119, DOI 10.1006/viro.2000.0590; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Suzuki K, 2003, EUR J BIOCHEM, V270, P771, DOI 10.1046/j.1432-1033.2003.03443.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANETTEN JL, 1991, MICROBIOL REV, V55, P586, DOI 10.1128/MMBR.55.4.586-620.1991; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; YAMADA T, 1991, APPL ENVIRON MICROB, V57, P3433, DOI 10.1128/AEM.57.12.3433-3437.1991; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075	44	49	51	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35572	35579		10.1074/jbc.M109.068056	http://dx.doi.org/10.1074/jbc.M109.068056			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19846561	Green Published, hybrid			2022-12-27	WOS:000272645600034
J	Song, DS; Tu, Z; Lee, FS				Song, Daisheng; Tu, Zheng; Lee, Frank S.			Human ISCA1 Interacts with IOP1/NARFL and Functions in Both Cytosolic and Mitochondrial Iron-Sulfur Protein Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUSTER BIOGENESIS; WD40 PROTEIN; HOMEOSTASIS; MATURATION; SCAFFOLD; SYSTEM; COMPONENT; MATRIX; IOP1	Iron-sulfur proteins play an essential role in many biologic processes. Hence, understanding their assembly is an important goal. In Escherichia coli, the protein IscA is a product of the isc (iron-sulfur cluster) operon and functions in the iron-sulfur cluster assembly pathway in this organism. IscA is conserved in evolution, but its function in mammalian cells is not known. Here, we provide evidence for a role for a human homologue of IscA, named IscA1, in iron-sulfur protein biogenesis. We observe that small interfering RNA knockdown of IscA1 in HeLa cells leads to decreased activity of two mitochondrial iron-sulfur enzymes, succinate dehydrogenase and mitochondrial aconitase, as well as a cytosolic iron-sulfur enzyme, cytosolic aconitase. IscA1 is observed both in cytosolic and mitochondrial fractions. We find that IscA1 interacts with IOP1 (iron-only hydrogenase-like protein 1)/NARFL (nuclear prelamin A recognition factor-like), a cytosolic protein that plays a role in the cytosolic iron-sulfur protein assembly pathway. We therefore propose that human IscA1 plays an important role in both mitochondrial and cytosolic iron-sulfur cluster biogenesis, and a notable component of the latter is the interaction between IscA1 and IOP1.	[Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, Philadelphia, PA 19104 USA	University of Pennsylvania	Lee, FS (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu		Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-GM71459]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM71459 (to F.S.L.).	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Cozar-Castellano I, 2004, BBA-PROTEINS PROTEOM, V1700, P179, DOI 10.1016/j.bbapap.2004.05.004; DAUM G, 1982, J BIOL CHEM, V257, P3028; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; HALLBERG EM, 1993, MOL CELL BIOL, V13, P3050, DOI 10.1128/MCB.13.5.3050; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnstone RW, 1998, J BIOL CHEM, V273, P10880, DOI 10.1074/jbc.273.18.10880; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Luban Jeremy, 1995, Current Opinion in Biotechnology, V6, P59, DOI 10.1016/0958-1669(95)80010-7; Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; ROSEN H, 1987, J BIOL CHEM, V262, P15004; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003	28	40	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35297	35307		10.1074/jbc.M109.040014	http://dx.doi.org/10.1074/jbc.M109.040014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19864422	hybrid, Green Published			2022-12-27	WOS:000272645600006
J	Kim, YC; Wu, SY; Lim, HS; Chiang, CM; Kodadek, T				Kim, Young-Chan; Wu, Shwu-Yuan; Lim, Hyun-Suk; Chiang, Cheng-Ming; Kodadek, Thomas			Non-proteolytic Regulation of p53-mediated Transcription through Destabilization of the Activator.Promoter Complex by the Proteasomal ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGGERED CROSS-LINKING; TATA-BINDING PROTEIN; RNA-POLYMERASE-II; PEPTOID INHIBITOR; 20S PROTEASOME; IN-VIVO; ACTIVATION; UBIQUITIN; P53; TURNOVER	It has been shown previously that sub-complexes of the 26 S proteasome can regulate gene expression via non-proteolytic mechanisms. One such mechanism is the disruption of activator.promoter complexes in an ATP-dependent fashion, which was discovered in the context of the yeast Gal4 system. This activity strongly inhibits Gal4-driven gene expression unless the activator is mono-ubiquitylated, which protects it from the ATPases. To address whether this paradigm is also applicable to medically important mammalian transcriptional activators we report here a study of the interaction of the proteasomal ATPases with p53. It is shown that p53 binds directly to the ATPases via its C-terminal tetramerization and regulatory domain and that p53.promoter complexes are indeed vulnerable to ATPase-dependent disruption by the ATPase complex in vitro. Knockdown of one of the ATPases, Rpt6, in living cells results in increased occupancy of the p21waf1 promoter by p53 and increased expression of the gene, consistent with the idea that the proteasomal ATPases negatively regulate p53 function in a non-proteolytic fashion.	[Kodadek, Thomas] Scripps Florida Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Kodadek, Thomas] Scripps Florida Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Kim, Young-Chan; Lim, Hyun-Suk; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dept Internal Med, Dallas, TX 75390 USA; [Kim, Young-Chan; Lim, Hyun-Suk; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dept Mol Biol, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Biochem, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Scripps Florida Res Inst, Dept Chem, 130 Scripps Way, Jupiter, FL 33458 USA.	Kodadek@scripps.edu	Moon, Heejo/F-5355-2013	Kodadek, Thomas/0000-0003-1930-4795	National Institutes of Health [GM71833, CA103867, CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM71833 ( to T. K.) and CA103867 and CA124760 ( to C. M. C.).	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Archer CT, 2008, J BIOL CHEM, V283, P12614, DOI 10.1074/jbc.M801050200; Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Brady KL, 2005, J BIOL CHEM, V280, P26743, DOI 10.1074/jbc.M502677200; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Brooks CL, 2004, CELL CYCLE, V3, P436; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Corton JC, 1998, J BIOL CHEM, V273, P13776, DOI 10.1074/jbc.273.22.13776; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Lim HS, 2007, J AM CHEM SOC, V129, P12936, DOI 10.1021/ja075469+; Lim HS, 2007, J AM CHEM SOC, V129, P7750, DOI 10.1021/ja072027p; Lin L, 2005, ONCOGENE, V24, P3385, DOI 10.1038/sj.onc.1208554; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; MELCHER K, 1995, MOL CELL BIOL, V15, P2839; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191	41	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34522	34530		10.1074/jbc.M109.017277	http://dx.doi.org/10.1074/jbc.M109.017277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846554	Green Published, hybrid			2022-12-27	WOS:000272439600006
J	Meulemans, A; Seneca, S; Pribyl, T; Smet, J; Alderweirldt, V; Waeytens, A; Lissens, W; Van Coster, R; De Meirleir, L; di Rago, JP; Gatti, DL; Ackerman, SH				Meulemans, Ann; Seneca, Sara; Pribyl, Thomas; Smet, Joel; Alderweirldt, Valerie; Waeytens, Anouk; Lissens, Willy; Van Coster, Rudy; De Meirleir, Linda; di Rago, Jean-Paul; Gatti, Domenico L.; Ackerman, Sharon H.			Defining the Pathogenesis of the Human Atp12p W94R Mutation Using a Saccharomyces cerevisiae Yeast Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUASI-NEWTON MATRICES; MOLECULAR-DYNAMICS; HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRIAL F-1-ATPASE; ESCHERICHIA-COLI; LEIGH-SYNDROME; ALPHA-SUBUNIT; F-1 ATPASE; SYNTHASE; PROTEINS	Studies in yeast have shown that a deficiency in Atp12p prevents assembly of the extrinsic domain (F-1) of complex V and renders cells unable to make ATP through oxidative phosphorylation. De Meirleir et al. (De Meirleir, L., Seneca, S., Lissens, W., De Clercq, I., Eyskens, F., Gerlo, E., Smet, J., and Van Coster, R. (2004) J. Med. Genet. 41, 120-124) have reported that a homozygous missense mutation in the gene for human Atp12p (HuAtp12p), which replaces Trp-94 with Arg, was linked to the death of a 14-month-old patient. We have investigated the impact of the pathogenic W94R mutation on Atp12p structure/function. Plasmid-borne wild type human Atp12p rescues the respiratory defect of a yeast ATP12 deletion mutant (Delta atp12). The W94R mutation alters the protein at the most highly conserved position in the Pfam sequence and renders HuAtp12p insoluble in the background of Delta atp12. In contrast, the yeast protein harboring the corresponding mutation, ScAtp12p(W103R), is soluble in the background of Delta atp12 but not in the background of Delta atp12 Delta fmc1, a strain that also lacks Fmc1p. Fmc1p is a yeast mitochondrial protein not found in higher eukaryotes. Tryptophan 94 (human) or 103 (yeast) is located in a positively charged region of Atp12p, and hence its mutation to arginine does not alter significantly the electrostatic properties of the protein. Instead, we provide evidence that the primary effect of the substitution is on the dynamic properties of Atp12p.	[Pribyl, Thomas; Gatti, Domenico L.; Ackerman, Sharon H.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Lissens, Willy] Vrije Univ Brussel, Ctr Genet, B-1050 Brussels, Belgium; [De Meirleir, Linda] Vrije Univ Brussel, UZ Brussel, Dept Pediat Neurol, B-1050 Brussels, Belgium; [Smet, Joel; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, B-9000 Ghent, Belgium; [Waeytens, Anouk] Ghent Univ Hosp, Dept Pathol, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium; [di Rago, Jean-Paul] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Wayne State University; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Ackerman, SH (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	sackerm@med.wayne.edu	De Meirleir, Linda/D-6591-2016; Lissens, Willy/B-2892-2013	Lissens, Willy/0000-0003-3875-9955; Meulemans, Ann/0000-0003-3938-2408; Seneca, Sara/0000-0002-0853-9890	National Institutes of Health [GM69840, GM48157]; Research Council of the Vrije Universiteit Brussel [OZR887, ORZ1216]; Fund of Scientific Research-Flanders [FWO 6.06666.06]; Agence Nationale de la Recherche; Association Francaise Contre les Myopathies; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048157, R01GM069840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of the Vrije Universiteit Brussel; Fund of Scientific Research-Flanders(FWO); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69840 (to D. L. G.) and GM48157 (to S. H. A.). This work was also supported by Research Council of the Vrije Universiteit Brussel Grants OZR887 and ORZ1216, the Fund of Scientific Research-Flanders Grant FWO 6.06666.06, Agence Nationale de la Recherche grants, and the Association Francaise Contre les Myopathies grants (to J.-P. d. R.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Ackerman SH, 2002, BBA-BIOENERGETICS, V1555, P101, DOI 10.1016/S0005-2728(02)00262-1; Ackerman Sharon H, 2007, Methods Mol Biol, V372, P363, DOI 10.1007/978-1-59745-365-3_26; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basu T, 1997, BIOCHEM MOL BIOL INT, V41, P1093; Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; BOWMAN S, 1991, J BIOL CHEM, V266, P7517; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188; Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hinton A, 2004, J BIOL CHEM, V279, P9016, DOI 10.1074/jbc.M312631200; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; METOKI K, 1984, J INHERIT METAB DIS, V7, P9, DOI 10.1007/BF01805611; MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2; NOCEDAL J, 1980, MATH COMPUT, V35, P773, DOI 10.1090/S0025-5718-1980-0572855-7; PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santamaria M, 2007, BIOL CHEM, V388, P943, DOI 10.1515/BC.2007.121; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang ZG, 1998, J BIOL CHEM, V273, P2993, DOI 10.1074/jbc.273.5.2993; Wang ZG, 2000, EMBO J, V19, P1486, DOI 10.1093/emboj/19.7.1486; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007	53	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					4099	4109		10.1074/jbc.M109.046920	http://dx.doi.org/10.1074/jbc.M109.046920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19933271	Green Published, hybrid			2022-12-27	WOS:000275254000062
J	Ross, JA; Cheng, HY; Nagy, ZS; Frost, JA; Kirken, RA				Ross, Jeremy A.; Cheng, Hanyin; Nagy, Zsuzsanna S.; Frost, Jeffrey A.; Kirken, Robert A.			Protein Phosphatase 2A Regulates Interleukin-2 Receptor Complex Formation and JAK3/STAT5 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-CELLS; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; FAMILY CYTOKINES; IL-2 RECEPTOR; SERINE/THREONINE KINASES; NEGATIVE REGULATOR; SIGNALING PATHWAY; IMMUNE-SYSTEM; OKADAIC ACID	Reversible protein phosphorylation plays a key role in interleukin-2 (IL-2) receptor-mediated activation of Janus tyrosine kinase 3 (JAK3) and signal transducer and activator of transcription 5 (STAT5) in lymphocytes. Although the mechanisms governing IL-2-induced tyrosine phosphorylation and activation of JAK3/STAT5 have been extensively studied, the role of serine/threonine phosphorylation in controlling these effectors remains to be elucidated. Using phosphoamino acid analysis, JAK3 and STAT5 were determined to be serine and tyrosine-phosphorylated in response to IL-2 stimulation of the human natural killer-like cell line, YT. IL-2 stimulation also induced serine/threonine phosphorylation of IL-2R beta, but not IL-2R gamma. To investigate the regulation of serine/threonine phosphorylation in IL-2 signaling, the roles of protein phosphatase 1 (PP1) and 2A (PP2A) were examined. Inhibition of phosphatase activity by calyculin A treatment of YT cells resulted in a significant induction of serine phosphorylation of JAK3 and STAT5, and serine/threonine phosphorylation of IL-2R beta. Moreover, inhibition of PP2A, but not PP1, diminished IL-2-induced tyrosine phosphorylation of IL-2R beta, JAK3, and STAT5, and abolished STAT5 DNA binding activity. Serine/threonine phosphorylation of IL-2R beta by a staurosporine-sensitive kinase also blocked its association with JAK3 and IL-2R beta in YT cells. Taken together, these data indicate that serine/threonine phosphorylation negatively regulates IL-2 signaling at multiple levels, including receptor complex formation and JAK3/STAT5 activation, and that this regulation is counteracted by PP2A. These findings also suggest that PP2A may serve as a therapeutic target for modulating JAK3/STAT5 activation in human disease.	[Ross, Jeremy A.; Cheng, Hanyin; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Cheng, Hanyin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Frost, Jeffrey A.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas El Paso; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kirken, RA (corresponding author), 500 W Univ Ave, El Paso, TX 79968 USA.	rkirken@utep.edu		Frost, Jeffrey/0000-0001-9722-1536	Lizanell and Colbert Coldwell Foundation; National Center for Research Resources [5G12RR008124]; National Institutes of Health [5RO1CA116356-02]; University of Texas at El Paso; NATIONAL CANCER INSTITUTE [R01CA116356] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER	Lizanell and Colbert Coldwell Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas at El Paso; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by grants from the Lizanell and Colbert Coldwell Foundation (to R.A.K.) and the National Center for Research Resources (5G12RR008124), a component of the National Institutes of Health, and the University of Texas at El Paso. This work was also supported by National Institutes of Health Grant 5RO1CA116356-02 (to J.A.F.).	ASAO H, 1992, FEBS LETT, V304, P141, DOI 10.1016/0014-5793(92)80605-G; Behbod F, 2003, J IMMUNOL, V171, P3919, DOI 10.4049/jimmunol.171.8.3919; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brockdorff J, 1997, TISSUE ANTIGENS, V49, P228, DOI 10.1111/j.1399-0039.1997.tb02743.x; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; HONKANAN RE, 1994, TOXICON, V32, P339, DOI 10.1016/0041-0101(94)90086-8; HOWARD OMZ, 1995, BIOCHEM J, V306, P217, DOI 10.1042/bj3060217; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Kirken RA, 1997, J BIOL CHEM, V272, P14098, DOI 10.1074/jbc.272.22.14098; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; Matthews SA, 2006, CURR OPIN IMMUNOL, V18, P314, DOI 10.1016/j.coi.2006.03.006; Matthews SA, 2009, IMMUNOL REV, V228, P241, DOI 10.1111/j.1600-065X.2008.00759.x; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mitsuhashi S, 2005, MOL CELL BIOCHEM, V269, P183, DOI 10.1007/s11010-005-3089-x; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Nagy ZS, 2006, J IMMUNOL, V177, P5032, DOI 10.4049/jimmunol.177.8.5032; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Schillace RV, 2006, CRIT REV IMMUNOL, V26, P113, DOI 10.1615/CritRevImmunol.v26.i2.20; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Winston LA, 1996, CURR BIOL, V6, P668, DOI 10.1016/S0960-9822(09)00445-X; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Woetmann A, 2003, J BIOL CHEM, V278, P2787, DOI 10.1074/jbc.M210196200; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yamashita H, 2001, MOL CELL ENDOCRINOL, V183, P151, DOI 10.1016/S0303-7207(01)00546-9; YODOI J, 1985, J IMMUNOL, V134, P1623; Yokoyama N, 2001, J INTERF CYTOK RES, V21, P369, DOI 10.1089/107999001750277844	60	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3582	3591		10.1074/jbc.M109.053843	http://dx.doi.org/10.1074/jbc.M109.053843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19923221	Green Published, hybrid			2022-12-27	WOS:000275254000009
J	Savkina, M; Temiakov, D; McAllister, WT; Anikin, M				Savkina, Maria; Temiakov, Dmitry; McAllister, William T.; Anikin, Michael			Multiple Functions of Yeast Mitochondrial Transcription Factor Mtf1p during Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE RNA-POLYMERASE; PROMOTER RECOGNITION; SPECIFICITY FACTOR; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; SIGMA-FACTORS; SC-MTTFB	Transcription of the yeast mitochondrial genome is carried out by an RNA polymerase (Rpo41p) that is related to single subunit bacteriophage RNA polymerases but requires an additional factor (Mtf1p) for initiation. In this work we show that Mtf1p is involved in multiple roles during initiation including discrimination of upstream base pairs in the promoter, initial melting of three to four base pairs around the site of transcript initiation, and suppression of nonspecific initiation. It, thus, appears that Mtf1p is functionally analogous to initiation factors of multisubunit RNA polymerases, such as sigma. Photocross-linking experiments reveal close proximity between Mtf1p and the promoter DNA and show that the C-terminal domain makes contacts with the template strand in the vicinity of the start site. Interestingly, Mtf1p is related to a class of RNA methyltransferases, suggesting an early evolutionary link between RNA synthesis and processing.	Univ Med & Dent New Jersey, Stratford Div, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA; [Savkina, Maria] Univ Med & Dent New Jersey, Stratford Div, Grad Sch Biomed Sci, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Anikin, M (corresponding author), 2 Med Ctr Dr,SC-B207, Stratford, NJ 08084 USA.	anikinmi@umdnj.edu	Savkina, Maria/C-9075-2018	Savkina, Maria/0000-0002-8527-2157	National Institutes of Health [GM38147]; Research Foundation of University of Medicine and Dentistry of New Jersey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Foundation of University of Medicine and Dentistry of New Jersey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38147 (to W. T. M.). This work was also supported by grants from the Research Foundation of University of Medicine and Dentistry of New Jersey (to M. A., D. T., and W. T. M.).	BISWAS TK, 1986, J BIOL CHEM, V261, P3927; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Cliften PF, 2000, MOL CELL BIOL, V20, P7013, DOI 10.1128/MCB.20.18.7013-7023.2000; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; Favre A, 1998, J PHOTOCH PHOTOBIO B, V42, P109, DOI 10.1016/S1011-1344(97)00116-4; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; JANG SH, 1991, J BIOL CHEM, V266, P22671; Karlok MA, 2002, J BIOL CHEM, V277, P28143, DOI 10.1074/jbc.M204123200; Ma KY, 2002, J BIOL CHEM, V277, P43206, DOI 10.1074/jbc.M206658200; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, J BIOL CHEM, V279, P2012, DOI 10.1074/jbc.M307819200; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; O'Farrell HC, 2004, J MOL BIOL, V339, P337, DOI 10.1016/j.jmb.2004.02.068; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; SCHINKEL AH, 1988, NUCLEIC ACIDS RES, V16, P9147, DOI 10.1093/nar/16.19.9147; SCHINKEL AH, 1986, EMBO J, V5, P1041, DOI 10.1002/j.1460-2075.1986.tb04320.x; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Temiakov D, 2003, METHOD ENZYMOL, V371, P133; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200	35	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3957	3964		10.1074/jbc.M109.051003	http://dx.doi.org/10.1074/jbc.M109.051003			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19920143	Green Published, hybrid			2022-12-27	WOS:000275254000049
J	Aryal, RP; Ju, TZ; Cummings, RD				Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.			The Endoplasmic Reticulum Chaperone Cosmc Directly Promotes in Vitro Folding of T-synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONE; CORE-1 BETA-1,3-GALACTOSYLTRANSFERASE; ESCHERICHIA-COLI; O-GLYCOSYLATION; QUALITY-CONTROL; BINDING; ATP; SPECIFICITY; EXPRESSION	The T-synthase is the key beta 3-galactosyltransferase essential for biosynthesis of core 1 O-glycans (Gal beta 1-3GalNAc alpha 1-Ser/Thr) in animal cell glycoproteins. Here we describe the novel ability of an endoplasmic reticulum-localized molecular chaperone termed Cosmc to specifically interact with partly denatured T-synthase in vitro to cause partial restoration of activity. By contrast, a mutated form of Cosmc observed in patients with Tn syndrome has reduced chaperone function. The chaperone activity of Cosmc is specific, does not require ATP in vitro, and is effective toward T-synthase but not another beta-galactosyltransferase. Cosmc represents the first ER chaperone identified to be required for folding of a glycosyltransferase.	[Cummings, Richard D.] Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), Emory Univ, Sch Med, O Wayne Rollins Res Ctr, Dept Biochem, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [R01 GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068559 (to R.D.C.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellis R J, 1990, Semin Cell Biol, V1, P1; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hafizur RM, 2004, J BIOCHEM, V135, P193, DOI 10.1093/jb/mvh023; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HILL RL, 1975, ADV ENZYMOL RAMB, V43, P411; Hoshino M, 1996, J MOL BIOL, V262, P575, DOI 10.1006/jmbi.1996.0536; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; ITZKOWITZ SH, 1990, CANCER-AM CANCER SOC, V66, P1960, DOI 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Marini I, 2005, CELL MOL LIFE SCI, V62, P599, DOI 10.1007/s00018-005-4474-z; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Muchowski PJ, 1998, P NATL ACAD SCI USA, V95, P1004, DOI 10.1073/pnas.95.3.1004; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; van Die I, 1999, FEBS LETT, V450, P52, DOI 10.1016/S0014-5793(99)00462-7; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZIEMIENOWICZ A, 1993, J BIOL CHEM, V268, P25425	51	49	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2456	2462		10.1074/jbc.M109.065169	http://dx.doi.org/10.1074/jbc.M109.065169			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923218	Green Published, hybrid			2022-12-27	WOS:000273697800024
J	Banerjee, S; Zmijewski, JW; Lorne, E; Liu, G; Sha, YG; Abraham, E				Banerjee, Sami; Zmijewski, Jaroslaw W.; Lorne, Emmanuel; Liu, Gang; Sha, Yonggang; Abraham, Edward			Modulation of SCF beta-TrCP-dependent I kappa B alpha Ubiquitination by Hydrogen Peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; F-BOX PROTEINS; NEUTROPHIL ACTIVATION; LIGASE COMPLEX; PROTEASOME ACTIVITY; ENDOTHELIAL-CELLS; EXTRACELLULAR-SUPEROXIDE; S-GLUTATHIONYLATION; OXIDATIVE STRESS; REDOX REGULATION	Reactive oxygen species are known to participate in the regulation of intracellular signaling pathways, including activation of NF-kappa B. Recent studies have indicated that increases in intracellular concentrations of hydrogen peroxide (H2O2) have antiinflammatory effects in neutrophils, including inhibition of the degradation of I kappa B alpha after TLR4 engagement. In the present experiments, we found that culture of lipopolysaccharide-stimulated neutrophils and HEK 293 cells with H2O2 resulted in diminished ubiquitination of I kappa B alpha and decreased SCF beta-TrCP ubiquitin ligase activity. Exposure of neutrophils or HEK 293 cells to H2O2 was associated with reduced binding between phosphorylated I kappa B alpha and SCF beta-TrCP but no change in the composition of the SCF beta-TrCP complex. Lipopolysaccharide-induced SCF beta-TrCP ubiquitin ligase activity as well as binding of beta-TrCP to phosphorylated I kappa B alpha was decreased in the lungs of acatalasemic mice and mice treated with the catalase inhibitor aminotriazole, situations in which intracellular concentrations of H2O2 are increased. Exposure to H2O2 resulted in oxidative modification of cysteine residues in beta-TrCP. Cysteine 308 in Blade 1 of the beta-TrCP beta-propeller region was found to be required for maximal binding between beta-TrCP and phosphorylated I kappa B alpha. These findings suggest that the anti-inflammatory effects of H2O2 may result from its ability to decrease ubiquitination as well as subsequent degradation of I kappa B alpha through inhibiting the association between I kappa B alpha and SCF beta-TrCP.	[Abraham, Edward] Univ Alabama, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Zmijewski, Jaroslaw W.; Abraham, Edward] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Abraham, E (corresponding author), Univ Alabama, Sch Med, Dept Med, BDB 420,1530 3rd Ave S, Birmingham, AL 35294 USA.	eabraham@uab.edu	Sha, Yonggang/J-5100-2012	Lorne, Emmanuel/0000-0001-6409-5449; , Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	National Institutes of Health [HL62221, HL76206, GM87748]; Societe Francaise d'Anesthesie et de Reanimation; University Hospital of Amiens (France); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076206, R01HL062221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Societe Francaise d'Anesthesie et de Reanimation; University Hospital of Amiens (France); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62221, HL76206, and GM87748 (to E. A.). This work was also supported by grants from the Societe Francaise d'Anesthesie et de Reanimation and the University Hospital of Amiens (France) (to E. L.).	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Arcaroli JJ, 2009, AM J RESP CRIT CARE, V179, P105, DOI 10.1164/rccm.200710-1566OC; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Blackwell TS, 1996, J IMMUNOL, V157, P1630; Brass DM, 2007, AM J PHYSIOL-LUNG C, V293, pL77, DOI 10.1152/ajplung.00282.2006; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Choi KS, 2006, PREP BIOCHEM BIOTECH, V36, P65, DOI 10.1080/10826060500388520; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Kanayama A, 2002, J BIOL CHEM, V277, P24049, DOI 10.1074/jbc.M110832200; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Landar A, 2006, FREE RADICAL BIO MED, V40, P459, DOI 10.1016/j.freeradbiomed.2005.08.046; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Pajonk F, 2002, FREE RADICAL BIO MED, V32, P536, DOI 10.1016/S0891-5849(02)00743-8; Pantano C, 2003, J BIOL CHEM, V278, P44091, DOI 10.1074/jbc.M308487200; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; Strassheim D, 2004, AM J PHYSIOL-CELL PH, V286, pC683, DOI 10.1152/ajpcell.00296.2003; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P121, DOI 10.1006/bbrc.1999.0296; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Torrie LJ, 2001, BRIT J PHARMACOL, V134, P393, DOI 10.1038/sj.bjp.0704259; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Vuillard L, 1999, FEBS LETT, V455, P311, DOI 10.1016/S0014-5793(99)00895-9; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wrona M, 2005, FREE RADICAL BIO MED, V38, P262, DOI 10.1016/j.freeradbiomed.2004.10.022; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yaron A, 1997, EMBO J, V16, P6486, DOI 10.1093/emboj/16.21.6486; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	71	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2665	2675		10.1074/jbc.M109.060822	http://dx.doi.org/10.1074/jbc.M109.060822			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933270	Green Published, hybrid			2022-12-27	WOS:000273697800045
J	Jeong, SM; Lee, C; Lee, SK; Kim, J; Seong, RH				Jeong, Seung Min; Lee, Changjin; Lee, Sung Kyu; Kim, Jieun; Seong, Rho Hyun			The SWI/SNF Chromatin-remodeling Complex Modulates Peripheral T Cell Activation and Proliferation by Controlling AP-1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KINASE-C-THETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GLUCOCORTICOID-INDUCED APOPTOSIS; MULTIPLE-SCLEROSIS LESIONS; TUMOR-NECROSIS-FACTOR; PKC-THETA; TRANSCRIPTION FACTORS; SRG3 EXPRESSION; BAF COMPLEX	The SWI/SNF chromatin-remodeling complex has been implicated in the activation and proliferation of T cells. After T cell receptor signaling, the SWI/SNF complex rapidly associates with chromatin and controls gene expression in T cells. However, the process by which the SWI/SNF complex regulates peripheral T cell activation has not been elucidated. In this study, we show that the SWI/SNF complex regulates cytokine production and proliferation of T cells. During T cell activation, the SWI/SNF complex is recruited to the promoter of the transcription factor AP-1, and it increases the expression of AP-1. Increased expression of the SWI/SNF complex resulted in enhanced AP-1 activity, cytokine production, and proliferation of peripheral T cells, whereas knockdown of the SWI/SNF complex expression impaired the AP-1 expression and reduced the activation and proliferation of T cells. Moreover, mice that constitutively expressed the SWI/SNF complex in T cells were much more susceptible to experimentally induced autoimmune encephalomyelitis than the normal mice were. These results suggest that the SWI/SNF complex plays a critical role during T cell activation and subsequent immune responses.	[Seong, Rho Hyun] Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet, Seoul 151742, South Korea; Seoul Natl Univ, Res Ctr Funct Cellul, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Seong, RH (corresponding author), Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet, 599 Gwanangno, Seoul 151742, South Korea.	rhseong@snu.ac.kr		Seong, Rho/0000-0001-5699-0718	National Research Foundation of Korea; Ministry of Education, Science, and Technology; Research Center for Functional Cellulomics; Priority Research Centers Program [2009-0094022]; Ministry of Education and Human Resources Development [BK21]; Seoul Science Fellowship	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Center for Functional Cellulomics; Priority Research Centers Program; Ministry of Education and Human Resources Development(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul Science Fellowship	This work was supported by grants from the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology, in part through the Research Center for Functional Cellulomics and in part through the Priority Research Centers Program (2009-0094022).; Supported by the BK21 Program of the Ministry of Education and Human Resources Development.; Supported by a Seoul Science Fellowship.	Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Burgos P, 2000, J RHEUMATOL, V27, P116; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Eberhardt W, 2000, J IMMUNOL, V165, P5788, DOI 10.4049/jimmunol.165.10.5788; Fontenot JD, 2004, SEMIN IMMUNOL, V16, P73, DOI 10.1016/j.smim.2003.12.002; Gebuhr TC, 2003, J EXP MED, V198, P1937, DOI 10.1084/jem.20030714; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Gveric D, 1998, J NEUROPATH EXP NEUR, V57, P168, DOI 10.1097/00005072-199802000-00008; Han SM, 2001, J IMMUNOL, V167, P805, DOI 10.4049/jimmunol.167.2.805; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jeon SH, 1997, J EXP MED, V185, P1827, DOI 10.1084/jem.185.10.1827; Jeong SM, 2004, J BIOL CHEM, V279, P34373, DOI 10.1074/jbc.M403461200; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Ko M, 2004, J BIOL CHEM, V279, P21903, DOI 10.1074/jbc.M402144200; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee KY, 2007, J IMMUNOL, V178, P7088, DOI 10.4049/jimmunol.178.11.7088; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Lichtinghagen R, 1999, J NEUROIMMUNOL, V99, P19, DOI 10.1016/S0165-5728(99)00094-6; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Ohashi PS, 2002, NAT REV IMMUNOL, V2, P427, DOI 10.1038/nri822; RIECKMANN P, 1995, ANN NEUROL, V37, P82, DOI 10.1002/ana.410370115; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Seetharaman R, 1999, J IMMUNOL, V163, P1577; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Tsokos GC, 2000, CURR OPIN RHEUMATOL, V12, P355, DOI 10.1097/00002281-200009000-00001; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Willenborg DO, 2003, ADV EXP MED BIOL, V520, P96; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	51	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2340	2350		10.1074/jbc.M109.026997	http://dx.doi.org/10.1074/jbc.M109.026997			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19910461	Green Published, hybrid			2022-12-27	WOS:000273697800014
J	Nasu-Nishimura, Y; Jaffe, H; Isaac, JTR; Roche, KW				Nasu-Nishimura, Yukiko; Jaffe, Howard; Isaac, John T. R.; Roche, Katherine W.			Differential Regulation of Kainate Receptor Trafficking by Phosphorylation of Distinct Sites on GluR6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; MOSSY FIBER SYNAPSES; ER RETENTION SIGNAL; PROTEIN-KINASE-C; SURFACE EXPRESSION; GLUTAMATE RELEASE; THALAMOCORTICAL SYNAPSES; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; SPLICE VARIANTS	Kainate receptors are widely expressed in the brain, and are present at pre- and postsynaptic sites where they play a prominent role in synaptic plasticity and the regulation of network activity. Within individual neurons, kainate receptors of different subunit compositions are targeted to various locations where they serve distinct functional roles. Despite this complex targeting, relatively little is known about the molecular mechanisms regulating kainate receptor subunit trafficking. Here we investigate the role of phosphorylation in the trafficking of the GluR6 kainate receptor subunit. We identify two specific residues on the GluR6 C terminus, Ser(846) and Ser(868), which are phosphorylated by protein kinase C(PKC) and dramatically regulate GluR6 surface expression. By using GluR6 containing phosphomimetic and nonphosphorylatable mutations for these sites expressed in heterologous cells or in neurons lacking endogenous GluR6, we show that phosphorylation of Ser(846) or Ser(868) regulates receptor trafficking through the biosynthetic pathway. Additionally, Ser(846) phosphorylation dynamically regulates endocytosis of GluR6 at the plasma membrane. Our findings thus demonstrate that phosphorylation of PKC sites on GluR6 regulates surface expression of GluR6 at distinct intracellular trafficking pathways, providing potential molecular mechanisms for the PKC-dependent regulation of synaptic kainate receptor function observed during various forms of synaptic plasticity.	[Nasu-Nishimura, Yukiko; Jaffe, Howard; Isaac, John T. R.; Roche, Katherine W.] NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roche, KW (corresponding author), Bldg 35,Rm 2C903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019	Roche, Katherine/0000-0001-7282-6539	National Institutes of Health; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003035, ZIANS002994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health NINDS Intramural Research Program and a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at National Institutes of Health.	Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; BAHN S, 1994, J NEUROSCI, V14, P5525; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Clarke VRJ, 2002, NEUROPHARMACOLOGY, V42, P889, DOI 10.1016/S0028-3908(02)00039-4; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hayes DM, 2003, BIOCHEM BIOPH RES CO, V310, P8, DOI 10.1016/j.bbrc.2003.08.115; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Kim CH, 2005, J BIOL CHEM, V280, P25409, DOI 10.1074/jbc.M502644200; Lauri SE, 2006, NEURON, V50, P415, DOI 10.1016/j.neuron.2006.03.020; Lauri SE, 2005, J NEUROSCI, V25, P4473, DOI 10.1523/JNEUROSCI.4050-04.2005; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Ren Z, 2003, J NEUROSCI, V23, P6608; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Scott HL, 2007, NEUROPHARMACOLOGY, V52, P185, DOI 10.1016/j.neuropharm.2006.06.016; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Wikstrom MA, 2003, NEUROPHARMACOLOGY, V45, P828, DOI 10.1016/S0028-3908(03)00336-8; WISDEN W, 1993, J NEUROSCI, V13, P3582	48	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2847	2856		10.1074/jbc.M109.081141	http://dx.doi.org/10.1074/jbc.M109.081141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920140	hybrid, Green Published			2022-12-27	WOS:000273697800060
J	Frietze, S; Lan, X; Jin, VX; Farnham, PJ				Frietze, Seth; Lan, Xun; Jin, Victor X.; Farnham, Peggy J.			Genomic Targets of the KRAB and SCAN Domain-containing Zinc Finger Protein 263	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING SITES; DNA RECOGNITION; IDENTIFICATION; WEB; BOX	Half of all human transcription factors use C2H2 zinc finger domains to specify site-specific DNA binding and yet very little is known about their role in gene regulation. Based on in vitro studies, a zinc finger code has been developed that predicts a binding motif for a particular zinc finger factor (ZNF). However, very few studies have performed genome-wide analyses of ZNF binding patterns, and thus, it is not clear if the binding code developed in vitro will be useful for identifying target genes of a particular ZNF. We performed genome-wide ChIP-seq for ZNF263, a C2H2 ZNF that contains 9 finger domains, a KRAB repression domain, and a SCAN domain and identified more than 5000 binding sites in K562 cells. Our results suggest that ZNF263 binds to a 24-nt site that differs from the motif predicted by the zinc finger code in several positions. Interestingly, many of the ZNF263 binding sites are located within the transcribed region of the target gene. Although ZNFs containing a KRAB domain are thought to function mainly as transcriptional repressors, many of the ZNF263 target genes are expressed at high levels. To address the biological role of ZNF263, we identified genes whose expression was altered by treatment of cells with ZNF263-specific small interfering RNAs. Our results suggest that ZNF263 can have both positive and negative effects on transcriptional regulation of its target genes.	[Lan, Xun; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; University of California System; University of California Davis	Jin, VX (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	Victor.Jin@osumc.edu; pjfarnham@ucdavis.edu		Farnham, Peggy/0000-0003-4469-7914; Lan, Xun/0000-0002-6523-046X	National Institutes of Health [CA45250, 1U54HG004558]; NCBI Gene Expression Omnibus [GSE19235, GSE19146]; NATIONAL CANCER INSTITUTE [R01CA045240] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCBI Gene Expression Omnibus; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA45250 and 1U54HG004558 (United States Public Health Service). The ChIP-seq data and the RNA expression array data of this protein can be accessed through the NCBI Gene Expression Omnibus under NCBI accession numbers GSE19235 and GSE19146.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 1997, J COMPUT BIOL, V4, P45, DOI 10.1089/cmb.1997.4.45; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cho SY, 2008, BIOCHEM BIOPH RES CO, V369, P845, DOI 10.1016/j.bbrc.2008.02.106; Hon LS, 2006, BIOINFORMATICS, V22, P1047, DOI 10.1093/bioinformatics/btl037; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Liu JJ, 2008, BIOINFORMATICS, V24, P1850, DOI 10.1093/bioinformatics/btn331; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Segal DJ, 2000, CURR OPIN CHEM BIOL, V4, P34, DOI 10.1016/S1367-5931(99)00048-4; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tanaka K, 2002, MOL CELL BIOL, V22, P4256, DOI 10.1128/MCB.22.12.4256-4267.2002; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yokoyama M, 1997, BBA-GENE STRUCT EXPR, V1353, P13, DOI 10.1016/S0167-4781(97)00074-2	25	72	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1393	1403		10.1074/jbc.M109.063032	http://dx.doi.org/10.1074/jbc.M109.063032			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887448	Green Published, hybrid			2022-12-27	WOS:000273258200059
J	Nogales, A; Garcia, C; Perez, J; Callow, P; Ezquerra, TA; Gonzalez-Rodriguez, J				Nogales, Aurora; Garcia, Carolina; Perez, Javier; Callow, Phil; Ezquerra, Tiberio A.; Gonzalez-Rodriguez, Jose			Three-dimensional Model of Human Platelet Integrin alpha IIb beta 3 in Solution Obtained by Small Angle Neutron Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; GLYCOPROTEIN-IIB; STRUCTURAL BASIS; DISULFIDE BONDS; X-RAY; ACTIVATION; ALPHA(IIB)BETA(3); ALPHA-V-BETA-3; MEMBRANE	Integrin alpha IIb beta 3 is the major membrane protein and adhesion receptor at the surface of blood platelets, which after activation plays a key role in platelet plug formation in hemostasis and thrombosis. Small angle neutron scattering (SANS) and shape reconstruction algorithms allowed formation of a low resolution three-dimensional model of whole alpha IIb beta 3 in Ca2+/detergent solutions. Model projections after 90 degrees rotation along its long axis show an elongated and "arched" form (135 degrees) not observed before and a "handgun" form. This 20-nm-long structure is well defined, despite alpha IIb beta 3 multidomain nature and expected segmental flexibility, with the largest region at the top, followed by two narrower and smaller regions at the bottom. Docking of this SANS envelope into the high resolution structure of alpha IIb beta 3, reconstructed from crystallographic and NMR data, shows that the solution structure is less constrained, allows tentative assignment of the disposition of the alpha IIb and beta 3 sub-units and their domains within the model, and points out the structural analogies and differences of the SANS model with the crystallographic models of the recombinant ectodomains of alpha IIb beta 3 and alpha V beta 3 and with the cryo-electron microscopy model of whole alpha IIb beta 3. The ectodomain is in the bent configuration at the top of the model, where alpha IIb and beta 3 occupy the concave and convex sides, respectively, at the arched projection, with their bent knees at its apex. It follows the narrower transmembrane region and the cytoplasmic domains at the bottom end. alpha IIb beta 3 aggregated in Mn2+/detergent solutions, which impeded to get its SANS model.	[Garcia, Carolina; Gonzalez-Rodriguez, Jose] Consejo Super Invest Cient, Dept Biofis, Inst Quim Fis, Madrid 28006, Spain; [Nogales, Aurora; Ezquerra, Tiberio A.] Consejo Super Invest Cient, Dept Fis Macromol, Inst Estructura Mat, Madrid 28006, Spain; [Perez, Javier] Synchrotron SOLEIL, SWING, F-91192 Gif Sur Yvette, France; [Callow, Phil] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM); SOLEIL Synchrotron; Institut Laue-Langevin (ILL)	Gonzalez-Rodriguez, J (corresponding author), Consejo Super Invest Cient, Dept Biofis, Inst Quim Fis, Serrano 119, Madrid 28006, Spain.	j.gonzalez-rodriguez@iqfr.csic.es	Ezquerra, Tiberio A/N-5011-2014; Nogales, Aurora/A-8768-2008; Garcia, Carolina/E-9104-2015	Ezquerra, Tiberio A/0000-0001-9966-519X; Nogales, Aurora/0000-0002-2494-3551; Garcia, Carolina/0000-0001-5138-6191	SAF [2003-042/66]; Intramural Frontera [200680F-0083]	SAF; Intramural Frontera	This work was supported by Grants SAF 2003-042/66 (2003-2007) and Intramural Frontera 200680F-0083 (2007-2008) (to J. G.-R.).	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; CALVETE JJ, 1989, BIOCHEM J, V261, P561, DOI 10.1042/bj2610561; Calzada MJ, 2002, J BIOL CHEM, V277, P39899, DOI 10.1074/jbc.M205886200; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Coutinho A, 2007, BIOPHYS CHEM, V130, P76, DOI 10.1016/j.bpc.2007.07.007; GAREWAL HS, 1973, ANAL BIOCHEM, V54, P319, DOI 10.1016/0003-2697(73)90359-X; Guinier A, 1955, SMALL ANGLE XRAY SCA; Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9; Hunt JF, 1997, J MOL BIOL, V273, P1004, DOI 10.1006/jmbi.1997.1330; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Rivas G, 1996, J MOL RECOGNIT, V9, P31, DOI 10.1002/(SICI)1099-1352(199601)9:1<31::AID-JMR237>3.3.CO;2-F; Rivas G A, 1991, Protein Expr Purif, V2, P248, DOI 10.1016/1046-5928(91)90080-3; RIVAS GA, 1991, EUR BIOPHYS J BIOPHY, V19, P335, DOI 10.1007/BF00183324; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	40	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1023	1031		10.1074/jbc.M109.050039	http://dx.doi.org/10.1074/jbc.M109.050039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897481	hybrid, Green Published			2022-12-27	WOS:000273258200023
J	Seronello, S; Ito, C; Wakita, T; Choi, J				Seronello, Scott; Ito, Chieri; Wakita, Takaji; Choi, Jinah			Ethanol Enhances Hepatitis C Virus Replication through Lipid Metabolism and Elevated NADH/NAD(+)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA REPLICATION; ALCOHOL; LIVER; ACETALDEHYDE; INTERFERON; INFECTION; PATHWAYS; CULTURE	Ethanol has been suggested to elevate HCV titer in patients and to increase HCV RNA in replicon cells, suggesting that HCV replication is increased in the presence and absence of the complete viral replication cycle, but the mechanisms remain unclear. In this study, we use Huh7 human hepatoma cells that naturally express comparable levels of CYP2E1 as human liver to demonstrate that ethanol, at subtoxic and physiologically relevant concentrations, enhances complete HCV replication. The viral RNA genome replication is affected for both genotypes 2a and 1b. Acetaldehyde, a major product of ethanol metabolism, likewise enhances HCV replication at physiological concentrations. The potentiation of HCV replication by ethanol is suppressed by inhibiting CYP2E1 or aldehyde dehydrogenase and requires an elevated NADH/NAD(+) ratio. In addition, acetate, isopropyl alcohol, and concentrations of acetone that occur in diabetics enhance HCV replication with corresponding increases in the NADH/NAD(+). Furthermore, inhibiting the host mevalonate pathway with lovastatin or fluvastatin and fatty acid synthesis with 5-(tetradecyloxy)-2-furoic acid or cerulenin significantly attenuates the enhancement of HCV replication by ethanol, acetaldehyde, acetone, as well as acetate, whereas inhibiting beta-oxidation with beta-mercaptopropionic acid increases HCV replication. Ethanol, acetaldehyde, acetone, and acetate increase the total intracellular cholesterol content, which is attenuated with lovastatin. In contrast, both endogenous and exogenous ROS suppress the replication of HCV genotype 2a, as previously shown with genotype 1b. Conclusion: Therefore, lipid metabolism and alteration of cellular NADH/NAD(+) ratio are likely to play a critical role in the potentiation of HCV replication by ethanol rather than oxidative stress.	[Seronello, Scott; Ito, Chieri; Choi, Jinah] Univ Calif, Sch Nat Sci, Atwater, CA 95343 USA; [Wakita, Takaji] Natl Inst Infect Dis, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID)	Choi, J (corresponding author), Univ Calif, Sch Nat Sci, 5200 N Lake Rd, Merced, CA 95343 USA.	jchoi@ucmerced.edu			University of California, Merced	University of California, Merced(University of California System)	This work was supported by start-up funds from the University of California, Merced (to J.C.).	ADACHI J, 1989, ALCOHOL CLIN EXP RES, V13, P601, DOI 10.1111/j.1530-0277.1989.tb00389.x; Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; BADAWY AAB, 1977, BRIT J ALCOHOL ALCOH, V12, P120; Bader T, 2008, AM J GASTROENTEROL, V103, P1383, DOI 10.1111/j.1572-0241.2008.01876.x; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; CEDERBAUM AI, 1991, ALCOHOL ALCOHOLISM, P291; Chang T K, 1998, Methods Mol Biol, V107, P147; Choi J, 2006, FREE RADICAL BIO MED, V41, P1488, DOI 10.1016/j.freeradbiomed.2006.08.008; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Clemens DL, 2002, HEPATOLOGY, V35, P1196, DOI 10.1053/jhep.2002.32668; Cromie SL, 1996, J HEPATOL, V25, P821, DOI 10.1016/S0168-8278(96)80284-4; Eysseric H, 1997, ALCOHOL, V14, P111, DOI 10.1016/S0741-8329(96)00112-7; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; GRETCH D, 1994, J INFECT DIS, V169, P1219, DOI 10.1093/infdis/169.6.1219; Honda M, 2000, GASTROENTEROLOGY, V118, P152, DOI 10.1016/S0016-5085(00)70424-0; Hosogaya S, 2006, TRANSL RES, V148, P79, DOI 10.1016/j.trsl.2006.03.004; Huang H, 2007, P NATL ACAD SCI USA, V104, P18666, DOI 10.1073/pnas.0708423104; Jamal MM, 2003, BEST PRACT RES CL GA, V17, P649, DOI 10.1016/S1521-6918(03)00018-0; Kalapos MP, 1999, MED HYPOTHESES, V53, P236, DOI 10.1054/mehy.1998.0752; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kuroki M, 2009, J VIROL, V83, P2338, DOI 10.1128/JVI.01840-08; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Marshall DJ, 1997, J CLIN MICROBIOL, V35, P3156, DOI 10.1128/JCM.35.12.3156-3162.1997; McCartney EM, 2008, J INFECT DIS, V198, P1766, DOI 10.1086/593216; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Plumlee CR, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-89; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Sata M, 1996, J VIRAL HEPATITIS, V3, P143, DOI 10.1111/j.1365-2893.1996.tb00005.x; Seronello S, 2007, FREE RADICAL BIO MED, V43, P869, DOI 10.1016/j.freeradbiomed.2007.05.036; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Shin HR, 2005, INTERVIROLOGY, V49, P18, DOI 10.1159/000087258; Tamai T, 2000, ALCOHOL CLIN EXP RES, V24, p106S, DOI 10.1111/j.1530-0277.2000.tb00023.x; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yano M, 2007, ANTIMICROB AGENTS CH, V51, P2016, DOI 10.1128/AAC.01426-06; Yano M, 2009, HEPATOLOGY, V50, P678, DOI 10.1002/hep.23026; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Zhang T, 2003, HEPATOLOGY, V38, P57, DOI 10.1053/jhep.2003.50295	40	37	37	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					845	854		10.1074/jbc.M109.045740	http://dx.doi.org/10.1074/jbc.M109.045740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19910460	hybrid, Green Published			2022-12-27	WOS:000273258200005
J	Umekawa, M; Li, CS; Higashiyama, T; Huang, W; Ashida, H; Yamamoto, K; Wang, LX				Umekawa, Midori; Li, Cishan; Higashiyama, Takayuki; Huang, Wei; Ashida, Hisashi; Yamamoto, Kenji; Wang, Lai-Xi			Efficient Glycosynthase Mutant Derived from Mucor hiemalis Endo-beta-N-acetylglucosaminidase Capable of Transferring Oligosaccharide from Both Sugar Oxazoline and Natural N-Glycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; SUBSTRATE-ASSISTED CATALYSIS; TRANSGLYCOSYLATION ACTIVITY; ARTHROBACTER-PROTOPHORMIAE; CHEMOENZYMATIC SYNTHESIS; MOLECULAR-CLONING; FLAVOBACTERIUM-MENINGOSEPTICUM; COMPLEX OLIGOSACCHARIDES; CAENORHABDITIS-ELEGANS; PRIMARY SEQUENCE	Endo-M, an endo-beta-N-acetylglucosaminidase from Mucor hiemalis, is a family 85 glycoside hydrolase. This enzyme is unique in that it can transfer en bloc the oligosaccharide of various types of N-glycans onto different acceptors, and thereby it enzymatically generates diverse glycoconjugates. In this study, we performed mutational and kinetic studies focusing on a key catalytic asparagine 175 of Endo-M. We have shown that most of the Asn-175 mutants had significantly diminished hydrolysis activity but acted as glycosynthases capable of using synthetic sugar oxazoline for transglycosylation. Our results confirm the critical role of this asparagine residue in promoting the formation of an oxazolinium ion intermediate in the first step of the substrate-assisted catalysis. Interestingly, the N175Q mutant was found to possess dramatically enhanced glycosynthase-like activity with sugar oxazoline in comparison with N175A and a transglycosidase-like activity with "natural" N-glycan as well. These results also implicated the significance of amide side chain in the asparagine 175 of Endo-M for promoting oxazoline transglycosylation in the second step of the catalysis. The highly efficient syntheses of glycopeptides/glycoproteins by N175Q combined with synthetic sugar oxazolines or natural N-glycan substrates were exemplified. In addition, we also identified several previously unknown residues that seem to play a role in the catalysis of Endo-M.	[Umekawa, Midori; Higashiyama, Takayuki; Ashida, Hisashi; Yamamoto, Kenji] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Li, Cishan; Huang, Wei; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Inst Human Virol, Baltimore, MD 21201 USA	Kyoto University; University System of Maryland; University of Maryland Baltimore	Yamamoto, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan.	yamamotk@kais.kyoto-u.ac.jp; LWang@som.umaryland.edu	Wang, Lai-Xi/E-8755-2019; Wang, Lai-Xi/E-8790-2019; Ashida, Hisashi/HCI-0293-2022; wang, xl/Y-8251-2019; Huang, Wei/A-2167-2011; Huang, Wei/P-9631-2017	Wang, Lai-Xi/0000-0003-4293-5819; Huang, Wei/0000-0001-6432-1848; Ashida, Hisashi/0000-0001-5844-4075; Umekawa, Midori/0000-0002-8071-3902	National Institutes of Health [R01 GM 080374, R01 GM 080374-S1]; Japan Society for the Promotion of Science [214774]; Scientific Research [20380052]; Japan Science and Technology Agency-CREST; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research; Japan Science and Technology Agency-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 GM 080374 and R01 GM 080374-S1 (to L. X. W.) from the United States Department of Health and Human Services. This work was also supported by the Japan Society for the Promotion of Science Grants-in-aid for Research Fellowships for Young Scientists 214774 (to M. U.) and for Scientific Research (B) 20380052 (to K. Y.) and by Japan Science and Technology Agency-CREST.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Fujita K, 2006, BBA-GEN SUBJECTS, V1760, P1631, DOI 10.1016/j.bbagen.2006.09.003; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Hauser S, 2005, BIOCHEM BIOPH RES CO, V328, P580, DOI 10.1016/j.bbrc.2005.01.012; Heidecke CD, 2008, CHEMBIOCHEM, V9, P2045, DOI 10.1002/cbic.200800214; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li HG, 2005, BIOORG MED CHEM LETT, V15, P895, DOI 10.1016/j.bmcl.2004.12.066; Ling ZL, 2009, J MOL BIOL, V389, P1, DOI 10.1016/j.jmb.2009.03.050; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Ochiai H, 2008, J AM CHEM SOC, V130, P13790, DOI 10.1021/ja805044x; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; TAKEGAWA K, 1991, BIOCHEM INT, V24, P849; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094, DOI 10.1074/jbc.270.7.3094; TARENTINO AL, 1992, J BIOL CHEM, V267, P3868; TARENTINO AL, 1993, J BIOL CHEM, V268, P9702; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umemura M, 2008, J MED CHEM, V51, P4496, DOI 10.1021/jm8000967; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174; Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658	32	114	124	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					511	521		10.1074/jbc.M109.059832	http://dx.doi.org/10.1074/jbc.M109.059832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19880511	Green Published, hybrid			2022-12-27	WOS:000273070100053
J	Tan, KM; Clancy, S; Borovilos, M; Zhou, M; Horer, S; Moy, S; Volkart, LL; Sassoon, J; Baumann, U; Joachimiak, A				Tan, Kemin; Clancy, Shonda; Borovilos, Maria; Zhou, Min; Hoerer, Stefan; Moy, Shiu; Volkart, Lour L.; Sassoon, Judyth; Baumann, Ulrich; Joachimiak, Andrzej			The Mannitol Operon Repressor MtlR Belongs to a New Class of Transcription Regulators in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PHOSPHOTRANSFERASE SYSTEM; NUCLEOTIDE-SEQUENCE; HIGH-THROUGHPUT; BINDING-SITES; LARGE-SCALE; ENZYME-II; PROTEIN; DEHYDROGENASE; TRANSPORT	Many bacteria express phosphoenolpyruvate-dependent phosphotransferase systems (PTS). The mannitol-specific PTS catalyze the uptake and phosphorylation of D-mannitol. The uptake system comprises several genes encoded in the single operon. The expression of the mannitol operon is regulated by a proposed transcriptional factor, mannitol operon repressor (MtlR) that was first studied in Escherichia coli. Here we report the first crystal structures of MtlR from Vibrio parahemeolyticus (Vp-MtlR) and its homolog YggD protein from Shigella flexneri (Sf-YggD). MtlR and YggD belong to the same protein family (Pfam05068). Although Vp-MtlR and Sf-YggD share low sequence identity (22%), their overall structures are very similar, representing a novel all alpha-helical fold, and indicate similar function. However, their lack of any known DNA-binding structural motifs and their unfavorable electrostatic properties imply that MtlR/YggD are unlikely to bind a specific DNA operator directly as proposed earlier. This structural observation is further corroborated by in vitro DNA-binding studies of E. coli MtlR (Ec-MtlR), which detected no interaction of Ec-MtlR with the well characterized mannitol operator/promoter region. Therefore, MtlR/YggD belongs to a new class of transcription factors in bacteria that may regulate gene expression indirectly as a part of a larger transcriptional complex.	[Tan, Kemin; Clancy, Shonda; Borovilos, Maria; Zhou, Min; Moy, Shiu; Volkart, Lour L.; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Tan, Kemin; Clancy, Shonda; Borovilos, Maria; Zhou, Min; Moy, Shiu; Volkart, Lour L.; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA; [Hoerer, Stefan; Sassoon, Judyth; Baumann, Ulrich] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Bern	Joachimiak, A (corresponding author), Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov	Baumann, Ulrich/B-1220-2013		National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. This work was created by UChicago Argonne, LLC, Operator of Argonne National Laboratory.	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behrens S, 2001, MICROBIOL-SGM, V147, P75, DOI 10.1099/00221287-147-1-75; BERKOWIT.D, 1971, J BACTERIOL, V105, P232, DOI 10.1128/JB.105.1.232-240.1971; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P36; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; DAVIS T, 1988, MOL MICROBIOL, V2, P405, DOI 10.1111/j.1365-2958.1988.tb00045.x; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felder CE, 1997, J MOL GRAPH MODEL, V15, P318, DOI 10.1016/S1093-3263(98)00005-9; FIGGE RM, 1994, J BACTERIOL, V176, P840, DOI 10.1128/jb.176.3.840-847.1994; GEORGE AJT, 1995, J IMMUNOL METHODS, V183, P51, DOI 10.1016/0022-1759(95)00031-5; Henstra SA, 1996, J BACTERIOL, V178, P5586, DOI 10.1128/jb.178.19.5586-5591.1996; Henstra SA, 1999, J BIOL CHEM, V274, P4754, DOI 10.1074/jbc.274.8.4754; Henstra SA, 2000, J BIOL CHEM, V275, P7037, DOI 10.1074/jbc.275.10.7037; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Honeyman AL, 2000, MICROBIOL-SGM, V146, P1565, DOI 10.1099/00221287-146-7-1565; JIANG W, 1990, MOL MICROBIOL, V4, P2003, DOI 10.1111/j.1365-2958.1990.tb02050.x; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; LEE CA, 1983, J BIOL CHEM, V258, P761; LENGELER J, 1975, J BACTERIOL, V124, P39, DOI 10.1128/JB.124.1.39-47.1975; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luscombe NM, 2000, GENOME BIOL, V1; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otte S, 2003, J BACTERIOL, V185, P2267, DOI 10.1128/JB.185.7.2267-2276.2003; Otte S, 2001, FEMS MICROBIOL LETT, V194, P221, DOI 10.1016/S0378-1097(00)00534-6; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; RAMSEIER TM, 1995, MICROBIOL-SGM, V141, P1901, DOI 10.1099/13500872-141-8-1901; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Rubio I, 1997, BIOTECHNIQUES, V22, P269, DOI 10.2144/97222bm15; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Sassoon J, 2001, ACTA CRYSTALLOGR D, V57, P711, DOI 10.1107/S0907444901002542; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; Watanabe S, 2003, J BACTERIOL, V185, P4816, DOI 10.1128/JB.185.16.4816-4824.2003; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Yu CF, 2007, BIOCHEM BIOPH RES CO, V362, P1001, DOI 10.1016/j.bbrc.2007.08.102	51	10	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36670	36679		10.1074/jbc.M109.062679	http://dx.doi.org/10.1074/jbc.M109.062679			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19840941	Green Published, hybrid			2022-12-27	WOS:000272970500067
J	Winkler, M; Kuhlgert, S; Hippler, M; Happe, T				Winkler, Martin; Kuhlgert, Sebastian; Hippler, Michael; Happe, Thomas			Characterization of the Key Step for Light-driven Hydrogen Evolution in Green Algae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHLAMYDOMONAS-REINHARDTII; FERREDOXIN-NADP(+) REDUCTASE; CLOSTRIDIUM-ACETOBUTYLICUM; THIOREDOXIN REDUCTASE; ANGSTROM RESOLUTION; ONLY HYDROGENASES; CRYSTAL-STRUCTURE; IRON HYDROGENASE; TRANSFER COMPLEX	Under anaerobic conditions, several species of green algae perform a light-dependent hydrogen production catalyzed by a special group of [FeFe] hydrogenases termed HydA. Although highly interesting for biotechnological applications, the direct connection between photosynthetic electron transport and hydrogenase activity is still a matter of speculation. By establishing an in vitro reconstitution system, we demonstrate that the photosynthetic ferredoxin (PetF) is essential for efficient electron transfer between photosystem I and HydA1. To investigate the electrostatic interaction process and electron transfer between PetF and HydA1, we performed site-directed mutagenesis. Kinetic analyses with several site-directed mutagenesis variants of HydA1 and PetF enabled us to localize the respective contact sites. These experiments in combination with in silico docking analyses indicate that electrostatic interactions between the conserved HydA1 residue Lys(396) and the C terminus of PetF as well as between the PetF residue Glu(122) and the N-terminal amino group of HydA1 play a major role in complex formation and electron transfer. Mapping of relevant HydA1 and PetF residues constitutes an important basis for manipulating the physiological photosynthetic electron flow in favor of light-driven H-2 production.	[Winkler, Martin; Happe, Thomas] Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44801 Bochum, Germany; [Kuhlgert, Sebastian; Hippler, Michael] Univ Munster, Inst Biochem & Biotechnol Pflanzen, D-49143 Munster, Germany	Ruhr University Bochum; University of Munster	Happe, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, Univ Str 150, D-44801 Bochum, Germany.	thomas.happe@rub.de		Happe, Thomas/0000-0003-1206-5234; Michael, Hippler/0000-0001-9670-6101	Deutsche Forschungsgemeinschaft (DFG) [HI 739/4-1, SFB 480]; European Union/Energy Network SolarH2 FP7 [212508]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union/Energy Network SolarH2 FP7(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants HI 739/4-1 and SFB 480 (to T. H. and M. W., respectively) and the European Union/Energy Network SolarH2 FP7 Contract 212508 (to T. H.).	Bes MT, 1999, STRUCT FOLD DES, V7, P1201, DOI 10.1016/S0969-2126(00)80054-4; Chang CH, 2007, BIOPHYS J, V93, P3034, DOI 10.1529/biophysj.107.108589; CINCO RM, 1993, PHOTOSYNTH RES, V38, P27, DOI 10.1007/BF00015058; COLVERT KK, 1983, ARCH BIOCHEM BIOPHYS, V225, P936, DOI 10.1016/0003-9861(83)90108-X; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; Fischer N, 1998, EMBO J, V17, P849, DOI 10.1093/emboj/17.4.849; Florin L, 2001, J BIOL CHEM, V276, P6125, DOI 10.1074/jbc.M008470200; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Happe T, 2002, TRENDS PLANT SCI, V7, P246, DOI 10.1016/S1360-1385(02)02274-4; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P11100, DOI 10.1021/bi9709001; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jacquot JP, 1997, FEBS LETT, V400, P293, DOI 10.1016/S0014-5793(96)01407-X; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Krippahl L, 2003, PROTEINS, V52, P19, DOI 10.1002/prot.10387; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MAYHEW SG, 1969, J BIOL CHEM, V244, P2830; Mayoral T, 2005, PROTEINS, V59, P592, DOI 10.1002/prot.20450; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2004, PHOTOSYNTH RES, V80, P401, DOI 10.1023/B:PRES.0000030421.31730.cb; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Morales R, 2000, EMBO REP, V1, P271, DOI 10.1093/embo-reports/kvd057; Morales R, 1999, BIOCHEMISTRY-US, V38, P15764, DOI 10.1021/bi991578s; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Palma PN, 2005, FEBS LETT, V579, P4585, DOI 10.1016/j.febslet.2005.07.027; Peters JW, 1999, CURR OPIN STRUC BIOL, V9, P670, DOI 10.1016/S0959-440X(99)00028-7; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Saitoh T, 2006, J BIOL CHEM, V281, P10482, DOI 10.1074/jbc.M510530200; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Winkler M, 2002, BBA-GENE STRUCT EXPR, V1576, P330, DOI 10.1016/S0167-4781(02)00239-7; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Xu XF, 2006, FEBS LETT, V580, P6714, DOI 10.1016/j.febslet.2006.11.027; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895	41	95	95	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36620	36627		10.1074/jbc.M109.053496	http://dx.doi.org/10.1074/jbc.M109.053496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846550	Green Published, hybrid			2022-12-27	WOS:000272970500062
J	Cheng, CY; Yang, J; Taylor, SS; Blumenthal, DK				Cheng, Cecilia Y.; Yang, Jie; Taylor, Susan S.; Blumenthal, Donald K.			Sensing Domain Dynamics in Protein Kinase A-I alpha Complexes by Solution X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; SMALL-ANGLE SCATTERING; SITE MUTATIONS DEFINE; SUBUNIT RI-ALPHA; REGULATORY SUBUNIT; BIOLOGICAL MACROMOLECULES; CATALYTIC SUBUNIT; STRUCTURE REVEALS; CAMP; PKA	The catalytic (C) and regulatory (R) subunits of protein kinase A are exceptionally dynamic proteins. Interactions between the R- and C-subunits are regulated by cAMP binding to the two cyclic nucleotide-binding domains in the R-subunit. Mammalian cells express four different isoforms of the R-subunit (RI alpha, RI beta, RII alpha, and RII beta) that all interact with the C-subunit in different ways. Here, we investigate the dynamic behavior of protein complexes between RI alpha and C-subunits using small angle x-ray scattering. We show that a single point mutation in RI alpha, R333K (which alters the cAMP-binding properties of Domain B) results in a compact shape compared with the extended shape of the wild-type R.C complex. A double mutant complex that disrupts the interaction site between the C-subunit and Domain B in RI alpha, RI alpha(AB)R333K.C(K285P), results in a broader P(r) curve that more closely resembles the P(r) profiles of wild-type complexes. These results together suggest that interactions between RI alpha Domain B and the C-subunit in the RI alpha.C complex involve large scale dynamics that can be disrupted by single point mutations in both proteins. In contrast to RI alpha.C complexes. Domain B in the RII beta.C heterodimer is not dynamic and is critical for both inhibition and complex formation. Our study highlights the functional differences of domain dynamics between protein kinase A isoforms, providing a framework for elucidating the global organization of each holoenzyme and the cross-talk between the R- and C-subunits.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah	Blumenthal, DK (corresponding author), 112 Skaggs Hall, Salt Lake City, UT 84112 USA.	Don.Blumenthal@pharm.utah.edu		Blumenthal, Donald/0000-0002-8614-1167	National Institutes of Health [GM34921, GM08326]; American Heart Association [07015019Y]; United States Department of Energy [DE-FG02-05ER64026]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM034921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM34921 (to S. S. T.) and GM08326 (to C. Y. C.). This work was also supported in part by American Heart Association (Western States Affiliate) Grant 07015019Y (to C. Y. C.).; We thank Dr. Michael Deal (University of California, San Diego) for providing the C-subunit protein used in these studies and Dr. Dennis Winge (University of Utah) for performing the amino acid analyses. We also thank Jon Steichen for helpful discussions on the manuscript. We thank Dr. Jill Trewhella for the generous use of laboratory facilities at the University of Utah. X-ray scattering data were collected at the University of Utah using facilities that are supported by the United States Department of Energy Grant DE-FG02-05ER64026 (to Jill Trewhella).	Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Anand GS, 2007, J MOL BIOL, V374, P487, DOI 10.1016/j.jmb.2007.09.035; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Chen TC, 1998, LAB INVEST, V78, P165; Dayal AK, 1996, ARTHRITIS RHEUM-US, V39, P23, DOI 10.1002/art.1780390104; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Groussin L, 2006, J CLIN ENDOCR METAB, V91, P1943, DOI 10.1210/jc.2005-2708; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Heller WT, 2002, BIOCHEMISTRY-US, V41, P15654, DOI 10.1021/bi026687c; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; Horvath A, 2008, CLIN CANCER RES, V14, P388, DOI 10.1158/1078-0432.CCR-07-1155; Huang LJS, 1998, J BIOL CHEM, V273, P26739, DOI 10.1074/jbc.273.41.26739; KAMMER GM, 1994, J CLIN INVEST, V94, P422, DOI 10.1172/JCI117340; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kennedy EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004746; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; MURPHY CS, 1985, SOMAT CELL MOLEC GEN, V11, P605, DOI 10.1007/BF01534725; Prowse CN, 2001, J BIOL CHEM, V276, P40817, DOI 10.1074/jbc.M105860200; STEINBERG RA, 1987, J BIOL CHEM, V262, P2664; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Vigil D, 2005, J BIOL CHEM, V280, P35521, DOI 10.1074/jbc.M506769200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200	37	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35916	35925		10.1074/jbc.M109.059493	http://dx.doi.org/10.1074/jbc.M109.059493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837668	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000272645600067
J	Khan, MA; Yumak, H; Goss, DJ				Khan, Mateen A.; Yumak, Hasan; Goss, Dixie J.			Kinetic Mechanism for the Binding of eIF4F and Tobacco Etch Virus Internal Ribosome Entry Site RNA EFFECTS OF eIF4B AND POLY(A)- BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; CAP-INDEPENDENT TRANSLATION; GENOME-LINKED PROTEIN; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; STOPPED-FLOW; POLY(A) TAIL; FACTOR 4F; FACTOR 4G; ANALOGS	The wheat germ eukaryotic translation initiation factor (eIF) 4F binds tightly to the mRNA internal ribosome entry site (IRES) of tobacco etch virus (TEV) to promote translation initiation. When eIF4F is limiting, TEV is preferentially translated compared with host cell mRNA. To gain insight into the dynamic process of protein synthesis initiation and the mechanism of binding, the kinetics of eIF4F binding to TEV IRES were examined. The association rate constant (k(on)) and dissociation rate constant (k(off)) for eIF4F binding to IRES were 59 +/- 2.1 mu M-1 s(-1) and 12.9 +/- 0.3 s(-1), respectively, comparable with the rates for capped RNA. Binding of eIF4E or eIF4F to the cap of mRNA is the rate-limiting step for initiation of cap-dependent protein synthesis. The concentration dependence of the reactions suggested a simple one-step association mechanism. However, the association rate was reduced more than 10-fold when KCl concentration was increased from 50 to 300 mM, whereas the dissociation rate constant was increased 2-fold. The addition of eIF4B and poly(A)-binding protein enhanced the association rate of eIF4F similar to 3-fold. These results suggest a mechanism where eIF4F initially binds electrostatically, followed by a conformational change to further stabilize binding. Poly(A)-binding protein and eIF4B mainly affect the eIF4F/TEV association rate. These results demonstrate the first direct kinetic measurements of translation initiation factor binding to an IRES.	CUNY Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA; CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Khan, Mateen A./0000-0002-2300-4595	National Institutes of Health Research Center in Minority Institution [RR-03037]; National Science Foundation [MCB 0814051]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER	National Institutes of Health Research Center in Minority Institution(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Research Center in Minority Institution Award RR-03037. This work was also supported by National Science Foundation Grant MCB 0814051 (to D. J. G.).	Blachut-Okrasinska E, 2000, EUR BIOPHYS J BIOPHY, V29, P487, DOI 10.1007/s002490000096; Blachut-Okrasinska E, 2007, BIOPHYS CHEM, V129, P289, DOI 10.1016/j.bpc.2007.06.009; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARBERRY SE, 1989, BIOCHEMISTRY-US, V28, P8078, DOI 10.1021/bi00446a017; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Cheng S, 2007, J BIOL CHEM, V282, P25247, DOI 10.1074/jbc.M702193200; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Dlugosz M, 2003, EUR BIOPHYS J BIOPHY, V31, P608, DOI 10.1007/s00249-002-0258-7; DOUGHERTY WG, 1988, ANNU REV PHYTOPATHOL, V26, P123, DOI 10.1146/annurev.py.26.090188.001011; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; GALLIE DR, 1995, GENE, V165, P233, DOI 10.1016/0378-1119(95)00521-7; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Katsamba PS, 2001, J BIOL CHEM, V276, P21476, DOI 10.1074/jbc.M101624200; Khan MA, 2005, BIOCHEMISTRY-US, V44, P4510, DOI 10.1021/bi047298g; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Khan MA, 2008, BBA-GENE REGUL MECH, V1779, P622, DOI 10.1016/j.bbagrm.2008.07.004; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; Morley SJ, 2001, PROG MOLEC, V27, P1; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; PETTERSSON RF, 1977, NATURE, V268, P270, DOI 10.1038/268270a0; Pilipenko EV, 2000, GENE DEV, V14, P2028; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; SHA M, 1995, J BIOL CHEM, V270, P29904; Slepenkov SV, 2008, J BIOL CHEM, V283, P25227, DOI 10.1074/jbc.M801786200; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; YISRAELI JK, 1989, METHOD ENZYMOL, V180, P42; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200	53	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35461	35470		10.1074/jbc.M109.038463	http://dx.doi.org/10.1074/jbc.M109.038463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858189	hybrid, Green Published			2022-12-27	WOS:000272645600022
J	Kubota, H; Mikhailenko, SV; Okabe, H; Taguchi, H; Ishiwata, S				Kubota, Hiroaki; Mikhailenko, Sergey V.; Okabe, Harumi; Taguchi, Hideki; Ishiwata, Shin'ichi			D-loop of Actin Differently Regulates the Motor Function of Myosins II and V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-CLEAVED ACTIN; F-ACTIN; CONFORMATIONAL-CHANGES; PROCESSIVE MOVEMENT; DICTYOSTELIUM ACTIN; BINDING LOOP; COORDINATION; FILAMENTS; FORCE; MODEL	To gain more information on the manner of actin-myosin interaction, we examined how the motile properties of myosins II and V are affected by the modifications of the DNase I binding loop (D-loop) of actin, performed in two different ways, namely, the proteolytic digestion with subtilisin and the M47A point mutation. In an in vitro motility assay, both modifications significantly decreased the gliding velocity on myosin II-heavy meromyosin due to a weaker generated force but increased it on myosin V. On the other hand, single molecules of myosin V "walked" with the same velocity on both the wild-type and modified actins; however, the run lengths decreased sharply, correlating with a lower affinity of myosin for actin due to the D-loop modifications. The difference between the single-molecule and the ensemble measurements with myosin V indicates that in an in vitro motility assay the non-coordinated multiple myosin V molecules impose internal friction on each other via binding to the same actin filament, which is reduced by the weaker binding to the modified actins. These results show that the D-loop strongly modulates the force generation by myosin II and the processivity of myosin V, presumably affecting actin-myosin interaction in the actomyosin-ADP center dot P-i state of both myosins.	[Kubota, Hiroaki; Mikhailenko, Sergey V.; Okabe, Harumi; Ishiwata, Shin'ichi] Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Taguchi, Hideki] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba 2778562, Japan; [Ishiwata, Shin'ichi] Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Waseda University; University of Tokyo; Waseda University	Ishiwata, S (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	ishiwata@waseda.jp	taguchi, hideki/AAM-2663-2021; Kubota, Hiroaki/AAP-2859-2020; Taguchi, Hideki/B-6946-2009	taguchi, hideki/0000-0002-6612-9339; Kubota, Hiroaki/0000-0002-6339-8568; Taguchi, Hideki/0000-0002-6612-9339	21st Century Centers of Excellence Program; "Academic Frontier" Project	21st Century Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Academic Frontier" Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (A), the 21st Century Centers of Excellence Program, and the "Academic Frontier" Project (to S.I.).	Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Kawai M, 2006, J PHYSIOL-LONDON, V574, P877, DOI 10.1113/jphysiol.2006.111708; KIESSLING P, 1995, BIOCHEMISTRY-US, V34, P14834, DOI 10.1021/bi00045a026; Kim E, 1996, BIOPHYS J, V70, P1439, DOI 10.1016/S0006-3495(96)79703-5; KONDO H, 1976, J BIOCHEM-TOKYO, V79, P159, DOI 10.1093/oxfordjournals.jbchem.a131043; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kuznetsova I, 1996, FEBS LETT, V383, P105, DOI 10.1016/0014-5793(96)00238-4; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Muhlrad A, 2004, J MOL BIOL, V342, P1559, DOI 10.1016/j.jmb.2004.08.010; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SCHWYTER DH, 1990, J CELL BIOL, V111, P465, DOI 10.1083/jcb.111.2.465; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; WEEDS AG, 1971, NATURE, V234, P85, DOI 10.1038/234085a0; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	33	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35251	35258		10.1074/jbc.M109.013565	http://dx.doi.org/10.1074/jbc.M109.013565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840951	Green Published, hybrid			2022-12-27	WOS:000272439600077
J	Liu, ZL; Zhou, SL; Liao, L; Chen, X; Meistrich, M; Xu, JM				Liu, Zhaoliang; Zhou, Suoling; Liao, Lan; Chen, Xian; Meistrich, Marvin; Xu, Jianming			Jmjd1a Demethylase-regulated Histone Modification Is Essential for cAMP-response Element Modulator-regulated Gene Expression and Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALE GERM-CELLS; METHYLATION; JHDM2A; SPERM; CREM; SPERMIOGENESIS; TRANSCRIPTION; ACTIVATION; FERTILITY; ACETYLTRANSFERASES	Spermatogenesis, a fundamental process in the male reproductive system, requires a series of tightly controlled epigenetic and genetic events in germ cells ranging from spermatogonia to spermatozoa. Jmjd1a is a key epigenetic regulator expressed in the testis. It specifically demethylates mono- and di-methylated histone H3 lysine 9 (H3K9me1 and H3K9me2) but not tri-methylated H3K9 (H3K9me3). In this study, we generated a Jmjd1a antibody for immunohistochemistry and found Jmjd1a was specifically produced in pachytene and secondary spermatocytes. Disruption of the Jmjd1a gene in mice significantly increased H3K9me1 and H3K9me2 levels in pachytene spermatocytes and early elongating spermatids without affecting H3K9me3 levels. Concurrently, the levels of histone acetylation were decreased in Jmjd1a knock-out germ cells. This suggests Jmjd1a promotes transcriptional activation by lowering histone methylation and increasing histone acetylation. Interestingly, the altered histone modifications in Jmjd1a-deficient germ cells caused diminished cAMP-response element modulator (Crem) recruitment to chromatin and decreased expression of the Crem coactivator Act and their target genes Tnp1 (transition protein 1), Tnp2, Prm1 (protamine 1), and Prm2, all of which are essential for chromatin condensation in spermatids. In agreement with these findings, Jmjd1a deficiency caused extensive germ cell apoptosis and blocked spermatid elongation, resulting in severe oligozoospermia, small testes, and infertility in male mice. These results indicate that the Jmjd1a-controlled epigenetic histone modifications are crucial for Crem-regulated gene expression and spermatogenesis.	[Liu, Zhaoliang; Zhou, Suoling; Liao, Lan; Chen, Xian; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liu, Zhaoliang; Chen, Xian; Xu, Jianming] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Meistrich, Marvin] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Xu, Jianming] Luzhou Med Coll, Luzhou 646000, Sichuan, Peoples R China	Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Southwest Medical University	Xu, JM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	jxu@bcm.tmc.edu			National Institutes of Health [DK058242, CA112403, CA119689, DK059820]; NATIONAL CANCER INSTITUTE [R01CA119689, R01CA112403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058242, P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK058242, CA112403, CA119689, and DK059820.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akimoto C, 2008, GENES CELLS, V13, P623, DOI 10.1111/j.1365-2443.2008.01193.x; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Couldrey C, 1999, HUM MOL GENET, V8, P2489, DOI 10.1093/hmg/8.13.2489; De Cesare D, 2003, MOL ENDOCRINOL, V17, P2554, DOI 10.1210/me.2003-0280; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Giorgini F, 2002, DEVELOPMENT, V129, P3669; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; HOOG C, 1991, MOL REPROD DEV, V30, P173, DOI 10.1002/mrd.1080300302; Jeyaraj DA, 2005, STEROIDS, V70, P704, DOI 10.1016/j.steroids.2005.03.015; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Ko SY, 2006, CELL STRUCT FUNCT, V31, P53, DOI 10.1247/csf.31.53; Kotaja N, 2004, P NATL ACAD SCI USA, V101, P10620, DOI 10.1073/pnas.0401947101; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; MALI P, 1989, REPROD FERT DEVELOP, V1, P369, DOI 10.1071/RD9890369; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Sambrook J., 2001, MOL CLONING LAB MANU; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tanaka H, 2005, MOL CELL BIOL, V25, P7107, DOI 10.1128/MCB.25.16.7107-7119.2005; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thomas T, 2007, GENE EXPR PATTERNS, V7, P657, DOI 10.1016/j.modgep.2007.03.005; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao M, 2004, BIOL REPROD, V71, P1016, DOI 10.1095/biolreprod.104.028191; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001	57	100	110	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2758	2770		10.1074/jbc.M109.066845	http://dx.doi.org/10.1074/jbc.M109.066845			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19910458	Green Published, hybrid			2022-12-27	WOS:000273697800053
J	Seong, HA; Jung, H; Ichijo, H; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Ichijo, Hidenori; Ha, Hyunjung			Reciprocal Negative Regulation of PDK1 and ASK1 Signaling by Direct Interaction and Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; PROMOTES CELL-SURVIVAL; TYROSINE PHOSPHORYLATION; PHYSICAL INTERACTION; OXIDATIVE STRESS; APOPTOSIS; ACTIVATION; DEATH; IDENTIFICATION	Cell survival and death-inducing signals are tightly associated with each other, and the decision as to whether a cell survives or dies is determined by controlling the relationship between these signals. However, the mechanism underlying the reciprocal regulation of such signals remains unclear. In this study, we reveal a functional association between PDK1 (3-phosphoinositide-dependent protein kinase 1), a critical mediator of cell survival, and ASK1 (apoptosis signal-regulating kinase 1), an apoptotic stress-activated MAPKKK. The physical association between PDK1 and ASK1 is mediated through the pleckstrin homology domain of PDK1 and the C-terminal regulatory domain of ASK1 and is decreased by ASK1-activating stimuli, such as H2O2, tumor necrosis factor alpha, thapsigargin, and ionomycin, as well as insulin, a PDK1 stimulator. Wild-type PDK1, but not kinase-dead PDK1, negatively regulates ASK1 activity by phosphorylating Ser(967), a binding site for 14-3-3 protein, on ASK1. PDK1 functionally suppresses ASK1-mediated AP-1 transactivation and H2O2-mediated apoptosis in a kinase-dependent manner. On the other hand, ASK1 has been shown to inhibit PDK1 functions, including PDK1-mediated regulation of apoptosis and cell growth, by phosphorylating PDK1 at Ser(394) and Ser(398), indicating that these putative phosphorylation sites are involved in the negative regulation of PDK1 activity. These results provide evidence that PDK1 and ASK1 directly interact and phosphorylate each other and act as negative regulators of their respective kinases in resting cells.	[Seong, Hyun-A; Jung, Haiyoung; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea; [Ichijo, Hidenori] Univ Tokyo, Japan Sci & Technol Corp, Global Ctr Excellence Program, Grad Sch Pharmaceut Sci,Lab Cell Signaling,Bunkyo, Tokyo 1130033, Japan	Chungbuk National University; Japan Science & Technology Agency (JST); University of Tokyo	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr		Ichijo, Hidenori/0000-0002-5005-6438	Korea Science and Engineering Foundation [R0A-2007-000-20006-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grant R0A-2007-000-20006-0.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Hetman M, 2000, J NEUROSCI, V20, P2567; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	37	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2397	2414		10.1074/jbc.M109.064295	http://dx.doi.org/10.1074/jbc.M109.064295			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920149	Green Published, hybrid			2022-12-27	WOS:000273697800020
J	Shao, HS; Wu, CY; Wells, A				Shao, Hanshuang; Wu, Chuanyue; Wells, Alan			Phosphorylation of alpha-Actinin 4 upon Epidermal Growth Factor Exposure Regulates Its Interaction with Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; BINDING DOMAIN; CELL MOTILITY; PHOSPHOINOSITIDE BINDING; SIGNALING PATHWAY; CALPAIN PROTEASES; CRYSTAL-STRUCTURE; ALPHA-ACTININ-4; MECHANISM; MIGRATION	The ubiquitously expressed family of alpha-actinins bridges actin filaments to stabilize adhesions, a process disrupted during growth factor-induced migration of cells. During the dissolution of the actin cytoskeleton, actinins are phosphorylated on tyrosines, although the consequences of this are unknown. We expressed the two isoforms of human alpha-actinin in murine fibroblasts that express human epidermal growth factor receptor (EGFR) and found that both alpha-actinin 1 (ACTN1) and alpha-actinin 4 (ACTN4) were phosphorylated on tyrosine residues after stimulation with EGF, although ACTN4 was phosphorylated to the greater extent. This required the activation of Src protein-tyrosine kinase and p38-MAPK (and phosphoinositide trisphosphate kinase in part) but not MEK/ERK or Rac1, as determined by inhibitors. The EGF-induced phosphorylation sites of ACTN4 were mapped to tyrosine 4, the major site, and tyrosine 31, the minor one. Truncation mutagenesis showed that the C-terminal domains of ACTN4 (amino acids 300 - 911), which cross-link the actin binding head domains, act as an inhibitory domain for both actin binding and EGF-mediated phosphorylation. These two properties were mutually exclusive; removal of the C terminus enhanced actin binding of ACTN4 mutants while limiting EGF-induced phosphorylation, and conversely EGF-stimulated phosphorylation of ACTN4 decreased its affinity to actin. Interestingly, a phosphomimetic of tyrosine 265 (which can be found in carcinoma cells and lies near the K255E mutation that causes focal segmental glomerulosclerosis) demonstrated increased actin binding activity and susceptibility of ACTN4 to calpain-mediated cleavage; this variant also retarded cell spreading. Remarkably, either treatment of cells with low concentrations of latrunculin A, which has been shown to depolymerize F-actin, or the deletion of the actin binding domain (100 - 252 amino acids) of ACTN4Y265E restored EGF-induced phosphorylation. An F-actin binding assay in vitro showed that Y4E/Y31E, a mimetic of diphosphorylated ACTN4, bound F-actin slightly compared with wild type (WT). Importantly, the EGF-mediated phosphorylation of ACTN4 at tyrosine 4 and 31 significantly inhibited multinucleation of proliferating NR6WT fibroblasts that overexpress ACTN4. These results suggest that EGF regulates the actin binding activity of ACTN4 by inducing tyrosyl-directed phosphorylation.	[Shao, Hanshuang; Wu, Chuanyue; Wells, Alan] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 713 Scaife, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institutes of Health NIGMS; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188, R01GM069668] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health NIGMS and NIDDK.	BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Chou J, 2003, EXP CELL RES, V287, P47, DOI 10.1016/S0014-4827(03)00119-8; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Lee SH, 2008, J MOL BIOL, V376, P317, DOI 10.1016/j.jmb.2007.11.084; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Selliah N, 1996, J IMMUNOL, V156, P3215; Sprague CR, 2008, J BIOL CHEM, V283, P9217, DOI 10.1074/jbc.M707436200; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wells A, 2000, ADV CANCER RES, V78, P31; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Xie H, 1998, J CELL SCI, V111, P615; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	23	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2591	2600		10.1074/jbc.M109.035790	http://dx.doi.org/10.1074/jbc.M109.035790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19920151	Green Published, hybrid			2022-12-27	WOS:000273697800038
J	Phan, J; Li, ZY; Kasprzak, A; Li, BZ; Sebti, S; Guida, W; Schonbrunn, E; Chen, JD				Phan, Jason; Li, Zhenyu; Kasprzak, Agnieszka; Li, Baozong; Sebti, Said; Guida, Wayne; Schoenbrunn, Ernst; Chen, Jiandong			Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; ACTIVATION; PROTEIN; PATHWAY; BINDING; APOPTOSIS; RESCUE; SUPPRESSION; GROWTH	MDM2 and MDMX function as key regulators of p53 by binding to its N terminus, inhibiting its transcriptional activity, and promoting degradation. MDM2 and MDMX overexpression or hyperactivation directly contributes to the loss of p53 function during the development of nearly 50% of human cancers. Recent studies showed that disrupting p53-MDM2 and p53-MDMX interactions can lead to robust activation of p53 but also revealed a need to develop novel dual specific or MDMX-specific inhibitors. Using phage display we identified a 12-residue peptide (pDI) with inhibitory activity against MDM2 and MDMX. The co-crystal structures of the pDI and a single mutant derivative (pDI6W) liganded with the N-terminal domains of human MDMX and MDM2 served as the basis for the design of 11 distinct pDI-derivative peptides that were tested for inhibitory potential. The best derivative (termed pDIQ) contained four amino acid substitutions and exhibited a 5-fold increase in potency over the parent peptide against both MDM2 (IC50 = 8 nM) and MDMX (IC50 = 110 nM). Further structural studies revealed key molecular features enabling the high affinity binding of the pDIQ to these proteins. These include large conformational changes of the pDIQ to reach into a hydrophobic site unique to MDMX. The findings suggest new strategies toward the rational design of small molecule inhibitors efficiently targeting MDMX.	[Phan, Jason; Kasprzak, Agnieszka; Sebti, Said; Guida, Wayne; Schoenbrunn, Ernst] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Li, Zhenyu; Li, Baozong; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Sebti, Said; Guida, Wayne; Schoenbrunn, Ernst; Chen, Jiandong] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Schonbrunn, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Ernst.Schonbrunn@moffitt.org; Jiandong.Chen@moffitt.org	li, baozong/K-4176-2012; Li, Baozong/ABD-4742-2020	Schonbrunn, Ernst/0000-0002-3589-3510	National Institutes of Health [CA109636, CA118210]; NATIONAL CANCER INSTITUTE [R01CA109636, P01CA118210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109636 (to J.C.) and CA118210 (to S. S.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; Fasan R, 2006, CHEMBIOCHEM, V7, P515, DOI 10.1002/cbic.200500452; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lawrence HR, 2009, BIOORG MED CHEM LETT, V19, P3756, DOI 10.1016/j.bmcl.2009.04.124; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; LUNA RMD, 1995, NATURE, V378, P203; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Prives C, 1999, J PATHOL, V187, P112; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2008, CELL CYCLE, V7, P1973, DOI 10.4161/cc.7.13.6072; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xia MX, 2008, CELL CYCLE, V7, P1604, DOI 10.4161/cc.7.11.5929; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhang RM, 2004, ANAL BIOCHEM, V331, P138, DOI 10.1016/j.ab.2004.03.009; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	42	116	130	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2174	2183		10.1074/jbc.M109.073056	http://dx.doi.org/10.1074/jbc.M109.073056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19910468	hybrid, Green Published			2022-12-27	WOS:000273429100061
J	Gump, JM; June, RK; Dowdy, SF				Gump, Jacob M.; June, Ronald K.; Dowdy, Steven F.			Revised Role of Glycosaminoglycans in TAT Protein Transduction Domain-mediated Cellular Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ARGININE-RICH PEPTIDES; PENETRATING PEPTIDES; SURFACE PROTEOGLYCANS; DELIVERY; CELLS; MACROPINOCYTOSIS; MECHANISMS; INTERNALIZATION; BINDING	Cellular uptake of the human immunodeficiency virus TAT protein transduction domain (PTD), or cell-penetrating peptide, has previously been surmised to occur in a manner dependent on the presence of heparan sulfate proteoglycans that are expressed ubiquitously on the cell surface. These acidic polysaccharides form a large pool of negative charge on the cell surface that TAT PTD binds avidly. Additionally, sulfated glycans have been proposed to aid in the interaction of TAT PTD and other arginine-rich PTDs with the cell membrane, perhaps aiding their translocation across the membrane. Surprisingly, however, TAT PTD-mediated induction of macropinocytosis and cellular transduction occurs in the absence of heparan sulfate and sialic acid. Using labeled TAT PTD peptides and fusion proteins, in addition to TAT PTD-Cre recombination-based phenotypic assays, we show that transduction occurs efficiently in mutant Chinese hamster ovary cell lines deficient in glycosaminoglycans and sialic acids. Similar results were obtained in cells where glycans were enzymatically removed. In contrast, enzymatic removal of proteins from the cell surface completely ablated TAT PTD-mediated transduction. Our findings support the hypothesis that acidic glycans form a pool of charge that TAT PTD binds on the cell surface, but this binding is independent of the PTD-mediated transduction mechanism and the induction of macropinocytotic uptake by TAT PTD.	[Gump, Jacob M.; June, Ronald K.; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Dowdy, SF (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Howard Hughes Med Inst, 9500 Gilman Dr,GPL 231B,MC 0686, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu	Gump, Jacob/F-9731-2011		Howard Hughes Medical Institute; Leukemia and Lymphoma Society; Pardee Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pardee Foundation	Supported by the Howard Hughes Medical Institute, the Leukemia and Lymphoma Society, and the Pardee Foundation.	Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; El-Andaloussi S, 2005, CURR PHARM DESIGN, V11, P3597, DOI 10.2174/138161205774580796; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Elson-Schwab L, 2007, J BIOL CHEM, V282, P13585, DOI 10.1074/jbc.M700463200; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1992, ADV EXP MED BIOL, V313, P97; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Goun EA, 2006, CHEMBIOCHEM, V7, P1497, DOI 10.1002/cbic.200600171; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hakansson S, 2001, PROTEIN SCI, V10, P2138, DOI 10.1110/ps.23401; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Meade BR, 2007, ADV DRUG DELIVER REV, V59, P134, DOI 10.1016/j.addr.2007.03.004; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996	28	104	112	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1500	1507		10.1074/jbc.M109.021964	http://dx.doi.org/10.1074/jbc.M109.021964			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19858185	Green Published, hybrid			2022-12-27	WOS:000273258200069
J	Zorina, Y; Iyengar, R; Bromberg, KD				Zorina, Yana; Iyengar, Ravi; Bromberg, Kenneth D.			Cannabinoid 1 Receptor and Interleukin-6 Receptor Together Induce Integration of Protein Kinase and Transcription Factor Signaling to Trigger Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC TYROSINE KINASE; PC12 CELLS; GROWTH-FACTOR; NEURONAL DIFFERENTIATION; CEREBROSPINAL-FLUID; PHOSPHATASE; ACTIVATION; PATHWAY; GP130; SHP-2	Activation of the G(o/i)-coupled cannabinoid 1 receptor (CB1R) has been shown to induce neurite outgrowth in Neuro2A cells through activation of Src kinase and STAT3 transcription factor. Signaling by the interleukin 6 receptor (IL-6R) also activates STAT3 through Jak kinase. We studied if signals from the two pathways could be integrated in a synergistic manner to trigger neurite outgrowth in Neuro2A cells. At low concentrations, when agonist at either receptor by itself has no effect, we found that CB1R and IL-6R stimulation together induced synergistic neurite outgrowth. Signal integration requires activation of transcription factors by Src, Jak, and mitogen-activated protein kinases. Mitogen-activated protein kinase can be activated by both receptors and shows enhanced early activation in the presence of both ligands. CREB and STAT3 transcription factors are required for synergy and show enhanced DNA-binding activity when both receptors are activated. STAT3 plays a critical role in integration of the signals downstream of the two receptors. When both pathways are activated, STAT3 phosphorylation is sustained for 6 h. This prolonged activation of STAT3 requires deactivation of SHP2 phosphatase. Reduction of SHP2 levels by RNA interference results in greater synergy in neurite outgrowth. Simultaneous knockdown of both SHP2 and STAT3 blocks the synergistic triggering of neurite outgrowth, indicating that STAT3 is downstream of SHP2. CB1R and IL-6R co-stimulation enhanced the differentiation of rat cortical neuron primary cultures. These results provide a mechanism where multiple protein kinases and transcription factors interact to integrate signals from G protein-coupled and cytokine receptor evoke neurite outgrowth in Neuro2A cells.	[Zorina, Yana; Iyengar, Ravi; Bromberg, Kenneth D.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Bromberg, KD (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave Levy Pl,Box 1215, New York, NY 10029 USA.	Kenneth.bromberg@mssm.edu		Zorina, Yana/0000-0002-0200-2742	National Institutes of Health [GM5408, P50GM071558, T32 CA88796]; American Cancer Society Spirit of Birmingham; Johnson Memorial Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA088796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, T32GM062754, P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Spirit of Birmingham; Johnson Memorial Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM5408, P50GM071558, and T32 CA88796 (to K.D.B.). This work was also supported by an American Cancer Society Spirit of Birmingham and Johnson Memorial Postdoctoral Fellowship Award.	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Arthur DB, 2006, BIOCHEM BIOPH RES CO, V347, P678, DOI 10.1016/j.bbrc.2006.06.141; Barua D, 2007, BIOPHYS J, V92, P2290, DOI 10.1529/biophysj.106.093484; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; FENG GS, 1993, SCIENCE, V259, P1611; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Horton AR, 1998, EUR J NEUROSCI, V10, P673, DOI 10.1046/j.1460-9568.1998.00079.x; Ihara S, 1996, J BIOCHEM, V120, P865; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kim HK, 1998, MOL CELL BIOL, V18, P1525, DOI 10.1128/MCB.18.3.1525; Kiyono M, 2000, J BIOL CHEM, V275, P5441, DOI 10.1074/jbc.275.8.5441; Kunioku H, 2001, NEUROSCI LETT, V309, P13, DOI 10.1016/S0304-3940(01)02012-2; Kuroda H, 2001, MED PEDIATR ONCOL, V36, P118, DOI 10.1002/1096-911X(20010101)36:1<118::AID-MPO1028>3.0.CO;2-R; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Morris VA, 2008, J VIROL, V82, P8771, DOI 10.1128/JVI.00766-08; Muller T, 1998, ACTA NEUROL SCAND, V98, P142; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; PENG ZY, 1995, ONCOGENE, V11, P1955; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; STRAUSS S, 1992, LAB INVEST, V66, P223; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; WEI W, 1994, GENE, V151, P279, DOI 10.1016/0378-1119(94)90671-8; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Wu YY, 1996, J BIOL CHEM, V271, P13033, DOI 10.1074/jbc.271.22.13033; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Yin TG, 1997, J BIOL CHEM, V272, P1032, DOI 10.1074/jbc.272.2.1032; Zhong J, 1999, J NEUROSCI, V19, P4305; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	58	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1358	1370		10.1074/jbc.M109.049841	http://dx.doi.org/10.1074/jbc.M109.049841			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19861414	Green Published, hybrid			2022-12-27	WOS:000273258200056
J	Bhattacharyya, S; Borthakur, A; Tyagi, S; Gill, R; Chen, ML; Dudeja, PK; Tobacman, JK				Bhattacharyya, Sumit; Borthakur, Alip; Tyagi, Sangeeta; Gill, Ravinder; Chen, Mei Ling; Dudeja, Pradeep K.; Tobacman, Joanne K.			B-cell CLL/Lymphoma 10 (BCL10) Is Required for NF-kappa B Production by Both Canonical and Noncanonical Pathways and for NF-kappa B-inducing Kinase (NIK) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; ACTIVATION; CARRAGEENAN; EXPRESSION; SUBUNIT; PROTEIN; IKK; T(1/14)(P22,Q32); LYMPHOTOXIN; RECEPTORS	B-cell CLL/lymphoma 10 (BCL10), the caspase recruitment domain (CARD)-containing protein involved in the etiology of the mucosa-associated lymphoid tissue (MALT) lymphomas, has been implicated in inflammatory processes in epithelial cells, as well as in immune cells. Experiments in this report indicate that BCL10 is required for activation of nuclear factor (NF)-kappa B by both canonical and noncanonical pathways, following stimulation by the sulfated polysaccharide carrageenan (CGN). In wild type and I kappa B-kinase (IKK)alpha(-/-) mouse embryonic fibroblasts, increases in phospho-I kappa B alpha, nuclear NF-kappa B p65 (RelA) and p50, and KC, the mouse analog of human interleukin-8, were markedly reduced by silencing BCL10 or by exposure to the free radical scavenger Tempol. In IKK beta(-/-) cells, BCL10 silencing, but not Tempol, reduced the CGN-induced increases in KC, phospho-NF-kappa B-inducing kinase (NIK), cytoplasmic NF-kappa B p100, and nuclear NF-kappa B p52 and RelB, suggesting a BCL10 requirement for activation of the noncanonical pathway. In NCM460 cells, derived from normal, human colonic epithelium, the CGN-induced increases in NF-kappa B family members, p65, p50, p52, and RelB, were inhibited by BCL10 silencing. Although enzyme-linked immunosorbent assay and confocal images demonstrated no change in total NIK following CGN, increases in phospho-NIK in the wild type, IKK beta(-/-) and IKK alpha(-/-) cells were inhibited by silencing BCL10. These findings indicate an upstream signaling role for BCL10, in addition to its effects on IKK gamma, the regulatory component of the IKK signalosome, and a requirement for BCL10 in both canonical and noncanonical pathways of NF-kappa B activation. Also, the commonly used food additive carrageenan can be added to the short list of known activators of both pathways.	[Bhattacharyya, Sumit; Borthakur, Alip; Tyagi, Sangeeta; Gill, Ravinder; Dudeja, Pradeep K.; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Chen, Mei Ling] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Dudeja, Pradeep K.; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,M-C 718,440 CSN, Chicago, IL 60612 USA.	jkt@uic.edu		Gill, Ravinder/0000-0002-5337-2567	Department of Veterans Affairs; NIDDK; National Institutes of Health [DK68324, DK54016]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068324, R01DK054016] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Department of Veterans Affairs (to J. K. T.) and by NIDDK, National Institutes of Health Grants DK68324 and DK54016 (to P. K. D.).	Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; BHATTACHARYYA S, 2009, J NUTR BIOCH; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2007, AM J PHYSIOL-GASTR L, V293, pG429, DOI 10.1152/ajpgi.00149.2007; Bhattacharyya S, 2009, INFLAMM BOWEL DIS, V15, P673, DOI 10.1002/ibd.20821; BORTHAKUR A, 2009, INFLAM BOWEL DI 0827; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Briones J, 2009, HISTOPATHOLOGY, V54, P478, DOI 10.1111/j.1365-2559.2009.03250.x; Chang HH, 2009, ORAL ONCOL, V45, P589, DOI 10.1016/j.oraloncology.2008.08.003; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Drew D, 2007, BIOCHEMISTRY-US, V46, P12482, DOI 10.1021/bi701137a; Endo T, 2007, BLOOD, V109, P703, DOI 10.1182/blood-2006-06-027755; EVANS SE, 2009, AM J RESP CELL  0327; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Loverre A, 2004, J AM SOC NEPHROL, V15, P2675, DOI 10.1097/01.ASN.0000139932.00971.E4; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Myers AC, 2002, BIOCHEM BIOPH RES CO, V291, P111, DOI 10.1006/bbrc.2002.6419; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; ter Braak M, 2009, BBA-MOL CELL BIOL L, V1791, P357, DOI 10.1016/j.bbalip.2009.01.019; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wharry CE, 2009, CANCER BIOL THER, V8, P1567, DOI 10.4161/cbt.8.16.8961; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	38	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					522	530		10.1074/jbc.M109.050815	http://dx.doi.org/10.1074/jbc.M109.050815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19897484	Green Published, hybrid			2022-12-27	WOS:000273070100054
J	Lee, DY; Li, YSJ; Chang, SF; Zhou, J; Ho, HM; Chiu, JJ; Chien, S				Lee, Ding-Yu; Li, Yi-Shuan J.; Chang, Shun-Fu; Zhou, Jing; Ho, Hui-Min; Chiu, Jeng-Jiann; Chien, Shu			Oscillatory Flow-induced Proliferation of Osteoblast-like Cells Is Mediated by alpha(v)beta(3) and beta(1) Integrins through Synergistic Interactions of Focal Adhesion Kinase and Shc with Phosphatidylinositol 3-Kinase and the Akt/mTOR/p70S6K Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUID SHEAR-STRESS; LOADING IN-VIVO; BONE-FORMATION; INDUCED MECHANOTRANSDUCTION; ALKALINE-PHOSPHATASE; EXTRACELLULAR-MATRIX; P85-ALPHA SUBUNIT; TYROSINE KINASES; PROTEIN-KINASE; NITRIC-OXIDE	Interstitial flow in and around bone tissue is oscillatory in nature and affects the mechanical microenvironment for bone cell growth and formation. We investigated the role of oscillatory shear stress (OSS) in modulating the proliferation of human osteoblast-like MG63 cells and its underlying mechanisms. Application of OSS (0.5 +/- 4 dynes/cm(2)) to MG63 cells induced sustained activation of phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR/p70S6K (p70S6 kinase) signaling cascades and hence cell proliferation, which was accompanied by increased expression of cyclins A and D1, cyclin-dependent protein kinases-2, -4, and -6, and bone formation-related genes (c-fos, Egr-1, and Cox-2) and decreased expression of p21(CIP1) and p27(KIP1). OSS-induced activation of PI3K/Akt/mTOR/p70S6K and cell proliferation were inhibited by specific antibodies or small interference RNAs of alpha(v)beta(3) and beta(1) integrins and by dominant-negative mutants of Shc (Shc-SH2) and focal adhesion kinase (FAK) (FAK(F397Y)). Co-immunoprecipitation assay showed that OSS induces sustained increases in association of Shc and FAK with alpha(v)beta(3) and beta(1) integrins and PI3K subunit p85, which were abolished by transfecting the cells with FAK(F397Y) or Shc-SH2. OSS also induced sustained activation of ERK, which was inhibited by the specific PI3K inhibitor LY294002 and was required for OSS-induced activation of mTOR/p70S6K and proliferation in MG63 cells. Our findings provide insights into the mechanisms by which OSS induces osteoblast-like cell proliferation through activation of alpha(v)beta(3) and beta(1) integrins and synergistic interactions of FAK and Shc with PI3K, leading to the modulation of downstream ERK and Akt/mTOR/p70S6K pathways.	[Lee, Ding-Yu; Chang, Shun-Fu; Ho, Hui-Min; Chiu, Jeng-Jiann] Natl Hlth Res Inst, Div Med Engn Res, Miaoli 350, Taiwan; [Lee, Ding-Yu; Li, Yi-Shuan J.; Zhou, Jing; Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 91093 USA; [Lee, Ding-Yu; Li, Yi-Shuan J.; Zhou, Jing; Chien, Shu] Univ Calif San Diego, Dept Med, La Jolla, CA 91093 USA; [Lee, Ding-Yu; Li, Yi-Shuan J.; Zhou, Jing; Chien, Shu] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 91093 USA; [Lee, Ding-Yu; Chiu, Jeng-Jiann] Natl Def Med Ctr, Inst Life Sci, Taipei 114, Taiwan	National Health Research Institutes - Taiwan; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Defense Medical Center	Chiu, JJ (corresponding author), Natl Hlth Res Inst, Div Med Engn Res, Miaoli 350, Taiwan.	jjchiu@nhri.org.tw; shuchien@ucsd.edu	Chiu, Jeng-Jiann/E-3980-2010	Zhou, Jing/0000-0002-2211-4901	National Institutes of Health [HL080518, HL085159]; National Health Research Institutes (Taiwan) [ME-097-PP-06]; National Science Council (Taiwan) [97-3112-B-400-006, 96-2628B- 400-002-MY3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085159, R01HL080518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes (Taiwan)(National Health Research Institutes - Taiwan); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080518 and HL085159 (to S. C.). This work was also supported by National Health Research Institutes (Taiwan) Grant ME-097-PP-06 and National Science Council (Taiwan) Grants 97-3112-B-400-006 and 96-2628B- 400-002-MY3 (to J.-J. C.).	Akagi T, 2002, MOL CELL BIOL, V22, P7015, DOI 10.1128/MCB.22.20.7015-7023.2002; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chow JWM, 1998, J BONE MINER RES, V13, P1760, DOI 10.1359/jbmr.1998.13.11.1760; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Forwood MR, 1996, J BONE MINER RES, V11, P1688; Forwood MR, 1996, AM J PHYSIOL-ENDOC M, V270, pE419, DOI 10.1152/ajpendo.1996.270.3.E419; Gayer CP, 2009, J BIOL CHEM, V284, P2001, DOI 10.1074/jbc.M804576200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Glantschnig H, 1996, ENDOCRINOLOGY, V137, P4536, DOI 10.1210/en.137.11.4536; Globus RK, 1998, J CELL SCI, V111, P1385; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; HILLAM RA, 1995, J BONE MINER RES, V10, P683; Hillsley MV, 1997, CALCIFIED TISSUE INT, V60, P48, DOI 10.1007/s002239900185; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998; Jiang GL, 2002, AM J PHYSIOL-ENDOC M, V283, pE383, DOI 10.1152/ajpendo.00547.2001; Kapur S, 2004, BONE, V35, P525, DOI 10.1016/j.bone.2004.04.007; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kozawa O, 2001, J CELL BIOCHEM, V81, P430, DOI 10.1002/1097-4644(20010601)81:3<430::AID-JCB1056>3.0.CO;2-G; Lee DY, 2008, J BONE MINER RES, V23, P1140, DOI 10.1359/JBMR.080302; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; MCMAHON AP, 1990, DEVELOPMENT, V108, P281; Miltenburger H G, 1987, Dev Biol Stand, V66, P91; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706; Ogata T, 1997, J CELL PHYSIOL, V170, P27, DOI 10.1002/(SICI)1097-4652(199701)170:1<27::AID-JCP4>3.0.CO;2-N; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Ren SY, 2005, MOL CELL BIOL, V25, P8001, DOI 10.1128/MCB.25.18.8001-8008.2005; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Scarlett A, 2008, J ENDOCRINOL, V196, P509, DOI 10.1677/JOE-07-0344; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Shoba LNN, 2003, J CELL BIOCHEM, V88, P1247, DOI 10.1002/jcb.10474; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; TURNER CH, 1996, ANN BIOMED ENG, V24, pS74; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Wu CC, 2006, J CELL BIOCHEM, V98, P632, DOI 10.1002/jcb.20697; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102	57	71	74	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					30	42		10.1074/jbc.M109.010512	http://dx.doi.org/10.1074/jbc.M109.010512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19889638	hybrid, Green Published			2022-12-27	WOS:000273070100005
J	Tyryshkin, A; Gorgun, FM; Fattah, EA; Mazumdar, T; Pandit, L; Zeng, SY; Eissa, NT				Tyryshkin, Alexey; Gorgun, F. Murat; Fattah, Elmoataz Abdel; Mazumdar, Tuhina; Pandit, Lavannya; Zeng, Shenyan; Eissa, N. Tony			Src Kinase-mediated Phosphorylation Stabilizes Inducible Nitric-oxide Synthase in Normal Cells and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL REGULATION; STRUCTURAL BASIS; LUNG-CANCER; NO; DEGRADATION; GROWTH; INOS	Src kinases are key regulators of cellular proliferation, survival, motility, and invasiveness. They play important roles in the regulation of inflammation and cancer. Overexpression or hyperactivity of c-Src has been implicated in the development of various types of cancer, including lung cancer. Src inhibition is currently being investigated as a potential therapy for non-small cell lung cancer in Phase I and II clinical trials. The mechanisms of Src implication in cancer and inflammation are linked to the ability of activated Src to phosphorylate multiple downstream targets that mediate its cellular effector functions. In this study, we reveal that inducible nitric-oxide synthase (iNOS), an enzyme also implicated in cancer and inflammation, is a downstream mediator of activated Src. We elucidate the molecular mechanisms of the association between Src and iNOS in models of inflammation induced by lipopolysaccharide and/or cytokines and in cancer cells and tissues. We identify human iNOS residue Tyr(1055) as a target for Src-mediated phosphorylation. These results are shown in normal cells and cancer cells as well as in vivo in mice. Importantly, such posttranslational modification serves to stabilize iNOS half-life. The data also demonstrate interactions and co-localization of iNOS and activated Src under inflammatory conditions and in cancer cells. This study demonstrates that phosphorylation of iNOS by Src plays an important role in the regulation of iNOS and nitric oxide production and hence could account for some Src-related roles in inflammation and cancer.	[Tyryshkin, Alexey; Gorgun, F. Murat; Fattah, Elmoataz Abdel; Mazumdar, Tuhina; Pandit, Lavannya; Zeng, Shenyan; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Eissa, NT (corresponding author), Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM 285 Suite 535E, Houston, TX 77030 USA.	teissa@bcm.edu			NHLBI; NIAID/National Institutes of Health; American Heart Association	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association)	This work was supported by NHLBI and NIAID/National Institutes of Health and the American Heart Association.	Adler KB, 2001, AM J RESP CELL MOL, V25, P397, DOI 10.1165/ajrcmb.25.4.f214; Chen GG, 2008, CANCER, V112, P372, DOI 10.1002/cncr.23166; Fulton D, 2005, J BIOL CHEM, V280, P35943, DOI 10.1074/jbc.M504606200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GHOSH DK, 1995, BIOCHEMISTRY-US, V34, P801, DOI 10.1021/bi00003a013; Giaccone G, 2008, ANN ONCOL, V19, P1219, DOI 10.1093/annonc/mdn048; Grimm EA, 2008, NITRIC OXIDE-BIOL CH, V19, P133, DOI 10.1016/j.niox.2008.04.009; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hausel P, 2006, ONCOGENE, V25, P198, DOI 10.1038/sj.onc.1209030; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Kolodziejski PJ, 2004, P NATL ACAD SCI USA, V101, P18141, DOI 10.1073/pnas.0406711102; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Page TH, 2009, CURR MOL MED, V9, P69, DOI 10.2174/156652409787314507; Pan JM, 1996, BIOCHEM J, V314, P889, DOI 10.1042/bj3140889; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; XIE QW, 1992, SCIENCE, V256, P228; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	27	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					784	792		10.1074/jbc.M109.055038	http://dx.doi.org/10.1074/jbc.M109.055038			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875457	hybrid, Green Published			2022-12-27	WOS:000273070100079
J	Jensen, PR; Peitersen, T; Karlsson, M; in't Zandt, R; Gisselsson, A; Hansson, G; Meier, S; Lerche, MH				Jensen, Pernille R.; Peitersen, Torben; Karlsson, Magnus; in't Zandt, Rene; Gisselsson, Anna; Hansson, Georg; Meier, Sebastian; Lerche, Mathilde H.			Tissue-specific Short Chain Fatty Acid Metabolism and Slow Metabolic Recovery after Ischemia from Hyperpolarized NMR in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-13 MAGNETIC-RESONANCE; RAT SKELETAL-MUSCLE; COENZYME-A; CARNITINE ACETYLTRANSFERASE; PROSTATE-CANCER; ACETATE; OXIDATION; SPECTROSCOPY; REPERFUSION; HEARTS	Mechanistic details of mammalian metabolism in vivo and dynamic metabolic changes in intact organisms are difficult to monitor because of the lack of spatial, chemical, or temporal resolution when applying traditional analytical tools. These limitations can be addressed by sensitivity enhancement technology for fast in vivo NMR assays of enzymatic fluxes in tissues of interest. We apply this methodology to characterize organ-specific short chain fatty acid metabolism and the changes of carnitine and coenzyme A pools in ischemia reperfusion. This is achieved by assaying acetyl-CoA synthetase and acetyl-carnitine transferase catalyzed transformations in vivo. The fast and predominant flux of acetate and propionate signal into acyl-carnitine pools shows the efficient buffering of free CoA levels. Sizeable acetyl-carnitine formation from exogenous acetate is even found in liver, where acetyl-CoA synthetase and acetylcarnitine transferase activities have been assumed sequestered in different compartments. In vivo assays of altered acetate metabolism were applied to characterize pathological changes of acetate metabolism upon ischemia. Coenzyme pools in ischemic skeletal muscle are reduced in vivo even 1 h after disturbing muscle perfusion. Impaired mitochondrial metabolism and slow restoration of free CoA are corroborated by assays employing fumarate to show persistently reduced tricarboxylic acid (TCA) cycle activity upon ischemia. In the same animal model, anaerobic metabolism of pyruvate and tissue perfusion normalize faster than mitochondrial bioenergetics.	[Jensen, Pernille R.; Peitersen, Torben; Karlsson, Magnus; in't Zandt, Rene; Gisselsson, Anna; Hansson, Georg; Lerche, Mathilde H.] Imagnia AB, S-20041 Malmo, Sweden; [Meier, Sebastian] Carlsberg Lab, DK-2500 Copenhagen, Denmark		Lerche, MH (corresponding author), Imagnia AB, Box 8225, S-20041 Malmo, Sweden.	mathilde.lerche@imagnia.se	Jensen, Pernille Rose/AAX-5696-2020; Jensen, Pernille Rose/J-8648-2016; Karlsson, Magnus/AAZ-1768-2021; Jensen, Pernille Rose/GQQ-6261-2022; Meier, Sebastian/A-4279-2015; Lerche, Mathilde Hauge/J-5487-2017	Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Meier, Sebastian/0000-0003-3761-3217; Karlsson, Magnus/0000-0001-7738-1700; Lerche, Mathilde Hauge/0000-0002-5899-2781; in 't Zandt, Rene/0000-0002-3610-9513	GE HealthCare	GE HealthCare(General ElectricGE Healthcare)	This work was supported by a commercial research grant from GE HealthCare.	Aharinejad S, 2001, TRANSPLANTATION, V72, P1043, DOI 10.1097/00007890-200109270-00011; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; BAHL JJ, 1987, ANNU REV PHARMACOL, V27, P257, DOI 10.1146/annurev.pa.27.040187.001353; Bertocci LA, 1999, J APPL PHYSIOL, V86, P2077, DOI 10.1152/jappl.1999.86.6.2077; Bertocci LA, 1997, J APPL PHYSIOL, V83, P32, DOI 10.1152/jappl.1997.83.1.32; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BLOISI W, 1990, EUR J BIOCHEM, V189, P539, DOI 10.1111/j.1432-1033.1990.tb15520.x; BROWN M, 1987, CIRCULATION, V76, P687, DOI 10.1161/01.CIR.76.3.687; Calvani M, 2000, BASIC RES CARDIOL, V95, P75, DOI 10.1007/s003950050167; CERDAN S, 1990, J BIOL CHEM, V265, P12916; Chen AP, 2008, MAGN RESON IMAGING, V26, P721, DOI 10.1016/j.mri.2008.01.002; Chen AP, 2007, MAGN RESON MED, V58, P1099, DOI 10.1002/mrm.21256; Cordente AG, 2004, J BIOL CHEM, V279, P33899, DOI 10.1074/jbc.M402685200; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; ENGEL AG, 1973, SCIENCE, V179, P899, DOI 10.1126/science.179.4076.899; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Golman K, 2008, MAGN RESON MED, V59, P1005, DOI 10.1002/mrm.21460; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; GROPLER RJ, 1993, J AM COLL CARDIOL, V22, P1587, DOI 10.1016/0735-1097(93)90582-L; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; HULSMANN WC, 1992, MOL CELL BIOCHEM, V116, P125, DOI 10.1007/BF01270579; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; ILICETO S, 1995, J AM COLL CARDIOL, V26, P380, DOI 10.1016/0735-1097(95)80010-E; Jensen PR, 2009, CHEM COMMUN, P5168, DOI 10.1039/b910626j; KOBAYASHI A, 1994, J MOL CELL CARDIOL, V26, P499, DOI 10.1006/jmcc.1994.1060; KOBAYASHI K, 1983, J MOL CELL CARDIOL, V15, P359, DOI 10.1016/0022-2828(83)90320-6; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; Merritt ME, 2008, MAGN RESON MED, V60, P1029, DOI 10.1002/mrm.21760; MINKLER PE, 1995, ANAL BIOCHEM, V231, P315, DOI 10.1006/abio.1995.0057; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Oyama N, 2002, J NUCL MED, V43, P181; Pouteau E, 1998, J NUTR, V128, P111, DOI [10.1093/jn/128.12.2659S, 10.1093/jn/128.12.2651S, 10.1093/jn/128.12.2654S]; Pouteau E, 1996, AM J PHYSIOL-ENDOC M, V271, pE58, DOI 10.1152/ajpendo.1996.271.1.E58; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; REBOUCHE CJ, 1986, ANNU REV NUTR, V6, P41, DOI 10.1146/annurev.nu.06.070186.000353; ROBITAILLE PML, 1993, J BIOL CHEM, V268, P26296; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Schroeder MA, 2009, FASEB J, V23, P2529, DOI 10.1096/fj.09-129171; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; SHUG AL, 1978, ARCH BIOCHEM BIOPHYS, V187, P25, DOI 10.1016/0003-9861(78)90003-6; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Szczepaniak L, 1996, MAGN RESON MED, V36, P451, DOI 10.1002/mrm.1910360318; 't Zandt HJAI, 1999, NMR BIOMED, V12, P327, DOI 10.1002/(SICI)1099-1492(199910)12:6<327::AID-NBM570>3.0.CO;2-9; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8	57	68	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36077	36082		10.1074/jbc.M109.066407	http://dx.doi.org/10.1074/jbc.M109.066407			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861411	Green Published, hybrid			2022-12-27	WOS:000272970500009
J	Titz, A; Butschi, A; Henrissat, B; Fan, YY; Hennet, T; Razzazi-Fazeli, E; Hengartner, MO; Wilson, IBH; Kunzler, M; Aebi, M				Titz, Alexander; Butschi, Alex; Henrissat, Bernard; Fan, Yao-Yun; Hennet, Thierry; Razzazi-Fazeli, Ebrahim; Hengartner, Michael O.; Wilson, Iain B. H.; Kuenzler, Markus; Aebi, Markus			Molecular Basis for Galactosylation of Core Fucose Residues in Invertebrates IDENTIFICATION OF CAENORHABDITIS ELEGANS N-GLYCAN CORE alpha 1,6-FUCOSIDE beta 1,4-GALACTOSYLTRANSFERASE GALT-1 AS A MEMBER OF A NOVEL GLYCOSYLTRANSFERASE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPRINOPSIS-CINEREA; COPRINUS-CINEREUS; DROSOPHILA-MELANOGASTER; PHYLOGENETIC TREES; TOXIN RESISTANCE; PROTEIN; GALECTINS; SEQUENCE; LECTINS; ACETYLGLUCOSAMINE	Galectin CGL2 from the ink cap mushroom Coprinopsis cinerea displays toxicity toward the model nematode Caenorhabditis elegans. A mutation in a putative glycosyltransferase-encoding gene resulted in a CGL2-resistant C. elegans strain characterized by N-glycans lacking the beta 1,4-galactoside linked to the alpha 1,6-linked core fucose. Expression of the corresponding GALT-1 protein in insect cells was used to demonstrate a manganese-dependent galactosyltransferase activity. In vitro, the GALT-1 enzyme showed strong selectivity for acceptors with alpha 1,6-linked N-glycan core fucosides and required Golgi-dependent modifications on the oligosaccharide antennae for optimal synthesis of the Gal-beta 1,4-fucose structure. Phylogenetic analysis of the GALT-1 protein sequence identified a novel glycosyltransferase family (GT92) with members widespread among eukarya but absent in mammals.	[Titz, Alexander; Fan, Yao-Yun; Kuenzler, Markus; Aebi, Markus] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Butschi, Alex; Hengartner, Michael O.] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; [Henrissat, Bernard] CNRS, UMR6098, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France; [Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Razzazi-Fazeli, Ebrahim] Univ Vet Med, VetOMICS Core Facil Prote & Metabol Studies, A-1210 Vienna, Austria; [Wilson, Iain B. H.] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Zurich; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna	Aebi, M (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Titz, Alexander/E-6701-2010; Fan, YaoYun/AAS-5920-2020; Wilson, Iain/B-3326-2009; Henrissat, Bernard/J-2475-2012; Hengartner, Michael O/E-6235-2011	Titz, Alexander/0000-0001-7408-5084; Wilson, Iain/0000-0001-8996-1518; Henrissat, Bernard/0000-0002-3434-8588; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301; Hengartner, Michael/0000-0002-7584-596X; Kunzler, Markus/0000-0003-1275-0629	Swiss National Science Foundation [3100A3-116827, 31003A-105541]; Roche Research Foundation; EMBO [ASTF-377.00-2008]; ETH Zurich; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P18447]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); ETH Zurich(ETH Zurich); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was supported by Swiss National Science Foundation Grants 3100A3-116827 (to M. K., M. J., and M. A.) and 31003A-105541 (to M. A.), the Roche Research Foundation (to A. T.), EMBO Grant ASTF-377.00-2008 (to A. T.), ETH Zurich, and Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grant P18447 (to I. B. H. W.).	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Barrows BD, 2006, METHOD ENZYMOL, V417, P340, DOI 10.1016/S0076-6879(06)17021-4; Boulianne RP, 2000, MICROBIOL-SGM, V146, P1841, DOI 10.1099/00221287-146-8-1841; BRENNER S, 1974, GENETICS, V77, P71; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cooper DNW, 1997, J BIOL CHEM, V272, P1514, DOI 10.1074/jbc.272.3.1514; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Klyosov AA, 2008, GALECTINS; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Miyoshi Eiji, 2002, P259; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Praitis V, 2001, GENETICS, V157, P1217; Rini J., 2009, ESSENTIALS GLYCOBIOL, P63; Roitinger A, 1998, GLYCOCONJUGATE J, V15, P89, DOI 10.1023/A:1006951802623; SAMBROOK J, 2000, MOL CLONING LAB MANU; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; VOYNOW JA, 1991, J BIOL CHEM, V266, P21572; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; Walser PJ, 2005, FUNGAL GENET BIOL, V42, P293, DOI 10.1016/j.fgb.2004.12.004; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Walti MA, 2006, EUKARYOT CELL, V5, P732, DOI 10.1128/EC.5.4.732-744.2006; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	46	39	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36223	36233		10.1074/jbc.M109.058354	http://dx.doi.org/10.1074/jbc.M109.058354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858195	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000272970500024
J	Band, AM; Bjorklund, M; Laiho, M				Band, Arja M.; Bjorklund, Mia; Laiho, Marikki			The Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Transforming Growth Factor-beta Signaling by Destabilizing Ski and Inducing Smad7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; KINASE B-GAMMA; TGF-BETA; C-SKI; MEDIATED PHOSPHORYLATION; CYTOPLASMIC LOCALIZATION; DEPENDENT REGULATION; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; INDUCED APOPTOSIS	Ski is an oncoprotein that negatively regulates transforming growth factor (TGF)-beta signaling. It acts as a transcriptional corepressor by binding to TGF-beta signaling molecules, Smads. Efficient TGF-beta signaling is facilitated by rapid proteasome-mediated degradation of Ski by TGF-beta. Here we report that Ski is phosphorylated by Akt/PKB kinase. Akt phosphorylates Ski on a highly conserved Akt motif at threonine 458 both in vitro and in vivo. The phosphorylation of Ski at threonine 458 is induced by Akt pathway activators including insulin, insulin-like growth factor-1, and hepatocyte growth factor. The phosphorylation of Ski causes its destabilization and reduces Ski-mediated inhibition of expression of another negative regulator of TGF-beta, Smad7. Induction of Smad7 levels leads to inactivation of TGF-beta receptors and TGF-beta signaling cascade, as indicated by reduced induction of TGF-beta target p15. Therefore, Akt modulates TGF-beta signaling by temporarily adjusting the levels of two TGF-beta pathway negative regulators, Ski and Smad7. These novel findings demonstrate that Akt pathway activation directly impacts TGF-beta pathway.	[Laiho, Marikki] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Band, Arja M.; Bjorklund, Mia; Laiho, Marikki] Univ Helsinki, Haartman Inst, FIN-00014 Helsinki, Finland; [Band, Arja M.; Bjorklund, Mia; Laiho, Marikki] Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Program, FIN-00014 Helsinki, Finland	Johns Hopkins University; Johns Hopkins Medicine; University of Helsinki; University of Helsinki	Laiho, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, 1550 Orleans St,Rm 444, Baltimore, MD 21231 USA.	mlaiho1@jhmi.edu			Academy of Finland Center of Excellence Program [213485]	Academy of Finland Center of Excellence Program(Academy of Finland)	This work was supported by Academy of Finland Center of Excellence Program Grant 213485.	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Band Arja, 2008, V1, P243, DOI 10.1007/978-1-59745-292-2_15; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; BOYER PL, 1993, ONCOGENE, V8, P457; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buess M, 2004, NEOPLASIA, V6, P207, DOI 10.1593/neo.03442; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Denissova NG, 2004, J BIOL CHEM, V279, P28143, DOI 10.1074/jbc.M404961200; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Itoh S, 1998, J BIOL CHEM, V273, P29195, DOI 10.1074/jbc.273.44.29195; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jacob C, 2008, J CELL BIOL, V182, P519, DOI 10.1083/jcb.200710161; Jang SW, 2009, J BIOL CHEM, V284, P24512, DOI 10.1074/jbc.M109.026237; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kokura K, 2003, J BIOL CHEM, V278, P20133, DOI 10.1074/jbc.M210855200; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Lee SB, 2008, P NATL ACAD SCI USA, V105, P16584, DOI 10.1073/pnas.0807668105; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Marcelain K, 2005, ONCOGENE, V24, P4321, DOI 10.1038/sj.onc.1208631; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nagata M, 2006, GENES CELLS, V11, P1267, DOI 10.1111/j.1365-2443.2006.01018.x; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakatani K, 1999, BIOCHEM BIOPH RES CO, V257, P906, DOI 10.1006/bbrc.1999.0559; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Prunier C, 2003, J BIOL CHEM, V278, P26249, DOI 10.1074/jbc.M304459200; Reed JA, 2001, CANCER RES, V61, P8074; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	65	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35441	35449		10.1074/jbc.M109.029488	http://dx.doi.org/10.1074/jbc.M109.029488			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19875456	Green Published, hybrid			2022-12-27	WOS:000272645600020
J	Jong, YJI; Kumar, V; O'Malley, KL				Jong, Yuh-Jiin I.; Kumar, Vikas; O'Malley, Karen L.			Intracellular Metabotropic Glutamate Receptor 5 (mGluR5) Activates Signaling Cascades Distinct from Cell Surface Counterparts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR CALCIUM; PROTEIN-KINASE; NEURONS; TRANSCRIPTION; ELK-1; BRAIN; RAT; PHOSPHORYLATION; IDENTIFICATION; MITOCHONDRIA	G-protein-coupled receptors are thought to transmit extracellular signals to the cytoplasm from their position on the cell surface. Some receptors, including the metabotropic glutamate receptor 5 (mGluR5), are also highly expressed on intracellular membranes where they serve unknown functions. Here, we show that activation of cell surface versus intracellular mGluR5 results in unique Ca2+ signatures leading to unique cellular responses. Specifically, activation of either cell surface or intracellular mGluR5 leads to JNK, Ca2+/calmodulin-dependent protein kinase (CaMK), and cyclic adenosine 3',5'-monophosphate-responsive element-binding protein phosphorylation, whereas activation of only intracellular mGluR5 leads to ERK1/2 and Elk-1 phosphorylation. Using pharmacological and genetic approaches, the present findings support a role for CaMK kinase in mediating mGluR5-dependent cyclic adenosine 3',5'-monophosphate-responsive element-binding protein phosphorylation, whereas CaMKII is upstream of intracellular mGluR5-mediated Elk-1 phosphorylation. Consistent with models showing Elk-1 regulating cascades of gene expression, the known Elk-1 targets c-fos and egr1 were up-regulated following intracellular mGluR5 activation, whereas a representative non-Elk-1 target, c-jun, was not. These findings emphasize that glutamate not only serves as a neurotransmitter for cell surface receptors but, when transported into the cell, can also activate intracellular receptors such as mGluR5. Glutamate activation of intracellular mGluR5 serves an important role in the regulation of nuclear Ca2+, transcriptional activation, and gene expression necessary for physiological processes such as synaptic plasticity.	[Jong, Yuh-Jiin I.; Kumar, Vikas; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	omalleyk@pcg.wustl.edu			NIMH [MH57817, MH69646]; Neuroscience Blueprint Core [NS057105]; The Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069646, R01MH057817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Neuroscience Blueprint Core; The Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH57817 and MH69646 from the NIMH and Neuroscience Blueprint Core Grant NS057105 to Washington University. This work was also supported by The Bakewell Family Foundation.	Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Gerasimenko O, 2004, J CELL SCI, V117, P3087, DOI 10.1242/jcs.01295; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gonzalez MI, 2007, J NEUROCHEM, V103, P1917, DOI 10.1111/j.1471-4159.2007.04881.x; Hubert GW, 2001, J NEUROSCI, V21, P1838, DOI 10.1523/JNEUROSCI.21-06-01838.2001; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Kingston AE, 2002, NEUROSCI LETT, V330, P127, DOI 10.1016/S0304-3940(02)00751-6; Klein C, 2008, FRONT BIOSCI-LANDMRK, V13, P1206, DOI 10.2741/2756; Klein J, 1997, NEUROPHARMACOLOGY, V36, P305, DOI 10.1016/S0028-3908(97)00024-5; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lopez-Bendito G, 2002, CEREB CORTEX, V12, P625, DOI 10.1093/cercor/12.6.625; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Olstad E, 2007, J CEREBR BLOOD F MET, V27, P811, DOI 10.1038/sj.jcbfm.9600400; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xiong TC, 2008, CELL CALCIUM, V43, P29, DOI 10.1016/j.ceca.2007.02.005; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	34	95	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35827	35838		10.1074/jbc.M109.046276	http://dx.doi.org/10.1074/jbc.M109.046276			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840937	Green Published, hybrid			2022-12-27	WOS:000272645600059
J	Ng, SS; Mahmoudi, T; Danenberg, E; Bejaoui, I; de Lau, W; Korswagen, HC; Schutte, M; Clevers, H				Ng, Ser Sue; Mahmoudi, Tokameh; Danenberg, Esther; Bejaoui, Ines; de Lau, Wim; Korswagen, Hendrik C.; Schutte, Mieke; Clevers, Hans			Phosphatidylinositol 3-Kinase Signaling Does Not Activate the Wnt Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HOX GENE-EXPRESSION; CANCER CELL-LINES; C-ELEGANS; TRANSCRIPTIONAL ACTIVATION; WNT/BETA-CATENIN; PROTEIN-KINASE; BETA-CATENIN; HUMAN BREAST; MIGRATION	Mutational activation of the phosphatidylinositol 3-kinase (PI3K) pathway occurs in a wide variety of tumors, whereas activating Wnt pathway mutants are predominantly found in colon cancer. Because GSK3 is a key component of both pathways, it is widely assumed that active PI3K signaling feeds positively into the Wnt pathway by protein kinase B (PKB)-mediatefd inhibition of GSK3. In addition, PKB has been proposed to modulate the canonical Wnt signaling through direct stabilization and nuclear localization of beta-catenin. Here, we show that compartmentalization by Axin of GSK3 prohibits cross-talk between the PI3K and Wnt pathways and that Wnt-mediated transcriptional activity is not modulated by activation of the PI3K/PKB pathway.	[Clevers, Hans] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Schutte, Mieke] Erasmus Univ, Med Ctr, Josephine Nefkens Inst Be414, Dept Med Oncol, NL-300 DR Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Clevers, H (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Korswagen, Hendrik/I-8782-2012	Ng, Ser Sue/0000-0001-9873-9433; Danenberg, Esther/0000-0002-1799-4457				Ch'ng' Q, 2003, GENETICS, V164, P1355; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Harris J, 1996, DEVELOPMENT, V122, P3117; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Maloof JN, 1999, DEVELOPMENT, V126, P37; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Silhankova M, 2007, CURR OPIN GENET DEV, V17, P320, DOI 10.1016/j.gde.2007.05.007; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; van de Wetering M, 2001, CANCER RES, V61, P278; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016	27	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35308	35313		10.1074/jbc.M109.078261	http://dx.doi.org/10.1074/jbc.M109.078261			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850932	Green Published, hybrid			2022-12-27	WOS:000272645600007
J	Zhang, T; Li, YY; Yu, YK; Zou, P; Jiang, YQ; Sun, DX				Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin			Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; KAPPA-B KINASE; CO-CHAPERONE; ANTITUMOR AGENT; ATPASE ACTIVITY; WITHAFERIN-A; BINDING SITE; CANCER-CELLS; GELDANAMYCIN; NOVOBIOCIN	The molecular chaperone heat shock protein 90 (Hsp90) is required for the stabilization and conformational maturation of various oncogenic proteins in cancer. The loading of protein kinases to Hsp90 is actively mediated by the cochaperone Cdc37. The crucial role of the Hsp90-Cdc37 complex has made it an exciting target for cancer treatment. In this study, we characterize Hsp90 and Cdc37 interaction and drug disruption using a reconstituted protein system. The GST pull-down assay and ELISA assay show that Cdc37 binds to ADP-bound/nucleotidefree Hsp90 but not ATP-bound Hsp90. Celastrol disrupts Hsp90-Cdc37 complex formation, whereas the classical Hsp90 inhibitors (e.g. geldanamycin) have no effect. Celastrol inhibits Hsp90 ATPase activity without blocking ATP binding. Proteolytic fingerprinting indicates celastrol binds to Hsp90 C-terminal domain to protect it from trypsin digestion. These data suggest that celastrol may represent a new class of Hsp90 inhibitor by modifying Hsp90 C terminus to allosterically regulate its chaperone activity and disrupt Hsp90-Cdc37 complex.	[Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sun, DX (corresponding author), 428 Church St,Rm 2020, Ann Arbor, MI 48109 USA.	duxins@umich.edu	Zou, Peng/F-1097-2011; Sun, Duxin/AAA-1774-2022; Zhang, Tao/A-7339-2012; Zou, Peng/J-9300-2015; Yu, Yanke/E-4919-2012	Zou, Peng/0000-0002-7940-5056	National Institutes of Health [R01 CA 120023]; UM Cancer Center Research Grant (Munn); UM Cancer Center Core; NATIONAL CANCER INSTITUTE [R01CA120023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UM Cancer Center Research Grant (Munn); UM Cancer Center Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA 120023. This work was also supported by a UM Cancer Center Research Grant (Munn), and UM Cancer Center Core Grant (to D. S.).	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chiosis G, 2006, ACS CHEM BIOL, V1, P279, DOI 10.1021/cb600224w; Cortajarena AL, 2008, ACS CHEM BIOL, V3, P161, DOI 10.1021/cb700260z; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; FUSKA J, 1984, NEOPLASMA, V31, P31; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Huang FC, 1998, BIOORG MED CHEM LETT, V8, P1883, DOI 10.1016/S0960-894X(98)00331-X; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kuduk SD, 2000, BIOORG MED CHEM LETT, V10, P1303, DOI 10.1016/S0960-894X(00)00208-0; Kuduk SD, 1999, BIOORG MED CHEM LETT, V9, P1233, DOI 10.1016/S0960-894X(99)00185-7; LAI BT, 1984, MOL CELL BIOL, V4, P2802, DOI 10.1128/MCB.4.12.2802; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lee P, 2004, MOL BIOL CELL, V15, P1785, DOI 10.1091/mbc.E03-07-0480; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Mandler R, 2002, BIOCONJUGATE CHEM, V13, P786, DOI 10.1021/bc010124g; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; MINAMI Y, 1991, J BIOL CHEM, V266, P10099; Neckers L, 2006, HANDB EXP PHARM, V172, P259; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; NGASSAPA O, 1994, J NAT PROD, V57, P1, DOI 10.1021/np50103a001; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Pacey S, 2006, HANDB EXP PHARM, V172, P331; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REED SI, 1980, GENETICS, V95, P561; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; SCHUNUR RC, 1995, J MED CHEM, V38, P3813; SCHUR RC, 1995, J MED CHEM, V38, P3806; Schwarze SR, 2003, CANCER RES, V63, P4614; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Smith JR, 2009, CELL CYCLE, V8, P362, DOI 10.4161/cc.8.3.7531; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Ward BK, 2002, J BIOL CHEM, V277, P40799, DOI 10.1074/jbc.M207097200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yi F, 2008, ACS CHEM BIOL, V3, P645, DOI 10.1021/cb800162x; YU Y, 2009, BIOCH PHARM IN PRESS; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	75	148	157	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35381	35389		10.1074/jbc.M109.051532	http://dx.doi.org/10.1074/jbc.M109.051532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858214	hybrid, Green Published			2022-12-27	WOS:000272645600014
J	Evangelista, KD; Andrich, F; de Rezende, FF; Niland, S; Cordeiro, MN; Horlacher, T; Castelli, R; Schmidt-Hederich, A; Seeberger, PH; Sanchez, EF; Richardson, M; de Figueiredo, SG; Eble, JA				Evangelista, Karla de Santana; Andrich, Filipe; de Rezende, Flavia Figueiredo; Niland, Stephan; Cordeiro, Marta N.; Horlacher, Tim; Castelli, Riccardo; Schmidt-Hederich, Alletta; Seeberger, Peter H.; Sanchez, Eladio F.; Richardson, Michael; de Figueiredo, Suely Gomes; Eble, Johannes A.			Plumieribetin, a Fish Lectin Homologous to Mannose-binding B-type Lectins, Inhibits the Collagen-binding alpha 1 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPIONFISH SCORPAENA-PLUMIERI; PLANT-LECTINS; TAKIFUGU-RUBRIPES; CRYSTAL-STRUCTURE; CELL-ADHESION; VENOM; PURIFICATION; DISINTEGRINS; RHODOCETIN; COMPLEXES	Recently, a few fish proteins have been described with a high homology to B-type lectins of monocotyledonous plants. Because of their mannose binding activity, they have been ascribed a role in innate immunity. By screening various fish venoms for their integrin inhibitory activity, we isolated a homologous protein from the fin stings and skin mucus of the scorpionfish (Scorpaena plumieri). This protein inhibits alpha 1 beta 1 integrin binding to basement membrane collagen IV. By protein chemical and spectroscopic means, we demonstrated that this fish protein, called plumieribetin, is a homotetramer and contains a high content of anti-parallel beta strands, similar to the mannose-binding monocot B-lectins. It lacks both N-linked glycoconjugates and common O-glycan motifs. Despite its B-lectin-like structure, plumieribetin binds to alpha 1 beta 1 integrin irrespective of N-glycosylation, suggesting a direct protein-protein interaction. This interaction is independent of divalent cations. On the cellular level, plumieribetin failed to completely detach hepatocarcinoma HepG2 cells and primary arterial smooth muscle cells from the collagen IV fragment CB3. However, plumieribetin weakened the cell-collagen contacts, reduced cell spreading, and altered the actin cytoskeleton, after the compensating alpha 1 beta 1 integrin was blocked. The integrin inhibiting effect of plumieribetin adds a new function to the B-lectin family, which is known for pathogen defense.	[Evangelista, Karla de Santana; de Rezende, Flavia Figueiredo; Niland, Stephan; Schmidt-Hederich, Alletta; Eble, Johannes A.] Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany; [Andrich, Filipe; de Figueiredo, Suely Gomes] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Andrich, Filipe] Univ Fed Minas Gerais, Dept Physiol & Biophys, Lab Venenos & Toxinas Anim, Dept Biochem & Immunol,Inst Biol Sci, Belo Horizonte, MG, Brazil; [Cordeiro, Marta N.; Sanchez, Eladio F.; Richardson, Michael] Ezequiel Dias Fdn, Ctr Res & Dev, BR-30510010 Belo Horizonte, MG, Brazil; [Horlacher, Tim; Castelli, Riccardo; Seeberger, Peter H.] ETH, Swiss Fed Inst Technol, Organ Chem Lab, CH-8093 Zurich, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universidade Federal do Espirito Santo; Universidade Federal de Minas Gerais; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eble, JA (corresponding author), Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, Bldg 9,Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Eble@med.uni-frankfurt.de	Sanchez, Eladio Flores/E-6942-2013	Flores Sanchez, Eladio Oswaldo/0000-0003-1637-9345	Deutsche Forschungsgemeinschaft [Eb177/4-2, SFB815]; German-Brazilian Exchange Program PROBRAL of the German Academic Exchange Service [D/05/30352]; CAPES [250/06]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [24000/01]; ETH Zurich; Schweizerischer Nationalfonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Brazilian Exchange Program PROBRAL of the German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); ETH Zurich(ETH Zurich); Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF))	This work was supported by Deutsche Forschungsgemeinschaft Grants Eb177/4-2 and SFB815 (to J.A.E.), German-Brazilian Exchange Program PROBRAL of the German Academic Exchange Service Grant D/05/30352, CAPES Process 250/06, Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais Edital 24000/01, and funds from the ETH Zurich and the Schweizerischer Nationalfonds.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bachhawat K, 2001, BIOCHEMISTRY-US, V40, P7291, DOI 10.1021/bi0027783; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Boletini-Santos D, 2008, TOXICON, V51, P585, DOI 10.1016/j.toxicon.2007.11.011; Bouckaert J, 1999, CURR OPIN STRUC BIOL, V9, P572, DOI 10.1016/S0959-440X(99)00007-X; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Carrijo LC, 2005, TOXICON, V45, P843, DOI 10.1016/j.toxicon.2005.01.021; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Eble JA, 2003, J BIOL CHEM, V278, P26488, DOI 10.1074/jbc.M301860200; Eble JA, 2002, MATRIX BIOL, V21, P547, DOI 10.1016/S0945-053X(02)00068-9; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Eble JA, 2001, OSTEOARTHR CARTILAGE, V9, pS131, DOI 10.1053/joca.2001.0455; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; EBLE JA, 2001, METHODS CELL MATRIX, P223; Gardner H, 2003, MOL B INT U, P25; GARNIER P, 1995, TOXICON, V33, P143, DOI 10.1016/0041-0101(94)00151-W; Haddad V, 2003, TOXICON, V42, P79, DOI 10.1016/S0041-0101(03)00103-X; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; Hester G, 1996, J MOL BIOL, V262, P516, DOI 10.1006/jmbi.1996.0532; Horlacher T, 2008, CHEM SOC REV, V37, P1414, DOI 10.1039/b708016f; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; LOW KSY, 1993, TOXICON, V31, P1471, DOI 10.1016/0041-0101(93)90212-2; Loyo J, 2008, INVEST CLIN, V49, P299; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ratner DM, 2002, EUR J ORG CHEM, V2002, P826; Rini JM, 1999, CURR OPIN STRUC BIOL, V9, P578, DOI 10.1016/S0959-440X(99)00008-1; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SCHAEFFE.RC, 1971, TOXICON, V9, P69, DOI 10.1016/0041-0101(71)90045-6; SPENCER R, 2005, VET IMMUNOL IMMUNOP, V108, P111; Theakston RDG, 2002, TOXICON, V40, P579, DOI 10.1016/S0041-0101(01)00244-6; Tsutsui S, 2006, COMP BIOCHEM PHYS B, V143, P514, DOI 10.1016/j.cbpb.2006.01.005; Tsutsui S, 2003, J BIOL CHEM, V278, P20882, DOI 10.1074/jbc.M301038200; Tsutsui S, 2006, COMP BIOCHEM PHYS D, V1, P122, DOI 10.1016/j.cbd.2005.09.005; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wood SD, 1999, ACTA CRYSTALLOGR D, V55, P1264, DOI 10.1107/S0907444999005326; WRIGHT CS, 1990, J BIOL CHEM, V265, P1676; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	48	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34747	34759		10.1074/jbc.M109.002873	http://dx.doi.org/10.1074/jbc.M109.002873			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850917	Green Published, hybrid			2022-12-27	WOS:000272439600030
J	Shaban, NM; Harvey, S; Perrino, FW; Hollis, T				Shaban, Nadine M.; Harvey, Scott; Perrino, Fred W.; Hollis, Thomas			The Structure of the Mammalian RNase H2 Complex Provides Insight into RNA center dot DNA Hybrid Processing to Prevent Immune Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; CRYSTAL-STRUCTURE; RNA/DNA HYBRID; SUBSTRATE-SPECIFICITY; TOPOISOMERASE-I; RIBONUCLEASE-H; TRANSCRIPTION; INITIATION; PROTEINS; PRIMER	The mammalian RNase H2 ribonuclease complex has a critical function in nucleic acid metabolism to prevent immune activation with likely roles in processing of RNA primers in Okazaki fragments during DNA replication, in removing ribonucleotides misinserted by DNA polymerases, and in eliminating RNA center dot DNA hybrids during cell death. Mammalian RNase H2 is a heterotrimeric complex of the RNase H2A, RNase H2B, and RNase H2C proteins that are all required for proper function and activity. Mutations in the human RNase H2 genes cause Aicardi-Goutieres syndrome. We have determined the crystal structure of the three-protein mouse RNase H2 enzyme complex to better understand the molecular basis of RNase H2 dysfunction in human autoimmunity. The structure reveals the intimately interwoven architecture of RNase H2B and RNase H2C that interface with RNase H2A in a complex ideally suited for nucleic acid binding and hydrolysis coupled to protein-protein interaction motifs that could allow for efficient participation in multiple cellular functions. We have identified four conserved acidic residues in the active site that are necessary for activity and suggest a two-metal ion mechanism of catalysis for RNase H2. An Okazaki fragment has been modeled into the RNase H2 nucleic acid binding site providing insight into the recognition of RNA center dot DNA junctions by the RNase H2. Further structural and biochemical analyses show that some RNase H2 disease-causing mutations likely result in aberrant protein-protein interactions while the RNase H2A subunit-G37S mutation appears to distort the active site accounting for the demonstrated substrate specificity modification.	[Shaban, Nadine M.; Harvey, Scott; Perrino, Fred W.; Hollis, Thomas] Wake Forest Univ, Bowman Gray Sch Med, Struct Biol Ctr, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Hollis, T (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Struct Biol Ctr, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.	thollis@wfubmc.edu			National Institutes of Health [R01-GM069962]; Alliance for Lupus Research [67692]; American Cancer Society [RSG-04-187-01-GMC]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM069962 (to F. W. P.). This work was also supported by the Alliance for Lupus Research (Grant 67692 to F. W. P.) and the American Cancer Society (Grant RSG-04-187-01-GMC to T. H.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Baaklini I, 2004, MOL MICROBIOL, V54, P198, DOI 10.1111/j.1365-2958.2004.04258.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Chon H, 2006, J MOL BIOL, V356, P165, DOI 10.1016/j.jmb.2005.11.017; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2008, DEV MED CHILD NEUROL, V50, P410, DOI 10.1111/j.1469-8749.2008.02062.x; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANK P, 1994, NUCLEIC ACIDS RES, V22, P5247, DOI 10.1093/nar/22.24.5247; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Haruki M, 2002, FEBS LETT, V531, P204, DOI 10.1016/S0014-5793(02)03503-2; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; Hraiky C, 2000, J BIOL CHEM, V275, P11257, DOI 10.1074/jbc.275.15.11257; Ide H, 1993, Nucleic Acids Symp Ser, P133; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kamada K, 2003, P NATL ACAD SCI USA, V100, P2296, DOI 10.1073/pnas.262798199; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kopka ML, 2003, J MOL BIOL, V334, P653, DOI 10.1016/j.jmb.2003.09.057; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Maitra S., 2000, AMIDE LINKAGE STRUCT, P495; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; OKAZAKI T, 1979, COLD SPRING HARB SYM, V43, P203, DOI 10.1101/SQB.1979.043.01.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallan PS, 2008, CELL CYCLE, V7, P2562, DOI 10.4161/cc.7.16.6461; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Robert F, 2000, METH MOL B, V148, P383; Robert F, 1998, MOL CELL, V2, P341, DOI 10.1016/S1097-2765(00)80278-6; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; TEMIN HM, 1985, MOL BIOL EVOL, V2, P455; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	60	40	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2010	285	6					3617	3624		10.1074/jbc.M109.059048	http://dx.doi.org/10.1074/jbc.M109.059048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	564YF	19923215	Green Published, hybrid			2022-12-27	WOS:000275254000013
J	Banci, L; Bertini, I; Cantini, F; Inagaki, S; Migliardi, M; Rosato, A				Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Inagaki, Sayaka; Migliardi, Manuele; Rosato, Antonio			The Binding Mode of ATP Revealed by the Solution Structure of the N-domain of Human ATP7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; MAGNETIC-RESONANCE RELAXATION; COPPER-TRANSPORTING ATPASE; MENKES DISEASE; CANDIDATE GENE; BACKBONE DYNAMICS; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; CALCIUM-PUMP; PROTEIN NMR	We report the solution NMR structures of the N-domain of the Menkes protein (ATP7A) in the ATP-free and ATP-bound forms. The structures consist of a twisted antiparallel six-stranded beta-sheet flanked by two pairs of alpha-helices. A protein loop of 50 amino acids located between beta 3 and beta 4 is disordered and mobile on the subnanosecond time scale. ATP binds with an affinity constant of (1.2 +/- 0.1) x 10(4) M-1 and exchanges with a rate of the order of 1 x 10(3) s(-1). The ATP-binding cavity is considerably affected by the presence of the ligand, resulting in a more compact conformation in the ATP-bound than in the ATP-free form. This structural variation is due to the movement of the alpha 1-alpha 2 and beta 2-beta 3 loops, both of which are highly conserved in copper(I)-transporting P-IB-type ATPases. The present structure reveals a characteristic binding mode of ATP within the protein scaffold of the copper(I)-transporting P-IB-type ATPases with respect to the other P-type ATPases. In particular, the binding cavity contains mainly hydrophobic aliphatic residues, which are involved in van der Waal's interactions with the adenine ring of ATP, and a Glu side chain, which forms a crucial hydrogen bond to the amino group of ATP.	[Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Inagaki, Sayaka; Migliardi, Manuele; Rosato, Antonio] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia; Bertini, Ivano; Cantini, Francesca; Rosato, Antonio] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia] FIORGEN Fdn, I-50019 Sesto Fiorentino, Italy	University of Florence; University of Florence	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Rosato, Antonio/M-3250-2019; Rosato, Antonio/D-8548-2011; Cantini, Francesca/O-1220-2015	Rosato, Antonio/0000-0001-6172-0368; Rosato, Antonio/0000-0001-6172-0368; Cantini, Francesca/0000-0003-0526-6732; BANCI, LUCIA/0000-0003-0562-5774	Ministero dell'Istruzione e dell' Universita e della Ricerca Fondo per gli Investimenti della Ricerca di Base-Proteomica [RBRN07BMCT]; Ente Cassa di Risparmio di Firenze Project; European Commission [SPINE2-COMPLEXES 031220]	Ministero dell'Istruzione e dell' Universita e della Ricerca Fondo per gli Investimenti della Ricerca di Base-Proteomica; Ente Cassa di Risparmio di Firenze Project(Fondazione Cassa Risparmio Firenze); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Ministero dell'Istruzione e dell' Universita e della Ricerca Fondo per gli Investimenti della Ricerca di Base-Proteomica Grant RBRN07BMCT, Ente Cassa di Risparmio di Firenze Project "Relazione varianti proteiche strutturali-malattie genetiche," and European Commission Project SPINE2-COMPLEXES 031220.	Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; CASE DA, 2008, AMBER 10 VERSION 8 0; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cox DW, 2002, J BIOENERG BIOMEMBR, V34, P333, DOI 10.1023/A:1021293818125; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Haupt M, 2006, J BIOL CHEM, V281, P9641, DOI 10.1074/jbc.M508290200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Kodama K, 1999, PEDIATR INT, V41, P430, DOI 10.1046/j.1442-200x.1999.01091.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Sharma S, 2009, J CHEM INF MODEL, V49, P76, DOI 10.1021/ci8002304; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	42	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2537	2544		10.1074/jbc.M109.054262	http://dx.doi.org/10.1074/jbc.M109.054262			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19917612	Green Published, hybrid			2022-12-27	WOS:000273697800032
J	Mbefo, MK; Paleologou, KE; Boucharaba, A; Oueslati, A; Schell, H; Fournier, M; Olschewski, D; Yin, GW; Zweckstetter, M; Masliah, E; Kahle, PJ; Hirling, H; Lashuel, HA				Mbefo, Martial K.; Paleologou, Katerina E.; Boucharaba, Ahmed; Oueslati, Abid; Schell, Heinrich; Fournier, Margot; Olschewski, Diana; Yin, Guowei; Zweckstetter, Markus; Masliah, Eliezer; Kahle, Philipp J.; Hirling, Harald; Lashuel, Hilal A.			Phosphorylation of Synucleins by Members of the Polo-like Kinase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SERINE/THREONINE KINASE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DROSOPHILA-POLO; RAT MODEL; INCLUSION FORMATION; SER-129; DOMAIN; IDENTIFICATION; LOCALIZATION	Phosphorylation of alpha-synuclein (alpha-syn) at Ser-129 is a hallmark of Parkinson disease and related synucleinopathies. However, the identity of the natural kinases and phosphatases responsible for regulating alpha-syn phosphorylation remain unknown. Here we demonstrate that three closely related members of the human Polo-like kinase (PLK) family (PLK1, PLK2, and PLK3) phosphorylate alpha-syn and beta-syn specifically at Ser-129 and Ser-118, respectively. Unlike other kinases reported to partially phosphorylate alpha-syn at Ser-129 in vitro, phosphorylation by PLK2 and PLK3 is quantitative (>95% conversion). Only PLK1 and PLK3 phosphorylate beta-syn at Ser-118, whereas no phosphorylation of gamma-syn was detected by any of the four PLKs (PLK1 to -4). PLK-mediated phosphorylation was greatly reduced in an isolated C-terminal fragment (residues 103 140) of alpha-syn, suggesting substrate recognition via the N-terminal repeats and/or the non-amyloid component domain of alpha-syn. PLKs specifically co-localized with phosphorylated Ser-129 (Ser(P)-129) alpha-syn in various subcellular compartments (cytoplasm, nucleus, and membranes) of mammalian cell lines and primary neurons as well as in alpha-syn transgenic mice, especially cortical brain areas involved in synaptic plasticity. Furthermore, we report that the levels of PLK2 are significantly increased in brains of Alzheimer disease and Lewy body disease patients. Taken together, these results provide biochemical and in vivo evidence of alpha-syn and beta-syn phosphorylation by specific PLKs. Our results suggest a need for further studies to elucidate the potential role of PLK-syn interactions in the normal biology of these proteins as well as their involvement in the pathogenesis of Parkinson disease and other synucleinopathies.	[Mbefo, Martial K.; Paleologou, Katerina E.; Oueslati, Abid; Fournier, Margot; Olschewski, Diana; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Boucharaba, Ahmed; Hirling, Harald] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Cellular Neurobiol, CH-1015 Lausanne, Switzerland; [Schell, Heinrich; Kahle, Philipp J.] Univ Clin Tubingen, Lab Funct Neurogenet, Dept Neurodegenerat, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Yin, Guowei; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37073 Gottingen, Germany; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; University of California System; University of California San Diego	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Oueslati, Abid/ABG-8116-2020; Lashuel, Hilal/M-3500-2017	Oueslati, Abid/0000-0003-1122-7086; Zweckstetter, Markus/0000-0002-2536-6581; Fournier, Margot/0000-0001-8906-1907	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation [310000-110027]; Michael J. Fox Foundation; German Science Foundation [ZW 71/2-1, ZW 71/3-1]; Helmholtz Alliance "Aging Brain"; Hertie Foundat	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Michael J. Fox Foundation; German Science Foundation(German Research Foundation (DFG)); Helmholtz Alliance "Aging Brain"; Hertie Foundat	This work was supported by the Swiss Federal Institute of Technology Lausanne and grants to the Laboratory of Molecular Neurobiology and Neuroproteomics from the Swiss National Science Foundation (Grant 310000-110027) and the Michael J. Fox Foundation.; Supported by German Science Foundation Grant Foundation Grants ZW 71/2-1 and 3-1.; Supported by the Helmholtz Alliance "Aging Brain" and the Hertie Foundat.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Bahassi ELM, 2004, ONCOGENE, V23, P2658, DOI 10.1038/sj.onc.1207425; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; CHEN L, 2009, J CLIN INVE IN PRESS; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; CLAY FJ, 1993, P NATL ACAD SCI USA, V90, P4882, DOI 10.1073/pnas.90.11.4882; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Draghetti C, 2009, J BIOL CHEM, V284, P32053, DOI 10.1074/jbc.M109.009324; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Fournier M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006629; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; HAMANAKA R, 1994, CELL GROWTH DIFFER, V5, P249; Harris PLR, 2000, NEUROBIOL AGING, V21, P837, DOI 10.1016/S0197-4580(00)00218-9; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hirling H, 2000, EUR J NEUROSCI, V12, P1913, DOI 10.1046/j.1460-9568.2000.00076.x; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kahle PJ, 2000, ANN NY ACAD SCI, V920, P33; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; MBEFO MK, 2008, SYNUCLEIN HLTH DIS L, P21; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V280, P1085, DOI 10.1006/bbrc.2000.4253; Negro A, 2001, FASEB J, V15, P210, DOI 10.1096/fj.01-0517fje; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Schell H, 2009, NEUROSCIENCE, V160, P796, DOI 10.1016/j.neuroscience.2009.03.002; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; WAXMAN EA, 2008, J NEUROPATH IN PRESS; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	58	181	186	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2807	2822		10.1074/jbc.M109.081950	http://dx.doi.org/10.1074/jbc.M109.081950			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19889641	Green Published, hybrid			2022-12-27	WOS:000273697800057
J	Ng, Y; Ramm, G; Burchfield, JG; Coster, ACF; Stockli, J; James, DE				Ng, Yvonne; Ramm, Georg; Burchfield, James G.; Coster, Adelle C. F.; Stoeckli, Jacqueline; James, David E.			Cluster Analysis of Insulin Action in Adipocytes Reveals a Key Role for Akt at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT/PROTEIN-KINASE-B; STIMULATED GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; GLUCOSE-TRANSPORT; PROTEIN; PHOSPHORYLATION; AS160; TRAFFICKING; DOWNSTREAM	The phosphatidylinositol 3-kinase/Akt pathway regulates many biological processes, including insulin-regulated GLUT4 insertion into the plasma membrane. However, Akt operates well below its capacity to facilitate maximal GLUT4 translocation. Thus, reconciling modest changes in Akt expression or activity as a cause of metabolic dysfunction is complex. To resolve this, we examined insulin regulation of components within the signaling cascade in a quantitative kinetic and dose-response study combined with hierarchical cluster analysis. This revealed a strong relationship between phosphorylation of Akt substrates and GLUT4 translocation but not whole cell Akt phosphorylation. In contrast, Akt activity at the plasma membrane strongly correlated with GLUT4 translocation and Akt substrate phosphorylation. Additionally, two of the phosphorylated sites in the Akt substrate AS160 clustered separately, with Thr(P)-642 grouped with other Akt substrates. Further experiments suggested that atypical protein kinase C zeta phosphorylates AS160 at Ser-588 and that these two sites are mutually exclusive. These data indicate the utility of hierarchical cluster analysis for identifying functionally related biological nodes and highlight the importance of subcellular partitioning of key signaling components for biological specificity.	[Ng, Yvonne; Ramm, Georg; Burchfield, James G.; Coster, Adelle C. F.; Stoeckli, Jacqueline; James, David E.] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia; [Ng, Yvonne; James, David E.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia; [Stoeckli, Jacqueline] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Ramm, Georg] Monash Univ, Sch Biomed Sci, Melbourne, Vic 3800, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Monash University	James, DE (corresponding author), Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW 2010, Australia.	d.james@garvan.org.au	Stoeckli, Jacqueline/D-7053-2016; Coster, Adelle CF/A-7234-2013; Burchfield, James/C-1779-2019; Stoeckli, Jacqueline/Z-4443-2019; Coster, Adelle/AAX-4829-2020	Stoeckli, Jacqueline/0000-0002-6446-7350; Coster, Adelle CF/0000-0002-5572-6832; Burchfield, James/0000-0002-6609-6151; Stoeckli, Jacqueline/0000-0002-6446-7350; Coster, Adelle/0000-0002-5572-6832; Ramm, Georg/0000-0003-3596-2288; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia; Swiss National Foundation; Novartis Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis)	This work was supported in part by grants from the National Health and Medical Research Council of Australia.; Supported by fellowships from the Swiss National Foundation and Novartis Foundation.	Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	36	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2255	2267		10.1074/jbc.M109.060236	http://dx.doi.org/10.1074/jbc.M109.060236			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19897488	Green Published, hybrid			2022-12-27	WOS:000273697800005
J	Higuero, AM; Sanchez-Ruiloba, L; Doglio, LE; Portillo, F; Abad-Rodriguez, J; Dotti, CG; Iglesias, T				Higuero, Alonso M.; Sanchez-Ruiloba, Lucia; Doglio, Laura E.; Portillo, Francisco; Abad-Rodriguez, Jose; Dotti, Carlos G.; Iglesias, Teresa			Kidins220/ARMS Modulates the Activity of Microtubule-regulating Proteins and Controls Neuronal Polarity and Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANS-GOLGI NETWORK; KINASE-D; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; GROWING AXONS; IN-VIVO; INTRACELLULAR-LOCALIZATION; SECRETORY TRAFFICKING; PHOSPHORYLATION SITES	In order for neurons to perform their function, they must establish a highly polarized morphology characterized, in most of the cases, by a single axon and multiple dendrites. Herein we find that the evolutionarily conserved protein Kidins220 (kinase D-interacting substrate of 220-kDa), also known as ARMS (ankyrin repeat-rich membrane spanning), a downstream effector of protein kinase D and neurotrophin and ephrin receptors, regulates the establishment of neuronal polarity and development of dendrites. Kidins220/ARMS gain and loss of function experiments render severe phenotypic changes in the processes extended by hippocampal neurons in culture. Although Kidins220/ARMS early overexpression hinders neuronal development, its down-regulation by RNA interference results in the appearance of multiple longer axon-like extensions as well as aberrant dendritic arbors. Wealso find that Kidins220/ARMS interacts with tubulin and microtubule-regulating molecules whose role in neuronal morphogenesis is well established (microtubule-associated proteins 1b, 1a, and 2 and two members of the stathmin family). Importantly, neurons where Kidins220/ARMS has been knocked down register changes in the phosphorylation activity of MAP1b and stathmins. Altogether, our results indicate that Kidins220/ARMS is a key modulator of the activity of microtubule-regulating proteins known to actively regulate neuronal morphogenesis and suggest a mechanism by which it contributes to control neuronal development.	[Higuero, Alonso M.; Sanchez-Ruiloba, Lucia; Portillo, Francisco; Iglesias, Teresa] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Madrid Alberto Sols, Madrid 28029, Spain; [Higuero, Alonso M.; Abad-Rodriguez, Jose] Hosp Nacl Paraplej, Membrane Biol & Axonal Repair Unit, Toledo 45071, Spain; [Doglio, Laura E.; Dotti, Carlos G.] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Doglio, Laura E.; Dotti, Carlos G.] VIB, Dept Dev Mol Genet, B-3000 Louvain, Belgium; [Higuero, Alonso M.; Sanchez-Ruiloba, Lucia; Iglesias, Teresa] Inst Salud Carlos III, CIBERNED, Madrid 28029, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Nacional de Paraplejicos; KU Leuven; Flanders Institute for Biotechnology (VIB); CIBERNED; Instituto de Salud Carlos III	Iglesias, T (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, C Arturo Duperier 4, Madrid 28029, Spain.	tiglesias@iib.uam.es	Dotti, Carlos G/I-5533-2015; Higuero, Alonso/L-7300-2014; Vacas, Teresa Iglesias/ABF-8663-2020; Higuero, Alonso/AAZ-8406-2021; Abad-Rodríguez, José/L-8274-2014	Dotti, Carlos G/0000-0003-4052-1719; Higuero, Alonso/0000-0003-3304-3616; Vacas, Teresa Iglesias/0000-0002-4326-9005; Higuero, Alonso/0000-0003-3304-3616; Abad-Rodríguez, José/0000-0002-0350-500X; Sanchez-Ruiloba, Lucia/0000-0001-5418-2290; Portillo Perez, Francisco/0000-0003-4922-346X	Ministerio de Ciencia e Innovacion [SAF2008-01951]; Comunidad de Madrid [CAM S-SAL-0202-2006-01]; "Instituto de Salud Carlos III" (Spain)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); "Instituto de Salud Carlos III" (Spain)(Instituto de Salud Carlos III)	This work was supported by "Ministerio de Ciencia e Innovacion" Grant SAF2008-01951, "Neurodegmodels" Grant CAM S-SAL-0202-2006-01 from "Comunidad de Madrid," and CIBERNED from "Instituto de Salud Carlos III" (Spain) (to T.I.).	Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; BAAS PW, 1993, J NEUROSCI, V13, P2177; BANKER G, 1998, CULTURING NERVE CELL; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; BLACK MM, 1994, J NEUROSCI, V14, P857; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; Bondallaz P, 2006, CELL MOTIL CYTOSKEL, V63, P681, DOI 10.1002/cm.20154; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BROWN A, 1992, J CELL BIOL, V119, P867, DOI 10.1083/jcb.119.4.867; Cabrera-Poch N, 2004, J BIOL CHEM, V279, P28592, DOI 10.1074/jbc.M312242200; CALVERT R, 1985, EMBO J, V4, P1171, DOI 10.1002/j.1460-2075.1985.tb03756.x; Czondor K, 2009, MOL BIOL CELL, V20, P2108, DOI 10.1091/mbc.E08-09-0957; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Del Rio JA, 2004, CURR BIOL, V14, P840, DOI 10.1016/j.cub.2004.04.046; DHAMODHARAN R, 1995, J CELL SCI, V108, P1679; Di Paolo G, 1997, J NEUROSCI RES, V50, P1000, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1000::AID-JNR10>3.0.CO;2-8; DiTella MC, 1996, J CELL SCI, V109, P467; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Edelmann W, 1996, P NATL ACAD SCI USA, V93, P1270, DOI 10.1073/pnas.93.3.1270; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; FISCHER I, 1990, J NEUROCHEM, V55, P328, DOI 10.1111/j.1471-4159.1990.tb08855.x; Foletti DL, 1999, NEURON, V23, P641, DOI 10.1016/S0896-6273(01)80022-2; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gavet O, 1998, J CELL SCI, V111, P3333; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Ghanekar Y, 2005, TRENDS CELL BIOL, V15, P511, DOI 10.1016/j.tcb.2005.08.001; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C, 2005, CEREB CORTEX, V15, P1134, DOI 10.1093/cercor/bhh213; Gonzalez-Billault C, 2004, J NEUROBIOL, V58, P48, DOI 10.1002/neu.10283; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Gonzalez-Billault C, 2002, J NEUROSCI RES, V67, P713, DOI 10.1002/jnr.10161; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Goold RG, 2004, BIOCHEM SOC T, V32, P809, DOI 10.1042/BST0320809; Goold RG, 2003, J NEUROCHEM, V87, P935, DOI 10.1046/j.1471-4159.2003.02062.x; Goold RG, 2001, J CELL SCI, V114, P4273; Goold RG, 1999, J CELL SCI, V112, P3373; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Johnstone M, 1997, J NEUROCHEM, V69, P1417; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Li Y, 1996, J NEUROSCI, V16, P531; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lopez-Menendez C, 2009, J CELL SCI, V122, P3554, DOI 10.1242/jcs.056473; Luo S, 2005, J CELL BIOL, V169, P813, DOI 10.1083/jcb.200412008; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; POULAIN FE, 2009, MOL CELL NE IN PRESS; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615; Trivedi N, 2005, J CELL SCI, V118, P993, DOI 10.1242/jcs.01697; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Wu SH, 2009, DEV NEUROBIOL, V69, P547, DOI 10.1002/dneu.20723; Ye B, 2006, J NEUROSCI, V26, P10631, DOI 10.1523/JNEUROSCI.3271-06.2006; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	96	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1343	1357		10.1074/jbc.M109.024703	http://dx.doi.org/10.1074/jbc.M109.024703			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19903810	hybrid, Green Published			2022-12-27	WOS:000273258200055
J	Hong, EH; Lee, SJ; Kim, JS; Lee, KH; Um, HD; Kim, JH; Kim, SJ; Kim, JI; Hwang, SG				Hong, Eun-Hee; Lee, Su-Jae; Kim, Jae-Sung; Lee, Kee-Ho; Um, Hong-Duck; Kim, Jae-Hong; Kim, Song-Ja; Kim, Jong-Il; Hwang, Sang-Gu			Ionizing Radiation Induces Cellular Senescence of Articular Chondrocytes via Negative Regulation of SIRT1 by p38 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; PREMATURE SENESCENCE; HUMAN-CELLS; TRANSCRIPTION FACTORS; ENDOTHELIAL-CELLS; GROWTH ARREST; BETA-CATENIN; CYCLE ARREST; MAP KINASES	Radiotherapy is increasingly used in the treatment of joint diseases, but limited information is available on the effects of radiation on cartilage. Here, we characterize the molecular mechanisms leading to cellular senescence in irradiated primary cultured articular chondrocytes. Ionizing radiation (IR) causes activation of ERK, in turn generating intracellular reactive oxygen species (ROS) with induction of senescence-associated beta-galactosidase (SA-beta-gal) activity. ROS activate p38 kinase, which further promotes ROS generation, forming a positive feedback loop to sustain ROS-p38 kinase signaling. The ROS inhibitors, nordihydroguaiaretic acid and GSH, suppress phosphorylation of p38 and cell numbers positive for SA-beta-gal following irradiation. Moreover, inhibition of the ERK and p38 kinase pathways leads to blockage of IR-induced SA-beta-gal activity via reduction of ROS generation. Although JNK is activated by ROS, this pathway is not associated with cellular senescence of chondrocytes. Interestingly, IR triggers down-regulation of SIRT1 protein expression but not the transcript level, indicative of post-transcriptional cleavage of the protein. SIRT1 degradation is markedly blocked by SB203589 or MG132 after IR treatment, suggesting that cleavage occurs as a result of binding with p38 kinase, followed by processing via the 26 S proteasomal degradation pathway. Overexpression or activation of SIRT1 significantly reduces the IR-induced senescence phenotype, whereas inhibition of SIRT1 activity induces senescence. Based on these findings, we propose that IR induces cellular senescence of articular chondrocytes by negative post-translational regulation of SIRT1 via ROS-dependent p38 kinase activation.	[Hwang, Sang-Gu] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Lee, Su-Jae] Hanyang Univ, Coll Nat Sci, Dept Chem, Seoul 133791, South Korea; [Kim, Jae-Hong] Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; [Kim, Song-Ja] Kongju Natl Univ, Coll Nat Sci, Dept Biol Sci, Kong Ju 314701, South Korea; [Kim, Jong-Il] Seoul Womens Univ, Coll Nat Sci, Dept Food & Microbial Technol, Seoul 139774, South Korea	Korea Institute of Radiological & Medical Sciences; Hanyang University; Korea University; Kongju National University; Seoul Women's University	Hwang, SG (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, 215-4 Gongneung Dong, Seoul 139706, South Korea.	sgh63@kcch.re.kr	Kim, Jae-Hong/B-2530-2009; Um, Hong-Duk/AAH-3733-2021	Kim, Jae-Hong/0000-0002-8019-0208; 	Korea Research Foundation [KRF-2005-041-C00344]; Korean Government	Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by the Korea Research Foundation Grant KRF-2005-041-C00344 and a Nuclear Research and Development Program of the Korea Science and Engineering Foundation grant funded by the Korean Government.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/00002281-200209000-00018; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen JH, 2005, DNA REPAIR, V4, P1140, DOI 10.1016/j.dnarep.2005.06.003; Clutton SM, 1996, CARCINOGENESIS, V17, P1633, DOI 10.1093/carcin/17.8.1633; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Damron TA, 2004, J HISTOCHEM CYTOCHEM, V52, P157, DOI 10.1177/002215540405200203; Damron TA, 2003, J BONE JOINT SURG AM, V85A, P1302, DOI 10.2106/00004623-200307000-00017; Dantuma NP, 2002, FEBS LETT, V529, P22, DOI 10.1016/S0014-5793(02)03252-0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; GOLDWEIN JW, 1991, CLIN ORTHOP RELAT R, P101; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Haq R, 2002, CANCER RES, V62, P5076; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; Honore S, 2003, EXP CELL RES, V285, P59, DOI 10.1016/S0014-4827(02)00038-1; Hristov Borislav, 2007, J Natl Compr Canc Netw, V5, P456; Hwang SG, 2005, J BIOL CHEM, V280, P29780, DOI 10.1074/jbc.M411793200; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Igrashi K, 2007, EXP CELL RES, V313, P3326, DOI 10.1016/j.yexcr.2007.06.001; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; KROLL SS, 1994, ANN SURG ONCOL, V1, P473, DOI 10.1007/BF02303612; Lee YJ, 2002, CELL GROWTH DIFFER, V13, P237; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328; Morales A, 1998, INT J RADIAT ONCOL, V42, P191, DOI 10.1016/S0360-3016(98)00185-0; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Narayanan PK, 1997, CANCER RES, V57, P3963; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Oh CW, 2001, RADIAT RES, V156, P232, DOI 10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;2; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Pateder DB, 2002, RADIAT RES, V157, P62, DOI 10.1667/0033-7587(2002)157[0062:ROPIPR]2.0.CO;2; Patel SL, 2008, DRUG-EDUC PREV POLIC, V15, P37, DOI 10.1080/09687630601138691; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Podtcheko A, 2005, THYROID, V15, P306, DOI 10.1089/thy.2005.15.306; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; ROBERTSON WW, 1991, J PEDIATR ORTHOPED, V11, P284; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Taher MM, 2000, PHOTOCHEM PHOTOBIOL, V71, P455, DOI 10.1562/0031-8655(2000)071<0455:ROTPAM>2.0.CO;2; Tateishi Y, 2008, BIOCHEM BIOPH RES CO, V366, P301, DOI 10.1016/j.bbrc.2007.11.039; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Xu H J, 1997, Adv Pharmacol, V40, P369, DOI 10.1016/S1054-3589(08)60145-3; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yudoh K, 2005, ARTHRITIS RES THER, V7, pR380, DOI 10.1186/ar1499; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	60	124	134	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1283	1295		10.1074/jbc.M109.058628	http://dx.doi.org/10.1074/jbc.M109.058628			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887452	hybrid, Green Published			2022-12-27	WOS:000273258200050
J	Miwa, HE; Gerken, TA; Jamison, O; Tabak, LA				Miwa, Hazuki E.; Gerken, Thomas A.; Jamison, Oliver; Tabak, Lawrence A.			Isoform-specific O-Glycosylation of Osteopontin and Bone Sialoprotein by Polypeptide N-Acetylgalactosaminyltransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; MUCIN TANDEM REPEAT; UDP-GALNAC; POSTTRANSLATIONAL MODIFICATIONS; LECTIN DOMAINS; STRUCTURAL-CHARACTERIZATION; MASS-SPECTROMETRY; BINDING-SITE; AMINO-ACID; GLYCOPEPTIDE	Mucin-type O-glycan biosynthesis is regulated by the family of UDP-GalNAc polypeptide: N-acetylgalactosaminlytransfersases (ppGalNAcTs) that catalyzes the first step in the pathway by transferring GalNAc to Ser or Thr residues in a protein from the sugar donor UDP-GalNAc. Because not all Ser/Thr residues are glycosylated, rules must exist that signal which hydroyxamino acids acquire sugar. To date, no universal consensus signal has emerged. Therefore, strategies to deduce the subset of proteins that will be glycosylated by distinct ppGalNAcTs must be developed. Mucin-type O-glycoproteins are present abundantly in bone, where we found multiple ppGalNAcT isoforms, including ppGalNAcT-1, to be highly expressed. Thus, we compared glycoproteins expressed in wild-type and Galnt1-null mice to identify bone-associated proteins that were glycosylated in a ppGalNAcT-1-dependent manner. A reduction in the apparent molecular masses of two SIBLINGs (small integrin binding ligand N-linked glycoproteins), osteopontin (OPN) and bone sialoprotein (BSP) in the Galnt1-null mice relative to those of the wild-type was observed. Several synthetic peptides derived from OPN and BSP sequences were designed to include either known or predicted (in silico) glycosylation sites. In vitro glycosylation assays of these peptides with recombinant ppGalNAcT-1, ppGalNAcT-2, or ppGalNAcT-3 demonstrated that both SIBLINGs contained Thr/Ser residues that were preferentially glycosylated by ppGalNAcT-1. In addition, lysates prepared from wild-type, but not those from Galnt1-null derived osteoblasts, could glycosylate these peptides efficiently, suggesting that OPN and BSP contain sites that are specific for ppGalNAcT-1. Our study presents a novel and systematic approach for identification of isoform-specific substrates of the ppGalNAcT family and suggests ppGalNAcT-1 to be indispensable for O-glycosylation at specific sites of the bone glycoproteins OPN and BSP.	[Miwa, Hazuki E.; Tabak, Lawrence A.] NIDDK, Sect Biol Chem, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Gerken, Thomas A.; Jamison, Oliver] Case Western Reserve Univ, Sch Med, WA Bernbaum Ctr Cyst Fibrosis Res, Dept Pediat, Cleveland, OH 44106 USA; [Gerken, Thomas A.; Jamison, Oliver] Case Western Reserve Univ, Sch Med, WA Bernbaum Ctr Cyst Fibrosis Res, Dept Biochem, Cleveland, OH 44106 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Case Western Reserve University	Tabak, LA (corresponding author), NIDDK, Sect Biol Chem, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	tabakl@mail.nih.gov			NIDDK [NCI-RO1CA-78834]; NATIONAL CANCER INSTITUTE [R01CA078834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK070012] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health intramural program of NIDDK and Grant NCI-RO1CA-78834 (to T. A. G.).	ALBONE EF, 1994, J BIOL CHEM, V269, P16845; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; FISHER LW, 1987, J BIOL CHEM, V262, P9702; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Gerken TA, 1998, J BIOL CHEM, V273, P26580, DOI 10.1074/jbc.273.41.26580; Gerken TA, 1997, J BIOL CHEM, V272, P9709; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jain A, 2008, BIOCHEMISTRY-US, V47, P5986, DOI 10.1021/bi800133n; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Lu L, 2009, PEPTIDES, V30, P359, DOI 10.1016/j.peptides.2008.09.020; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Midura RJ, 1996, GLYCOBIOLOGY, V6, P677, DOI 10.1093/glycob/6.7.677; MIDURA RJ, 1990, J BIOL CHEM, V265, P5285; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; OCONNELL BC, 1993, ANAL BIOCHEM, V210, P423, DOI 10.1006/abio.1993.1219; Pe'er I, 2004, PROTEINS, V54, P20, DOI 10.1002/prot.10559; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Sasaki K., 2009, IPSJ T BIOINFORM, V2, P25, DOI DOI 10.2197/ipsjtbio.2.25; Seipert RR, 2009, J PROTEOME RES, V8, P493, DOI 10.1021/pr8007072; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; Tye CE, 2005, J BIOL CHEM, V280, P13487, DOI 10.1074/jbc.M408923200; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wuttke M, 2001, J BIOL CHEM, V276, P36839, DOI 10.1074/jbc.M105689200; Yoshinao W, 2008, TRENDS GLYCOSCI GLYC, V20, P69; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zaia J, 2001, BIOCHEMISTRY-US, V40, P12983, DOI 10.1021/bi010887r; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	51	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1208	1219		10.1074/jbc.M109.035436	http://dx.doi.org/10.1074/jbc.M109.035436			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19880513	Green Published, hybrid			2022-12-27	WOS:000273258200043
J	Singh, AK; Kumar, RP; Pandey, N; Singh, N; Sinha, M; Bhushan, A; Kaur, P; Sharma, S; Singh, TP				Singh, Amit K.; Kumar, Ramasamy P.; Pandey, Nisha; Singh, Nagendra; Sinha, Mau; Bhushan, Asha; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases BINDING STUDIES AND CRYSTAL STRUCTURE OF BOVINE LACTOPEROXIDASE WITH ISONIAZID AT 2.7 angstrom RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTHROMYCES-RAMOSUS PEROXIDASE; ISONICOTINIC-ACID HYDRAZIDE; X-RAY CRYSTALLOGRAPHY; MYCOBACTERIUM-TUBERCULOSIS; SALICYLHYDROXAMIC-ACID; HORSERADISH-PEROXIDASE; HUMAN MYELOPEROXIDASE; CATALASE-PEROXIDASE; BENZHYDROXAMIC ACID; OXIDATIVE STRESS	Isoniazid (INH) is an anti-tuberculosis prodrug that is activated by mammalian lactoperoxidase and Mycobacterium tuberculosis catalase peroxidase (MtCP). We report here binding studies, an enzyme assay involving INH, and the crystal structure of the complex of bovine lactoperoxidase (LPO) with INH to illuminate binding properties and INH activation as well as the mode of diffusion and interactions together with a detailed structural and functional comparison with MtCP. The structure determination shows that isoniazid binds to LPO at the substrate binding site on the distal heme side. The substrate binding site is connected to the protein surface through a long hydrophobic channel. The acyl hydrazide moiety of isoniazid interacts with Phe(422) O, Gln(423) O-epsilon 1, and Phe(254) O. In this arrangement, pyridinyl nitrogen forms a hydrogen bond with a water molecule, W-1, which in turn forms three hydrogen bonds with Fe3+, His(109) N epsilon 2, and Gln(105) N-epsilon 2. The remaining two sides of isoniazid form hydrophobic interactions with the atoms of heme pyrrole ring A, C-beta and C-gamma atoms of Glu(258), and C-gamma and C-delta atoms of Arg(255). The binding studies indicate that INH binds to LPO with a value of 0.9 x 10(-6) M for the dissociation constant. The nitro blue tetrazolium reduction assay shows that INH is activated by the reaction of LPO-H2O2 with INH. This suggests that LPO can be used for INH activation. It also indicates that the conversion of INH into isonicotinoyl radical by LPO may be the cause of INH toxicity.	[Singh, Amit K.; Kumar, Ramasamy P.; Pandey, Nisha; Singh, Nagendra; Sinha, Mau; Bhushan, Asha; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, Ansari Nagar, New Delhi 110029, India.	tpsingh.aiims@gmail.com	Ramasamy, Prem Kumar/I-6801-2019	Ramasamy, Prem Kumar/0000-0002-6555-8289; SINHA, MAU/0000-0003-3011-9160				Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; BHAT TN, 1974, ACTA CRYSTALLOGR B, V30, P2921, DOI 10.1107/S0567740874008521; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; BORS W, 1978, PHOTOCHEM PHOTOBIOL, V28, P629, DOI 10.1111/j.1751-1097.1978.tb06982.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; CHARLAND MB, 1995, SIGMAPLOT SCI; Davey CA, 1996, BIOCHEMISTRY-US, V35, P10967, DOI 10.1021/bi960577m; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DEVI BG, 1975, BIOCHEM J, V149, P187, DOI 10.1042/bj1490187; DOERGE DR, 1994, CHEM RES TOXICOL, V7, P164, DOI 10.1021/tx00038a008; FERRARI RP, 1993, SPECTROCHIM ACTA A, V49, P1261, DOI 10.1016/0584-8539(93)80034-8; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Gerson C, 2000, AM J RESP CELL MOL, V22, P665, DOI 10.1165/ajrcmb.22.6.3980; Ghibaudi EM, 2000, REDOX REP, V5, P229, DOI 10.1179/135100000101535672; Henriksen A, 1998, BIOCHEMISTRY-US, V37, P8054, DOI 10.1021/bi980234j; IKEDASAITO M, 1991, J BIOL CHEM, V266, P3611; Itakura H, 1997, FEBS LETT, V412, P107, DOI 10.1016/S0014-5793(97)00751-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIMURA S, 1988, PROTEINS, V3, P113, DOI 10.1002/prot.340030206; KUNISHIMA N, 1994, J MOL BIOL, V235, P331, DOI 10.1016/S0022-2836(05)80037-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; METODIEWA D, 1989, BIOCHEM BIOPH RES CO, V160, P1183, DOI 10.1016/S0006-291X(89)80128-7; METODIEWA D, 1989, ARCH BIOCHEM BIOPHYS, V274, P601, DOI 10.1016/0003-9861(89)90475-X; Monzani E, 1997, BIOCHEMISTRY-US, V36, P1918, DOI 10.1021/bi961868y; Oakley GG, 1996, CHEM RES TOXICOL, V9, P1285, DOI 10.1021/tx960103o; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; POULOS TL, 1980, J BIOL CHEM, V255, P575; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RAMAKRISHNA NVS, 1993, CHEM RES TOXICOL, V6, P837, DOI 10.1021/tx00036a013; Sawatdee S, 2006, MALAYS J PHARM SCI, V4, P43; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sheikh IA, 2009, J BIOL CHEM, V284, P14849, DOI 10.1074/jbc.M807644200; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P399, DOI 10.1128/AAC.27.3.399; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; Singh AK, 2009, J BIOL CHEM, V284, P20311, DOI 10.1074/jbc.M109.010280; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; SIPE HJ, 1994, CARCINOGENESIS, V15, P2637, DOI 10.1093/carcin/15.11.2637; STEVENS FJ, 1987, MOL IMMUNOL, V24, P1055, DOI 10.1016/0161-5890(87)90073-3; Tsukamoto K, 1999, BIOCHEMISTRY-US, V38, P12558, DOI 10.1021/bi982925l; Welinder KG., 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [10.1016/0959-440x(92)90230-5, DOI 10.1016/0959-440X(92)90230-5]; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5; ZHANG HC, 1993, CAN J CHEM, V71, P1990, DOI 10.1139/v93-248; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3161, DOI 10.1021/bi062218p	49	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1569	1576		10.1074/jbc.M109.060327	http://dx.doi.org/10.1074/jbc.M109.060327			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19907057	Green Published, hybrid			2022-12-27	WOS:000273258200075
J	Xiao, YC; Xu, JW; Mao, CM; Jin, M; Wu, Q; Zou, J; Gu, QL; Zhang, Y; Zhang, YY				Xiao, Yichuan; Xu, Jingwei; Mao, Chaoming; Jin, Min; Wu, Qiong; Zou, Jie; Gu, Qiaoli; Zhang, Yi; Zhang, Yanyun			18 beta-Glycyrrhetinic Acid Ameliorates Acute Propionibacterium acnes-induced Liver Injury through Inhibition of Macrophage Inflammatory Protein-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL PRECURSORS; FULMINANT HEPATIC-FAILURE; TOLL-LIKE RECEPTORS; NF-KAPPA-B; GLYCYRRHETINIC ACID; UP-REGULATION; TH1 RESPONSE; LYMPH-NODES; MYD88; ACTIVATION	18 beta-Glycyrrhetinic acid (GA), the major bioactive component of licorice root extract, has a protective effect on hepatic injury and exhibits antiinflammatory activity. Here, we investigate the effect of GA in Propionibacterium acnes-induced acute inflammatory liver injury. C57BL/6 mice were primed with P. acnes followed by lipopolysaccharide challenge to induce fulminant hepatitis. GA (75 mg/kg) or vehicle control was administered intraperitoneally daily 1 day after P. acnes priming, and GA significantly improved mouse mortality. Then, to investigate the underlying mechanisms of GA in this acute inflammatory liver injury model, we primed C57BL/6 mice with P. acnes only. We propose that GA ameliorates acute P. acnes-induced liver injury through reduced macrophage inflammatory protein (MIP)-1 alpha expression in Kupffer cells by down-regulating MyD88 expression and inhibiting NF-kappa B activation. Reduced MIP-1 alpha expression lowered the recruitment of CD11c(+)B22(-) dendritic cell precursors into the liver. Consequently, GA treatment inhibits the activation and proliferation of liver-infiltrating CD4(+) T cells and reduces the production of serum alanine aminotransferase and proinflammatory cytokines such as interferon-gamma and tumor necrosis factor-alpha. Moreover, anti-MIP-1 alpha treatment in P. acnes-primed mice inhibits the recruitment of dendritic cell precursors into the liver and suppresses mouse mortality as GA does. Taken together, our results suggest that GA exhibits antiinflammatory effects through inhibition of MIP-1 alpha in a mouse model of acute P. acnes-induced inflammatory liver injury.	[Xiao, Yichuan; Xu, Jingwei; Mao, Chaoming; Jin, Min; Wu, Qiong; Zou, Jie; Gu, Qiaoli; Zhang, Yanyun] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Xiao, Yichuan; Xu, Jingwei; Mao, Chaoming; Jin, Min; Wu, Qiong; Zou, Jie; Gu, Qiaoli; Zhang, Yanyun] SJTUSM, Shanghai Inst Immunol, Inst Med Sci, Shanghai 200025, Peoples R China; [Zhang, Yi] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Michigan System; University of Michigan	Zhang, YY (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, 227 S Chongqing Rd, Shanghai 200025, Peoples R China.	yyzhang@sibs.ac.cn			Ministry of Science and Technology of China [2010CB945600, 2009ZX09503]; Chinese Academy of Sciences [KSCX1-YW-22]; National Natural Science Foundation of China [30670911, 30901317]; Shanghai Municipality Programs [074319102, 07JC14070]; Shanghai Municipal Education Commission [J50207]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipality Programs; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the Ministry of Science and Technology of China 2010CB945600 and 2009ZX09503-24, Knowledge Innovation Project of The Chinese Academy of Sciences KSCX1-YW-22, National Natural Science Foundation of China 30670911 and 30901317, Science and Technology Commission of Shanghai Municipality Programs 074319102 and 07JC14070, and Leading Academic Discipline Project of Shanghai Municipal Education Commission J50207.	Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Eisenbrand Gerhard, 2006, Mol Nutr Food Res, V50, P1087, DOI 10.1002/mnfr.200500278; Farina C, 1998, FARMACO, V53, P22, DOI 10.1016/S0014-827X(97)00013-X; He S, 2008, J LEUKOCYTE BIOL, V84, P1549, DOI 10.1189/jlb.0708420; HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1002/hep.1840210137; Hritz I, 2008, HEPATOLOGY, V48, P1342, DOI 10.1002/hep.22557; Jeong HG, 2002, PHARMACOL RES, V46, P221, DOI 10.1016/S1043-6618(02)00121-4; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Kang OH, 2005, INT J MOL MED, V15, P981; Kroes BH, 1997, IMMUNOLOGY, V90, P115, DOI 10.1046/j.1365-2567.1997.00131.x; Layland LE, 2005, EUR J IMMUNOL, V35, P3248, DOI 10.1002/eji.200526273; Lin G, 1999, TOXICON, V37, P1259, DOI 10.1016/S0041-0101(98)00263-3; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Lu JW, 2008, J HEPATOL, V48, P442, DOI 10.1016/j.jhep.2007.10.014; Matsuno K, 2000, INT REV CYTOL, V197, P83, DOI 10.1016/S0074-7696(00)97003-7; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nakayama Y, 2005, HEPATOLOGY, V42, P915, DOI 10.1002/hep.20872; PULFORD K, 1980, CLIN EXP IMMUNOL, V42, P67; Resto VA, 2008, J BIOL CHEM, V283, P15816, DOI 10.1074/jbc.M708899200; Romics L, 2004, HEPATOLOGY, V40, P555, DOI 10.1002/hep.20350; Rossi T, 2003, ANTICANCER RES, V23, P3813; Soriano ME, 2004, J BIOL CHEM, V279, P36803, DOI 10.1074/jbc.M405297200; Ukil A, 2005, J IMMUNOL, V175, P1161, DOI 10.4049/jimmunol.175.2.1161; Varrin-Doyer M, 2009, J BIOL CHEM, V284, P13265, DOI 10.1074/jbc.M807664200; Velayudham A, 2006, J HEPATOL, V45, P813, DOI 10.1016/j.jhep.2006.06.017; Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang BS, 2007, WORLD J GASTROENTERO, V13, P462, DOI 10.3748/wjg.v13.i3.462; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yoneyama H, 2002, J EXP MED, V195, P1257, DOI 10.1084/jem.20011983; Zhang YY, 2004, JNCI-J NATL CANCER I, V96, P201, DOI 10.1093/jnci/djh024	35	40	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1128	1137		10.1074/jbc.M109.037705	http://dx.doi.org/10.1074/jbc.M109.037705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897483	Green Published, hybrid			2022-12-27	WOS:000273258200035
J	Xiao, ZS; Zhang, SQ; Cao, L; Qiu, N; David, V; Quarles, LD				Xiao, Zhousheng; Zhang, Shiqin; Cao, Li; Qiu, Ni; David, Valentin; Quarles, L. Darryl			Conditional Disruption of Pkd1 in Osteoblasts Results in Osteopenia Due to Direct Impairment of Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC KIDNEY-DISEASE; RENAL EPITHELIAL-CELLS; SIGNALING PATHWAY; GENE-PRODUCT; MICE; RECEPTOR; DIFFERENTIATION; SKELETOGENESIS; CYSTOGENESIS; EXPRESSION	PKD1 (polycystin-1), the disease-causing gene for ADPKD, is widely expressed in various cell types, including osteoblasts, where its function is unknown. Although global inactivation of Pkd1 in mice results in abnormal skeletal development, the presence of polycystic kidneys and perinatal lethality confound ascertaining the direct osteoblastic functions of PKD1 in adult bone. To determine the role of PKD1 in osteoblasts, we conditionally inactivated Pkd1 in postnatal mature osteoblasts by crossing Oc (osteocalcin)-Cre mice with floxed Pkd1 (Pkd1(flox/m1Bei)) mice to generate conditional heterozygous (Oc-Cre;Pkd1(flox/+)) and homozygous (Oc-Cre; Pkd1flox/m1Bei) Pkd1-deficient mice. Cre-mediated recombination (Pkd1(Delta flox)) occurred exclusively in bone. Compared with control mice, the conditional deletion of Pkd1 from osteoblasts resulted in a gene dose-dependent reduction in bone mineral density, trabecular bone volume, and cortical thickness. In addition, mineral apposition rates and osteoblast-related gene expression, including Runx2-II (Runt-related transcription factor 2), osteocalcin, osteopontin, and bone sialoprotein, were reduced proportionate to the reduction of Pkd1 gene dose in bone of Oc-Cre; Pkd1(flox/+) and Oc-Cre; Pkd1(flox/m1Bei) mice. Primary osteoblasts derived from Oc-Cre;Pkd1(flox/m1Bei) displayed impaired differentiation and suppressed activity of the phosphatidylinositdol 3-kinase-Akt-GSK3 beta-beta-catenin signaling pathways. The conditional deletion of Pkd1 also resulted in increased adipogenesis in bone marrow and in osteoblast cultures. Thus, PKD1 directly functions in osteoblasts to regulate bone formation.	[Xiao, Zhousheng; Zhang, Shiqin; Cao, Li; Qiu, Ni; David, Valentin; Quarles, L. Darryl] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Quarles, LD (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, MS 3018,3901 Rainbow Blvd,6018 Wahl Hall E, Kansas City, KS 66160 USA.	dquarles@kumc.edu		Quarles, L. Darryl/0000-0002-5082-7896; xiao, zhousheng/0000-0002-3363-5673	National Institutes of Health [R01-AR049712, R21-AR056794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049712, R21AR056794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR049712 and R21-AR056794.	Aoki Koji, 2008, V468, P307, DOI 10.1007/978-1-59745-249-6_24; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Boca M, 2006, J AM SOC NEPHROL, V17, P637, DOI 10.1681/ASN.2005050534; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; DHARMARAJAN A, 2008, J MOL SIGNAL, V3, P10; Driscoll JA, 2008, CHEST, V133, P1181, DOI 10.1378/chest.07-2147; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hassane S, 2007, ARTERIOSCL THROM VAS, V27, P2177, DOI 10.1161/ATVBAHA.107.149252; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; Housset C, 2005, GASTROEN CLIN BIOL, V29, P861, DOI 10.1016/S0399-8320(05)86361-4; Iwaniec UT, 2007, J BONE MINER RES, V22, P394, DOI 10.1359/JBMR.061118; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kim D, 2006, STEM CELLS, V24, P1798, DOI 10.1634/stemcells.2005-0480; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Kolpakova-Hart E, 2008, MATRIX BIOL, V27, P505, DOI 10.1016/j.matbio.2008.05.002; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lantinga-van Leeuwen IS, 2006, GENESIS, V44, P225, DOI 10.1002/dvg.20207; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Lian J B, 1995, Iowa Orthop J, V15, P118; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Peczkowska M, 2004, BLOOD PRESSURE, V13, P283, DOI 10.1080/08037050410016492; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Takaoki Muneo, 2004, Biol Sci Space, V18, P181; Torra R, 1999, AM J HUM GENET, V65, P345, DOI 10.1086/302501; TURCO AE, 1993, J MED GENET, V30, P419, DOI 10.1136/jmg.30.5.419; vanDijk MA, 1995, J AM SOC NEPHROL, V6, P1670; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wilson PD, 1999, LAB INVEST, V79, P1311; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xu H, 2001, DNA SEQUENCE, V12, P361, DOI 10.3109/10425170109084460; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	50	47	47	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1177	1187		10.1074/jbc.M109.050906	http://dx.doi.org/10.1074/jbc.M109.050906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887454	Green Published, hybrid			2022-12-27	WOS:000273258200040
J	Zheng, HY; Nagaraja, GM; Kaur, P; Asea, EE; Asea, A				Zheng, Hongying; Nagaraja, Ganachari M.; Kaur, Punit; Asea, Edwina E.; Asea, Alexzander			Chaperokine Function of Recombinant Hsp72 Produced in Insect Cells Using a Baculovirus Expression System Is Retained	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TOLL-LIKE RECEPTORS; TUMOR-NECROSIS-FACTOR; IMMUNE-RESPONSE; MURINE MACROPHAGES; CANCER-IMMUNOTHERAPY; ANTIGEN PRESENTATION; EXTRACELLULAR HSP72; PEPTIDE COMPLEXES; ADAPTIVE IMMUNITY	Extracellular heat shock protein 72 (Hsp72; inducible form of the 70-kDa heat shock protein) plays a critical role in innate and adaptive immune responses and has shown promise as an ideal adjuvant for the optimization of antigen-specific anti-tumor vaccines. Recent studies suggest that to correctly elucidate the mechanisms by which Hsp72 exerts its beneficial effects in vitro, great care must be taken to ensure that endotoxin by-products do not invalidate the findings. In this study, we have taken advantage of the baculovirus expression vector system for production of endotoxin-free recombinant Hsp72. The coding sequence of human hsp72 was recombined into the baculovirus immediately downstream of the strong polyhedron gene promoter. Ninety-six h post-infection of Sf9 insect cells with recombinant baculovirus, maximal levels of Hsp72 protein were detected. The recombinant human Hsp72 was purified by affinity chromatography from insect cells, and purity was confirmed by SDS-PAGE and mass spectrometry. The purified human recombinant Hsp72(bv) (Hsp72 produced using the BEVS) was demonstrated to have no endotoxin contamination and was shown to have stimulated potent calcium flux in the human monocytic cell line. Furthermore, recombinant Hsp72(bv) enhanced the tolerance of neuroblastoma cells to heat stress-induced cell death and displayed classical chaperokine functions including augmentation of inflammatory cytokine productions in mouse splenocytes. The production of functional, endotoxin-free recombinant human Hsp72(bv) in insect cells is inexpensive and convenient and eliminates the need of special procedures for endotoxin depletion. Endotoxin-free recombinant human Hsp72(bv) can now be used to unlock the important role Hsp72 plays in modulating immune function.	[Asea, Alexzander] Scott & White Mem Hosp & Clin, Div Investigat Pathol, Temple, TX 76508 USA; Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX 76508 USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Asea, A (corresponding author), 1901 S 1st St,Bldg 205, Temple, TX 76508 USA.	aasea@swmail.sw.org	Asea, Alexzander/X-6432-2019; Asea, Alexzander A/I-4112-2013	Asea, Alexzander A/0000-0003-3592-3481	National Institutes of Health [RO1CA91889]; Scott & White Memorial Hospital and Clinic; TX A& M Health Science Center College of Medicine; Central Texas Veterans Health Administration; Cain Foundation; NATIONAL CANCER INSTITUTE [R01CA091889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scott & White Memorial Hospital and Clinic; TX A& M Health Science Center College of Medicine; Central Texas Veterans Health Administration; Cain Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant RO1CA91889. This work was also supported by institutional support from Scott & White Memorial Hospital and Clinic, TX A& M Health Science Center College of Medicine, the Central Texas Veterans Health Administration, and an endowment from the Cain Foundation (to A. A.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2005, EXERC IMMUNOL REV, V11, P34; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea A, 2008, NOVART FDN SYMP, V291, P179; Asea Alexzander, 2008, V183, P111; Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; Asea Alexzander, 2008, Novartis Found Symp, V291, P173; Asea Alexzander A. A., 2007, V1, P3; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Calderwood SK, 2005, EUR J IMMUNOL, V35, P2518, DOI 10.1002/eji.200535002; Castelli C, 2004, CANCER IMMUNOL IMMUN, V53, P227, DOI 10.1007/s00262-003-0481-9; Gao BC, 2004, BIOCHEM BIOPH RES CO, V317, P1149, DOI 10.1016/j.bbrc.2004.03.160; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; Kaur P, 2010, HEAT SHOCK PROTEINS, V4, P153, DOI 10.1007/978-90-481-2976-8_8; Lehner T, 2000, EUR J IMMUNOL, V30, P594, DOI 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.3.CO;2-T; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; MAGGI E, 1992, J IMMUNOL, V148, P2142; Manjili MH, 2004, EXPERT OPIN BIOL TH, V4, P363, DOI 10.1517/14712598.4.3.363; MCLEISH KR, 1989, INFLAMMATION, V13, P681, DOI 10.1007/BF00914312; Menoret A, 2004, METHODS, V32, P7, DOI 10.1016/S1046-2023(03)00180-4; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Possee RD., 1992, BACULOVIRUS EXPRESSI; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1994, EXPERIENTIA, V50, P1054, DOI 10.1007/BF01923461; SRIVASTAVA PK, 1994, CURR OPIN IMMUNOL, V6, P728, DOI 10.1016/0952-7915(94)90076-0; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; Takakura Y, 2007, CURR OPIN MOL THER, V9, P385; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200	48	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					349	356		10.1074/jbc.M109.024612	http://dx.doi.org/10.1074/jbc.M109.024612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861412	hybrid, Green Published			2022-12-27	WOS:000273070100036
J	Cardarelli, F; Bizzarri, R; Serresi, M; Albertazzi, L; Beltram, F				Cardarelli, Francesco; Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio			Probing Nuclear Localization Signal-Importin alpha Binding Equilibria in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH MOTIF; PROTEIN IMPORT; IN-VIVO; TRANSPORT-PROPERTIES; FLUORESCENT PROTEIN; BETA; RAN; RECOGNITION; SEQUENCE; IDENTIFICATION	The regulated process of protein import into the nucleus of a eukaryotic cell is mediated by specific nuclear localization signals (NLSs) that are recognized by protein-import receptors. In this study, we present fluorescence-based methods to quantitatively address the physicochemical details of NLS recognition by the receptor protein importin alpha (Imp alpha) in living cells. First, by combining fluorescence recovery after photobleaching measurements and protein-concentration calibration, we quantitatively define nuclear import saturability and afford an affinity value for NLS-Imp alpha binding. Second, by fluorescence lifetime imaging microscopy, we directly monitor the occurrence of NLS-Imp alpha interaction and measure its effective dissociation constant (K-D) in the actual cellular environment. Our kinetic and thermodynamic analyses independently indicate that the subsaturation of Imp alpha with the expressed NLS cargo regulates nuclear import rates in living cells, in contrast to what can be predicted on the basis of available in vitro data. Finally, our experiments also provide evidence for the regulation of nuclear import mediated by the intrasteric importin beta-binding domain of Imp alpha and yield the first estimate of its autoinhibition energy in living cells.	[Cardarelli, Francesco; Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Cardarelli, Francesco; Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio] CNR, Ist Nazl Fis Mat, I-56126 Pisa, Italy; [Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio] Ctr Nanotechnol Innovat, IIT NEST, I-56126 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Istituto Italiano di Tecnologia - IIT	Cardarelli, F (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92697 USA.	f.cardarelli@sns.it	Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011; Beltram, Fabio/L-9486-2019; Bizzarri, Ranieri/ABH-8343-2020; Albertazzi, Lorenzo/E-8323-2013	Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672; Beltram, Fabio/0000-0002-6081-436X; Albertazzi, Lorenzo/0000-0002-6837-0812	Italian Ministry for University and Research under the framework of "Fondo per gli Investimenti della Ricerca di Base" [RBLA03ER38]	Italian Ministry for University and Research under the framework of "Fondo per gli Investimenti della Ricerca di Base"	This work was partially supported by the Italian Ministry for University and Research under the framework of "Fondo per gli Investimenti della Ricerca di Base" Project RBLA03ER38.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Brown CM, 2008, J MICROSC-OXFORD, V229, P78, DOI 10.1111/j.1365-2818.2007.01871.x; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Percipalle P, 1999, J MOL BIOL, V292, P263, DOI 10.1006/jmbi.1999.3077; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370	31	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36638	36646		10.1074/jbc.M109.036699	http://dx.doi.org/10.1074/jbc.M109.036699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858191	Green Published, hybrid			2022-12-27	WOS:000272970500064
J	De Schutter, J; Guillabert, A; Imbault, V; Degraef, C; Erneux, C; Communi, D; Pirson, I				De Schutter, Julie; Guillabert, Aude; Imbault, Virginie; Degraef, Chantal; Erneux, Christophe; Communi, David; Pirson, Isabelle			SHIP2 (SH2 Domain-containing Inositol Phosphatase 2) SH2 Domain Negatively Controls SHIP2 Monoubiquitination in Response to Epidermal Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-INTERACTING MOTIFS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; POLYPHOSPHATE 5-PHOSPHATASE; LIPID PHOSPHATASE; ADAPTER PROTEIN; C-CBL; TYROSINE PHOSPHORYLATION; BINDING DOMAINS; EGF RECEPTOR; STIMULATION	The SH2 domain containing inositol 5-phosphatase SHIP2 contains several interacting domains that are important for scaffolding properties. We and others have previously reported that SHIP2 interacts with the E3 ubiquitin ligase c-Cbl. Here, we identified human SHIP2 monoubiquitination on lysine 315. SHIP2 could also be polyubiquitinated but was not degraded by the 26 S proteasome. Furthermore, we identified a ubiquitin-interacting motif at the C-terminal end of SHIP2 that confers ubiquitin binding capacity. However, this ubiquitin-interacting motif is dispensable for its monoubiquitination. We showed that neither c-Cbl nor Nedd4-1 play the role of ubiquitin ligase for SHIP2. Strikingly, monoubiquitination of the Delta SH2-SHIP2 mutant (lacking the N-terminal SH2 domain) is strongly increased, suggesting an intrinsic inhibitory effect of the SHIP2 SH2 domain on its monoubiquitination. Moreover, SHIP2 monoubiquitination was increased upon 30 min of epidermal growth factor stimulation. This correlates with the loss of interaction between the SHIP2 SH2 domain and c-Cbl. In this model, c-Cbl could mask the monoubiquitination site and thereby prevent SHIP2 monoubiquitination. The present study thus reveals an unexpected and novel role of SHIP2 SH2 domain in the regulation of its newly identified monoubiquitination.	[De Schutter, Julie; Guillabert, Aude; Imbault, Virginie; Degraef, Chantal; Erneux, Christophe; Communi, David; Pirson, Isabelle] Free Univ Brussels, Sch Med, Inst Interdisciplinary Res, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Pirson, I (corresponding author), Free Univ Brussels, Sch Med, Inst Interdisciplinary Res, Campus Erasme,Bldg C,Route Lenn 808, B-1070 Brussels, Belgium.	ilpirson@ulb.ac.be			National Fund for Scientific Research (FNRS); Fonds pour la formation a Recherche clans l'Industrie et dans l'Agriculture; Televie, Brussels, Belgium	National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a Recherche clans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); Televie, Brussels, Belgium	This work was supported by a grant from the National Fund for Scientific Research (FNRS), Fonds pour la formation a Recherche clans l'Industrie et dans l'Agriculture, and Televie, Brussels, Belgium.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blero D, 2001, BIOCHEM BIOPH RES CO, V282, P839, DOI 10.1006/bbrc.2001.4639; Campo PA, 2002, CELL GROWTH DIFFER, V13, P409; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Communi D, 2001, J BIOL CHEM, V276, P38738, DOI 10.1074/jbc.M105640200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Drayer AL, 1996, BIOCHEM SOC T, V24, P1001, DOI 10.1042/bst0241001; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Giuriato S, 2003, BIOCHEM J, V376, P199, DOI 10.1042/BJ20030581; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ishihara H, 1999, BIOCHEM BIOPH RES CO, V260, P265, DOI 10.1006/bbrc.1999.0888; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kalesnikoff J, 2004, REV PHYSIOL BIOCH P, V149, P87, DOI 10.1007/s10254-003-0016-y; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Muraille E, 2000, IMMUNOL LETT, V72, P7, DOI 10.1016/S0165-2478(00)00162-0; Muraille E, 1999, BIOCHEM J, V342, P697, DOI 10.1042/0264-6021:3420697; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Onnockx S, 2008, J CELL PHYSIOL, V214, P260, DOI 10.1002/jcp.21193; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Paternotte N, 2005, FEBS J, V272, P6052, DOI 10.1111/j.1742-4658.2005.04996.x; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; Pesesse X, 2001, J BIOL CHEM, V276, P28348, DOI 10.1074/jbc.M103537200; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2009, BIOCHEMISTRY-US, V48, P6285, DOI 10.1021/bi900492d; Prasad NK, 2005, J BIOL CHEM, V280, P13129, DOI 10.1074/jbc.M410289200; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Sanada F, 2009, HYPERTENSION, V53, P77, DOI 10.1161/HYPERTENSIONAHA.108.120725; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHIRAKI K, 1991, J GEN VIROL, V72, P1393, DOI 10.1099/0022-1317-72-6-1393; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Soubeyran P, 2003, BIOCHEM J, V370, P29, DOI 10.1042/BJ20021539; Taylor V, 2000, MOL CELL BIOL, V20, P6860, DOI 10.1128/MCB.20.18.6860-6871.2000; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Vandenbroere I, 2003, BIOCHEM BIOPH RES CO, V300, P494, DOI 10.1016/S0006-291X(02)02894-2; Vandeput F, 2006, CELL SIGNAL, V18, P2193, DOI 10.1016/j.cellsig.2006.05.010; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang Y, 1996, J BIOL CHEM, V271, P17, DOI 10.1074/jbc.271.1.17; Wang YJ, 2004, J IMMUNOL, V173, P6820, DOI 10.4049/jimmunol.173.11.6820; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xie JW, 2008, CELL SIGNAL, V20, P1432, DOI 10.1016/j.cellsig.2008.03.010; Yang CK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-12; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	72	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36062	36076		10.1074/jbc.M109.064923	http://dx.doi.org/10.1074/jbc.M109.064923			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19880507	Green Published, hybrid			2022-12-27	WOS:000272970500008
J	Lazebnik, MB; Tussie-Luna, MI; Hinds, PW; Roy, AL				Lazebnik, Maria B.; Tussie-Luna, Maria Isabel; Hinds, Philip W.; Roy, Ananda L.			Williams-Beuren Syndrome-associated Transcription Factor TFII-I Regulates Osteogenic Marker Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; CLEIDOCRANIAL DYSPLASIA; RETINOBLASTOMA PROTEIN; INITIATOR ELEMENT; BONE-FORMATION; EXPRESSION; BETA; CBFA1; COMPLEXES	Williams-Beuren syndrome (WBS), an autosomal dominant genetic disorder, is characterized by a unique cognitive profile and craniofacial defects. WBS results from a microdeletion at the chromosomal location 7q11.23 that encompasses the genes encoding the members of TFII-I family of transcription factors. Given that the haploinsufficiency for TFII-I is causative to the craniofacial phenotype in humans, we set out to analyze the effect of post-transcriptional silencing of TFII-I during BMP-2-driven osteoblast differentiation in the C2C12 cell line. Our results show that TFII-I plays an inhibitory role in regulating genes that are essential in osteogenesis and intersects with the bone-specific transcription factor Runx2 and the retinoblastoma protein, pRb. Identification of pathways regulated by TFII-I family transcription factors may begin to shed light on the molecular determinants of WBS.	[Lazebnik, Maria B.; Hinds, Philip W.; Roy, Ananda L.] Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Program Immunol, Boston, MA 02111 USA; [Tussie-Luna, Maria Isabel; Roy, Ananda L.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; [Hinds, Philip W.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts Medical Center	Hinds, PW (corresponding author), Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA.	phinds@tuftsmedicalcenter.org; ananda.roy@tufts.edu		Tussie-Luna, Maria Isabel/0000-0002-5033-408X	National Institutes of Health [AG020208, HD04603]; NATIONAL INSTITUTE ON AGING [R01AG020208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG020208 (to P. H.) and HD04603 (to A. L. R.)	Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Cheriyath V, 2002, J BIOL CHEM, V277, P22798, DOI 10.1074/jbc.M202956200; Cheriyath V, 1998, MOL CELL BIOL, V18, P4444, DOI 10.1128/MCB.18.8.4444; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Crusselle-Davis VJ, 2007, FEBS J, V274, P6065, DOI 10.1111/j.1742-4658.2007.06128.x; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gagliardi C, 2003, J MED GENET, V40, P526, DOI 10.1136/jmg.40.7.526; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Hakre S, 2006, MOL CELL, V24, P301, DOI 10.1016/j.molcel.2006.09.005; Hinsley TA, 2004, PROTEIN SCI, V13, P2588, DOI 10.1110/ps.04747604; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lazebnik MB, 2008, J BIOL CHEM, V283, P11078, DOI 10.1074/jbc.C800049200; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Ogura Y, 2006, GENES CELLS, V11, P373, DOI 10.1111/j.1365-2443.2006.00952.x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Tiemann F, 1998, EMBO J, V17, P1040, DOI 10.1093/emboj/17.4.1040; Tussie-Luna MI, 2002, P NATL ACAD SCI USA, V99, P12807, DOI 10.1073/pnas.192464499; van Wijnen AJ, 2004, ONCOGENE, V23, P4209, DOI 10.1038/sj.onc.1207758; Young EJ, 2008, GENES BRAIN BEHAV, V7, P224, DOI 10.1111/j.1601-183X.2007.00343.x; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	38	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36234	36239		10.1074/jbc.C109.063115	http://dx.doi.org/10.1074/jbc.C109.063115			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19880526	Green Published, hybrid			2022-12-27	WOS:000272970500025
J	Wang, MJ; Lin, SK				Wang, Ming Jen; Lin, Shankung			A Region within the 5 '-Untranslated Region of Hypoxia-inducible Factor-1 alpha mRNA Mediates Its Turnover in Lung Adenocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACT-BINDING-PROTEIN; FACTOR 1-ALPHA; TUMOR PROGRESSION; EXPRESSION; ANGIOGENESIS; TRANSLATION; SELECTION; INVASION; HIF-1; PTB	Previously, we showed that CL1-5 cells express more hypoxia-inducible factor-1 alpha (HIF-1 alpha) than the parental CL1 cells, which bestows CL1-5 cells a stronger invasive activity. Here, we investigated the mechanisms underlying the differential expression of HIF-1 alpha mRNA in CL1 and CL1-5 cells. Data showed that the transcription rate of HIF-1 alpha gene in CL1 cells was slightly higher than that of CL1-5 cells, suggesting that the expression of HIF-1 alpha mRNA in CL1 cells was repressed by post-transcriptional mechanisms. RNA electrophoretic mobility shift assays revealed a 61-base segment (designated as D5) within the 5'-untranslated repeat of HIF-1 alpha mRNA, with which the CL1 cell lysates formed more prominent complexes (including complex I) than did CL1-5 cell lysates. Insertion of D5 into a reporter construct reduced the half-life of the chimeric transcripts in transfected CL1 but not CL1-5 cells; conversely, overexpression of D5-containing reporter construct in CL1 cells increased HIF-1 alpha mRNA. We also identified the polypyrimidine tract-binding protein (PTB) as a required component of complex I. Deletion of the RNA recognition motif 1 (RRM1) or RRM3 of PTB abolished the formation of complex I. Our data showed that CL1 cells expressed more PTB than CL1-5 cells. Inhibition of PTB expression in CL1 cells decreased the formation of complex I, whereas overexpression of PTB in CL1-5 cells increased the levels of complex I, decreased the stability of HIF-1 alpha and D5-containing chimeric mRNAs, and decreased cell invasiveness. In sum, we have identified in lung adenocarcinoma cells a mechanism that regulates HIF-1 alpha expression by modulating HIF-1 alpha mRNA stability.	[Wang, Ming Jen; Lin, Shankung] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Lin, SK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	shankung@nhri.org.tw	Lin, Shan-Kung/B-1062-2010		National Science Council of Taiwan [92-2320-B-341-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council (Grant 92-2320-B-341-002 to S. L.) of Taiwan.	Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Blagosklonny MV, 1999, BIOESSAYS, V21, P704, DOI 10.1002/(SICI)1521-1878(199908)21:8<704::AID-BIES10>3.0.CO;2-5; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Jiang BH, 1997, CANCER RES, V57, P5328; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Shyu KG, 2007, EXP CELL RES, V313, P1181, DOI 10.1016/j.yexcr.2007.01.013; Tillmar L, 2002, MOL MED, V8, P263, DOI 10.1007/BF03402152; Wenger RH, 1997, BIOL CHEM, V378, P609; Xu MG, 2007, BIOL REPROD, V76, P1025, DOI 10.1095/biolreprod.107.060079; YANG PC, 1992, AM J RESP CELL MOL, V7, P161, DOI 10.1165/ajrcmb/7.2.161; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhong H, 1999, CANCER RES, V59, P5830; Zhong H, 2000, CANCER RES, V60, P1541	28	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36500	36510		10.1074/jbc.M109.008904	http://dx.doi.org/10.1074/jbc.M109.008904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19887373	Green Published, hybrid			2022-12-27	WOS:000272970500052
J	Mutoh, S; Osabe, M; Inoue, K; Moore, R; Pedersen, L; Perera, L; Rebolloso, Y; Sueyoshi, T; Negishi, M				Mutoh, Shingo; Osabe, Makoto; Inoue, Kaoru; Moore, Rick; Pedersen, Lee; Perera, Lalith; Rebolloso, Yvette; Sueyoshi, Tatsuya; Negishi, Masahiko			Dephosphorylation of Threonine 38 Is Required for Nuclear Translocation and Activation of Human Xenobiotic Receptor CAR (NR1I3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; MOUSE PRIMARY HEPATOCYTES; DRUG-METABOLISM; X-RECEPTOR; CYP2B GENE; LIVER; HETERODIMER; INDUCTION	Upon activation by therapeutics, the nuclear xenobiotic/constitutive active/androstane receptor (CAR) regulates various liver functions ranging from drug metabolism and excretion to energy metabolism. CAR can also be a risk factor for developing liver diseases such as hepatocellular carcinoma. Here we have characterized the conserved threonine 38 of human CAR as the primary residue that regulates nuclear translocation and activation of CAR. Protein kinase C phosphorylates threonine 38 located on the alpha-helix spanning from residues 29-42 that constitutes a part of the first zinc finger and continues into the region between the zinc fingers. Molecular dynamics study has revealed that this phosphorylation may destabilize this helix, thereby inactivating CAR binding to DNA as well as sequestering it in the cytoplasm. We have found, in fact, that helix-stabilizing mutations reversed the effects of phosphorylation. Immunohistochemical study using an anti-phosphothreonine 38 peptide antibody has, in fact, demonstrated that the classic CAR activator phenobarbital dephosphorylates the corresponding threonine 48 of mouse CAR in the cytoplasm of mouse liver and translocates CAR into the nucleus. These results define CAR as a cell signal-regulated constitutive active nuclear receptor. These results also provide phosphorylation/dephosphorylation of the threonine as the primary drug target for CAR activation.	[Mutoh, Shingo; Osabe, Makoto; Inoue, Kaoru; Moore, Rick; Sueyoshi, Tatsuya; Negishi, Masahiko] NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Pedersen, Lee; Perera, Lalith] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Rebolloso, Yvette] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Perera, Lalith/ABB-9995-2021; Pedersen, Lee G/E-3405-2013; Negishi, Masahiko/F-7805-2019; perera, Lalith/B-6879-2012	Pedersen, Lee G/0000-0003-1262-9861; Negishi, Masahiko/0000-0002-2076-8928; perera, Lalith/0000-0003-0823-1631	National Institutes of Health Intramural Research Program [Z01ES71005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, ZIAES043010] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Z01ES71005-01 through the NIEHS.	Case D. A., 2008, AMBER MOL DYNAMICS P, P10; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Honkakoski P, 1998, BIOCHEM J, V330, P889, DOI 10.1042/bj3300889; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	20	104	111	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34785	34792		10.1074/jbc.M109.048108	http://dx.doi.org/10.1074/jbc.M109.048108			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19858220	Green Published, hybrid			2022-12-27	WOS:000272439600034
J	Takeuchi, K; Kiefer, P; Reimmann, C; Keel, C; Dubuis, C; Rolli, J; Vorholt, JA; Haas, D				Takeuchi, Kasumi; Kiefer, Patrick; Reimmann, Cornelia; Keel, Christoph; Dubuis, Christophe; Rolli, Joelle; Vorholt, Julia A.; Haas, Dieter			Small RNA-dependent Expression of Secondary Metabolism Is Controlled by Krebs Cycle Function in Pseudomonas fluorescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLACK ROOT-ROT; BIOCONTROL FACTOR EXPRESSION; GRAM-NEGATIVE BACTERIA; III SECRETION SYSTEM; EXOPRODUCT FORMATION; BIOLOGICAL-CONTROL; MASS-SPECTROMETRY; GENE-EXPRESSION; AERUGINOSA PAO1; REGULATORY RNA	Pseudomonas fluorescens CHA0, an antagonist of phytopathogenic fungi in the rhizosphere of crop plants, elaborates and excretes several secondary metabolites with antibiotic properties. Their synthesis depends on three small RNAs (RsmX, RsmY, and RsmZ), whose expression is positively controlled by the GacS-GacA two-component system at high cell population densities. To find regulatory links between primary and secondary metabolism in P. fluorescens and in the related species Pseudomonas aeruginosa, we searched for null mutations that affected central carbon metabolism as well as the expression of rsmY-gfp and rsmZ-gfp reporter constructs but without slowing down the growth rate in rich media. Mutation in the pycAB genes (for pyruvate carboxylase) led to down-regulation of rsmXYZ and secondary metabolism, whereas mutation in fumA (for a fumarase isoenzyme) resulted in up-regulation of the three small RNAs and secondary metabolism in the absence of detectable nutrient limitation. These effects required the GacS sensor kinase but not the accessory sensors RetS and LadS. An analysis of intracellular metabolites in P. fluorescens revealed a strong positive correlation between small RNA expression and the pools of 2-oxoglutarate, succinate, and fumarate. We conclude that Krebs cycle intermediates (already known to control GacA-dependent virulence factors in P. aeruginosa) exert a critical trigger function in secondary metabolism via the expression of GacA-dependent small RNAs.	[Takeuchi, Kasumi; Reimmann, Cornelia; Keel, Christoph; Dubuis, Christophe; Rolli, Joelle; Haas, Dieter] Univ Lausanne, Dept Microbiol Fondamentale, CH-1015 Lausanne, Switzerland; [Takeuchi, Kasumi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Kiefer, Patrick; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	University of Lausanne; National Institute of Agrobiological Sciences - Japan; Swiss Federal Institutes of Technology Domain; ETH Zurich	Haas, D (corresponding author), Univ Lausanne, Dept Microbiol Fondamentale, Batiment Biophore, CH-1015 Lausanne, Switzerland.	dieter.haas@unil.ch	Vorholt, Julia/K-3514-2016; Keel, Christoph/U-4071-2017; Kiefer, Patrick/G-5138-2010	Vorholt, Julia/0000-0002-6011-4910; Keel, Christoph/0000-0002-8968-735X; Takeuchi, Kasumi/0000-0002-6521-6748	Swiss National Foundation [3100A0-100180]; Japan Society for the Promotion of Science-Swiss National Foundation; Organisation for Economic Co-operation and Development	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Japan Society for the Promotion of Science-Swiss National Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Organisation for Economic Co-operation and Development	This work was supported by Swiss National Foundation for Scientific Research Project 3100A0-100180, the Japan Society for the Promotion of Science-Swiss National Foundation for Scientific Research Exchange Program, and an Organisation for Economic Co-operation and Development fellowship (to T. K.).	BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; CARMI R, 1994, J NAT PROD, V57, P1200, DOI 10.1021/np50111a002; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; DEMAIN AL, 1986, PURE APPL CHEM, V58, P219, DOI 10.1351/pac198658020219; Dubuis C, 2006, APPL ENVIRON MICROB, V72, P2606, DOI 10.1128/AEM.72.4.2606-2613.2006; Dubuis C, 2007, EUR J PLANT PATHOL, V119, P311, DOI 10.1007/s10658-007-9157-1; Dubuis C, 2007, APPL ENVIRON MICROB, V73, P650, DOI 10.1128/AEM.01681-06; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Fox A, 2008, APPL ENVIRON MICROB, V74, P1902, DOI 10.1128/AEM.02539-07; GAMPER M, 1992, J MOL BIOL, V226, P943, DOI 10.1016/0022-2836(92)91044-P; Gonzalez N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-167; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hill RL, 1969, METHOD ENZYMOL, V8, P91, DOI 10.1016/0076-6879(69)13021-9; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; IRETON K, 1995, P NATL ACAD SCI USA, V92, P2845, DOI 10.1073/pnas.92.7.2845; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P1121, DOI 10.1094/MPMI-19-1121; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Lai HF, 2006, APPL ENVIRON MICROB, V72, P7785, DOI 10.1128/AEM.01564-06; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Leoni L, 1996, J BACTERIOL, V178, P2299, DOI 10.1128/jb.178.8.2299-2313.1996; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Miller J. H, 1972, EXPT MOL GENETICS; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Mulcahy H, 2006, INFECT IMMUN, V74, P3012, DOI 10.1128/IAI.74.5.3012-3015.2006; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; ORNSTON LN, 1966, J BIOL CHEM, V241, P3776; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; PHIBBS PV, 1974, J BACTERIOL, V118, P999, DOI 10.1128/JB.118.3.999-1009.1974; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rietsch A, 2004, INFECT IMMUN, V72, P1383, DOI 10.1128/IAI.72.3.1383-1390.2004; Sambrook J., 2001, MOL CLONING LAB MANU; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Siddiqui IA, 2005, APPL ENVIRON MICROB, V71, P5646, DOI 10.1128/AEM.71.9.5646-5649.2005; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; STUTZ EW, 1986, PHYTOPATHOLOGY, V76, P181, DOI 10.1094/Phyto-76-181; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; VOISARD C, 1988, FEMS MICROBIOL LETT, V55, P9, DOI 10.1016/0378-1097(88)90143-7; VOISARD C, 1989, EMBO J, V8, P351, DOI 10.1002/j.1460-2075.1989.tb03384.x; Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Zuber S, 2003, MOL PLANT MICROBE IN, V16, P634, DOI 10.1094/MPMI.2003.16.7.634	63	56	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34976	34985		10.1074/jbc.M109.052571	http://dx.doi.org/10.1074/jbc.M109.052571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840935	Green Published, hybrid			2022-12-27	WOS:000272439600053
J	Nakajima, H; Amano, W; Kubo, T; Fukuhara, A; Ihara, H; Azuma, YT; Tajima, H; Inui, T; Sawa, A; Takeuchi, T				Nakajima, Hidemitsu; Amano, Wataru; Kubo, Takeya; Fukuhara, Ayano; Ihara, Hideshi; Azuma, Yasu-Taka; Tajima, Hisao; Inui, Takashi; Sawa, Akira; Takeuchi, Tadayoshi			Glyceraldehyde-3-phosphate Dehydrogenase Aggregate Formation Participates in Oxidative Stress-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURODEGENERATIVE DISEASES; NEUROBLASTOMA-CELLS; NITRIC-OXIDE; GAPDH; PROTEIN; METHAMPHETAMINE; DOPAMINE; APOPTOSIS; NEUROTOXICITY; BINDING	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 2 is a classic glycolytic enzyme that also mediates cell death by its nuclear translocation under oxidative stress. Meanwhile, we previously presented that oxidative stress induced disulfide-bonded GAPDH aggregation in vitro. Here, we propose that GAPDH aggregate formation might participate in oxidative stress-induced cell death both in vitro and in vivo. We show that human GAPDH amyloid-like aggregate formation depends on the active site cysteine-152 (Cys-152) in vitro. In SH-SY5Y neuroblastoma, treatment with dopamine decreases the cell viability concentration-dependently (IC50 = 202 mu M). Low concentrations of dopamine (50-100 mu M) mainly cause nuclear translocation of GAPDH, whereas the levels of GAPDH aggregates correlate with high concentrations of dopamine (200-300 mu M)-induced cell death. Doxycycline-inducible overexpression of wild-typeGAPDHin SH-SY5Y, but not the Cys-152-substituted mutant (C152A-GAPDH), accelerates cell death accompanying both endogenous and exogenous GAPDH aggregate formation in response to high concentrations of dopamine. Deprenyl, a blocker of GAPDH nuclear translocation, fails to inhibit the aggregation both in vitro and in cells but reduced cell death in SH-SY5Y treated with only a low concentration of dopamine (100 mu M). These results suggest that GAPDH participates in oxidative stress-induced cell death via an alternative mechanism in which aggregation but not nuclear translocation of GAPDH plays a role. Moreover, we observe endogenous GAPDH aggregate formation in nigra-striatum dopaminergic neurons after methamphetamine treatment in mice. In transgenic mice overexpressing wildtype GAPDH, increased dopaminergic neuron loss and GAPDH aggregate formation are observed. These data suggest a critical role of GAPDH aggregates in oxidative stress-induced brain damage.	[Takeuchi, Tadayoshi] Osaka Prefecture Univ, Lab Vet Pharmacol, Osaka 5988531, Japan; [Fukuhara, Ayano; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Grad Sch Sci, Lab Prot Sci, Osaka 5988531, Japan; [Ihara, Hideshi] Osaka Prefecture Univ, Dept Sci, Osaka 5988531, Japan; [Tajima, Hisao] Ono Pharmaceut Co Ltd, Dev Res Labs, Osaka 6188585, Japan; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Ono Pharmaceutical Co Ltd; Johns Hopkins University; Johns Hopkins University		hnakajima@vet.oskafu-u.ac.jp	Inui, Takashi/G-1069-2011; Tajima, Hisao/E-3241-2010; Azuma, Yasu-Taka/C-7561-2009	Azuma, Yasu-Taka/0000-0002-3515-171X; Nakajima, Hidemitsu/0000-0002-0441-1929	Japan Society for the Promotion of Science; Osaka Prefecture University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Prefecture University	This work was supported in part by Grant-in-aid 19580346 for Scientific Research (to H.N.) from the Japan Society for the Promotion of Science and a special research grant (to H.N.) from Osaka Prefecture University.	Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Iwashita A, 2004, J PHARMACOL EXP THER, V310, P1114, DOI 10.1124/jpet.104.068932; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Larsen KE, 2002, J NEUROSCI, V22, P8951; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Lee MK, 2007, EXP MOL MED, V39, P376, DOI 10.1038/emm.2007.42; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; Mark KA, 2007, J NEUROSCI, V27, P6823, DOI 10.1523/JNEUROSCI.0013-07.2007; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Serpell LC, 2000, J MOL BIOL, V299, P225, DOI 10.1006/jmbi.2000.3650; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200	27	98	100	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34331	34341		10.1074/jbc.M109.027698	http://dx.doi.org/10.1074/jbc.M109.027698			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837666	hybrid, Green Published			2022-12-27	WOS:000272165200063
J	Donnelly, S; O'Neill, SM; Stack, CM; Robinson, MW; Turnbull, L; Whitchurch, C; Dalton, JP				Donnelly, Sheila; O'Neill, Sandra M.; Stack, Colin M.; Robinson, Mark W.; Turnbull, Lynne; Whitchurch, Cynthia; Dalton, John P.			Helminth Cysteine Proteases Inhibit TRIF-dependent Activation of Macrophages via Degradation of TLR3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA PROMOTER; FASCIOLA-HEPATICA; LIVER FLUKE; BORDETELLA-PERTUSSIS; MEDIATED CLEAVAGE; IMMUNE EVASION; CATHEPSIN L1; LIPOPOLYSACCHARIDE; PROTEINASES; INFECTION	Helminth pathogens prepare a Th2 type immunological environment in their hosts to ensure their longevity. They achieve this by secreting molecules that not only actively drive type 2 responses but also suppress type 1 responses. Here, we show that the major cysteine proteases secreted from the helminth pathogens Fasciola hepatica (FheCL1) and Schistosoma mansoni (SmCB1) protect mice from the lethal effects of lipopolysaccharide by preventing the release of inflammatory mediators, nitric oxide, interleukin-6, tumor necrosis factor alpha, and interleukin-12, from macrophages. The proteases specifically block the MyD88-independent TRIF-dependent signaling pathway of Toll-like receptor (TLR) 4 and TLR3. Microscopical and flow cytometric studies, however, show that alteration of macrophage function by cysteine protease is not mediated by cleavage of components of the TLR4 complex on the cell surface but occurs by degradation of TLR3 within the endosome. This is the first study to describe a parasite molecule that degrades this receptor and pinpoints a novel mechanism by which helminth parasites modulate the innate immune responses of their hosts to suppress the development of Th1 responses.	[Donnelly, Sheila] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Dalton, John P.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Sydney, NSW 2007, Australia; [O'Neill, Sandra M.] Dublin City Univ, Sch Nursing, Dublin 9, Ireland; [Stack, Colin M.] Univ Western Sydney, Sch Biomed & Hlth Sci, Campbelltown, NSW 2560, Australia; [Dalton, John P.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Maynooth University; University of Technology Sydney; Dublin City University; Western Sydney University; McGill University	Donnelly, S (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.	sheila.donnelly@nuim.ie	Dalton, John/K-4457-2014; Stack, Colin M/D-4601-2009; Donnelly, Sheila/H-7733-2014; Turnbull, Lynne/A-2605-2012; Whitchurch, Cynthia/A-5954-2008	Turnbull, Lynne/0000-0002-9255-9033; Robinson, Mark/0000-0001-7191-0034; Stack, Colin/0000-0002-7539-7677; Whitchurch, Cynthia/0000-0003-2296-3791; Donnelly, Sheila/0000-0003-2005-3698	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01HL46703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Balic A, 2006, INT IMMUNOL, V18, P1421, DOI 10.1093/intimm/dxl075; Berasain P, 2000, EXP PARASITOL, V94, P99, DOI 10.1006/expr.1999.4479; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; Brannstrom K, 2009, INFECT IMMUN, V77, P1144, DOI 10.1128/IAI.01126-08; Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Elliott DE, 2007, INT J PARASITOL, V37, P457, DOI 10.1016/j.ijpara.2006.12.009; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Huang JR, 2008, IMMUNOL INVEST, V37, P263, DOI 10.1080/08820130802083622; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Joshi AD, 2008, EUR J IMMUNOL, V38, P3436, DOI 10.1002/eji.200838629; Kanaji S, 2007, FEBS LETT, V581, P4260, DOI 10.1016/j.febslet.2007.07.072; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Kuroda E, 2001, PARASITE IMMUNOL, V23, P305, DOI 10.1046/j.1365-3024.2001.00387.x; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lee ZH, 2001, J LEUKOCYTE BIOL, V69, P490; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; MEEUSEN E, 1995, PARASITE IMMUNOL, V17, P37, DOI 10.1111/j.1365-3024.1995.tb00964.x; O'Neill SM, 2001, PARASITE IMMUNOL, V23, P541, DOI 10.1046/j.1365-3024.2001.00411.x; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Robinson MW, 2008, TRENDS BIOCHEM SCI, V33, P601, DOI 10.1016/j.tibs.2008.09.001; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Semnani RT, 2004, J IMMUNOL, V172, P6229, DOI 10.4049/jimmunol.172.10.6229; Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199; SMITH AM, 1993, INT J PARASITOL, V23, P977, DOI 10.1016/0020-7519(93)90117-H; Stack CM, 2005, J IMMUNOL METHODS, V304, P151, DOI 10.1016/j.jim.2005.07.019; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Stack CM, 2007, J BIOL CHEM, V282, P16532, DOI 10.1074/jbc.M611501200; Stadecker MJ, 2004, IMMUNOL REV, V201, P168, DOI 10.1111/j.0105-2896.2004.00197.x; Sugawara S, 2000, J IMMUNOL, V165, P411, DOI 10.4049/jimmunol.165.1.411; SUNG CK, 1986, J PARASITOL, V72, P891, DOI 10.2307/3281841; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Tse K, 2007, ANN RHEUM DIS, V66, P77, DOI 10.1136/ard.2007.078998; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	46	101	107	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3383	3392		10.1074/jbc.M109.060368	http://dx.doi.org/10.1074/jbc.M109.060368			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19923225	hybrid, Green Published			2022-12-27	WOS:000273829000053
J	Parodi, J; Sepulveda, FJ; Roa, J; Opazo, C; Inestrosa, NC; Aguayo, LG				Parodi, Jorge; Sepulveda, Fernando J.; Roa, Jorge; Opazo, Carlos; Inestrosa, Nibaldo C.; Aguayo, Luis G.			beta-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; ION CHANNELS; HIPPOCAMPAL SYNAPSES; CALCIUM-CHANNELS; ALPHA-LATROTOXIN; PROTEIN; MECHANISM; NEURONS	Alzheimer disease is a progressive neurodegenerative brain disorder that leads to major debilitating cognitive deficits. It is believed that the alterations capable of causing brain circuitry dysfunctions have a slow onset and that the full blown disease may take several years to develop. Therefore, it is important to understand the early, asymptomatic, and possible reversible states of the disease with the aim of proposing preventive and disease-modifying therapeutic strategies. It is largely unknown how amyloid beta-peptide (A beta), a principal agent in Alzheimer disease, affects synapses in brain neurons. In this study, we found that similar to other pore-forming neurotoxins, A beta induced a rapid increase in intracellular calcium and miniature currents, indicating an enhancement in vesicular transmitter release. Significantly, blockade of these effects by low extracellular calcium and a peptide known to act as an inhibitor of the A beta-induced pore prevented the delayed failure, indicating that A beta blocks neurotransmission by causing vesicular depletion. This new mechanism for A beta synaptic toxicity should provide an alternative pathway to search for small molecules that can antagonize these effects of A beta.	[Aguayo, Luis G.] Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile; [Sepulveda, Fernando J.; Opazo, Carlos] Univ Concepcion, Dept Physiol, Lab Neurobiomet, Concepcion, Chile; [Aguayo, Luis G.] Univ Concepcion, Ctr Invest Avanzada Educ, Concepcion, Chile; [Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol Joaquin V Luco, Ctr Envejecimiento & Regenerac CARE, Millenium Inst Fundamental & Appl Biol,Fac Cienci, Santiago, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; Pontificia Universidad Catolica de Chile	Aguayo, LG (corresponding author), Univ Concepcion, Dept Physiol, Neurophysiol Lab, POB 160-C, Concepcion, Chile.	laguayo@udec.cl		Opazo, Carlos/0000-0003-3473-7548; Parodi, Jorge/0000-0002-9117-5433	Fondo Nacional de Desarrollo Cientifico y Technologico [1060368]; Ring of Research Programa Bicentenario de Ciencia y Tecnologia [ACT-04, CIE-05]; Direccion de Investigacion Universidad de Concepcion [205.033.101-1.0]	Fondo Nacional de Desarrollo Cientifico y Technologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ring of Research Programa Bicentenario de Ciencia y Tecnologia; Direccion de Investigacion Universidad de Concepcion	This work was supported by Fondo Nacional de Desarrollo Cientifico y Technologico Grant 1060368, Ring of Research Programa Bicentenario de Ciencia y Tecnologia ACT-04, CIE-05 (to L. G. A. and C. O.) and Direccion de Investigacion Universidad de Concepcion Grant 205.033.101-1.0 (to J. R.). 1 Both authors contributed equally to this work.	Alarcon JM, 2006, PEPTIDES, V27, P95, DOI 10.1016/j.peptides.2005.07.004; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; ARISPE N, 1994, ANN NY ACAD SCI, V747, P256; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; Blanchard BJ, 1997, BRAIN RES, V776, P40, DOI 10.1016/S0006-8993(97)01003-2; Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243; Chauhan NB, 2002, J NEUROSCI RES, V69, P10, DOI 10.1002/jnr.10286; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Diaz JC, 2006, BIOL RES, V39, P447, DOI 10.4067/S0716-97602006000300007; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; GOODMAN LS, 2001, GOODMAN GILMANS PHAR, P203; Grace EA, 2002, NEUROSCIENCE, V114, P265, DOI 10.1016/S0306-4522(02)00241-5; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kelly BL, 2005, J BIOL CHEM, V280, P31746, DOI 10.1074/jbc.M503259200; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Khvotchev M, 2000, NEUROSCIENCE, V101, P793, DOI 10.1016/S0306-4522(00)00378-X; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P255, DOI 10.1023/A:1010995121153; KRIEBEL ME, 1987, NEUROSCIENCE, V23, P745, DOI 10.1016/0306-4522(87)90092-3; Lonart G, 2006, BRAIN RES, V1107, P42, DOI 10.1016/j.brainres.2006.05.092; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Nomura I, 2005, NEUROSCI LETT, V391, P1, DOI 10.1016/j.neulet.2005.08.024; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Qi JS, 2001, NEUROSCIENCE, V105, P845, DOI 10.1016/S0306-4522(01)00244-5; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ramsden M, 2001, J NEUROCHEM, V79, P699, DOI 10.1046/j.1471-4159.2001.00618.x; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103, DOI 10.1152/jn.1994.72.3.1103; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; Tapia JC, 2001, NEUROSCIENCE, V108, P493, DOI 10.1016/S0306-4522(01)00348-7; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Yao PJ, 1998, NEUROSCI LETT, V252, P33, DOI 10.1016/S0304-3940(98)00547-3; Ye CP, 2004, NEUROSCI LETT, V366, P320, DOI 10.1016/j.neulet.2004.05.060	50	141	143	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2506	2514		10.1074/jbc.M109.030023	http://dx.doi.org/10.1074/jbc.M109.030023			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19915004	hybrid, Green Published			2022-12-27	WOS:000273697800029
J	Ha, SD; Ham, B; Mogridge, J; Saftig, P; Lin, SC; Kim, SO				Ha, Soon-Duck; Ham, Boram; Mogridge, Jeremy; Saftig, Paul; Lin, Shengcai; Kim, Sung Ouk			Cathepsin B-mediated Autophagy Flux Facilitates the Anthrax Toxin Receptor 2-mediated Delivery of Anthrax Lethal Factor into the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; MACROPHAGE CELL-DEATH; PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; LATE ENDOSOMES; NALP3 INFLAMMASOME; TUMOR ENDOTHELIUM; MEMBRANE; FUSION; LYSOSOMES	Anthrax lethal toxin (LeTx) is a virulence factor secreted by Bacillus anthracis and has direct cytotoxic effects on most cells once released into the cytoplasm. The cytoplasmic delivery of the proteolytically active component of LeTx, lethal factor (LF), is carried out by the transporter component, protective antigen, which interacts with either of two known surface receptors known as anthrax toxin receptor (ANTXR) 1 and 2. We found that the cytoplasmic delivery of LF by ANTXR2 was mediated by cathepsin B (CTSB) and required lysosomal fusion with LeTx-containing endosomes. Also, binding of protective antigen to ANXTR1 or 2 triggered autophagy, which facilitated the cytoplasmic delivery of ANTXR2-associated LF. We found that whereas cells treated with the membrane-permeable CTSB inhibitor CA074-Me- or CTSB-deficient cells had no defect in fusion of LC3-containing autophagic vacuoles with lysosomes, autophagic flux was significantly delayed. These results suggested that the ANTXR2-mediated cytoplasmic delivery of LF was enhanced by CTSB-dependent autophagic flux.	[Ha, Soon-Duck; Ham, Boram; Kim, Sung Ouk] Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; [Ha, Soon-Duck; Ham, Boram; Kim, Sung Ouk] Univ Western Ontario, Infect Dis Res Grp, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; [Mogridge, Jeremy] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON N5S 1A8, Canada; [Lin, Shengcai] Xiamen Univ, Sch Life Sci, Xiamen 361005, Peoples R China; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Xiamen University; University of Kiel	Kim, SO (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, London, ON N6G 2V4, Canada.	sung.kim@schulich.uwo.ca	KIM, Sung Ouk/A-1309-2008; Kim, Sung Ouk/AAO-1795-2020; Saftig, Paul/A-7966-2010; Lin, SC/G-4666-2010	Kim, Sung Ouk/0000-0002-0282-6661; 	Canadian Institute of Health Research Operating [MOP68841]; China-Canada Joint Health Research Initiative [CCI82416]	Canadian Institute of Health Research Operating(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative	This work was supported by Canadian Institute of Health Research Operating Grant MOP68841 and China-Canada Joint Health Research Initiative Grant CCI82416 (to S. O. K.).	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Banks DJ, 2005, CELL MICROBIOL, V7, P1173, DOI 10.1111/j.1462-5822.2005.00545.x; Blom TS, 2003, HUM MOL GENET, V12, P257, DOI 10.1093/hmg/ddg025; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bottger G, 1996, J BIOL CHEM, V271, P29191, DOI 10.1074/jbc.271.46.29191; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bright NA, 1997, J CELL SCI, V110, P2027; Carson-Walter EB, 2001, CANCER RES, V61, P6649; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Go MY, 2009, INFECT IMMUN, V77, P52, DOI 10.1128/IAI.01073-08; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rmali KA, 2004, INT J MOL MED, V14, P75; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; St Croix B, 2000, SCIENCE, V289, P1197; Tan YK, 2009, BIOCHEM BIOPH RES CO, V379, P293, DOI 10.1016/j.bbrc.2008.12.048; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Wolfe JT, 2005, J BIOL CHEM, V280, P39417, DOI 10.1074/jbc.M509049200; Yan SQ, 2003, BIOL CHEM, V384, P845, DOI 10.1515/BC.2003.095	68	57	58	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2120	2129		10.1074/jbc.M109.065813	http://dx.doi.org/10.1074/jbc.M109.065813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19858192	Green Published, hybrid			2022-12-27	WOS:000273429100056
J	Hagiwara, Y; Sugishima, M; Khawn, H; Kinoshita, H; Inomata, K; Shang, LX; Lagarias, JC; Takahashi, Y; Fukuyama, K				Hagiwara, Yoshinori; Sugishima, Masakazu; Khawn, Htoi; Kinoshita, Hideki; Inomata, Katsuhiko; Shang, Lixia; Lagarias, J. Clark; Takahashi, Yasuhiro; Fukuyama, Keiichi			Structural Insights into Vinyl Reduction Regiospecificity of Phycocyanobilin:Ferredoxin Oxidoreductase (PcyA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; CRYSTAL-STRUCTURE; FERREDOXIN OXIDOREDUCTASE; HEME OXYGENASE; CYANOBACTERIAL PHYCOCYANOBILIN; ESCHERICHIA-COLI; KEY ENZYME; BILIVERDIN; COMPLEX; BIOSYNTHESIS	Phycocyanobilin: ferredoxin oxidoreductase (PcyA) is the best characterized member of the ferredoxin-dependent bilin reductase family. Unlike other ferredoxin-dependent bilin reductases that catalyze a two-electron reduction, PcyA sequentially reduces D-ring (exo) and A-ring (endo) vinyl groups of biliverdin IX alpha (BV) to yield phycocyanobilin, a key pigment precursor of the light-harvesting antennae complexes of red algae, cyanobacteria, and cryptophytes. To address the structural basis for the reduction regiospecificity of PcyA, we report new high resolution crystal structures of bilin substrate complexes of PcyA from Synechocystis sp. PCC6803, all of which lack exo-vinyl reduction activity. These include the BV complex of the E76Q mutant as well as substrate-bound complexes of wild-type PcyA with the reaction intermediate 18(1),18(2)-dihydrobiliverdin IX alpha (18EtBV) and with biliverdin XIII alpha (BV13), a synthetic substrate that lacks an exo-vinyl group. Although the overall folds and the binding sites of the U-shaped substrates of all three complexes were similar with wild-type PcyA-BV, the orientation of the Glu-76 side chain, which was in close contact with the exo-vinyl group in PcyA-BV, was rotated away from the bilin D-ring. The local structures around the A-rings in the three complexes, which all retain the ability to reduce the A-ring of their bound pigments, were nearly identical with that of wild-type PcyA-BV. Consistent with the proposed proton-donating role of the carboxylic acid side chain of Glu-76 for exo-vinyl reduction, these structures reveal new insight into the reduction regiospecificity of PcyA.	[Hagiwara, Yoshinori; Fukuyama, Keiichi] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Osaka 5600043, Japan; [Sugishima, Masakazu] Kurume Univ, Sch Med, Dept Med Biochem, Fukuoka 8300011, Japan; [Khawn, Htoi; Kinoshita, Hideki; Inomata, Katsuhiko] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa 9201192, Japan; [Shang, Lixia; Lagarias, J. Clark] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; [Takahashi, Yasuhiro] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan	Osaka University; Kurume University; Kanazawa University; University of California System; University of California Davis; Saitama University	Fukuyama, K (corresponding author), Osaka Univ, Dept Biol Sci, Grad Sch Sci, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	fukuyama@bio.sci.osaka-u.ac.jp	Lagarias, John Clark/L-3139-2013; Sugishima, Masakazu/M-2773-2019; Takahashi, Yasuhiro/F-1119-2011; Sugishima, Masakazu/B-1049-2010	Lagarias, John Clark/0000-0002-2093-0403; Sugishima, Masakazu/0000-0002-0840-4929; Takahashi, Yasuhiro/0000-0002-0588-6045; Sugishima, Masakazu/0000-0002-0840-4929; Hagiwara, Yoshinori/0000-0002-0895-3004	Japan Society for the Promotion of Science [20370037, 18570105, 19.1065]; United States National Science Foundation [MCB-0843625]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); United States National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Grants-in-aid for Scientific Research 20370037 and 18570105 (to K.F.), by Grant-in-aid for Research Fellows of the Japan Society for the Promotion of Science 19.1065 (to Y.H.), and by United States National Science Foundation Grant MCB-0843625 (to Andrew J. Fisher and J.C.L.).	Afonin AV, 1996, RUSS CHEM B+, V45, P1137, DOI 10.1007/BF01431606; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Dammeyer T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1121, DOI 10.1039/b807209b; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; DeLano W.L, PYMOL MOL GRAPHICS S; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg N., 2003, PORPHYRIN HDB, P211; Franklin KA, 2005, INT J DEV BIOL, V49, P653, DOI 10.1387/ijdb.051989kf; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hagiwara Y, 2006, FEBS LETT, V580, P3823, DOI 10.1016/j.febslet.2006.05.075; Hughes Jon, 1999, Plant Physiology (Rockville), V121, P1059, DOI 10.1104/pp.121.4.1059; Inomata K, 2008, B CHEM SOC JPN, V81, P25, DOI 10.1246/bcsj.81.25; Kakiuchi T, 1998, CHEM LETT, P1001, DOI 10.1246/cl.1998.1001; Kakiuchi T, 1999, SYNLETT, P901; KARNIOL B, 2005, PHOTOMORPHOGENESIS P, P65; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; MA JS, 1984, J HETEROCYCLIC CHEM, V21, P1005, DOI 10.1002/jhet.5570210415; McDonagh A. F., 1979, PORPHYRINS, VVI; MCDONAGH AF, 1980, BIOCHEM J, V189, P193, DOI 10.1042/bj1890193; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Migita CT, 2003, EUR J BIOCHEM, V270, P687, DOI 10.1046/j.1432-1033.2003.03421.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHELDRICK WS, 1976, J CHEM SOC PERK T 2, P1457, DOI 10.1039/p29760001457; Stoll S, 2009, J AM CHEM SOC, V131, P1986, DOI 10.1021/ja808573f; Sugishima M, 2005, BIOCHEMISTRY-US, V44, P4257, DOI 10.1021/bi0480483; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Sugishima M, 2003, J BIOL CHEM, V278, P32352, DOI 10.1074/jbc.M303682200; Sugishima M, 2009, J MOL BIOL, V389, P376, DOI 10.1016/j.jmb.2009.04.017; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; TERRY MJ, 1995, J BIOL CHEM, V270, P11111, DOI 10.1074/jbc.270.19.11111; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2006, J BIOL CHEM, V281, P3127, DOI 10.1074/jbc.M510126200; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; WAGNER UG, 1995, J MOL BIOL, V247, P326, DOI 10.1006/jmbi.1994.0142; Wuthrich KL, 2000, PLANT J, V21, P189, DOI 10.1046/j.1365-313x.2000.00667.x; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x	49	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1000	1007		10.1074/jbc.M109.055632	http://dx.doi.org/10.1074/jbc.M109.055632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887371	Green Published, hybrid			2022-12-27	WOS:000273258200020
J	Haller, JF; Smith, C; Liu, DL; Zheng, HY; Tornheim, K; Han, GS; Carman, GM; Zoeller, RA				Haller, Jorge F.; Smith, Conor; Liu, Dailan; Zheng, Hongying; Tornheim, Keith; Han, Gil-Soo; Carman, George M.; Zoeller, Raphael A.			Isolation of Novel Animal Cell Lines Defective in Glycerolipid Biosynthesis Reveals Mutations in Glucose-6-phosphate Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSPHEROCYTIC HEMOLYTIC-ANEMIA; AUTOCRINE MOTILITY FACTOR; SACCHAROMYCES-CEREVISIAE; METABOLIC SYNDROME; LIPID-METABOLISM; PHOSPHOGLUCOSE ISOMERASE; PHOSPHOHEXOSE ISOMERASE; PHOSPHATASE ENZYMES; ENZYMATIC SYNTHESIS; CRYSTAL-STRUCTURE	Glycerolipids are structural components for membranes and serve in energy storage. We describe here the use of a photodynamic selection technique to generate a population of Chinese hamster ovary cells that display a global deficiency in glycerolipid biosynthesis. One isolate from this population, GroD1, displayed a profound reduction in the synthesis of phosphatidylcholine, phosphatidylethanolamine, and triglycerides but presented high levels of phosphatidic acid and normal levels of phosphatidylinositol synthesis. This was accompanied by a reduction in phosphatidate phosphatase 1 (PAP1) activity. Expression cloning and sequencing of the cDNA obtained from GroD1 revealed a point mutation, Gly-189 -> Glu, in glucose-6-phosphate isomerase (GPI), a glycolytic enzyme involved in an inherited disorder that results in anemia and neuromuscular symptoms in humans. GPI activity was reduced by 87% in GroD1. No significant differences were found in DNA synthesis, protein synthesis, and ATP levels, whereas glycerol 3-phosphate levels were increased in the mutant. Expression of wild-type hamster GPI restored GPI activity, glycerolipid biosynthesis, and PAP1 activity in GroD1. Two additional, independently isolated GPI-deficient mutants displayed similar phenotypes with respect to PAP1 activity and glycerolipid biosynthesis. These findings uncover a novel relationship between GPI, involved in carbohydrate metabolism, and PAP1, a lipogenic enzyme. These results may also help to explain neuromuscular symptoms associated with inherited GPI deficiency.	[Haller, Jorge F.; Smith, Conor; Liu, Dailan; Zheng, Hongying; Zoeller, Raphael A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Tornheim, Keith] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Boston University; Boston University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zoeller, RA (corresponding author), 700 Albany St,W-317, Boston, MA 02118 USA.	rzoeller@bu.edu		Tornheim, Keith/0000-0002-6235-5128; Zoeller, Raphael/0000-0002-6560-0993	National Institutes of Health [GM-28140]; American Heart Association [GIA 0455753T]; Boston Obesity Nutrition Research Center [DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Boston Obesity Nutrition Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G.M.C.). This work was also supported by American Heart Association Grant GIA 0455753T and a Pilot and Feasibility project from the Boston Obesity Nutrition Research Center (Grant DK46200) (to R.A.Z.).	AGRANOFF BW, 1958, J BIOL CHEM, V233, P1077; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; BAUMANN M, 1990, CANCER INVEST, V8, P351, DOI 10.3109/07357909009012053; Beutler E, 1997, BLOOD CELL MOL DIS, V23, P402, DOI 10.1006/bcmd.1997.0157; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Cheung O, 2008, SEMIN LIVER DIS, V28, P351, DOI 10.1055/s-0028-1091979; Chou CC, 2000, J BIOL CHEM, V275, P23154, DOI 10.1074/jbc.M002017200; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; ESKO JD, 1980, P NATL ACAD SCI-BIOL, V77, P5192, DOI 10.1073/pnas.77.9.5192; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; GOMM SA, 1988, BRIT J CANCER, V58, P797, DOI 10.1038/bjc.1988.312; Gracy R W, 1975, Methods Enzymol, V41, P392; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; James PF, 1997, J BIOL CHEM, V272, P23540, DOI 10.1074/jbc.272.38.23540; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KIYASU JY, 1963, J BIOL CHEM, V238, P2293; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KUGE O, 1985, P NATL ACAD SCI USA, V82, P1926, DOI 10.1073/pnas.82.7.1926; Kugler W, 1998, HUM GENET, V103, P450, DOI 10.1007/s004390050849; Kugler W, 2000, BEST PRACT RES CL HA, V13, P89, DOI 10.1053/beha.1999.0059; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LARSSON K, 1993, MOL MICROBIOL, V10, P1101, DOI 10.1111/j.1365-2958.1993.tb00980.x; MAITRA PK, 1971, J BACTERIOL, V107, P759, DOI 10.1128/JB.107.3.759-769.1971; MERKLE S, 1993, BLOOD, V81, P206; Mittra S, 2008, DRUG DISCOV TODAY, V13, P211, DOI 10.1016/j.drudis.2008.01.006; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; PAGLIA DE, 1974, AM J CLIN PATHOL, V62, P740; PREISS J, 1986, J BIOL CHEM, V261, P8597; Read J, 2001, J MOL BIOL, V309, P447, DOI 10.1006/jmbi.2001.4680; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROGERS TJ, 1983, METHOD ENZYMOL, V92, P237; Rumberger JM, 2003, J BIOL CHEM, V278, P28547, DOI 10.1074/jbc.M302793200; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; SHALEV O, 1993, ANN HEMATOL, V67, P197, DOI 10.1007/BF01695868; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; SMITH SW, 1957, J BIOL CHEM, V228, P915; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; VOELKER DR, 1986, J BIOL CHEM, V261, P1002; Watanabe H, 1996, CANCER RES, V56, P2960; WEISS SB, 1960, J BIOL CHEM, V235, P40; Xu W, 1996, BLOOD, V87, P4502, DOI 10.1182/blood.V87.11.4502.bloodjournal87114502; ZOELLER RA, 1986, P NATL ACAD SCI USA, V83, P5170, DOI 10.1073/pnas.83.14.5170; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	59	6	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					866	877		10.1074/jbc.M109.068213	http://dx.doi.org/10.1074/jbc.M109.068213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19903819	hybrid, Green Published			2022-12-27	WOS:000273258200007
J	Islam, MM; Nautiyal, M; Wynn, RM; Mobley, JA; Chuang, DT; Hutson, SM				Islam, Mohammad Mainul; Nautiyal, Manisha; Wynn, R. Max; Mobley, James A.; Chuang, David T.; Hutson, Susan M.			Branched-chain Amino Acid Metabolon INTERACTION OF GLUTAMATE DEHYDROGENASE WITH THE MITOCHONDRIAL BRANCHED-CHAIN AMINOTRANSFERASE (BCATm)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOACID DEHYDROGENASE; PANCREATIC BETA-CELLS; INSULIN-SECRETION; ESCHERICHIA-COLI; REGULATORY MUTATIONS; SKELETAL-MUSCLE; CXXC MOTIF; AMINOTRANSFERASE; LEUCINE; COMPLEXES	The catabolic pathway for branched-chain amino acids includes deamination followed by oxidative decarboxylation of the deaminated product branched-chain alpha-keto acids, catalyzed by the mitochondrial branched-chain aminotransferase (BCATm) and branched-chain alpha-keto acid dehydrogenase enzyme complex (BCKDC). We found that BCA Tm binds to the E1 decarboxylase of BCKDC, forming a metabolon that allows channeling of branched-chain alpha-keto acids from BCATm to E1. The protein complex also contains glutamate dehydrogenase (GDH1), 4-nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homolog 1, pyruvate carboxylase, and BCKDC kinase. GDH1 binds to the pyridoxamine 5'-phosphate (PMP) form of BCATm (PMP-BCATm) but not to the pyridoxal 5'-phosphate-BCATm and other metabolon proteins. Leucine activates GDH1, and oxidative deamination of glutamate is increased further by addition of PMP-BCATm. Isoleucine and valine are not allosteric activators of GDH1, but in the presence of 5'-phosphate-BCATm, they convert BCATm to PMP-BCATm, stimulating-GDH1 activity. Sensitivity to ADP activation of GDH1 was unaffected by PMP-BCATm; however, addition of a 3 or higher molar ratio of PMP-BCATm to GDH1 protected GDH1 from GTP inhibition by 50%. Kinetic results suggest that GDH1 facilitates regeneration of the form of BCATm that binds to E1 decarboxylase of the BCKDC, promotes metabolon formation, branched-chain amino acid oxidation, and cycling of nitrogen through glutamate.	[Islam, Mohammad Mainul; Hutson, Susan M.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Nautiyal, Manisha] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham	Hutson, SM (corresponding author), Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.	susanh5@vt.edu		Wynn, Richard/0000-0002-1879-2136	USPHS [DK34738, DK26758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758, R01DK034738, R56DK034738] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34738 (to S.M.H.) and DK26758 (to D.T.C.) from the USPHS.	Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; BAYLEY PM, 1980, EUR J BIOCHEM, V112, P521; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Choi MM, 2005, FEBS LETT, V579, P4125, DOI 10.1016/j.febslet.2005.06.041; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Conway ME, 2000, METHOD ENZYMOL, V324, P355; Conway ME, 2004, BIOCHEMISTRY-US, V43, P7356, DOI 10.1021/bi0498050; Conway ME, 2002, BIOCHEMISTRY-US, V41, P9070, DOI 10.1021/bi020200i; Davoodi J, 1998, J BIOL CHEM, V273, P4982, DOI 10.1074/jbc.273.9.4982; Fang J, 2002, BIOCHEM J, V363, P81, DOI 10.1042/0264-6021:3630081; FELIG P, 1973, P SOC EXP BIOL MED, V142, P230; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; GYLFE E, 1976, ACTA DIABETOL LAT, V13, P20, DOI 10.1007/BF02591577; HARRIS RA, 1985, ARCH BIOCHEM BIOPHYS, V243, P542, DOI 10.1016/0003-9861(85)90531-4; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P12229, DOI 10.1021/bi00096a036; HUTSON SM, 1986, J BIOL CHEM, V261, P4420; HUTSON SM, 1978, J BIOL CHEM, V253, P8126; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; HUTSON SM, 1989, ANN NY ACAD SCI, V573, P230, DOI 10.1111/j.1749-6632.1989.tb15000.x; Hutson SM, 2001, J NUTR, V131, p846S, DOI 10.1093/jn/131.3.846S; HUTTON JC, 1980, J BIOL CHEM, V255, P7340; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kagamiyama H, 2000, METHOD ENZYMOL, V324, P103; Kawajiri M, 2006, PEDIATR RES, V59, P359, DOI 10.1203/01.pdr.0000198775.22719.46; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Li J, 2004, J BIOL CHEM, V279, P32968, DOI 10.1074/jbc.M403611200; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; Machius M, 2006, STRUCTURE, V14, P287, DOI 10.1016/j.str.2005.10.009; MCCARTHY AD, 1985, BIOCHEM J, V230, P95, DOI 10.1042/bj2300095; Newsholme P, 2005, CLIN SCI, V108, P185, DOI 10.1042/CS20040290; PALMER TN, 1985, BIOSCIENCE REP, V5, P1015, DOI 10.1007/BF01119623; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Srere PA, 2000, TRENDS BIOCHEM SCI, V25, P150, DOI 10.1016/S0968-0004(00)01550-4; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Wallace JC, 1998, INT J BIOCHEM CELL B, V30, P1, DOI 10.1016/S1357-2725(97)00147-7; WALLIN R, 1990, J BIOL CHEM, V265, P6019; Wynn RM, 2000, METHOD ENZYMOL, V324, P179; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Yennawar N, 2001, ACTA CRYSTALLOGR D, V57, P506, DOI 10.1107/S0907444901001925; Yennawar NH, 2006, J BIOL CHEM, V281, P39660, DOI 10.1074/jbc.M607552200; Yennawar NH, 2002, BIOCHEMISTRY-US, V41, P11592, DOI 10.1021/bi020221c; Yoon HY, 2004, BIOCHIMIE, V86, P261, DOI 10.1016/j.biochi.2004.04.005; ZEIRI L, 1979, BIOPOLYMERS, V18, P2289, DOI 10.1002/bip.1979.360180916; Zimmerman LJ, 2005, J PROTEOME RES, V4, P1672, DOI 10.1021/pr050138m	58	67	68	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					265	276		10.1074/jbc.M109.048777	http://dx.doi.org/10.1074/jbc.M109.048777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858196	Green Published, hybrid			2022-12-27	WOS:000273070100028
J	Kim, JH; Yoon, MS; Chen, J				Kim, Jeong-Ho; Yoon, Mee-Sup; Chen, Jie			Signal Transducer and Activator of Transcription 3 (STAT3) Mediates Amino Acid Inhibition of Insulin Signaling through Serine 727 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAXIMAL ACTIVATION; S6 KINASE; RESISTANCE; METABOLISM; PROTEINS; GLUCOSE; TARGET; SUPPRESSOR; MECHANISM; RAPAMYCIN	Nutrient overload is associated with the development of obesity, insulin resistance, and type II diabetes. High plasma concentrations of amino acids have been found to correlate with insulin resistance. At the cellular level, excess amino acids impair insulin signaling, the mechanisms of which are not fully understood. Here, we report that STAT3 plays a key role in amino acid dampening of insulin signaling in hepatic cells. Excess amino acids inhibited insulin-stimulated Akt phosphorylation and glycogen synthesis in mouse primary hepatocytes as well as in human hepatocarcinoma HepG2 cells. STAT3 knockdown protected insulin sensitivity from inhibition by amino acids. Amino acids stimulated the phosphorylation of STAT3 at Ser(727), but not Tyr(705). Replacement of the endogenous STAT3 with wild-type, but not S727A, recombinant STAT3 restored the ability of amino acids to inhibit insulin signaling, suggesting that Ser(727) phosphorylation was critical for STAT3-mediated amino acid effect. Furthermore, overexpression of STAT3-S727D was sufficient to inhibit insulin signaling in the absence of excess amino acids. Our results also indicated that mammalian target of rapamycin was likely responsible for the phosphorylation of STAT3 at Ser(727) in response to excess amino acids. Finally, we found that STAT3 activity and the expression of its target gene socs3, known to be involved in insulin resistance, were both stimulated by excess amino acids and inhibited by rapamycin. In conclusion, our study reveals STAT3 as a novel mediator of nutrient signals and identifies a Ser(727) phosphorylation-dependent and Tyr(705) phosphorylation-independent STAT3 activation mechanism in the modulation of insulin signaling.	[Kim, Jeong-Ho; Yoon, Mee-Sup; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), 601 S Goodwin Ave,B107, Urbana, IL 61801 USA.	jiechen@illinois.edu		Chen, Jie/0000-0002-7887-3747	NIAMS/National Institutes of Health [AR48914]; American Diabetes Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS/National Institutes of Health Grant AR48914 and by the American Diabetes Association (J.C.).	ADIBI SA, 1968, J APPL PHYSIOL, V25, P52, DOI 10.1152/jappl.1968.25.1.52; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Baum JI, 2005, AM J PHYSIOL-ENDOC M, V288, pE86, DOI 10.1152/ajpendo.00272.2004; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; FELIG P, 1970, NEW ENGL J MED, V282, P166; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; FELIG P, 1974, J CLIN INVEST, V53, P582, DOI 10.1172/JCI107593; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Krebs DL, 2000, J CELL SCI, V113, P2813; KREBS DL, 2003, SCI STKE, pPE6; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Linn T, 2000, DIABETOLOGIA, V43, P1257, DOI 10.1007/s001250051521; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Moh A, 2008, DIABETES, V57, P1227, DOI 10.2337/db06-1582; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schulze MB, 2003, DIABETOLOGIA, V46, P1465, DOI 10.1007/s00125-003-1220-7; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7	45	67	71	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35425	35432		10.1074/jbc.M109.051516	http://dx.doi.org/10.1074/jbc.M109.051516			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19875458	hybrid, Green Published			2022-12-27	WOS:000272645600018
J	Puri, C				Puri, Claudia			Loss of Myosin VI No Insert Isoform (NoI) Induces a Defect in Clathrin-mediated Endocytosis and Leads to Caveolar Endocytosis of Transferrin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SNELLS-WALTZER; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE DOMAINS; INNER-EAR; INTERNALIZATION; DEAFNESS; TRANSPORT; BINDING; MUTANT	Myosin VI is a motor protein that moves toward the minus end of actin filaments. It is involved in clathrin-mediated endocytosis and associates with clathrin-coated pits/vesicles at the plasma membrane. In this article the effect of the loss of myosin VI no insert isoform (NoI) on endocytosis in nonpolarized cells was examined. The absence of myosin VI in fibroblasts derived from the Snell's waltzer mouse (myosin VI knock-out) gives rise to defective clathrin-mediated endocytosis with shallow clathrin-coated pits and a strong reduction in the internalization of clathrin-coated vesicles. To compensate for this defect in clathrin-mediated endocytosis, plasma membrane receptors such as the transferrin receptor (TfR) are internalized by a caveola-dependent pathway. Moreover the clathrin adaptor protein, AP-2, necessary for TfR internalization, follows the receptor and relocalizes in caveolae in Snell's waltzer fibroblasts.	Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge	Puri, C (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	cp344@cam.ac.uk			Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK.	Abban CY, 2008, AM J THER, V15, P304, DOI 10.1097/MJT.0b013e3181754134; Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Biemesderfer D, 2002, AM J PHYSIOL-RENAL, V282, pF785, DOI 10.1152/ajprenal.00287.2001; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Danielsen EM, 2006, MOL MEMBR BIOL, V23, P71, DOI 10.1080/09687860500445604; DEOL MS, 1966, GENET RES, V8, P339, DOI 10.1017/S0016672300010193; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Horonchik L, 2008, CHEM BIOL, V15, P647, DOI 10.1016/j.chembiol.2008.05.011; Imelli N, 2004, J VIROL, V78, P3089, DOI 10.1128/JVI.78.6.3089-3098.2004; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kurzchalia TV, 1996, FEBS LETT, V389, P52, DOI 10.1016/0014-5793(96)00585-6; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; SAKAI T, 1991, J BIOCHEM-TOKYO, V109, P528, DOI 10.1093/oxfordjournals.jbchem.a123415; Sato O, 2004, J BIOL CHEM, V279, P28844, DOI 10.1074/jbc.M314332200; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Vogel U, 1998, J CELL SCI, V111, P825; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	60	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34998	35014		10.1074/jbc.M109.012328	http://dx.doi.org/10.1074/jbc.M109.012328			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840950	Green Published, hybrid			2022-12-27	WOS:000272439600055
J	Lim, ST; Miller, NLG; Nam, JO; Chen, XL; Lim, Y; Schlaepfer, DD				Lim, Ssang-Taek; Miller, Nichol L. G.; Nam, Ju-Ock; Chen, Xiao Lei; Lim, Yangmi; Schlaepfer, David D.			Pyk2 Inhibition of p53 as an Adaptive and Intrinsic Mechanism Facilitating Cell Proliferation and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; JUN NH2-TERMINAL KINASE; OVARIAN-CANCER; NUCLEAR TRANSLOCATION; FERM DOMAIN; FAK; ACTIVATION; PROGRESSION; MIGRATION; PROTEIN	Pyk2 is a cytoplasmic tyrosine kinase related to focal adhesion kinase (FAK). Compensatory Pyk2 expression occurs upon FAK loss in mice. However, the impact of Pyk2 up-regulation remains unclear. Previous studies showed that nuclear-localized FAK promotes cell proliferation and survival through FAK FERM domain-enhanced p53 tumor suppressor degradation (Lim, S. T., Chen, X. L., Lim, Y., Hanson, D. A., Vo, T. T., Howerton, K., Larocque, N., Fisher, S. J., Schlaepfer, D. D., and Ilic, D. (2008) Mol. Cell 29, 9-22). Here, we show that FAK knockdown triggered p53 activation and G(1) cell cycle arrest in human umbilical vein endothelial cells after 4 days. However, by 7 days elevated Pyk2 expression occurred with a reduction in p53 levels and the release of the G1 block under conditions of continued FAK knockdown. To determine whether Pyk2 regulates p53, experiments were performed in FAK(-/-)p21(-/-) mouse embryo fibroblasts expressing endogenous Pyk2 and in ID8 ovarian carcinoma cells expressing both Pyk2 and FAK. In both cell lines, Pyk2 knockdown increased p53 levels and inhibited cell proliferation associated with G1 cell cycle arrest. Pyk2 FERM domain re-expression was sufficient to reduce p53 levels and promote increased BrdUrd incorporation. Pyk2 FERM promoted Mdm2-dependent p53 ubiquitination. Pyk2 FERM effects on p53 were blocked by proteasomal inhibition or mutational-inactivation of Pyk2 FERM nuclear localization. Staurosporine stress of ID8 cells promoted endogenous Pyk2 nuclear accumulation and enhanced Pyk2 binding to p53. Pyk2 knockdown potentiated ID8 cell death upon staurosporine addition. Moreover, Pyk2 FERM expression in human fibroblasts upon FAK knockdown prevented cisplatin-mediated apoptosis. Our studies demonstrate that nuclear Pyk2 functions to limit p53 levels, thus facilitating cell growth and survival in a kinase-independent manner.	[Lim, Ssang-Taek; Miller, Nichol L. G.; Nam, Ju-Ock; Chen, Xiao Lei; Lim, Yangmi; Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, Dept Reprod Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Schlaepfer, DD (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Reprod Med, 0803,3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	dschlaepfer@ucsd.edu		Lim, Steve/0000-0003-0323-8607	National Institutes of Health [HL093156, CA102310]; NATIONAL CANCER INSTITUTE [R01CA102310] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093156 and CA102310 (to D. S.).	Alfonso-De Matte MY, 2004, CANCER RES, V64, P23, DOI 10.1158/0008-5472.CAN-03-2820; Aoto H, 2002, CELL STRUCT FUNCT, V27, P47, DOI 10.1247/csf.27.47; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Behmoaram E, 2008, AM J PATHOL, V173, P1540, DOI 10.2353/ajpath.2008.080292; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Corsi JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-198; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Essayem S, 2006, ONCOGENE, V25, P1081, DOI 10.1038/sj.onc.1209130; Faure C, 2007, J CELL SCI, V120, P3034, DOI 10.1242/jcs.009613; Gilmore AP, 2009, CURR OPIN CELL BIOL, V21, P654, DOI 10.1016/j.ceb.2009.05.009; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Ilic D, 2003, CIRC RES, V92, P300, DOI 10.1161/01.RES.0000055016.36679.23; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lipinski CA, 2008, J NEURO-ONCOL, V90, P181, DOI 10.1007/s11060-008-9656-8; Lipinski CA, 2006, BIOCHEM BIOPH RES CO, V349, P939, DOI 10.1016/j.bbrc.2006.08.134; Loftus JC, 2009, MOL CANCER THER, V8, P1505, DOI 10.1158/1535-7163.MCT-08-1055; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Menashi EB, 2009, CELL TISSUE RES, V337, P243, DOI 10.1007/s00441-009-0807-9; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Mitra SK, 2006, ONCOGENE, V25, P4429, DOI 10.1038/sj.onc.1209482; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Ossovskaya V, 2008, FEBS LETT, V582, P2402, DOI 10.1016/j.febslet.2008.06.004; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Schlaepfer DD, 2007, J BIOL CHEM, V282, P17450, DOI 10.1074/jbc.M610672200; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066	46	53	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1743	1753		10.1074/jbc.M109.064212	http://dx.doi.org/10.1074/jbc.M109.064212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19880522	Green Published, hybrid			2022-12-27	WOS:000273429100020
J	Roan, NR; Sowinski, S; Munch, J; Kirchhoff, F; Greene, WC				Roan, Nadia R.; Sowinski, Stefanie; Muench, Jan; Kirchhoff, Frank; Greene, Warner C.			Aminoquinoline Surfen Inhibits the Action of SEVI (Semen-derived Enhancer of Viral Infection)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACID-PHOSPHATASE; HIV-INFECTION; PREVENTION; SULFATE; FIBRILS; BINDING; FUSION	In semen, proteolytic peptide fragments from prostatic acid phosphatase can form amyloid fibrils termed SEVI (semen-derived enhancer of viral infection). These fibrils greatly enhance human immunodeficiency virus (HIV) infectivity by increasing the attachment of virions to target cells. Therefore, SEVI may have a significant impact on whether HIV is successfully transmitted during sexual contact. Here, we demonstrate that surfen, a small molecule heparan sulfate proteoglycan antagonist, inhibits both SEVI- and semen-mediated enhancement of HIV type 1 infection. Surfen interferes with the binding of SEVI to both target cells and HIV type 1 virions but does not deaggregate SEVI fibrils. Because SEVI can increase HIV infectivity by several orders of magnitude, supplementing current HIV microbicide candidates with SEVI inhibitors, such as surfen, might greatly increase their potency.	[Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Muench, Jan; Kirchhoff, Frank] Univ Clin Ulm, Inst Virol, D-89081 Ulm, Germany; Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Ulm University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco		wgreene@gladstone.ucsf.edu		Jan, Munch/0000-0001-7316-7141	National Institutes of Health [P01 A1083050-01, 1R01AI067057-01A2, P30 AI027763]; NICHD [P01 HD40543]; Giannini Foundation; Deutsche Forschungsgemeinschaft; WHIN PPG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI067057, P01AI083050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Giannini Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); WHIN PPG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 A1083050-01 (to W. C. G.), 1R01AI067057-01A2 (to F. K.), P30 AI027763 (to University of California San Francisco-GIVI CFAR), and P01 HD40543 WHIN PPG (to W. C. G.) from NICHD. This work was also supported by The Giannini Foundation fellowship (to N. R. R.), the Deutsche Forschungsgemeinschaft (to F. K.), and the WHIN PPG grant (to W. C. G.).	CALLAHAN LN, 1991, J VIROL, V65, P1543, DOI 10.1128/JVI.65.3.1543-1550.1991; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Cohen J, 2009, SCIENCE, V323, P996, DOI 10.1126/science.323.5917.996; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; LANZA TJ, 1992, J MED CHEM, V35, P252, DOI 10.1021/jm00080a008; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rider CC, 1997, GLYCOCONJUGATE J, V14, P639, DOI 10.1023/A:1018596728605; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; RONNBERG L, 1981, INT J ANDROL, V4, P372, DOI 10.1111/j.1365-2605.1981.tb00721.x; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; UMBER F., 1938, Klinische Wochenschrift, V17, P443, DOI 10.1007/BF01775866; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002	20	60	64	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1861	1869		10.1074/jbc.M109.066167	http://dx.doi.org/10.1074/jbc.M109.066167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19897482	Green Published, hybrid			2022-12-27	WOS:000273429100032
J	da Costa, KA; Rai, KS; Craciunescu, CN; Parikh, K; Mehedint, MG; Sanders, LM; McLean-Pottinger, A; Zeisel, SH				da Costa, Kerry-Ann; Rai, Kiranmai S.; Craciunescu, Corneliu N.; Parikh, Komal; Mehedint, Mihai G.; Sanders, Lisa M.; McLean-Pottinger, Audrey; Zeisel, Steven H.			Dietary Docosahexaenoic Acid Supplementation Modulates Hippocampal Development in the Pemt(-/-) Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERINATAL CHOLINE SUPPLEMENTATION; EMBRYONIC-DEVELOPMENT ALTERS; POLYUNSATURATED FATTY-ACIDS; PROGENITOR-CELL MITOSIS; N-METHYLTRANSFERASE; GENE-EXPRESSION; PEMT GENE; AVAILABILITY ALTERS; IN-VITRO; BRAIN	The development of fetal brain is influenced by nutrients such as docosahexaenoic acid (DHA, 22: 6) and choline. Phosphatidylethanolamine-N-methyltransferase (PEMT) catalyzes the biosynthesis of phosphatidylcholine from phosphatidylethanolamine enriched in DHA and many humans have functional genetic polymorphisms in the PEMT gene. Previously, it was reported that Pemt(-/-) mice have altered hippocampal development. The present study explores whether abnormal phosphatidylcholine biosynthesis causes altered incorporation of DHA into membranes, thereby influencing brain development, and determines whether supplemental dietary DHA can reverse some of these changes. Pregnant C57BL/6 wild type (WT) and Pemt(-/-) mice were fed a control diet, or a diet supplemented with 3 g/kg of DHA, from gestational day 11 to 17. Brains from embryonic day 17 fetuses derived from Pemt(-/-) dams fed the control diet had 25-50% less phospholipid-DHA as compared with WT (p < 0.05). Also, they had 60% more neural progenitor cell proliferation (p < 0.05), 60% more neuronal apoptosis (p < 0.01), and 30% less calretinin expression (p < 0.05; a marker of neuronal differentiation) in the hippocampus compared with WT. The DHA-supplemented diet increased fetal brain Pemt(-/-) phospholipid-DHA to WT levels, and abrogated the neural progenitor cell proliferation and apoptosis differences. Although this diet did not change proliferation in the WT group, it halved the rate of apoptosis (p < 0.05). In both genotypes, the DHA-supplemented diet increased calretinin expression 2-fold (p < 0.05). These results suggest that the changes in hippocampal development in the Pemt(-/-) mouse could be mediated by altered DHA incorporation into membrane phospholipids, and that maternal dietary DHA can influence fetal brain development.	[da Costa, Kerry-Ann; Rai, Kiranmai S.; Craciunescu, Corneliu N.; Parikh, Komal; McLean-Pottinger, Audrey; Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Sch Publ Hlth, Chapel Hill, NC 27599 USA; [da Costa, Kerry-Ann; Rai, Kiranmai S.; Craciunescu, Corneliu N.; Parikh, Komal; McLean-Pottinger, Audrey; Zeisel, Steven H.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Mehedint, Mihai G.; Zeisel, Steven H.] Univ N Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Sanders, Lisa M.] Tate & Lyle, Decatur, IL 62525 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Sanders, Lisa M./AAC-7105-2020	Sanders, Lisa M./0000-0003-1347-1533	National Institutes of Health [AG09525, DK55865, DK56350, DK034987]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055865, P30DK056350, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG09525, DK55865, and DK56350 (to S.H.Z.) and Grant DK034987 to the University of North Carolina Histology Core.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Albright CD, 1999, DEV BRAIN RES, V115, P123, DOI 10.1016/S0165-3806(99)00057-7; Albright CD, 2005, DEV BRAIN RES, V159, P149, DOI 10.1016/j.devbrainres.2005.07.002; Albright CD, 2003, NUTR NEUROSCI, V6, P129, DOI 10.1080/1028415031000084418; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; BAUR FJ, 1945, J AM CHEM SOC, V67, P1899, DOI 10.1021/ja01227a007; BAZAN NG, 1990, UPSALA J MED SCI, P97; Bergmann RL, 2007, J PERINAT MED, V35, P295, DOI 10.1515/JPM.2007.085; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowen RAR, 2005, BRIT J NUTR, V93, P601, DOI 10.1079/BJN20041390; Chen CT, 2008, J LIPID RES, V49, P147, DOI 10.1194/jlr.M700386-JLR200; CHERIAN G, 1992, POULTRY SCI, V71, P1658, DOI 10.3382/ps.0711658; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Denkins Y, 2005, J LIPID RES, V46, P1278, DOI 10.1194/jlr.M400474-JLR200; Fan XT, 2006, P NATL ACAD SCI USA, V103, P19338, DOI 10.1073/pnas.0609663103; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Green P, 1996, LIPIDS, V31, pS235, DOI 10.1007/BF02637082; Guo MQ, 2007, J MOL NEUROSCI, V33, P67, DOI 10.1007/s12031-007-0046-z; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Innis SM, 2007, EARLY HUM DEV, V83, P761, DOI 10.1016/j.earlhumdev.2007.09.004; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Institute of Medicine, 1998, DIET REF INT THIAM R, P390, DOI [DOI 10.17226/6015, 10.17226/6015]; Jacobowitz D.M, 1998, CHEMOARCHITECTONIC A; Jones JP, 1999, DEV BRAIN RES, V118, P159, DOI 10.1016/S0165-3806(99)00103-0; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; MALLAMPALLI RK, 1994, AM J PHYSIOL-LUNG C, V267, pL641, DOI 10.1152/ajplung.1994.267.6.L641; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 1997, NEUROREPORT, V8, P2831, DOI 10.1097/00001756-199709080-00005; Miyama S, 1997, CEREB CORTEX, V7, P678, DOI 10.1093/cercor/7.7.678; Montoya DAC, 2000, DEV BRAIN RES, V123, P25, DOI 10.1016/S0165-3806(00)00075-4; Muthayya S, 2009, EUR J CLIN NUTR, V63, P340, DOI 10.1038/sj.ejcn.1602933; Narayanan NK, 2005, INT J ONCOL, V26, P785; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2005, MOL BRAIN RES, V134, P309, DOI 10.1016/j.molbrainres.2004.11.001; Park JJ, 1996, J NEUROBIOL, V30, P315, DOI 10.1002/(SICI)1097-4695(199607)30:3<315::AID-NEU1>3.0.CO;2-7; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Stead LM, 2006, AM J CLIN NUTR, V83, P5; TACCONI M, 1985, J NEUROCHEM, V45, P805, DOI 10.1111/j.1471-4159.1985.tb04064.x; Tam O, 2006, DEV NEUROSCI-BASEL, V28, P222, DOI 10.1159/000091920; Tang XH, 2007, J LIPID RES, V48, P165, DOI 10.1194/jlr.M600419-JLR200; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhu XN, 2005, MOL BRAIN RES, V134, P239, DOI 10.1016/j.molbrainres.2004.10.040; Zhu XN, 2004, DEV BRAIN RES, V149, P121, DOI 10.1016/j.devbrainres.2004.01.004	59	35	35	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1008	1015		10.1074/jbc.M109.017137	http://dx.doi.org/10.1074/jbc.M109.017137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19889625	Green Published, hybrid			2022-12-27	WOS:000273258200021
J	Duc, M; Johansen, FE; Corthesy, B				Duc, Melanie; Johansen, Finn-Eirik; Corthesy, Blaise			Antigen Binding to Secretory Immunoglobulin A Results in Decreased Sensitivity to Intestinal Proteases and Increased Binding to Cellular Fc Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IG RECEPTOR; ALPHA-R CD89; IMMUNE-RESPONSES; MONOCLONAL-ANTIBODIES; MUCOSAL SURFACES; M-CELLS; COMPONENT; DOMAIN; IDENTIFICATION; ASSOCIATION	In intestinal secretions, secretory IgA (SIgA) plays an important sentinel and protective role in the recognition and clearance of enteric pathogens. In addition to serving as a first line of defense, SIgA and SIgA center dot antigen immune complexes are selectively transported across Peyer's patches to underlying dendritic cells in the mucosa-associated lymphoid tissue, contributing to immune surveillance and immunomodulation. To explain the unexpected transport of immune complexes in face of the large excess of free SIgA in secretions, we postulated that SIgA experiences structural modifications upon antigen binding. To address this issue, we associated specific polymeric IgA and SIgA with antigens of various sizes and complexity (protein toxin, virus, bacterium). Compared with free antibody, we found modified sensitivity of the three antigens assayed after exposure to proteases from intestinal washes. Antigen binding further impacted on the immunoreactivity toward polyclonal antisera specific for the heavy and light chains of the antibody, as a function of the antigen size. These conformational changes promoted binding of the SIgA-based immune complex compared with the free antibody to cellular receptors (Fc alpha RI and polymeric immunoglobulin receptor) expressed on the surface of premyelocytic and epithelial cell lines. These data reveal that antigen recognition by SIgA triggers structural changes that confer to the antibody enhanced receptor binding properties. This identifies immune complexes as particular structural entities integrating the presence of bound antigens and adds to the known function of immune exclusion and mucus anchoring by SIgA.	[Duc, Melanie; Corthesy, Blaise] Univ State Hosp CHUV, Dept Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Johansen, Finn-Eirik] Univ Oslo, Inst Pathol, N-0027 Oslo, Norway; [Johansen, Finn-Eirik] Univ Oslo, Ctr Immune Regulat, N-0027 Oslo, Norway	University of Oslo; University of Oslo	Corthesy, B (corresponding author), Univ State Hosp CHUV, Dept Immunol & Allergy, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch			Swiss Science Research Foundation [3200-109545, 3200-122039]	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss Science Research Foundation Grants 3200-109545 and 3200-122039 (to B.C.).	ALLAOUI A, 1992, MOL MICROBIOL, V6, P1605, DOI 10.1111/j.1365-2958.1992.tb00885.x; BAKOS MA, 1991, J IMMUNOL, V146, P162; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Carayannopoulos L, 1996, J EXP MED, V183, P1579, DOI 10.1084/jem.183.4.1579; Ciarlet M, 1999, J GEN VIROL, V80, P943, DOI 10.1099/0022-1317-80-4-943; Crottet P, 1998, J IMMUNOL, V161, P5445; Crottet P, 1999, J BIOL CHEM, V274, P31445, DOI 10.1074/jbc.274.44.31445; Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Hendrickson BA, 1996, J IMMUNOL, V157, P750; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; Hexham JM, 1999, J EXP MED, V189, P747, DOI 10.1084/jem.189.4.747; Honorio-Fransa AC, 2001, J LEUKOCYTE BIOL, V69, P289; Jerlstrom PG, 1996, INFECT IMMUN, V64, P2787; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Lullau E, 1996, J BIOL CHEM, V271, P16300, DOI 10.1074/jbc.271.27.16300; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Moura IC, 2001, J EXP MED, V194, P417, DOI 10.1084/jem.194.4.417; Muller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2; Oortwijn BD, 2007, MOL IMMUNOL, V44, P966, DOI 10.1016/j.molimm.2006.03.014; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; PHALIPON A, 1995, J EXP MED, V182, P769, DOI 10.1084/jem.182.3.769; Pleass RJ, 1999, J BIOL CHEM, V274, P23508, DOI 10.1074/jbc.274.33.23508; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Reterink TJF, 1997, EUR J IMMUNOL, V27, P2219, DOI 10.1002/eji.1830270915; Rey J, 2004, J IMMUNOL, V172, P3026, DOI 10.4049/jimmunol.172.5.3026; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; Roe M, 1999, J IMMUNOL, V162, P6046; STENBERG L, 1994, J BIOL CHEM, V269, P13458; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; van Spriel AB, 2002, J IMMUNOL, V169, P3831, DOI 10.4049/jimmunol.169.7.3831; Woof JM, 2002, BIOCHEM SOC T, V30, P491, DOI 10.1042/bst0300491	39	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					953	960		10.1074/jbc.M109.059220	http://dx.doi.org/10.1074/jbc.M109.059220			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19910466	Green Published, hybrid			2022-12-27	WOS:000273258200015
J	El Gazzar, M; Liu, TF; Yoza, BK; McCall, CE				El Gazzar, Mohamed; Liu, Tiefu; Yoza, Barbara K.; McCall, Charles E.			Dynamic and Selective Nucleosome Repositioning during Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN MONOCYTIC CELLS; RNA-POLYMERASE-II; NF-KAPPA-B; ASSEMBLY PROTEIN-1; TRANSCRIPTIONAL ACTIVATION; CHROMATIN-STRUCTURE; GENE ACTIVATION; HISTONE H2A.Z; DNA-SEQUENCE	Sepsis is encoded by a sequel of transcription activation and repression events that initiate, sustain, and resolve severe systemic inflammation. The repression/silencing phase occurs in blood leukocytes of animals and humans following the initiation of systemic inflammation due to developing endotoxin tolerance. We previously reported that NF-kappa B transcription factor RelB and histone H3 lysine methyltransferase G9a directly interact to induce facultative heterochromatin assembly and regulate epigenetic silencing during endotoxin tolerance, which is a major feature of sepsis. The general objective of this study was to assess whether dynamic temporal, structural, and positional changes of nucleosomes influence the sepsis phenotype. We used the THP-1 sepsis cell model to isolate mononucleosomes by rapid cell permeabilization and digestion of chromatin with micrococcal nuclease and then compared tumor necrosis factor alpha (TNF alpha) proximal promoter nucleosome alignment in endotoxin-responsive and-tolerant phenotypes. We found differential and dynamic repositioning of nucleosomes from permissive to repressive locations during the activation and silencing phases of transcription reprogramming and identified the following mechanisms that may participate in the process. 1) Two proximal nucleosomes repositioned to expose the primary NF-kappa B DNA binding site in endotoxin-responsive cells, and this "promoter opening" required the ATP-independent chaperone NAP1 to replace the core histone H2A with the H2A.Z variant. 2) During RelB-dependent endotoxin tolerance, the two nucleosomes repositioned and masked the primary NF-kappa B DNA binding site. 3) Small interfering RNA-mediated inhibition of RelB expression prevented repressive nucleosome repositioning and tolerance induction, but the "open" promoter required endotoxin-induced NF-kappa B p65 promoter binding to initiate transcription, supporting the known requirement of p65 posttranslational modifications for transactivation. 4) Sustaining the permissive promoter state after RelB knockdown required ATP-dependent nucleosome remodeler BAF complex. Moreover, we found that forced expression of RelB in responsive cells induced repressive nucleosome positioning and silenced TNF alpha transcription, demonstrating the plasticity of nucleosome remodeling and its dependence on RelB. Our data suggest that nucleosome repositioning controls both the induction and epigenetic silencing phases of TNF alpha transcription associated with sepsis.	[El Gazzar, Mohamed] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Gen Surg, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	El Gazzar, M (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	melgazza@wfubmc.edu			National Institutes of Health [R01AI-065791, R01AI-079144]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079144, R01AI065791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI-065791 and R01AI-079144.	Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Asahara H, 2002, MOL CELL BIOL, V22, P2974, DOI 10.1128/MCB.22.9.2974-2983.2002; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENEZRA R, 1986, CELL, V44, P697, DOI 10.1016/0092-8674(86)90835-4; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; BUCKLE R, 1991, NUCLEIC ACIDS RES, V19, P1219, DOI 10.1093/nar/19.6.1219; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Chen C, 2001, MOL CELL BIOL, V21, P7682, DOI 10.1128/MCB.21.22.7682-7695.2001; Chen JG, 2006, MOL ENDOCRINOL, V20, P1, DOI 10.1210/me.2005-0192; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; El Gazzar M, 2007, INFLAMM RES, V56, P162, DOI 10.1007/s00011-006-6112-0; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Gervais AL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-18; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Goriely S, 2003, BLOOD, V101, P4894, DOI 10.1182/blood-2002-09-2851; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs JE, 2000, CRIT REV EUKAR GENE, V10, P1; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GF, 1998, P NATL ACAD SCI USA, V95, P4772, DOI 10.1073/pnas.95.8.4772; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Pazin MJ, 1997, SCIENCE, V276, P809, DOI 10.1126/science.276.5313.809; Placek BJ, 2005, PROTEIN SCI, V14, P514, DOI 10.1110/ps.041026405; RADMANLIVAJA M, 2009, DEV BIOL IN PRESS; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Schnitzler GR, 2008, CELL BIOCHEM BIOPHYS, V51, P67, DOI 10.1007/s12013-008-9015-6; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Sims HI, 2008, NUCLEIC ACIDS RES, V36, P6118, DOI 10.1093/nar/gkn623; Steger David J., 1996, Bioessays, V18, P875, DOI 10.1002/bies.950181106; TREDE NS, 1995, J IMMUNOL, V155, P902; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; VIRCA GD, 1989, J BIOL CHEM, V264, P21951; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	64	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1259	1271		10.1074/jbc.M109.067330	http://dx.doi.org/10.1074/jbc.M109.067330			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19901031	Green Published, hybrid			2022-12-27	WOS:000273258200048
J	Kawasaki, Y; Jigami, T; Furukawa, S; Sagara, M; Echizen, K; Shibata, Y; Sato, R; Akiyama, T				Kawasaki, Yoshihiro; Jigami, Takafumi; Furukawa, Shiori; Sagara, Masaki; Echizen, Kanae; Shibata, Yoko; Sato, Rina; Akiyama, Tetsu			The Adenomatous Polyposis Coli-associated Guanine Nucleotide Exchange Factor Asef Is Involved in Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR APC; ENDOTHELIAL-CELLS; COLORECTAL-CANCER; GROWTH-FACTOR; ACTIVATION; CDC42; MIGRATION; RAC1; PATHWAY; IDENTIFICATION	Mutation of the tumor suppressor adenomatous polyposis coli (APC) is a key early event in the development of most colorectal tumors. APC promotes degradation of beta-catenin and thereby negatively regulates Wnt signaling, whereas mutated APCs present in colorectal tumor cells are defective in this activity. APC also stimulates the activity of the guanine nucleotide exchange factor Asef and regulates cell morphology and migration. Truncated mutant APCs constitutively activate Asef and induce aberrant migration of colorectal tumor cells. Furthermore, we have recently found that Asef and APC function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinase. We show here that Asef is required for basic fibroblast growth factor-and vascular endothelial growth factor-induced endothelial cell migration. We further demonstrate that Asef is required for basic fibroblast growth factor-and vascular endothelial growth factor-induced microvessel formation. Furthermore, we show that the growth as well as vascularity of subcutaneously implanted tumors are markedly impaired in Asef(-/-) mice compared with wild-type mice. Thus, Asef plays a critical role in tumor angiogenesis and may be a promising target for cancer chemotherapy.	[Kawasaki, Yoshihiro; Jigami, Takafumi; Furukawa, Shiori; Sagara, Masaki; Echizen, Kanae; Shibata, Yoko; Sato, Rina; Akiyama, Tetsu] Univ Tokyo, Lab Mol & Genet Informat, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Akiyama, T (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1130032, Japan.	akiyama@iam.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research on Priority Areas and the Organization for Pharmaceutical Safety and Research and in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; BOUT D, 1981, CELL IMMUNOL, V63, P198, DOI 10.1016/0008-8749(81)90041-1; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kawasaki Y, 2009, J BIOL CHEM, V284, P22436, DOI 10.1074/jbc.M109.020768; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lee SH, 2007, CANCER RES, V67, P11045, DOI 10.1158/0008-5472.CAN-07-0986; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Miao WM, 2001, CANCER RES, V61, P7830; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017	36	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1199	1207		10.1074/jbc.M109.040691	http://dx.doi.org/10.1074/jbc.M109.040691			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19897489	Green Published, hybrid			2022-12-27	WOS:000273258200042
J	Reed, CA; Mayhew, CN; McClendon, AK; Knudsen, ES				Reed, Christopher A.; Mayhew, Christopher N.; McClendon, A. Kathleen; Knudsen, Erik S.			Unique Impact of RB Loss on Hepatic Proliferation TUMORIGENIC STRESSES UNCOVER DISTINCT PATHWAYS OF CELL CYCLE CONTROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; HUMAN HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; GENOME INTEGRITY; DNA-DAMAGE; PROTEINS; CANCER; E2F; TRANSCRIPTION; PATHOGENESIS	The retinoblastoma (RB) tumor suppressor pathway is disrupted at high frequency in hepatocellular carcinoma. However, the mechanisms through which RB modulates physiological responses in the liver remain poorly defined. Despite the well established role of RB in cell cycle control, the deletion of RB had no impact on the kinetics of cell cycle entry or the restoration of quiescence during the course of liver regeneration. Although these findings indicated compensatory effects from the RB-related proteins p107 and p130, even the dual deletion of RB with p107 or p130 failed to deregulate hepatic proliferation. Furthermore, although these findings suggested a modest role for the RB-pathway in the context of proliferative control, RB loss had striking effects on response to the genotoxic hepatocarcinogen diethylnitrosamine. With diethylnitrosamine, RB deletion resulted in inappropriate cell cycle entry that facilitated secondary genetic damage and further uncoupling of DNA replication with mitotic entry. Analysis of the mechanism underlying the differential impact of RB status on liver biology revealed that, while liver regeneration is associated with the conventional induction of cyclin D1 expression, the RB-dependent cell cycle entry, occurring with diethylnitrosamine treatment, was independent of cyclin D1 levels and associated with the specific induction of E2F1. Combined, these studies demonstrate that RB loss has disparate effects on the response to unique tumorigenic stresses, which is reflective of distinct mechanisms of cell cycle entry.	[Knudsen, Erik S.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Mayhew, Christopher N.] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	Jefferson University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org	Mayhew, Christopher N/AGB-4929-2022		National Cancer Institute [CA 104213]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Cancer Institute Grant CA 104213.	ALBRECHT JH, 1995, BIOCHEM BIOPH RES CO, V209, P648, DOI 10.1006/bbrc.1995.1548; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Azechi H, 2001, ONCOLOGY-BASEL, V60, P346, DOI 10.1159/000058531; Bioulac-Sage P, 2003, HEPATOLOGY, V37, P480, DOI 10.1053/jhep.2003.50058; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; DeGregori J, 2006, CURR MOL MED, V6, P739; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; FAN GS, 1995, CELL GROWTH DIFFER, V6, P1463; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2006, CURR MOL MED, V6, P749; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; LAZAREVA MN, 1981, ONCODEV BIOL MED, V2, P89; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; PAULSEN J E, 1990, Chronobiology International, V7, P271, DOI 10.3109/07420529009064632; Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750; Rogoff HA, 2004, CELL CYCLE, V3, P845; Skawran B, 2008, MODERN PATHOL, V21, P1479, DOI 10.1038/modpathol.2008.147; Stevens C, 2003, CELL CYCLE, V2, P435, DOI 10.4161/cc.2.5.462; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; ZHANG X, 1994, CANCER RES, V54, P4177; ZHANG YJ, 1993, BIOCHEM BIOPH RES CO, V196, P1010, DOI 10.1006/bbrc.1993.2350	35	10	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1089	1096		10.1074/jbc.M109.043380	http://dx.doi.org/10.1074/jbc.M109.043380			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19887370	Green Published, hybrid			2022-12-27	WOS:000273258200030
J	Gangolf, M; Wins, P; Thiry, M; El Moualij, B; Bettendorff, L				Gangolf, Marjorie; Wins, Pierre; Thiry, Marc; El Moualij, Benaissa; Bettendorff, Lucien			Thiamine Triphosphate Synthesis in Rat Brain Occurs in Mitochondria and Is Coupled to the Respiratory Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC ADENYLATE KINASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; PHOSPHATE-ESTERS; ADENINE-NUCLEOTIDES; ELECTRIC ORGAN; ELECTROPHORUS-ELECTRICUS; METABOLIZING ENZYMES; ALZHEIMERS-DISEASE; LIVER-MITOCHONDRIA; CHEMICAL-SYNTHESIS	In animals, thiamine deficiency leads to specific brain lesions, generally attributed to decreased levels of thiamine diphosphate, an essential cofactor in brain energy metabolism. However, another far less abundant derivative, thiamine triphosphate (ThTP), may also have a neuronal function. Here, we show that in the rat brain, ThTP is essentially present and synthesized in mitochondria. In mitochondrial preparations from brain (but not liver), ThTP can be produced from thiamine diphosphate and P-i. This endergonic process is coupled to the oxidation of succinate orNADHthrough the respiratory chain but cannot be energized by ATP hydrolysis. ThTP synthesis is strongly inhibited by respiratory chain inhibitors, such as myxothiazol and inhibitors of the H+ channel of F0F1-ATPase. It is also impaired by disruption of the mitochondria or by depolarization of the inner membrane (by protonophores or valinomycin), indicating that a proton-motive force (Delta p) is required. Collapsing Delta p after ThTP synthesis causes its rapid disappearance, suggesting that both synthesis and hydrolysis are catalyzed by a reversible H+-translocating ThTP synthase. The synthesized ThTP can be released from mitochondria in the presence of external P-i. However, ThTP probably does not accumulate in the cytoplasm in vivo, because it is not detected in the cytosolic fraction obtained from a brain homogenate. Our results show for the first time that a high energy triphosphate compound other than ATP can be produced by a chemiosmotic type of mechanism. This might shed a new light on our understanding of the mechanisms of thiamine deficiency-induced brain lesions.	[Gangolf, Marjorie; Wins, Pierre; Thiry, Marc; Bettendorff, Lucien] Univ Liege, GIGA Neurosci B36, B-4000 Liege 1, Sart Tilman, Belgium; [El Moualij, Benaissa] Univ Liege, Dept Human Histol, B-4000 Liege 1, Sart Tilman, Belgium	University of Liege; University of Liege		L.Bettendorff@ulg.ac.be			Fonds de la Recherche Fondamentale Collective; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture	Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the "Fonds de la Recherche Fondamentale Collective" (to F. R. F. C.) and the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (to M. G.).	Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; BARCHI RL, 1972, J BIOL CHEM, V247, P7668; BARILE M, 1990, ARCH BIOCHEM BIOPHYS, V280, P352, DOI 10.1016/0003-9861(90)90341-U; BERGMEYER HU, 1974, METHODEN ENZYMATISCH, P607; BETTENDORFF L, 1993, J MEMBRANE BIOL, V136, P281; BETTENDORFF L, 1991, ANAL BIOCHEM, V198, P52, DOI 10.1016/0003-2697(91)90505-N; BETTENDORFF L, 1993, NEUROSCIENCE, V52, P1009, DOI 10.1016/0306-4522(93)90547-S; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; BETTENDORFF L, 1989, J NEUROCHEM, V53, P738, DOI 10.1111/j.1471-4159.1989.tb11767.x; Bettendorff L, 1996, J NEUROCHEM, V66, P250; Bettendorff L, 1997, J NEUROCHEM, V69, P2005; BETTENDORFF L, 1989, J NEUROCHEM, V53, P80, DOI 10.1111/j.1471-4159.1989.tb07297.x; BETTENDORFF L, 1994, METAB BRAIN DIS, V9, P183, DOI 10.1007/BF01991194; BETTENDORFF L, 1987, J NEUROCHEM, V49, P495, DOI 10.1111/j.1471-4159.1987.tb02891.x; BETTENDORFF L, 1993, J NEUROCHEM, V60, P423, DOI 10.1111/j.1471-4159.1993.tb03168.x; Bettendorff L, 2007, NAT CHEM BIOL, V3, P211, DOI 10.1038/nchembio867; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; Butterworth RF, 2003, NUTR RES REV, V16, P277, DOI 10.1079/NRR200367; Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHERNIKEVICH I P, 1984, Biokhimiya, V49, P899; COOPER JR, 1969, SCIENCE, V164, P74, DOI 10.1126/science.164.3875.74; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Desjardins P, 2005, MOL NEUROBIOL, V31, P17, DOI 10.1385/MN:31:1-3:017; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; ECKERT T, 1964, H-S Z PHYSIOL CHEM, V338, P286, DOI 10.1515/bchm2.1964.338.1-2.286; EDER L, 1980, J NEUROCHEM, V35, P1278, DOI 10.1111/j.1471-4159.1980.tb08999.x; EGI Y, 1986, BIOCHEM INT, V12, P385; ELIASSON SG, 1976, NEUROCHEM RES, V1, P191, DOI 10.1007/BF00966110; Frederich M, 2009, FEBS J, V276, P3256, DOI 10.1111/j.1742-4658.2009.07040.x; Gigliobianco T, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-16; Hazell AS, 2009, ALCOHOL ALCOHOLISM, V44, P141, DOI 10.1093/alcalc/agn120; HILL M, 1987, METHOD ENZYMOL, V148, P132; Hill RL, 1969, METHOD ENZYMOL, V8, P91, DOI 10.1016/0076-6879(69)13021-9; ISHII K, 1979, J NUTR SCI VITAMINOL, V25, P517, DOI 10.3177/jnsv.25.517; ITOKAWA Y, 1970, BIOCHIM BIOPHYS ACTA, V196, P274, DOI 10.1016/0005-2736(70)90015-5; IWATA H, 1988, J CHROMATOGR, V450, P317, DOI 10.1016/S0021-9673(01)83586-X; Ji HF, 2009, EUR J NEUROSCI, V29, P1883, DOI 10.1111/j.1460-9568.2009.06735.x; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Karuppagounder SS, 2009, NEUROBIOL AGING, V30, P1587, DOI 10.1016/j.neurobiolaging.2007.12.013; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2004, J BIOL CHEM, V279, P17142, DOI 10.1074/jbc.M313569200; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; LEVITT B, 1984, ANAL BIOCHEM, V137, P93, DOI 10.1016/0003-2697(84)90352-X; Lindhurst MJ, 2006, P NATL ACAD SCI USA, V103, P15927, DOI 10.1073/pnas.0607661103; Makarchikov AF, 2003, CELL MOL LIFE SCI, V60, P1477, DOI 10.1007/s00018-003-3098-4; MAKARCHIKOV AF, 1992, BIOCHIM BIOPHYS ACTA, V1117, P326, DOI 10.1016/0304-4165(92)90032-P; Makarchikov AF, 2002, BBA-MOL CELL RES, V1592, P117, DOI 10.1016/S0167-4889(02)00277-X; Makarchikov Alexander F., 2007, BMC Biochemistry, V8, P17, DOI 10.1186/1471-2091-8-17; Marobbio CMT, 2002, EMBO J, V21, P5653, DOI 10.1093/emboj/cdf583; Mastrogiacomo F, 1996, ANN NEUROL, V39, P585, DOI 10.1002/ana.410390507; MIYOSHI K, 1990, J BIOCHEM-TOKYO, V108, P267, DOI 10.1093/oxfordjournals.jbchem.a123192; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; NISHINO K, 1983, J BIOL CHEM, V258, P1871; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; REINHART PH, 1982, BIOCHEM J, V204, P731, DOI 10.1042/bj2040731; RINDI G, 1961, BIOCHEM J, V78, P602, DOI 10.1042/bj0780602; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; SHIKATA H, 1989, BIOCHEM INT, V18, P933; SHIODA T, 1991, BIOCHIM BIOPHYS ACTA, V1115, P30, DOI 10.1016/0304-4165(91)90007-4; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Szyniarowski P, 2005, BBA-GEN SUBJECTS, V1725, P93, DOI 10.1016/j.bbagen.2005.05.026; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; VOSKOBOEV A I, 1985, Biokhimiya, V50, P1421	68	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					583	594		10.1074/jbc.M109.054379	http://dx.doi.org/10.1074/jbc.M109.054379			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19906644	hybrid, Green Published			2022-12-27	WOS:000273070100060
J	Serasinghe, MN; Seneviratne, AMPB; Smrcka, AV; Yoon, Y				Serasinghe, Madhavika N.; Seneviratne, A. M. P. B.; Smrcka, Alan V.; Yoon, Yisang			Identification and Characterization of Unique Proline-rich Peptides Binding to the Mitochondrial Fission Protein hFis1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; FUSION; APOPTOSIS; OPA1; FIS1; MORPHOLOGY	Mammalian mitochondrial fission requires at least two proteins, hFis1 and the dynamin-like GTPase DLP1/Drp1. The mitochondrial protein hFis1 is anchored at the outer membrane by a C-terminal transmembrane domain. The cytosolic domain of hFis1 contains six alpha helices [alpha 1-alpha 6] out of which [alpha 2-alpha 5] form tetratricopeptide repeat (TPR)-like motifs. DLP1 and possibly other proteins are thought to interact with the hFis1 TPR region during the fission process. It has also been suggested that the alpha 1-helix regulates protein-protein interactions at the TPR. We performed random peptide phage display screening using the hFis1[alpha 2-alpha 6] as the target and identified ten different peptide sequences. Phage ELISA using mutant hFis1 indicates that the peptide binding requires the alpha 2 and alpha 3 helices and the intact TPR structure. Competition experiments and surface plasmon resonance analyses confirmed that a subset of free peptides enriched with proline residues directly bind to the target. Two of these peptides bind to the alpha 1-containing intact cytosolic domain of hFis1 with decreased affinity. Peptide microinjection into cells abolished the mitochondrial swelling induced by overexpression of alpha 1-deleted hFis1, and significantly decreased cytochrome c release from mitochondria upon apoptotic induction. Our data demonstrate that hFis1 can bind to multiple amino acid sequences selectively, and that the TPR constitutes the main binding region of hFis1, providing a first insight into the hFis1 TPR as a potential therapeutic target.	[Serasinghe, Madhavika N.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Dept Anesthesiol, Rochester, NY 14642 USA; [Serasinghe, Madhavika N.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Seneviratne, A. M. P. B.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Smrcka, Alan V.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Serasinghe, Madhavika N.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Mitochondrial Res & Innovat Grp, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Yoon, Y (corresponding author), 601 Elmwood Ave,Box 604, Rochester, NY 14642 USA.	yisang_yoon@urmc.rochester.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [DK 078618, GM 081772, GM 060286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060286, R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 078618 (to Y. Y.) and GM 081772 and GM 060286 (to A. V. S.).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; Millward SW, 2007, ACS CHEM BIOL, V2, P625, DOI 10.1021/cb7001126; MORRIS RL, 1993, J CELL SCI, V104, P917; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Westermann B, 2003, BBA-MOL CELL RES, V1641, P195, DOI 10.1016/S0167-4889(03)00091-0; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	55	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					620	630		10.1074/jbc.M109.027508	http://dx.doi.org/10.1074/jbc.M109.027508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864424	Green Published, hybrid			2022-12-27	WOS:000273070100063
J	Stanford, KI; Wang, LC; Castagnola, J; Song, DY; Bishop, JR; Brown, JR; Lawrence, R; Bai, XM; Habuchi, H; Tanaka, M; Cardoso, WV; Kimata, K; Esko, JD				Stanford, Kristin I.; Wang, Lianchun; Castagnola, Jan; Song, Danyin; Bishop, Joseph R.; Brown, Jillian R.; Lawrence, Roger; Bai, Xaiomei; Habuchi, Hiroko; Tanaka, Masakazu; Cardoso, Wellington V.; Kimata, Koji; Esko, Jeffrey D.			Heparan Sulfate 2-O-Sulfotransferase Is Required for Triglyceride-rich Lipoprotein Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-RELATED PROTEIN; PROTEOGLYCAN-BINDING-SITE; APOLIPOPROTEIN-E; LDL RECEPTOR; HEPATIC LIPASE; REMNANT LIPOPROTEINS; CHYLOMICRON REMNANTS; MICE LACKING; SUBSTRATE-SPECIFICITY	Hepatic clearance of triglyceride-rich lipoproteins depends on heparan sulfate and low density lipoprotein receptors expressed on the basal membrane of hepatocytes. Binding and uptake of the lipoproteins by way of heparan sulfate depends on the degree of sulfation of the chains based on accumulation of plasma triglycerides and delayed clearance of triglyceride-rich lipoproteins in mice bearing a hepatocyte-specific alteration of N-acetylglucosamine (GlcNAc) N-deacetylase-N-sulfotransferase 1 (Ndst1) (MacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A., Witztum, J. L., and Esko, J. D. (2007) J. Clin. Invest. 117, 153-164). Inactivation of Ndst1 led to decreased overall sulfation of heparan sulfate due to coupling of uronyl 2-O-sulfation and glucosaminyl 6-O-sulfation to initial N-deacetylation and N-sulfation of GlcNAc residues. To determine whether lipoprotein clearance depends on 2-O-and 6-O-sulfation, we evaluated plasma triglyceride levels in mice containing loxP-flanked conditional alleles of uronyl 2-O-sulfotransferase (Hs2st(f/f)) and glucosaminyl 6-O-sulfotransferase-1 (Hs6st1(f/f)) and the bacterial Cre recombinase expressed in hepatocytes from the rat albumin (Alb) promoter. We show that Hs2st(f/f) AlbCre(+) mice accumulated plasma triglycerides and exhibited delayed clearance of intestinally derived chylomicrons and injected human very low density lipoproteins to the same extent as observed in Ndst1(f/f) AlbCre(+) mice. In contrast, Hs6st1(f/f) AlbCre(+) mice did not exhibit any changes in plasma triglycerides. Chemically modified heparins lacking N-sulfate and 2-O-sulfate groups did not block very low density lipoprotein binding and uptake in isolated hepatocytes, whereas heparin lacking 6-O-sulfate groups was as active as unaltered heparin. Our findings show that plasma lipoprotein clearance depends on specific subclasses of sulfate groups and not on overall charge of the chains.	[Stanford, Kristin I.; Wang, Lianchun; Castagnola, Jan; Song, Danyin; Bishop, Joseph R.; Brown, Jillian R.; Lawrence, Roger; Bai, Xaiomei; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Stanford, Kristin I.; Wang, Lianchun; Castagnola, Jan; Song, Danyin; Bishop, Joseph R.; Brown, Jillian R.; Lawrence, Roger; Bai, Xaiomei; Esko, Jeffrey D.] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Stanford, Kristin I.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Habuchi, Hiroko; Tanaka, Masakazu; Kimata, Koji] Aichi Med Univ, Aichi 4801195, Japan; [Cardoso, Wellington V.] Boston Univ, Dept Med, Boston, MA 02118 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Aichi Medical University; Boston University	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jesko@ucsd.edu		Cardoso, Wellington/0000-0002-2550-3697	National Institutes of Health [HL57345, GM33063]; American Heart Association [0735038N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339, P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063, P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL57345 and GM33063 (to J.D.E.). This work was also supported by American Heart Association Grant 0735038N (to J.R.B.).	AlHaideri M, 1997, BIOCHEMISTRY-US, V36, P12766, DOI 10.1021/bi9631024; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BAME KJ, 1991, J BIOL CHEM, V266, P10287; Bazin HG, 2002, BIOCHEMISTRY-US, V41, P8203, DOI 10.1021/bi025817e; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Conrad H. E., 1998, HEPARIN BINDING PROT; Dong J, 2001, BIOCHEMISTRY-US, V40, P2826, DOI 10.1021/bi002417n; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Elson-Schwab L, 2007, J BIOL CHEM, V282, P13585, DOI 10.1074/jbc.M700463200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Flood C, 2002, J BIOL CHEM, V277, P32228, DOI 10.1074/jbc.M204053200; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Goldberg IJ, 1998, J BIOL CHEM, V273, P35355, DOI 10.1074/jbc.273.52.35355; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; HAVEL RJ, 2001, METABOLIC MOL BASES, P2705; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; ISHIHARA M, 1993, GLYCOBIOLOGY, V3, P83, DOI 10.1093/glycob/3.1.83; Izvolsky KI, 2008, GENESIS, V46, P8, DOI 10.1002/dvg.20355; Jakel H, 2006, ANN MED, V38, P2, DOI 10.1080/07853890500407488; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; JI ZS, 1994, J BIOL CHEM, V269, P13421; JI ZS, 1994, J BIOL CHEM, V269, P13429; JI ZS, 1993, J BIOL CHEM, V268, P10160; Ji ZS, 1997, J BIOL CHEM, V272, P31285, DOI 10.1074/jbc.272.50.31285; JI ZS, 1995, J LIPID RES, V36, P583; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; KUSCHE M, 1990, J BIOL CHEM, V265, P15403; LARNKJAER A, 1995, BIOCHEM J, V307, P205, DOI 10.1042/bj3070205; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Libeu CP, 2001, J BIOL CHEM, V276, P39138, DOI 10.1074/jbc.M104746200; Lookene A, 2005, J BIOL CHEM, V280, P25383, DOI 10.1074/jbc.M501589200; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Mahley RW, 1999, J LIPID RES, V40, P1; MERCHANT ZM, 1986, ATHEROSCLEROSIS, V62, P151, DOI 10.1016/0021-9150(86)90061-4; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; MORTIMER BC, 1995, J BIOL CHEM, V270, P28767, DOI 10.1074/jbc.270.48.28767; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Otarod Jila Kaberi, 2004, Curr Atheroscler Rep, V6, P335, DOI 10.1007/s11883-004-0043-4; PARTHASARATHY N, 1994, J BIOL CHEM, V269, P22391; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Sendak RA, 2000, J LIPID RES, V41, P260; Spillmann D, 2006, J BIOL CHEM, V281, P23405, DOI 10.1074/jbc.M604702200; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; VARKI A, 2009, ESSENTIALS GLYCOBIOL, P12; Williams K J, 2001, Methods Mol Biol, V171, P457; Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253; WILLIAMS KJ, 1992, J BIOL CHEM, V267, P13284; Wilsie LC, 2003, J BIOL CHEM, V278, P15758, DOI 10.1074/jbc.M208786200; Windler E, 1996, HEPATOLOGY, V24, P344; YOUNG SG, 1986, CLIN CHEM, V32, P1484; Yu W, 2006, BIOCHEM BIOPH RES CO, V343, P659, DOI 10.1016/j.bbrc.2006.02.175; Zeng BJ, 1998, J LIPID RES, V39, P845	71	65	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					286	294		10.1074/jbc.M109.063701	http://dx.doi.org/10.1074/jbc.M109.063701			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19889634	hybrid, Green Published			2022-12-27	WOS:000273070100030
J	van der Wijst, J; Glaudemans, B; Venselaar, H; Nair, AV; Forst, AL; Hoenderop, JGJ; Bindels, RJM				van der Wijst, Jenny; Glaudemans, Bob; Venselaar, Hanka; Nair, Anil V.; Forst, Anna-Lena; Hoenderop, Joost G. J.; Bindels, Rene J. M.			Functional Analysis of the Kv1.1 N255D Mutation Associated with Autosomal Dominant Hypomagnesemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL GENE; EPISODIC ATAXIA TYPE-1; MAMMALIAN K+ CHANNEL; GATED ION CHANNELS; KCNA1; INACTIVATION; EXPRESSION; DIVERSITY; RESIDUES; EPILEPSY	Mutations in the voltage-gated K+ channel Kv1.1 have been linked with a mixed phenotype of episodic ataxia and/or myokymia. Recently, we presented autosomal dominant hypomagnesemia as a new phenotypic characteristic associated with a mutation in Kv1.1 (N255D) (Glaudemans, B., van der Wijst, J., Scola, R. H., Lorenzoni, P. J., Heister, A., van der Kemp, A. W., Knoers, N.V., Hoenderop, J. G., and Bindels, R. J. (2009) J. Clin. Invest. 119, 936-942). A conserved asparagine at position 255 in the third transmembrane segment was converted into an aspartic acid, resulting in a non-functional channel. In this study, we explored the functional consequence of this conserved residue by substitution with other hydrophobic, polar, or charged amino acids (N255E, N255Q, N255A, N255V, N255T, and N255H). Upon overexpression in human embryonic kidney (HEK293) cells, cell surface biotinylation revealed plasma membrane expression of all mutant channels. Next, we used the whole-cell patch clamp technique to demonstrate that the N255E and N255Q mutants were non-functional. Substitution of Asn-255 with other amino acids (N255A, N255V, N255T, and N255H) did not prevent ion conduction, and these mutant channels activated at more negative potentials when compared with wild-type channels, -41.5 +/- 1.6, -45.5 +/- 2.0, -50.5 +/- 1.9, and -33.8 +/- 1.3 mV to -29.4 +/- 1.1 mV, respectively. The time constant of activation was significantly faster for the two most hydrophobic mutations, N255A (6.2 +/- 0.2 ms) and N255V (5.2 +/- 0.3 ms), and the hydrophilic mutant N255T (9.8 +/- 0.4 ms) in comparison with wild type (13.0 +/- 0.9 ms). Furthermore, the voltage dependence of inactivation was shifted similar to 13 mV to more negative potentials in all mutant channels except for N255H. Taken together, our data showed that an asparagine at position 255 in Kv1.1 is required for normal voltage dependence and kinetics of channel gating.	[van der Wijst, Jenny; Glaudemans, Bob; Nair, Anil V.; Forst, Anna-Lena; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Bindels, RJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, 286 Physiol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	r.bindels@fysiol.umcn.nl	Forst, Anna-Lena/K-1909-2015; van der Wijst, Jenny/D-9726-2016; Hoenderop, Joost G.J./H-8047-2014; Venselaar, Hanka/D-2009-2016; Bindels, René JM/B-9824-2013; van der Wijst, Jenny/T-1620-2019	van der Wijst, Jenny/0000-0002-1547-516X; Hoenderop, Joost G.J./0000-0002-1816-8544; Venselaar, Hanka/0000-0001-9824-6559; Bindels, René JM/0000-0003-1167-1339; van der Wijst, Jenny/0000-0002-1547-516X	Netherlands Organization for Scientific Research [ZonMw 9120.6110, NWO-CW 700.55.302, ZonMw 9120.8026]; European Science Foundation; Dutch Kidney foundation [C03.6017, C08.2252]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Science Foundation(European Science Foundation (ESF)European Commission); Dutch Kidney foundation	This work was supported by grants from the Netherlands Organization for Scientific Research (Grants ZonMw 9120.6110, NWO-CW 700.55.302, and ZonMw 9120.8026), a European Young Investigator award from the European Science Foundation, and the Dutch Kidney foundation (Grants C03.6017 and C08.2252).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen HJ, 2007, NEUROGENETICS, V8, P131, DOI 10.1007/s10048-006-0071-z; Christie MJ, 1995, CLIN EXP PHARMACOL P, V22, P944, DOI 10.1111/j.1440-1681.1995.tb02331.x; Dolly JO, 1996, J BIOENERG BIOMEMBR, V28, P231, DOI 10.1007/BF02110698; Eunson LH, 2000, ANN NEUROL, V48, P647; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Glaudemans B, 2009, J CLIN INVEST, V119, P936, DOI 10.1172/JCI36948; Grottesi A, 2005, CURR BIOL, V15, pR771, DOI 10.1016/j.cub.2005.08.054; Gulbis JM, 2002, NOVART FDN SYMP, V245, P127; Hille B., 2001, ION CHANNELS EXCITAB, P131; Joosten RP, 2009, ACTA CRYSTALLOGR D, V65, P176, DOI 10.1107/S0907444908037591; Klein A, 2004, NEUROPEDIATRICS, V35, P147, DOI 10.1055/s-2004-817921; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lee Hane, 2004, Hum Mutat, V24, P536, DOI 10.1002/humu.9295; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; O'Grady SM, 2005, INT J BIOCHEM CELL B, V37, P1578, DOI 10.1016/j.biocel.2005.04.002; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sands Z, 2005, CURR BIOL, V15, pR44, DOI 10.1016/j.cub.2004.12.050; Shook SJ, 2008, MUSCLE NERVE, V37, P399, DOI 10.1002/mus.20904; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Sokolov MV, 2007, NEUROPHARMACOLOGY, V53, P272, DOI 10.1016/j.neuropharm.2007.05.008; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zerr P, 1998, J NEUROSCI, V18, P2842; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817; [No title captured]	38	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					171	178		10.1074/jbc.M109.041517	http://dx.doi.org/10.1074/jbc.M109.041517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19903818	Green Published, hybrid			2022-12-27	WOS:000273070100018
J	Fernandez-Murray, JP; Gaspard, GJ; Jesch, SA; McMaster, CR				Fernandez-Murray, J. Pedro; Gaspard, Gerard J.; Jesch, Stephen A.; McMaster, Christopher R.			NTE1-encoded Phosphatidylcholine Phospholipase B Regulates Transcription of Phospholipid Biosynthetic Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPATHY TARGET ESTERASE; UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; LIPIN HOMOLOG; FFAT MOTIF; YEAST; EXPRESSION; INOSITOL; CHOLINE	The Saccharomyces cerevisiae NTE1 gene encodes an evolutionarily conserved phospholipase B localized to the endoplasmic reticulum (ER) that degrades phosphatidylcholine (PC) generating glycerophosphocholine and free fatty acids. We show here that the activity of NTE1-encoded phospholipase B (Nte1p) prevents the attenuation of transcription of genes encoding enzymes involved in phospholipid synthesis in response to increased rates of PC synthesis by affecting the nuclear localization of the transcriptional repressor Opi1p. Nte1p activity becomes necessary for cells growing in inositol-free media under conditions of high rates of PC synthesis elicited by the presence of choline at 37 degrees C. The specific choline transporter encoded by the HNM1 gene is necessary for the burst of PC synthesis observed at 37 degrees C as follows: (i) Nte1p is dispensable in an hnm1 Delta strain under these conditions, and (ii) there is a 3-fold increase in the rate of choline transport via the Hnm1p choline transporter upon a shift to 37 degrees C. Overexpression of NTE1 alleviated the inositol auxotrophy of a plethora of mutants, including scs2 Delta, scs3 Delta, ire1 Delta, and hac1 Delta among others. Overexpression of NTE1 sustained phospholipid synthesis gene transcription under conditions that normally repress transcription. This effect was also observed in a strain defective in the activation of free fatty acids for phosphatidic acid synthesis. No changes in the levels of phosphatidic acid were detected under conditions of altered expression of NTE1. Consistent with a synthetic impairment between challenged ER function and inositol deprivation, increased expression of NTE1 improved the growth of cells exposed to tunicamycin in the absence of inositol. We describe a new role for Nte1p toward membrane homeostasis regulating phospholipid synthesis gene transcription. We propose that Nte1p activity, by controlling PC abundance at the ER, affects lateral membrane packing and that this parameter, in turn, impacts the repressing transcriptional activity of Opi1p, the main regulator of phospholipid synthesis gene transcription.	[Fernandez-Murray, J. Pedro; Gaspard, Gerard J.; McMaster, Christopher R.] Dalhousie Univ, Fac Med, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; [Fernandez-Murray, J. Pedro; Gaspard, Gerard J.; McMaster, Christopher R.] Dalhousie Univ, Fac Med, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada; [Jesch, Stephen A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Dalhousie University; Dalhousie University; Cornell University	McMaster, CR (corresponding author), Dalhousie Univ, Fac Med, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	National Institutes of Health [GM019629]; McMaster; Henry laboratories; Canadian Institutes for Health Research [14124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019629, R37GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McMaster; Henry laboratories; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM019629 (to S. Henry supporting the work of S. A. J. and collaborative studies between the McMaster and Henry laboratories). This work was also supported by Canadian Institutes for Health Research Grant 14124 (to C.R.M.).	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Ford J, 2008, BIOCHEM BIOPH RES CO, V373, P602, DOI 10.1016/j.bbrc.2008.06.079; Ford J, 2007, BIOCHEM BIOPH RES CO, V361, P974, DOI 10.1016/j.bbrc.2007.07.109; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Glynn P, 2006, TOXICOL LETT, V162, P94, DOI 10.1016/j.toxlet.2005.10.012; Glynn P, 2005, BBA-MOL CELL BIOL L, V1736, P87, DOI 10.1016/j.bbalip.2005.08.002; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HOSAKA K, 1994, J BIOCHEM-TOKYO, V116, P1317, DOI 10.1093/oxfordjournals.jbchem.a124681; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; KODAKI T, 1995, J BIOCHEM-TOKYO, V117, P362, DOI 10.1093/jb/117.2.362; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; McMaster CR, 2004, TOP CURR GENET, V6, P5; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Newton AC, 2004, TRENDS PHARMACOL SCI, V25, P175, DOI 10.1016/j.tips.2004.02.010; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	60	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36034	36046		10.1074/jbc.M109.063958	http://dx.doi.org/10.1074/jbc.M109.063958			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19841481	Green Published, hybrid			2022-12-27	WOS:000272970500005
J	Li, Y; Santoso, NG; Yu, SQ; Woodward, OM; Qian, F; Guggino, WB				Li, Yun; Santoso, Netty G.; Yu, Shengqiang; Woodward, Owen M.; Qian, Feng; Guggino, William B.			Polycystin-1 Interacts with Inositol 1,4,5-Trisphosphate Receptor to Modulate Intracellular Ca2+ Signaling with Implications for Polycystic Kidney Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; C-TERMINAL FRAGMENT; PKD1 GENE-PRODUCT; FUNCTIONAL POLYCYSTIN-1; EPITHELIAL-CELLS; CALCIUM-RELEASE; MOLECULAR-BASIS; CATION CHANNEL; CYST FORMATION; NUCLEAR-FACTOR	The PKD1 or PKD2 genes encode polycystins (PC) 1 and 2, which are associated with polycystic kidney disease. Previously we demonstrated that PC2 interacts with the inositol 1,4,5-trisphosphate receptor (IP3R) to modulate Ca2+ signaling. Here, we investigate whether PC1 also regulates IP3R. We generated a fragment encoding the last six transmembrane (TM) domains of PC1 and the C-terminal tail (QIF38), a section with the highest homology to PC2. Using a Xenopus oocyte Ca2+ imaging system, we observed that expression of QIF38 significantly reduced the initial amplitude of IP3-induced Ca2+ transients, whereas a mutation lacking the C-terminal tail did not. Thus, the C terminus is essential to QIF38 function. Co-immunoprecipitation assays demonstrated that through its C terminus, QIF38 associates with the IP3-binding domain of IP3R. A shorter PC1 fragment spanning only the last TM and the C-terminal tail also reduced IP3-induced Ca2+ release, whereas another C-terminal fragment lacking any TM domain did not. Thus, only endoplasmic reticulum-localized PC1 can modulate IP3R. Finally, we show that in the polarized Madin-Darby canine kidney cells, heterologous expression of full-length PC1 resulted in a smaller IP3-induced Ca2+ response. Overexpression of the IP3-binding domain of IP3R reversed the inhibitory effect of PC1, suggesting interaction of full-length PC1 (or its cleavage forms) with endogenous IP3R in Madin-Darby canine kidney cells. These results indicate that the behavior of full-length PC1 in mammalian cells is congruent with that of PC1 C-terminal fragments in the oocyte system. These data demonstrate that PC1 inhibits Ca2+ release, perhaps opposing the effect of PC2, which facilitates Ca2+ release through the IP3R.	[Li, Yun; Santoso, Netty G.; Woodward, Owen M.; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Yu, Shengqiang; Qian, Feng] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institutes of Health [5 R01 DK 32753, DK 062199]; Polycystic Kidney Disease Foundation [125a2f]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199, R01DK032753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polycystic Kidney Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 R01 DK 32753 (to W. B. G.) and DK 062199 (to F. Q.). This work was also supported by Polycystic Kidney Disease Foundation Postdoctoral Fellowship Grant 125a2f (to Y. L.).	Aguiari G, 2008, CELL PROLIFERAT, V41, P554, DOI 10.1111/j.1365-2184.2008.00529.x; Aguiari G, 2003, BIOCHEM BIOPH RES CO, V301, P657, DOI 10.1016/S0006-291X(02)03011-5; Ahrabi AK, 2007, J AM SOC NEPHROL, V18, P1740, DOI 10.1681/ASN.2006010052; Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bukanov NO, 2002, HUM MOL GENET, V11, P923, DOI 10.1093/hmg/11.8.923; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Camandola S, 2005, J BIOL CHEM, V280, P22287, DOI 10.1074/jbc.M410923200; Chapman AB, 2007, J AM SOC NEPHROL, V18, P1399, DOI 10.1681/ASN.2007020155; Chernova MN, 2005, KIDNEY INT, V68, P632, DOI 10.1111/j.1523-1755.2005.00441.x; Stokely MY, 2006, J NEUROSCI RES, V84, P1727, DOI 10.1002/jnr.21076; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; Gallagher AR, 2002, CELL MOL LIFE SCI, V59, P682, DOI 10.1007/s00018-002-8457-z; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Grantham JJ, 2003, KIDNEY INT, V64, P1157, DOI 10.1046/j.1523-1755.2003.00242.x; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hooper KM, 2005, AM J PHYSIOL-RENAL, V289, pF521, DOI 10.1152/ajprenal.00355.2004; Huan YH, 1999, J CLIN INVEST, V104, P1459, DOI 10.1172/JCI5111; Ikeda M, 2002, CURR OPIN NEPHROL HY, V11, P539, DOI 10.1097/00041552-200209000-00010; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Kip SN, 2005, CIRC RES, V96, P873, DOI 10.1161/01.RES.0000163278.68142.8a; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; LIn XN, 2005, J BIOL CHEM, V280, P12820, DOI 10.1074/jbc.M411591200; Manzati E, 2005, EXP CELL RES, V304, P391, DOI 10.1016/j.yexcr.2004.10.023; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; Sandford R, 1999, CELL MOL LIFE SCI, V56, P567, DOI 10.1007/s000180050454; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vandorpe DH, 2001, J BIOL CHEM, V276, P4093, DOI 10.1074/jbc.M006252200; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Weston BS, 2003, FEBS LETT, V538, P8, DOI 10.1016/S0014-5793(03)00130-3; Wildman SS, 2003, AM J PHYSIOL-RENAL, V285, pF1168, DOI 10.1152/ajprenal.00171.2003; Wilson PD, 1999, LAB INVEST, V79, P1311; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; YE M, 1993, NEW ENGL J MED, V329, P310, DOI 10.1056/NEJM199307293290503; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zatti A, 2005, MOL BIOL CELL, V16, P5087, DOI 10.1091/mbc.E05-03-0200	61	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36431	36441		10.1074/jbc.M109.068916	http://dx.doi.org/10.1074/jbc.M109.068916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19854836	Green Published, hybrid			2022-12-27	WOS:000272970500045
J	Nagase, Y; Iwasawa, M; Akiyama, T; Kadono, Y; Nakamura, M; Oshima, Y; Yasui, T; Matsumoto, T; Hirose, J; Nakamura, H; Miyamoto, T; Bouillet, P; Nakamura, K; Tanaka, S				Nagase, Yuichi; Iwasawa, Mitsuyasu; Akiyama, Toru; Kadono, Yuho; Nakamura, Masaki; Oshima, Yasushi; Yasui, Tetsuro; Matsumoto, Takumi; Hirose, Jun; Nakamura, Hiroaki; Miyamoto, Takeshi; Bouillet, Philippe; Nakamura, Kozo; Tanaka, Sakae			Anti-apoptotic Molecule Bcl-2 Regulates the Differentiation, Activation, and Survival of Both Osteoblasts and Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC KINASE-ACTIVITY; TARGETED DISRUPTION; SIGNALING PATHWAY; BONE-CELLS; C-SRC; EXPRESSION; FAMILY; DEATH; GENE; OSTEOPETROSIS	The anti-apoptotic molecule Bcl-2 inhibits apoptosis by preventing cytochrome c release from mitochondria. Although several studies have indicated the importance of Bcl-2 in maintaining skeletal integrity, the detailed cellular and molecular mechanisms remain elusive. Bcl-2(-/-) mice are growth-retarded and exhibit increased bone volume of the primary spongiosa, mainly due to the decreased number and dysfunction of osteoclasts. Osteoblast function is also impaired in Bcl-2(-/-) mice. Ex vivo studies on osteoblasts and osteoclasts showed that Bcl-2 promoted the differentiation, activation, and survival of both cell types. Because Bcl-2(-/-) mice die before 6 weeks of age due to renal failure and cannot be compared with adult wild type mice, we generated Bcl-2(-/-)Bim(+/-) mice, in which a single Bim allele was inactivated, and compared them with their Bcl-2(-/-)Bim(+/-) littermates. Loss of a single Bim allele restored normal osteoclast function in Bcl-2(-/-) mice but did not restore the impaired function of osteoblasts, and the mice exhibited osteopenia. These data demonstrate that Bcl-2 promotes the differentiation, activity, and survival of both osteoblasts and osteoclasts. The balance between Bcl-2 and Bim regulates osteoclast apoptosis and function, whereas other pro-apoptotic members are important for osteoblasts.	[Nagase, Yuichi; Iwasawa, Mitsuyasu; Akiyama, Toru; Kadono, Yuho; Nakamura, Masaki; Oshima, Yasushi; Yasui, Tetsuro; Matsumoto, Takumi; Hirose, Jun; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; [Nakamura, Hiroaki] Matsumoto Dent Univ, Dept Histol & Cell Biol, Nagano 3990781, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Bouillet, Philippe] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	University of Tokyo; Matsumoto Dental University; Keio University; Walter & Eliza Hall Institute	Tanaka, S (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	TANAKAS-ORT@h.u-tokyo.ac.jp	Hirose, Jun/AAO-8474-2020; Tanaka, Sakae/Y-3061-2019; Bouillet, Philippe/E-1241-2013; Akiyama, Toru/AAA-5887-2020; Kadono, Yuho/AAO-2405-2020	Tanaka, Sakae/0000-0001-9210-9414; Bouillet, Philippe/0000-0002-9012-6058; Akiyama, Toru/0000-0001-9493-4768; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and health science research grants from the Ministry of Health, Labor, and Welfare of Japan (to S. T.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Boot-Handford RP, 1998, INT J EXP PATHOL, V79, P329, DOI 10.1046/j.1365-2613.1998.790411.x; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kitamura T, 1998, INT J HEMATOL, V67, P351; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mocetti P, 2001, TISSUE CELL, V33, P1, DOI 10.1054/tice.2000.0144; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Okahashi N, 1998, BONE, V23, P33, DOI 10.1016/S8756-3282(98)00069-6; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Yamashita J, 2008, J BONE MINER RES, V23, P621, DOI 10.1359/JBMR.071211; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang W, 2007, CALCIFIED TISSUE INT, V80, P111, DOI 10.1007/s00223-006-0168-2	44	49	54	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36659	36669		10.1074/jbc.M109.016915	http://dx.doi.org/10.1074/jbc.M109.016915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846553	hybrid, Green Published			2022-12-27	WOS:000272970500066
J	Singh, V; Aballay, A				Singh, Varsha; Aballay, Alejandro			Regulation of DAF-16-mediated Innate Immunity in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATA TRANSCRIPTION FACTOR; SIGNALING PATHWAY; C. ELEGANS; LIFE-SPAN; FUNCTIONAL-ANALYSIS; KAPPA-B; DAF-16; STRESS; BACTERIAL; EXPRESSION	Activation of the innate immune system results in a rapid microbicidal response against microorganisms, which needs to be fine-tuned because uncontrolled immune responses can lead to infection and cancer, as well as conditions such as Crohn disease, atherosclerosis, and Alzheimer disease. Here we report that excessive activity of the conserved FOXO transcription factor DAF-16 enhances susceptibility to bacterial infections in Caenorhabditis elegans. We found that increased temperature activates not only DAF-16 nuclear import but also a control mechanism involved in DAF-16 nuclear export. The nuclear export of DAF-16 requires heat shock transcription factor HSF-1 and Hsp70/HSP-1. Furthermore, we show that increased expression of the water channel Aquoporin-1 is responsible for the deleterious consequences of excessive DAF-16-mediated immune response. These studies reveal a stress-inducible mechanism involved in the regulation of DAF-16 and indicate that uncontrolled DAF-16 activity and water homeostasis are a cause of the deleterious effects of excessive immune responses.	[Singh, Varsha; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 268 Jones,Box 3054, Durham, NC 27710 USA.	a.aballay@duke.edu			National Institutes of Health [GM070977]; Whitehead Scholars Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Scholars Program	This work was supported, in whole or in part, by National Institutes of Health Grant GM070977 and The Whitehead Scholars Program ( to A. A.).	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bicego KC, 2002, J APPL PHYSIOL, V93, P512, DOI 10.1152/japplphysiol.00121.2002; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Iser WB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001240; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nikolaidis N, 2004, MOL BIOL EVOL, V21, P498, DOI 10.1093/molbev/msh041; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Snoeks L, 2008, INFECT IMMUN, V76, P4677, DOI 10.1128/IAI.00227-08; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tops BBJ, 2005, NUCLEIC ACIDS RES, V33, P347, DOI 10.1093/nar/gki183; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	41	59	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35580	35587		10.1074/jbc.M109.060905	http://dx.doi.org/10.1074/jbc.M109.060905			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858203	hybrid, Green Published			2022-12-27	WOS:000272645600035
J	Bogan, KL; Evans, C; Belenky, P; Song, P; Burant, CF; Kennedy, R; Brenner, C				Bogan, Katrina L.; Evans, Charles; Belenky, Peter; Song, Peng; Burant, Charles F.; Kennedy, Robert; Brenner, Charles			Identification of Isn1 and Sdt1 as Glucose- and Vitamin-regulated Nicotinamide Mononucleotide and Nicotinic Acid Adenine Dinucleotide 5 '-Nucleotidases Responsible for Production of Nicotinamide Riboside and Nicotinic Acid Riboside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; BIOCHEMICAL GENOMICS APPROACH; CALORIE RESTRICTION; NAD(+); METABOLISM; ACTIVATION; ENCODES; SALVAGE; GENE; BIOSYNTHESIS	Recently, we discovered that nicotinamide riboside and nicotinic acid riboside are biosynthetic precursors of NAD(+), which are utilized through two pathways consisting of distinct enzymes. In addition, we have shown that exogenously supplied nicotinamide riboside is imported into yeast cells by a dedicated transporter, and it extends replicative lifespan on high glucose medium. Here, we show that nicotinamide riboside and nicotinic acid riboside are authentic intracellular metabolites in yeast. Secreted nicotinamide riboside was detected with a biological assay, and intracellular levels of nicotinamide riboside, nicotinic acid riboside, and other NAD(+) metabolites were determined by a liquid chromatography-mass spectrometry method. A biochemical genomic screen indicated that three yeast enzymes possess nicotinamide mononucleotide 5'-nucleotidase activity in vitro. Metabolic profiling of knock-out mutants established that Isn1 and Sdt1 are responsible for production of nicotinamide riboside and nicotinic acid riboside in cells. Isn1, initially classified as an IMP-specific 5'-nucleotidase, and Sdt1, initially classified as a pyrimidine 5'-nucleotidase, area additionally responsible for dephosphorylation of pyridine mononucleotides. Sdt1 overexpression is growth-inhibitory to cells in a manner that depends on its active site and correlates with reduced cellular NAD(+). Expression of Isn1 protein is positively regulated by the availability of nicotinic acid and glucose. These results reveal unanticipated and highly regulated steps in NAD(+) metabolism.	[Bogan, Katrina L.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Bogan, Katrina L.; Belenky, Peter; Brenner, Charles] Dartmouth Med Sch, Biochem Grad Program, Lebanon, NH 03756 USA; [Evans, Charles; Song, Peng; Kennedy, Robert] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Evans, Charles; Burant, Charles F.] Univ Michigan, Michigan Metabol & Obes Ctr, Ann Arbor, MI 48109 USA	University of Iowa; Dartmouth College; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Brenner, C (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, 51 Newton Rd,4-403 BSB, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu	Burant, Charles/GPC-5690-2022; Kennedy, Robert/G-9095-2016; Brenner, Charles/D-6339-2014	Burant, Charles/0000-0001-9189-5003; Kennedy, Robert/0000-0003-2447-7471; Evans, Charles/0000-0001-6698-5330; Brenner, Charles/0000-0002-4955-3226	National Institutes of Health [R37-DK046960, R01-DK079084, T32-DK07245]; National Science Foundation [MCB-0822581]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007245, R37DK046960, R01DK079084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK046960, R01-DK079084, and T32-DK07245 and by National Science Foundation Grant MCB-0822581.	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33056, DOI 10.1074/jbc.M302276200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brachmann CB, 1998, YEAST, V14, P115; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grose JH, 2005, J BACTERIOL, V187, P4521, DOI 10.1128/JB.187.13.4521-4530.2005; HAYAKAWA T, 1984, AGR BIOL CHEM TOKYO, V48, P445, DOI 10.1080/00021369.1984.10866148; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; Hu G, 2007, ARCH BIOCHEM BIOPHYS, V461, P66, DOI 10.1016/j.abb.2007.01.037; Itoh Roichi, 2003, BMC Biochem, V4, P4, DOI 10.1186/1471-2091-4-4; Kurtz JE, 2002, CURR GENET, V41, P132, DOI 10.1007/s00294-002-0296-9; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Phizicky EM, 2002, METHOD ENZYMOL, V350, P546; PREISS J, 1958, J BIOL CHEM, V233, P493; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Suda Y, 2003, YEAST, V20, P995, DOI 10.1002/yea.1008; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	40	41	44	7	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34861	34869		10.1074/jbc.M109.056689	http://dx.doi.org/10.1074/jbc.M109.056689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846558	Green Published, hybrid			2022-12-27	WOS:000272439600041
J	Engel, J; Schmalhorst, PS; Dork-Bousset, T; Ferrieres, V; Routier, FH				Engel, Jakob; Schmalhorst, Philipp S.; Doerk-Bousset, Thilo; Ferrieres, Vincent; Routier, Francoise H.			A Single UDP-galactofuranose Transporter Is Required for Galactofuranosylation in Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE SUGAR TRANSPORTERS; GDP-MANNOSE TRANSPORT; CELL-WALL; GALACTOPYRANOSE MUTASE; ENDOPLASMIC-RETICULUM; GALACTOSE TRANSPORTER; BETA-GALACTOFURANOSE; LEISHMANIA-MAJOR; GENE FAMILY; IDENTIFICATION	Galactofuranose (Galf) containing molecules have been described at the cell surface of several eukaryotes and shown to contribute to the virulence of the parasite Leishmania major and the fungus Aspergillus fumigatus. It is anticipated that a number of the surface glycoconjugates such as N-glycans or glycolipids are galactofuranosylated in the Golgi apparatus. This raises the question of how the substrate for galactofuranosylation reactions, UDP-Galf, which is synthesized in the cytosol, translocates into the organelles of the secretory pathway. Here we report the first identification of a Golgi-localized nucleotide sugar transporter, named GlfB, with specificity for a UDP-Galf. In vitro transport assays established binding of UDP-Galf to GlfB and excluded transport of several other nucleotide sugars. Furthermore, the implication of glfB in the galactofuranosylation of A. fumigatus glycoconjugates and galactomannan was demonstrated by a targeted gene deletion approach. Our data reveal a direct connection between galactomannan and the organelles of the secretory pathway that strongly suggests that the cell wall-bound polysaccharide originates from its glycosylphosphatidylinositol-anchored form.	[Routier, Francoise H.] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Doerk-Bousset, Thilo] Hannover Med Sch, Ctr Biochem & Gynecol, Res Unit, Clin Obstet, D-30625 Hannover, Germany; [Doerk-Bousset, Thilo] Hannover Med Sch, Ctr Biochem & Gynecol, Res Unit, Clin Gynecol, D-30625 Hannover, Germany; [Ferrieres, Vincent] Ecole Natl Super Chim Rennes, CNRS, UMR 6226, CS 50837, F-35708 Rennes 7, France; [Ferrieres, Vincent] Univ Europeenne Bretagne, F-35000 Rennes, France	Hannover Medical School; Hannover Medical School; Hannover Medical School; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Superieure de Chimie de Rennes (ENSCR); Universite de Bretagne Occidentale	Routier, FH (corresponding author), Hannover Med Sch, Inst Cellular Chem, OE 4330,Carl Neuberg Str 1, D-30625 Hannover, Germany.	Routier.Francoise@mh-hannover.de	Routier, Francoise/O-1611-2019; Dörk, Thilo/J-8620-2012; FERRIERES, Vincent/B-4452-2009	Dörk, Thilo/0000-0002-9458-0282; Schmalhorst, Philipp/0000-0002-5795-0133; Routier, Francoise/0000-0002-7163-0590; FERRIERES, Vincent/0000-0002-2780-7774	German Research Foundation (Deutsche Forschungsgemeinschaft); French Research Agency [ANR JCJC06_140075]; Region Bretagne	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); French Research Agency(French National Research Agency (ANR)); Region Bretagne(Region Bretagne)	This work was supported by Graduate School 745 of the German Research Foundation (Deutsche Forschungsgemeinschaft), French Research Agency Grant ANR JCJC06_140075, and the Region Bretagne.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Bakker H, 2005, GLYCOBIOLOGY, V15, P193, DOI 10.1093/glycob/cwh159; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; CAPASSO JM, 1984, BIOCHIM BIOPHYS ACTA, V777, P133, DOI 10.1016/0005-2736(84)90505-4; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; Costachel C, 2005, J BIOL CHEM, V280, P39835, DOI 10.1074/jbc.M510163200; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; DELEDERKREMER RM, 1995, GLYCOBIOLOGY, V5, P547, DOI 10.1093/glycob/5.6.547; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Gao XD, 2001, J BIOL CHEM, V276, P4424, DOI 10.1074/jbc.M009114200; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; GREEN JR, 1983, ISOLATION MEMBRANES, P135; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Kabuss R, 2005, GLYCOBIOLOGY, V15, P905, DOI 10.1093/glycob/cwi085; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Klis F., 2007, BIOL FUNGAL CELL, P97; Knappe S, 2003, PLANT PHYSIOL, V131, P1178, DOI 10.1104/pp.016519; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Krappmann S, 2005, EUKARYOT CELL, V4, P1298, DOI 10.1128/EC.4.7.1298-1307.2005; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Lee R, 1996, ANAL BIOCHEM, V242, P1, DOI 10.1006/abio.1996.0419; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; LORD JM, 1973, J CELL BIOL, V57, P659, DOI 10.1083/jcb.57.3.659; Marino K, 2005, EUR J ORG CHEM, V2005, P2958; Marlow AL, 2001, ORG LETT, V3, P2517, DOI 10.1021/ol016170d; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Muraoka M, 2007, J BIOL CHEM, V282, P24615, DOI 10.1074/jbc.M611358200; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishikawa A, 2002, YEAST, V19, P691, DOI 10.1002/yea.854; Nishikawa A, 2002, J BACTERIOL, V184, P29, DOI 10.1128/JB.184.1.29-42.2002; Novelli JF, 2009, DEV BIOL, V335, P340, DOI 10.1016/j.ydbio.2009.09.010; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; Peltier P, 2007, ORG LETT, V9, P5227, DOI 10.1021/ol702392x; Peltier P, 2008, EUR J ORG CHEM, V2008, P5988, DOI 10.1002/ejoc.200800742; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; PUNT PJ, 1992, METHOD ENZYMOL, V216, P447; Record E, 1998, CAN J MICROBIOL, V44, P945, DOI 10.1139/cjm-44-10-945; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Rollwitz I, 2006, FEBS LETT, V580, P4246, DOI 10.1016/j.febslet.2006.06.082; Roy SK, 2000, J BIOL CHEM, V275, P13580, DOI 10.1074/jbc.275.18.13580; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schmidt M, 2004, MICROBIOL-SGM, V150, P3253, DOI 10.1099/mic.0.27197-0; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Segawa H, 2005, J BIOL CHEM, V280, P2028, DOI 10.1074/jbc.M404915200; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; Suzuki E, 1997, GLYCOBIOLOGY, V7, P463, DOI 10.1093/glycob/7.4.463; Tiralongo J, 2006, GLYCOBIOLOGY, V16, P73, DOI 10.1093/glycob/cwj029; Toledo MS, 2007, J LIPID RES, V48, P1801, DOI 10.1194/jlr.M700149-JLR200; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang K, 2004, MOL BIOCHEM PARASIT, V136, P11, DOI 10.1016/j.molbiopara.2004.02.012; Zhou H, 2007, EUKARYOT CELL, V6, P2260, DOI 10.1128/EC.00261-07	69	44	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33859	33868		10.1074/jbc.M109.070219	http://dx.doi.org/10.1074/jbc.M109.070219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19840949	Green Published, hybrid			2022-12-27	WOS:000272165200018
J	Tao, Z; Zhang, YW; Agyiri, A; Rudnick, G				Tao, Zhen; Zhang, Yuan-Wei; Agyiri, Alice; Rudnick, Gary			Ligand Effects on Cross-linking Support a Conformational Mechanism for Serotonin Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; TRANSMEMBRANE DOMAIN-I; BACTERIAL HOMOLOG; ESCHERICHIA-COLI; PERMEATION PATHWAY; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; RESIDUES; COCAINE; BINDING	Serotonin transporter (SERT) is responsible for the re-uptake of 5-hydroxytryptamine (5-HT) from the synaptic cleft after release from serotonergic neurons. We show here that cysteine residues at positions in transmembranes 1 and 3 of SERT, like the corresponding positions in the gamma-aminobutyric acid transporter, can be cross-linked using copper(II)(1,10-phenanthroline) 3. The presence of a cross-link was detected by a novel methionine mutagenesis strategy. A change in mobility for an N-terminal cyanogen bromide fragment accompanied disulfide cross-linking of the two cysteine residues. Cross-linking also inhibited transport, and this process was blocked by cocaine, which is expected to stabilize SERT in conformations where the two positions are separated, but cocaine did not decrease accessibility of either of the two cysteines to modification by 2-aminoethyl methanethiosulfonate. Cysteine was required at both positions on the same molecule for efficient cross-linking, indicating that the reaction was intramolecular.	[Tao, Zhen; Zhang, Yuan-Wei; Agyiri, Alice; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Rudnick, G (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu		ZHANG, YUAN-WEI/0000-0002-4276-9251	National Institutes of Health through the National Institute on Drug Abuse [DA007259]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007259, R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health through the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA007259 through the National Institute on Drug Abuse.	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Barker EL, 1999, J NEUROSCI, V19, P4705; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; GALLAGHER S, 2003, CURRENT PROTOCOLS PR, P1; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaiser R, 1999, ANAL BIOCHEM, V266, P1, DOI 10.1006/abio.1998.2945; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MITCHELL P, 1990, RES MICROBIOL, V141, P286, DOI 10.1016/0923-2508(90)90002-8; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P11959, DOI 10.1021/bi971172k; URSITTI JA, 2001, CURRENT PROTOCOLS PR, P1; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	34	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33807	33814		10.1074/jbc.M109.071977	http://dx.doi.org/10.1074/jbc.M109.071977			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837674	hybrid, Green Published			2022-12-27	WOS:000272165200012
J	Noguchi, TQP; Gomibuchi, Y; Murakami, K; Ueno, H; Hirose, K; Wakabayashi, T; Uyeda, TQP				Noguchi, Taro Q. P.; Gomibuchi, Yuki; Murakami, Kenji; Ueno, Hironori; Hirose, Keiko; Wakabayashi, Takeyuki; Uyeda, Taro Q. P.			Dominant Negative Mutant Actins Identified in Flightless Drosophila Can Be Classified into Three Classes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; HYDROPHOBIC LOOP 262-274; RABBIT SKELETAL-MUSCLE; IN-VITRO MOTILITY; YEAST ACTIN; F-ACTIN; THIN-FILAMENTS; CROSS-LINKING; TROPOMYOSIN-BINDING; DICTYOSTELIUM ACTIN	Strongly dominant negative mutant actins, identified by An and Mogami (An, H. S., and Mogami, K. (1996) J. Mol. Biol. 260, 492-505), in the indirect flight muscle of Drosophila impaired its flight, even when three copies of the wild-type gene were present. Understanding how these strongly dominant negative mutant actins disrupt the function of wild-type actin would provide useful information about the molecular mechanism by which actin functions in vivo. Here, we expressed and purified six of these strongly dominant negative mutant actins in Dictyostelium and classified them into three groups based on their biochemical phenotypes. The first group, G156D, G156S, and G268D actins, showed impaired polymerization and a tendency to aggregate under conditions favoring polymerization. G63D actin of the second group was also unable to polymerize but, unlike those in the first group, remained soluble under polymerizing conditions. Kinetic analyses using G63D actin or G63D actin gelsolin complexes suggested that the pointed end surface is defective, which would alter the polymerization kinetics of wild-type actin when mixed and could affect formation of thin filament structures in indirect flight muscle. The third group, R95C and E226K actins, was normal in terms of polymerization, but their motility on heavy meromyosin surfaces in the presence of tropomyosin-troponin indicated altered sensitivity to Ca2+. Cofilaments in which R95C or E226K actins were copolymerized with a 3-fold excess of wild-type actin also showed altered Ca2+ sensitivity in the presence of tropomyosin-troponin.	[Noguchi, Taro Q. P.; Ueno, Hironori; Hirose, Keiko; Uyeda, Taro Q. P.] AIST, Res Inst Cell Engn, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Noguchi, Taro Q. P.; Hirose, Keiko; Uyeda, Taro Q. P.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Gomibuchi, Yuki; Murakami, Kenji; Wakabayashi, Takeyuki] Teikyo Univ, Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Teikyo University; National Institute of Advanced Industrial Science & Technology (AIST)	Uyeda, TQP (corresponding author), AIST, Res Inst Cell Engn, Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	t-uyeda@aist.go.jp	Hirose, Keiko/M-5429-2018	Hirose, Keiko/0000-0003-4587-8346	Ministry of Science, Culture, Sports, and Technology	Ministry of Science, Culture, Sports, and Technology	This work was supported in part by grants-in-aid for scientific research from the Ministry of Science, Culture, Sports, and Technology (to T. U. and T. N.).	An HS, 1996, J MOL BIOL, V260, P492, DOI 10.1006/jmbi.1996.0417; ANSON M, 1995, BIOPHYS J, V68, P1991, DOI 10.1016/S0006-3495(95)80376-0; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Cammarato A, 2005, J MOL BIOL, V347, P889, DOI 10.1016/j.jmb.2005.02.022; CARLIER MF, 1992, PHILOS T R SOC B, V336, P93, DOI 10.1098/rstb.1992.0048; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; COOK RK, 1992, J BIOL CHEM, V267, P9430; DOI Y, 1984, J BIOL CHEM, V259, P1868; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; HARRIS DA, 1981, P NATL ACAD SCI-BIOL, V78, P6798, DOI 10.1073/pnas.78.11.6798; Hegyi G, 2006, FEBS J, V273, P1896, DOI 10.1111/j.1742-4658.2006.05197.x; HIROMI Y, 1986, CELL, V44, P293, DOI 10.1016/0092-8674(86)90763-4; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; JOHANNES FJ, 1991, EMBO J, V10, P3951, DOI 10.1002/j.1460-2075.1991.tb04965.x; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; JOHNSON P, 1978, BIOCHEM BIOPH RES CO, V82, P1013, DOI 10.1016/0006-291X(78)90884-7; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; KURTH MC, 1983, J BIOL CHEM, V258, P895; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; MILLER CJ, 1995, BIOCHEMISTRY-US, V34, P2694, DOI 10.1021/bi00008a037; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; MURRAY JM, 1982, METHOD ENZYMOL, V85, P15; Nagasaki A, 2004, MOL BIOL CELL, V15, P435, DOI 10.1091/mbc.E03-05-0329; Nagasaki A, 2008, EXP CELL RES, V314, P1136, DOI 10.1016/j.yexcr.2007.12.002; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Oosawa F., 1972, COLD SPRING HARB SYM, V37, P277; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; PRINGLE JWS, 1981, J EXP BIOL, V94, P1; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; SHORTLE D, 1982, SCIENCE, V217, P371, DOI 10.1126/science.7046050; Shvetsov A, 2002, BIOCHEMISTRY-US, V41, P10787, DOI 10.1021/bi020205f; Shvetsov A, 2008, J MOL BIOL, V375, P793, DOI 10.1016/j.jmb.2007.10.076; SOLOMON TL, 1988, J BIOL CHEM, V263, P19662; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WANG LL, 1981, CELL, V25, P637, DOI 10.1016/0092-8674(81)90171-9; WERTMAN KF, 1992, GENETICS, V132, P337; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200	57	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4337	4347		10.1074/jbc.M109.059881	http://dx.doi.org/10.1074/jbc.M109.059881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19933578	hybrid, Green Published			2022-12-27	WOS:000275274800010
J	Lidke, DS; Huang, F; Post, JN; Rieger, B; Wilsbacher, J; Thomas, JL; Pouyssegur, J; Jovin, TM; Lenormand, P				Lidke, Diane S.; Huang, Fang; Post, Janine N.; Rieger, Bernd; Wilsbacher, Julie; Thomas, James L.; Pouyssegur, Jacques; Jovin, Thomas M.; Lenormand, Philippe			ERK Nuclear Translocation Is Dimerization-independent but Controlled by the Rate of Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; EFFECTOR DOMAIN PROTEIN; MAP KINASE; NUCLEOCYTOPLASMIC TRANSPORT; LIVING CELLS; LOCALIZATION; MECHANISM; PEA-15	Upon activation, ERKs translocate from the cytoplasm to the nucleus. This process is required for the induction of many cellular responses, yet the molecular mechanisms that regulate ERK nuclear translocation are not fully understood. We have used a mouse embryo fibroblast ERK1-knock-out cell line expressing green fluorescent protein (GFP)-tagged ERK1 to probe the spatio-temporal regulation of ERK1. Real time fluorescence microscopy and fluorescence correlation spectroscopy revealed that ERK1 nuclear accumulation increased upon serum stimulation, but the mobility of the protein in the nucleus and cytoplasm remained unchanged. Dimerization of ERK has been proposed as a requirement for nuclear translocation. However, ERK1-Delta 4, the mutant shown consistently to be dimerization-deficient in vitro, accumulated in the nucleus to the same level as wild type (WT), indicating that dimerization of ERK1 is not required for nuclear entry and retention. Consistent with this finding, energy migration Forster resonance energy transfer and fluorescence correlation spectroscopy measurements in living cells did not detect dimerization of GFP-ERK1-WT upon activation. In contrast, the kinetics of nuclear accumulation and phosphorylation of GFP-ERK1-Delta 4 were slower than that of GFP-ERK1-WT. These results indicate that the differential shuttling behavior of the mutant is a consequence of delayed phosphorylation of ERK by MEK rather than dimerization. Our data demonstrate for the first time that a delay in cytoplasmic activation of ERK is directly translated into a delay in nuclear translocation.	[Pouyssegur, Jacques; Lenormand, Philippe] Univ Nice, CNRS, UMR6543, Inst Dev Biol & Canc,Ctr A Lacassagne, F-06189 Nice, France; [Jovin, Thomas M.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany; [Huang, Fang; Thomas, James L.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Wilsbacher, Julie] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75235 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Max Planck Society; University of New Mexico; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lenormand, P (corresponding author), Univ Nice, CNRS, UMR6543, Inst Dev Biol & Canc,Ctr A Lacassagne, F-06189 Nice, France.	Philippe.LENORMAND@unice.fr	Lenormand, Philippe/N-5996-2018; Post, Janine N./E-9983-2011	Post, Janine N./0000-0002-6645-6583	European Union FP5 Project [QLRT-2000-02278]; CNRS, Centre A. Lacassagne, Association pour la Recherche sur le Cancer [3338]; American Cancer Society [IRG 192]; National Institutes of Health [DK34128]; Army Research Office [W911NF0510464]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016918, S10RR019287, S10RR014668, P20RR011830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034128, R37DK034128] Funding Source: NIH RePORTER	European Union FP5 Project; CNRS, Centre A. Lacassagne, Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerCentre National de la Recherche Scientifique (CNRS)); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by European Union FP5 Project QLRT-2000-02278 (MAP Kinase) (to T. M. J. and J. P.), the CNRS, Centre A. Lacassagne, Association pour la Recherche sur le Cancer Contract 3338, and American Cancer Society Grant IRG 192 (to D. S. L.). This work was supported in part by National Institutes of Health Grant DK34128 (to J. W.).; Supported by the Army Research Office Grant W911NF0510464.; Supported by a predoctoral fellowship from the Howard Hughes Medical Institute. Present address: Cancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Rd., Abbott Park, IL 60064.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P560; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Dittrich P, 2001, BIOL CHEM, V382, P491, DOI 10.1515/BC.2001.061; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Furuno T, 2001, J IMMUNOL, V166, P4416, DOI 10.4049/jimmunol.166.7.4416; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; HAUPTS U, 1995, P NATL ACAD SCI USA, V92, P3834, DOI 10.1073/pnas.92.9.3834; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Philipova R, 2005, J CELL SCI, V118, P5767, DOI 10.1242/jcs.02683; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; SCHNEIDER MB, 1981, APPL OPTICS, V20, P1382, DOI 10.1364/AO.20.001382; Sur R, 2005, BIOCHEM J, V387, P315, DOI 10.1042/BJ20041713; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Volmat V, 2001, J CELL SCI, V114, P3433; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Widengren J, 1998, CELL MOL BIOL, V44, P857; Wilsbacher JL, 2006, BIOCHEMISTRY-US, V45, P13175, DOI 10.1021/bi061041w; Wolf I, 2001, J BIOL CHEM, V276, P24490, DOI 10.1074/jbc.M103352200; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	50	79	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5							3092	10.1074/jbc.M109.064972	http://dx.doi.org/10.1074/jbc.M109.064972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19920141	Green Published, hybrid			2022-12-27	WOS:000273829000025
J	Kahlfeldt, N; Vahedi-Faridi, A; Koo, SJ; Schafer, JG; Krainer, G; Keller, S; Saenger, W; Krauss, M; Haucke, V				Kahlfeldt, Nina; Vahedi-Faridi, Ardeschir; Koo, Seong Joo; Schaefer, Johannes G.; Krainer, Georg; Keller, Sandro; Saenger, Wolfram; Krauss, Michael; Haucke, Volker			Molecular Basis for Association of PIPKI gamma-p90 with Clathrin Adaptor AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; ENDOCYTIC SORTING ADAPTER; GAMMA; CARGO; AP2; COMPLEX; BINDING; PHOSPHORYLATION; RECOGNITION; MOTIFS	Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) is an essential determinant in clathrin-mediated endocytosis (CME). In mammals three type I phosphatidylinositol-4-phosphate 5-kinase (PIPK) enzymes are expressed, with the I gamma-p90 isoform being highly expressed in the brain where it regulates synaptic vesicle (SV) exo-/endocytosis at nerve terminals. How precisely PI(4,5)P-2 metabolism is controlled spatially and temporally is still uncertain, but recent data indicate that direct interactions between type I PIPK and components of the endocytic machinery, in particular the AP-2 adaptor complex, are involved. Here we demonstrated that PIPKI gamma-p90 associates with both the mu and beta 2 subunits of AP-2 via multiple sites. Crystallographic data show that a peptide derived from the splice insert of the human PIPKI gamma-p90 tail binds to a cognate recognition site on the sandwich subdomain of the beta 2 appendage. Partly overlapping aromatic and hydrophobic residues within the same peptide also can engage the C-terminal sorting signal binding domain of AP-2 mu, thereby potentially competing with the sorting of conventional YXXempty set motif-containing cargo. Biochemical and structure-based mutagenesis analysis revealed that association of the tail domain of PIPKI gamma-p90 with AP-2 involves both of these sites. Accordingly the ability of overexpressed PIPKI gamma tail to impair endocytosis of SVs in primary neurons largely depends on its association with AP-2 beta and AP-2 mu. Our data also suggest that interactions between AP-2 and the tail domain of PIPKI gamma-p90 may serve to regulate complex formation and enzymatic activity. We postulate a model according to which multiple interactions between PIPKI gamma-p90 and AP-2 lead to spatiotemporally controlled PI(4,5)P-2 synthesis during clathrin-mediated SV endocytosis.	[Kahlfeldt, Nina; Vahedi-Faridi, Ardeschir; Koo, Seong Joo; Schaefer, Johannes G.; Krainer, Georg; Saenger, Wolfram; Krauss, Michael; Haucke, Volker] Free Univ Berlin, Inst Chem & Biochem, Dept Membrane Biochem, D-14195 Berlin, Germany; [Kahlfeldt, Nina; Vahedi-Faridi, Ardeschir; Koo, Seong Joo; Schaefer, Johannes G.; Krainer, Georg; Saenger, Wolfram; Krauss, Michael; Haucke, Volker] Free Univ Berlin, Dept Prot Crystallog, D-14195 Berlin, Germany; [Haucke, Volker] Charite, D-14195 Berlin, Germany; [Krainer, Georg; Keller, Sandro; Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Free University of Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Krauss, M (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Dept Membrane Biochem, Takustr 6, D-14195 Berlin, Germany.	mkrauss@chemie.fu-berlin.de; volker.haucke@fu-berlin.de	Keller, Sandro/G-7202-2016; Krainer, Georg/AAW-4764-2020; Keller, Sandro/T-3487-2019	Keller, Sandro/0000-0001-5469-8772; Krainer, Georg/0000-0002-9626-7636; Keller, Sandro/0000-0001-5469-8772; Krauss, Michael/0000-0003-1010-9723; Haucke, Volker/0000-0003-3119-6993	German Research Foundation (DFG) [HA2686/2-1, HA2686/2-2]; Exc 257-Neurocure;  [FG 806];  [SFB 449];  [TP A11];  [TP Z3]	German Research Foundation (DFG)(German Research Foundation (DFG)); Exc 257-Neurocure; ; ; ; 	This work was supported by German Research Foundation (DFG) Grants HA2686/2-1, -/2-2, and FG 806 (to V. H.), SFB 449: TP A11 (to V. H.), TP Z3 (to W. S.), and Exc 257-Neurocure.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; GALLI T, 2004, SCI STKE, pRE19; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jung N, 2007, J CELL BIOL, V179, P1497, DOI 10.1083/jcb.200708107; Jung N, 2007, TRAFFIC, V8, P1129, DOI 10.1111/j.1600-0854.2007.00595.x; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kittler JT, 2008, P NATL ACAD SCI USA, V105, P3616, DOI 10.1073/pnas.0707920105; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; McPherson PS, 2005, MOL NEUROBIOL, V32, P73, DOI 10.1385/MN:32:1:073; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1	42	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2734	2749		10.1074/jbc.M109.074906	http://dx.doi.org/10.1074/jbc.M109.074906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19903820	Green Published			2022-12-27	WOS:000273697800051
J	Olmo, VN; Grote, E				Olmo, Valerie N.; Grote, Eric			Prm1 Functions as a Disulfide-linked Complex in Yeast Mating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE FUSION; CELL-CELL FUSION; INFLUENZA HEMAGGLUTININ; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN; GLYCOPROTEIN-120; HEMIFUSION; TRIMERS; ELEGANS	Prm1 is a pheromone-induced membrane glycoprotein that promotes plasma membrane fusion in yeast mating pairs. HA-Prm1 migrates at twice its expected molecular weight on non-reducing SDS-PAGE gels and coprecipitates with Prm1-TAP, indicating that Prm1 is a disulfide-linked homodimer. The N terminus of a plasma membrane-localized GFP-Prm1 endocytic mutant projects into the cytoplasm, where it is protected from low pH quenching in live cells and from external protease in spheroplasts. In a revised topological map, Prm1 has four transmembrane domains and two large extracellular loops. Mutation of all four cysteines in the extracellular loops blocked disulfide bond formation and destabilized the Prm1 homodimer without preventing Prm1 transport to contact sites in mating pairs. Cys(120) in loop 1 and Cys(545) in loop 2 form disulfide cross-links in the Prm1 homodimer and are required for fusion activity. Cys(120) lies between a hydrophobic segment formerly thought to be a transmembrane domain and an amphipathic helix. An interaction between either of these regions and the opposing membrane could promote fusion.	[Olmo, Valerie N.; Grote, Eric] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Grote, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	egrote@jhsph.edu			American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Research Scholar award from the American Cancer Society (to E. G.).	Aguilar PS, 2007, MOL BIOL CELL, V18, P547, DOI 10.1091/mbc.E06-09-0776; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Chatterjee I, 2005, DEVELOPMENT, V132, P2795, DOI 10.1242/dev.01868; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Heiman MG, 2007, J CELL BIOL, V176, P209, DOI 10.1083/jcb.200609182; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jin H, 2004, EUKARYOT CELL, V3, P1664, DOI 10.1128/EC.3.6.1664-1673.2004; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Leikina E, 2000, MOL BIOL CELL, V11, P2359, DOI 10.1091/mbc.11.7.2359; Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433; Markovic I, 1998, J CELL BIOL, V143, P1155, DOI 10.1083/jcb.143.5.1155; Muller EM, 2003, J BIOL CHEM, V278, P38461, DOI 10.1074/jbc.M304089200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nolan S, 2006, MOL BIOL CELL, V17, P2439, DOI 10.1091/mbc.E05-11-1015; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rickman C, 2005, BIOCHEM J, V388, P75, DOI 10.1042/BJ20041818; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Singh M, 1999, J MOL BIOL, V290, P1031, DOI 10.1006/jmbi.1999.2796; Tang HY, 2004, CURR PROTOC PROTEIN; Ydenberg Casey A., 2008, V475, P3, DOI 10.1007/978-1-59745-250-2_1; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177	38	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2284	2293		10.1074/jbc.M109.068874	http://dx.doi.org/10.1074/jbc.M109.068874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19933274	Green Published, hybrid			2022-12-27	WOS:000273697800007
J	Thomas, RM; Chen, CX; Chunder, N; Ma, LZ; Taylor, J; Pearce, EJ; Wells, AD				Thomas, Rajan M.; Chen, Chunxia; Chunder, Neelanjana; Ma, Lingzhi; Taylor, Justin; Pearce, Edward J.; Wells, Andrew D.			Ikaros Silences T-bet Expression and Interferon-gamma Production during T Helper 2 Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR; HISTONE ACETYLATION; REGULATORY ELEMENTS; LINEAGE COMMITMENT; GENE-EXPRESSION; PROMOTER; REPRESSION; GATA-3; LYMPHOCYTES	CD4+ T cells can be instructed by nonantigen-specific signals to differentiate into functionally distinct lineages with mutually exclusive patterns of cytokine production. The molecular events that drive interferon-gamma (IFN gamma) production during Th1 development are well understood, but mechanisms that silence this cytokine during Th2 polarization are not clear. In this study, we find that the tbx21 gene encoding the Th1 master regulator T-bet is a direct target of the transcriptional repressor Ikaros. In Th2 cells, which do not express T-bet, strong Ikaros binding could be detected at the endogenous tbx21 promoter, whereas this gene was not occupied by Ikaros in T-bet-expressing Th1 cells. Inhibition of Ikaros DNA binding activity during Th2 polarization resulted in loss of Ikaros promoter occupancy, increased T-bet expression, and inappropriate T-bet-dependent production of IFN gamma. Ikaros was also required for epigenetic imprinting of the ifn gamma locus during Th2 polarization, and loss of Ikaros function in vivo led to an inappropriate Th1 response to the parasite Shistosoma mansoni. These studies demonstrate that Ikaros, a factor with an established role in lymphocyte development, also regulates the development of peripheral T helper responses.	[Thomas, Rajan M.; Chen, Chunxia; Chunder, Neelanjana; Ma, Lingzhi; Wells, Andrew D.] Univ Penn, Sch Vet Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Thomas, Rajan M.; Chen, Chunxia; Chunder, Neelanjana; Ma, Lingzhi; Wells, Andrew D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Taylor, Justin; Pearce, Edward J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Wells, AD (corresponding author), Univ Penn, Sch Vet Med, Childrens Hosp Philadelphia, 916E Abramson Res Ctr,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu	Thomas, Rajan M/AAW-7207-2021		National Institutes of Health [AI070807, AI059881, AI032573, AI053825]; Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070807, R56AI032573, R01AI032573, R21AI059881, R01AI053825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070807 (to A. W.), AI059881 (to A. W.), AI032573 (to E. P.), and AI053825 (to E. P.) and by the Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kaminuma O, 2004, FEBS LETT, V570, P63, DOI 10.1016/j.febslet.2004.06.026; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winders BR, 2004, J IMMUNOL, V173, P7377, DOI 10.4049/jimmunol.173.12.7377	33	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2010	285	4					2545	2553		10.1074/jbc.M109.038794	http://dx.doi.org/10.1074/jbc.M109.038794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	544YP	19923223	hybrid, Green Published			2022-12-27	WOS:000273697800033
J	Brown, CR; Dunton, D; Chiang, HL				Brown, C. Randell; Dunton, Danielle; Chiang, Hui-Ling			The Vacuole Import and Degradation Pathway Utilizes Early Steps of Endocytosis and Actin Polymerization to Deliver Cargo Proteins to the Vacuole for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; HEAT-SHOCK-PROTEIN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MOLECULAR MACHINERY; ENDOSOME FUNCTION; TARGETING SIGNAL; SELECTIVE UPTAKE; VID VESICLES; AMINO-ACIDS	When glucose is added to yeast cells that are starved for 3 days, fructose-1,6-bisphosphatase (FBPase) and malate dehydrogenase 2 are degraded in the vacuole via the vacuole import and degradation (Vid) pathway. In this study, we examined the distribution of FBPase at the ultrastructural level. FBPase was observed in areas close to the plasma membrane and in cytoplasmic structures that are heterogeneous in size and density. We have isolated these intracellular structures that contain FBPase, the Vid vesicle marker Vid24p, and the endosomal marker Pep12p. They appeared irregular in size and shape. In yeast, actin polymerization plays an important role in early steps of endocytosis. Mutants that affect actin polymerization inhibited FBPase degradation, suggesting that actin polymerization is important for FBPase degradation. Both FBPase and malate dehydrogenase 2 were associated with actin patches. Vid vesicle proteins such as Vid24p or Sec28p were also at actin patches, although they dissociated from these structures at later time points. We propose that Vid24p and Sec28p are present at actin patches during glucose starvation. Cargo proteins arrive at these sites following the addition of glucose, and the endocytic vesicles then pinch off from the plasma membrane. Following the fusion of endosomes with the vacuole, cargo proteins are then degraded in the vacuole.	[Brown, C. Randell; Dunton, Danielle; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	hlchiang@psu.edu			National Institutes of Health [R01 GM 59480]; Pennsylvania Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 59480 (to H.-L.C.). This work was also supported by a grant from the Pennsylvania Tobacco Settlement Fund (to H.-L.C.). S The on-line version of this article (availableat http://www.jbc.org) contains supplemental Fig. S1.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Dewar H, 2002, MOL BIOL CELL, V13, P3646, DOI 10.1091/mbc.E02-05-0262; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hoffman M, 1996, GENETICS, V143, P1555; Howard JP, 2002, J CELL BIOL, V157, P315, DOI 10.1083/jcb.200110027; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; JONES EW, 1991, J BIOL CHEM, V266, P7963; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; MORTIMORE GE, 1983, P NATL ACAD SCI-BIOL, V80, P2179, DOI 10.1073/pnas.80.8.2179; MORTIMORE GE, 1973, BIOCHEM BIOPH RES CO, V54, P89, DOI 10.1016/0006-291X(73)90892-9; NEELY AN, 1977, J BIOL CHEM, V252, P6948; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Seglen P O, 1990, Semin Cell Biol, V1, P441; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; TUTTLE DL, 1995, J CELL SCI, V108, P25; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Warren DT, 2002, J CELL SCI, V115, P1703; WHITNEY JA, 1995, CELL, V83, P703; Wieland F, 1999, CURR OPIN CELL BIOL, V11, P440, DOI 10.1016/S0955-0674(99)80063-5; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	65	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1516	1528		10.1074/jbc.M109.028241	http://dx.doi.org/10.1074/jbc.M109.028241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19892709	Green Published, hybrid			2022-12-27	WOS:000273258200071
J	Gao, WT; Kang, JH; Liao, Y; Ding, WX; Gambotto, AA; Watkins, SC; Liu, YJ; Stolz, DB; Yin, XM				Gao, Wentao; Kang, Jeong Han; Liao, Yong; Ding, Wen-Xing; Gambotto, Andrea A.; Watkins, Simon C.; Liu, Yong-Jian; Stolz, Donna B.; Yin, Xiao-Ming			Biochemical Isolation and Characterization of the Tubulovesicular LC3-positive Autophagosomal Compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; ENDOPLASMIC-RETICULUM; ENDOCYTIC PATHWAYS; PROTEIN; MEMBRANE; VACUOLES; MACROAUTOPHAGY; MATURATION; YEAST; ATG9	Autophagosomes and their precursors are best defined by electron microscopy but may also be traced in living cells based on the distribution of specific autophagy molecules. LC3, the most commonly examined autophagy marker in mammalian cells, labels structures that are frequently manifested as dots or rings using light microscopy; however, the nature of these structures is not entirely clear. We reported here a novel approach to examine the LC3-positive compartment in cell-free lysates, which revealed that they were actually tubulovesicular structures with considerable heterogeneity. Using affinity purification, we isolated these membranes for electron microscopy, which indicated that they possessed ultrastructural features consistent with autophagosomal membranes at various maturation stages. Further biochemical and proteomics analyses demonstrated the presence of multiple autophagy-related and other functional molecules. The different distribution patterns of Atg5, Atg16, Atg9, and p62/SQSTM1 on the LC3-positive compartment provided new clues on how these molecules might be involved in the dynamics of the autophagosomal membranes. Finally, several morphologically unique groups of LC3-positive membranes were categorized. Their topological configurations suggested that double-membrane vesicles could be derived from single membrane compartments via different means, including tubule-to-vesicle conversion, whose presence was supported by live cell imaging. These findings thus provide new information on the dynamics of the autophagosomal compartment.	[Yin, Xiao-Ming] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Gambotto, Andrea A.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA; [Watkins, Simon C.; Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Liu, Yong-Jian] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yin, XM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA.	xmyin@pitt.edu	Kang, Jeong-Han/J-3541-2019; Liu, Yongjian/J-7852-2018; Watkins, Simon/ABG-2590-2021	Kang, Jeong-Han/0000-0002-9693-0696; Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [CA111456, CA83817, NS058463]; NATIONAL CANCER INSTITUTE [R01CA111456, R01CA083817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA111456 and CA83817 (to X.M.Y.) and NS058463 (to Y.J.L.).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fengsrud M, 2004, AUTOPHAGY, P11; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; He CC, 2008, MOL BIOL CELL, V19, P5506, DOI 10.1091/mbc.E08-05-0544; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JH, 2006, PROTEOMICS, V6, P1261, DOI 10.1002/pmic.200500290; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Overbye A, 2007, AUTOPHAGY, V3, P300, DOI 10.4161/auto.3910; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602; Zheng JY, 1998, J CELL SCI, V111, P1061	46	69	73	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1371	1383		10.1074/jbc.M109.054197	http://dx.doi.org/10.1074/jbc.M109.054197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19910472	hybrid, Green Published			2022-12-27	WOS:000273258200057
J	Cracan, V; Padovani, D; Banerjee, R				Cracan, Valentin; Padovani, Dominique; Banerjee, Ruma			IcmF Is a Fusion between the Radical B-12 Enzyme Isobutyryl-CoA Mutase and Its G-protein Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-CINNAMONENSIS; ESCHERICHIA-COLI; BUTYRIVIBRIO-FIBRISOLVENS; INSERTIONAL INACTIVATION; GEOBACILLUS-KAUSTOPHILUS; RECOMBINANT ENZYME; GENE FUSION; COENZYME; DEHYDROGENASE; CLONING	Coenzyme B-12 is used by two highly similar radical enzymes, which catalyze carbon skeleton rearrangements, methylmalonyl-CoA mutase and isobutyryl-CoA mutase (ICM). ICM catalyzes the reversible interconversion of isobutyryl-CoA and n-butyryl-CoA and exists as a heterotetramer. In this study, we have identified >70 bacterial proteins, which represent fusions between the subunits of ICM and a P-loop GTPase and are currently misannotated as methylmalonyl-CoA mutases. Wedesignate this fusion protein as IcmF (isobutyryl-CoA mutase fused). All IcmFs are composed of the following three domains: the N-terminal 5'-deoxyadenosylcobalamin binding region that is homologous to the small subunit of ICM (IcmB), a middle P-loop GTPase domain, and a C-terminal part that is homologous to the large subunit of ICM (IcmA). The P-loop GTPase domain has very high sequence similarity to the Methylobacterium extorquens MeaB, which is a chaperone for methylmalonyl-CoA mutase. We have demonstrated that IcmF is an active ICM by cloning, expressing, and purifying the IcmFs from Geobacillus kaustophilus, Nocardia farcinica, and Burkholderia xenovorans. This finding expands the known distribution of ICM activity well beyond the genus Streptomyces, where it is involved in polyketides biosynthesis, and suggests a role for this enzyme in novel bacterial pathways for amino acid degradation, myxalamid biosynthesis, and acetyl-CoA assimilation.	[Cracan, Valentin; Padovani, Dominique; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), 3220B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801; Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776.	Akopiants K, 2006, J IND MICROBIOL BIOT, V33, P141, DOI 10.1007/s10295-005-0029-4; Alber BE, 2008, J BACTERIOL, V190, P1383, DOI 10.1128/JB.01593-07; Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Asanuma N, 2005, CURR MICROBIOL, V51, P91, DOI 10.1007/s00284-005-4477-x; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; BANERJEE R, 1999, METHYLMALONYL COA MU, P707; BECKER DF, 1993, BIOCHEMISTRY-US, V32, P10736, DOI 10.1021/bi00091a026; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; BIRCH A, 1993, J BACTERIOL, V175, P3511, DOI 10.1128/jb.175.11.3511-3519.1993; Bode HB, 2007, CHEMBIOCHEM, V8, P2139, DOI 10.1002/cbic.200700401; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GERTH K, 1983, J ANTIBIOT, V36, P1150, DOI 10.7164/antibiotics.36.1150; HOLLOWAY DE, 1994, J BIOL CHEM, V269, P20425; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; MILLER TL, 1979, J BACTERIOL, V138, P99, DOI 10.1128/JB.138.1.99-104.1979; Montoro-Garcia S, 2009, J BACTERIOL, V191, P3076, DOI 10.1128/JB.01060-08; Muller RH, 2008, MICROBIOL-SGM, V154, P1414, DOI 10.1099/mic.0.2007/014159-0; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; TAOKA S, 1994, J BIOL CHEM, V269, P31630; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Zambelli B, 2007, BIOCHEMISTRY-US, V46, P3171, DOI 10.1021/bi6024676; Zerbe-Burkhardt K, 1998, J BIOL CHEM, V273, P6508, DOI 10.1074/jbc.273.11.6508; ZERBEBURKHARDT K, 1998, CHEM BIOCH B12, P859	41	24	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					655	666		10.1074/jbc.M109.062182	http://dx.doi.org/10.1074/jbc.M109.062182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864421	Green Published, hybrid			2022-12-27	WOS:000273070100066
J	Martin, C; Gomez-Bilbao, G; Ostolaza, H				Martin, Cesar; Gomez-Bilbao, Geraxane; Ostolaza, Helena			Bordetella Adenylate Cyclase Toxin Promotes Calcium Entry into Both CD11b(+) and CD11b(-) Cells through cAMP-dependent L-type-like Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS LEUKOTOXIN; PASTEURELLA-HAEMOLYTICA LEUKOTOXIN; ESCHERICHIA-COLI; TARGET-CELLS; INTRACELLULAR CALCIUM; SIGNAL-TRANSDUCTION; LIPID MICRODOMAINS; EPITHELIAL-CELLS; ALPHA-HEMOLYSIN; PERTUSSIS	Adenylate cyclase toxin (ACT), a 200 kDa protein, is an essential virulence factor for Bordetella pertussis, the bacterium that causes whooping cough. ACT is a member of the pore-forming RTX(repeats-in-toxin) family of proteins that share a characteristic calcium-binding motif of Gly- and Asp-rich nonapeptide repeats and a marked cytolytic or cytotoxic activity. In addition, ACT exhibits a distinctive feature: it has an N-terminal calmodulin-dependent adenylate cyclase domain. Translocation of this domain into the host cytoplasm results in uncontrolled production of cAMP, and it has classically been assumed that this surge in cAMP is the basis for the toxin-mediated killing. Several members of the RTX family of toxins, including ACT, have been shown to induce intracellular calcium increases, through different mechanisms. We show here that ACT stimulates a raft-mediated calcium influx, through its cAMP production activity, that activates PKA, which in turn activates calcium channels with L-type properties. This process is shown to occur both in CD11b(+) and CD11b(-) cells, suggesting a common mechanism, independent of the toxin receptor. We also show that this ACT-induced calcium influx does not correlate with the toxin-induced cytotoxicity.	[Ostolaza, Helena] Univ Basque Country, Ctr Mixto, CSIC, Unidad Biofis,EHU, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Ostolaza, H (corresponding author), Univ Basque Country, Ctr Mixto, CSIC, Unidad Biofis,EHU, Aptdo 644, E-48080 Bilbao, Spain.	gbzoseth@lg.ehu.es	martin, cesar/L-1303-2014	martin, cesar/0000-0002-4087-8729; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975	Spanish Ministerio de Ciencia y Tecnologia [BFU 2007-62062]; Basque Government; University of Basque Country [UE06/10]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government(Basque Government); University of Basque Country	This work was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (Project BFU 2007-62062), the Basque Government (ETORTEK Program), and the University of Basque Country (UPV/EHU, Project UE06/10).	Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Bassinet L, 2004, INFECT IMMUN, V72, P5530, DOI 10.1128/IAI.72.9.5530-5533.2004; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1994, J BIOL CHEM, V269, P27231; Bergmeyer HU., 1974, METHODS ENZYMATIC AN, P574, DOI [10.1016/B978-0-12-091302-2.50010-4, DOI 10.1016/B978-0-12-091302-2.50010-4]; Berridge MJ, 2004, BBA-MOL CELL RES, V1742, P3, DOI 10.1016/j.bbamcr.2004.08.012; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Colucci A, 2009, ARCH BIOCHEM BIOPHYS, V481, P80, DOI 10.1016/j.abb.2008.10.002; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; Cudd L, 1999, FEMS MICROBIOL LETT, V172, P123, DOI 10.1111/j.1574-6968.1999.tb13459.x; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; Gao ZY, 2002, BIOCHEM J, V368, P397, DOI 10.1042/BJ20020999; GERBIG DG, 1989, VET MICROBIOL, V19, P325, DOI 10.1016/0378-1135(89)90098-9; Giorgi C, 2008, CURR MOL MED, V8, P119; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Grafton G, 2003, BIOCHEM PHARMACOL, V66, P2001, DOI 10.1016/j.bcp.2003.07.005; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HANSKI E, 1985, J BIOL CHEM, V260, P5526; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; Hsuan SL, 1998, INFECT IMMUN, V66, P2836, DOI 10.1128/IAI.66.6.2836-2844.1998; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; IWASWE M, 1992, J LEUKOCYTE BIOL, V52, P224, DOI 10.1002/jlb.52.2.224; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Okazaki R, 2009, INT HEART J, V50, P353, DOI 10.1536/ihj.50.353; ORTIZCARRANZA O, 1992, J LEUKOCYTE BIOL, V52, P558, DOI 10.1002/jlb.52.5.558; OTERO AS, 1995, J BIOL CHEM, V270, P9695, DOI 10.1074/jbc.270.17.9695; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Philipova R, 2005, J BIOL CHEM, V280, P24957, DOI 10.1074/jbc.M414437200; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rhodes CR, 2001, ARCH BIOCHEM BIOPHYS, V395, P169, DOI 10.1006/abbi.2001.2553; SHENKER BJ, 1994, J LEUKOCYTE BIOL, V55, P153, DOI 10.1002/jlb.55.2.153; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; SZABO G, 1994, J BIOL CHEM, V269, P22496; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538	54	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					357	364		10.1074/jbc.M109.003491	http://dx.doi.org/10.1074/jbc.M109.003491			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875442	Green Published, hybrid			2022-12-27	WOS:000273070100037
J	Pruessmeyer, J; Martin, C; Hess, FM; Schwarz, N; Schmidt, S; Kogel, T; Hoettecke, N; Schmidt, B; Sechi, A; Uhlig, S; Ludwig, A				Pruessmeyer, Jessica; Martin, Christian; Hess, Franz M.; Schwarz, Nicole; Schmidt, Sven; Kogel, Tanja; Hoettecke, Nicole; Schmidt, Boris; Sechi, Antonio; Uhlig, Stefan; Ludwig, Andreas			A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and-4 by Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; TNF-ALPHA; TRANSMEMBRANE CHEMOKINES; SOLUBLE SYNDECAN-1; REGULATED RELEASE; GROWTH-FACTOR; ADHESION; MATRIX; ECTODOMAINS; MIGRATION	Syndecans are cell surface proteoglycans that bind and modulate various proinflammatory mediators and can be proteolytically shed from the cell surface. Within the lung, syndecan-1 and -4 are expressed as transmembrane proteins on epithelial cells and released in the bronchoalveolar fluid during inflammation. We here characterize the mechanism leading to the generation of soluble syndecan-1 and -4 in cultured epithelial cells and murine lung tissue. We show that the bladder carcinoma epithelial cell line ECV304, the lung epithelial cell line A459 and primary alveolar epithelial cells express and constitutively release syndecan-1 and -4. This release involves the activity of the disintegrin-like metalloproteinase ADAM17 as demonstrated by use of specific inhibitors and lentivirally transduced shRNA. Stimulation of epithelial cells with PMA, thrombin, or proinflammatory cytokines (TNF alpha/IFN gamma) led to the down-regulation of surface-expressed syndecan-1 and -4, which was associated with a significant increase of soluble syndecans and cell-associated cleavage fragments. The enhanced syndecan release was not related to gene induction of syndecans or ADAM17, but rather due to increased ADAM17 activity. Soluble syndecan-1 and -4 were also released into the bronchoalveolar fluid of mice. Treatment with TNF alpha/IFN gamma increased ADAM17 activity and syndecan release in murine lungs. Both constitutive and induced syndecan shedding was prevented by the ADAM17 inhibitor. ADAM17 may therefore be an important regulator of syndecan functions on inflamed lung epithelium.	[Pruessmeyer, Jessica; Martin, Christian; Hess, Franz M.; Schwarz, Nicole; Schmidt, Sven; Kogel, Tanja; Uhlig, Stefan; Ludwig, Andreas] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, D-52074 Aachen, Germany; [Pruessmeyer, Jessica; Kogel, Tanja; Ludwig, Andreas] Rhein Westfal TH Aachen, Fac Med, Interdisciplinary Ctr Clin Res Biomat, D-52074 Aachen, Germany; [Hoettecke, Nicole; Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, D-64287 Darmstadt, Germany; [Sechi, Antonio] Rhein Westfal TH Aachen, Fac Med, Inst Biomed Engn, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University; Technical University of Darmstadt; RWTH Aachen University	Ludwig, A (corresponding author), Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Pauwelsstr 30, D-52074 Aachen, Germany.	aludwig@ukaachen.de	Ludwig, Andreas/I-5685-2012; Schmidt, Boris/D-3293-2009; Schwarz, Nicole/ABC-8096-2020; Sechi, Antonio S/A-5595-2009; Uhlig, Stefan/A-7290-2014; Schmidt, Boris/M-7886-2019	Ludwig, Andreas/0000-0001-8536-4986; Schmidt, Boris/0000-0003-1662-2392; Sechi, Antonio S/0000-0002-1374-1794; Uhlig, Stefan/0000-0003-2332-1280; Schmidt, Boris/0000-0003-1662-2392; Schwarz, Nicole/0000-0001-7888-6970	RWTH Aachen;  [SFB 542]	RWTH Aachen; 	This work was supported in part by IZKF BioMAT of the RWTH Aachen and by SFB 542 Projects A12 and C16.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Bartlett AH, 2007, MOL CELLS, V24, P153; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Black RA, 2003, BIOCHEM SOC SYMP, V70, P39, DOI 10.1042/bss0700039; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; DE SB, 1999, NATURE, V398, P518; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Hasegawa M, 2007, RESPIROLOGY, V12, P140, DOI 10.1111/j.1440-1843.2006.00967.x; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Held HD, 2000, AM J RESP CRIT CARE, V162, P1547, DOI 10.1164/ajrccm.162.4.9912079; Holen I, 2001, BRIT J HAEMATOL, V114, P414, DOI 10.1046/j.1365-2141.2001.02963.x; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Joensuu H, 2002, CANCER RES, V62, P5210; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Seidel C, 2000, BLOOD, V95, P388, DOI 10.1182/blood.V95.2.388; Su G, 2008, CANCER RES, V68, P9558, DOI 10.1158/0008-5472.CAN-08-1645; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Zhang YH, 2004, INT IMMUNOPHARMACOL, V4, P1845, DOI 10.1016/j.intimp.2004.08.003	39	120	124	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					555	564		10.1074/jbc.M109.059394	http://dx.doi.org/10.1074/jbc.M109.059394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875451	hybrid, Green Published			2022-12-27	WOS:000273070100057
J	Wang, P; Wu, F; Ma, YP; Li, L; Lai, R; Young, LC				Wang, Peng; Wu, Fang; Ma, Yupo; Li, Liang; Lai, Raymond; Young, Leah C.			Functional Characterization of the Kinase Activation Loop in Nucleophosmin (NPM)-Anaplastic Lymphoma Kinase (ALK) Using Tandem Affinity Purification and Liquid Chromatography-Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NPM-ALK; ANAPLASTIC LYMPHOMA; TYROSINE KINASE; PROTEIN; IDENTIFICATION; DIGESTION; DOMAIN; GENE; PHOSPHORYLATION; FUSION	Previous studies have shown that the kinase activation loop (KAL) of the oncogenic fusion protein NPM-ALK regulates its overall tyrosine phosphorylation status and tumorigenicity. Using tandem affinity purification-mass spectrometry, we assessed how the KAL of NPM-ALK regulates the phosphorylation status of its individual tyrosines. Using the lysates of GP293 cells transfected with NPM-ALK, our highly reproducible results showed evidence of phosphorylation in all 3 tyrosines in KAL and 8 tyrosines outside KAL. We created 7 KAL mutants, each of which carried a Tyr-to-Phe mutation of >= 1 of the 3 tyrosines in KAL. A complete loss of the 8 phosphotyrosines outside KAL was found in 3 KAL mutants, and their oncogenicity (assessed by cell viability, colony formation, and the ability to phosphorylate effector proteins) was abrogated. A partial loss of the 8 phosphotyrosines was found in 4 KAL mutants, but their oncogenicity did not show simple correlation with the number of residual phosphotyrosines. Tyr-to-Phe mutations of each of the 8 phosphotyrosines outside KAL did not result in a significant decrease in the oncogenicity. In conclusion, we have provided details of how the KAL in NPM-ALK regulates its tyrosine phosphorylation pattern. Our results challenge some of the current concepts regarding the relationship between the tyrosine phosphorylation and oncogenicity of NPM-ALK.	[Lai, Raymond] Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Wu, Fang; Li, Liang] Univ Alberta, Dept Chem, Edmonton, AB T6G 2Z2, Canada; [Ma, Yupo] Nevada Canc Inst, Div Lab Med, Las Vegas, NV 89135 USA	University of Alberta; University of Alberta; University of California System; University of California San Diego	Lai, R (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada.	rlai@ualberta.ca	Young, Leah/AAN-3579-2020; Young, Leah C/B-9051-2012; Li, Liang/D-1822-2011	Young, Leah C/0000-0001-7156-1006; 	Canadian Institutes of Health Research; Alberta Cancer Research Institute; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research and the Alberta Cancer Research Institute (to R. L.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chairs Program (to L. L.).	Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bard JD, 2008, LEUKEMIA, V22, P1595, DOI 10.1038/leu.2008.129; Boccalatte FE, 2009, BLOOD, V113, P2776, DOI 10.1182/blood-2008-06-161018; Delsol G, 2001, WHO CLASSIFICATION T, P230; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Doucette A, 2003, J AM SOC MASS SPECTR, V14, P203, DOI 10.1016/S1044-0305(02)00909-1; Doucette A, 2000, ANAL CHEM, V72, P3355, DOI 10.1021/ac000176j; Falini B, 2007, HAEMATOLOGICA, V92, P519, DOI 10.3324/haematol.11007; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Kaiser Peter, 2008, V439, P309, DOI 10.1007/978-1-59745-188-8_21; Leventaki V, 2007, BLOOD, V110, P1621, DOI 10.1182/blood-2006-11-059451; LEVINE BA, 1991, J BIOL CHEM, V266, P3565; Marzec M, 2007, ONCOGENE, V26, P5606, DOI 10.1038/sj.onc.1210346; Marzec M, 2007, ONCOGENE, V26, P813, DOI 10.1038/sj.onc.1209843; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Slupianek A, 2004, EXP HEMATOL, V32, P1265, DOI 10.1016/j.exphem.2004.11.002; Slupianek A, 2001, CANCER RES, V61, P2194; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tartari CJ, 2008, J BIOL CHEM, V283, P3743, DOI 10.1074/jbc.M706067200; Turner SD, 2007, CELL SIGNAL, V19, P740, DOI 10.1016/j.cellsig.2006.09.007; Wan WH, 2006, BLOOD, V107, P1617, DOI 10.1182/blood-2005-08-3254; Wang N, 2008, ANAL CHEM, V80, P4696, DOI 10.1021/ac800260w; Wang N, 2007, J PROTEOME RES, V6, P263, DOI 10.1021/pr060367o; Wang P, 2009, J PROTEOME RES, V8, P3403, DOI 10.1021/pr9000477; Wu F, 2009, AM J PATHOL, V174, P361, DOI 10.2353/ajpath.2009.080521; ZHANG B, 1991, J BIOL CHEM, V266, P990	31	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					95	103		10.1074/jbc.M109.059758	http://dx.doi.org/10.1074/jbc.M109.059758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887368	Green Published, hybrid			2022-12-27	WOS:000273070100010
J	Zhao, CX; Matveeva, EA; Ren, QS; Whiteheart, SW				Zhao, Chunxia; Matveeva, Elena A.; Ren, Qiansheng; Whiteheart, Sidney W.			Dissecting the N-Ethylmaleimide-sensitive Factor REQUIRED ELEMENTS OF THE N AND D1 DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE FTSH; AAA PLUS PROTEINS; CRYSTAL-STRUCTURE; FUSION PROTEIN; ATPASE ACTIVITY; CONFORMATIONAL-CHANGES; TERMINAL DOMAIN; IN-VIVO; P97/VALOSIN-CONTAINING PROTEIN; CONSERVED ARGININE	N-Ethylmaleimide-sensitive factor (NSF) is a homo-hexameric member of the AAA(+) (ATPases associated with various cellular activities plus) family. It plays an essential role in most intracellular membrane trafficking through its binding to and disassembly of soluble NSF attachment protein (SNAP) receptor (SNARE) complexes. Each NSF protomer contains an N-terminal domain (NSF-N) and two AAA domains, a catalytic NSF-D1 and a structural NSF-D2. This study presents detailed mutagenesis analyses of NSF-N and NSF-D1, dissecting their roles in ATP hydrolysis, SNAP.SNARE binding, and complex disassembly. Our results show that a positively charged surface on NSF-N, bounded by Arg(67) and Lys(105), and the conserved residues in the central pore of NSF-D1 (Tyr(296) and Gly(298)) are involved in SNAP.SNARE binding but not basal ATP hydrolysis. Mutagenesis of Sensor 1 (Thr(373)-Arg(375)), Sensor 2 (Glu(440)-Glu(442)), and Arginine Fingers (Arg(385) and Arg(388)) in NSF-D1 shows that each region plays a discrete role. Sensor 1 is important for basal ATPase activity and nucleotide binding. Sensor 2 plays a role in ATP-and SNAP-dependent SNARE complex binding and disassembly but does so in cis and not through inter-protomer interactions. Arginine Fingers are important for SNAP.SNARE complex-stimulated ATPase activity and complex disassembly. Mutants at these residues have a dominant-negative phenotype in cells, suggesting that Arginine Fingers function in trans via inter-protomer interactions. Taken together, these data establish functional roles for many of the structural elements of the N domain and of the D1 ATP-binding site of NSF.	[Zhao, Chunxia; Matveeva, Elena A.; Ren, Qiansheng; Whiteheart, Sidney W.] Univ Kentucky, Med Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Whiteheart, SW (corresponding author), 741 S Limestone,BBSRB B261, Lexington, KY 40536 USA.	whitehe@uky.edu		Whiteheart, Sidney/0000-0001-5577-0473	National Institutes of Health [NS046242]; American Heart Association Predoctoral Fellowship [065238B]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant NS046242 (to S. W. W.). This work was also supported by a Steckler award (to C. Z.) and American Heart Association Predoctoral Fellowship 065238B (to Q. R.).	Aker J, 2007, PLANT PHYSIOL, V145, P339, DOI 10.1104/pp.107.103986; Babor SM, 1999, P NATL ACAD SCI USA, V96, P14759, DOI 10.1073/pnas.96.26.14759; Barnard RJO, 1996, MOL BIOL CELL, V7, P693, DOI 10.1091/mbc.7.5.693; Besche H, 2004, FEBS LETT, V574, P161, DOI 10.1016/j.febslet.2004.08.021; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Haynes LP, 1998, FEBS LETT, V436, P1, DOI 10.1016/S0014-5793(98)01088-6; Hishida T, 2004, P NATL ACAD SCI USA, V101, P9573, DOI 10.1073/pnas.0403584101; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; Horsnell WGC, 2002, BIOCHEMISTRY-US, V41, P5230, DOI 10.1021/bi0160359; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Inoue M, 2008, TRAFFIC, V9, P2180, DOI 10.1111/j.1600-0854.2008.00831.x; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li CS, 2006, ARCH BIOCHEM BIOPHYS, V450, P176, DOI 10.1016/j.abb.2006.04.002; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Matveeva EA, 2002, BIOCHEMISTRY-US, V41, P530, DOI 10.1021/bi015632s; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Rothballer A, 2007, FEBS LETT, V581, P1197, DOI 10.1016/j.febslet.2007.02.031; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schumacher J, 2007, J BIOL CHEM, V282, P9825, DOI 10.1074/jbc.M611532200; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shiozawa K, 2006, FEBS J, V273, P4959, DOI 10.1111/j.1742-4658.2006.05494.x; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Steel GJ, 2000, MOL BIOL CELL, V11, P1345, DOI 10.1091/mbc.11.4.1345; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Takahashi N, 2002, J BIOL CHEM, V277, P16033, DOI 10.1074/jbc.M108615200; Takehara M, 2008, BIOCHEM J, V413, P535, DOI 10.1042/BJ20070484; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	70	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					761	772		10.1074/jbc.M109.056739	http://dx.doi.org/10.1074/jbc.M109.056739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19887446	Green Published, hybrid			2022-12-27	WOS:000273070100077
J	Bienert, R; Rombach-Riegraf, V; Diez, M; Graber, P				Bienert, Roland; Rombach-Riegraf, Verena; Diez, Manuel; Graeber, Peter			Subunit Movements in Single Membrane-bound H+-ATP Synthases from Chloroplasts during ATP Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NUCLEOTIDE-BINDING-SITES; COUPLING FACTOR-I; GAMMA-SUBUNIT; COVALENT MODIFICATION; ESCHERICHIA-COLI; F-ATPASE; CONFORMATIONAL-CHANGES; MOLECULE FLUORESCENCE; CATALYTIC SITES	Subunit movements within the H+-ATP synthase from chloroplasts (CF0F1) are investigated during ATP synthesis. The gamma-subunit (gamma Cys-322) is covalently labeled with a fluorescence donor (ATTO532). A fluorescence acceptor (adenosine 5'-(beta,gamma-imino) triphosphate (AMPPNP)-ATTO665) is noncovalently bound to a noncatalytic site at one alpha-subunit. The labeled CF0F1 is integrated into liposomes, and a transmembrane pH difference is generated by an acid base transition. Single-pair fluorescence resonance energy transfer is measured in freely diffusing proteoliposomes with a confocal two-channel microscope. The fluorescence time traces reveal a repetitive three-step rotation of the gamma-subunit relative to the alpha-subunit during ATP synthesis. Some traces show splitting into sublevels with fluctuations between the sublevels. During catalysis the central stalk interacts, with equal probability, with each alpha beta-pair. Without catalysis the central stalk interacts with only one specific alpha beta-pair, and no stepping between FRET levels is observed. Two inactive states of the enzyme are identified: one in the presence of AMPPNP and one in the presence of ADP.	[Graeber, Peter] Univ Freiburg, Inst Phys Chem, Dept Phys Chem, D-79104 Freiburg, Germany	University of Freiburg	Graber, P (corresponding author), Univ Freiburg, Inst Phys Chem, Dept Phys Chem, Albertstr 23A, D-79104 Freiburg, Germany.	peter.graeber@physchem.uni-freiburg.de						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Borsch M, 1998, FEBS LETT, V437, P251, DOI 10.1016/S0014-5793(98)01247-2; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; Bottcher B, 2000, J MOL BIOL, V296, P449, DOI 10.1006/jmbi.1999.3435; BOTTCHER B, 2008, PHOTOSYNTHETIC PROTE, P201; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BRUIST MF, 1981, BIOCHEMISTRY-US, V20, P6298, DOI 10.1021/bi00525a003; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRABER P, 1977, BIOCHIM BIOPHYS ACTA, V461, P426, DOI 10.1016/0005-2728(77)90231-6; Gumbiowski K, 2001, J BIOL CHEM, V276, P42287, DOI 10.1074/jbc.M106884200; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; MAGDE D, 1979, J PHYS CHEM-US, V83, P696, DOI 10.1021/j100469a012; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; Mellwig C, 2003, J BIOL CHEM, V278, P18544, DOI 10.1074/jbc.M212852200; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Possmayer FE, 2000, BBA-BIOENERGETICS, V1459, P202, DOI 10.1016/S0005-2728(00)00148-1; Possmayer FE, 2000, BBA-BIOENERGETICS, V1456, P77, DOI 10.1016/S0005-2728(99)00106-1; Possmayer FE, 2001, BBA-BIOMEMBRANES, V1510, P378, DOI 10.1016/S0005-2736(00)00371-0; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SHAPIRO AB, 1991, J BIOL CHEM, V266, P17276; SNYDER B, 1984, BIOCHEMISTRY-US, V23, P5787, DOI 10.1021/bi00319a018; Sokolov M, 1999, J BIOL CHEM, V274, P13824, DOI 10.1074/jbc.274.20.13824; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682; Zimmermann B, 2006, BBA-BIOENERGETICS, V1757, P311, DOI 10.1016/j.bbabio.2006.03.020	38	6	6	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36240	36247		10.1074/jbc.M109.060376	http://dx.doi.org/10.1074/jbc.M109.060376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864418	Green Published, hybrid			2022-12-27	WOS:000272970500026
J	Borner, C; Smida, M; Hollt, V; Schraven, B; Kraus, J				Boerner, Christine; Smida, Michal; Hoellt, Volker; Schraven, Burkhart; Kraus, Juergen			Cannabinoid Receptor Type 1-and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID RECEPTOR; PROTEIN-KINASE-A; TRANSMEMBRANE ADAPTER; IMMUNE FUNCTION; RAT-BRAIN; ENDOCANNABINOID SYSTEM; ENRICHED MICRODOMAINS; NEGATIVE REGULATION; MOUSE SPLENOCYTES; ADENYLYL-CYCLASE	The aim of this study was to characterize inhibitory mechanisms on T cell receptor signaling mediated by the cannabinoid receptors CB1 and CB2. Both receptors are coupled to G(i/o) proteins, which are associated with inhibition of cyclic AMP formation. In human primary and Jurkat T lymphocytes, activation of CB1 by R(+)-methanandamide, CB2 by JWH015, and both by Delta 9-tetrahydrocannabinol induced a short decrease in cyclic AMP lasting less than 1 h. However, this decrease was followed by a massive (up to 10-fold) and sustained (at least up to 48 h) increase in cyclic AMP. Mediated by the cyclic AMP-activated protein kinase A and C-terminal Src kinase, the cannabinoids induced a stable phosphorylation of the inhibitory Tyr-505 of the leukocyte-specific protein tyrosine kinase (Lck). By thus arresting Lck in its inhibited form, the cannabinoids prevented the dephosphorylation of Lck at Tyr-505 in response to T cell receptor activation, which is necessary for the subsequent initiation of T cell receptor signaling. In this way the cannabinoids inhibited the T cell receptor-triggered signaling, i.e. the activation of the zeta-chain-associated protein kinase of 70 kDa, the linker for activation of T cells, MAPK, the induction of interleukin-2, and T cell proliferation. All of the effects of the cannabinoids were blocked by the CB1 and CB2 antagonists AM281 and AM630. These findings help to better understand the immunosuppressive effects of cannabinoids and explain the beneficial effects of these drugs in the treatment of T cell-mediated autoimmune disorders like multiple sclerosis.	[Kraus, Juergen] Univ Magdeburg, Dept Pharmacol & Toxicol, D-39120 Magdeburg, Germany; [Smida, Michal; Schraven, Burkhart] Univ Magdeburg, Dept Mol & Clin Immunol, D-39120 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Kraus, J (corresponding author), Univ Magdeburg, Dept Pharmacol & Toxicol, 44 Leipzigerstr, D-39120 Magdeburg, Germany.	juergen.kraus@med.ovgu.de	Smida, Michal/J-5046-2014	Smida, Michal/0000-0002-7335-3435	government of the state of Sachsen-Anhalt; University of Magdeburg, Faculty of Medicine (Initialprojekt); Deutsche Forschungsgemeinschaft [KR 1740/10-1]	government of the state of Sachsen-Anhalt; University of Magdeburg, Faculty of Medicine (Initialprojekt); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by research grants from the government of the state of Sachsen-Anhalt (to V. H. and B. S.), a grant from the University of Magdeburg, Faculty of Medicine (Initialprojekt) (to C. B.), and Deutsche Forschungsgemeinschaft Grant KR 1740/10-1 (to J. K.).	Ammer H, 1997, J PHARMACOL EXP THER, V280, P512; Ashton JC, 2006, NEUROSCI LETT, V396, P113, DOI 10.1016/j.neulet.2005.11.038; Bayewitch M, 1996, J BIOL CHEM, V271, P9902, DOI 10.1074/jbc.271.17.9902; Bayewitch ML, 1998, J BIOL CHEM, V273, P2273, DOI 10.1074/jbc.273.4.2273; Borner C, 2008, NEUROIMMUNOMODULAT, V14, P281, DOI 10.1159/000117809; Borner C, 2008, MOL PHARMACOL, V73, P1013, DOI 10.1124/mol.107.042945; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Borner C, 2007, J NEUROIMMUNOL, V188, P56, DOI 10.1016/j.jneuroim.2007.05.007; Borner C, 2006, MOL PHARMACOL, V69, P1486, DOI 10.1124/mol.105.018325; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Curfs JHAJ, 1997, CLIN MICROBIOL REV, V10, P742, DOI 10.1128/CMR.10.4.742; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daigle TL, 2008, NEUROPHARMACOLOGY, V54, P36, DOI 10.1016/j.neuropharm.2007.06.005; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Garzon J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-11; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; HORTON JK, 1992, J IMMUNOL METHODS, V155, P31, DOI 10.1016/0022-1759(92)90268-X; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Ihenetu K, 2003, EUR J PHARMACOL, V464, P207, DOI 10.1016/S0014-2999(03)01379-7; Kaplan BLF, 2005, TOXICOL APPL PHARM, V205, P107, DOI 10.1016/j.taap.2004.09.013; Kaplan BLF, 2003, INT IMMUNOPHARMACOL, V3, P1503, DOI 10.1016/S1567-5769(03)00163-2; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Klein TW, 1998, J NEUROIMMUNOL, V83, P102, DOI 10.1016/S0165-5728(97)00226-9; Klein TW, 2004, J NEUROIMMUNOL, V147, P91, DOI 10.1016/j.jneuroim.2003.10.019; KLEIN TW, 1995, P SOC EXP BIOL MED, V209, P205; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; LEE M, 1995, J PHARMACOL EXP THER, V275, P529; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Mackie K, 2005, LIFE SCI, V77, P1667, DOI 10.1016/j.lfs.2005.05.011; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Massi P, 1998, J NEUROIMMUNOL, V92, P60, DOI 10.1016/S0165-5728(98)00177-5; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; OKADA M, 1991, J BIOL CHEM, V266, P24249; Ouyang YL, 1998, MOL PHARMACOL, V53, P676, DOI 10.1124/mol.53.4.676; Paquette JJ, 2007, BEHAV PHARMACOL, V18, P767, DOI 10.1097/FBP.0b013e3282f15890; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Porcella A, 1998, EUR J NEUROSCI, V10, P1743, DOI 10.1046/j.1460-9568.1998.00175.x; PRATHER PL, 2004, SCI STKE, pPE1; Rhee MH, 2000, MOL PHARMACOL, V57, P746, DOI 10.1124/mol.57.4.746; Rockwell CE, 2006, MOL PHARMACOL, V70, P101, DOI 10.1124/mol.105.019117; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Roth MD, 2002, CHEM PHYS LIPIDS, V121, P229, DOI 10.1016/S0009-3084(02)00159-7; Rubino T, 2000, NEUROPHARMACOLOGY, V39, P1331, DOI 10.1016/S0028-3908(99)00196-3; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Vang T, 2003, J BIOL CHEM, V278, P17597, DOI 10.1074/jbc.C300077200; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Yea SS, 2000, J PHARMACOL EXP THER, V292, P597; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3	58	77	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35450	35460		10.1074/jbc.M109.006338	http://dx.doi.org/10.1074/jbc.M109.006338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858202	Green Published, hybrid			2022-12-27	WOS:000272645600021
J	Kofuku, Y; Yoshiura, C; Ueda, T; Terasawa, H; Hirai, T; Tominaga, S; Hirose, M; Maeda, Y; Takahashi, H; Terashima, Y; Matsushima, K; Shimada, I				Kofuku, Yutaka; Yoshiura, Chie; Ueda, Takumi; Terasawa, Hiroaki; Hirai, Takahiro; Tominaga, Sae; Hirose, Masako; Maeda, Yoshitake; Takahashi, Hideo; Terashima, Yuya; Matsushima, Kouji; Shimada, Ichio			Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-SATURATION EXPERIMENTS; MONOMER-DIMER EQUILIBRIUM; CRYSTAL-STRUCTURE; HIV-1 ENTRY; FACTOR-I; FUNCTIONAL-CHARACTERIZATION; LIGAND; CORECEPTOR; FACTOR-1-ALPHA; DIMERIZATION	The chemokine stromal cell-derived factor-1 (SDF-1/CXCL12) and its G-protein-coupled receptor (GPCR) CXCR4 play fundamental roles in many physiological processes, and CXCR4 is a drug target for various diseases such as cancer metastasis and human immunodeficiency virus, type 1, infection. However, almost no structural information about the SDF1-CXCR4 interaction is available, mainly because of the difficulties in expression, purification, and crystallization of CXCR4. In this study, an extensive investigation of the preparation of CXCR4 and optimization of the experimental conditions enables NMR analyses of the interaction between the full-length CXCR4 and SDF-1. We demonstrated that the binding of an extended surface on the SDF-1 beta-sheet, 50-s loop, and N-loop to the CXCR4 extracellular region and that of the SDF-1 N terminus to the CXCR4 transmembrane region, which is critical for G-protein signaling, take place independently by methyl-utilizing transferred cross-saturation experiments along with the usage of the CXCR4-selective antagonist AMD3100. Furthermore, based upon the data, we conclude that the highly dynamic SDF-1 N terminus in the 1st step bound state plays a crucial role in efficiently searching the deeply buried binding pocket in the CXCR4 transmembrane region by the "fly-casting" mechanism. This is the first structural analyses of the interaction between a full-length GPCR and its chemokine, and our methodology would be applicable to other GPCR-ligand systems, for which the structural studies are still challenging.	[Kofuku, Yutaka; Yoshiura, Chie; Ueda, Takumi; Terasawa, Hiroaki; Hirai, Takahiro; Tominaga, Sae; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Terashima, Yuya; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hirose, Masako; Maeda, Yoshitake] Kyowa Hakko Kirin Co Ltd, Gunma 3701295, Japan; [Hirose, Masako; Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Terashima, Yuya] ECI Inc, Meguro Ku, Tokyo 1530042, Japan	University of Tokyo; University of Tokyo; Kyowa Kirin Ltd; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp		Terashima, Yuya/0000-0003-3127-367X	Japan New Energy and Industrial Technology Development Organization	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a grant from the Japan New Energy and Industrial Technology Development Organization.	Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Dukkipati A, 2006, PROTEIN EXPRES PURIF, V50, P203, DOI 10.1016/j.pep.2006.07.016; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Goddard T. D., 2006, SPARKY 3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Kupce E, 1995, J MAGN RESON SER B, V109, P329, DOI 10.1006/jmrb.1995.9985; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nagasawa T, 1999, Adv Immunol, V71, P211; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Princen K, 2005, CYTOKINE GROWTH F R, V16, P659, DOI 10.1016/j.cytogfr.2005.05.009; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SENN H, 1989, FEBS LETT, V249, P113, DOI 10.1016/0014-5793(89)80027-4; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tugarinov V, 2004, J BIOMOL NMR, V28, P165, DOI 10.1023/B:JNMR.0000013824.93994.1f; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wang JH, 2008, DRUG DISCOV TODAY, V13, P625, DOI 10.1016/j.drudis.2008.04.004; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	69	118	124	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35240	35250		10.1074/jbc.M109.024851	http://dx.doi.org/10.1074/jbc.M109.024851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837984	Green Published, hybrid			2022-12-27	WOS:000272439600076
